Citrus Sinensis ID: 001426
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1079 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGV1 | 1135 | LRR receptor-like serine/ | yes | no | 0.971 | 0.923 | 0.539 | 0.0 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.958 | 0.906 | 0.524 | 0.0 | |
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.922 | 0.912 | 0.491 | 0.0 | |
| C0LGF5 | 1072 | Probable LRR receptor-lik | no | no | 0.961 | 0.967 | 0.462 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.941 | 0.921 | 0.397 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.939 | 0.920 | 0.384 | 0.0 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.936 | 0.898 | 0.380 | 1e-178 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.873 | 0.754 | 0.366 | 1e-170 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.865 | 0.746 | 0.357 | 1e-166 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.881 | 0.949 | 0.360 | 1e-166 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1110 bits (2872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 586/1087 (53%), Positives = 753/1087 (69%), Gaps = 39/1087 (3%)
Query: 3 RNEITIILLFVNISLFPAI-----SALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNP 57
+ +T+ + +SLF A SA E +L+SWL + NS + FS WNPS +P
Sbjct: 10 KKALTVSHFSITLSLFLAFFISSTSASTNEVSALISWLHSSNSPP-PSVFSGWNPSDSDP 68
Query: 58 CNWDYIKCSR------TEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGN 111
C W YI CS TEI + S+ + FP + SF+ L LV+SN NLTG I IG+
Sbjct: 69 CQWPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGD 128
Query: 112 LSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDN 171
S LI +DLS N+L G IP +GKL L+ L LNSN + G IP E+G+C L+ LE++DN
Sbjct: 129 CSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDN 188
Query: 172 QLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVG 231
LS N+P E+G++ LE IRAGGN + G+IPEEI NC+ L LGLA T ISG +P S+G
Sbjct: 189 YLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLG 248
Query: 232 ELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQ 291
+L+ L++LSVY+ ++G IP+E+GNCS L NLFLY+N + G +P ELG L+NL+++LLWQ
Sbjct: 249 QLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQ 308
Query: 292 NNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFG 351
NNL G IPE +G SL ID+S+N G +P S NL L+EL+LS NNI+G IPS
Sbjct: 309 NNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILS 368
Query: 352 NFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSH 410
N ++L Q ++D N+ G IPP IG LKEL +F WQN+L GNIP ELA C LQALDLS
Sbjct: 369 NCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQ 428
Query: 411 NFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIG 470
N+LTGS+P+ LF L+NLT+LLLISN SG IP EIG CT L+RLRL +N +G IP IG
Sbjct: 429 NYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIG 488
Query: 471 LLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSM 530
L L+FL+LSEN +G +P EI NC QL+M++L N LQG +P SL L L VLD+S
Sbjct: 489 FLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSS 548
Query: 531 NSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIG 590
N + G IP++LG L SLN+L+LSKN+ G IP SLG C +LQLLDLSSN I+G+IPEE+
Sbjct: 549 NDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELF 608
Query: 591 RLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSY 650
+Q LDI LNLSWN+L G IPE S L++L+ LD+S+NML+G L L L+NLVSLN+S+
Sbjct: 609 DIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISH 668
Query: 651 NHFSGILPNTKLFHGLPASAFYGNQQLCVN--RSQCHINNSLH-----GRNSTKNLIICA 703
N FSG LP++K+F L + GN LC RS C ++NS G +S + I
Sbjct: 669 NRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRS-CFVSNSSQLTTQRGVHSHRLRIAIG 727
Query: 704 LLSVTVTLFIVLFGIILFIRFRGTTFRENDEE--ENELEWDFTPFQKLNFSVDDVVTRLS 761
LL ++VT + + G++ IR + +ND E EN W FTPFQKLNF+V+ V+ L
Sbjct: 728 LL-ISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLV 786
Query: 762 DTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPE-------RDQFSAEVQTLGSI 814
+ N++GKG SGIVY+ E+P+R+VIAVKKLWPV L E RD FSAEV+TLGSI
Sbjct: 787 EGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSI 846
Query: 815 RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK--VFLDWDSRYKIILGVAHGLA 872
RHKNIVR LGCC N TRLL++DY+SNGSL LLHE+ L W+ RYKIILG A GLA
Sbjct: 847 RHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLA 906
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAP 932
YLHHDCVPPI+HRDIK+NNIL+GP FE ++ DFGLAKL + + +R+SN++AGSYGYIAP
Sbjct: 907 YLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAP 966
Query: 933 EYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992
EYGYS+KITEKSDVYSYGVV+LEVLTGK+P D IPDG HI+ WV +K ++
Sbjct: 967 EYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWV------KKIRDIQVI 1020
Query: 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSLS 1052
D+ L R ++++EM+Q LGVALLC+NP PE+RPTMKDV AML EI E ++ K + S
Sbjct: 1021 DQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEICQEREESMKVDGCS 1080
Query: 1053 RAVTNPK 1059
+ N +
Sbjct: 1081 GSCNNGR 1087
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1050 bits (2716), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 556/1061 (52%), Positives = 721/1061 (67%), Gaps = 27/1061 (2%)
Query: 25 NPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCN-WDYIKCSR----TEIAITSIHIPT 79
NPE L SWL + + + S+ +WN PCN W +I CS T+I I S+ +
Sbjct: 36 NPEASILYSWLHSSSPTPSSLSLFNWNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQL 95
Query: 80 SFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAEL 139
S P L +F L L +S ANLTG +P ++G+ L LDLS N L G+IP + KL L
Sbjct: 96 SLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNL 155
Query: 140 ELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIH 199
E L LNSN + G IP +I CSKL+ L L+DN L+G+IP E+G+L LE+IR GGN I
Sbjct: 156 ETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEIS 215
Query: 200 GEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSA 259
G+IP EI +C L LGLA+T +SG +P S+G+L L TLS+YT I+G IP ++GNCS
Sbjct: 216 GQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSE 275
Query: 260 LENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLG 319
L +LFLYEN + G IP E+G L L++L LWQN+L G IPE +GNCS+L +ID+SLN L
Sbjct: 276 LVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLS 335
Query: 320 GEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKE 379
G +P S+ L LEE ++S N SG IP+ N S L QL+LD N+ G IP +G L +
Sbjct: 336 GSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTK 395
Query: 380 LLLFFAWQNQLHGNIPE-LAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFS 438
L LFFAW NQL G+IP LA C LQALDLS N LTG++PS LF L+NLT+LLLISN S
Sbjct: 396 LTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLS 455
Query: 439 GEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQ 498
G IP EIG C+ L+RLRLG N +G IPS IG L ++ FL+ S N+ G++P EIG+C++
Sbjct: 456 GFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSE 515
Query: 499 LEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNIT 558
L+M+DL N L+G++P+ + L GL VLD+S N G IP +LG+L SLNKL+LSKN +
Sbjct: 516 LQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFS 575
Query: 559 GLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLS 618
G IP SLG+C LQLLDL SN ++G IP E+G ++ L+I LNLS N LTG IP ++L+
Sbjct: 576 GSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLN 635
Query: 619 KLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLC 678
KL+ LDLS+NML G L L +++NLVSLN+SYN FSG LP+ KLF L GN++LC
Sbjct: 636 KLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLC 695
Query: 679 VN-RSQCHIN----NSL---HGRNSTKNLIICALLSVTVTLFIVLFGIILFIRFRGTTFR 730
+ + C + N L + T+ L + L +T+T+ +++ G + IR R
Sbjct: 696 SSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDN 755
Query: 731 ENDEEENE-LEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKK 789
E D E E +W FTPFQKLNFSVD ++ L + N++GKG SG+VYR ++ + +VIAVKK
Sbjct: 756 ERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKK 815
Query: 790 LWPVK-NGELPE-----RDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGS 843
LWP NG E RD FSAEV+TLG+IRHKNIVR LGCC N TRLL++DY+ NGS
Sbjct: 816 LWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS 875
Query: 844 LAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFL 902
L LLHE++ LDWD RY+I+LG A GLAYLHHDC+PPI+HRDIK+NNIL+G FE ++
Sbjct: 876 LGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYI 935
Query: 903 ADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
ADFGLAKL + + R SN+VAGSYGYIAPEYGYS+KITEKSDVYSYGVV+LEVLTGK+P
Sbjct: 936 ADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQP 995
Query: 963 TDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCP 1022
D +P+G H++ WV + R +LD L R+ + EM+QVLG ALLCVN P
Sbjct: 996 IDPTVPEGIHLVDWV-----RQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSP 1050
Query: 1023 EERPTMKDVTAMLKEIRHENDDLEKPNSLSRAVTNPKAAVH 1063
+ERPTMKDV AMLKEI+ E ++ K + L + P +
Sbjct: 1051 DERPTMKDVAAMLKEIKQEREEYAKVDLLLKKSPPPTTTMQ 1091
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 894 bits (2311), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/1043 (49%), Positives = 691/1043 (66%), Gaps = 48/1043 (4%)
Query: 23 ALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSR----TEIAITSIHIP 78
+L+ +G +LLSW S N S A FSSW+ + +PCNW +KC+R +EI + + +
Sbjct: 24 SLDQQGQALLSWKSQLNISGDA--FSSWHVADTSPCNWVGVKCNRRGEVSEIQLKGMDLQ 81
Query: 79 TSFPY-QLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLA 137
S P L S LTSL LS+ NLTG IP IG+ + L LDLS N+L+G+IP EI +L
Sbjct: 82 GSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIFRLK 141
Query: 138 ELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPG 197
+L+ LSLN+N++ G IP EIGN S L L L+DN+LSG IP IG+L+ L+++RAGGN
Sbjct: 142 KLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGGNKN 201
Query: 198 IHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNC 257
+ GE+P EI NC+ LV LGLA+T +SG++P S+G L ++T+++YT+ ++G IP+EIG C
Sbjct: 202 LRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYC 261
Query: 258 SALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNS 317
+ L+NL+LY+N I G IP +G LK L+ LLLWQNNL G IP LGNC L +ID S N
Sbjct: 262 TELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENL 321
Query: 318 LGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQL 377
L G +P S L L+EL LS N ISG IP N ++L LE+DNN G+IP + L
Sbjct: 322 LTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNL 381
Query: 378 KELLLFFAWQNQLHGNIPE-LAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNR 436
+ L +FFAWQN+L GNIP+ L+ C +LQA+DLS+N L+GS+P +F L+NLT+LLL+SN
Sbjct: 382 RSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSND 441
Query: 437 FSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNC 496
SG IPP+IG CT L RLRL N +G IPS IG L L F+++SEN+ G IPP I C
Sbjct: 442 LSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISGC 501
Query: 497 TQLEMVDLHQNKLQG-----TIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLV 551
LE +DLH N L G T+P SL+F +D S N++ T+P +G LT L KL
Sbjct: 502 ESLEFLDLHTNSLSGSLLGTTLPKSLKF------IDFSDNALSSTLPPGIGLLTELTKLN 555
Query: 552 LSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIP 611
L+KN ++G IP+ + C+ LQLL+L N +G IP+E+G++ L I LNLS N G IP
Sbjct: 556 LAKNRLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRFVGEIP 615
Query: 612 ESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAF 671
FS+L L LD+S+N LTG+L VL L NLVSLN+SYN FSG LPNT F LP S
Sbjct: 616 SRFSDLKNLGVLDVSHNQLTGNLNVLTDLQNLVSLNISYNDFSGDLPNTPFFRRLPLSDL 675
Query: 672 YGNQQLCVNRSQCHINNSLHGR--NSTKNLIICAL---LSVTVTLFIVLFGIILFIRFRG 726
N+ L +I+N++ R +T+N + L + V VT +VL + +R R
Sbjct: 676 ASNRGL-------YISNAISTRPDPTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRARA 728
Query: 727 TTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIA 786
+ EE + W+ T +QKL+FS+DD+V L+ N++G G SG+VYR+ IPS + +A
Sbjct: 729 AGKQLLGEEID--SWEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRITIPSGESLA 786
Query: 787 VKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAG 846
VKK+W + E F++E++TLGSIRH+NIVRLLG C+N +LL +DY+ NGSL+
Sbjct: 787 VKKMWSKE-----ESGAFNSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSS 841
Query: 847 LLH--EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904
LH K +DW++RY ++LGVAH LAYLHHDC+P IIH D+K+ N+L+GP FE +LAD
Sbjct: 842 RLHGAGKGGCVDWEARYDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLAD 901
Query: 905 FGLAKLFESS-----ESSRASNS--VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVL 957
FGLA+ + ++ +N +AGSYGY+APE+ +ITEKSDVYSYGVVLLEVL
Sbjct: 902 FGLARTISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVL 961
Query: 958 TGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLC 1017
TGK P D +P GAH++ WV L E K++ + +LD +L R+ + + EMLQ L VA LC
Sbjct: 962 TGKHPLDPDLPGGAHLVKWVRDHLAE-KKDPSRLLDPRLDGRTDSIMHEMLQTLAVAFLC 1020
Query: 1018 VNPCPEERPTMKDVTAMLKEIRH 1040
V+ ERP MKDV AML EIRH
Sbjct: 1021 VSNKANERPLMKDVVAMLTEIRH 1043
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 825 bits (2130), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/1065 (46%), Positives = 673/1065 (63%), Gaps = 28/1065 (2%)
Query: 3 RNEITIILLFVN-ISLFPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWD 61
R+ + LF + +S+ +L+ +G +LLS S + FSSW+P + PC+W
Sbjct: 5 RSNFFFLFLFCSWVSMAQPTLSLSSDGQALLSL-----KRPSPSLFSSWDPQDQTPCSWY 59
Query: 62 YIKCSRTEIAITSIHIPTSF-----PYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLI 116
I CS I S+ IP +F L S S L L LS+ NL+G IPP+ G L+ L
Sbjct: 60 GITCSADNRVI-SVSIPDTFLNLSSIPDLSSLSSLQFLNLSSTNLSGPIPPSFGKLTHLR 118
Query: 117 NLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGN 176
LDLS N+L+G IP E+G+L+ L+ L LN+N + G IP +I N L+ L L DN L+G+
Sbjct: 119 LLDLSSNSLSGPIPSELGRLSTLQFLILNANKLSGSIPSQISNLFALQVLCLQDNLLNGS 178
Query: 177 IPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNL 236
IP+ G L +L+ R GGN + G IP ++ K L LG A +G+SG IP + G L NL
Sbjct: 179 IPSSFGSLVSLQQFRLGGNTNLGGPIPAQLGFLKNLTTLGFAASGLSGSIPSTFGNLVNL 238
Query: 237 RTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSG 296
+TL++Y I+G IP ++G CS L NL+L+ N++ G IP ELG L+ + LLLW N+LSG
Sbjct: 239 QTLALYDTEISGTIPPQLGLCSELRNLYLHMNKLTGSIPKELGKLQKITSLLLWGNSLSG 298
Query: 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRL 356
IP + NCSSL V DVS N L G++P L LV LE+L LS N +G+IP N S L
Sbjct: 299 VIPPEISNCSSLVVFDVSANDLTGDIPGDLGKLVWLEQLQLSDNMFTGQIPWELSNCSSL 358
Query: 357 KQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLTG 415
L+LD N+ G IP IG LK L FF W+N + G IP C L ALDLS N LTG
Sbjct: 359 IALQLDKNKLSGSIPSQIGNLKSLQSFFLWENSISGTIPSSFGNCTDLVALDLSRNKLTG 418
Query: 416 SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRL 475
+P LF+LK L++LLL+ N SG +P + C L+RLR+G N SG IP IG L L
Sbjct: 419 RIPEELFSLKRLSKLLLLGNSLSGGLPKSVAKCQSLVRLRVGENQLSGQIPKEIGELQNL 478
Query: 476 TFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
FL+L N F+G +P EI N T LE++D+H N + G IP+ L L L LDLS NS G
Sbjct: 479 VFLDLYMNHFSGGLPYEISNITVLELLDVHNNYITGDIPAQLGNLVNLEQLDLSRNSFTG 538
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
IP + G L+ LNKL+L+ N +TG IPKS+ + L LLDLS N ++G IP+E+G++ L
Sbjct: 539 NIPLSFGNLSYLNKLILNNNLLTGQIPKSIKNLQKLTLLDLSYNSLSGEIPQELGQVTSL 598
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
I L+LS+N TG IPE+FS+L++L +LDLS+N L G +KVLGSL +L SLN+S N+FSG
Sbjct: 599 TINLDLSYNTFTGNIPETFSDLTQLQSLDLSSNSLHGDIKVLGSLTSLASLNISCNNFSG 658
Query: 656 ILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTV-TLFIV 714
+P+T F + +++ N LC + ++ N K+ I AL +V + ++ I
Sbjct: 659 PIPSTPFFKTISTTSYLQNTNLCHSLDGITCSSHTGQNNGVKSPKIVALTAVILASITIA 718
Query: 715 LFGIILFIRFRGTTFRE--------NDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIV 766
+ L I ++ + E+ W F PFQKL +V+++VT L+D N++
Sbjct: 719 ILAAWLLILRNNHLYKTSQNSSSSPSTAEDFSYPWTFIPFQKLGITVNNIVTSLTDENVI 778
Query: 767 GKGVSGIVYRVEIPSRQVIAVKKLWPVK-NGELPER--DQFSAEVQTLGSIRHKNIVRLL 823
GKG SGIVY+ EIP+ ++AVKKLW K N E E D F+AE+Q LG+IRH+NIV+LL
Sbjct: 779 GKGCSGIVYKAEIPNGDIVAVKKLWKTKDNNEEGESTIDSFAAEIQILGNIRHRNIVKLL 838
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
G C+N +LLL++Y NG+L LL + LDW++RYKI +G A GLAYLHHDCVP I+
Sbjct: 839 GYCSNKSVKLLLYNYFPNGNLQQLLQGNRN-LDWETRYKIAIGAAQGLAYLHHDCVPAIL 897
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR-ASNSVAGSYGYIAPEYGYSLKITE 942
HRD+K NNIL+ ++EA LADFGLAKL +S + A + VAGSYGYIAPEYGY++ ITE
Sbjct: 898 HRDVKCNNILLDSKYEAILADFGLAKLMMNSPNYHNAMSRVAGSYGYIAPEYGYTMNITE 957
Query: 943 KSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGT 1002
KSDVYSYGVVLLE+L+G+ + +I DG HI+ WV ++ + ++LD +L
Sbjct: 958 KSDVYSYGVVLLEILSGRSAVEPQIGDGLHIVEWVKKKMGTFEPAL-SVLDVKLQGLPDQ 1016
Query: 1003 QIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEK 1047
+QEMLQ LG+A+ CVNP P ERPTMK+V +L E++ ++ K
Sbjct: 1017 IVQEMLQTLGIAMFCVNPSPVERPTMKEVVTLLMEVKCSPEEWGK 1061
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 671 bits (1730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/1074 (39%), Positives = 586/1074 (54%), Gaps = 58/1074 (5%)
Query: 22 SALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTE-------IAITS 74
+ LN EG LL S F + +WN + PC W + CS + ++S
Sbjct: 25 TGLNLEGQYLLEIKSKFVDAKQN--LRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSS 82
Query: 75 IHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIG 134
+ + + HL L LS L+G+IP IGN SSL L L+ N G IP EIG
Sbjct: 83 MVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIG 142
Query: 135 KLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGG 194
KL LE L + +N I G +P EIGN L +L Y N +SG +P IG L+ L RAG
Sbjct: 143 KLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQ 202
Query: 195 NPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI 254
N I G +P EI C+ LV LGLA +SG++P+ +G L L + ++ +G+IP EI
Sbjct: 203 NM-ISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREI 261
Query: 255 GNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVS 314
NC++LE L LY+NQ+ G IP ELG L++L+ L L++N L+G+IP +GN S ID S
Sbjct: 262 SNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFS 321
Query: 315 LNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTI 374
N+L GE+P+ L N+ LE L L N ++G IP L +L+L N G IP
Sbjct: 322 ENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGF 381
Query: 375 GQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLI 433
L+ L + +QN L G IP +L + L LD+S N L+G +PS L N+ L L
Sbjct: 382 QYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLG 441
Query: 434 SNRFSGEIPPEIGGCTGLIRLRL------------------------GSNNFSGHIPSRI 469
+N SG IP I C L++LRL G N F G IP +
Sbjct: 442 TNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREV 501
Query: 470 GLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLS 529
G L L+L++N FTGE+P EIG +QL +++ NKL G +PS + L LD+
Sbjct: 502 GNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMC 561
Query: 530 MNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI 589
N+ GT+P +G L L L LS NN++G IP +LG L L + N NGSIP E+
Sbjct: 562 CNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPREL 621
Query: 590 GRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSL-KVLGSLDNLVSLNV 648
G L GL I LNLS+N LTG IP SNL L L L+NN L+G + +L +L+ N
Sbjct: 622 GSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNF 681
Query: 649 SYNHFSGILPNTKLFHGLPASAFYGNQQLC-VNRSQC---------HINNSLHGRNSTKN 698
SYN +G +P L + S+F GN+ LC +QC G S+K
Sbjct: 682 SYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI 738
Query: 699 LIICALLSVTVTLFIVLFGIILFIR-FRGTTFRENDEEENELEWDFTPFQKLNFSVDDVV 757
+ I A + V+L ++ + L R R D + +E+ D K F+ D+V
Sbjct: 739 IAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLV 798
Query: 758 T---RLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPER--DQFSAEVQTLG 812
++ +VG+G G VY+ +P+ +AVKKL G + F AE+ TLG
Sbjct: 799 AATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLG 858
Query: 813 SIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLA 872
+IRH+NIV+L G CN+ + LLL++Y+ GSL +LH+ LDW R+KI LG A GLA
Sbjct: 859 NIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLA 918
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAP 932
YLHHDC P I HRDIKSNNIL+ +FEA + DFGLAK+ + S++ +++AGSYGYIAP
Sbjct: 919 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPH-SKSMSAIAGSYGYIAP 977
Query: 933 EYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992
EY Y++K+TEKSD+YSYGVVLLE+LTGK P I G ++ WV +R R + +L
Sbjct: 978 EYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP-IDQGGDVVNWVRSYIR-RDALSSGVL 1035
Query: 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLE 1046
D +L + + ML VL +ALLC + P RP+M+ V ML E + E
Sbjct: 1036 DARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIESERSEGEQE 1089
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 651 bits (1680), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/1067 (38%), Positives = 579/1067 (54%), Gaps = 53/1067 (4%)
Query: 18 FPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSR----TEIAIT 73
F + +LN EG LL + + N S+ + +SWN NPCNW I C+ T + +
Sbjct: 18 FILVRSLNEEGRVLLEFKAFLNDSNG--YLASWNQLDSNPCNWTGIACTHLRTVTSVDLN 75
Query: 74 SIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEI 133
+++ + + L L +S ++G IP + SL LDL N G IP ++
Sbjct: 76 GMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQL 135
Query: 134 GKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAG 193
+ L+ L L N + G IPR+IGN S L+ L +Y N L+G IP + +L L IIRAG
Sbjct: 136 TMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAG 195
Query: 194 GNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEE 253
N G G IP EIS C+ L LGLA+ + G +P+ + +L NL L ++ ++G IP
Sbjct: 196 RN-GFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPS 254
Query: 254 IGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDV 313
+GN S LE L L+EN G IP E+G L +KRL L+ N L+G IP +GN ID
Sbjct: 255 VGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDF 314
Query: 314 SLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPT 373
S N L G +P +++ L+ L L N + G IP G + L++L+L NR G IP
Sbjct: 315 SENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQE 374
Query: 374 IGQLKELLLFFAWQNQLHGNIPEL-AYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLL 432
+ L L+ + NQL G IP L + LD+S N L+G +P+ + L L L
Sbjct: 375 LQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSL 434
Query: 433 ISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIP------------------------SR 468
SN+ SG IP ++ C L +L LG N +G +P +
Sbjct: 435 GSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISAD 494
Query: 469 IGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDL 528
+G L L L L+ N FTGEIPPEIGN T++ ++ N+L G IP L + LDL
Sbjct: 495 LGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDL 554
Query: 529 SMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEE 588
S N G I + LG+L L L LS N +TG IP S G L L L N ++ +IP E
Sbjct: 555 SGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVE 614
Query: 589 IGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKV-LGSLDNLVSLN 647
+G+L L I LN+S N L+G IP+S NL L L L++N L+G + +G+L +L+ N
Sbjct: 615 LGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICN 674
Query: 648 VSYNHFSGILPNTKLFHGLPASAFYGNQQLC-VNRSQCH---------INNSLHGRNSTK 697
+S N+ G +P+T +F + +S F GN LC RS C +N ++G K
Sbjct: 675 ISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQK 734
Query: 698 NLIICALLSVTVTLFIVLFGIILFIRFRGTTFRENDEEENELEWDFTPFQKLNFSVD--- 754
L I ++ +V L I G+ I+ R F +++ D F K F+
Sbjct: 735 ILTITCIVIGSVFL-ITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLV 793
Query: 755 DVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI 814
D S+ ++G+G G VY+ E+ +VIAVKKL G + + F AE+ TLG I
Sbjct: 794 DATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSD-NSFRAEISTLGKI 852
Query: 815 RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLH--EKKVFLDWDSRYKIILGVAHGLA 872
RH+NIV+L G C + + LLL++Y+S GSL L EK LDW++RY+I LG A GL
Sbjct: 853 RHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLC 912
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAP 932
YLHHDC P I+HRDIKSNNIL+ +F+A + DFGLAKL + S S++ ++VAGSYGYIAP
Sbjct: 913 YLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLS-YSKSMSAVAGSYGYIAP 971
Query: 933 EYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992
EY Y++K+TEK D+YS+GVVLLE++TGK P + G ++ WV +R +
Sbjct: 972 EYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRSIRNMIPTI-EMF 1029
Query: 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039
D +L + EM VL +AL C + P RPTM++V AM+ E R
Sbjct: 1030 DARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1615), Expect = e-178, Method: Compositional matrix adjust.
Identities = 419/1101 (38%), Positives = 595/1101 (54%), Gaps = 91/1101 (8%)
Query: 10 LLFVNISLFPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTE 69
+LF+ L +LN +G LL L S +WN PCNW + CS
Sbjct: 19 VLFLLTLLVWTSESLNSDGQFLLE-LKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQG 77
Query: 70 IAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNI 129
+ +S + +TSL LS+ NL+G + P+IG L +L+ L+L++NALTG+I
Sbjct: 78 SSSSSNSLV------------VTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDI 125
Query: 130 PEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALE- 188
P EIG ++LE++ LN+N G IP EI S+LR + +N+LSG +P EIG L LE
Sbjct: 126 PREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEE 185
Query: 189 -----------------------IIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQ 225
RAG N G IP EI C L LGLA ISG+
Sbjct: 186 LVAYTNNLTGPLPRSLGNLNKLTTFRAGQN-DFSGNIPTEIGKCLNLKLLGLAQNFISGE 244
Query: 226 IPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLK 285
+P+ +G L L+ + ++ +G+IP++IGN ++LE L LY N + G IP E+G++K+LK
Sbjct: 245 LPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLK 304
Query: 286 RLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALE------------ 333
+L L+QN L+G+IP+ LG S + ID S N L GE+PV L+ + L
Sbjct: 305 KLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGI 364
Query: 334 ------------ELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELL 381
+L LS N+++G IP F N + ++QL+L +N G IP +G L
Sbjct: 365 IPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLW 424
Query: 382 LFFAWQNQLHGNIPE-LAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGE 440
+ +NQL G IP + L L+L N + G++P + K+L QL ++ NR +G+
Sbjct: 425 VVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQ 484
Query: 441 IPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLE 500
P E+ L + L N FSG +P IG +L L L+ NQF+ +P EI + L
Sbjct: 485 FPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLV 544
Query: 501 MVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGL 560
++ N L G IPS + L LDLS NS G++P LG L L L LS+N +G
Sbjct: 545 TFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGN 604
Query: 561 IPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKL 620
IP ++G L L + N +GSIP ++G L L I +NLS+N +G IP NL L
Sbjct: 605 IPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLL 664
Query: 621 ANLDLSNNMLTGSL-KVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLC- 678
L L+NN L+G + +L +L+ N SYN+ +G LP+T++F + ++F GN+ LC
Sbjct: 665 MYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCG 724
Query: 679 --------VNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFIVLFGIIL-FIR--FRGT 727
+ S HI +SL ++ + II + SV + ++L I++ F+R T
Sbjct: 725 GHLRSCDPSHSSWPHI-SSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPT 783
Query: 728 TFRENDEEENELEWDFTPFQKLNFSVDDVVTR---LSDTNIVGKGVSGIVYRVEIPSRQV 784
+D+E E D K F+V D++ D+ IVG+G G VY+ +PS +
Sbjct: 784 APYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKT 843
Query: 785 IAVKKL----WPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCC--NNGRTRLLLFDY 838
IAVKKL N + F AE+ TLG IRH+NIVRL C + LLL++Y
Sbjct: 844 IAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEY 903
Query: 839 ISNGSLAGLLHEKKVF-LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ 897
+S GSL LLH K +DW +R+ I LG A GLAYLHHDC P IIHRDIKSNNIL+
Sbjct: 904 MSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDEN 963
Query: 898 FEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVL 957
FEA + DFGLAK+ + S S +VAGSYGYIAPEY Y++K+TEK D+YS+GVVLLE+L
Sbjct: 964 FEAHVGDFGLAKVIDMPLSKSVS-AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELL 1022
Query: 958 TGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL-MRSGTQIQEMLQVLGVALL 1016
TGK P + G + TW +R+ + ILD L + + M+ V +A+L
Sbjct: 1023 TGKAPVQP-LEQGGDLATWTRNHIRDHSLT-SEILDPYLTKVEDDVILNHMITVTKIAVL 1080
Query: 1017 CVNPCPEERPTMKDVTAMLKE 1037
C P +RPTM++V ML E
Sbjct: 1081 CTKSSPSDRPTMREVVLMLIE 1101
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 600 bits (1547), Expect = e-170, Method: Compositional matrix adjust.
Identities = 410/1120 (36%), Positives = 579/1120 (51%), Gaps = 178/1120 (15%)
Query: 81 FPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELE 140
P QL S ++ SL + + L G+IP +GNL +L L L+ LTG IP ++G+L ++
Sbjct: 135 IPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQ 194
Query: 141 LLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHG 200
L L N + G IP E+GNCS L +N L+G IPAE+G+LE LEI+ N + G
Sbjct: 195 SLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANN-SLTG 253
Query: 201 EIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSAL 260
EIP ++ L +L L + G IP+S+ +L NL+TL + N+TG IPEE N S L
Sbjct: 254 EIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQL 313
Query: 261 ENLFLYENQIFGKIPDELGSLK-NLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLG 319
+L L N + G +P + S NL++L+L LSG IP L C SL +D+S NSL
Sbjct: 314 LDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLA 373
Query: 320 GEVPVSLANLVALEELLLSGNNI------------------------------------- 342
G +P +L LV L +L L N +
Sbjct: 374 GSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRK 433
Query: 343 -----------SGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLH 391
SGEIP GN + LK +++ N F G+IPP+IG+LKEL L QN+L
Sbjct: 434 LEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELV 493
Query: 392 GNIP-ELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSG----------- 439
G +P L C +L LDL+ N L+GS+PSS LK L QL+L +N G
Sbjct: 494 GGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRN 553
Query: 440 ------------------------------------EIPPEIGGCTGLIRLRLGSNNFSG 463
EIP E+G L RLRLG N +G
Sbjct: 554 LTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTG 613
Query: 464 HIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIP--------- 514
IP +G + L+ L++S N TG IP ++ C +L +DL+ N L G IP
Sbjct: 614 KIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQL 673
Query: 515 -----SSLEFLFGLN----------VLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITG 559
SS +F+ L VL L NS+ G+IP+ +G L +LN L L KN +G
Sbjct: 674 GELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSG 733
Query: 560 LIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSK 619
+P+++G L L LS N + G IP EIG+LQ L L+LS+N TG IP + LSK
Sbjct: 734 SLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSK 793
Query: 620 LANLDLSNNMLTGSLK-VLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLC 678
L LDLS+N LTG + +G + +L LNVS+N+ G L K F PA +F GN LC
Sbjct: 794 LETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFSRWPADSFLGNTGLC 851
Query: 679 VNR-SQCH---INNSLHGRNSTKNLIICALLSVTVTLFIVLFGIILFIRFRGTTFRE--- 731
+ S+C+ NN G ++ +II A+ ++T ++L I LF + R F++
Sbjct: 852 GSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILV-IALFFKQRHDFFKKVGH 910
Query: 732 ---------------------NDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGV 770
N ++++ W+ + + LS+ ++G G
Sbjct: 911 GSTAYTSSSSSSQATHKPLFRNGASKSDIRWE---------DIMEATHNLSEEFMIGSGG 961
Query: 771 SGIVYRVEIPSRQVIAVKK-LWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG 829
SG VY+ E+ + + +AVKK LW +L FS EV+TLG IRH+++V+L+G C++
Sbjct: 962 SGKVYKAELENGETVAVKKILW---KDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSK 1018
Query: 830 RT--RLLLFDYISNGSLAGLLHE-------KKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
LL+++Y+ NGS+ LHE KK LDW++R +I +G+A G+ YLHHDCVP
Sbjct: 1019 SEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVP 1078
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAK-LFESSESSRASNS-VAGSYGYIAPEYGYSL 938
PI+HRDIKS+N+L+ EA L DFGLAK L E+ +++ SN+ A SYGYIAPEY YSL
Sbjct: 1079 PIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSL 1138
Query: 939 KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998
K TEKSDVYS G+VL+E++TGK PTDS ++ WV L ++D +L
Sbjct: 1139 KATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKP 1198
Query: 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
+ QVL +AL C P+ERP+ + L +
Sbjct: 1199 LLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 588 bits (1515), Expect = e-166, Method: Compositional matrix adjust.
Identities = 400/1118 (35%), Positives = 595/1118 (53%), Gaps = 184/1118 (16%)
Query: 81 FPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELE 140
P QL S +L SL L + L G IP GNL +L L L+ LTG IP G+L +L+
Sbjct: 136 IPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQ 195
Query: 141 LLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHG 200
L L N + G IP EIGNC+ L N+L+G++PAE+ +L+ L+ + G N G
Sbjct: 196 TLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDN-SFSG 254
Query: 201 EIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSAL 260
EIP ++ + + +L L + G IP+ + EL NL+TL + + N+TG I EE + L
Sbjct: 255 EIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQL 314
Query: 261 ENLFLYENQIFGKIPDELGSLK-NLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLG 319
E L L +N++ G +P + S +LK+L L + LSG IP + NC SL ++D+S N+L
Sbjct: 315 EFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLT 374
Query: 320 GEVPVSLANLVALEELLLSGNNI------------------------------------- 342
G++P SL LV L L L+ N++
Sbjct: 375 GQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGK 434
Query: 343 -----------SGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLH 391
SGE+P GN +RL++++ NR G+IP +IG+LK+L +N+L
Sbjct: 435 LEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELV 494
Query: 392 GNIP-ELAYCVKLQALDLSHNFLTGSVPSS------------------------LFNLKN 426
GNIP L C ++ +DL+ N L+GS+PSS L NLKN
Sbjct: 495 GNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKN 554
Query: 427 LTQLLLISNRFSG-----------------------EIPPEIGGCTGLIRLRLGSNNFSG 463
LT++ SN+F+G +IP E+G T L RLRLG N F+G
Sbjct: 555 LTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTG 614
Query: 464 HIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIP--------- 514
IP G + L+ L++S N +G IP E+G C +L +DL+ N L G IP
Sbjct: 615 RIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLL 674
Query: 515 -----SSLEFLFGL--------NVLDLSM--NSIGGTIPENLGKLTSLNKLVLSKNNITG 559
SS +F+ L N+L L + NS+ G+IP+ +G L +LN L L +N ++G
Sbjct: 675 GELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSG 734
Query: 560 LIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSK 619
+P ++G L L LS N + G IP EIG+LQ L L+LS+N TG IP + S L K
Sbjct: 735 PLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPK 794
Query: 620 LANLDLSNNMLTGSLK-VLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLC 678
L +LDLS+N L G + +G + +L LN+SYN+ G L K F A AF GN LC
Sbjct: 795 LESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLC 852
Query: 679 VNR-SQCHINNSLHGRN-STKNLIICALLSVTVTLFIVLFGIILFIRFRGTTFRE----- 731
+ S C+ S + R+ S K ++I + +S + +++ IILF + F++
Sbjct: 853 GSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGN 912
Query: 732 ----------------NDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVY 775
N +++++WD + + L++ ++G G SG VY
Sbjct: 913 SAFSSNSSSSQAPLFSNGGAKSDIKWD---------DIMEATHYLNEEFMIGSGGSGKVY 963
Query: 776 RVEIPSRQVIAVKK-LWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT--R 832
+ E+ + + IAVKK LW +L F+ EV+TLG+IRH+++V+L+G C++
Sbjct: 964 KAELKNGETIAVKKILW---KDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLN 1020
Query: 833 LLLFDYISNGSLAGLLH-----EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDI 887
LL+++Y++NGS+ LH +KK L W++R KI LG+A G+ YLH+DCVPPI+HRDI
Sbjct: 1021 LLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDI 1080
Query: 888 KSNNILVGPQFEAFLADFGLAKLFESS-ESSRASNSV-AGSYGYIAPEYGYSLKITEKSD 945
KS+N+L+ EA L DFGLAK+ + +++ SN++ AGSYGYIAPEY YSLK TEKSD
Sbjct: 1081 KSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSD 1140
Query: 946 VYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN--------GELRERKREFTTILDRQLL 997
VYS G+VL+E++TGK PT++ + ++ WV E RE+ ++D +L
Sbjct: 1141 VYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREK------LIDSELK 1194
Query: 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
+ + QVL +AL C P+ERP+ + + L
Sbjct: 1195 SLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 586 bits (1510), Expect = e-166, Method: Compositional matrix adjust.
Identities = 383/1061 (36%), Positives = 558/1061 (52%), Gaps = 110/1061 (10%)
Query: 30 SLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFS 89
+LLS S+F + +SWN S C+W + C +S
Sbjct: 30 ALLSLKSSFTIDEHSPLLTSWNLS-TTFCSWTGVTCD-------------------VSLR 69
Query: 90 HLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSI 149
H+TSL LS NL+G + + +L L NL L+ N ++G IP +I L EL L+L++N
Sbjct: 70 HVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVF 129
Query: 150 HGGIPREIGN-CSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISN 208
+G P E+ + LR L+LY+N L+G++P + +N
Sbjct: 130 NGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSL-------------------------TN 164
Query: 209 CKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFL-YE 267
L L L SG+IP + G L L+V +TG IP EIGN + L L++ Y
Sbjct: 165 LTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYY 224
Query: 268 NQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLA 327
N +P E+G+L L R L+G IP +G L + + +N+ G + L
Sbjct: 225 NAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELG 284
Query: 328 NLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQ 387
+ +L+ + LS N +GEIP+ F L L L N+ +G IP IG++ EL + W+
Sbjct: 285 LISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWE 344
Query: 388 NQLHGNIPE-LAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIG 446
N G+IP+ L +L LDLS N LTG++P ++ + L L+ + N G IP +G
Sbjct: 345 NNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLG 404
Query: 447 GCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCT-QLEMVDLH 505
C L R+R+G N +G IP + L +L+ +EL +N TGE+P G + L + L
Sbjct: 405 KCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLS 464
Query: 506 QNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSL 565
N+L G++P+++ L G+ L L N G+IP +G+L L+KL S N +G I +
Sbjct: 465 NNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEI 524
Query: 566 GLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANL 623
CK L +DLS N ++G IP E L G+ IL LNLS N L G IP +
Sbjct: 525 SRCKLLTFVDLSRNELSGDIPNE---LTGMKILNYLNLSRNHLVGSIPVT---------- 571
Query: 624 DLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLC----- 678
+ S+ +L S++ SYN+ SG++P+T F ++F GN LC
Sbjct: 572 -------------IASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLG 618
Query: 679 ---VNRSQCHIN--NSLHGRNSTKNLIICALLSVTVTLFIVLFGIILFIRFRGTTFREND 733
Q H+ ++ L+ C+++ F I+ I+ R + R
Sbjct: 619 PCGKGTHQSHVKPLSATTKLLLVLGLLFCSMV----------FAIVAIIKAR--SLRNAS 666
Query: 734 EEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPV 793
E + W T FQ+L+F+ DDV+ L + NI+GKG +GIVY+ +P ++AVK+L +
Sbjct: 667 EAK---AWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATM 723
Query: 794 KNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV 853
+G + F+AE+QTLG IRH++IVRLLG C+N T LL+++Y+ NGSL +LH KK
Sbjct: 724 SHGSSHDHG-FNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG 782
Query: 854 -FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912
L W++RYKI L A GL YLHHDC P I+HRD+KSNNIL+ FEA +ADFGLAK +
Sbjct: 783 GHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQ 842
Query: 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAH 972
S +S +++AGSYGYIAPEY Y+LK+ EKSDVYS+GVVLLE++TGK+P DG
Sbjct: 843 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPV-GEFGDGVD 901
Query: 973 IITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVT 1032
I+ WV K ++D +L S + E+ V VALLCV ERPTM++V
Sbjct: 902 IVQWVRSMTDSNKDCVLKVIDLRL---SSVPVHEVTHVFYVALLCVEEQAVERPTMREVV 958
Query: 1033 AMLKEIRHENDDLEKPNSLSRAVTNPKAAVHCSSFSRSAEP 1073
+L EI L K + VT A++ SS + P
Sbjct: 959 QILTEI--PKIPLSKQQAAESDVTEKAPAINESSPDSGSPP 997
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1079 | ||||||
| 224085083 | 1083 | predicted protein [Populus trichocarpa] | 0.997 | 0.993 | 0.775 | 0.0 | |
| 224062928 | 1083 | predicted protein [Populus trichocarpa] | 0.998 | 0.994 | 0.775 | 0.0 | |
| 359492322 | 1088 | PREDICTED: LRR receptor-like serine/thre | 1.0 | 0.991 | 0.758 | 0.0 | |
| 255570376 | 1083 | Brassinosteroid LRR receptor kinase prec | 0.997 | 0.993 | 0.762 | 0.0 | |
| 449443958 | 1094 | PREDICTED: receptor-like protein kinase | 0.982 | 0.968 | 0.747 | 0.0 | |
| 449475472 | 1068 | PREDICTED: receptor-like protein kinase | 0.978 | 0.988 | 0.748 | 0.0 | |
| 356509310 | 1089 | PREDICTED: LRR receptor-like serine/thre | 0.993 | 0.984 | 0.721 | 0.0 | |
| 357463755 | 1086 | Receptor-like protein kinase [Medicago t | 0.994 | 0.988 | 0.712 | 0.0 | |
| 356515997 | 1089 | PREDICTED: LRR receptor-like serine/thre | 0.994 | 0.985 | 0.721 | 0.0 | |
| 356551167 | 1088 | PREDICTED: LRR receptor-like serine/thre | 0.993 | 0.985 | 0.700 | 0.0 |
| >gi|224085083|ref|XP_002307483.1| predicted protein [Populus trichocarpa] gi|222856932|gb|EEE94479.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1633 bits (4229), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 841/1085 (77%), Positives = 960/1085 (88%), Gaps = 9/1085 (0%)
Query: 1 MSRNEITIILLFVNISLFPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNW 60
MS N ITI LLF+NIS+FPAISALN EG SLLSWLSTFNSS S+TFFS+W+PSH+NPC W
Sbjct: 2 MSSNAITIFLLFLNISIFPAISALNQEGHSLLSWLSTFNSSFSSTFFSTWDPSHQNPCKW 61
Query: 61 DYIKCSR----TEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLI 116
DY++CS +EI ITSI++PT FP QLLSF+HLT+LVLSN NLTGEIP +IGNLSSL
Sbjct: 62 DYVRCSSNGFVSEIIITSINLPTGFPTQLLSFNHLTTLVLSNGNLTGEIPRSIGNLSSLS 121
Query: 117 NLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGN 176
LDLSFN+LTGNIP EIG+L++L+LL+LN+NS+HG IP+EIGNCS LR+LEL+DNQLSG
Sbjct: 122 TLDLSFNSLTGNIPAEIGRLSQLQLLALNTNSLHGEIPKEIGNCSTLRQLELFDNQLSGK 181
Query: 177 IPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNL 236
IPAEIGQL ALE RAGGNPGI+G+IP +ISNCK L+FLGLADTGISG+IP S+GEL +L
Sbjct: 182 IPAEIGQLLALETFRAGGNPGIYGQIPMQISNCKGLLFLGLADTGISGEIPSSLGELKHL 241
Query: 237 RTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSG 296
TLSVYTAN+TG IP EIGNCSALE+L+LYENQ+ G++PDEL SL NLK+LLLWQNNL+G
Sbjct: 242 ETLSVYTANLTGSIPAEIGNCSALEHLYLYENQLSGRVPDELASLTNLKKLLLWQNNLTG 301
Query: 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRL 356
SIP+ALGNC SL VID+S+N L G++P SLANLVALEELLLS N +SGEIP F GN+ L
Sbjct: 302 SIPDALGNCLSLEVIDLSMNFLSGQIPGSLANLVALEELLLSENYLSGEIPPFVGNYFGL 361
Query: 357 KQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLTG 415
KQLELDNNRF G+IPP IGQLKEL LFFAWQNQLHG+IP ELA C KLQALDLSHNFLT
Sbjct: 362 KQLELDNNRFTGEIPPAIGQLKELSLFFAWQNQLHGSIPAELARCEKLQALDLSHNFLTS 421
Query: 416 SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRL 475
S+P SLF+LKNLTQLLLISN FSGEIPP+IG C GLIRLRLGSN FSG IPS IGLLH L
Sbjct: 422 SIPPSLFHLKNLTQLLLISNGFSGEIPPDIGNCIGLIRLRLGSNYFSGQIPSEIGLLHSL 481
Query: 476 TFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
+FLELS+NQFTGEIP EIGNCTQLEMVDLH N+L GTIP+S+EFL LNVLDLS NSI G
Sbjct: 482 SFLELSDNQFTGEIPAEIGNCTQLEMVDLHNNRLHGTIPTSVEFLVSLNVLDLSKNSIAG 541
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
++PENLG LTSLNKLV+++N ITG IPKSLGLC+DLQLLD+SSNR+ GSIP+EIGRLQGL
Sbjct: 542 SVPENLGMLTSLNKLVINENYITGSIPKSLGLCRDLQLLDMSSNRLTGSIPDEIGRLQGL 601
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
DILLNLS N+LTGPIPESF++LSKL+NLDLS NMLTG+L VLGSLDNLVSLNVSYN+FSG
Sbjct: 602 DILLNLSRNSLTGPIPESFASLSKLSNLDLSYNMLTGTLTVLGSLDNLVSLNVSYNNFSG 661
Query: 656 ILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFIVL 715
+LP+TK FH LPAS + GNQ+LC+NR++CH++ S HG+N TKNL+ C LLSVTVTL IVL
Sbjct: 662 LLPDTKFFHDLPASVYAGNQELCINRNKCHMDGSHHGKN-TKNLVACTLLSVTVTLLIVL 720
Query: 716 FGIILFIRFRGTTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVY 775
G +LFIR RG +F DE+ LEWDFTPFQKLNFSV+D++T+LSD+NIVGKGVSGIVY
Sbjct: 721 LGGLLFIRTRGASFGRKDEDI--LEWDFTPFQKLNFSVNDILTKLSDSNIVGKGVSGIVY 778
Query: 776 RVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835
RVE P +QVIAVK+LWP+KNGE+PERD FSAEV+ LGSIRHKNIVRLLGCCNNG+TRLLL
Sbjct: 779 RVETPMKQVIAVKRLWPLKNGEVPERDLFSAEVRALGSIRHKNIVRLLGCCNNGKTRLLL 838
Query: 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG 895
FDYISNGSLA LLHEK VFLDWD+RY IILG AHGLAYLHHDC+PPI+HRDIK+NNIL+G
Sbjct: 839 FDYISNGSLAELLHEKNVFLDWDTRYNIILGAAHGLAYLHHDCIPPIVHRDIKANNILIG 898
Query: 896 PQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLE 955
PQFEAFLADFGLAKL +S+E SR SN+VAGSYGYIAPEYGYS +ITEKSDVYSYGVVLLE
Sbjct: 899 PQFEAFLADFGLAKLVDSAECSRVSNTVAGSYGYIAPEYGYSFRITEKSDVYSYGVVLLE 958
Query: 956 VLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVAL 1015
VLTGKEPTD+RIP+G HI+TWV+ LRER+ E T+I+D QLL+RSGTQ+QEMLQV+GVAL
Sbjct: 959 VLTGKEPTDNRIPEGVHIVTWVSKALRERRTELTSIIDPQLLLRSGTQLQEMLQVIGVAL 1018
Query: 1016 LCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSLSR-AVTNPKAAVHCSSFSRSAEPL 1074
LCVNP PEERPTMKDV AMLKEIRHEN+ EKP + A TNPKAAVH SSFSRS+EPL
Sbjct: 1019 LCVNPSPEERPTMKDVIAMLKEIRHENEYSEKPKYRGKEAATNPKAAVHSSSFSRSSEPL 1078
Query: 1075 IRSPS 1079
IRSPS
Sbjct: 1079 IRSPS 1083
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224062928|ref|XP_002300934.1| predicted protein [Populus trichocarpa] gi|222842660|gb|EEE80207.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1633 bits (4229), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 841/1085 (77%), Positives = 958/1085 (88%), Gaps = 8/1085 (0%)
Query: 1 MSRNEITIILLFVNISLFPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNW 60
MS N ITI LLF+NIS+FPAISALN EG LLSWLSTFNSS SATFFS+W+PSH+NPC W
Sbjct: 1 MSSNAITIFLLFLNISIFPAISALNQEGHCLLSWLSTFNSSLSATFFSTWDPSHKNPCKW 60
Query: 61 DYIKCSR----TEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLI 116
DY++CS + I ITSI++PTSFP QLLSF+HLT+LVLSNANLTGEIP +IGNLSSL
Sbjct: 61 DYVRCSSIGFVSGITITSINLPTSFPTQLLSFNHLTTLVLSNANLTGEIPRSIGNLSSLS 120
Query: 117 NLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGN 176
LDLSFN+LTG+IP EIG+L++L+LL+LN+NS+HG IP+EIGNCS+LR+LEL+DNQLSG
Sbjct: 121 TLDLSFNSLTGDIPAEIGRLSQLKLLALNTNSLHGEIPKEIGNCSRLRQLELFDNQLSGK 180
Query: 177 IPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNL 236
IPAEIGQL AL+ RAGGNPGI+GEIP +ISNCK L+FLGLADTGISGQIP +GEL +L
Sbjct: 181 IPAEIGQLLALKTFRAGGNPGIYGEIPMQISNCKELLFLGLADTGISGQIPSILGELKHL 240
Query: 237 RTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSG 296
TLSVYTA +TG IP +IGNCSA+E+L+LY NQI G+IPDEL L NLKRLLLWQNNL+G
Sbjct: 241 ETLSVYTAKLTGSIPADIGNCSAMEHLYLYGNQISGRIPDELALLTNLKRLLLWQNNLTG 300
Query: 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRL 356
SIP+ALGNC +L VID+S+NSL G++P SLANL ALEELLLS N ++GEIP F GNF L
Sbjct: 301 SIPDALGNCLALEVIDLSMNSLSGQIPGSLANLAALEELLLSDNYLTGEIPPFVGNFFGL 360
Query: 357 KQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLTG 415
KQLELDNNRF G+IPP IGQLKELL+FFAWQNQLHG+IP ELA C KLQALDLSHNFLTG
Sbjct: 361 KQLELDNNRFTGEIPPAIGQLKELLIFFAWQNQLHGSIPAELAKCEKLQALDLSHNFLTG 420
Query: 416 SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRL 475
S+P SLF+LKNL+QLLLISN FSGEIPP+IG C GLIRLRLGSNNF+G +P IGLLH+L
Sbjct: 421 SIPHSLFHLKNLSQLLLISNGFSGEIPPDIGNCIGLIRLRLGSNNFTGQLPPEIGLLHKL 480
Query: 476 TFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
+FLELS+NQFTGEIP EIGNCTQLEMVDLH N+L GTIP+S+EFL LNVLDLS NSI G
Sbjct: 481 SFLELSDNQFTGEIPLEIGNCTQLEMVDLHSNRLHGTIPTSVEFLVSLNVLDLSKNSIAG 540
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
++P+NLG LTSLNKLV+S+N ITG IPKSLGLC+DLQLLD+SSNR+ GSIP+EIG LQGL
Sbjct: 541 SVPDNLGMLTSLNKLVISENYITGSIPKSLGLCRDLQLLDMSSNRLTGSIPDEIGGLQGL 600
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
DILLNLS N+LTG IPESF+NLS LANLDLS+NMLTG+L VLGSLDNLVSLNVS+N+FSG
Sbjct: 601 DILLNLSRNSLTGSIPESFANLSNLANLDLSHNMLTGTLTVLGSLDNLVSLNVSHNNFSG 660
Query: 656 ILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFIVL 715
+LP+TKLFH LPASA+ GNQ+LC+NR++CH+N S HG+NST+NL++C LLSVTVTL IV
Sbjct: 661 LLPDTKLFHDLPASAYAGNQELCINRNKCHMNGSDHGKNSTRNLVVCTLLSVTVTLLIVF 720
Query: 716 FGIILFIRFRGTTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVY 775
G +LF R RG F DEE+N LEWD TPFQKLNFSV+D+VT+LSD+NIVGKGVSG+VY
Sbjct: 721 LGGLLFTRIRGAAFGRKDEEDN-LEWDITPFQKLNFSVNDIVTKLSDSNIVGKGVSGMVY 779
Query: 776 RVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835
RVE P +QVIAVKKLWP+KNGE+PERD FSAEV+ LGSIRHKNIVRLLGCCNNG+TRLLL
Sbjct: 780 RVETPMKQVIAVKKLWPLKNGEVPERDLFSAEVRALGSIRHKNIVRLLGCCNNGKTRLLL 839
Query: 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG 895
FDYIS GSLAGLLHE KVFLDWD+RY IILG AHGLAYLHHDC+PPI+HRDIK+NNILVG
Sbjct: 840 FDYISMGSLAGLLHE-KVFLDWDARYNIILGAAHGLAYLHHDCIPPIVHRDIKTNNILVG 898
Query: 896 PQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLE 955
PQFEAFLADFGLAKL +S E SR SN VAGS+GYIAPEYGY L+ITEKSDVYSYGVVLLE
Sbjct: 899 PQFEAFLADFGLAKLVDSEECSRVSNVVAGSFGYIAPEYGYCLRITEKSDVYSYGVVLLE 958
Query: 956 VLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVAL 1015
VLTGKEPTD RIP+G HI+TWV+ LRER+ E TTILD QLL+RSGTQ+QEMLQVLGVAL
Sbjct: 959 VLTGKEPTDDRIPEGVHIVTWVSKALRERRTELTTILDPQLLLRSGTQLQEMLQVLGVAL 1018
Query: 1016 LCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSLS-RAVTNPKAAVHCSSFSRSAEPL 1074
LCVNP PEERPTMKDVTAMLKEIRH N+D EKPN A +NPKAAVH SSFSRS+EPL
Sbjct: 1019 LCVNPSPEERPTMKDVTAMLKEIRHVNEDFEKPNYRGMEATSNPKAAVHSSSFSRSSEPL 1078
Query: 1075 IRSPS 1079
IRSPS
Sbjct: 1079 IRSPS 1083
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492322|ref|XP_002278001.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase RCH1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1605 bits (4157), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 823/1085 (75%), Positives = 939/1085 (86%), Gaps = 6/1085 (0%)
Query: 1 MSRNEITIILLFVNISLFPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNW 60
MS N ITI LLF+NISLFPAI ALN EGLSLLSWLSTFN+SSSA FFSSWNP+H+NPC W
Sbjct: 1 MSSNAITIFLLFLNISLFPAICALNQEGLSLLSWLSTFNTSSSAAFFSSWNPNHQNPCKW 60
Query: 61 DYIKCSR----TEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLI 116
DYIKCS +EI I+SI T+FP Q+LSF+ LT+LV+S+ NLTGEIPP+IGNLSSLI
Sbjct: 61 DYIKCSSAGFVSEITISSIDFHTTFPTQILSFNFLTTLVISDGNLTGEIPPSIGNLSSLI 120
Query: 117 NLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGN 176
LDLSFNALTG IP IGKL+EL+LL LNSNSI G IPREIGNCSKLR+LEL+DNQLSG
Sbjct: 121 VLDLSFNALTGKIPPAIGKLSELQLLLLNSNSIVGEIPREIGNCSKLRQLELFDNQLSGK 180
Query: 177 IPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNL 236
+PAE+GQL L + RAGGN GI+GEIP ++SNC+ LV LGLADTGISGQIP S G+L L
Sbjct: 181 VPAEVGQLWGLAVFRAGGNSGIYGEIPMQMSNCQELVLLGLADTGISGQIPYSFGQLKKL 240
Query: 237 RTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSG 296
+TLS+YTAN+TG IP EIGNCS+LENLF+Y+NQI G+IP ELG LKNL+R+LLWQNNL+G
Sbjct: 241 KTLSIYTANLTGEIPPEIGNCSSLENLFVYQNQISGEIPAELGLLKNLRRVLLWQNNLAG 300
Query: 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRL 356
SIP LGNC LTVID SLNSL GE+P+S ANL ALEELLLS NNISG+IP F G+FSR+
Sbjct: 301 SIPATLGNCLGLTVIDFSLNSLTGEIPMSFANLGALEELLLSDNNISGKIPPFIGSFSRM 360
Query: 357 KQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLTG 415
KQLELDNN G+IP TIGQLKEL LFFAWQNQL G+IP ELA C KLQ LDLSHNFL+G
Sbjct: 361 KQLELDNNLLSGEIPATIGQLKELSLFFAWQNQLSGSIPIELANCEKLQDLDLSHNFLSG 420
Query: 416 SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRL 475
SVP+SLFNLKNLT+LLLISN SGEIPP+IG CT LIRLRLGSN F+G IP IGLL L
Sbjct: 421 SVPNSLFNLKNLTKLLLISNGLSGEIPPDIGNCTSLIRLRLGSNKFTGQIPPEIGLLSNL 480
Query: 476 TFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
+FLELSENQFTGEIPP+IGNCTQLEMVDLH N+LQGTIP+S +FL LNVLDLSMN + G
Sbjct: 481 SFLELSENQFTGEIPPDIGNCTQLEMVDLHGNRLQGTIPTSFQFLVSLNVLDLSMNRMSG 540
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
++PENLG+LTSLNKL+L++N ITG IP SLGLCKDLQ LD+SSNRI GSIPEEIGRLQGL
Sbjct: 541 SVPENLGRLTSLNKLILNENYITGPIPNSLGLCKDLQFLDMSSNRITGSIPEEIGRLQGL 600
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
DILLNLS N+L+GP+PESFSNLS LANLDLS+NMLTGSL+VLG+LDNLVSLNVSYN+FSG
Sbjct: 601 DILLNLSRNSLSGPVPESFSNLSNLANLDLSHNMLTGSLRVLGNLDNLVSLNVSYNNFSG 660
Query: 656 ILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFIVL 715
+P+TK F LPA+ F GNQ+LCVN++ CH + SL GR S +NLIIC +L VT+T+ I+
Sbjct: 661 SIPDTKFFQDLPATVFSGNQKLCVNKNGCHSSGSLDGRISNRNLIICVVLGVTLTIMIMC 720
Query: 716 FGIILFIRFRGTTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVY 775
+I +R G F + +EEN LEWDFTPFQKLNFSV+D+V +LSD+N+VGKG SG+VY
Sbjct: 721 AVVIFLLRTHGAEFGSSSDEENSLEWDFTPFQKLNFSVNDIVNKLSDSNVVGKGCSGMVY 780
Query: 776 RVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835
RVE P +QVIAVKKLWP K+ ELPERD FSAEV TLGSIRHKNIVRLLGCC+NGRTRLLL
Sbjct: 781 RVETPMKQVIAVKKLWPKKSDELPERDLFSAEVTTLGSIRHKNIVRLLGCCDNGRTRLLL 840
Query: 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG 895
FDYISNGS +GLLHEK+VFLDWD+RYKIILG AHGL YLHHDC+PPI+HRDIK+NNILVG
Sbjct: 841 FDYISNGSFSGLLHEKRVFLDWDARYKIILGAAHGLTYLHHDCIPPIVHRDIKANNILVG 900
Query: 896 PQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLE 955
PQFEAFLADFGLAKL SS+SS ASN+VAGSYGYIAPEYGYSL+ITEKSDVYSYG+VLLE
Sbjct: 901 PQFEAFLADFGLAKLVGSSDSSEASNTVAGSYGYIAPEYGYSLRITEKSDVYSYGIVLLE 960
Query: 956 VLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVAL 1015
LTG EPTD +IP+GAHI+TW+N ELRER+REFT+ILD+QLL+ SGTQ QEMLQVLGVAL
Sbjct: 961 ALTGMEPTDHQIPEGAHIVTWINKELRERRREFTSILDQQLLIMSGTQTQEMLQVLGVAL 1020
Query: 1016 LCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSLSRAV-TNPKAAVHCSSFSRSAEPL 1074
LCVNP PEERP+MKDVTAMLKEIR EN+D EKPN L + V NPKA V CSSFS+S+EPL
Sbjct: 1021 LCVNPNPEERPSMKDVTAMLKEIRQENEDYEKPNFLGKGVPINPKATVDCSSFSKSSEPL 1080
Query: 1075 IRSPS 1079
IRSP+
Sbjct: 1081 IRSPT 1085
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570376|ref|XP_002526147.1| Brassinosteroid LRR receptor kinase precursor, putative [Ricinus communis] gi|223534524|gb|EEF36223.1| Brassinosteroid LRR receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1602 bits (4147), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 827/1085 (76%), Positives = 946/1085 (87%), Gaps = 9/1085 (0%)
Query: 1 MSRNEITIILLFVNISLFPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNW 60
MS N ITI LLF+NISLFPAISALN EG SLLSWLSTFNSS SA FF+SW+PSH+NPC W
Sbjct: 2 MSSNAITIFLLFLNISLFPAISALNQEGHSLLSWLSTFNSSLSANFFASWDPSHQNPCKW 61
Query: 61 DYIKCSRT----EIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLI 116
+++KCS + +I I +I PTSFP Q S +HLT+LVLSN NL+GEIPP+IGNLSSLI
Sbjct: 62 EFVKCSSSGFVSDITINNIATPTSFPTQFFSLNHLTTLVLSNGNLSGEIPPSIGNLSSLI 121
Query: 117 NLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGN 176
LDLSFNAL GNIP EIGKL++L+ LSLNSN +HG IPREIGNCS+LR LEL+DNQLSG
Sbjct: 122 TLDLSFNALAGNIPAEIGKLSQLQSLSLNSNMLHGEIPREIGNCSRLRELELFDNQLSGK 181
Query: 177 IPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNL 236
IP EIGQL ALE RAGGN GIHGEIP +ISNCK L++LGLADTGISGQIP S+GEL L
Sbjct: 182 IPTEIGQLVALENFRAGGNQGIHGEIPMQISNCKGLLYLGLADTGISGQIPSSLGELKYL 241
Query: 237 RTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSG 296
+TLSVYTAN++G IP EIGNCSALE LFLYENQ+ G IP+EL SL NLKRLLLWQNNL+G
Sbjct: 242 KTLSVYTANLSGNIPAEIGNCSALEELFLYENQLSGNIPEELASLTNLKRLLLWQNNLTG 301
Query: 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRL 356
IPE LGNCS L VID+S+NSL G VP SLA LVALEELLLS N +SGEIP F GNFS L
Sbjct: 302 QIPEVLGNCSDLKVIDLSMNSLTGVVPGSLARLVALEELLLSDNYLSGEIPHFVGNFSGL 361
Query: 357 KQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLTG 415
KQLELDNNRF G+IP TIGQLKEL LFFAWQNQLHG+IP EL+ C KLQALDLSHNFLTG
Sbjct: 362 KQLELDNNRFSGEIPATIGQLKELSLFFAWQNQLHGSIPAELSNCEKLQALDLSHNFLTG 421
Query: 416 SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRL 475
SVP SLF+LKNLTQLLL+SN FSGEIP +IG C GLIRLRLGSNNF+G IP IG L L
Sbjct: 422 SVPHSLFHLKNLTQLLLLSNEFSGEIPSDIGNCVGLIRLRLGSNNFTGQIPPEIGFLRNL 481
Query: 476 TFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
+FLELS+NQFTG+IP EIG CTQLEM+DLH NKLQG IP++L FL LNVLDLS+NSI G
Sbjct: 482 SFLELSDNQFTGDIPREIGYCTQLEMIDLHGNKLQGVIPTTLVFLVNLNVLDLSINSITG 541
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
IPENLGKLTSLNKLV+S+N+ITGLIPKS+GLC+DLQLLD+SSN++ G IP EIG+LQGL
Sbjct: 542 NIPENLGKLTSLNKLVISENHITGLIPKSIGLCRDLQLLDMSSNKLTGPIPNEIGQLQGL 601
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
DILLNLS N+LTG +P+SF+NLSKLANLDLS+N LTG L +LG+LDNLVSL+VSYN FSG
Sbjct: 602 DILLNLSRNSLTGSVPDSFANLSKLANLDLSHNKLTGPLTILGNLDNLVSLDVSYNKFSG 661
Query: 656 ILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFIVL 715
+LP+TK FH LPA+A+ GN +LC NR++C ++ + HG+N T+NLI+C LLS+TVTL +VL
Sbjct: 662 LLPDTKFFHELPATAYAGNLELCTNRNKCSLSGNHHGKN-TRNLIMCTLLSLTVTLLVVL 720
Query: 716 FGIILFIRFRGTTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVY 775
G+++FIR R NDEE ++W+FTPFQKLNFSV+D++ +LSDTNI+GKG SG+VY
Sbjct: 721 VGVLIFIRIRQAALERNDEEN--MQWEFTPFQKLNFSVNDIIPKLSDTNIIGKGCSGMVY 778
Query: 776 RVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835
RVE P RQVIAVKKLWPVKNGE+PERD FSAEV+TLGSIRHKNIVRLLGCCNNG+T+LLL
Sbjct: 779 RVETPMRQVIAVKKLWPVKNGEVPERDWFSAEVRTLGSIRHKNIVRLLGCCNNGKTKLLL 838
Query: 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG 895
FDYISNGSLAGLLHEK+++LDWD+RY I+LG AHGL YLHHDC PPI+HRDIK+NNILVG
Sbjct: 839 FDYISNGSLAGLLHEKRIYLDWDARYNIVLGAAHGLEYLHHDCTPPIVHRDIKANNILVG 898
Query: 896 PQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLE 955
PQFEAFLADFGLAKL +S+ESS+ SN+VAGSYGYIAPEYGYS +ITEKSDVYSYGVVLLE
Sbjct: 899 PQFEAFLADFGLAKLVDSAESSKVSNTVAGSYGYIAPEYGYSFRITEKSDVYSYGVVLLE 958
Query: 956 VLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVAL 1015
VLTGKEPTD++IP+GAHI+TWVN ELRER+REFTTILD+QLL+RSGTQ+QEMLQVLGVAL
Sbjct: 959 VLTGKEPTDNQIPEGAHIVTWVNKELRERRREFTTILDQQLLLRSGTQLQEMLQVLGVAL 1018
Query: 1016 LCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNS-LSRAVTNPKAAVHCSSFSRSAEPL 1074
LCVNP PEERPTMKDVTAMLKEIRHEN+DLEKP+ A +N KAAVH SSFSRS+EPL
Sbjct: 1019 LCVNPSPEERPTMKDVTAMLKEIRHENEDLEKPHCHNKAAASNSKAAVHSSSFSRSSEPL 1078
Query: 1075 IRSPS 1079
IRSPS
Sbjct: 1079 IRSPS 1083
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449443958|ref|XP_004139742.1| PREDICTED: receptor-like protein kinase 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1553 bits (4020), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 798/1067 (74%), Positives = 915/1067 (85%), Gaps = 7/1067 (0%)
Query: 17 LFPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSR----TEIAI 72
L P+IS LN +G+SLLSWLSTFNSSSSATFFSSW+ +H+NPC+WDY++CS TEI I
Sbjct: 23 LLPSISGLNQQGISLLSWLSTFNSSSSATFFSSWDLTHQNPCSWDYVQCSGDRFVTEIEI 82
Query: 73 TSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEE 132
+SI++ T+FP QLLSF+ LT LVLSNANLTGEIPPAIGNLSSLI LDLSFNALTG IP +
Sbjct: 83 SSINLQTTFPLQLLSFNSLTKLVLSNANLTGEIPPAIGNLSSLIVLDLSFNALTGKIPAK 142
Query: 133 IGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRA 192
IG++++LE LSLNSNS G IP EIGNCS L+RLELYDN L G IPAE G+LEALEI RA
Sbjct: 143 IGEMSKLEFLSLNSNSFSGEIPPEIGNCSMLKRLELYDNLLFGKIPAEFGRLEALEIFRA 202
Query: 193 GGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPE 252
GGN GIHGEIP+EIS C+ L FLGLADTGISG+IPRS G L NL+TLSVYTAN+ G IP
Sbjct: 203 GGNQGIHGEIPDEISKCEELTFLGLADTGISGRIPRSFGGLKNLKTLSVYTANLNGEIPP 262
Query: 253 EIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVID 312
EIGNCS LENLFLY+NQ+ G+IP+ELG++ N++R+LLWQNNLSG IPE+LGN + L VID
Sbjct: 263 EIGNCSLLENLFLYQNQLSGRIPEELGNMMNIRRVLLWQNNLSGEIPESLGNGTGLVVID 322
Query: 313 VSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPP 372
SLN+L GEVPVSLA L ALEELLLS N ISG IPSFFGNFS LKQLELDNNRF GQIP
Sbjct: 323 FSLNALTGEVPVSLAKLTALEELLLSENEISGHIPSFFGNFSFLKQLELDNNRFSGQIPS 382
Query: 373 TIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLL 431
+IG LK+L LFFAWQNQL GN+P EL+ C KL+ALDLSHN LTG +P SLFNLKNL+Q L
Sbjct: 383 SIGLLKKLSLFFAWQNQLTGNLPAELSGCEKLEALDLSHNSLTGPIPESLFNLKNLSQFL 442
Query: 432 LISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPP 491
LISNRFSGEIP +G CTGL RLRLGSNNF+G IPS IGLL L+FLELSEN+F EIP
Sbjct: 443 LISNRFSGEIPRNLGNCTGLTRLRLGSNNFTGRIPSEIGLLRGLSFLELSENRFQSEIPS 502
Query: 492 EIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLV 551
EIGNCT+LEMVDLH N+L G IPSS FL GLNVLDLSMN + G IPENLGKL+SLNKL+
Sbjct: 503 EIGNCTELEMVDLHGNELHGNIPSSFSFLLGLNVLDLSMNRLTGAIPENLGKLSSLNKLI 562
Query: 552 LSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIP 611
L N ITG IP SLGLCKDLQLLDLSSNRI+ SIP EIG +Q LDILLNLS N+LTG IP
Sbjct: 563 LKGNFITGSIPSSLGLCKDLQLLDLSSNRISYSIPSEIGHIQELDILLNLSSNSLTGHIP 622
Query: 612 ESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAF 671
+SFSNLSKLANLD+S+NML G+L +LG+LDNLVSL+VS+N+FSG+LP+TK F GLPASAF
Sbjct: 623 QSFSNLSKLANLDISHNMLIGNLGMLGNLDNLVSLDVSFNNFSGVLPDTKFFQGLPASAF 682
Query: 672 YGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFIVLFGIILFIRFRGTTFRE 731
GNQ LC+ R+ CH + + HGR +++NLII LS+ VL + LFI+ RGT F +
Sbjct: 683 AGNQNLCIERNSCHSDRNDHGRKTSRNLIIFVFLSIIAAASFVLIVLSLFIKVRGTGFIK 742
Query: 732 NDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLW 791
+ E+ +L+W+FTPFQK +FSV+D++TRLSD+NIVGKG SGIVYRVE P++QVIAVKKLW
Sbjct: 743 SSHED-DLDWEFTPFQKFSFSVNDIITRLSDSNIVGKGCSGIVYRVETPAKQVIAVKKLW 801
Query: 792 PVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEK 851
P+KNGE+PERD FSAEVQ LGSIRH+NIVRLLGCCNNG+TRLLLFDYISNGSLAGLLH+K
Sbjct: 802 PLKNGEVPERDLFSAEVQILGSIRHRNIVRLLGCCNNGKTRLLLFDYISNGSLAGLLHDK 861
Query: 852 KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911
+ FLDWD+RYKIILG AHGLAYLHHDC+PPI+HRDIK+NNILVG QFEA LADFGLAKL
Sbjct: 862 RPFLDWDARYKIILGAAHGLAYLHHDCIPPILHRDIKANNILVGSQFEAVLADFGLAKLV 921
Query: 912 ESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA 971
+SS SR SN+VAGSYGYIAPEYGYSL+ITEKSDVYSYGVVLLEVLTGK PTD+ IP+G
Sbjct: 922 DSSGCSRPSNAVAGSYGYIAPEYGYSLRITEKSDVYSYGVVLLEVLTGKPPTDNTIPEGV 981
Query: 972 HIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
HI+TWVN ELR+RK EFT ILD QLL RSGTQIQ+MLQVLGVALLCVN PE+RPTMKDV
Sbjct: 982 HIVTWVNKELRDRKNEFTAILDPQLLQRSGTQIQQMLQVLGVALLCVNTSPEDRPTMKDV 1041
Query: 1032 TAMLKEIRHENDDLEKPNSLSR-AVTNPKAAVHCSSFSRSAEPLIRS 1077
TAMLKEI+HE+++ EKPNSL R A+TNPKAAVHCSSFSRS+EPLIR+
Sbjct: 1042 TAMLKEIKHESEEYEKPNSLERGAITNPKAAVHCSSFSRSSEPLIRA 1088
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449475472|ref|XP_004154463.1| PREDICTED: receptor-like protein kinase 2-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1547 bits (4006), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 796/1063 (74%), Positives = 912/1063 (85%), Gaps = 7/1063 (0%)
Query: 21 ISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSR----TEIAITSIH 76
IS LN +G+SLLSWLSTFNSSSSATFFSSW+ +H+NPC+WDY++CS TEI I+SI+
Sbjct: 1 ISGLNQQGISLLSWLSTFNSSSSATFFSSWDLTHQNPCSWDYVQCSGDRFVTEIEISSIN 60
Query: 77 IPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKL 136
+ T+FP QLLSF+ LT LVLSNANLTGEIPPAIGNLSSLI LDLSFNALTG IP +IG++
Sbjct: 61 LQTTFPLQLLSFNSLTKLVLSNANLTGEIPPAIGNLSSLIVLDLSFNALTGKIPAKIGEM 120
Query: 137 AELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNP 196
++LE LSLNSNS G IP EIGNCS L+RLELYDN L G IPAE G+LEALEI RAGGN
Sbjct: 121 SKLEFLSLNSNSFSGEIPPEIGNCSMLKRLELYDNLLFGKIPAEFGRLEALEIFRAGGNQ 180
Query: 197 GIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGN 256
GIHGEIP+EIS C+ L FLGLADTGISG+IPRS G L NL+TLSVYTAN+ G IP EIGN
Sbjct: 181 GIHGEIPDEISKCEELTFLGLADTGISGRIPRSFGGLKNLKTLSVYTANLNGEIPPEIGN 240
Query: 257 CSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLN 316
CS LENLFLY+NQ+ G+IP+ELG++ N++R+LLWQNNLSG IPE+LGN + L VID SLN
Sbjct: 241 CSLLENLFLYQNQLSGRIPEELGNMMNIRRVLLWQNNLSGEIPESLGNGTGLVVIDFSLN 300
Query: 317 SLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQ 376
+L GEVPVSLA L ALEELLLS N ISG IPSFFGNFS LKQLELDNNRF GQIP +IG
Sbjct: 301 ALTGEVPVSLAKLTALEELLLSENEISGHIPSFFGNFSFLKQLELDNNRFSGQIPSSIGL 360
Query: 377 LKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISN 435
LK+L LFFAWQNQL GN+P EL+ C KL+ALDLSHN LTG +P SLFNLKNL+Q LLISN
Sbjct: 361 LKKLSLFFAWQNQLTGNLPAELSGCEKLEALDLSHNSLTGPIPESLFNLKNLSQFLLISN 420
Query: 436 RFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGN 495
RFSGEIP +G CTGL RLRLGSNNF+G IPS IGLL L+FLELSEN+F EIP EIGN
Sbjct: 421 RFSGEIPRNLGNCTGLTRLRLGSNNFTGRIPSEIGLLRGLSFLELSENRFQSEIPSEIGN 480
Query: 496 CTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKN 555
CT+LEMVDLH N+L G IPSS FL GLNVLDLSMN + G IPENLGKL+SLNKL+L N
Sbjct: 481 CTELEMVDLHGNELHGNIPSSFSFLLGLNVLDLSMNRLTGAIPENLGKLSSLNKLILKGN 540
Query: 556 NITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFS 615
ITG IP SLGLCKDLQLLDLSSNRI+ SIP EIG +Q LDILLNLS N+LTG IP+SFS
Sbjct: 541 FITGSIPSSLGLCKDLQLLDLSSNRISYSIPSEIGHIQELDILLNLSSNSLTGHIPQSFS 600
Query: 616 NLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQ 675
NLSKLANLD+S+NML G+L +LG+LDNLVSL+VS+N+FSG+LP+TK F GLPASAF GNQ
Sbjct: 601 NLSKLANLDISHNMLIGNLGMLGNLDNLVSLDVSFNNFSGVLPDTKFFQGLPASAFAGNQ 660
Query: 676 QLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFIVLFGIILFIRFRGTTFRENDEE 735
LC+ R+ CH + + HGR +++NLII LS+ VL + LFI+ RGT F ++ E
Sbjct: 661 NLCIERNSCHSDRNDHGRKTSRNLIIFVFLSIIAAASFVLIVLSLFIKVRGTGFIKSSHE 720
Query: 736 ENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKN 795
+ +L+W+FTPFQK +FSV+D++TRLSD+NIVGKG SGIVYRVE P++QVIAVKKLWP+KN
Sbjct: 721 D-DLDWEFTPFQKFSFSVNDIITRLSDSNIVGKGCSGIVYRVETPAKQVIAVKKLWPLKN 779
Query: 796 GELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFL 855
GE+PERD FSAEVQ LGSIRH+NIVRLLGCCNNG+TRLLLFDYISNGSLAGLLH+K+ FL
Sbjct: 780 GEVPERDLFSAEVQILGSIRHRNIVRLLGCCNNGKTRLLLFDYISNGSLAGLLHDKRPFL 839
Query: 856 DWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915
DWD+RYKIILG AHGLAYLHHDC+PPI+HRDIK+NNILVG QFEA LADFGLAKL +SS
Sbjct: 840 DWDARYKIILGAAHGLAYLHHDCIPPILHRDIKANNILVGSQFEAVLADFGLAKLVDSSG 899
Query: 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIIT 975
SR SN+VAGSYGYIAPEYGYSL+ITEKSDVYSYGVVLLEVLTGK PTD+ IP+G HI+T
Sbjct: 900 CSRPSNAVAGSYGYIAPEYGYSLRITEKSDVYSYGVVLLEVLTGKPPTDNTIPEGVHIVT 959
Query: 976 WVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
WVN ELR+RK EFT ILD QLL RSGTQIQ+MLQVLGVALLCVN PE+RPTMKDVTAML
Sbjct: 960 WVNKELRDRKNEFTAILDPQLLQRSGTQIQQMLQVLGVALLCVNTSPEDRPTMKDVTAML 1019
Query: 1036 KEIRHENDDLEKPNSLSR-AVTNPKAAVHCSSFSRSAEPLIRS 1077
KEI+HE+++ EKPNSL R A+TNPKAAVHCSSFSRS+EPLIR+
Sbjct: 1020 KEIKHESEEYEKPNSLERGAITNPKAAVHCSSFSRSSEPLIRA 1062
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356509310|ref|XP_003523393.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RCH1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1536 bits (3977), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 781/1083 (72%), Positives = 926/1083 (85%), Gaps = 11/1083 (1%)
Query: 1 MSRNEITIILLFVNISLFPAIS-ALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCN 59
MS N +T+ +LF+NI L P+IS ALN EGLSLLSWLSTFNSS+SAT FSSW+P++++PC
Sbjct: 1 MSSNALTLFILFLNI-LCPSISGALNHEGLSLLSWLSTFNSSNSATAFSSWDPTNKDPCT 59
Query: 60 WDYIKCSR----TEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSL 115
WDYI CS +EI ITSI I + FP QL SF HLT+LV+SN NLTG+IP ++GNLSSL
Sbjct: 60 WDYITCSEEGFVSEIIITSIDIRSGFPSQLHSFGHLTTLVISNGNLTGQIPSSVGNLSSL 119
Query: 116 INLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSG 175
+ LDLSFNAL+G+IPEEIG L++L+LL LNSNS+ GGIP IGNCS+LR +E++DNQLSG
Sbjct: 120 VTLDLSFNALSGSIPEEIGMLSKLQLLLLNSNSLQGGIPTTIGNCSRLRHVEIFDNQLSG 179
Query: 176 NIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTN 235
IP EIGQL ALE +RAGGNPGIHGEIP +IS+CK LVFLGLA TG+SG+IP S+GEL N
Sbjct: 180 MIPGEIGQLRALETLRAGGNPGIHGEIPMQISDCKALVFLGLAVTGVSGEIPPSIGELKN 239
Query: 236 LRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLS 295
L+TLSVYTA +TG+IP EI NCSALE+LFLYENQ+ G IP ELGS+++L+R+LLW+NNL+
Sbjct: 240 LKTLSVYTAQLTGHIPAEIQNCSALEDLFLYENQLSGSIPYELGSVQSLRRVLLWKNNLT 299
Query: 296 GSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSR 355
G+IPE+LGNC++L VID SLNSLGG++PVSL++L+ LEE LLS NNI GEIPS+ GNFSR
Sbjct: 300 GTIPESLGNCTNLKVIDFSLNSLGGQIPVSLSSLLLLEEFLLSDNNIFGEIPSYIGNFSR 359
Query: 356 LKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLT 414
LKQ+ELDNN+F G+IPP +GQLKEL LF+AWQNQL+G+IP EL+ C KL+ALDLSHNFL+
Sbjct: 360 LKQIELDNNKFSGEIPPVMGQLKELTLFYAWQNQLNGSIPTELSNCEKLEALDLSHNFLS 419
Query: 415 GSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHR 474
GS+PSSLF+L NLTQLLLISNR SG+IP +IG CT LIRLRLGSNNF+G IPS IGLL
Sbjct: 420 GSIPSSLFHLGNLTQLLLISNRLSGQIPADIGSCTSLIRLRLGSNNFTGQIPSEIGLLSS 479
Query: 475 LTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIG 534
LTF+ELS N +G+IP EIGNC LE++DLH N LQGTIPSSL+FL GLNVLDLS+N I
Sbjct: 480 LTFIELSNNLLSGDIPFEIGNCAHLELLDLHGNVLQGTIPSSLKFLVGLNVLDLSLNRIT 539
Query: 535 GTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQG 594
G+IPENLGKLTSLNKL+LS N I+G+IP +LGLCK LQLLD+S+NRI GSIP+EIG LQ
Sbjct: 540 GSIPENLGKLTSLNKLILSGNLISGVIPGTLGLCKALQLLDISNNRITGSIPDEIGYLQE 599
Query: 595 LDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFS 654
LDILLNLSWN+LTGPIPE+FSNLSKL+ LDLS+N LTG+L VL SLDNLVSLNVSYN FS
Sbjct: 600 LDILLNLSWNSLTGPIPETFSNLSKLSILDLSHNKLTGTLTVLVSLDNLVSLNVSYNSFS 659
Query: 655 GILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFIV 714
G LP+TK F LP +AF GN LC+ S+CH + G S +N+I+ L V + V
Sbjct: 660 GSLPDTKFFRDLPTAAFAGNPDLCI--SKCHASEDGQGFKSIRNVILYTFLGVVLISIFV 717
Query: 715 LFGIILFIRFRGTTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIV 774
FG+IL +R +G F N +E E+EW FTPFQKLNFS++D++T+LS++NIVGKG SGIV
Sbjct: 718 TFGVILTLRIQGGNFGRNFDEGGEMEWAFTPFQKLNFSINDILTKLSESNIVGKGCSGIV 777
Query: 775 YRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834
YRVE P +Q+IAVKKLWP+K E PERD F+AEVQTLGSIRHKNIVRLLGCC+NGRTRLL
Sbjct: 778 YRVETPMKQMIAVKKLWPIKKEEPPERDLFTAEVQTLGSIRHKNIVRLLGCCDNGRTRLL 837
Query: 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV 894
LFDYI NGSL GLLHE ++FLDWD+RYKIILG AHGL YLHHDC+PPI+HRDIK+NNILV
Sbjct: 838 LFDYICNGSLFGLLHENRLFLDWDARYKIILGAAHGLEYLHHDCIPPIVHRDIKANNILV 897
Query: 895 GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLL 954
GPQFEAFLADFGLAKL SSE S AS++VAGSYGYIAPEYGYSL+ITEKSDVYSYGVVLL
Sbjct: 898 GPQFEAFLADFGLAKLVSSSECSGASHTVAGSYGYIAPEYGYSLRITEKSDVYSYGVVLL 957
Query: 955 EVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVA 1014
EVLTG EPT++RIP+GAHI+ WV+ E+RE++REFT+ILD+QL++++GT+ EMLQVLGVA
Sbjct: 958 EVLTGMEPTENRIPEGAHIVAWVSNEIREKRREFTSILDQQLVLQNGTKTSEMLQVLGVA 1017
Query: 1015 LLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSLSRAV--TNPKAAVHCSSFSRSAE 1072
LLCVNP PEERPTMKDVTAMLKEIRHENDD EKPN L +++ TNPKAAVHCSSFSRS E
Sbjct: 1018 LLCVNPSPEERPTMKDVTAMLKEIRHENDDFEKPNFLHKSMVTTNPKAAVHCSSFSRSCE 1077
Query: 1073 PLI 1075
PLI
Sbjct: 1078 PLI 1080
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463755|ref|XP_003602159.1| Receptor-like protein kinase [Medicago truncatula] gi|355491207|gb|AES72410.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1517 bits (3927), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 772/1084 (71%), Positives = 918/1084 (84%), Gaps = 11/1084 (1%)
Query: 1 MSRNEITIILLFVNISLFPAISALNPEGLSLLSWLSTFNSSSS--ATFFSSWNPSHRNPC 58
MS N + ++LF+ ISLFP IS+LN EGLSLLSWLSTFNSS+S T FSSW+P+H+NPC
Sbjct: 1 MSNNALNFLILFLTISLFPFISSLNQEGLSLLSWLSTFNSSNSVPTTTFSSWDPTHKNPC 60
Query: 59 NWDYIKCSRTE----IAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSS 114
WDYIKCS E I ITSI + + FP Q LSF+HLT+LV+SN NLTGEIP ++GNLSS
Sbjct: 61 RWDYIKCSAAEFVEEIVITSIDLHSGFPTQFLSFNHLTTLVISNGNLTGEIPSSVGNLSS 120
Query: 115 LINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLS 174
L+ LDLS+N LTG IP+EIGKL+EL LSLNSNS+HGGIP IGNCSKL++L L+DNQLS
Sbjct: 121 LVTLDLSYNTLTGTIPKEIGKLSELRWLSLNSNSLHGGIPTTIGNCSKLQQLALFDNQLS 180
Query: 175 GNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELT 234
G IP EIGQL+ALE +RAGGN GI GEIP +IS+CK LVFLGLA TGISG+IP S+GEL
Sbjct: 181 GMIPGEIGQLKALESLRAGGNQGIFGEIPMQISDCKALVFLGLAVTGISGEIPASIGELQ 240
Query: 235 NLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNL 294
NL+TLSVYTA++TG IP EI NCS+LE+LFLYEN + G I ELGS+++LKR+LLWQNN
Sbjct: 241 NLKTLSVYTAHLTGQIPLEIQNCSSLEDLFLYENHLSGNILYELGSMQSLKRVLLWQNNF 300
Query: 295 SGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFS 354
+G+IPE+LGNC++L VID SLNSL G++P+SL+NL++LEELL+S NNI GEIPS+ GNFS
Sbjct: 301 TGTIPESLGNCTNLKVIDFSLNSLVGQLPLSLSNLLSLEELLVSDNNIYGEIPSYIGNFS 360
Query: 355 RLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFL 413
L QLELDNN+F G+IP +G LKEL LF+AWQNQLHG+IP EL+ C KL+A+DLSHNFL
Sbjct: 361 MLNQLELDNNKFTGEIPRVMGNLKELTLFYAWQNQLHGSIPTELSNCEKLEAVDLSHNFL 420
Query: 414 TGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLH 473
TG +P+SLF+L+NLTQLLLISNR SG+IPP+IG CT LIRLRLGSNNF+G IP IGLL
Sbjct: 421 TGPIPNSLFHLQNLTQLLLISNRLSGQIPPDIGRCTSLIRLRLGSNNFTGQIPQEIGLLR 480
Query: 474 RLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSI 533
L+FLELS+N + IP EIGNC LEM+DLH+N+LQGTIPSSL+ L LNVLDLS N I
Sbjct: 481 SLSFLELSDNNLSENIPYEIGNCAHLEMLDLHKNELQGTIPSSLKLLVDLNVLDLSSNRI 540
Query: 534 GGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQ 593
G+IP++ G+LTSLNKL+LS N ITGLIP+SLGLCKDLQLLD S+N++ GSIP EIG LQ
Sbjct: 541 TGSIPKSFGELTSLNKLILSGNLITGLIPQSLGLCKDLQLLDFSNNKLIGSIPNEIGYLQ 600
Query: 594 GLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHF 653
GLDILLNLSWN+LTGPIP++FSNLSKL+ LDLS N LTG+L VLG+LDNLVSLNVSYN F
Sbjct: 601 GLDILLNLSWNSLTGPIPKTFSNLSKLSILDLSYNKLTGTLIVLGNLDNLVSLNVSYNRF 660
Query: 654 SGILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFI 713
SG LP+TK F LP++AF GN LC+N+ CH + +L G S +N+II L + +T +
Sbjct: 661 SGTLPDTKFFQDLPSAAFAGNPDLCINK--CHTSGNLQGNKSIRNIIIYTFLGIILTSAV 718
Query: 714 VLFGIILFIRFRGTTFR-ENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSG 772
V G+IL +R +G + N EE E+EW FTPFQKLNF+++D+VT+LSD+NIVGKGVSG
Sbjct: 719 VTCGVILALRIQGDNYYGSNSFEEVEMEWSFTPFQKLNFNINDIVTKLSDSNIVGKGVSG 778
Query: 773 IVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832
+VYRVE P++Q+IAVKKLWPVKN E PERD F+AEVQTLGSIRHKNIVRLLGCC+NGRT+
Sbjct: 779 VVYRVETPTKQLIAVKKLWPVKNEEPPERDLFTAEVQTLGSIRHKNIVRLLGCCDNGRTK 838
Query: 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNI 892
+LLFDYI NGSL GLLHEK++FLDWD+RYKIILG AHGL YLHHDC+PPI+HRD+K+NNI
Sbjct: 839 MLLFDYICNGSLFGLLHEKRMFLDWDARYKIILGTAHGLEYLHHDCIPPIVHRDVKANNI 898
Query: 893 LVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVV 952
LVG QFEAFLADFGLAKL SSE +RAS+ VAGSYGYIAPEYGYSL+ITEKSDVYSYGVV
Sbjct: 899 LVGQQFEAFLADFGLAKLVISSECARASHVVAGSYGYIAPEYGYSLRITEKSDVYSYGVV 958
Query: 953 LLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLG 1012
LLE+LTG EPTD+RIP+GAHI+TWV E+RE+K+EFT+I+D+QLL++ GT+ EMLQVLG
Sbjct: 959 LLEMLTGMEPTDNRIPEGAHIVTWVISEIREKKKEFTSIIDQQLLLQCGTKTPEMLQVLG 1018
Query: 1013 VALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSLSRAVTNPKAAVHCSSFSRSAE 1072
VALLCVNP PEERPTMKDVTAMLKEIRHENDDL+KPN +TNPKAAVHCSSFSRS E
Sbjct: 1019 VALLCVNPSPEERPTMKDVTAMLKEIRHENDDLDKPNK-GMVITNPKAAVHCSSFSRSCE 1077
Query: 1073 PLIR 1076
LI
Sbjct: 1078 LLIE 1081
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515997|ref|XP_003526683.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RCH1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1514 bits (3921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 781/1083 (72%), Positives = 927/1083 (85%), Gaps = 10/1083 (0%)
Query: 1 MSRNEITIILLFVNISLFPAIS-ALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCN 59
MS N +T+ +LF+NIS+ P+IS ALN EGLSLLSWLS+FNSS+SAT FSSW+P++++PC
Sbjct: 1 MSSNALTLFILFLNISMCPSISVALNQEGLSLLSWLSSFNSSNSATAFSSWDPTNKDPCT 60
Query: 60 WDYIKCSR----TEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSL 115
WDYI CS+ +EI ITSI + + FP +L SF HLT+L++SN NLTG+IP ++GNLSSL
Sbjct: 61 WDYITCSKEGYVSEIIITSIDLRSGFPSRLNSFYHLTTLIISNGNLTGQIPSSVGNLSSL 120
Query: 116 INLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSG 175
+ LDLSFNAL+G+IPEEIGKL+ L+LL LNSNS+ GGIP IGNCS+LR + L+DNQ+SG
Sbjct: 121 VTLDLSFNALSGSIPEEIGKLSNLQLLLLNSNSLQGGIPTTIGNCSRLRHVALFDNQISG 180
Query: 176 NIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTN 235
IP EIGQL ALE +RAGGNPGIHGEIP +IS+CK LVFLGLA TG+SG+IP S+GEL N
Sbjct: 181 MIPGEIGQLRALETLRAGGNPGIHGEIPMQISDCKALVFLGLAVTGVSGEIPPSIGELKN 240
Query: 236 LRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLS 295
L+T+SVYTA++TG+IP EI NCSALE+LFLYENQ+ G IP ELGS+++L+R+LLW+NNL+
Sbjct: 241 LKTISVYTAHLTGHIPAEIQNCSALEDLFLYENQLSGSIPYELGSMQSLRRVLLWKNNLT 300
Query: 296 GSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSR 355
G+IPE+LGNC++L VID SLNSL G++PV+L++L+ LEE LLS NNI GEIPS+ GNFSR
Sbjct: 301 GTIPESLGNCTNLKVIDFSLNSLRGQIPVTLSSLLLLEEFLLSDNNIYGEIPSYIGNFSR 360
Query: 356 LKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLT 414
LKQ+ELDNN+F G+IPP IGQLKEL LF+AWQNQL+G+IP EL+ C KL+ALDLSHNFLT
Sbjct: 361 LKQIELDNNKFSGEIPPVIGQLKELTLFYAWQNQLNGSIPTELSNCEKLEALDLSHNFLT 420
Query: 415 GSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHR 474
GS+PSSLF+L NLTQLLLISNR SG+IP +IG CT LIRLRLGSNNF+G IPS IGLL
Sbjct: 421 GSIPSSLFHLGNLTQLLLISNRLSGQIPADIGSCTSLIRLRLGSNNFTGQIPSEIGLLSS 480
Query: 475 LTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIG 534
LTFLELS N F+G+IP EIGNC LE++DLH N LQGTIPSSL+FL LNVLDLS N I
Sbjct: 481 LTFLELSNNLFSGDIPFEIGNCAHLELLDLHSNVLQGTIPSSLKFLVDLNVLDLSANRIT 540
Query: 535 GTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQG 594
G+IPENLGKLTSLNKL+LS N I+G+IP +LG CK LQLLD+S+NRI GSIP+EIG LQG
Sbjct: 541 GSIPENLGKLTSLNKLILSGNLISGVIPGTLGPCKALQLLDISNNRITGSIPDEIGYLQG 600
Query: 595 LDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFS 654
LDILLNLSWN+LTGPIPE+FSNLSKL+ LDLS+N LTG+L VL SLDNLVSLNVSYN FS
Sbjct: 601 LDILLNLSWNSLTGPIPETFSNLSKLSILDLSHNKLTGTLTVLVSLDNLVSLNVSYNGFS 660
Query: 655 GILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFIV 714
G LP+TK F +PA+AF GN LC+ S+CH + + G S +N+II L V + V
Sbjct: 661 GSLPDTKFFRDIPAAAFAGNPDLCI--SKCHASENGQGFKSIRNVIIYTFLGVVLISVFV 718
Query: 715 LFGIILFIRFRGTTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIV 774
FG+IL +R +G F N + E+EW FTPFQKLNFS++D++T+LS++NIVGKG SGIV
Sbjct: 719 TFGVILTLRIQGGNFGRNFDGSGEMEWAFTPFQKLNFSINDILTKLSESNIVGKGCSGIV 778
Query: 775 YRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834
YRVE P +Q IAVKKLWP+K E PERD F+AEVQTLGSIRHKNIVRLLGCC+NGRTRLL
Sbjct: 779 YRVETPMKQTIAVKKLWPIKKEEPPERDLFTAEVQTLGSIRHKNIVRLLGCCDNGRTRLL 838
Query: 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV 894
LFDYI NGSL GLLHE ++FLDWD+RYKIILGVAHGL YLHHDC+PPI+HRDIK+NNILV
Sbjct: 839 LFDYICNGSLFGLLHENRLFLDWDARYKIILGVAHGLEYLHHDCIPPIVHRDIKANNILV 898
Query: 895 GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLL 954
GPQFEAFLADFGLAKL SSE S AS+++AGSYGYIAPEYGYSL+ITEKSDVYSYGVVLL
Sbjct: 899 GPQFEAFLADFGLAKLVSSSECSGASHTIAGSYGYIAPEYGYSLRITEKSDVYSYGVVLL 958
Query: 955 EVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVA 1014
EVLTG EPTD+RIP+GAHI TWV+ E+RE++REFT+ILD+QL+++SGT+ EMLQVLGVA
Sbjct: 959 EVLTGMEPTDNRIPEGAHIATWVSDEIREKRREFTSILDQQLVLQSGTKTSEMLQVLGVA 1018
Query: 1015 LLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSLSRAV--TNPKAAVHCSSFSRSAE 1072
LLCVNP PEERPTMKDVTAMLKEIRHENDD EKPN L ++V TNPKAAVHCSSFSRS E
Sbjct: 1019 LLCVNPSPEERPTMKDVTAMLKEIRHENDDFEKPNFLHKSVVTTNPKAAVHCSSFSRSCE 1078
Query: 1073 PLI 1075
PLI
Sbjct: 1079 PLI 1081
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551167|ref|XP_003543949.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RCH1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1484 bits (3842), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 763/1089 (70%), Positives = 905/1089 (83%), Gaps = 17/1089 (1%)
Query: 1 MSRNEITIILLFVNISLFPA-ISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCN 59
MS N +T+ +LF+NISLFPA S+LN EGLSLLSWLSTFNSS SAT FSSW+P+H +PC
Sbjct: 1 MSSNALTLFILFLNISLFPAATSSLNQEGLSLLSWLSTFNSSDSATAFSSWDPTHHSPCR 60
Query: 60 WDYIKCSRT----EIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSS- 114
WDYI+CS+ EI I SI + T+FP QLLSF +LT+LV+SNANLTG+IP ++GNLSS
Sbjct: 61 WDYIRCSKEGFVLEIIIESIDLHTTFPTQLLSFGNLTTLVISNANLTGKIPGSVGNLSSS 120
Query: 115 LINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLS 174
L+ LDLSFNAL+G IP EIG L +L+ L LNSNS+ GGIP +IGNCS+LR+LEL+DNQ+S
Sbjct: 121 LVTLDLSFNALSGTIPSEIGNLYKLQWLYLNSNSLQGGIPSQIGNCSRLRQLELFDNQIS 180
Query: 175 GNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELT 234
G IP EIGQL LEI+RAGGNP IHGEIP +ISNCK LV+LGLADTGISG+IP ++GEL
Sbjct: 181 GLIPGEIGQLRDLEILRAGGNPAIHGEIPMQISNCKALVYLGLADTGISGEIPPTIGELK 240
Query: 235 NLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNL 294
+L+TL +YTA++TG IP EI NCSALE LFLYENQ+ G IP ELGS+ +L+++LLWQNN
Sbjct: 241 SLKTLQIYTAHLTGNIPPEIQNCSALEELFLYENQLSGNIPSELGSMTSLRKVLLWQNNF 300
Query: 295 SGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFS 354
+G+IPE++GNC+ L VID S+NSL GE+PV+L++L+ LEELLLS NN SGEIPS+ GNF+
Sbjct: 301 TGAIPESMGNCTGLRVIDFSMNSLVGELPVTLSSLILLEELLLSNNNFSGEIPSYIGNFT 360
Query: 355 RLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFL 413
LKQLELDNNRF G+IPP +G LKEL LF+AWQNQLHG+IP EL++C KLQALDLSHNFL
Sbjct: 361 SLKQLELDNNRFSGEIPPFLGHLKELTLFYAWQNQLHGSIPTELSHCEKLQALDLSHNFL 420
Query: 414 TGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLH 473
TGS+PSSLF+L+NLTQLLL+SNR SG IPP+IG CT L+RLRLGSNNF+G IP IG L
Sbjct: 421 TGSIPSSLFHLENLTQLLLLSNRLSGPIPPDIGSCTSLVRLRLGSNNFTGQIPPEIGFLR 480
Query: 474 RLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSI 533
L+FLELS+N TG+IP EIGNC +LEM+DLH NKLQG IPSSLEFL LNVLDLS+N I
Sbjct: 481 SLSFLELSDNSLTGDIPFEIGNCAKLEMLDLHSNKLQGAIPSSLEFLVSLNVLDLSLNRI 540
Query: 534 GGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQ 593
G+IPENLGKL SLNKL+LS N I+GLIP+SLG CK LQLLD+S+NRI+GSIP+EIG LQ
Sbjct: 541 TGSIPENLGKLASLNKLILSGNQISGLIPRSLGFCKALQLLDISNNRISGSIPDEIGHLQ 600
Query: 594 GLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHF 653
LDILLNLSWN LTGPIPE+FSNLSKL+NLDLS+N L+GSLK+L SLDNLVSLNVSYN F
Sbjct: 601 ELDILLNLSWNYLTGPIPETFSNLSKLSNLDLSHNKLSGSLKILASLDNLVSLNVSYNSF 660
Query: 654 SGILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFI 713
SG LP+TK F LP +AF GN LC+ ++C ++ HG S +N+II L V T
Sbjct: 661 SGSLPDTKFFRDLPPAAFAGNPDLCI--TKCPVSGHHHGIESIRNIIIYTFLGVIFTSGF 718
Query: 714 VLFGIILFIRFRGTTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGI 773
V FG+IL ++ +G T ++E++W FTPFQKLNFS++D++ +LSD+NIVGKG SG+
Sbjct: 719 VTFGVILALKIQGGT-----SFDSEMQWAFTPFQKLNFSINDIIPKLSDSNIVGKGCSGV 773
Query: 774 VYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833
VYRVE P QV+AVKKLWP K+ E PERD F+AEV TLGSIRHKNIVRLLGC NNGRTRL
Sbjct: 774 VYRVETPMNQVVAVKKLWPPKHDETPERDLFAAEVHTLGSIRHKNIVRLLGCYNNGRTRL 833
Query: 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNIL 893
LLFDYI NGSL+GLLHE VFLDW++RYKIILG AHGL YLHHDC+PPIIHRDIK+NNIL
Sbjct: 834 LLFDYICNGSLSGLLHENSVFLDWNARYKIILGAAHGLEYLHHDCIPPIIHRDIKANNIL 893
Query: 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVL 953
VGPQFEA LADFGLAKL SS+ S AS VAGSYGYIAPEYGYSL+ITEKSDVYS+GVVL
Sbjct: 894 VGPQFEASLADFGLAKLVASSDYSGASAIVAGSYGYIAPEYGYSLRITEKSDVYSFGVVL 953
Query: 954 LEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGV 1013
+EVLTG EP D+RIP+G+HI+ WV E+RE+K EF ILD++L ++ GTQI EMLQVLGV
Sbjct: 954 IEVLTGMEPIDNRIPEGSHIVPWVIREIREKKTEFAPILDQKLALQCGTQIPEMLQVLGV 1013
Query: 1014 ALLCVNPCPEERPTMKDVTAMLKEIRHE--NDDLEKPNSLSRA-VTNPKAAVHCSSFSRS 1070
ALLCVN PEERPTMKDVTAMLKEIRHE + D EK + L ++ VTNPKAAV C +FSRS
Sbjct: 1014 ALLCVNQSPEERPTMKDVTAMLKEIRHESVDFDFEKSDLLHKSVVTNPKAAVQCPNFSRS 1073
Query: 1071 AEPLIRSPS 1079
+PL SPS
Sbjct: 1074 CKPLTESPS 1082
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1079 | ||||||
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.892 | 0.843 | 0.424 | 3.2e-200 | |
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.898 | 0.888 | 0.441 | 1.6e-214 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.926 | 0.917 | 0.430 | 3.3e-214 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.890 | 0.846 | 0.433 | 2.7e-203 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.879 | 0.861 | 0.358 | 3.1e-151 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.706 | 0.608 | 0.310 | 2.2e-150 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.551 | 0.529 | 0.338 | 1.8e-146 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.556 | 0.480 | 0.343 | 2.8e-140 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.892 | 0.874 | 0.344 | 9.5e-137 | |
| TAIR|locus:2007918 | 1088 | PEPR2 "PEP1 receptor 2" [Arabi | 0.552 | 0.547 | 0.338 | 4.6e-135 |
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1938 (687.3 bits), Expect = 3.2e-200, P = 3.2e-200
Identities = 429/1011 (42%), Positives = 570/1011 (56%)
Query: 66 SRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNAL 125
S ++ I+ ++ + P L L L LS+ L G+IP ++ L +L L L+ N L
Sbjct: 106 SLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQL 165
Query: 126 TGNIPEEIGKLAXXXXXXXXXXXIHGGIPREIGNCSKLRRLELYDN-QLSGNIPAEIGQL 184
TG IP +I K + + G IP E+G S L + + N ++SG IP+EIG
Sbjct: 166 TGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDC 225
Query: 185 EALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTA 244
L ++ + G +P + K L L + T ISG+IP +G + L L +Y
Sbjct: 226 SNLTVLGLA-ETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYEN 284
Query: 245 NITGYIPEEIGNCSALENLFLYENQIFGKIPDEXXXXXXXXXXXXXXXXXSGSIPEALGN 304
+++G IP EIG + LE LFL++N + G IP+E SGSIP ++G
Sbjct: 285 SLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGR 344
Query: 305 CSSLTVIDVSLNSLGGEVPXXXXXXXXXXXXXXXXXNISGEIPSFFGNFSRLKQLELDNN 364
S L +S N G +P ISG IPS G ++L +N
Sbjct: 345 LSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSN 404
Query: 365 RFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSXXXX 424
+ G IPP G LA C LQALDLS N LTG++PS
Sbjct: 405 QLEGSIPP-------------------G----LADCTDLQALDLSRNSLTGTIPSGLFML 441
Query: 425 XXXXXXXXXXXRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQ 484
SG IP EIG C+ L+RLRLG N +G IPS IG L ++ FL+ S N+
Sbjct: 442 RNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNR 501
Query: 485 FTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKL 544
G++P EIG+C++L+M+DL N L+G++P+ + L GL VLD+S N G IP +LG+L
Sbjct: 502 LHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRL 561
Query: 545 TSLNKLVLSKNNITGLIPXXXXXXXXXXXXXXXXNRINGSIPEEIGRLQGLDILLNLSWN 604
SLNKL+LSKN +G IP N ++G IP E+G ++ L+I LNLS N
Sbjct: 562 VSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSN 621
Query: 605 ALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFH 664
LTG IP ++L+KL+ LDLS+NML G L L +++NLVSLN+SYN FSG LP+ KLF
Sbjct: 622 RLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFR 681
Query: 665 GLPASAFYGNQQLCVN-RSQCHIN----NSLH-----GRNSTKNLIICALLSVTXXXXXX 714
L GN++LC + + C + N L R L + L+++T
Sbjct: 682 QLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMIL 741
Query: 715 XXXXXXXXXXXXXTFRXXXXXXXXXXWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIV 774
R W FTPFQKLNFSVD ++ L + N++GKG SG+V
Sbjct: 742 GAVAVIRARRNIDNERDSELGETYK-WQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVV 800
Query: 775 YRVEIPSRQVIAVKKLWPVK-NGELPE-----RDQFSAEVQTLGSIRHKNIVRLLGCCNN 828
YR ++ + +VIAVKKLWP NG E RD FSAEV+TLG+IRHKNIVR LGCC N
Sbjct: 801 YRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWN 860
Query: 829 GRTRLLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDI 887
TRLL++DY+ NGSL LLHE++ LDWD RY+I+LG A GLAYLHHDC+PPI+HRDI
Sbjct: 861 RNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDI 920
Query: 888 KSNNILVGPQFEAFLADFGLAKLFXXXXXXXXXXXXXXXYGYIAPEYGYSLKITEKSDVY 947
K+NNIL+G FE ++ADFGLAKL YGYIAPEYGYS+KITEKSDVY
Sbjct: 921 KANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVY 980
Query: 948 SYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEM 1007
SYGVV+LEVLTGK+P D +P+G H++ WV + R +LD L R+ + EM
Sbjct: 981 SYGVVVLEVLTGKQPIDPTVPEGIHLVDWVR-----QNRGSLEVLDSTLRSRTEAEADEM 1035
Query: 1008 LQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSLSRAVTNP 1058
+QVLG ALLCVN P+ERPTMKDV AMLKEI+ E ++ K + L + P
Sbjct: 1036 MQVLGTALLCVNSSPDERPTMKDVAAMLKEIKQEREEYAKVDLLLKKSPPP 1086
|
|
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2073 (734.8 bits), Expect = 1.6e-214, P = 1.6e-214
Identities = 444/1005 (44%), Positives = 589/1005 (58%)
Query: 56 NPCNWDYIKCSR----TEIAITSIHIPTSFPY-QLLSFSHLTSLVLSNANLTGEIPPAIG 110
+PCNW +KC+R +EI + + + S P L S LTSL LS+ NLTG IP IG
Sbjct: 55 SPCNWVGVKCNRRGEVSEIQLKGMDLQGSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIG 114
Query: 111 NLSSLINLDLSFNALTGNIPEEIGKLAXXXXXXXXXXXIHGGIPREIGNCSKLRRLELYD 170
+ + L LDLS N+L+G+IP EI +L + G IP EIGN S L L L+D
Sbjct: 115 DFTELELLDLSDNSLSGDIPVEIFRLKKLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFD 174
Query: 171 NQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSV 230
N+LSG IP IG+L+ L+++RAGGN + GE+P EI NC+ LV LGLA+T +SG++P S+
Sbjct: 175 NKLSGEIPRSIGELKNLQVLRAGGNKNLRGELPWEIGNCENLVMLGLAETSLSGKLPASI 234
Query: 231 GELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDEXXXXXXXXXXXXX 290
G L ++T+++YT+ ++G IP+EIG C+ L+NL+LY+N I G IP
Sbjct: 235 GNLKRVQTIAIYTSLLSGPIPDEIGYCTELQNLYLYQNSISGSIPTTIGGLKKLQSLLLW 294
Query: 291 XXXXSGSIPEALGNCSSLTVIDVSLNSLGGEVPXXXXXXXXXXXXXXXXXNISGEIPSFF 350
G IP LGNC L +ID S N L G +P ISG IP
Sbjct: 295 QNNLVGKIPTELGNCPELWLIDFSENLLTGTIPRSFGKLENLQELQLSVNQISGTIPEEL 354
Query: 351 GNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPE-LAYCVKLQALDLS 409
N ++L LE+DNN G+IP + L+ L +FFAWQN+L GNIP+ L+ C +LQA+DLS
Sbjct: 355 TNCTKLTHLEIDNNLITGEIPSLMSNLRSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLS 414
Query: 410 HNFLTGSVPSSXXXXXXXXXXXXXXXRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRI 469
+N L+GS+P SG IPP+IG CT L RLRL N +G IPS I
Sbjct: 415 YNSLSGSIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEI 474
Query: 470 GLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQG-----TIPSSLEFLFGLN 524
G L L F+++SEN+ G IPP I C LE +DLH N L G T+P SL+F+
Sbjct: 475 GNLKNLNFVDISENRLVGSIPPAISGCESLEFLDLHTNSLSGSLLGTTLPKSLKFI---- 530
Query: 525 VLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPXXXXXXXXXXXXXXXXNRINGS 584
D S N++ T+P +G LT L KL L+KN ++G IP N +G
Sbjct: 531 --DFSDNALSSTLPPGIGLLTELTKLNLAKNRLSGEIPREISTCRSLQLLNLGENDFSGE 588
Query: 585 IPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLV 644
IP+E+G++ L I LNLS N G IP FS+L L LD+S+N LTG+L VL L NLV
Sbjct: 589 IPDELGQIPSLAISLNLSCNRFVGEIPSRFSDLKNLGVLDVSHNQLTGNLNVLTDLQNLV 648
Query: 645 SLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICAL 704
SLN+SYN FSG LPNT F LP S N+ L ++ + + +S L I L
Sbjct: 649 SLNISYNDFSGDLPNTPFFRRLPLSDLASNRGLYISNAISTRPDPTTRNSSVVRLTILIL 708
Query: 705 LSVTXXXXXXXXXXXXXXXXXXXTFRXXXXXXXXXXWDFTPFQKLNFSVDDVVTRLSDTN 764
+ VT W+ T +QKL+FS+DD+V L+ N
Sbjct: 709 VVVTAVLVLMAVYTLVRARAAGKQL----LGEEIDSWEVTLYQKLDFSIDDIVKNLTSAN 764
Query: 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
++G G SG+VYR+ IPS + +AVKK+W + E F++E++TLGSIRH+NIVRLLG
Sbjct: 765 VIGTGSSGVVYRITIPSGESLAVKKMWSKE-----ESGAFNSEIKTLGSIRHRNIVRLLG 819
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHE--KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
C+N +LL +DY+ NGSL+ LH K +DW++RY ++LGVAH LAYLHHDC+P I
Sbjct: 820 WCSNRNLKLLFYDYLPNGSLSSRLHGAGKGGCVDWEARYDVVLGVAHALAYLHHDCLPTI 879
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFXXXXXXXXXXXX-------XXXYGYIAPEYG 935
IH D+K+ N+L+GP FE +LADFGLA+ YGY+APE+
Sbjct: 880 IHGDVKAMNVLLGPHFEPYLADFGLARTISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHA 939
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995
+ITEKSDVYSYGVVLLEVLTGK P D +P GAH++ WV L E+K + + +LD +
Sbjct: 940 SMQRITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVKWVRDHLAEKK-DPSRLLDPR 998
Query: 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040
L R+ + + EMLQ L VA LCV+ ERP MKDV AML EIRH
Sbjct: 999 LDGRTDSIMHEMLQTLAVAFLCVSNKANERPLMKDVVAMLTEIRH 1043
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2070 (733.7 bits), Expect = 3.3e-214, P = 3.3e-214
Identities = 451/1048 (43%), Positives = 605/1048 (57%)
Query: 56 NPCNWDYIKCSR----TEIAITSIHIPTSFPY-QLLSFSHLTSLVLSNANLTGEIPPAIG 110
NPC W IKC+ +EI + + P L LT L L++ NLTG IP +G
Sbjct: 58 NPCQWVGIKCNERGQVSEIQLQVMDFQGPLPATNLRQIKSLTLLSLTSVNLTGSIPKELG 117
Query: 111 NLSSLINLDLSFNALTGNIPEEIGKLAXXXXXXXXXXXIHGGIPREIGNCSKLRRLELYD 170
+LS L LDL+ N+L+G IP +I KL + G IP E+GN L L L+D
Sbjct: 118 DLSELEVLDLADNSLSGEIPVDIFKLKKLKILSLNTNNLEGVIPSELGNLVNLIELTLFD 177
Query: 171 NQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSV 230
N+L+G IP IG+L+ LEI RAGGN + GE+P EI NC+ LV LGLA+T +SG++P S+
Sbjct: 178 NKLAGEIPRTIGELKNLEIFRAGGNKNLRGELPWEIGNCESLVTLGLAETSLSGRLPASI 237
Query: 231 GELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDEXXXXXXXXXXXXX 290
G L ++T+++YT+ ++G IP+EIGNC+ L+NL+LY+N I G IP
Sbjct: 238 GNLKKVQTIALYTSLLSGPIPDEIGNCTELQNLYLYQNSISGSIPVSMGRLKKLQSLLLW 297
Query: 291 XXXXSGSIPEALGNCSSLTVIDVSLNSLGGEVPXXXXXXXXXXXXXXXXXNISGEIPSFF 350
G IP LG C L ++D+S N L G +P +SG IP
Sbjct: 298 QNNLVGKIPTELGTCPELFLVDLSENLLTGNIPRSFGNLPNLQELQLSVNQLSGTIPEEL 357
Query: 351 GNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPE-LAYCVKLQALDLS 409
N ++L LE+DNN+ G+IPP IG+L L +FFAWQNQL G IPE L+ C +LQA+DLS
Sbjct: 358 ANCTKLTHLEIDNNQISGEIPPLIGKLTSLTMFFAWQNQLTGIIPESLSQCQELQAIDLS 417
Query: 410 HNFLTGSVPSSXXXXXXXXXXXXXXXRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRI 469
+N L+GS+P+ SG IPP+IG CT L RLRL N +G+IP+ I
Sbjct: 418 YNNLSGSIPNGIFEIRNLTKLLLLSNYLSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEI 477
Query: 470 GLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLS 529
G L L F+++SEN+ G IPPEI CT LE VDLH N L G +P +L L +DLS
Sbjct: 478 GNLKNLNFIDISENRLIGNIPPEISGCTSLEFVDLHSNGLTGGLPGTLPK--SLQFIDLS 535
Query: 530 MNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPXXXXXXXXXXXXXXXXNRINGSIPEEI 589
NS+ G++P +G LT L KL L+KN +G IP N G IP E+
Sbjct: 536 DNSLTGSLPTGIGSLTELTKLNLAKNRFSGEIPREISSCRSLQLLNLGDNGFTGEIPNEL 595
Query: 590 GRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVS 649
GR+ L I LNLS N TG IP FS+L+ L LD+S+N L G+L VL L NLVSLN+S
Sbjct: 596 GRIPSLAISLNLSCNHFTGEIPSRFSSLTNLGTLDVSHNKLAGNLNVLADLQNLVSLNIS 655
Query: 650 YNHFSGILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTX 709
+N FSG LPNT F LP S N+ L ++ N + R+ + + ++L
Sbjct: 656 FNEFSGELPNTLFFRKLPLSVLESNKGLFISTRP---ENGIQTRHRSAVKVTMSILVAAS 712
Query: 710 XXXXXXXXXXXXXXXXXXTFRXXXXXXXXXXWDFTPFQKLNFSVDDVVTRLSDTNIVGKG 769
R W+ T +QKL+FS+DD+V L+ N++G G
Sbjct: 713 VVLVLMAVYTLVKAQ-----RITGKQEELDSWEVTLYQKLDFSIDDIVKNLTSANVIGTG 767
Query: 770 VSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG 829
SG+VYRV IPS + +AVKK+W + E F++E+ TLGSIRH+NI+RLLG C+N
Sbjct: 768 SSGVVYRVTIPSGETLAVKKMWSKE-----ENRAFNSEINTLGSIRHRNIIRLLGWCSNR 822
Query: 830 RTRLLLFDYISNGSLAGLLH---EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRD 886
+LL +DY+ NGSL+ LLH + DW++RY ++LGVAH LAYLHHDC+PPI+H D
Sbjct: 823 NLKLLFYDYLPNGSLSSLLHGAGKGSGGADWEARYDVVLGVAHALAYLHHDCLPPILHGD 882
Query: 887 IKSNNILVGPQFEAFLADFGLAKLFXXXXXXXXXXXXXX-------XYGYIAPEYGYSLK 939
+K+ N+L+G +FE++LADFGLAK+ YGY+APE+
Sbjct: 883 VKAMNVLLGSRFESYLADFGLAKIVSGEGVTDGDSSKLSNRPPLAGSYGYMAPEHASMQH 942
Query: 940 ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMR 999
ITEKSDVYSYGVVLLEVLTGK P D +P GAH++ WV L +K + ILD +L R
Sbjct: 943 ITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVQWVRDHLAGKK-DPREILDPRLRGR 1001
Query: 1000 SGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH------ENDDL-----EK- 1047
+ + EMLQ L V+ LCV+ +RP MKD+ AMLKEIR E+D + EK
Sbjct: 1002 ADPIMHEMLQTLAVSFLCVSNKASDRPMMKDIVAMLKEIRQFDMDRSESDMIKGGKCEKW 1061
Query: 1048 -PNSL--SRAVTNPKAAVHCSSFSRSAE 1072
P L + V+ P+ + +CS F+ S E
Sbjct: 1062 QPQPLPPEKIVSTPRGSSNCS-FAYSDE 1088
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1967 (697.5 bits), Expect = 2.7e-203, P = 2.7e-203
Identities = 438/1010 (43%), Positives = 583/1010 (57%)
Query: 66 SRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNAL 125
S ++ I++ ++ + ++ S L + LS+ +L GEIP ++G L +L L L+ N L
Sbjct: 107 SLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGL 166
Query: 126 TGNIPEEIGKLAXXXXXXXXXXXIHGGIPREIGNCSKLRRLELYDN-QLSGNIPAEIGQL 184
TG IP E+G + +P E+G S L + N +LSG IP EIG
Sbjct: 167 TGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNC 226
Query: 185 EALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTA 244
L+++ I G +P + L L + T +SG+IP+ +G + L L +Y
Sbjct: 227 RNLKVLGLAATK-ISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDN 285
Query: 245 NITGYIPEEIGNCSALENLFLYENQIFGKIPDEXXXXXXXXXXXXXXXXXSGSIPEALGN 304
+++G +P+E+G LE + L++N + G IP+E SG+IP++ GN
Sbjct: 286 DLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGN 345
Query: 305 CSSLTVIDVSLNSLGGEVPXXXXXXXXXXXXXXXXXNISGEIPSFFGNFSRLKQLELDNN 364
S+L + +S N++ G +P ISG IP G LK+L N
Sbjct: 346 LSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIG---LLKEL----N 398
Query: 365 RFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSXXXX 424
F G G + + ELA C LQALDLS N+LTGS+P+
Sbjct: 399 IFLGWQNKLEGNIPD----------------ELAGCQNLQALDLSQNYLTGSLPAGLFQL 442
Query: 425 XXXXXXXXXXXRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQ 484
SG IP EIG CT L+RLRL +N +G IP IG L L+FL+LSEN
Sbjct: 443 RNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENN 502
Query: 485 FTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKL 544
+G +P EI NC QL+M++L N LQG +P SL L L VLD+S N + G IP++LG L
Sbjct: 503 LSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHL 562
Query: 545 TSLNKLVLSKNNITGLIPXXXXXXXXXXXXXXXXNRINGSIPEEIGRLQGLDILLNLSWN 604
SLN+L+LSKN+ G IP N I+G+IPEE+ +Q LDI LNLSWN
Sbjct: 563 ISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWN 622
Query: 605 ALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFH 664
+L G IPE S L++L+ LD+S+NML+G L L L+NLVSLN+S+N FSG LP++K+F
Sbjct: 623 SLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFR 682
Query: 665 GLPASAFYGNQQLCVN--RSQCHINNSLH-----GRNSTK-NLIICALLSVTXXXXXXXX 716
L + GN LC RS C ++NS G +S + + I L+SVT
Sbjct: 683 QLIGAEMEGNNGLCSKGFRS-CFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGV 741
Query: 717 XXXXXXXXXXXTFRXXXXXXXXXXWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYR 776
W FTPFQKLNF+V+ V+ L + N++GKG SGIVY+
Sbjct: 742 LAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYK 801
Query: 777 VEIPSRQVIAVKKLWPVKNGELPE-------RDQFSAEVQTLGSIRHKNIVRLLGCCNNG 829
E+P+R+VIAVKKLWPV L E RD FSAEV+TLGSIRHKNIVR LGCC N
Sbjct: 802 AEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNK 861
Query: 830 RTRLLLFDYISNGSLAGLLHEKK--VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDI 887
TRLL++DY+SNGSL LLHE+ L W+ RYKIILG A GLAYLHHDCVPPI+HRDI
Sbjct: 862 NTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDI 921
Query: 888 KSNNILVGPQFEAFLADFGLAKLFXXXXXXXXXXXXXXXYGYIAPEYGYSLKITEKSDVY 947
K+NNIL+GP FE ++ DFGLAKL YGYIAPEYGYS+KITEKSDVY
Sbjct: 922 KANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVY 981
Query: 948 SYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEM 1007
SYGVV+LEVLTGK+P D IPDG HI+ WV ++R+ + ++D+ L R ++++EM
Sbjct: 982 SYGVVVLEVLTGKQPIDPTIPDGLHIVDWVK-KIRDIQ-----VIDQGLQARPESEVEEM 1035
Query: 1008 LQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSLSRAVTN 1057
+Q LGVALLC+NP PE+RPTMKDV AML EI E ++ K + S + N
Sbjct: 1036 MQTLGVALLCINPIPEDRPTMKDVAAMLSEICQEREESMKVDGCSGSCNN 1085
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1454 (516.9 bits), Expect = 3.1e-151, Sum P(2) = 3.1e-151
Identities = 360/1003 (35%), Positives = 497/1003 (49%)
Query: 65 CSRTEIA-ITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFN 123
CS EI + + P ++ L +L++ N ++G +P IGNL SL L N
Sbjct: 120 CSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSN 179
Query: 124 ALTGNIPEEIGKLAXXXXXXXXXXXIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQ 183
++G +P IG L I G +P EIG C L L L NQLSG +P EIG
Sbjct: 180 NISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGM 239
Query: 184 LEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYT 243
L+ L + N G IP EISNC L L L + G IP+ +G+L +L L +Y
Sbjct: 240 LKKLSQVILWENE-FSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYR 298
Query: 244 ANITGYIPEEIGNCSALENLFLYENQIFGKIPDEXXXXXXXXXXXXXXXXXSGSIPEALG 303
+ G IP EIGN S + EN + G+IP E +G+IP L
Sbjct: 299 NGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELS 358
Query: 304 NCSSLTVIDVSLNSLGGEVPXXXXXXXXXXXXXXXXXNISGEIPSFFGNFSRLKQLELDN 363
+L+ +D+S+N+L G +P ++SG IP G +S L L++ +
Sbjct: 359 TLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSD 418
Query: 364 NRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPE-LAYCVKLQALDLSHNFLTGSVPSSXX 422
N G+IP + +++ N L GNIP + C L L L+ N L G PS+
Sbjct: 419 NHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLC 478
Query: 423 XXXXXXXXXXXXXRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSE 482
RF G IP E+G C+ L RL+L N F+G +P IG+L +L L +S
Sbjct: 479 KQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISS 538
Query: 483 NQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLG 542
N+ TGE+P EI NC L+ +D+ N GT+PS + L+ L +L LS N++ GTIP LG
Sbjct: 539 NKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALG 598
Query: 543 KLTSLNKLVLSKNNITGLIPXXXXXXXXXXXXXXXXNRINGSIPEEIGRLQGLDILLNLS 602
L+ L +L + N NGSIP E+G L GL I LNLS
Sbjct: 599 NLSRLTELQMG------------------------GNLFNGSIPRELGSLTGLQIALNLS 634
Query: 603 WNALTGPIPESFSNLSKLANLDLSNNMLTGSL-KVLGSLDNLVSLNVSYNHFSGILPNTK 661
+N LTG IP SNL L L L+NN L+G + +L +L+ N SYN +G +P
Sbjct: 635 YNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP--- 691
Query: 662 LFHGLPASAFYGNQQLC-VNRSQCHINNSLHGRNSTKN---LIICALLSVTXXXXXXXXX 717
L + S+F GN+ LC +QC ST + ++++T
Sbjct: 692 LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSL 751
Query: 718 XXXXXXXXXXTFRXXXXXXXXXXWDFTPFQ---------KLNFSVDDVVT---RLSDTNI 765
R D P + K F+ D+V ++ +
Sbjct: 752 MLIALIVYL--MRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFV 809
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPER--DQFSAEVQTLGSIRHKNIVRLL 823
VG+G G VY+ +P+ +AVKKL G + F AE+ TLG+IRH+NIV+L
Sbjct: 810 VGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLH 869
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
G CN+ + LLL++Y+ GSL +LH+ LDW R+KI LG A GLAYLHHDC P I
Sbjct: 870 GFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIF 929
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFXXXXXXXXXXXXXXXYGYIAPEYGYSLKITEK 943
HRDIKSNNIL+ +FEA + DFGLAK+ YGYIAPEY Y++K+TEK
Sbjct: 930 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGS-YGYIAPEYAYTMKVTEK 988
Query: 944 SDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQ 1003
SD+YSYGVVLLE+LTGK P I G ++ WV +R R + +LD +L +
Sbjct: 989 SDIYSYGVVLLELLTGKAPVQP-IDQGGDVVNWVRSYIR-RDALSSGVLDARLTLEDERI 1046
Query: 1004 IQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLE 1046
+ ML VL +ALLC + P RP+M+ V ML E + E
Sbjct: 1047 VSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIESERSEGEQE 1089
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 923 (330.0 bits), Expect = 2.2e-150, Sum P(2) = 2.2e-150
Identities = 244/787 (31%), Positives = 379/787 (48%)
Query: 82 PYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAXXXX 141
P QL + L L L G IP + L++L LDLS N LTG I EE ++
Sbjct: 257 PSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEF 316
Query: 142 XXXXXXXIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHG 200
+ G +P+ I N + L++L L + QLSG IPAEI ++L+++ N + G
Sbjct: 317 LVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNT-LTG 375
Query: 201 EIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSAL 260
+IP+ + L L L + + G + S+ LTNL+ ++Y N+ G +P+EIG L
Sbjct: 376 QIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKL 435
Query: 261 ENLFLYENQIFGKIPDEXXXXXXXXXXXXXXXXXSGSIPEALGNCSSLTVIDVSLNSLGG 320
E ++LYEN+ G++P E SG IP ++G LT + + N L G
Sbjct: 436 EIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVG 495
Query: 321 EVPXXXXXXXXXXXXXXXXXNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKEL 380
+P +SG IPS FG + L+ + NN G +P ++ LK L
Sbjct: 496 NIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNL 555
Query: 381 LLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSXXXXXXXXXXXXXXXRFSGE 440
N+ +G+I L + D++ N G +P +F+G
Sbjct: 556 TRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGR 615
Query: 441 IPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLE 500
IP G + L L + N+ SG IP +GL +LT ++L+ N +G IP +G L
Sbjct: 616 IPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLG 675
Query: 501 MVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGL 560
+ L NK G++P+ + L + L L NS+ G+IP+ +G L +LN L L +N ++G
Sbjct: 676 ELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGP 735
Query: 561 IPXXXXXXXXXXXXXXXXNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKL 620
+P N + G IP EIG+LQ L L+LS+N TG IP + S L KL
Sbjct: 736 LPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKL 795
Query: 621 ANLDLSNNMLTGSLK-VLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLCV 679
+LDLS+N L G + +G + +L LN+SYN+ G L K F A AF GN LC
Sbjct: 796 ESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLK--KQFSRWQADAFVGNAGLCG 853
Query: 680 NR-SQCHINNSLHGRN-STKNLIICALLSVTXXXXXXXXXXXXXXXXXXXTFRXXXXXXX 737
+ S C+ S + R+ S K ++I + +S F+
Sbjct: 854 SPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNS 913
Query: 738 XXXWDFTPFQ---------KLNFSVDDVVTR---LSDTNIVGKGVSGIVYRVEIPSRQVI 785
+ + Q K + DD++ L++ ++G G SG VY+ E+ + + I
Sbjct: 914 AFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETI 973
Query: 786 AVKK-LWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT--RLLLFDYISNG 842
AVKK LW +L F+ EV+TLG+IRH+++V+L+G C++ LL+++Y++NG
Sbjct: 974 AVKKILW---KDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANG 1030
Query: 843 SLAGLLH 849
S+ LH
Sbjct: 1031 SVWDWLH 1037
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 1.8e-146, Sum P(2) = 1.8e-146
Identities = 203/600 (33%), Positives = 294/600 (49%)
Query: 82 PYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAXXXX 141
P ++ + S L + L+N G IP I LS L + ++ N L+G +PEEIG L
Sbjct: 126 PREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEE 185
Query: 142 XXXXXXXIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGE 201
+ G +PR +GN +KL N SGNIP EIG+ L+++ N I GE
Sbjct: 186 LVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQN-FISGE 244
Query: 202 IPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALE 261
+P+EI L + L SG IP+ +G LT+L TL++Y ++ G IP EIGN +L+
Sbjct: 245 LPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLK 304
Query: 262 NLFLYENQIFGKIPDEXXXXXXXXXXXXXXXXXSGSIPEALGNCSSLTVIDVSLNSLGGE 321
L+LY+NQ+ G IP E SG IP L S L ++ + N L G
Sbjct: 305 KLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGI 364
Query: 322 VPXXXXXXXXXXXXXXXXXNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELL 381
+P +++G IP F N + ++QL+L +N G IP +G L
Sbjct: 365 IPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLW 424
Query: 382 LFFAWQNQLHGNIPELAYCVK--LQALDLSHNFLTGSVPSSXXXXXXXXXXXXXXXRFSG 439
+ +NQL G IP C + L L+L N + G++P R +G
Sbjct: 425 VVDFSENQLSGKIPPFI-CQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTG 483
Query: 440 EIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQL 499
+ P E+ L + L N FSG +P IG +L L L+ NQF+ +P EI + L
Sbjct: 484 QFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNL 543
Query: 500 EMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITG 559
++ N L G IPS + L LDLS NS G++P LG L L L LS+N +G
Sbjct: 544 VTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSG 603
Query: 560 LIPXXXXXXXXXXXXXXXXNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSK 619
IP N +GSIP ++G L L I +NLS+N +G IP NL
Sbjct: 604 NIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHL 663
Query: 620 LANLDLSNNMLTGSLKV-LGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLC 678
L L L+NN L+G + +L +L+ N SYN+ +G LP+T++F + ++F GN+ LC
Sbjct: 664 LMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLC 723
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 2.8e-140, Sum P(2) = 2.8e-140
Identities = 210/612 (34%), Positives = 296/612 (48%)
Query: 56 NPCNWDYIKCSRTE----IAI--TSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAI 109
N C+W + C T IA+ T + + S F +L L LS+ NL G IP A+
Sbjct: 56 NYCSWTGVTCDNTGLFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTAL 115
Query: 110 GNLSSLINLDLSFNALTGNIPEEIGKLAXXXXXXXXXXXIHGGIPREIGNCSKLRRLELY 169
NL+SL +L L N LTG IP ++G L + G IP +GN L+ L L
Sbjct: 116 SNLTSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALA 175
Query: 170 DNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRS 229
+L+G IP+++G+L ++ + N + G IP E+ NC L A+ ++G IP
Sbjct: 176 SCRLTGPIPSQLGRLVRVQSLILQDNY-LEGPIPAELGNCSDLTVFTAAENMLNGTIPAE 234
Query: 230 VGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDEXXXXXXXXXXXX 289
+G L NL L++ ++TG IP ++G S L+ L L NQ+ G IP
Sbjct: 235 LGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDL 294
Query: 290 XXXXXSGSIPEALGNCSSLTVIDVSLNSLGGEVPXXX-XXXXXXXXXXXXXXNISGEIPS 348
+G IPE N S L + ++ N L G +P +SGEIP
Sbjct: 295 SANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPV 354
Query: 349 FFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNI-PELAYCVKLQALD 407
LKQL+L NN G IP + +L EL + N L G + P ++ LQ L
Sbjct: 355 ELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLV 414
Query: 408 LSHNFLTGSVPSSXXXXXXXXXXXXXXXRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPS 467
L HN L G +P RFSGEIP EIG CT L + + N+F G IP
Sbjct: 415 LYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPP 474
Query: 468 RIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLD 527
IG L L L L +N+ G +P +GNC QL ++DL N+L G+IPSS FL GL L
Sbjct: 475 SIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLM 534
Query: 528 LSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPXXXXXXXXXXXXXXXXNRINGSIPE 587
L NS+ G +P++L L +L ++ LS N + G I N IP
Sbjct: 535 LYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTI-HPLCGSSSYLSFDVTNNGFEDEIPL 593
Query: 588 EIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKV-LGSLDNLVSL 646
E+G Q LD L L N LTG IP + + +L+ LD+S+N LTG++ + L L +
Sbjct: 594 ELGNSQNLD-RLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHI 652
Query: 647 NVSYNHFSGILP 658
+++ N SG +P
Sbjct: 653 DLNNNFLSGPIP 664
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1339 (476.4 bits), Expect = 9.5e-137, P = 9.5e-137
Identities = 341/990 (34%), Positives = 490/990 (49%)
Query: 69 EIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGN 128
++ +++ I P L L L L G IP + + +L L L N L G+
Sbjct: 95 KLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGS 154
Query: 129 IPEEIGKLAXXXXXXXXXXXIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALE 188
IP +IG L+ + G IP + +LR + N SG IP+EI E+L+
Sbjct: 155 IPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLK 214
Query: 189 IIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITG 248
++ N + G +P+++ + L L L +SG+IP SVG ++ L L+++ TG
Sbjct: 215 VLGLAENL-LEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTG 273
Query: 249 YIPEEIGNCSALENLFLYENQIFGKIPDEXXXXXXXXXXXXXXXXXSGSIPEALGNCSSL 308
IP EIG + ++ L+LY NQ+ G+IP E +G IP+ G+ +L
Sbjct: 274 SIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNL 333
Query: 309 TVIDVSLNSLGGEVPXXXXXXXXXXXXXXXXXNISGEIPSFFGNFSRLKQLELDNNRFFG 368
++ + N L G +P ++G IP L L+L +N+ G
Sbjct: 334 KLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEG 393
Query: 369 QIPPTIGQLKELLLFFAWQNQLHGNIPELAYC--VKLQALDLSHNFLTGSVPSSXXXXXX 426
+IPP IG + N L G IP +C L L L N L+G++P
Sbjct: 394 KIPPLIGFYSNFSVLDMSANSLSGPIPA-HFCRFQTLILLSLGSNKLSGNIPRDLKTCKS 452
Query: 427 XXXXXXXXXRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFT 486
+ +G +P E+ L L L N SG+I + +G L L L L+ N FT
Sbjct: 453 LTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFT 512
Query: 487 GEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTS 546
GEIPPEIGN T++ ++ N+L G IP L + LDLS N G I + LG+L
Sbjct: 513 GEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVY 572
Query: 547 LNKLVLSKNNITGLIPXXXXXXXXXXXXXXXXNRINGSIPEEIGRLQGLDILLNLSWNAL 606
L L LS N +TG IP N ++ +IP E+G+L L I LN+S N L
Sbjct: 573 LEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNL 632
Query: 607 TGPIPESFSNLSKLANLDLSNNMLTGSLKV-LGSLDNLVSLNVSYNHFSGILPNTKLFHG 665
+G IP+S NL L L L++N L+G + +G+L +L+ N+S N+ G +P+T +F
Sbjct: 633 SGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQR 692
Query: 666 LPASAFYGNQQLCVN-RSQC-----HINNSLH----GRNSTKNLIICALLSVTXXXXXXX 715
+ +S F GN LC + RS C H ++ L+ G K L I ++ +
Sbjct: 693 MDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIV-IGSVFLITF 751
Query: 716 XXXXXXXXXXXXTFRXXXXXXXXXXWDFTPFQKLNFSVDDVV--TR-LSDTNIVGKGVSG 772
F D F K F+ +V TR S+ ++G+G G
Sbjct: 752 LGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACG 811
Query: 773 IVYRVEIPSRQVIAVKKLWPVKNGELPERDQ-FSAEVQTLGSIRHKNIVRLLGCCNNGRT 831
VY+ E+ +VIAVKKL GE D F AE+ TLG IRH+NIV+L G C + +
Sbjct: 812 TVYKAEMSGGEVIAVKKL--NSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNS 869
Query: 832 RLLLFDYISNGSLAGLLH--EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKS 889
LLL++Y+S GSL L EK LDW++RY+I LG A GL YLHHDC P I+HRDIKS
Sbjct: 870 NLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKS 929
Query: 890 NNILVGPQFEAFLADFGLAKLFXXXXXXXXXXXXXXXYGYIAPEYGYSLKITEKSDVYSY 949
NNIL+ +F+A + DFGLAKL YGYIAPEY Y++K+TEK D+YS+
Sbjct: 930 NNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGS-YGYIAPEYAYTMKVTEKCDIYSF 988
Query: 950 GVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQ 1009
GVVLLE++TGK P + G ++ WV +R + D +L + EM
Sbjct: 989 GVVLLELITGKPPVQP-LEQGGDLVNWVRRSIRNMIPTIE-MFDARLDTNDKRTVHEMSL 1046
Query: 1010 VLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039
VL +AL C + P RPTM++V AM+ E R
Sbjct: 1047 VLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
|
| TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 809 (289.8 bits), Expect = 4.6e-135, Sum P(2) = 4.6e-135
Identities = 204/602 (33%), Positives = 289/602 (48%)
Query: 82 PYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAXXXX 141
P L + + L L LSN + +GE+P G+L +L L L N L+G IP +G L
Sbjct: 117 PSTLGNCTSLEYLDLSNNDFSGEVPDIFGSLQNLTFLYLDRNNLSGLIPASVGGLIELVD 176
Query: 142 XXXXXXXIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGE 201
+ G IP +GNCSKL L L +N+L+G++PA + LE L + N + G
Sbjct: 177 LRMSYNNLSGTIPELLGNCSKLEYLALNNNKLNGSLPASLYLLENLGELFVSNN-SLGGR 235
Query: 202 IPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALE 261
+ SNCK LV L L+ G +P +G ++L +L + N+TG IP +G +
Sbjct: 236 LHFGSSNCKKLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPSSMGMLRKVS 295
Query: 262 NLFLYENQIFGKIPDEXXXXXXXXXXXXXXXXXSGSIPEALGNCSSLTVIDVSLNSLGGE 321
+ L +N++ G IP E G IP AL L +++ N L GE
Sbjct: 296 VIDLSDNRLSGNIPQELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGE 355
Query: 322 VPXXXXXXXXXXXXXXXXXNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELL 381
+P ++GE+P LK+L L NN F+G IP ++G + L
Sbjct: 356 IPIGIWKIQSLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRSLE 415
Query: 382 LFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLTGSVPSSXXXXXXXXXXXXXXXRFSGE 440
N+ G IP L + KL+ L N L G +P+S + SG
Sbjct: 416 EVDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERVRLEDNKLSGV 475
Query: 441 IPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLE 500
+P E L + LGSN+F G IP +G L ++LS+N+ TG IPPE+GN L
Sbjct: 476 LP-EFPESLSLSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIPPELGNLQSLG 534
Query: 501 MVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGL 560
+++L N L+G +PS L L D+ NS+ G+IP + SL+ LVLS NN G
Sbjct: 535 LLNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVLSDNNFLGA 594
Query: 561 IPXXXXXXXXXXXXXXXXNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKL 620
IP N G IP +G L+ L L+LS N TG IP + L L
Sbjct: 595 IPQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPTTLGALINL 654
Query: 621 ANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLCVN 680
L++SNN LTG L VL SL +L ++VSYN F+G +P L + +S F GN LC+
Sbjct: 655 ERLNISNNKLTGPLSVLQSLKSLNQVDVSYNQFTGPIPVNLLSN---SSKFSGNPDLCIQ 711
Query: 681 RS 682
S
Sbjct: 712 AS 713
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| C0LGV1 | RCH1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5390 | 0.9712 | 0.9233 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| eugene3.00020660 | hypothetical protein (1083 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1079 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-156 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 4e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.001 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 489 bits (1260), Expect = e-156
Identities = 340/1038 (32%), Positives = 524/1038 (50%), Gaps = 109/1038 (10%)
Query: 9 ILLFVNISLFPAISALNPEGLSLL-SWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSR 67
L+F+ LF S L+ E L LL S+ S+ N + S+WN S + C W I C+
Sbjct: 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLK--YLSNWNSSA-DVCLWQGITCN- 66
Query: 68 TEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTG 127
+ S + S+ LS N++G+I AI L + ++LS N L+G
Sbjct: 67 -------------------NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSG 107
Query: 128 NIPEEIGKLA-ELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEA 186
IP++I + L L+L++N+ G IPR G+ L L+L +N LSG IP +IG +
Sbjct: 108 PIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSS 165
Query: 187 LEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANI 246
L+++ GGN + G+IP ++N L FL LA + GQIPR +G++ +L+ + + N+
Sbjct: 166 LKVLDLGGNV-LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
Query: 247 TGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCS 306
+G IP EIG ++L +L L N + G IP LG+LKNL+ L L+QN LSG IP ++ +
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284
Query: 307 SLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRF 366
L +D+S NSL GE+P + L LE L L NN +G+IP + RL+ L+L +N+F
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 367 FGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKN 426
G+IP +G+ H N L LDLS N LTG +P L + N
Sbjct: 345 SGEIPKNLGK--------------HNN---------LTVLDLSTNNLTGEIPEGLCSSGN 381
Query: 427 LTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFT 486
L +L+L SN GEIP +G C L R+RL N+FSG +PS L + FL++S N
Sbjct: 382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ 441
Query: 487 GEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFG---LNVLDLSMNSIGGTIPENLGK 543
G I + L+M+ L +NK G +P S FG L LDLS N G +P LG
Sbjct: 442 GRINSRKWDMPSLQMLSLARNKFFGGLPDS----FGSKRLENLDLSRNQFSGAVPRKLGS 497
Query: 544 LTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSW 603
L+ L +L LS+N ++G IP L CK L LDLS N+
Sbjct: 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ----------------------- 534
Query: 604 NALTGPIPESFSNLSKLANLDLSNNMLTGSL-KVLGSLDNLVSLNVSYNHFSGILPNTKL 662
L+G IP SFS + L+ LDLS N L+G + K LG++++LV +N+S+NH G LP+T
Sbjct: 535 --LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 663 FHGLPASAFYGNQQLCVNRSQCHINNSLHGRNS-TKNLIICALLSVTVTLFIVLFGIILF 721
F + ASA GN LC + + R + + I L + L +V FG +
Sbjct: 593 FLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFI 652
Query: 722 IRFRGTTFRENDEEENELEWDF--TPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEI 779
+ + E+ E F + K + +++D+++ L + N++ +G G Y+ +
Sbjct: 653 RGRNNLELKRVENEDGTWELQFFDSKVSK-SITINDILSSLKEENVISRGKKGASYKGKS 711
Query: 780 PSRQV-IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838
+ VK++ V + +P +E+ +G ++H NIV+L+G C + + L+ +Y
Sbjct: 712 IKNGMQFVVKEINDVNS--IPS-----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764
Query: 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF 898
I +L+ +L L W+ R KI +G+A L +LH C P ++ ++ I++ +
Sbjct: 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820
Query: 899 EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT 958
E L L L + S++ Y+APE + ITEKSD+Y +G++L+E+LT
Sbjct: 821 EPHLR-LSLPGLLCTDTKCFISSA------YVAPETRETKDITEKSDIYGFGLILIELLT 873
Query: 959 GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCV 1018
GK P D+ I+ W +D + E+++V+ +AL C
Sbjct: 874 GKSPADAEFGVHGSIVEW--ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCT 931
Query: 1019 NPCPEERPTMKDVTAMLK 1036
P RP DV L+
Sbjct: 932 ATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 5e-46
Identities = 78/270 (28%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G G G VY+ + +++AVK L + E++ L + H NIVRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK-KDQTARREIRILRRLSHPNIVRLI 64
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
+ L+ +Y G L L + +++ KI L + GL YLH + II
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAK-KIALQILRGLEYLHSN---GII 120
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-YGYSLKITE 942
HRD+K NIL+ +ADFGLAK +SS + + G+ Y+APE
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLL--KSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 943 KSDVYSYGVVLLEVLTGKEP-TDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
K DV+S GV+L E+LTGK P + I D +I R D
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLI--------RRILGPPLEFDEPKWSSGS 230
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+E ++ L N P +RPT +++
Sbjct: 231 ---EEAKDLIKKCL---NKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 4e-43
Identities = 66/193 (34%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G G VY + + +A+K + K ++ E++ L + H NIV+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
+ L+ +Y GSL LL E + L D +I+L + GL YLH + IIH
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 885 RDIKSNNILVG-PQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-YGYSLKITE 942
RD+K NIL+ + LADFGL+KL S +S ++ G+ Y+APE +E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 943 KSDVYSYGVVLLE 955
KSD++S GV+L E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 764 NIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+G+G G VY + + +++A+K + K +R++ E++ L ++H NIVRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIK--KKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ L+ +Y G L LL ++ + ++R+ + + L YLH I
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-YLRQILSALEYLHSKG---I 118
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------YGY 936
+HRD+K NIL+ LADFGLA+ + E + G+ Y+APE YG
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEP--TDSRIPDGAHIITWVNGELRERKREFTTILDR 994
D++S GV+L E+LTGK P D ++ + I + + + +
Sbjct: 176 ------AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEA-K 228
Query: 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
L+ + LL + PE+R T ++
Sbjct: 229 DLIRK---------------LLVKD--PEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
++G+G G VY ++ + +++AVK + + E + E++ L S++H NIVR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 823 LGCC--NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWD-SRY-KIILGVAHGLAYLH-HD 877
G T + +Y+S GSL+ LL + + +Y + IL GLAYLH +
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL---EGLAYLHSNG 121
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---- 933
I+HRDIK NILV LADFG AK E+ + SV G+ ++APE
Sbjct: 122 ----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 934 --YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
YG +D++S G ++E+ TGK P
Sbjct: 178 EEYGR------AADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 45/289 (15%)
Query: 760 LSDTNIVGKGVSGIVYR-----VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI 814
L+ +G+G G VY+ + +AVK L + + + ++F E + + +
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58
Query: 815 RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL 874
H N+V+LLG C ++ +Y+ G L L + + L L +A G+ YL
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 875 HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS---VAGSYGYIA 931
IHRD+ + N LVG ++DFGL++ + R + ++A
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMA 171
Query: 932 PEYGYSLKI---TEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWV-NGELRERKR 986
PE SLK T KSDV+S+GV+L E+ T G++P ++ ++ NG +
Sbjct: 172 PE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLEYLKNGYRLPQPP 226
Query: 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
E+ ++ L C PE+RPT ++ +L
Sbjct: 227 NCP---------------PELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 46/283 (16%)
Query: 767 GKGVSGIVYR-----VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVR 821
G+G G VY+ +AVK L + + + ++F E + + + H NIV+
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNIVK 65
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVP 880
LLG C +++ +Y+ G L L + + L L +A G+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS---VAGSYGYIAPEYGYS 937
IHRD+ + N LVG ++DFGL++ + + + ++APE S
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPE---S 175
Query: 938 LKI---TEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWV-NGELRERKREFTTIL 992
LK T KSDV+S+GV+L E+ T G+EP A ++ ++ G +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM--SNAEVLEYLKKGYRLPKPPNCP--- 230
Query: 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
E+ +++ L C PE+RPT ++ +L
Sbjct: 231 ------------PELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 73/297 (24%), Positives = 122/297 (41%), Gaps = 59/297 (19%)
Query: 764 NIVGKGVSGIVYRVEI-----PSRQVIAVKKLWPVKNGELP-ERDQFSAEVQTLGSIRHK 817
+G+G G VY+ ++ + +V AVK L K ER F E + + + H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEV-AVKTL---KEDASEEERKDFLKEARVMKKLGHP 56
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV--------FLDWDSRYKIILGVAH 869
N+VRLLG C L+ +Y+ G L L + + L + +A
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
G+ YL +HRD+ + N LVG ++DFGL++ + R +
Sbjct: 117 GMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREF 988
+APE T KSDV+S+GV+L E+ T G P +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP-------------------------Y 208
Query: 989 TTILDRQLL--MRSGTQI-------QEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036
+ + ++L +R G ++ E+ +++ L C PE+RPT ++ L+
Sbjct: 209 PGLSNEEVLEYLRKGYRLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 81/280 (28%), Positives = 124/280 (44%), Gaps = 40/280 (14%)
Query: 767 GKGVSGIVYR-----VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGSIRHKNIV 820
G+G G VY+ + +AVK L K G ER++F E + + H NIV
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCV 879
RLLG C G ++ +Y+ G L L + L ++ L +A G+ YL +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNF- 123
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL- 938
+HRD+ + N LV ++DFGL++ + R ++APE SL
Sbjct: 124 ---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE---SLK 177
Query: 939 --KITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995
K T KSDV+S+GV+L E+ T G++P P N E+ E + D
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP----YPG------MSNEEVLEL------LEDGY 221
Query: 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
L R E+ +++ L C PE+RPT ++ L
Sbjct: 222 RLPRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+GKG G VY+ + + +A+K + ++++ E+Q L +H NIV+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLES---KEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH--HDCVPPI 882
++ ++ S GSL LL L + + GL YLH I
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG-----I 119
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------YGY 936
IHRDIK+ NIL+ E L DFGL+ ++A N++ G+ ++APE Y Y
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEP 962
K+D++S G+ +E+ GK P
Sbjct: 177 ------KADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+++G+G G+VY+ + + + +A+K++ K E E+ L +++H NIV+
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKY 64
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLH------EKKVFLDWDSRYKIILGVAHGLAYLHH 876
+G + ++ +Y NGSL ++ E V + Y + V GLAYLH
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----AVY--VYQVLQGLAYLHE 117
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGY 936
+IHRDIK+ NIL LADFG+A + ++ S+ SV G+ ++APE
Sbjct: 118 Q---GVIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEP 962
+ SD++S G ++E+LTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 71/218 (32%), Positives = 112/218 (51%), Gaps = 35/218 (16%)
Query: 761 SDTNIV---GKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH 816
SD V G+G SG+VY+V P+ ++ A+KK+ V +G+ R Q E++TL S
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HV-DGDEEFRKQLLRELKTLRSCES 58
Query: 817 KNIVRLLGC-CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG-----VAHG 870
+V+ G G ++L +Y+ GSLA LL + + +L + G
Sbjct: 59 PYVVKCYGAFYKEGEISIVL-EYMDGGSLADLLKKVGKIPE------PVLAYIARQILKG 111
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
L YLH IIHRDIK +N+L+ + E +ADFG++K+ E++ N+ G+ Y+
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYM 167
Query: 931 APE------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+PE Y Y+ +D++S G+ LLE GK P
Sbjct: 168 SPERIQGESYSYA------ADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 763 TNIVGKGVSGIVYR--VEIPSRQVI--AVKKLWPVKNGELP-ERDQFSAEVQTLGSIRHK 817
++G G G V R +++P ++ I A+K L K G +R F E +G H
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL---KAGSSDKQRLDFLTEASIMGQFDHP 65
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
NI+RL G R +++ +Y+ NGSL L E ++ G+A G+ YL
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
+HRD+ + NILV ++DFGL++ E SE++ + + APE
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 938 LKITEKSDVYSYGVVLLEVLT-GKEP 962
K T SDV+S+G+V+ EV++ G+ P
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 32/214 (14%)
Query: 763 TNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERD--QFSAEVQTLGSIRH--- 816
++G+G G VYR +P+ +V+A+K + N + P+ D EV L +R
Sbjct: 6 LELIGRGAYGAVYRGKHVPTGRVVALK----IINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK--IILGVAHGLAYL 874
NI + G G ++ +Y GS+ L+ + +Y II V L Y+
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI----AEKYISVIIREVLVALKYI 117
Query: 875 HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY 934
H +IHRDIK+ NILV L DFG+A L + S R+ + G+ ++APE
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS--TFVGTPYWMAPEV 172
Query: 935 GYSLKITE------KSDVYSYGVVLLEVLTGKEP 962
ITE K+D++S G+ + E+ TG P
Sbjct: 173 -----ITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 45/278 (16%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+GKG G VY V S + V K + N ER+ EV+ L + H NI++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKII---LGVAHGLAYLH--HDCVP 880
++ +Y G L+ + ++K +I+ + + L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---- 123
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------Y 934
I+HRDIK NI + L DFG++K+ S+ + +V G+ Y++PE Y
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPY 180
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR-IPDGAHIITWVNGELRERKREFTTILD 993
Y KSD++S G VL E+ T K P + + + A I + G+ ++++ L
Sbjct: 181 NY------KSDIWSLGCVLYELCTLKHPFEGENLLELALKI--LKGQYPPIPSQYSSEL- 231
Query: 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
R L + +LQ PEERP++ +
Sbjct: 232 RNL-------VSSLLQ----------KDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 767 GKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
G G SG+V +V P+ +++AVK + + Q E+ L IV G
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 826 C-NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
NNG + + +Y+ GSL +L E + + KI + V GL YLH IIH
Sbjct: 68 FYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIH 124
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA----GSYGYIAPEYGYSLKI 940
RD+K +NILV + + L DFG+ S + NS+A G+ Y+APE
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGV--------SGQLVNSLAKTFVGTSSYMAPERIQGNDY 176
Query: 941 TEKSDVYSYGVVLLEVLTGKEP 962
+ KSD++S G+ L+E+ TG+ P
Sbjct: 177 SVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 105 bits (261), Expect = 5e-24
Identities = 78/299 (26%), Positives = 121/299 (40%), Gaps = 24/299 (8%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH-KNIVRLLG 824
+G+G G VY R+++A+K L + E ++F E+Q L S+ H NIV+L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHE--KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ + L+ +Y+ GSL LL + +K L I+ + L YLH I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122
Query: 883 IHRDIKSNNILVGPQ-FEAFLADFGLAKLFESSESSRA----SNSVAGSYGYIAPEYGYS 937
IHRDIK NIL+ L DFGLAKL S+ + ++ G+ GY+APE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 938 L---KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994
L + SD++S G+ L E+LTG P + A T L + L
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII-LELPTPSLASPLSP 241
Query: 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM-LKEIRHENDDLEKPNSLS 1052
++L+ + P+ R + + L +
Sbjct: 242 SNPELISKAASDLLKK------LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 82/295 (27%), Positives = 130/295 (44%), Gaps = 50/295 (16%)
Query: 766 VGKGVSGIVYRVEI------PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
+G+G G VY+ E+ S +A+K L +N E + +F E + + ++H NI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLL---------------HEKKVFLDWDSRYKII 864
V LLG C + +LF+Y+++G L L K LD I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 865 LGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922
+ +A G+ YL HH +HRD+ + N LVG ++DFGL++ S++ R +
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 923 VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGEL 981
++ PE K T +SD++S+GVVL E+ + G +P + N E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP----------YYGFSNQEV 235
Query: 982 RERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036
E R RQLL +V + + C N P RP KD+ L+
Sbjct: 236 IEMIRS------RQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKL----WPVKNGELPERDQFSAEVQTLGSIRHKN 818
++G G + +VY +P+ + +A+K++ D+ EVQ + H N
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ------TSVDELRKEVQAMSQCNHPN 60
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEK--KVFLDWDSRYKIILGVAHGLAYLHH 876
+V+ G L+ Y+S GSL ++ + LD ++ V GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGL-AKLFESSE-SSRASNSVAGSYGYIAPE- 933
+ IHRDIK+ NIL+G +ADFG+ A L + + + + + G+ ++APE
Sbjct: 121 N---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+GY K+D++S+G+ +E+ TG P
Sbjct: 178 MEQVHGY----DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSA----EVQTLGSIRHKN 818
+G+G G VY+ + +++A+KK+ ++N E++ F E++ L +RH N
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI-RMEN----EKEGFPITAIREIKLLQKLRHPN 59
Query: 819 IVRLLG-CCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHH 876
IVRL + G+ + ++F+Y+ + L GLL +V + + GL YLH
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--- 933
+ I+HRDIK +NIL+ LADFGLA+ + S+ +N V + Y PE
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW-YRPPELLL 174
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
YG + D++S G +L E+ GK
Sbjct: 175 GATRYGP------EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 37/280 (13%)
Query: 754 DDVVTRLSDTNIVGKGVSGIVY--RVEIP---SRQVIAVKKLWPVKNGELPERDQFSAEV 808
+ + +G+G G V R + + + +AVK L +GE R F E+
Sbjct: 3 KRHLKFIKQ---LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH--SGEEQHRSDFEREI 57
Query: 809 QTLGSIRHKNIVRLLGCC--NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG 866
+ L ++ H+NIV+ G C GR+ L+ +Y+ +GSL L + ++
Sbjct: 58 EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ 117
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
+ G+ YL IHRD+ + NILV + ++DFGLAK+ + S
Sbjct: 118 ICKGMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 927 --YGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER 984
+ Y APE + K + SDV+S+GV L E+ T +P+ S
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA---------------- 217
Query: 985 KREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEE 1024
EF ++ T++ E+L+ G L CP+E
Sbjct: 218 --EFLRMIGIAQGQMIVTRLLELLKE-GERLPRPPSCPDE 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 765 IVGKGVSGIVY-RVEIPSRQVIAVKK--LWPVKNGELPER-----DQFSAEVQTLGSIRH 816
++GKG G VY + + + +++AVK+ L G R +E++TL + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHH 876
NIV+ LG + +Y+ GS+ L F + R+ V GLAYLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-FTEQVLEGLAYLHS 126
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--- 933
I+HRD+K++N+LV ++DFG++K + + + S+ GS ++APE
Sbjct: 127 K---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 934 ---YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
GYS K+ D++S G V+LE+ G+ P
Sbjct: 184 SYSQGYSAKV----DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 5e-23
Identities = 66/203 (32%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+GKG G V V + + ++ A+K L K + E + E L I H IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 825 CCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH-HDCV 879
+L L+ +Y G L L ++ F + +R+ +I+L L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLHSLG-- 113
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLK 939
II+RD+K NIL+ L DFGLAK S S N+ G+ Y+APE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT--NTFCGTPEYLAPEVLLGKG 169
Query: 940 ITEKSDVYSYGVVLLEVLTGKEP 962
+ D +S GV+L E+LTGK P
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G V+ +R +A+K L K+ +L ++ F EVQ L +RHK+++ L
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKIL---KSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 826 CNNGRTRLLLFDYISNGSLAGLLH--EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
C+ G ++ + + GSL L E +V L S + VA G+AYL I
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ---NSI 126
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEK 943
HRD+ + NILVG +ADFGLA+L + + + Y + APE + K
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTK 184
Query: 944 SDVYSYGVVLLEVLT-GKEP 962
SDV+S+G++L E+ T G+ P
Sbjct: 185 SDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 11/215 (5%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSA---EVQTLGSIRHKNIV 820
++GKG G VY Q+IAVK++ + L ++ EV L S++H NIV
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
+ LG C + T + +++ GS++ +L+ + K + G+AYLH++CV
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVAYLHNNCV- 123
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLA-KLFESSESSRASN---SVAGSYGYIAPEYGY 936
+HRDIK NN+++ P L DFG A +L SN S+ G+ ++APE
Sbjct: 124 --VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA 971
KSD++S G + E+ TGK P S A
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 71/270 (26%), Positives = 121/270 (44%), Gaps = 38/270 (14%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G+V+ + + +A+K + + G + E D F E + + + H N+V+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSE-DDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885
C R ++ +Y++NG L L E+K L + + V + YL + IHR
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF---IHR 124
Query: 886 DIKSNNILVGPQFEAFLADFGLAKL-----FESSESSRASNSVAGSYGYIAPEYGYSLKI 940
D+ + N LVG ++DFGLA+ + SS+ ++ A PE +
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA------PPEVFDYSRF 178
Query: 941 TEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMR 999
+ KSDV+S+GV++ EV + GK P + + N E+ E + L R
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYE----------RFSNSEVVES------VSAGYRLYR 222
Query: 1000 SGTQIQEMLQVLGVALLCVNPCPEERPTMK 1029
E+ ++ C + PE+RP K
Sbjct: 223 PKLAPTEVYTIMY---SCWHEKPEDRPAFK 249
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 80/301 (26%), Positives = 131/301 (43%), Gaps = 62/301 (20%)
Query: 766 VGKGVSGIVYRVE----IP--SRQVIAVKKLWPVKNGELPE-RDQFSAEVQTLGSIRHKN 818
+G+G G V+ E P ++++AVK L K + R F E + L + +H+N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL---KETASNDARKDFEREAELLTNFQHEN 69
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLH-------------EKKVFLDWDSRYKIIL 865
IV+ G C G +++F+Y+ +G L L L +I +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 866 GVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSV 923
+A G+ YL H +HRD+ + N LVG + DFG+++ +++ R
Sbjct: 130 QIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 924 AGSYGYIAPE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWV-- 977
++ PE Y K T +SDV+S+GVVL E+ T GK+P W
Sbjct: 185 MLPIRWMPPESIMYR---KFTTESDVWSFGVVLWEIFTYGKQP-------------WYGL 228
Query: 978 -NGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036
N E+ E I +LL R T E+ ++ L C P++R +KD+ L+
Sbjct: 229 SNEEVIE------CITQGRLLQRPRTCPSEVYDIM---LGCWKRDPQQRINIKDIHERLQ 279
Query: 1037 E 1037
+
Sbjct: 280 K 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 7e-22
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 10/212 (4%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
S D + +G+G SG VY+ + + + +A+KK+ ++ ++ E+
Sbjct: 13 SEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRK---QNKELIINEILI 68
Query: 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+ +H NIV G ++ +Y+ GSL ++ + V ++ + V G
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
L YLH +IHRDIKS+NIL+ LADFG A +S R NSV G+ ++
Sbjct: 129 LEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWM 183
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
APE K D++S G++ +E+ G+ P
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 8/204 (3%)
Query: 764 NIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
N +GKG G+V++V + ++V A+K++ + ER++ E + L + I+R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQI-DLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLH-EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
+ ++ +Y NG L LL ++ L D ++ + + GLA+LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---K 121
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
I+HRDIKS N+ + + D G+AKL S+++ +N++ G+ Y++PE
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 942 EKSDVYSYGVVLLEVLTGKEPTDS 965
EKSDV++ GVVL E TGK P D+
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 75/246 (30%), Positives = 111/246 (45%), Gaps = 31/246 (12%)
Query: 785 IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844
+AVK L K G + F E Q + +RH +V+L C+ ++ +Y+S GSL
Sbjct: 33 VAVKTL---KPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL 88
Query: 845 AGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLA 903
L + L + +A G+AYL IHRD+ + NILVG +A
Sbjct: 89 LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY---IHRDLAARNILVGENLVCKIA 145
Query: 904 DFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPT 963
DFGLA+L E E + A + APE + T KSDV+S+G++L E++T
Sbjct: 146 DFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT----- 199
Query: 964 DSRIP-DGAHIITWVNGELRERKREFTTILDRQLLM-RSGTQIQEMLQVLGVALLCVNPC 1021
R+P G RE ++R M R +E+ ++ L C +
Sbjct: 200 YGRVPYPGMT------------NREVLEQVERGYRMPRPPNCPEELYDLM---LQCWDKD 244
Query: 1022 PEERPT 1027
PEERPT
Sbjct: 245 PEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+GKG G V + ++V AVK L K+ + F AE + ++RH N+V+LLG
Sbjct: 14 IGKGEFGDVMLGDYRGQKV-AVKCL---KD-DSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
G ++ +Y++ GSL L + + + + L V G+ YL +H
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS 944
RD+ + N+LV A ++DFGLAK E+S+ +S + APE K + KS
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 945 DVYSYGVVLLEVLT-GKEPTDSRIP 968
DV+S+G++L E+ + G+ P RIP
Sbjct: 181 DVWSFGILLWEIYSFGRVPY-PRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 17/208 (8%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
N +G G G VY V + + +++AVK++ +++ + + + E++ L ++H N+V+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 823 LGCCNNGRTRLLLF-DYISNGSLAGLLHEKKVFLDWD--SRYKIILGVAHGLAYLHHDCV 879
G R ++ +F +Y S G+L LL ++ LD Y + L GLAYLH
Sbjct: 65 YGV-EVHREKVYIFMEYCSGGTLEELLEHGRI-LDEHVIRVYTLQLLE--GLAYLHSH-- 118
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS--NSVAGSYGYIAPEYGYS 937
I+HRDIK NI + L DFG A +++ ++ S+AG+ Y+APE
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 938 LKITEK---SDVYSYGVVLLEVLTGKEP 962
K +D++S G V+LE+ TGK P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 71/208 (34%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPER--DQFSAEVQTLGSIRHKNIVRL 822
+G G G VY + + AVK++ +G+ + Q E+ L ++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSR-Y--KIILGVAHGLAYLHHDCV 879
LG + + + GSLA LL + F + R Y +I+LG L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR-- 121
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY----- 934
+HRDIK NILV LADFG+AK + E S A S GS ++APE
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAK-SFKGSPYWMAPEVIAQQG 177
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
GY L D++S G +LE+ TGK P
Sbjct: 178 GYGLAA----DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 9/202 (4%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G+V+ ++ +A+K ++ G + E D F E Q + + H +V+L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT---IREGAMSEED-FIEEAQVMMKLSHPKLVQLYGV 67
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885
C L+F+++ +G L+ L ++ ++ + L V G+AYL V IHR
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV---IHR 124
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSD 945
D+ + N LVG ++DFG+ + F + +S + +PE K + KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 946 VYSYGVVLLEVLT-GKEPTDSR 966
V+S+GV++ EV + GK P ++R
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENR 205
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 765 IVGKGVSGIVYR--VEIPSRQ--VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
++G G G V+R +++P R+ +A+K L P + +R F +E +G H NI+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNII 69
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
RL G + +++ +Y+ NG+L L + ++ G+A G+ YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---M 126
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS-ESSRASNSVAGSYGYIAPEYGYSLK 939
+HRD+ + NILV E ++DFGL+++ E E + ++ + APE K
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 940 ITEKSDVYSYGVVLLEVLT-GKEP 962
T SDV+S+G+V+ EV++ G+ P
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-20
Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 36/215 (16%)
Query: 765 IVGKGVSGIVYRVEIPSRQV-IAVKKLWPVKNGELPERDQFSAEVQTL-------GSIRH 816
++GKG GIVY S QV IA+K E+PERD S VQ L ++H
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIK--------EIPERD--SRYVQPLHEEIALHSYLKH 64
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG--VAHGLAYL 874
+NIV+ LG + + + + GSL+ LL K L + + I + GL YL
Sbjct: 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 875 HHDCVPPIIHRDIKSNNILVGPQFEAF-LADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
H + I+HRDIK +N+LV ++DFG +K + + + + G+ Y+APE
Sbjct: 125 HDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAPE 179
Query: 934 Y------GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
GY +D++S G ++E+ TGK P
Sbjct: 180 VIDKGPRGYG----APADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-20
Identities = 67/209 (32%), Positives = 111/209 (53%), Gaps = 15/209 (7%)
Query: 765 IVGKGVSGIVY-RVEIPSRQVIAVKKL---WPVKNGELPERDQFSA---EVQTLGSIRHK 817
++G G G VY + S +++AVK++ + + +R A E+ L ++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
NIV+ LG + + +Y+ GS+A LL+ F + R + + GL YLH+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLHNR 125
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN----SVAGSYGYIAPE 933
IIHRDIK NILV + ++DFG++K E++ S +N S+ GS ++APE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
T K+D++S G +++E+LTGK P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G+G G VY+ + + QV+A+K + PV+ + + E+ L IV+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV-PVEE----DLQEIIKEISILKQCDSPYIVKYY 64
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
G ++ +Y GS++ ++ L + I+ GL YLH + I
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKI 121
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEK 943
HRDIK+ NIL+ + +A LADFG++ + +++ N+V G+ ++APE + K
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179
Query: 944 SDVYSYGVVLLEVLTGKEP 962
+D++S G+ +E+ GK P
Sbjct: 180 ADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 783 QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCC-NNGRTRL-LLFDYIS 840
+V+AVKKL L RD F E++ L S++H NIV+ G C + GR L L+ +Y+
Sbjct: 34 EVVAVKKLQHSTAEHL--RD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 841 NGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEA 900
GSL L + + LD + G+ YL +HRD+ + NILV +
Sbjct: 91 YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRV 147
Query: 901 FLADFGLAKLF-ESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTG 959
+ DFGL K+ + E + + APE K + SDV+S+GVVL E+ T
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 207
Query: 960 KEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEML----QVLGVAL 1015
+ + S + ++ G ++ + +++ L+++ ++ ++ +
Sbjct: 208 SDKSCSPPAEFMRMM----GNDKQGQMIVYHLIE---LLKNNGRLPAPPGCPAEIYAIMK 260
Query: 1016 LCVNPCPEERPTMKDVTAMLKEIR 1039
C N P +RP+ ++ ++ IR
Sbjct: 261 ECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 766 VGKGVSGIVYRVE----IPS--RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
+G+G G V+ E +P + ++AVK L K R F E + L ++H++I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTVLQHQHI 69
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSL----------AGLLHEKKVF----LDWDSRYKIIL 865
VR G C GR L++F+Y+ +G L A +L + L I
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 866 GVAHGLAYL---HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922
+A G+ YL H +HRD+ + N LVG + DFG+++ S++ R
Sbjct: 130 QIASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183
Query: 923 VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
++ PE K T +SD++S+GVVL E+ T GK+P
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 765 IVGKGVSGIVY--RVEIPSR--QVIAVKKLWPVKNGELPE-RDQFSAEVQTLGSIRHKNI 819
++G G G V R+++P + +A+K L K+G + R F +E +G H NI
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL---KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIIL------GVAHGLAY 873
+ L G R +++ +++ NG+L L + D ++ +I G+A G+ Y
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQN------DGQFTVIQLVGMLRGIAAGMKY 121
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS---YGYI 930
L +HRD+ + NILV ++DFGL++ E S S G +
Sbjct: 122 LSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
APE K T SDV+SYG+V+ EV++ G+ P
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 5e-19
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA----EVQTLGSIRHKNI 819
+G+G G+VY+ + + +++A+KK ++ E + + E+ L ++H NI
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKK---IRLDN--EEEGIPSTALREISLLKELKHPNI 60
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG-VAHGLAYLHHDC 878
V+LL + R L+F+Y L L ++ L + K I+ + GLAY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS-PNLIKSIMYQLLRGLAYCHSHR 118
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----- 933
I+HRD+K NIL+ LADFGLA+ F ++ V + Y APE
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVVTLW-YRAPEILLGS 173
Query: 934 --YGYSLKITEKSDVYSYGVVLLEVLTGKE--PTDSRI 967
Y ++ D++S G + E++TGK P DS I
Sbjct: 174 KHYSTAV------DIWSVGCIFAEMITGKPLFPGDSEI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 758 TRLSDTNIVGKGVSGIVY--RVEIPSRQVIAVK-KLWPVKNGELPERDQFSAEVQTLGSI 814
+ + ++G G G V R+++P ++ I V K E RD F +E +G
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQF 62
Query: 815 RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIIL------GVA 868
H NI+ L G + +++ +Y+ NGSL L + D ++ +I G+A
Sbjct: 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH------DGQFTVIQLVGMLRGIA 116
Query: 869 HGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS-ESSRASNSVAGSY 927
G+ YL +HRD+ + NILV ++DFGL+++ E E++ +
Sbjct: 117 SGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173
Query: 928 GYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+ APE K T SDV+SYG+V+ EV++ G+ P
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 759 RLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERD--QFSAEVQTLGSIR 815
+ +GKG G VY+ ++ + QV+A+K + + E E + E+Q L R
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI----DLEEAEDEIEDIQQEIQFLSQCR 57
Query: 816 HKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH 875
I + G G ++ +Y GS LL K LD I+ V GL YLH
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK--LDETYIAFILREVLLGLEYLH 115
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY- 934
+ IHRDIK+ NIL+ + + LADFG++ S+ S R N+ G+ ++APE
Sbjct: 116 EEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR--NTFVGTPFWMAPEVI 170
Query: 935 ---GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
GY EK+D++S G+ +E+ G+ P
Sbjct: 171 KQSGYD----EKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 766 VGKGVSGIVYRVEI----PS--RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
+G+G G V+ E P+ + ++AVK L K+ L R F E + L +++H++I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHI 69
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLH----EKKVFLDWDSR-----------YKII 864
V+ G C +G +++F+Y+ +G L L + + +D R I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 865 LGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA 924
+A G+ YL +HRD+ + N LVG + DFG+++ S++ R
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
++ PE K T +SDV+S+GV+L E+ T GK+P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 79/274 (28%), Positives = 124/274 (45%), Gaps = 30/274 (10%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGEL-PERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G G V+ +A+K L P G + PE F E Q + +RH+ +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPE--AFLQEAQVMKKLRHEKLVQLYA 68
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLH-EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
+ ++ +Y+S GSL L E +L + +A G+AY+ +
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 124
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEK 943
HRD+++ NILVG +ADFGLA+L E +E + A + APE + T K
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 944 SDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQ 1003
SDV+S+G++L E+ T R+P + RE ++R M +
Sbjct: 184 SDVWSFGILLTEL-----TTKGRVPYPGMV-----------NREVLDQVERGYRMPCPPE 227
Query: 1004 IQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037
E L L C PEERPT + + A L++
Sbjct: 228 CPESLHDL--MCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+ +G+G G V + + + +I K ++ Q E++ S + IV+
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK-QILRELEINKSCKSPYIVKYY 65
Query: 824 GCCNNGRTRLL--LFDYISNGSLAGLLHE---------KKVFLDWDSRYKIILGVAHGLA 872
G + + + +Y GSL + + +KV KI V GL+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG------KIAESVLKGLS 119
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG---- 928
YLH IIHRDIK +NIL+ + + L DFG+ S NS+AG++
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV--------SGELVNSLAGTFTGTSF 168
Query: 929 YIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG 970
Y+APE + SDV+S G+ LLEV + P P+G
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF---PPEG 207
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 14/182 (7%)
Query: 785 IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844
+AVK L K G + +D F AE Q + +RH +++L C ++ + + GSL
Sbjct: 33 VAVKTL---KPGTMDPKD-FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL 88
Query: 845 AGLLHEKKV-FLDWDSRYKIILGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAF 901
L L + VA G+AYL + IHRD+ + N+LVG
Sbjct: 89 LEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN-----YIHRDLAARNVLVGENNICK 143
Query: 902 LADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GK 960
+ADFGLA++ + A + APE + + KSDV+S+G++L E++T G+
Sbjct: 144 VADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
Query: 961 EP 962
P
Sbjct: 203 MP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 758 TRLSDTNIVGKGVSGIVY---------RVEIPSRQVIAVKKLWPVKNGELPERDQ-FSAE 807
T L ++G G G VY +V+IP +A+K L + P+ ++ E
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIP----VAIKVL---REETSPKANKEILDE 59
Query: 808 VQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGV 867
+ S+ H ++VRLLG C L+ + G L + K + + +
Sbjct: 60 AYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI 118
Query: 868 AHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAG 925
A G++YL ++HRD+ + N+LV + DFGLAKL + E +
Sbjct: 119 AKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173
Query: 926 SYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDS 965
++A E T KSDV+SYGV + E++T G +P +
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G G V +V+ IP+ V+A K + + R Q E+Q + R IV G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV--RKQILRELQIMHECRSPYIVSFYG 70
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVF--LDWDSRYKIILGVAHGLAYLHHDCVPPI 882
N + +++ GSL + K + + KI + V GL YL++ V I
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRI 125
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA----GSYGYIAPEYGYSL 938
+HRDIK +NILV + + L DFG+ S NS+A G+ Y++PE
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGV--------SGELINSIADTFVGTSTYMSPERIQGG 177
Query: 939 KITEKSDVYSYGVVLLEVLTGKEP-TDSRIPDGA 971
K T KSDV+S G+ ++E+ GK P S I D
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 32/228 (14%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPE-RDQFSAEVQTLGSIRHKNIVRLLG 824
+GKG G VY+ + +AVK ++ P+ + +F E + L H NIV+L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKT---CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
C + ++ + + GSL L +KK L ++ L A G+ YL IH
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---IH 116
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE---YGY 936
RD+ + N LVG ++DFG+ S E +V+ I APE YG
Sbjct: 117 RDLAARNCLVGENNVLKISDFGM-----SREEEGGIYTVSDGLKQIPIKWTAPEALNYG- 170
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER 984
+ T +SDV+SYG++L E + D+ P N + RER
Sbjct: 171 --RYTSESDVWSYGILLWETFSLG---DTPYPG------MSNQQTRER 207
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-18
Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 758 TRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGEL-PERD-QFSAEVQTLGSI 814
T L ++G G G VY+ + +P + + + + N P+ + +F E + S+
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66
Query: 815 RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK------VFLDWDSRYKIILGVA 868
H ++VRLLG C + +L+ + +G L +HE K + L+W + +A
Sbjct: 67 DHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIA 119
Query: 869 HGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG 928
G+ YL ++HRD+ + N+LV + DFGLA+L E E ++
Sbjct: 120 KGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 929 YIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDS----RIPD 969
++A E + K T +SDV+SYGV + E++T G +P D IPD
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD 222
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 764 NIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELP--ERDQFSAEVQTLGSIRHKNIV 820
+GKG G V +V +++ K++ G + E+ Q +EV L ++H NIV
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 821 RLLGCCNNGRTRLL--LFDYISNGSLAGLL---HEKKVFLDWDSRYKIILGVAHGLAYLH 875
R + + L + +Y G LA L+ +++ +++ + ++I+ + L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 876 HDCVPP--IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
+ P ++HRD+K NI + L DFGLAK+ SS A V Y Y++PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYVGTPY-YMSPE 180
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ EKSD++S G ++ E+ P
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-18
Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 33/225 (14%)
Query: 766 VGKGVSGIVYRVEIPS------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
+G+G G V++ P ++AVK L + + F E + H NI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDHPNI 70
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLH---------------------EKKVFLDWD 858
V+LLG C G+ LLF+Y++ G L L + L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 859 SRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918
+ I VA G+AYL +HRD+ + N LVG +ADFGL++ S++ +
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
AS + A ++ PE + + T +SDV++YGVVL E+ + G +P
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G+V + + +A+K +K G + E D+F E + + + H+ +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKM---IKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885
C R ++ +Y+SNG L L E ++ V G+AYL IHR
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSY--GYIAPEYGYSLKITEK 943
D+ + N LV Q ++DFGL++ E ++SV + + PE K + K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 944 SDVYSYGVVLLEVLT-GKEPTD 964
SDV+++GV++ EV + GK P +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 38/285 (13%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
VG+G G+V + + +++A+KK ++ E ++ EV+ L +RH+NIV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKE 67
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPII 883
L+F+Y+ +L LL L D+ I + +AY H H+ II
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN----II 122
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-------YGY 936
HRDIK NILV L DFG A+ + +S ++ VA + Y APE YG
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAPELLVGDTNYGK 181
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKE--PTDSRIPDGAHIITWVNGELRERKRE------- 987
+ DV++ G ++ E+L G+ P DS I D ++I G L +E
Sbjct: 182 PV------DVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSNPR 234
Query: 988 -----FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPT 1027
F + L R L C+ P+ER T
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVS-SPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 767 GKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
GKG G VY+V+ + Q A+K++ + + ER+ E++ L S+ H NI+
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 826 CNNGRTRLLLFDYISNGSLAGLL---HEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+G ++ +Y G L+ + +K+ + ++I + + GL LH I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
+HRD+KS NIL+ + D G++K+ + + G+ Y+APE +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 943 KSDVYSYGVVLLEVLTGKEPTDSR 966
KSD++S G +L E+ T P ++R
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 758 TRLSDTNIVGKGVSGIVYRVEI------PSRQVIAVKKLWPVKNGELPERD--QFSAEVQ 809
RL+ +G+G G V + E +AVK L + E+D +E++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSDLVSEME 67
Query: 810 TLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLH-------EKKVFLDWDSRY 861
+ I +HKNI+ LLG C ++ +Y ++G+L L
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 862 KIIL--------GVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913
+ VA G+ +L IHRD+ + N+LV +ADFGLA+
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT 958
+ R + + ++APE + T +SDV+S+GV+L E+ T
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 30/209 (14%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQ---FSA--EVQTLGSIRHKNI 819
+G+G +VY+ + + +++A+KK +K GE E F+A E++ L ++H NI
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKK---IKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK-IILGVAHGLAYLHHDC 878
+ LL + L+F+++ L ++ +K + L + K +L GL YLH +
Sbjct: 65 IGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLT-PADIKSYMLMTLRGLEYLHSNW 122
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----- 933
I+HRD+K NN+L+ LADFGLA+ F S V Y APE
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT--RWYRAPELLFGA 177
Query: 934 --YGYSLKITEKSDVYSYGVVLLEVLTGK 960
YG + D++S G + E+L
Sbjct: 178 RHYGVGV------DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 41/287 (14%)
Query: 767 GKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCC 826
GK G +Y + Q++A+K L + N + + +F E + + H NIV LLG
Sbjct: 19 GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ--QWGEFQQEASLMAELHHPNIVCLLGVV 76
Query: 827 NNGRTRLLLFDYISNGSLAGLLHEK----------------KVFLDWDSRYKIILGVAHG 870
+ +LF+Y++ G L L + K LD I + +A G
Sbjct: 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAG 136
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
+ YL +H+D+ + NIL+G Q ++D GL++ S++ R ++
Sbjct: 137 MEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM 193
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFT 989
PE K + SD++S+GVVL E+ + G +P + N E+ E R+
Sbjct: 194 PPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP----------YYGFSNQEVIEMVRK-- 241
Query: 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036
RQLL S M ++ C P RP KD+ L+
Sbjct: 242 ----RQLLPCSEDCPPRMYSLMTE---CWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 757 VTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSA----EVQTL 811
VT N +G+G GIVYR + S +++A+KK V+ ERD E+ L
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKK---VRMDN--ERDGIPISSLREITLL 60
Query: 812 GSIRHKNIVRLLGCCNNGR--TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK-IILGVA 868
++RH NIV L + L+ +Y LA LL +S+ K ++L +
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFS-ESQVKCLMLQLL 118
Query: 869 HGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG 928
GL YLH + IIHRD+K +N+L+ + +ADFGLA+ + V +
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLW 173
Query: 929 YIAPE--YGYSLKITEKSDVYSYGVVLLEVLTGK 960
Y APE G T D+++ G +L E+L K
Sbjct: 174 YRAPELLLG-CTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 34/274 (12%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G+V+ + ++ +A+K + G + E D F E + + + H +V+L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEED-FIEEAKVMMKLSHPKLVQLYGV 67
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885
C + ++ +++ NG L L +++ L D + V G+ YL + IHR
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLF---ESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
D+ + N LV ++DFG+ + E + SS A V S PE K +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS----PPEVFNFSKYSS 180
Query: 943 KSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
KSDV+S+GV++ EV T GK P + + ++ ++ R + + +
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMISRGFRLYRPKLAS----------- 227
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
+ V V C + PE RPT ++ +
Sbjct: 228 ------MTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+GKG G V + +V AVK +KN + F AE + +RH N+V+LLG
Sbjct: 13 TIGKGEFGDVMLGDYRGNKV-AVK---CIKNDATAQ--AFLAEASVMTQLRHSNLVQLLG 66
Query: 825 CCNNGRTRL-LLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ L ++ +Y++ GSL L + + L D K L V + YL +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
+HRD+ + N+LV A ++DFGL K E+S ++ + APE K +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 943 KSDVYSYGVVLLEVLT-GKEPTDSRIP 968
KSDV+S+G++L E+ + G+ P RIP
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPY-PRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 76/273 (27%), Positives = 121/273 (44%), Gaps = 28/273 (10%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G+G G V+ +A+K L P +PE F E Q + +RH +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPE--AFLQEAQIMKKLRHDKLVPLYAV 69
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
+ ++ +++ GSL L E +L + +A G+AY+ IH
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIH 125
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS 944
RD+++ NILVG +ADFGLA+L E +E + A + APE + T KS
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 945 DVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQI 1004
DV+S+G++L E++ T R+P + RE ++R M
Sbjct: 185 DVWSFGILLTELV-----TKGRVPYPGMV-----------NREVLEQVERGYRMPCPQGC 228
Query: 1005 QEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037
E L L LC P+ERPT + + + L++
Sbjct: 229 PESLHEL--MKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 77/306 (25%), Positives = 133/306 (43%), Gaps = 38/306 (12%)
Query: 738 ELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRV--EIPSRQVIAVKKLWPVKN 795
+L+W+F P L+F + GK V Y + +V AVK L P
Sbjct: 27 DLKWEF-PRNNLSFG------KTLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKP--T 76
Query: 796 GELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK-V 853
ER+ +E++ + + H+NIV LLG C G L++ +Y G L L K+
Sbjct: 77 AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES 136
Query: 854 FLDWDSRYKIILGVAHGLAYL-HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912
FL + VA G+A+L +C IHRD+ + N+L+ + DFGLA+
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIM 192
Query: 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGA 971
+ + + ++APE ++ T +SDV+SYG++L E+ + G P +P +
Sbjct: 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG-MPVDS 251
Query: 972 HIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ R + E +I ++++ C + P +RPT K +
Sbjct: 252 KFYKLIKEGYRMAQPEHAP-----------AEIYDIMKT------CWDADPLKRPTFKQI 294
Query: 1032 TAMLKE 1037
++ +
Sbjct: 295 VQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G G VY+ +I + +++A+K + ++ G+ + + E+ L RH NIV G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI-KLEPGD--DFEIIQQEISMLKECRHPNIVAYFG 67
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
++ +Y GSL + + L + GLAYLH IH
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK---IH 124
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-------YGYS 937
RDIK NIL+ + LADFG++ ++ + R S G+ ++APE GY
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--KSFIGTPYWMAPEVAAVERKGGY- 181
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEP 962
K D+++ G+ +E+ + P
Sbjct: 182 ---DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 50/295 (16%)
Query: 766 VGKGVSGIVYRVEI----PSRQ--VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
+G+G G V+ E P + ++AVK L K+ R F E + L +++H++I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQHEHI 69
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLH------------EKKVFLDWDSRYKIILGV 867
V+ G C G +++F+Y+ +G L L + L I +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 868 AHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSY 927
A G+ YL +HRD+ + N LVG + DFG+++ S++ R
Sbjct: 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 928 GYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWV---NGELRE 983
++ PE K T +SDV+S GVVL E+ T GK+P W N E+ E
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-------------WYQLSNNEVIE 233
Query: 984 RKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
I ++L R T +E+ ++ L C P R +K++ ++L+ +
Sbjct: 234 ------CITQGRVLQRPRTCPKEVYDLM---LGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 82/280 (29%), Positives = 121/280 (43%), Gaps = 42/280 (15%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGEL-PERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G G V+ +AVK L P G + PE F E Q + +RH +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP---GTMSPE--SFLEEAQIMKKLRHDKLVQLYA 68
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY-------KIILGVAHGLAYLHHD 877
+ ++ +Y+S GSL L D + R + VA G+AY+
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLK------DGEGRALKLPNLVDMAAQVAAGMAYIER- 120
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
IHRD++S NILVG +ADFGLA+L E +E + A + APE
Sbjct: 121 --MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY 177
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997
+ T KSDV+S+G++L E++ T R+P RE ++R
Sbjct: 178 GRFTIKSDVWSFGILLTELV-----TKGRVPYPGM-----------NNREVLEQVERGYR 221
Query: 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037
M L L L C PEERPT + + + L++
Sbjct: 222 MPCPQDCPISLHEL--MLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 77/280 (27%), Positives = 124/280 (44%), Gaps = 52/280 (18%)
Query: 783 QVIAVKKLWPVKNGELPE-RDQFSAEVQTLGSIRHKNIVRLLGCCNN--GRTRLLLFDYI 839
+++AVK L K + + E+ L ++ H+NIV+ GCC+ G+ L+ +Y+
Sbjct: 34 EMVAVKTL---KRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 840 SNGSLAGLLHEKKVFLDWDSRYKIIL---GVAHGLAYLHHDCVPPIIHRDIKSNNILVGP 896
GSL L + K+ L +++L + G+AYLH IHRD+ + N+L+
Sbjct: 91 PLGSLRDYLPKHKLNLA-----QLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDN 142
Query: 897 QFEAFLADFGLAKLF-ESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLE 955
+ DFGLAK E E R + A E K + SDV+S+GV L E
Sbjct: 143 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYE 202
Query: 956 VLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVAL 1015
+LT + S P E+ K+ T++ ++ E+L+ G+ L
Sbjct: 203 LLTHCDSKQS--PPKKFE------EMIGPKQGQMTVV----------RLIELLE-RGMRL 243
Query: 1016 LCVNPCPEE---------------RPTMKDVTAMLKEIRH 1040
C CP+E RPT + + +LKE+ H
Sbjct: 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 72/284 (25%), Positives = 104/284 (36%), Gaps = 40/284 (14%)
Query: 764 NIVGKGVSGIVY------RVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHK 817
+G G G VY R +AVK L P E E D F E + H+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESD-FLMEALIMSKFNHQ 69
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY------KIILGVAHGL 871
NIVRL+G R +L + ++ G L L E + + S VA G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 872 AYLHHDCVPPIIHRDIKSNNILV---GPQFEAFLADFGLAKLFESSESSRASNSVAGSYG 928
YL + IHRDI + N L+ GP A +ADFG+A+ + R
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 929 YIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKRE 987
++ PE T K+DV+S+GV+L E+ + G P R +E
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-----------------TNQE 229
Query: 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ + V + C PE+RP +
Sbjct: 230 VMEFVTGGGRLDPPKGCPG--PVYRIMTDCWQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 757 VTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQ-FSAEVQTLGSIR 815
+ +L+ I+G+G G V + E ++V VKN + Q F E + +
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEYTGQKV-------AVKNIKCDVTAQAFLEETAVMTKLH 57
Query: 816 HKNIVRLLGCC-NNGRTRLLLFDYISNGSLAGLLHEKKVFL-DWDSRYKIILGVAHGLAY 873
HKN+VRLLG +NG ++ + +S G+L L + L + L VA G+ Y
Sbjct: 58 HKNLVRLLGVILHNGL--YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
L ++HRD+ + NILV A ++DFGLA++ S ++ + APE
Sbjct: 116 LESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPE 167
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
K + KSDV+SYGV+L EV + G+ P
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 46/291 (15%)
Query: 766 VGKGVSGIVYR---VEIPSRQV---IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
+G+G G+VY + + +A+K + N + ER +F E + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE--NASMRERIEFLNEASVMKEFNCHHV 71
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK------VFLDWDSRYKII---LGVAHG 870
VRLLG + G+ L++ + ++ G L L ++ L + K I +A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
+AYL +HRD+ + N +V + DFG+ + ++ R ++
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 931 APEYGYSLK---ITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKR 986
APE SLK T KSDV+S+GVVL E+ T ++P G E
Sbjct: 189 APE---SLKDGVFTTKSDVWSFGVVLWEMATLAEQP--------------YQGLSNEEVL 231
Query: 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037
+F ++D L ++L+++ +C P+ RPT ++ + LK+
Sbjct: 232 KF--VIDGGHLDLPENCPDKLLELM---RMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 764 NIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
++GKG G V V+ ++++ A+K + K E E + L + H +V L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ L+ D + G L L +K F + ++ I + L YLH I
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLHSK---GI 121
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYSL 938
IHRDIK +NIL+ Q + DF +A + S +G+ GY+APE GYS+
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSV 178
Query: 939 KITEKSDVYSYGVVLLEVLTGKEP 962
+ D +S GV E L GK P
Sbjct: 179 AV----DWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 57/197 (28%), Positives = 105/197 (53%), Gaps = 10/197 (5%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G GIV++ + + + +A+KK+ ++ E +Q E++ L + +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
+G +L+ +Y+ L+ +L +++ L + + G+AY+H + I+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--YGYSLKITE 942
RD+K N+L+ +ADFGLA+LF E S+ VA + Y APE YG + K
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYG-ARKYDP 180
Query: 943 KSDVYSYGVVLLEVLTG 959
D+++ G + E+L G
Sbjct: 181 GVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 758 TRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPE---RDQFSA---EVQT 810
T L ++G GV G V++ + IP I + PV + + R F +
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKI----PVAIKTIQDRSGRQTFQEITDHMLA 62
Query: 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+GS+ H IVRLLG C G + L+ GSL + + + LD + +A G
Sbjct: 63 MGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
+ YL ++HR++ + NIL+ +ADFG+A L + + ++
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
A E + T +SDV+SYGV + E+++ G EP
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA---EVQTLGSIRHKNIV 820
++G+G G VY ++ + + +AVK++ P + + +A E+Q L +++H+ IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQV-PFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
+ GC + T + +Y+ GS+ L + +R K + G+ YLH +
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSN--- 123
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS-NSVAGSYGYIAPE----YG 935
I+HRDIK NIL L DFG +K ++ SS SV G+ +++PE G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y K+DV+S G ++E+LT K P
Sbjct: 184 YG----RKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 16/217 (7%)
Query: 751 FSVDDVVTRLSDTNIVGKGVSGIVY-RVEIPSRQVIAVKKLWPVKNGELPERDQ-FSAEV 808
F DD + +G G G VY + +V+AVKK+ + E+ Q EV
Sbjct: 14 FYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM-SYSGKQTNEKWQDIIKEV 72
Query: 809 QTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA 868
+ L ++H N + GC T L+ +Y GS + LL K L I G
Sbjct: 73 KFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGAL 131
Query: 869 HGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG 928
GLAYLH +IHRDIK+ NIL+ + LADFG S+ S +NS G+
Sbjct: 132 QGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG------SASKSSPANSFVGTPY 182
Query: 929 YIAPEYGYSL---KITEKSDVYSYGVVLLEVLTGKEP 962
++APE ++ + K DV+S G+ +E+ K P
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-16
Identities = 33/78 (42%), Positives = 52/78 (66%)
Query: 81 FPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELE 140
P + HL S+ LS ++ G IPP++G+++SL LDLS+N+ G+IPE +G+L L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 141 LLSLNSNSIHGGIPREIG 158
+L+LN NS+ G +P +G
Sbjct: 494 ILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 81/302 (26%), Positives = 142/302 (47%), Gaps = 50/302 (16%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+VG+G G+V + + + Q++A+KK ++ ++ ++ E++ L +RH+N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPI 882
+ L+F+++ + L L LD K + + G+ + H H+ I
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHN----I 121
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-------YG 935
IHRDIK NILV L DFG A+ + ++ VA + Y APE YG
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRW-YRAPELLVGDTKYG 179
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKE--PTDSRIPDGAHIITWVNGELRERKREFTTILD 993
++ D+++ G ++ E+LTG+ P DS I D + I G L R +E I
Sbjct: 180 RAV------DIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQE---IFQ 229
Query: 994 RQLL---MRSGTQIQEMLQ-----------VLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039
+ L MR +++E+ VL +A C+ P++RP+ ++ L +
Sbjct: 230 KNPLFAGMRL-PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQL--LH 282
Query: 1040 HE 1041
HE
Sbjct: 283 HE 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 751 FSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQ 809
FS DD +D +G G G VY ++ + +V+A+KK+ + EV+
Sbjct: 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 810 TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAH 869
L +RH N + GC T L+ +Y GS + +L K L I G
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQ 126
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GLAYLH IHRDIK+ NIL+ LADFG A L +NS G+ +
Sbjct: 127 GLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYW 177
Query: 930 IAPEYGYSL---KITEKSDVYSYGVVLLEVLTGKEP 962
+APE ++ + K DV+S G+ +E+ K P
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 9e-16
Identities = 74/267 (27%), Positives = 130/267 (48%), Gaps = 20/267 (7%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
SV D + + +G+G SG VY ++I + Q +A+K++ + P+++ E+
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILV 69
Query: 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+ ++ NIV L G ++ +Y++ GSL ++ E +D +
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQA 127
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
L +LH + +IHRDIKS+NIL+G L DFG +S R+ ++ G+ ++
Sbjct: 128 LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWM 182
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG--ELRERKR-- 986
APE K D++S G++ +E++ G+ P + P A + NG EL+ +R
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLS 242
Query: 987 -EFTTILDRQLLM---RSGTQIQEMLQ 1009
F L+R L M R G+ +E+LQ
Sbjct: 243 AVFRDFLNRCLEMDVDRRGSA-KELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 44/228 (19%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVK-----------KLWPVKNGELPERDQFSAEVQTLG 812
I+G+G V E + + A+K K+ VK E++ +
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI----EKEVLTR------ 57
Query: 813 SIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLA 872
H I++L + + +Y NG L + + + +R+ + L
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-YAAEILLALE 116
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS--------------- 917
YLH IIHRD+K NIL+ + DFG AK+ + + S
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 918 ---RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
R S G+ Y++PE + SD+++ G ++ ++LTGK P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 785 IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844
+AVK L P + R+ F EV+ L + NI RLLG C ++ +Y+ NG L
Sbjct: 49 VAVKVLRP--DASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 845 AGLLHEKKVFLDWDSRYK----------IILGVAHGLAYL-HHDCVPPIIHRDIKSNNIL 893
L + + + +A G+ YL + V HRD+ + N L
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV----HRDLATRNCL 162
Query: 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVL 953
VG + +ADFG+++ SS+ R ++A E K T KSDV+++GV L
Sbjct: 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222
Query: 954 LEVLT-GKEPTDSRIPD 969
E+LT +E + D
Sbjct: 223 WEILTLCREQPYEHLTD 239
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 71/253 (28%), Positives = 121/253 (47%), Gaps = 16/253 (6%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
SV D + + +G+G SG VY +++ + Q +A+K++ + P+++ E+
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILV 69
Query: 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+ +H NIV L G ++ +Y++ GSL ++ E +D +
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQA 127
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
L +LH + V IHRDIKS+NIL+G L DFG + E S+ S V Y ++
Sbjct: 128 LEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPY-WM 182
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG--ELRERKRE- 987
APE K D++S G++ +E++ G+ P + P A + NG EL+ ++
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 988 --FTTILDRQLLM 998
F L+R L M
Sbjct: 243 AIFRDFLNRCLEM 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 47/287 (16%)
Query: 766 VGKGVSGIVYRVE--IPSRQVI--AVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVR 821
+G G G+V R E +VI AVK L K ++ D F E + S+ H+N++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLDHENLIR 60
Query: 822 LLGCCNNGRTR--LLLFDYISNGSLAGLLHEKK-------VFLDWDSRYKIILGVAHGLA 872
L G T +++ + GSL L + D+ + +A+G+
Sbjct: 61 LYGVV---LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA------VQIANGMR 111
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK-LFESSESSRASNSVAGSYGYIA 931
YL IHRD+ + NIL+ + + DFGL + L ++ + + + + A
Sbjct: 112 YLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 932 PEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTT 990
PE + + SDV+ +GV L E+ T G+EP G+ I+ ++ E
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQILKKIDKEG--------- 217
Query: 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037
+ L R Q++ V+ L C P +RPT + L E
Sbjct: 218 ----ERLERPEACPQDIYNVM---LQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 74/270 (27%), Positives = 123/270 (45%), Gaps = 34/270 (12%)
Query: 774 VYRVEIPSRQVIAVKKLWPVKNGELP-ERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832
VY ++ +AVK L K + + +F E + + H IVRL+G C G
Sbjct: 15 VYLMKSGKEVEVAVKTL---KQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPL 70
Query: 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNI 892
+L+ + G L L +++ D + ++ VA G+AYL +HRD+ + N+
Sbjct: 71 MLVMELAPLGPLLKYLKKRREIPVSDLK-ELAHQVAMGMAYLESK---HFVHRDLAARNV 126
Query: 893 LVGPQFEAFLADFGLAK-LFESSESSRASNSVAGSY--GYIAPEYGYSLKITEKSDVYSY 949
L+ + +A ++DFG+++ L S+ RA+ AG + + APE K + KSDV+SY
Sbjct: 127 LLVNRHQAKISDFGMSRALGAGSDYYRATT--AGRWPLKWYAPECINYGKFSSKSDVWSY 184
Query: 950 GVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEML 1008
GV L E + G +P GA +I + R L R QE+
Sbjct: 185 GVTLWEAFSYGAKPY--GEMKGAEVIAMLESGER--------------LPRPEECPQEIY 228
Query: 1009 QVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
++ L C PE+RPT ++ + +
Sbjct: 229 SIM---LSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPE--RDQFSAEVQTLGSIRHKNIVRL 822
++GKG G V++ + + +AVK +LP+ + +F +E + L H NIV+L
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTC----KEDLPQELKIKFLSEARILKQYDHPNIVKL 57
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPP 881
+G C + ++ + + G L +KK L K L A G+AYL +C
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC--- 114
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG-------YIAPE- 933
IHRD+ + N LVG ++DFG+ S + + + S G + APE
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGM--------SRQEDDGIYSSSGLKQIPIKWTAPEA 165
Query: 934 --YGYSLKITEKSDVYSYGVVLLEVLT 958
YG + + +SDV+SYG++L E +
Sbjct: 166 LNYG---RYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 760 LSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
L N +G G G VY+V P+ ++ A+K ++ N E R Q E++ L + H N
Sbjct: 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY--GNHEDTVRRQICREIEILRDVNHPN 133
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
+V+ ++ +L +++ GSL G + FL +R + G+AYLH
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ-----ILSGIAYLHRR- 187
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY---- 934
I+HRDIK +N+L+ +ADFG++++ +++ NS G+ Y++PE
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIAYMSPERINTD 243
Query: 935 -------GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
GY+ D++S GV +LE G+ P
Sbjct: 244 LNHGAYDGYA------GDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRL 822
++G+G G VY+ + Q++A+K + +++ E ++ E L H NI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATF 68
Query: 823 LGC------CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK------IILGVAHG 870
G N L+ + GS+ L+ K R K I+ G
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYILRETLRG 125
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
LAYLH + V IHRDIK NIL+ E L DFG++ +S+ R N+ G+ ++
Sbjct: 126 LAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFIGTPYWM 180
Query: 931 APE-----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
APE +SDV+S G+ +E+ GK P
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 14/216 (6%)
Query: 751 FSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQ 809
F +D +D +G G G VY ++ + +V+A+KK+ + EV+
Sbjct: 18 FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 810 TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAH 869
L I+H N + GC T L+ +Y GS + LL K L I G
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQ 136
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GLAYLH +IHRDIK+ NIL+ + LADFG A + + +NS G+ +
Sbjct: 137 GLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYW 187
Query: 930 IAPEYGYSL---KITEKSDVYSYGVVLLEVLTGKEP 962
+APE ++ + K DV+S G+ +E+ K P
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 26/203 (12%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFS 805
+ F D V++ +G+G G V++ ++Q++A+KK+ ++N E++ F
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL-MEN----EKEGFP 55
Query: 806 A----EVQTLGSIRHKNIVRLLGCCNNGRTR--------LLLFDYISNGSLAGLLHEKKV 853
E++ L ++H+N+V L+ C T L+F++ + LAGLL K V
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNV 114
Query: 854 FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913
K++ + +GL Y+H + I+HRD+K+ NIL+ LADFGLA+ F
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 914 SESS---RASNSVAGSYGYIAPE 933
S++S R +N V + Y PE
Sbjct: 172 SKNSKPNRYTNRVVTLW-YRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 88/313 (28%), Positives = 139/313 (44%), Gaps = 57/313 (18%)
Query: 757 VTRLSDTNIVGK---GVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA----EV 808
++L D I+GK G G VY+ +I + +V+A+KK+ + N E+D F E+
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL-MHN----EKDGFPITALREI 58
Query: 809 QTLGSIRHKNIVRLLGCC-----NNGRTRL---LLFDYISNGSLAGLLHEKKVFLDWDSR 860
+ L ++H N+V L+ + R R ++ Y+ + L+GLL V L +S+
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLT-ESQ 116
Query: 861 YK-IILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE------- 912
K +L + G+ YLH + I+HRDIK+ NIL+ Q +ADFGLA+ ++
Sbjct: 117 IKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 913 --SSESSRASNSVAGSYGYIAPEYGYSLK-ITEKSDVYSYGVVLLEVLTGKE--PTDSRI 967
+R ++ + Y PE + T D++ G V E+ T + S I
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233
Query: 968 PDGAHII----------TWVNGEL---RERKREFTTILDRQLLMRSGTQIQEMLQVLGVA 1014
D H+I TW E FT R L R G E L +L
Sbjct: 234 -DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTN-YPRTLEERFGKLGPEGLDLLS-K 290
Query: 1015 LLCVNPCPEERPT 1027
LL ++ P +R T
Sbjct: 291 LLSLD--PYKRLT 301
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 40/285 (14%)
Query: 766 VGKGVSGIVYRVEI--PSRQVIAVKKLW---PVKNGELPERDQ----FSAEVQTLG-SIR 815
+G G G VY+V + ++A+K++ P + ERD+ +EV + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 816 HKNIVRLLGCCNNGRTRLLLFDYISNGSLAGL---LHEKKVFLDWDSRYKIILGVAHGLA 872
H NIVR ++ D I L L EKK + + I + + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAP 932
YLH + I+HRD+ NNI++G + + DFGLAK + S+ + SV G+ Y P
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLT-SVVGTILYSCP 182
Query: 933 EYGYSLKITEKSDVYSYGVVLLEVLTGKEP--TDSRIPDGAHIITWVNGELRERKREFTT 990
E + EK+DV+++G +L ++ T + P + + + I+ V L E
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG------ 236
Query: 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
M S + +++ C+ P E RP + V+AM+
Sbjct: 237 -------MYS-EDVTDVITS------CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 774 VYRVEIPSRQV-IAVKKLWPVKNG-ELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831
VY++ +Q+ +A+K L KN E RD+ E + + + + IVR++G C
Sbjct: 15 VYKMR--KKQIDVAIKVL---KNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEA 68
Query: 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNN 891
+L+ + S G L L KK + + +++ V+ G+ YL +HRD+ + N
Sbjct: 69 LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARN 125
Query: 892 ILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSY--GYIAPEYGYSLKITEKSDVYSY 949
+L+ Q A ++DFGL+K + +S + S AG + + APE K + +SDV+SY
Sbjct: 126 VLLVNQHYAKISDFGLSKALGADDSYYKARS-AGKWPLKWYAPECINFRKFSSRSDVWSY 184
Query: 950 GVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELR 982
G+ + E + G++P G +++++ R
Sbjct: 185 GITMWEAFSYGQKPYKKM--KGPEVMSFIEQGKR 216
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 77/285 (27%), Positives = 124/285 (43%), Gaps = 52/285 (18%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G V+ +A+K L K G + + F AE + ++H +VRL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL---KQGSM-SPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG--------VAHGLAYLHHD 877
++ +Y+ NGSL FL K+ + +A G+A++
Sbjct: 70 VTQ-EPIYIITEYMENGSLVD-------FLKTPEGIKLTINKLIDMAAQIAEGMAFIE-- 119
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---Y 934
IHRD+++ NILV +ADFGLA+L E +E + A + APE Y
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY 177
Query: 935 GYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993
G T KSDV+S+G++L E++T G+ P E L+
Sbjct: 178 G---TFTIKSDVWSFGILLTEIVTYGRIPYPGM-----------------TNPEVIQNLE 217
Query: 994 RQLLM-RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037
R M R +E+ +++ LC PEERPT + + ++L++
Sbjct: 218 RGYRMPRPDNCPEELYELM---RLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 16/217 (7%)
Query: 751 FSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQ 809
F DD SD +G G G VY ++ + +V+A+KK+ + EV+
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 810 TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAH 869
L +RH N ++ GC T L+ +Y GS + LL K L + G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 870 GLAYLH-HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG 928
GLAYLH H+ +IHRD+K+ NIL+ L DFG A + +N G+
Sbjct: 127 GLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPY 176
Query: 929 YIAPEYGYSL---KITEKSDVYSYGVVLLEVLTGKEP 962
++APE ++ + K DV+S G+ +E+ K P
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 27/273 (9%)
Query: 763 TNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+VG+G GIV+ + Q + + K PV+ ER E Q L + H NI+
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
+ +++ +Y G+LA + ++ LD D+ I+ L LHH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT---ILHFFVQILLALHHVHTKL 121
Query: 882 IIHRDIKSNNILVGP-QFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKI 940
I+HRD+K+ NIL+ + + DFG++K+ S S+A +V G+ YI+PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS--KSKAY-TVVGTPCYISPELCEGKPY 178
Query: 941 TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRS 1000
+KSD+++ G VL E+ + K R + A++ V L+ F I DR
Sbjct: 179 NQKSDIWALGCVLYELASLK-----RAFEAANLPALV---LKIMSGTFAPISDR------ 224
Query: 1001 GTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033
L+ L +++L ++ P +RP + + A
Sbjct: 225 ---YSPDLRQLILSMLNLD--PSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 6e-15
Identities = 62/249 (24%), Positives = 119/249 (47%), Gaps = 11/249 (4%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
S+ D + + +G+G SG V+ +++ + Q +A+K++ K P+++ E+
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILV 69
Query: 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+ +++ NIV L G ++ +Y++ GSL ++ E +D +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQA 127
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
L +LH + +IHRDIKS+N+L+G L DFG +S R+ ++ G+ ++
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWM 182
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTT 990
APE K D++S G++ +E++ G+ P + P A + NG + E +
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 991 ILDRQLLMR 999
+ R L R
Sbjct: 243 PIFRDFLNR 251
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSA---EVQTLGSIRHKNIV 820
+G G Y+ ++ + ++AVK++ V+N + + A E++ + + H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 821 RLLGC-CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCV 879
R+LG C + L + ++++ GS++ LL + F + + GL+YLH +
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVI-INYTEQLLRGLSYLHEN-- 122
Query: 880 PPIIHRDIKSNNILVGPQFEAF-LADFGLA-KLFESSESSRA---SNSVAGSYGYIAPE- 933
IIHRD+K N+L+ + +ADFG A +L +++ + A + G+ ++APE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARL--AAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 934 -----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
YG S DV+S G V++E+ T K P
Sbjct: 180 LRGEQYGRS------CDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 37/278 (13%)
Query: 765 IVGKGVSG--IVYRVEIPSRQV----IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
++GKG G +YR V + + +L ER E+ L ++H N
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE------KERRDALNEIVILSLLQHPN 60
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAG-LLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
I+ + T L+ +Y + G+L ++ +K + + + + ++Y+H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
I+HRDIK+ NI + L DFG++K+ SE S A +V G+ Y++PE
Sbjct: 121 ---GILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAE-TVVGTPYYMSPELCQG 175
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997
+K KSD+++ G VL E+LT K R D + + V I+
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLK-----RTFDATNPLNLVVK-----------IVQGNYT 219
Query: 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
E++ ++ +LL + PE+RPT +V
Sbjct: 220 PVVSVYSSELISLVH-SLLQQD--PEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 765 IVGKGVSGIVYRV-------EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHK 817
++G+G G VY E+ ++QV + P E E+Q L +++H+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQV----QFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 818 NIVRLLGCCNN--GRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH 875
IV+ GC + +T + +Y+ GS+ L + +R K + G++YLH
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH 123
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES-SESSRASNSVAGSYGYIAPEY 934
+ I+HRDIK NIL L DFG +K ++ S SV G+ +++PE
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
K+DV+S G ++E+LT K P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 9e-15
Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 15/188 (7%)
Query: 783 QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL--GCCNNGRTRLLLFDYIS 840
+A+K L E +R +F E + H NIV LL G G +F+Y+
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLL-FAVFEYVP 62
Query: 841 NGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV---GPQ 897
+L +L L +++L V LA H+ I+HRD+K NI+V G +
Sbjct: 63 GRTLREVLAADGA-LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVR 118
Query: 898 FEAFLADFGLAKL---FESSESSRAS--NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVV 952
A + DFG+ L ++ + + V G+ Y APE +T SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 953 LLEVLTGK 960
LE LTG+
Sbjct: 179 FLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 9e-15
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 758 TRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH 816
T ++ + +G G G VY V +AVK L + E ++F E + I+H
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 61
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHE-KKVFLDWDSRYKIILGVAHGLAYLH 875
N+V+LLG C ++ ++++ G+L L E + ++ + ++ + YL
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYG 935
IHRD+ + N LVG +ADFGL++L ++ A + APE
Sbjct: 122 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 177
Query: 936 YSLKITEKSDVYSYGVVLLEVLT 958
K + KSDV+++GV+L E+ T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 63/249 (25%), Positives = 118/249 (47%), Gaps = 11/249 (4%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
SV D + + +G+G SG VY +++ + Q +A++++ + P+++ E+
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILV 70
Query: 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+ ++ NIV L G ++ +Y++ GSL ++ E +D +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQA 128
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
L +LH + +IHRDIKS+NIL+G L DFG +S R+ ++ G+ ++
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWM 183
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTT 990
APE K D++S G++ +E++ G+ P + P A + NG + E +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 991 ILDRQLLMR 999
+ R L R
Sbjct: 244 AIFRDFLNR 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-14
Identities = 41/88 (46%), Positives = 55/88 (62%), Gaps = 1/88 (1%)
Query: 526 LDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSI 585
L L + G IP ++ KL L + LS N+I G IP SLG L++LDLS N NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 586 PEEIGRLQGLDILLNLSWNALTGPIPES 613
PE +G+L L I LNL+ N+L+G +P +
Sbjct: 483 PESLGQLTSLRI-LNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-14
Identities = 33/80 (41%), Positives = 55/80 (68%)
Query: 272 GKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVA 331
G IP+++ L++L+ + L N++ G+IP +LG+ +SL V+D+S NS G +P SL L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 332 LEELLLSGNNISGEIPSFFG 351
L L L+GN++SG +P+ G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G V+ + +AVK L P G + F E + +++H +VRL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP---GTM-SVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIIL--------GVAHGLAYLHHD 877
++ +Y++ GSL FL D K++L +A G+AY+
Sbjct: 70 VTKEEPIYIITEYMAKGSLLD-------FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
IHRD+++ N+LV +ADFGLA++ E +E + A + APE
Sbjct: 123 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINF 178
Query: 938 LKITEKSDVYSYGVVLLEVLT-GKEP 962
T KSDV+S+G++L E++T GK P
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 767 GKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCC 826
G G G VY+ + + A K+ +++ E E + F E+ L +H NIV L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEE--ELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 827 NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRD 886
+L ++ G+L ++ E + L + + L +LH +IHRD
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 887 IKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-----------YG 935
+K+ NIL+ + LADFG++ +S+ R ++ G+ ++APE Y
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y K+D++S G+ L+E+ + P
Sbjct: 187 Y------KADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-14
Identities = 39/89 (43%), Positives = 53/89 (59%)
Query: 94 LVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGI 153
L L N L G IP I L L +++LS N++ GNIP +G + LE+L L+ NS +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 154 PREIGNCSKLRRLELYDNQLSGNIPAEIG 182
P +G + LR L L N LSG +PA +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 42/113 (37%), Positives = 56/113 (49%), Gaps = 24/113 (21%)
Query: 454 LRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTI 513
L L + G IP+ I L L + LS N G IPP +G+ T
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT---------------- 466
Query: 514 PSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLG 566
L VLDLS NS G+IPE+LG+LTSL L L+ N+++G +P +LG
Sbjct: 467 --------SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 41/296 (13%)
Query: 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTL 811
+ L + +G+G G V+ + ++ VK L K+ L + +F E+
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMF 62
Query: 812 GSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDS--------RYKI 863
+ HKN+VRLLG C ++ +Y G L L K + + +
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 864 ILGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921
+A G+ +L +HRD+ + N LV Q E ++ L+K +SE + N
Sbjct: 123 CTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL 981
++ ++APE + KSDV+S+GV++ EV T E + D + G+L
Sbjct: 178 ALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236
Query: 982 RERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037
E +L+ R C P++RP+ ++ + L E
Sbjct: 237 ELPVPEGCPSRLYKLMTR-----------------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 38/226 (16%)
Query: 757 VTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA----EVQTL 811
V + +G+G G VY+ + + +++A+KK+ + N E++ F E++ L
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDN----EKEGFPITAIREIKIL 60
Query: 812 GSIRHKNIVRLLGCCNNGRTRL----------LLFDYISNGSLAGLLHEKKVFLDWDSRY 861
+ H+NIV L + + L L+F+Y+ + L GLL V D
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIK 119
Query: 862 KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921
+ + GL Y H +HRDIK +NIL+ + + LADFGLA+L+ S ES +N
Sbjct: 120 SFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 922 SVAGSYGYIAPE-------YGYSLKITEKSDVYSYGVVLLEVLTGK 960
V + Y PE YG ++ DV+S G +L E+ T K
Sbjct: 177 KVITLW-YRPPELLLGEERYGPAI------DVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+GKG G VY+ ++ +++V+A+K + ++ E E + E+ L I R G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIK-IIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
G ++ +Y+ GS LL K L+ I+ + GL YLH + IH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE---RKIH 124
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS 944
RDIK+ N+L+ Q + LADFG+A ++ R N+ G+ ++APE K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 945 DVYSYGVVLLEVLTGKEPTDSRIP 968
D++S G+ +E+ G+ P P
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 65/237 (27%), Positives = 115/237 (48%), Gaps = 34/237 (14%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSA-EVQTLGSIRHKNIVRLL 823
+G+G G+V++ + Q++A+KK V++ + P + + E++ L ++H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVF---LDWDSRYKIILGVAHGLAYLH-HDCV 879
R L+F+Y + +L+E + + KII + + H H+C
Sbjct: 67 EVFRRKRKLHLVFEYCDHT----VLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC- 121
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------ 933
IHRD+K NIL+ Q + L DFG A++ + ++ VA + Y APE
Sbjct: 122 ---IHRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYVATRW-YRAPELLVGDT 176
Query: 934 -YGYSLKITEKSDVYSYGVVLLEVLTGKE--PTDSRIPDGAHIITWVNGELRERKRE 987
YG + DV++ G V E+LTG+ P S + D ++I G+L R ++
Sbjct: 177 QYGPPV------DVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTLGDLIPRHQQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 56/210 (26%), Positives = 83/210 (39%), Gaps = 38/210 (18%)
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVF-LDWDSRYKIILGVAHGLAYLHH 876
+ +L + L+ +Y++ G A L+ DW +Y I V G+ LH
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQ 115
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGY 936
IIHRDIK N+L+ L DFGL S + + G+ Y+APE
Sbjct: 116 R---GIIHRDIKPENLLIDQTGHLKLTDFGL------SRNGLENKKFVGTPDYLAPETIL 166
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG------AHIITWVNGELRERKREFTT 990
+ + SD +S G V+ E L G P + PD + I W E +EF +
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW-----PEEVKEFCS 221
Query: 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNP 1020
L+ R LLC++P
Sbjct: 222 PEAVDLINR---------------LLCMDP 236
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 27/229 (11%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLW--PVKNGELPERDQFSAEVQTLGSIRHKNIVR 821
++G+G G VY + + + +AVK++ P E + E+Q L ++RH IV+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 822 LLGCCNNGRTRLL--LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCV 879
GC + + L +Y+ GS+ L + +R + + G++YLH +
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLHSNM- 126
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES-SESSRASNSVAGSYGYIAPEYGYSL 938
I+HRDIK NIL L DFG +K ++ S SV G+ +++PE
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 939 KITEKSDVYSYGVVLLEVLTGK-----------------EPTDSRIPDG 970
K+DV+S ++E+LT K +PT +PDG
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG 866
E + L H IV+L + + +L +Y G L +L ++ +F ++ +R+ I
Sbjct: 43 EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-YIAC 101
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
V YLH+ II+RD+K N+L+ L DFG AK +S + + + G+
Sbjct: 102 VVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK---KLKSGQKTWTFCGT 155
Query: 927 YGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y+APE Y +S D +S G++L E+LTG+ P
Sbjct: 156 PEYVAPEIILNKGYDFS------VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 8/179 (4%)
Query: 783 QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN--GRTRLLLFDYIS 840
+ +AVK L P G E++ L ++ H+NIV+ G C G L+ +++
Sbjct: 34 EQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 841 NGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEA 900
+GSL L K ++ + K + + G+ YL +HRD+ + N+LV + +
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQV 148
Query: 901 FLADFGLAKLFESS-ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT 958
+ DFGL K E+ E + + + APE K SDV+S+GV L E+LT
Sbjct: 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-13
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 15/211 (7%)
Query: 754 DDVVTRLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLG 812
DD R+S+ +G G G+V +V+ PS ++A K + + R+Q E+Q L
Sbjct: 4 DDDFERISE---LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAI--RNQIIRELQVLH 58
Query: 813 SIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLA 872
IV G + + +++ GSL +L E K + + K+ + V GLA
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSIAVLRGLA 117
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA-KLFESSESSRASNSVAGSYGYIA 931
YL I+HRD+K +NILV + E L DFG++ +L +S +NS G+ Y++
Sbjct: 118 YLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMS 170
Query: 932 PEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
PE + +SD++S G+ L+E+ G+ P
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+GKG +VY+ + +V+A+KK+ + + R E+ L + H N+++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 825 CCNNGRTRLLLFDYISNGSLAGLL---HEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
++ + G L+ ++ ++K + + +K + + L ++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---R 126
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY----GYS 937
I+HRDIK N+ + L D GL + F SS+++ A + V Y Y++PE GY+
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPY-YMSPERIHENGYN 184
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEP 962
KSD++S G +L E+ + P
Sbjct: 185 F----KSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 73/299 (24%), Positives = 128/299 (42%), Gaps = 53/299 (17%)
Query: 767 GKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
GK V +R++ +AVK L +N E +E L + H ++++L G
Sbjct: 14 GKVVKATAFRLKGRAGYTTVAVKML--KENASSSELRDLLSEFNLLKQVNHPHVIKLYGA 71
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHE-KKV--------------FLDWDSRYKIILG---- 866
C+ LL+ +Y GSL L E +KV +LD + +G
Sbjct: 72 CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLIS 131
Query: 867 ----VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK--LFESSESSRAS 920
++ G+ YL ++HRD+ + N+LV + ++DFGL++ E S R+
Sbjct: 132 FAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSK 188
Query: 921 NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNG 979
+ ++A E + T +SDV+S+GV+L E++T G P P
Sbjct: 189 GRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP----------- 235
Query: 980 ELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
+R F + + R +EM ++ L C P++RPT D++ L+++
Sbjct: 236 -----ERLFNLLKTGYRMERPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-13
Identities = 36/89 (40%), Positives = 56/89 (62%)
Query: 215 LGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKI 274
LGL + G+ G IP + +L +L+++++ +I G IP +G+ ++LE L L N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 275 PDELGSLKNLKRLLLWQNNLSGSIPEALG 303
P+ LG L +L+ L L N+LSG +P ALG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 34/281 (12%)
Query: 767 GKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCC 826
GK + G +R + +V+ VK+L + E+ F EVQ + H N+++ LG C
Sbjct: 9 GKVLLGEAHRG-MSKARVV-VKELRASATPD--EQLLFLQEVQPYRELNHPNVLQCLGQC 64
Query: 827 NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAH----GLAYLHHDCVPPI 882
LL+ ++ G L L + + ++ ++ +A GL +LH
Sbjct: 65 IESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DF 121
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYSL 938
IH D+ N + + D+GLA + + A ++APE G L
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL 181
Query: 939 ---KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR- 994
T+KS+++S GV + E+ T + + D L++ RE L +
Sbjct: 182 LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQVLKQVVREQDIKLPKP 233
Query: 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
QL ++ + E++Q + PE RPT ++V +L
Sbjct: 234 QLDLKYSDRWYEVMQFCWLD-------PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 75/290 (25%), Positives = 125/290 (43%), Gaps = 46/290 (15%)
Query: 764 NIVGKGVSGIVYRVEI----PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
++GKG G VY + + AVK L + +L E +QF E + H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNV 58
Query: 820 VRLLGCC--NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKII-------LGVAHG 870
+ LLG C + G + L++ Y+ +G L + F+ ++ + L VA G
Sbjct: 59 LSLLGICLPSEG-SPLVVLPYMKHGDL-------RNFIRSETHNPTVKDLIGFGLQVAKG 110
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSY--G 928
+ YL +HRD+ + N ++ F +ADFGLA+ E N
Sbjct: 111 MEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 929 YIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREF 988
++A E + K T KSDV+S+GV+L E++T P + D I ++ R + E+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYLLQGRRLLQPEY 226
Query: 989 TTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
+ ML C +P PE RPT ++ + +++I
Sbjct: 227 C----------PDPLYEVMLS-------CWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 765 IVGKGVSGIVYR--VEIPSRQ--VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
I+G G G + R +++PS++ +A+ L + + +R F AE TLG H NIV
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK--QRRGFLAEALTLGQFDHSNIV 69
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
RL G G T +++ +Y+SNG+L L + + L ++ G+A G+ YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAK--LFESSESSRASNSVAGSYGYIAPEYGYSL 938
+H+ + ++ +LV ++ F + E+ ++ + S + APE
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV---LWAAPEAIQYH 183
Query: 939 KITEKSDVYSYGVVLLEVLT-GKEP 962
+ SDV+S+G+V+ EV++ G+ P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-13
Identities = 37/89 (41%), Positives = 55/89 (61%)
Query: 502 VDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLI 561
+ L L+G IP+ + L L ++LS NSI G IP +LG +TSL L LS N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 562 PKSLGLCKDLQLLDLSSNRINGSIPEEIG 590
P+SLG L++L+L+ N ++G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-13
Identities = 41/121 (33%), Positives = 59/121 (48%), Gaps = 25/121 (20%)
Query: 359 LELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVP 418
L LDN G IP I +L+ LQ+++LS N + G++P
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-----------------------HLQSINLSGNSIRGNIP 459
Query: 419 SSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIG--LLHRLT 476
SL ++ +L L L N F+G IP +G T L L L N+ SG +P+ +G LLHR +
Sbjct: 460 PSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS 519
Query: 477 F 477
F
Sbjct: 520 F 520
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-13
Identities = 85/244 (34%), Positives = 121/244 (49%), Gaps = 11/244 (4%)
Query: 201 EIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGN-CSA 259
+ E + N L L L + I + ELTNL +L + NIT IP IG S
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNIT-DIPPLIGLLKSN 141
Query: 260 LENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLG 319
L+ L L +N+I +P L +L NLK L L N+LS +P+ L N S+L +D+S N +
Sbjct: 142 LKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 320 GEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKE 379
++P + L ALEEL LS N+I E+ S N L LEL NN+ +P +IG L
Sbjct: 200 -DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSN 256
Query: 380 LLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSG 439
L NQ+ +I L L+ LDLS N L+ ++P L L LL++ +
Sbjct: 257 LETLDLSNNQI-SSISSLGSLTNLRELDLSGNSLSNALPLI--ALLLLLLELLLNLLLTL 313
Query: 440 EIPP 443
+
Sbjct: 314 KALE 317
|
Length = 394 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 47/279 (16%)
Query: 784 VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGS 843
++AVK L P N R+ F EV+ L ++ NI+RLLG C + ++ +Y+ NG
Sbjct: 48 LVAVKILRPDANKN--ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 844 LAGLLHEKKVF------------------LDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885
L L + + + S + L +A G+ YL +HR
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHR 162
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSD 945
D+ + N LVG +ADFG+++ + + R ++A E K T SD
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASD 222
Query: 946 VYSYGVVLLEVLT--GKEP----TDSRIPDGAHIITWVNGEL-RERKREFTTILDRQLLM 998
V+++GV L E+L ++P TD ++ + A GE R++ R+ L
Sbjct: 223 VWAFGVTLWEILMLCKEQPYGELTDEQVIENA-------GEFFRDQGRQV-------YLF 268
Query: 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037
R Q + +++ L C + ERP+ D+ A L E
Sbjct: 269 RPPPCPQGLYELM---LQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-13
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLW-PVKNGELPERDQFSAEVQ 809
+V ++ R D VG G G+V + + Q +A+KK+ P L +R E++
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELK 61
Query: 810 TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV-------FLDWDSRYK 862
L +RH+NI+ L + + + L LL + + FL Y+
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFL-----YQ 116
Query: 863 IILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922
I+ GL Y+H V +HRD+K +NIL+ + + DFGLA++ + + +
Sbjct: 117 IL----RGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGY 165
Query: 923 VAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGK 960
V+ Y Y APE + K + D++S G + E+L GK
Sbjct: 166 VSTRY-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 764 NIVGKGVSGIVYR---VEI------PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI 814
N +G G G VY +I P R +AVK L K E+ +F E + +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIR--VAVKTL--RKGATDQEKKEFLKEAHLMSNF 56
Query: 815 RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV------FLDWDSRYKIILGVA 868
H NIV+LLG C + ++ + + G L L + +V L I L VA
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 869 HGLAYLHHDCVPPIIHRDIKSNNILVG-PQFEAF----LADFGLAKLFESSESSRASNSV 923
G YL IHRD+ + N LV ++A + DFGLA+ S+ R
Sbjct: 117 KGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 924 AGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
++APE K T +SDV+S+GV++ E+LT G++P
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 41/221 (18%)
Query: 764 NIVGKGVSGIVYRVEIPS---RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNI 819
+++G+G G V + I R A+K++ + + RD F+ E++ L + H NI
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRD-FAGELEVLCKLGHHPNI 70
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKII--------------- 864
+ LLG C + L +Y +G+L L + +V L+ D + I
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV-LETDPAFAIANSTASTLSSQQLLHF 129
Query: 865 -LGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSV 923
VA G+ YL IHRD+ + NILVG + A +ADFGL++ E V
Sbjct: 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YV 178
Query: 924 AGSYGYIAPEY------GYSLKITEKSDVYSYGVVLLEVLT 958
+ G + + YS+ T SDV+SYGV+L E+++
Sbjct: 179 KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+GKG G V++ ++ ++QV+A+K + ++ E E + E+ L + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
G ++ +Y+ GS LL D ++ + GL YLH + IH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLHSE---KKIH 124
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS 944
RDIK+ N+L+ Q + LADFG+A ++ R N+ G+ ++APE K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 945 DVYSYGVVLLEVLTGKEPTDSRIP 968
D++S G+ +E+ G+ P P
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 758 TRLSDTNIVGKGVSGIVYRVEI-------PSRQV-IAVKKLWPVKNGELPERDQFSAEVQ 809
TRL+ +G+G G V E P++ V +AVK L + + +E++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML--KDDATDKDLSDLVSEME 69
Query: 810 TLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK---VFLDWDS------ 859
+ I +HKNI+ LLG C +L +Y S G+L L ++ + +D+
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129
Query: 860 --RYKIILG----VAHGLAYL-HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912
+K ++ VA G+ YL C IHRD+ + N+LV +ADFGLA+
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+ + + + + ++APE + T +SDV+S+GV+L E+ T G P
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 68/252 (26%), Positives = 111/252 (44%), Gaps = 42/252 (16%)
Query: 740 EWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEI-------PSRQV-IAVKKLW 791
E++ + FS D +L+ +G+G G V E P V +AVK L
Sbjct: 1 EYELPEDPRWEFSRD----KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML- 55
Query: 792 PVKNGELPERD--QFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLL 848
+ E+D +E++ + I +HKNI+ LLG C ++ +Y S G+L L
Sbjct: 56 ---KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 112
Query: 849 HEKKVFLDWDSRYKI----------------ILGVAHGLAYL-HHDCVPPIIHRDIKSNN 891
++ + Y I VA G+ YL C IHRD+ + N
Sbjct: 113 RARRP-PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARN 167
Query: 892 ILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGV 951
+LV +ADFGLA+ + + + + + ++APE + T +SDV+S+GV
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 227
Query: 952 VLLEVLT-GKEP 962
++ E+ T G P
Sbjct: 228 LMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 765 IVGKGVSGIV-----------YRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTL-G 812
++GKG G V Y V++ ++ I KK E++ AE L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK----------EQNHIMAERNVLLK 51
Query: 813 SIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLA 872
+++H +V L + DY++ G L L ++ FL+ +R+ VA +
Sbjct: 52 NLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIG 110
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAP 932
YLH II+RD+K NIL+ Q L DFGL K E E +++ G+ Y+AP
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAP 165
Query: 933 EYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966
E D + G VL E+L G P SR
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIVRL 822
+G+G G+VY+ + + +++A+KK +K E +A E++ L + H NI++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKK---IKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPP 881
L + L+F+++ L L+ +++ L + + GLA+ H H
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---- 118
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKI- 940
I+HRD+K N+L+ + LADFGLA+ F S ++ V + Y APE K
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRW-YRAPELLLGDKGY 176
Query: 941 TEKSDVYSYGVVLLEVLTGK 960
+ D++S G + E+L+ +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 34/86 (39%), Positives = 50/86 (58%), Gaps = 1/86 (1%)
Query: 118 LDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNI 177
L L L G IP +I KL L+ ++L+ NSI G IP +G+ + L L+L N +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 178 PAEIGQLEALEIIRAGGNPGIHGEIP 203
P +GQL +L I+ GN + G +P
Sbjct: 483 PESLGQLTSLRILNLNGN-SLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 28/228 (12%)
Query: 758 TRLSDTNIVGKGVSGIVYR---------VEIPSRQVIAVKKLWPVKNGELPERDQFSAEV 808
T L ++G G G VY+ V+IP + + P N E+ + E
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD------EA 60
Query: 809 QTLGSIRHKNIVRLLGCCNNGRTRLL--LFDYISNGSLAGLLHEKKVFLDWDSRYKIILG 866
+ + + RLLG C +L+ L Y G L + E K + +
Sbjct: 61 YVMAGVGSPYVCRLLGICLTSTVQLVTQLMPY---GCLLDYVRENKDRIGSQDLLNWCVQ 117
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
+A G++YL ++HRD+ + N+LV + DFGLA+L + E+ ++
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174
Query: 927 YGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDS----RIPD 969
++A E + T +SDV+SYGV + E++T G +P D IPD
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 222
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 55/238 (23%)
Query: 758 TRLSDTNIVGKGVSGIVYR---------VEIPSRQVIAVKKLW----PVKNGELPERDQF 804
T ++G G G VY+ V+IP +A+K+L P N E+ +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP----VAIKELREATSPKANKEILD---- 58
Query: 805 SAEVQTLGSIRHKNIVRLLGCCNNGRTRLL--------LFDYISNGSLAGLLHEKKV--- 853
E + S+ + ++ RLLG C +L+ L DY+ H+ +
Sbjct: 59 --EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ 109
Query: 854 -FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV-GPQFEAFLADFGLAKLF 911
L+W + +A G+ YL ++HRD+ + N+LV PQ + DFGLAKL
Sbjct: 110 YLLNW------CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 159
Query: 912 ESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIP 968
+ E + ++A E T +SDV+SYGV + E++T G +P D IP
Sbjct: 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 70/286 (24%), Positives = 131/286 (45%), Gaps = 54/286 (18%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G V+ +AVK + P G + + F AE + +++H +V+L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP---GSM-SVEAFLAEANVMKTLQHDKLVKL--- 66
Query: 826 CNNGRTR---LLLFDYISNGSLAGLLHEKK-------VFLDWDSRYKIILGVAHGLAYLH 875
+ T+ ++ ++++ GSL L + +D+ ++ +A G+A++
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIE 119
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-- 933
IHRD+++ NILV +ADFGLA++ E +E + A + APE
Sbjct: 120 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI 175
Query: 934 -YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991
+G T KSDV+S+G++L+E++T G+ P +I R +R +
Sbjct: 176 NFG---SFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVI-------RALERGYR-- 221
Query: 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037
+ R +E+ ++ + C PEERPT + + ++L +
Sbjct: 222 -----MPRPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 765 IVGKGVSGIVYRVE----IPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKN 818
++G+G G V+ V + Q+ A+K L K L RD+ E L + H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
IV+L L+ D++ G L L ++ +F + D ++ + +A L +LH
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLHS-- 116
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL 938
II+RD+K NIL+ + L DFGL+K ES + + + S G+ Y+APE
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 939 KITEKSDVYSYGVVLLEVLTGKEP 962
T+ +D +S+GV++ E+LTG P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G G +Y + S V K + + E++ EV L ++H NIV
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 825 CCNNGRTRLLLFDYISNGSLA-------GLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
++ +Y G L G+L + L W + ++ GL ++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIHDR 120
Query: 878 CVPPIIHRDIKSNNILVGPQ-FEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGY 936
I+HRDIKS NI + A L DFG+A+ ++S + + G+ Y++PE
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPEICQ 175
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEPTDS 965
+ K+D++S G VL E+ T K P +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQ----FSAEVQTLGSIRHKNI 819
++G+G G VY + + + +AVK++ + E PE + E+Q L ++ H+ I
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQ--FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 820 VRLLGCCNNG--RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
V+ GC + RT + +++ GS+ L + +R K + G++YLH +
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHSN 125
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES-SESSRASNSVAGSYGYIAPEYGY 936
I+HRDIK NIL L DFG +K ++ S SV G+ +++PE
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEP 962
K+D++S G ++E+LT K P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 766 VGKGVSGIV--YRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G+G +GIV R + RQV AVK + K R+ EV + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQV-AVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
G +L +++ G+L ++ + + L+ + + V L YLH V I
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGV---I 139
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEK 943
HRDIKS++IL+ L+DFG R S+ G+ ++APE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRTPYGTE 197
Query: 944 SDVYSYGVVLLEVLTGKEPTDSRIP 968
D++S G++++E++ G+ P S P
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 70/272 (25%), Positives = 116/272 (42%), Gaps = 44/272 (16%)
Query: 783 QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNG 842
Q +A+K L E P R++F E ++H NIV LLG + ++F Y S+
Sbjct: 36 QAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 843 SLAGLL-----HEKKVFLDWDSRYK----------IILGVAHGLAYL--HHDCVPPIIHR 885
L L H D D K I+ +A G+ +L HH ++H+
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHK 148
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSD 945
D+ + N+LV + ++D GL + +++ + + +++PE K + SD
Sbjct: 149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSD 208
Query: 946 VYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQI 1004
++SYGVVL EV + G +P + N ++ E R +RQ+L
Sbjct: 209 IWSYGVVLWEVFSYGLQP----------YCGYSNQDVIEMIR------NRQVLPCPDDCP 252
Query: 1005 QEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036
V + L C N P RP KD+ + L+
Sbjct: 253 A---WVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 765 IVGKGVSGIVYR----VEIPSRQVIAVKKLWPVKNGELPE-RDQFSAEVQTLGSIRHKNI 819
+G+G G VY+ + +AVK KN P R++F E + H +I
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKT---CKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHH-DC 878
V+L+G +++ + G L L K LD S ++ LAYL
Sbjct: 70 VKLIGVITENPVWIVM-ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF 128
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL 938
V HRDI + N+LV L DFGL++ E +AS ++APE
Sbjct: 129 V----HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFR 183
Query: 939 KITEKSDVYSYGVVLLEVLT-GKEP 962
+ T SDV+ +GV + E+L G +P
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 78/279 (27%), Positives = 121/279 (43%), Gaps = 16/279 (5%)
Query: 393 NIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQL------LLISNRFSGEIPPEIG 446
L+ + L + T + F NL + L +S+ +P +
Sbjct: 8 LKSALSSNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLS 67
Query: 447 GCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQ 506
L L + + + L L L+L+ N+ I + T L +DL
Sbjct: 68 RLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDN 125
Query: 507 NKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLG 566
N + P L LDLS N I ++P L L +L L LS N+++ +PK L
Sbjct: 126 NNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLS 183
Query: 567 LCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLS 626
+L LDLS N+I+ +P EI L L+ L +LS N++ + S SNL L+ L+LS
Sbjct: 184 NLSNLNNLDLSGNKIS-DLPPEIELLSALEEL-DLSNNSII-ELLSSLSNLKNLSGLELS 240
Query: 627 NNMLTGSLKVLGSLDNLVSLNVSYN---HFSGILPNTKL 662
NN L + +G+L NL +L++S N S + T L
Sbjct: 241 NNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNL 279
|
Length = 394 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 13/217 (5%)
Query: 748 KLNFSVDDVVTRLSDTNIVGKGVSGIV-YRVEIPSRQVIAVKKLWPVKNGELPERDQFSA 806
+L D + L + +G+G +GIV + + + +AVKK+ K R+
Sbjct: 9 QLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFN 65
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG 866
EV + +H NIV + G ++ +++ G+L ++ + ++ + + L
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL-AKLFESSESSRASNSVAG 925
V L++LH V IHRDIKS++IL+ L+DFG A++ S E R + V
Sbjct: 124 VLKALSFLHAQGV---IHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEVPRRKSLVGT 178
Query: 926 SYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y ++APE L + D++S G++++E++ G+ P
Sbjct: 179 PY-WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G VY+ + V+A K+ K+ E E + + E+ L S H NIV+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885
+L ++ + G++ ++ E + L + L YLH + IIHR
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-----------Y 934
D+K+ NIL + LADFG++ +++ + + +S G+ ++APE Y
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y K+DV+S G+ L+E+ + P
Sbjct: 186 DY------KADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 48/138 (34%), Positives = 72/138 (52%), Gaps = 21/138 (15%)
Query: 834 LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHDCVPPIIHRDIKSN 890
L+ DY++ G L L++++ F + + R +I+L + H LH II+RDIK
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH----LHQ---LGIIYRDIKLE 134
Query: 891 NILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY------GYSLKITEKS 944
NIL+ + L DFGL+K F + E RA S G+ Y+APE G+ +
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAV---- 189
Query: 945 DVYSYGVVLLEVLTGKEP 962
D +S GV+ E+LTG P
Sbjct: 190 DWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 20/169 (11%)
Query: 800 ERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL-------AGLLHEKK 852
ER++ EV L +++H NIV+ ++ DY G L G+L +
Sbjct: 42 EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED 101
Query: 853 VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912
LDW +I L + H HD I+HRDIKS NI + L DFG+A++
Sbjct: 102 QILDW--FVQICLALKH-----VHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152
Query: 913 SS-ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGK 960
S+ E +R + G+ Y++PE + KSD+++ G VL E+ T K
Sbjct: 153 STVELAR---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-12
Identities = 36/94 (38%), Positives = 54/94 (57%)
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
L +HH +IHRDIKS NIL+ L DFG +K++ ++ S + G+ Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
APE ++K+D++S GV+L E+LT K P D
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 16/186 (8%)
Query: 784 VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGS 843
++AVK L R+ F E++ + +++ NI+RLLG C + ++ +Y+ NG
Sbjct: 46 LVAVKMLRADVTKT--ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 844 LAGLLHEKKVF-----------LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNI 892
L L ++++ + + + + +A G+ YL +HRD+ + N
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNC 160
Query: 893 LVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVV 952
LVG + +ADFG+++ S + R ++A E K T SDV+++GV
Sbjct: 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT 220
Query: 953 LLEVLT 958
L E+ T
Sbjct: 221 LWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 75/299 (25%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 766 VGKGVSGIVYRVEI----PSRQ----VIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RH 816
+G+G G V R E SR +AVK L N + +E++ + I +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML--KDNATDKDLADLISEMELMKLIGKH 77
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV---------------FLDWDSRY 861
KNI+ LLG C ++ +Y + G+L L ++ L +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 862 KIILGVAHGLAYLH-HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920
VA G+ YL C IHRD+ + N+LV +ADFGLA+ + + +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 921 NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNG 979
++ ++APE + T +SDV+S+G+++ E+ T G P IP G
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFKLLREG 252
Query: 980 ELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
++ T L +LMR C + P +RPT K + L ++
Sbjct: 253 HRMDKPSNCTHEL--YMLMRE----------------CWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 766 VGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGE--LP-ERDQFSAEVQTLGSIRHKNIVR 821
+G G G VY+ P S +A+K + V+ E LP + A ++ L + H NIVR
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 822 LLGCCNNGRTR-----LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHH 876
L+ C RT L+F+++ L L ++ ++ GL +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGY 936
+C I+HRD+K NILV + LADFGLA+++ A V + Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEVLL 180
Query: 937 SLKITEKSDVYSYGVVLLEVLTGK 960
D++S G + E+ K
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 10/198 (5%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+GKG G V++ ++ +++V+A+K + ++ E E + E+ L + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
++ +Y+ GS LL LD I+ + GL YLH + IH
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE---KKIH 124
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS 944
RDIK+ N+L+ E LADFG+A ++ R N+ G+ ++APE K+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 945 DVYSYGVVLLEVLTGKEP 962
D++S G+ +E+ G+ P
Sbjct: 183 DIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-12
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 765 IVGKGVSGIV-----------YRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGS 813
++GKG G V Y V++ ++ I KK E+ S L +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK---------EEKHIMSERNVLLKN 52
Query: 814 IRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAY 873
++H +V L + DYI+ G L L ++ FL+ +R+ +A L Y
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGY 111
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
LH I++RD+K NIL+ Q L DFGL K E+ E + +++ G+ Y+APE
Sbjct: 112 LHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPE 166
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966
+ D + G VL E+L G P SR
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-12
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 763 TNIVGKGVSGIVY---RVEIPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRH 816
T +VG+ + + R P +V+A K L + Q + +E+ L + H
Sbjct: 72 TTLVGRNPTTAAFVATRGSDPKEKVVA-------KFVMLNDERQAAYARSELHCLAACDH 124
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSL----AGLLHEKKVFLDWDSR---YKIILGVAH 869
IV+ + LL+ +Y S G L L E F +++ Y+I+L
Sbjct: 125 FGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA--- 181
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
L +H ++HRD+KS NI + P L DFG +K + S S ++S G+ Y
Sbjct: 182 -LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+APE + ++K+D++S GV+L E+LT P
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 36/218 (16%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLL 823
+GKG G VY+V + AVK L P+ + + ++ AE L S+ H N+V+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEAEYNILQSLPNHPNVVKFY 85
Query: 824 GC------CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK------IILGVAHGL 871
G G+ L+L + + GS+ L+ K L R I+ G GL
Sbjct: 86 GMFYKADKLVGGQLWLVL-ELCNGGSVTELV---KGLLICGQRLDEAMISYILYGALLGL 141
Query: 872 AYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIA 931
+LH++ IIHRD+K NNIL+ + L DFG++ S+ R N+ G+ ++A
Sbjct: 142 QHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMA 196
Query: 932 PE-------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
PE Y YS + DV+S G+ +E+ G P
Sbjct: 197 PEVIACEQQYDYSYD--ARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 15/175 (8%)
Query: 800 ERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR------LLLFDYISNGSLAGLL----- 848
E + F +E + H N++RL+G C +++ ++ +G L L
Sbjct: 43 EMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRL 102
Query: 849 HEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908
+ +L K + +A G+ YL IHRD+ + N ++ +ADFGL+
Sbjct: 103 GDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159
Query: 909 KLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
K + + R +IA E T KSDV+S+GV + E+ T G+ P
Sbjct: 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 53/198 (26%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 766 VGKGVSGIV-YRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G +GIV E + + +AVKK+ K R+ EV + H+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
G ++ +++ G+L ++ + ++ + + L V L+YLH+ V IH
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGV---IH 141
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS 944
RDIKS++IL+ L+DFG + S+ S+ G+ ++APE L +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 945 DVYSYGVVLLEVLTGKEP 962
D++S G++++E++ G+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 765 IVGKGVSGIVYRVEI----PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
I+G+G G V ++ S+ +AVK + + E ++F +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 821 RLLGCCNNGRTR------LLLFDYISNGSLAGLL-----HEKKVFLDWDSRYKIILGVAH 869
+L+G C + +++ ++ +G L L L + K ++ +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
G+ YL + IHRD+ + N ++ +ADFGL+K S + R +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
IA E T KSDV+++GV + E+ T G+ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 784 VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGS 843
++AVK L N R+ F E++ + ++ NI+RLL C ++ +Y+ NG
Sbjct: 48 LVAVKMLREDANKN--ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 844 LAGLL--HE--------KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNIL 893
L L HE V + + + + +A G+ YL +HRD+ + N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL 162
Query: 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVL 953
VG + +ADFG+++ S + R +++ E K T SDV+++GV L
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222
Query: 954 LEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLG 1012
E+LT KE S++ D I E EF RQ+ + + L L
Sbjct: 223 WEILTLCKEQPYSQLSDEQVI---------ENTGEFFRDQGRQVYLPKPALCPDSLYKL- 272
Query: 1013 VALLCVNPCPEERPTMKDVTAMLKE 1037
L C +ERP+ +++ A L E
Sbjct: 273 -MLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 69/240 (28%), Positives = 102/240 (42%), Gaps = 60/240 (25%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQ---FSAEVQTLGSIRHKNIV 820
++G+G G V+ V + + QV A+K L + ++ +R+Q AE L IV
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVL---RKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGV--AHGLAYLH 875
+L + L+ +Y+ G L LL K VF + +R+ +++L + H L +
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF-- 122
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK------------------LFESSESS 917
IHRDIK +NIL+ LADFGL K LF +
Sbjct: 123 -------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 918 RA---------SNSVAGSYGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
R +NS G+ YIAPE YG D +S GV+L E+L G P
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGE-LPERDQFSA--EVQTLGSIRHKNIVR 821
+G+G G+VY+ + +V+A+KK+ E +P +A E+ L + H NIV+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS----TAIREISLLKELNHPNIVK 63
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA--------HGLAY 873
LL + L+F+++ + K F+D I L + GLA+
Sbjct: 64 LLDVIHTENKLYLVFEFLH--------QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
H V +HRD+K N+L+ + LADFGLA+ F + V + Y APE
Sbjct: 116 CHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 170
Query: 934 YGYSLKI-TEKSDVYSYGVVLLEVLTGKE--PTDSRI 967
K + D++S G + E++T + P DS I
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 766 VGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
+G+G G+VY V+ +A+K + + + ER +F E + ++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLH------EKKVFLDWDSRYKIIL---GVAHG 870
VRLLG + G+ L++ + ++ G L L E S K+I +A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
+AYL+ + +HRD+ + N +V F + DFG+ + ++ R ++
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 931 APEYGYSLK---ITEKSDVYSYGVVLLEVLTGKE 961
+PE SLK T SDV+S+GVVL E+ T E
Sbjct: 189 SPE---SLKDGVFTTYSDVWSFGVVLWEIATLAE 219
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 50/184 (27%), Positives = 91/184 (49%), Gaps = 8/184 (4%)
Query: 781 SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYIS 840
S + +AVK L N +D+ E + + + IVR++G C + +L+ +
Sbjct: 21 SEKTVAVKILKNDNNDP-ALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78
Query: 841 NGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEA 900
G L L + K + + +++ V+ G+ YL +HRD+ + N+L+ Q A
Sbjct: 79 LGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYA 134
Query: 901 FLADFGLAKLFESSES-SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT- 958
++DFGL+K + E+ +A + APE K + KSDV+S+GV++ E +
Sbjct: 135 KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSY 194
Query: 959 GKEP 962
G++P
Sbjct: 195 GQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 2e-11
Identities = 70/219 (31%), Positives = 103/219 (47%), Gaps = 47/219 (21%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFS---------AEV---QTLG 812
+GKG GIV++ ++ +++V+A+KK++ D F E+ Q LG
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIF----------DAFRNATDAQRTFREIMFLQELG 64
Query: 813 SIRHKNIVRLLGC--CNNGRTRLLLFDYISNGSLAGLLHE---KKVFLDWDSRYKIILGV 867
H NIV+LL N + L+F+Y+ LH + D RY I+ +
Sbjct: 65 D--HPNIVKLLNVIKAENDKDIYLVFEYMETD-----LHAVIRANILEDVHKRY-IMYQL 116
Query: 868 AHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSY 927
L Y+H V IHRD+K +NIL+ LADFGLA+ E + N V Y
Sbjct: 117 LKALKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN-PENPVLTDY 172
Query: 928 ----GYIAPE--YGYSLKITEKSDVYSYGVVLLEVLTGK 960
Y APE G S + T+ D++S G +L E+L GK
Sbjct: 173 VATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 52/198 (26%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 766 VGKGVSGIVYRVEIPSR-QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G +GIV + S +++AVKK+ K R+ EV + +H+N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
G ++ +++ G+L ++ + ++ + + L V L+ LH V IH
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQGV---IH 139
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS 944
RDIKS++IL+ L+DFG + S+ S+ G+ ++APE L +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 945 DVYSYGVVLLEVLTGKEP 962
D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G VY+ + +A K+ K+ E E + + E++ L + H IV+LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885
++ ++ G++ ++ E L I + L YLH IIHR
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHR 134
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-----------Y 934
D+K+ N+L+ + LADFG++ ++ ++ + +S G+ ++APE Y
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y K+D++S G+ L+E+ + P
Sbjct: 193 DY------KADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 2e-11
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G G V V S + A+K L K +L + + E + L SIRH +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHDCVPP 881
+ L+ +Y+ G L L + F + +R+ +++L L YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL----ALEYLHSL---D 121
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------YG 935
I++RD+K N+L+ + DFG AK R ++ G+ Y+APE YG
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAKR----VKGRTY-TLCGTPEYLAPEIILSKGYG 176
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG 970
+ D ++ G+++ E+L G P P
Sbjct: 177 KA------VDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 51/225 (22%)
Query: 767 GKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
G+G G+V ++ +P+ ++AVK++ N S E + L + +I
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVN---------SQEQKRL--LMDLDISMRSVD 58
Query: 826 CNN---------GRTRLLLFDYISNGSLAGL---LHEKKVFLDWDSRYKIILGVAHGLAY 873
C + + + + SL +++K + + D KI + + L Y
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSV-----AGSYG 928
LH +IHRD+K +N+L+ + L DFG+ S +SV AG
Sbjct: 119 LHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI--------SGYLVDSVAKTIDAGCKP 168
Query: 929 YIAPE--------YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDS 965
Y+APE GY + KSDV+S G+ ++E+ TG+ P DS
Sbjct: 169 YMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 59/192 (30%), Positives = 87/192 (45%), Gaps = 42/192 (21%)
Query: 764 NIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGE--LPE---RDQFSAEVQTLGSIR-- 815
+G+G G VY+ ++ + + +A+KK+ V E +P R E+ L +
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLR-----EIALLKQLESF 58
Query: 816 -HKNIVRLLGCCNNGRTR-----LLLF--------DYISNGSLAGLLHEKKVFLDWDSRY 861
H NIVRLL C+ RT L+F Y+S GL E L
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ--- 115
Query: 862 KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921
+L G+ +LH I+HRD+K NILV + +ADFGLA+++ S E +
Sbjct: 116 --LLR---GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMAL--T 164
Query: 922 SVAGSYGYIAPE 933
SV + Y APE
Sbjct: 165 SVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 29/213 (13%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVR 821
+ KG G V+ + + + A+K +K ++ ++Q E L + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKV---IKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
L + L+ +Y+ G LA LL D D I + L YLH +
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSL-DEDVARIYIAEIVLALEYLHSN---G 113
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKL------FESSESSRASNSVAGSYGYIAPE-- 933
IIHRD+K +NIL+ L DFGL+K+ ++ + + G+ YIAPE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ + D +S G +L E L G P
Sbjct: 174 LGQGHSKT------VDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 8/159 (5%)
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRYKIIL 865
E Q L IR + L T+L L+ DYI+ G L L +++ F ++ +
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF----KEQEVQI 109
Query: 866 GVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAG 925
+ L H II+RDIK NIL+ L DFGL+K F E RA S G
Sbjct: 110 YSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY-SFCG 168
Query: 926 SYGYIAPEY--GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ Y+AP+ G + D +S GV++ E+LTG P
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 25/155 (16%)
Query: 816 HKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH 875
+ N ++L + +L+ DYI +G L LL K+ L KII + L LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 876 -HDCVPPIIHRDIKSNNIL-VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
H+ IIH DIK N+L + +L D+GL K+ + S G+ Y +PE
Sbjct: 127 KHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTPSCY-----DGTLDYFSPE 176
Query: 934 ------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y S D ++ GV+ E+LTGK P
Sbjct: 177 KIKGHNYDVSF------DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 766 VGKGVSGIVYRVEIPSRQV-IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G G V+ + + +AVK +L + +F E + L H NIVRL+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
C + ++ + + G L + L +++ A G+ YL IH
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IH 117
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---YGYSLKIT 941
RD+ + N LV + ++DFG+++ E + + APE YG + +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG---RYS 174
Query: 942 EKSDVYSYGVVLLEVLT 958
+SDV+S+G++L E +
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 43/232 (18%)
Query: 751 FSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQ 809
F+ +D L D +G+G G V + + PS ++AVK++ + + E+ + ++
Sbjct: 1 FTAED----LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK--EQKRLLMDLD 54
Query: 810 TLGSIRH-KNIVRLLG-------C--CNNGRTRLLLFDYISNGSLAGLLHEK-KVFLDWD 858
+ IV+ G C C + L D IS ++E K + +
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWIC------MELMD-ISLDKFYKYVYEVLKSVIPEE 107
Query: 859 SRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA-KLFESSESS 917
KI + L YL + IIHRD+K +NIL+ L DFG++ +L +S +
Sbjct: 108 ILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT 165
Query: 918 RASNSVAGSYGYIAPEY-------GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
R AG Y+APE GY ++ SDV+S G+ L EV TGK P
Sbjct: 166 RD----AGCRPYMAPERIDPSARDGYDVR----SDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 34/79 (43%), Positives = 52/79 (65%)
Query: 248 GYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSS 307
G+IP +I L+++ L N I G IP LGS+ +L+ L L N+ +GSIPE+LG +S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 308 LTVIDVSLNSLGGEVPVSL 326
L +++++ NSL G VP +L
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 34/209 (16%)
Query: 767 GKGVSGIVYRVEIPSRQVIAVKKL--WPVKNGELPE-RDQFSAEVQTLGSIRHKNIVRLL 823
G G G+V +V +I +KL +K P R+Q E++ L IV
Sbjct: 10 GAGNGGVVTKVLHRPSGLIMARKLIHLEIK----PAIRNQIIRELKVLHECNSPYIVGFY 65
Query: 824 GC-CNNGRTRLLLFDYISNGSL------AGLLHEKKVFLDWDSRYKIILGVAHGLAYLH- 875
G ++G + + +++ GSL AG + E L KI + V GL YL
Sbjct: 66 GAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEN--ILG-----KISIAVLRGLTYLRE 117
Query: 876 -HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA-KLFESSESSRASNSVAGSYGYIAPE 933
H I+HRD+K +NILV + E L DFG++ +L +S +NS G+ Y++PE
Sbjct: 118 KHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPE 168
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
T +SD++S G+ L+E+ G+ P
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 47/133 (35%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 834 LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHDCVPPIIHRDIKSN 890
L+ DY+S G + L+++ F + + R+ +IIL + H LH I++RDIK
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH----LHK---LGIVYRDIKLE 134
Query: 891 NILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS-DVYSY 949
NIL+ + L DFGL+K F S E R + S G+ Y+APE K+ D +S
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSL 193
Query: 950 GVVLLEVLTGKEP 962
G+++ E+LTG P
Sbjct: 194 GILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIV-YRVEIPSRQVIAVKKLWPVKNGELPERDQFS 805
Q++N ++ +V R D VG G G V ++ + +A+KKL+ EL + +
Sbjct: 4 QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY-----ISNGSLAGLL-HEKKVFLDWDS 859
E++ L ++H+N++ LL + D+ L L+ HEK L D
Sbjct: 64 -ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDR 119
Query: 860 RYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919
++ + GL Y+H IIHRD+K N+ V E + DFGLA+ S
Sbjct: 120 IQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEM 172
Query: 920 SNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGK 960
+ V + Y APE + + T+ D++S G ++ E+LTGK
Sbjct: 173 TGYVVTRW-YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 754 DDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGS 813
DD ++S+ +G G G+V++V +I +KL ++ + R+Q E+Q L
Sbjct: 4 DDDFEKISE---LGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHE 59
Query: 814 IRHKNIVRLLGCCNNGRTRLLLFDYISNGSL------AGLLHEKKVFLDWDSRYKIILGV 867
IV G + + +++ GSL AG + E+ + K+ + V
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-------GKVSIAV 112
Query: 868 AHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA-KLFESSESSRASNSVAGS 926
GL YL I+HRD+K +NILV + E L DFG++ +L +S +NS G+
Sbjct: 113 IKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGT 165
Query: 927 YGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y++PE + +SD++S G+ L+E+ G+ P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 764 NIVGKGVSGIVYRVEIPS--RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIV 820
+++G+G G V R I ++ A K+ E RD F+ E++ L + H NI+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLGHHPNII 66
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY----------------KII 864
LLG C N + +Y G+L L + +V L+ D + +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRV-LETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 865 LGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA 924
VA G+ YL IHRD+ + N+LVG + +ADFGL++ E + +
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYVKKTMGRLP 181
Query: 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT 958
+ I YS+ T KSDV+S+GV+L E+++
Sbjct: 182 VRWMAIE-SLNYSV-YTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 766 VGKGVSGIVYRV---EIPSRQVIAVKKLWPVKNGELPERDQFSA----EVQTLGSIRHKN 818
+G+G G VY+ + A+KK G+ + S E+ L ++H+N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALLRELKHEN 63
Query: 819 IVRLLGCC--NNGRTRLLLFDYISNGSLAGLLH---EKKVFLDWDSRYKIIL-GVAHGLA 872
+V L+ + ++ LLFDY + L ++ + K S K +L + +G+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 873 YLHHDCVPPIIHRDIKSNNILV-GPQFE---AFLADFGLAKLFES-SESSRASNSVAGSY 927
YLH + ++HRD+K NILV G E + D GLA+LF + + + V +
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 928 GYIAPE-------YGYSLKITEKSDVYSYGVVLLEVLT 958
Y APE Y T+ D+++ G + E+LT
Sbjct: 180 WYRAPELLLGARHY------TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 40/276 (14%)
Query: 765 IVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+VGKG G V V + + +KKL ++N ER E Q L ++H NIV
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 824 GCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFL-------DWDSRYKIILGVAHGLAYLH 875
L ++ + G L L E+K L +W + +A L YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYLH 119
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYG 935
I+HRD+K+ N+ + + D G+A++ E ++ AS + Y Y++PE
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPY-YMSPELF 174
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995
+ KSDV++ G + E+ T K +++ + + + + G+L ++++ L
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-SLVYRIIEGKLPPMPKDYSPEL--- 230
Query: 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
G I ML + PE+RP++K +
Sbjct: 231 -----GELIATML----------SKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 70/300 (23%), Positives = 131/300 (43%), Gaps = 58/300 (19%)
Query: 766 VGKGVSGIVY--------RVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHK 817
+G+G G+VY + E +R +AVK + ++ L ER +F E +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETR--VAVKTV--NESASLRERIEFLNEASVMKGFTCH 69
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSR-------------YKII 864
++VRLLG + G+ L++ + +++G L L L ++ ++
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS----LRPEAENNPGRPPPTLQEMIQMA 125
Query: 865 LGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA 924
+A G+AYL+ +HRD+ + N +V F + DFG+ + ++ R
Sbjct: 126 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 925 GSYGYIAPEYGYSLK---ITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGE 980
++APE SLK T SD++S+GVVL E+ + ++P G
Sbjct: 183 LPVRWMAPE---SLKDGVFTTSSDMWSFGVVLWEITSLAEQP--------------YQGL 225
Query: 981 LRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040
E+ +F ++D L + + + ++ +C P+ RPT ++ +LK+ H
Sbjct: 226 SNEQVLKF--VMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDDLH 280
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 765 IVGKGVSGIVYRVEI----PSRQVIAVK---KLWPVKNGELPERDQFSAEVQTLGSIRHK 817
++GKG G V++V + ++ A+K K V+N + + AE L +++H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQK--DTAHTKAERNILEAVKHP 60
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFL-DWDSRY--KIILGVAHGLAYL 874
IV L+ G L+ +Y+S G L L + +F+ D Y +I L + H L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEH----L 116
Query: 875 HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY 934
H II+RD+K NIL+ Q L DFGL K ES +++ G+ Y+APE
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPE- 170
Query: 935 GYSLKITEKS------DVYSYGVVLLEVLTGKEP 962
I +S D +S G ++ ++LTG P
Sbjct: 171 -----ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 765 IVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTL----------GS 813
++G+G G V E + ++ A+K L K G++ RD EV++L S
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKAL---KKGDIIARD----EVESLMCEKRIFETANS 58
Query: 814 IRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLH-EKKVFLDWDSRYKIILG-VAHGL 871
RH +V L C + +Y + G L ++H VF + R V GL
Sbjct: 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSE--PRAVFYAACVVLGL 114
Query: 872 AYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIA 931
YLH + I++RD+K +N+L+ + +ADFGL K E +++ G+ ++A
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLA 169
Query: 932 PEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
PE T D + GV++ E+L G+ P
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-11
Identities = 32/90 (35%), Positives = 47/90 (52%)
Query: 405 ALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGH 464
L L + L G +P+ + L++L + L N G IPP +G T L L L N+F+G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 465 IPSRIGLLHRLTFLELSENQFTGEIPPEIG 494
IP +G L L L L+ N +G +P +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 46/201 (22%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G VYR + R+ +A+KK+ + + R E+ L + H N+++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 825 CCNNGRTRLLLFDYISNGSLAGLL---HEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
++ + G L+ ++ ++K + + +K + + + ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
++HRDIK N+ + L D GL + F S + A++S+ G+ Y++PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYN 184
Query: 942 EKSDVYSYGVVLLEVLTGKEP 962
KSD++S G +L E+ + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 9e-11
Identities = 59/224 (26%), Positives = 88/224 (39%), Gaps = 34/224 (15%)
Query: 766 VGKGVSGIVYRV------EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
VG+G G V+ EI + + + L+ +L E E L + + + +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWL 63
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA-----HGLAYL 874
V+LL + L +Y+ G LL+ V + +R+ + H L Y
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY- 122
Query: 875 HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY 934
IHRD+K N L+ L DFGL+K + +NSV GS Y+APE
Sbjct: 123 --------IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEV 169
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN 978
D +S G +L E L G P P+ TW N
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE----TWEN 209
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 778 EIPSRQV-IAVKKLWPVKNGELPERD--QFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRL 833
E P+R +AVK L + E+D +E++ + I +HKNI+ LLG C
Sbjct: 45 EKPNRVTKVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 100
Query: 834 LLFDYISNGSLAGLLHEKKV---------------FLDWDSRYKIILGVAHGLAYL-HHD 877
++ +Y S G+L L ++ L + VA G+ YL
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
C IHRD+ + N+LV +ADFGLA+ + + + + ++APE +
Sbjct: 161 C----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 216
Query: 938 LKITEKSDVYSYGVVLLEVLT-GKEP 962
T +SDV+S+GV+L E+ T G P
Sbjct: 217 RIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 764 NIVGKGVSGIVYRVEIPSR--QVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIV 820
+++G+G G V + I ++ A K + RD F+ E++ L + H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 59
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY----------------KII 864
LLG C + L +Y +G+L L + +V L+ D +
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV-LETDPAFAIANSTASTLSSQQLLHFA 118
Query: 865 LGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA 924
VA G+ YL IHRD+ + NILVG + A +ADFGL++ + + +
Sbjct: 119 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLP 174
Query: 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT 958
+ I YS+ T SDV+SYGV+L E+++
Sbjct: 175 VRWMAIE-SLNYSV-YTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 47/225 (20%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSA-----EVQTLGSIRHKNI 819
+G+G G+VY+ + + + IA+KK+ L + D+ E+ L ++H NI
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI------RLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 820 VRLLGCCNNGRTRLLLFDYI---------SNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
VRL ++ + L+F+Y+ S+ A K +L Y+I+ G
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL-----YQIL----RG 114
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAF-LADFGLAKLFESSESSRASNSVAGSYGY 929
+AY H ++HRD+K N+L+ + A LADFGLA+ F R + Y
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWY 169
Query: 930 IAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGKE--PTDSRI 967
APE YS + D++S G + E++ K P DS I
Sbjct: 170 RAPEILLGSRHYSTPV----DIWSVGCIFAEMVNQKPLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 41/129 (31%), Positives = 67/129 (51%), Gaps = 12/129 (9%)
Query: 837 DYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHDCVPPIIHRDIKSNNIL 893
+Y++ G L + F + +R+ +II G L +LH II+RD+K +N+L
Sbjct: 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKK---GIIYRDLKLDNVL 128
Query: 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVL 953
+ +ADFG+ K + E +++ G+ YIAPE K E D +S+GV+L
Sbjct: 129 LDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLL 186
Query: 954 LEVLTGKEP 962
E+L G+ P
Sbjct: 187 YEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 50/221 (22%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G G VY++ + V+AVK++ N E +R +V L S IV+ G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDCPYIVKCYG 81
Query: 825 CCNNGRTRLLLFDYISNGS-----------LAGLLHEKKVFLDWDSRYKIILGVAHGLAY 873
+I++ L LL + + D K+ + + L Y
Sbjct: 82 Y------------FITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129
Query: 874 L--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA-KLFESSESSRASNSVAGSYGYI 930
L H +IHRD+K +NIL+ L DFG++ +L +S +R+ AG Y+
Sbjct: 130 LKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS----AGCAAYM 181
Query: 931 APEYGYSLKITEK---------SDVYSYGVVLLEVLTGKEP 962
APE +I +DV+S G+ L+E+ TG+ P
Sbjct: 182 APE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 763 TNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIV 820
+GKG G V++V + AVK L P+ + + ++ AE L ++ H N+V
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSDHPNVV 78
Query: 821 RLLGC-----CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK--IILGVAH---- 869
+ G NG L+ + + GS+ L+ K FL R + II + H
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERMEEPIIAYILHEALM 135
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GL +LH + IHRD+K NNIL+ + L DFG++ S+ R N+ G+ +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFW 190
Query: 930 IAPEY---GYSLKIT--EKSDVYSYGVVLLEVLTGKEP 962
+APE L T + DV+S G+ +E+ G P
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-10
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 26/115 (22%)
Query: 310 VID-VSLNSLG--GEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRF 366
ID + L++ G G +P ++ L L+ + LSGN+I G IP G+ + L+ L+L N F
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 367 FGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSL 421
G IP ++GQL L+ L+L+ N L+G VP++L
Sbjct: 479 NGSIPESLGQL-----------------------TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
VG G G V+ V + S A+K + + L + E + L + H I+RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHDCVPP 881
++ R +L +Y+ G L L F + + +I+ L YLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA----LEYLHSK---E 121
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
I++RD+K NIL+ + L DFG AK + + ++ G+ Y+APE S
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVIQSKGHN 176
Query: 942 EKSDVYSYGVVLLEVLTGKEPTDSRIPDG 970
+ D ++ G+++ E+L G P P G
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 8/204 (3%)
Query: 765 IVGKGVSGIVYRVEIPSRQVI-AVKKLWPVKNGELPERDQFSAEVQTL-GSIRHKNIVRL 822
++GKG G V + + AVK L + E+ AE L +++H +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ DY++ G L L ++ F + +R+ +A L YLH I
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNI 117
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
I+RD+K NIL+ Q L DFGL K E E S+ +++ G+ Y+APE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 943 KSDVYSYGVVLLEVLTGKEPTDSR 966
D + G VL E+L G P SR
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRL 822
+VG G G VY+ + + Q+ A+K V + E ++ E+ L H+NI
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIK----VMDVTEDEEEEIKLEINMLKKYSHHRNIATY 78
Query: 823 LGC------CNNGRTRLLLFDYISNGSLAGLLHEKK---VFLDWDSRYKIILGVAHGLAY 873
G + L+ ++ GS+ L+ K + DW + I + GLA+
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAH 136
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
LH +IHRDIK N+L+ E L DFG++ + + R N+ G+ ++APE
Sbjct: 137 LH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPE 191
Query: 934 -----------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y Y +SD++S G+ +E+ G P
Sbjct: 192 VIACDENPDATYDY------RSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-10
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 766 VGKGVSGIVYRVEIP--SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G G G+V+ V P ++V A+KK+ V + + F E++ L +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRV-ALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSAL 65
Query: 824 GCCNNGR----------TRLLLFDY----ISNGSLAGLLHEKKVFLDWDSRYKIILGVAH 869
T L+ D +S L+ KVFL Y+I+
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSS--DHVKVFL-----YQIL----R 114
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GL YLH I+HRDIK N+LV + DFGLA++ E ES + V Y Y
Sbjct: 115 GLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 930 IAPE--YGYSLKITEKSDVYSYGVVLLEVLTGK 960
APE G S T D++S G + E+L +
Sbjct: 171 RAPEILMG-SRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 52/166 (31%), Positives = 81/166 (48%), Gaps = 29/166 (17%)
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN---------GSLAGLLHEKKVFLDW 857
EV L +++H NIV L + R L+F+Y+ + G+L + H K+F+
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSM-HNVKIFM-- 109
Query: 858 DSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917
+ GL+Y H I+HRD+K N+L+ + E LADFGLA+ +S +
Sbjct: 110 -------FQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTK 158
Query: 918 RASNSVAGSYGYIAPEYGYSLKITEKS---DVYSYGVVLLEVLTGK 960
SN V + Y P+ L TE S D++ G +L E+ TG+
Sbjct: 159 TYSNEVVTLW-YRPPD--VLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 50/163 (30%), Positives = 72/163 (44%), Gaps = 18/163 (11%)
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLA-------GLLHEKKVFLDWDS 859
E L ++H NIV ++ +Y G L G L + L W
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 860 RYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919
++ LGV H +H V +HRDIKS NI + + L DFG A+L +S + A
Sbjct: 108 --QMCLGVQH----IHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLL-TSPGAYA 157
Query: 920 SNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
V Y Y+ PE ++ KSD++S G +L E+ T K P
Sbjct: 158 CTYVGTPY-YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/277 (20%), Positives = 121/277 (43%), Gaps = 25/277 (9%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G VYR + +A+KK+ + R E+ L + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLH---EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
++ + G L+ ++ ++K + + +K + + L ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---R 126
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
++HRDIK N+ + L D GL + F S + A++S+ G+ Y++PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYN 184
Query: 942 EKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
KSD++S G +L E+ + P D ++ + + + ++ + S
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYG---DKMNLYSLCK---KIEQCDYPP-------LPSD 231
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
+E+ Q++ +C+NP PE+RP + V + K +
Sbjct: 232 HYSEELRQLVN---MCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 32/233 (13%)
Query: 756 VVTRLSDTNIVGKGVSGIVYR-----VEIPSRQVIAVKKLW-PVKNGELPERDQFSAEVQ 809
V+ R +G G GIV + I +AVKKL P +N +R E+
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGIN----VAVKKLSRPFQNQTHAKRAY--RELV 72
Query: 810 TLGSIRHKNIVRLLGCCNNGRT-----RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKII 864
L + HKNI+ LL ++ + L + + +L ++H + LD + ++
Sbjct: 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLL 129
Query: 865 LGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA 924
+ G+ +LH IIHRD+K +NI+V + DFGLA+ + + + V
Sbjct: 130 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVV 184
Query: 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA-HIITW 976
Y Y APE + E D++S G ++ E++ G S I G HI W
Sbjct: 185 TRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG-----SVIFQGTDHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 2e-09
Identities = 61/238 (25%), Positives = 94/238 (39%), Gaps = 70/238 (29%)
Query: 759 RLSDTNIVGKGVSGIVYRV--EIPSRQVIAVKKLWPVKNGELPERDQFSA-----EVQTL 811
R +G G G+V + R+V A+KK+ D A E++ L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKV-AIKKI------SNVFDDLIDAKRILREIKLL 53
Query: 812 GSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV-----FLDWDSRYKII-- 864
+RH+NI+ LL +L + V ++ D +K+I
Sbjct: 54 RHLRHENIIGLL--------DILRPPSPED--------FNDVYIVTELMETD-LHKVIKS 96
Query: 865 ---LGVAH----------GLAYLH--HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909
L H GL YLH + +IHRD+K +NILV + + DFGLA+
Sbjct: 97 PQPLTDDHIQYFLYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLAR 151
Query: 910 LFESSESSRA--SNSVAGSYGYIAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
+ E + + V + Y APE Y+ I D++S G + E+LT K
Sbjct: 152 GVDPDEDEKGFLTEYVVTRW-YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 35/213 (16%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA----EVQTLGSIRHKN 818
N + +G G+VYR + + +++A+KKL K + E++ F E+ L ++H N
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKL---KMEK--EKEGFPITSLREINILLKLQHPN 65
Query: 819 IVRL----LGCCNNGRTRLLLFDYISNGSLAGLL-HEKKVFLDWDSRYK-IILGVAHGLA 872
IV + +G +N ++ +Y+ + L L+ K+ FL S K ++L + G+A
Sbjct: 66 IVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQ--SEVKCLMLQLLSGVA 120
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAP 932
+LH + I+HRD+K++N+L+ + + DFGLA+ + S V + Y AP
Sbjct: 121 HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAP 175
Query: 933 E--YG---YSLKITEKSDVYSYGVVLLEVLTGK 960
E G YS I D++S G + E+LT K
Sbjct: 176 ELLLGAKEYSTAI----DMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 30/82 (36%), Positives = 46/82 (56%)
Query: 294 LSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNF 353
L G IP + L I++S NS+ G +P SL ++ +LE L LS N+ +G IP G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 354 SRLKQLELDNNRFFGQIPPTIG 375
+ L+ L L+ N G++P +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 40/109 (36%), Positives = 59/109 (54%), Gaps = 6/109 (5%)
Query: 574 LDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGS 633
L L + + G IP +I +L+ L + NLS N++ G IP S +++ L LDLS N GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSI-NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 634 L-KVLGSLDNLVSLNVSYNHFSGILPNT---KLFHGLPASAFYGNQQLC 678
+ + LG L +L LN++ N SG +P +L H + F N LC
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN-FTDNAGLC 529
|
Length = 623 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGR-TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIIL 865
E L ++ H +++R+ +G T ++L Y S+ L L ++ L D I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD--LYTYLTKRSRPLPIDQALIIEK 164
Query: 866 GVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAG 925
+ GL YLH IIHRD+K+ NI + + + D G A+ + A +AG
Sbjct: 165 QILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAG 218
Query: 926 SYGYIAPEYGYSLKITEKSDVYSYGVVLLEVL 957
+ APE K K+D++S G+VL E+L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-09
Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 765 IVGKGVSGIVYRVEIP--SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
++GKG G VY P SR+V A+KK+ + + +F E + + H IV +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRV-ALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLL-------------HEK---KVFLDWDSRYKIILG 866
C++G YI +L LL EK FL I
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL------SIFHK 121
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS---- 922
+ + Y+H ++HRD+K +NIL+G E + D+G A + E
Sbjct: 122 ICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 923 ------------VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ G+ Y+APE + +E +D+Y+ GV+L ++LT P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 13/201 (6%)
Query: 766 VGKGVSGIVYRVEIPSRQVI----AVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVR 821
+GKG G V +V Q I ++K V E+ AE L + IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEV---THTLAERTVLAQVNCPFIVP 57
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
L + L+ +I+ G L L + F +R+ A L L +
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT----AELLCALENLHKFN 113
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
+I+RD+K NIL+ Q L DFGL KL + + +N+ G+ Y+APE T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 942 EKSDVYSYGVVLLEVLTGKEP 962
+ D ++ GV+L E+LTG P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 65/263 (24%), Positives = 108/263 (41%), Gaps = 50/263 (19%)
Query: 765 IVGKGVSGIV-----------YRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTL-G 812
++GKG G V Y V++ ++++ +K E+ AE L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK----------EQKHIMAERNVLLK 51
Query: 813 SIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLA 872
+++H +V L + D+++ G L L ++ F + +R+ +A L
Sbjct: 52 NVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARF-YAAEIASALG 110
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAP 932
YLH I++RD+K NIL+ Q L DFGL K E S + + G+ Y+AP
Sbjct: 111 YLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAP 165
Query: 933 EYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992
E D + G VL E+L G P R D A + + IL
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR--DVAEM--------------YDNIL 209
Query: 993 DRQLLMRSGTQ------IQEMLQ 1009
+ L++R G ++E+L+
Sbjct: 210 HKPLVLRPGASLTAWSILEELLE 232
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
I+G G G VY+ + +R+++AVK + EL + Q +E++ L I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVEL--QKQIMSELEILYKCDSPYIIGF 64
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
G + +++ GSL + L +I + V GL YL I
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKI 116
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSY----GYIAPEYGYSL 938
+HRD+K +N+LV + + L DFG+ S++ NS+A +Y Y+APE
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGV--------STQLVNSIAKTYVGTNAYMAPERISGE 168
Query: 939 KITEKSDVYSYGVVLLEVLTGKEP 962
+ SDV+S G+ +E+ G+ P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 765 IVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERD-----QFSAEVQTLGSIRHKN 818
++GKG G V E+ + ++ AVK L K + + D V L +H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVL---KKDVILQDDDVECTMTEKRVLALAG-KHPF 57
Query: 819 IVRLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYL 874
+ +L C + RL + +Y++ G L + F + +R+ +I+LG L +L
Sbjct: 58 LTQLH-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFL 112
Query: 875 H-HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
H II+RD+K +N+L+ + +ADFG+ K E +++ G+ YIAPE
Sbjct: 113 HERG----IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPE 166
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
D ++ GV+L E+L G+ P +
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFS 805
Q+LN +V +V R + VG G G V + RQ +AVKKL + R +
Sbjct: 4 QELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR 63
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRT-----RLLLFDYISNGSLAGLLHEKKVFLDWDSR 860
E++ L ++H+N++ LL + + L + L ++ +K L +
Sbjct: 64 -ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK--LSDEHV 120
Query: 861 YKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920
+I + GL Y+H IIHRD+K +N+ V E + DFGLA+ +
Sbjct: 121 QFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMT 173
Query: 921 NSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGK 960
VA + Y APE + + + D++S G ++ E+L GK
Sbjct: 174 GYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQ---FSA--EVQTLGSIRHKNI 819
+G+G G+VY+ + + +++A+KK+ L D+ +A E+ L + H NI
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI------RLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDC 878
VRLL ++ L+F+++ + LD + + G+AY H H
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR- 119
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY---- 934
++HRD+K N+L+ + LADFGLA+ F R + Y APE
Sbjct: 120 ---VLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGS 174
Query: 935 -GYSLKITEKSDVYSYGVVLLEVLTGKE--PTDSRI 967
YS + D++S G + E++ + P DS I
Sbjct: 175 RQYSTPV----DIWSIGCIFAEMVNRRPLFPGDSEI 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 34/183 (18%)
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN---------GSLAGLLHEKKVFLDW 857
EV L ++H NIV L + ++ L+F+Y+ G++ + H K+FL
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-HNVKIFL-- 110
Query: 858 DSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917
Y+I+ GLAY H ++HRD+K N+L+ + E LADFGLA+ +S +
Sbjct: 111 ---YQIL----RGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTK 159
Query: 918 RASNSVAGSYGYIAPEY-----GYSLKITEKSDVYSYGVVLLEVLTGKEP-TDSRIPDGA 971
SN V + Y P+ YS +I D++ G + E+ +G+ S + D
Sbjct: 160 TYSNEVVTLW-YRPPDVLLGSSEYSTQI----DMWGVGCIFFEMASGRPLFPGSTVEDEL 214
Query: 972 HII 974
H+I
Sbjct: 215 HLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVRL 822
VG G G VY+ + + +L VK +L D FS E+ + +H NIV
Sbjct: 17 VGSGTYGDVYKA-----RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
G + + +Y GSL + H + Y + GLAYLH
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLHSKGK--- 127
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLK--- 939
+HRDIK NIL+ + LADFG+A ++ + R S G+ ++APE K
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEKNGG 185
Query: 940 ITEKSDVYSYGVVLLEVLTGKEP 962
+ D+++ G+ +E+ + P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 2/87 (2%)
Query: 170 DNQ-LSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPR 228
DNQ L G IP +I +L L+ I GN I G IP + + L L L+ +G IP
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGN-SIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 229 SVGELTNLRTLSVYTANITGYIPEEIG 255
S+G+LT+LR L++ +++G +P +G
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 63/247 (25%), Positives = 105/247 (42%), Gaps = 65/247 (26%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIV 820
++G+G G V V + + + A+KKL + E+ E++Q + AE L + +V
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKL---RKSEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKI---ILGV--AHGLAYLH 875
+L + L+ +Y+ G + LL +K F + ++R+ I IL + H L Y
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY-- 122
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS------------------ 917
IHRDIK +N+L+ + L+DFGL + S +
Sbjct: 123 -------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 918 --------RASN----------SVAGSYGYIAPE----YGYSLKITEKSDVYSYGVVLLE 955
+A S G+ YIAPE GY+ ++ D +S GV++ E
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN----KECDWWSLGVIMYE 231
Query: 956 VLTGKEP 962
+L G P
Sbjct: 232 MLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 17/109 (15%)
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
++ GL +LH II+RD+K +N+++ + +ADFG+ K E + + G+
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGT 164
Query: 927 YGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPD 969
YIAPE YG S+ D ++YGV+L E+L G+ P D D
Sbjct: 165 PDYIAPEIIAYQPYGKSV------DWWAYGVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPER--DQFSAEVQTLGSIRHKNIVRL 822
+GKG G VY+V P+ +A+K++ EL E +Q E+ L IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI----RLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVF--LDWDSRYKIILGVAHGLAYLHHDCVP 880
G + +Y+ GSL L + D +I V GL +L +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--H 122
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKI 940
IIHRD+K N+LV + L DFG++ +S + + G Y+APE S
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGP 178
Query: 941 TE------KSDVYSYGVVLLEVLTGKEP 962
+ +SDV+S G+ +LE+ G+ P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 17/104 (16%)
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
+A GL +LH II+RD+K +N+++ + +ADFG+ K E+ + + + G+
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164
Query: 927 YGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
YIAPE YG S+ D +++GV+L E+L G+ P D
Sbjct: 165 PDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GL +LH II+RD+K +N+++ +ADFG+ K E+ +++ G+ Y
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDY 162
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
IAPE LK T D +S+GV+L E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GL +LH I++RD+K +NIL+ +ADFG+ K E+ + + G+ Y
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDY 162
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
IAPE K D +S+GV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 765 IVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-----RHKN 818
++G+G V VE+ R++ A+K V EL D+ VQT + H
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMK----VIKKELVNDDEDIDWVQTEKHVFETASNHPF 57
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH 875
+V L C + +++S G L + ++ + +R+ +I L L +LH
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLH 113
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-- 933
II+RD+K +N+L+ + L D+G+ K E +++ G+ YIAPE
Sbjct: 114 ER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
YG+S+ D ++ GV++ E++ G+ P D
Sbjct: 169 RGEDYGFSV------DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 61/260 (23%), Positives = 103/260 (39%), Gaps = 54/260 (20%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVR 821
+G G G V V ++ + + A+K L + ++ R+Q + AE L ++ +V+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTL---RKADVLMRNQAAHVKAERDILAEADNEWVVK 65
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
L + + DYI G + LL +F + +R+ I + + +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARF-YIAELTCAIESVHK---MG 121
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGL---------AKLFESSESSRA------------- 919
IHRDIK +NIL+ L DFGL +K ++ + R
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 920 -------------------SNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGK 960
++S+ G+ YIAPE T+ D +S GV+L E+L G+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 961 EPTDSRIPDGAH--IITWVN 978
P + P +I W
Sbjct: 242 PPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-----RHKNI 819
++G+G V V + + I K V EL D+ VQT + H +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMK---VVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 58
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCV 879
V L C + +Y++ G L + ++ + +R+ ++ L YLH
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER-- 115
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------ 933
II+RD+K +N+L+ + L D+G+ K E +++ G+ YIAPE
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
YG+S+ D ++ GV++ E++ G+ P D
Sbjct: 173 YGFSV------DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
++G+G G V V S+QV A+K L + + + F E + + IV+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY--KIILGVA--HGLAYLHHDCV 879
+ + ++ +Y+ G L L+ + W Y +++L + H + +
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGF------ 163
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------ 933
IHRD+K +N+L+ LADFG +++ R +V G+ YI+PE
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
YG + D +S GV L E+L G P
Sbjct: 220 GDGYYG------RECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 33/168 (19%)
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN---------GSLAGLLHEKKVFLDW 857
EV L ++H NIV L + ++ L+F+Y+ G+ + H K+FL
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINM-HNVKLFL-- 110
Query: 858 DSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917
++++ GL Y H ++HRD+K N+L+ + E LADFGLA+ +S +
Sbjct: 111 ---FQLL----RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTK 159
Query: 918 RASNSVAGSYGYIAPEY-----GYSLKITEKSDVYSYGVVLLEVLTGK 960
SN V + Y P+ YS +I D++ G + E+ TG+
Sbjct: 160 TYSNEVVTLW-YRPPDILLGSTDYSTQI----DMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRTR-----LLLFDYISNGSLAGLLHEKKVFLDWDSR 860
A ++ L + H N+VRL C RT L+F+++ L + + ++
Sbjct: 53 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 112
Query: 861 YKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920
++ + GL +LH V +HRD+K NILV + LADFGLA+++ A
Sbjct: 113 KDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---AL 166
Query: 921 NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGK 960
SV + Y APE D++S G + E+ K
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 43/141 (30%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 823 LGCCNNGRTRLL-LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
L CC + RL + +Y++ G L + + F + SR+ V L +LH V
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHGV-- 117
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
I+RD+K +NIL+ + LADFG+ K E + + + G+ YIAPE L+
Sbjct: 118 -IYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 942 EKSDVYSYGVVLLEVLTGKEP 962
D ++ GV++ E++ G+ P
Sbjct: 175 PSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 67/230 (29%), Positives = 106/230 (46%), Gaps = 48/230 (20%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIVRLL 823
G+G VY+ + Q++A+K++ E E F+A E L ++H NIV L
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEI----RLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 824 GCCNNGRTRLLLFDYI---------SNGSLAGL-LHEKKVFLDWDSRYKIILGVAHGLAY 873
+ +T L+F+Y+ G GL +H ++FL ++++ GLAY
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGG--GLSMHNVRLFL-----FQLL----RGLAY 118
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAP- 932
H ++HRD+K N+L+ + E LADFGLA+ +S S SN V + Y P
Sbjct: 119 CHQR---RVLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVVTLW-YRPPD 173
Query: 933 ------EYGYSLKITEKSDVYSYGVVLLEVLTGKE--PTDSRIPDGAHII 974
EY SL D++ G + E+ TG+ P + + D H I
Sbjct: 174 VLLGSTEYSTSL------DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIV-YRVEIPSRQVIAVKKLWPVKNGELPERDQFS 805
Q+LN ++ +V R + + VG G G V + + +AVKKL + + +
Sbjct: 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRT-----RLLLFDYISNGSLAGLLHEKKVFLDWDSR 860
E++ L ++H+N++ LL R+ + L ++ L ++ +K L D
Sbjct: 66 -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHV 122
Query: 861 YKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920
+I + GL Y+H IIHRD+K +N+ V E + DFGLA+ +
Sbjct: 123 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT 175
Query: 921 NSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGK 960
VA + Y APE + + + D++S G ++ E+LTG+
Sbjct: 176 GYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 15/133 (11%)
Query: 834 LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHDCVPPIIHRDIKSN 890
+ D ++ G L L + VF + + R+ +IILG+ H +H+ V ++RD+K
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEH----MHNRFV---VYRDLKPA 126
Query: 891 NILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS-DVYSY 949
NIL+ ++D GLA F S + ++ G++GY+APE + S D +S
Sbjct: 127 NILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSL 182
Query: 950 GVVLLEVLTGKEP 962
G +L ++L G P
Sbjct: 183 GCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 765 IVGKGVSGIV----YRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
++GKG G V + E S Q +AVK L + ++F E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 821 RLLGCCNNGRTR------LLLFDYISNGSLAGLL-----HEKKVFLDWDSRYKIILGVAH 869
+L+G R + +++ ++ +G L L E+ L + + ++ +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
G+ YL IHRD+ + N ++ +ADFGL+K S + R + +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+A E T SDV+++GV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQ---FSA--EVQTLGSIRHKNI 819
+G+G G V++ + +++A+K++ L + D+ SA E+ L ++HKNI
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVF------LDWDSRYKIILGVAHGLAY 873
VRL ++ + L+F+Y KK F +D + + + GLA+
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDL-------KKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
H V +HRD+K N+L+ E LADFGLA+ F ++ V + Y P+
Sbjct: 115 CHSHNV---LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPD 169
Query: 934 YGYSLKITEKS-DVYSYGVVLLEVLTGKEP 962
+ K+ S D++S G + E+ P
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIVRL 822
+G+G VY+ + + Q++A+K V + + E F+A E L ++H NIV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALK----VISMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 823 LGCCNNGRTRLLLFDYISNGSLA-------GLLHEKKVFLDWDSRYKIILGVAHGLAYLH 875
+ T +F+Y+ LA G LH V L + + GLAY+H
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIH 120
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYG 935
I+HRD+K N+L+ E LADFGLA+ S S+ +S + Y P+
Sbjct: 121 GQ---HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPD-- 173
Query: 936 YSLKITEKS---DVYSYGVVLLEVLTGK 960
L T+ S D++ G + +E+L G+
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 40/237 (16%)
Query: 756 VVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSA-----EVQ 809
V+ R + +G G GIV + + Q +A+KKL P ++ A E+
Sbjct: 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL------SRPFQNVTHAKRAYRELV 67
Query: 810 TLGSIRHKNIVRLLGCCNNGRT-----RLLLFDYISNGSLA-----GLLHEKKVFLDWDS 859
+ + HKNI+ LL ++ + L + + +L L HE+ +L
Sbjct: 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYL---- 123
Query: 860 RYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919
Y+++ G+ H LH IIHRD+K +NI+V + DFGLA+ + S
Sbjct: 124 LYQMLCGIKH----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM 174
Query: 920 SNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITW 976
+ V Y Y APE + E D++S G ++ E++ G P HI W
Sbjct: 175 TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT----VLFPGTDHIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 45/275 (16%)
Query: 765 IVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN----- 818
++G+G V V + + Q+ A+K V EL D+ VQT + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMK----VVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
+V L C L+ +Y++ G L + ++ + +R+ + L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHER- 115
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----- 933
II+RD+K +N+L+ L D+G+ K E +++ G+ YIAPE
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 934 -YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992
YG+S+ D ++ GV++ E++ G+ P D IIT N ++ F IL
Sbjct: 172 EYGFSV------DWWALGVLMFEMMAGRSPFD--------IIT-DNPDMNTEDYLFQVIL 216
Query: 993 DRQLLMRSGTQIQEMLQVLGVALL--CVNPCPEER 1025
++ + +I L V +L +N P+ER
Sbjct: 217 EKPI------RIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-08
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 43/250 (17%)
Query: 742 DFTPFQKLNFSVDDVVTRLSDT-----------------NIVGKGVSGIVYRVEIPS-RQ 783
DF +K N ++D+ + R DT ++G+G G V V S R+
Sbjct: 11 DFPALRK-NKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 69
Query: 784 VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGS 843
V A+K L + + + F E + +V+L + R ++ +Y+ G
Sbjct: 70 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 129
Query: 844 LAGLLHEKKVFLDWDSRY--KIILGV--AHGLAYLHHDCVPPIIHRDIKSNNILVGPQFE 899
L L+ V W Y +++L + H + + IHRD+K +N+L+
Sbjct: 130 LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGH 180
Query: 900 AFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY-------GYSLKITEKSDVYSYGVV 952
LADFG R +V G+ YI+PE GY + D +S GV
Sbjct: 181 LKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGY---YGRECDWWSVGVF 236
Query: 953 LLEVLTGKEP 962
L E+L G P
Sbjct: 237 LYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 7e-08
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 754 DDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLG 812
DV +R +G G G+V ++ S + +A+KK+ P + E++ L
Sbjct: 1 FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILR 59
Query: 813 SIRHKNIVRLLGCC----NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKI--ILG 866
+H NI+ + + + ++ D + + L ++H + + RY + +L
Sbjct: 60 HFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLL- 117
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS--ESSRASNSVA 924
GL Y+H V IHRD+K +N+LV E + DFG+A+ SS E
Sbjct: 118 --RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 925 GSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKE 961
+ Y APE SL + T D++S G + E+L ++
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 26/179 (14%)
Query: 867 VAHGLAYL-HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK-LFESSESSRASNSVA 924
VA G+ +L C IHRD+ + NIL+ + DFGLA+ +++ + R ++
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRE 983
++APE + T +SDV+S+GV+L E+ + G P G I N E +
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-----PGVQI----NEEFCQ 288
Query: 984 RKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042
R ++ T MR+ ++ + L C P+ERPT + +L ++ EN
Sbjct: 289 RLKDGTR-------MRAPENATP--EIYRIMLACWQGDPKERPTFSALVEILGDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 34/234 (14%)
Query: 756 VVTRLSDTNIVGKGVSGIVYRV--EIPSRQVIAVKKL-WPVKNGELPERDQFSAEVQTLG 812
V+ R + +G G GIV I R V A+KKL P +N +R E+ +
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNV-AIKKLSRPFQNQTHAKRAY--RELVLMK 78
Query: 813 SIRHKNIVRLLGCCNNGRT-----RLLLFDYISNGSLAGLL-----HEKKVFLDWDSRYK 862
+ HKNI+ LL ++ + + + + +L ++ HE+ +L Y+
Sbjct: 79 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL----LYQ 134
Query: 863 IILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922
++ G+ H LH IIHRD+K +NI+V + DFGLA+ + S +
Sbjct: 135 MLCGIKH----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 185
Query: 923 VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITW 976
V Y Y APE + E D++S G ++ E++ G P HI W
Sbjct: 186 VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 42/165 (25%), Positives = 76/165 (46%), Gaps = 10/165 (6%)
Query: 802 DQFSAEVQTLGSIRHKNIVRLLG----CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDW 857
D E++ L I NI+++ G ++ L+ +Y + G L +L ++K L +
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD-LSF 121
Query: 858 DSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917
++ + + GL L+ P ++++ S + LV ++ + GL K+ S
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK 179
Query: 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ V SY + + + T K D+YS GVVL E+ TGK P
Sbjct: 180 NVNFMVYFSYKMLNDIFS---EYTIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 765 IVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSA---EVQTLGSIRHKNIV 820
++GKG G V + S ++ AVK L K + + D E + L R+ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVL---KKDVILQDDDVECTMTEKRILSLARNHPFL 58
Query: 821 RLLGCCNNGRTRLL-LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCV 879
L CC RL + ++++ G L + + + F + +R+ + L +LH
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLHDK-- 115
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLK 939
II+RD+K +N+L+ + LADFG+ K E + + +++ G+ YIAPE +
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 940 ITEKSDVYSYGVVLLEVLTGKEPTDSRIPD 969
D ++ GV+L E+L G P ++ D
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 19/171 (11%)
Query: 807 EVQTLGSIRHKNIVRL--LGCCNNGRTRLLLFDY-------ISNGSLAGLLHEKKVFLDW 857
E+ L ++H N++ L + + R LLFDY I A ++K V L
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 858 DSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV---GPQF-EAFLADFGLAKLFES 913
++ + G+ YLH + V +HRD+K NILV GP+ +AD G A+LF S
Sbjct: 108 GMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 914 SESSRAS-NSVAGSYGYIAPEYGYSLK-ITEKSDVYSYGVVLLEVLTGKEP 962
A + V ++ Y APE + T+ D+++ G + E+LT EP
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-07
Identities = 23/60 (38%), Positives = 32/60 (53%)
Query: 283 NLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNI 342
NLK L L N L+ A +L V+D+S N+L P + + L +L L LSGNN+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 23/138 (16%)
Query: 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKI---ILGVAHGLAYLH-HDCVPPIIHRDIKS 889
L+ DY+S G L L ++ F + +++ I +L + H LH +D I++RD+K
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH----LHKYD----IVYRDLKP 124
Query: 890 NNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY-----GYSLKITEKS 944
NIL+ L DFGL+K + ++ +N+ G+ Y+APE GY T+
Sbjct: 125 ENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY----TKHV 178
Query: 945 DVYSYGVVLLEVLTGKEP 962
D +S GV++ E+ G P
Sbjct: 179 DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 26/186 (13%)
Query: 855 LDWDSRYKIILGVAHGLAYL-HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913
LD D + VA G+ +L +C IHRD+ + N+L+ A + DFGLA+ +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAH 972
+ + ++APE + T +SDV+SYG++L E+ + GK P + +
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--- 321
Query: 973 IITWVNGELRERKREFTTILDRQLLM-RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+F ++ R M R E+ ++ +C N P ERPT +
Sbjct: 322 -------------SKFYKMVKRGYQMSRPDFAPPEIYSIMK---MCWNLEPTERPTFSQI 365
Query: 1032 TAMLKE 1037
+ +++
Sbjct: 366 SQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRL 822
+VG G G VY+ + + Q+ A+K V + E ++ E+ L H+NI
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIK----VMDVTGDEEEEIKQEINMLKKYSHHRNIATY 68
Query: 823 LGCCNNGR------TRLLLFDYISNGSLAGLLHEKK---VFLDWDSRYKIILGVAHGLAY 873
G L+ ++ GS+ L+ K + +W + I + GL++
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSH 126
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
LH +IHRDIK N+L+ E L DFG++ + + R N+ G+ ++APE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPE 181
Query: 934 Y-----GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
KSD++S G+ +E+ G P
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 24/181 (13%)
Query: 834 LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHDCVPPIIHRDIKSN 890
+ D ++ G L L + VF + + R+ +IILG+ H +H+ V ++RD+K
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEH----MHNRFV---VYRDLKPA 126
Query: 891 NILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-YGYSLKITEKSDVYSY 949
NIL+ ++D GLA F S + ++ G++GY+APE + +D +S
Sbjct: 127 NILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 182
Query: 950 GVVLLEVLTGKEPTDSRIPDGAHII---------TWVNGELRERKREFTTILDRQLLMRS 1000
G +L ++L G P H I + E + +L R + R
Sbjct: 183 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 242
Query: 1001 G 1001
G
Sbjct: 243 G 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 11/156 (7%)
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG 866
E L ++H NIV L + T L+F+Y+ L + + L ++ +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQ 111
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
+ GL+Y+H I+HRD+K N+L+ E LADFGLA+ +S S SN V
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTL 167
Query: 927 YGYIAPEYGYSLKITEKS---DVYSYGVVLLEVLTG 959
+ Y P+ L TE S D++ G + +E++ G
Sbjct: 168 W-YRPPD--VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-07
Identities = 17/43 (39%), Positives = 25/43 (58%), Gaps = 1/43 (2%)
Query: 24 LNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCS 66
LN + +LL++ S+ N S SSWNPS +PC+W + C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSG-ALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSA-EVQTLGSIRHKNIVRL-- 822
VG+G G VY+ + R+ +K + +K E + E+ L ++H N++ L
Sbjct: 9 VGRGTYGHVYKAK---RKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 823 LGCCNNGRTRLLLFDY-------ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH 875
+ ++ R LLFDY I A ++K + L ++ + G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 876 HDCVPPIIHRDIKSNNILV---GPQF-EAFLADFGLAKLFESSESSRAS-NSVAGSYGYI 930
+ V +HRD+K NILV GP+ +AD G A+LF S A + V ++ Y
Sbjct: 126 ANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 931 APEYGYSLK-ITEKSDVYSYGVVLLEVLTGKEP 962
APE + T+ D+++ G + E+LT EP
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT-SEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 19/204 (9%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+G G G VY+ + +A K+ ++ GE + E+ + +H NIV G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885
+ ++ GSL + H + Y + GL YLH +HR
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLHSKGK---MHR 130
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY-------GYSL 938
DIK NIL+ LADFG++ ++ + R S G+ ++APE GY+
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVERKGGYN- 187
Query: 939 KITEKSDVYSYGVVLLEVLTGKEP 962
+ D+++ G+ +E+ + P
Sbjct: 188 ---QLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 12/234 (5%)
Query: 86 LSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLN 145
L S+L L LS+ + +P + NL +L NLDLSFN L+ ++P+ + L+ L L L+
Sbjct: 137 LLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194
Query: 146 SNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE 205
N I +P EI S L L+L +N + + + + L+ L + N ++PE
Sbjct: 195 GNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE--DLPES 250
Query: 206 ISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFL 265
I N L L L++ IS S+G LTNLR L + +++ +P LE L
Sbjct: 251 IGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL-- 306
Query: 266 YENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLG 319
N + EL L +N S PEAL SL + N+L
Sbjct: 307 -LNLLLTLKALELKLNSILL-NNNILSNGETSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPE--RDQFSAEVQTLGSIRHKNIVR 821
+VG+G G+V + +++++A+KK K+ E E ++ E++ L +++ +NIV
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKF---KDSEENEEVKETTLRELKMLRTLKQENIVE 64
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
L L+F+Y+ L LL E + + I + + + H +
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---D 120
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
I+HRDIK N+L+ L DFG A+ ++ + VA + Y +PE
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELLLGAPYG 179
Query: 942 EKSDVYSYGVVLLEVLTGKE--PTDSRI 967
+ D++S G +L E+ G+ P +S I
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 3e-07
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 756 VVTRLSDTNIVGKGVSGIVYRV--EIPSRQVIAVKKL-WPVKNGELPERDQFSAEVQTLG 812
V+ R + +G G GIV + R V A+KKL P +N +R E+ +
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV-AIKKLSRPFQNQTHAKRAY--RELVLMK 71
Query: 813 SIRHKNIVRLLGCCNNGRT-----RLLLFDYISNGSLAGLL-----HEKKVFLDWDSRYK 862
+ HKNI+ LL ++ + L + + +L ++ HE+ +L Y+
Sbjct: 72 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQ 127
Query: 863 IILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922
++ G+ H LH IIHRD+K +NI+V + DFGLA+ + S +
Sbjct: 128 MLCGIKH----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 178
Query: 923 VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGK 960
V Y Y APE + E D++S G ++ E++ K
Sbjct: 179 VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 28/180 (15%)
Query: 867 VAHGLAYL-HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK-LFESSESSRASNSVA 924
VA G+ +L C IHRD+ + NIL+ + DFGLA+ +++ + R
Sbjct: 182 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDAR 236
Query: 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRE 983
++APE + T +SDV+S+GV+L E+ + G P G I
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-----PGVQI---------- 281
Query: 984 RKREFTTILDRQLLMRSGTQ-IQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042
EF L MR+ E+ ++ L C + PE+RPT ++ +L ++ EN
Sbjct: 282 -DEEFCRRLKEGTRMRAPEYATPEIYSIM---LDCWHNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 29/212 (13%)
Query: 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQ---FSAEVQTLGSIRHKNIVR 821
++G+G G V V S Q + KL + E+ +R F E + +V+
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK----IILGVAHGLAYLHHD 877
L + + ++ +Y+ G L L+ V W Y + L H +
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG----- 162
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY--- 934
+IHRD+K +N+L+ LADFG + + R +V G+ YI+PE
Sbjct: 163 ----LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKS 217
Query: 935 ----GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
GY + D +S GV L E+L G P
Sbjct: 218 QGGDGY---YGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 48/169 (28%), Positives = 84/169 (49%), Gaps = 33/169 (19%)
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI---------SNGSLAGL-LHEKKVFLD 856
E+ + ++H+NIVRL + +L+F+Y+ ++G L + K F
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFT- 106
Query: 857 WDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916
Y+++ G+A+ H + ++HRD+K N+L+ + E LADFGLA+ F
Sbjct: 107 ----YQLL----KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPV 154
Query: 917 SRASNSVAGSYGYIAPEY-----GYSLKITEKSDVYSYGVVLLEVLTGK 960
+ SN V + Y AP+ YS I D++S G ++ E++TG+
Sbjct: 155 NTFSNEVVTLW-YRAPDVLLGSRTYSTSI----DIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 5e-07
Identities = 62/236 (26%), Positives = 97/236 (41%), Gaps = 54/236 (22%)
Query: 767 GKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERD---QFSAEVQTLGSIRHKNIVRL 822
GKG G V+ V + ++ A+K L K E+ +R+ + E + L ++ H + L
Sbjct: 10 GKGDVGRVFLVRLKGTGKLFALKVL--DKK-EMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHE--KKVFLDWDSRY---KIILGVAHGLAYLHHD 877
L+ DY G L LL K + +R+ +++L L YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYLH-- 120
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL--------------------------- 910
+ I++RD+K NIL+ L+DF L+K
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 911 FESSESSRASNSVAGSYGYIAPE----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
S E S SNS G+ YIAPE G+ + D ++ G++L E+L G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 52/232 (22%)
Query: 755 DVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA----EVQ 809
DV R + + +G+G G+V P+ +A+KK+ P E F E++
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF------EHQTFCQRTLREIK 55
Query: 810 TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWD----SRYKII- 864
L +H+NI+ + D I S V++ + YK+I
Sbjct: 56 ILRRFKHENIIGI-------------LDIIRPPSFESF---NDVYIVQELMETDLYKLIK 99
Query: 865 ---LGVAH----------GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911
L H GL Y+H V +HRD+K +N+L+ + + DFGLA++
Sbjct: 100 TQHLSNDHIQYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIA 156
Query: 912 --ESSESSRASNSVAGSYGYIAPEYGYSLKITEKS-DVYSYGVVLLEVLTGK 960
E + + VA + Y APE + K K+ D++S G +L E+L+ +
Sbjct: 157 DPEHDHTGFLTEYVATRW-YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 57/255 (22%), Positives = 103/255 (40%), Gaps = 54/255 (21%)
Query: 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVR 821
++G+G G V V+ I K+ ++ ++ E++Q + AE L +V+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKI--LRKADMLEKEQVAHIRAERDILVEADGAWVVK 65
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKI---ILGV--AHGLAYLHH 876
+ + R L+ +++ G + LL +K + +++ I +L + H L +
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF--- 122
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK----------------------LFESS 914
IHRDIK +N+L+ + L+DFGL F++
Sbjct: 123 ------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 915 ESSRASN-----------SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPT 963
S R + S G+ YIAPE + D +S GV++ E+L G P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 964 DSRIPDGAH--IITW 976
S P + ++ W
Sbjct: 237 CSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-07
Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIV-YRVEIPSRQVIAVKKLWPVKNGELPERDQFS 805
+++N +V ++ R + VG G G V ++ + + +A+KKL E+ + +
Sbjct: 4 EEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 806 AEVQTLGSIRHKNIVRLLG------CCNNGRTRLLLFDYISN--GSLAGL-LHEKKVFLD 856
E+ L ++H+N++ LL + + L+ Y+ + G L E KV
Sbjct: 64 -ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKV--- 119
Query: 857 WDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916
+Y ++ + GL Y+H IIHRD+K N+ V E + DFGLA+
Sbjct: 120 ---QY-LVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR----HAD 168
Query: 917 SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGK 960
+ + V + Y APE + + + D++S G ++ E+LTGK
Sbjct: 169 AEMTGYVVTRW-YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 7e-07
Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 754 DDVVTRLSDTNIV---GKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
DD +RL++ ++ G G G V+ V+ Q K + + E+ Q EV
Sbjct: 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNV 65
Query: 811 LGSIRHKNIVRLLG-CCNNGRTRL-LLFDYISNGSLAGLLHE-KKVF--LDWDSRYKIIL 865
+ ++HKNIVR + N +L +L ++ G L+ + + K+F ++ + I
Sbjct: 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125
Query: 866 GVAHGLAYLHHDCVPP----IIHRDIKSNNILVGPQFE-----------------AFLAD 904
+ H LAY H+ P ++HRD+K NI + A + D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 905 FGLAKLFESSESSRASNSVAGSYGYIAPE--YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
FGL+K S A + V Y Y +PE + +KSD+++ G ++ E+ +GK P
Sbjct: 186 FGLSK--NIGIESMAHSCVGTPY-YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 48/185 (25%), Positives = 73/185 (39%), Gaps = 40/185 (21%)
Query: 793 VKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL--------LFDYISNGSL 844
V G+ P R E+ L +I H+ I+ L+ T + LF Y+
Sbjct: 127 VTGGKTPGR-----EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV----- 176
Query: 845 AGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904
++ L + I + LAYLH IIHRD+K+ NI + A L D
Sbjct: 177 -----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGD 228
Query: 905 FGLA-KLFESSESSRASNSVAGSYGYI------APEYGYSLKITEKSDVYSYGVVLLEVL 957
FG A KL ++ + YG+ +PE K+D++S G+VL E+
Sbjct: 229 FGAACKLDAHPDTPQ-------CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
Query: 958 TGKEP 962
Sbjct: 282 VKNVT 286
|
Length = 392 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-07
Identities = 55/225 (24%), Positives = 85/225 (37%), Gaps = 61/225 (27%)
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKII- 864
AE L ++ +V+L + + DYI G + LL +VF + +R+ I
Sbjct: 50 AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAE 109
Query: 865 LGVA----HGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR-- 918
L +A H + + IHRDIK +NIL+ L DFGL F + +S+
Sbjct: 110 LTLAIESVHKMGF---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160
Query: 919 -------------------------------------------ASNSVAGSYGYIAPEYG 935
++S+ G+ YIAPE
Sbjct: 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAH--IITWVN 978
T+ D +S GV+L E+L G+ P + P +I W N
Sbjct: 221 LRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 48/198 (24%), Positives = 83/198 (41%), Gaps = 16/198 (8%)
Query: 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+V + SG Y ++I ++VI K E E + L + RH + L
Sbjct: 13 LVREKASGKYYAMKILKKEVIIAKD----------EVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
+ +Y++ G L L ++VF + +R+ + L YLH I++
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG---KIVY 118
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS 944
RD+K N+++ + DFGL K E + + G+ Y+APE
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 945 DVYSYGVVLLEVLTGKEP 962
D + GVV+ E++ G+ P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 48/202 (23%), Positives = 87/202 (43%), Gaps = 24/202 (11%)
Query: 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL-HHDCVPPIIHRDIKSNNILVGP 896
YI + +L E ++ LD + VA G+++L +C IHRD+ + NIL+
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTH 249
Query: 897 QFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEV 956
+ DFGLA+ + + + ++APE ++ T +SDV+SYG++L E+
Sbjct: 250 GRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
Query: 957 LT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVAL 1015
+ G P +P + + R E EM ++
Sbjct: 310 FSLGSSPY-PGMPVDSKFYKMIKEGYRMLSPECAP--------------SEMYDIMKS-- 352
Query: 1016 LCVNPCPEERPTMKDVTAMLKE 1037
C + P +RPT K + ++++
Sbjct: 353 -CWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 63/247 (25%), Positives = 101/247 (40%), Gaps = 46/247 (18%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKL----WPVKNGELPERDQFSAEVQTLGSIRHKNI 819
++ G G VY V +RQ A+KK+ ++N + Q E L + +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRN----QIQQVFVERDILTFAENPFV 63
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLL-HEKKVFLDWDSRY--KIILGVAHGLAYLHH 876
V + R ++ +Y+ G A LL + + +D Y + +L L YLH+
Sbjct: 64 VSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA----LEYLHN 119
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK---------LFESSESSRA----SNSV 923
I+HRD+K +N+L+ L DFGL+K L+E V
Sbjct: 120 ---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 924 AGSYGYIAPEY----GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG--AHIIT-- 975
G+ YIAPE GY + D ++ G++L E L G P P+ +I+
Sbjct: 177 CGTPEYIAPEVILRQGYGKPV----DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232
Query: 976 --WVNGE 980
W G+
Sbjct: 233 IEWPEGD 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 1e-06
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 51/218 (23%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--------EVQTLGSI-R 815
+G G G VY + +++A+KK+ + +F + EV++L +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM----------KKKFYSWEECMNLREVKSLRKLNE 56
Query: 816 HKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLL--HEKKVFLDWDSRYKIILGVAHGLAY 873
H NIV+L +F+Y+ G+L L+ + K F + R II + GLA+
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRS-IIYQILQGLAH 114
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE------SSRASNSVAGSY 927
+H HRD+K N+LV +ADFGLA+ S S+R
Sbjct: 115 IHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR--------- 162
Query: 928 GYIAPEY-----GYSLKITEKSDVYSYGVVLLEVLTGK 960
Y APE YS + D+++ G ++ E+ T +
Sbjct: 163 WYRAPEILLRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 17/109 (15%)
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
+A GL +LH II+RD+K +N+++ + +ADFG+ K E+ + + G+
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164
Query: 927 YGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPD 969
YIAPE YG S+ D +++GV+L E+L G+ P + D
Sbjct: 165 PDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 28/74 (37%), Positives = 38/74 (51%)
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
IIHRDIK+ N+LV + L DFG A S S+ +AG+ APE T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340
Query: 942 EKSDVYSYGVVLLE 955
D++S G+V+ E
Sbjct: 341 PSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 32/228 (14%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLW-PVKNGELPERDQF 804
Q+LN +V +V R + + VG G G V + + +A+KKL P ++ +R
Sbjct: 4 QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY- 62
Query: 805 SAEVQTLGSIRHKNIVRLLGC-----CNNGRTRLLLFDYISNGSLAGLLHEKKV------ 853
E++ L + H+N++ LL + L ++ L ++ +K+
Sbjct: 63 -RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQ 121
Query: 854 FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913
FL Y+I+ GL Y+H IIHRD+K +NI V E + DFGLA+ +
Sbjct: 122 FL----VYQIL----RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD- 169
Query: 914 SESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGK 960
+ VA + Y APE + + + D++S G ++ E+LTGK
Sbjct: 170 ---DEMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSA--------------EV 808
+G+G G V + + +++A+KK VK E+ E+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKK---VKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 809 QTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK-IILGV 867
+ + I+H+NI+ L+ G L+ D ++ L ++ ++K+ L +S+ K I+L +
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV-DRKIRLT-ESQVKCILLQI 128
Query: 868 AHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF------------ESSE 915
+GL LH +HRD+ NI + + +ADFGLA+ + E+ +
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 916 SSRASNSVAGSYGYIAPE--YGYSLKITEKSDVYSYGVVLLEVLTGK 960
S + Y APE G + K D++S G + E+LTGK
Sbjct: 186 RREEMTSKVVTLWYRAPELLMG-AEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 51/169 (30%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 800 ERDQFSAEVQTLGSIRHKNIVRLLGCCN-NGRTRLLLFDYISNGSLAGLLHEKKVFLDWD 858
+R + E L +I H +I++L G N T L+L Y ++ L L K+ D
Sbjct: 126 QRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICD 183
Query: 859 SRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918
I V + YLH + IIHRDIK+ NI + + L DFG A F ++
Sbjct: 184 I-LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINAN 238
Query: 919 ASNSVAGSYGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKE 961
AG+ APE YG ++ D++S G+VL E+ T +
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAV------DIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 62/272 (22%), Positives = 103/272 (37%), Gaps = 76/272 (27%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIV 820
++GKG G V V+ + ++ A+K L E+ ++DQ + AE L +V
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTL---LKSEMFKKDQLAHVKAERDVLAESDSPWVV 64
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVA--HGLAYLH 875
L + + L+ +++ G L +L + F + +R+ + +L + H L +
Sbjct: 65 SLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF-- 122
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA-------------KLFESSESSRASN- 921
IHRDIK +NIL+ L+DFGL+ KL + + +
Sbjct: 123 -------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 922 -------------------------------SVAGSYGYIAPE----YGYSLKITEKSDV 946
S G+ YIAPE GY ++ D
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG----QECDW 231
Query: 947 YSYGVVLLEVLTGKEPTDSRIPDGAH--IITW 976
+S G ++ E L G P S + II W
Sbjct: 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 53/223 (23%), Positives = 84/223 (37%), Gaps = 61/223 (27%)
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKII- 864
AE L ++ +VRL + + DYI G + LL +F + +R+ I
Sbjct: 50 AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE 109
Query: 865 ----LGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL---------AKLF 911
+ H + + IHRDIK +NIL+ L DFGL +K +
Sbjct: 110 LTCAVESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160
Query: 912 ESSESSRA------------------------------------SNSVAGSYGYIAPEYG 935
+S + R ++S+ G+ YIAPE
Sbjct: 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL 220
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIP--DGAHIITW 976
T+ D +S GV+L E+L G+ P ++ P +I W
Sbjct: 221 LRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 759 RLSD---TNIVGKGVSGIVYRVEIPSR----QVIAVKKLWPVKNGELPERDQFSAEVQTL 811
+LSD +G G G RV I + A+K L + ++ + + E L
Sbjct: 16 KLSDFEMGETLGTGSFG---RVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSIL 72
Query: 812 GSIRHKNIVRLL-GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGV 867
+ H IV ++ + R LL +++ G L L + F + +++ +++L
Sbjct: 73 MELSHPFIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA- 130
Query: 868 AHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSY 927
YLH II+RD+K N+L+ + + DFG AK + + ++ G+
Sbjct: 131 ---FEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTP 179
Query: 928 GYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y+APE S + D ++ GV+L E + G P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 50/180 (27%), Positives = 79/180 (43%), Gaps = 28/180 (15%)
Query: 867 VAHGLAYL-HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK-LFESSESSRASNSVA 924
VA G+ +L C IHRD+ + NIL+ + DFGLA+ +++ + R ++
Sbjct: 188 VAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRE 983
++APE + T +SDV+S+GV+L E+ + G P G I
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKI---------- 287
Query: 984 RKREFTTILDRQLLMRSGT-QIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042
EF L MR+ EM Q + L C + P +RPT ++ L + N
Sbjct: 288 -DEEFCRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 43/219 (19%)
Query: 766 VGKGVSGIVYRV---EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVR 821
+G+G GIV E + +A+KK+ V + ++ + E++ L R HKNI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGL-LHEKKVFLDWDSRYKII-----LGVAH------ 869
L D + G+ L L+E+ + D ++II L AH
Sbjct: 67 LYD-----------MDIVFPGNFNELYLYEELMEADL---HQIIRSGQPLTDAHFQSFIY 112
Query: 870 ----GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS---ESSRASNS 922
GL Y+H V +HRD+K N+LV E + DFGLA+ F + + +
Sbjct: 113 QILCGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 923 VAGSYGYIAPEYGYSLKITEKS-DVYSYGVVLLEVLTGK 960
VA + Y APE S + K+ DV+S G +L E+L K
Sbjct: 170 VATRW-YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 69/286 (24%), Positives = 128/286 (44%), Gaps = 37/286 (12%)
Query: 766 VGKGVSGIVYRVEIPS----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVR 821
+G G G V E+ S QV+ VK+L + + E+ +F E Q S++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKEL--RVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV--FLDWDSR--YKIILGVAHGLAYLHHD 877
LG C LL+ ++ G L G L + + D ++ +A GL +LH +
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---- 933
IH D+ N L+ + D+GL+ + + + +IAPE
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 934 -YGYSLKI--TEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFT 989
+G L + T++S+V+S GV + E+ G +P R ++T+ +RE++ +
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY--RHLSDEQVLTYT---VREQQLKLP 231
Query: 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
+L + + E++Q + PE+RP+ ++V +L
Sbjct: 232 K---PRLKLPLSDRWYEVMQFCWLQ-------PEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 862 KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921
+II G+ H LH II+RD+K N+L+ ++D GLA E + +
Sbjct: 105 QIISGLEH----LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTK 155
Query: 922 SVAGSYGYIAP------EYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966
AG+ G++AP EY +S+ D ++ GV L E++ + P +R
Sbjct: 156 GYAGTPGFMAPELLQGEEYDFSV------DYFALGVTLYEMIAARGPFRAR 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 6e-06
Identities = 21/60 (35%), Positives = 29/60 (48%)
Query: 522 GLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
L LDLS N + L +L L LS NN+T + P++ L+ LDLS N +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-06
Identities = 58/256 (22%), Positives = 104/256 (40%), Gaps = 56/256 (21%)
Query: 765 IVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQ---FSAEVQTLGSIRHKNIV 820
++G+G G V V+ + V A+K L + ++ E++Q AE L +V
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKIL---RKADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKI---ILGV--AHGLAYLH 875
++ + L+ +++ G + LL +K + ++++ I +L + H L +
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF-- 122
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK----------------------LFES 913
IHRDIK +N+L+ + L+DFGL F++
Sbjct: 123 -------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 914 SESSRASN-----------SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
S R + S G+ YIAPE + D +S GV++ E+L G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 963 TDSRIPDGAH--IITW 976
S P + ++ W
Sbjct: 236 FCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-06
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 765 IVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
++G+G G V V++ + +V A+K L + + E F E L + ++ I L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWD------SRYKIILGVAHGLAYLHHD 877
+ L+ DY G L LL + + L D + I + H L Y
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFG-LAKLFESSESSRASNSVAGSYGYIAPEYGY 936
+HRDIK +NIL+ LADFG KL E + + S+ G+ YI+PE
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQSSVAVGTPDYISPEILQ 176
Query: 937 SL-----KITEKSDVYSYGVVLLEVLTGKEP 962
++ K + D +S GV + E+L G+ P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 38/151 (25%), Positives = 66/151 (43%), Gaps = 20/151 (13%)
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GL LH + I++RD+K NIL+ ++D GLA ++ + G+ GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGY 167
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989
+APE + + T D ++ G +L E++ G+ P R ++ KRE
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR--------------KKKIKREEV 213
Query: 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNP 1020
L +++ + + L LLC +P
Sbjct: 214 ERLVKEVQEEYSEKFSPDARSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 10/105 (9%)
Query: 862 KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921
+II G+ H LH I++RD+K N+L+ ++D GLA + + +
Sbjct: 103 QIICGLEH----LHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR- 154
Query: 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966
AG+ GY+APE D ++ G L E++ G+ P R
Sbjct: 155 --AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 54/242 (22%), Positives = 94/242 (38%), Gaps = 49/242 (20%)
Query: 804 FSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK--VFLDWDSRY 861
F + + HK++V+L G C ++ +Y+ G L LH +K V L W +
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRDENIMVE-EYVKFGPLDVFLHREKNNVSLHW--KL 104
Query: 862 KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV-------GPQFEAFLADFGLAKLFESS 914
+ +A L YL ++H ++ NILV G L+D G+ S
Sbjct: 105 DVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161
Query: 915 ES--SRASNSVAGSYGYIAPEY--GYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPD 969
E R +IAPE +T +D +S+G LLE+ + G+EP +
Sbjct: 162 EERVERIP--------WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL--- 210
Query: 970 GAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMK 1029
E++R + +L M ++ ++ C P +RP+ +
Sbjct: 211 ----------SSSEKERFYQD--QHRLPMPDCAELANLINQ------CWTYDPTKRPSFR 252
Query: 1030 DV 1031
+
Sbjct: 253 AI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 43/139 (30%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 834 LLFDYISNGSLAGLLH--EKKVFLDWDSRY--KIILGVAHGLAYLHHDCVPPIIHRDIKS 889
L+ DY G L LL E ++ D Y +++L + H + LH+ +HRDIK
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIHQLHY------VHRDIKP 130
Query: 890 NNILVGPQFEAFLADFGLAKLFESSESSRASNSVA-GSYGYIAPEYGYSL-----KITEK 943
+N+L+ LADFG + ++ +SVA G+ YI+PE ++ K +
Sbjct: 131 DNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188
Query: 944 SDVYSYGVVLLEVLTGKEP 962
D +S GV + E+L G+ P
Sbjct: 189 CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GL LH + ++RD+K NIL+ ++D GLA ES R G+ GY
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGY 167
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966
+APE + + T D + G ++ E++ G+ P R
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 67/274 (24%), Positives = 106/274 (38%), Gaps = 89/274 (32%)
Query: 805 SAEVQTLGSIR-HKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLH-------------- 849
E+Q L + H NI+RL+ LFD G LA +
Sbjct: 45 LREIQALRRLSPHPNILRLIEV---------LFD-RKTGRLALVFELMDMNLYELIKGRK 94
Query: 850 ----EKKV--FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLA 903
EK+V ++ Y+++ + H +H + I HRDIK NIL+ LA
Sbjct: 95 RPLPEKRVKSYM-----YQLLKSLDH----MHRN---GIFHRDIKPENILI-KDDILKLA 141
Query: 904 DFGLAKLFESSESSRASNSVAGSYGYI------APE-------YGYSLKITEKSDVYSYG 950
DFG S R S YI APE YG K D+++ G
Sbjct: 142 DFG---------SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP------KMDIWAVG 186
Query: 951 VVLLEVLT------GKEPTD--SRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGT 1002
V E+L+ G D ++I D ++ + E+ ++ R + ++ + GT
Sbjct: 187 CVFFEILSLFPLFPGTNELDQIAKIHD---VLGTPDAEVLKKFR-KSRHMNYNFPSKKGT 242
Query: 1003 QIQEMLQVL---GVALLC--VNPCPEERPTMKDV 1031
++++L G+ LL + P+ER T K
Sbjct: 243 GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA 276
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 4/108 (3%)
Query: 803 QFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK 862
Q AE L + IV L + L+ +Y+ G + LLH F D + K
Sbjct: 50 QVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYF-DEEMAVK 108
Query: 863 IILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910
I VA L YLH IIHRD+K +N+L+ + L DFGL+K+
Sbjct: 109 YISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 41/183 (22%), Positives = 80/183 (43%), Gaps = 19/183 (10%)
Query: 785 IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844
+A+K+ K + + D +E + L I H V L G + L+ +++ G
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 845 AGLLHEKKVFLD-----WDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFE 899
L K F + + ++ +I L I++RD+K N+L+
Sbjct: 119 FTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGF 169
Query: 900 AFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTG 959
+ DFG AK+ ++ + ++ G+ YIAPE ++ + +D ++ G+ + E+L G
Sbjct: 170 IKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
Query: 960 KEP 962
P
Sbjct: 225 CPP 227
|
Length = 340 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 58/242 (23%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSA---EVQTLGSIRHKN-I 819
+G+G G VY+ + + +++A+KK E+ E E+ L + I
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKK----TRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 820 VRLLGC----CNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSR-------------- 860
VRLL NG+ L L+F+Y+ + + K F+D + R
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS--------DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 861 -YKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF-LADFGLAKLFESSESSR 918
Y+++ GVAH H V +HRD+K N+LV Q +AD GL + F S
Sbjct: 116 MYQLLKGVAH----CHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY 168
Query: 919 ASNSVAGSYGYIAPEY-----GYSLKITEKSDVYSYGVVLLEVLTGKE--PTDSRIPDGA 971
V + Y APE YS + D++S G + E+ + P DS +
Sbjct: 169 THEIV--TLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGDSELQQLL 222
Query: 972 HI 973
HI
Sbjct: 223 HI 224
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 20/200 (10%)
Query: 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+V + +G Y ++I ++VI K E E + L + RH + L
Sbjct: 13 LVREKATGRYYAMKILRKEVIIAKD----------EVAHTVTESRVLQNTRHPFLTALKY 62
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG--VAHGLAYLHHDCVPPI 882
+ +Y + G L L ++VF + +R+ G + L YLH V
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSALEYLHSRDV--- 116
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
++RDIK N+++ + DFGL K E + G+ Y+APE
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 943 KSDVYSYGVVLLEVLTGKEP 962
D + GVV+ E++ G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIV 820
++GKG G V V E + + A+K L K + +D+ + E + L + RH +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKIL---KKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHD 877
L + +Y + G L L ++VF + +R+ +I+ L YLH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LGYLHSC 114
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---- 933
+++RD+K N+++ + DFGL K E + G+ Y+APE
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 934 --YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966
YG ++ D + GVV+ E++ G+ P ++
Sbjct: 170 NDYGRAV------DWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-05
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 35/211 (16%)
Query: 475 LTFLELSENQFTGEIPPEIG-------NCTQLEMVDLHQNKLQGTIPSSLEFL---FGLN 524
L L LS N TG IP + L+ +DL N L LE L L
Sbjct: 53 LKELCLSLN-ETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQ 111
Query: 525 VLDLSMNSIGGTIPENLGK-LTS----LNKLVLSKNNITGL----IPKSLGLCKDLQLLD 575
L L+ N +G L K L L KLVL +N + G + K+L +DL+ L+
Sbjct: 112 ELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELN 171
Query: 576 LSSNRING----SIPEEIGRLQGLDILLNLSWNALT----GPIPESFSNLSKLANLDLSN 627
L++N I ++ E + L++L +L+ N LT + E+ ++L L L+L +
Sbjct: 172 LANNGIGDAGIRALAEGLKANCNLEVL-DLNNNGLTDEGASALAETLASLKSLEVLNLGD 230
Query: 628 NMLT--GSLKVLGSL----DNLVSLNVSYNH 652
N LT G+ + +L +L++L++S N
Sbjct: 231 NNLTDAGAAALASALLSPNISLLTLSLSCND 261
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 33/94 (35%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL-FESSESSRASNSVAGSYG 928
L Y+H V HRD+K NIL + + DFGLA++ F + ++ +
Sbjct: 115 ALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 929 YIAPEYGYSL--KITEKSDVYSYGVVLLEVLTGK 960
Y APE S K T D++S G + EVLTGK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 6/97 (6%)
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GL LH + I++RD+K NIL+ ++D GLA E+ R G+ GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGY 167
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966
+APE + + T D + G ++ E++ GK P R
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-05
Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 867 VAHGLAYL-HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK--LFESSESSRASNSV 923
VA+G+ +L +CV HRD+ + N+L+ + DFGLA+ + +S+ S+ S +
Sbjct: 248 VANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 924 AGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT 958
++APE ++ T SDV+S+G++L E+ T
Sbjct: 304 --PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GL L + I++RD+K NIL+ + ++D GLA E+ R G+ GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---VGTVGY 167
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+APE + K T D + G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 15/198 (7%)
Query: 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+V + +G Y ++I ++VI K E E + L + RH + L
Sbjct: 13 LVKEKATGRYYAMKILKKEVIVAKD----------EVAHTLTENRVLQNSRHPFLTALKY 62
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
+ +Y + G L L ++VF + +R+ + L YLH + +++
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHSE--KNVVY 119
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS 944
RD+K N+++ + DFGL K E + + G+ Y+APE
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 177
Query: 945 DVYSYGVVLLEVLTGKEP 962
D + GVV+ E++ G+ P
Sbjct: 178 DWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 45/224 (20%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G G+VY+ + Q++A+KK+ +++ E E+ L ++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLD-------WDSR------YKIILGVAHGL 871
L+F+++S + K +LD D+ Y+I+ G+
Sbjct: 67 VLMQESRLYLIFEFLS--------MDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL--- 115
Query: 872 AYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIA 931
+ H V +HRD+K N+L+ + LADFGLA+ F R + Y A
Sbjct: 116 -FCHSRRV---LHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRA 169
Query: 932 PEY-----GYSLKITEKSDVYSYGVVLLEVLTGKEPT---DSRI 967
PE YS + D++S G + E+ T K+P DS I
Sbjct: 170 PEVLLGSPRYSTPV----DIWSIGTIFAEMAT-KKPLFHGDSEI 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-05
Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 803 QFSAEVQTLGSIRHKNIVRL---LGCCNNG-----RTRLLLFDYISNGSLAGLLHEKKVF 854
Q E+ LG + H+NI+++ L N + L+ ++ + + K
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF----DWKDRP 264
Query: 855 LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914
L +R I+ + + Y+H +IHRDIK NI + + L DFG A FE
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT 958
+ V G+ +PE E +D++S G++LL++L+
Sbjct: 321 REAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-05
Identities = 44/146 (30%), Positives = 66/146 (45%), Gaps = 33/146 (22%)
Query: 834 LLFDYISNGSLAGLLH--EKKVFLDWDSRY--KIILGV--AHGLAYLHHDCVPPIIHRDI 887
L+ DY G L LL E ++ D Y +++L + H L Y +HRDI
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY---------VHRDI 128
Query: 888 KSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-----------YGY 936
K +N+L+ LADFG + L ++ + SN G+ YI+PE YG
Sbjct: 129 KPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYG- 186
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEP 962
+ D +S GV + E+L G+ P
Sbjct: 187 -----PECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 26/85 (30%), Positives = 36/85 (42%), Gaps = 25/85 (29%)
Query: 546 SLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNA 605
+L L LS N +T + + +L++LDLS N + SI
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SIS------------------- 40
Query: 606 LTGPIPESFSNLSKLANLDLSNNML 630
PE+FS L L +LDLS N L
Sbjct: 41 -----PEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 56/236 (23%), Positives = 91/236 (38%), Gaps = 38/236 (16%)
Query: 456 LGSNNFSGHIPSRIGLL-------HRLTFLELSENQFTGEIPPEIGNCTQ---LEMVDLH 505
S N +G IP + L L L+LS+N + + + + L+ + L+
Sbjct: 57 CLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLN 116
Query: 506 QNKLQGTI-----PSSLEFLFGLNVLDLSMNSIGGTIPENLGKL----TSLNKLVLSKNN 556
N L + L L L N + G E L K L +L L+ N
Sbjct: 117 NNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNG 176
Query: 557 ITG----LIPKSLGLCKDLQLLDLSSNRIN----GSIPEEIGRLQGLDILLNLSWNALTG 608
I + + L +L++LDL++N + ++ E + L+ L++L NL N LT
Sbjct: 177 IGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVL-NLGDNNLTD 235
Query: 609 PI-----PESFSNLSKLANLDLSNNMLT--GSLKVLGSLDN---LVSLNVSYNHFS 654
S L L LS N +T G+ + L L+ L++ N F
Sbjct: 236 AGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 30/200 (15%)
Query: 780 PSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836
P+ ++AVKK+ N + ++ E+ T ++H NI+ + ++
Sbjct: 23 PTNTLVAVKKI----NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVS 78
Query: 837 DYISNGSLAGLLHEKKVFLDWDSRYKI--IL-GVAHGLAYLHHDCVPPIIHRDIKSNNIL 893
++ GS LL K F + I IL V + L Y+H IHR +K+++IL
Sbjct: 79 PLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHIL 133
Query: 894 VGPQFEAFLADFGLA-KLFESSESSRA----SNSVAGSYGYIAPE------YGYSLKITE 942
+ + L+ + + + + R S + +++PE GY E
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY----NE 189
Query: 943 KSDVYSYGVVLLEVLTGKEP 962
KSD+YS G+ E+ G P
Sbjct: 190 KSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 24/174 (13%)
Query: 867 VAHGLAYL-HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAG 925
VA G+ +L +CV HRD+ + N+L+ + DFGLA+ + + S
Sbjct: 246 VARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 926 SYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRER 984
++APE + T SDV+SYG++L E+ + G P I D + R
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYNKIKSGYRMA 360
Query: 985 KREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
K + T QE+ ++ + C N PE+RP+ ++ +++ +
Sbjct: 361 KPDHAT--------------QEVYDIM---VKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 764 NIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
++VG+G G V V E + + A+K + F E L I +L
Sbjct: 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWD-SRY---KIILGV--AHGLAYLHH 876
+ L+ +Y G L LL+ + D D +++ +++L + H + Y
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY--- 123
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGY 936
+HRDIK N+L+ LADFG A +++ + V G+ YIAPE
Sbjct: 124 ------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLT 176
Query: 937 SLKITEKS------DVYSYGVVLLEVLTGKEP 962
++ K D +S GV+ E++ G+ P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 23/60 (38%), Positives = 31/60 (51%)
Query: 498 QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNI 557
L+ +DL N+L + + L L VLDLS N++ PE L SL L LS NN+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 60/284 (21%), Positives = 114/284 (40%), Gaps = 34/284 (11%)
Query: 766 VGKGVSGIVYRVEI---PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+G G G V EI + VK+L N E+++F + ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKEL--KANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLL-HEKKVFLDWDSRY--KIILGVAHGLAYLH-HDC 878
LG C LL+F+Y G L L E+ + ++ +A G+ ++H H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL 938
+H D+ N + + D+G+ + + ++APE
Sbjct: 120 ---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 939 -------KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991
+ T+ S+V++ GV L E+ S + D ++ V +++++ +
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHV---IKDQQ---VKL 229
Query: 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
QL + + E+LQ C PE+R T ++V +L
Sbjct: 230 FKPQLELPYSERWYEVLQ------FCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 28/79 (35%), Positives = 38/79 (48%), Gaps = 5/79 (6%)
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
I+ RD+ NNIL+ + L F SE + + A Y APE G + T
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGISEET 160
Query: 942 EKSDVYSYGVVLLEVLTGK 960
E D +S G +L E+LTGK
Sbjct: 161 EACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-04
Identities = 80/350 (22%), Positives = 134/350 (38%), Gaps = 54/350 (15%)
Query: 89 SHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNS 148
++L +L LS+ + E+P +I L+ L +LD+S +P I L L L+L+
Sbjct: 657 TNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSG-- 713
Query: 149 IHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISN 208
CS+L+ +I I L+ E I E P +
Sbjct: 714 -----------CSRLKSFP--------DISTNISWLDLDET-------AIE-EFPSNL-R 745
Query: 209 CKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYEN 268
+ L L L + S ++ V LT L T+ + L LFL +
Sbjct: 746 LENLDELILCEMK-SEKLWERVQPLTPLMTMLSPS----------------LTRLFLSDI 788
Query: 269 QIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLAN 328
++P + +L L+ L + ++P + N SL +D+S S P N
Sbjct: 789 PSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTN 847
Query: 329 LVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKEL-LLFFAWQ 387
+ +L LS I E+P + FS L L+++ ++ I +LK L + F+
Sbjct: 848 ---ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC 903
Query: 388 NQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRF 437
L + A D H+ L +V + N NL Q L+ +
Sbjct: 904 GALTEASWNGSPSEVAMATDNIHSKLPSTVCINFINCFNLDQEALLQQQS 953
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 18/102 (17%)
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
+ G+ +LH I++RD+K N+L+ Q L+D GLA + ++ AG+
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGT 157
Query: 927 YGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
GY+APE Y Y + D ++ G + E++ G+ P
Sbjct: 158 NGYMAPEILKEEPYSYPV------DWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-04
Identities = 76/334 (22%), Positives = 109/334 (32%), Gaps = 86/334 (25%)
Query: 276 DELGSLKNLKRLLLWQNNLSGS----IPEALGNCSSLTVIDVSLNSLGGEVPV------S 325
+ L L L+ L L N L + AL SL + +SLN G
Sbjct: 17 ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQG 76
Query: 326 LANLVALEELLLSGNNISGEIPSFFGNFSR---LKQLELDNNRFFGQIPPTIGQ-LKELL 381
L L+EL LS N + + + R L++L+L+NN + + + LK+L
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136
Query: 382 LFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEI 441
L+ L L N L G+ S L L +NR
Sbjct: 137 P-------------------ALEKLVLGRNRLEGA---SCEALAKA----LRANR----- 165
Query: 442 PPEIGGCTGLIRLRLGSNNFSGHIPSRI--GLLH--RLTFLELSENQFTGEIPPEIGNCT 497
L L L +N + GL L L+L+ N T E +
Sbjct: 166 --------DLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE------GAS 211
Query: 498 QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTI-----PENLGKLTSLNKLVL 552
L L+ VL+L N++ L SL L L
Sbjct: 212 ALAETLASLKSLE--------------VLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257
Query: 553 SKNNITGLIPKSL-GLCKD---LQLLDLSSNRIN 582
S N+IT K L + + L LDL N+
Sbjct: 258 SCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-04
Identities = 50/229 (21%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 755 DVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGS 813
D+ +R D +G G +G+V+ V+ + +AVKK+ + E++ +
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV---KHALREIKIIRR 58
Query: 814 IRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVF-----LDWDSRYKIILG-- 866
+ H NIV++ + L + L V+ ++ D + G
Sbjct: 59 LDHDNIVKVYEVLGPSGSDL-------TEDVGSLTELNSVYIVQEYMETDLANVLEQGPL 111
Query: 867 -----------VAHGLAYLHHDCVPPIIHRDIKSNNILVGP-QFEAFLADFGLAKLFES- 913
+ GL Y+H V +HRD+K N+ + + DFGLA++ +
Sbjct: 112 SEEHARLFMYQLLRGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168
Query: 914 -SESSRASNSVAGSYGYIAPEYGYSLK-ITEKSDVYSYGVVLLEVLTGK 960
S S + + Y +P S T+ D+++ G + E+LTGK
Sbjct: 169 YSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-04
Identities = 34/116 (29%), Positives = 53/116 (45%), Gaps = 11/116 (9%)
Query: 740 EWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGEL 798
+W+F P +L+F + GK V Y + + + +AVK L P + L
Sbjct: 29 KWEF-PRNRLSFG------KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKP--SAHL 79
Query: 799 PERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV 853
ER+ +E++ L + H NIV LLG C G L++ +Y G L L K+
Sbjct: 80 TEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRD 135
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 12/197 (6%)
Query: 766 VGKGVSGIVYRV---EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+GKG G VY V + + + + V K PV E Q + E Q L + H IV+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKII---LGVAHGLAYLHHDCV 879
++ +Y L L E K S ++ + + G+ Y+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---Q 124
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLK 939
I+HRD+K+ NI + + DFG+++L S + + G+ Y++PE
Sbjct: 125 RRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMG--SCDLATTFTGTPYYMSPEALKHQG 181
Query: 940 ITEKSDVYSYGVVLLEV 956
KSD++S G +L E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 32/209 (15%)
Query: 772 GIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCC-NNGR 830
GI+ + + + VK + + + E L + H+NI+ +L C +G
Sbjct: 25 GILIDEKPGKEEEVFVKTV--KDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82
Query: 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKII---------------LGVAHGLAYLH 875
+L+ Y++ G+L K+FL R + +A G++YLH
Sbjct: 83 PPFVLYPYMNWGNL-------KLFLQ-QCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK-LFESSESSRASNSVAGSYGYIAPEY 934
+IH+DI + N ++ + + + D L++ LF N ++A E
Sbjct: 135 KR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE-NRPVKWMALES 190
Query: 935 GYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+ + + SDV+S+GV+L E++T G+ P
Sbjct: 191 LVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.002
Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 18/98 (18%)
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GL Y+H ++HRD+K +N+L+ + + DFGLA+ +SE + Y
Sbjct: 120 GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWY 174
Query: 930 IAPE-------YGYSLKITEKSDVYSYGVVLLEVLTGK 960
APE Y ++ DV+S G + E+L K
Sbjct: 175 RAPELLLNCSEYTTAI------DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.003
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 34/213 (15%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
NI+G G G+VY + I + + +A+KK+ L + + E+ + ++ H NI+ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNLNHINIIFL 124
Query: 823 -----LGCCNNGRTRLLL---FDYISNGSLAGLLHEKK------VFLDWDSRYKIILGVA 868
C + L ++I + H + +FL Y++
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL----C 180
Query: 869 HGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF-LADFGLAKLFESSESSRASNSVAGSY 927
LAY+H I HRD+K N+L+ P L DFG AK + + S S S
Sbjct: 181 RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV---SYICSR 234
Query: 928 GYIAPEYGY-SLKITEKSDVYSYGVVLLEVLTG 959
Y APE + T D++S G ++ E++ G
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 22/61 (36%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 114 SLINLDLSFNALTGNIPEEI-GKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQ 172
+L +LDLS N LT IP+ L L++L L+ N++ P LR L+L N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 173 L 173
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 27/61 (44%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 90 HLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNS 148
+L SL LSN LT IP A L +L LDLS N LT PE L L L L+ N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 149 I 149
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 815 RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGL 871
RH NI+ G ++ +++ GS LL K F + S I+ G GL
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLL--KTYFPEGMSEALIGNILFGALRGL 114
Query: 872 AYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF---ESSESSRAS----NSVA 924
YLH + IHR+IK+++IL+ + ++ GL+ L+ + + ++
Sbjct: 115 NYLHQN---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 925 GSYGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+++PE YGY++K SD+YS G+ E+ TG+ P
Sbjct: 170 SVLPWLSPELLRQDLYGYNVK----SDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1079 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.42 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.15 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.14 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.14 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.02 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.01 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.98 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.68 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.66 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.38 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.37 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.33 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-114 Score=1112.73 Aligned_cols=919 Identities=34% Similarity=0.581 Sum_probs=742.0
Q ss_pred ChhhHHHHHHHhhCCCCCCCccccCCCCCCCCCCccceeeecCCceeEEecccCCCCccccccCCcccEEEcCCCccccc
Q 001426 25 NPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGE 104 (1079)
Q Consensus 25 ~~~~~~ll~~~~~~~~~~~~~~l~sW~~~~~~~c~W~gv~C~~~~~~~~~~~l~~~~~~~~~~l~~l~~L~L~~~~l~~~ 104 (1079)
..|..||++||+++.+ +.+.+.+|+. ..|||.|.||+|+.. ++++.|+|++++++|.
T Consensus 28 ~~~~~~l~~~~~~~~~--~~~~~~~w~~-~~~~c~w~gv~c~~~--------------------~~v~~L~L~~~~i~~~ 84 (968)
T PLN00113 28 AEELELLLSFKSSIND--PLKYLSNWNS-SADVCLWQGITCNNS--------------------SRVVSIDLSGKNISGK 84 (968)
T ss_pred HHHHHHHHHHHHhCCC--CcccCCCCCC-CCCCCcCcceecCCC--------------------CcEEEEEecCCCcccc
Confidence 4678899999999853 4567899975 468999999999854 3688999999999999
Q ss_pred CCccccccCCCCEEeccCCcccCCCCcccC-CcCcccEEeccCCcccccCccccccccccceEecccccccCCCChhhch
Q 001426 105 IPPAIGNLSSLINLDLSFNALTGNIPEEIG-KLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQ 183 (1079)
Q Consensus 105 ~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~ 183 (1079)
+|+++..+++|++|+|++|+++|.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|..++.
T Consensus 85 ~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~ 162 (968)
T PLN00113 85 ISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGS 162 (968)
T ss_pred CChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhc
Confidence 999999999999999999999999998766 999999999999999988885 56899999999999998777765554
Q ss_pred hhhHHHHHhCCCCCcccCCCcccccccceeEeecccCCCccCCCccccccccccccccccccccccCCccccccccccee
Q 001426 184 LEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENL 263 (1079)
Q Consensus 184 l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L 263 (1079)
+++|++|++++|.+.+.+|..++++++|++|++++|.+++.+|..++++++|++|
T Consensus 163 -------------------------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 217 (968)
T PLN00113 163 -------------------------FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI 217 (968)
T ss_pred -------------------------CCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEE
Confidence 4556666777777777788888888888888888888888888888888888888
Q ss_pred cccccccccCCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeeccccccc
Q 001426 264 FLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNIS 343 (1079)
Q Consensus 264 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 343 (1079)
+|++|.+++.+|..++++++|++|++++|++++.+|..+.++++|+.|++++|++.+.+|..+.++++|++|++++|.++
T Consensus 218 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~ 297 (968)
T PLN00113 218 YLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297 (968)
T ss_pred ECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeec
Confidence 88888888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred ccccccccccccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCCCCCccccccc
Q 001426 344 GEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFN 423 (1079)
Q Consensus 344 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~~p~~l~~ 423 (1079)
+.+|..+.++++|+.|++++|.+++..|..+..+ ++|+.|++++|.+++.+|..+..
T Consensus 298 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l-----------------------~~L~~L~L~~n~l~~~~p~~l~~ 354 (968)
T PLN00113 298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL-----------------------PRLQVLQLWSNKFSGEIPKNLGK 354 (968)
T ss_pred cCCChhHcCCCCCcEEECCCCccCCcCChhHhcC-----------------------CCCCEEECcCCCCcCcCChHHhC
Confidence 8888888888888888888888877766655443 46888888888888888888888
Q ss_pred cccccccccccccccccCCCcccCCCCceEEEecCCCccccCccccccccccCeeeeccCcccCCCCCCCCCCCcccEEe
Q 001426 424 LKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVD 503 (1079)
Q Consensus 424 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 503 (1079)
+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..|.+++.|+.|+
T Consensus 355 ~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 434 (968)
T PLN00113 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434 (968)
T ss_pred CCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEE
Confidence 88888888988888888888888888899999999998888888888888999999999999888888888899999999
Q ss_pred cCCCcCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEecccccccCCCCCccccccccccccccCccccC
Q 001426 504 LHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRING 583 (1079)
Q Consensus 504 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 583 (1079)
+++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|++++..|..|..+++|+.|+|++|++.+
T Consensus 435 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 513 (968)
T PLN00113 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSG 513 (968)
T ss_pred CcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCccee
Confidence 99999988888888888999999999999988888765 45899999999999999999999999999999999999999
Q ss_pred CChhhhhcccchhhhhcccCCcccccccccccCCCcccEEeccCccccccccc-cCcccccceeeccCCcCcCCCCCCcc
Q 001426 584 SIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKV-LGSLDNLVSLNVSYNHFSGILPNTKL 662 (1079)
Q Consensus 584 ~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~ls~N~l~~~~p~~~~ 662 (1079)
.+|+.+..+++| ..|++++|.+++.+|..|.++++|+.|||++|++++..|. +..+++|+.|++++|++.|.+|....
T Consensus 514 ~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~ 592 (968)
T PLN00113 514 EIPDELSSCKKL-VSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592 (968)
T ss_pred eCChHHcCccCC-CEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcch
Confidence 999999999998 5579999999999999999999999999999999986655 88999999999999999999999999
Q ss_pred cCCCCCCcccCCCcCccCC-----CCCcCCCCCCCCCCCcc-hhhhhHhhHHHHHHHHHHHHhhhheeccc-cccccchh
Q 001426 663 FHGLPASAFYGNQQLCVNR-----SQCHINNSLHGRNSTKN-LIICALLSVTVTLFIVLFGIILFIRFRGT-TFRENDEE 735 (1079)
Q Consensus 663 ~~~~~~~~~~~n~~~~~~~-----~~c~~~~~~~~~~s~~~-~~i~~i~~v~~~~~lil~~li~~~~~R~~-~~~~~~~~ 735 (1079)
|..+...++.||+.+|... ++|... +.+... +++++++++++++++++++ ++++++|++ +.++.+.+
T Consensus 593 ~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 666 (968)
T PLN00113 593 FLAINASAVAGNIDLCGGDTTSGLPPCKRV-----RKTPSWWFYITCTLGAFLVLALVAFG-FVFIRGRNNLELKRVENE 666 (968)
T ss_pred hcccChhhhcCCccccCCccccCCCCCccc-----cccceeeeehhHHHHHHHHHHHHHHH-HHHHHhhhcccccccccc
Confidence 9999999999999999532 245321 112222 2222223222222222222 222222221 11111111
Q ss_pred hcccccCcCcc---ccccCCHHHHhhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHH
Q 001426 736 ENELEWDFTPF---QKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTL 811 (1079)
Q Consensus 736 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l 811 (1079)
. ..|....+ ....+.+++....++..++||+|+||.||+|+. .++..||||++..... ....|++++
T Consensus 667 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l 737 (968)
T PLN00113 667 D--GTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADM 737 (968)
T ss_pred c--ccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHH
Confidence 1 11221111 112356677778899999999999999999987 5788999998853221 123468899
Q ss_pred hcCCCCceeeeeeEEEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 001426 812 GSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNN 891 (1079)
Q Consensus 812 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~N 891 (1079)
++++|||||+++|+|.+++..++||||+++|+|.++++. ++|..+.+++.|+++|++|||..+.++|+||||||+|
T Consensus 738 ~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~N 813 (968)
T PLN00113 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813 (968)
T ss_pred hhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHh
Confidence 999999999999999999999999999999999999953 7899999999999999999996655699999999999
Q ss_pred eEECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 001426 892 ILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA 971 (1079)
Q Consensus 892 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~ 971 (1079)
|+++.++.+++. ||.+..... .....+|+.|+|||+..+..++.++|||||||++|||++|+.||+.......
T Consensus 814 il~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~ 886 (968)
T PLN00113 814 IIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886 (968)
T ss_pred EEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence 999999988876 665543221 1223678999999999999999999999999999999999999976555555
Q ss_pred hHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccCCCCC
Q 001426 972 HIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLE 1046 (1079)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 1046 (1079)
.+..|+...... .......|+..........+++.++.+++.+||+.||++||||+||+++|+++.+..++..
T Consensus 887 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~ 959 (968)
T PLN00113 887 SIVEWARYCYSD--CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCV 959 (968)
T ss_pred cHHHHHHHhcCc--cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccc
Confidence 566665543322 1223344444433333445667788999999999999999999999999999876544433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-62 Score=631.41 Aligned_cols=549 Identities=39% Similarity=0.614 Sum_probs=395.3
Q ss_pred cccCCCCCCCCCCccceeeecCCceeEEecccCCCCccccccCCcccEEEcCCCcccccCCcccc-ccCCCCEEeccCCc
Q 001426 46 FFSSWNPSHRNPCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIG-NLSSLINLDLSFNA 124 (1079)
Q Consensus 46 ~l~sW~~~~~~~c~W~gv~C~~~~~~~~~~~l~~~~~~~~~~l~~l~~L~L~~~~l~~~~p~~l~-~l~~L~~L~Ls~n~ 124 (1079)
..++|.. -.|...+ .-.........+.+..+..+..+++|+.|+|++|+++|.+|..+. .+++|++|+|++|.
T Consensus 56 ~~c~w~g---v~c~~~~---~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~ 129 (968)
T PLN00113 56 DVCLWQG---ITCNNSS---RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129 (968)
T ss_pred CCCcCcc---eecCCCC---cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCc
Confidence 3679974 2354322 122233333344455567788899999999999999999998876 99999999999999
Q ss_pred ccCCCCcccCCcCcccEEeccCCcccccCccccccccccceEecccccccCCCChhhchhhhHHHHHhCCCCCcccCCCc
Q 001426 125 LTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPE 204 (1079)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~ 204 (1079)
++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|++++|
T Consensus 130 l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n--------- 198 (968)
T PLN00113 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN--------- 198 (968)
T ss_pred cccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCC---------
Confidence 9998885 67999999999999999999999999999999999999999888877776666555555554
Q ss_pred ccccccceeEeecccCCCccCCCccccccccccccccccccccccCCcccccccccceecccccccccCCCcCccCCCCC
Q 001426 205 EISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNL 284 (1079)
Q Consensus 205 ~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 284 (1079)
.+.+.+|..++++++|++|++++|++++.+|..++++++|++|++++|.+++.+|..++++++|
T Consensus 199 ----------------~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 262 (968)
T PLN00113 199 ----------------QLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262 (968)
T ss_pred ----------------CCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCC
Confidence 4555556666666666666666666666666666666666666666666666666666666666
Q ss_pred CeEeccCcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeecccccccccccccccccccCcEeeccCC
Q 001426 285 KRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364 (1079)
Q Consensus 285 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 364 (1079)
++|+|++|++.+.+|..+.++++|++|++++|++.+.+|..+..+++|++|++++|.+++..|..+..+++|+.|++++|
T Consensus 263 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n 342 (968)
T PLN00113 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342 (968)
T ss_pred CEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCC
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccCCccccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCCCCCccccccccccccccccccccccccCCCc
Q 001426 365 RFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPE 444 (1079)
Q Consensus 365 ~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 444 (1079)
++++.+|..++.+ ++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..
T Consensus 343 ~l~~~~p~~l~~~-----------------------~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~ 399 (968)
T PLN00113 343 KFSGEIPKNLGKH-----------------------NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399 (968)
T ss_pred CCcCcCChHHhCC-----------------------CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHH
Confidence 6665555444332 35666666666666666666666666677777777766666666
Q ss_pred ccCCCCceEEEecCCCccccCccccccccccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhhhhcCCC
Q 001426 445 IGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLN 524 (1079)
Q Consensus 445 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 524 (1079)
+..+++|+.|++++|++++.+|..+..++.|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+. ..+|+
T Consensus 400 ~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~ 478 (968)
T PLN00113 400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLE 478 (968)
T ss_pred HhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccce
Confidence 66677777777777777766666677777777777777777776666666677777777777777766666543 46677
Q ss_pred cccccccccccccccccccCCCCceEecccccccCCCCCccccccccccccccCccccCCChhhhhcccchhhhhcccCC
Q 001426 525 VLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWN 604 (1079)
Q Consensus 525 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N 604 (1079)
.|++++|++++..|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|.+++.+|..+..+++| ..|++++|
T Consensus 479 ~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N 557 (968)
T PLN00113 479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVL-SQLDLSQN 557 (968)
T ss_pred EEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccC-CEEECCCC
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777 44577788
Q ss_pred cccccccccccCCCcccEEeccCccccccccccCcccccceeeccCCc
Q 001426 605 ALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNH 652 (1079)
Q Consensus 605 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~ls~N~ 652 (1079)
++++.+|..+.++++|+.|++++|++++.+|..+.+..+....+.+|+
T Consensus 558 ~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~ 605 (968)
T PLN00113 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNI 605 (968)
T ss_pred cccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCc
Confidence 888888888888889999999999999887776666666666777886
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=422.69 Aligned_cols=281 Identities=44% Similarity=0.743 Sum_probs=238.6
Q ss_pred HHHHhhCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-e
Q 001426 753 VDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR-T 831 (1079)
Q Consensus 753 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 831 (1079)
+..+++.|...++||+|+||.||+|...+++.||||++....... .++|..|++++.+++|||+|+++|||.+.+ +
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 344568999999999999999999999999999999875322211 456999999999999999999999999988 5
Q ss_pred EEEEEEecCCCChhhhhhccCc-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 832 RLLLFDYISNGSLAGLLHEKKV-FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
.++||||+++|+|.++++.... .++|..|.+|+.++|+||+|||+.+.+.|||||||++|||+|+++++||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 9999999999999999998765 789999999999999999999999888899999999999999999999999999976
Q ss_pred ccC-Cccccccccc-ccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC-CcchHHHHHHhHHhhhhhc
Q 001426 911 FES-SESSRASNSV-AGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIP-DGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 911 ~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 987 (1079)
... ... .... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+...+ ....+..|+.....+. .
T Consensus 227 ~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--~ 301 (361)
T KOG1187|consen 227 GPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--K 301 (361)
T ss_pred CCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--c
Confidence 554 211 1111 899999999999999999999999999999999999998886542 3444788886665553 7
Q ss_pred hhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
+.+++|+.+........+++.++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 788899887632222226788899999999999999999999999999776543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=404.45 Aligned_cols=258 Identities=35% Similarity=0.523 Sum_probs=214.2
Q ss_pred CCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-eEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR-TRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 838 (1079)
+...+.+|+|+||+||+|.+++...||||++......... .+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 3445569999999999999997777999999754444333 789999999999999999999999999887 79999999
Q ss_pred cCCCChhhhhhc-cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEeCCCCCCeEECCCC-cEEEeeccccccccCCc
Q 001426 839 ISNGSLAGLLHE-KKVFLDWDSRYKIILGVAHGLAYLHHDCVPP-IIHRDIKSNNILVGPQF-EAFLADFGLAKLFESSE 915 (1079)
Q Consensus 839 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~ 915 (1079)
+++|+|.++++. .+..+++..+.+++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999988 467799999999999999999999999 7 99999999999999998 99999999998765432
Q ss_pred ccccccccccCcccccccccC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGY--SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
...+...||+.|||||++. ...++.|+||||||+++|||+||+.||....+ .......+....+. .+..
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp---~~p~--- 269 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRP---PIPK--- 269 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCC---CCCc---
Confidence 3344578999999999999 56999999999999999999999999987655 22222221111111 1100
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
.....+..++.+||+.||++||++.+++..|+.+...
T Consensus 270 -----------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 270 -----------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred -----------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1233667788899999999999999999999988754
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=408.58 Aligned_cols=484 Identities=30% Similarity=0.450 Sum_probs=415.6
Q ss_pred ccccCCcccEEEcCCCcccccCCccccccCCCCEEeccCCcccCCCCcccCCcCcccEEeccCCcccccCcccccccccc
Q 001426 84 QLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKL 163 (1079)
Q Consensus 84 ~~~~l~~l~~L~L~~~~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 163 (1079)
.+|.-..++.|++++|.++ .+.+.+.+|..|++|++++|++. ..|.+++.+..++.|+.++|+++ .+|++++.+.+|
T Consensus 40 ~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l 116 (565)
T KOG0472|consen 40 NWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISL 116 (565)
T ss_pred hhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhh
Confidence 4555678899999999999 88888999999999999999999 89999999999999999999999 899999999999
Q ss_pred ceEecccccccCCCChhhchhhhHHHHHhCCCCCcccCCCcccccccceeEeecccCCCccCCCcccccccccccccccc
Q 001426 164 RRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYT 243 (1079)
Q Consensus 164 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~ 243 (1079)
+.|+.++|.+. .+|++++.+..|+.++..+|. ....|+.+.++.+|..+++.+|++. .+|+..-.++.|++|+...
T Consensus 117 ~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~--i~slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~ 192 (565)
T KOG0472|consen 117 VKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQ--ISSLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNS 192 (565)
T ss_pred hhhhcccccee-ecCchHHHHhhhhhhhccccc--cccCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccch
Confidence 99999999998 889999999999999999997 6789999999999999999999999 4555555599999999977
Q ss_pred ccccccCCcccccccccceecccccccccCCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccCccc
Q 001426 244 ANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVP 323 (1079)
Q Consensus 244 ~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 323 (1079)
|-+ +.+|+.++.|.+|+.|||.+|++. .+| +|..++.|++|+++.|+|+-...+...++++|.+||+.+|+++ ..|
T Consensus 193 N~L-~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~P 268 (565)
T KOG0472|consen 193 NLL-ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVP 268 (565)
T ss_pred hhh-hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCc
Confidence 665 488999999999999999999998 667 8999999999999999999444445669999999999999999 889
Q ss_pred cccccccccceeecccccccccccccccccccCcEeeccCCcccccCCcccc--chhhHHHHHh-----hcCcccc----
Q 001426 324 VSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIG--QLKELLLFFA-----WQNQLHG---- 392 (1079)
Q Consensus 324 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~l~l-----~~n~l~~---- 392 (1079)
..++.+.+|++||+|+|.|+ ..|..++++ .|+.|.+.+|++..+-.+.+. .-.-|+++.- .-++-.+
T Consensus 269 de~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~ 346 (565)
T KOG0472|consen 269 DEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTET 346 (565)
T ss_pred hHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccc
Confidence 99999999999999999999 478889999 999999999999743222221 1122344432 1111111
Q ss_pred -------cCCcccccccCcEEeccCCCCCCCcccccccccc---ccccccccccccccCCCcccCCCCceE-EEecCCCc
Q 001426 393 -------NIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKN---LTQLLLISNRFSGEIPPEIGGCTGLIR-LRLGSNNF 461 (1079)
Q Consensus 393 -------~~~~l~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~-L~L~~N~l 461 (1079)
..++.....+.+.|+++.-+++ .+|+..+.... .+..+++.|++. ++|..+..+..+.+ +.+++|.+
T Consensus 347 ~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 347 AMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred cCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc
Confidence 2233445678999999999999 67877776655 899999999998 88888877776655 45555555
Q ss_pred cccCccccccccccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhhhhcCCCccccccccccccccccc
Q 001426 462 SGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL 541 (1079)
Q Consensus 462 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 541 (1079)
+ .+|..+..+++|..|+|++|-+. .+|..++.+..|+.||++.|++. .+|..+..+..|+.+-.++|++..+.|+.+
T Consensus 425 s-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l 501 (565)
T KOG0472|consen 425 S-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGL 501 (565)
T ss_pred c-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHh
Confidence 5 88999999999999999999998 88999999999999999999998 889999999999999999999998888889
Q ss_pred ccCCCCceEecccccccCCCCCccccccccccccccCccccCCChh
Q 001426 542 GKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPE 587 (1079)
Q Consensus 542 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 587 (1079)
.+|.+|.+|||.+|.|. .+|..+++|++|+.|++++|+|+ .++.
T Consensus 502 ~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~ 545 (565)
T KOG0472|consen 502 KNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRH 545 (565)
T ss_pred hhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHH
Confidence 99999999999999999 66889999999999999999998 4433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=399.34 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=217.0
Q ss_pred CCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEec
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
++..+.||+|.||.||.|.++....||+|.++.. ....+.|.+|+++|++++|++||+++|+|..+++++|||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 3445679999999999999999999999998543 234478899999999999999999999999999999999999
Q ss_pred CCCChhhhhhc-cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 840 SNGSLAGLLHE-KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 840 ~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+.|+|.+|++. .+..+...+...++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+.+.++. ..
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~ 359 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YT 359 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc-ee
Confidence 99999999987 566789999999999999999999999 99999999999999999999999999999555443 44
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......-+..|.|||.+...+++.|||||||||++|||+| |+.||..+.. .++.+.++...+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------------~ev~~~le~GyR 422 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------------EEVLELLERGYR 422 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------------HHHHHHHhccCc
Confidence 4555667889999999999999999999999999999999 8888876532 112223333333
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccC
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 1042 (1079)
+..+.. +...++++|..||+.+|++|||++.+...++++....
T Consensus 423 lp~P~~--CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 423 LPRPEG--CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCCC--CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 333333 3447889999999999999999999999999987643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=376.75 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=213.4
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-eEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR-TRLLLF 836 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 836 (1079)
+++....||+|..|+|||++.+ +++.+|+|.+. .......++++.+|++++++.+||+||++||+|.... ...|+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~--~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL--LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec--ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 4566788999999999999765 78899999983 2344456789999999999999999999999999988 599999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|||++|+|.+++.+.+. +++...-+|+.+|++||.|||+.. +||||||||+|||++..|.|||||||.++.+...
T Consensus 158 EYMDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999999987654 899999999999999999999732 9999999999999999999999999999977644
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.....+||..|||||.+.+..|+.++||||||+.++|+++|+.||....+........+.....+.++.+..
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~------ 304 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE------ 304 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc------
Confidence 456678999999999999999999999999999999999999999875332233333332222222221111
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhccc
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRH 1040 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 1040 (1079)
. ....++.+++..|+++||.+|||++|+++ .+.+...
T Consensus 305 ------~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 305 ------G-EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred ------c-cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 1 23446778999999999999999999998 4444433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=391.63 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=213.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|...+.||+|+|+.||+++. .+|+.||+|++.+..-.....++.+.+|+++.++++|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999987 899999999998765556667789999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+|+.|+|.++++ .+..+++.+++.+++||+.|+.|||++ +|+|||||..|++++++.++||+|||+|..+..++
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999999998 455699999999999999999999999 99999999999999999999999999999887543
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
......+|||.|.|||++....++..+||||+|||+|-|+.|++||+...- . .....+.....
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v---------k-------ety~~Ik~~~Y 235 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV---------K-------ETYNKIKLNEY 235 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH---------H-------HHHHHHHhcCc
Confidence 234457899999999999999999999999999999999999999986311 0 01111111111
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.++. .-.....++|.+++++||.+|||+++|+.
T Consensus 236 ~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 SMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 12235668999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=367.31 Aligned_cols=203 Identities=30% Similarity=0.479 Sum_probs=181.9
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
..+|...+.||+|+||+||+|+.+ ++.+||||.+.+..- ....++....|+.+++.++|||||.+++++.+++..|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 456888888999999999999765 679999999864332 344567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC------CcEEEeeccccc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ------FEAFLADFGLAK 909 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~DFGla~ 909 (1079)
||||.||+|.+|++.++. +++..+..++.|+|.|+++||++ +||||||||+|||++.. -.+||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999998875 89999999999999999999999 99999999999999865 468999999999
Q ss_pred cccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 001426 910 LFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRI 967 (1079)
Q Consensus 910 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~ 967 (1079)
.+..+ ......+|++-|||||++...+|+.|+|+||+|+++||+++|+.||+...
T Consensus 164 ~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 88754 34456789999999999999999999999999999999999999998643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=368.11 Aligned_cols=256 Identities=24% Similarity=0.333 Sum_probs=207.4
Q ss_pred HhhCCCCCCeeeecCcEEEEEE-EeCCCCeEEEEEeccccCCC----chhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGE----LPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR 830 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 830 (1079)
+.+.|...+.+|+|+||.|-+| +.++|+.||||++.+.+... ......+++|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456778899999999999999 55689999999997654332 112345679999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC---CcEEEeeccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ---FEAFLADFGL 907 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGl 907 (1079)
..|+||||++||+|.+.+-.++. +.+.....+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999987665 67777788999999999999999 99999999999999766 6799999999
Q ss_pred cccccCCcccccccccccCcccccccccCCCCC---CccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKI---TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER 984 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 984 (1079)
|+..+. ...+...+|||.|.|||++.+..+ ..++|+||+||++|-+++|.+||.+...+.....+...+.....
T Consensus 326 AK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 326 AKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred hhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 998764 345667899999999999876543 34789999999999999999999876544323333333322221
Q ss_pred hhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 985 KREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+. ...+-..+..+++.+|+..||++|||++|+++
T Consensus 403 p~---------------~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 403 PL---------------QWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Ch---------------hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11 11123346778999999999999999999987
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=392.57 Aligned_cols=268 Identities=23% Similarity=0.387 Sum_probs=224.7
Q ss_pred CCCCCeeeecCcEEEEEEEeC----CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP----SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
..+.++||.|.||.||+|+++ ....||||.++ ....+..+.+|..|+.||.++.||||+++.|+....++.+||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK--~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLK--AGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeec--cCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345688999999999999875 24468999884 445566778999999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
+|||++|+|+.+++++...+++.+..-++++||.||+||.+. ++|||||.++|||++.+-.+|++|||+++.+.++.
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999999999877799999999999999999999999 99999999999999999999999999999886654
Q ss_pred -ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 916 -SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 916 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
....+..-.-+.+|.|||.+..++++.++|||||||+|||.|+ |..||.++...+. ...++
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-----------------IkaIe 848 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-----------------IKAIE 848 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-----------------HHHHH
Confidence 2233334455789999999999999999999999999999998 9999988754211 11222
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccCCCCCCCccc
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSL 1051 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~ 1051 (1079)
..++.++ ..++...+.++++.||++|-.+||+++||+.+|+++-.+.........+
T Consensus 849 ~gyRLPp--PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~ 904 (996)
T KOG0196|consen 849 QGYRLPP--PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPE 904 (996)
T ss_pred hccCCCC--CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCC
Confidence 2222222 3345568899999999999999999999999999998775554444443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=351.51 Aligned_cols=255 Identities=21% Similarity=0.357 Sum_probs=204.6
Q ss_pred hCCCCCCeeeecCcEEEEEE-EeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeee-EEEcCCe-EEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG-CCNNGRT-RLL 834 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 834 (1079)
..|++.+.||+|+||+|||+ ...+|..+|.|.+. -...+..++.+...|+.++++++|||||++++ .+.++.. .+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 45778889999999999999 45689999999986 44445566788999999999999999999999 4554444 899
Q ss_pred EEEecCCCChhhhhh---ccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCeEECCCCcEEEeeccccc
Q 001426 835 LFDYISNGSLAGLLH---EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP--IIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~DFGla~ 909 (1079)
|||||++|+|.+.++ +.+..+++..+|+++.|+++||.++|+... + |+||||||.||+++.+|.||++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999985 346679999999999999999999999433 4 8999999999999999999999999999
Q ss_pred cccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchh
Q 001426 910 LFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 910 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
++.... ......+|||.||+||.+.+.+|+.||||||+||++|||+.-++||++. .+...-. ++.. .++.
T Consensus 177 ~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~-KI~q--gd~~ 246 (375)
T KOG0591|consen 177 FLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK-KIEQ--GDYP 246 (375)
T ss_pred Hhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH-HHHc--CCCC
Confidence 887653 3345678999999999999999999999999999999999999999864 2222111 1111 1111
Q ss_pred hhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
...+. --...+..++..|+.+||+.||+.-.+++.
T Consensus 247 ~~p~~----------~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 247 PLPDE----------HYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred CCcHH----------HhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 11111 123366678889999999999984444433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=394.98 Aligned_cols=258 Identities=30% Similarity=0.487 Sum_probs=215.8
Q ss_pred CCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
....+.||+|+||+||+|+.. ....||||.++. ..+.+.+.+|++|++++..++|||||+++|+|.++++++
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd--~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD--KAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc--cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 445677999999999999754 355799999853 334447799999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcc---------CcC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcE
Q 001426 834 LLFDYISNGSLAGLLHEK---------KVF----LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEA 900 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~---------~~~----~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 900 (1079)
+|+|||..|||.+++... +.. ++..+.+.||.|||.||+||-++ .+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 999999999999999643 222 78889999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHh
Q 001426 901 FLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNG 979 (1079)
Q Consensus 901 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 979 (1079)
||+|||+++.+...++++......-+.+|||||.+..++++.+||||||||++||+++ |+-||++...++ .++.+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--VIe~i~- 719 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--VIECIR- 719 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--HHHHHH-
Confidence 9999999999888887776656677899999999999999999999999999999999 999998754321 111111
Q ss_pred HHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 980 ELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
+.++. . ....+...++.++..||+..|++||+++||-..|......
T Consensus 720 -------------~g~lL-~--~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 720 -------------AGQLL-S--CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -------------cCCcc-c--CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 11111 0 1112345889999999999999999999999999988654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=378.68 Aligned_cols=507 Identities=29% Similarity=0.369 Sum_probs=340.6
Q ss_pred EEEcCCCcccccCCcccccc-------------CCCCEEeccCCcccCCCCcccCCcCcccEEeccCCcccccCcccccc
Q 001426 93 SLVLSNANLTGEIPPAIGNL-------------SSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGN 159 (1079)
Q Consensus 93 ~L~L~~~~l~~~~p~~l~~l-------------~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 159 (1079)
.|+++++.+. ..|..+.++ .-|+.|++++|.++ .+-+.+.+|..|.+|++.+|+++ .+|.+++.
T Consensus 13 ~lnlsnr~l~-~vp~~vyq~~~t~~e~e~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~ 89 (565)
T KOG0472|consen 13 SLNLSNRSLK-DVPTEVYQINLTTGEGENWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGE 89 (565)
T ss_pred ccccccchhh-hccHHHHHHHhhccchhhhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHH
Confidence 4556665554 445443322 34556666666665 44445566666666666666665 55666666
Q ss_pred ccccceEecccccccCCCChhhchhhhHHHHHhCCCCCcccCCCcccccccceeEeecccCCCccCCCcccccccccccc
Q 001426 160 CSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTL 239 (1079)
Q Consensus 160 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L 239 (1079)
+.+++.|+.++|.++ .+|.+++.+.+|..|+ +++|.+. ++|++++.+..|..|
T Consensus 90 l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~-------------------------~s~n~~~-el~~~i~~~~~l~dl 142 (565)
T KOG0472|consen 90 LEALKSLNVSHNKLS-ELPEQIGSLISLVKLD-------------------------CSSNELK-ELPDSIGRLLDLEDL 142 (565)
T ss_pred HHHHHHhhcccchHh-hccHHHhhhhhhhhhh-------------------------cccccee-ecCchHHHHhhhhhh
Confidence 666666666666665 5555555555555554 4444454 566666777777777
Q ss_pred ccccccccccCCcccccccccceecccccccccCCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEccccccc
Q 001426 240 SVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLG 319 (1079)
Q Consensus 240 ~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 319 (1079)
+..+|+++ ..|+.++++.+|..|++.+|.+... |+..-+++.|++||...|-++ .+|+.++.+.+|+.|++..|+|.
T Consensus 143 ~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~ 219 (565)
T KOG0472|consen 143 DATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR 219 (565)
T ss_pred hccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc
Confidence 77666666 4566677777777777777777633 333333777777777777776 56677777777777777777776
Q ss_pred CccccccccccccceeecccccccccccccccccccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCcccc
Q 001426 320 GEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAY 399 (1079)
Q Consensus 320 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~ 399 (1079)
.+| .|.++..|++|+++.|+|.....+...++++|..|||.+|+++ ..|+.++-+++|.++++++|.+.+.++++++
T Consensus 220 -~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgn 296 (565)
T KOG0472|consen 220 -FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGN 296 (565)
T ss_pred -cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCccccc
Confidence 555 6777777777777777777444444457777777777777776 6777777766665555555555555555555
Q ss_pred cccCcEEeccCCCCCCCccccccccc---ccccccc--ccccccccCCCcccCCCCceEEEecCCCccccCccccccccc
Q 001426 400 CVKLQALDLSHNFLTGSVPSSLFNLK---NLTQLLL--ISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHR 474 (1079)
Q Consensus 400 ~~~L~~L~Ls~N~l~~~~p~~l~~l~---~L~~L~L--~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 474 (1079)
+ +|+.|-+.+|.+..+ -..+-+.. -|++|.= ..-.++..-...-..+ -... ........+.+
T Consensus 297 l-hL~~L~leGNPlrTi-Rr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~----------t~~~-~~~~~~~~~i~ 363 (565)
T KOG0472|consen 297 L-HLKFLALEGNPLRTI-RREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAM----------TLPS-ESFPDIYAIIT 363 (565)
T ss_pred c-eeeehhhcCCchHHH-HHHHHcccHHHHHHHHHHhhccCCCCCCcccccccC----------CCCC-Ccccchhhhhh
Confidence 5 666777777766522 11111111 1222210 0011110000000000 0000 11122344567
Q ss_pred cCeeeeccCcccCCCCCCCCCCCc---ccEEecCCCcCcccCChhhhhhcCCCc-ccccccccccccccccccCCCCceE
Q 001426 475 LTFLELSENQFTGEIPPEIGNCTQ---LEMVDLHQNKLQGTIPSSLEFLFGLNV-LDLSMNSIGGTIPENLGKLTSLNKL 550 (1079)
Q Consensus 475 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L 550 (1079)
.+.|++++-+++ .+|.......+ ...++++.|++. .+|..+..+..+.+ +++++|.++ .+|..++.+++|..|
T Consensus 364 tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L 440 (565)
T KOG0472|consen 364 TKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFL 440 (565)
T ss_pred hhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceee
Confidence 888999999998 56655443333 788999999998 78888888887655 455555555 889999999999999
Q ss_pred ecccccccCCCCCccccccccccccccCccccCCChhhhhcccchhhhhcccCCcccccccccccCCCcccEEeccCccc
Q 001426 551 VLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNML 630 (1079)
Q Consensus 551 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 630 (1079)
+|++|-+. .+|..++.+..|+.||+|.|+|. .+|+.+..++.++++ -.+.|++....|..+.+|.+|..|||.+|.|
T Consensus 441 ~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtl-las~nqi~~vd~~~l~nm~nL~tLDL~nNdl 517 (565)
T KOG0472|consen 441 DLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETL-LASNNQIGSVDPSGLKNMRNLTTLDLQNNDL 517 (565)
T ss_pred ecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHH-HhccccccccChHHhhhhhhcceeccCCCch
Confidence 99999998 56888999999999999999998 899999999998554 5677999988888899999999999999999
Q ss_pred cccccccCcccccceeeccCCcCc
Q 001426 631 TGSLKVLGSLDNLVSLNVSYNHFS 654 (1079)
Q Consensus 631 ~~~~~~~~~l~~L~~L~ls~N~l~ 654 (1079)
...||.+++|.+|++|++++|+|.
T Consensus 518 q~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 518 QQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhCChhhccccceeEEEecCCccC
Confidence 999999999999999999999999
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=341.21 Aligned_cols=267 Identities=20% Similarity=0.310 Sum_probs=208.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+...++|+|+||+|||++.+ +|+.||||++.... .+....+--.+|++++++++|+|+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46778889999999999999876 69999999996432 22334567789999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|||+. ++.+-++......+.+.+.++++|++.|+.|+|++ ++|||||||+|||++.+|.+|+||||+|+.+...
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 99988 77777777777799999999999999999999999 9999999999999999999999999999988742
Q ss_pred cccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
....+..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|.+..+- +....+.....+-.+....++...
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi--DQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI--DQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH--HHHHHHHHHHcccCHHHHHHhccC
Confidence 234456788999999998776 68999999999999999999999988765332 212222211111111111111100
Q ss_pred -----hhccc---CccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 996 -----LLMRS---GTQIQ-----EMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 996 -----~~~~~---~~~~~-----~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+..+. .+..+ ...-+++++..|++.||++|++-+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 01111 11111 1236789999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=352.44 Aligned_cols=244 Identities=27% Similarity=0.319 Sum_probs=203.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..++||+|+||+||.++.+ .++.+|+|.+.+.......+.+...+|..++.+++||+||+++..|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 56899999999999999999665 68899999998766656667889999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+.||.|..++++.+. +++..+.-++..|+.||.|||++ +|||||+||+|||+|.+|+++|+|||+++.-....
T Consensus 105 d~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~- 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG- 179 (357)
T ss_pred eccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence 99999999999987776 88898999999999999999999 99999999999999999999999999998544332
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
..+...+||+.|||||++.+..|+.++|.||+|+++|||++|.+||..... ..+.....+.+.......+
T Consensus 180 -~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~I~~~k~~~~p~~l---- 249 (357)
T KOG0598|consen 180 -DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDKILKGKLPLPPGYL---- 249 (357)
T ss_pred -CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHHHhcCcCCCCCccC----
Confidence 234457999999999999999999999999999999999999999986421 1222211111111111111
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCC
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERP 1026 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 1026 (1079)
.....+++.+.+..||++|.
T Consensus 250 ----------s~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 250 ----------SEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----------CHHHHHHHHHHhccCHHHhc
Confidence 11455788889999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=367.15 Aligned_cols=272 Identities=28% Similarity=0.371 Sum_probs=213.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+++...+.||+|+||+||+|+|.+ .||||++.... -..+..+.|+.|+.++++-||.||+=+.|||..... .||+.
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDD-PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHhhccceeccccccceeeccccc--ceEEEEEecCC-CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 445677899999999999999964 46999986433 334467899999999999999999999999998776 99999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
+|+|.+|+.+++..+..++..+.+.|++||++||.|||.+ +|||||||..||++.++++|||+|||++..-..-...
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 9999999999999888899999999999999999999999 9999999999999999999999999999754332112
Q ss_pred ccccccccCcccccccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYS---LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
.....-.|...|||||++.. .+|+..+||||||+++|||++|..||.....+ . .-|+.+.. ..-+
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-q--IifmVGrG---------~l~p 612 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-Q--IIFMVGRG---------YLMP 612 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-h--eEEEeccc---------ccCc
Confidence 22333457789999998764 46899999999999999999999999842221 1 11111111 0001
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccCCCCCCCccc
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSL 1051 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~ 1051 (1079)
+.... ......++.+++..||..+|++||.+.+|+.+|+.+....+..+.+.+.
T Consensus 613 d~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~ 666 (678)
T KOG0193|consen 613 DLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASE 666 (678)
T ss_pred cchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCc
Confidence 11000 0122336778899999999999999999999999987765544444333
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=394.25 Aligned_cols=258 Identities=28% Similarity=0.424 Sum_probs=214.6
Q ss_pred CCCCCeeeecCcEEEEEEEeCC--CC----eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPS--RQ----VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
.+..+.||+|+||.||+|.+.+ +. .||||.+. +..+.++..+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~--~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK--RLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEecc--ccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 3445779999999999997753 33 38888884 3455678899999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcc------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 834 LLFDYISNGSLAGLLHEK------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
|++|||++|+|..|+++. ...++..+...++.|||+|+.||+++ ++|||||.++|+|+++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999887 66789999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhh
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKR 986 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1079)
|+.+.+.++++......-..+|||||.+.++.++.|+|||||||++||++| |..||...... +.+.-+..+. +-
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~~~~gg-RL--- 923 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLDVLEGG-RL--- 923 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHHHHhCC-cc---
Confidence 997777776655555456789999999999999999999999999999999 88888764321 1111122211 11
Q ss_pred chhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
..+. .+...++++|..||+.+|++||+++.+++.+.++.+.
T Consensus 924 ------------~~P~--~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 924 ------------DPPS--YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ------------CCCC--CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1111 1233677999999999999999999999988887644
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=359.71 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=207.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 835 (1079)
.+|...++||+|+|++|++|+. ++++.||||++.+.-.-.+...+.+.+|-++|.+| .||.|++++..|++...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 4577889999999999999955 57999999988543333333456788899999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
+||+++|+|.++|++.+. +++...+.++.+|+.|++|||+. |||||||||+|||+|+||++||+|||.|+.+.+..
T Consensus 153 Le~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999999999998876 89999999999999999999999 99999999999999999999999999999886532
Q ss_pred cc---------cc--ccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh
Q 001426 916 SS---------RA--SNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER 984 (1079)
Q Consensus 916 ~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 984 (1079)
.. .. ....+||..|++||++.....+..+|+|+||||+|+|+.|++||.+..+ +
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----y----------- 293 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----Y----------- 293 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----H-----------
Confidence 11 11 2458899999999999999999999999999999999999999976321 1
Q ss_pred hhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 985 KREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
-.+..+.+-.+...... ...+.+++.+-+..||.+|+|.+||.+.
T Consensus 294 -liFqkI~~l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 -LIFQKIQALDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HHHHHHHHhcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11112221111111111 1356688999999999999999999873
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.92 Aligned_cols=273 Identities=26% Similarity=0.413 Sum_probs=208.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhc--CCCCceeeeeeEEEcCC----e
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGS--IRHKNIVRLLGCCNNGR----T 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~ 831 (1079)
..++..++||+|+||.||||.+.+ +.||||++. .+++..|+.|-+|.+. ++|+||++++++-.... .
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 345667889999999999999875 889999984 4567889999888765 48999999999976555 7
Q ss_pred EEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEeCCCCCCeEECCCCcEEEeec
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC------VPPIIHRDIKSNNILVGPQFEAFLADF 905 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~kl~DF 905 (1079)
+++|+||.+.|+|.+|+..+. ++|....+|+..+++||+|||+.. +++|+|||||++|||+..|+++.|+||
T Consensus 283 ywLVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eeEEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 899999999999999997654 799999999999999999999864 378999999999999999999999999
Q ss_pred cccccccCCcccccccccccCcccccccccCCCC------CCccchHHHHHHHHHHHHhCCCCCCC-CCCCcc-hHHHHH
Q 001426 906 GLAKLFESSESSRASNSVAGSYGYIAPEYGYSLK------ITEKSDVYSYGVVLLEVLTGKEPTDS-RIPDGA-HIITWV 977 (1079)
Q Consensus 906 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~el~tg~~p~~~-~~~~~~-~~~~~~ 977 (1079)
|+|..+..+......-..+||.+|||||++.+.- .-.+.||||+|.++|||++.+..++. ..++.. .+..-+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999988776666666789999999999976542 23479999999999999998776542 221111 111111
Q ss_pred HhHHhhhhhchhhhhhhhhhcc----cCccH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccCCC
Q 001426 978 NGELRERKREFTTILDRQLLMR----SGTQI---QEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDD 1044 (1079)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~---~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1044 (1079)
.. .+.+.++.+--+..+ ..... ..+..+.+.+..||+.||+.|.|+.=|.+++.++....++
T Consensus 441 G~-----hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 441 GN-----HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred cC-----CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 00 011111111000000 00000 2345677889999999999999999999999999766554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.66 Aligned_cols=270 Identities=20% Similarity=0.269 Sum_probs=210.1
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCC-e
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGR-T 831 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~ 831 (1079)
.+.++|...+.||.|.||+||+|+. ..++.||||++++.- ...++. .=.+|+..+++++ |||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4567899999999999999999965 578999999985432 222222 2357999999998 999999999999988 8
Q ss_pred EEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccc
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~ 911 (1079)
+|+|||||+. +|++.++.++..+++..+..|++||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.+
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999999976 99999999999999999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCcccccccccccCcccccccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHH---hHHhhhhhc
Q 001426 912 ESSESSRASNSVAGSYGYIAPEYGY-SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN---GELRERKRE 987 (1079)
Q Consensus 912 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~ 987 (1079)
.... ..+..+.|..|.|||++. ..-|+.+.||||+|||++|+.+-++-|.+..+- +++.+... ....+.|.+
T Consensus 161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHHHHHHHHhCCCccccchh
Confidence 7654 345568899999999854 567899999999999999999999988764321 22222211 111111111
Q ss_pred ---hhhhhhhhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 988 ---FTTILDRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 988 ---~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
+......++..-.+..+ ....+..+++.+|+.+||++||||+|+++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111111111111 234578899999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=350.73 Aligned_cols=259 Identities=28% Similarity=0.399 Sum_probs=202.8
Q ss_pred CCCCCCeeeecCcEEEEEEEeCC-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC--eEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR--TRLLL 835 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 835 (1079)
+|...+.||+|+||+||++...+ |...|||.+... .....+.+.+|+.+|++++|||||+++|...... .+++.
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 46778899999999999997764 899999988432 1122677899999999999999999999855444 68999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-CCcEEEeeccccccccC-
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-QFEAFLADFGLAKLFES- 913 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~- 913 (1079)
|||+++|+|.+++.+.+..+++..+..+.+||++||+|||++ +||||||||+|||++. ++.+||+|||.++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999999998765799999999999999999999999 9999999999999999 79999999999987764
Q ss_pred CcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
...........||+.|||||++..+ ....++||||+||++.||+||+.||.........+.. .......+.+..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~---ig~~~~~P~ip~-- 246 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL---IGREDSLPEIPD-- 246 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH---HhccCCCCCCCc--
Confidence 1222334567899999999999854 3345999999999999999999999753111111111 000000011110
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccc
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 1040 (1079)
. -.....+++.+|+..+|++||||+++++.--....
T Consensus 247 ----------~--ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 247 ----------S--LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ----------c--cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1 12256689999999999999999999987655433
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=365.28 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=210.1
Q ss_pred CCCCCCeeeecCcEEEEEEEeCC--C--Ce-EEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPS--R--QV-IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
+....++||+|+||.||+|+++. + .. ||||..............+|.+|+++|++++|||||++||++....+++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34445899999999999997653 2 23 8999875433345566789999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+|||+|.||+|.+|+++.+..++..++..++.+.|+||+|||++ +++||||.++|+|++.++.+||+|||+++.-.
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~- 313 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS- 313 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc-
Confidence 99999999999999998887899999999999999999999999 99999999999999999999999999987543
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
.+........-+.+|+|||.+....++.++|||||||++||+++ |..||.+.... ....++. ..
T Consensus 314 -~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~---~~--------- 378 (474)
T KOG0194|consen 314 -QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIV---KN--------- 378 (474)
T ss_pred -ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHH---hc---------
Confidence 11111112346789999999999999999999999999999999 88898765322 1111110 11
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccCC
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEND 1043 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 1043 (1079)
...+..+. .....+..++.+||..+|++||||.++.+.++.+.....
T Consensus 379 --~~r~~~~~--~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 379 --GYRMPIPS--KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --CccCCCCC--CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11111111 223355667789999999999999999999999976544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.92 Aligned_cols=269 Identities=22% Similarity=0.306 Sum_probs=211.3
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--CeEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG--RTRL 833 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 833 (1079)
.+.|+..++||+|.||.||+|+. .+|+.||+|+++... ..........+|+.+|++++||||+++.+...+. ..+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 35577788999999999999954 689999999996433 2334456778999999999999999999998876 6899
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+|+|||++ +|..++...+..+++.++..++.|++.||+|+|++ +|+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999988 99999998888899999999999999999999999 999999999999999999999999999998876
Q ss_pred CcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHH--hHH-hhhhhchh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN--GEL-RERKREFT 989 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~--~~~-~~~~~~~~ 989 (1079)
... ...+..+-|..|.|||.+.+. .|+.+.|+||.|||+.||++|++.|.+..+ ..++..+.+ |.. .+.|+ ..
T Consensus 271 ~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklcGSP~e~~W~-~~ 347 (560)
T KOG0600|consen 271 SGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLCGSPTEDYWP-VS 347 (560)
T ss_pred CCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHhCCCChhccc-cc
Confidence 653 345667789999999987765 699999999999999999999999987643 222222222 111 11222 11
Q ss_pred hhhhhhh-h--cccCccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 990 TILDRQL-L--MRSGTQIQE-----MLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 990 ~~~~~~~-~--~~~~~~~~~-----~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
....... . ..+...+.+ ....++++..++..||++|.||.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1110000 0 011111222 235678899999999999999999886
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=341.91 Aligned_cols=260 Identities=26% Similarity=0.355 Sum_probs=206.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+.|+..+.||.|..++||+|+. ..+++||||++.-.+- ..+.+.+++|+..|+.++||||++.+..|..+..+|+||
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 5688899999999999999965 5789999999954332 234688999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 837 DYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
.||.+|++.+.+... ...+++..+..|++++++||.|||.+ |.||||||+.|||++++|.|||+|||.+..+.+.+
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999765 55589999999999999999999999 99999999999999999999999999987665543
Q ss_pred cc-ccc-cccccCcccccccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhch-hh
Q 001426 916 SS-RAS-NSVAGSYGYIAPEYGYS--LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREF-TT 990 (1079)
Q Consensus 916 ~~-~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 990 (1079)
.. ... ...+||+.|||||++.. ..|+.|+||||||++.+|+++|..||....|-.. .-.+++..++.. ..
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-----Ll~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-----LLLTLQNDPPTLLTS 255 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----HHHHhcCCCCCcccc
Confidence 21 112 55689999999999443 3689999999999999999999999987654221 112222222111 01
Q ss_pred hhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.++..-.... ...+..++..|++.||++|||++++++
T Consensus 256 ~~~~d~~k~~------~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDEDKKF------SKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHHhhhh------cHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111111 125567788899999999999999886
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=363.83 Aligned_cols=392 Identities=23% Similarity=0.233 Sum_probs=311.8
Q ss_pred eEeecccCCCccCCCcccccc--ccccccccccccccccCCcccccccccceecccccccccCCCcCccCCCCCCeEecc
Q 001426 213 VFLGLADTGISGQIPRSVGEL--TNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLW 290 (1079)
Q Consensus 213 ~~L~l~~~~~~~~~p~~l~~L--~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 290 (1079)
..|+.+.+++.......+... +.-++|++++|.+....+..|.++++|++++|..|.++ .+|...+...+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 345666666654322222221 23456888888888777788888888888888888887 677666666778888888
Q ss_pred CcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeecccccccccccccccccccCcEeeccCCcccccC
Q 001426 291 QNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQI 370 (1079)
Q Consensus 291 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 370 (1079)
+|.|+.+-.+.+..++.|+.||||.|.|+...-..|..-.++++|+|++|.|+....+.|.++.+|..|.|++|+++...
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence 88888777777888888888888888887555556777778888888888888777788888888888888888887544
Q ss_pred CccccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCCCCCccccccccccccccccccccccccCCCcccCCCC
Q 001426 371 PPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTG 450 (1079)
Q Consensus 371 p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 450 (1079)
+..|.+ +++|+.|+|..|+|.-.---.|.++++|+.|.|..|.++..-...|.++.+
T Consensus 214 ~r~Fk~-----------------------L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~k 270 (873)
T KOG4194|consen 214 QRSFKR-----------------------LPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEK 270 (873)
T ss_pred HHHhhh-----------------------cchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecc
Confidence 444444 457888888888887444667888889999999999888777788888999
Q ss_pred ceEEEecCCCccccCccccccccccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhhhhcCCCcccccc
Q 001426 451 LIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSM 530 (1079)
Q Consensus 451 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 530 (1079)
+++|+|+.|++...-..++.+++.|+.|+||+|.|..+.++.+..+++|++|+|++|+|+...+++|..|..|++|+|++
T Consensus 271 me~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~ 350 (873)
T KOG4194|consen 271 MEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSH 350 (873)
T ss_pred cceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccc
Confidence 99999999999888888888899999999999999888888888889999999999999988888899999999999999
Q ss_pred cccccccccccccCCCCceEecccccccCCCC---CccccccccccccccCccccCCChhhhhcccchhhhhcccCCccc
Q 001426 531 NSIGGTIPENLGKLTSLNKLVLSKNNITGLIP---KSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALT 607 (1079)
Q Consensus 531 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 607 (1079)
|+|+..-..+|.++.+|++|||++|.|+..+. ..|.+|++|+.|+|.+|+|..+....|..+..| ..|||.+|.|.
T Consensus 351 Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~L-E~LdL~~Naia 429 (873)
T KOG4194|consen 351 NSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEAL-EHLDLGDNAIA 429 (873)
T ss_pred cchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccc-ceecCCCCcce
Confidence 99988777888889999999999999886654 457788899999999999987667788888888 45689999998
Q ss_pred ccccccccCCCcccEEeccCccc
Q 001426 608 GPIPESFSNLSKLANLDLSNNML 630 (1079)
Q Consensus 608 ~~~p~~~~~l~~L~~L~ls~N~l 630 (1079)
++-|++|..| .|++|-++.-.+
T Consensus 430 SIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 430 SIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred eecccccccc-hhhhhhhcccce
Confidence 8889999988 888887755443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=354.23 Aligned_cols=248 Identities=26% Similarity=0.358 Sum_probs=210.0
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.. ..+.+.+.+.+|++++++++|||||.++++|....+.|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 46778889999999999999665 68899999986433 33456788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+.| +|..++...+. ++++.+..++.+++.||.|||+. +|+|||+||+|||++..+.+|+||||+|+.+..+
T Consensus 81 e~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-- 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-- 153 (808)
T ss_pred hhhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence 99988 99999987776 89999999999999999999999 9999999999999999999999999999977653
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
....+...|||-|||||...+++|+..+|+||+||++||+++|++||... .+...++....+..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v----------- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPV----------- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCC-----------
Confidence 34556788999999999999999999999999999999999999999752 23333332222211
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.........+..++...+..||.+|.|..+++.
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 111123346678888999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=320.67 Aligned_cols=269 Identities=22% Similarity=0.305 Sum_probs=214.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|...+++|+|.||.||+|+. ++|+.||||++...... ..-.....+|+..++.++|+||+.++++|...+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4677888999999999999954 58999999999654222 122356679999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||++. +|...++.....++...+..++.++++|++|||++ .|+|||+||.|+|++++|.+||+|||+|+.+....
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 99976 99999999888899999999999999999999999 89999999999999999999999999999887654
Q ss_pred cccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHH---hHHhhhhhchhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN---GELRERKREFTTIL 992 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 992 (1079)
......+-|..|.|||.+++. .|+...||||.|||+.||+-|.+-|.+..+ -+++....+ ....+.|++....-
T Consensus 156 -~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 -RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred -cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCcccCccccccc
Confidence 233344789999999998775 689999999999999999998877765432 222222222 22344566665555
Q ss_pred hhhhhcccC-ccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 993 DRQLLMRSG-TQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 993 ~~~~~~~~~-~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
|..-....+ ... ....+.++++.+++..||.+|+|+.|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 443221111 111 123456899999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=362.64 Aligned_cols=261 Identities=26% Similarity=0.429 Sum_probs=204.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEe------CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcC-
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI------PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNG- 829 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 829 (1079)
++|+..+.||+|+||.||+|.. .+++.||+|++... ......+.+.+|+.++..+ +||||++++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 5688899999999999999964 23567999988532 2233456799999999999 899999999998764
Q ss_pred CeEEEEEEecCCCChhhhhhccC---------------------------------------------------------
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKK--------------------------------------------------------- 852 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 852 (1079)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 45899999999999999987532
Q ss_pred ----cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccccccCcc
Q 001426 853 ----VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG 928 (1079)
Q Consensus 853 ----~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 928 (1079)
..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++.+.............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 2377888899999999999999999 999999999999999999999999999987654332222334456789
Q ss_pred cccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHH
Q 001426 929 YIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEM 1007 (1079)
Q Consensus 929 y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1079)
|+|||++.+..++.++|||||||++|||++ |..||....... .+.... ..... . .... ...
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~----~~~~~---------~--~~~~--~~~ 303 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRL----KDGTR---------M--RAPE--NAT 303 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHH----hcCCC---------C--CCCC--CCC
Confidence 999999998899999999999999999997 999997543211 111110 00000 0 0000 112
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 1008 LQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 1008 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3577899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=347.47 Aligned_cols=264 Identities=27% Similarity=0.412 Sum_probs=215.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
..+..+++||+|-||.|..++..++..||||++++... ...+++|.+|+++|.+++|||||+++|+|..++++++|+|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34566788999999999999999999999999976443 3457899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEKKVF-LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++|+|.+|+.++... ...+...+|+.||+.||+||.+. ++||||+.++|+|+++++++||+|||+++-+..+++
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999999877432 35556678999999999999999 999999999999999999999999999998888887
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT--GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
.+.....+-+.+|||||.+.-++++.++|||+||+++||+++ ...||....++ +..+-..+..+.+...
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~~~~------- 763 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQGRQ------- 763 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCCCcc-------
Confidence 777777788899999999999999999999999999999988 66788754322 1111111111111100
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.+. ....-+...+++++..||+.+-++||+++++...|.+.
T Consensus 764 ~~l---~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVL---SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eec---cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 000 00111233677999999999999999999999988764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=354.33 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=208.4
Q ss_pred HhhCCCCCCeeeecCcEEEEEEE-eCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEE
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 834 (1079)
-...|+..+.||+|+.|.||.++ ..+++.||||++..... ..++.+.+|+.+|+..+|+|||++++.|..++..|+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 34568888999999999999995 45788999999854332 335678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
||||++||+|.+.+.... +++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 348 VMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 999999999999997554 89999999999999999999999 9999999999999999999999999999988765
Q ss_pred cccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
. ......+|||.|||||+.....|+.|+||||+|++++||+.|.+||..+.+-.+-+.-...+..+.+
T Consensus 423 ~--~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk---------- 490 (550)
T KOG0578|consen 423 Q--SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLK---------- 490 (550)
T ss_pred c--CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcC----------
Confidence 4 2456678999999999999999999999999999999999999999864432221111111111100
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. ...-...+.+++.+|+..||++||+++|+++
T Consensus 491 -----~--~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 -----N--PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -----C--ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 0 0011236678999999999999999999987
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=358.53 Aligned_cols=382 Identities=26% Similarity=0.231 Sum_probs=236.2
Q ss_pred cccEEEcCCCcccccCCccccc-c-CCCCEEeccCCcccCCCCcccCCcCcccEEeccCCcccccCccccccccccceEe
Q 001426 90 HLTSLVLSNANLTGEIPPAIGN-L-SSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLE 167 (1079)
Q Consensus 90 ~l~~L~L~~~~l~~~~p~~l~~-l-~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 167 (1079)
....||.+++++...--..+.. + ..-+.||+|+|++....+..|.++++|+.+++..|.++ .||...+...+|+.|+
T Consensus 53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~ 131 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD 131 (873)
T ss_pred CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence 4456777777766221111111 1 23345666666666666666666666666666666666 5666555555566666
Q ss_pred cccccccCCCChhhchhhhHHHHHhCCCCCcccCCCcccccccceeEeecccCCCccCCCcccccccccccccccccccc
Q 001426 168 LYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANIT 247 (1079)
Q Consensus 168 Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~~~ 247 (1079)
|.+|.|+
T Consensus 132 L~~N~I~------------------------------------------------------------------------- 138 (873)
T KOG4194|consen 132 LRHNLIS------------------------------------------------------------------------- 138 (873)
T ss_pred eeccccc-------------------------------------------------------------------------
Confidence 6666554
Q ss_pred ccCCcccccccccceecccccccccCCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccCccccccc
Q 001426 248 GYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLA 327 (1079)
Q Consensus 248 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 327 (1079)
..-.+++..++.|+.|||+.|.|+...-..|..-.++++|+|++|.|+....++|..+.+|..|.|+.|+++...+..|.
T Consensus 139 sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk 218 (873)
T KOG4194|consen 139 SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFK 218 (873)
T ss_pred cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhh
Confidence 22233455566777777777777755555677777888888888888877778888888888888888888866666777
Q ss_pred cccccceeecccccccccccccccccccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCcccccccCcEEe
Q 001426 328 NLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALD 407 (1079)
Q Consensus 328 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~ 407 (1079)
++++|+.|+|..|+|.-.---.|.++++|+.|.|..|.+...-... |..+.++++|+
T Consensus 219 ~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~-----------------------Fy~l~kme~l~ 275 (873)
T KOG4194|consen 219 RLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGA-----------------------FYGLEKMEHLN 275 (873)
T ss_pred hcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcc-----------------------eeeecccceee
Confidence 7888888888888876433456777777777777777765322222 33345677777
Q ss_pred ccCCCCCCCccccccccccccccccccccccccCCCcccCCCCceEEEecCCCccccCccccccccccCeeeeccCcccC
Q 001426 408 LSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTG 487 (1079)
Q Consensus 408 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 487 (1079)
|+.|+++..-..++.+++.|++|+|++|.|..+-++...-+++|++|+|++|+|+...++.|..+..|+.|+|++|.++
T Consensus 276 L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~- 354 (873)
T KOG4194|consen 276 LETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID- 354 (873)
T ss_pred cccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-
Confidence 7777777666666677777777777777666555555555556666666666655555555555555555555555555
Q ss_pred CCCCCCCCCCcccEEecCCCcCcccCChhhhhhcCCCcccccccccccccc---cccccCCCCceEecccccccCCCCCc
Q 001426 488 EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIP---ENLGKLTSLNKLVLSKNNITGLIPKS 564 (1079)
Q Consensus 488 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~~ 564 (1079)
.....+|..+.+|++|||++|.|+..+. ..|.+|++|+.|+|.+|+|..+...+
T Consensus 355 -----------------------~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krA 411 (873)
T KOG4194|consen 355 -----------------------HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRA 411 (873)
T ss_pred -----------------------HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhh
Confidence 4444444445555555555555444332 23455555555555555555555555
Q ss_pred cccccccccccccCccccCCChhhhhcc
Q 001426 565 LGLCKDLQLLDLSSNRINGSIPEEIGRL 592 (1079)
Q Consensus 565 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 592 (1079)
|.++++|+.|||.+|.|..+-|+.|..+
T Consensus 412 fsgl~~LE~LdL~~NaiaSIq~nAFe~m 439 (873)
T KOG4194|consen 412 FSGLEALEHLDLGDNAIASIQPNAFEPM 439 (873)
T ss_pred hccCcccceecCCCCcceeecccccccc
Confidence 5555555555555555555555555554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.09 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=207.1
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
.++|+...+||+|+||.||.|+.+ +|+.+|+|++.+...-...+.+.++.|-++|...++|.||++|..|++.+.+|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 356888999999999999999765 6999999999877666677788999999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC-
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS- 914 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~- 914 (1079)
|||++||++..++...+. ++++.+..++.+.+.|++.+|+. |||||||||+|+|+|..|++|++|||++.-+...
T Consensus 220 MEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999987765 88899999999999999999999 9999999999999999999999999998532210
Q ss_pred ---------------------cccc----c-------------------ccccccCcccccccccCCCCCCccchHHHHH
Q 001426 915 ---------------------ESSR----A-------------------SNSVAGSYGYIAPEYGYSLKITEKSDVYSYG 950 (1079)
Q Consensus 915 ---------------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 950 (1079)
+... . .-..+|||.|||||++.+..|+..+|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0000 0 0123699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCC---
Q 001426 951 VVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPT--- 1027 (1079)
Q Consensus 951 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt--- 1027 (1079)
||+|||+.|.+||....+... ....+... .....+.+.+...+..++|.+|+. ||++|..
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T-~rkI~nwr---------------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQET-YRKIVNWR---------------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHH-HHHHHHHh---------------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999998655322 11111111 000111112223577889999999 9999986
Q ss_pred HHHHHH
Q 001426 1028 MKDVTA 1033 (1079)
Q Consensus 1028 ~~evl~ 1033 (1079)
+.||.+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 555544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.78 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=207.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
..|+..+.||+|+||.||+|.. +.++.||+|++.- .....+.+++++|+.++.+++++||.++|+.+..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~L--e~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDL--EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEech--hhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 3477778999999999999955 5789999999953 344567789999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|||.||++.+.+..... +.+..+..|++++..|+.|+|.+ +.+|||||+.||++..+|.+|++|||++..+.....
T Consensus 91 ey~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHhcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999999975543 47788888999999999999999 999999999999999999999999999998776543
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.....+|||.|||||++....|+.|+||||+|++.+||++|.+|+.+..|.-.- .-..+..++.+..
T Consensus 167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-----flIpk~~PP~L~~------ 233 (467)
T KOG0201|consen 167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-----FLIPKSAPPRLDG------ 233 (467)
T ss_pred --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-----EeccCCCCCcccc------
Confidence 236789999999999999889999999999999999999999999887652110 0000111111111
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.....+.+++..|++.||+.||+|.++++
T Consensus 234 --------~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 --------DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred --------ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 12235668899999999999999998875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=318.36 Aligned_cols=203 Identities=25% Similarity=0.352 Sum_probs=184.0
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
.++|+..+.||.|+||.|..++.+ +|..+|+|++.+.+.-.....+...+|..+++.+.||+++++++.|.+.+..|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356788899999999999999765 6889999999765544555567888999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|||++||.|..++++.++ +++..++.++.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||.|+.+...
T Consensus 123 meyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999999988776 89999999999999999999999 9999999999999999999999999999976532
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIP 968 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~ 968 (1079)
+-..+|||.|+|||++...++..++|.|||||++|||+.|.+||.+..+
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 3456899999999999999999999999999999999999999987644
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.60 Aligned_cols=259 Identities=24% Similarity=0.315 Sum_probs=207.3
Q ss_pred HhhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCC-C-chhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCe
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNG-E-LPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 831 (1079)
...+|...+.||+|+||+|+.|.. .+++.||+|++.+.... . ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346789999999999999999955 47899999976543211 1 123466778999999999 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC-CcEEEeecccccc
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ-FEAFLADFGLAKL 910 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~~ 910 (1079)
.++||||+.||+|.+++.+ ...+.+..+..+++|+++|++|+|++ +|+||||||+||+++.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999998 44588899999999999999999999 99999999999999999 9999999999997
Q ss_pred ccCCcccccccccccCcccccccccCCCC-CC-ccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhch
Q 001426 911 FESSESSRASNSVAGSYGYIAPEYGYSLK-IT-EKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREF 988 (1079)
Q Consensus 911 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1079)
.. ..........||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++... ..+... +....-.+
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--~~l~~k----i~~~~~~~ 242 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--PNLYRK----IRKGEFKI 242 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--HHHHHH----HhcCCccC
Confidence 74 1123455678999999999999877 75 789999999999999999999987321 111111 11111111
Q ss_pred hhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccc
Q 001426 989 TTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 1040 (1079)
...+ . ......++.+|+..||.+|+|+.+++ .-.-++.
T Consensus 243 p~~~------------~-S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 243 PSYL------------L-SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred CCCc------------C-CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1111 1 33667899999999999999999999 4444443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.41 Aligned_cols=268 Identities=25% Similarity=0.344 Sum_probs=205.6
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHh--cCCCCceeeeeeEEEcCC----
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLG--SIRHKNIVRLLGCCNNGR---- 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~---- 830 (1079)
.++....+.||+|.||.||+|+|+ |+.||||++. +.+ .....+|.++.+ .+||+||..++++-..+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~-----srd-E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS-----SRD-ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEec-----ccc-hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 366777899999999999999998 7778999994 222 234555666655 469999999999865433
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEeCCCCCCeEECCCCcEEEeec
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD-----CVPPIIHRDIKSNNILVGPQFEAFLADF 905 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~DF 905 (1079)
.+|+|++|.+.|+|+||+... .++.+...+++..+|.||+|||.. +.|.|.|||||+.||||.+++++.|+|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 469999999999999999764 478999999999999999999974 4579999999999999999999999999
Q ss_pred cccccccCCcc--cccccccccCcccccccccCCCC------CCccchHHHHHHHHHHHHhC----------CCCCCCCC
Q 001426 906 GLAKLFESSES--SRASNSVAGSYGYIAPEYGYSLK------ITEKSDVYSYGVVLLEVLTG----------KEPTDSRI 967 (1079)
Q Consensus 906 Gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~el~tg----------~~p~~~~~ 967 (1079)
|+|........ .......+||.+|||||++...- ....+||||||.++||++-. +.||++..
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 99987765532 23345678999999999865431 23479999999999999863 35777765
Q ss_pred CCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 968 PDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 968 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
+.+-.+..+.+- ...+.+.|.+. ..-...+.+..+.++++.||..+|..|.|+-.+.+.+.++.+.
T Consensus 441 p~DPs~eeMrkV-------VCv~~~RP~ip-nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 441 PSDPSFEEMRKV-------VCVQKLRPNIP-NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCCHHHHhcc-------eeecccCCCCC-cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 554444333211 11111112111 1122336677889999999999999999999999999998754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=344.82 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=202.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC-----------------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCcee
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-----------------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 820 (1079)
.+|+..+.||+|+||.||+|.+++ +..||+|.+... ........|.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--ANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC--CCHHHHHHHHHHHHHHhhcCCCCee
Confidence 468888999999999999997542 336899988532 2233457899999999999999999
Q ss_pred eeeeEEEcCCeEEEEEEecCCCChhhhhhccC------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 001426 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK------------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882 (1079)
Q Consensus 821 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~i 882 (1079)
++++++.+....++||||+++|+|.+++.... ..+++..+++++.||+.||+|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 99999999999999999999999999985431 2467888999999999999999999 99
Q ss_pred EEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh--CC
Q 001426 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT--GK 960 (1079)
Q Consensus 883 vH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t--g~ 960 (1079)
+||||||+||++++++.+||+|||+++.+.............++..|+|||+..+..++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999987654433333334456889999999888889999999999999999997 45
Q ss_pred CCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 961 EPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 961 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
.||..... ......+............. . .. ......+.+++.+||+.||++|||++||.+.|++
T Consensus 240 ~p~~~~~~--~~~~~~~~~~~~~~~~~~~~-~------~~---~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTD--EQVIENAGEFFRDQGRQVYL-F------RP---PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCH--HHHHHHHHHHhhhccccccc-c------CC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 66654321 11111111111110000000 0 00 0112367789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.28 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=201.1
Q ss_pred CCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
.+...+-+|.|+-|-||+|+++ ++.||||+++. .-..+++-|++++||||+.|.|+|....-++|||||
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLH-NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred HhhhhhhhccCcccceeeeecc-CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 3455677999999999999997 55679998742 223478889999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
|..|-|...++.... ++......+..+||.||.|||.+ +|||||||.-||||+.+..|||+|||.++...+. .
T Consensus 194 Ca~GqL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---S 266 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---S 266 (904)
T ss_pred cccccHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---h
Confidence 999999999976554 78888899999999999999999 9999999999999999999999999999977653 3
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhc
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
....++||..|||||++...+.++|+|||||||++|||+||..||.+-+. ..++++.... .+..
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-----sAIIwGVGsN-----------sL~L 330 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-----SAIIWGVGSN-----------SLHL 330 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-----heeEEeccCC-----------cccc
Confidence 34467899999999999999999999999999999999999999975321 1111121111 1111
Q ss_pred ccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccc
Q 001426 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 999 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 1040 (1079)
..+. .+...+.-+++.||+..|..||+|++++..|+-+..
T Consensus 331 pvPs--tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 331 PVPS--TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred cCcc--cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 1112 223356678999999999999999999999976543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=329.35 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=212.9
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++.+..++++.-.+++|++||..++||||+.+|++|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788889999999999999955 78999999999888888877888899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|||..+|.|++|+.+.+. +++.++..+++||..|+.|+|.+ ++||||+|.+|||+|.++++||+|||++-.+.++.
T Consensus 132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999999988776 88899999999999999999999 99999999999999999999999999998887654
Q ss_pred ccccccccccCcccccccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKI-TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
....++|+|-|.+||+..+.+| ++.+|-||+||++|-++.|..||++.+. ...++..- ...+. .+
T Consensus 208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQIs---~GaYr---EP 273 (668)
T KOG0611|consen 208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQIS---RGAYR---EP 273 (668)
T ss_pred ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHhh---ccccc---CC
Confidence 3345789999999999999988 5789999999999999999999987421 11111100 01110 00
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
+......-+|++|+..+|++|.|+.+|...-
T Consensus 274 ----------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ----------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111344688999999999999999998754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=341.91 Aligned_cols=257 Identities=24% Similarity=0.370 Sum_probs=213.6
Q ss_pred CCCCCCeeeecCcEEEEEEEeCC---CC--eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPS---RQ--VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
..+..++||.|-||.||+|.+.+ |+ .||||.-+ .+...+..+.|..|..+|+.++|||||+++|+|.+ .+.|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK--~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCK--TDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhc--cCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 35566889999999999996632 33 47777663 33445568899999999999999999999999986 4789
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
||||.++.|.|.+|++..+..++......+++||+.||+|||+. ++|||||..+|||+....-||++|||+++.+.+
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999999999888899999999999999999999999 999999999999999999999999999999988
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
+.+... +...-+..|||||.+.-++++.++|||.|||.+||++. |..||.+-...+... .+
T Consensus 544 ~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-----------------~i 605 (974)
T KOG4257|consen 544 DAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-----------------HI 605 (974)
T ss_pred cchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-----------------Ee
Confidence 775443 35566889999999999999999999999999999988 999998643322210 00
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
+.. .+.+....+...++.++-+||..+|.+||++.++...|.++..+
T Consensus 606 EnG--eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 606 ENG--ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred cCC--CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 000 01122224556888999999999999999999999999988764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=337.93 Aligned_cols=251 Identities=20% Similarity=0.299 Sum_probs=200.2
Q ss_pred CCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc----CCeEEEEEEe
Q 001426 763 TNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN----GRTRLLLFDY 838 (1079)
Q Consensus 763 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 838 (1079)
...||+|++|.||+|.+ +|+.||||++...........+.|.+|+.++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999988 578899999865443333335788999999999999999999999876 3467999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+++|+|.+++.+.+ .+++.....++.|++.|++|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 99999999997654 4889999999999999999999742 78899999999999999999999999998654322
Q ss_pred cccccccCcccccccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 919 ASNSVAGSYGYIAPEYGYS--LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
....++..|+|||+..+ ..++.++|||||||++|||++|+.||...... .+...+. ... .. .
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~---~~~-~~--------~ 241 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLII---NKN-NS--------L 241 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH---hcC-CC--------C
Confidence 23457899999999875 67899999999999999999999999754221 1111110 000 00 0
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccc
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 1040 (1079)
..+ ......+.+++.+||+.||++|||++|+++.|++++.
T Consensus 242 --~~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 --KLP--LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --CCC--CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 000 0122357789999999999999999999999998753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=353.06 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=204.3
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe------CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcC
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI------PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNG 829 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 829 (1079)
.++|+..+.||+|+||.||+|.+ .++..||||++.... .....+.+.+|+++++.+ +||||++++++|.++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45788999999999999999863 245689999885322 233456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhccC---------------------------------------------------------
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKK--------------------------------------------------------- 852 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 852 (1079)
...++||||+++|+|.+++.+..
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999986432
Q ss_pred -----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 853 -----------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 853 -----------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 2468889999999999999999998 99999999999999999999999999998765433
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
.........++..|+|||+..+..++.++|||||||++|||++ |..||...... ..+...+....+. ..+
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~--------~~~ 339 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRM--------LSP 339 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccC--------CCC
Confidence 2222223345678999999999999999999999999999998 88888653221 1122211110000 000
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
. .....+.+++.+||+.||++|||++|+++.|++.
T Consensus 340 ------~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ------E---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 0123577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=340.24 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=214.5
Q ss_pred CCCCCCeeeecCcEEEEEEEeCC-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+++..++||-|.||.||.|.|+. .-.||||.++ .+.-+.++|..|+.+|+.++|||+|+++|+|.....+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK----EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhh----hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 45667899999999999999875 4568999874 334567899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||.+|+|.+|+++. +..++.-....++.||+.||+||..+ ++|||||.++|+|+.++..|||+|||+++++..+.+
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 99999999999865 44467777889999999999999999 999999999999999999999999999999876653
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.. -....-.+.|.|||.+....++.|+|||+|||++||+.| |..||.+. ++ .++.+.++..
T Consensus 421 TA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dl------------SqVY~LLEkg 482 (1157)
T KOG4278|consen 421 TA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DL------------SQVYGLLEKG 482 (1157)
T ss_pred ec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cH------------HHHHHHHhcc
Confidence 32 223345789999999988899999999999999999999 88888642 11 2233445555
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
+++..++. +...++++++.||++.|.+||+++|+-+.++.+..+
T Consensus 483 yRM~~PeG--CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 483 YRMDGPEG--CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ccccCCCC--CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 55544443 344788999999999999999999999999877543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=346.51 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=214.5
Q ss_pred CCCCCCeeeecCcEEEEEEEe-CCCC----eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEI-PSRQ----VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
+.+..++||+|+||+||+|.| ..|+ +||+|++.. ........++.+|+.+|.+++|||+++++|+|.... ..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~--~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE--FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeec--cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 345678899999999999966 3333 578887743 333445688999999999999999999999998765 78
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
||++|++.|+|.+|++.++..+-.+..+.+..|||+||.|||++ ++|||||.++||||.+-..+||.|||+|+....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999999999988899999999999999999999999 999999999999999999999999999998887
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
++.........-.+.|||=|.+....++.++|||||||++||++| |..|+++...+ ++.+.+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dll 913 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDLL 913 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHHH
Confidence 766666666667789999999999999999999999999999999 99999865321 111122
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
....+ .........+++-++.+||..|+..||+|+++.+.+.++.+.
T Consensus 914 e~geR--LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 914 EKGER--LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred hcccc--CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 11111 111223445788899999999999999999999999988654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=351.14 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=204.1
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcC
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNG 829 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 829 (1079)
.++|+..+.||+|+||.||+|... ++..||+|++.... .......+.+|+++++.+ +|+|||+++++|.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 356888999999999999998642 34579999985322 223456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhccC---------------------------------------------------------
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKK--------------------------------------------------------- 852 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 852 (1079)
...++||||+++|+|.+++.+..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999986431
Q ss_pred ------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccc
Q 001426 853 ------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920 (1079)
Q Consensus 853 ------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 920 (1079)
..+++..+++++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+.........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 2367888999999999999999999 9999999999999999999999999999866443222222
Q ss_pred cccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcc
Q 001426 921 NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMR 999 (1079)
Q Consensus 921 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1079)
....++..|+|||+..+..++.++|||||||++|||++ |+.||....... .+........+ ...+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~--------~~~~----- 337 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQ--------MSRP----- 337 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccC--------ccCC-----
Confidence 23345678999999988899999999999999999997 999997643221 11111110000 0000
Q ss_pred cCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 1000 SGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 1000 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
. .....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 338 --~--~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 --D--FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --C--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0 01236778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=343.67 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=205.0
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 835 (1079)
++|....+||+|+||+|+.++.+ +++.+|||.+++...-..++.+..+.|.+|+... +||.++.++.+|++.++.|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 56788899999999999999876 5789999999887777778889999999998877 599999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|||+.||++..+. +...+++..+.-++..|+.||.|||++ +|||||||.+|||+|.+|.+||+|||+++.---.
T Consensus 448 mey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~- 521 (694)
T KOG0694|consen 448 MEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ- 521 (694)
T ss_pred EEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC-
Confidence 9999999955444 334589999999999999999999999 9999999999999999999999999999854322
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
...++..+|||.|||||++.+..|+.++|.|||||++|||+.|+.||.+.+.+ +++|..
T Consensus 522 -g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------------------e~FdsI 580 (694)
T KOG0694|consen 522 -GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------------------EVFDSI 580 (694)
T ss_pred -CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------------HHHHHH
Confidence 23566789999999999999999999999999999999999999999864321 122222
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTM 1028 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 1028 (1079)
+.....+..-...+...++.+.+..+|++|..+
T Consensus 581 ~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222222222334467788999999999999976
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.97 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=199.9
Q ss_pred CCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|+||+||+|.. .+++.||+|.+.+...........+.+|++++++++|++|+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 56678999999999999976 57899999988643333333345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 839 ISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 839 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 9999999888643 34589999999999999999999999 99999999999999999999999999998754332
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..............
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~---------- 223 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKEDQEE---------- 223 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhccccc----------
Confidence 12345689999999999999999999999999999999999999986432111 00000000000000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPT-----MKDVTA 1033 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 1033 (1079)
... .-...+.+++.+||+.||++||+ ++++++
T Consensus 224 --~~~--~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 --YSE--KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --CCc--cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 000 11235678999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=312.74 Aligned_cols=287 Identities=21% Similarity=0.236 Sum_probs=214.9
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc--CCe
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN--GRT 831 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 831 (1079)
.-++.|+..+.|++|+||.||+|+.+ +++.||+|+++..+... ..--.-.+|+.++.+++|||||.+..+... -+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 34567889999999999999999765 78899999996543221 112345789999999999999999998764 456
Q ss_pred EEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccc
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~ 911 (1079)
+|+|||||+. +|...++.-+..+...++..++.|+++|++|||.. .|+|||+|++|+|+++.|.+||+|||+|+.+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 8999999988 99999998888899999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHH---hHHhhhhhc
Q 001426 912 ESSESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN---GELRERKRE 987 (1079)
Q Consensus 912 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~ 987 (1079)
+... ...+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+.... +++..... ..-...|+.
T Consensus 228 gsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 228 GSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred cCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhCCCccccCCC
Confidence 7653 345667889999999987765 5899999999999999999999998765432 12222221 111222333
Q ss_pred hhhhhhh---hhhcccCccHH-------HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccCCCCCCCccc
Q 001426 988 FTTILDR---QLLMRSGTQIQ-------EMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSL 1051 (1079)
Q Consensus 988 ~~~~~~~---~~~~~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~ 1051 (1079)
+.+.--. .....+....+ -...-++++...+..||++|.|+.|.++. +...+.+-+..|..+
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMF 376 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhc
Confidence 3222111 00000000111 11355688889999999999999998863 333333444444444
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.58 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=203.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC----CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP----SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
++|+..++||+|+||.||+|.++ .+..||+|.+... ........|.+|+.++++++||||+++++++..+...+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG--CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC--CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 45788899999999999999753 3568999988532 22334567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+||||+++|+|.+++......+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999999987666789999999999999999999999 999999999999999999999999998765432
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
.. ........++..|+|||...+..++.++|||||||++||+++ |..||...... .+...+. ...
T Consensus 160 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~----~~~------- 225 (266)
T cd05064 160 EA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVE----DGF------- 225 (266)
T ss_pred cc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHH----CCC-------
Confidence 21 111122345678999999988899999999999999999875 99999754221 1111110 000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
...... .....+.+++..||+.+|++||+++|+.+.|+++
T Consensus 226 ----~~~~~~--~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ----RLPAPR--NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCC--CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000001 1223567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=333.21 Aligned_cols=249 Identities=33% Similarity=0.508 Sum_probs=193.6
Q ss_pred CCeeeecCcEEEEEEEeC-----CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 763 TNIVGKGVSGIVYRVEIP-----SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 763 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
.+.||.|+||.||+|.+. .+..|+||.+.. .......+.|.+|++.+++++||||++++|++...+..++|+|
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 467999999999999877 356789998843 2333457899999999999999999999999998888999999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++|+|.+++... ...+++..++.++.||++||+|||+. +++||||+++||++++++.+||+|||+++.......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999999887 66799999999999999999999999 999999999999999999999999999987743333
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
............|+|||...+..++.++||||||+++|||++ |+.||.... ...+...+. .......
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~~~~~~~~---~~~~~~~------- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--NEEIIEKLK---QGQRLPI------- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HHHHHHHHH---TTEETTS-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc---cccccee-------
Confidence 333344557789999999988889999999999999999999 778876531 111111110 0000000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
.......+.+++..||+.+|++|||++++++.|
T Consensus 227 -------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 -------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 001123577899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=370.03 Aligned_cols=483 Identities=27% Similarity=0.316 Sum_probs=252.7
Q ss_pred EEcCCCcccccCCccccccCCCCEEeccCCcccCCCCcccCCcCcccEEeccCCcccccCccccccccccceEecccccc
Q 001426 94 LVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQL 173 (1079)
Q Consensus 94 L~L~~~~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l 173 (1079)
+|.++.+++ .||..+..-..|+.|+++.|-+-...-+.+.+..+|+.|||++|++. ..|..+..+.+|+.|.+++|.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 567777777 77877776666888888888776322234445556888888888887 7788888888888888888888
Q ss_pred cCCCChhhchhhhHHHHHhCCCCCcccCCCcccccccceeEeecccCCCccCCCccccccccccccccccccccccCCcc
Q 001426 174 SGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEE 253 (1079)
Q Consensus 174 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~ 253 (1079)
. .+|.+.+++.+|++|.|.+|. ....|.++..+++|++|+++.|++. .+|..+..++.+..+..++|.....
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~--l~~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~---- 152 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNR--LQSLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR---- 152 (1081)
T ss_pred h-hCchhhhhhhcchhheeccch--hhcCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----
Confidence 7 677777777777777777764 4455556666666666666666554 5555555555555555555522111
Q ss_pred cccccccceecccccccccCCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccCccccccccccccc
Q 001426 254 IGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALE 333 (1079)
Q Consensus 254 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 333 (1079)
++... ++++++..|.+.+.++..+..+.+ .|+|.+|.+. . -.+.++.+|+.|....|++... --..++|+
T Consensus 153 lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~ 222 (1081)
T KOG0618|consen 153 LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSEL----EISGPSLT 222 (1081)
T ss_pred hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceE----EecCcchh
Confidence 11111 445555555555555444444444 4555555544 1 1234444455555555544411 11223444
Q ss_pred eeecccccccccccccccccccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCC
Q 001426 334 ELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFL 413 (1079)
Q Consensus 334 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l 413 (1079)
.|+.++|.++...+. ..-.+|++++++.|+++ .+|.+++ .|.+|+.++..+|++
T Consensus 223 ~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~-----------------------~~~nle~l~~n~N~l 276 (1081)
T KOG0618|consen 223 ALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIG-----------------------ACANLEALNANHNRL 276 (1081)
T ss_pred eeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHH-----------------------hcccceEecccchhH
Confidence 444444444421111 11234444444444443 1222222 233455555555555
Q ss_pred CCCccccccccccccccccccccccccCCCcccCCCCceEEEecCCCccccCccccccccc-cCeeeeccCcccCCCCCC
Q 001426 414 TGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHR-LTFLELSENQFTGEIPPE 492 (1079)
Q Consensus 414 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~ 492 (1079)
+ .+|..+..+++|+.|.+..|.++ -+|....++..|++|+|..|+|...++..+..+.. |..|+.+.|.+.
T Consensus 277 ~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~------ 348 (1081)
T KOG0618|consen 277 V-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS------ 348 (1081)
T ss_pred H-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc------
Confidence 4 44555555555555555555554 34444444555555555555554332222222222 444444444444
Q ss_pred CCCCCcccEEecCCCcCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEecccccccCCCCCccccccccc
Q 001426 493 IGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQ 572 (1079)
Q Consensus 493 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 572 (1079)
......=..+..|+.|.+.+|+++...-..+.+.++|+.|+|++|+|..++...+.++..|+
T Consensus 349 ------------------~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~Le 410 (1081)
T KOG0618|consen 349 ------------------TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELE 410 (1081)
T ss_pred ------------------ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhH
Confidence 22211112233455555555555544444455555555555555555555445555555555
Q ss_pred cccccCccccCCChhhhhcccchhhhhcccCCcccccccccccCCCcccEEeccCcccccc-ccccCcccccceeeccCC
Q 001426 573 LLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGS-LKVLGSLDNLVSLNVSYN 651 (1079)
Q Consensus 573 ~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~~~~~~l~~L~~L~ls~N 651 (1079)
+|+||+|+++ .+|+.+.++..|+ .|...+|+|. ..| .+.++++|+.+|+|.|+|+.. .+.....++|++||+++|
T Consensus 411 eL~LSGNkL~-~Lp~tva~~~~L~-tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN 486 (1081)
T KOG0618|consen 411 ELNLSGNKLT-TLPDTVANLGRLH-TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGN 486 (1081)
T ss_pred HHhcccchhh-hhhHHHHhhhhhH-HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCC
Confidence 5555555554 4455555555552 2344455554 334 455555555555555555532 222233355555555555
Q ss_pred c
Q 001426 652 H 652 (1079)
Q Consensus 652 ~ 652 (1079)
.
T Consensus 487 ~ 487 (1081)
T KOG0618|consen 487 T 487 (1081)
T ss_pred c
Confidence 4
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.81 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=205.5
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCC----eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQ----VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
.+|+..+.||+|+||.||+|.+. +++ .||+|.+.. .......+.+.+|+.+++.++||||++++|+|... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc--cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 45888999999999999999764 333 388998743 22233457889999999999999999999999865 56
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
++|+||+++|+|.+++.+....+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 899999999999999988766789999999999999999999999 99999999999999999999999999998765
Q ss_pred CCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
............++..|+|||+..+..++.++||||||+++|||++ |+.||..... ..+..... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~~~~----~-------- 226 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILE----K-------- 226 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHh----C--------
Confidence 4432222223345678999999999899999999999999999998 9999875321 11111111 0
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccC
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 1042 (1079)
....... ......+..++.+||+.+|++|||+.+++..+.++....
T Consensus 227 ---~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 227 ---GERLPQP--PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---CCCCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0000000 011235678999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=340.00 Aligned_cols=256 Identities=25% Similarity=0.329 Sum_probs=209.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.-|+..+.||.|+-|.|..|+. .+|+.+|||++.+...-.......+.+|+-+|+-+.||||+++|+++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3467778899999999999965 689999999997654444445578899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|.|.+|+-+++. +++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|..-..+
T Consensus 92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 99999999999998887 77778888999999999999999 9999999999999999999999999999865443
Q ss_pred cccccccccCcccccccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKI-TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
......+|+|-|.|||++.+.+| +.++||||+|||+|.|++|+.||++ +.+...... .+. +.+.
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlK-V~~--G~f~------ 230 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLK-VQR--GVFE------ 230 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHH-HHc--Cccc------
Confidence 23455689999999999999988 5689999999999999999999984 222222111 111 1111
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhccc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM--LKEIRH 1040 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~ 1040 (1079)
++ . ....+..+++.+|+..||++|.|++||.+. +.+...
T Consensus 231 --MP--s--~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 231 --MP--S--NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred --CC--C--cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 01 0 112366789999999999999999999984 444443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=325.47 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=202.7
Q ss_pred HhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCC-----------CchhHHHHHHHHHHHhcCCCCceeeee
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNG-----------ELPERDQFSAEVQTLGSIRHKNIVRLL 823 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv~l~ 823 (1079)
..++|+....||+|.||.|-+|+.. +++.||+|++.+.... .....+..++|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578999999999999999999765 7899999998653321 111235889999999999999999999
Q ss_pred eEEEc--CCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEE
Q 001426 824 GCCNN--GRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF 901 (1079)
Q Consensus 824 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 901 (1079)
++..+ .+.+|+|+|||..|.+.+.=.. +..+++.+++++++++..||+|||.+ +||||||||+|+|++++|+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 99876 4578999999999887655432 22388999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCCc---ccccccccccCcccccccccCCCC----CCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHH
Q 001426 902 LADFGLAKLFESSE---SSRASNSVAGSYGYIAPEYGYSLK----ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHII 974 (1079)
Q Consensus 902 l~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~ 974 (1079)
|+|||.+.....+. ........+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||-+... +
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~- 325 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----L- 325 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----H-
Confidence 99999998763321 112223478999999999876632 35789999999999999999999975321 0
Q ss_pred HHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 975 TWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.-+..++...+...... +....+.+++.+++.+||++|.+..+|.....-.
T Consensus 326 -----------~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 326 -----------ELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred -----------HHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 11222222222222222 2334667899999999999999999998766443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=344.55 Aligned_cols=244 Identities=21% Similarity=0.239 Sum_probs=196.8
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNG 842 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 842 (1079)
+.||+|+||.||+|+.+ +++.||+|++.+...........+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 78899999986543333345567889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccc
Q 001426 843 SLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922 (1079)
Q Consensus 843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 922 (1079)
+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence 9999997654 489999999999999999999999 99999999999999999999999999987533221 22334
Q ss_pred cccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCc
Q 001426 923 VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGT 1002 (1079)
Q Consensus 923 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1079)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ .. ...+ ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~~~---~~-~~~~------------p~ 216 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELIL---ME-EIRF------------PR 216 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHHHHH---cC-CCCC------------CC
Confidence 5799999999999998999999999999999999999999975321 11111100 00 0000 00
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001426 1003 QIQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 1003 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 1033 (1079)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 --TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1123567899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=340.07 Aligned_cols=247 Identities=25% Similarity=0.292 Sum_probs=200.1
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|... +++.||+|.+...........+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5788899999999999999775 688999999854332233345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 82 YVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 999999999997655 488999999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+ ......+.
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~i----~~~~~~~~-------- 218 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEKI----LAGKLEFP-------- 218 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH----HhCCcCCC--------
Confidence 12346899999999999888999999999999999999999999754221 111100 00000000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPT-----MKDVTAM 1034 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 1034 (1079)
. .....+.+++.+|++.||.+||+ ++|+++.
T Consensus 219 --~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 --R----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --c----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 01235678999999999999995 7777753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=303.45 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=209.4
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
.++|+..+.||+|-||.||.|+.+ ++-.||+|++.+..-.......++.+|+++-..++||||.++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356889999999999999999664 6788999999776544445568899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 836 FDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
+||...|.+...+.+. ...+++...+.++.|+|.|+.|+|.. +++||||||+|+|++.++..||+|||-+..-+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 9999999999999854 44588999999999999999999999 99999999999999999999999999987533
Q ss_pred cccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
.......+||..|.|||...+..++..+|+|++|++.||++.|.+||+... .+..+.+..+. +...+
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~----------~~~~p 242 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV----------DLKFP 242 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc----------cccCC
Confidence 234556789999999999999999999999999999999999999998653 22222221111 11111
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
. .-.....+++.+|+..+|.+|.+..|+++.
T Consensus 243 -------~--~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 -------S--TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------c--ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 112256689999999999999999999863
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.89 Aligned_cols=247 Identities=21% Similarity=0.249 Sum_probs=200.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|+..+.||+|+||.||+|+.+ +++.||+|.+.+.........+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999875 68899999986433223334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999999997655 478889999999999999999999 99999999999999999999999999998664322
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....+. .... ........+...
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~----~i~~~~~~~p~~----- 237 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIYE----KILAGRLKFPNW----- 237 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHHH----HHhcCCcCCCCC-----
Confidence 2346899999999999989999999999999999999999999753211 1110 001100000000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPT-----MKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 1033 (1079)
....+.+++.+||+.||++||+ ++++++
T Consensus 238 ---------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 238 ---------FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1124568999999999999997 677764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=326.34 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=202.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||.||+|+++++..+|+|.+... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG----AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC----CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 347778899999999999999988889999987422 1234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++......+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+|++|||.++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY- 155 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence 9999999999986555689999999999999999999999 999999999999999999999999999986543321
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......++..|+|||+..+..++.++||||||+++|||++ |+.||..... ......+. .. .. ...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~---~~-~~----~~~~~- 224 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMIS---RG-FR----LYRPK- 224 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH---CC-CC----CCCCC-
Confidence 12223345678999999988889999999999999999999 8999865321 11111110 00 00 00000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
.....+.+++.+||+++|++||+++++++.|
T Consensus 225 --------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 --------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0123678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=345.52 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=205.5
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeCC------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcC
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIPS------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNG 829 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 829 (1079)
.++|.+.+.||+|+||.||+|.... +..||||++.+. ......+.+.+|++++++++ ||||++++++|.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 3578889999999999999997532 346999988543 22344578999999999996 99999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhccC---------------------------------------------------------
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKK--------------------------------------------------------- 852 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 852 (1079)
...++||||+++|+|.+++++..
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999999986431
Q ss_pred --------------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEE
Q 001426 853 --------------------------------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV 894 (1079)
Q Consensus 853 --------------------------------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll 894 (1079)
..+++..+..++.|+++|++|||+. +|+||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 2367888899999999999999998 99999999999999
Q ss_pred CCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchH
Q 001426 895 GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHI 973 (1079)
Q Consensus 895 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~ 973 (1079)
++++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |..||........ +
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~ 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-F 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-H
Confidence 9999999999999987654332222333457789999999988889999999999999999997 9999875432211 1
Q ss_pred HHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccc
Q 001426 974 ITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 1040 (1079)
...+. .. . ... ........+.+++.+||+.+|++|||+.++.++|+++..
T Consensus 350 ~~~~~----~~---~--------~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YNKIK----SG---Y--------RMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHh----cC---C--------CCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11110 00 0 000 000112367789999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=368.06 Aligned_cols=493 Identities=28% Similarity=0.351 Sum_probs=397.5
Q ss_pred ccccccCCcccEEEcCCCcccccCC-ccccccCCCCEEeccCCcccCCCCcccCCcCcccEEeccCCcccccCccccccc
Q 001426 82 PYQLLSFSHLTSLVLSNANLTGEIP-PAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNC 160 (1079)
Q Consensus 82 ~~~~~~l~~l~~L~L~~~~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 160 (1079)
|..+..-.+++.|+++.|-+- ..| +.+...-+|+.||+|+|.+. ..|..+..+..|+.|+++.|.|. .+|.+.+++
T Consensus 14 p~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~ 90 (1081)
T KOG0618|consen 14 PEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNM 90 (1081)
T ss_pred chhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhh
Confidence 444444456899999998776 334 34455556999999999998 89999999999999999999998 889999999
Q ss_pred cccceEecccccccCCCChhhchhhhHHHHHhCCCCCcccCCCcccccccceeEeecccCCCccCCCccccccccccccc
Q 001426 161 SKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLS 240 (1079)
Q Consensus 161 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~ 240 (1079)
.+|++|.|..|++. ..|.++..+++|+.|+++.|. .+.+|..+..+..+..+..++|.-. ..++... .+.++
T Consensus 91 ~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~--f~~~Pl~i~~lt~~~~~~~s~N~~~----~~lg~~~-ik~~~ 162 (1081)
T KOG0618|consen 91 RNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNH--FGPIPLVIEVLTAEEELAASNNEKI----QRLGQTS-IKKLD 162 (1081)
T ss_pred hcchhheeccchhh-cCchhHHhhhcccccccchhc--cCCCchhHHhhhHHHHHhhhcchhh----hhhcccc-chhhh
Confidence 99999999999998 899999999999999999997 7789999999999999999999222 1233333 89999
Q ss_pred cccccccccCCcccccccccceecccccccccCCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccC
Q 001426 241 VYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGG 320 (1079)
Q Consensus 241 l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 320 (1079)
+..|.+.+.++.++.+++. .|+|.+|.+. --.+..+.+|+.|....|++.... -..++|+.|+.++|.++.
T Consensus 163 l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~ 233 (1081)
T KOG0618|consen 163 LRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTT 233 (1081)
T ss_pred hhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCccee
Confidence 9999999999998888887 8999999986 235778899999999999998432 234789999999999984
Q ss_pred ccccccccccccceeecccccccccccccccccccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCccccc
Q 001426 321 EVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYC 400 (1079)
Q Consensus 321 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~ 400 (1079)
..+. ..-.+|+++++++|++++ .|++++.+.+|+.++..+|+++ .+|..+....
T Consensus 234 ~~~~--p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~---------------------- 287 (1081)
T KOG0618|consen 234 LDVH--PVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRIT---------------------- 287 (1081)
T ss_pred eccc--cccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhh----------------------
Confidence 3332 223579999999999995 6699999999999999999995 5666555444
Q ss_pred ccCcEEeccCCCCCCCccccccccccccccccccccccccCCCcc-cCCC-CceEEEecCCCccccCccccccccccCee
Q 001426 401 VKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCT-GLIRLRLGSNNFSGHIPSRIGLLHRLTFL 478 (1079)
Q Consensus 401 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 478 (1079)
+|+.|++.+|.+. .+|....+++.|+.|+|..|+|. ..|+.+ .-+. .|..|+.+.|++....-..=..+..|+.|
T Consensus 288 -~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~L 364 (1081)
T KOG0618|consen 288 -SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQEL 364 (1081)
T ss_pred -hHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHH
Confidence 5666777777777 67888889999999999999998 555543 3333 37888889999985442223456789999
Q ss_pred eeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEeccccccc
Q 001426 479 ELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNIT 558 (1079)
Q Consensus 479 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 558 (1079)
++.+|.+++..-+.+.+..+|+.|+|++|+|.......+.++..|+.|+||+|+++ .+|.++..+..|++|...+|+|.
T Consensus 365 ylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~ 443 (1081)
T KOG0618|consen 365 YLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL 443 (1081)
T ss_pred HHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence 99999999888888999999999999999999777778899999999999999999 77899999999999999999999
Q ss_pred CCCCCccccccccccccccCccccCCChhhhhcccchhhhhcccCCcccccccccccCCCcccEEeccCccc-ccccccc
Q 001426 559 GLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNML-TGSLKVL 637 (1079)
Q Consensus 559 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l-~~~~~~~ 637 (1079)
. .| .+..++.|+.+|+|.|.|+.. .+|.... .++|++|||++|.- .-....+
T Consensus 444 ~-fP-e~~~l~qL~~lDlS~N~L~~~------------------------~l~~~~p-~p~LkyLdlSGN~~l~~d~~~l 496 (1081)
T KOG0618|consen 444 S-FP-ELAQLPQLKVLDLSCNNLSEV------------------------TLPEALP-SPNLKYLDLSGNTRLVFDHKTL 496 (1081)
T ss_pred e-ch-hhhhcCcceEEecccchhhhh------------------------hhhhhCC-CcccceeeccCCcccccchhhh
Confidence 4 45 889999999999999999721 1122111 17788888888863 3233335
Q ss_pred CcccccceeeccCC
Q 001426 638 GSLDNLVSLNVSYN 651 (1079)
Q Consensus 638 ~~l~~L~~L~ls~N 651 (1079)
..+.++...++.-|
T Consensus 497 ~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 497 KVLKSLSQMDITLN 510 (1081)
T ss_pred HHhhhhhheecccC
Confidence 55556666666555
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=340.56 Aligned_cols=243 Identities=25% Similarity=0.277 Sum_probs=193.6
Q ss_pred eeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCCh
Q 001426 766 VGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 844 (1079)
||+|+||.||+|+.. +++.||+|++.+...........+.+|+.++++++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999775 5788999998644333344567788999999999999999999999999999999999999999
Q ss_pred hhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccccc
Q 001426 845 AGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA 924 (1079)
Q Consensus 845 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 924 (1079)
.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 99997654 489999999999999999999999 99999999999999999999999999998543222 2233457
Q ss_pred cCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccH
Q 001426 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQI 1004 (1079)
Q Consensus 925 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1079)
||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... ...+. .
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~-~~~~~------------~-- 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQE-PLRFP------------D-- 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcC-CCCCC------------C--
Confidence 89999999999998999999999999999999999999975321 1111111110 00000 0
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 1005 QEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 1005 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.....+.+++.+||+.||++||++.++.+.
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 112256688999999999999865444333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=331.79 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=205.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCC------CeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSR------QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
.+|+..+.||+|+||.||+|..... ..||+|.+... ........|.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 4678889999999999999976432 57899987432 223345679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccC---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC
Q 001426 832 RLLLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP 896 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~ 896 (1079)
.+++|||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 999999999999999996531 3478889999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHH
Q 001426 897 QFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIIT 975 (1079)
Q Consensus 897 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~ 975 (1079)
++.+||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |..||...... ....
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~ 237 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIE 237 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH
Confidence 99999999999986654433333344566889999999988899999999999999999998 99998764321 1111
Q ss_pred HHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 976 WVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.+. ... .. .........+.+++.+||+.||++||+++||++.|+.+
T Consensus 238 ~i~----~~~--~~-----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 MIR----SRQ--LL-----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHH----cCC--cC-----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 110 000 00 00011234678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=338.78 Aligned_cols=244 Identities=22% Similarity=0.245 Sum_probs=195.8
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNG 842 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 842 (1079)
+.||+|+||.||+++.. +++.||+|++.+...........+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 68999999986543333345567889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccc
Q 001426 843 SLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922 (1079)
Q Consensus 843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 922 (1079)
+|..++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence 9999887654 489999999999999999999999 99999999999999999999999999987533221 12234
Q ss_pred cccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCc
Q 001426 923 VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGT 1002 (1079)
Q Consensus 923 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1079)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ...... ..+ . .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~---~~~~~~-~~~----------p--~ 216 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFE---LILMEE-IRF----------P--R 216 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHHH---HHhcCC-CCC----------C--C
Confidence 56899999999999889999999999999999999999999753221 1100 000000 000 0 0
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001426 1003 QIQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 1003 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 1033 (1079)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 --TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1123566899999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.91 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=202.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCC----eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQ----VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
++|+..+.||+|+||+||+|.+. +++ .+++|.+.. .........+..|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc--ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 45778899999999999999874 344 366776632 1222344678888999999999999999999864 457
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
++++||+++|+|.+++......+++..+..++.||+.|++|||+. +++||||||+||++++++.+|++|||+++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 899999999999999987776789999999999999999999999 99999999999999999999999999998765
Q ss_pred CCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
............++..|+|||...+..++.++||||||+++||+++ |+.||.+..+. .....+. .. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~----~~----~~~ 230 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLE----KG----ERL 230 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH----CC----CcC
Confidence 4432223334557789999999988899999999999999999998 99998754321 1111110 00 000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccc
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 1040 (1079)
..+. . ....+..++.+||..+|++|||+.|+++.|..+.+
T Consensus 231 ~~~~-------~--~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 AQPQ-------I--CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC-------C--CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0000 0 11245678899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=338.12 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=204.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEc-C
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNN-G 829 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~ 829 (1079)
++|++.+.||+|+||.||+|... +++.||+|++... ......+.+..|+.+++++ +|+||++++++|.. +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG--ATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC--CCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 46888999999999999998542 3478999988532 1223456788899999999 89999999998864 4
Q ss_pred CeEEEEEEecCCCChhhhhhccC---------------------------------------------------------
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKK--------------------------------------------------------- 852 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 852 (1079)
...+++|||+++|+|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 56889999999999999985421
Q ss_pred ---cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccccccCccc
Q 001426 853 ---VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929 (1079)
Q Consensus 853 ---~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 929 (1079)
..+++..+..++.||+.|++|||+. +|+||||||+||++++++.+||+|||+++.+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 2578999999999999999999999 9999999999999999999999999999876544322333344567889
Q ss_pred ccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHH
Q 001426 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEML 1008 (1079)
Q Consensus 930 ~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1079)
+|||+..+..++.++|||||||++|||++ |..||......+ .+.... .... .... ......
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~----~~~~-----------~~~~--~~~~~~ 303 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRL----KEGT-----------RMRA--PEYATP 303 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHH----hccC-----------CCCC--CccCCH
Confidence 99999999999999999999999999998 999987533221 111111 1100 0000 001123
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 1009 QVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 1009 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
.+.+++.+||+.+|++||++.|+++.|+++..+
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 677899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=342.36 Aligned_cols=255 Identities=23% Similarity=0.279 Sum_probs=203.7
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|+.. +++.||+|++.+...........+..|+++++.++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788899999999999999876 588999999865433333455778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999997654 478999999999999999999999 999999999999999999999999999986543
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........ .........
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~---------~~~~~~~~~ 222 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKYW---------KETLQRPVY 222 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHhc---------cccccCCCC
Confidence 2234578999999999998899999999999999999999999997543211 01110000 000000000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
..........+.+++.+|+..+|++||+++++++.
T Consensus 223 --~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 --DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00001123366789999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.86 Aligned_cols=287 Identities=21% Similarity=0.277 Sum_probs=214.8
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc-----CC
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN-----GR 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 830 (1079)
..+|...+.||+|+||.|+++.. .+|+.||+|++...- ......+.-.+|+..++.++|+||+.+++.+.. -.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566678999999999999965 478999999985322 233456788899999999999999999999865 34
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
..|+|+|+|+ .+|.+.++.... ++.+.+..+++|+++|++|+|+. +++|||+||+|++++.+...||+|||+|+.
T Consensus 100 DvYiV~elMe-tDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceee
Confidence 6799999994 488888876544 89999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCcccccccccccCcccccccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchh
Q 001426 911 FESSESSRASNSVAGSYGYIAPEYGY-SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 911 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
.........++..+.|..|.|||.+. ...|+.+.||||.|||+.||++|++-|.+... .+....+-........+..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQLILELLGTPSEEDL 252 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHHHHHhcCCCCHHHH
Confidence 76543344556778899999999865 45799999999999999999999999976432 1111111111111000000
Q ss_pred hhhh--------hhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhccccCCCCCCCccc
Q 001426 990 TILD--------RQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRHENDDLEKPNSL 1051 (1079)
Q Consensus 990 ~~~~--------~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~~~~~~~~~ 1051 (1079)
..+. ..+...+.... ......++++.+|+..||.+|+|++|+++ .++.+....+++..+..+
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~ 329 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIF 329 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCC
Confidence 0000 00001111111 11246779999999999999999999998 678887777776554443
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=338.32 Aligned_cols=245 Identities=22% Similarity=0.236 Sum_probs=197.1
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNG 842 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 842 (1079)
++||+|+||.||+++.. +++.||+|++.+...........+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 68899999986543334445678889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccc
Q 001426 843 SLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922 (1079)
Q Consensus 843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 922 (1079)
+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 9999987654 489999999999999999999999 99999999999999999999999999987543221 22234
Q ss_pred cccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCc
Q 001426 923 VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGT 1002 (1079)
Q Consensus 923 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1079)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......... ...+ ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~-~~~~------------p~ 216 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILME-DIKF------------PR 216 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccC-CccC------------CC
Confidence 57999999999999889999999999999999999999999753211 111100000 0000 00
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 001426 1003 QIQEMLQVLGVALLCVNPCPEERP-----TMKDVTAM 1034 (1079)
Q Consensus 1003 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 1034 (1079)
.....+.+++.+|++.||++|| ++.|+++.
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 --TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0122566899999999999997 89998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.94 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=210.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe-EEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT-RLLL 835 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 835 (1079)
++|...+.+|+|+||.++.++.+ +++.+++|++.-.. ....++.....|+.++++++|||||.+.+.|.+++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~-~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEK-LTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccc-cCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 56888999999999999998654 67789999986444 334556688899999999999999999999998888 8999
Q ss_pred EEecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 836 FDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
|+||+||++.+.+.+++ ..++++.+..++.|++.|+.|||++ +|+|||||+.||+++.++.|||+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998764 7899999999999999999999988 9999999999999999999999999999988765
Q ss_pred cccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
. .......||+.||.||...+.+|..|+||||+||++|||++-+++|.... +...+....+.. ..+
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----m~~Li~ki~~~~-------~~P 225 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----MSELILKINRGL-------YSP 225 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----hHHHHHHHhhcc-------CCC
Confidence 4 24456789999999999999999999999999999999999999997642 222222211111 011
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
........+..++..|++.+|+.||++.+++..
T Consensus 226 -------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 -------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 011122356678899999999999999999986
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.10 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=206.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC----CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
++|+..+.||+|+||+||+|.++. ...||+|.+... ........|.+|+.++++++||||+++++++......+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC--CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 458888999999999999998742 457899987432 23344578899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+||||+++++|.+++......+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||+++....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999999987666789999999999999999999998 999999999999999999999999999987753
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
...........++..|+|||...+..++.++||||||+++|||++ |..||...... ...... .....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~----~~~~~------ 226 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAV----EDGYR------ 226 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHH----HcCCC------
Confidence 222222223345678999999988899999999999999999998 99998653211 111111 00000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
..........+.+++.+||+.+|++||+++|+++.|+++
T Consensus 227 -------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 -------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000011223577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=334.11 Aligned_cols=268 Identities=18% Similarity=0.235 Sum_probs=200.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||+||+|+.. +++.||+|++..... ......+.+|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 56888999999999999999876 688999999854321 223356778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||++ +++.+++.+....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 9995 688888877666689999999999999999999999 99999999999999999999999999987543221
Q ss_pred cccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhH---Hhhhhhchhh--
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE---LRERKREFTT-- 990 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-- 990 (1079)
.......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....+....+....... ....++....
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 22234568899999998765 4578899999999999999999999986432211111111100 0000000000
Q ss_pred hhhh-hhhcccCccHH-------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 991 ILDR-QLLMRSGTQIQ-------EMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 991 ~~~~-~~~~~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
...+ ........... ....+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00000000110 1135668999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=302.74 Aligned_cols=265 Identities=25% Similarity=0.377 Sum_probs=208.9
Q ss_pred HHHHhhCCCCCCeeeecCcEEEEEEE-eCCCCeEEEEEeccccCCCc-----hhHHHHHHHHHHHhcC-CCCceeeeeeE
Q 001426 753 VDDVVTRLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGEL-----PERDQFSAEVQTLGSI-RHKNIVRLLGC 825 (1079)
Q Consensus 753 ~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~ 825 (1079)
-++....|...+++|+|..++|.++. .++++.+|+|++........ .-.+.-.+|+.+++++ .||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 34566789999999999999999874 45788899998854322211 1125567899999998 69999999999
Q ss_pred EEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeec
Q 001426 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADF 905 (1079)
Q Consensus 826 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 905 (1079)
|..+...++|+|.|+.|.|.+|+.+.- .+++++..+|++|+.+|++|||.. +|||||+||+|||++++.++||+||
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 999999999999999999999997654 488999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCcccccccccccCcccccccccC------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHH-HHHH
Q 001426 906 GLAKLFESSESSRASNSVAGSYGYIAPEYGY------SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHII-TWVN 978 (1079)
Q Consensus 906 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~-~~~~ 978 (1079)
|+|+.+..+. .....+|||+|+|||.+. ...|+...|+||.|||+|.++.|++||+... ..-+. ..+.
T Consensus 168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlMLR~Ime 242 (411)
T KOG0599|consen 168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLMLRMIME 242 (411)
T ss_pred ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHHHHHHh
Confidence 9999888765 344578999999999743 3458889999999999999999999997421 11111 1111
Q ss_pred hHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhcccc
Q 001426 979 GELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRHE 1041 (1079)
Q Consensus 979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~ 1041 (1079)
|+.+-..++. .+......+++.+|++.||++|.|++|+++ .+.++..+
T Consensus 243 GkyqF~speW---------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 243 GKYQFRSPEW---------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred cccccCCcch---------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 1111111111 122345678999999999999999999987 45555444
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.25 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=206.6
Q ss_pred hCCCCCCeeeecCcEEEEEEE-eCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC-----Ce
Q 001426 758 TRLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG-----RT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 831 (1079)
+||++.+.+|+|+|+.||.++ ..+++.+|+|++.-. ..++.+..++|++..++++|||+++++++...+ .+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 579999999999999999996 567889999988432 235678889999999999999999999987543 34
Q ss_pred EEEEEEecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccc
Q 001426 832 RLLLFDYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla 908 (1079)
.|++++|+..|+|.+.++. ++..+++.++..|+.+|++||++||+... +++||||||.||++.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999875 36679999999999999999999999833 5999999999999999999999999999
Q ss_pred ccccCCccc-------ccccccccCcccccccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHH
Q 001426 909 KLFESSESS-------RASNSVAGSYGYIAPEYGY---SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN 978 (1079)
Q Consensus 909 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 978 (1079)
+...-.-.. ........|..|.|||.+. +...++++||||+||++|+||.|..||+.....+..+.-
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL--- 253 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL--- 253 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE---
Confidence 765322111 1112234688999999754 456789999999999999999999999864333322111
Q ss_pred hHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 979 GELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.+....+....... -...+.+++.+|++.||.+||++.+++..++++
T Consensus 254 -----------Av~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 -----------AVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----------eeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11122222222222 234778899999999999999999999999876
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.06 Aligned_cols=261 Identities=20% Similarity=0.349 Sum_probs=209.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|+..+.||+|+||.||+|+.. +++.||+|.+.............+.+|+++++.++||||+++++++.+....++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999764 78899999876443344445577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 837 DYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 837 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
||+++|+|.+++.. ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 234578899999999999999999999 999999999999999999999999999987654
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
... ......+++.|+|||...+..++.++||||+|+++|||++|+.||.............+. . ....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~----~--~~~~---- 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE----Q--CDYP---- 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh----c--CCCC----
Confidence 321 122346888999999998888999999999999999999999998654322111111110 0 0000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
..........+.+++.+||+.+|++||++++|++.+++++
T Consensus 227 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 ------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0000112246778999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=341.01 Aligned_cols=249 Identities=20% Similarity=0.233 Sum_probs=200.5
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeCC--CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIPS--RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 834 (1079)
.++|+..+.||+|+||.||+|..+. +..||+|++...........+.+.+|+++++.++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568888999999999999997543 36899998864433333445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999997655 488999999999999999999999 9999999999999999999999999999865432
Q ss_pred cccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||....+. ...... ......+
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i-----~~~~~~~------ 247 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKI-----LEGIIYF------ 247 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHH-----hcCCCCC------
Confidence 22356899999999998888999999999999999999999999754221 001111 1100000
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTAM 1034 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 1034 (1079)
+... ...+.+++.+|++.||++|+ +++++++.
T Consensus 248 ------p~~~--~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 ------PKFL--DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCC--CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0001 12456899999999999995 88888763
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.77 Aligned_cols=269 Identities=24% Similarity=0.322 Sum_probs=203.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-----e
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR-----T 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 831 (1079)
-.|+..+++|.|+||.||+|... .++.||||++.+.+... .+|+++|+.++|||||+++.+|.... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 35777899999999999999765 46899999997654432 36999999999999999999885432 2
Q ss_pred EEEEEEecCCCChhhhhhcc---CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC-CcEEEeeccc
Q 001426 832 RLLLFDYISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ-FEAFLADFGL 907 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGl 907 (1079)
..+||||++. +|.++++.. +..++...+.-+..||++|++|||+. +|+||||||+|+|+|.+ |.+||||||.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence 3699999987 999999743 55688888999999999999999998 99999999999999986 8999999999
Q ss_pred cccccCCcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHH-----
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL----- 981 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----- 981 (1079)
|+.+..+... ....-|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+.. ...++...++--.
T Consensus 173 AK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 173 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred ceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHH
Confidence 9988766533 334568899999998876 68999999999999999999999998743 2233333332111
Q ss_pred --hhhhhchhhhhhhhhhcccC---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhcccc
Q 001426 982 --RERKREFTTILDRQLLMRSG---TQIQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRHE 1041 (1079)
Q Consensus 982 --~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~ 1041 (1079)
..-.+...+...+.+..... .......+.++++.+++..+|.+|.++.|+++ .+++++..
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11111111111111111111 01123457789999999999999999999986 56666655
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.64 Aligned_cols=267 Identities=19% Similarity=0.240 Sum_probs=200.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||+||+|+.+ +++.||+|.+.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 46888899999999999999765 68899999885332 2223456789999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++ +|.+++...+..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 99975 99999987766689999999999999999999999 99999999999999999999999999997654322
Q ss_pred cccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHh---HHhhhhhchh---
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG---ELRERKREFT--- 989 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~--- 989 (1079)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....... .+...... ...+.++.+.
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccch
Confidence 12234567899999998765 568999999999999999999999997543211 11111110 0011111110
Q ss_pred ---hhhhhhhhcccC--ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 990 ---TILDRQLLMRSG--TQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 990 ---~~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
....+....... ..........+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 00011235678999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.18 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=205.5
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++++.++...+++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 568888999999999999999888889999987431 2245789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++|+|.+++.+. +..+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999754 45588999999999999999999998 999999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......++..|+|||+.....++.++||||||+++|||++ |+.||...... .....+... . ..
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~-------~----~~- 223 (261)
T cd05072 159 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRG-------Y----RM- 223 (261)
T ss_pred -eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcC-------C----CC-
Confidence 12223346778999999988889999999999999999998 99998653211 111111100 0 00
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.... .....+.+++.+||+.+|++||+++++.+.|+++
T Consensus 224 ---~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 ---PRME--NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCC--CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0000 1123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.76 Aligned_cols=266 Identities=19% Similarity=0.267 Sum_probs=201.0
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|++.+.||+|+||+||+|+.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 6888899999999999999876 678899999864322 22345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|++++.+..+. .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 155 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N 155 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence 99987766554 3344589999999999999999999999 99999999999999999999999999998764432 1
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHh--HHh-hhh------hch
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG--ELR-ERK------REF 988 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~~~-~~~------~~~ 988 (1079)
.......|++.|+|||+..+..++.++||||+||++|||++|+.||....... ........ ... +.. +..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccchh
Confidence 22234568999999999988889999999999999999999999997643211 11111100 000 000 000
Q ss_pred hhhhhhhhhcccCccH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 989 TTILDRQLLMRSGTQI------QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 989 ~~~~~~~~~~~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.....+.. ...... .....+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAV--NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcc--cCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 000000 11235889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.70 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=197.2
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNG 842 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 842 (1079)
+.||+|+||.||+|... +++.+|+|.+... ........+.+|++++++++||||++++++|......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999774 7888999987422 22334578999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccc
Q 001426 843 SLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922 (1079)
Q Consensus 843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 922 (1079)
+|.+++...+..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++..............
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99999987666689999999999999999999999 999999999999999999999999999876543221111112
Q ss_pred cccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 923 VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 923 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...+..|+|||.+.+..++.++||||+|+++|||++ |..||....+. ...... .. ... ..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~----~~-----------~~~--~~ 216 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAI----EQ-----------GVR--LP 216 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHH----Hc-----------CCC--CC
Confidence 233567999999988889999999999999999998 88888643211 000000 00 000 00
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
........+.+++.+||+.+|++|||+.++.++|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 00011236778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=334.42 Aligned_cols=200 Identities=29% Similarity=0.409 Sum_probs=175.0
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+++.. ++..+|+|.+... ......+.+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 57888999999999999999776 6788899987532 12234578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++.... .+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 83 EHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999999997654 4889999999999999999999862 6999999999999999999999999999865432
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 223456899999999999889999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=331.81 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=190.6
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhc-CCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGS-IRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||.||+|+.. +++.||+|.+.+.........+.+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999775 578899999865433233344556667777765 4899999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999997654 489999999999999999999999 99999999999999999999999999998543322 2233
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..+.. . .......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~~---~-i~~~~~~~~------------ 216 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELFD---S-ILNDRPHFP------------ 216 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHHH---H-HHcCCCCCC------------
Confidence 45789999999999988999999999999999999999999975421 11111 0 000000000
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTMK-DVT 1032 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl 1032 (1079)
. .....+.+++.+||+.||++||+++ ++.
T Consensus 217 ~--~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 R--WISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred C--CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 0122456889999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=316.30 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=207.0
Q ss_pred CCCCCeeeecCcEEEEEEE-eCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|.+++++|+|+||.||++. ..+|+++|+|++. ...+..++..|+.+|++++.|++|++||.|.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP-----V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP-----VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecC-----ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 5567789999999999994 4589999999883 234567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
|..|+..+.++.+.+.+++.++..+++..+.||+|||.. +-+|||||+.|||++.+|.+|++|||+|..+.+. ..
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA 184 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence 999999999999988999999999999999999999998 7899999999999999999999999999877654 33
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhc
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
....+.|||.|||||++..-.|+.++||||+|+...||..|++||.+..|--+.+. .....++.+.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-----IPT~PPPTF~--------- 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-----IPTKPPPTFK--------- 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-----ccCCCCCCCC---------
Confidence 45567899999999999999999999999999999999999999987654211100 0001111111
Q ss_pred ccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 999 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.++ .=...+-++++.|+-..|++|.|+.++++
T Consensus 251 -KPE--~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 -KPE--EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -ChH--hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 111 11336678999999999999999998876
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=343.11 Aligned_cols=256 Identities=24% Similarity=0.301 Sum_probs=196.6
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
.|+..+.||+|+||+||+|+.. +++.||+|++.+...........+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4677889999999999999664 678999999865333333445778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++.+.+. +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999976554 78888999999999999999999 9999999999999999999999999998643211000
Q ss_pred ---------------------------------------------ccccccccCcccccccccCCCCCCccchHHHHHHH
Q 001426 918 ---------------------------------------------RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVV 952 (1079)
Q Consensus 918 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvi 952 (1079)
.......||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123469999999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHh--ccCCCCCCCCCHHH
Q 001426 953 LLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALL--CVNPCPEERPTMKD 1030 (1079)
Q Consensus 953 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~e 1030 (1079)
+|||++|+.||....+.... ...... . . ....... ......+.+++.+ |+.++|..||+++|
T Consensus 238 l~elltG~~Pf~~~~~~~~~-~~i~~~---~--~--------~~~~~~~--~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQ-LKVINW---E--N--------TLHIPPQ--VKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHH-HHHHcc---c--c--------ccCCCCC--CCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999999764321111 110000 0 0 0000000 0011244456655 66777778999999
Q ss_pred HHHH
Q 001426 1031 VTAM 1034 (1079)
Q Consensus 1031 vl~~ 1034 (1079)
+++.
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.33 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=202.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||+||+|++.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 3577788999999999999998887789999874321 234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+.+|+|.+++......+++..++.++.||+.|++|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY- 155 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence 9999999999987655789999999999999999999999 999999999999999999999999999986644321
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......++..|+|||...+..++.++||||||+++|||++ |+.||...... ....... .....
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~---~~~~~---------- 220 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVS---QGLRL---------- 220 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHh---cCCCC----------
Confidence 12223345678999999988889999999999999999998 99998653221 1111100 00000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
.... .....+.+++.+||+++|++|||+.++++.++
T Consensus 221 --~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPH--LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCC--CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0000 11236778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=325.59 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=206.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
.+|...+.||+|+||+||++... ++..+|+|.+.. ......+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC---cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35778889999999999999742 345688887742 223445789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccC------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCc
Q 001426 832 RLLLFDYISNGSLAGLLHEKK------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFE 899 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 899 (1079)
.++||||+++++|.+++...+ ..+++..++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999999997443 2489999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHH
Q 001426 900 AFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVN 978 (1079)
Q Consensus 900 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 978 (1079)
+|++|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||....... .......
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~~ 237 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQ 237 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc
Confidence 99999999986654332223334456788999999988889999999999999999998 888886542211 0111100
Q ss_pred hHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccC
Q 001426 979 GELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 1042 (1079)
..... ... .....+.+++.+||+.+|.+|||+.++.+.|+++.+..
T Consensus 238 ----~~~~~------------~~~--~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 238 ----GRVLQ------------RPR--TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred ----CCcCC------------CCC--CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 00000 000 11235788999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=326.01 Aligned_cols=271 Identities=25% Similarity=0.363 Sum_probs=203.4
Q ss_pred hCC-CCCCeeeecCcEEEEEEEe-----CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--
Q 001426 758 TRL-SDTNIVGKGVSGIVYRVEI-----PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG-- 829 (1079)
Q Consensus 758 ~~~-~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 829 (1079)
++| +..+.||+|+||+||++.+ .+++.||+|.+.... .......+.+|++++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 344 7889999999999988643 357789999885321 223456788999999999999999999998653
Q ss_pred CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccc
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~ 909 (1079)
...++||||+++|+|.+++... .+++..++.++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 4579999999999999999754 389999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCcccc-cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhch
Q 001426 910 LFESSESSR-ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREF 988 (1079)
Q Consensus 910 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1079)
......... ......++..|+|||...+..++.++||||||+++|||++|+.|+...............+... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT--VVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc--hhhh
Confidence 765433211 1222345667999999988889999999999999999999999986543221111111110000 0001
Q ss_pred hhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 989 TTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
.+..+...... ........+.+++..||+++|++|||++++++.|+++.
T Consensus 234 ~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111111100 01112347888999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=343.93 Aligned_cols=260 Identities=25% Similarity=0.324 Sum_probs=206.4
Q ss_pred CCCCCCeeeecCcEEEEEEEeCCC-CeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEE-Ec------C
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPSR-QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCC-NN------G 829 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~------~ 829 (1079)
++++.++|.+|+|+.||.|....+ ..||+|++... ++...+.+.+|+++|+.|+ |+|||.+++.. .. .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 466778999999999999988766 99999998532 4456688999999999997 99999999932 11 2
Q ss_pred CeEEEEEEecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccc
Q 001426 830 RTRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla 908 (1079)
.+.++.||||.||.|.+++.++ ...+++.++++|++|+++|+++||... ++|||||||-+|||++.++..||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 4578999999999999999865 334999999999999999999999873 47999999999999999999999999999
Q ss_pred ccccCCcc-ccc------ccccccCccccccccc---CCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHH
Q 001426 909 KLFESSES-SRA------SNSVAGSYGYIAPEYG---YSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN 978 (1079)
Q Consensus 909 ~~~~~~~~-~~~------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 978 (1079)
.-...... ... .-....|+.|.|||++ .+.++++|+||||+||++|-|+..+.||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 74432221 111 1123579999999974 466899999999999999999999999986422
Q ss_pred hHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccCCC
Q 001426 979 GELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDD 1044 (1079)
Q Consensus 979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1044 (1079)
..+++..+..+.. ......+.+||..|+++||++||++.||+..+..+.....-
T Consensus 264 ----------laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 ----------LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ----------eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 1122222222221 13344777899999999999999999999999988765433
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=321.39 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=204.6
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4578889999999999999998888889999885322 235678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++++|.+++.... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999997653 5689999999999999999999999 999999999999999999999999999987653321
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
........+..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+. .... .
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~----~~~~---~----- 223 (261)
T cd05068 159 -EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVD----QGYR---M----- 223 (261)
T ss_pred -cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH----cCCC---C-----
Confidence 11122233468999999988899999999999999999999 99998653211 1111110 0000 0
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.........+.+++.+||+.+|++||++.++++.|+++
T Consensus 224 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 -----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00001223677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=333.94 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=205.7
Q ss_pred CCCCCCeeeecCcEEEEEEEeC--CCC--eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP--SRQ--VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 834 (1079)
+++..+.||+|+||.|++|.|. +|+ .||||.+...... ....+|.+|+.+|.+++|+|++++||++.+ ....+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3455678999999999999885 344 5899998654433 267899999999999999999999999998 78899
Q ss_pred EEEecCCCChhhhhhc-cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 835 LFDYISNGSLAGLLHE-KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
|+|.++.|+|.+.+++ ....+-......++.|||.||.||.++ ++||||+.++|+++-....|||+|||+++-+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999988 455678888899999999999999999 999999999999999999999999999998876
Q ss_pred Ccccccc-cccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 914 SESSRAS-NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 914 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.+..+.+ ....-.+.|+|||.+....++.++|||+|||++|||++ |..||-+.. +..+.+ .
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--g~qIL~---------------~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--GIQILK---------------N 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--HHHHHH---------------h
Confidence 6544433 33455779999999999999999999999999999999 888987642 122222 1
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
+|..-+..... .+..+++++++.||..+|++||||..+.+.+
T Consensus 328 iD~~erLpRPk--~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 328 IDAGERLPRPK--YCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccccCCCCC--CChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22111111111 2445889999999999999999999998554
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=332.95 Aligned_cols=245 Identities=20% Similarity=0.298 Sum_probs=192.1
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||.||+|+.. +++.||+|++.+.........+.+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 6789999998654433444556788899988776 899999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|..++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence 99999887654 489999999999999999999999 99999999999999999999999999987533221 1223
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC---cchHHHHHHhHHhhhhhchhhhhhhhhhc
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPD---GAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.......... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CC
Confidence 457899999999999999999999999999999999999999642211 11111111111111000 00
Q ss_pred ccCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 001426 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTM 1028 (1079)
Q Consensus 999 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 1028 (1079)
.. .....+.+++.+||+.||++|||+
T Consensus 225 p~----~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 PR----SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CC----CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 00 112356689999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=326.23 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=203.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
++|...+.||+|+||.||+|...+ ++.||+|.+... ......+.+.+|+++++.++|+||+++++++..+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 457788899999999999997643 478999988532 222245789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccC-------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC
Q 001426 832 RLLLFDYISNGSLAGLLHEKK-------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF 898 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~ 898 (1079)
.++||||+++|+|.+++...+ ..+++..+..++.|++.|++|||+. +++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 999999999999999997542 3478889999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHH
Q 001426 899 EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWV 977 (1079)
Q Consensus 899 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~ 977 (1079)
.+|++|||+++.+.............+++.|+|||++.+..++.++||||+|+++|||++ |..||...... ......
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH
Confidence 999999999986544332222334456789999999999999999999999999999998 99998654221 111111
Q ss_pred HhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 978 NGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
. ..... .... .....+.+++.+||+.||++|||++||++.|++
T Consensus 238 ~---~~~~~------------~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 T---QGRLL------------QRPR--TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H---cCCcC------------CCCC--CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0 00000 0000 112367789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.87 Aligned_cols=274 Identities=20% Similarity=0.263 Sum_probs=209.5
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCc-eeeeeeEEEcCC----
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN-IVRLLGCCNNGR---- 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~---- 830 (1079)
...|...++||+|+||+||+|+. .+|+.||+|++...... +..-..-.+|+.++++++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34566778899999999999965 47889999999754332 222345678999999999999 999999998877
Q ss_pred --eEEEEEEecCCCChhhhhhccC---cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeec
Q 001426 831 --TRLLLFDYISNGSLAGLLHEKK---VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADF 905 (1079)
Q Consensus 831 --~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 905 (1079)
..++|+||++. +|..|+.... ..++...+..+++||++|++|||++ +|+||||||+||+++++|.+||+||
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence 78999999976 9999998765 4578889999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHH---HHhHH
Q 001426 906 GLAKLFESSESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITW---VNGEL 981 (1079)
Q Consensus 906 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~---~~~~~ 981 (1079)
|+|+.+.-. ....+..++|..|.|||++.+. .|+...||||+|||++||++++.-|.+..+. .++... +....
T Consensus 165 GlAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 165 GLARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPN 241 (323)
T ss_pred chHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCC
Confidence 999965532 2335566789999999998876 6899999999999999999999888765331 111111 11111
Q ss_pred hhhhhchhhhhhhhhhcccC---ccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhc
Q 001426 982 RERKREFTTILDRQLLMRSG---TQIQ-----EMLQVLGVALLCVNPCPEERPTMKDVTAM--LKEI 1038 (1079)
Q Consensus 982 ~~~~~~~~~~~~~~~~~~~~---~~~~-----~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 1038 (1079)
.+.|+......+........ .... ......+++.+|++.+|.+|.|++.+++. +.++
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 23344443333332211111 1111 12367899999999999999999999986 5554
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=326.49 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=203.1
Q ss_pred CCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
+|+..+.||+|+||.||+|... ....+|+|.+... ........+.+|+.+++.++||||++++++|..+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC--CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 3677889999999999999653 2356888877432 2223457899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcc-----------------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 001426 833 LLLFDYISNGSLAGLLHEK-----------------------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKS 889 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~ 889 (1079)
++++||+.+|+|.+++... ...+++..++.++.|++.|++|||+. +|+||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 9999999999999998642 12478899999999999999999998 999999999
Q ss_pred CCeEECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCC
Q 001426 890 NNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIP 968 (1079)
Q Consensus 890 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~ 968 (1079)
+||++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||....+
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999986544332222233446778999999888889999999999999999998 9999865322
Q ss_pred CcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 969 DGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
. .+...... ....... ......+.+++.+||+++|++||+++++++.|+++...
T Consensus 236 ~--~~~~~~~~---------------~~~~~~~--~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 E--RLFNLLKT---------------GYRMERP--ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred H--HHHHHHhC---------------CCCCCCC--CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1 11111110 0000000 01123677899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=335.64 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=193.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|+..+.||+|+||+||+|+.. +++.||+|++... ........+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC--CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 45677789999999999999765 6899999998532 22334578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+.. ..++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+....
T Consensus 152 e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 152 EFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred ecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 999999987543 246777889999999999999999 99999999999999999999999999998664322
Q ss_pred cccccccccCcccccccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-----LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||...... ................
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~---- 295 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICMSQPPE---- 295 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhccCCCC----
Confidence 12234578999999998643 23456899999999999999999999732211 1111111100000000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
........+.+++.+||+.||++|||++|+++.
T Consensus 296 ----------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 ----------APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112357789999999999999999999974
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=332.44 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=195.7
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
++||+|+||.||+|+.. +++.||+|++.+.........+.+..|..+++.+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999765 6889999998654333334556788999999988 799999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.+++.+.+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 99999987654 489999999999999999999999 99999999999999999999999999987432211 1223
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC---cchHHHHHHhHHhhhhhchhhhhhhhhhc
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPD---GAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+.......... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------CC
Confidence 457899999999999989999999999999999999999999643211 11111111111111100 00
Q ss_pred ccCccHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 001426 999 RSGTQIQEMLQVLGVALLCVNPCPEERPT------MKDVTA 1033 (1079)
Q Consensus 999 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~ 1033 (1079)
.. .....+.+++.+|++.||++||| ++|+++
T Consensus 225 p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 PR----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 00 11235678999999999999997 567664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=325.05 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=202.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-----CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-----PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
.+|+..+.||+|+||.||+|.. .++..+|+|.+... ........+.+|++++++++||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4577788999999999999974 35678999988532 2233447889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcc----------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC
Q 001426 833 LLLFDYISNGSLAGLLHEK----------------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP 896 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~ 896 (1079)
++||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 9999999999999998532 22478888999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHH
Q 001426 897 QFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIIT 975 (1079)
Q Consensus 897 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~ 975 (1079)
++.+|++|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||....+ ..+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~ 237 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIE 237 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence 99999999999987654432223334456778999999988889999999999999999998 8889865321 11111
Q ss_pred HHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 976 WVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
.+.. .... .... .....+.+++.+||+.||++||+++++.+.|+.
T Consensus 238 ~~~~---~~~~------------~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRK---RQLL------------PCSE--DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHc---CCcC------------CCCC--CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1110 0000 0000 112356788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=302.67 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=202.8
Q ss_pred hhCCCCCCeeeecCcEEEEEE-EeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
.++|+..+.||+|.|+.||++ ...+|+.+|+|++...+- +....+++.+|++|.+.++|||||++.+.+.+....|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-ccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999997 456899999998854333 334678899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC---CCcEEEeecccccccc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP---QFEAFLADFGLAKLFE 912 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGla~~~~ 912 (1079)
+|+++|++|..-+-++ ..+++..+-.+++||++++.|+|.+ +|||||+||+|+++.. ..-+|++|||+|..+.
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999998777554 3478888888999999999999999 9999999999999954 3468999999999887
Q ss_pred CCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
+ .......+|||+|||||+....+|+..+|||+.||++|-++.|+.||++... ..-+.+...+...-..++.
T Consensus 165 ~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~~g~yd~~~~~w---- 236 (355)
T KOG0033|consen 165 D---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIKAGAYDYPSPEW---- 236 (355)
T ss_pred C---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhccccCCCCccc----
Confidence 3 3455678899999999999999999999999999999999999999987421 1112222222111111100
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. .-.....+++.+|+..||.+|.|+.|.+.
T Consensus 237 ---------~--~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 237 ---------D--TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---------C--cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 0 11224567899999999999999988763
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=340.53 Aligned_cols=254 Identities=21% Similarity=0.219 Sum_probs=201.8
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+.+++.++|+||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5788899999999999999765 688999999865443333455778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++.+....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+......
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999999987756799999999999999999999999 9999999999999999999999999999876543321
Q ss_pred ccccccccCcccccccccC------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 918 RASNSVAGSYGYIAPEYGY------SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+...... ...
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~~---------~~~ 227 (330)
T cd05601 159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNNIMNF---------QRF 227 (330)
T ss_pred -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHHHHcC---------CCc
Confidence 223346899999999876 456789999999999999999999999753211 011110000 000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. ..........+.+++.+|++ +|++|||++++++
T Consensus 228 ~~------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LK------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cC------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 00000112356678889998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=320.82 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=202.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|+..+.||+|+||.||+|..+ .++.||+|.+.. .....+.+.+|++++++++|+||+++++++..+...++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC----CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 34677889999999999999765 588899998742 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 837 DYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
||+++++|.+++... ...+++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999754 34589999999999999999999998 99999999999999999999999999998765432
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
. .......++..|+|||...+..++.++||||||+++|||++ |..||...... ...... .. . ...
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~----~~---~----~~~ 224 (263)
T cd05052 159 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELL----EK---G----YRM 224 (263)
T ss_pred e-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH----HC---C----CCC
Confidence 1 11222334678999999988899999999999999999998 88998653211 111100 00 0 000
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.... .....+.+++.+||+++|++|||+.+++++|+.+
T Consensus 225 ----~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ----ERPE--GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCC--CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0000 1123677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=319.86 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=201.1
Q ss_pred CCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
+|+..+.||+|+||.||+|.++++..+|+|.+.+.. .....+.+|++++++++||||+++++++.+....++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA----MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC----CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 477888999999999999998888889999874321 2345788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+++++|.+++......+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.++....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~ 156 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T 156 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence 999999999987666789999999999999999999999 999999999999999999999999999986543221 1
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......++..|+|||...+..++.++||||||+++|||++ |+.||....+. ....... . . ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~----~---~----~~~--- 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVS----A---G----YRL--- 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHH----c---C----CcC---
Confidence 1122234568999999988899999999999999999999 88888653221 1111110 0 0 000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
.... .....+.+++.+||..+|++|||+.|+++.|
T Consensus 221 -~~~~--~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 -YRPK--LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCC--CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0000 1233678899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=336.50 Aligned_cols=245 Identities=20% Similarity=0.237 Sum_probs=195.6
Q ss_pred CeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCC
Q 001426 764 NIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNG 842 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 842 (1079)
+.||+|+||.||+++. .+++.||+|++.+...........+..|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 478899999986543333344567788999999999999999999999999999999999999
Q ss_pred ChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 843 SLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHH-DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
+|.+++...+ .+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence 9999987654 48999999999999999999997 6 99999999999999999999999999987543221 1223
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .. ...+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i~---~~-~~~~----------p-- 216 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELIL---ME-EIRF----------P-- 216 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--HHHHHHHh---cC-CCCC----------C--
Confidence 45699999999999988999999999999999999999999975321 11111100 00 0000 0
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTAM 1034 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 1034 (1079)
. .....+.+++.+|++.||++|+ +++++++.
T Consensus 217 ~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 R--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 0122566899999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=333.48 Aligned_cols=244 Identities=24% Similarity=0.335 Sum_probs=193.7
Q ss_pred CeeeecCcEEEEEEEe----CCCCeEEEEEeccccC-CCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 764 NIVGKGVSGIVYRVEI----PSRQVIAVKKLWPVKN-GELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
+.||+|+||.||+++. ..++.||+|.+..... ........+..|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 3578899999864321 1222345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+++|+|.+++...+. +.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 155 (323)
T cd05584 82 LSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T 155 (323)
T ss_pred CCCchHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence 999999999976554 78888889999999999999999 99999999999999999999999999987543222 1
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhc
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......... ...+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~~-~~~~---------- 219 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILKG-KLNL---------- 219 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcC-CCCC----------
Confidence 223456899999999999888999999999999999999999999753211 111110000 0000
Q ss_pred ccCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001426 999 RSGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 999 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 1033 (1079)
.. .....+.+++.+||+.+|++|| +++++++
T Consensus 220 ~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PP----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CC----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 00 0123567899999999999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=352.94 Aligned_cols=269 Identities=22% Similarity=0.311 Sum_probs=208.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|+..+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999765 58899999986543333344578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcc----------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecc
Q 001426 837 DYISNGSLAGLLHEK----------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFG 906 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG 906 (1079)
||++||+|.+++... ....++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642 12356677889999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcc----------------cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCc
Q 001426 907 LAKLFESSES----------------SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG 970 (1079)
Q Consensus 907 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~ 970 (1079)
+++....... ........||+.|+|||+..+..++.++||||+||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986622110 011123469999999999999999999999999999999999999997532211
Q ss_pred chHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHhccccCCCCC
Q 001426 971 AHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP-TMKDVTAMLKEIRHENDDLE 1046 (1079)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~~~~~ 1046 (1079)
.... ..... .... .. ..+....+.+++.+|++.||++|| +++++.+.|+...+..++..
T Consensus 239 i~~~----~~i~~-P~~~----------~p--~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~ 298 (932)
T PRK13184 239 ISYR----DVILS-PIEV----------AP--YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWT 298 (932)
T ss_pred hhhh----hhccC-hhhc----------cc--cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcccc
Confidence 1000 00000 0000 00 001123566889999999999996 67888888888876555433
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=332.95 Aligned_cols=247 Identities=22% Similarity=0.305 Sum_probs=193.2
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHH---hcCCCCceeeeeeEEEcCCeEEEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTL---GSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
|++.+.||+|+||.||+|... +++.||||++.+.........+.+.+|++++ +.++||||+++++++.++...|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999765 6889999998654322333456677776655 567899999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|||+++|+|..++.+. .+++..+..++.||+.|++|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999988643 489999999999999999999999 99999999999999999999999999987533221
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... . ..... ......+
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~---~~~~i-~~~~~~~------- 220 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--E---VFDSI-VNDEVRY------- 220 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--H---HHHHH-HhCCCCC-------
Confidence 2233467899999999999889999999999999999999999999754211 1 11100 0000000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 1033 (1079)
. . .....+.+++.+||+.||++|| ++.++++
T Consensus 221 ---p--~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 ---P--R--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---C--C--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 0 0122566899999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=325.60 Aligned_cols=267 Identities=21% Similarity=0.273 Sum_probs=195.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC--CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC---CCCceeeeeeEEEc----
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP--SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI---RHKNIVRLLGCCNN---- 828 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 828 (1079)
++|+..+.||+|+||+||+|+.. +++.||+|.+...... ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 36888999999999999999763 4678999988543322 22334566777777665 69999999999852
Q ss_pred -CCeEEEEEEecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecc
Q 001426 829 -GRTRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFG 906 (1079)
Q Consensus 829 -~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG 906 (1079)
....++||||+. ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999996 5899998754 34589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHH---hh
Q 001426 907 LAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL---RE 983 (1079)
Q Consensus 907 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~ 983 (1079)
+++..... .......||+.|+|||...+..++.++||||+||++|||++|+.||....+. ..+........ +.
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 231 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChh
Confidence 99865433 2233456899999999998888999999999999999999999999764321 11222211110 00
Q ss_pred hhhchhhhhhhhhhcccCccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 984 RKREFTTILDRQLLMRSGTQIQ-----EMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.++..................+ ....+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1110000000000000111111 1235568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=322.48 Aligned_cols=257 Identities=22% Similarity=0.391 Sum_probs=201.6
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 830 (1079)
.++|+..+.||+|+||.||+|... .++.||+|++... ........+.+|+.+++.++||||+++++++.++.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 457889999999999999998653 3467999987432 22234567899999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhccC---------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEE
Q 001426 831 TRLLLFDYISNGSLAGLLHEKK---------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF 901 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 901 (1079)
..++||||+++|+|.+++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 9999999999999999996532 2357788999999999999999998 999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhH
Q 001426 902 LADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGE 980 (1079)
Q Consensus 902 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 980 (1079)
++|||+++...............+++.|+|||...+..++.++|||||||++|||++ |..||...... .....+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~-- 235 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVM-- 235 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH--
Confidence 999999986654332222223345788999999988889999999999999999999 78888653211 1111110
Q ss_pred HhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 981 LRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
....... .. .....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 236 -~~~~~~~------------~~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 -EGGLLDK------------PD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -cCCcCCC------------CC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0000000 00 112357789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=332.84 Aligned_cols=239 Identities=22% Similarity=0.304 Sum_probs=190.8
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||+||+|+.+ +++.||+|++.+.........+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 5889999998643322334456778888888876 699999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.+++.+.+ .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence 99999987654 488999999999999999999999 99999999999999999999999999987543221 2233
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+.. ..... .... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~---~i~~~-~~~~----------~-- 216 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFE---AILND-EVVY----------P-- 216 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHH---HHhcC-CCCC----------C--
Confidence 457899999999999889999999999999999999999999753211 1111 10000 0000 0
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTM 1028 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 1028 (1079)
. .....+.+++.+|++.||++||++
T Consensus 217 ~--~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 T--WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred C--CCCHHHHHHHHHHcccCHHHCCCC
Confidence 0 012256789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=338.90 Aligned_cols=204 Identities=25% Similarity=0.344 Sum_probs=176.3
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||+||+|+.. +++.||+|++.+...........+.+|+.++.+++|+||+++++++.+....|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 5788899999999999999765 688999999864332233345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++.+.+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999997654 489999999999999999999999 9999999999999999999999999999765321100
Q ss_pred ---------------------------------ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 001426 918 ---------------------------------RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964 (1079)
Q Consensus 918 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~ 964 (1079)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123469999999999999899999999999999999999999997
Q ss_pred CC
Q 001426 965 SR 966 (1079)
Q Consensus 965 ~~ 966 (1079)
..
T Consensus 238 ~~ 239 (363)
T cd05628 238 SE 239 (363)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=323.63 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=205.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
.+|...+.||+|+||.||+|... ++..+++|.+.. ......+.+.+|++++++++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC---ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 34677789999999999999643 345688887632 223345679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccC---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC
Q 001426 832 RLLLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP 896 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~ 896 (1079)
.++||||+++++|.+++...+ ..+++..++.++.||+.|++|||++ +|+||||||+||++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 999999999999999996532 2478999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHH
Q 001426 897 QFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIIT 975 (1079)
Q Consensus 897 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~ 975 (1079)
++.++|+|||+++...............++..|+|||...+..++.++||||||+++|||++ |+.||....+. ....
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~ 236 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVIE 236 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH
Confidence 99999999999986654432233334556789999999988899999999999999999999 99998653221 1111
Q ss_pred HHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 976 WVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
.. ........ . ......+.+++.+||+++|++|||+++|+++|+++.+.
T Consensus 237 ~~---~~~~~~~~-----------~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CI---TQGRVLER-----------P---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HH---hCCCCCCC-----------C---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 10 00000000 0 01123577899999999999999999999999999664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=329.05 Aligned_cols=257 Identities=24% Similarity=0.332 Sum_probs=213.9
Q ss_pred HHHhhCCCCCCeeeecCcEEEEEEEeCC-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCe
Q 001426 754 DDVVTRLSDTNIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 754 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 831 (1079)
+.....|+..+.||+|.||.||++..+. |+.+|+|.+.+...........+.+|+.+|+++. |||||.++++|.+...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3455678888999999999999997764 9999999997766555456789999999999998 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC----CcEEEeeccc
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ----FEAFLADFGL 907 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DFGl 907 (1079)
.++|||++.||.|.+.+.+. .+++..+..++.|++.|++|||+. +|||||+||+|+|+... +.+|++|||+
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999999877 399999999999999999999998 99999999999999643 4799999999
Q ss_pred cccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhc
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
|..... .......+||+.|+|||+.....++.++||||.||++|.|++|..||.+...... ......+.. .
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-~~~i~~~~~-----~ 256 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-FLAILRGDF-----D 256 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-HHHHHcCCC-----C
Confidence 998776 3355678999999999999999999999999999999999999999987543222 112222211 1
Q ss_pred hhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
+.. .+.. .....+.+++..|+..||.+|+|++++++.
T Consensus 257 f~~--------~~w~--~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 FTS--------EPWD--DISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCC--------CCcc--ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 100 0111 123356689999999999999999999993
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=326.75 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=204.6
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCC
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGR 830 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 830 (1079)
.+|+..+.||+|+||.||++...+ ...+|+|.+... ........+.+|+++++++ +|+||+++++++..+.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC--CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 467888999999999999997642 357899987532 2233456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcc---------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEEC
Q 001426 831 TRLLLFDYISNGSLAGLLHEK---------------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG 895 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~ 895 (1079)
..++||||+++|+|.++++.. ...+++..++.++.|++.|++|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999999642 34588999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHH
Q 001426 896 PQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHII 974 (1079)
Q Consensus 896 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~ 974 (1079)
+++.+|++|||+++.+.............++..|+|||+..+..++.++|||||||++|||++ |..||...... ...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~ 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--ELF 244 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--HHH
Confidence 999999999999987654432222333345678999999988889999999999999999998 88888653211 111
Q ss_pred HHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 975 TWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
.... .. .. ..........+.+++.+||+++|++|||++|+++.|+++.
T Consensus 245 ~~~~----~~-----------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KLLK----EG-----------YR--MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHH----cC-----------Cc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1110 00 00 0000112236778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=323.80 Aligned_cols=253 Identities=22% Similarity=0.255 Sum_probs=199.5
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|+||+||++... +++.||+|++.............+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 677889999999999999764 6889999988543322223345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 839 ISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 839 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 9999999988654 34589999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......|++.|+|||++.+..++.++||||+||++|||++|+.||........ ... +..........
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~---------- 223 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-REE-VERRVKEDQEE---------- 223 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HHH-HHHHhhhcccc----------
Confidence 12234689999999999888899999999999999999999999976432110 000 00000000000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTAM 1034 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 1034 (1079)
... .....+.+++.+||+.||++|| +++++++.
T Consensus 224 --~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 --YSE--KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cCc--ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 000 1123567899999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=321.51 Aligned_cols=261 Identities=21% Similarity=0.329 Sum_probs=208.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|+..+.||+|+||.||+|.. .+++.+|||.+.............+.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4577888999999999999975 478899999886444334445578899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 837 DYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 837 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
||+++++|.+++.. ....+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999863 234589999999999999999999999 999999999999999999999999999886654
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
... ......++..|+|||+..+..++.++||||||+++|||++|..||............... . ...
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~-------~~~ 225 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE----Q-------CDY 225 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh----c-------CCC
Confidence 321 123346889999999998888999999999999999999999998653222111111000 0 000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
+.. ........+.+++.+||+.+|++||||.+|+++++++.
T Consensus 226 ~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPL-----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCC-----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000 00012336778999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=322.60 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=204.0
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCC----eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQ----VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
.+|+..++||+|+||+||+|++. +++ .||+|.+... ........+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 46788899999999999999753 444 4789987432 2333457788999999999999999999999754 56
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
++++||+++|+|.+++.+....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 899999999999999987666689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
............+++.|+|||...+..++.++|||||||++|||++ |..||..... .....++... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~-----~----- 228 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKG-----E----- 228 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCC-----C-----
Confidence 4332222223345678999999988899999999999999999998 8888865321 1111111100 0
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
.... .......+.+++.+||+.||++||++.++++.|+++...
T Consensus 229 -----~~~~--~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 229 -----RLPQ--PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred -----cCCC--CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0000 001223567899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=341.29 Aligned_cols=254 Identities=23% Similarity=0.301 Sum_probs=198.3
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||+||+|+.. +++.||||++.............+.+|+++++.++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 5788899999999999999775 688999999864332223345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+......
T Consensus 82 ~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999997655 489999999999999999999999 9999999999999999999999999998765322100
Q ss_pred c------------------------------------cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCC
Q 001426 918 R------------------------------------ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKE 961 (1079)
Q Consensus 918 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~ 961 (1079)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 0112468999999999998899999999999999999999999
Q ss_pred CCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 001426 962 PTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPT---MKDVTA 1033 (1079)
Q Consensus 962 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~ 1033 (1079)
||....+.. ...... .... ........ .....+.+++.+|+. +|.+|++ ++|+++
T Consensus 238 Pf~~~~~~~-~~~~i~-----~~~~--------~~~~~~~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNPQE-TYRKII-----NWKE--------TLQFPDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCHHH-HHHHHH-----cCCC--------ccCCCCCC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 997543211 000000 0000 00000000 112245677888886 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=341.44 Aligned_cols=255 Identities=25% Similarity=0.305 Sum_probs=203.8
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||+||+|+.. +++.||+|++.+...........+.+|++++..++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 6888899999999999999776 688999999865433333456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc--
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE-- 915 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~-- 915 (1079)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999876 4589999999999999999999998 99999999999999999999999999998665432
Q ss_pred -------------------------ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCc
Q 001426 916 -------------------------SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG 970 (1079)
Q Consensus 916 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~ 970 (1079)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~- 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ- 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH-
Confidence 001223456899999999999999999999999999999999999999764311
Q ss_pred chHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 001426 971 AHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPT-MKDVTAM 1034 (1079)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~ 1034 (1079)
...... ..... ........ .....+.+++.+|+. ||++||+ ++|+++.
T Consensus 237 ~~~~~i-----~~~~~--------~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETYNKI-----INWKE--------SLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHH-----hccCC--------cccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 000000 00000 00000000 012356688899997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=339.23 Aligned_cols=255 Identities=22% Similarity=0.256 Sum_probs=199.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|+.. +++.||+|.+.+...........+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 56888899999999999999765 68899999986433233334466889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 123 Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 123 EYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999998654 378888889999999999999999 999999999999999999999999999986643321
Q ss_pred cccccccccCcccccccccCCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSL----KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.... .....
T Consensus 198 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~-----~~~~~----- 265 (370)
T cd05596 198 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIM-----DHKNS----- 265 (370)
T ss_pred -ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHH-----cCCCc-----
Confidence 122345799999999987643 4788999999999999999999999764221 0111110 00000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEE--RPTMKDVTAM 1034 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 1034 (1079)
. ...........+.+++.+|++.+|++ |||++|+++.
T Consensus 266 ---~--~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 ---L--TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---C--CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 00011111235668999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=336.99 Aligned_cols=261 Identities=20% Similarity=0.224 Sum_probs=196.6
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|++.+.||+|+||.||+|.. .+++.||+|+.. ...+.+|++++++++|||||++++++......++|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 4699999999999999999966 468889999642 245678999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|++. ++|.+++.... .+++..+..++.||+.||+|||+. +||||||||+||+++.++.+||+|||+|+......
T Consensus 163 e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred ecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 9995 68988886654 488999999999999999999999 99999999999999999999999999997543321
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC------cchHHHHHHhHH--hhh-h--
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPD------GAHIITWVNGEL--RER-K-- 985 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~------~~~~~~~~~~~~--~~~-~-- 985 (1079)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+........ +.. +
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 12233457999999999999889999999999999999999999887543211 111111111000 000 0
Q ss_pred --hchhhhh---hhhhhcccC------ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 986 --REFTTIL---DRQLLMRSG------TQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 986 --~~~~~~~---~~~~~~~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
....... ......... ........+.+++.+|++.||++|||++|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 000000000 00112346778999999999999999999985
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=323.30 Aligned_cols=260 Identities=22% Similarity=0.369 Sum_probs=207.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC-----CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc-CCe
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN-GRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 831 (1079)
++|+..+.||+|+||.||+|.... +..|++|++.. .......+.+.+|+.++++++|+||+++++++.. +..
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD--HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC--CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 567888999999999999998765 67889998742 2334456788999999999999999999998876 567
Q ss_pred EEEEEEecCCCChhhhhhccC-------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEee
Q 001426 832 RLLLFDYISNGSLAGLLHEKK-------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 904 (1079)
.++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999996542 4589999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhh
Q 001426 905 FGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRE 983 (1079)
Q Consensus 905 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 983 (1079)
||+++.+.............++..|+|||+..+..++.++||||||+++||+++ |+.||....+ ..+..+......
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~- 237 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYR- 237 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCC-
Confidence 999986654432222233456778999999988889999999999999999999 9999975322 111111111000
Q ss_pred hhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 984 RKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
. .. .......+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 238 ------------~--~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 ------------L--AQ--PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ------------C--CC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0 00 001123577899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.34 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=199.9
Q ss_pred CeeeecCcEEEEEEEeCC-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCC
Q 001426 764 NIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNG 842 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 842 (1079)
-++|+|.||+||-|+..+ ...+|||.+.. .......-+.+|+..-++++|+|||+++|+|.++++.-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe---kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE---KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccc---ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 369999999999998764 55688998742 22234567888999999999999999999999999999999999999
Q ss_pred ChhhhhhccCcCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-CCcEEEeeccccccccCCccccc
Q 001426 843 SLAGLLHEKKVFL--DWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-QFEAFLADFGLAKLFESSESSRA 919 (1079)
Q Consensus 843 ~L~~~l~~~~~~~--~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~ 919 (1079)
+|.++++.+-.++ .+.++-.+..||++||.|||+. .|||||||-+|||++. .|.+||+|||.++.+..- ...
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~ 732 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPC 732 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC--Ccc
Confidence 9999999885556 6778888999999999999999 9999999999999975 689999999999876532 345
Q ss_pred ccccccCcccccccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 920 SNSVAGSYGYIAPEYGYSL--KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 920 ~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
+....||..|||||++..+ .|+.++|||||||++.||.||++||.....+.+.+.+. |.++.
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--GmyKv-------------- 796 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--GMYKV-------------- 796 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--cceec--------------
Confidence 5678899999999998765 48899999999999999999999998765544433221 11111
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.++...+-..+...++.+|+.+||.+||++.++++
T Consensus 797 -HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 -HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11112233456678999999999999999999987
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=330.84 Aligned_cols=240 Identities=25% Similarity=0.284 Sum_probs=187.3
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHH-HHhcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQ-TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
++||+|+||.||+|+.. +++.||+|++.+...........+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 68899999986433222233345555554 67889999999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 99999886544 478888999999999999999998 99999999999999999999999999987532221 2233
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....... .. .......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i-~~----------~~~~~~~- 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNI-LH----------KPLQLPG- 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHH-hc----------CCCCCCC-
Confidence 45689999999999988999999999999999999999999975321 1111100 00 0000000
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTMK 1029 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 1029 (1079)
.....+.+++.+|++.||++||++.
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 ---GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1123567899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=323.87 Aligned_cols=247 Identities=21% Similarity=0.231 Sum_probs=194.0
Q ss_pred eeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCCh
Q 001426 766 VGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 844 (1079)
||+|+||+||++... +++.||+|++.+.........+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 6889999998543322333446778899999999999999999999999999999999999999
Q ss_pred hhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 845 AGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 845 ~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||.+..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988753 234589999999999999999999999 999999999999999999999999999986654321 223
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||+..+..++.++||||||+++|||++|+.||........ ....... ....... .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~-----------~~~~~~~--~- 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQR-----------ILNDSVT--Y- 220 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHh-----------hcccCCC--C-
Confidence 45789999999999999999999999999999999999999975432111 0000000 0000000 0
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 1033 (1079)
.......+.+++.+||+.||++|| |++++++
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 -PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred -cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 001223567899999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=324.44 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=200.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC---------------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeee
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS---------------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 822 (1079)
.+|+..+.||+|+||.||++...+ ...||+|++... ........|.+|++++++++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 478889999999999999986542 234899988532 223445679999999999999999999
Q ss_pred eeEEEcCCeEEEEEEecCCCChhhhhhccC-----------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 001426 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKK-----------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNN 891 (1079)
Q Consensus 823 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~N 891 (1079)
++++......++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 999999999999999999999999986432 2368889999999999999999999 99999999999
Q ss_pred eEECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCC
Q 001426 892 ILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT--GKEPTDSRIPD 969 (1079)
Q Consensus 892 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t--g~~p~~~~~~~ 969 (1079)
|++++++.+|++|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 9999999999999999986544332222333455779999999988889999999999999999998 5567654321
Q ss_pred cchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 970 GAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
................. ....... .....+.+++.+||+.+|++|||+++|++.|++
T Consensus 239 -~~~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 -EQVIENTGEFFRNQGRQ--------IYLSQTP--LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHHHhhhhcccc--------ccCCCCC--CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111100000000 0000000 112368899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=331.93 Aligned_cols=244 Identities=20% Similarity=0.267 Sum_probs=193.7
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+|+..+.||+|+||.||+|+.. +++.||+|.+.+...........+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3677889999999999999765 5779999998654333333445677788888877 5899999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++...+. +++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 99999999999976544 88999999999999999999999 99999999999999999999999999997543221
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+ ......+
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i----~~~~~~~-------- 220 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSI----MEHNVAY-------- 220 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCCCCC--------
Confidence 123345789999999999999999999999999999999999999975422 1111110 0100000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTM 1028 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 1028 (1079)
.. .....+.+++.+|++.||++|++.
T Consensus 221 ----p~--~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 ----PK--SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----CC--cCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 112356789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=332.95 Aligned_cols=272 Identities=22% Similarity=0.311 Sum_probs=198.4
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC-----CeE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG-----RTR 832 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 832 (1079)
+|+..+.||+|+||.||+|... +++.||+|++.... ........+.+|+++++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 4778889999999999999764 68999999885322 2223446788999999999999999999998543 247
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
|+||||+. ++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 80 YVVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 99999995 68999887554 489999999999999999999999 99999999999999999999999999998653
Q ss_pred CCcc-cccccccccCcccccccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhc--
Q 001426 913 SSES-SRASNSVAGSYGYIAPEYGYS--LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE-- 987 (1079)
Q Consensus 913 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 987 (1079)
.... ........||+.|+|||+..+ ..++.++|||||||++|||++|+.||..... ......+..........
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHH
Confidence 3221 122234578999999998765 5789999999999999999999999975321 11111111000000000
Q ss_pred -------hhhhhhhhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhcc
Q 001426 988 -------FTTILDRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTAM--LKEIR 1039 (1079)
Q Consensus 988 -------~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~ 1039 (1079)
....+.. +........ .....+.+++.+||+.||++|||++|+++. ++++.
T Consensus 233 ~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 233 SRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 0000000 000000000 012356789999999999999999999973 44443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.89 Aligned_cols=200 Identities=28% Similarity=0.400 Sum_probs=174.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||++... ++..+|+|.+... ........+.+|++++++++||||++++++|.+++..++||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 57889999999999999999776 6788888887532 12234577999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++...+ .+++..+..++.|++.|++|||+.+ +|+||||||+||++++++.+||+|||++..+....
T Consensus 83 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 83 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999997654 3788999999999999999999752 79999999999999999999999999997654321
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
.....|+..|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 23346899999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=330.19 Aligned_cols=240 Identities=25% Similarity=0.285 Sum_probs=188.6
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHH-HHhcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQ-TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||+||+|... +++.||+|++.+...........+..|.. +++.++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999775 68899999986433222233345555554 56889999999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 99999997654 488999999999999999999999 99999999999999999999999999987533221 2233
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~-----------~~~~~~~~ 218 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILN-----------KPLRLKPN 218 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHc-----------CCCCCCCC
Confidence 45689999999999998999999999999999999999999975321 111111000 00000110
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTMK 1029 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 1029 (1079)
....+.+++.+|++.||++||+++
T Consensus 219 ----~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ----ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 123567899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=332.07 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=194.6
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
++||+|+||.||+|+.. +++.||+|++.+...........+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999775 5789999998654333334556778899998866 799999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|..++.+.+ .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT 154 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence 99999987654 488999999999999999999999 99999999999999999999999999987543222 2233
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||++.+..++.++||||+||++|||++|+.||....+. .... ..... ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~---~i~~~-----------~~~~p~- 217 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFE---SILHD-----------DVLYPV- 217 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHH---HHHcC-----------CCCCCC-
Confidence 456899999999999889999999999999999999999999754221 1111 00000 000000
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERP-------TMKDVTAM 1034 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RP-------t~~evl~~ 1034 (1079)
.....+.+++.+|++.||++|| +++++++.
T Consensus 218 ---~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 ---WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ---CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0112566899999999999999 77777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.91 Aligned_cols=255 Identities=22% Similarity=0.250 Sum_probs=206.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+.|+..+.||.|.-|+||.++.++ +..+|+|++.+..........+.+.|-+||+.++||.++.+|+.+..++..|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346677889999999999998875 5899999997655444555677888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC-
Q 001426 837 DYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS- 914 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~- 914 (1079)
|||+||+|....+++ +..+++..+..++..|+-||+|||.. |||+|||||+||||.++|++.++||.++......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999876 66799999999999999999999999 9999999999999999999999999987543110
Q ss_pred --------------------------------cc---------------------cccccccccCcccccccccCCCCCC
Q 001426 915 --------------------------------ES---------------------SRASNSVAGSYGYIAPEYGYSLKIT 941 (1079)
Q Consensus 915 --------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 941 (1079)
.. .......+||-.|+|||++.+..++
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 00 0112235799999999999999999
Q ss_pred ccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCC
Q 001426 942 EKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPC 1021 (1079)
Q Consensus 942 ~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d 1021 (1079)
.++|.|+|||++|||+.|+.||-+.... +.+...+ -..+..... ..-+....++|++.+.+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv---------------~~~l~Fp~~--~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIV---------------GQPLKFPEE--PEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHh---------------cCCCcCCCC--CcchhHHHHHHHHHhccC
Confidence 9999999999999999999999875322 1122221 111111111 133457778999999999
Q ss_pred CCCCCC----HHHHHH
Q 001426 1022 PEERPT----MKDVTA 1033 (1079)
Q Consensus 1022 P~~RPt----~~evl~ 1033 (1079)
|.+|.. ++||.+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999998 777765
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.43 Aligned_cols=261 Identities=22% Similarity=0.367 Sum_probs=209.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++|+|++++++++.++...++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46888899999999999999776 78999999886544444445678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 837 DYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 837 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
||+++|+|.+++.. ....+++..++.++.+++.|++|||+. +|+||||+|+||+++.++.++++|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999864 244589999999999999999999999 999999999999999999999999999886543
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
.. .......+++.|+|||...+..++.++|||||||++|||++|+.||...... ........... .....
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~---~~~~~-- 228 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEKC---DYPPL-- 228 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhhhhcC---CCCCC--
Confidence 32 1122346788999999998888999999999999999999999998653211 11111110000 00000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
........+.+++.+||+++|++|||+.+|+++++++.
T Consensus 229 --------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 --------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00012235678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.79 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=206.6
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
..+|+..+.||+|+||.||+|...+++.+|+|.+... .......+..|+.+++.++|+||+++++++.+....++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc---chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 3468888999999999999999888999999987532 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 837 DYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
||+++|+|.+++.+. +..+++..++.++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999764 44589999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
. ......++..|+|||...+..++.++||||||+++|+|++ |+.||..... ......... .
T Consensus 159 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~---~----------- 220 (261)
T cd05148 159 Y--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQITA---G----------- 220 (261)
T ss_pred c--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHHh---C-----------
Confidence 1 1223446778999999988889999999999999999998 8999865321 111111110 0
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.. ..........+.+++.+||+.||++|||++++++.|+.+
T Consensus 221 -~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 -YR--MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -Cc--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00 000112223577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=333.72 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=196.6
Q ss_pred CCCCCCeeeecCcEEEEEEEe----CCCCeEEEEEeccccC-CCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEI----PSRQVIAVKKLWPVKN-GELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 832 (1079)
+|+..+.||+|+||.||+++. .+++.||+|++.+... ......+.+..|+.+++.+ +|++|+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 367788999999999999865 3678999999864321 1223346788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999997654 488999999999999999999999 99999999999999999999999999998654
Q ss_pred CCcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+... .......+.
T Consensus 157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~-~~~~~~~~~-- 231 (332)
T cd05614 157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRR-ILKCDPPFP-- 231 (332)
T ss_pred ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHH-HhcCCCCCC--
Confidence 3321 222345799999999998765 478899999999999999999999975322111 1111110 000000000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 1033 (1079)
. .....+.+++.+||+.||++|| +++++++
T Consensus 232 ----------~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 232 ----------S--FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----------C--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 1122566889999999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=335.19 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=203.0
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCC
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGR 830 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 830 (1079)
++|...+.||+|+||.||+|++. .++.||+|++.... .....+.+.+|++++.++. |||||+++++|....
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 56778899999999999999864 34679999985432 2233467889999999997 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhccC----------------------------------------------------------
Q 001426 831 TRLLLFDYISNGSLAGLLHEKK---------------------------------------------------------- 852 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 852 (1079)
..++||||+++|+|.+++++.+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999996432
Q ss_pred ---------------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeE
Q 001426 853 ---------------------------------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNIL 893 (1079)
Q Consensus 853 ---------------------------------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIl 893 (1079)
..+++..+..++.|++.|++|||+. +++||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 1356778889999999999999998 9999999999999
Q ss_pred ECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcch
Q 001426 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAH 972 (1079)
Q Consensus 894 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~ 972 (1079)
+++++.+|++|||+++.+.............+++.|+|||...+..++.++|||||||++|||++ |..||....... .
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-~ 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-Q 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-H
Confidence 99999999999999986543322222233457889999999988889999999999999999998 888886432111 1
Q ss_pred HHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 973 IITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
....+... ....... .....+.+++.+||+.+|++||+++|+++.|+++.
T Consensus 351 ~~~~~~~~---------------~~~~~p~--~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYNAIKRG---------------YRMAKPA--HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHcC---------------CCCCCCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111000 0000000 11236778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=337.02 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=197.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|+.. +++.+|+|.+.+...........+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 57889999885433333334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 123 Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~- 196 (370)
T cd05621 123 EYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG- 196 (370)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC-
Confidence 999999999999654 378889999999999999999999 99999999999999999999999999998764332
Q ss_pred cccccccccCcccccccccCCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSL----KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.... .....
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~-----~~~~~----- 265 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIM-----DHKNS----- 265 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHH-----hCCcc-----
Confidence 1222355799999999987654 3788999999999999999999999754211 0111110 00000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEE--RPTMKDVTAM 1034 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 1034 (1079)
. ...........+.+++..|+..+|.+ |||++|+++.
T Consensus 266 ---~--~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 ---L--NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---c--CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 00111111234556788888755543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=341.12 Aligned_cols=255 Identities=23% Similarity=0.301 Sum_probs=196.5
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||+||+++.. +++.||+|++.+.........+.+.+|++++++++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 5788899999999999999664 788999999864332233445778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999997654 488899999999999999999999 9999999999999999999999999999643221000
Q ss_pred ------------c---------------------------------cccccccCcccccccccCCCCCCccchHHHHHHH
Q 001426 918 ------------R---------------------------------ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVV 952 (1079)
Q Consensus 918 ------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvi 952 (1079)
. ......||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0012468999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCC---CCHH
Q 001426 953 LLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEER---PTMK 1029 (1079)
Q Consensus 953 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~ 1029 (1079)
+|||++|+.||....+. ..+..... +.. ...... .......+.+++.+|+. +|.+| +|+.
T Consensus 238 l~elltG~~Pf~~~~~~-~~~~~i~~------~~~-------~~~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 238 MFECLIGWPPFCSENSH-ETYRKIIN------WRE-------TLYFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred hhhhhcCCCCCCCCCHH-HHHHHHHc------cCC-------ccCCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999754321 11111100 000 000000 00112356678888997 67665 5999
Q ss_pred HHHHH
Q 001426 1030 DVTAM 1034 (1079)
Q Consensus 1030 evl~~ 1034 (1079)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=330.04 Aligned_cols=244 Identities=22% Similarity=0.301 Sum_probs=194.8
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||+||+|+.. +++.||+|++.+...........+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 5789999998654333334556778899999888 799999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|..++.+.+ .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence 99999987654 489999999999999999999999 99999999999999999999999999987532221 1223
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... ...... .......+ .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~----i~~~~~~~----------~-- 216 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQS----ILEDEVRY----------P-- 216 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHH----HHcCCCCC----------C--
Confidence 34689999999999999999999999999999999999999975321 111110 00000000 0
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTM-----KDVTA 1033 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 1033 (1079)
. .....+.+++.+||+.||++|||+ .++++
T Consensus 217 ~--~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 R--WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred C--cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0 112356789999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=344.18 Aligned_cols=255 Identities=24% Similarity=0.303 Sum_probs=202.5
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-----
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR----- 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 830 (1079)
.++|+..+.||+|+||+||+|+. .+++.||||++.... ........+.+|+.++..++|+||+++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc-CCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 36899999999999999999965 478999999985432 23345677889999999999999999988775432
Q ss_pred ---eEEEEEEecCCCChhhhhhcc---CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEee
Q 001426 831 ---TRLLLFDYISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904 (1079)
Q Consensus 831 ---~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 904 (1079)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|+|+. +|+||||||+||++++++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999999653 34588999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh
Q 001426 905 FGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER 984 (1079)
Q Consensus 905 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 984 (1079)
||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~~~~ 261 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTLAGR 261 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhcCC
Confidence 999987654332333345679999999999999899999999999999999999999997532 111111111110
Q ss_pred hhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 985 KREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
... +. . .....+.+++.+||+.||++||++.++++.
T Consensus 262 ~~~----~~--------~--~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP----LP--------P--SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC----CC--------C--CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000 00 0 112357789999999999999999999863
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=330.79 Aligned_cols=244 Identities=20% Similarity=0.270 Sum_probs=193.5
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCC-ceeeeeeEEEcCCeEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHK-NIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 836 (1079)
+|+..+.||+|+||.||+|+.. +++.||+|++.+.........+.+..|.+++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3677889999999999999765 5778999998654333334557788899999999765 6889999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 9999999999997655 378999999999999999999999 99999999999999999999999999987432211
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+ ......+.
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i----~~~~~~~~------- 221 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQSI----MEHNVSYP------- 221 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHH----HcCCCCCC-------
Confidence 122345689999999999998999999999999999999999999975421 1111110 00000000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTM 1028 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 1028 (1079)
. .....+.+++.+|++.||.+|++.
T Consensus 222 -----~--~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 -----K--SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -----C--CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 012256689999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.20 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=204.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCC
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGR 830 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 830 (1079)
++|...+.||+|+||.||+|... .+..||+|++.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 56888999999999999998642 34578999875322 233457899999999999 7999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~ 909 (1079)
..++||||+.+|+|.++++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997543 3489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhch
Q 001426 910 LFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREF 988 (1079)
Q Consensus 910 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1079)
.+.............++..|+|||...+..++.++||||+||++|||++ |..||...... ..+..... ..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~~~----~~---- 260 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIK----EG---- 260 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHHHH----cC----
Confidence 6654322222223346788999999988889999999999999999998 99998754321 11111110 00
Q ss_pred hhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 989 TTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
...... ......+.+++.+||+++|++|||+.|+++.|+++
T Consensus 261 -------~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -------YRMAQP--EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------CcCCCC--CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000000 01123677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=331.28 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=202.0
Q ss_pred hCCCCCCeeeecCcEEEEEEEe------CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEc-C
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI------PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNN-G 829 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~ 829 (1079)
++|+..+.||+|+||.||+|.. .+++.||||++... ........+.+|+.++.++ +||||+++++++.. +
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC--CChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 5789999999999999999963 35678999998532 2223456788999999999 68999999998865 4
Q ss_pred CeEEEEEEecCCCChhhhhhccC---------------------------------------------------------
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKK--------------------------------------------------------- 852 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 852 (1079)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999999999986431
Q ss_pred ---------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccccc
Q 001426 853 ---------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSV 923 (1079)
Q Consensus 853 ---------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 923 (1079)
..+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||+++..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 2367888899999999999999999 9999999999999999999999999999876443322222334
Q ss_pred ccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCc
Q 001426 924 AGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGT 1002 (1079)
Q Consensus 924 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1079)
.+++.|+|||...+..++.++||||||+++|||++ |..||........ +...+ ..... . ....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~----~~~~~---------~--~~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRL----KEGTR---------M--RAPD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHH----hccCC---------C--CCCC
Confidence 46678999999988889999999999999999997 8889865322111 11110 00000 0 0000
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 1003 QIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 1003 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
.....+.+++..||+.+|++|||+.|+++.|+.+.+.
T Consensus 306 --~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 306 --YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0112567889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=327.97 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=191.0
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhc-CCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGS-IRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||+||+|+.. +++.||+|.+.+...........+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 578899999865322222334566778888876 4899999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence 99999997643 478999999999999999999999 99999999999999999999999999987532221 1223
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+ ......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i----~~~~~~~~------------ 216 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSI----RMDNPCYP------------ 216 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCCCCCC------------
Confidence 45689999999999988999999999999999999999999975321 1111111 00000000
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTMK-DVTA 1033 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 1033 (1079)
. .....+.+++.+||+.||++||++. ++.+
T Consensus 217 ~--~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 R--WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred c--cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0 0112466889999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=326.71 Aligned_cols=249 Identities=28% Similarity=0.353 Sum_probs=205.2
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
.+.|...+-||.|+||-||-|+. .+.++||||++......+.+...++..|+..+++++|||+|.+.|||....+.|+|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34577778899999999999965 57889999999776666666778999999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
||||-| +-.|.+.-.++++-+.++..|+.+.+.||+|||++ +.||||||+.|||+++.|.||++|||.|....+
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 999955 88999988888899999999999999999999999 999999999999999999999999999986554
Q ss_pred ccccccccccCccccccccc---CCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYG---YSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
...++|||.|||||++ ..+.|+-|+||||+|+++.|+...++|...+.. ........+...+.+.
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----MSALYHIAQNesPtLq--- 246 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNESPTLQ--- 246 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----HHHHHHHHhcCCCCCC---
Confidence 3457899999999985 456899999999999999999999999765421 1111111122111111
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. +=...+..++..|++.-|.+|||.++++.
T Consensus 247 --------s~--eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 --------SN--EWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --------Cc--hhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 01 12336778999999999999999887654
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=320.81 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=199.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
++|+..+.||+|+||.||+|...+ +..||+|.+.. .........|.+|+.++++++|+||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCC--CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 468888999999999999997753 56788887642 2223345679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccC------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC---cEEE
Q 001426 832 RLLLFDYISNGSLAGLLHEKK------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF---EAFL 902 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl 902 (1079)
.++||||+++++|.+++.+.+ ..+++..+.+++.||+.|++|||+. +++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 999999999999999997653 2589999999999999999999999 999999999999998754 5999
Q ss_pred eeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHH
Q 001426 903 ADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGEL 981 (1079)
Q Consensus 903 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 981 (1079)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~-- 236 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFVTG-- 236 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc--
Confidence 99999987643332222222334578999999998899999999999999999997 99998753321 11111110
Q ss_pred hhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 982 RERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
..... .. ......+.+++.+||+.+|++|||+++|++.|+
T Consensus 237 -~~~~~------------~~--~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 -GGRLD------------PP--KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -CCcCC------------CC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00000 00 011236778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.15 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=196.9
Q ss_pred CCCCeeeecCcEEEEEEEeCCCC---eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC------Ce
Q 001426 761 SDTNIVGKGVSGIVYRVEIPSRQ---VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG------RT 831 (1079)
Q Consensus 761 ~~~~~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 831 (1079)
.+.+.||+|+||.||+|.+.... .+|+|.+.... ......+.+..|+.+++.++|+||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 45678999999999999876433 58888875322 2334567889999999999999999999987532 24
Q ss_pred EEEEEEecCCCChhhhhhc-----cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecc
Q 001426 832 RLLLFDYISNGSLAGLLHE-----KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFG 906 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG 906 (1079)
.++||||+++|+|.+++.. ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998742 234478999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhh
Q 001426 907 LAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERK 985 (1079)
Q Consensus 907 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 985 (1079)
+++.+.............+++.|+|||...+..++.++||||||+++|||++ |+.||..... ..+...+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~----~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYL----RQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----HcCC
Confidence 9987654432222233456778999999998899999999999999999999 7888865321 1111111 0000
Q ss_pred hchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 986 REFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
. . .... .....+.+++.+||+++|++|||++++++.|+++
T Consensus 232 ~-~----------~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 R-L----------KQPP--DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C-C----------CCCC--CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0 0000 1123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.81 Aligned_cols=246 Identities=20% Similarity=0.279 Sum_probs=192.9
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||+||+|+.. +++.||+|++.+.........+.+..|+.++.++ +||+|+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 6788999998654433344567788999999888 699999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.+++...+ .+++..+..++.||+.|++|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence 99999987554 489999999999999999999999 99999999999999999999999999987532211 1223
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCc-chHHHHHHhHHhhhhhchhhhhhhhhhccc
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG-AHIITWVNGELRERKREFTTILDRQLLMRS 1000 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1079)
...||+.|+|||++.+..++.++||||+||++|||++|+.||....... .................+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------p- 223 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI----------P- 223 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC----------C-
Confidence 4568999999999999999999999999999999999999996532211 111111111111110000 0
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001426 1001 GTQIQEMLQVLGVALLCVNPCPEERPTMK 1029 (1079)
Q Consensus 1001 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 1029 (1079)
. .....+.+++.+|++.||++||++.
T Consensus 224 -~--~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 -R--FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -C--CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0 0112456899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.13 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=189.6
Q ss_pred eeeecCcEEEEEEEeCC---CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 765 IVGKGVSGIVYRVEIPS---RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 765 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
.||+|+||.||+|...+ +..+|+|.+.... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 58999999999997653 3568888874332 223446788999999999999999999999999999999999999
Q ss_pred CChhhhhhccC----cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 842 GSLAGLLHEKK----VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 842 g~L~~~l~~~~----~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+|.+++.... ...++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||.++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999997532 2457778888999999999999999 9999999999999999999999999999765443322
Q ss_pred ccccccccCcccccccccCCC-------CCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchh
Q 001426 918 RASNSVAGSYGYIAPEYGYSL-------KITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
.......++..|+|||+.... .++.++||||||+++|||++ |+.||....+.. ...+. ..... .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~---~~~~~---~ 228 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT---VREQQ---L 228 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH---hhccc---C
Confidence 223345578899999987532 35789999999999999996 999996543211 11110 00000 0
Q ss_pred hhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
...++.... .....+.+++..|| .+|++|||++||++.|+
T Consensus 229 ~~~~~~~~~------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKL------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCC------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 011111100 01124566888999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.47 Aligned_cols=254 Identities=27% Similarity=0.423 Sum_probs=202.8
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
.+|+..+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++.+ ...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc----cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 4688899999999999999988877789999885321 234678999999999999999999998754 56799999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++|+|.+++.+. +..+++..+..++.|++.||+|+|+. +++||||||+||++++++.+||+|||.++.+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999999764 34579999999999999999999999 999999999999999999999999999987654332
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......++..|+|||+..+..++.++||||||+++|||++ |..||....+.. .... .... .
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~~---~------- 220 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ----VERG---Y------- 220 (262)
T ss_pred -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHH----HhcC---C-------
Confidence 12223456778999999988899999999999999999999 787886532211 0000 0000 0
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
. .....+....+.+++.+||+.+|++||+++++++.|++..
T Consensus 221 -~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 221 -R--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -C--CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0 0001122346778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=328.02 Aligned_cols=243 Identities=22% Similarity=0.283 Sum_probs=191.0
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||.||+|+.+ +++.||+|.+.+...........+..|..++... +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999776 6889999998643322223445667788888754 899999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.+++.+.+ .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence 99999997654 488999999999999999999999 99999999999999999999999999987432221 1233
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....... ......+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~----~~~~~~~~~----------- 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESI----RVDTPHYPR----------- 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCCCCCCC-----------
Confidence 45689999999999998999999999999999999999999975321 1111111 110000000
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTMK-DVT 1032 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl 1032 (1079)
.....+.+++.+||+.||++||++. ++.
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 ---WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0112566899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.28 Aligned_cols=260 Identities=27% Similarity=0.392 Sum_probs=203.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC--------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEc
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP--------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNN 828 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 828 (1079)
++|.+.+.||+|+||.||+|+.. ....+|+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC--CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 56888999999999999999653 2346899988532 2233456788999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhccC---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeE
Q 001426 829 GRTRLLLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNIL 893 (1079)
Q Consensus 829 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIl 893 (1079)
....++||||+++|+|.+++...+ ..+++..+..++.|++.|++|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 999999999999999999997542 2478899999999999999999998 9999999999999
Q ss_pred ECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcch
Q 001426 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAH 972 (1079)
Q Consensus 894 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~ 972 (1079)
+++++.+||+|||.++...............+++.|+|||+..+..++.++||||+||++|||++ |..||..... ..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~ 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HH
Confidence 99999999999999986643322222222334578999999988889999999999999999998 8888864321 11
Q ss_pred HHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 973 IITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
+..... ... ..... ......+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 251 ~~~~~~----~~~-----------~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 LFKLLK----EGH-----------RMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHH----cCC-----------CCCCC--CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111111 000 00000 01123667899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.52 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=195.4
Q ss_pred eeecCcEEEEEEEeC---CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCC
Q 001426 766 VGKGVSGIVYRVEIP---SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNG 842 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 842 (1079)
||+|+||.||+|.+. .+..||+|.+... ......+.+.+|+.++++++||||+++++++.. ...++||||+++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 899999999999764 3456899987532 223345679999999999999999999999864 5779999999999
Q ss_pred ChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc-ccc
Q 001426 843 SLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR-ASN 921 (1079)
Q Consensus 843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~ 921 (1079)
+|.+++......+++..+..++.|++.|++|||++ +++||||||+||+++.++.+|++|||+++.+....... ...
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999987666789999999999999999999999 99999999999999999999999999998654433211 122
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhccc
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRS 1000 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1079)
...++..|+|||...+..++.++||||||+++||+++ |+.||....+. .....+.... .. ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~---~~------------~~ 219 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGK---RL------------DC 219 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC---CC------------CC
Confidence 2334678999999888889999999999999999996 99999764321 1111111000 00 00
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 1001 GTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 1001 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
+ ......+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 ~--~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 P--AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred C--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0 01123667899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.59 Aligned_cols=253 Identities=30% Similarity=0.441 Sum_probs=201.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||.||+|..+++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++.. ...+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT----MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC----CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence 4688889999999999999998888889999885422 224578999999999999999999998854 56799999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++++|.+++.+. ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||.+..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999764 34589999999999999999999999 999999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......++..|+|||...+..++.++||||||+++|||++ |..||..... ........ ....
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~---~~~~---------- 221 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVE---RGYR---------- 221 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHH---cCCC----------
Confidence 11222345678999999988889999999999999999999 8888865321 11111110 0000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
..........+.+++.+||+++|++|||++++.+.|++.
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 222 ----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 000011223677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.13 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=198.6
Q ss_pred CeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCC
Q 001426 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGS 843 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 843 (1079)
++||+|+||.||+|...+++.+|+|.+.... .......+.+|+++++.++||||+++++++......++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 3689999999999998888999999875322 22334578899999999999999999999999999999999999999
Q ss_pred hhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccccc
Q 001426 844 LAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSV 923 (1079)
Q Consensus 844 L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 923 (1079)
|.+++......+++..+..++.|++.|+.|+|+. +++||||+|+||++++++.+|++|||++........ ......
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 154 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK 154 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence 9999987666689999999999999999999998 999999999999999999999999999975443221 111223
Q ss_pred ccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCc
Q 001426 924 AGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGT 1002 (1079)
Q Consensus 924 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1079)
.+++.|+|||+..+..++.++||||||+++||+++ |..||...... ..... .... . ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~----~~~~---~--------~~~~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQ----VEKG---Y--------RMSCPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHH----HHcC---C--------CCCCCC
Confidence 44678999999988889999999999999999998 99998654221 11110 0000 0 000000
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 1003 QIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 1003 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
.....+.+++.+||+.+|++||++.|+++.|+
T Consensus 218 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 --KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11236778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.12 Aligned_cols=249 Identities=21% Similarity=0.245 Sum_probs=194.1
Q ss_pred eeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCCh
Q 001426 766 VGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 844 (1079)
||+|+||.||+++.+ +++.||+|.+.............+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999765 6899999998543322222344566799999999999999999999999999999999999999
Q ss_pred hhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccccc
Q 001426 845 AGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSV 923 (1079)
Q Consensus 845 ~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 923 (1079)
.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 9888654 34588999999999999999999999 99999999999999999999999999998665432 12334
Q ss_pred ccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCcc
Q 001426 924 AGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQ 1003 (1079)
Q Consensus 924 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1079)
.|+..|+|||+..+..++.++||||+||++|||++|+.||........ .......... ....... .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~-----------~~~~~~~-~- 220 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLE-----------DEVKFEH-Q- 220 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhc-----------ccccccc-c-
Confidence 689999999999888899999999999999999999999975322111 1111111000 0000000 0
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 1004 IQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 1004 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
.....+.+++.+||+.||++||+++|+++..
T Consensus 221 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 221 -NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 1122567899999999999999998876433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=323.08 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=200.2
Q ss_pred CCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
+|+..+.||+|+||.||+|... .+..||+|++.... .....+.+.+|+.+++.++||||+++++++.+....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4666788999999999999763 24689999885322 223356789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcc---------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC
Q 001426 833 LLLFDYISNGSLAGLLHEK---------------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ 897 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~ 897 (1079)
++++||+.+++|.+++... ...+++..+..++.|++.|++|+|+. +|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 9999999999999998532 23478888999999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHH
Q 001426 898 FEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITW 976 (1079)
Q Consensus 898 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~ 976 (1079)
+.+||+|||+++...............+++.|+|||...+..++.++||||+|+++|||++ |..||..... ......
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~ 238 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVIEM 238 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Confidence 9999999999987654433333334456789999999988889999999999999999998 8888865321 111111
Q ss_pred HHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 977 VNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
+. ..... .... .....+.+++..||+.+|++||++++|++.|+.
T Consensus 239 i~---~~~~~------------~~~~--~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IR---NRQVL------------PCPD--DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH---cCCcC------------CCCC--CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 10 00000 0000 112356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=341.48 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=199.1
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-C-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-S-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.|...+.||+|+||.||+|... + ++.||+|++.. ........+.+|+.+++.++|||||++++++..++..|+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML---NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4788899999999999999654 3 56778886532 22334467888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcc---CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 837 DYISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
||+++|+|.+++.+. ...+++..+..++.||+.||+|+|+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999999988642 34588999999999999999999999 999999999999999999999999999987654
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
...........||+.|+|||+..+..++.++|||||||++|||++|+.||..... . ............
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~---~~~~~~~~~~~~------- 289 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--R---EIMQQVLYGKYD------- 289 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHHHhCCCC-------
Confidence 4322233456799999999999988999999999999999999999999965321 1 111110000000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+ .. ......+.+++.+||+.||++||++++++.
T Consensus 290 ~-----~~--~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 P-----FP--CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C-----CC--ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 00 011235778999999999999999999875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=333.20 Aligned_cols=240 Identities=25% Similarity=0.309 Sum_probs=191.4
Q ss_pred CeeeecCcEEEEEEEe----CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEec
Q 001426 764 NIVGKGVSGIVYRVEI----PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
+.||+|+||.||+++. .+++.||+|++.+... .......+..|++++++++||||+++++++.+....|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999864 3678999999864322 1223456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccc
Q 001426 840 SNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919 (1079)
Q Consensus 840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 919 (1079)
++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~ 154 (318)
T cd05582 81 RGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154 (318)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence 9999999997654 489999999999999999999999 99999999999999999999999999998654331 12
Q ss_pred ccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcc
Q 001426 920 SNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMR 999 (1079)
Q Consensus 920 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1079)
.....|++.|+|||...+..++.++|||||||++|||++|+.||...... . ........ ...+ .
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~---~~~~i~~~-~~~~----------p 218 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--E---TMTMILKA-KLGM----------P 218 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--H---HHHHHHcC-CCCC----------C
Confidence 23456899999999998888999999999999999999999999753211 1 11000000 0000 0
Q ss_pred cCccHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 001426 1000 SGTQIQEMLQVLGVALLCVNPCPEERPTMKD 1030 (1079)
Q Consensus 1000 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 1030 (1079)
. .....+.+++.+||+.||++||++.+
T Consensus 219 --~--~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 --Q--FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --C--CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 01225668999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.62 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=204.7
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC--------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP--------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCN 827 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 827 (1079)
..+|++.+.||+|+||.||+|+.. ++..||+|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 456788899999999999999641 2447899987432 2234457889999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhhccC---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCe
Q 001426 828 NGRTRLLLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNI 892 (1079)
Q Consensus 828 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NI 892 (1079)
.....++||||+++|+|.+++.+.. ..+++..+..++.||++|++|||+. +|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 9999999999999999999997532 3478888999999999999999999 999999999999
Q ss_pred EECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 001426 893 LVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGA 971 (1079)
Q Consensus 893 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~ 971 (1079)
++++++.+||+|||+++...............+++.|+|||+..+..++.++||||||+++|||++ |..||..... .
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~ 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--E 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--H
Confidence 999999999999999987654433323333456778999999988889999999999999999998 7778754321 1
Q ss_pred hHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccc
Q 001426 972 HIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 1040 (1079)
.+.... ..... . .. .......+.+++.+||+++|++|||+.|+++.|+++..
T Consensus 247 ~~~~~~----~~~~~---------~--~~--~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 ELFKLL----KEGHR---------M--DK--PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHH----HcCCc---------C--CC--CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 111111 11000 0 00 00123367789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=339.13 Aligned_cols=204 Identities=26% Similarity=0.336 Sum_probs=174.0
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||+||+|+.. +++.||+|++.+...........+.+|++++++++|||||++++++.++...++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4778899999999999999764 688999999864332233445788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc-
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES- 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~- 916 (1079)
|+++|+|.+++.+.+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999997654 478888999999999999999999 999999999999999999999999999753321000
Q ss_pred --------------------------------------------cccccccccCcccccccccCCCCCCccchHHHHHHH
Q 001426 917 --------------------------------------------SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVV 952 (1079)
Q Consensus 917 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvi 952 (1079)
........||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123468999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 001426 953 LLEVLTGKEPTDSR 966 (1079)
Q Consensus 953 l~el~tg~~p~~~~ 966 (1079)
+|||++|+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (382)
T cd05625 238 LYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=320.32 Aligned_cols=271 Identities=25% Similarity=0.379 Sum_probs=202.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-----CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc--CC
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-----PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN--GR 830 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 830 (1079)
.+|+..+.||+|+||+||+|.. .+++.||+|++.. ......+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH---STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3577889999999999999974 3578899998753 223445788999999999999999999998754 34
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
..++||||+++|+|.+++.+.+..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 67999999999999999987666689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCcccc-cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHh--hhhhc
Q 001426 911 FESSESSR-ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR--ERKRE 987 (1079)
Q Consensus 911 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 987 (1079)
........ ......++..|+|||+..+..++.++||||||+++|||++|..|+..... ........... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccchHH
Confidence 65433211 11122344569999999888899999999999999999999887643211 01000000000 00000
Q ss_pred hhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
..+......... ........+.+++.+||+++|++|||++|+++.|++++
T Consensus 235 ~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 235 LIELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000010000000 01112236778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.96 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=208.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 836 (1079)
..|++.+.||+|+.+.||++...+.+.||+|++.. ...+......|..|+..|.+++ |.+||++|+|-..++.+|+||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 46888999999999999999999889999998753 3345566789999999999994 999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||-+ .+|.+++.++....+.-.++.+..|++.|+.++|.+ ||||.||||.|+|+-+ |.+||+|||.|..+..+..
T Consensus 440 E~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 9764 599999998866666447788999999999999999 9999999999999975 5899999999999888776
Q ss_pred cccccccccCcccccccccCCC-----------CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSL-----------KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERK 985 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 985 (1079)
.......+||+.|||||.+... ++++++||||+|||+|+|+.|+.||.. ++..+
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~---------------~~n~~ 579 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ---------------IINQI 579 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH---------------HHHHH
Confidence 6667788999999999975422 367899999999999999999999964 12223
Q ss_pred hchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 986 REFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
..+..+.++...+..+.. ....++.++++.|+..||++|||+.++++
T Consensus 580 aKl~aI~~P~~~Iefp~~-~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDI-PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHhhcCCCccccccCC-CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 334444555332222211 11123788999999999999999999987
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.36 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=200.6
Q ss_pred CCCCCeeeecCcEEEEEEEeCC----CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe----
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPS----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT---- 831 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 831 (1079)
|+..+.||+|+||.||+|.... +..||+|++.... ........+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 4667889999999999997642 3679999885322 223445789999999999999999999999876554
Q ss_pred --EEEEEEecCCCChhhhhhcc-----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEee
Q 001426 832 --RLLLFDYISNGSLAGLLHEK-----KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904 (1079)
Q Consensus 832 --~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 904 (1079)
.++++||+++|+|..++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 79999999999999998543 23589999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhh
Q 001426 905 FGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRE 983 (1079)
Q Consensus 905 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 983 (1079)
||+++.+.............++..|+|||...+..++.++||||||+++|||++ |..||..... ......... .
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~~---~ 231 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRH---G 231 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---C
Confidence 999987654433322333345678999999988889999999999999999999 8888865321 111111110 0
Q ss_pred hhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 984 RKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
... .........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 232 ~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRL--------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC--------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 00011233678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=340.77 Aligned_cols=205 Identities=26% Similarity=0.343 Sum_probs=174.5
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|++.+.||+|+||.||+|+.. +++.||+|++.+...........+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999999999999764 688999999854332223345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc--
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE-- 915 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~-- 915 (1079)
|+++|+|.+++.+.+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999997655 478888899999999999999999 99999999999999999999999999985331100
Q ss_pred ---------------------------------------ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHH
Q 001426 916 ---------------------------------------SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEV 956 (1079)
Q Consensus 916 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el 956 (1079)
.........||+.|+|||++.+..++.++||||+||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00011234699999999999998999999999999999999
Q ss_pred HhCCCCCCCCC
Q 001426 957 LTGKEPTDSRI 967 (1079)
Q Consensus 957 ~tg~~p~~~~~ 967 (1079)
++|+.||....
T Consensus 238 l~G~~Pf~~~~ 248 (376)
T cd05598 238 LVGQPPFLADT 248 (376)
T ss_pred hhCCCCCCCCC
Confidence 99999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=321.48 Aligned_cols=263 Identities=28% Similarity=0.431 Sum_probs=203.5
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC-----------------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCcee
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-----------------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 820 (1079)
.+|+..+.||+|+||.||+|.... +..||+|.+... ......+.+.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD--ASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 468889999999999999986542 245889987532 2224567899999999999999999
Q ss_pred eeeeEEEcCCeEEEEEEecCCCChhhhhhccC----------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 001426 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK----------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSN 890 (1079)
Q Consensus 821 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~ 890 (1079)
++++++..+...++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 99999999999999999999999999997643 2589999999999999999999998 9999999999
Q ss_pred CeEECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCC
Q 001426 891 NILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT--GKEPTDSRIP 968 (1079)
Q Consensus 891 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t--g~~p~~~~~~ 968 (1079)
||+++.++.++++|||+++...............+++.|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999986654433333334556789999999888889999999999999999998 6667754321
Q ss_pred CcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 969 DGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
............... ....... .......+.+++.+||+.||++|||++|+++.|++
T Consensus 240 --~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDG--------RQIYLPR--PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhcccccc--------ccccCCC--ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111000000 0000000 00112367889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=327.57 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=192.9
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCeEEEEEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 837 (1079)
|+..+.||+|+||+||+|+.. +++.||+|++.+.........+.+..|..+++.+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 566789999999999999765 68899999986543333344567888999998885 5778889999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++.+.+. +++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-- 155 (323)
T cd05615 82 YVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-- 155 (323)
T ss_pred CCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC--
Confidence 9999999999976554 89999999999999999999999 99999999999999999999999999987543222
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....+ ...... . .......
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~---i-~~~~~~~--------- 220 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQS---I-MEHNVSY--------- 220 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHH---H-HhCCCCC---------
Confidence 122345689999999999988999999999999999999999999975421 111110 0 0000000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMK 1029 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 1029 (1079)
. . .....+.+++.+|++.+|++|++..
T Consensus 221 -p--~--~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 221 -P--K--SLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -C--c--cCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0 0 1122566899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.09 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=196.4
Q ss_pred eeeecCcEEEEEEEe---CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 765 IVGKGVSGIVYRVEI---PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 765 ~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
.||+|+||.||+|.+ ++++.+|+|++... .......+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC-CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999965 35788999987532 2223345789999999999999999999999864 567899999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc-cc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR-AS 920 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~ 920 (1079)
|+|.+++...+ .+++..+..++.|++.|++|+|+. +|+||||||+||++++++.+||+|||+++......... ..
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 80 GPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999997554 489999999999999999999999 99999999999999999999999999998765443211 12
Q ss_pred cccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcc
Q 001426 921 NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMR 999 (1079)
Q Consensus 921 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1079)
....++..|+|||......++.++||||||+++|||++ |+.||..... ......+.. .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~---~~~~~------------ 218 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIES---GERME------------ 218 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHC---CCCCC------------
Confidence 22344679999999888889999999999999999998 9999975422 111111110 00000
Q ss_pred cCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 1000 SGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 1000 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
... .....+.+++.+||++||++||++++|++.|+++.
T Consensus 219 ~~~--~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 219 CPQ--RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred CCC--CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 000 11235678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.35 Aligned_cols=256 Identities=24% Similarity=0.400 Sum_probs=203.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
++|+..+.||+|+||.||+|.... +..||+|.+.. .........+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE--NASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCC--ccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 567888999999999999997642 36799998742 2223445678899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccC---------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEE
Q 001426 832 RLLLFDYISNGSLAGLLHEKK---------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFL 902 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 902 (1079)
.++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 999999999999999996432 2368889999999999999999998 9999999999999999999999
Q ss_pred eeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHH
Q 001426 903 ADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGEL 981 (1079)
Q Consensus 903 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 981 (1079)
+|||+++.+.............++..|+|||...+..++.++|||||||++||+++ |..||..... ........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~--- 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVI--- 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHh---
Confidence 99999986654432223334456789999999988889999999999999999998 8888864322 11111111
Q ss_pred hhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 982 RERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
...... ... .....+.+++.+||+.+|++|||+.++++.|++
T Consensus 236 ~~~~~~------------~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLD------------LPE--NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCC------------CCC--CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 000000 000 113467789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=331.45 Aligned_cols=244 Identities=24% Similarity=0.283 Sum_probs=190.8
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHH-HHhcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQ-TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||+||+|+.. +++.||+|++.+...........+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 68899999986543333334455556655 47789999999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|..++...+ .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence 99999987554 489999999999999999999999 99999999999999999999999999987533221 2233
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... .........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~-----------~~~~~~~~~- 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNI-----------LHKPLVLRP- 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHH-----------HcCCccCCC-
Confidence 456899999999999999999999999999999999999999753211 111100 000000111
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.....+.+++.+|++.+|++||++++.++
T Consensus 218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 ---GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ---CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 11235668899999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=321.51 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=200.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC-CC--eEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-RQ--VIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 833 (1079)
++|+..+.||+|+||.||+|..++ +. .+++|.+.. .......+.+.+|+.++.++ +||||+++++++.+....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 468888999999999999997653 32 467777642 12223456789999999999 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhccC---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC
Q 001426 834 LLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF 898 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~ 898 (1079)
+|+||+++|+|.+++.+.. ..+++..++.++.|++.|++|||+. +|+||||||+||++++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 9999999999999996532 2478899999999999999999998 999999999999999999
Q ss_pred cEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHH
Q 001426 899 EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWV 977 (1079)
Q Consensus 899 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~ 977 (1079)
.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||....... ..
T Consensus 157 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~ 228 (297)
T cd05089 157 ASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LY 228 (297)
T ss_pred eEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HH
Confidence 9999999998643211 11111233567999999988889999999999999999997 999997543211 11
Q ss_pred HhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccC
Q 001426 978 NGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 1042 (1079)
.. ... ........ .....+.+++.+||+.+|.+|||++++++.|+++....
T Consensus 229 ~~-~~~-----------~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 EK-LPQ-----------GYRMEKPR--NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HH-Hhc-----------CCCCCCCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 000 00000000 11235678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.49 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=202.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 5688889999999999999998889999999885322 23467899999999999999999999875 456899999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++|+|.+++... +..+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999998654 44689999999999999999999998 999999999999999999999999999986653321
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......++..|+|||+..+..++.++||||||+++||+++ |+.||..... ........... ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~---~~--------- 222 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNLERGY---RM--------- 222 (260)
T ss_pred -ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHcCC---CC---------
Confidence 12223346778999999988889999999999999999999 9999975421 11111110000 00
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.... .....+.+++.+||+.+|++|||++++.+.|+++
T Consensus 223 ---~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 223 ---PRPD--NCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ---CCCC--CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 0000 1123677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=319.77 Aligned_cols=259 Identities=23% Similarity=0.392 Sum_probs=202.4
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 830 (1079)
.++|++.+.||+|+||.||+|..+ .+..||+|.+... ........+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 467899999999999999998653 2457899987432 22234456889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhccC---------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEE
Q 001426 831 TRLLLFDYISNGSLAGLLHEKK---------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF 901 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 901 (1079)
..++||||+++|+|.+++.+.+ ...++..+..++.|++.|++|||+. +|+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997532 2346778889999999999999999 999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhH
Q 001426 902 LADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGE 980 (1079)
Q Consensus 902 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 980 (1079)
++|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||...... .......
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~-- 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFVM-- 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH--
Confidence 999999986654332222223345778999999988889999999999999999999 78888653211 1111110
Q ss_pred HhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 981 LRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
...... ... .....+.+++.+|++.+|++|||+.++++.+++..
T Consensus 236 -~~~~~~------------~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 -DGGYLD------------QPD--NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -cCCCCC------------CCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 000000 000 11246788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=329.97 Aligned_cols=244 Identities=24% Similarity=0.260 Sum_probs=188.3
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHH-HHHhcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEV-QTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||+||+|+.. +++.||+|++.+...........+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999775 5778999998643222222233444444 457889999999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.+++...+. +++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~ 154 (325)
T cd05602 81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS 154 (325)
T ss_pred CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence 999999976544 77888888999999999999999 99999999999999999999999999997543221 2233
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......... ...+ ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~-~~~~----------~~- 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNILNK-PLQL----------KP- 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHHHHHhC-CcCC----------CC-
Confidence 457999999999999999999999999999999999999999753211 111100000 0000 00
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.....+.+++.+|++.||++||++.+.+.
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 ---NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ---CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 11225668899999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=337.31 Aligned_cols=371 Identities=30% Similarity=0.399 Sum_probs=252.3
Q ss_pred cCCCCEEeccCCccc-CCCCcccCCcCcccEEeccCCcccccCccccccccccceEecccccccCCCChhhchhhhHHHH
Q 001426 112 LSSLINLDLSFNALT-GNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEII 190 (1079)
Q Consensus 112 l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 190 (1079)
|+..+-.|+|+|.++ +..|.....+++++.|.|...++. .+|++++.|.+|++|.+++|++. .+-.+++.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~------- 76 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSD------- 76 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhcc-------
Confidence 344445555566555 345555555555555555555555 55555555666666666665554 22222333
Q ss_pred HhCCCCCcccCCCcccccccceeEeecccCCCccCCCcccccccccccccccccccc-ccCCcccccccccceecccccc
Q 001426 191 RAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANIT-GYIPEEIGNCSALENLFLYENQ 269 (1079)
Q Consensus 191 ~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~~~-~~~p~~l~~l~~L~~L~L~~n~ 269 (1079)
|+.|+.+.+..|++. .-+|..+..|..|+.|+|++|+
T Consensus 77 ------------------------------------------Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNq 114 (1255)
T KOG0444|consen 77 ------------------------------------------LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQ 114 (1255)
T ss_pred ------------------------------------------chhhHHHhhhccccccCCCCchhcccccceeeecchhh
Confidence 333333333333332 2356777888888888999999
Q ss_pred cccCCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeeccccccccccccc
Q 001426 270 IFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSF 349 (1079)
Q Consensus 270 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 349 (1079)
+. ..|..+..-+++-.|+||+|+|..+....|.+++.|-.||||+|++. .+|+.+..+..|++|+|++|.+...--..
T Consensus 115 L~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQ 192 (1255)
T KOG0444|consen 115 LR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQ 192 (1255)
T ss_pred hh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhc
Confidence 87 78888999999999999999999555556789999999999999998 77888999999999999999887544455
Q ss_pred ccccccCcEeeccCCccc-ccCCccccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCCCCCcccccccccccc
Q 001426 350 FGNFSRLKQLELDNNRFF-GQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLT 428 (1079)
Q Consensus 350 ~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 428 (1079)
+..+.+|+.|.+++.+=+ ..+|.++. .+.+|..+|+|.|.+. ++|+.+.++++|+
T Consensus 193 LPsmtsL~vLhms~TqRTl~N~Ptsld-----------------------~l~NL~dvDlS~N~Lp-~vPecly~l~~Lr 248 (1255)
T KOG0444|consen 193 LPSMTSLSVLHMSNTQRTLDNIPTSLD-----------------------DLHNLRDVDLSENNLP-IVPECLYKLRNLR 248 (1255)
T ss_pred CccchhhhhhhcccccchhhcCCCchh-----------------------hhhhhhhccccccCCC-cchHHHhhhhhhh
Confidence 666778888888876543 23444443 4456777777777777 6777777777777
Q ss_pred ccccccccccccCCCcccCCCCceEEEecCCCccccCccccccccccCeeeeccCccc-CCCCCCCCCCCcccEEecCCC
Q 001426 429 QLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFT-GEIPPEIGNCTQLEMVDLHQN 507 (1079)
Q Consensus 429 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N 507 (1079)
.|+|++|+|+ .+........+|++|+|+.|+++ ..|+++..+++|+.|++.+|+++ .-+|..++.+.+|+.+..++|
T Consensus 249 rLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN 326 (1255)
T KOG0444|consen 249 RLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANN 326 (1255)
T ss_pred eeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcc
Confidence 7777777776 44444555566777777777777 66777777777777777777765 235666777777777777777
Q ss_pred cCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEecccccccCCCCC
Q 001426 508 KLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPK 563 (1079)
Q Consensus 508 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 563 (1079)
++. .+|+.+..+..|+.|.|++|++- ..|+++.-++.|+.||+..|.---.+|.
T Consensus 327 ~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 327 KLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred ccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 776 66777777777777777777766 5677777777777777777653334443
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.68 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=202.5
Q ss_pred CCCCCCeeeecCcEEEEEEEeCC-C---CeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPS-R---QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 834 (1079)
.|+..+.||+|+||.||+|.... + ..||+|.+... ........|..|+.+++.++||||+++++++.++...++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 46778899999999999997653 3 35899987432 234456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
||||+++|+|.+++...+..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999987666789999999999999999999998 9999999999999999999999999999866543
Q ss_pred cccccccc---cccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhh
Q 001426 915 ESSRASNS---VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTT 990 (1079)
Q Consensus 915 ~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1079)
........ ...+..|+|||...+..++.++||||+|+++||+++ |..||..... ......+.. . .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~---~-~----- 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQ---D-Y----- 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHc---C-C-----
Confidence 22111111 112457999999998899999999999999999887 9999875321 111111110 0 0
Q ss_pred hhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
..... .+....+.+++.+||+.+|++||+++++++.|+++
T Consensus 229 ------~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ------RLPPP--MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------cCCCc--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 01123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=319.61 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=200.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-----------------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCcee
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-----------------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 820 (1079)
++|+..+.||+|+||.||+++.. ++..+|+|.+... ........+.+|+.+++.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 46888999999999999998543 2346889987532 2233457899999999999999999
Q ss_pred eeeeEEEcCCeEEEEEEecCCCChhhhhhccC----------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 001426 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK----------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSN 890 (1079)
Q Consensus 821 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~ 890 (1079)
++++++..++..++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 99999999999999999999999999997542 2367788999999999999999999 9999999999
Q ss_pred CeEECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCC
Q 001426 891 NILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT--GKEPTDSRIP 968 (1079)
Q Consensus 891 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t--g~~p~~~~~~ 968 (1079)
||++++++.++++|||+++.+.............+++.|+|||....+.++.++|||||||++|||++ |..||....+
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999986644332222233345678999999888889999999999999999998 6678764322
Q ss_pred CcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 969 DGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
. ............... .... .... .....+.+++.+||+.||++||++++|++.|++
T Consensus 240 ~--~~~~~~~~~~~~~~~---~~~~-----~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 E--QVIENTGEFFRDQGR---QVYL-----PKPA--LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H--HHHHHHHHHHhhccc---cccC-----CCCC--CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 111111100000000 0000 0000 122467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.12 Aligned_cols=257 Identities=26% Similarity=0.446 Sum_probs=203.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CC---CeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SR---QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
.+|+..+.||+|+||.||+|... ++ ..+|+|.+... ......+.+..|++++++++|+||+++.+++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 35777889999999999999765 23 36889887432 22334578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+||||+++++|.+++.+....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999987666689999999999999999999999 999999999999999999999999999986644
Q ss_pred Cccccc-ccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 914 SESSRA-SNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 914 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
...... ......++.|+|||+.....++.++|||||||++|||++ |+.||...... .....+. ..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~----~~------- 226 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAIN----DG------- 226 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHh----cC-------
Confidence 321111 112223567999999988889999999999999999998 99998653211 1111111 00
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
. ...........+.+++.+||+.+|++||++++|++.|+++
T Consensus 227 ----~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ----F--RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----C--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0000011223677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.33 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=203.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC----CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP----SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
.+|+..+.||+|+||.||+|... .+..+|+|.+... ......+.+..|+.++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45778899999999999999763 2336899987432 22334578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+||||+++++|.+++.+....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++.+..
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999999987766689999999999999999999999 999999999999999999999999999987654
Q ss_pred Ccccc-cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 914 SESSR-ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 914 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
..... ......++..|+|||...+..++.++||||||+++||+++ |+.||...... ....... +...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~----~~~~----- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIE----EGYR----- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHh----CCCc-----
Confidence 32111 1122234568999999998889999999999999999887 99998754321 1111111 0000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
..........+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000001123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.25 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=203.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCC--eEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQ--VIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 833 (1079)
.+|+..+.||+|+||.||+|..+ ++. .+|+|.+.. .........+.+|++++.++ +||||+++++++.++...+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 46788899999999999999864 344 456666532 22334457889999999999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhccC---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC
Q 001426 834 LLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF 898 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~ 898 (1079)
+||||+++|+|.+++++.+ ..+++..++.++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 9999999999999997542 2578999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHH
Q 001426 899 EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWV 977 (1079)
Q Consensus 899 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~ 977 (1079)
.+||+|||+++..... .......++..|+|||...+..++.++|||||||++|||++ |..||...... ......
T Consensus 162 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~ 236 (303)
T cd05088 162 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL 236 (303)
T ss_pred cEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHH
Confidence 9999999998643211 11112234678999999888889999999999999999998 99998653221 111100
Q ss_pred HhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccCCCCCC
Q 001426 978 NGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEK 1047 (1079)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 1047 (1079)
... ...... ......+.+++.+||+.+|++||+++++++.++++.........
T Consensus 237 ----~~~-----------~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~ 289 (303)
T cd05088 237 ----PQG-----------YRLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 289 (303)
T ss_pred ----hcC-----------CcCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhh
Confidence 000 000000 01123567899999999999999999999999998766554433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=318.76 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=200.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
++|...+.||+|+||.||++... ++..+|+|.+.. ........+.+|+++++.++|+||+++++++.++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc---CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 45777889999999999999642 356788887642 233456789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccC--------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC
Q 001426 832 RLLLFDYISNGSLAGLLHEKK--------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ 897 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~ 897 (1079)
.+++|||+++|+|.+++...+ ..+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 999999999999999997543 2478899999999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHH
Q 001426 898 FEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITW 976 (1079)
Q Consensus 898 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~ 976 (1079)
+.+||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |..||...... .....
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~ 236 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAIEC 236 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHHHH
Confidence 9999999999986544332222333445788999999988899999999999999999998 88888643221 11100
Q ss_pred HHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 977 VNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
. ...... .... .....+.+++.+||+.||.+||+++++++.|+.
T Consensus 237 ~---~~~~~~------------~~~~--~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 I---TQGREL------------ERPR--TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred H---HcCccC------------CCCC--CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0 000000 0000 112356789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.81 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=201.0
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|...+.||+|+||.||+|..+++..+|+|.+.... ...+.+.+|++++++++|+|++++++++.. ...++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence 4578888999999999999998887789999874321 234678899999999999999999998854 56789999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++|+|.+++.+. ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999999764 34578999999999999999999998 999999999999999999999999999987644321
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......++..|+|||...+..++.++||||||+++|||++ |..||....+. ....... ... ..
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~----~~~---~~----- 222 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVE----RGY---RM----- 222 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH----cCC---CC-----
Confidence 12223346778999999988899999999999999999999 88898754221 1111110 000 00
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
... ......+.+++.+||+.+|++||+++++++.|+++
T Consensus 223 ---~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 223 ---PCP--QGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred ---CCC--cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 000 01224677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=313.99 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=194.2
Q ss_pred CeeeecCcEEEEEEEeC----CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEE-cCCeEEEEEEe
Q 001426 764 NIVGKGVSGIVYRVEIP----SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCN-NGRTRLLLFDY 838 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~ 838 (1079)
+.||+|+||.||+|... .+..+|+|.+.. .......+.+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCc--cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999999753 245789998742 222344578889999999999999999999875 45567999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc-
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS- 917 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~- 917 (1079)
+.+|+|.+++.+.....++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.+......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999999987665678888899999999999999998 9999999999999999999999999999865432211
Q ss_pred -ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCC-CCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 918 -RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGK-EPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 918 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......++..|+|||...+..++.++||||||+++|||++|. .||.... .......+. .....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~---~~~~~--------- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLL---QGRRL--------- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHh---cCCCC---------
Confidence 1112344677899999998888999999999999999999954 4554321 111111110 00000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 1040 (1079)
.... .....+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 222 ---~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 ---LQPE--YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---CCCC--cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0000 112357789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=312.54 Aligned_cols=249 Identities=28% Similarity=0.466 Sum_probs=202.7
Q ss_pred CeeeecCcEEEEEEEeCC----CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEec
Q 001426 764 NIVGKGVSGIVYRVEIPS----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
+.||+|+||.||+|.... +..||+|.+....... ..+.+.+|+++++.++|+||+++++++.++...++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 469999999999997764 7889999886433222 4678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcc--------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccc
Q 001426 840 SNGSLAGLLHEK--------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911 (1079)
Q Consensus 840 ~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~ 911 (1079)
++++|.+++... ...+++..++.++.|++.|++|||+. +++||||+|+||++++++.+|++|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 999999999876 46689999999999999999999998 9999999999999999999999999999877
Q ss_pred cCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhh
Q 001426 912 ESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTT 990 (1079)
Q Consensus 912 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1079)
.............++..|+|||......++.++||||+|+++|||++ |..||....+ ..+...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~---~------- 223 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK---G------- 223 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc---C-------
Confidence 65433333445567889999999888889999999999999999999 6899876421 111111110 0
Q ss_pred hhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
... ... ......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 224 ---~~~--~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---YRL--PKP--EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCC--CCC--ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 000 011346778999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=316.38 Aligned_cols=260 Identities=26% Similarity=0.386 Sum_probs=205.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC-CC----eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-RQ----VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
.+|+..+.||+|+||.||+|..+. ++ .+|+|...... .......+.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 467888999999999999997642 32 57888764322 23345788999999999999999999999987 788
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
++||||+++|+|.+++......+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.++...
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999999988766799999999999999999999998 99999999999999999999999999998765
Q ss_pred CCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
............++..|+|||......++.++|+||||+++||+++ |+.||...... .+...+. ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~----~~~~----- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLE----KGER----- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHh----CCCC-----
Confidence 4332222222334678999999988889999999999999999998 99999754221 1111111 0000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccC
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 1042 (1079)
..... .....+.+++.+||..+|.+|||+.++++.|+++.+..
T Consensus 230 ----~~~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 230 ----LPQPP----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ----CCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 00000 11235678899999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=327.36 Aligned_cols=205 Identities=26% Similarity=0.300 Sum_probs=176.6
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||+||+++.. +++.||+|++.+.........+.+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888899999999999999765 68899999986433333345567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++.+.+..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999987666689999999999999999999999 999999999999999999999999999976544321
Q ss_pred cccccccccCcccccccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-----LKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 12233468999999998763 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=315.96 Aligned_cols=252 Identities=26% Similarity=0.362 Sum_probs=186.5
Q ss_pred eeeecCcEEEEEEEeCC---CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 765 IVGKGVSGIVYRVEIPS---RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 765 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
.||+|+||.||+|...+ ...+|+|.+.. .........+.+|+.+++.++|+||+++++++.+....++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRA--SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCc--cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999997543 34677776632 22233456788999999999999999999999999999999999999
Q ss_pred CChhhhhhccC----cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 842 GSLAGLLHEKK----VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 842 g~L~~~l~~~~----~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+|.+++.+.. ...++..+..++.||+.|++|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999997643 2346778889999999999999999 9999999999999999999999999998765433322
Q ss_pred ccccccccCcccccccccC-------CCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchh
Q 001426 918 RASNSVAGSYGYIAPEYGY-------SLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
.......+++.|+|||+.. ...++.++||||+||++|||++ |..||....+. ....... .....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~----~~~~~--- 228 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQVV----REQDI--- 228 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHh----hccCc---
Confidence 2223345677899999853 3456889999999999999999 77787643221 1111111 11000
Q ss_pred hhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
....+... ......+..++..||. ||++|||+++|++.|.
T Consensus 229 ~~~~~~~~------~~~~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLD------LKYSDRWYEVMQFCWL-DPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCccc------ccCCHHHHHHHHHHhc-CcccccCHHHHHHHhc
Confidence 00011000 0112244567788984 9999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=310.65 Aligned_cols=250 Identities=28% Similarity=0.382 Sum_probs=202.3
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|+||.||+|..+ +++.|++|.+.... ........+.+|++++++++||||+++++++.++...++||||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh-CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 667788999999999999775 68889999875322 2344567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 839 ISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 839 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
+++++|.+++... +..+++..++.++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999875 55689999999999999999999998 999999999999999999999999999986654321
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......|++.|+|||+..+..++.++||||||+++|||++|+.||..... ..... .......+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~---~~~~~~~~~~--------- 221 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALIL---KIIRGVFPPV--------- 221 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHH---HHHcCCCCCC---------
Confidence 12334678899999999988899999999999999999999999975421 11110 0000000000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.. .....+.+++.+||+.+|++||++.++++.
T Consensus 222 ---~~--~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ---SQ--MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---cc--ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 112367789999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=324.30 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=204.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC--------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEc
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS--------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNN 828 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 828 (1079)
.+|++.+.||+|+||.||+|+..+ +..||+|.+.. .......+.+.+|+++++++ +||||++++++|..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD--DATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccc--ccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 468889999999999999996421 23689997742 22233457899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhccC---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeE
Q 001426 829 GRTRLLLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNIL 893 (1079)
Q Consensus 829 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIl 893 (1079)
+...++++||+++|+|.+++.+.. ..+++..+..++.|++.|++|||+. +|+||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 999999999999999999997532 3478889999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcch
Q 001426 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAH 972 (1079)
Q Consensus 894 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~ 972 (1079)
+++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||..... ..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~ 244 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--EE 244 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--HH
Confidence 99999999999999986654332222223344578999999998899999999999999999998 8888865321 11
Q ss_pred HHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccCC
Q 001426 973 IITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEND 1043 (1079)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 1043 (1079)
...... ..... ... ......+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 245 ~~~~~~---~~~~~------------~~~--~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 LFKLLK---EGHRM------------DKP--ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHH---cCCCC------------CCC--CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 111110 00000 000 0112367789999999999999999999999999975443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=321.96 Aligned_cols=260 Identities=26% Similarity=0.411 Sum_probs=203.5
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC--------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEc
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP--------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNN 828 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 828 (1079)
++|...+.||+|+||.||+|+.. ....+|+|.+... ........+..|+.+++++ +||||+++++++.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 56788899999999999999642 2456889987532 2234456788999999999 69999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhccC---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeE
Q 001426 829 GRTRLLLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNIL 893 (1079)
Q Consensus 829 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIl 893 (1079)
....++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 999999999999999999996532 3478899999999999999999998 9999999999999
Q ss_pred ECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcch
Q 001426 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAH 972 (1079)
Q Consensus 894 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~ 972 (1079)
+++++.+|++|||.++...............++..|+|||+..+..++.++||||||+++|||++ |..||..... ..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~ 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--EE 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--HH
Confidence 99999999999999986654332222222334568999999988889999999999999999999 8888865321 11
Q ss_pred HHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 973 IITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
...... .... . ... ......+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 245 ~~~~~~----~~~~-----~------~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 245 LFKLLR----EGHR-----M------DKP--SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHH----cCCC-----C------CCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 111111 0000 0 000 01122566899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=313.07 Aligned_cols=254 Identities=29% Similarity=0.449 Sum_probs=204.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||.||+|..++++.+|+|.+... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG----TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC----ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 568889999999999999999888888999988532 2245679999999999999999999999999899999999
Q ss_pred ecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++++|.+++.+.. ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||.++.+....
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 999999999997653 4689999999999999999999999 99999999999999999999999999998665422
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
........++..|+|||...+..++.++||||+|+++||+++ |+.||..... ......... .....
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~-------~~~~~---- 224 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVER-------GYRMP---- 224 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc-------CCCCC----
Confidence 111222335678999999998889999999999999999998 9999865321 111111000 00000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
... .....+.+++.+||+.+|++||+++++++.|+++
T Consensus 225 ----~~~--~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 225 ----RPP--NCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred ----CCC--CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 000 1123677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=317.78 Aligned_cols=256 Identities=29% Similarity=0.516 Sum_probs=201.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
++|+..+.||+|+||.||+|... ++..||+|.+.. .......+.+.+|+.++++++||||+++++++.++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~--~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCC--CcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 46888899999999999999764 467899998743 2223345779999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccC---------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 001426 832 RLLLFDYISNGSLAGLLHEKK---------------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSN 890 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~ 890 (1079)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999996431 2467888999999999999999999 9999999999
Q ss_pred CeEECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCC
Q 001426 891 NILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPD 969 (1079)
Q Consensus 891 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~ 969 (1079)
||++++++.++++|||+++.+..............+..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999886544332222233345678999999988899999999999999999998 88888643221
Q ss_pred cchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 970 GAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
...... .. .... .... .....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 --~~~~~~----~~--~~~~---------~~~~--~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EVIYYV----RD--GNVL---------SCPD--NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHH----hc--CCCC---------CCCC--CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111110 00 0000 0000 112367789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=332.11 Aligned_cols=256 Identities=21% Similarity=0.245 Sum_probs=196.5
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|+.+ +++.||+|.+.+...........+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67899999999999999999775 67889999885433223334566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 123 Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~- 196 (371)
T cd05622 123 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG- 196 (371)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-
Confidence 999999999999654 378888899999999999999999 99999999999999999999999999998765332
Q ss_pred cccccccccCcccccccccCCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSL----KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
........||+.|+|||++... .++.++||||+||++|||++|+.||...... ....... ...... ..
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~-----~~~~~~-~~- 268 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIM-----NHKNSL-TF- 268 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHH-----cCCCcc-cC-
Confidence 1223346799999999997653 3788999999999999999999999753211 0011110 000000 00
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEE--RPTMKDVTAML 1035 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~L 1035 (1079)
.........+.+++.+|+..+|.+ ||+++|+++..
T Consensus 269 --------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 --------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000011234567888899843433 67888888743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=318.83 Aligned_cols=272 Identities=25% Similarity=0.404 Sum_probs=206.8
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-----CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc--CC
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-----SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN--GR 830 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 830 (1079)
+.|+..+.||+|+||.||+|.+. +++.+|+|.+...... ...+.|.+|+++++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 35677889999999999999754 4678999988543222 346789999999999999999999999877 56
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
..++||||+++++|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 78999999999999999987766699999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCccc-ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchh
Q 001426 911 FESSESS-RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 911 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
....... .......++..|+|||...+..++.++||||||+++|||++|+.|+.........+...... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG--QMIVTRLL 236 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc--cccHHHHH
Confidence 6533221 11222345667999999988899999999999999999999999986532221110000000 00000000
Q ss_pred hhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
........... .......+.+++.+||+.+|++||||.||+++|+.+
T Consensus 237 ~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111110000 111224678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=310.37 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=200.8
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCC--chhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGE--LPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 834 (1079)
+.|+..+.||+|+||.||+|.. .+++.+|+|.+....... ....+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 3578889999999999999975 468899999886432221 2234678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
|+||+++++|.+++...+ .+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999997654 378899999999999999999999 9999999999999999999999999999865432
Q ss_pred cccc-cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 915 ESSR-ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 915 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
.... ......++..|+|||...+..++.++||||+|+++|||++|+.||...... ..............+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~----- 228 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQPTNPQL----- 228 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHHHhccCCCCCC-----
Confidence 2111 112345788999999999888999999999999999999999998653211 111000000000000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.. .....+.+++.+||+.+|++|||+.|+++.
T Consensus 229 -------~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 -------PS--HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -------Cc--cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 112256789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=317.47 Aligned_cols=269 Identities=23% Similarity=0.351 Sum_probs=202.5
Q ss_pred CCCCCeeeecCcEEEEEEEe-----CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--CeE
Q 001426 760 LSDTNIVGKGVSGIVYRVEI-----PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG--RTR 832 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 832 (1079)
|+..+.||+|+||.||++++ .++..||+|.+.... .......+.+|+++++.++||||+++++++.+. ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 57788999999999999974 357889999885332 233456899999999999999999999999775 568
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
++||||+++++|.+++.+....+++..+..++.|++.||+|+|+. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 999999999999999977655689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCccc-ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHH-hhhhhchhh
Q 001426 913 SSESS-RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL-RERKREFTT 990 (1079)
Q Consensus 913 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 990 (1079)
..... .......++..|+|||+..+..++.++||||||+++|||++++.|+...... ......... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcccccccccHHHHHH
Confidence 43221 1222345677899999988888999999999999999999988765432110 000000000 000000000
Q ss_pred hhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
....... ..........+.+++.+||+.+|++|||++++++.++++
T Consensus 238 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKR--LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCcc--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000 000011234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=310.21 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=196.9
Q ss_pred CeeeecCcEEEEEEEeCC----CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEec
Q 001426 764 NIVGKGVSGIVYRVEIPS----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
+.||+|+||.||+|.+.. +..+|+|.+...... ...+.+.+|+++++.++|+||+++++++.. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 469999999999996532 267899988543222 345789999999999999999999998764 5679999999
Q ss_pred CCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc-
Q 001426 840 SNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR- 918 (1079)
Q Consensus 840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~- 918 (1079)
++|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.........
T Consensus 78 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 78 PLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999998665 589999999999999999999999 99999999999999999999999999998765433211
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......++..|+|||...+..++.++||||||+++|||++ |+.||....+ ......+....+ .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~---~----------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER---L----------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc---C-----------
Confidence 1112234568999999988899999999999999999998 9999875422 122222111000 0
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
.... .....+.+++.+||..+|++||++.++++.|+++.
T Consensus 218 -~~~~--~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -PRPE--ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCC--CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0000 11236778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=309.28 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=199.0
Q ss_pred CeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCC
Q 001426 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGS 843 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 843 (1079)
++||+|+||.||++...+++.||+|.+..... ......+.+|++++++++|+||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 46899999999999887799999998753322 1355789999999999999999999999999999999999999999
Q ss_pred hhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccccc
Q 001426 844 LAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSV 923 (1079)
Q Consensus 844 L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 923 (1079)
|.+++.+....+++..+..++.+++.|++|||+. +++||||+|+||+++.++.+||+|||.++..............
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9999977666688999999999999999999999 9999999999999999999999999999865432211111223
Q ss_pred ccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCc
Q 001426 924 AGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGT 1002 (1079)
Q Consensus 924 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1079)
.++..|+|||...+..++.++||||||+++|||++ |..||....+. ....... ... .. ...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~----~~~----~~-------~~~- 217 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIE----SGY----RM-------PAP- 217 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHh----cCC----CC-------CCC-
Confidence 34667999999988889999999999999999999 88888654221 1111110 000 00 000
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 1003 QIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 1003 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 218 -~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 -QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 011236778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=315.07 Aligned_cols=252 Identities=19% Similarity=0.259 Sum_probs=198.0
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|+||+||+|... +++.+|+|.+.............+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999764 6889999988543322223345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 839 ISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 839 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999988654 33589999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......|+..|+|||+..+..++.++|+||+|+++|||++|+.||........ ...+..........+
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~~~~--------- 224 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLETEEVY--------- 224 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhcccccc---------
Confidence 12234689999999999888999999999999999999999999975422110 111111111100000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPT-----MKDVTA 1033 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 1033 (1079)
.. .....+.+++..||+.||++||+ ++++++
T Consensus 225 ---~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 ---SA--KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ---Cc--cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00 11225668999999999999999 667766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=320.84 Aligned_cols=272 Identities=16% Similarity=0.256 Sum_probs=202.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|...+.||+|+||+||+|+.+ +++.||+|.+..... ......+.+|++++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 46888899999999999999765 678899998854322 223356778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++ ++.+++...+..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 99975 89998877766689999999999999999999999 99999999999999999999999999997643322
Q ss_pred cccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHh---HHhhhhhchhh--
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG---ELRERKREFTT-- 990 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-- 990 (1079)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ........ ...+.++....
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchh
Confidence 12223467899999998764 468899999999999999999999997643211 11111110 00111111100
Q ss_pred -hhhhhhhcccCcc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhc
Q 001426 991 -ILDRQLLMRSGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEI 1038 (1079)
Q Consensus 991 -~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 1038 (1079)
..+.......... ........+++.+|++.||++|||++|+++ .+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0000000000000 011235678999999999999999999987 44443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=314.35 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=198.8
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|+||+||++... +++.||+|.+.+...........+..|+.++++++|++|+++++++.++...++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566788999999999999765 6889999988644333333345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 839 ISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 839 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999998654 33589999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||........ ... ......... ...
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~-~~~~~~~~~--------~~~- 224 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REE-VERLVKEVQ--------EEY- 224 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHH-HHhhhhhhh--------hhc-
Confidence 12234689999999999988999999999999999999999999976432110 000 000000000 000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPT-----MKDVTA 1033 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 1033 (1079)
.. .....+.+++.+||+.||++||| ++|+++
T Consensus 225 ---~~--~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 ---SE--KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---Cc--cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00 01224668899999999999999 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=310.83 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=203.4
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.++|+..+.||+|+||.||+|...++..+|+|.+.. .....+.+.+|++++++++|+||+++++++.+ ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP----GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCC----ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 357888999999999999999988888899998753 12345788999999999999999999999887 7789999
Q ss_pred EecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 837 DYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
||+++|+|.+++.+. +...++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999764 44578899999999999999999998 99999999999999999999999999998665432
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
. .......++..|+|||++....++.++|+|||||++||+++ |+.||..... ........ ...
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~----~~~--------- 220 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALE----RGY--------- 220 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHh----CCC---------
Confidence 1 12223345678999999988889999999999999999999 8989865321 11111111 000
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
..... ......+.+++.+||+++|++||++.++.+.|+++
T Consensus 221 --~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 221 --RMPRP--ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred --CCCCc--ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 00000 01223677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=332.99 Aligned_cols=205 Identities=25% Similarity=0.356 Sum_probs=176.5
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||+||+|... +++.||+|++.+...........+.+|+.++..++||+|+++++++.+++..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5778899999999999999765 688999999864333333445788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++.+.+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999997654 488999999999999999999999 9999999999999999999999999998755321100
Q ss_pred ---------------------------------ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 001426 918 ---------------------------------RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964 (1079)
Q Consensus 918 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~ 964 (1079)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00113469999999999999999999999999999999999999997
Q ss_pred CCC
Q 001426 965 SRI 967 (1079)
Q Consensus 965 ~~~ 967 (1079)
...
T Consensus 238 ~~~ 240 (360)
T cd05627 238 SET 240 (360)
T ss_pred CCC
Confidence 643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=312.87 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=203.6
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC----CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
++|+..+.||+|+||.||+|...+ ...||+|..... ......+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 457788899999999999997643 346888877432 223455789999999999999999999999876 4568
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+||||+++|+|.+++.+....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999999987666689999999999999999999998 999999999999999999999999999986654
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
... .......++..|+|||......++.++||||||+++||+++ |..||...... ...... ....
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~----~~~~------- 225 (270)
T cd05056 160 ESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRI----ENGE------- 225 (270)
T ss_pred ccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH----HcCC-------
Confidence 322 12223345578999999888889999999999999999986 99999654321 111110 0000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccC
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 1042 (1079)
... ... .....+.+++.+||.++|++|||+.++++.|+++..+.
T Consensus 226 --~~~--~~~--~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 226 --RLP--MPP--NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --cCC--CCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 000 000 11236778999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=318.68 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=202.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCC----eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQ----VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
++|+..+.||+|+||.||+|.+. +++ .+|+|.+... ........+.+|+.+++.++||||++++++|... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 45778889999999999999764 343 4688877432 2223345788999999999999999999999764 46
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
++++||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 799999999999999987766789999999999999999999999 99999999999999999999999999998765
Q ss_pred CCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
............++..|+|||...+..++.++||||||+++|||++ |+.||..... .....++... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~-----~~---- 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKG-----ER---- 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCC-----CC----
Confidence 4332222333446778999999988899999999999999999998 8999865321 1111111100 00
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
..... .....+..++..||..+|++||+++++++.++++...
T Consensus 230 ----~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 ----LPQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00000 1123567889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.58 Aligned_cols=254 Identities=29% Similarity=0.415 Sum_probs=197.4
Q ss_pred CCCCCeeeecCcEEEEEEEeCC-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|+||+||+++... ++.+|+|.+..... .........+|+.++++++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-cccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 4567889999999999998764 56899999854321 112223345699999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||.+..... ...
T Consensus 80 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp ETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred ccccccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--ccc
Confidence 9999999999833 3479999999999999999999999 999999999999999999999999999976421 123
Q ss_pred cccccccCcccccccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 919 ASNSVAGSYGYIAPEYGY-SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......++..|+|||+.. +..++.++||||+|+++|+|++|..||.... .............. ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~-----------~~~ 220 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKR-----------PLP 220 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHT-----------HHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhcccc-----------ccc
Confidence 344567899999999988 7889999999999999999999999998641 11111111111000 000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
............+.+++.+||+.||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000011257889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.11 Aligned_cols=254 Identities=28% Similarity=0.369 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCC---chhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGE---LPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
+|+..+.||+|+||+||+|...+++.+|+|.+....... ......+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988889999999885432211 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
+||+++++|.+++.+.+ .+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999997654 478999999999999999999998 99999999999999999999999999988653211
Q ss_pred ----ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 916 ----SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 916 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.........++..|+|||+..+..++.++||||+|+++|||++|+.||....... ....... .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~--~~~~~~~---- 229 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGA--HRGLMPR---- 229 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhh--ccCCCCC----
Confidence 1112233568899999999998889999999999999999999999997532111 1100000 0000000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+. . .....+.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~--------~--~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LP--------D--SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC--------C--CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0 11235678999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.16 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=197.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEE-cCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCN-NGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||++... ++.+|+|.+.. ....+.+.+|+.++++++|+|++++++++. ++...++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN-----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCC-----CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 46788899999999999999776 66789998742 123567899999999999999999999764 456789999
Q ss_pred EecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 837 DYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
||+++++|.+++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999997653 3478999999999999999999998 99999999999999999999999999987543321
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
....++..|+|||+..+..++.++||||||+++|||++ |+.||..... ......+.. .....
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~---~~~~~------- 219 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEK---GYKMD------- 219 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhc---CCCCC-------
Confidence 22344678999999988889999999999999999998 9988864321 111111100 00000
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
. .......+.+++.+||+.+|++|||++++++.|+++
T Consensus 220 -~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -A------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -C------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0 001123677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=312.16 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=185.1
Q ss_pred eeeecCcEEEEEEEeCCCC---eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 765 IVGKGVSGIVYRVEIPSRQ---VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 765 ~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
.||+|+||+||+|+..++. .+++|.+.. .......+.|.+|+.+++.++||||++++++|.+....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKA--NASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecC--CCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5899999999999765433 345565532 22233467899999999999999999999999999999999999999
Q ss_pred CChhhhhhccC---cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 842 GSLAGLLHEKK---VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 842 g~L~~~l~~~~---~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
|+|.+++.+.. ...++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999997642 3356777889999999999999998 99999999999999999999999999986433222222
Q ss_pred cccccccCcccccccccCC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhh
Q 001426 919 ASNSVAGSYGYIAPEYGYS-------LKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTT 990 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1079)
......++..|+|||+... ..++.++||||||+++|||++ |..||....+ ...+.... .... ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~----~~~~---~~ 228 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVI----KDQQ---VK 228 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH----hhcc---cc
Confidence 2234567889999998643 345789999999999999997 5667754321 11111111 1111 11
Q ss_pred hhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
..++..... ....+.+++..|| .+|++||++++|++.|.
T Consensus 229 ~~~~~~~~~------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELP------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCC------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111111 1124566888899 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.89 Aligned_cols=250 Identities=25% Similarity=0.433 Sum_probs=201.2
Q ss_pred CCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
+|+..+.||+|+||.||+|.+.+++.+|+|.+... ......|.+|++++++++|||++++++++......++||||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG----AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC----CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 56777899999999999998877888999987432 12345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+++++|.+++......++++.++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 156 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence 999999999987666689999999999999999999999 99999999999999999999999999998654332 11
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......++.+|+|||...+..++.++||||+|+++|||++ |+.||..... . ..... ..... ....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~---~~~~~-~~~~~----~~~~~~~- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--S---EVVET-INAGF----RLYKPRL- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--H---HHHHH-HhCCC----CCCCCCC-
Confidence 1223345678999999988889999999999999999998 9999875321 1 11111 01000 0000100
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
....+.+++.+||+.+|++|||+.++++.|
T Consensus 226 --------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 --------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 123678899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.57 Aligned_cols=249 Identities=29% Similarity=0.416 Sum_probs=201.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||.||+|... ++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 46788899999999999999876 7788999885322 246789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999997654 3589999999999999999999999 999999999999999999999999999986633221
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
...++..|+|||+..+..++.++||||||+++||+++ |+.||..... ........ ...
T Consensus 158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~----~~~---------- 216 (256)
T cd05039 158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVE----KGY---------- 216 (256)
T ss_pred -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHh----cCC----------
Confidence 2334678999999988889999999999999999997 9999865321 11111110 000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.... .......+.+++.+||..+|++|||+.+++++|+.+
T Consensus 217 -~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 -RMEA--PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCC--ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0000 001124677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=311.57 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=192.8
Q ss_pred CeeeecCcEEEEEEEeCC-CC--eEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEEEec
Q 001426 764 NIVGKGVSGIVYRVEIPS-RQ--VIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
++||+|+||.||+|..++ +. .+|+|.+.. .........+.+|+++++++ +||||+++++++......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc--cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999998754 33 467777642 12233456889999999999 7999999999999999999999999
Q ss_pred CCCChhhhhhccC---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEee
Q 001426 840 SNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904 (1079)
Q Consensus 840 ~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 904 (1079)
++|+|.+++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 9999999997532 2478899999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhh
Q 001426 905 FGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRE 983 (1079)
Q Consensus 905 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 983 (1079)
||++...... ........+..|+|||+.....++.++||||||+++|||++ |..||...... ..... ...
T Consensus 156 fgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~-~~~ 226 (270)
T cd05047 156 FGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEK-LPQ 226 (270)
T ss_pred CCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHH-HhC
Confidence 9998632211 11112234567999999988889999999999999999997 99998653211 11100 000
Q ss_pred hhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 984 RKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
. ...... ......+.+++.+||+.+|.+|||++++++.|+++.
T Consensus 227 ~-----------~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 G-----------YRLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C-----------CCCCCC--CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 000000 011235678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=313.58 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=198.6
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 5688999999999999999976 468889999885322 223467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++++|.+++...+ .+++..+..++.|++.|++|||+. +|+|||++|+||++++++.+||+|||+++.+....
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 86 EYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 9999999999987554 478999999999999999999999 99999999999999999999999999998664322
Q ss_pred cccccccccCcccccccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGY---SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
.......+++.|+|||.+. ...++.++||||+||++|||++|+.||....+.... ..+... .+. .
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~-------~~~---~ 228 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKS-------NFQ---P 228 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecC-------CCC---C
Confidence 1223356889999999874 345788999999999999999999998643321110 000000 000 0
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
+.. .........+.+++.+||+.+|++|||++++++.
T Consensus 229 ~~~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 229 PKL----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCC----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 000 0000112367789999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=322.42 Aligned_cols=204 Identities=26% Similarity=0.294 Sum_probs=175.0
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||+||+++.+ +++.+|+|++.+...........+.+|+.++..++|++|+++++++.+....++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5788899999999999999876 577899998854322223344568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++|+|.+++.+....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..+.... .
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~ 157 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-T 157 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC-c
Confidence 9999999999987666689999999999999999999999 99999999999999999999999999997654332 1
Q ss_pred ccccccccCcccccccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 918 RASNSVAGSYGYIAPEYGY-----SLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 2223457999999999875 346788999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=310.09 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=202.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|.... ++.+|+|.+... ...+.+.+|++++++++|+||+++++++.++...++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 468888999999999999998764 788999988432 12678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++++|.+++...+..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 99999999999987777789999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......++..|+|||+..+..++.++||||||+++|||++|+.||....+.... ... ..... +.
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~~-----~~~~~-------~~- 218 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMI-----PNKPP-------PT- 218 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hhh-----ccCCC-------CC-
Confidence 1223445788999999998889999999999999999999999999754221110 000 00000 00
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
..........+.+++.+||+.+|++|||+.|+++
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 ---LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ---CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000011235778999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=331.14 Aligned_cols=263 Identities=23% Similarity=0.245 Sum_probs=197.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|.+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+|||++++++..++..++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36888899999999999999775 57889999531 234678999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|++. ++|.+++......+++..+..++.|+++||+|||+. +||||||||+|||++.++.+||+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9995 699999877666799999999999999999999999 999999999999999999999999999987644322
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC------CcchHHHHHHhHHhhhhhchhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIP------DGAHIITWVNGELRERKREFTT 990 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 990 (1079)
........||+.|+|||++.+..++.++|||||||++|||++|..|+..... ....+...+..... ...++..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~-~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV-HVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc-ccccCCC
Confidence 2222345799999999999999999999999999999999998876543211 11122222211000 0000000
Q ss_pred h----hhhhhh------ccc---CccH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 991 I----LDRQLL------MRS---GTQI----QEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 991 ~----~~~~~~------~~~---~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
. +..... ... .... .....+.+++.+|++.||++|||++|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000000 000 0000 112256789999999999999999999863
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=310.48 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=197.6
Q ss_pred CeeeecCcEEEEEEEeCC--CC--eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEec
Q 001426 764 NIVGKGVSGIVYRVEIPS--RQ--VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
+.||+|+||.||+|.+.+ ++ .||+|.+...... ...+.+.+|+.++++++||||+++++++.+ ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999997643 32 5899988543322 456789999999999999999999999988 8899999999
Q ss_pred CCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc-
Q 001426 840 SNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS- 917 (1079)
Q Consensus 840 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~- 917 (1079)
++|+|.+++.+.. ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++.+......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999997765 5689999999999999999999999 9999999999999999999999999999877543221
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......++..|+|||+..+..++.++||||||+++|||++ |+.||...... ....... .. .. ..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~---~~-~~--------~~ 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKID---KE-GE--------RL 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH---hc-CC--------cC
Confidence 12223457789999999988899999999999999999998 99998643211 1111110 00 00 00
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
. .. ......+.+++.+||+.+|++|||++++++.|.
T Consensus 221 ~--~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 E--RP--EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred C--CC--ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 00 011236778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.64 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=200.4
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||++... +++.+|+|.+.... .....+.+..|+.+++.++|+||+++++++.++...++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4677889999999999999765 68889999875322 22345788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++|+|.+++... +..+++..+..++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 99999999998653 44578999999999999999999999 99999999999999999999999999998664332
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......+++.|+|||+..+..++.++|+||||+++|+|++|..||...... ..... ... ..... +
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~-~~~--~~~~~-~---- 220 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILK-VCQ--GSYKP-L---- 220 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHH-Hhc--CCCCC-C----
Confidence 1223456889999999998888999999999999999999999999753211 11100 000 00000 0
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.. .....+.+++.+||+.||++|||+.+++..
T Consensus 221 ----~~--~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ----PS--HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----Cc--ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 112256689999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=325.83 Aligned_cols=267 Identities=22% Similarity=0.256 Sum_probs=197.2
Q ss_pred CCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-----eE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR-----TR 832 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 832 (1079)
+|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+.+|+++++.++|+||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 367788999999999999976 478999999885322 22234567889999999999999999999998776 78
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
|+|+||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 99999996 57888876544 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh-hh----
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER-KR---- 986 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~---- 986 (1079)
... ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||....+.. .+..... ..... ..
T Consensus 155 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~-~~g~~~~~~~~~ 231 (372)
T cd07853 155 PDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITD-LLGTPSLEAMRS 231 (372)
T ss_pred cCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHH-HcCCCCHHHHHH
Confidence 332 1223344678999999998764 47899999999999999999999997643211 1111110 00000 00
Q ss_pred ---chhhhhhhhhhccc------CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 987 ---EFTTILDRQLLMRS------GTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 987 ---~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.....+........ .........+.+++.+|++.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000000 0000112356789999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=310.57 Aligned_cols=240 Identities=21% Similarity=0.335 Sum_probs=187.2
Q ss_pred CeeeecCcEEEEEEEeCC-------------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC
Q 001426 764 NIVGKGVSGIVYRVEIPS-------------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR 830 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 830 (1079)
+.||+|+||.||+|.... ...||+|.+... .......|.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999997532 224778876432 2234467889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCc-------EEEe
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFE-------AFLA 903 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~kl~ 903 (1079)
..++||||+++|+|..++......+++..++.++.||++|++|||+. +|+||||||+||+++.++. ++++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999999999987666689999999999999999999999 9999999999999987664 8999
Q ss_pred eccccccccCCcccccccccccCcccccccccC-CCCCCccchHHHHHHHHHHHH-hCCCCCCCCCCCcchHHHHHHhHH
Q 001426 904 DFGLAKLFESSESSRASNSVAGSYGYIAPEYGY-SLKITEKSDVYSYGVVLLEVL-TGKEPTDSRIPDGAHIITWVNGEL 981 (1079)
Q Consensus 904 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~el~-tg~~p~~~~~~~~~~~~~~~~~~~ 981 (1079)
|||++...... ....++..|+|||... +..++.++|||||||++|||+ +|..|+....... .....
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~---- 222 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFY---- 222 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHH----
Confidence 99998754322 2345788999999876 467899999999999999998 4887776432110 00000
Q ss_pred hhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 982 RERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
. .. ... .. .....+.+++.+||+.||++||+++++++.++
T Consensus 223 -~--~~-~~~--------~~---~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 -E--GQ-CML--------VT---PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -h--cC-ccC--------CC---CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 00 000 00 01235678999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=325.44 Aligned_cols=205 Identities=25% Similarity=0.291 Sum_probs=176.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||+||+++.. +++.||+|.+.+...........+.+|..++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999765 67889999885433223334566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++.+....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999987656689999999999999999999999 999999999999999999999999999986654321
Q ss_pred cccccccccCcccccccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-----LKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 12233569999999998765 46788999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=317.08 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=203.3
Q ss_pred CHHHHhhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC
Q 001426 752 SVDDVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR 830 (1079)
Q Consensus 752 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 830 (1079)
++.+...+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..+.
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 3445557899999999999999999975 468899999885322 234577889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
..++||||+++++|.+++.+. .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 999999999999999998643 378999999999999999999999 999999999999999999999999999886
Q ss_pred ccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhh
Q 001426 911 FESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTT 990 (1079)
Q Consensus 911 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1079)
..... .......+++.|+|||...+..++.++|||||||++|||++|+.||....+... ..... ......
T Consensus 166 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~----~~~~~~--- 235 (296)
T cd06654 166 ITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIA----TNGTPE--- 235 (296)
T ss_pred ccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHh----cCCCCC---
Confidence 54332 122334688999999999888899999999999999999999999975432111 00000 000000
Q ss_pred hhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. .... .....+.+++.+||.++|++|||+.++++
T Consensus 236 -----~--~~~~--~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 -----L--QNPE--KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -----C--CCcc--ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 0000 11235678999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=319.91 Aligned_cols=196 Identities=26% Similarity=0.291 Sum_probs=169.8
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CC-----ceeeeeeEEEcCC
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HK-----NIVRLLGCCNNGR 830 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 830 (1079)
.+|.+.++||+|+||.|.+|.. ++++.||||+++.. .....+-..|+.+|..++ |. |+|+++++|....
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 4899999999999999999955 57999999998532 234466778999999997 43 8999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC--cEEEeeccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF--EAFLADFGL 907 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DFGl 907 (1079)
+.|||+|.++. +|+++++.. -..++...++.|+.||+.||.+||+. +|||+||||+|||+.+.. .+||+|||.
T Consensus 262 HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 262 HLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred ceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 99999999965 999999865 44589999999999999999999999 999999999999997643 799999999
Q ss_pred cccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
|++.....+ ...-+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+.
T Consensus 338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 997654432 345678999999999999999999999999999999997777553
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.81 Aligned_cols=265 Identities=25% Similarity=0.317 Sum_probs=200.3
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||++... ++..+|+|.+... ........+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 5788899999999999999765 5778888887432 223345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++++|.+++.+.+ .+++..+..++.|+++||+|||+.+ +++||||||+||++++++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 80 HMDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred ccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 999999999997664 4889999999999999999999732 89999999999999999999999999987654321
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhh------------
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERK------------ 985 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 985 (1079)
.....++..|+|||...+..++.++||||||+++|||++|+.||..... .....+.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCCC
Confidence 2335688999999998888899999999999999999999999864321 111111110000000
Q ss_pred ------hchhhhhhhhhhcccCc--cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 986 ------REFTTILDRQLLMRSGT--QIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 986 ------~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
....+..+......... .......+.+++.+||+.+|++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000000 00012357789999999999999999999886
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=310.41 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=196.6
Q ss_pred CCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|.. .+++.||+|.+... ........+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC--CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 577788999999999999965 57889999988532 223345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++..+...
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 99999997653 367888999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchH--HHHHHhHHhhhhhchhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHI--ITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
......++..|+|||+..+..++.++||||||+++|||++|+.||.......... ............ +.
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 219 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--------PV 219 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--------CC
Confidence 2233578999999999998889999999999999999999999997533221110 011000000000 00
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.. .......+.+++.+||+.+|++||+++|+++.
T Consensus 220 ~~-----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LP-----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC-----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 00112356789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=324.55 Aligned_cols=201 Identities=26% Similarity=0.345 Sum_probs=170.1
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC---
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR--- 830 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 830 (1079)
.+.++|+..+.||+|+||.||++... +++.||+|++.... ........+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 35688999999999999999999764 68899999985432 22234567889999999999999999999986543
Q ss_pred ---eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 831 ---TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 831 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
..++||||+++ ++.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999976 56666643 378889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9754332 1223457899999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=311.72 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=195.9
Q ss_pred CeeeecCcEEEEEEEeCC-------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 764 NIVGKGVSGIVYRVEIPS-------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+.||+|+||.||+|+..+ +..+|+|.+... ........+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc--cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 368999999999997643 257888887432 22234678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcc------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-----cEEEeec
Q 001426 837 DYISNGSLAGLLHEK------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-----EAFLADF 905 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~DF 905 (1079)
||+++++|.+++... ...+++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .++++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 999999999999653 23478899999999999999999998 999999999999999887 8999999
Q ss_pred cccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhh
Q 001426 906 GLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRER 984 (1079)
Q Consensus 906 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 984 (1079)
|+++...............++..|+|||...+..++.++||||||+++|||++ |+.||..... ......+. .
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~----~- 228 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVT----A- 228 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHh----c-
Confidence 99986644332222233445789999999998899999999999999999998 9999864321 11111110 0
Q ss_pred hhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 985 KREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
........ .....+.+++.+||..+|++||+++++++.|++
T Consensus 229 ----------~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 ----------GGRLQKPE--NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----------CCccCCcc--cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000001 112367789999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=341.85 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=198.7
Q ss_pred HhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc--CCeE
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN--GRTR 832 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 832 (1079)
...+|++.+.||+|+||+||+|... ++..||+|.+.... ........|..|+.++++++|||||+++++|.+ ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~-l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc-cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 4467999999999999999999765 56788888875332 233456789999999999999999999998854 4568
Q ss_pred EEEEEecCCCChhhhhhcc---CcCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEeCCCCCCeEECCC--------
Q 001426 833 LLLFDYISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHDCV----PPIIHRDIKSNNILVGPQ-------- 897 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~gL~~LH~~~~----~~ivH~Dlk~~NIll~~~-------- 897 (1079)
|+||||+++|+|.+++... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999753 3458999999999999999999998521 259999999999999642
Q ss_pred ---------CcEEEeeccccccccCCcccccccccccCcccccccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 898 ---------FEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS--LKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 898 ---------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 358999999998664332 2234578999999998754 45889999999999999999999999743
Q ss_pred CCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhc
Q 001426 967 IPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEI 1038 (1079)
Q Consensus 967 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 1038 (1079)
.. ...++.. .... + .+... .....+.+++..||+.+|++||++.|++. .+..+
T Consensus 247 ~~----~~qli~~-lk~~-p--------~lpi~-----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 247 NN----FSQLISE-LKRG-P--------DLPIK-----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred Cc----HHHHHHH-HhcC-C--------CCCcC-----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 21 1111111 0000 0 00000 11235778999999999999999999984 45544
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=317.91 Aligned_cols=195 Identities=27% Similarity=0.398 Sum_probs=159.9
Q ss_pred CCeeeecCcEEEEEEEeC---CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc--CCeEEEEEE
Q 001426 763 TNIVGKGVSGIVYRVEIP---SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN--GRTRLLLFD 837 (1079)
Q Consensus 763 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 837 (1079)
..+||+|+||+||+|+.. +++.||+|.+... .....+.+|+.++++++||||+++++++.. +...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 357999999999999764 4678999988432 123457789999999999999999999854 456799999
Q ss_pred ecCCCChhhhhhcc--------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEE----CCCCcEEEeec
Q 001426 838 YISNGSLAGLLHEK--------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV----GPQFEAFLADF 905 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DF 905 (1079)
|+.+ +|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9865 888877532 23488999999999999999999999 99999999999999 45678999999
Q ss_pred cccccccCCcc-cccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 906 GLAKLFESSES-SRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 906 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
|+++.+..... ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99987654321 1223456789999999998764 5889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.29 Aligned_cols=252 Identities=27% Similarity=0.367 Sum_probs=198.9
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCc------hhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGEL------PERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
+|.....||+|+||.||+|... +++.+|+|.+........ ...+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999764 678899998854332221 123578899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccc
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~ 911 (1079)
.++||||+++++|.+++...+ .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999997654 478899999999999999999998 9999999999999999999999999999876
Q ss_pred cCCccc----ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhc
Q 001426 912 ESSESS----RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 912 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
...... .......|+..|+|||...+..++.++||||+|+++|||++|+.||...... ...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~--~~---- 226 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAIFKI--GE---- 226 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHHHHH--hc----
Confidence 532111 1112345788999999998888999999999999999999999999753211 110000 00
Q ss_pred hhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
...+.. .......+.+++.+||++||++||++.|+++
T Consensus 227 ---~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ---NASPEI------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---cCCCcC------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000000 0011236678999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.76 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=199.6
Q ss_pred CCCCCeeeecCcEEEEEEEeCCCCeEE-EEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPSRQVIA-VKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~~~~va-vK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|.+..-||.|+||.||+|..++...+| .|.+ ...+..+.++|.-|++|+..++||+||++++.|.....+||+.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvI---etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVI---ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhh---cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 556677999999999999877655544 4544 234456778999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
|.||-+...+-+-+..+++.++..+++|++.||.|||++ +|||||||+.|||++-+|.++++|||++...... ..
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ 185 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence 999999999988888899999999999999999999999 9999999999999999999999999998643322 23
Q ss_pred cccccccCcccccccc-----cCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 919 ASNSVAGSYGYIAPEY-----GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~-----~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
....+.|||.|||||+ +...+|+.++||||||+++.||..+.+|...-. .+...++....+ + ...+.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----pMRVllKiaKSe-P---PTLlq 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLKIAKSE-P---PTLLQ 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----hHHHHHHHhhcC-C---CcccC
Confidence 4556889999999997 446789999999999999999999999875422 222222211111 1 11111
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
|. .=...+-+++.+|+..||..||+++|+++
T Consensus 258 PS---------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 PS---------HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cc---------hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 11225668899999999999999999875
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=331.77 Aligned_cols=267 Identities=19% Similarity=0.244 Sum_probs=193.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC-------
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG------- 829 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 829 (1079)
++|+..+.||+|+||.||+|... +++.||||++... .....+|+.+++.++|||||++++++...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 46888999999999999999764 6889999988421 12345799999999999999999886432
Q ss_pred -CeEEEEEEecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-cEEEee
Q 001426 830 -RTRLLLFDYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-EAFLAD 904 (1079)
Q Consensus 830 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~D 904 (1079)
...++||||+++ ++.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 246799999975 77777643 345689999999999999999999999 999999999999999765 799999
Q ss_pred ccccccccCCcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhh
Q 001426 905 FGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE 983 (1079)
Q Consensus 905 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 983 (1079)
||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ..+..........
T Consensus 215 FGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p 290 (440)
T PTZ00036 215 FGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTP 290 (440)
T ss_pred cccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence 99998765432 22235689999999987654 6899999999999999999999999764321 1122211110000
Q ss_pred hhhchhhhhhhhh-----hcccCccH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhccc
Q 001426 984 RKREFTTILDRQL-----LMRSGTQI------QEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRH 1040 (1079)
Q Consensus 984 ~~~~~~~~~~~~~-----~~~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 1040 (1079)
...... ...+.. ........ .....+.+++.+||+.||++|||++|+++ .++++..
T Consensus 291 ~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 291 TEDQLK-EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CHHHHH-HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 000000 000000 00000000 01236778999999999999999999985 5555543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.35 Aligned_cols=361 Identities=30% Similarity=0.418 Sum_probs=245.5
Q ss_pred eEeecccCCCc-cCCCccccccccccccccccccccccCCcccccccccceecccccccccCCCcCccCCCCCCeEeccC
Q 001426 213 VFLGLADTGIS-GQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQ 291 (1079)
Q Consensus 213 ~~L~l~~~~~~-~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 291 (1079)
+-.+++.|.++ +..|..+..+++++.|.|...++. .+|++++.+.+|++|.+++|++. .+-..++.++.|+.+.+..
T Consensus 10 rGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~ 87 (1255)
T KOG0444|consen 10 RGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRD 87 (1255)
T ss_pred ecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhc
Confidence 33444555555 234555555555555555444443 45555555555555555555554 3344455555555555555
Q ss_pred cccCC-CcCcccccCCCccEEEcccccccCccccccccccccceeecccccccccccccccccccCcEeeccCCcccccC
Q 001426 292 NNLSG-SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQI 370 (1079)
Q Consensus 292 n~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 370 (1079)
|++.. -+|..+..+..|++||||+|+++ ..|..+...+++-.|+||+|+|..++-..|.++..|-.|||++|++. .+
T Consensus 88 N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~L 165 (1255)
T KOG0444|consen 88 NNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-ML 165 (1255)
T ss_pred cccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hc
Confidence 55542 24445555555666666666655 55555555555555666666655444444555555666666666654 45
Q ss_pred CccccchhhHHHHHhhcCcccc-cCCcccccccCcEEeccCCCCC-CCccccccccccccccccccccccccCCCcccCC
Q 001426 371 PPTIGQLKELLLFFAWQNQLHG-NIPELAYCVKLQALDLSHNFLT-GSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGC 448 (1079)
Q Consensus 371 p~~l~~l~~L~~l~l~~n~l~~-~~~~l~~~~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 448 (1079)
|+.+..+..|++|.+++|.+.. .+..+..+++|++|++++.+-+ .-+|.++..+.+|..+|++.|.+. .+|+.+.++
T Consensus 166 PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l 244 (1255)
T KOG0444|consen 166 PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKL 244 (1255)
T ss_pred CHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhh
Confidence 5555555555555555554432 2334556678888888887644 357888888999999999999988 888888888
Q ss_pred CCceEEEecCCCccccCccccccccccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcCcc-cCChhhhhhcCCCccc
Q 001426 449 TGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQG-TIPSSLEFLFGLNVLD 527 (1079)
Q Consensus 449 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~ 527 (1079)
.+|+.|+|++|+|+ ......+...+|+.|+||.|+++ .+|..+..++.|+.|++.+|+++- -+|+.++.|.+|+.+.
T Consensus 245 ~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~ 322 (1255)
T KOG0444|consen 245 RNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFH 322 (1255)
T ss_pred hhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHH
Confidence 99999999999988 45555667778888999999988 788888888888888888888762 4688888888888888
Q ss_pred ccccccccccccccccCCCCceEecccccccCCCCCccccccccccccccCcccc
Q 001426 528 LSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRIN 582 (1079)
Q Consensus 528 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 582 (1079)
.++|.+. ..|+.++.+..|+.|.|++|++. ..|+++.-++.|+.|||..|+--
T Consensus 323 aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 323 AANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 8888887 77888888888888888888887 45788888888888888888754
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=322.68 Aligned_cols=190 Identities=25% Similarity=0.316 Sum_probs=164.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|+..+.||+|+||.||+|... +++.||+|+... .....|+.++++++||||+++++++......++|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 46899999999999999999775 567888886421 12356899999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+. ++|.+++......+++..+..++.||+.||+|||+. +||||||||+||+++.++.+||+|||.++.....
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 9995 589999887767799999999999999999999999 9999999999999999999999999999753322
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCC
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPT 963 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~ 963 (1079)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999989999999999999999999965554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=341.05 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=207.6
Q ss_pred CCCCCCeeeecCcEEEEEEEeC--------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcC
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP--------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNG 829 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 829 (1079)
+....+.+|+|+||.||+|... ....||||..+.... ..+.+.+..|+++|+.+ +|+||+.++|+|..+
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3445569999999999998643 145689998854332 36778999999999999 699999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhccC---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEE
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV 894 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll 894 (1079)
+..++|+||+..|+|.+|++..+ ..++....+.++.|||.|++||++. ++||||+.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 99999999999999999998776 4488899999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeccccccccCCccccccc-ccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcch
Q 001426 895 GPQFEAFLADFGLAKLFESSESSRASN-SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAH 972 (1079)
Q Consensus 895 ~~~~~~kl~DFGla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~ 972 (1079)
+++..+||+|||+|+.....+...... ...-+.+|||||.+....++.|+|||||||++||+++ |..||.+.. ....
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~ 530 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEE 530 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHH
Confidence 999999999999999776655443221 1114567999999999999999999999999999999 888886522 1112
Q ss_pred HHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 973 IITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
+.++++...+. ..+. .+..+++++++.||+.+|++||++.|+++.++...
T Consensus 531 l~~~l~~G~r~---------------~~P~--~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 LLEFLKEGNRM---------------EQPE--HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHhcCCCC---------------CCCC--CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 22222221111 1111 12347889999999999999999999999999953
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.36 Aligned_cols=253 Identities=28% Similarity=0.374 Sum_probs=202.9
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||++..+ +++.+|+|.+.... .....+.+.+|++++++++||||+++++++..+...++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 5677789999999999999776 68889999885432 22455788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHH-DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++++|.+++......+++..+..++.|++.|++|+|+ . +++||||+|+||++++++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 999999999998765668999999999999999999999 7 99999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||.........................
T Consensus 156 ---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 224 (265)
T cd06605 156 ---AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL-------- 224 (265)
T ss_pred ---hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC--------
Confidence 112668889999999988899999999999999999999999997643222222222111111100000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
... .....+.+++.+||..+|++|||+.|++.
T Consensus 225 ----~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 ----PSG-KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ----Chh-hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 000 02235778999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=328.32 Aligned_cols=264 Identities=20% Similarity=0.252 Sum_probs=199.5
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC---CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP---SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
..+|...+.||+|+||.||++... .+..||+|.+... +.+.+|++++++++|||||++++++......+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 356889999999999999999653 3567888877421 23568999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+|||++. ++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 163 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9999996 588888843 34589999999999999999999999 999999999999999999999999999987655
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCc--chHHHHHHhHHhhhhhchh--
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG--AHIITWVNGELRERKREFT-- 989 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~-- 989 (1079)
...........||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ..+...... .......+.
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~~ 316 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQN 316 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCCc
Confidence 433333345679999999999998899999999999999999999999997654321 111111111 000000000
Q ss_pred ------hhhh-hhhhcccCccH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 990 ------TILD-RQLLMRSGTQI-------QEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 990 ------~~~~-~~~~~~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
..+. .....+..... .....+.+++.+|++.||++|||+.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00000000000 112356688999999999999999999874
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=322.95 Aligned_cols=267 Identities=22% Similarity=0.254 Sum_probs=197.9
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC----
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG---- 829 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 829 (1079)
.+.++|+..+.||+|+||.||++... .++.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 35678999999999999999999764 68889999885432 2223456788899999999999999999998643
Q ss_pred --CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 830 --RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 830 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
...++||||+++ ++.+++.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 346999999975 67776643 378889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhc
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.. .....++
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~-~~~~~~~ 240 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQ-LGTPCPE 240 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-hCCCCHH
Confidence 98654321 223457899999999999889999999999999999999999999754211 111111100 0000000
Q ss_pred --------hhhhhhh----------hh------hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 988 --------FTTILDR----------QL------LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 988 --------~~~~~~~----------~~------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.....+. .. .............+.+++.+|++.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00 00000000112356789999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=314.20 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=203.4
Q ss_pred HHHHhhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 753 VDDVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 753 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
+.+...+|+..+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++|+||+++++++..+..
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC---ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence 445567899999999999999999976 57899999988532 22345678899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccc
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~ 911 (1079)
.++||||+++++|.+++.+. .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred EEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 99999999999999998653 378899999999999999999999 9999999999999999999999999999865
Q ss_pred cCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 912 ESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 912 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.... .......+++.|+|||...+..++.++|||||||++|+|++|+.||....+...... ... ...+.
T Consensus 166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~----~~~~~---- 234 (297)
T cd06656 166 TPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT----NGTPE---- 234 (297)
T ss_pred cCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ecc----CCCCC----
Confidence 4332 122334688899999999888899999999999999999999999975432111000 000 00000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. . ........+.+++.+||+.+|++||+++++++
T Consensus 235 ----~--~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 ----L--Q--NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----C--C--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 00011234668899999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.02 Aligned_cols=266 Identities=23% Similarity=0.264 Sum_probs=192.8
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC---CCCceeeeeeEEEc-----C
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI---RHKNIVRLLGCCNN-----G 829 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~ 829 (1079)
+|+..+.||+|+||+||+|+.. +++.||+|.+...... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4778899999999999999765 6889999988543221 12224556677776655 79999999999864 3
Q ss_pred CeEEEEEEecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccc
Q 001426 830 RTRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla 908 (1079)
...++||||+.+ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 457999999975 898888754 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhH---Hhhhh
Q 001426 909 KLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE---LRERK 985 (1079)
Q Consensus 909 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~ 985 (1079)
+...... ......+|..|+|||++.+..++.++||||+||++|||++|+.||...... ..+....... ....+
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhC
Confidence 8664332 223356889999999998889999999999999999999999999654221 1111111100 00001
Q ss_pred hchhhhhhhhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 986 REFTTILDRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+.................. .....+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000000000000 11235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=302.98 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=202.2
Q ss_pred CCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||.++. .+++.+++|++.... ........+.+|++++++++|+||+++++++.+....+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc-cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 478889999999999999865 468889999875332 223455778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++|+|.+++.+. +..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999999765 45689999999999999999999998 999999999999999999999999999986644331
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
......+++.|+|||...+..++.++||||+|+++|||++|..||...... ......... .....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~---~~~~~----- 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQG---NYTPV----- 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHcC---CCCCC-----
Confidence 223456899999999998888899999999999999999999998653211 111110000 00000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 ------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 00112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.55 Aligned_cols=238 Identities=19% Similarity=0.312 Sum_probs=185.4
Q ss_pred eeeecCcEEEEEEEeCC-------------------------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCce
Q 001426 765 IVGKGVSGIVYRVEIPS-------------------------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819 (1079)
Q Consensus 765 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 819 (1079)
.||+|+||.||+|.... ...||+|.+... .......|.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 58999999999986421 134788877432 22334678889999999999999
Q ss_pred eeeeeEEEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-
Q 001426 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF- 898 (1079)
Q Consensus 820 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~- 898 (1079)
++++++|.+....++||||+++|+|..++.+....+++..+..++.||++||+|||+. +|+||||||+||++++++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999999977666689999999999999999999998 999999999999997643
Q ss_pred ------cEEEeeccccccccCCcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHH-hCCCCCCCCCCCc
Q 001426 899 ------EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVL-TGKEPTDSRIPDG 970 (1079)
Q Consensus 899 ------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~-tg~~p~~~~~~~~ 970 (1079)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999988643221 22357788999998765 56899999999999999995 6898887543211
Q ss_pred chHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 971 AHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
...+.. . ....... ....+.+++.+||+.+|++|||++++++.|
T Consensus 230 --~~~~~~----~-----------~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 --KERFYE----K-----------KHRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred --HHHHHH----h-----------ccCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111100 0 0000000 112567899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=306.03 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=202.0
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 46788899999999999999765 57789999885322 225678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++++|.+++......+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.+.......
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999999999987655689999999999999999999998 99999999999999999999999999998654321
Q ss_pred cccccccccCcccccccccCCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSL---KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
.......++..|+|||...+. .++.++||||||+++|||++|+.||....+... ...... ..+. .
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~-------~~~~---~ 223 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISK-------SNFP---P 223 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh-------ccCC---C
Confidence 122345678899999998776 789999999999999999999999975332111 000000 0000 0
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. ..........+.+++.+||..+|.+|||+.+++.
T Consensus 224 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PK----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc----ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0011122346778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.92 Aligned_cols=268 Identities=19% Similarity=0.258 Sum_probs=198.1
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|... +|+.||+|.+.... ........+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc-ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4777889999999999999775 68899999885432 222233567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|++ ++|.+++......+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 997 588888876656689999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHH---hhhhhchhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL---RERKREFTTILD 993 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 993 (1079)
.......+++.|+|||++.+. .++.++||||+||++|||++|+.|+.........+........ ...++......+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 122334578899999987664 4689999999999999999999997543322221111111000 000111111000
Q ss_pred hhhh--cccCcc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQLL--MRSGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~~~--~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.... ...... ......+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 000000 011236678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=310.43 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=198.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+.|++.+.||+|+||.||+|+.. +++.+|+|.+.. ......+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET---KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc---CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 45888899999999999999775 578899998743 23345678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++++|..++.+....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 99999999998877666789999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccccccCcccccccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGY-----SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
........+++.|+|||.+. ...++.++|||||||++|||++|..||....+. .....+. ....+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~----~~~~~----- 233 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIA----KSEPP----- 233 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHh----cCCCc-----
Confidence 12223456788999999874 345688999999999999999999998653221 1111110 00000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
... ........+.+++.+||+.+|++||+++|+++
T Consensus 234 ---~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 ---TLS----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---cCC----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00011235678999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=313.82 Aligned_cols=266 Identities=18% Similarity=0.242 Sum_probs=198.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|..+ +++.||+|.+..... ......+.+|+.+++.++||||+++++++......++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 56888999999999999999765 678899998853322 223456778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||++ ++|.+++...+..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 9997 599999987766789999999999999999999999 99999999999999999999999999997543322
Q ss_pred cccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHH----hhhhhchhh-
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL----RERKREFTT- 990 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~- 990 (1079)
.......+++.|+|||...+ ..++.++||||+||++|||++|+.||...... .......... ...+.....
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhcc
Confidence 12233457889999998765 35788999999999999999999999754321 1111111100 000100000
Q ss_pred --hhhhhhhcccCc-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 991 --ILDRQLLMRSGT-----QIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 991 --~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
............ .......+.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000000 0001225678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=321.48 Aligned_cols=267 Identities=21% Similarity=0.262 Sum_probs=198.2
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC----
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG---- 829 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 829 (1079)
.+.++|+..+.||+|+||.||+|... .++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 35678999999999999999999764 68889999885432 2233456788999999999999999999987543
Q ss_pred --CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 830 --RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 830 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
...|+||||+++ ++.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 77777743 378889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhc
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
++...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+...+. ......+.
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~ 247 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIE-QLGTPCPE 247 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-hcCCCCHH
Confidence 98654321 223456899999999999999999999999999999999999999754321 11111111 00000000
Q ss_pred hhhhhhh----------------------hhhcccC--ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 988 FTTILDR----------------------QLLMRSG--TQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 988 ~~~~~~~----------------------~~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
+...+.+ ....... ........+.+++.+|++.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0000000 000112356789999999999999999999883
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=313.64 Aligned_cols=260 Identities=22% Similarity=0.249 Sum_probs=201.8
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||++... .++.||+|.+...........+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999765 578899998854332223345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc-
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES- 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~- 916 (1079)
|+++++|.+++...+ .+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+|++|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999997654 488999999999999999999999 999999999999999999999999999874211100
Q ss_pred ------------cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh
Q 001426 917 ------------SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER 984 (1079)
Q Consensus 917 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 984 (1079)
........++..|+|||.+.+..++.++|+||||+++|||++|..||.+..+. .+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~~~~~~~ 232 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQVISDD 232 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcc
Confidence 00111245788999999998888999999999999999999999999753211 1111100000
Q ss_pred hhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 985 KREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
. ..+ .........+.+++.+||+.+|++||++.++.+.++.-.
T Consensus 233 ---~---~~~------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 233 ---I---EWP------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred ---c---CCC------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 0 000 000011235678999999999999999888888777743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=322.14 Aligned_cols=243 Identities=25% Similarity=0.270 Sum_probs=186.3
Q ss_pred eeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC---CCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 766 VGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI---RHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
||+|+||+||+|+.. +++.||+|++.+...........+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999765 6889999998543222223344556677777665 699999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.+++.+.+ .+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence 99999987654 489999999999999999999999 99999999999999999999999999987543322 2233
Q ss_pred ccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhccc
Q 001426 922 SVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRS 1000 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1079)
...||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..... .......+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~-i~~~~~~~----------~- 217 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRN-IAFGKVRF----------P- 217 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHH-HHcCCCCC----------C-
Confidence 45799999999998654 4789999999999999999999999753211 11110 00000000 0
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCC----CHHHHHH
Q 001426 1001 GTQIQEMLQVLGVALLCVNPCPEERP----TMKDVTA 1033 (1079)
Q Consensus 1001 ~~~~~~~~~l~~l~~~Cl~~dP~~RP----t~~evl~ 1033 (1079)
.. .....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~--~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KN--VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred Cc--cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00 0112456789999999999998 4556554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.55 Aligned_cols=238 Identities=21% Similarity=0.353 Sum_probs=188.1
Q ss_pred CeeeecCcEEEEEEEeCCCC-----------eEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeE
Q 001426 764 NIVGKGVSGIVYRVEIPSRQ-----------VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
+.||+|+||.||+|...+.. .+++|.+.... .....|.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999876433 46667653211 126788999999999999999999999988 778
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-------cEEEeec
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-------EAFLADF 905 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl~DF 905 (1079)
++||||+++|+|.+++......+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+|++||
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999999987765789999999999999999999998 999999999999999887 7999999
Q ss_pred cccccccCCcccccccccccCcccccccccCCC--CCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHh
Q 001426 906 GLAKLFESSESSRASNSVAGSYGYIAPEYGYSL--KITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELR 982 (1079)
Q Consensus 906 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 982 (1079)
|++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...... ....+..
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~---- 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQ---- 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHh----
Confidence 99986543 2233466789999998776 78999999999999999999 56677543211 1111100
Q ss_pred hhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 983 ERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
. .. .. .. .....+.+++.+||..+|++|||+.++++.|+
T Consensus 221 ~-~~--------~~--~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 D-QH--------RL--PM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred c-CC--------CC--CC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 00 00 00147778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.32 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=205.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.-|...+.||+|.|..|-.|+. -.|+.||||++.+.+-.. .....+.+|++.|+-++|||||++|++......+|+|+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3467778899999999998854 479999999997655433 34567778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEEC-CCCcEEEeeccccccccCCc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG-PQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~~~~~ 915 (1079)
|.-++|+|++|+-++...+.++...+++.||+.|+.|+|+. .+||||+||+||.+- +-|-||+.|||++-.+.++.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999999888899999999999999999999999 899999999999875 56899999999998776654
Q ss_pred ccccccccccCcccccccccCCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKIT-EKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
.....+|+..|-|||++.+..|+ +++||||+|||+|.+++|+.||+.-.+. ..+..+.|=
T Consensus 174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTmImDC 234 (864)
T KOG4717|consen 174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTMIMDC 234 (864)
T ss_pred ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhhhhcc
Confidence 34456899999999999998886 5899999999999999999999753221 111111111
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.+.-...-..+..++|..|+..||++|.+.++|+..
T Consensus 235 ----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 ----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ----cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 111111223456689999999999999999999863
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=309.85 Aligned_cols=256 Identities=28% Similarity=0.350 Sum_probs=202.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||+||++... +++.||+|++... ......+.+.+|+++++.++||||+++++++......++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec--CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 45778889999999999999765 6888999987532 22334578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++++|.+++.+.+ .+++..+..++.+++.|+.|||+.+ +++||||+|+||++++++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 83 EFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred ecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 9999999999987654 4899999999999999999999742 8999999999999999999999999998754322
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcc------hHHHHHHhHHhhhhhchhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA------HIITWVNGELRERKREFTT 990 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 990 (1079)
......|+..|+|||++.+..++.++|||||||++||+++|+.||....+... .+..+......+...
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 231 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP---- 231 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC----
Confidence 12235689999999998888899999999999999999999999986433211 011111111111000
Q ss_pred hhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
.. ........+.+++.+||+.||++|||+.|+++..
T Consensus 232 ----~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 ----RL-----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ----CC-----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00 0001223577899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=308.95 Aligned_cols=267 Identities=21% Similarity=0.260 Sum_probs=196.9
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|... +++.||+|++.... ......+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 3677889999999999999775 68899999885432 222334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 838 YISNGSLAGLLHEK--KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|++ ++|.+++... +..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 5898888653 25689999999999999999999999 99999999999999999999999999997554321
Q ss_pred ccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhH---Hhhhhhchhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE---LRERKREFTTI 991 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 991 (1079)
.......+++.|+|||+..+. .++.++||||+|+++|||++|+.||....... ......... ....+......
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhh
Confidence 122334578899999987654 57889999999999999999999997543211 111111000 00001100000
Q ss_pred hhhhhhcc--cCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 992 LDRQLLMR--SGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.+...... ..... ....++.+++.+||+.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 00000 01235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=308.42 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=195.5
Q ss_pred HhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcC----
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNG---- 829 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---- 829 (1079)
....|+..+.||+|+||.||+|... +++.||+|.+... ......+..|+.+++++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3456788889999999999999765 6788999987432 22346788999999998 799999999998753
Q ss_pred --CeEEEEEEecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecc
Q 001426 830 --RTRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFG 906 (1079)
Q Consensus 830 --~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG 906 (1079)
...++||||+.+|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 4579999999999999999864 34589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCcccccccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHH
Q 001426 907 LAKLFESSESSRASNSVAGSYGYIAPEYGY-----SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL 981 (1079)
Q Consensus 907 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 981 (1079)
+++...... .......|++.|+|||++. +..++.++||||+||++|||++|+.||....+... ... .
T Consensus 157 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----~~~--~ 228 (272)
T cd06637 157 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----LFL--I 228 (272)
T ss_pred Cceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----HHH--H
Confidence 998654322 2233456889999999875 34578899999999999999999999965322110 000 0
Q ss_pred hhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 982 RERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. .. .+... .. .....+.+++.+||+.+|++|||++|+++
T Consensus 229 ~~--~~-----~~~~~---~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PR--NP-----APRLK---SK--KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hc--CC-----CCCCC---CC--CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 00 00000 00 11235678999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=302.47 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=199.6
Q ss_pred CCCCCeeeecCcEEEEEEEeCC-----CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPS-----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 834 (1079)
++..+.||+|+||.||++.... +..||+|.+... ......+.+..|+++++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED--ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC--CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 3566889999999999997764 478999988432 222256789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCcC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 835 LFDYISNGSLAGLLHEKKVF-LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+|||+++++|.+++...... +++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||+++....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999999765544 89999999999999999999999 999999999999999999999999999987665
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
...... ....+++.|+|||...+..++.++||||+|+++|||++ |+.||..... ..+..... .....
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~---~~~~~------ 223 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLK---KGYRL------ 223 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHh---cCCCC------
Confidence 432221 12347789999999988889999999999999999998 7888765211 11111110 00000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
... ......+.+++.+|+..+|++|||+.|+++.|
T Consensus 224 ------~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ------PKP--ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCC--CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 01233677899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=304.38 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=193.7
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
.+.....||+|+||.||+|... ++..||+|.+.. ......+.+.+|+.++++++|+||+++++++..+...++|+|
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE---RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecC---CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3444568999999999999754 677899998743 223345789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-CCcEEEeeccccccccCC
Q 001426 838 YISNGSLAGLLHEKKVFL--DWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-QFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~ 914 (1079)
|+++++|.+++......+ ++..+..++.||+.|++|||+. +|+||||||+||+++. ++.++|+|||.+..+...
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 999999999998654445 7888899999999999999998 9999999999999986 679999999998765432
Q ss_pred cccccccccccCcccccccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSL--KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
. .......+++.|+|||+..+. .++.++||||||+++|||++|+.||......... .+....... .+.+.
T Consensus 163 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~~~-~~~~~--- 234 (268)
T cd06624 163 N--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMFKI-HPEIP--- 234 (268)
T ss_pred C--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhhcc-CCCCC---
Confidence 2 122234578999999987654 3788999999999999999999998653221111 110000000 00000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
......+.+++.+||+.+|++|||+.|+++
T Consensus 235 -----------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 -----------ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -----------cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011235678899999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=308.58 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=196.5
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|+||.||+|... ++..+++|.+.. ......+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT---KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC---CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 566788999999999999876 467788887732 2234457789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+++++|..++.+....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++....... .
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 999999999876666689999999999999999999999 99999999999999999999999999987654321 2
Q ss_pred cccccccCcccccccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 919 ASNSVAGSYGYIAPEYGY-----SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
......+++.|+|||++. +..++.++|||||||++|||++|+.||....+. ........ ..... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~----~~~~~---~~~ 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAK----SEPPT---LAQ 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-HHHHHHhh----cCCCC---CCC
Confidence 223456889999999873 445778999999999999999999998753221 11111110 00000 000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.. .....+.+++.+||+.+|++|||++++++.
T Consensus 231 -------~~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 -------PS--RWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -------cc--ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 112356789999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=317.98 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=197.9
Q ss_pred CCCCeeeecCcEEEEEEEeC-CCCeEEEEEecc-ccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe--EEEEE
Q 001426 761 SDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWP-VKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT--RLLLF 836 (1079)
Q Consensus 761 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 836 (1079)
+..++||+|+|-+||||... .|..||--.+.. .......+.+.|..|+.+|+.|+|||||++|.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999654 566666322211 112334456899999999999999999999999987554 78999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-CCcEEEeeccccccccCCc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-QFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~~ 915 (1079)
|.+..|+|..|+.+.+. .....+..+++||++||.|||++. |+|+|||||-+||+|+. .|.|||+|+|+|+......
T Consensus 123 EL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999999988776 788899999999999999999985 59999999999999986 5899999999999776433
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
...+.|||.|||||... ..|++.+||||||+++.||+|+..||..-......+.+...|..+ ..+..+-|+
T Consensus 201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP---~sl~kV~dP- 271 (632)
T KOG0584|consen 201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP---AALSKVKDP- 271 (632)
T ss_pred ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH---HHhhccCCH-
Confidence 33478999999999876 689999999999999999999999997544333333333333222 233334344
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
++.++|.+|+.. .++|||+.|++.
T Consensus 272 -------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 -------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 455799999998 999999999986
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=320.12 Aligned_cols=266 Identities=22% Similarity=0.275 Sum_probs=195.4
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC----
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG---- 829 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 829 (1079)
++.++|+..+.||+|+||+||+|.. .+++.||||++.... ........+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3457899999999999999999975 467899999885322 1223345677899999999999999999987543
Q ss_pred --CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 830 --RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 830 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
...++++|++ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999987 77998887543 489999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhh
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR 986 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1079)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+..+.... .....
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~-~~~~~ 237 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVV-GTPSP 237 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHh-CCCCH
Confidence 9865432 234568999999999876 56889999999999999999999999653211 1111111100 00000
Q ss_pred chhhhhh--------hhhhcccCccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 987 EFTTILD--------RQLLMRSGTQIQ-----EMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 987 ~~~~~~~--------~~~~~~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.....+. ..+......... ....+.+++.+|++.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000000000000 11246789999999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.95 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=197.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 45777788999999999999764 6889999987532 2234467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++++|.+++...+ .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 86 EFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 9999999999987655 489999999999999999999999 99999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGY---SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
.......|++.|+|||++. ...++.++||||+||++|||++|+.||....+... ....... ... .
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~-------~~~---~ 228 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKS-------NFQ---P 228 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhcc-------CCC---C
Confidence 2233457899999999864 44688899999999999999999999865432111 1000000 000 0
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+... ... .....+.+++.+|++.+|++|||++++++
T Consensus 229 ~~~~--~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLK--DKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred Cccc--ccC--CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000 000 01124668999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=310.47 Aligned_cols=268 Identities=19% Similarity=0.274 Sum_probs=198.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|..+ +++.||+|.+...... .....+.+|++++++++|+||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 56888899999999999999775 6889999998543221 22345678999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+.+ +|.+++......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 157 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS- 157 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence 99985 99999987666789999999999999999999999 99999999999999999999999999987543221
Q ss_pred cccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHh---HHhhhhhchhhh-
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG---ELRERKREFTTI- 991 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~- 991 (1079)
.......++..|+|||+..+ ..++.++||||+|+++|||++|+.||................ ...+.+......
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 11222346889999998765 457899999999999999999999997543211111111100 000000000000
Q ss_pred --hh-------hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 992 --LD-------RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 --~~-------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. +.................+++.+|++++|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0000000001111246678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=330.80 Aligned_cols=267 Identities=17% Similarity=0.208 Sum_probs=192.2
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCC------CceeeeeeEEEcC
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH------KNIVRLLGCCNNG 829 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~ 829 (1079)
..+|++.+.||+|+||+||+|... .++.||||++.... .....+..|+.+++.++| .+++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 467899999999999999999764 67889999985321 223455667777777654 4588999988764
Q ss_pred -CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC----------
Q 001426 830 -RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF---------- 898 (1079)
Q Consensus 830 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---------- 898 (1079)
...++|||++ +++|.+++.+.+ .+++..+..++.||+.||+|||++. +||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccccc
Confidence 5678999988 678999887654 4899999999999999999999731 899999999999998765
Q ss_pred ------cEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcch
Q 001426 899 ------EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAH 972 (1079)
Q Consensus 899 ------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~ 972 (1079)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~ 352 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL--E 352 (467)
T ss_pred cCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--H
Confidence 49999999886432 2233467999999999999999999999999999999999999999764321 1
Q ss_pred HHHHHH---hHHhhhhhc------hhhhhh----------hhhh-----cccCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 001426 973 IITWVN---GELRERKRE------FTTILD----------RQLL-----MRSGTQIQEMLQVLGVALLCVNPCPEERPTM 1028 (1079)
Q Consensus 973 ~~~~~~---~~~~~~~~~------~~~~~~----------~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 1028 (1079)
....+. +..+..+.. ....++ +... ............+.+++.+|++.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 111111 111110000 000000 0000 0000001112456799999999999999999
Q ss_pred HHHHH--HHHhc
Q 001426 1029 KDVTA--MLKEI 1038 (1079)
Q Consensus 1029 ~evl~--~L~~~ 1038 (1079)
+|+++ .+.+.
T Consensus 433 ~e~L~Hp~~~~~ 444 (467)
T PTZ00284 433 RQMTTHPYVLKY 444 (467)
T ss_pred HHHhcCcccccc
Confidence 99997 45443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=335.68 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=194.1
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc-----
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN----- 828 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 828 (1079)
+...+|+..++||+||||.||+++.+ +|+.||||++.... +......+.+|+..+.+++|||||+++.++.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 34567788899999999999999887 89999999995432 44556788999999999999999999876411
Q ss_pred --------------------------------------------------C-----------------------------
Q 001426 829 --------------------------------------------------G----------------------------- 829 (1079)
Q Consensus 829 --------------------------------------------------~----------------------------- 829 (1079)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHH
Q 001426 830 -----------------------------------RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL 874 (1079)
Q Consensus 830 -----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~L 874 (1079)
..+||-||||+..++.+++++....-.....|+++++|++|++|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 124799999999888888876544325778899999999999999
Q ss_pred HhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc------C----------CcccccccccccCcccccccccCCC
Q 001426 875 HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE------S----------SESSRASNSVAGSYGYIAPEYGYSL 938 (1079)
Q Consensus 875 H~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~------~----------~~~~~~~~~~~gt~~y~aPE~~~~~ 938 (1079)
|+. |||||||||.||+++++..|||+|||+|+... + +......+..+||.-|+|||.+.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 99999999999999999999999999998721 0 1111234567899999999997765
Q ss_pred C---CCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHH
Q 001426 939 K---ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVAL 1015 (1079)
Q Consensus 939 ~---~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 1015 (1079)
. |+.|+|+||+||+++||+. ||....+....+.... +..+........+++..-.+++.
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR---------------~g~iP~~~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR---------------KGSIPEPADFFDPEHPEEASLIR 852 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc---------------cCCCCCCcccccccchHHHHHHH
Confidence 4 9999999999999999974 5654221111111111 11111111111233344457899
Q ss_pred hccCCCCCCCCCHHHHHH
Q 001426 1016 LCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 1016 ~Cl~~dP~~RPt~~evl~ 1033 (1079)
++++.||.+||||.|++.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=307.19 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=199.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
++|+..+.||+|+||+||+|+.+ +.+.+++|.+... ......+.+.+|++++++++|+||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 46788899999999999999864 3457888877421 222245789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccC--------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001426 832 RLLLFDYISNGSLAGLLHEKK--------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLA 903 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 903 (1079)
.++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 999999999999999997543 1489999999999999999999999 99999999999999999999999
Q ss_pred eccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHh
Q 001426 904 DFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELR 982 (1079)
Q Consensus 904 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 982 (1079)
|||+++...... ........++..|+|||...+..++.++||||||+++|||++ |..||...... .......
T Consensus 160 ~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~---- 232 (275)
T cd05046 160 LLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQ---- 232 (275)
T ss_pred ccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHH----
Confidence 999987543322 222333456778999999888888999999999999999999 77888643211 1111110
Q ss_pred hhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 983 ERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
. .... . .... .....+.+++.+||+.+|++|||+.|+++.|.
T Consensus 233 ~--~~~~-~-------~~~~--~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 A--GKLE-L-------PVPE--GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred c--CCcC-C-------CCCC--CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0 0000 0 0000 11236778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=307.91 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=197.2
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|... +++.||+|.+... ........+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 5788899999999999999876 7889999987432 223345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 838 YISNGSLAGLLHEK--KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|+++++|.+++... ...+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||.+..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999998764 235899999999999999999999742 8999999999999999999999999999765332
Q ss_pred ccccccccccCcccccccccCCC------CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSL------KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
......+++.|+|||...+. .++.++||||+||++|||++|+.||....... ...............+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~- 230 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSAIVDGDPPTL- 230 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHHHhhcCCCCC-
Confidence 22234578899999987544 34789999999999999999999996532111 0000000000000000
Q ss_pred hhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
. ......+.+++.+||+.+|++||++++++..
T Consensus 231 -----------~--~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 231 -----------P--SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----------C--cccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0 0122356689999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=311.54 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=200.6
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
.++|+..+.||.|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++......++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc---cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 35688889999999999999965 57889999988532 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
+||+++++|.+++.+. .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 95 MEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999999998654 479999999999999999999999 99999999999999999999999999988655432
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
. ......++..|+|||...+..++.++|||||||++|||++|+.||....+... ..... ......
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~----~~~~~~-------- 234 (296)
T cd06655 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIA----TNGTPE-------- 234 (296)
T ss_pred c--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH----hcCCcc--------
Confidence 1 22334688899999999888899999999999999999999999976432111 10000 000000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. ... .....+.+++.+||..||++|||+.+++.
T Consensus 235 ~~--~~~--~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 LQ--NPE--KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cC--Ccc--cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00 000 11225668899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=305.49 Aligned_cols=248 Identities=28% Similarity=0.382 Sum_probs=200.7
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||.|+||.||+|... +++.||+|.+... ........+.+|+++++.++|+||+++++++.++...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecc--ccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 5778889999999999999765 6889999988532 223445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++++|.+++... .+++..++.++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++.+....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 99999999999765 589999999999999999999999 99999999999999999999999999998775432
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
.......+++.|+|||...+..++.++||||||+++|||++|+.||....+.. ... ..... ..+...
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~----~~~~~-------~~~~~~ 219 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLF----LIPKN-------NPPSLE 219 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHH----Hhhhc-------CCCCCc
Confidence 22234567889999999988889999999999999999999999997543211 000 00000 000000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. .....+.+++.+||..+|++|||++++++
T Consensus 220 ~~-----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GN-----KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cc-----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00 01225678899999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=309.94 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=200.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|++.+.||+|+||.||+|... +++.+|+|.+.. ......+.+.+|++++++++||||+++++++..+...++||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI---ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee---CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 46888889999999999999775 688999998742 23344578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++++|.+++.+.+..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 99999999999987766799999999999999999999999 99999999999999999999999999987554322
Q ss_pred cccccccccCcccccccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGY-----SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.......+++.|+|||... +..++.++||||||+++|||++|+.||...... ..+..+.. ...+
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~----~~~~----- 226 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILK----SEPP----- 226 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhc----CCCC-----
Confidence 1223456889999999864 345778999999999999999999999754221 11111100 0000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
... ... .....+.+++..||+.+|++||++.++++.
T Consensus 227 ---~~~--~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 ---TLD--QPS--KWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CcC--Ccc--cCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 000 112256688999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=301.38 Aligned_cols=250 Identities=27% Similarity=0.333 Sum_probs=199.0
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCC--CchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNG--ELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
+|+..+.||+|+||.||+|... +++.|++|.+...... ..+..+.+.+|+++++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999876 7899999988543321 123447889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
+||+++++|.+++.+.+ .+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999997654 478999999999999999999999 99999999999999999999999999988654332
Q ss_pred ccccccccccCcccccccccCCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLK-ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
......++..|+|||...... ++.++|+||||+++|+|++|+.||....+ ...............+.
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~----- 224 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIGRSKELPPIP----- 224 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHHhcccCCCcC-----
Confidence 223456889999999887666 89999999999999999999999975421 11000000000000000
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. .....+.+++.+||+.+|++||++.+++.
T Consensus 225 -------~--~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 225 -------D--HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -------C--CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0 11235567899999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=309.07 Aligned_cols=267 Identities=21% Similarity=0.224 Sum_probs=197.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|...+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++++++.++...++|+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 56888899999999999999764 688999998853321 223356788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+. +++.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9996 688877765555578888999999999999999999 99999999999999999999999999997543321
Q ss_pred cccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhh----------
Q 001426 917 SRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERK---------- 985 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 985 (1079)
.......+++.|+|||...+. .++.++||||+||++|||++|+.||+...+....+..... ......
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT-VLGVPTEDTWPGVSKL 235 (291)
T ss_pred -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH-HcCCCChhhhhhhhhc
Confidence 122334578899999987653 5788999999999999999999999764332221111110 000000
Q ss_pred hchhhhhhh----hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 986 REFTTILDR----QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 986 ~~~~~~~~~----~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+........ ...............+.+++.+|++.||++|||++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 000000001112346678999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=306.18 Aligned_cols=258 Identities=25% Similarity=0.364 Sum_probs=197.7
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCC-------chhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGE-------LPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR 830 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 830 (1079)
+|...+.||+|+||.||+|... +++.+|+|.+....... ....+.+.+|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999654 68899999875321111 112356888999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
..++||||+++|+|.+++.+.+ .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999997764 489999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCcccccccccccCcccccccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhch
Q 001426 911 FESSESSRASNSVAGSYGYIAPEYGYSLK--ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREF 988 (1079)
Q Consensus 911 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1079)
..............++..|+|||...... ++.++|+||+|+++||+++|..||..... ...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~- 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFKLGNKRSAPP- 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHHhhccccCCc-
Confidence 54322122223456889999999877654 78999999999999999999999864321 111111000000000
Q ss_pred hhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 989 TTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
+.... .......+.+++.+||+++|++|||++||++.
T Consensus 233 ---~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 ---IPPDV------SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---CCccc------cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000 00112467788999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.66 Aligned_cols=240 Identities=17% Similarity=0.335 Sum_probs=186.6
Q ss_pred CeeeecCcEEEEEEEeCC--------CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 764 NIVGKGVSGIVYRVEIPS--------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
+.||+|+||.||+|.... ...+|+|.+.. ......+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc---hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 468999999999997642 23477776532 1223446788999999999999999999999998999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCc--------EEEeeccc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFE--------AFLADFGL 907 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~DFGl 907 (1079)
|||+++|+|.+++...+..+++..+..++.||+.|++|||+. +|+||||||+||+++.++. ++++|||.
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999999987766789999999999999999999999 9999999999999987765 68999998
Q ss_pred cccccCCcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCC-CCCCCCCCCcchHHHHHHhHHhhhh
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGK-EPTDSRIPDGAHIITWVNGELRERK 985 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 985 (1079)
+...... ....+++.|+|||++.+. .++.++||||||+++|||++|. .|+....+. ...... .. .
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~~~----~~-~ 221 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQFY----ED-R 221 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHHHH----Hc-c
Confidence 8754321 234578899999998764 5789999999999999999985 454432111 000000 00 0
Q ss_pred hchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 986 REFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
.. ... .....+.+++.+||+.+|++|||++++++.|+
T Consensus 222 ~~----------~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQ----------LPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc----------CCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 000 11135678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=300.53 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=198.3
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc-CCeEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN-GRTRLLLF 836 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 836 (1079)
+|+..+.||+|+||.||++..+ +++.||+|++.... ......+.+.+|++++++++|+|++++++.+.. +...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 4778899999999999999765 57889999885322 223445678999999999999999999998764 44679999
Q ss_pred EecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 837 DYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
||+++++|.+++... ...+++..++.++.|++.|++|+|+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999764 44589999999999999999999999 99999999999999999999999999998664322
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......+++.|+|||+..+..++.++||||+|+++|||++|+.||..... ............+..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~------- 222 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGKLPPM------- 222 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCCCCC-------
Confidence 222345688999999999998999999999999999999999999874321 111111000000000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.......+.+++.+||+.+|++|||+.++++
T Consensus 223 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 -------PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -------ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0012236778999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=314.96 Aligned_cols=272 Identities=18% Similarity=0.228 Sum_probs=196.5
Q ss_pred CCeeeec--CcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEec
Q 001426 763 TNIVGKG--VSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 763 ~~~lG~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
.++||+| +|++||++.. .+++.||+|++..... .....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 4679999 7889999966 5789999999853322 2233467888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc-
Q 001426 840 SNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS- 917 (1079)
Q Consensus 840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~- 917 (1079)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999754 34489999999999999999999999 9999999999999999999999999876543221111
Q ss_pred ----ccccccccCcccccccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhh------
Q 001426 918 ----RASNSVAGSYGYIAPEYGYS--LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERK------ 985 (1079)
Q Consensus 918 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 985 (1079)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .......+..+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCCccccccccchh
Confidence 01123356778999999875 458899999999999999999999997532211 11111111110000
Q ss_pred -hchh-----hhhhhhh----h---------cc--cCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhcc
Q 001426 986 -REFT-----TILDRQL----L---------MR--SGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIR 1039 (1079)
Q Consensus 986 -~~~~-----~~~~~~~----~---------~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~ 1039 (1079)
.+.. ...+... . .. ..........+.+++.+||+.||++|||++|+++ .+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0000 0000000 0 00 0000012346778999999999999999999987 455543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=302.84 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=193.1
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCC--CchhHHHHHHHHHHHhcCCCCceeeeeeEEEc--CCeEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNG--ELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN--GRTRL 833 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 833 (1079)
.|+..+.||+|+||.||+|... +++.||+|++...... .......+.+|+.++++++||||+++++++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 4788899999999999999764 6889999987543321 22334678999999999999999999999875 35678
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+++||+++++|.+++...+. +++..++.++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||+++....
T Consensus 83 l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 99999999999999976543 78899999999999999999998 999999999999999999999999999986543
Q ss_pred Ccc-cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 914 SES-SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
... ........++..|+|||...+..++.++||||+||++|||++|+.||...... ...... ... . .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~~~~~-~~~--~-----~ 226 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AAIFKI-ATQ--P-----T 226 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HHHHHH-hcC--C-----C
Confidence 211 11122345888999999998888999999999999999999999999753211 100000 000 0 0
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.+.. .......+..++ .||..+|++||+++|+++
T Consensus 227 ~~~~------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQL------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCC------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000 001112333444 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=312.59 Aligned_cols=194 Identities=27% Similarity=0.401 Sum_probs=159.0
Q ss_pred CeeeecCcEEEEEEEeC---CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc--CCeEEEEEEe
Q 001426 764 NIVGKGVSGIVYRVEIP---SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN--GRTRLLLFDY 838 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 838 (1079)
.+||+|+||+||+|+.. .+..||+|.+... .....+.+|++++++++||||+++++++.. +...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC-----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 57999999999999865 3568999987432 123467889999999999999999999853 5677999999
Q ss_pred cCCCChhhhhhcc--------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEE----CCCCcEEEeecc
Q 001426 839 ISNGSLAGLLHEK--------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV----GPQFEAFLADFG 906 (1079)
Q Consensus 839 ~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DFG 906 (1079)
+++ +|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||++ ++++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 875 787776421 23478899999999999999999999 99999999999999 566789999999
Q ss_pred ccccccCCcc-cccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 907 LAKLFESSES-SRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 907 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
+++.+..... ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9987654321 1223345689999999988764 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=309.40 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=198.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+.|+..+.||+|+||.||+|... +++.||+|.+... ......+.+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc--cchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 34666778999999999999764 5788999987432 22334578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++++|.+++.. ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||++..+....
T Consensus 82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 82 EYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred EccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999999999864 3478999999999999999999998 99999999999999999999999999998665432
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......++..|+|||...+..++.++||||||+++|||++|+.|+....+... ... .... ..+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~----~~~~-------~~~~~ 221 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFL----IPKN-------SPPTL 221 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhh----hhcC-------CCCCC
Confidence 122234578899999999988899999999999999999999999875332110 000 0000 00000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.......+.+++.+||+.+|++|||+.++++.
T Consensus 222 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00122356789999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.59 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=200.3
Q ss_pred CCCCCCeeeecCcEEEEEEEeCC--CCeEEEEEeccccC-------CCchhHHHHHHHHHHHhc-CCCCceeeeeeEEEc
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPS--RQVIAVKKLWPVKN-------GELPERDQFSAEVQTLGS-IRHKNIVRLLGCCNN 828 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 828 (1079)
.|+..+.||+|+||.||+|..+. ++.+|+|.+..... ........+..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999998765 78899998753221 222334667788888865 799999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeec
Q 001426 829 GRTRLLLFDYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADF 905 (1079)
Q Consensus 829 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 905 (1079)
++..++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+.. +++||||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998743 3456899999999999999999999631 8999999999999999999999999
Q ss_pred cccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhh
Q 001426 906 GLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERK 985 (1079)
Q Consensus 906 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 985 (1079)
|.+....... ......++..|+|||...+..++.++||||||+++|||++|+.||..... ....... ..
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~~-~~-- 227 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATKI-VE-- 227 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHHH-hh--
Confidence 9998765432 23345688999999999988899999999999999999999999864321 1111100 00
Q ss_pred hchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 986 REFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
...... . .......+.+++.+||+.||++||++.|+.+++++
T Consensus 228 ~~~~~~---------~-~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYEPL---------P-EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCCcC---------C-cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 000000 0 00112356789999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=308.40 Aligned_cols=267 Identities=24% Similarity=0.327 Sum_probs=202.8
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|... +++.||+|++.... ......+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccc-ccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 4778889999999999999764 68899999985432 222345789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+ +++|.+++......+++..++.++.||++|++|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 99 9999999987667799999999999999999999999 999999999999999999999999999987654331
Q ss_pred ccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHH----hhhhhchhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL----RERKREFTTIL 992 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 992 (1079)
.......++..|+|||...+. .++.++||||+|+++|||++|..||....+ ..... ...... ...++...+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLA-IVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHH-HHHHHcCCCChHHHhhccCcc
Confidence 223345688999999987654 468999999999999999999877764322 11111 111111 11111111111
Q ss_pred hhhhh---cccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLL---MRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~---~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+.... ....... +....+.+++.+|++.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 10000 0000000 11257789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=306.95 Aligned_cols=246 Identities=24% Similarity=0.294 Sum_probs=199.3
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||++... +++.+|+|.+.+.........+.+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5788899999999999999765 688999998864433333445778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++++|.+++...+ .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999997664 489999999999999999999998 9999999999999999999999999999866433
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
.....+++.|+|||...+...+.++||||||+++|||++|+.||..... ...... .......+
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~~~~~~~--------- 217 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYEK----ILEGKVRF--------- 217 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HhcCCccC---------
Confidence 2334688999999998888889999999999999999999999975331 100000 00000000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 1033 (1079)
... ....+.+++.+||..+|++|| +++|+++
T Consensus 218 ---~~~--~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 ---PSF--FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---Ccc--CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 000 123566899999999999999 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.34 Aligned_cols=267 Identities=22% Similarity=0.321 Sum_probs=199.6
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|..+ +++.||+|++..... .....+.+.+|+.++++++|+|++++++++..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 36788899999999999999876 588999998854322 2223467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||++++++..+..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 80 EYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred eccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999988888775443 489999999999999999999998 999999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh-
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR- 994 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 994 (1079)
......++..|+|||...+ ..++.++||||||+++|||++|+.||....+.+. ...... ............++.
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRK-TLGDLIPRHQQIFSTN 231 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH-HhCCCChHHhhhcccc
Confidence 2223457889999998765 4578899999999999999999999976432211 111110 000000000000000
Q ss_pred ----hhhccc---CccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 995 ----QLLMRS---GTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 995 ----~~~~~~---~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
...... .... .....+.+++.+||+.+|++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 0000 11246778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.00 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=200.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
..|+..+.||+|+||.||+|... +++.||+|.+... ........+.+|+.++++++||||+++++++.++...++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45777888999999999999765 5888999987432 22344578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++|+|.+++... .+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 82 e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 82 EYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred ecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 999999999998653 478899999999999999999998 99999999999999999999999999997664432
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......++..|+|||+..+..++.++|+||||+++|||++|..||....+.... .. ......
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~---~~~~~~----------- 218 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--FL---IPKNNP----------- 218 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--hh---hhcCCC-----------
Confidence 1223346788999999998888999999999999999999999999754321110 00 000000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
..........+.+++.+||+.+|++||+++++++.
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 ---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00011223467789999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=302.48 Aligned_cols=246 Identities=28% Similarity=0.409 Sum_probs=195.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||.||++.. .++.||+|.+.. ......+.+|+.++++++|||++++++++... ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~-----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKC-----DVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecC-----cchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 4588899999999999999975 577789998742 12346789999999999999999999998765 4699999
Q ss_pred ecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999997653 3578999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
......+..|+|||...+..++.++||||||+++|||++ |+.||...... .... .... .
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~-~~~~-----------~ 213 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVKE-CVEK-----------G 213 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHHH-HHhC-----------C
Confidence 112234578999999988899999999999999999998 89998653221 1110 0000 0
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
....... .....+.+++.+||+.+|++||+++++++.|++
T Consensus 214 ~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 YRMEPPE--GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCC--cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0000000 112366789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=303.65 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=202.6
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||.|+||+||+|... ++..+|+|++..... ....+.+.+|+++++.++|+||+++++.+..+...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 36888899999999999999764 678899998853222 225678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcc--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 837 DYISNGSLAGLLHEK--KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999999764 24589999999999999999999998 9999999999999999999999999999876554
Q ss_pred cccc--cccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 915 ESSR--ASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 915 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.... ......++..|+|||++... .++.++|+|||||++|||++|+.||....+.. ....... .........
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~----~~~~~~~~~ 230 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQ----NDPPSLETG 230 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhc----CCCCCcCCc
Confidence 3221 22344688999999998776 78999999999999999999999997543211 1111111 100000000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.........+.+++.+||+.||++|||++++++
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ---------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ---------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000011235678999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=309.33 Aligned_cols=266 Identities=23% Similarity=0.363 Sum_probs=198.9
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|..+ +++.||+|.+...... ....+.+.+|+++++.++||||+++++++.++...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 5788899999999999999875 5889999987543322 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|++++++.++..... .+++..+..++.||+.|++|||+. +++||||+|+||++++++.++++|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence 999999888775543 389999999999999999999999 99999999999999999999999999998654432
Q ss_pred ccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh-
Q 001426 918 RASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ- 995 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 995 (1079)
.......++..|+|||+..+ ..++.++||||||+++|||++|+.||..... ......... .............+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIK-CLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHH-HhCCCchhhHHHhccch
Confidence 22233457889999998765 4578899999999999999999998865321 111111110 0000000000000000
Q ss_pred -----hhc--ccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 996 -----LLM--RSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 996 -----~~~--~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
... ...... .....+.+++.+||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 000000 11346778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.71 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=200.7
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||++... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 4788899999999999999664 688999998853222 23345688999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++++|.+++... ...+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 99999999999764 34578999999999999999999998 99999999999999999999999999998664432
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......|++.|+|||+..+..++.++|||||||++|||++|+.||..... ...+..........
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~--------- 220 (256)
T cd08218 156 -ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGSYPP--------- 220 (256)
T ss_pred -hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCCCCC---------
Confidence 112234578899999999888899999999999999999999999864321 11111100000000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
........+.+++.+||+.+|++||++++|++
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 -----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00011236778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=311.22 Aligned_cols=253 Identities=28% Similarity=0.345 Sum_probs=200.3
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
+..++|+..+.||+|+||+||+|... +++.||+|.+...........+.+.+|+++++.++||||++++++|.++...+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 33466888999999999999999765 68899999885443334444577899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+||||+. |++.+++......+++..+..++.|++.|+.|||+. +|+||||+|+||++++++.++|+|||++.....
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9999997 578888766555689999999999999999999998 999999999999999999999999999875432
Q ss_pred CcccccccccccCcccccccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGY---SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTT 990 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1079)
. ....+++.|+|||+.. ...++.++||||||+++|||++|+.||....... ............
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~--- 233 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNDSPT--- 233 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HHHHHhcCCCCC---
Confidence 2 2345788999999864 4568889999999999999999999986532111 000000000000
Q ss_pred hhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
. ........+.+++.+||+.+|++||++.+++...
T Consensus 234 -----~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 234 -----L-----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -----C-----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 0001223677899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=282.47 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=198.9
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+++...-+|.|+-|.||+++.+ +|...|||.+.. .+..++.+.+...++++..- ..|.||+.+|||..+...++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r--t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR--TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecc--cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3455667999999999999876 588999999954 34455667888888887655 4899999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|.|.. ....++..-...+++..+-++...++.||.||.+++ +|+|||+||+|||+|+.|++|+||||++.++.+...
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 98854 666666666667888888889999999999999986 999999999999999999999999999987765542
Q ss_pred cccccccccCcccccccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYS---LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
.+..+|-+.|||||.+.. .+|+.++||||||+.++|++||+.||.....+...+...+..+.+ .++
T Consensus 248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP--------~L~ 316 (391)
T KOG0983|consen 248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP--------LLP 316 (391)
T ss_pred ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC--------CCC
Confidence 234578899999998764 468899999999999999999999998755444444433332111 111
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. ... -...+.+++..|++.|+.+||...++++
T Consensus 317 ~------~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 G------HMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred c------ccC--cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1 110 1236678899999999999999988775
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=310.17 Aligned_cols=254 Identities=23% Similarity=0.276 Sum_probs=201.4
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||+||+|... +++.||+|.+.+.........+.+..|+++++.++|+||+++++++.++...++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5788889999999999999775 589999999865433333456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+.+++|.+++... +..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999754 35689999999999999999999999 999999999999999999999999999875533211
Q ss_pred c---------------------------ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC
Q 001426 917 S---------------------------RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPD 969 (1079)
Q Consensus 917 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~ 969 (1079)
. .......|+..|+|||+..+..++.++||||||+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 0112346788999999998888999999999999999999999999754321
Q ss_pred cchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 001426 970 GAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPT----MKDVTA 1033 (1079)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~evl~ 1033 (1079)
..+... .+...... ........+.+++.+||+.+|++||| ++|+++
T Consensus 239 -~~~~~~---------------~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 -ETFSNI---------------LKKEVTFP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred -HHHHHH---------------hcCCccCC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 111110 00000000 00012346788999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.98 Aligned_cols=254 Identities=28% Similarity=0.406 Sum_probs=201.0
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|++++++++|+||+++++++......++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 5788899999999999999764 688999999864332 23456889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++++|.+++.... .+++..+..++.|+++|++|||+. +++||||+|+||++++++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999997654 378899999999999999999999 9999999999999999999999999999876544321
Q ss_pred cc--ccccccCcccccccccCCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 918 RA--SNSVAGSYGYIAPEYGYSLK---ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 918 ~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
.. .....+++.|+|||+..+.. ++.++||||||+++||+++|+.||........ ....... .....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~~~---~~~~~----- 226 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGA---GHKPP----- 226 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHHhc---CCCCC-----
Confidence 11 12356788999999987766 88999999999999999999999975321111 1000000 00000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. +........+.+++.+||+.+|++|||++|++.
T Consensus 227 ---~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 ---I----PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---C----CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 000111235568999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=304.35 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=197.7
Q ss_pred CCCCCeeeecCcEEEEEEEeC----CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-----
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP----SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR----- 830 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 830 (1079)
|+..+.||+|+||.||+|.+. .+..||+|.+.... ......+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 456788999999999999753 36789999885332 22334577899999999999999999999886532
Q ss_pred -eEEEEEEecCCCChhhhhhcc-----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEee
Q 001426 831 -TRLLLFDYISNGSLAGLLHEK-----KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904 (1079)
Q Consensus 831 -~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 904 (1079)
..++++||+.+|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 247899999999999887432 22478899999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhh
Q 001426 905 FGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRE 983 (1079)
Q Consensus 905 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 983 (1079)
||.++...............+++.|++||...+..++.++||||||+++|||++ |+.||..... .....+... .
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~---~ 231 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIK---G 231 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHc---C
Confidence 999987654332222233445678999999988889999999999999999999 8888864321 111111110 0
Q ss_pred hhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhc
Q 001426 984 RKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 1038 (1079)
.. .. .. ......+.+++.+||+.+|++||++.++++.|+++
T Consensus 232 --~~--------~~--~~--~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 --NR--------LK--QP--PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --Cc--------CC--CC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00 00 01123677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=303.58 Aligned_cols=258 Identities=25% Similarity=0.321 Sum_probs=198.1
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--CeEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG--RTRLLL 835 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 835 (1079)
+|+..+.||.|++|.||+|... +++.+|+|.+.... .......+.+|++++++++||||++++++|.+. ...++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 5677889999999999999875 67889999885322 223457789999999999999999999998653 468999
Q ss_pred EEecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 836 FDYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
|||+++++|.+++.. ....+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999988753 345578999999999999999999999 99999999999999999999999999987554
Q ss_pred CCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
... .....++..|+|||...+..++.++||||+|+++|||++|+.||...........................
T Consensus 157 ~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (287)
T cd06621 157 NSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD-- 230 (287)
T ss_pred ccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc--
Confidence 321 12345788999999998889999999999999999999999999764221111111111110000000000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.......-...+.+++.+||+.+|++|||+.|+++
T Consensus 231 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 ------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00000112346779999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=306.78 Aligned_cols=254 Identities=26% Similarity=0.344 Sum_probs=195.7
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEE-----
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCN----- 827 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~----- 827 (1079)
+..++|+..+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++++ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc----cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 45578999999999999999999764 6788999987421 12235688899999999 6999999999884
Q ss_pred cCCeEEEEEEecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEee
Q 001426 828 NGRTRLLLFDYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904 (1079)
Q Consensus 828 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 904 (1079)
.+...++||||+++++|.+++.. .+..+++..+..++.|+++|+.|||+. +|+||||||+||++++++.+|++|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEcc
Confidence 34568999999999999998753 244588999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccCcccccccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHh
Q 001426 905 FGLAKLFESSESSRASNSVAGSYGYIAPEYGY-----SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG 979 (1079)
Q Consensus 905 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 979 (1079)
||+++.+.... .......|++.|+|||++. +..++.++||||+||++|||++|+.||....+.. .+....
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~~-- 242 (286)
T cd06638 168 FGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKIP-- 242 (286)
T ss_pred CCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhcc--
Confidence 99998664332 1223346899999999864 3457889999999999999999999997542211 000000
Q ss_pred HHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 980 ELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.... ....++. .....+.+++.+||+.||++|||+.|+++.
T Consensus 243 --~~~~---~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 --RNPP---PTLHQPE---------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --ccCC---CcccCCC---------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 0000000 011256789999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.91 Aligned_cols=268 Identities=23% Similarity=0.277 Sum_probs=200.0
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCC--CchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNG--ELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
+|+..+.||+|+||.||+|... +++.||+|.+...... .......+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677788999999999999765 6889999998654322 122335677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|||+ +|+|.+++......+++..+..++.||++||+|||+. +|+||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 8999999987665689999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhH---Hhhhhhchhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE---LRERKREFTTI 991 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 991 (1079)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|..||....+. ..+....... ....++.....
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 --RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred --ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccc
Confidence 12223456788999998754 46789999999999999999998777654321 1111111000 00001000000
Q ss_pred hhhhh-hcccCcc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 992 LDRQL-LMRSGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~-~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.+... ....... ......+.+++.+||+++|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000 0000000 012346778999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.00 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=195.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCC--CchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--CeE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNG--ELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG--RTR 832 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 832 (1079)
+.|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 35788899999999999999764 5889999987532221 223457889999999999999999999998763 467
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
+++|||+++++|.+++.+.+. +++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 899999999999999976543 78888999999999999999999 99999999999999999999999999998654
Q ss_pred CCcc-cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 913 SSES-SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 913 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.... ........++..|+|||...+..++.++||||||+++|||++|+.||...... ...... ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~-~~~--~----- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFKI-ATQ--P----- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHHH-hcC--C-----
Confidence 3211 11223346889999999998888999999999999999999999999753211 111000 000 0
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
..+ .........+.+++.+|+. +|++||+++|+++
T Consensus 226 ~~~------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 TNP------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCC------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000 0011122356678888885 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=298.11 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=199.6
Q ss_pred CCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||++.. .+++.+|+|.+.... ........+.+|++++++++||||+++++.+..+...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ-MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc-cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 477888999999999999866 468889999885432 233456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-cEEEeeccccccccCCc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-EAFLADFGLAKLFESSE 915 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~ 915 (1079)
|+++++|.+++.+. +..+++..+..++.+++.|++|||+. +++||||+|+||++++++ .+|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999999765 34589999999999999999999999 999999999999998654 68999999998765432
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
......++..|+|||...+..++.++||||||+++|+|++|+.||....... ............+..
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~----- 223 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVLKIMSGTFAPISD----- 223 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHHHHHhcCCCCCCC-----
Confidence 1223467889999999988889999999999999999999999986542211 111100000000000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.....+.+++.+||+++|++|||++|+++
T Consensus 224 ---------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 ---------RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---------CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11235678999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=302.67 Aligned_cols=250 Identities=24% Similarity=0.283 Sum_probs=201.6
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||.|+||.||+|... +++.||+|.+.+.........+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999775 688999999865443333456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+.+++|.+++.+. ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999766 4588999999999999999999999 99999999999999999999999999988665432
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......|+..|+|||...+..++.++|+||+|+++|+|++|+.||....... ..... ..........
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~-~~~~~~~~~~--------- 221 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIR-AKQETADVLY--------- 221 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHH-HHhccccccC---------
Confidence 2234568889999999988889999999999999999999999998653321 11111 1100000000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTM--KDVT 1032 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~evl 1032 (1079)
.......+.+++.+||+.||++||++ +|++
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 -----PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00112467789999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.17 Aligned_cols=267 Identities=21% Similarity=0.250 Sum_probs=199.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--CeEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG--RTRLL 834 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 834 (1079)
++|+..+.||+|+||.||+|..+ +++.+|+|.+...... ......+.+|+.++++++||||+++++++... ...++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 56888899999999999999876 5888999988543222 22335677899999999999999999998877 88999
Q ss_pred EEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
||||+++ +|.+++......+++..+..++.||+.||+|||+. +++||||+|+||++++++.+||+|||+++.....
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999975 99999877666789999999999999999999999 9999999999999999999999999999876543
Q ss_pred cccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHh---HHhhhhhchhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG---ELRERKREFTT 990 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 990 (1079)
. .......+++.|+|||...+. .++.++|+||+|+++|||++|+.||...... ......... .....++.+..
T Consensus 160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhc
Confidence 2 122334578899999987654 4688999999999999999999999754321 111111100 00000110000
Q ss_pred hhh-----------hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 991 ILD-----------RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 991 ~~~-----------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
... ..+.... ........+.+++.+||+.+|++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKF-PALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccc-cccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 0000000 00001335678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=308.73 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=197.7
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
.+.|.....||+|+||.||++... ++..||+|++.. ......+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL---RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec---chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 344555677999999999999764 688999998742 2233456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|||+++++|.+++... .+++..+..++.||+.|++|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 98 ~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 98 MEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999999988543 378999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......++..|+|||...+..++.++||||||+++|||++|+.||....+. .....+. . ...+.
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~----~-------~~~~~ 237 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIR----D-------NLPPR 237 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH----h-------cCCCc
Confidence 1223356889999999998888999999999999999999999999753221 1000000 0 00000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.. ........+.+++.+||..||.+|||++|+++.
T Consensus 238 ~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 238 VK----DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cc----cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 000112256678999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=287.29 Aligned_cols=203 Identities=23% Similarity=0.278 Sum_probs=182.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|...+++|+|.||.|..++-+ +++.+|+|++++...-..++...-..|-++++..+||.+..+.-.|+..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56778889999999999999654 79999999998766666677788888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+.||.|.-++...+. +++.....+-..|+.||.|||++ +||+||+|.+|.|+|+||++||+|||+++.--..
T Consensus 248 eyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-- 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-- 321 (516)
T ss_pred EEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc--
Confidence 99999999999976554 88888888999999999999999 9999999999999999999999999999853322
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
...++..+|||.|+|||++....|+.++|.|.+||++|||++|+.||+..
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 34566789999999999999999999999999999999999999999864
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=299.45 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=199.7
Q ss_pred CCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCC---chhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGE---LPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 834 (1079)
+|+..+.||+|+||.||+|.. .+++.||+|.+....... ....+.+.+|+.++++++|+||+++++++.+....++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 377788999999999999975 578899999886433222 1234788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-cEEEeeccccccccC
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-EAFLADFGLAKLFES 913 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~ 913 (1079)
|+||+++++|.+++.+.+ .+++..+..++.|++.|++|||+. +++||||+|+||+++.++ .+||+|||.+..+..
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997654 478999999999999999999999 999999999999998776 599999999987654
Q ss_pred Cccc--ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 914 SESS--RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 914 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.... .......++..|+|||...+..++.++||||+|+++|||++|..||........ .......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~---~~--- 228 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKIASA---TT--- 228 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHHhcc---CC---
Confidence 3211 112234678999999999888899999999999999999999999964322111 1110000000 00
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
...........+.+++.+|++.+|++|||+.+++.
T Consensus 229 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 -------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00001112236778999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=309.96 Aligned_cols=271 Identities=21% Similarity=0.273 Sum_probs=197.7
Q ss_pred CCCCCCeeeecCcEEEEEEEeC---CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--CeEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP---SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG--RTRL 833 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 833 (1079)
+|+..+.||+|+||.||+|... .++.||+|.+.............+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999775 4789999998653322223346778899999999999999999999988 7899
Q ss_pred EEEEecCCCChhhhhhcc----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC----CCcEEEeec
Q 001426 834 LLFDYISNGSLAGLLHEK----KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP----QFEAFLADF 905 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~DF 905 (1079)
+||||+++ ++.+++... ...+++..++.++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 677766432 23588999999999999999999999 9999999999999999 899999999
Q ss_pred cccccccCCcc-cccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcc--------hHHH
Q 001426 906 GLAKLFESSES-SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA--------HIIT 975 (1079)
Q Consensus 906 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~--------~~~~ 975 (1079)
|+++....... ........+++.|+|||...+ ..++.++||||||+++|||++|+.||........ .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987654322 122334567889999998765 4578999999999999999999999976543320 1111
Q ss_pred HHHhH---Hhhhhh------chhhhhhhhhhcccC-ccH--------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 976 WVNGE---LRERKR------EFTTILDRQLLMRSG-TQI--------QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 976 ~~~~~---~~~~~~------~~~~~~~~~~~~~~~-~~~--------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
++... .+..+. +.....+........ ... .....+.+++.+|+++||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11100 000000 000000000000000 010 12246789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=342.16 Aligned_cols=254 Identities=26% Similarity=0.319 Sum_probs=206.3
Q ss_pred hCCCCCCeeeecCcEEEEEEE-eCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
-+|.....||.|.||.||-|. .++|+..|+|.+..-.. .....+...+|+.++..++|||+|++||+-.+.+..+|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~-~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS-DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc-ccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 467777899999999999984 56799999998753322 2444578899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc-
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE- 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~- 915 (1079)
|||++|+|.+.+.. +...++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+....
T Consensus 1314 EyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999864 33366667777899999999999999 99999999999999999999999999998876542
Q ss_pred -ccccccccccCcccccccccCCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 916 -SSRASNSVAGSYGYIAPEYGYSL---KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 916 -~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.........||+.|||||++.+. ....++||||+||++.||+||+.||...+.+-+.+.....++.+.-+..
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~---- 1465 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER---- 1465 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh----
Confidence 12233467899999999998754 4677999999999999999999999877666555555544433331111
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
-..+-.+++..|+..||++|.++.|+++.
T Consensus 1466 --------------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1466 --------------LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------------hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12244578999999999999999887764
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=297.83 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=199.4
Q ss_pred CCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc--CCeEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN--GRTRLLL 835 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 835 (1079)
+|+..+.||.|+||.||++.. .+++.+|+|.+.... ......+.+..|+++++.++|+||+++++++.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc-CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 467788999999999999965 467889999875322 233455778899999999999999999998764 4567999
Q ss_pred EEecCCCChhhhhhcc---CcCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 836 FDYISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLH-----HDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~gL~~LH-----~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
|||+++++|.+++... ...+++..++.++.|++.|++||| +. +++||||+|+||+++.++.+|++|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999999653 456899999999999999999999 66 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhc
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
+........ ......+++.|+|||...+..++.++||||||+++|+|++|+.||.... ...+.... .. ..
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~----~~--~~ 226 (265)
T cd08217 157 AKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKI----KE--GK 226 (265)
T ss_pred cccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHH----hc--CC
Confidence 987654331 1233468899999999988889999999999999999999999997542 11111111 10 00
Q ss_pred hhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
. +. ........+.+++.+|++.+|++|||+++|++.
T Consensus 227 ~-----~~------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 F-----RR------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C-----CC------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00 001123467789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=297.14 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=203.3
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|++|.||+|... +++.||+|++..... ......+.+|++++.+++|+||+++++++......++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 5778899999999999999776 589999998854322 1456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHH-DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+++++|.+++... ..+++..++.++.|+++|++|+|+ . +++||||+|+||++++++.++++|||.+........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999999765 448999999999999999999999 8 999999999999999999999999999986654321
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
......++..|+|||...+..++.++||||||+++|||++|+.||...... ............... ...
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~----~~~--- 224 (264)
T cd06623 156 --QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICDGPPP----SLP--- 224 (264)
T ss_pred --cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhcCCCC----CCC---
Confidence 112346788999999998888999999999999999999999999764321 111111111100000 000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.. .....+.+++.+||+++|++|||+.|+++.
T Consensus 225 -----~~-~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 -----AE-EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----cc-cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 022367789999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=311.80 Aligned_cols=295 Identities=23% Similarity=0.337 Sum_probs=211.6
Q ss_pred HhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcC--Ce
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNG--RT 831 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~ 831 (1079)
+.++|+..+.||+|+||.||+|... +++.+|+|++.... ........+.+|+.+++++ +||||++++++|... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4567888999999999999999765 68899999885422 2223445677899999999 999999999998643 46
Q ss_pred EEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccc
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~ 911 (1079)
.++||||++ ++|.+++.+. .+++..+..++.||+.||+|||+. +|+||||+|+||++++++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 799999997 5999998765 578999999999999999999998 9999999999999999999999999999866
Q ss_pred cCCccc---ccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh---
Q 001426 912 ESSESS---RASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER--- 984 (1079)
Q Consensus 912 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 984 (1079)
...... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....+.. .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHH
Confidence 543321 22234568899999998754 457889999999999999999999996543211 1111111000000
Q ss_pred hh----c-hhhhhhhhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhccccCCCCCCCcccc
Q 001426 985 KR----E-FTTILDRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTAM--LKEIRHENDDLEKPNSLS 1052 (1079)
Q Consensus 985 ~~----~-~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~~~~~~~~~~~~ 1052 (1079)
.. . ....++ .......... .....+.+++.+||+.+|++|||++++++. +.++.....+...+....
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~ 315 (337)
T cd07852 237 IESIKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPIT 315 (337)
T ss_pred HHHHHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCcc
Confidence 00 0 000000 0000000000 013467889999999999999999999985 666655544544454444
Q ss_pred ccccCCc
Q 001426 1053 RAVTNPK 1059 (1079)
Q Consensus 1053 ~~~~~~~ 1059 (1079)
....+++
T Consensus 316 ~~~~~~~ 322 (337)
T cd07852 316 IPLDDNV 322 (337)
T ss_pred CCccccc
Confidence 4444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=325.98 Aligned_cols=275 Identities=17% Similarity=0.208 Sum_probs=190.7
Q ss_pred HHHhhCCCCCCeeeecCcEEEEEEEeCC--CCeEEEE--------------EeccccCCCchhHHHHHHHHHHHhcCCCC
Q 001426 754 DDVVTRLSDTNIVGKGVSGIVYRVEIPS--RQVIAVK--------------KLWPVKNGELPERDQFSAEVQTLGSIRHK 817 (1079)
Q Consensus 754 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 817 (1079)
+++..+|++.+.||+|+||+||++..+. +..+++| .+.+...........+.+|+.++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456789999999999999999986532 2222222 11111112223346788999999999999
Q ss_pred ceeeeeeEEEcCCeEEEEEEecCCCChhhhhhccC----cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeE
Q 001426 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK----VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNIL 893 (1079)
Q Consensus 818 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIl 893 (1079)
|||++++++.+.+..|+|+|++. +++.+++.... .......+..++.||+.||+|||+. +||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 99999999999999999999985 47777775431 1234566778999999999999999 9999999999999
Q ss_pred ECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CCC-Ccc
Q 001426 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDS-RIP-DGA 971 (1079)
Q Consensus 894 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~-~~~-~~~ 971 (1079)
++.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|..++.. ... ...
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999987654321 222345799999999999999999999999999999999998765432 211 112
Q ss_pred hHHHHHHhH------HhhhhhchhhhhhhhhhcccCccHH-------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 972 HIITWVNGE------LRERKREFTTILDRQLLMRSGTQIQ-------EMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 972 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.+....... +++....+...++............ ....+.+++.+|++.||++|||+.|+++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 222222110 0000000111111000000000110 1124567788999999999999999986
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=298.06 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=198.5
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
-|+..+.||+|+||.||+|... +++.||+|.+... ......+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3677788999999999999764 6889999987432 222345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++..+.....
T Consensus 83 ~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 83 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999999998643 478999999999999999999998 999999999999999999999999999876644321
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......++..|+|||...+..++.++|||||||++|||++|..||....+. .....+ .....+. +.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~---~~~~~~~----~~---- 222 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLI---PKNNPPT----LE---- 222 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHH---hcCCCCC----CC----
Confidence 122346788999999998888899999999999999999999998653211 011000 0000000 00
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
......+.+++.+||+.+|++||+++++++.
T Consensus 223 ------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 ------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ------cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0112356688999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=305.87 Aligned_cols=254 Identities=27% Similarity=0.349 Sum_probs=200.5
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+.|+..+.||+|+||.||+|... ++..+|+|++.............+..|++++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34677888999999999999764 68899999886443333344568899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+.+ ++.+++......+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 99974 88888876666689999999999999999999999 9999999999999999999999999998754322
Q ss_pred cccccccccCcccccccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGY---SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
....+++.|+|||... ...++.++|||||||++|||++|+.||...... .....+.. ....
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~----~~~~------- 242 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ----NESP------- 242 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh----ccCC-------
Confidence 2346788999999863 456889999999999999999999998653211 00111110 0000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
..........+.+++.+||+.+|.+||++.++++....+.
T Consensus 243 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 243 ------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000011235678999999999999999999998765544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=303.34 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=195.9
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcC---
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNG--- 829 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--- 829 (1079)
+..++|+..+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.+++++ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34567999999999999999999774 6888999987432 12346778899999999 899999999998753
Q ss_pred --CeEEEEEEecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEee
Q 001426 830 --RTRLLLFDYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904 (1079)
Q Consensus 830 --~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 904 (1079)
...++||||+++|+|.++++. .+..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEee
Confidence 357999999999999998863 345689999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccCcccccccccCCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHh
Q 001426 905 FGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL-----KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG 979 (1079)
Q Consensus 905 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 979 (1079)
||.+........ ......++..|+|||..... .++.++|||||||++|||++|+.||....+. .....+.
T Consensus 172 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~-- 246 (291)
T cd06639 172 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIP-- 246 (291)
T ss_pred cccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHh--
Confidence 999886543321 12234688999999986543 3688999999999999999999999754321 1111110
Q ss_pred HHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 980 ELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. .......+ ..+....+.+++.+||+.+|++||++.|+++
T Consensus 247 ---~--~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 ---R--NPPPTLLH---------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---c--CCCCCCCc---------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 00000000 0011235778999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=302.11 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=190.6
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHH-HhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQT-LGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+|+..+.||+|+||.||+|... +++.||+|++..... ......+..|+.+ ++..+||||+++++++..+...++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 5778889999999999999775 689999998854322 1233455556664 66679999999999999999999999
Q ss_pred EecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 837 DYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 837 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
||++ |+|.+++.. ....+++..++.++.||+.|++|||++. +++||||||+||++++++.+||+|||+++.+..
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9997 588887754 2346899999999999999999999853 799999999999999999999999999986543
Q ss_pred CcccccccccccCcccccccccCC----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYS----LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
.. ......++..|+|||...+ ..++.++|+||+|+++|||++|+.||.........+..... ....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~--- 226 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE----EPSP--- 226 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh----cCCC---
Confidence 21 1223467889999998754 45688999999999999999999999653222111111110 0000
Q ss_pred hhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
... .. .....+.+++.+||..+|++||+++++++
T Consensus 227 -----~~~---~~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 -----QLP---AE--KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -----CCC---cc--ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 11235678999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=307.03 Aligned_cols=276 Identities=23% Similarity=0.341 Sum_probs=200.8
Q ss_pred cCCHHHHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc
Q 001426 750 NFSVDDVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN 828 (1079)
Q Consensus 750 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 828 (1079)
.+.+.+..++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 3455666778999999999999999999765 688999998853322 22223456789999999999999999999876
Q ss_pred CC--------eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcE
Q 001426 829 GR--------TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEA 900 (1079)
Q Consensus 829 ~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 900 (1079)
.. ..++||||+.+ ++.+++......+++..++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGIL 158 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcE
Confidence 54 34999999965 88888877665689999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCccc--ccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHH
Q 001426 901 FLADFGLAKLFESSESS--RASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWV 977 (1079)
Q Consensus 901 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~ 977 (1079)
||+|||++..+...... .......++..|+|||...+. .++.++||||||+++|||++|+.||....+. .....+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~ 236 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLI 236 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 99999999866443211 122234578899999987654 4688999999999999999999998754321 111111
Q ss_pred HhHH---hh-hhhchh--hhhhhhhhcccCc--cH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 978 NGEL---RE-RKREFT--TILDRQLLMRSGT--QI-------QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 978 ~~~~---~~-~~~~~~--~~~~~~~~~~~~~--~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.... .. ..+... ...+. ....... .. .....+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKK-MELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHhCCCChhhcccccchhhhhh-ccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1100 00 000000 00000 0000000 00 01235568999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=303.47 Aligned_cols=267 Identities=23% Similarity=0.303 Sum_probs=199.9
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|..+ +++.||+|.+.... ......+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 5788899999999999999776 57899999875432 223345789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|++++.+..+..+. ..+++..++.++.||+.|++|||+. +++|||++|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 99987776655443 4489999999999999999999999 999999999999999999999999999987654432
Q ss_pred ccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh--hh
Q 001426 918 RASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL--DR 994 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 994 (1079)
.......++..|+|||+..+. .++.++||||||+++|||++|+.||...... ........ ......+...... ++
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQK-CLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HhCCCCHHHhhhcccCc
Confidence 122345678899999998887 7899999999999999999999998754221 11111000 0000000000000 00
Q ss_pred hhhc----cc--CccH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 995 QLLM----RS--GTQI------QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 995 ~~~~----~~--~~~~------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.... .. .... .....+.+++.+||+.+|++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 00 0000 01346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=296.88 Aligned_cols=244 Identities=26% Similarity=0.331 Sum_probs=196.4
Q ss_pred eeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCCh
Q 001426 766 VGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 844 (1079)
||.|+||.||+|... +++.+|+|.+.+.........+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999876 4889999998654433334557899999999999999999999999999999999999999999
Q ss_pred hhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccccc
Q 001426 845 AGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA 924 (1079)
Q Consensus 845 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 924 (1079)
.+++.+.. .+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99997654 388999999999999999999998 99999999999999999999999999998765432 122346
Q ss_pred cCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHh-hhhhchhhhhhhhhhcccCcc
Q 001426 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR-ERKREFTTILDRQLLMRSGTQ 1003 (1079)
Q Consensus 925 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 1003 (1079)
+++.|+|||...+..++.++|+||+|+++|||++|..||.....+..... ..... .... ..+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~------------~~~~- 217 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY---NDILKGNGKL------------EFPN- 217 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH---HHHhccCCCC------------CCCc-
Confidence 78899999998888899999999999999999999999976532111111 10000 0000 0000
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001426 1004 IQEMLQVLGVALLCVNPCPEERPT-----MKDVTA 1033 (1079)
Q Consensus 1004 ~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 1033 (1079)
.....+.+++.+||+.+|++||+ ++|+++
T Consensus 218 -~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 -YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11336788999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=300.88 Aligned_cols=261 Identities=18% Similarity=0.235 Sum_probs=184.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCC----CeEEEEEeccccCCCchhH--------HHHHHHHHHHhcCCCCceeeeeeE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSR----QVIAVKKLWPVKNGELPER--------DQFSAEVQTLGSIRHKNIVRLLGC 825 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~l~~~ 825 (1079)
++|.+.+.||+|+||+||+|...++ ..+|+|+..........+. .....+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5789999999999999999987654 4556654321111110110 112233445667789999999998
Q ss_pred EEcCC----eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEE
Q 001426 826 CNNGR----TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF 901 (1079)
Q Consensus 826 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 901 (1079)
+.... ..++++|++.. ++.+.+.... ..++..+..++.|++.|++|||+. +|+||||||+|||+++++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence 76543 34778887744 5666654432 357888899999999999999999 999999999999999999999
Q ss_pred EeeccccccccCCccc-----ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHH
Q 001426 902 LADFGLAKLFESSESS-----RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITW 976 (1079)
Q Consensus 902 l~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~ 976 (1079)
|+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||......... ...
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~-~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL-IHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH-HHH
Confidence 9999999876432211 1122346999999999999999999999999999999999999999765322211 111
Q ss_pred HHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 977 VNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
....... .......... .....+.+++..||..+|++||+++++++.+
T Consensus 246 ~~~~~~~------~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIK------RLHEGKIKIK-----NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHH------HhhhhhhccC-----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1110000 0000101000 1123677899999999999999999999876
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=299.97 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=197.5
Q ss_pred CCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC---CCceeeeeeEEEcCCeEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR---HKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 834 (1079)
.|+..+.||+|+||.||+|.. .+++.||+|.+... ......+.+.+|+.++++++ |||++++++++.++...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC--CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 367788999999999999976 57889999987532 22334567889999999997 9999999999999999999
Q ss_pred EEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
||||+++++|.+++... .+++..++.++.|++.|++|||+. +|+||||+|+||++++++.++++|||.+..+...
T Consensus 80 v~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999998654 589999999999999999999999 9999999999999999999999999999876544
Q ss_pred cccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
. .......|+..|+|||...+ ..++.++||||||+++|+|++|+.||....... ..........
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~~~~~-------- 219 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLIPKSKP-------- 219 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhccccCCC--------
Confidence 3 22234468899999998765 456889999999999999999999997532211 0000000000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+... .. .....+.+++.+||+.||++||++.|++.
T Consensus 220 ~~~~--~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 PRLE--DN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCC--cc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0000 00 02236778999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=302.43 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=196.4
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
.|+..+.||+|+||.||+|+.. +++.||+|++.... ........+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 3678889999999999999765 68899999885332 222334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+. ++|.+++... +..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||+++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 996 5899988654 34589999999999999999999999 99999999999999999999999999987654322
Q ss_pred cccccccccCcccccccccCCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHh---hhhhchhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLK-ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR---ERKREFTTIL 992 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 992 (1079)
.......+++.|+|||...+.. ++.++||||||+++|||+||+.||...... ....+....... ..++......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1222345688999999876544 588999999999999999999999753221 111111111000 0000000000
Q ss_pred hhh--hhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQ--LLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~--~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+.. ......... .....+.+++.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 000000000 01235668999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=301.44 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=194.4
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEc------
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNN------ 828 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------ 828 (1079)
...|+..+.||+|+||.||+|... +++.+|+|.+.. .......+..|+.+++++ +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~----~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec----ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 457888899999999999999764 678899998742 223446788899999998 69999999999853
Q ss_pred CCeEEEEEEecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 829 GRTRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 829 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
....+++|||+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 45789999999999999999754 34578888999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCcccccccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHh
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGY-----SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR 982 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 982 (1079)
+....... .......|++.|+|||.+. +..++.++|||||||++|||++|+.||....+.... .. ..
T Consensus 168 ~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~-----~~ 239 (282)
T cd06636 168 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-FL-----IP 239 (282)
T ss_pred hhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-hh-----Hh
Confidence 87654221 1223456889999999865 346788999999999999999999999653221110 00 00
Q ss_pred hhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 983 ERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. . ..+... .......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~--~-----~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 R--N-----PPPKLK-----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h--C-----CCCCCc-----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0 000000 0011236778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=293.61 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=201.8
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|+++++.++|++++++++++..+...++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 677889999999999999875 688899998854222 3567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+++++|.+++......+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999999987656689999999999999999999998 999999999999999999999999999987654431
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhc
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
.....++..|+|||...+..++.++||||||+++|+|++|+.||........ .... ...... ...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~---~~~~~~---~~~------ 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKI---ATNGPP---GLR------ 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHH---HhcCCC---CcC------
Confidence 3345688999999999888899999999999999999999999875321100 0000 000000 000
Q ss_pred ccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 999 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
....-...+.+++.+||+.||++|||++|+++
T Consensus 219 ---~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 ---NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ---cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00001235778999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=305.22 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=196.2
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+....||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR---KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec---ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 334457999999999999764 6889999988432 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+++++|.+++.. ..+++..++.++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++..+.... .
T Consensus 100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~ 172 (297)
T cd06659 100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 172 (297)
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence 999999998754 3478999999999999999999999 99999999999999999999999999987554332 1
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhc
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
......++..|+|||+..+..++.++||||||+++|||++|+.||....+. ....... ...... ..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~----~~~~~~-------~~- 238 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLR----DSPPPK-------LK- 238 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh----ccCCCC-------cc-
Confidence 223456889999999998888999999999999999999999999753221 1111110 000000 00
Q ss_pred ccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 999 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
... .....+.+++.+||+.+|++||+++++++.
T Consensus 239 -~~~--~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 -NAH--KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -ccC--CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 112256688999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=299.70 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=196.4
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCC----
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGR---- 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 830 (1079)
.++|+..+.||+|+||.||+|..+ +++.+++|.+... ....+.+.+|+++++++ +|+||+++++++.+..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII----EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC----chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 467899999999999999999875 5788999987432 22456799999999999 7999999999997644
Q ss_pred --eEEEEEEecCCCChhhhhhcc---CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeec
Q 001426 831 --TRLLLFDYISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADF 905 (1079)
Q Consensus 831 --~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 905 (1079)
..++||||+++++|.+++... +..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 489999999999999998653 35689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCcccccccccccCcccccccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhH
Q 001426 906 GLAKLFESSESSRASNSVAGSYGYIAPEYGYS-----LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE 980 (1079)
Q Consensus 906 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 980 (1079)
|.+....... .......++..|+|||.+.. ..++.++||||+|+++|||++|+.||....+. .......
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~--- 231 (275)
T cd06608 158 GVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIP--- 231 (275)
T ss_pred ccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhh---
Confidence 9987654322 22234568899999998643 34678999999999999999999999753211 1111100
Q ss_pred HhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 981 LRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.... +.. .........+.+++.+||+.||++|||++|+++
T Consensus 232 -~~~~--------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RNPP--------PTL----KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -ccCC--------CCC----CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000 000 000112236678999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=293.33 Aligned_cols=253 Identities=29% Similarity=0.383 Sum_probs=203.8
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--CeEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG--RTRLLL 835 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 835 (1079)
+|+..+.||+|++|.||+|... +++.|++|.+...... ....+.+.+|++++++++|+||+++++++.+. ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 3677789999999999999876 7889999988543322 34568899999999999999999999999988 889999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
+||+++++|.+++.+.. .+++..++.++.|+++|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 99999999999998765 689999999999999999999998 99999999999999999999999999998766543
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.........++..|+|||...+...+.++||||||+++|+|++|+.||............. .. .....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~-~~~~~------ 223 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI-----GS-SGEPP------ 223 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc-----cc-cCCCc------
Confidence 2112334568899999999988889999999999999999999999997643111000000 00 00000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.... .....+.+++.+|++.+|++||++.|+++
T Consensus 224 ---~~~~--~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 ---EIPE--HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---CCCc--ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0000 11346778999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=304.84 Aligned_cols=268 Identities=25% Similarity=0.289 Sum_probs=197.7
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--CeEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG--RTRL 833 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 833 (1079)
.++|+..+.||+|+||.||+|... +++.||+|.+..... .......+.+|+.++++++|+||+++++++.+. +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457889999999999999999775 689999998854322 112234567899999999999999999998755 4689
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+||||+++ +|.+++......+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99999975 89988877666689999999999999999999999 999999999999999999999999999987654
Q ss_pred CcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhh----hhhch
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE----RKREF 988 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 988 (1079)
.. .......+++.|+|||...+ ..++.++||||+|+++|||++|+.||....+. ..+.... ..... .++.+
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~-~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLII-QLLGTPNESIWPGF 236 (309)
T ss_pred cc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HhcCCCChhhchhh
Confidence 32 12223345788999998765 45789999999999999999999999754321 1111111 11000 00000
Q ss_pred hhhhh---hhhhcccCccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 989 TTILD---RQLLMRSGTQIQ-----EMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 989 ~~~~~---~~~~~~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
..... ............ ....+.+++.+|+++||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000000000000 1345678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=298.80 Aligned_cols=245 Identities=20% Similarity=0.220 Sum_probs=186.8
Q ss_pred eeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHh---cCCCCceeeeeeEEEcCCeEEEEEEecC
Q 001426 765 IVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLG---SIRHKNIVRLLGCCNNGRTRLLLFDYIS 840 (1079)
Q Consensus 765 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 840 (1079)
+||+|+||.||++... +++.+|+|.+.+...........+.+|..+++ ..+||||+++++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 68899999886543322222334445544443 3479999999999999999999999999
Q ss_pred CCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccc
Q 001426 841 NGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920 (1079)
Q Consensus 841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 920 (1079)
+|+|.+++...+. +++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 9999999876554 89999999999999999999999 99999999999999999999999999987554322 2
Q ss_pred cccccCcccccccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcc
Q 001426 921 NSVAGSYGYIAPEYGY-SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMR 999 (1079)
Q Consensus 921 ~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1079)
....|+..|+|||... +..++.++||||+||++|||++|..||.......... ........ ...+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~---------~~~~--- 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTV---------NVEL--- 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHHhhcC---------CcCC---
Confidence 2346899999999876 4568899999999999999999999997543221111 00000000 0000
Q ss_pred cCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 001426 1000 SGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTAM 1034 (1079)
Q Consensus 1000 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 1034 (1079)
.......+.+++.+|++.||++|| |++++++.
T Consensus 219 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 001123567889999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=299.96 Aligned_cols=246 Identities=21% Similarity=0.219 Sum_probs=192.2
Q ss_pred eeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCCh
Q 001426 766 VGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 844 (1079)
||+|+||+||+|... +++.||+|.+.............+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999654 6889999988643322233455678899999999999999999999999999999999999999
Q ss_pred hhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccccc
Q 001426 845 AGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSV 923 (1079)
Q Consensus 845 ~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 923 (1079)
.+++.+.. ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.+|++|||.+...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence 99997654 3589999999999999999999999 9999999999999999999999999998765432 122334
Q ss_pred ccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCcc
Q 001426 924 AGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQ 1003 (1079)
Q Consensus 924 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1079)
.++..|+|||+..+..++.++||||+|+++|+|++|+.||........ ....... ....... ...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-~~~~~~~------------~~~- 219 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRR-TLEMAVE------------YPD- 219 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhc-ccccccc------------CCc-
Confidence 678899999998888899999999999999999999999975432111 0000000 0000000 000
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001426 1004 IQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 1004 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 1033 (1079)
.....+.+++.+||+.+|++|| ++.++++
T Consensus 220 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 -KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1123567899999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=303.04 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=201.3
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
+...+|+..+.||+|+||.||++.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++......+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 3346889999999999999999975 46788999987421 2234567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+|+||+++++|.+++.+. .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 93 lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999999999999754 378899999999999999999999 999999999999999999999999999876544
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
... ......+++.|+|||......++.++||||||+++||+++|+.||....+.... .... ....+.+
T Consensus 168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~~----~~~~~~~----- 235 (293)
T cd06647 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIA----TNGTPEL----- 235 (293)
T ss_pred ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eehh----cCCCCCC-----
Confidence 321 223346888999999988888999999999999999999999999754321110 0000 0000000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.........+.+++.+||+.+|++||++++++..
T Consensus 236 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 -------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000112356689999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=300.95 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=202.9
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
+..+.|+..+.||+|+||.||+|..+ ++..+|+|.+..... ..+.+.+|+++++.++|+|++++++++......+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 34456888889999999999999876 688899998853221 4577889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+|+||+++++|.+++......+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999999987765689999999999999999999998 999999999999999999999999999875543
Q ss_pred CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
.. .......++..|+|||...+..++.++||||||+++|||++|+.||....+. ....... ..... ....
T Consensus 169 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~----~~~~~---~~~~ 238 (286)
T cd06614 169 EK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLIT----TKGIP---PLKN 238 (286)
T ss_pred ch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH----hcCCC---CCcc
Confidence 32 1223345788999999998888999999999999999999999998653221 1111000 00000 0000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.......+.+++.+||+.+|.+|||+.++++
T Consensus 239 ---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 ---------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0001235778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=299.01 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=197.0
Q ss_pred eeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCCh
Q 001426 766 VGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 844 (1079)
||+|+||.||++... +++.+|+|.+...........+.+.+|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999886 4899999988543333334557889999999999999999999999999999999999999999
Q ss_pred hhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc------cc
Q 001426 845 AGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES------SR 918 (1079)
Q Consensus 845 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~------~~ 918 (1079)
.+++.+.+ .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998765 589999999999999999999999 999999999999999999999999999875443211 11
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhc
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
......++..|+|||...+...+.++||||||+++||+++|..||....+. ....... .. .. .
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~---~~-~~------~----- 219 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EIFQNIL---NG-KI------E----- 219 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh---cC-Cc------C-----
Confidence 223456788999999988888999999999999999999999999754311 0000000 00 00 0
Q ss_pred ccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 999 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
..........+.+++.+||+.+|++|||+.++.+.|+
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 -WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000001346678999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=304.98 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=203.5
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
..|.....||+|.|+.|..|+. .++..||+|.+.+..... .....+.+|+++|+.++|||||+++.+......+|+||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4578888999999999999965 479999999987654433 23345889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+.+|.+.+|+.+++...+ ..+..++.|+.+|++|||++ .|||||||++||+++.+.++||+|||++.++..+
T Consensus 135 eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc--
Confidence 99999999999998887444 88888999999999999999 9999999999999999999999999999988744
Q ss_pred cccccccccCcccccccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKI-TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
......+|++.|.|||++.+.++ ++++|+||+|+++|-|+.|..||++..-..- + ...+...
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------------r----~rvl~gk 271 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------------R----PRVLRGK 271 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc------------c----chheeee
Confidence 34556789999999999998876 5799999999999999999999986321100 0 0111111
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
+++.... ....-+++++++-.+|.+|++++++...
T Consensus 272 ~rIp~~m----s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 YRIPFYM----SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eccccee----echhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111 1234467888899999999999999874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=297.89 Aligned_cols=262 Identities=22% Similarity=0.218 Sum_probs=193.2
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcC--CeEEEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNG--RTRLLL 835 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 835 (1079)
|+..+.||+|+||.||+|... +++.||+|++...... .......+|+.++.++. |+|++++++++.++ +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS--LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC--chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 566788999999999999764 6889999988543222 12234457888998885 99999999999987 889999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|||++ |++.+++......+++..+..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||+++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99997 588888877666789999999999999999999999 9999999999999999 999999999998664332
Q ss_pred ccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
. .....++..|+|||...+ ..++.++||||+||++|||++|..||....+. ....................+..
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcc
Confidence 1 123457889999997644 45788999999999999999999999764321 11111111111100000000000
Q ss_pred h------hhcccCcc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 995 Q------LLMRSGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 995 ~------~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. ........ ......+.+++.+||+++|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 00000000 012457889999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=303.81 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=192.0
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCeEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+|+..+.||+|+||.||++... +++.+|+|.+..... ......+.+|+.++.++. |+||+++++++..+...+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4556678999999999999765 688999998854322 245578899999999996 999999999999989999999
Q ss_pred EecCCCChhhh---hhc-cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 837 DYISNGSLAGL---LHE-KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 837 e~~~~g~L~~~---l~~-~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
||+.. ++.++ +.. ....+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99864 55443 322 2355899999999999999999999742 89999999999999999999999999997654
Q ss_pred CCcccccccccccCcccccccccCCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchh
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSL---KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
... ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||..... .............+
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~--- 229 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKGDPP--- 229 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCCCCC---
Confidence 322 11233578899999998765 688999999999999999999999965321 11111110000000
Q ss_pred hhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
... ..........+.+++.+||+.+|++|||+++|++.
T Consensus 230 -----~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 -----ILS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -----cCC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00101123467789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=294.04 Aligned_cols=248 Identities=22% Similarity=0.222 Sum_probs=199.6
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+.|+.-++||+|+||.||-++.+ +|+.+|.|++.+...........-..|-.|+.++..+.||.+--+|.+.+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45777789999999999998765 68999999886544444444456778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 837 DYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
..|.||+|.=+|...+ ..+++..+..++.+|+.||++||+. +||+||+||+|||+|+.|+++|+|.|+|..+..+.
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999997764 4589999999999999999999999 99999999999999999999999999999887764
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
. ....+||.+|||||++.+..|+...|.||+||++|||+.|+.||....... -.+-+|++
T Consensus 342 ~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-----------------k~eEvdrr 401 (591)
T KOG0986|consen 342 P---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-----------------KREEVDRR 401 (591)
T ss_pred c---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-----------------hHHHHHHH
Confidence 3 234489999999999999999999999999999999999999997532110 01112222
Q ss_pred hhccc-CccHHHHHHHHHHHHhccCCCCCCCCCH
Q 001426 996 LLMRS-GTQIQEMLQVLGVALLCVNPCPEERPTM 1028 (1079)
Q Consensus 996 ~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 1028 (1079)
..... .....-..+..++....++.||++|...
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 21110 0011112355567777899999999743
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=298.81 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=197.4
Q ss_pred CCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
.|...+.||+|++|.||++.. .+++.+++|++.. ......+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL---RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec---cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 455667999999999999975 4688899998742 222345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++++|||.+.......
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 97 FLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 9999999999976 3488999999999999999999999 99999999999999999999999999887554322
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
.......|++.|+|||...+..++.++||||||+++|||++|+.||....+. ..... ...... +...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~~-~~~~~~-------~~~~ 236 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMKR-IRDNLP-------PKLK 236 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHH-HHhcCC-------CCCc
Confidence 1223356889999999998888999999999999999999999998653221 11110 000000 0000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
........+.+++.+||+.+|++|||+.++++
T Consensus 237 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 ----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ----ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00011236788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=306.73 Aligned_cols=200 Identities=26% Similarity=0.363 Sum_probs=169.7
Q ss_pred HhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC-----
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG----- 829 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 829 (1079)
+.++|+..+.||+|+||.||+|... +++.||+|.+.... ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4578999999999999999999764 78899999875322 2223446778899999999999999999998643
Q ss_pred -CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccc
Q 001426 830 -RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908 (1079)
Q Consensus 830 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla 908 (1079)
...++||||+.+ +|.+++... +++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 346999999964 888887543 78899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 909 KLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 909 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
+...... ......++..|+|||...+..++.++||||+||++|+|++|+.||...
T Consensus 166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 8654322 123346788999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=299.66 Aligned_cols=267 Identities=23% Similarity=0.282 Sum_probs=199.5
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--CeEEEEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG--RTRLLLF 836 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 836 (1079)
|+..+.||+|+||.||+|... +++.+|+|++.... ........+.+|++++++++|+|++++++++.+. +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 566788999999999999876 58899999986543 2233446788999999999999999999999988 8899999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++ +|.+++......+++..++.++.||++|++|||+. +++|+||+|+||++++++.+||+|||.+........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 99975 89999877656689999999999999999999999 999999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhH---Hhhhhhchhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE---LRERKREFTTIL 992 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 992 (1079)
.......++..|+|||...+ ..++.++||||||+++|||++|+.||...... .......... ....++......
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccch
Confidence 12233456789999997664 45789999999999999999999999764321 1111111100 001111111100
Q ss_pred -hhhhhcc--cCc----cHH--HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 -DRQLLMR--SGT----QIQ--EMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 -~~~~~~~--~~~----~~~--~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
....... ... ... ....+.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 000 000 1346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=295.09 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=198.6
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||+|..+ ++..+|+|.+.... ......+.+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh-ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4677889999999999999775 57889999885432 222345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-cEEEeeccccccccCCc
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-EAFLADFGLAKLFESSE 915 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~ 915 (1079)
|+++++|.+++... +..+++..+..++.|+++|++|||+. +++|+||+|+||++++++ .+|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999999764 33579999999999999999999998 999999999999999886 46999999998665332
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||..... ............. ...+
T Consensus 157 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~----~~~~- 224 (257)
T cd08225 157 --ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQGYFA----PISP- 224 (257)
T ss_pred --ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhcccCC----CCCC-
Confidence 122234588999999998888899999999999999999999999864321 1111111111000 0000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.....+.+++.+||+.+|++|||++|+++
T Consensus 225 ---------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 225 ---------NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11235778899999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=306.34 Aligned_cols=275 Identities=21% Similarity=0.339 Sum_probs=200.0
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-----
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR----- 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 830 (1079)
.++|+..+.||+|+||.||+|.. .+++.||+|.+.+. ........+.+|+.++++++|+||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 35788899999999999999965 46889999988532 12234467888999999999999999999876543
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
..++|+||+++ ++.+++... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred eEEEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 47999999975 888877543 489999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCccc-ccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh-hhc
Q 001426 911 FESSESS-RASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER-KRE 987 (1079)
Q Consensus 911 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 987 (1079)
....... .......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||..... .............. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHH
Confidence 6443211 12233568899999998654 4688999999999999999999999965321 11111110000000 000
Q ss_pred hhhhhhhh-------hhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhcccc
Q 001426 988 FTTILDRQ-------LLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTAM--LKEIRHE 1041 (1079)
Q Consensus 988 ~~~~~~~~-------~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~ 1041 (1079)
.....+.. ......... .....+.+++.+||+.+|++|||++|+++. +++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00000000 000000000 113467799999999999999999999986 7766554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=299.20 Aligned_cols=266 Identities=21% Similarity=0.267 Sum_probs=196.2
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|++|.||+|... +|+.||+|++.... ......+.+.+|+++++.++|||++++++++.++...+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc-ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 567789999999999999764 78999999885432 2222346788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 839 ISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
++ ++|.+++.... ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||.++......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 95 68999987654 4589999999999999999999998 99999999999999999999999999997654321
Q ss_pred ccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHh---hhhhchhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR---ERKREFTTILD 993 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 993 (1079)
.......++..|+|||+..+. .++.++||||||+++|||++|+.||....+.. ........... ..+.......+
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchh
Confidence 112233568899999987654 57889999999999999999999997543211 11111111000 00000000000
Q ss_pred h--hhh-cccCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 R--QLL-MRSGT----QIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~--~~~-~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. ... ..... .......+.+++.+||+.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000 00000 0011236778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=283.72 Aligned_cols=260 Identities=21% Similarity=0.281 Sum_probs=211.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC------CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc-CC
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN-GR 830 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 830 (1079)
.|++..-.+.+|.||.||+|.|. +.+.|.||.++ ...+.-....+..|.-.+..+.|||+..+.+++.+ .+
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk--~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK--QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH--hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 45666677899999999999554 34456677663 22344456788899999999999999999999865 55
Q ss_pred eEEEEEEecCCCChhhhhhc-------cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001426 831 TRLLLFDYISNGSLAGLLHE-------KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLA 903 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 903 (1079)
..+.++.++.-|+|..++.. ..+.++..+...++.|++.|++|||++ ++||.||.++|.++++.-++|++
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEec
Confidence 67999999999999999972 234467777888999999999999999 99999999999999999999999
Q ss_pred eccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHh
Q 001426 904 DFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELR 982 (1079)
Q Consensus 904 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 982 (1079)
|=.+++.+-+.++.........+.+||+||.+....|+.++|||||||++|||+| |+.|+...+|. .+..+.+...+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--Em~~ylkdGyR 516 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--EMEHYLKDGYR 516 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--HHHHHHhccce
Confidence 9999999988888777777778899999999999999999999999999999999 99998765432 12222221111
Q ss_pred hhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 983 ERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
......+..+++.++..||..+|++||+++|++.-|.++..+
T Consensus 517 -----------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 517 -----------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -----------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 112223445788899999999999999999999999988654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=325.16 Aligned_cols=285 Identities=22% Similarity=0.236 Sum_probs=215.9
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|.++++||+|+||.|..++.+ ++++||+|++.+-..-...+...|..|-++|..-+.+-||.+.-+|.+..++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 56889999999999999999775 68899999986533233345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||++||+|..++.+.+ .++++.+..++..|+-||+-+|+. |+|||||||+|||+|..|++|++|||.+-.+..++
T Consensus 155 dY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG- 229 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG- 229 (1317)
T ss_pred ecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCC-
Confidence 9999999999999888 699999999999999999999999 99999999999999999999999999998777554
Q ss_pred cccccccccCcccccccccC----C-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGY----S-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.-.....+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||+... ++.- .+++
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveT-Y~KI---------- 293 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVET-YGKI---------- 293 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHH-HHHH----------
Confidence 33455678999999999854 3 578999999999999999999999998531 1110 0111
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHHHhccccCCCCCCCccc-cccccCCccccccccc
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPT---MKDVTAMLKEIRHENDDLEKPNSL-SRAVTNPKAAVHCSSF 1067 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 1067 (1079)
.+..-....+....-.....++|..-+. +|+.|.. +.++... -...+.++..-+.. +..+-.-.|...+|++
T Consensus 294 m~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H---pFF~g~~W~~iR~~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 294 MNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH---PFFEGIDWDNIRESVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred hchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC---ccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence 1110000111111222345566666555 7888887 6666542 22344555444443 3334444555566666
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=308.49 Aligned_cols=272 Identities=22% Similarity=0.273 Sum_probs=201.9
Q ss_pred CCCCCeeeecCcEEEEEEE-eCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC------eE
Q 001426 760 LSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR------TR 832 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 832 (1079)
|...+.||+|+||.||+|+ ..+|+.||||.+.+.. ....++...+|++++++++|+|||+++++=.+.. ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3455789999999999998 5689999999986543 3445678889999999999999999999865433 45
Q ss_pred EEEEEecCCCChhhhhhcc--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEEC--CCC--cEEEeecc
Q 001426 833 LLLFDYISNGSLAGLLHEK--KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG--PQF--EAFLADFG 906 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~DFG 906 (1079)
.+|||||.+|+|..++++. ...+++.++..++.+++.||.|||++ +||||||||.||++- ++| -.||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 8999999999999999864 44689999999999999999999999 999999999999984 334 46999999
Q ss_pred ccccccCCcccccccccccCcccccccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhh
Q 001426 907 LAKLFESSESSRASNSVAGSYGYIAPEYGY-SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERK 985 (1079)
Q Consensus 907 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 985 (1079)
.|+.+.++. .....+||..|.+||... .+.|+..+|.|||||++|+.+||..||.....+............+. +
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk-p 245 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK-P 245 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC-C
Confidence 999887654 566789999999999988 48899999999999999999999999986543321111111111111 1
Q ss_pred hchhhhh--------hhhhhcccCccH--HHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHhccc
Q 001426 986 REFTTIL--------DRQLLMRSGTQI--QEMLQVLGVALLCVNPCPEERP--TMKDVTAMLKEIRH 1040 (1079)
Q Consensus 986 ~~~~~~~--------~~~~~~~~~~~~--~~~~~l~~l~~~Cl~~dP~~RP--t~~evl~~L~~~~~ 1040 (1079)
....... +.....+.+... .....+-.....++.++|++|- .+.+..+.+.++.+
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1111000 000011111111 1233455566667778888888 77777776666643
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=296.15 Aligned_cols=266 Identities=19% Similarity=0.282 Sum_probs=197.3
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|++|.||+|+.. +++.||+|.+.... .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc--cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4778899999999999999875 68899999885432 22234667889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccC--cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 838 YISNGSLAGLLHEKK--VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|+++ +|.+++...+ ..+++..+..++.|+++|++|||+. +++||||+|+||++++++.++++|||+++......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9985 8998886543 4589999999999999999999998 99999999999999999999999999997654321
Q ss_pred ccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhH---Hhhhhhchhh-
Q 001426 916 SSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE---LRERKREFTT- 990 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~- 990 (1079)
.......++..|+|||+..+ ..++.++||||+|+++|||++|+.||......+ ......... ....+.....
T Consensus 155 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 155 --NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred --cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcC
Confidence 12223457889999998765 356889999999999999999999997643221 111111100 0000000000
Q ss_pred -hhhhhhhcccCcc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 991 -ILDRQLLMRSGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 991 -~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.+........... ......+.+++.+|++.||++||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000000 011235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=290.22 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=202.6
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||++... +++.+|+|++.... ......+.+.+|+++++.++|+|++++++.+..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc-CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4777889999999999999775 68899999885322 223456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc---CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 838 YISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
|+++++|.+++.+. +..+++..+..++.+++.|++|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999765 36789999999999999999999999 9999999999999999999999999999866543
Q ss_pred cccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
. .......+++.|+|||...+..++.++||||+|+++|+|++|+.||..... ...............
T Consensus 157 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~------ 223 (258)
T cd08215 157 V--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQYPPI------ 223 (258)
T ss_pred c--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCCCCC------
Confidence 2 122335688899999998888899999999999999999999999865321 111111111100000
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. .....+.+++.+||..+|++|||+.++++
T Consensus 224 ------~~--~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ------PS--QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ------CC--CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 11235678999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=305.60 Aligned_cols=279 Identities=19% Similarity=0.280 Sum_probs=204.2
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC-----C
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG-----R 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 830 (1079)
..+|...+.||+|+||+||+|... +++.||+|.+..... .......+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 457888999999999999999764 688999998854322 223345677899999999999999999988654 3
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
..++|+||+. ++|.+++...+ .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 4799999996 68999887654 489999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhh-ch
Q 001426 911 FESSESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR-EF 988 (1079)
Q Consensus 911 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 988 (1079)
..... .......++..|+|||.... ..++.++|||||||++|+|++|+.||..... ................ ..
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCChHHh
Confidence 64332 12233467889999998764 4688999999999999999999999965321 1111111000000000 00
Q ss_pred --------hhhhhhhhhcccCcc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhccccCCCCC
Q 001426 989 --------TTILDRQLLMRSGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTAM--LKEIRHENDDLE 1046 (1079)
Q Consensus 989 --------~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~~~~~~ 1046 (1079)
..... ......... ......+.+++.+||+++|++|||++|+++. ++.+.....+..
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~ 305 (337)
T cd07858 234 GFIRNEKARRYIR-SLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV 305 (337)
T ss_pred hhcCchhhhHHHH-hcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc
Confidence 00000 000000000 0123467799999999999999999999986 777765544433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=301.42 Aligned_cols=252 Identities=27% Similarity=0.340 Sum_probs=197.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+.|+..+.||+|+||.||+|... +++.+|+|.+.............+.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777788999999999999765 67889999885433333344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+. |++.+++......+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9996 588888766566689999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccccCcccccccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGY---SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
....+++.|+|||... ...++.++|||||||++|||++|+.||....... ....+.. ...
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~----~~~-------- 231 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ----NES-------- 231 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhh----cCC--------
Confidence 2345788999999864 3467889999999999999999999986532110 0000000 000
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 1037 (1079)
+.. ........+.+++.+||+.+|++||++.+++..-..
T Consensus 232 ~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 232 PAL-----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred CCc-----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 000 000122356789999999999999999999976443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=294.16 Aligned_cols=247 Identities=23% Similarity=0.266 Sum_probs=188.1
Q ss_pred CeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHH-hcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTL-GSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
+.||+|+||.||+|... +++.||+|.+.+...........+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999764 6889999988543222222233445555544 455899999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
++|.+++...+ .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999997654 478999999999999999999999 999999999999999999999999999875432 22
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
...+++.|+|||...+..++.++||||+|+++|||++|..||...... ..... ......... ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~~~~~~~~----------~~ 215 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AVFDN----ILSRRINWP----------EE 215 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHH----HHhcccCCC----------Cc
Confidence 346788999999988888899999999999999999999999653221 11100 000000000 00
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
........+.+++.+||+.+|++||++.++.+.++
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 00011236778999999999999998876655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=299.30 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=193.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCeEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 835 (1079)
++|+..+.||+|+||.||+|..++ ++.||||.+.... .......+..|+.++.+.. ||||+++++++.++...++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 567888999999999999998875 8899999985322 2233456677777776664 99999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|||+. +++.+++......+++..+..++.|++.|++|||+.. +|+||||+|+||++++++.+||+|||++..+....
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99985 4777777665557899999999999999999999732 89999999999999999999999999998664332
Q ss_pred ccccccccccCcccccccccCCCC----CCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLK----ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||.........+..... ......
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~--- 239 (296)
T cd06618 170 ---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ----EEPPSL--- 239 (296)
T ss_pred ---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc----CCCCCC---
Confidence 112335788999999876543 788999999999999999999999653221111111111 100000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.... .....+.+++.+||+.||++||++.++++.
T Consensus 240 -------~~~~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 -------PPNE--GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------CCCC--CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 112357789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-31 Score=296.25 Aligned_cols=247 Identities=28% Similarity=0.371 Sum_probs=194.9
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|...+.||+|+||+||+|... +++.||+|++.............+.+|+++++.++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999764 6889999988644333334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+. |++.+++......+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 588888876666689999999999999999999999 999999999999999999999999999864321
Q ss_pred cccccccCcccccccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 919 ASNSVAGSYGYIAPEYGY---SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.....|+..|+|||++. ...++.++|||||||++|||++|..||....... .. ........+ ...
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~---~~~~~~~~~---~~~--- 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL---YHIAQNDSP---TLQ--- 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HH---HHHHhcCCC---CCC---
Confidence 22356888999999874 4568889999999999999999999987542211 00 000000000 000
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.. .....+.+++.+||+.+|++||++.+++..
T Consensus 242 -----~~--~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -----SN--EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----cc--ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011246689999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-33 Score=279.31 Aligned_cols=273 Identities=23% Similarity=0.292 Sum_probs=202.9
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC---C--CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc-CC
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP---S--RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN-GR 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 830 (1079)
..+|+....||+|.||.||+|.-+ + .+.+|+|++...+++. .....-.+|+..++.++|||++.+..++.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 356899999999999999999432 2 3378999986554433 223456789999999999999999999977 77
Q ss_pred eEEEEEEecCCCChhhhhhc----cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC----CcEEE
Q 001426 831 TRLLLFDYISNGSLAGLLHE----KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ----FEAFL 902 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl 902 (1079)
..++++||.+. +|.+.++- ....++...+..|+.||+.|+.|||++ =|+|||+||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 89999999988 88888853 245688999999999999999999999 68999999999999887 89999
Q ss_pred eeccccccccCCc-ccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCC--------cch
Q 001426 903 ADFGLAKLFESSE-SSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPD--------GAH 972 (1079)
Q Consensus 903 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~--------~~~ 972 (1079)
+|||+|+.+...- .......++-|..|.|||.+.+. .|+.+.||||.|||+.||+|-.+-|.+.... ..+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999886542 22345567789999999998876 5789999999999999999998888653211 111
Q ss_pred HHHHH---HhHHhhhhhchhhhhhhhhhc-----ccCcc--HH--------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 973 IITWV---NGELRERKREFTTILDRQLLM-----RSGTQ--IQ--------EMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 973 ~~~~~---~~~~~~~~~~~~~~~~~~~~~-----~~~~~--~~--------~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
+.+.. .......|+.+....+..... ..... +. .....+++..+++..||.+|-|+.|+++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 11111 111223344333332221100 00000 00 11236789999999999999999998763
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=297.46 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=195.2
Q ss_pred CCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEec
Q 001426 761 SDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 761 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
+...+||+|+||.||++..+ +++.||+|++.. ........+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDL---RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecc---cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33467999999999999774 788999998742 22334577999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccc
Q 001426 840 SNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919 (1079)
Q Consensus 840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 919 (1079)
++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++....... ..
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~ 172 (292)
T cd06657 100 EGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR 172 (292)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc--cc
Confidence 999999987543 378999999999999999999999 99999999999999999999999999987654332 12
Q ss_pred ccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcc
Q 001426 920 SNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMR 999 (1079)
Q Consensus 920 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1079)
.....+++.|+|||...+..++.++|+||+|+++|||++|+.||..... ...........+ +....
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~-----------~~~~~- 238 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLP-----------PKLKN- 238 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCC-----------cccCC-
Confidence 2335688999999998888889999999999999999999999875321 111111111000 00000
Q ss_pred cCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 1000 SGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 1000 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.......+.+++.+||+.+|.+||++.++++
T Consensus 239 ---~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 ---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ---cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0011235667899999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=297.91 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=201.5
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCeEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+|...+.||+|+||.||+|... +++.||+|.+.+.........+.+.+|++++++++ ||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5788889999999999999765 78999999886533333344578899999999998 999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
||+++++|.+++.+.+ .+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999998765 489999999999999999999999 999999999999999999999999999986654321
Q ss_pred c------------------ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHH
Q 001426 917 S------------------RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN 978 (1079)
Q Consensus 917 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 978 (1079)
. .......++..|+|||...+..++.++||||+|++++++++|+.||..... .... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~-~ 232 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTF-Q 232 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HHHH-H
Confidence 1 122334578899999998888899999999999999999999999975421 1100 0
Q ss_pred hHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 001426 979 GELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTM----KDVTA 1033 (1079)
Q Consensus 979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~ 1033 (1079)
..... ...+ .. .....+.+++.+||+.+|++|||+ +|+++
T Consensus 233 ~~~~~-~~~~------------~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 KILKL-EYSF------------PP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHhc-CCCC------------CC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000 0000 00 112356789999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=296.63 Aligned_cols=267 Identities=18% Similarity=0.204 Sum_probs=193.7
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCe-----
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRT----- 831 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 831 (1079)
+|+..+.||+|+||.||+|... +++.||+|++.... ........+.+|+.+++.++ ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5788899999999999999775 68899999875432 22223467888999999995 6999999999987665
Q ss_pred EEEEEEecCCCChhhhhhcc----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-CCcEEEeecc
Q 001426 832 RLLLFDYISNGSLAGLLHEK----KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-QFEAFLADFG 906 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFG 906 (1079)
.|+||||+++ ++.+++... ...+++..++.++.||+.||+|||+. +|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 898888653 23579999999999999999999999 9999999999999998 8899999999
Q ss_pred ccccccCCcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHH---h
Q 001426 907 LAKLFESSESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL---R 982 (1079)
Q Consensus 907 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---~ 982 (1079)
.++.+.... .......+++.|+|||+..+ ..++.++||||||+++|||++|..||....+.. .......... .
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence 998654321 11223356889999998765 457899999999999999999999997542211 1111111000 0
Q ss_pred hhhhchhhhhhhhhhcc-cCcc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 983 ERKREFTTILDRQLLMR-SGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 983 ~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
..+.......+...... .... ......+.+++.+||++||++||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000000000 0000 012235778999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=294.76 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=200.6
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|++|.||+|... +++.+++|.+..... .......+.+|++++++++|+||+++++++.++...++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 566788999999999999765 788899998854332 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+++ ++.+++......+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||.+....... .
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 975 89888877656689999999999999999999999 99999999999999999999999999998765432 1
Q ss_pred cccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHh----hhhhchhhhhh
Q 001426 919 ASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR----ERKREFTTILD 993 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 993 (1079)
......++..|+|||...+. .++.++||||+|+++|+|++|+.||...... ..+... ..... ..+........
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKI-FRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-HHHcCCCchHhcccchhhhh
Confidence 22234578899999998776 7899999999999999999999998654321 111111 11110 11111111000
Q ss_pred hh---hhcccCcc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQ---LLMRSGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~---~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. ........ ......+.+++.+||++||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 00000000 012347789999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=288.79 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=201.1
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|++|.||++... +++.|++|.+..... .....+.+.+|++++++++|+|++++++++.++...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4777899999999999999765 678899999865432 22456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
|+++++|.+++... ..+++..++.++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 99999999999766 4589999999999999999999999 999999999999999999999999999987654432
Q ss_pred ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1079)
......++..|+|||...+..++.++||||+|+++|+|++|+.||....+ ........ ......+
T Consensus 155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~--------- 219 (254)
T cd06627 155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-QDDHPPL--------- 219 (254)
T ss_pred -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-ccCCCCC---------
Confidence 12345678899999998887889999999999999999999999875321 11110000 0000000
Q ss_pred cccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 998 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. .....+.+++.+|++.+|++|||+.+++.
T Consensus 220 ---~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ---PE--GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CC--CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00 11235668999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=297.18 Aligned_cols=269 Identities=25% Similarity=0.299 Sum_probs=199.2
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC---
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR--- 830 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 830 (1079)
...++|+..+.||+|+||.||+|..+ +++.||+|.+..... .......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 34577899999999999999999875 588999998854322 2223457788999999999999999999987654
Q ss_pred -------eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001426 831 -------TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLA 903 (1079)
Q Consensus 831 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 903 (1079)
..++|+||+++ ++.+++......+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 77787776655689999999999999999999999 99999999999999999999999
Q ss_pred eccccccccCCcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHh---
Q 001426 904 DFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG--- 979 (1079)
Q Consensus 904 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~--- 979 (1079)
|||.+........ .......++..|+|||...+ ..++.++||||+||++|||++|+.||..... ...+......
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGS 236 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCC
Confidence 9999987654331 12223346788999998754 3578899999999999999999999975321 1111111110
Q ss_pred HHhhhhhchhhhh-----hh------hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 980 ELRERKREFTTIL-----DR------QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 980 ~~~~~~~~~~~~~-----~~------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.....++.+.... +. ...... . .....+.+++..||+.+|++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-S--FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhc-C--CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000111110000 00 000000 0 01246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=289.45 Aligned_cols=243 Identities=21% Similarity=0.276 Sum_probs=187.1
Q ss_pred hhCCCCCCee--eecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeE
Q 001426 757 VTRLSDTNIV--GKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 757 ~~~~~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 832 (1079)
.+.|+..+.+ |+|+||.||++..+ ++..+|+|.+...... . .|+.....+ +||||+++++++......
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------A--IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------h--hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 4566666665 99999999999764 6788898887432111 1 122222222 799999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-cEEEeeccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-EAFLADFGLAKLF 911 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~ 911 (1079)
++||||+++|+|.+++.... .+++..+..++.|+++|++|||+. +++||||+|+||+++.++ .++|+|||.++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999999997765 689999999999999999999999 999999999999999998 9999999998765
Q ss_pred cCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 912 ESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 912 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
... ....++..|+|||+..+..++.++||||+|+++|||++|+.||............+.... .. ....
T Consensus 161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~--- 229 (267)
T PHA03390 161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK-KLPF--- 229 (267)
T ss_pred CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc-cCCc---
Confidence 432 224578999999999988899999999999999999999999985433322222221111 00 0000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPT-MKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~ 1033 (1079)
.......+.+++.+|++.+|++||+ ++|+++
T Consensus 230 -----------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 -----------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0012236778999999999999996 688874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=297.89 Aligned_cols=268 Identities=21% Similarity=0.269 Sum_probs=195.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|++|+||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.++...++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46888899999999999999775 688999998754322 2233467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-CCcEEEeeccccccccCC
Q 001426 837 DYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-QFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~ 914 (1079)
||++ +++.+++... ....++..+..++.||+.||+|||+. +++||||+|+||++++ ++.+||+|||+++.....
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9996 5788887544 33367888899999999999999999 9999999999999985 557999999999765432
Q ss_pred cccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHh---HHhhhhhchhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG---ELRERKREFTT 990 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 990 (1079)
. .......+++.|+|||+..+ ..++.++||||+|+++|||++|+.||....+.+ ........ .....+..+..
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhcccccc
Confidence 1 12233457889999998765 457899999999999999999999997643221 11111100 00000100000
Q ss_pred hhhhhhhcc--cCcc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 991 ILDRQLLMR--SGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 991 ~~~~~~~~~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
..+...... .... ......+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 0000 011235678999999999999999999986
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=291.87 Aligned_cols=244 Identities=19% Similarity=0.208 Sum_probs=186.3
Q ss_pred eeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHH---HHhcCCCCceeeeeeEEEcCCeEEEEEEecC
Q 001426 765 IVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQ---TLGSIRHKNIVRLLGCCNNGRTRLLLFDYIS 840 (1079)
Q Consensus 765 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 840 (1079)
+||+|+||.||+|... +++.||+|.+.+...........+..|.. .++...||+|+++++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 68899999886433222222223444443 4445679999999999999999999999999
Q ss_pred CCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccc
Q 001426 841 NGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920 (1079)
Q Consensus 841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 920 (1079)
+|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.+.... .
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 999999987654 489999999999999999999998 99999999999999999999999999987654322 2
Q ss_pred cccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcc
Q 001426 921 NSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMR 999 (1079)
Q Consensus 921 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1079)
....|+..|+|||...++ .++.++||||+|+++|||++|+.||......... ...... .. .....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~-~~--------~~~~~--- 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMT-LT--------MAVEL--- 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHh-hc--------cCCCC---
Confidence 234689999999998754 6889999999999999999999999764321111 000000 00 00000
Q ss_pred cCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001426 1000 SGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 1000 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 1033 (1079)
.. .....+.+++.+|+..+|.+|| ++.++++
T Consensus 219 -~~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 -PD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CC--cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 00 1123677889999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=288.23 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=195.2
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccC--CCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--CeEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKN--GELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG--RTRL 833 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 833 (1079)
.|+..+.||+|+||.||+|... +++.||+|.+..... ........+.+|++++++++|+||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 5788899999999999999764 688999998743221 2233457899999999999999999999998764 4578
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+++||+++++|.+++...+. +++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 99999999999999976544 78899999999999999999999 999999999999999999999999999986543
Q ss_pred Ccc-cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 914 SES-SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
... ........++..|+|||...+..++.++|||||||++|||++|+.||...... ..... ..... ....+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~---~~~~~ 230 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AAIFK-IATQP---TKPML 230 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HHHHH-HHcCC---CCCCC
Confidence 211 11122346889999999998888999999999999999999999999753211 11110 00000 00000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.. .....+.+++.+||. +|.+|||+.+++.
T Consensus 231 --------p~--~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 231 --------PD--GVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --------Cc--ccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00 112357789999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=293.36 Aligned_cols=265 Identities=23% Similarity=0.262 Sum_probs=195.2
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC---CCCceeeeeeEEEcCCe----
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI---RHKNIVRLLGCCNNGRT---- 831 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~---- 831 (1079)
|++.+.||+|+||.||+|+.+ +++.||+|++..... .......+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 566788999999999999886 489999999864332 222335666788777666 59999999999988776
Q ss_pred -EEEEEEecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccc
Q 001426 832 -RLLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 832 -~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~ 909 (1079)
.+++|||+.+ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||.+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 8999887643 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHH---hhhhh
Q 001426 910 LFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL---RERKR 986 (1079)
Q Consensus 910 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 986 (1079)
.+.... ......++..|+|||+..+..++.++||||||+++|||++|+.||...... .....+..... ...+.
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcC
Confidence 764432 122335788999999999889999999999999999999999998754321 11111111000 00000
Q ss_pred chh----hhhhhhhhcccCcc-HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 987 EFT----TILDRQLLMRSGTQ-IQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 987 ~~~----~~~~~~~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
... ..+........... ......+.+++.+||+.||++||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 00000000000000 012346678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=303.17 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=198.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc----CCeE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN----GRTR 832 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 832 (1079)
.+|+..+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 57888899999999999999764 689999998864322 22345677889999999999999999998753 3467
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
++||||+. |+|.+++...+. +++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999996 589999876544 89999999999999999999998 99999999999999999999999999997654
Q ss_pred CCccc--ccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchh
Q 001426 913 SSESS--RASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 913 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .............+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHhh
Confidence 33211 11234568899999998765 46889999999999999999999999764321 111111111111000000
Q ss_pred ---------hhhhhhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 990 ---------TILDRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 990 ---------~~~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
...+ .......... .....+.+++.+||+.+|++|||++++++
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000 0000001110 12346789999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=296.67 Aligned_cols=261 Identities=23% Similarity=0.260 Sum_probs=200.5
Q ss_pred CCCCCeeeecCcEEEEEEEe----CCCCeEEEEEeccccCC-CchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEI----PSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 833 (1079)
|+..+.||+|+||.||++.. .+++.||||.+.+.... .....+.+.+|++++.++ +||||+++++++..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 66778999999999999864 35678999988543221 122346788999999999 5999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||+++.+..
T Consensus 82 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999997654 478899999999999999999998 999999999999999999999999999886544
Q ss_pred CcccccccccccCcccccccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLK--ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
... .......++..|+|||...+.. .+.++||||||+++|||++|..||....... ....+........ ..
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~-~~---- 230 (288)
T cd05583 158 EEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKSK-PP---- 230 (288)
T ss_pred ccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHccC-CC----
Confidence 321 1222345789999999977654 7889999999999999999999986432111 1111111100000 00
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcccc
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
... .....+.+++.+||+.+|++|||++++.+.|+...-+
T Consensus 231 --------~~~--~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~ 270 (288)
T cd05583 231 --------FPK--TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270 (288)
T ss_pred --------CCc--ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccc
Confidence 000 1123567889999999999999999998888775433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=298.41 Aligned_cols=269 Identities=18% Similarity=0.191 Sum_probs=193.3
Q ss_pred eeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCCh
Q 001426 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844 (1079)
Q Consensus 765 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 844 (1079)
.+|.|+++.||++.. +++.||+|++.... ......+.+.+|+++++.++|+||+++++++.+....+++|||+++|++
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 344555555555544 68899999986432 2334567899999999999999999999999999999999999999999
Q ss_pred hhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc-----c
Q 001426 845 AGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS-----R 918 (1079)
Q Consensus 845 ~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-----~ 918 (1079)
.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+..+...... .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999764 44588999999999999999999999 9999999999999999999999999998755432211 1
Q ss_pred cccccccCcccccccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhh---------hhhc
Q 001426 919 ASNSVAGSYGYIAPEYGYS--LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE---------RKRE 987 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~ 987 (1079)
......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .......+..+. ....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhhcCC
Confidence 1223457788999998765 357889999999999999999999997543211 111111111000 0000
Q ss_pred hhh----hhhhhhhc--ccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhcc
Q 001426 988 FTT----ILDRQLLM--RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIR 1039 (1079)
Q Consensus 988 ~~~----~~~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~ 1039 (1079)
... ..++.... ...........+.+++.+||+.||++|||++|+++ .++.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000 00000000 00011122346778999999999999999999998 444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=300.16 Aligned_cols=283 Identities=23% Similarity=0.297 Sum_probs=209.9
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-----eE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR-----TR 832 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 832 (1079)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4778899999999999999875 58899999885432 12334578899999999999999999999998775 78
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
|+||||++ ++|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99999998 48999887655 689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCccc-ccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhh----
Q 001426 913 SSESS-RASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR---- 986 (1079)
Q Consensus 913 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 986 (1079)
..... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... .....+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhh
Confidence 43211 123345678899999998887 7899999999999999999999999765321 111111100000000
Q ss_pred -----chhhhhhhhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhccccCCCCCCCcc
Q 001426 987 -----EFTTILDRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRHENDDLEKPNS 1050 (1079)
Q Consensus 987 -----~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~~~~~~~~ 1050 (1079)
.....+.. ......... .....+.+++.+||+++|++|||++++++ .++++.....+......
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~ 307 (330)
T cd07834 233 FITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPP 307 (330)
T ss_pred hccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCc
Confidence 00000000 000000000 11346778999999999999999999998 47777665444433333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=289.70 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=200.5
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|+..+.||+|+||.||++..+ +++.+|+|.+..... .......+.+|++++++++|+||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 4677889999999999999654 678899998854332 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcc---CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 838 YISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
|+++++|.+++.+. +..+++..++.++.|++.|++|||+. +++||||+|+||++++++.+|++|||+++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999998652 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred cccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
......+++.|+|||...+..++.++|+||+|+++|||++|+.||...... .+.... .....+
T Consensus 157 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~---~~~~~~-------- 219 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKV---QRGKYP-------- 219 (256)
T ss_pred ----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---hcCCCC--------
Confidence 122345788999999999888999999999999999999999999754221 111100 000000
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.........+.+++.+|++.+|++|||+.|+++
T Consensus 220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 ------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000122346788999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=300.00 Aligned_cols=270 Identities=20% Similarity=0.273 Sum_probs=195.4
Q ss_pred eeeec--CcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 765 IVGKG--VSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 765 ~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
.||+| +||+||++... .++.||+|++.... ......+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN-CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 45666 99999999764 78999999885432 2223457899999999999999999999999999999999999999
Q ss_pred CChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc--
Q 001426 842 GSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR-- 918 (1079)
Q Consensus 842 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-- 918 (1079)
|++.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998764 33588999999999999999999998 99999999999999999999999998654332211111
Q ss_pred ---cccccccCcccccccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhh----------
Q 001426 919 ---ASNSVAGSYGYIAPEYGYSL--KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE---------- 983 (1079)
Q Consensus 919 ---~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------- 983 (1079)
......++..|+|||+..+. .++.++||||+||++|||++|+.||....... ............
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHhcCCCCCCccccccchh
Confidence 01112345679999998763 47899999999999999999999997543211 111111000000
Q ss_pred ------hhhchh--------------hhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhcccc
Q 001426 984 ------RKREFT--------------TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRHE 1041 (1079)
Q Consensus 984 ------~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~ 1041 (1079)
...... ...... ............+.+++.+||+.||++|||++|+++ .++.++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSER--LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhccchhhhhcccccchhcccccccccccc--ccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 000000 000000 001111223457889999999999999999999975 55555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=294.21 Aligned_cols=253 Identities=23% Similarity=0.273 Sum_probs=193.8
Q ss_pred CCCCCeeeecCcEEEEEEEe----CCCCeEEEEEeccccCC-CchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEI----PSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 833 (1079)
|+..+.||+|+||.||+|+. .+|+.||+|.+...... .....+.+.+|+++++++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 67788999999999999976 36889999988543221 122346788999999999 5999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 82 LILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999997654 478899999999999999999998 999999999999999999999999999986644
Q ss_pred CcccccccccccCcccccccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSL--KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
... .......|+..|+|||..... .++.++||||||+++|+|++|+.||...... .....+........ ...
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~-~~~--- 231 (290)
T cd05613 158 DEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE-PPY--- 231 (290)
T ss_pred ccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccC-CCC---
Confidence 321 122234588999999987653 4678999999999999999999998643211 11111111100000 000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 1033 (1079)
.......+.+++.+||+.+|++|| ++++++.
T Consensus 232 -----------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 232 -----------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001123567899999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=286.32 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=198.5
Q ss_pred hhCCCCCCeeeecCcEEEEEE-EeCCCCeEEEEEeccccCCCchhH----HHHHHHHHHHhcCCCCceeeeeeEEE-cCC
Q 001426 757 VTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPER----DQFSAEVQTLGSIRHKNIVRLLGCCN-NGR 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~-~~~ 830 (1079)
.++|-...+||+|+|+.||+| +....+.||||+-...+.+..+.. +...+|.+|-+.++||.||++|+++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 356777889999999999999 556788899998765555443332 56678999999999999999999985 566
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC---CCcEEEeeccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP---QFEAFLADFGL 907 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGl 907 (1079)
.+|-|+|||+|.+|.=|+.+++. ++++++..|+.||+.||.||.+.. ++|||.|+||.|||+-. -|.+||+|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecch
Confidence 78999999999999999977665 899999999999999999999875 48999999999999953 57899999999
Q ss_pred cccccCCcccc-----cccccccCcccccccccCC----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHH
Q 001426 908 AKLFESSESSR-----ASNSVAGSYGYIAPEYGYS----LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN 978 (1079)
Q Consensus 908 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 978 (1079)
++.+.++.+.. .++..+||.+|++||++.- .+++.|+||||+|||+|+.+.|+.||........ ...
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd----ILq 695 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD----ILQ 695 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH----HHh
Confidence 99887654332 2345689999999998643 3578899999999999999999999986432211 111
Q ss_pred hHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001426 979 GELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVT 1032 (1079)
Q Consensus 979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 1032 (1079)
...--...+ +..+... .-..+...+|++|+++.-++|....++.
T Consensus 696 eNTIlkAtE--------VqFP~KP--vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 ENTILKATE--------VQFPPKP--VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhchhccee--------ccCCCCC--ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 110000010 0101111 1122556789999999999998776654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=290.66 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=195.3
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCeEEEEEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 837 (1079)
|+..+.||+|+||+||+|... +++.||+|++...... .......+|+..+++++ |+||+++++++.++...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 566788999999999999876 5788999987533221 22334557999999999 9999999999999999999999
Q ss_pred ecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 838 YISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+ +|+|.+++.... ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||.++......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 99 789999987654 5689999999999999999999999 99999999999999999999999999998664332
Q ss_pred cccccccccCcccccccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHH---hHHhhhhhc---hh
Q 001426 917 SRASNSVAGSYGYIAPEYGY-SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN---GELRERKRE---FT 989 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~---~~ 989 (1079)
......++..|+|||+.. ...++.++|+||||+++|||++|+.||....... .+..... ......+.+ ..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhhhhHhhhh
Confidence 122345788999999874 4457899999999999999999999986543211 1111100 000000000 00
Q ss_pred hhhhhhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 990 TILDRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
...+........... .....+.+++.+||+.+|++|||++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000000 11346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=298.42 Aligned_cols=274 Identities=24% Similarity=0.293 Sum_probs=200.5
Q ss_pred HHHHhhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-
Q 001426 753 VDDVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR- 830 (1079)
Q Consensus 753 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 830 (1079)
+.++.++|+..+.||+|+||.||+|.. .+++.||||++.... ........+.+|++++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 444567899999999999999999965 478899999885322 22233467889999999999999999999987543
Q ss_pred -----eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeec
Q 001426 831 -----TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADF 905 (1079)
Q Consensus 831 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 905 (1079)
..++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 6799888864 3489999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh
Q 001426 906 GLAKLFESSESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER 984 (1079)
Q Consensus 906 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 984 (1079)
|++...... .....+++.|+|||...+ ..++.++|+||+|+++|++++|+.||...... ............ .
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~-~ 235 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGT-P 235 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCC-C
Confidence 999865432 223457889999998765 45789999999999999999999999754221 111111110000 0
Q ss_pred hhchhhhhhhh--------hhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhccc
Q 001426 985 KREFTTILDRQ--------LLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRH 1040 (1079)
Q Consensus 985 ~~~~~~~~~~~--------~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 1040 (1079)
+..+...+... +........ .....+.+++.+|++.||++|||+.++++ .++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 00000000000 000000000 11235778999999999999999999994 5555543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=294.38 Aligned_cols=295 Identities=20% Similarity=0.216 Sum_probs=202.2
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-C--CCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcC----C
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-S--RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNG----R 830 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~ 830 (1079)
+|+..+.||+|+||.||+++.. . +..||+|++..... .....+.+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 3677788999999999999765 3 67899998753221 222346788899999999 599999999975432 4
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
..++++||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 5688888886 58999886544 489999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCccc--ccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhc
Q 001426 911 FESSESS--RASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 911 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
+...... .......|+..|+|||...+ ..++.++||||+||++|+|++|+.||....... .+...+..........
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 6543211 11233568999999998765 468899999999999999999999987543110 1111000000000000
Q ss_pred hhhhhhh-------hhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhccccCCCCCCCccccc
Q 001426 988 FTTILDR-------QLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRHENDDLEKPNSLSR 1053 (1079)
Q Consensus 988 ~~~~~~~-------~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~~~~~~~~~~~ 1053 (1079)
......+ .......... .....+.+++.+|+++||++|||++|++. .+.+..+....+.-..++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~ 313 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDF 313 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccC
Confidence 0000000 0000000000 01246778999999999999999999986 34444333333334444444
Q ss_pred cccCCcc
Q 001426 1054 AVTNPKA 1060 (1079)
Q Consensus 1054 ~~~~~~~ 1060 (1079)
.++..++
T Consensus 314 ~~~~~~~ 320 (332)
T cd07857 314 SFESEDS 320 (332)
T ss_pred Ccccccc
Confidence 4444443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-33 Score=277.46 Aligned_cols=254 Identities=26% Similarity=0.330 Sum_probs=194.8
Q ss_pred CCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHH-HhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQT-LGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++....||.|+||+|+|... ++|+..|||+++.... ..+.+++..|.++ ++.-+.||||++||++...+..|+.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34456799999999999854 5899999999964333 4566788888876 555589999999999999999999999
Q ss_pred ecCCCChhhhh---hc-cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 838 YISNGSLAGLL---HE-KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 838 ~~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
.|+- ++..+- +. +...+++.-.-.|....+.||.||-... +|+|||+||+|||++..|.+|+||||.+..+.+
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9954 555443 22 3455888888888889999999999874 899999999999999999999999999986654
Q ss_pred CcccccccccccCcccccccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSL--KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
. ...+.-+|-..|||||.+... .|+.++||||+|+++||++||..|+..+....+++...+.+..+.
T Consensus 221 S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~-------- 289 (361)
T KOG1006|consen 221 S---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI-------- 289 (361)
T ss_pred H---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe--------
Confidence 3 223345688899999987643 488999999999999999999999987654333333333322111
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
........+-...+..++..|+.+|-..||.+.++...
T Consensus 290 -----l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 -----LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -----ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111112334567789999999999999999998763
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=298.04 Aligned_cols=272 Identities=22% Similarity=0.284 Sum_probs=197.8
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC---
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR--- 830 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 830 (1079)
++..+|...+.||+|+||.||+|... +++.||+|++..... .......+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 34467888899999999999999764 689999998854321 2223456889999999999999999999986542
Q ss_pred ---eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 831 ---TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 831 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
..++|+||+.. ++..+. +..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred CCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 676665 23478999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhh
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR 986 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1079)
++..... .....++..|+|||...+ ..++.++|||||||++|||++|+.||...... ..+..... ......+
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~-~~~~~~~ 236 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILK-VTGVPGP 236 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-hcCCCCH
Confidence 8754321 223467889999998766 46889999999999999999999999754211 11111111 0000000
Q ss_pred chhhhhhh--------hhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhcccc
Q 001426 987 EFTTILDR--------QLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRHE 1041 (1079)
Q Consensus 987 ~~~~~~~~--------~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~ 1041 (1079)
.+.+..+. .......... .....+.+++.+||++||++||++++++. .+++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 01000000 0000000000 11235678999999999999999999995 47777543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=290.45 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=199.0
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|+||.||+|... +++.+|+|.+.... ......+.+..|+.++++++|+|++++++++.+....++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 456678999999999999776 58999999986433 2223346788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
++ ++|.+++.+....+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||.++.......
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 98 599999987655689999999999999999999999 999999999999999999999999999986654321
Q ss_pred cccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHH---hHHhhhhhchhhh--h
Q 001426 919 ASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVN---GELRERKREFTTI--L 992 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~--~ 992 (1079)
......++..|+|||...+. .++.++||||||+++|||++|+.||...... ..+..... ......+...... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 22234457789999998766 7899999999999999999999998653211 11111110 0000111111000 0
Q ss_pred hhhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+........... .....+.+++..||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 11346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=293.62 Aligned_cols=271 Identities=21% Similarity=0.259 Sum_probs=195.1
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-----
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR----- 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 830 (1079)
.++|+..+.||+|+||.||+|... +++.+|+|++...... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 467889999999999999999765 6888999988543221 122346778999999999999999999875433
Q ss_pred ---eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 831 ---TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 831 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
..++|+||+.+ ++..++......+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||+
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999975 78877776666799999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcccc---------cccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHH
Q 001426 908 AKLFESSESSR---------ASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWV 977 (1079)
Q Consensus 908 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~ 977 (1079)
++......... ......+++.|+|||...+ ..++.++||||||+++|||++|+.||.+..+.. ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 98654332111 1123456888999998765 457899999999999999999999997543211 111111
Q ss_pred HhH---Hhhhhhc---hhhhhhhhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 978 NGE---LRERKRE---FTTILDRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 978 ~~~---~~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
... ....++. .....+........... .....+.+++.+|++.+|++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 0000000 00000000000000000 01135778999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=285.63 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=193.2
Q ss_pred CCCCCCeeeecCcEEEEEEEeCC-CCeEEEEEeccccCC--CchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNG--ELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
+|...+.||+|+||.||++.... +..+++|.+...... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999997653 444566655433222 223345677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhc---cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc
Q 001426 836 FDYISNGSLAGLLHE---KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
|||+++++|.+++.+ ....+++..++.++.|++.|++|||+. +++|+||+|+||++++ +.++++|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999864 345689999999999999999999998 9999999999999975 569999999998664
Q ss_pred CCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
... .......+++.|+|||...+..++.++|+||||+++|+|++|..||.... .............+
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~------ 223 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVEGPTP------ 223 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcCCCC------
Confidence 332 12223457889999999888888999999999999999999999986421 11111110000000
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.........+.+++.+||+.+|++||++.|+++
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 --------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 001112236678999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=319.22 Aligned_cols=149 Identities=29% Similarity=0.381 Sum_probs=133.4
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
.++|.+.+.||+|+||+||+|... +++.||+|++.............+..|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357888899999999999999876 6889999998654433344457889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~ 909 (1079)
|||+.+++|.+++...+ .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997654 378899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=297.23 Aligned_cols=270 Identities=21% Similarity=0.224 Sum_probs=194.6
Q ss_pred hCCCC-CCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCch-----------hHHHHHHHHHHHhcCCCCceeeeee
Q 001426 758 TRLSD-TNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELP-----------ERDQFSAEVQTLGSIRHKNIVRLLG 824 (1079)
Q Consensus 758 ~~~~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 824 (1079)
++|.. .+.||+|+||+||+|... +++.||+|++......... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 577999999999999765 6889999988543221100 0125778999999999999999999
Q ss_pred EEEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEee
Q 001426 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904 (1079)
Q Consensus 825 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 904 (1079)
++..+...++||||+. |+|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECC
Confidence 9999999999999997 59999986544 488999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCcc------------cccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 001426 905 FGLAKLFESSES------------SRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA 971 (1079)
Q Consensus 905 FGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~ 971 (1079)
||.++....... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||....+.+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999986652110 1112233467889999988764 46889999999999999999999997643211
Q ss_pred hHHHHHHhH---Hhhhhhchhhhhhhh-hhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 972 HIITWVNGE---LRERKREFTTILDRQ-LLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 972 ~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.+....... ....++......... ......... .....+.+++.+|++.+|++|||++|++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111111100 000000000000000 000000000 11235778999999999999999999986
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=282.93 Aligned_cols=239 Identities=27% Similarity=0.297 Sum_probs=192.9
Q ss_pred eeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCCh
Q 001426 766 VGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 844 (1079)
||+|+||.||++... +++.+|+|.+.............+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999775 5889999988654433334567899999999999999999999999999999999999999999
Q ss_pred hhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccccc
Q 001426 845 AGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA 924 (1079)
Q Consensus 845 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 924 (1079)
.+++.... .+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||.+....... .......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 99997664 489999999999999999999998 99999999999999999999999999998654432 1233456
Q ss_pred cCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccH
Q 001426 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQI 1004 (1079)
Q Consensus 925 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1079)
++..|+|||...+...+.++|+||||+++||+++|..||..... ...... .... ...+.. .
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~---~~~~-~~~~~~------------~- 215 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEK---ILKD-PLRFPE------------F- 215 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH---HhcC-CCCCCC------------C-
Confidence 78899999999888889999999999999999999999965321 111111 0000 000000 0
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHH
Q 001426 1005 QEMLQVLGVALLCVNPCPEERPTMKD 1030 (1079)
Q Consensus 1005 ~~~~~l~~l~~~Cl~~dP~~RPt~~e 1030 (1079)
....+.+++.+||..||++|||+++
T Consensus 216 -~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 -LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0235678999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=270.52 Aligned_cols=260 Identities=21% Similarity=0.292 Sum_probs=192.7
Q ss_pred CeeeecCcEEEEEE-EeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 764 NIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
++||+|+|+.|--+ ...++..||||++.+. ....+..+.+|++++.+. .|+||+.++++|.+++..|+|||.|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 67999999999987 5678999999998543 335678889999999999 599999999999999999999999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC---cEEEeeccccccccCCc---
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF---EAFLADFGLAKLFESSE--- 915 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFGla~~~~~~~--- 915 (1079)
|.|..+++++.. +++.++.++..+|+.||+|||.+ ||.|||+||+|||..+.. -+|||||.++.-+....
T Consensus 161 GplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 161 GPLLSHIQKRKH-FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred chHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999999987765 89999999999999999999999 999999999999997654 47999998875432211
Q ss_pred --ccccccccccCcccccccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh-hhc
Q 001426 916 --SSRASNSVAGSYGYIAPEYGY-----SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER-KRE 987 (1079)
Q Consensus 916 --~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 987 (1079)
........+|+..|||||+.. ...|+.+.|.||+|||+|-|+.|..||.+....+- .|-+++.... ...
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---CccCCCccHHHHHH
Confidence 112223456888999999732 33578899999999999999999999987644221 1211111100 000
Q ss_pred hhhhhhhhhhcccCccH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 988 FTTILDRQLLMRSGTQI-QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 988 ~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+.+-++.....-+..+. ....+..+++...+-.|+.+|.++.+++.
T Consensus 314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 00111111000111111 11234556677777789999999999987
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=295.10 Aligned_cols=269 Identities=22% Similarity=0.255 Sum_probs=195.6
Q ss_pred HHHHhhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC--
Q 001426 753 VDDVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG-- 829 (1079)
Q Consensus 753 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 829 (1079)
+..+.++|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 344557899999999999999999965 578899999885422 1222346788899999999999999999988643
Q ss_pred ----CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeec
Q 001426 830 ----RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADF 905 (1079)
Q Consensus 830 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 905 (1079)
...+++++++ +++|.+++... .+++..++.++.|+++|++|||+. +|+||||||+||++++++.+||+||
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~df 164 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 164 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecc
Confidence 3367888876 77998887643 489999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHh--
Q 001426 906 GLAKLFESSESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR-- 982 (1079)
Q Consensus 906 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 982 (1079)
|+++.... ......++..|+|||...+ ..++.++||||+||++|||++|+.||...... ............
T Consensus 165 g~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 238 (345)
T cd07877 165 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 238 (345)
T ss_pred cccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence 99875432 2233467889999998765 46788999999999999999999999653221 111111111100
Q ss_pred -hhhhchhhhhhhh----hhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 983 -ERKREFTTILDRQ----LLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 983 -~~~~~~~~~~~~~----~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
............. ......... .....+.+++.+|++.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000 000000000 112357789999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=291.09 Aligned_cols=271 Identities=21% Similarity=0.286 Sum_probs=198.3
Q ss_pred HhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc-CCeEE
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN-GRTRL 833 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 833 (1079)
..++|+..+.||+|+||.||+|... +++.||+|++.+... .....+.+.+|++++++++||||+++++++.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4567899999999999999999755 788999998854322 22345678899999999999999999999865 56789
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
+|+||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||+|+||++++++.++++|||.++....
T Consensus 87 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 999998 56898888643 368888889999999999999999 999999999999999999999999999875432
Q ss_pred CcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchh---
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT--- 989 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 989 (1079)
. .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....... .... ..........++.
T Consensus 161 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~-~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSI-ITDLLGTPPDDVINTI 233 (328)
T ss_pred C-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhCCCCHHHHHhc
Confidence 1 123457889999998765 568999999999999999999999996543210 0000 0000000000000
Q ss_pred ------hhhhhhhhcccCccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhcccc
Q 001426 990 ------TILDRQLLMRSGTQIQ-----EMLQVLGVALLCVNPCPEERPTMKDVTAM--LKEIRHE 1041 (1079)
Q Consensus 990 ------~~~~~~~~~~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~ 1041 (1079)
+.+. ........... ....+.+++.+|++.+|++|||+++++.. ++.....
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 234 CSENTLRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred cchhhHHHHh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 0000 00000000111 12467889999999999999999999875 4444433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=288.55 Aligned_cols=245 Identities=21% Similarity=0.276 Sum_probs=192.9
Q ss_pred CCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCC
Q 001426 763 TNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 763 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
.+++|+|.||+||-|.. ++|+.||||.+.+.+-... ...++++|+.|++.++||.||.+...|...+..+.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 47899999999999955 5899999999976554443 347899999999999999999999999999999999999977
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC---CcEEEeeccccccccCCcccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ---FEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~~~~~~~~~~ 918 (1079)
.=|.-.+......+++.....++.||+.||.|||.+ +|||+|+||+|||+.+. .++||||||+|+.++...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 555555555556688888888999999999999999 99999999999999653 489999999999988654
Q ss_pred cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhc
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
....++|||.|+|||++....|...-|+||.|||+|--++|..||....+..++++...- +
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF-------------------M 782 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF-------------------M 782 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc-------------------c
Confidence 345678999999999999999999999999999999999999999753222111111111 1
Q ss_pred ccCccH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 999 RSGTQI-QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 999 ~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.+.... +......++|...++..=.+|-|.++.+.
T Consensus 783 yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 783 YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 111111 11234556666677766677777766543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=268.37 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=194.3
Q ss_pred HhhCCCC-CCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEc----
Q 001426 756 VVTRLSD-TNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNN---- 828 (1079)
Q Consensus 756 ~~~~~~~-~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 828 (1079)
++++|++ .++||-|-.|.|..+.. .+++.+|+|++. +...-++|++.--.. .|||||.++++|..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--------DSPKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 3455555 36799999999999855 478999999874 223456787764444 69999999999854
Q ss_pred CCeEEEEEEecCCCChhhhhhccCc-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC---CCcEEEee
Q 001426 829 GRTRLLLFDYISNGSLAGLLHEKKV-FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP---QFEAFLAD 904 (1079)
Q Consensus 829 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~D 904 (1079)
.+-+.+|||.++||.|.+.+++++. .+++.++..|+.||+.|+.|||+. +|.||||||+|+|... +..+|++|
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 3456899999999999999987754 689999999999999999999999 9999999999999975 45799999
Q ss_pred ccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh
Q 001426 905 FGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER 984 (1079)
Q Consensus 905 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 984 (1079)
||+|+.-.. ......-.-||.|.|||++...+|+...|+||+||++|-|++|.+||+.... ..+..-++..++..
T Consensus 208 fGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~g 282 (400)
T KOG0604|consen 208 FGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTG 282 (400)
T ss_pred cccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhcc
Confidence 999986543 2233445679999999999999999999999999999999999999998653 22222222222221
Q ss_pred hhchhhhhhhhhhcccCccHHH-HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 985 KREFTTILDRQLLMRSGTQIQE-MLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.-+| +..+..+ .....++++..+..+|++|.|+.|+++
T Consensus 283 qy~F-----------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 QYEF-----------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CccC-----------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1111 1122222 345668999999999999999999987
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=245.30 Aligned_cols=267 Identities=19% Similarity=0.289 Sum_probs=202.7
Q ss_pred CCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+|...++||+|.||+||+|+.. +++.||+|.++.... ++..-....+|+-+++.++|+|||+++++...+....+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4566788999999999999764 688999999865432 33344677899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
||.. +|..|...-...++.+.+..++.|+++|+.|+|++ ++.|||+||+|.+++.+|+.|++|||+|+-++-.-
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 9976 89999887766789999999999999999999999 99999999999999999999999999999765432
Q ss_pred ccccccccCcccccccccCCCC-CCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHH---hHHhhhhhchhhhh
Q 001426 918 RASNSVAGSYGYIAPEYGYSLK-ITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVN---GELRERKREFTTIL 992 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 992 (1079)
.-.+..+-|..|.+|.++++.+ |+...|+||-|||+.|+.. |++-|.+.+ .++++.+..+ ....++|+......
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhCCCccccCCccccCC
Confidence 2233446789999999998875 7889999999999999999 554454432 2223332222 12344566665555
Q ss_pred hhhhhcccCc--cHHH-HH----HHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 993 DRQLLMRSGT--QIQE-ML----QVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~--~~~~-~~----~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
|......++. ...+ .. .-.++..+.+.-+|.+|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 5443222221 1111 11 1235566666778999999988765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=277.33 Aligned_cols=244 Identities=22% Similarity=0.296 Sum_probs=194.8
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 835 (1079)
.+|....+||+|+||.|..++.+ +.+.+|||++++...-..++.+--+.|-+++.-- +-|.++.+..+|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 45777889999999999999765 5778999998765544445556666788888766 578999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~ 915 (1079)
|||+.||+|--.+++.+. +.+..+..++..||-||-|||++ +|++||||.+|||++.+|++||+|||+++.---++
T Consensus 429 MEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred EEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 999999999999988776 67777888999999999999999 99999999999999999999999999998543322
Q ss_pred ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhh
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
..+....|||.|+|||++...+|+..+|.|||||++|||+.|++||++.+.+ .+ +..+.+..
T Consensus 505 --~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--el--------------F~aI~ehn 566 (683)
T KOG0696|consen 505 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--EL--------------FQAIMEHN 566 (683)
T ss_pred --cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--HH--------------HHHHHHcc
Confidence 3455688999999999999999999999999999999999999999875321 11 11112222
Q ss_pred hhcccCccHHHHHHHHHHHHhccCCCCCCCCC
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPT 1027 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 1027 (1079)
+..+. .-..+...+...-+...|.+|..
T Consensus 567 vsyPK----slSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 VSYPK----SLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CcCcc----cccHHHHHHHHHHhhcCCccccC
Confidence 21111 11234556777778889998863
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=295.46 Aligned_cols=263 Identities=22% Similarity=0.286 Sum_probs=195.8
Q ss_pred HhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCe---
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT--- 831 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 831 (1079)
+.++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|+.+++.++|+||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4567888999999999999999875 57889999875322 122334667889999999999999999998876554
Q ss_pred ---EEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccc
Q 001426 832 ---RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908 (1079)
Q Consensus 832 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla 908 (1079)
.++|+||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||+|+||++++++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 56999998653 489999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCcccccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhc
Q 001426 909 KLFESSESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 909 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
...... .....++..|+|||...+ ..++.++||||+|+++||+++|+.||...... ......... .......
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~-~~~~~~~ 238 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNL-VGTPDEE 238 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHh-cCCCCHH
Confidence 865432 233467889999998765 36789999999999999999999999654221 111111110 0000000
Q ss_pred hhh---------hhhhhhhcccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 988 FTT---------ILDRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 988 ~~~---------~~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+.. .... ......... .....+.+++.+|++++|++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQS-LPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHh-ccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 0000 000000000 11346789999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=295.80 Aligned_cols=266 Identities=19% Similarity=0.276 Sum_probs=191.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcC-------
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNG------- 829 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 829 (1079)
.+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 57888999999999999999764 68899999885322 23457788999999999999999999876543
Q ss_pred -------CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-CCcEE
Q 001426 830 -------RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-QFEAF 901 (1079)
Q Consensus 830 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~k 901 (1079)
...++||||++ ++|.+++... .+++..++.++.||+.|++|||+. +|+||||||+||+++. ++.+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 5898888543 478999999999999999999999 9999999999999985 55789
Q ss_pred EeeccccccccCCccc-ccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHh
Q 001426 902 LADFGLAKLFESSESS-RASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG 979 (1079)
Q Consensus 902 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 979 (1079)
++|||.++........ .......++..|+|||.... ..++.++|||||||++|||++|+.||....+.. ........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence 9999999865432111 11223457889999997654 567889999999999999999999997543211 11111110
Q ss_pred HHhh---hhhchhhhhhhhhh---cccCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 980 ELRE---RKREFTTILDRQLL---MRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 980 ~~~~---~~~~~~~~~~~~~~---~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.... ....+......... ....... .....+.+++.+|+++||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 00000000000000 0000000 11235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=265.02 Aligned_cols=275 Identities=23% Similarity=0.344 Sum_probs=202.8
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc-----
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN----- 828 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 828 (1079)
+....|....+||+|.||.||+|+.+ +++.||+|++.-.. .....-..-.+|++++..++|+|++.+++.|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 34456777889999999999999765 57778988764211 111122456789999999999999999998843
Q ss_pred ---CCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeec
Q 001426 829 ---GRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADF 905 (1079)
Q Consensus 829 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 905 (1079)
...+|+|+++|+. +|...+......++..++.+++.++..||.|+|.. .|+|||+||.|+|++.++.+||+||
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence 3357999999987 89999988877899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCcc--cccccccccCcccccccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcc-hHHH-HHHhH
Q 001426 906 GLAKLFESSES--SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA-HIIT-WVNGE 980 (1079)
Q Consensus 906 Gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~-~~~~-~~~~~ 980 (1079)
|+|+.+...+. ....+..+-|..|.+||.+.+ +.++++.|||+-||++.||+|+.+.+++...... ++.. .....
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99986654332 233445667999999998765 5789999999999999999999999887543211 1111 11122
Q ss_pred Hhhhhhchhhhhhhh------hhcccCccH-HHH------HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 981 LRERKREFTTILDRQ------LLMRSGTQI-QEM------LQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 981 ~~~~~~~~~~~~~~~------~~~~~~~~~-~~~------~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
.++-|++....--.. +........ +.. .+.++++.+++..||++|+++++++..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 233444333211100 000000001 111 256789999999999999999998763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=287.33 Aligned_cols=238 Identities=25% Similarity=0.297 Sum_probs=190.5
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 835 (1079)
++|.....+|.|+|+.|-.+.. .+++..+||++.+. ..+-.+|+.++... +||||+++.+.+.++...|+|
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc-------ccccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 4566667799999999988854 57888999998533 23345677666655 699999999999999999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEE-CCCCcEEEeeccccccccCC
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV-GPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DFGla~~~~~~ 914 (1079)
||++.++-+.+.+...+. +. .++..|+.+|+.|+.|||++ |+||||+||+|||+ +..++++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999988876654 22 67778999999999999998 99999999999999 68999999999999976654
Q ss_pred cccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
....+-|..|.|||+.....+++++|+||+|+++|+|++|+.||..... +..+... .+.+.+.
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-~~ei~~~------i~~~~~s----- 532 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-GIEIHTR------IQMPKFS----- 532 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc-hHHHHHh------hcCCccc-----
Confidence 2233568899999999999999999999999999999999999986432 2222111 1111111
Q ss_pred hhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
..-.....+++.+|++.||.+||+|+++..
T Consensus 533 ---------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ---------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 112235668999999999999999999976
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-31 Score=280.73 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=202.6
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCe-EEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQV-IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+++....||-|+||.|-.+..++... +|+|++++...-.....+.+..|-.+|...+.|.||++|..|.+.++.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 345566779999999999998876554 8888887655555556678889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|-|-||.+...+++++. ++......++..+.+|++|||++ +||+||+||+|.+++.+|-+|+.|||+|+.+..+.
T Consensus 500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 99999999999988776 78888888999999999999999 99999999999999999999999999999887654
Q ss_pred cccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.+-..+|||.|.|||++.+..++.++|.||+|+++||+++|.+||.+.++-. .+....++...-. +. +
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-tYn~ILkGid~i~---~P----r-- 642 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-TYNLILKGIDKIE---FP----R-- 642 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHhhhhhhh---cc----c--
Confidence 3345789999999999999999999999999999999999999998754321 1111122211110 00 0
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPT-----MKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 1033 (1079)
.......+++++..+.+|.+|.. +.+|.+
T Consensus 643 --------~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 643 --------RITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred --------ccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 01113446777777889999986 556554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=269.81 Aligned_cols=266 Identities=20% Similarity=0.278 Sum_probs=201.5
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CC-----ceeeeeeEEE
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HK-----NIVRLLGCCN 827 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~ 827 (1079)
.+..+|.++..+|+|.||.|-++-. +.+..||+|+++.+.. -++.-+-|+++++++. +. -+|.+.+||.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 3468999999999999999999854 4578999999864332 2355677999999993 32 3888899999
Q ss_pred cCCeEEEEEEecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC----------
Q 001426 828 NGRTRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP---------- 896 (1079)
Q Consensus 828 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~---------- 896 (1079)
..++.+||+|.+ |-++.+++.+. ...++...+..|+.|++++++|||+. +++|.|+||+||++.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 999999999988 55999999874 55689999999999999999999999 9999999999999842
Q ss_pred ----------CCcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 897 ----------QFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 897 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
...++++|||.|++-.... ...+.|.-|.|||++.+-.++.++||||+|||++|+++|..-|+..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 2357999999998755433 4567899999999999999999999999999999999999999865
Q ss_pred CC-CcchHHHHHHhHHhhh-----------------hhchhh------hhh--hhhhcccCccHHHHHHHHHHHHhccCC
Q 001426 967 IP-DGAHIITWVNGELRER-----------------KREFTT------ILD--RQLLMRSGTQIQEMLQVLGVALLCVNP 1020 (1079)
Q Consensus 967 ~~-~~~~~~~~~~~~~~~~-----------------~~~~~~------~~~--~~~~~~~~~~~~~~~~l~~l~~~Cl~~ 1020 (1079)
.. +.-.+.+.+-|.++.. |++... .++ ..+.........+...+++++.+++..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 42 1112222222221111 000000 000 000011112224566899999999999
Q ss_pred CCCCCCCHHHHHH
Q 001426 1021 CPEERPTMKDVTA 1033 (1079)
Q Consensus 1021 dP~~RPt~~evl~ 1033 (1079)
||.+|+|++|++.
T Consensus 393 DP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 393 DPARRITLREALS 405 (415)
T ss_pred CccccccHHHHhc
Confidence 9999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=286.54 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=200.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEc-----CC
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNN-----GR 830 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~ 830 (1079)
+.|++.+.||.|.+|.||+++. ++++.+|+|+..... +..+++..|+++++.. .|||++.++|+|.. ++
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 4577888999999999999954 578899999886433 3446788899999888 69999999999853 56
Q ss_pred eEEEEEEecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~ 909 (1079)
.+|+|||||.+|+..|+++.- +..+.|+.+..|++.++.|+.+||.. .++|||||-.|||++.++.||++|||++.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeee
Confidence 789999999999999999753 66799999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCcccccccccccCcccccccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh
Q 001426 910 LFESSESSRASNSVAGSYGYIAPEYGY-----SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER 984 (1079)
Q Consensus 910 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 984 (1079)
.++.. ........|||.|||||++. ...|+.++|+||+|++..||.-|.+|+-++.|--+ +-...+..
T Consensus 172 QldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-----LF~IpRNP 244 (953)
T KOG0587|consen 172 QLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIPRNP 244 (953)
T ss_pred eeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----hccCCCCC
Confidence 77654 23455678999999999854 33577899999999999999999999988765211 11111111
Q ss_pred hhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 985 KREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
++.+. ... .-..++-++|..|+..|-++||++.++++
T Consensus 245 PPkLk----------rp~--kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 245 PPKLK----------RPK--KWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred Ccccc----------chh--hHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11110 011 11336778999999999999999987764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=244.73 Aligned_cols=210 Identities=25% Similarity=0.348 Sum_probs=172.8
Q ss_pred CCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhc-CCCCceeeeeeEEEcCCeEEEEEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGS-IRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
+.....||+|+||.|-+.+. .+|...|+|.+..... .++.+....|+++..+ ...|.+|.+||........|+.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 44456799999999999865 5899999999864433 4556778888887555 479999999999999999999999
Q ss_pred ecCCCChhhhhh---ccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 838 YISNGSLAGLLH---EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 838 ~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
.|+- +|..+-. +++..+++..+-+|+..|.+||.|||++- .++|||+||+|||++.+|++|+||||.+..+.+.
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9965 7776654 35777999999999999999999999984 8999999999999999999999999999877654
Q ss_pred cccccccccccCcccccccccC----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHH
Q 001426 915 ESSRASNSVAGSYGYIAPEYGY----SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWV 977 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~ 977 (1079)
- ..+...|-..|||||.+. ...|+.|+||||+|+.++||.+++.||+.+..+...+.+.+
T Consensus 203 i---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 203 I---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred h---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 2 122245778999999854 33688999999999999999999999998776655555444
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=269.37 Aligned_cols=220 Identities=23% Similarity=0.198 Sum_probs=174.3
Q ss_pred cCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCChhhh
Q 001426 769 GVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGL 847 (1079)
Q Consensus 769 G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 847 (1079)
|.||.||++.. .+++.||+|++.... .+..|...+....||||+++++++.+....++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 89999999966 478899999885321 234455555666799999999999999999999999999999999
Q ss_pred hhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccccccCc
Q 001426 848 LHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSY 927 (1079)
Q Consensus 848 l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 927 (1079)
+.+.. .+++..+..++.|+++|++|+|+. +|+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 76 l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 76 ISKFL-NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred HHHhc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 97654 489999999999999999999998 9999999999999999999999999988755432 12234567
Q ss_pred ccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHH
Q 001426 928 GYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEM 1007 (1079)
Q Consensus 928 ~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1079)
.|+|||...+..++.++||||+|+++|||++|+.|+........ . ... .... . ...
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------~-~~~--------~~~~--~--~~~ 202 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------T-HTT--------LNIP--E--WVS 202 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------c-ccc--------cCCc--c--cCC
Confidence 89999998888899999999999999999999988753211000 0 000 0000 0 012
Q ss_pred HHHHHHHHhccCCCCCCCCCHH
Q 001426 1008 LQVLGVALLCVNPCPEERPTMK 1029 (1079)
Q Consensus 1008 ~~l~~l~~~Cl~~dP~~RPt~~ 1029 (1079)
..+.+++.+|++.||++||++.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCC
Confidence 3566899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=276.70 Aligned_cols=209 Identities=28% Similarity=0.382 Sum_probs=178.4
Q ss_pred CCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|...+.||-|+||.|..++. ++...||+|.+.+...-....+..++.|-+||..-+.+-||++|..|.+++.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 55567899999999999855 45778999988765544455667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccccc------
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE------ 912 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~------ 912 (1079)
++||++-.++-+.+. +++..+..++..+.+|+++.|.. |+|||||||+|||||.||++|++|||+++=+.
T Consensus 711 IPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred cCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999999999988776 78888888999999999999999 99999999999999999999999999985321
Q ss_pred ---CCcccc-------------------------------cccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh
Q 001426 913 ---SSESSR-------------------------------ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT 958 (1079)
Q Consensus 913 ---~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t 958 (1079)
.++..+ .....+||+.|+|||++....++..+|.||.|||+|||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 110000 0012369999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcch
Q 001426 959 GKEPTDSRIPDGAH 972 (1079)
Q Consensus 959 g~~p~~~~~~~~~~ 972 (1079)
|+.||-...+.+.+
T Consensus 867 g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQ 880 (1034)
T ss_pred CCCCccCCCCCcce
Confidence 99999887766553
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=298.83 Aligned_cols=256 Identities=17% Similarity=0.222 Sum_probs=167.1
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeCC-----CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeE------
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIPS-----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC------ 825 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------ 825 (1079)
.++|+..+.||+|+||.||+|...+ +..||+|++.... ..+....| .+....+.+++.++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4578889999999999999998754 6889999874211 11111111 1112222222222221
Q ss_pred EEcCCeEEEEEEecCCCChhhhhhccCcC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeC
Q 001426 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVF-------------------LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRD 886 (1079)
Q Consensus 826 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~D 886 (1079)
+..+...++||||+.+++|.+++...... .....+..++.|++.||+|||+. +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 24566789999999999999998754321 12234567999999999999999 999999
Q ss_pred CCCCCeEECC-CCcEEEeeccccccccCCcccccccccccCcccccccccCCC----------------------CCCcc
Q 001426 887 IKSNNILVGP-QFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL----------------------KITEK 943 (1079)
Q Consensus 887 lk~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 943 (1079)
|||+|||+++ ++.+||+|||+|+.+.... ........+++.|+|||..... .++.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999986 5799999999998664432 2233456789999999954321 23456
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhh---hchhhhhhhhhhcccCccHH--------HHHHHHH
Q 001426 944 SDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERK---REFTTILDRQLLMRSGTQIQ--------EMLQVLG 1012 (1079)
Q Consensus 944 sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~--------~~~~l~~ 1012 (1079)
+||||+||++|||+++..|++.. ...+... ..... ..+.....+. ...+.. ......+
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~------~~~~~~~-l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~d~~~~~~~d 428 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN------LIQFNRQ-LKRNDYDLVAWRKLVEPR----ASPDLRRGFEVLDLDGGAGWE 428 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH------HHHHHHH-HHhcCCcHHHHHHhhccc----cchhhhhhhhhccccchHHHH
Confidence 79999999999999976664321 1111110 00000 0000111110 000000 1123458
Q ss_pred HHHhccCCCCCCCCCHHHHHHH
Q 001426 1013 VALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 1013 l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
++.+|++.||++|||++|+++.
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHccCCcccCCCHHHHhCC
Confidence 9999999999999999999873
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=253.41 Aligned_cols=250 Identities=20% Similarity=0.300 Sum_probs=200.7
Q ss_pred hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 834 (1079)
..+|...++||+|+|..|..++.+ +.+.+|+|++++.-....+..+-.+.|-.+..+. +||.+|-+..+|+.....++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457888999999999999999775 6788999998775555555667778888888776 79999999999999999999
Q ss_pred EEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
|.||++||+|-=+++++++ ++++.+..+...|.-||.|||++ ||++||+|.+|||+|..|.+|++|+|+++.--..
T Consensus 329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999888877665 88888888999999999999999 9999999999999999999999999999853322
Q ss_pred cccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC--CCCcchHHHHHHhHHhhhhhchhhhh
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR--IPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
...++...|||.|.|||++.+..|...+|.|++||+++|||.|+.||+-- ..++.....+.-.. ++
T Consensus 405 --gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv----------il 472 (593)
T KOG0695|consen 405 --GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV----------IL 472 (593)
T ss_pred --CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH----------Hh
Confidence 23456789999999999999999999999999999999999999999742 22233222222211 22
Q ss_pred hhhhhcccCccHHHHHHHHHHHHhccCCCCCCCC
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP 1026 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 1026 (1079)
++.++++.... .+...+++.-+.+||++|.
T Consensus 473 ekqiriprsls----vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 473 EKQIRIPRSLS----VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhcccccceee----hhhHHHHHHhhcCCcHHhc
Confidence 22222222222 2444677778899999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=263.17 Aligned_cols=239 Identities=28% Similarity=0.385 Sum_probs=191.3
Q ss_pred CcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCChhhhh
Q 001426 770 VSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLL 848 (1079)
Q Consensus 770 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l 848 (1079)
+||.||+|... +++.+|+|++....... ..+.+.+|++.+++++|+||+++++++......++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999886 48899999985432211 1688999999999999999999999999999999999999999999999
Q ss_pred hccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccccccCcc
Q 001426 849 HEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG 928 (1079)
Q Consensus 849 ~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 928 (1079)
..... +++..++.++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 79 ~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 79 KKRGR-LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred HhccC-CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 76554 88999999999999999999999 99999999999999999999999999998765432 3334567889
Q ss_pred cccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHH
Q 001426 929 YIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEML 1008 (1079)
Q Consensus 929 y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1079)
|+|||......++.++||||+|+++|++++|..||...... ........ ....... ........
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~----~~~~~~~-----------~~~~~~~~ 215 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIG----KPKPPFP-----------PPEWKISP 215 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHh----ccCCCCc-----------cccccCCH
Confidence 99999998888899999999999999999999998653211 11111111 0000000 00000223
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 1009 QVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 1009 ~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.+.+++.+||..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 6778999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=287.27 Aligned_cols=244 Identities=28% Similarity=0.401 Sum_probs=188.6
Q ss_pred CCCCCeeeecCcEE-EEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEEEEEE
Q 001426 760 LSDTNIVGKGVSGI-VYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
|...+++|.|+-|+ ||+|.++ |+.||||++.. +..+..++|+..++.- +|||||++++.-.+....||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 34456789999984 6899886 66899998842 3345678999999988 59999999999999999999999
Q ss_pred ecCCCChhhhhhccCcCC---CHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC---C--CcEEEeeccccc
Q 001426 838 YISNGSLAGLLHEKKVFL---DWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP---Q--FEAFLADFGLAK 909 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~---~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~DFGla~ 909 (1079)
.|.. +|.++++..+... .....+.++.|+++|+++||+. +||||||||+|||++. + .+++|+|||+++
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9966 9999998741111 1134577899999999999998 9999999999999976 3 478999999999
Q ss_pred cccCCccc-ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHhHHhhhhhc
Q 001426 910 LFESSESS-RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 910 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
.+..+... .......||-+|+|||++....-+.++||||+||++|+.++ |.+||++....+..+. .+.. .
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl---~~~~-----~ 731 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL---TGNY-----T 731 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh---cCcc-----c
Confidence 88766432 33556789999999999999888899999999999999999 5999987432222111 1100 0
Q ss_pred hhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+.. ... ..++ ...++|.+|++++|..||+|.+|+.
T Consensus 732 L~~-------L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LVH-------LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eee-------ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000 001 1111 5668999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=276.17 Aligned_cols=266 Identities=18% Similarity=0.156 Sum_probs=177.1
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe-----------------CCCCeEEEEEeccccCCCc-----------hhHHHHHHHH
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-----------------PSRQVIAVKKLWPVKNGEL-----------PERDQFSAEV 808 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~ 808 (1079)
.++|++.++||+|+||+||+|.. ..++.||||++........ ...+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 35788999999999999999853 2456799999853221110 0112344577
Q ss_pred HHHhcCCCCce-----eeeeeEEEc--------CCeEEEEEEecCCCChhhhhhccC-----------------------
Q 001426 809 QTLGSIRHKNI-----VRLLGCCNN--------GRTRLLLFDYISNGSLAGLLHEKK----------------------- 852 (1079)
Q Consensus 809 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------- 852 (1079)
.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888876654 677887753 346799999999999999986421
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccccccCcccccc
Q 001426 853 VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAP 932 (1079)
Q Consensus 853 ~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 932 (1079)
...++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+++...... ........+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence 1245678889999999999999999 99999999999999999999999999997654332 1122233458899999
Q ss_pred cccCCCCC----------------------CccchHHHHHHHHHHHHhCCC-CCCCCCCCcchHHHHHHhHHhhhhhchh
Q 001426 933 EYGYSLKI----------------------TEKSDVYSYGVVLLEVLTGKE-PTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 933 E~~~~~~~----------------------~~~sDvwSlGvil~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
|.+..... ..+.||||+||++|||++|.. |+.....-......+. .....|..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~--~~~~~~r~-- 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD--NDLNRWRM-- 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc--chHHHHHh--
Confidence 98653221 234799999999999999875 6543210000000000 00000000
Q ss_pred hhhhhhhhcccCccHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCP---EERPTMKDVTA 1033 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~evl~ 1033 (1079)
....... ............+++.+++..+| .+|+|++|+++
T Consensus 456 -~~~~~~~--~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 -YKGQKYD--FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -hcccCCC--cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000000 00000122356788888998765 78999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=251.27 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=191.8
Q ss_pred CCCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-----eEE
Q 001426 760 LSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR-----TRL 833 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 833 (1079)
.+..+.||.|+||.||.+.. ++|+.||.|++.... ......+.+-+|+.++..++|+|+...++...-.. ++|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 45567899999999999966 589999999885332 23344578889999999999999999888765432 357
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
.++|.+.. +|...+-. ...++.+.+.-+.+||++||+|||+. +|.||||||.|.+++.+...||||||+|+.-..
T Consensus 134 V~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 78888754 77776654 34588889999999999999999999 999999999999999999999999999996554
Q ss_pred CcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh----hhch
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER----KREF 988 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~ 988 (1079)
++ ...++..+-|..|.|||.+++. .|+.+.||||.|||+.|++..+.-|+...|.. ....+....... ....
T Consensus 209 d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq--QL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 209 RD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE--QLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred hh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH--HHHHHHHHhCCCcHHHHHHH
Confidence 44 3344555678899999998875 58999999999999999999888887543321 111111100000 0000
Q ss_pred hh-----hh-----hhhh--hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 989 TT-----IL-----DRQL--LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 989 ~~-----~~-----~~~~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
++ ++ .+.. ..............+.+.+++++.||++|.+.++.+...
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00 00 0000 000111111223456788889999999999999887754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=254.55 Aligned_cols=284 Identities=22% Similarity=0.265 Sum_probs=201.6
Q ss_pred ccccccCCHHHHh--hCCCCCCeeeecCcEEEEEE-EeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-----C
Q 001426 745 PFQKLNFSVDDVV--TRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-----H 816 (1079)
Q Consensus 745 ~~~~~~~~~~~~~--~~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h 816 (1079)
.-.+..+.+.+.. .+|-+.++||-|.|++||.+ +....+.||+|+.+ .+..-.+.-..|+++|++++ |
T Consensus 63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK----SAqhYtEaAlDEIklL~~v~~~Dp~~ 138 (590)
T KOG1290|consen 63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK----SAQHYTEAALDEIKLLQQVREGDPND 138 (590)
T ss_pred cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe----hhhHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3334445555554 58999999999999999999 45678899999874 23334466778999999984 2
Q ss_pred ---CceeeeeeEEEc----CCeEEEEEEecCCCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC
Q 001426 817 ---KNIVRLLGCCNN----GRTRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIK 888 (1079)
Q Consensus 817 ---~niv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk 888 (1079)
.+||++++.|.. +.+.++|+|++ |.+|..+|... -+.++...+.+|++||+.||.|||.+| +|||.|||
T Consensus 139 ~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlK 215 (590)
T KOG1290|consen 139 PGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLK 215 (590)
T ss_pred CCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCC
Confidence 379999999864 56789999999 55888888654 455899999999999999999999998 99999999
Q ss_pred CCCeEECCC-----------------------------------------------------------------------
Q 001426 889 SNNILVGPQ----------------------------------------------------------------------- 897 (1079)
Q Consensus 889 ~~NIll~~~----------------------------------------------------------------------- 897 (1079)
|+|||+..+
T Consensus 216 PENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~ 295 (590)
T KOG1290|consen 216 PENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIE 295 (590)
T ss_pred cceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccc
Confidence 999998411
Q ss_pred --------------------------------------------------------------------------------
Q 001426 898 -------------------------------------------------------------------------------- 897 (1079)
Q Consensus 898 -------------------------------------------------------------------------------- 897 (1079)
T Consensus 296 ~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~ 375 (590)
T KOG1290|consen 296 EEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIA 375 (590)
T ss_pred ccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccc
Confidence
Q ss_pred ---------------CcEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 001426 898 ---------------FEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962 (1079)
Q Consensus 898 ---------------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p 962 (1079)
-+|||+|||-|+.+... .+.-..|..|.|||++.+..|+..+||||++|++|||+||..-
T Consensus 376 ~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyL 450 (590)
T KOG1290|consen 376 SNPLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYL 450 (590)
T ss_pred cccccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCcee
Confidence 01233333333322110 1112357899999999999999999999999999999999999
Q ss_pred CCCCCC-----CcchHHHHHHhHH----------------hhhhhchhhh-------hhhhhhcccCccHHHHHHHHHHH
Q 001426 963 TDSRIP-----DGAHIITWVNGEL----------------RERKREFTTI-------LDRQLLMRSGTQIQEMLQVLGVA 1014 (1079)
Q Consensus 963 ~~~~~~-----~~~~~~~~~~~~~----------------~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~l~ 1014 (1079)
|+.... +++++..++.-.. -.+..++..+ +..-+...+....++..++.+++
T Consensus 451 FePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL 530 (590)
T KOG1290|consen 451 FEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL 530 (590)
T ss_pred ecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence 876422 2334433332110 0111111100 01111223444557788999999
Q ss_pred HhccCCCCCCCCCHHHHHH--HHHhccc
Q 001426 1015 LLCVNPCPEERPTMKDVTA--MLKEIRH 1040 (1079)
Q Consensus 1015 ~~Cl~~dP~~RPt~~evl~--~L~~~~~ 1040 (1079)
.-|++.+|++||||++.++ .|.....
T Consensus 531 ~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 531 SPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHHhcCccccccHHHHhcCccccCCCC
Confidence 9999999999999999986 4554433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=235.94 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=199.1
Q ss_pred hhCCCCCCeeeecCcEEEEEEE-eCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcC--CeE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNG--RTR 832 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~ 832 (1079)
.++|++.+++|+|.|+.||.|. ..+.+.++||++++++ .+.+.+|+.+++.++ ||||+++++...+. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3568888999999999999995 4678889999986543 467999999999997 99999999999764 456
Q ss_pred EEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-cEEEeeccccccc
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-EAFLADFGLAKLF 911 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~ 911 (1079)
.+|+||+.+.+....-. .++...+..++.+++.||.|+|+. ||+|||+||.||++|... ..+++|+|+|.++
T Consensus 111 aLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 89999999877666553 366778889999999999999999 999999999999999754 7899999999998
Q ss_pred cCCcccccccccccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhh------
Q 001426 912 ESSESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER------ 984 (1079)
Q Consensus 912 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 984 (1079)
..+... ...+.+..|..||.+..- .++..-|+|||||++..|+..+.||-...+..+++++.++-...+.
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 776432 234567788999987654 5788899999999999999999999776666666666554321111
Q ss_pred ------hhchhhhhhhhhhccc------CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 985 ------KREFTTILDRQLLMRS------GTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 985 ------~~~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.+.+..++......+. ...---..+.++++.+.++.|-.+|||++|+++
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1112121111111000 000001246788999999999999999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=260.75 Aligned_cols=200 Identities=23% Similarity=0.296 Sum_probs=170.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchh-----HHHHHHHHHHHhcCC---CCceeeeeeEEEc
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPE-----RDQFSAEVQTLGSIR---HKNIVRLLGCCNN 828 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 828 (1079)
..|+..+.+|+|+||.|+.|..+ +...|++|.+.+.+.-.... ...+-.|+.||..++ |+||+|++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35788899999999999999765 46678889886544211111 124567999999997 9999999999999
Q ss_pred CCeEEEEEEec-CCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 829 GRTRLLLFDYI-SNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 829 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
++.+|++||.. ++.+|.+++.-+.. +++.++..|+.||+.|+++||+. +|||||||-+||.++.+|-+|++|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 99999999987 45699999976554 89999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCcccccccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCC
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKI-TEKSDVYSYGVVLLEVLTGKEPTDS 965 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~el~tg~~p~~~ 965 (1079)
|.....+. ....+||..|.|||++.+.+| +..-|||++|+++|.++....||+.
T Consensus 717 aa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 98665443 345789999999999999887 5678999999999999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=239.11 Aligned_cols=211 Identities=33% Similarity=0.525 Sum_probs=182.7
Q ss_pred eeecCcEEEEEEEeCC-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCCh
Q 001426 766 VGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 844 (1079)
||+|++|.||++...+ ++.+++|++....... ..+.+.+|++.++.++|++|+++++++......++++||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 6899999999998864 8899999985432211 357899999999999999999999999999999999999999999
Q ss_pred hhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-CCcEEEeeccccccccCCccccccccc
Q 001426 845 AGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-QFEAFLADFGLAKLFESSESSRASNSV 923 (1079)
Q Consensus 845 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 923 (1079)
.+++......+++..++.++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 999976644589999999999999999999999 9999999999999999 89999999999986654321 23335
Q ss_pred ccCcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCc
Q 001426 924 AGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGT 1002 (1079)
Q Consensus 924 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1079)
.+...|++||..... .++.++|+|++|++++++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999998877 788999999999999999
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 1003 QIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 1003 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
..+.+++.+|++.+|++||+++++++.
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 255678899999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=233.36 Aligned_cols=256 Identities=18% Similarity=0.271 Sum_probs=188.4
Q ss_pred HHHhhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeE-EEcCC
Q 001426 754 DDVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGC-CNNGR 830 (1079)
Q Consensus 754 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~ 830 (1079)
-++.+.|.+.+.+|+|.||.+-.++.+ +.+.+++|.+.. .....++|.+|..---.+ .|.||+.-|++ |+..+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~----p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR----PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc----chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 356678999999999999999999776 577889998753 223468899998765555 58999987775 67788
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEEC--CCCcEEEeecccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG--PQFEAFLADFGLA 908 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DFGla 908 (1079)
.+++++||++.|+|.+-+...+ +.+....+++.|+++|+.|+|++ ++||||||.+|||+- +..++|+||||..
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred eEEEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 8999999999999999997755 67778889999999999999999 999999999999994 3348999999998
Q ss_pred ccccCCcccccccccccCcccccccccCCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhh
Q 001426 909 KLFESSESSRASNSVAGSYGYIAPEYGYSL-----KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE 983 (1079)
Q Consensus 909 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 983 (1079)
+..+. .......+..|.|||..... ...+.+|||.||+++|.++||+.||+...-.+..+.+|.....+.
T Consensus 171 ~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 171 RKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred cccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 75432 22334456789999964322 356789999999999999999999985433344444443322111
Q ss_pred hhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001426 984 RKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
.. ...+.+.+ -...++++.++-+.++|++|=-..++..+-
T Consensus 246 ~~-~~P~~F~~-----------fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 NP-ALPKKFNP-----------FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred Cc-cCchhhcc-----------cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11 01111110 112556777888999999995555544443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=265.48 Aligned_cols=252 Identities=24% Similarity=0.275 Sum_probs=198.7
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.+|.|.||.|||++.. +++.+|+|.++-. .....+..++|+-+++..+|||||.++|.+...+..|+.|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 56888899999999999999764 7889999988532 2345677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|||.+|+|.+.-+.-+. +++.++..+++...+|++|||+. +-+|||||-.||++++.|.+|++|||.+..++..
T Consensus 92 EycgggslQdiy~~Tgp-lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGP-LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred EecCCCcccceeeeccc-chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh--
Confidence 99999999998765554 88899999999999999999999 8899999999999999999999999999877643
Q ss_pred cccccccccCccccccccc---CCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 917 SRASNSVAGSYGYIAPEYG---YSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
-.+.....||+.|||||+. ..+.|..++|||+.|+...|+-.-+.|..+..+...- ++.. +. .++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l---~LmT-----kS----~~q 233 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL---FLMT-----KS----GFQ 233 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH---HHhh-----cc----CCC
Confidence 3445678899999999974 4567899999999999999999888875543321110 0000 00 111
Q ss_pred hhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
+.-... .. .-...+-++++.|+..+|++|||++.+++
T Consensus 234 pp~lkD-k~--kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKD-KT--KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccC-Cc--cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 110000 00 11225567899999999999999887653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-28 Score=250.95 Aligned_cols=428 Identities=22% Similarity=0.209 Sum_probs=299.9
Q ss_pred eeecCCceeEEecccCCCCccccccCCcccEEEcCCCcccccCCccccccCCCCEEeccCCcccCCCCcccCCcCcccEE
Q 001426 63 IKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELL 142 (1079)
Q Consensus 63 v~C~~~~~~~~~~~l~~~~~~~~~~l~~l~~L~L~~~~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 142 (1079)
|.|+..++..++.+|| +..+.++|..|+|+...|.+|+.+.+|++||||+|.|+.+-|+.|.+|.+|..|
T Consensus 51 VdCr~~GL~eVP~~LP----------~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~L 120 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLP----------PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSL 120 (498)
T ss_pred EEccCCCcccCcccCC----------CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHH
Confidence 8999988877777776 478999999999996666789999999999999999999999999999998887
Q ss_pred eccC-CcccccCccccccccccceEecccccccCCCChhhchhhhHHHHHhCCCCCcccCCCc-ccccccceeEeecccC
Q 001426 143 SLNS-NSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPE-EISNCKVLVFLGLADT 220 (1079)
Q Consensus 143 ~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~-~l~~l~~L~~L~l~~~ 220 (1079)
-+-+ |+|+....+.|++|..|+.|.+.-|++.-.....|..|++|..|.+..|. ...+++ .+..+..++.+.++.|
T Consensus 121 vlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~--~q~i~~~tf~~l~~i~tlhlA~n 198 (498)
T KOG4237|consen 121 VLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNK--IQSICKGTFQGLAAIKTLHLAQN 198 (498)
T ss_pred HhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchh--hhhhccccccchhccchHhhhcC
Confidence 7766 99996666789999999999999999998888899999999999998885 555665 6888888999998888
Q ss_pred C------------CccCCCccccccccccccccccccccccCCcccccc-cccceecccccccccCCC-cCccCCCCCCe
Q 001426 221 G------------ISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNC-SALENLFLYENQIFGKIP-DELGSLKNLKR 286 (1079)
Q Consensus 221 ~------------~~~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~ 286 (1079)
. +.-..|..++..+-..-..+....+...-+..|... ..+..-..+.+...+..| ..|.+|++|++
T Consensus 199 p~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ 278 (498)
T KOG4237|consen 199 PFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRK 278 (498)
T ss_pred ccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceE
Confidence 7 233344445555555555555555544444433321 222222223333333444 35888899999
Q ss_pred EeccCcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeecccccccccccccccccccCcEeeccCCcc
Q 001426 287 LLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRF 366 (1079)
Q Consensus 287 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 366 (1079)
|+|++|+|+++-+.+|.++.+++.|.|..|+|...-...|.++..|+.|+|.+|+|+...|.+|..+..|..|+|-.|.+
T Consensus 279 lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 279 LNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred eccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 99999999988888899999999999999998877777788889999999999999888888999888999999888877
Q ss_pred cccCCccccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCCCCC---ccccccccccccccccccccccccCCC
Q 001426 367 FGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGS---VPSSLFNLKNLTQLLLISNRFSGEIPP 443 (1079)
Q Consensus 367 ~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~---~p~~l~~l~~L~~L~L~~N~l~~~~p~ 443 (1079)
... +++..|. -++..+.-.+.++ -..-..++.++++++.+... .|+... . . ..+.
T Consensus 359 ~Cn-----C~l~wl~-~Wlr~~~~~~~~~-Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~---------~-----~-~s~~ 416 (498)
T KOG4237|consen 359 NCN-----CRLAWLG-EWLRKKSVVGNPR-CQSPGFVRQIPISDVAFGDFRCGGPEELG---------C-----L-TSSP 416 (498)
T ss_pred cCc-----cchHHHH-HHHhhCCCCCCCC-CCCCchhccccchhccccccccCCccccC---------C-----C-CCCC
Confidence 421 1222211 1333344223222 22223466666666655421 111110 0 0 0111
Q ss_pred cccCCCCceEE-EecCCCccccCccccccccccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhhhhcC
Q 001426 444 EIGGCTGLIRL-RLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFG 522 (1079)
Q Consensus 444 ~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 522 (1079)
.-..++-+.+. ..+++.++ .+|..+ ....+.|++.+|.++ .+|.. .+.+| .+|+++|+|.......|.+++.
T Consensus 417 cP~~c~c~~tVvRcSnk~lk-~lp~~i--P~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tq 489 (498)
T KOG4237|consen 417 CPPPCTCLDTVVRCSNKLLK-LLPRGI--PVDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQ 489 (498)
T ss_pred CCCCcchhhhhHhhcccchh-hcCCCC--CchhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhh
Confidence 11223333332 34444444 445433 235677888888888 66665 56777 8888999888777778888888
Q ss_pred CCccccccc
Q 001426 523 LNVLDLSMN 531 (1079)
Q Consensus 523 L~~L~Ls~N 531 (1079)
|.+|.|++|
T Consensus 490 l~tlilsyn 498 (498)
T KOG4237|consen 490 LSTLILSYN 498 (498)
T ss_pred hheeEEecC
Confidence 888888876
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=234.40 Aligned_cols=278 Identities=22% Similarity=0.307 Sum_probs=200.4
Q ss_pred hhCCCCCCeeeecCcEEEEEE-EeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCC-----
Q 001426 757 VTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR----- 830 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 830 (1079)
..+|.....+|.|+- .|-.+ +.-.++.||+|+..... ......+.-.+|...+..++|+||++++.++.-.+
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 356777888999988 55554 33468889999875542 22344577789999999999999999999986543
Q ss_pred -eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccc
Q 001426 831 -TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 831 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~ 909 (1079)
..|+|||++.. +|.+.+. ..++-+++..+..|+++|++|+|+. +|+||||||+||++..+..+||.|||+|+
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 45999999965 8888887 2356788899999999999999999 99999999999999999999999999998
Q ss_pred cccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhH--Hhhhh--
Q 001426 910 LFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE--LRERK-- 985 (1079)
Q Consensus 910 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~-- 985 (1079)
.-... -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+. ..+.+|-+.. .....
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHH
Confidence 54332 3566778899999999999888999999999999999999999988643 2333332210 00000
Q ss_pred ---------------------hchhhhhhhh-hhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhcccc
Q 001426 986 ---------------------REFTTILDRQ-LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRHE 1041 (1079)
Q Consensus 986 ---------------------~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~ 1041 (1079)
..+.+.+... ............-..-+++.+|+-.+|++|-+++++++ .++ +.-.
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~-vw~~ 318 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK-VWYD 318 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee-eecc
Confidence 1111111000 00000000011224557889999999999999999987 344 3334
Q ss_pred CCCCCCCccc
Q 001426 1042 NDDLEKPNSL 1051 (1079)
Q Consensus 1042 ~~~~~~~~~~ 1051 (1079)
..+.+.|.+.
T Consensus 319 ~~ev~ap~pe 328 (369)
T KOG0665|consen 319 PDEVEAPPPE 328 (369)
T ss_pred cccccCCCCc
Confidence 4444444444
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=234.67 Aligned_cols=200 Identities=32% Similarity=0.456 Sum_probs=172.6
Q ss_pred CCCCCeeeecCcEEEEEEEeCC-CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|+..+.||+|++|.||+|.... ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 4566889999999999998875 888999998543221 2567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 918 (1079)
+++++|.+++......+++..+..++.+++.++.|+|+. +++|+|++|+||+++.++.++|+|||.+........ .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 999999999976554378999999999999999999999 999999999999999999999999999987654421 1
Q ss_pred cccccccCccccccccc-CCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 001426 919 ASNSVAGSYGYIAPEYG-YSLKITEKSDVYSYGVVLLEVLTGKEPTDS 965 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~el~tg~~p~~~ 965 (1079)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345677899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=242.65 Aligned_cols=270 Identities=23% Similarity=0.243 Sum_probs=203.0
Q ss_pred cCCHHHH-hhCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC------CCceee
Q 001426 750 NFSVDDV-VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR------HKNIVR 821 (1079)
Q Consensus 750 ~~~~~~~-~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~ 821 (1079)
.+.+.++ ..+|.+....|+|-|++|.+|... .|..||||++.. .+...+.=..|+++|+++. --|+++
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn----NE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN----NEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec----chHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 3444444 467999999999999999999654 577999999953 2233456678999999995 348999
Q ss_pred eeeEEEcCCeEEEEEEecCCCChhhhhhccCc--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-
Q 001426 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV--FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF- 898 (1079)
Q Consensus 822 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~- 898 (1079)
++..|....++|+|+|.+.- +|.+.+.+.+. .+....+..++.|+.-||..|-.. +|+|.||||+||||++.-
T Consensus 499 l~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 99999999999999998854 99999987644 467788899999999999999988 999999999999999865
Q ss_pred cEEEeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHH-
Q 001426 899 EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWV- 977 (1079)
Q Consensus 899 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~- 977 (1079)
..||||||.|....... .+.+.-+..|.|||++.+.+|+...|+||.||++||+.||+..|.+..... +..+.
T Consensus 575 iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~--MLrl~m 648 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ--MLRLFM 648 (752)
T ss_pred eeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH--HHHHHH
Confidence 67999999998776543 223345678999999999999999999999999999999999997754332 22221
Q ss_pred --HhHHhhh---hhchh-hhhh--------------------------h------hhhc---ccCccHHHHHHHHHHHHh
Q 001426 978 --NGELRER---KREFT-TILD--------------------------R------QLLM---RSGTQIQEMLQVLGVALL 1016 (1079)
Q Consensus 978 --~~~~~~~---~~~~~-~~~~--------------------------~------~~~~---~~~~~~~~~~~l~~l~~~ 1016 (1079)
+|.++.. ...|. ..+| | .+.. .+..+......+.+++.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 1111110 11110 0000 0 0100 112233445678899999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 001426 1017 CVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 1017 Cl~~dP~~RPt~~evl~ 1033 (1079)
|+..||++|.|..|+++
T Consensus 729 ml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALK 745 (752)
T ss_pred HhccChhhcCCHHHHhc
Confidence 99999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=235.13 Aligned_cols=267 Identities=24% Similarity=0.370 Sum_probs=196.0
Q ss_pred HHhhCCCCCCeeeecCcEEEEEEEeC----CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcC
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP----SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNG 829 (1079)
Q Consensus 755 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 829 (1079)
.+.+.|..+++||+|+|++||++... ..+.||+|.+... .....+..|+++|..+. +.||+++.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34567889999999999999998543 4678999998543 33456899999999994 89999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-CCcEEEeecccc
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-QFEAFLADFGLA 908 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla 908 (1079)
+...+|+||++...-.++... ++...+..+++.+..||+++|.. |||||||||+|++++. .+.-.|.|||+|
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 999999999999988888854 55778889999999999999999 9999999999999986 467889999999
Q ss_pred ccccCCc----------------------------------ccc--------cccccccCcccccccccCCC-CCCccch
Q 001426 909 KLFESSE----------------------------------SSR--------ASNSVAGSYGYIAPEYGYSL-KITEKSD 945 (1079)
Q Consensus 909 ~~~~~~~----------------------------------~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~sD 945 (1079)
..+.... +.. ..-..+||++|.|||++... ..+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7321100 000 00123699999999997765 5688999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHH----h------hh---h--hc---hhhh------hh-hhhhc-c
Q 001426 946 VYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGEL----R------ER---K--RE---FTTI------LD-RQLLM-R 999 (1079)
Q Consensus 946 vwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----~------~~---~--~~---~~~~------~~-~~~~~-~ 999 (1079)
|||.|||+.-+++++.||....++...+...+..-. + .+ + .. ..+. ++ ..... +
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999999765544443333322100 0 00 0 00 0000 00 00000 0
Q ss_pred c-CccH---HH--HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 1000 S-GTQI---QE--MLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 1000 ~-~~~~---~~--~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
. .... .+ ....+++..+|+..||.+|-|+++.+.
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 0000 11 236789999999999999999999886
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-26 Score=237.62 Aligned_cols=274 Identities=24% Similarity=0.254 Sum_probs=187.9
Q ss_pred eeEeecccCCCccCCCccccccccccccccccccccccCCcccccccccceecccc-cccccCCCcCccCCCCCCeEecc
Q 001426 212 LVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYE-NQIFGKIPDELGSLKNLKRLLLW 290 (1079)
Q Consensus 212 L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~ 290 (1079)
-+.++|..|+|+...|.+|+.+++|+.|+|++|+|+.+-|+.|.++.+|..|-+.+ |+|+....+.|++|..|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 46788889999977788889999999999999999988889999998888887766 88886666678889999999999
Q ss_pred CcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeeccccccc------------ccccccccccccCcE
Q 001426 291 QNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNIS------------GEIPSFFGNFSRLKQ 358 (1079)
Q Consensus 291 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~------------~~~~~~~~~l~~L~~ 358 (1079)
-|++.-...++|..+++|..|.+.+|.+....-..|..+..++.+.+..|.+. ...|..++.......
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 99998888888899999999999999888444447888888888888888732 233444555555555
Q ss_pred eeccCCcccccCCcccc-chhhHHHHHhhcCcccccCC--cccccccCcEEeccCCCCCCCccccccccccccccccccc
Q 001426 359 LELDNNRFFGQIPPTIG-QLKELLLFFAWQNQLHGNIP--ELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISN 435 (1079)
Q Consensus 359 L~L~~N~l~~~~p~~l~-~l~~L~~l~l~~n~l~~~~~--~l~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 435 (1079)
..+.++++...-+..|. .++++..-........+.-| .|..+++|++|+|++|+|+++-+.+|.++..+++|.|..|
T Consensus 229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N 308 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN 308 (498)
T ss_pred HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence 55556655433333332 22233222222332333333 2555666666666666666666666666666666666666
Q ss_pred cccccCCCcccCCCCceEEEecCCCccccCccccccccccCeeeeccCcc
Q 001426 436 RFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQF 485 (1079)
Q Consensus 436 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 485 (1079)
+|...-...|.++.+|+.|+|++|+|+...|.+|..+..|..|+|-.|.+
T Consensus 309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 309 KLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred hHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 66655555566666666666666666666666666666666666666554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-24 Score=215.71 Aligned_cols=171 Identities=22% Similarity=0.213 Sum_probs=130.3
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 921 (1079)
|+|.++++..+..+++..++.++.||+.||+|||+. + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999987777799999999999999999999998 5 999999999999999 99998654322
Q ss_pred ccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccC
Q 001426 922 SVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001 (1079)
Q Consensus 922 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1079)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..+.......... .. ...
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~-~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---------DR-SNL 132 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------cc-ccH
Confidence 2588999999999999999999999999999999999999975433222222222111110000 00 000
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccc
Q 001426 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 1002 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 1040 (1079)
........+.+++.+||+.+|++|||+.|+++.+.....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 011111257899999999999999999999999877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=271.07 Aligned_cols=196 Identities=16% Similarity=0.216 Sum_probs=139.8
Q ss_pred cCCC-CceeeeeeEE-------EcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 001426 813 SIRH-KNIVRLLGCC-------NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884 (1079)
Q Consensus 813 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH 884 (1079)
.++| +||++++++| ...+.++.++||+ +++|.+++......+++.++..++.||++||+|||++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 4556 6888888887 2334567888887 5699999987666699999999999999999999999 9999
Q ss_pred eCCCCCCeEECCC-------------------CcEEEeeccccccccCCcc--------------cccccccccCccccc
Q 001426 885 RDIKSNNILVGPQ-------------------FEAFLADFGLAKLFESSES--------------SRASNSVAGSYGYIA 931 (1079)
Q Consensus 885 ~Dlk~~NIll~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~a 931 (1079)
|||||+|||++.. +.+|++|||+++....... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999653 4556666666654221000 000112357889999
Q ss_pred ccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHH
Q 001426 932 PEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVL 1011 (1079)
Q Consensus 932 PE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1011 (1079)
||++.+..++.++|||||||++|||++|..|+.... ..+...... ...+.. ........
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~-----------~~~~~~-------~~~~~~~~ 242 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHR-----------VLPPQI-------LLNWPKEA 242 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHh-----------hcChhh-------hhcCHHHH
Confidence 999999999999999999999999999888764211 001110000 000000 11122345
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 001426 1012 GVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 1012 ~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.++.+||+++|.+||+|.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7788999999999999999976
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-23 Score=264.96 Aligned_cols=278 Identities=23% Similarity=0.229 Sum_probs=169.2
Q ss_pred CCccccccccccccccccccccccCCcccccccccceecccccccccCCCcCccCCCCCCeEeccCcccCCCcCcccccC
Q 001426 226 IPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNC 305 (1079)
Q Consensus 226 ~p~~l~~L~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l 305 (1079)
+|..+..+++|+.|+++++...+.+|. ++.+++|+.|+|++|.....+|..++.+++|+.|++++|..-+.+|..+ ++
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l 703 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL 703 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence 333344444555555544443334442 4445555555555554434455555555555555555543333444433 45
Q ss_pred CCccEEEcccccccCccccccccccccceeecccccccccccccccccccCcEeeccCCcccccCCccccchhhHHHHHh
Q 001426 306 SSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFA 385 (1079)
Q Consensus 306 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l 385 (1079)
++|+.|++++|......|.. ..+|++|++++|.+. .+|..+ .+++|++|++.++... .+...+..+..+
T Consensus 704 ~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~-~l~~~~~~l~~~----- 772 (1153)
T PLN03210 704 KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSE-KLWERVQPLTPL----- 772 (1153)
T ss_pred CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchh-hccccccccchh-----
Confidence 55555665555433333321 245666666666665 344333 4566666666654432 111111111110
Q ss_pred hcCcccccCCcccccccCcEEeccCCCCCCCccccccccccccccccccccccccCCCcccCCCCceEEEecCCCccccC
Q 001426 386 WQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHI 465 (1079)
Q Consensus 386 ~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 465 (1079)
.....++|+.|+|++|...+.+|..+.++++|+.|++++|...+.+|..+ .+++|++|++++|..-..+
T Consensus 773 ----------~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~ 841 (1153)
T PLN03210 773 ----------MTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTF 841 (1153)
T ss_pred ----------hhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccc
Confidence 01123578888898888777888888889999999998875444677665 6888999999887655455
Q ss_pred ccccccccccCeeeeccCcccCCCCCCCCCCCcccEEecCCC-cCcccCChhhhhhcCCCcccccccc
Q 001426 466 PSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQN-KLQGTIPSSLEFLFGLNVLDLSMNS 532 (1079)
Q Consensus 466 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~ 532 (1079)
|.. .++|+.|+|++|.++ .+|..+..+++|+.|+|++| ++. .+|..+..++.|+.|++++|.
T Consensus 842 p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 842 PDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 542 467889999999998 67888889999999999884 555 567677888888888887764
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=267.80 Aligned_cols=338 Identities=21% Similarity=0.234 Sum_probs=238.6
Q ss_pred cccccCCCccEEEccccc------ccCcccccccccc-ccceeecccccccccccccccccccCcEeeccCCcccccCCc
Q 001426 300 EALGNCSSLTVIDVSLNS------LGGEVPVSLANLV-ALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPP 372 (1079)
Q Consensus 300 ~~l~~l~~L~~L~Ls~N~------l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 372 (1079)
.+|.++.+|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|+.|+|.+|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 345555555555554432 1223344444443 3556666655554 344444 3455666666666554 3445
Q ss_pred cccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCCCCCccccccccccccccccccccccccCCCcccCCCCce
Q 001426 373 TIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLI 452 (1079)
Q Consensus 373 ~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 452 (1079)
.+..+++|+.+.+.++.....+|.+..+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|..+ ++++|+
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~ 707 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence 5555555555555555444455566777899999999987666889999999999999999875545677665 788999
Q ss_pred EEEecCCCccccCccccccccccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcC-------cccCChhhhhhcCCCc
Q 001426 453 RLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKL-------QGTIPSSLEFLFGLNV 525 (1079)
Q Consensus 453 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-------~~~~~~~~~~l~~L~~ 525 (1079)
+|++++|.....+|.. ..+|+.|++++|.++ .+|..+ .+++|+.|++.++.. ....+..+...++|+.
T Consensus 708 ~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~ 782 (1153)
T PLN03210 708 RLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782 (1153)
T ss_pred EEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchh
Confidence 9999998765555543 467899999999987 667655 578888888877432 2222333344578999
Q ss_pred ccccccccccccccccccCCCCceEecccccccCCCCCccccccccccccccCccccCCChhhhhcccchhhhhcccCCc
Q 001426 526 LDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNA 605 (1079)
Q Consensus 526 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~ 605 (1079)
|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ .+++|+.|+|++|.....+|....+++ .|+|++|.
T Consensus 783 L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~----~L~Ls~n~ 857 (1153)
T PLN03210 783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNIS----DLNLSRTG 857 (1153)
T ss_pred eeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccC----EeECCCCC
Confidence 9999998877889999999999999999875433556555 689999999999876556666554444 34899999
Q ss_pred ccccccccccCCCcccEEeccC-ccccccccccCcccccceeeccCCc
Q 001426 606 LTGPIPESFSNLSKLANLDLSN-NMLTGSLKVLGSLDNLVSLNVSYNH 652 (1079)
Q Consensus 606 l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~~~~~~l~~L~~L~ls~N~ 652 (1079)
++ .+|.++..+++|+.|++++ |+|+..+.....+++|+.++++++.
T Consensus 858 i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 858 IE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred Cc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 98 6788899999999999998 5788777778888999999998874
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-24 Score=211.38 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=186.6
Q ss_pred CCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecC
Q 001426 761 SDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYIS 840 (1079)
Q Consensus 761 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 840 (1079)
....+|.+...|..|+|+|.++.. ++|++. +........++|..|.-.++-+.||||+.++|+|.......+|..||+
T Consensus 193 nl~tkl~e~hsgelwrgrwqgndi-vakil~-vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGNDI-VAKILN-VREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhccCCCcccccccccCcch-hhhhhh-hhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344568899999999999985554 556553 333333444789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCccccc
Q 001426 841 NGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919 (1079)
Q Consensus 841 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 919 (1079)
.|+|+..+++. ....+..++.+++.++|+|++|||+... -|..--+.+..|++|++.+++|+--. +++ .-.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad-~kf------sfq 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMAD-TKF------SFQ 342 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheeccc-cee------eee
Confidence 99999999987 3446778899999999999999999742 23345688999999999988875211 111 111
Q ss_pred ccccccCcccccccccCCCCC---CccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhh
Q 001426 920 SNSVAGSYGYIAPEYGYSLKI---TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 920 ~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.....-.|.||+||.++..+- -.++|+|||++++||+.|...||.+..+-+..+.....+. ...+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl------------rv~i 410 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL------------RVHI 410 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc------------cccC
Confidence 122345689999999887654 3579999999999999999999987655333222211111 0000
Q ss_pred hcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhcc
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 1039 (1079)
++ .....+.+++.-|+..||.+||.++.|+-.|+++.
T Consensus 411 --pp----gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 --PP----GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --CC----CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11 11225566788899999999999999999999874
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=240.93 Aligned_cols=265 Identities=25% Similarity=0.321 Sum_probs=146.3
Q ss_pred cceecccccccccCCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeeccc
Q 001426 260 LENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSG 339 (1079)
Q Consensus 260 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 339 (1079)
-..|++++|.++ .+|+.+. ++|+.|++++|+++. +|. ..++|++|++++|+|+ .+|.. .++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 445666666665 4555554 356666666666663 343 1356666666666666 33432 24566666666
Q ss_pred ccccccccccccccccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCCCCCccc
Q 001426 340 NNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPS 419 (1079)
Q Consensus 340 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~~p~ 419 (1079)
|.++. +|.. ..+|+.|++++|+++. +|.. .++|+.|+|++|+|++ +|.
T Consensus 272 N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~-LP~~--------------------------p~~L~~LdLS~N~L~~-Lp~ 319 (788)
T PRK15387 272 NPLTH-LPAL---PSGLCKLWIFGNQLTS-LPVL--------------------------PPGLQELSVSDNQLAS-LPA 319 (788)
T ss_pred Cchhh-hhhc---hhhcCEEECcCCcccc-cccc--------------------------ccccceeECCCCcccc-CCC
Confidence 66653 3332 2456666666666652 2211 1356677777777664 333
Q ss_pred cccccccccccccccccccccCCCcccCCCCceEEEecCCCccccCccccccccccCeeeeccCcccCCCCCCCCCCCcc
Q 001426 420 SLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQL 499 (1079)
Q Consensus 420 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 499 (1079)
.. .+|+.|++++|+|+ .+|.. ..+|++|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|.. ..+|
T Consensus 320 lp---~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L 384 (788)
T PRK15387 320 LP---SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGL 384 (788)
T ss_pred Cc---ccccccccccCccc-ccccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---cccc
Confidence 21 34556666666665 34431 1356666666666663 3332 235566666666666 34432 2356
Q ss_pred cEEecCCCcCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEecccccccCCCCCccccccccccccccCc
Q 001426 500 EMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSN 579 (1079)
Q Consensus 500 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 579 (1079)
+.|++++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|
T Consensus 385 ~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N 455 (788)
T PRK15387 385 KELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 455 (788)
T ss_pred ceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCC
Confidence 666666666663 3322 2356666666666663 3432 234566666666666 34556666666666666666
Q ss_pred cccCCChhhhhc
Q 001426 580 RINGSIPEEIGR 591 (1079)
Q Consensus 580 ~l~~~~p~~~~~ 591 (1079)
+|++.+|..+..
T Consensus 456 ~Ls~~~~~~L~~ 467 (788)
T PRK15387 456 PLSERTLQALRE 467 (788)
T ss_pred CCCchHHHHHHH
Confidence 666655555533
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=221.60 Aligned_cols=177 Identities=21% Similarity=0.216 Sum_probs=134.8
Q ss_pred HhhCCCCCCeeeecCcEEEEEEEeC--CCCeEEEEEeccccC--CCchhHHHHHHHHHHHhcCCCCceee-eeeEEEcCC
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP--SRQVIAVKKLWPVKN--GELPERDQFSAEVQTLGSIRHKNIVR-LLGCCNNGR 830 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~ 830 (1079)
+..+|+..+.||+|+||+||+|..+ +++.+|||++..... ........|.+|++++++++|+|+++ ++++ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4567999999999999999999764 577889998742211 12223567999999999999999985 4432 4
Q ss_pred eEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC-CCCCeEECCCCcEEEeeccccc
Q 001426 831 TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDI-KSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DFGla~ 909 (1079)
..|+||||++|++|.. ....+ ...++.++++||+|+|+. +|+|||| ||+||+++.++.+||+|||+|+
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~~~-------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARPHG-------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CcEEEEEccCCCCHHH-hCccc-------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 5799999999999973 21111 145788999999999999 9999999 9999999999999999999999
Q ss_pred cccCCccccc------ccccccCcccccccccCCCC------CCccchHH
Q 001426 910 LFESSESSRA------SNSVAGSYGYIAPEYGYSLK------ITEKSDVY 947 (1079)
Q Consensus 910 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~sDvw 947 (1079)
.+........ .....+++.|+|||.+...+ .+..+|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7765432211 23566889999999866433 23446666
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=239.99 Aligned_cols=260 Identities=26% Similarity=0.341 Sum_probs=146.6
Q ss_pred CCCeEeccCcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeecccccccccccccccccccCcEeecc
Q 001426 283 NLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELD 362 (1079)
Q Consensus 283 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 362 (1079)
.-..|+|++|.++ .+|..+. ++|+.|++++|+++ .+|. .+++|++|+|++|+|+. +|.. .++|+.|+++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence 4567788888887 5666654 36777888888777 3443 23566666666666663 3322 2455666666
Q ss_pred CCcccccCCccccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCCCCCccccccccccccccccccccccccCC
Q 001426 363 NNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIP 442 (1079)
Q Consensus 363 ~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 442 (1079)
+|+++. +|.. ..+|+.|++++|+++. +|.. +++|++|+|++|+|++ +|
T Consensus 271 ~N~L~~-Lp~l--------------------------p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp 318 (788)
T PRK15387 271 SNPLTH-LPAL--------------------------PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LP 318 (788)
T ss_pred CCchhh-hhhc--------------------------hhhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CC
Confidence 665541 1111 0235555566665552 3321 2344455555554442 22
Q ss_pred CcccCCCCceEEEecCCCccccCccccccccccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhhhhcC
Q 001426 443 PEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFG 522 (1079)
Q Consensus 443 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 522 (1079)
.. ...|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|.. ..+
T Consensus 319 ~l---------------------------p~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~ 363 (788)
T PRK15387 319 AL---------------------------PSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLAS-LPTL---PSE 363 (788)
T ss_pred CC---------------------------cccccccccccCccc-ccccc---ccccceEecCCCccCC-CCCC---Ccc
Confidence 21 123445555555555 23321 1355566666666653 3322 234
Q ss_pred CCcccccccccccccccccccCCCCceEecccccccCCCCCccccccccccccccCccccCCChhhhhcccchhhhhccc
Q 001426 523 LNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLS 602 (1079)
Q Consensus 523 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~ 602 (1079)
|+.|++++|+|++ +|.. ..+|+.|++++|+|+++ |.. .++|+.|++++|+|++ +|..+.++ ..|+++
T Consensus 364 L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~L-P~l---~s~L~~LdLS~N~Lss-IP~l~~~L----~~L~Ls 430 (788)
T PRK15387 364 LYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSL-PVL---PSELKELMVSGNRLTS-LPMLPSGL----LSLSVY 430 (788)
T ss_pred cceehhhcccccc-Cccc---ccccceEEecCCcccCC-CCc---ccCCCEEEccCCcCCC-CCcchhhh----hhhhhc
Confidence 5566666666663 4432 24677777777777753 322 2467777888888773 55544333 234777
Q ss_pred CCcccccccccccCCCcccEEeccCccccccc
Q 001426 603 WNALTGPIPESFSNLSKLANLDLSNNMLTGSL 634 (1079)
Q Consensus 603 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 634 (1079)
+|+|+ .+|..|.++++|+.|+|++|+|++..
T Consensus 431 ~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~ 461 (788)
T PRK15387 431 RNQLT-RLPESLIHLSSETTVNLEGNPLSERT 461 (788)
T ss_pred cCccc-ccChHHhhccCCCeEECCCCCCCchH
Confidence 77777 56777777788888888888877643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-20 Score=208.81 Aligned_cols=262 Identities=20% Similarity=0.259 Sum_probs=191.8
Q ss_pred CCCCCCeeeecCcEEEEEEEeCCC--CeEEEEEeccccCCCchhHHHHHHHHHHHhcCCC----CceeeeeeEE-EcCCe
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPSR--QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH----KNIVRLLGCC-NNGRT 831 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~ 831 (1079)
+|.+.+.||+|+||.||.|...+. ..+|+|......... ...+..|..++..+.. .++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 789999999999999999987654 478888764322221 1267788888888863 6899999999 47788
Q ss_pred EEEEEEecCCCChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC-----CcEEEeec
Q 001426 832 RLLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ-----FEAFLADF 905 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~DF 905 (1079)
.++||+.+ |.+|.++..... ..++..++.+|+.|++.+|+++|+. |++||||||.|+++... ..+.+.||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 89999987 669999886554 6799999999999999999999999 99999999999999865 36899999
Q ss_pred cccc--cccCCcc-----ccc-ccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHH
Q 001426 906 GLAK--LFESSES-----SRA-SNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWV 977 (1079)
Q Consensus 906 Gla~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~ 977 (1079)
|+|+ .+..... ... .....||.+|+++++..+.+.+++.|+||++.++.|+..|..||........ ...+.
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHH
Confidence 9998 3322211 111 2345699999999999999999999999999999999999999965332111 11111
Q ss_pred HhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccccC
Q 001426 978 NGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 1042 (1079)
.......... ....... .+.++...+-..+..++|....+...+++.....
T Consensus 251 ~~~~~~~~~~-----------~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLTDR-----------FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcccc-----------ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1100000000 0011112 2233333344478899999999999998886553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=191.63 Aligned_cols=200 Identities=21% Similarity=0.318 Sum_probs=174.7
Q ss_pred CCCCCCeeeecCcEEEEEEE-eCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCeEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.|++.++||+|+||.++.|+ +-+++.||||.-. ...+..++..|++..+.+. .++|...|-+..++.+-.+|+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-----rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-----RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc-----ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 58889999999999999995 4589999999763 2234567888999999884 689999999999999999999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-----cEEEeeccccccc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-----EAFLADFGLAKLF 911 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~DFGla~~~ 911 (1079)
|.+ |-+|.|+..-.+..++.+++..+|.|++.-++|+|++ .+|.|||||+|+||...+ .+.++|||+|+.+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 988 6699999988888899999999999999999999999 999999999999997543 5789999999988
Q ss_pred cCCccc-----ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 001426 912 ESSESS-----RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRI 967 (1079)
Q Consensus 912 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~ 967 (1079)
.+.... +......||.+||+=....+++.+.+.|+-|+|-++++.+-|..||++..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 765432 33456779999999999999999999999999999999999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.2e-22 Score=233.41 Aligned_cols=255 Identities=20% Similarity=0.229 Sum_probs=187.7
Q ss_pred CCCCeeeecCcEEEEEEEe-CCCCeEEEEEeccc--cCCCchh-HHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 761 SDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPV--KNGELPE-RDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 761 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
...+++|.|++|.|+.+.. ...+.++.|.++.. ....... ...+..|+-+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999998887643 34444555544311 1111111 123667888888999999998888887777776679
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|||++ +|...+...+ .++..++..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+..+.-...
T Consensus 401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 9999997653 378888999999999999999999 999999999999999999999999999986654433
Q ss_pred c--ccccccccCcccccccccCCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhh
Q 001426 917 S--RASNSVAGSYGYIAPEYGYSLKITE-KSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993 (1079)
Q Consensus 917 ~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1079)
. .......|+..|+|||+..+.+|.+ ..||||.|++++.|++|+.||......+..+...... .+....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~---~~~~~~----- 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS---DQRNIF----- 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc---cccccc-----
Confidence 3 5566788999999999999999876 5899999999999999999997644333322000000 000000
Q ss_pred hhhhcccCccH--HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 994 RQLLMRSGTQI--QEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 ~~~~~~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.+...+ .-..+...++.++++++|.+|-|+++|++
T Consensus 548 -----~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 -----EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -----cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000000 11224456888999999999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=185.19 Aligned_cols=202 Identities=22% Similarity=0.291 Sum_probs=171.3
Q ss_pred hCCCCCCeeeecCcEEEEEEE-eCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCC-CceeeeeeEEEcCCeEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH-KNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv 835 (1079)
.+|..+++||.|+||.+|.|. ..+|+.||+|.-... ....+...|..+.+.+++ ..|..+..+..+..+-.+|
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 678999999999999999994 578999999976321 223567889999999975 6788888888899999999
Q ss_pred EEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC---CCcEEEeecccccccc
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP---QFEAFLADFGLAKLFE 912 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGla~~~~ 912 (1079)
||.+ |-+|.+...-....++..++...+-|++.-++|+|.+ +++||||||+|+|+.- ...+.++|||+|+.+.
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9988 6699999876667799999999999999999999999 9999999999999964 3468899999999876
Q ss_pred CCccc-----ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 001426 913 SSESS-----RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIP 968 (1079)
Q Consensus 913 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~ 968 (1079)
+.... +......||.+|.+=....+...+.+.|+-|+|.++.++--|..||++..+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 54322 333456799999999888888889999999999999999999999997643
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=223.14 Aligned_cols=247 Identities=24% Similarity=0.409 Sum_probs=124.8
Q ss_pred CCCCEEeccCCcccCCCCcccCCcCcccEEeccCCcccccCccccccccccceEecccccccCCCChhhchhhhHHHHHh
Q 001426 113 SSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRA 192 (1079)
Q Consensus 113 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l 192 (1079)
.+.+.|+++++.++ .+|..+. ++|+.|+|++|+++ .+|..+. .+|++|++++|+++ .+|..+.
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---------- 240 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP---------- 240 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh----------
Confidence 34556666666666 4555443 35666666666666 4555443 35666666666665 3343221
Q ss_pred CCCCCcccCCCcccccccceeEeecccCCCccCCCccccccccccccccccccccccCCcccccccccceeccccccccc
Q 001426 193 GGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFG 272 (1079)
Q Consensus 193 ~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~ 272 (1079)
..|+.|++++|.+. .+|..+. ++|+.|++++|++. .+|..+. ++|+.|++++|+++
T Consensus 241 -----------------~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt- 296 (754)
T PRK15370 241 -----------------DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR- 296 (754)
T ss_pred -----------------ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-
Confidence 12333444444444 3343332 34555555555554 2444332 35666666666665
Q ss_pred CCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeecccccccccccccccc
Q 001426 273 KIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGN 352 (1079)
Q Consensus 273 ~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 352 (1079)
.+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+.
T Consensus 297 ~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp- 366 (754)
T PRK15370 297 TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP- 366 (754)
T ss_pred cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc-
Confidence 2443332 356666666666663 343332 456666666666663 444332 46666666666666 3444332
Q ss_pred cccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCccc----ccccCcEEeccCCCCC
Q 001426 353 FSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELA----YCVKLQALDLSHNFLT 414 (1079)
Q Consensus 353 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~----~~~~L~~L~Ls~N~l~ 414 (1079)
++|+.|+|++|+++ .+|+.+. ..|+.+++.+|++...+..+. .++.+..|++.+|.++
T Consensus 367 -~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 -PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred -CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 46777777777766 3444332 133344444444332222111 1244555555555554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-19 Score=204.08 Aligned_cols=261 Identities=27% Similarity=0.356 Sum_probs=198.9
Q ss_pred CCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCC-ceeeeeeEEEcCCeEEEEEEe
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHK-NIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 838 (1079)
|...+.+|.|+||.||++... ..+++|.+.............+.+|+.+++.+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566778999999999999877 77899988654443333568899999999999988 799999999877778999999
Q ss_pred cCCCChhhhhhccC--cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC-cEEEeeccccccccCCc
Q 001426 839 ISNGSLAGLLHEKK--VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-EAFLADFGLAKLFESSE 915 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~ 915 (1079)
+.++++.+++.... ..++......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776654 2588999999999999999999999 899999999999999998 79999999998655443
Q ss_pred ccc----cccccccCcccccccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCC--cchHHHHHHhHHhhhhh
Q 001426 916 SSR----ASNSVAGSYGYIAPEYGYS---LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPD--GAHIITWVNGELRERKR 986 (1079)
Q Consensus 916 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 986 (1079)
... ......|+..|+|||...+ ..+....|+||+|++++++++|..||...... .......+... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL----PT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc----CC
Confidence 221 3456789999999999887 57889999999999999999999997654321 11111111100 00
Q ss_pred chhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
. ....... ..........+.+++..|+..+|..|.++.+....
T Consensus 233 ~---~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P---SLASPLS--PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c---ccccccC--ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 0000000 00001112356688889999999999999887764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=225.89 Aligned_cols=221 Identities=27% Similarity=0.451 Sum_probs=120.4
Q ss_pred ceecccccccccCCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeecccc
Q 001426 261 ENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGN 340 (1079)
Q Consensus 261 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 340 (1079)
..|+++++.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+++ .+|..+. .+|+.|+|++|
T Consensus 181 ~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N 251 (754)
T PRK15370 181 TELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSIN 251 (754)
T ss_pred eEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCC
Confidence 44455555554 3443332 34555555555555 3333332 35566666666655 3343332 24666666666
Q ss_pred cccccccccccccccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCCCCCcccc
Q 001426 341 NISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSS 420 (1079)
Q Consensus 341 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~~p~~ 420 (1079)
.+. .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+|++ +|..
T Consensus 252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~-------------------------~sL~~L~Ls~N~Lt~-LP~~ 301 (754)
T PRK15370 252 RIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP-------------------------EELRYLSVYDNSIRT-LPAH 301 (754)
T ss_pred ccC-cCChhHh--CCCCEEECcCCccC-ccccccC-------------------------CCCcEEECCCCcccc-Cccc
Confidence 665 3444332 35667777777665 2343221 256777777777763 4443
Q ss_pred ccccccccccccccccccccCCCcccCCCCceEEEecCCCccccCccccccccccCeeeeccCcccCCCCCCCCCCCccc
Q 001426 421 LFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLE 500 (1079)
Q Consensus 421 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 500 (1079)
+. ++|+.|++++|+++ .+|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. ++|+
T Consensus 302 lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~ 370 (754)
T PRK15370 302 LP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTIT 370 (754)
T ss_pred ch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcC
Confidence 32 35677777777776 3444332 466777777777664 444332 46777777777766 4454442 4666
Q ss_pred EEecCCCcCcccCChhhhhhcCCCcccccccccc
Q 001426 501 MVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIG 534 (1079)
Q Consensus 501 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 534 (1079)
.|+|++|+|+ .+|..+. ..|+.|++++|+|+
T Consensus 371 ~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~ 401 (754)
T PRK15370 371 TLDVSRNALT-NLPENLP--AALQIMQASRNNLV 401 (754)
T ss_pred EEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc
Confidence 6777766666 3344333 24556666666665
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.6e-20 Score=188.04 Aligned_cols=174 Identities=11% Similarity=0.122 Sum_probs=135.3
Q ss_pred HhhCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHH------HHHHHHHHhcCCCCceeeeeeEEEcC
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQ------FSAEVQTLGSIRHKNIVRLLGCCNNG 829 (1079)
Q Consensus 756 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 829 (1079)
+..+|+..+++|.|+||.||.++. ++..+|+|.+.+........... +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 346899999999999999999876 46689999997654443333233 68999999999999999999886533
Q ss_pred --------CeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEE
Q 001426 830 --------RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF 901 (1079)
Q Consensus 830 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 901 (1079)
...++||||++|.+|.++.. .+. ....+++.++..+|+. +++|||++|+||++++++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988742 232 2456899999999999 999999999999999998 99
Q ss_pred EeeccccccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHH
Q 001426 902 LADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVL 957 (1079)
Q Consensus 902 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~ 957 (1079)
++|||........... ..+.....+..++|+|+||+.+....
T Consensus 175 liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988754322111 01333445667999999999988664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=182.89 Aligned_cols=142 Identities=15% Similarity=0.135 Sum_probs=109.8
Q ss_pred CCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchh-----------------------HHHHHHHHHHHhcCCCCce
Q 001426 763 TNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPE-----------------------RDQFSAEVQTLGSIRHKNI 819 (1079)
Q Consensus 763 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~ni 819 (1079)
...||+|+||.||+|...+|+.||||++++........ ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999988889999999987542211110 1223459999999988877
Q ss_pred eeeeeEEEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEeCCCCCCeEECCCC
Q 001426 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL-HHDCVPPIIHRDIKSNNILVGPQF 898 (1079)
Q Consensus 820 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~L-H~~~~~~ivH~Dlk~~NIll~~~~ 898 (1079)
.....+... ..++||||++++++.....+. ..++...+..++.|++.+++|+ |+. +|+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence 544333222 238999999998776554333 3588999999999999999999 677 999999999999998 47
Q ss_pred cEEEeeccccccc
Q 001426 899 EAFLADFGLAKLF 911 (1079)
Q Consensus 899 ~~kl~DFGla~~~ 911 (1079)
.++++|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=200.38 Aligned_cols=218 Identities=28% Similarity=0.486 Sum_probs=166.6
Q ss_pred HhcCCCCceeeeeeEEEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EEeCCCC
Q 001426 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI-IHRDIKS 889 (1079)
Q Consensus 811 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~i-vH~Dlk~ 889 (1079)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......+++.....++++|+.||+|+|+. .| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 4678999999999999999999999999999999999998888899999999999999999999998 44 8999999
Q ss_pred CCeEECCCCcEEEeeccccccccCCcccccccccccCcccccccccCCC-------CCCccchHHHHHHHHHHHHhCCCC
Q 001426 890 NNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL-------KITEKSDVYSYGVVLLEVLTGKEP 962 (1079)
Q Consensus 890 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvil~el~tg~~p 962 (1079)
+|.+++..+.+|++|||+....................-|.|||.+... ..+.++||||||++++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876431111111222344579999987653 146789999999999999999999
Q ss_pred CCCCCCCcc--hHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhccc
Q 001426 963 TDSRIPDGA--HIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 963 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 1040 (1079)
|........ .+...+.. .... .+.|.+.... +....+..++..||..+|++||++++|-..++.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~---~~~~----~~rP~i~~~~----e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK---GGSN----PFRPSIELLN----ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh---cCCC----CcCcchhhhh----hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 987433222 22222211 0111 1111111000 122267889999999999999999999999998876
Q ss_pred cC
Q 001426 1041 EN 1042 (1079)
Q Consensus 1041 ~~ 1042 (1079)
..
T Consensus 227 ~~ 228 (484)
T KOG1023|consen 227 GG 228 (484)
T ss_pred cc
Confidence 43
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=173.07 Aligned_cols=190 Identities=14% Similarity=0.024 Sum_probs=139.2
Q ss_pred CCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCc-hhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCeEEEEEEe
Q 001426 761 SDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGEL-PERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 761 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
.+...|++|+||+||.+.. .+.+++.+.+........ .....+.+|+++|+++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998766 566666665532211111 11236899999999995 5889999886 346999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC-CCCCeEECCCCcEEEeeccccccccCCccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDI-KSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DFGla~~~~~~~~~ 917 (1079)
+.|.+|.+.... . ...++.|++++++++|+. ||+|||| ||.||++++++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998754321 1 134778999999999999 9999999 799999999999999999999865433210
Q ss_pred ----c--c-----ccccccCcccccccccC--CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 001426 918 ----R--A-----SNSVAGSYGYIAPEYGY--SLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966 (1079)
Q Consensus 918 ----~--~-----~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~el~tg~~p~~~~ 966 (1079)
. . ......++.|++|+... ..+--.+.+.++-|..+|.++|+..+....
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 11223677888887532 222236788999999999999999987653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=176.33 Aligned_cols=144 Identities=15% Similarity=0.140 Sum_probs=112.4
Q ss_pred CCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCch-----------------------hHHHHHHHHHHHhcCCCCce
Q 001426 763 TNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELP-----------------------ERDQFSAEVQTLGSIRHKNI 819 (1079)
Q Consensus 763 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~ni 819 (1079)
...||+|+||.||+|...+|+.||||++.+....... ....+..|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999998878999999998754221000 01234689999999999987
Q ss_pred eeeeeEEEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCeEECCCC
Q 001426 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHH-DCVPPIIHRDIKSNNILVGPQF 898 (1079)
Q Consensus 820 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~ 898 (1079)
.....+... ..++||||++++++....... ..++......++.|++.++.++|+ . ||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CC
Confidence 655444333 248999999988654432222 346788889999999999999999 8 999999999999999 78
Q ss_pred cEEEeeccccccccC
Q 001426 899 EAFLADFGLAKLFES 913 (1079)
Q Consensus 899 ~~kl~DFGla~~~~~ 913 (1079)
.++|+|||+|+....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-19 Score=211.84 Aligned_cols=251 Identities=20% Similarity=0.222 Sum_probs=178.5
Q ss_pred CCCCCCeeeecCcEEEEEEEeCCCCeEEEEEecccc-CCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVK-NGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++...+.+|++.|=+|.+|+.+.|. |+||++.+.. .-......+-.+|++ ...++|||.+++.-+-...+.-|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4666788999999999999998888 7888885433 222333333344444 555699999999888777777889999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc--ccCCc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL--FESSE 915 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~--~~~~~ 915 (1079)
|..+ +|+|.+..+ ..+...+.+.|+.|++.|+.-+|.. ||+|||||.+|||++.=.-+.++||..-+. ++.+
T Consensus 102 yvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD- 175 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED- 175 (1431)
T ss_pred HHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC-
Confidence 9866 999988654 3466777788999999999999999 999999999999999988999999976542 2222
Q ss_pred ccccccccc----cCcccccccccCC----------CC-CCccchHHHHHHHHHHHHh-CCCCCCCCCCCcchHHHHHHh
Q 001426 916 SSRASNSVA----GSYGYIAPEYGYS----------LK-ITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNG 979 (1079)
Q Consensus 916 ~~~~~~~~~----gt~~y~aPE~~~~----------~~-~~~~sDvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 979 (1079)
......... .-..|.|||.+.. .. .+++-||||.||++.|+++ |++||.- .++..+..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLLAYRSG 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHHhHhcc
Confidence 122222222 2247999997543 12 5778999999999999999 7888853 233333332
Q ss_pred HHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 980 ELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
........+.++-|. .+..++..|++.||++|.++++.++.-.
T Consensus 251 ~~~~~e~~Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred CccCHHHHHHhCcCc--------------cHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 211100111111111 3446778899999999999999998743
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-20 Score=174.53 Aligned_cols=164 Identities=33% Similarity=0.567 Sum_probs=114.0
Q ss_pred cccCCcccEEEcCCCcccccCCccccccCCCCEEeccCCcccCCCCcccCCcCcccEEeccCCcccccCccccccccccc
Q 001426 85 LLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLR 164 (1079)
Q Consensus 85 ~~~l~~l~~L~L~~~~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 164 (1079)
+....++|.|.||+|.++ .+|+.|.+|.+|+.|++++|+++ .+|.++++|++|+.|+++-|++. .+|..||.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 344567888888888888 78888888888888888888887 77888888888888888888887 7788888888888
Q ss_pred eEecccccccC-CCChhhchhhhHHHHHhCCCCCcccCCCcccccccceeEeecccCCCccCCCcccccccccccccccc
Q 001426 165 RLELYDNQLSG-NIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYT 243 (1079)
Q Consensus 165 ~L~Ls~n~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~ 243 (1079)
+|||..|+++. .+|..|--++.|+-|+++.|. +. .+|..+++|++|+.|.+..
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dnd-------------------------fe-~lp~dvg~lt~lqil~lrd 159 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDND-------------------------FE-ILPPDVGKLTNLQILSLRD 159 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCC-------------------------cc-cCChhhhhhcceeEEeecc
Confidence 88888877763 456666666666666665553 33 4555566666666666655
Q ss_pred ccccccCCcccccccccceecccccccccCCCcCcc
Q 001426 244 ANITGYIPEEIGNCSALENLFLYENQIFGKIPDELG 279 (1079)
Q Consensus 244 ~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 279 (1079)
|.+. .+|.+++.++.|++|++.+|+++ .+|..++
T Consensus 160 ndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~ 193 (264)
T KOG0617|consen 160 NDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELA 193 (264)
T ss_pred Cchh-hCcHHHHHHHHHHHHhcccceee-ecChhhh
Confidence 5554 45555666666666666666665 4444443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-19 Score=168.31 Aligned_cols=147 Identities=32% Similarity=0.580 Sum_probs=125.6
Q ss_pred CccccccCCcccEEEcCCCcccccCCccccccCCCCEEeccCCcccCCCCcccCCcCcccEEeccCCcccc-cCcccccc
Q 001426 81 FPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHG-GIPREIGN 159 (1079)
Q Consensus 81 ~~~~~~~l~~l~~L~L~~~~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~ 159 (1079)
.|..+..+.++++|++++|+++ .+|.+++.++.|+.|+++.|++. .+|..||.++.|++|||..|.+.. .+|+.|.-
T Consensus 48 vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~ 125 (264)
T KOG0617|consen 48 VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFY 125 (264)
T ss_pred cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhH
Confidence 4567788899999999999999 89999999999999999999998 899999999999999999999864 78999999
Q ss_pred ccccceEecccccccCCCChhhchhhhHHHHHhCCCCCcccCCCcccccccceeEeecccCCCccCCCcccccccccccc
Q 001426 160 CSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTL 239 (1079)
Q Consensus 160 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L 239 (1079)
++.|+-|+|++|.+. .+|..+++|++|+. |.+.+|.+- .+|..++.|+.|++|
T Consensus 126 m~tlralyl~dndfe-~lp~dvg~lt~lqi-------------------------l~lrdndll-~lpkeig~lt~lrel 178 (264)
T KOG0617|consen 126 MTTLRALYLGDNDFE-ILPPDVGKLTNLQI-------------------------LSLRDNDLL-SLPKEIGDLTRLREL 178 (264)
T ss_pred HHHHHHHHhcCCCcc-cCChhhhhhcceeE-------------------------EeeccCchh-hCcHHHHHHHHHHHH
Confidence 999999999999998 77777777665555 455555555 688888888999999
Q ss_pred ccccccccccCCcccccc
Q 001426 240 SVYTANITGYIPEEIGNC 257 (1079)
Q Consensus 240 ~l~~~~~~~~~p~~l~~l 257 (1079)
.+.+|.++ .+|.+++++
T Consensus 179 hiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 179 HIQGNRLT-VLPPELANL 195 (264)
T ss_pred hcccceee-ecChhhhhh
Confidence 99888887 556556654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4e-18 Score=178.84 Aligned_cols=197 Identities=20% Similarity=0.278 Sum_probs=135.6
Q ss_pred CCCceeeeeeEEEc---------------------------CCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHH
Q 001426 815 RHKNIVRLLGCCNN---------------------------GRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGV 867 (1079)
Q Consensus 815 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i 867 (1079)
+|||||++.++|.+ +...|+||.-++. +|.+|+..+. .+......++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999998744 3356899998866 9999996554 3444556689999
Q ss_pred HHHHHHHHhCCCCCeEEeCCCCCCeEE--CCCC--cEEEeeccccccccCC----cccccccccccCcccccccccCCCC
Q 001426 868 AHGLAYLHHDCVPPIIHRDIKSNNILV--GPQF--EAFLADFGLAKLFESS----ESSRASNSVAGSYGYIAPEYGYSLK 939 (1079)
Q Consensus 868 ~~gL~~LH~~~~~~ivH~Dlk~~NIll--~~~~--~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~ 939 (1079)
++|+.|||.+ ||.|||+|++|||+ |+|+ ...|+|||.+---... ++.......-|.-.-||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 99999999999998 4443 5689999986421111 1111122334677899999866443
Q ss_pred ------CCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHH
Q 001426 940 ------ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGV 1013 (1079)
Q Consensus 940 ------~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 1013 (1079)
-..|+|.|+.|.+.||+++...||+....-.-+...+...+.+ ...+ .....+.++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP----alp~--------------~vpp~~rql 489 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP----ALPS--------------RVPPVARQL 489 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC----CCcc--------------cCChHHHHH
Confidence 2458999999999999999999998743322222221111111 1111 112244567
Q ss_pred HHhccCCCCCCCCCHHHHHHHH
Q 001426 1014 ALLCVNPCPEERPTMKDVTAML 1035 (1079)
Q Consensus 1014 ~~~Cl~~dP~~RPt~~evl~~L 1035 (1079)
+..-++.||.+|++..-....+
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 7778999999999866555544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.7e-19 Score=196.22 Aligned_cols=187 Identities=26% Similarity=0.308 Sum_probs=158.4
Q ss_pred eeecCcEEEEEEE----eCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCeEEEEEEecC
Q 001426 766 VGKGVSGIVYRVE----IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRTRLLLFDYIS 840 (1079)
Q Consensus 766 lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 840 (1079)
+|+|+||.|+.++ .+.+..+|+|..++......... ....|..++..++ ||.+|++..+++.+...+++++|..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 6899999999863 34577788888765443332222 5667888899897 9999999999999999999999999
Q ss_pred CCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccc
Q 001426 841 NGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920 (1079)
Q Consensus 841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 920 (1079)
+|++...+.+... ++......+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 9999999876654 66667777888899999999999 9999999999999999999999999999876543321
Q ss_pred cccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 001426 921 NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDS 965 (1079)
Q Consensus 921 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~ 965 (1079)
+||..|||||+.. .+..++|.||||++++||++|..||..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999987 678899999999999999999999975
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-19 Score=204.95 Aligned_cols=280 Identities=25% Similarity=0.265 Sum_probs=136.4
Q ss_pred eecccccccc-cCCCcCccCCCCCCeEeccCcccCCC----cCcccccCCCccEEEcccccccC------cccccccccc
Q 001426 262 NLFLYENQIF-GKIPDELGSLKNLKRLLLWQNNLSGS----IPEALGNCSSLTVIDVSLNSLGG------EVPVSLANLV 330 (1079)
Q Consensus 262 ~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~ 330 (1079)
.|+|..+.++ +.....+..+.+|++|++++|.++.. ++..+...++|+.|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4566666665 23344455666777777777776432 34445556667777777766652 1222344455
Q ss_pred ccceeeccccccccccccccccccc---CcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCccccc-ccCcEE
Q 001426 331 ALEELLLSGNNISGEIPSFFGNFSR---LKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYC-VKLQAL 406 (1079)
Q Consensus 331 ~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~-~~L~~L 406 (1079)
+|++|++++|.+.+..+..+..+.+ |++|++++|++++.....+. ..+..+ ++|++|
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~-------------------~~l~~~~~~L~~L 142 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA-------------------KGLKDLPPALEKL 142 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH-------------------HHHHhCCCCceEE
Confidence 5666666665555444444433333 55555555555421000000 001111 345555
Q ss_pred eccCCCCCCCccccccccccccccccccccccccCCCcccCCCCceEEEecCCCcccc----CccccccccccCeeeecc
Q 001426 407 DLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGH----IPSRIGLLHRLTFLELSE 482 (1079)
Q Consensus 407 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~ 482 (1079)
++++|.+++.... .++..+..+..|++|++++|.+++. ++..+..+++|+.|++++
T Consensus 143 ~L~~n~l~~~~~~--------------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~ 202 (319)
T cd00116 143 VLGRNRLEGASCE--------------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202 (319)
T ss_pred EcCCCcCCchHHH--------------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccC
Confidence 5555555421111 1122233344455555555555421 122233334566666666
Q ss_pred CcccCC----CCCCCCCCCcccEEecCCCcCcccCChhhhh-----hcCCCccccccccccc----ccccccccCCCCce
Q 001426 483 NQFTGE----IPPEIGNCTQLEMVDLHQNKLQGTIPSSLEF-----LFGLNVLDLSMNSIGG----TIPENLGKLTSLNK 549 (1079)
Q Consensus 483 N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~ 549 (1079)
|.+++. ++..+..+++|+.|++++|.+++.....+.. ...|+.|++++|.++. .+...+..+++|++
T Consensus 203 n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~ 282 (319)
T cd00116 203 NGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE 282 (319)
T ss_pred CccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccE
Confidence 655422 2223445566666666666665432222221 1456666666666541 12233444566666
Q ss_pred EecccccccCC----CCCccccc-cccccccccCcc
Q 001426 550 LVLSKNNITGL----IPKSLGLC-KDLQLLDLSSNR 580 (1079)
Q Consensus 550 L~L~~N~l~~~----~~~~~~~l-~~L~~L~Ls~N~ 580 (1079)
+++++|.++.. ....+... +.|++||+.+|+
T Consensus 283 l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 283 LDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred EECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 66666666643 22223333 456666666664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-17 Score=174.21 Aligned_cols=233 Identities=22% Similarity=0.276 Sum_probs=150.6
Q ss_pred CCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCC----------CceeeeeeEEEc
Q 001426 760 LSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH----------KNIVRLLGCCNN 828 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~~ 828 (1079)
+...+.||.|+++.||.++.. +++.+|+|.+.-.......+.+.+++|.-....+.+ -.++..++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999775 589999999876665555667888888866665432 233333333211
Q ss_pred ---------C---C-----eEEEEEEecCCCChhhhhhc---cCc---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 001426 829 ---------G---R-----TRLLLFDYISNGSLAGLLHE---KKV---FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885 (1079)
Q Consensus 829 ---------~---~-----~~~lv~e~~~~g~L~~~l~~---~~~---~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~ 885 (1079)
. . ..+++|+-+ .++|.+.+.. ... ......+..+..|+++.+++||+. |+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1 1 126778877 4588877642 211 233445567778999999999999 99999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccccCCcccccccccccCcccccccccCC--------CCCCccchHHHHHHHHHHHH
Q 001426 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS--------LKITEKSDVYSYGVVLLEVL 957 (1079)
Q Consensus 886 Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvil~el~ 957 (1079)
||+|+|++++++|.++++||+.....+.... ....+..|.+||.... ..++.+.|.|++|+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999998775443211 1234578999996533 35788999999999999999
Q ss_pred hCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCC
Q 001426 958 TGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEER 1025 (1079)
Q Consensus 958 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 1025 (1079)
+|..||+...+...... .+.. .. +....+..++..+++++|++|
T Consensus 245 C~~lPf~~~~~~~~~~~------------~f~~-----------C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW------------DFSR-----------CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG------------GGTT-----------SS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc------------cchh-----------cC-CcCHHHHHHHHHHccCCcccC
Confidence 99999986533211100 1110 01 222356678999999999988
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-19 Score=202.42 Aligned_cols=191 Identities=26% Similarity=0.295 Sum_probs=95.7
Q ss_pred cccccccceecccccccccC----CCcCccCCCCCCeEeccCcccCC------CcCcccccCCCccEEEcccccccCccc
Q 001426 254 IGNCSALENLFLYENQIFGK----IPDELGSLKNLKRLLLWQNNLSG------SIPEALGNCSSLTVIDVSLNSLGGEVP 323 (1079)
Q Consensus 254 l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~------~~~~~l~~l~~L~~L~Ls~N~l~~~~p 323 (1079)
+..+.+|+.|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..+++|+.|++++|.+.+..+
T Consensus 19 ~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~ 98 (319)
T cd00116 19 LPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGC 98 (319)
T ss_pred HHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHH
Confidence 33444455555555444221 23333444455555555555441 123345556666666666666655445
Q ss_pred cccccccc---cceeecccccccc----ccccccccc-ccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCC
Q 001426 324 VSLANLVA---LEELLLSGNNISG----EIPSFFGNF-SRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP 395 (1079)
Q Consensus 324 ~~l~~l~~---L~~L~Ls~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~ 395 (1079)
..+..+.+ |++|++++|.+++ .+...+..+ ++|+.|++++|.+++.....+. .
T Consensus 99 ~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~-------------------~ 159 (319)
T cd00116 99 GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA-------------------K 159 (319)
T ss_pred HHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH-------------------H
Confidence 44544444 7777777776652 222334455 6777777777777632111110 0
Q ss_pred cccccccCcEEeccCCCCCCC----cccccccccccccccccccccccc----CCCcccCCCCceEEEecCCCccc
Q 001426 396 ELAYCVKLQALDLSHNFLTGS----VPSSLFNLKNLTQLLLISNRFSGE----IPPEIGGCTGLIRLRLGSNNFSG 463 (1079)
Q Consensus 396 ~l~~~~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 463 (1079)
.+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 122344677777777776632 122233344566666666655422 12233344555555555555543
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.5e-17 Score=198.35 Aligned_cols=195 Identities=20% Similarity=0.210 Sum_probs=159.8
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC---CCceeeeeeEEEcCCeEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR---HKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 834 (1079)
+.|.+.+.||+|+||+||+|...+|+.||+|+-.+...++ |..=.+++.+|+ -+-|..+..++...+.-++
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 4577888999999999999988889999999876544433 222334445554 2455666666777788899
Q ss_pred EEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-------CCcEEEeeccc
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-------QFEAFLADFGL 907 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~kl~DFGl 907 (1079)
|+||.+.|+|.+++... ..++|.-+..++.|+++.+++||.. +||||||||+|+++.. ...++|+|||.
T Consensus 772 v~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 99999999999999844 4489999999999999999999999 9999999999999942 34689999999
Q ss_pred cccccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p 962 (1079)
+..+..-.........++|-.+-.+|+..+++++.++|.|.++-+++-|+.|+..
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9766544334455667889999999999999999999999999999999999764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.3e-17 Score=166.12 Aligned_cols=137 Identities=17% Similarity=0.208 Sum_probs=105.8
Q ss_pred CCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-----CCCceeeeeeEEEcCC---e
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-----RHKNIVRLLGCCNNGR---T 831 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~ 831 (1079)
++..+.||+|+||.||. .-.++.. +||++.... ....+.+.+|+.+++.+ .||||++++|++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 45678899999999996 3334444 688875422 22456799999999999 5799999999998864 3
Q ss_pred -EEEEEEe--cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEeCCCCCCeEECC----CCcEEEe
Q 001426 832 -RLLLFDY--ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGL-AYLHHDCVPPIIHRDIKSNNILVGP----QFEAFLA 903 (1079)
Q Consensus 832 -~~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~ 903 (1079)
..+|+|| +.+|+|.+++.+.. +++. ..++.+++.++ +|||++ +||||||||+||+++. ++.++|+
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 3378999 55899999996532 5555 35677888777 999999 9999999999999974 3479999
Q ss_pred ecccc
Q 001426 904 DFGLA 908 (1079)
Q Consensus 904 DFGla 908 (1079)
||+-+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.4e-16 Score=165.15 Aligned_cols=144 Identities=15% Similarity=0.156 Sum_probs=111.5
Q ss_pred CCCCCeeeecCcEEEEEEE--eCCCCeEEEEEeccccCCCc-----------------h----hHHHHHHHHHHHhcCCC
Q 001426 760 LSDTNIVGKGVSGIVYRVE--IPSRQVIAVKKLWPVKNGEL-----------------P----ERDQFSAEVQTLGSIRH 816 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~~~-----------------~----~~~~~~~E~~~l~~l~h 816 (1079)
|++.+.||+|+||.||+|. ..+|+.||+|++........ . ....+..|+..++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6778899999999999998 56899999999864321000 0 11346789999999975
Q ss_pred Cc--eeeeeeEEEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEeCCCCCCeE
Q 001426 817 KN--IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP-IIHRDIKSNNIL 893 (1079)
Q Consensus 817 ~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~-ivH~Dlk~~NIl 893 (1079)
.. +.+++++ ...++||||++++++..+..... ..+......++.|++.+++++|+. + |+||||||+||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl 181 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL 181 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence 33 3444443 23589999999988877653332 355666788999999999999999 8 999999999999
Q ss_pred ECCCCcEEEeecccccccc
Q 001426 894 VGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 894 l~~~~~~kl~DFGla~~~~ 912 (1079)
++ ++.++++|||.+....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999987543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=183.46 Aligned_cols=140 Identities=21% Similarity=0.324 Sum_probs=113.1
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCC----CchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNG----ELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
..|...+.||+|+||+||+|.+.+...++.+++.+.... .....+.+.+|+++++.++|++++..+.++.+....+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 345667899999999999998876554333333211111 1112357889999999999999998888888777889
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
+||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ +++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999885 3467899999999999999 99999999999999 677999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=160.50 Aligned_cols=137 Identities=18% Similarity=0.311 Sum_probs=113.8
Q ss_pred CeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCc-----hhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEe
Q 001426 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGEL-----PERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
+.||+|++|.||+|.. .+..+++|+......... .....+.+|++++..++|+++.....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 566788887643221111 1225688899999999999998888887777888999999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
++|++|.+++.... + .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 7788999999999999999 999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-15 Score=158.19 Aligned_cols=133 Identities=21% Similarity=0.365 Sum_probs=107.6
Q ss_pred eeeecCcEEEEEEEeCCCCeEEEEEeccccCCC-----chhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEec
Q 001426 765 IVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGE-----LPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 765 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
.||+|+||.||+|.+ ++..+++|......... ......+.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 46778888764322111 112366788999999999987766666666666779999999
Q ss_pred CCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 840 SNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
+|++|.+++..... .++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.++.
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998754321 7899999999999999 999999999999999 78999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=157.88 Aligned_cols=140 Identities=17% Similarity=0.171 Sum_probs=109.6
Q ss_pred CCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCc-------------------hhHHHHHHHHHHHhcCCCCc--
Q 001426 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGEL-------------------PERDQFSAEVQTLGSIRHKN-- 818 (1079)
Q Consensus 760 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~n-- 818 (1079)
|...+.||+|+||.||++..++|+.||||++........ .....+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 667789999999999999888899999998754221100 01124678899999998774
Q ss_pred eeeeeeEEEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC
Q 001426 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF 898 (1079)
Q Consensus 819 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~ 898 (1079)
+.+.++. ...++||||+++++|...... .....++.+++.++.++|+. +|+||||+|+||++++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCC
Confidence 4444442 345899999999998776431 23457889999999999998 999999999999999999
Q ss_pred cEEEeeccccccccC
Q 001426 899 EAFLADFGLAKLFES 913 (1079)
Q Consensus 899 ~~kl~DFGla~~~~~ 913 (1079)
.++|+|||.+.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.3e-16 Score=171.84 Aligned_cols=123 Identities=24% Similarity=0.384 Sum_probs=107.8
Q ss_pred CeEEEEEEecCCCChhhhhhcc--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccc
Q 001426 830 RTRLLLFDYISNGSLAGLLHEK--KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl 907 (1079)
...||.|++|...+|.+|+... +...++.....++.|++.|++| + +.+|||+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999643 4457888889999999999999 5 899999999999999999999999999
Q ss_pred cccccCCc----ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHh
Q 001426 908 AKLFESSE----SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT 958 (1079)
Q Consensus 908 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~t 958 (1079)
........ .....+...||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 88665543 2334556789999999999999999999999999999999987
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.5e-15 Score=180.59 Aligned_cols=153 Identities=33% Similarity=0.516 Sum_probs=125.5
Q ss_pred cccChhhHHHHHHHhhCCCCCCCccccCCCCCCCCCC-----ccceeeecCCceeEEecccCCCCccccccCCcccEEEc
Q 001426 22 SALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPC-----NWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVL 96 (1079)
Q Consensus 22 ~~~~~~~~~ll~~~~~~~~~~~~~~l~sW~~~~~~~c-----~W~gv~C~~~~~~~~~~~l~~~~~~~~~~l~~l~~L~L 96 (1079)
.+...|.+||+++|+++... . ..+|+. |+| .|.||.|+..... ....++.|+|
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~--~--~~~W~g---~~C~p~~~~w~Gv~C~~~~~~---------------~~~~v~~L~L 425 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLP--L--RFGWNG---DPCVPQQHPWSGADCQFDSTK---------------GKWFIDGLGL 425 (623)
T ss_pred ccCchHHHHHHHHHHhcCCc--c--cCCCCC---CCCCCcccccccceeeccCCC---------------CceEEEEEEC
Confidence 34556888999999998532 1 248964 344 7999999632110 0024788999
Q ss_pred CCCcccccCCccccccCCCCEEeccCCcccCCCCcccCCcCcccEEeccCCcccccCccccccccccceEecccccccCC
Q 001426 97 SNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGN 176 (1079)
Q Consensus 97 ~~~~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 176 (1079)
++|+++|.+|+.++.|++|+.|+|++|.+.|.+|..++.+++|++|+|++|+++|.+|..++++++|++|+|++|+++|.
T Consensus 426 ~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~ 505 (623)
T PLN03150 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505 (623)
T ss_pred CCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CChhhchh-hhHHHHHhCCCC
Q 001426 177 IPAEIGQL-EALEIIRAGGNP 196 (1079)
Q Consensus 177 ~p~~~~~l-~~L~~L~l~~n~ 196 (1079)
+|..++.+ .++..+++.+|.
T Consensus 506 iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 506 VPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CChHHhhccccCceEEecCCc
Confidence 99988753 234445555554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.7e-15 Score=175.38 Aligned_cols=167 Identities=29% Similarity=0.378 Sum_probs=121.2
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
.+|...+.|-.|+||.||.++.+ ..+.+|+|+- +. ..+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq--------~lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQ--------NLILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-cc--------chhhhc--cccccCCccee----------------
Confidence 45788889999999999999776 4677888432 10 111110 33333444443
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcc
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 916 (1079)
|+-...+...+. ++.+. +.+++|+|+. +|||||+||+|.+++.-|.+|++|||+++..-....
T Consensus 136 -----gDc~tllk~~g~-lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGP-LPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred -----chhhhhcccCCC-Ccchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 344444433332 33222 6789999998 999999999999999999999999999875422110
Q ss_pred c-------------ccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 001426 917 S-------------RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIP 968 (1079)
Q Consensus 917 ~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~ 968 (1079)
. -..+..+||+.|.|||++....|+..+|.|++|+|+||.+-|+.||.+..+
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 0 011345799999999999999999999999999999999999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.1e-16 Score=184.02 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=195.4
Q ss_pred hCCCCCCeeeecCcEEEEEEEeCC--CCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCeEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS--RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 834 (1079)
..|...+.||+|+|+.|-...... ...+|+|.+.... ......+....|..+-+.+. |+|++.+++...+.+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 356777889999999999876533 4455666553322 23344566667888888886 9999999999999999999
Q ss_pred EEEecCCCChhhhh-hccCcCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEeCCCCCCeEECCCC-cEEEeeccccccc
Q 001426 835 LFDYISNGSLAGLL-HEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPIIHRDIKSNNILVGPQF-EAFLADFGLAKLF 911 (1079)
Q Consensus 835 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~gL~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~ 911 (1079)
+++|.+++++.+-+ +......+......++.|+..|+.|+| .. ++.|||+||+|.+++..+ ..+++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999999 555435666777789999999999999 76 999999999999999999 9999999999988
Q ss_pred cC-Cccccccccccc-CcccccccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhch
Q 001426 912 ES-SESSRASNSVAG-SYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREF 988 (1079)
Q Consensus 912 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1079)
.. .+.........| ++.|+|||...+. ...+..|+||.|+++.-+.+|..|++...........|..........
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 253 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL-- 253 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC--
Confidence 77 555555566778 9999999998874 456789999999999999999999987554443333333221000000
Q ss_pred hhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 989 TTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
... .......++..+++..+|+.|.+.+++..
T Consensus 254 -----------~~~--~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 254 -----------PWN--SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -----------ccc--cCChhhhhcccccccCCchhccccccccc
Confidence 000 11124456777888899999999888765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.9e-14 Score=147.10 Aligned_cols=139 Identities=16% Similarity=0.221 Sum_probs=99.7
Q ss_pred CCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHH---------------------HHHHHHHHhcCCCCc--e
Q 001426 763 TNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQ---------------------FSAEVQTLGSIRHKN--I 819 (1079)
Q Consensus 763 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~n--i 819 (1079)
.+.||+|+||+||+|...+++.||||++.+........... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988889999999886432221111111 135666666665443 4
Q ss_pred eeeeeEEEcCCeEEEEEEecCCCChhhh-hhccCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCeEECCC
Q 001426 820 VRLLGCCNNGRTRLLLFDYISNGSLAGL-LHEKKVFLDWDSRYKIILGVAHGLAYLHH-DCVPPIIHRDIKSNNILVGPQ 897 (1079)
Q Consensus 820 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~ 897 (1079)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. . +|+||||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 444443 235899999999654322 11111 11 5677899999999999999 7 999999999999999 8
Q ss_pred CcEEEeecccccccc
Q 001426 898 FEAFLADFGLAKLFE 912 (1079)
Q Consensus 898 ~~~kl~DFGla~~~~ 912 (1079)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-13 Score=137.42 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=113.8
Q ss_pred CCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCC--CceeeeeeEEEcCCeEEEEEEec
Q 001426 762 DTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH--KNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 762 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
+.+.+|+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .+++++++++...+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 35679999999999999865 6789998743221 4678999999999976 58999999988888899999999
Q ss_pred CCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 840 SNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
+++.+..+ +......++.+++++++++|.....+++|||++|+||++++.+.+++.|||.++.
T Consensus 76 ~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 98877765 4566677899999999999986434799999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.5e-13 Score=143.41 Aligned_cols=138 Identities=22% Similarity=0.270 Sum_probs=106.2
Q ss_pred CCeee-ecCcEEEEEEEeCCCCeEEEEEecccc------C----CCchhHHHHHHHHHHHhcCCCCce--eeeeeEEEcC
Q 001426 763 TNIVG-KGVSGIVYRVEIPSRQVIAVKKLWPVK------N----GELPERDQFSAEVQTLGSIRHKNI--VRLLGCCNNG 829 (1079)
Q Consensus 763 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~------~----~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 829 (1079)
..+|| .|+.|+||+++.. +..+++|.+.... . ........+.+|++++..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 9999999999886 6677888774211 1 111234678899999999998875 6777765432
Q ss_pred Ce----EEEEEEecCC-CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEee
Q 001426 830 RT----RLLLFDYISN-GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904 (1079)
Q Consensus 830 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 904 (1079)
.. .++|||++++ .+|.+++.+. .++.. .+.+++.++.++|+. ||+||||||.|||++.++.++++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 22 2599999997 6899888643 24443 356899999999999 999999999999999999999999
Q ss_pred cccccc
Q 001426 905 FGLAKL 910 (1079)
Q Consensus 905 FGla~~ 910 (1079)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998874
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.4e-13 Score=159.97 Aligned_cols=244 Identities=34% Similarity=0.427 Sum_probs=181.7
Q ss_pred ccccCcEEeccCCCCCCCccccccccc-cccccccccccccccCCCcccCCCCceEEEecCCCccccCccccccccccCe
Q 001426 399 YCVKLQALDLSHNFLTGSVPSSLFNLK-NLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTF 477 (1079)
Q Consensus 399 ~~~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 477 (1079)
..+.++.|++.+|.++ .++.....+. +|++|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.++.|+.
T Consensus 114 ~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~ 190 (394)
T COG4886 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN 190 (394)
T ss_pred cccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhh
Confidence 3467999999999999 6777777775 9999999999998 66678899999999999999999 56665668899999
Q ss_pred eeeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEecccccc
Q 001426 478 LELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNI 557 (1079)
Q Consensus 478 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 557 (1079)
|++++|+++ .+|........|++|++++|++. ..+..+..+.++..|.+++|++.. .+..++.++++++|++++|++
T Consensus 191 L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i 267 (394)
T COG4886 191 LDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQI 267 (394)
T ss_pred eeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceeccccccc
Confidence 999999999 67776666777999999999654 567788999999999999999984 467788899999999999999
Q ss_pred cCCCCCccccccccccccccCccccCCChhhhhcccchhhhhcccCCcccccccccccCCCcccEEeccCcccccccccc
Q 001426 558 TGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVL 637 (1079)
Q Consensus 558 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~ 637 (1079)
+.+.+ ++.+.+|+.||+++|.+....|.............+ +.++ ..+..+.....+...++..|.....+..+
T Consensus 268 ~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (394)
T COG4886 268 SSISS--LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLN---LLLT-LKALELKLNSILLNNNILSNGETSSPEAL 341 (394)
T ss_pred ccccc--ccccCccCEEeccCccccccchhhhccchhHHhhhh---hhhh-cccccccccccccccccccccccccchhh
Confidence 97644 889999999999999998776665544433322222 2222 22333333444444555555555444444
Q ss_pred CcccccceeeccCCcCc
Q 001426 638 GSLDNLVSLNVSYNHFS 654 (1079)
Q Consensus 638 ~~l~~L~~L~ls~N~l~ 654 (1079)
.....+..+++..+...
T Consensus 342 ~~~~~~~~~~~~~~~~~ 358 (394)
T COG4886 342 SILESLNNLWTLDNALD 358 (394)
T ss_pred cccccccCceecccccc
Confidence 44444444555444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.4e-14 Score=157.59 Aligned_cols=180 Identities=32% Similarity=0.486 Sum_probs=136.9
Q ss_pred cCcEEeccCCCCCCCccccccccccccccccccccccccCCCcccCCCCceEEEecCCCccccCccccccccccCeeeec
Q 001426 402 KLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELS 481 (1079)
Q Consensus 402 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 481 (1079)
.-...||+.|++. .+|..+..+-.|+.+.|..|.+. .+|..++++..|+.|+|+.|+++ ..|..++.++ |+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 3456677777777 67777777777888888888777 77777777888888888888877 5666666664 7888888
Q ss_pred cCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEecccccccCCC
Q 001426 482 ENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLI 561 (1079)
Q Consensus 482 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 561 (1079)
+|+++ .+|..++.+..|..||.+.|.+. .+|..+.++.+|+.|.+..|++. .+|..+.. -.|..||+|.|+++ .+
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YL 226 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ec
Confidence 88887 77777887788888888888887 66777888888888888888887 45555653 35778888888888 56
Q ss_pred CCccccccccccccccCccccCCChhhhhc
Q 001426 562 PKSLGLCKDLQLLDLSSNRINGSIPEEIGR 591 (1079)
Q Consensus 562 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 591 (1079)
|-.|..|+.|++|-|.+|+++ ..|..+.-
T Consensus 227 Pv~fr~m~~Lq~l~LenNPLq-SPPAqIC~ 255 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLENNPLQ-SPPAQICE 255 (722)
T ss_pred chhhhhhhhheeeeeccCCCC-CChHHHHh
Confidence 778888888888888888887 66665543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-12 Score=151.79 Aligned_cols=155 Identities=18% Similarity=0.247 Sum_probs=107.9
Q ss_pred CHHHHhhCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCch--------------------------h-----
Q 001426 752 SVDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELP--------------------------E----- 800 (1079)
Q Consensus 752 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------------------~----- 800 (1079)
.+++....|+. +.||.|++|.||+|+.++|+.||||+.++....... .
T Consensus 112 ~~~~~F~~fd~-~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~ 190 (437)
T TIGR01982 112 PLEELFAEFEE-KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEF 190 (437)
T ss_pred CHHHHHhhCCC-cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHH
Confidence 34455555553 689999999999999999999999998653211000 0
Q ss_pred ------HHHHHHHHHHHhcCC----CCceeeeeeEE-EcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHH
Q 001426 801 ------RDQFSAEVQTLGSIR----HKNIVRLLGCC-NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAH 869 (1079)
Q Consensus 801 ------~~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~ 869 (1079)
.-+|.+|++.+.+++ |.+-+.+-.++ ......++||||++|+++.++........+ +..++.+++.
T Consensus 191 ~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~ 267 (437)
T TIGR01982 191 EKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLAR 267 (437)
T ss_pred HHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHH
Confidence 013555666666552 33223333333 223457999999999999988753322222 3446666665
Q ss_pred -HHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccC
Q 001426 870 -GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 870 -gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~ 913 (1079)
.+..+|.. |++|+|++|.||+++++++++++|||++..+..
T Consensus 268 ~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 268 SFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 47788988 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=152.22 Aligned_cols=200 Identities=33% Similarity=0.502 Sum_probs=121.7
Q ss_pred EEeccCCcccCCCCcccCCcCcccEEeccCCcccccCcccccccc-ccceEecccccccCCCChhhchhhhHHHHHhCCC
Q 001426 117 NLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCS-KLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGN 195 (1079)
Q Consensus 117 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n 195 (1079)
.|+++.|.+. ..+..+..++.++.|++.+|.++ .+|...+.+. +|++|++++|++.
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~--------------------- 153 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE--------------------- 153 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh---------------------
Confidence 4566666554 22333445556666666666666 5555555553 6666666666654
Q ss_pred CCcccCCCcccccccceeEeecccCCCccCCCccccccccccccccccccccccCCcccccccccceecccccccccCCC
Q 001426 196 PGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIP 275 (1079)
Q Consensus 196 ~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 275 (1079)
.+|..+..+++|+.|++++|++. .+|...+.++.|+.|++++|++. .+|
T Consensus 154 -----------------------------~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~ 202 (394)
T COG4886 154 -----------------------------SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLP 202 (394)
T ss_pred -----------------------------hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCc
Confidence 22233445555555555555555 33433445666777777777766 555
Q ss_pred cCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccCccccccccccccceeeccccccccccccccccccc
Q 001426 276 DELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSR 355 (1079)
Q Consensus 276 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 355 (1079)
.....+..|++|.+++|.+. ..+..+.+++++..+.+++|++. ..+..+..++++++|++++|.++.... ++.+.+
T Consensus 203 ~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~ 278 (394)
T COG4886 203 PEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTN 278 (394)
T ss_pred hhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccccc--ccccCc
Confidence 55555566777777777543 35566677777777777777776 335566777777777777777774333 777777
Q ss_pred CcEeeccCCcccccCCccc
Q 001426 356 LKQLELDNNRFFGQIPPTI 374 (1079)
Q Consensus 356 L~~L~L~~N~l~~~~p~~l 374 (1079)
|+.|++++|.+....+...
T Consensus 279 l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 279 LRELDLSGNSLSNALPLIA 297 (394)
T ss_pred cCEEeccCccccccchhhh
Confidence 8888888877775555443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.7e-14 Score=153.72 Aligned_cols=182 Identities=29% Similarity=0.444 Sum_probs=131.6
Q ss_pred cCCCccEEEcccccccCccccccccccccceeecccccccccccccccccccCcEeeccCCcccccCCccccchhhHHHH
Q 001426 304 NCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLF 383 (1079)
Q Consensus 304 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l 383 (1079)
.+.--...|++.|++. .+|..++.+..|+.+.|..|.+. .+|..++++..|++|||+.|+++ .+|..++.++
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp----- 144 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP----- 144 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-----
Confidence 3444556677777776 66777777777777777777776 56666777777777777777765 4555555543
Q ss_pred HhhcCcccccCCcccccccCcEEeccCCCCCCCccccccccccccccccccccccccCCCcccCCCCceEEEecCCCccc
Q 001426 384 FAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSG 463 (1079)
Q Consensus 384 ~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 463 (1079)
|+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++.
T Consensus 145 -------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~- 202 (722)
T KOG0532|consen 145 -------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE- 202 (722)
T ss_pred -------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-
Confidence 888888888888 67778888888888888888887 67777888888888888888877
Q ss_pred cCccccccccccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhh
Q 001426 464 HIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLE 518 (1079)
Q Consensus 464 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 518 (1079)
..|..+..+ .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.++ ..|..+.
T Consensus 203 ~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 203 DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 455555544 4777888888887 77777888888888888888877 4455443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.7e-12 Score=130.92 Aligned_cols=201 Identities=21% Similarity=0.309 Sum_probs=140.0
Q ss_pred HHHHhcCCCCceeeeeeEEEcCC-----eEEEEEEecCCCChhhhhhcc---CcCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 001426 808 VQTLGSIRHKNIVRLLGCCNNGR-----TRLLLFDYISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHDCV 879 (1079)
Q Consensus 808 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~gL~~LH~~~~ 879 (1079)
.+-+-++.|-|||++..|+.+.+ ...++.||++.|++..++++- ...+....-.+++.||..||.|||+- .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455667999999999987644 368999999999999999753 44566777788999999999999985 5
Q ss_pred CCeEEeCCCCCCeEECCCCcEEEeeccccccccC--CcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHH
Q 001426 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES--SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVL 957 (1079)
Q Consensus 880 ~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~ 957 (1079)
+.|+|+++..+-|++..++-+|++--.-...... ...........+-++|.|||.......+.++|||+||....||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 6999999999999999999888752211111000 00011223345678999999988888889999999999999998
Q ss_pred hCCCCCCCCCCC---cchHHHHHHhHHhhhhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001426 958 TGKEPTDSRIPD---GAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 958 tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 1034 (1079)
-+..-....... ...+..... .....++ ..++.+|++..|..||+|++++..
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~--------~len~lq-----------------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVII--------GLENGLQ-----------------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhhhee--------eccCccc-----------------cCcCcccccCCCCCCcchhhhhcC
Confidence 876643221110 000000000 0000011 145677999999999999988653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.7e-12 Score=144.12 Aligned_cols=251 Identities=22% Similarity=0.211 Sum_probs=185.4
Q ss_pred hCCCCCCeeee--cCcEEEEEEEe---CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCC-CCceeeeeeEEEcCCe
Q 001426 758 TRLSDTNIVGK--GVSGIVYRVEI---PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 831 (1079)
..+.....+|. |.+|.||.+.. .++..+|+|+-...... ......=.+|+.....++ |++.++.+..+..++.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~-p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP-PLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC-ccccccccchhhcccccCccccccccCcccccCCc
Confidence 45667788999 99999999866 46788898874322221 122233446777777774 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEeCCCCCCeEECCC-CcEEEeecc
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAH----GLAYLHHDCVPPIIHRDIKSNNILVGPQ-FEAFLADFG 906 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----gL~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFG 906 (1079)
.++-+|++. .++..+.+.....++....+.+..+..+ |+.++|+. +++|-|+||.||+..++ ...+++|||
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 999999996 6999999888777888999999999999 99999999 99999999999999999 889999999
Q ss_pred ccccccCCcccccc---cccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhh
Q 001426 907 LAKLFESSESSRAS---NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE 983 (1079)
Q Consensus 907 la~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 983 (1079)
+...+.+....... ....|...|++||...+ .++.++|+|++|.++.+-.++.+++..... .
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------------~ 333 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN--------------S 333 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC--------------C
Confidence 99988776532221 22357889999998765 678899999999999999998877643210 1
Q ss_pred hhhchhhhhhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001426 984 RKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 1033 (1079)
.|..+.....+.-..... ..++-..+..+++.+|..|++++.+..
T Consensus 334 ~W~~~r~~~ip~e~~~~~-----s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 SWSQLRQGYIPLEFCEGG-----SSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CccccccccCchhhhcCc-----chhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111111110000111 112233777899999999999887765
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.3e-12 Score=153.85 Aligned_cols=88 Identities=36% Similarity=0.685 Sum_probs=49.0
Q ss_pred CceEecccccccCCCCCccccccccccccccCccccCCChhhhhcccchhhhhcccCCcccccccccccCCCcccEEecc
Q 001426 547 LNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLS 626 (1079)
Q Consensus 547 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls 626 (1079)
++.|+|++|.+++.+|..++.+++|+.|+|++|.++|.+|..++.+.+| +.|+|++|++++.+|+.+++|++|+.|+|+
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L-~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL-EVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCC-CEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 4555555555555555555555555555555555555555555555555 334555555555555555555555556665
Q ss_pred Ccccccccc
Q 001426 627 NNMLTGSLK 635 (1079)
Q Consensus 627 ~N~l~~~~~ 635 (1079)
+|+++|.+|
T Consensus 499 ~N~l~g~iP 507 (623)
T PLN03150 499 GNSLSGRVP 507 (623)
T ss_pred CCcccccCC
Confidence 555555443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.5e-12 Score=132.41 Aligned_cols=134 Identities=31% Similarity=0.356 Sum_probs=88.0
Q ss_pred hhhcCCCcccccccccccccccccccCCCCceEecccccccCCCCCccccccccccccccCccccCCChhhhhcccchhh
Q 001426 518 EFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDI 597 (1079)
Q Consensus 518 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 597 (1079)
.....|++||||+|.|+ .+.++..-+|.++.|++|+|.|..+ +.+..+++|+.||||+|.++ .+..+-.++.+. .
T Consensus 281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI-K 355 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI-K 355 (490)
T ss_pred chHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCE-e
Confidence 33445666666666666 4445555566666666666666633 33666666666666666665 333333334443 2
Q ss_pred hhcccCCcccccccccccCCCcccEEeccCcccccccc--ccCcccccceeeccCCcCcCCCC
Q 001426 598 LLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLK--VLGSLDNLVSLNVSYNHFSGILP 658 (1079)
Q Consensus 598 ~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~--~~~~l~~L~~L~ls~N~l~~~~p 658 (1079)
.|+|+.|.|.+. ..+..|.+|..||+++|+|..... .++++|-|+.+.|.+|++.+++-
T Consensus 356 tL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 356 TLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred eeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 236666666533 346778889999999999987544 48999999999999999998764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.4e-11 Score=143.75 Aligned_cols=153 Identities=12% Similarity=0.134 Sum_probs=101.3
Q ss_pred CCHHHHhhCCCCCCeeeecCcEEEEEEEeCC-CCeEEEEEeccccCCC--------------------------c-----
Q 001426 751 FSVDDVVTRLSDTNIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNGE--------------------------L----- 798 (1079)
Q Consensus 751 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------~----- 798 (1079)
-.++++...|+. +.||+|++|.||+|+.++ |+.||||+.++..... .
T Consensus 113 ~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~ 191 (537)
T PRK04750 113 GPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA 191 (537)
T ss_pred CCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence 345666777887 789999999999999987 9999999997542110 0
Q ss_pred hhHH------HHHHHHHHHhcCC----CCceeeeeeEEEc-CCeEEEEEEecCCCChhhhh--hccCc---CCCHHHHHH
Q 001426 799 PERD------QFSAEVQTLGSIR----HKNIVRLLGCCNN-GRTRLLLFDYISNGSLAGLL--HEKKV---FLDWDSRYK 862 (1079)
Q Consensus 799 ~~~~------~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~---~~~~~~~~~ 862 (1079)
+..+ +|.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++- ...+. .+....+..
T Consensus 192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence 0011 2344444444442 3333433333322 34568999999999998753 22221 122222333
Q ss_pred HHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC----cEEEeeccccccccCC
Q 001426 863 IILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF----EAFLADFGLAKLFESS 914 (1079)
Q Consensus 863 i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DFGla~~~~~~ 914 (1079)
++.|+ ... |++|+|+||.||+++.++ ++++.|||++..++..
T Consensus 272 ~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 272 FFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 33333 345 999999999999999988 9999999999877653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.6e-10 Score=128.14 Aligned_cols=167 Identities=17% Similarity=0.225 Sum_probs=126.4
Q ss_pred EeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEEecCCCChhhhhhccCcCCCH
Q 001426 778 EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDW 857 (1079)
Q Consensus 778 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 857 (1079)
+..++.+|.|....... . .......+-+.-++.+|||+|+++++.+...+..|+|+|-+. .|..++.+.+ .
T Consensus 33 ~k~~~~~vsVF~~~~~~--~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~ 103 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSN--G-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----K 103 (690)
T ss_pred eeccCCceEEEEEeCCC--c-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----H
Confidence 34467777777663211 1 334567778889999999999999999999999999999886 5677776544 4
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccccccccccCcccccccccCC
Q 001426 858 DSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937 (1079)
Q Consensus 858 ~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 937 (1079)
..+...+.||+.||.|||+.+ +++|++|...-|++++.|..||++|.++........ ......--..|..|+.+..
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence 566678899999999999876 899999999999999999999999998864432221 1222223345677775443
Q ss_pred CCCCccchHHHHHHHHHHHHhC
Q 001426 938 LKITEKSDVYSYGVVLLEVLTG 959 (1079)
Q Consensus 938 ~~~~~~sDvwSlGvil~el~tg 959 (1079)
.. -..|.|.||++++|++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 32 346999999999999999
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.1e-12 Score=128.58 Aligned_cols=127 Identities=35% Similarity=0.355 Sum_probs=58.4
Q ss_pred ccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEecc
Q 001426 474 RLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLS 553 (1079)
Q Consensus 474 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 553 (1079)
.|+.||||+|.|+ .+.++..-.+.++.|++|+|.|..+ +.+..+++|+.||||+|.++ .+..+-.++-++++|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 3444444444444 3333444444455555555544422 22444555555555555544 222233344455555555
Q ss_pred cccccCCCCCccccccccccccccCccccCCC-hhhhhcccchhhhhcccCCccc
Q 001426 554 KNNITGLIPKSLGLCKDLQLLDLSSNRINGSI-PEEIGRLQGLDILLNLSWNALT 607 (1079)
Q Consensus 554 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~~L~l~~N~l~ 607 (1079)
+|.|... ..++.+.+|..||+++|+|.... -..+++++-|+ .+.|.+|.|.
T Consensus 361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE-~l~L~~NPl~ 412 (490)
T KOG1259|consen 361 QNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLE-TLRLTGNPLA 412 (490)
T ss_pred hhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHH-HHhhcCCCcc
Confidence 5555433 33445555555555555554210 12345555552 2345555555
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.5e-12 Score=134.60 Aligned_cols=255 Identities=25% Similarity=0.312 Sum_probs=164.1
Q ss_pred ccccCCCCEEeccCCcccC----CCCcccCCcCcccEEeccCC---cccccCcccc-------ccccccceEeccccccc
Q 001426 109 IGNLSSLINLDLSFNALTG----NIPEEIGKLAELELLSLNSN---SIHGGIPREI-------GNCSKLRRLELYDNQLS 174 (1079)
Q Consensus 109 l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~L~~n---~l~~~~p~~~-------~~l~~L~~L~Ls~n~l~ 174 (1079)
+.....+++|+||+|.|.. .+...+.+.++|+..++++- ++...+|..+ -.+++|++||||+|.+.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 4445666667777766642 24445666667777777653 3333455443 34568999999999887
Q ss_pred CCCChhhchhhhHHHHHhCCCCCcccCCCcccccccceeEeecccCCCccCCCccccccccccccccccccccccCCccc
Q 001426 175 GNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI 254 (1079)
Q Consensus 175 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~l 254 (1079)
-.-+..|+.+ ++++..|++|+|.+|++...--..++. .|..|. .++ ..
T Consensus 106 ~~g~~~l~~l---------------------l~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~ 153 (382)
T KOG1909|consen 106 PKGIRGLEEL---------------------LSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KA 153 (382)
T ss_pred ccchHHHHHH---------------------HHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------cc
Confidence 5555444432 344566677777777766332222221 233332 111 23
Q ss_pred ccccccceecccccccccCC----CcCccCCCCCCeEeccCcccCCC----cCcccccCCCccEEEcccccccCcc----
Q 001426 255 GNCSALENLFLYENQIFGKI----PDELGSLKNLKRLLLWQNNLSGS----IPEALGNCSSLTVIDVSLNSLGGEV---- 322 (1079)
Q Consensus 255 ~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~---- 322 (1079)
++-+.|+++..++|++.... ...|...+.|+.+.+.+|.|... +..+|..+++|++|||.+|.++...
T Consensus 154 ~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~L 233 (382)
T KOG1909|consen 154 ASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVAL 233 (382)
T ss_pred CCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHH
Confidence 34477999999999986432 23466778999999999998732 3356788999999999999987543
Q ss_pred ccccccccccceeecccccccccccccc-----cccccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCcc
Q 001426 323 PVSLANLVALEELLLSGNNISGEIPSFF-----GNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPEL 397 (1079)
Q Consensus 323 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l 397 (1079)
...++.+++|+.|++++|.+.......| ...|+|+.|.|.+|.|+..-...+ .. ..
T Consensus 234 akaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~l---------a~----------~~ 294 (382)
T KOG1909|consen 234 AKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALAL---------AA----------CM 294 (382)
T ss_pred HHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHH---------HH----------HH
Confidence 3456778899999999999987655444 247899999999999863211111 00 11
Q ss_pred cccccCcEEeccCCCCC
Q 001426 398 AYCVKLQALDLSHNFLT 414 (1079)
Q Consensus 398 ~~~~~L~~L~Ls~N~l~ 414 (1079)
...+.|+.|+|++|.+.
T Consensus 295 ~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 295 AEKPDLEKLNLNGNRLG 311 (382)
T ss_pred hcchhhHHhcCCccccc
Confidence 22356888888888884
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.5e-10 Score=117.25 Aligned_cols=130 Identities=19% Similarity=0.142 Sum_probs=95.7
Q ss_pred CCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCcee-eeeeEEEcCCeEEEEEEecCC
Q 001426 763 TNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV-RLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 763 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
.+.++.|.++.||+++.. ++.+++|....... ....+..|+.+++.+.+.+++ +++.+.. ...++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 356899999999999876 66789998643221 223567899999988765554 4444432 345899999999
Q ss_pred CChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCCeEECCCCcEEEeeccccc
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC--VPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~ 909 (1079)
.++.+.- . ....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+.
T Consensus 76 ~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred Ccccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 8876541 1 11245678999999999983 12369999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.4e-12 Score=146.65 Aligned_cols=174 Identities=30% Similarity=0.343 Sum_probs=93.3
Q ss_pred CcEEeccCCCCCCCccccccccccccccccccccccccCC-CcccCCCCceEEEecCCCccccCccccccccccCeeeec
Q 001426 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIP-PEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELS 481 (1079)
Q Consensus 403 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 481 (1079)
|+.|++++|.|+.. ..+..++.|+.+++++|++...-+ . ...+..++.+++++|.+.. ...+..+..+..+++.
T Consensus 142 L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~ 216 (414)
T KOG0531|consen 142 LKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLL 216 (414)
T ss_pred hhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcc
Confidence 44445555544421 233334555555555555543222 1 3445555555566665542 2233444445555666
Q ss_pred cCcccCCCCCCCCCCC--cccEEecCCCcCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEecccccccC
Q 001426 482 ENQFTGEIPPEIGNCT--QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITG 559 (1079)
Q Consensus 482 ~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 559 (1079)
.|.++..-+ +..+. .|+.+++++|.+. ..+..+..+..+..|++++|++... ..+...+.+..+.++.|.+..
T Consensus 217 ~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~ 291 (414)
T KOG0531|consen 217 DNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLAL 291 (414)
T ss_pred cccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcc
Confidence 666653222 11222 2667777777766 3335566667777777777777643 234455667777777777652
Q ss_pred C---CCCc-cccccccccccccCccccCCCh
Q 001426 560 L---IPKS-LGLCKDLQLLDLSSNRINGSIP 586 (1079)
Q Consensus 560 ~---~~~~-~~~l~~L~~L~Ls~N~l~~~~p 586 (1079)
. .... ....+.++.+++..|.+....+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 292 SEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhhhhccccccccccccccccccCccccccc
Confidence 1 1111 4556777788888887765443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.2e-12 Score=132.97 Aligned_cols=134 Identities=23% Similarity=0.258 Sum_probs=71.2
Q ss_pred CCCceEEEecCCCccccC----ccccccccccCeeeeccCcccCC----CCCCCCCCCcccEEecCCCcCcc----cCCh
Q 001426 448 CTGLIRLRLGSNNFSGHI----PSRIGLLHRLTFLELSENQFTGE----IPPEIGNCTQLEMVDLHQNKLQG----TIPS 515 (1079)
Q Consensus 448 l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~~~ 515 (1079)
-+.|+++..++|++..-. ...|...+.|+.+.++.|.|... ....|..+++|+.|||..|-++. .+..
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 346777777777765322 22344456667777777766421 11234556666666666666653 2233
Q ss_pred hhhhhcCCCccccccccccccccccc-----ccCCCCceEecccccccCC----CCCccccccccccccccCccc
Q 001426 516 SLEFLFGLNVLDLSMNSIGGTIPENL-----GKLTSLNKLVLSKNNITGL----IPKSLGLCKDLQLLDLSSNRI 581 (1079)
Q Consensus 516 ~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l 581 (1079)
.+..++.|+.|+++++.++.....+| ...++|+.|.|.+|.|+.. +...+...+.|..|+|++|++
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 44555556666666666654333222 1245666666666666521 122233445566666666666
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.1e-10 Score=107.48 Aligned_cols=133 Identities=23% Similarity=0.388 Sum_probs=104.8
Q ss_pred CeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchh------HHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEEE
Q 001426 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPE------RDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
..+++|+-+.||.+.+.+.. +++|.- ..+.....+ .....+|++++.+++--.|...+=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~R-i~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKER-IPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEee-cCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999886544 455543 233333222 2567789999999987777777777777888899999
Q ss_pred ecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecccccc
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~ 910 (1079)
|++|-.|.+++... ...++..+-.-+.-||.. +|||+|+.++||.+..+. +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999898654 245777788888999999 999999999999999875 99999999873
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.7e-11 Score=117.80 Aligned_cols=128 Identities=32% Similarity=0.314 Sum_probs=43.8
Q ss_pred CCCCCcccEEecCCCcCcccCChhhh-hhcCCCcccccccccccccccccccCCCCceEecccccccCCCCCcccccccc
Q 001426 493 IGNCTQLEMVDLHQNKLQGTIPSSLE-FLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDL 571 (1079)
Q Consensus 493 ~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 571 (1079)
+.+..++++|+|++|+|+.+ +.++ .+.+|+.|+|++|+|+.. +.+..+++|++|++++|+|+.+.+.....+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNL 90 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence 44455677777777777633 2344 456677777777777743 246667777777777777775432222356777
Q ss_pred ccccccCccccCCChhhhhcccchhhhhcccCCcccccccccccCCCcccEEeccCccccccccc----cCcccccceee
Q 001426 572 QLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKV----LGSLDNLVSLN 647 (1079)
Q Consensus 572 ~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~----~~~l~~L~~L~ 647 (1079)
+.|++++|+|... .. -..+..+++|+.|+|.+|+++..... +..+|+|+.||
T Consensus 91 ~~L~L~~N~I~~l-----~~-------------------l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 91 QELYLSNNKISDL-----NE-------------------LEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -EEE-TTS---SC-----CC-------------------CGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CEEECcCCcCCCh-----HH-------------------hHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 7777777777521 11 13456788899999999999865432 56788888877
Q ss_pred c
Q 001426 648 V 648 (1079)
Q Consensus 648 l 648 (1079)
-
T Consensus 147 ~ 147 (175)
T PF14580_consen 147 G 147 (175)
T ss_dssp T
T ss_pred C
Confidence 4
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.8e-11 Score=142.32 Aligned_cols=247 Identities=30% Similarity=0.311 Sum_probs=126.5
Q ss_pred cccccceecccccccccCCCcCccCCCCCCeEeccCcccCCCcCcccccCCCccEEEcccccccCcccccccccccccee
Q 001426 256 NCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEEL 335 (1079)
Q Consensus 256 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 335 (1079)
.+..++.+.+..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|++++|+|+... .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 34555555566666542 22335555666666666666653 2222455556666666666655332 23444445555
Q ss_pred ecccccccccccccccccccCcEeeccCCcccccCCccccchhhHHHHHhhcCcccccCCcccccccCcEEeccCCCCCC
Q 001426 336 LLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTG 415 (1079)
Q Consensus 336 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~n~l~~~~~~l~~~~~L~~L~Ls~N~l~~ 415 (1079)
++++|.|+. ...+..+.+|+.+++++|+++..-+.
T Consensus 146 ~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~------------------------------------------- 180 (414)
T KOG0531|consen 146 NLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIEND------------------------------------------- 180 (414)
T ss_pred eeccCcchh--ccCCccchhhhcccCCcchhhhhhhh-------------------------------------------
Confidence 555555542 12333345555555555554422110
Q ss_pred CccccccccccccccccccccccccCCCcccCCCCceEEEecCCCccccCcccccccc--ccCeeeeccCcccCCCCCCC
Q 001426 416 SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLH--RLTFLELSENQFTGEIPPEI 493 (1079)
Q Consensus 416 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~ 493 (1079)
. ...+.+++.+++.+|.+.. ...+..+..+..+++..|.++..-+ +..+. .|+.+++++|.+. ..+..+
T Consensus 181 ---~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~ 251 (414)
T KOG0531|consen 181 ---E-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGL 251 (414)
T ss_pred ---h-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccc
Confidence 1 2334444444444444431 1222223333333444454442211 11111 3666677777666 333455
Q ss_pred CCCCcccEEecCCCcCcccCChhhhhhcCCCcccccccccccc---cccc-cccCCCCceEecccccccCCCC
Q 001426 494 GNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGT---IPEN-LGKLTSLNKLVLSKNNITGLIP 562 (1079)
Q Consensus 494 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~L~L~~N~l~~~~~ 562 (1079)
..+..+..|++.+|++... ..+.....+..+.+..|.+... .... ....+.++.+.+..|.+....+
T Consensus 252 ~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 252 ENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 6667777777777776533 2344555566666777766522 1121 5567888999999998886544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.4e-09 Score=108.44 Aligned_cols=139 Identities=15% Similarity=0.201 Sum_probs=99.6
Q ss_pred CeeeecCcEEEEEEEeCC-------CCeEEEEEeccccC----------CC---------chhHHHHH----HHHHHHhc
Q 001426 764 NIVGKGVSGIVYRVEIPS-------RQVIAVKKLWPVKN----------GE---------LPERDQFS----AEVQTLGS 813 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~----------~~---------~~~~~~~~----~E~~~l~~ 813 (1079)
..||.|--+.||.|...+ +..+|||+.+.... +. ...++.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 47899998653210 00 11133444 89999999
Q ss_pred CCC--CceeeeeeEEEcCCeEEEEEEecCCCChhh-hhhccCcCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEeCCCC
Q 001426 814 IRH--KNIVRLLGCCNNGRTRLLLFDYISNGSLAG-LLHEKKVFLDWDSRYKIILGVAHGLAYL-HHDCVPPIIHRDIKS 889 (1079)
Q Consensus 814 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~gL~~L-H~~~~~~ivH~Dlk~ 889 (1079)
+.. -++.+++++ ...++||||+.++.+.. .+.. ..++.+....+..+++.+|.++ |+. ++||||+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 864 456666654 45689999998754422 2221 1244556677889999999999 777 999999999
Q ss_pred CCeEECCCCcEEEeecccccccc
Q 001426 890 NNILVGPQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 890 ~NIll~~~~~~kl~DFGla~~~~ 912 (1079)
.||+++ ++.++++|||.|....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.4e-09 Score=102.95 Aligned_cols=143 Identities=18% Similarity=0.234 Sum_probs=108.7
Q ss_pred CCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCC------chhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEE
Q 001426 762 DTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGE------LPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 762 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
...++-+|+-+.|+++.+. |+...||.-.+ +... .-.++...+|++.+.+++--.|....-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~-K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFS-KRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeeccc-ccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4578999999999999886 55556664332 2222 12346788999999999876766666667777777899
Q ss_pred EEecCC-CChhhhhhccCcCCCHHHH-HHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCC---cEEEeeccccc
Q 001426 836 FDYISN-GSLAGLLHEKKVFLDWDSR-YKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF---EAFLADFGLAK 909 (1079)
Q Consensus 836 ~e~~~~-g~L~~~l~~~~~~~~~~~~-~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFGla~ 909 (1079)
|||++| .++.+++......-..+.. ..++..|-+.+.-||.. +|+|+||..+||++.+++ .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 999977 5888888765333333333 67889999999999999 999999999999997665 45899999986
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-10 Score=115.22 Aligned_cols=122 Identities=30% Similarity=0.328 Sum_probs=32.9
Q ss_pred CceEEEecCCCccccCccccc-cccccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhh-hhhcCCCccc
Q 001426 450 GLIRLRLGSNNFSGHIPSRIG-LLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSL-EFLFGLNVLD 527 (1079)
Q Consensus 450 ~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~ 527 (1079)
.+++|+|.+|.|+. +. .++ .+.+|+.|+|++|.|+.. . .+..++.|+.|++++|+|+.. ...+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEE
Confidence 44555555555542 21 232 345555555555555522 1 344555666666666666532 2223 3455566666
Q ss_pred ccccccccccc-cccccCCCCceEecccccccCCC---CCccccccccccccc
Q 001426 528 LSMNSIGGTIP-ENLGKLTSLNKLVLSKNNITGLI---PKSLGLCKDLQLLDL 576 (1079)
Q Consensus 528 Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L 576 (1079)
|++|+|..... ..+..+++|+.|+|.+|.++... ...+..+|+|+.||-
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 66665553211 23445566666666666655321 012344555555553
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.6e-11 Score=127.29 Aligned_cols=213 Identities=25% Similarity=0.237 Sum_probs=109.5
Q ss_pred ccccccccccccccccccCC--CcccCCCCceEEEecCCCccccC--ccccccccccCeeeeccCcccCCCCCCC-CCCC
Q 001426 423 NLKNLTQLLLISNRFSGEIP--PEIGGCTGLIRLRLGSNNFSGHI--PSRIGLLHRLTFLELSENQFTGEIPPEI-GNCT 497 (1079)
Q Consensus 423 ~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~ 497 (1079)
++++|+++.|.+.... ..+ .....|++++.|||+.|-+.... -.....+++|+.|+|+.|++........ ..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 3445555555555443 222 23445556666666666555322 1234556777777777777652211111 1345
Q ss_pred cccEEecCCCcCccc-CChhhhhhcCCCcccccccccccccccccccCCCCceEecccccccCCC-CCcccccccccccc
Q 001426 498 QLEMVDLHQNKLQGT-IPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLI-PKSLGLCKDLQLLD 575 (1079)
Q Consensus 498 ~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~ 575 (1079)
+|+.|.|+.|.++-. +......+++|+.|+|..|...........-+..|++|||++|++-... -...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 666666666666521 1122344555666666666422222233334455566666665554332 12344455555555
Q ss_pred ccCccccCCChhhhhcccchhhhhcccCCcccccccccccCCCcccEEeccCcccccc--ccccCcccccceeeccCCcC
Q 001426 576 LSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGS--LKVLGSLDNLVSLNVSYNHF 653 (1079)
Q Consensus 576 Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~~~~~~l~~L~~L~ls~N~l 653 (1079)
++.+.+...- +....++ +....+++|++|+++.|++... ...+..+.+|+.|....|.|
T Consensus 278 ls~tgi~si~---~~d~~s~----------------~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~l 338 (505)
T KOG3207|consen 278 LSSTGIASIA---EPDVESL----------------DKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYL 338 (505)
T ss_pred ccccCcchhc---CCCccch----------------hhhcccccceeeecccCccccccccchhhccchhhhhhcccccc
Confidence 5555554210 0000000 1124567888888888888653 34466777777777777777
Q ss_pred cC
Q 001426 654 SG 655 (1079)
Q Consensus 654 ~~ 655 (1079)
+.
T Consensus 339 n~ 340 (505)
T KOG3207|consen 339 NK 340 (505)
T ss_pred cc
Confidence 64
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4e-10 Score=139.24 Aligned_cols=42 Identities=26% Similarity=0.348 Sum_probs=26.1
Q ss_pred cccccCcEEeccCCCCCCCccccccccccccccccccccccc
Q 001426 398 AYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSG 439 (1079)
Q Consensus 398 ~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 439 (1079)
...++|+.|++.++.....+.+....+..+.++.+..+.+.+
T Consensus 767 ~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 767 LFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred hccCcccEEEEecccccccCCCHHHHhhhcccEEeccccccc
Confidence 345678888888777665555555556656655555555543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.8e-09 Score=112.21 Aligned_cols=142 Identities=20% Similarity=0.285 Sum_probs=110.3
Q ss_pred CeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCC--ceeeeeeEEEcCC---eEEEEEEe
Q 001426 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHK--NIVRLLGCCNNGR---TRLLLFDY 838 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~ 838 (1079)
+.++.|.++.||+++..+|+.+++|........ .....+..|+++++.+++. .+.+++.+..... ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998877788999987432221 2345789999999999764 4577777776543 56899999
Q ss_pred cCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC---------------------------------------- 878 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~---------------------------------------- 878 (1079)
++|+++.+.+.. ..++......++.++++++.+||+..
T Consensus 82 i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 82 VDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred eCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 999988886642 23677777888889999999888531
Q ss_pred -------------CCCeEEeCCCCCCeEECC--CCcEEEeeccccc
Q 001426 879 -------------VPPIIHRDIKSNNILVGP--QFEAFLADFGLAK 909 (1079)
Q Consensus 879 -------------~~~ivH~Dlk~~NIll~~--~~~~kl~DFGla~ 909 (1079)
...++|+|+++.||++++ ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 146799999999999998 5678999999876
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.1e-10 Score=144.21 Aligned_cols=231 Identities=23% Similarity=0.278 Sum_probs=105.1
Q ss_pred cCCcCcccEEeccCCcccccCccccccccccceEecccccccCCCChhhchhhhHHHHHhCCCCCcccCCCcccccccce
Q 001426 133 IGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVL 212 (1079)
Q Consensus 133 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L 212 (1079)
|..++.|++|||++|.=-+.+|..+++|-+||+|+|++..++ .+|..+++|..|.+|++..+..... +|..+..+.+|
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~-~~~i~~~L~~L 644 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLES-IPGILLELQSL 644 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheecccccccccc-ccchhhhcccc
Confidence 444444444444444333344444444444444444444444 4444444444444444444332111 13333335555
Q ss_pred eEeecccCCCc--cCCCccccccccccccccccccccccCCcccccccccc----eecccccccccCCCcCccCCCCCCe
Q 001426 213 VFLGLADTGIS--GQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALE----NLFLYENQIFGKIPDELGSLKNLKR 286 (1079)
Q Consensus 213 ~~L~l~~~~~~--~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~l~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~ 286 (1079)
++|.+...... ...-..+.+|.+|+.+....... .+-..+..+..|. .+.+.++... ..+..+..+.+|+.
T Consensus 645 r~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~ 721 (889)
T KOG4658|consen 645 RVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEE 721 (889)
T ss_pred cEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcce
Confidence 55554433311 11122233334444443322222 1112223333333 3333333322 44556777778888
Q ss_pred EeccCcccCCCcCcccccCC------CccEEEcccccccCccccccccccccceeecccccccccccccccccccCcEee
Q 001426 287 LLLWQNNLSGSIPEALGNCS------SLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLE 360 (1079)
Q Consensus 287 L~L~~n~l~~~~~~~l~~l~------~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 360 (1079)
|.+.++.+.......+.... ++..+...++..- ..+.+..-.++|+.|++..+.....+......+..++.+.
T Consensus 722 L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i 800 (889)
T KOG4658|consen 722 LSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELI 800 (889)
T ss_pred EEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEE
Confidence 88888777643333322111 1222222222111 2223333456788888887777666666666666666666
Q ss_pred ccCCccccc
Q 001426 361 LDNNRFFGQ 369 (1079)
Q Consensus 361 L~~N~l~~~ 369 (1079)
+..+.+.+.
T Consensus 801 ~~f~~~~~l 809 (889)
T KOG4658|consen 801 LPFNKLEGL 809 (889)
T ss_pred ecccccccc
Confidence 666666544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.6e-11 Score=126.09 Aligned_cols=86 Identities=30% Similarity=0.249 Sum_probs=36.3
Q ss_pred CCCCCeEeccCcccCCCcC--cccccCCCccEEEcccccccCcccc--ccccccccceeecccccccccccccc-ccccc
Q 001426 281 LKNLKRLLLWQNNLSGSIP--EALGNCSSLTVIDVSLNSLGGEVPV--SLANLVALEELLLSGNNISGEIPSFF-GNFSR 355 (1079)
Q Consensus 281 l~~L~~L~L~~n~l~~~~~--~~l~~l~~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~ 355 (1079)
+++|++..|.++... ..+ +....|++++.||||.|-+....+. -...+++|+.|+|+.|++........ ..++.
T Consensus 120 ~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 120 LKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred HHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 344444444444443 111 2334445555555555544422221 12344455555555554432111111 13455
Q ss_pred CcEeeccCCccc
Q 001426 356 LKQLELDNNRFF 367 (1079)
Q Consensus 356 L~~L~L~~N~l~ 367 (1079)
|+.|.|+.|.++
T Consensus 199 lK~L~l~~CGls 210 (505)
T KOG3207|consen 199 LKQLVLNSCGLS 210 (505)
T ss_pred hheEEeccCCCC
Confidence 555555555553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.1e-10 Score=128.70 Aligned_cols=248 Identities=21% Similarity=0.216 Sum_probs=170.2
Q ss_pred hhCCCCCCeeeecCcEEEEEEEe--CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeEEEcCCeEE
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI--PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 757 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 833 (1079)
..+|..+..||.|.|+.|++... .++..|++|...........+.. -..|+.+...+ -|.+++..+..+...+..|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 35677788999999999999854 46788999877543322222211 13455555555 5888998888888888888
Q ss_pred EEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCC-CcEEEeecccccccc
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ-FEAFLADFGLAKLFE 912 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~~~~ 912 (1079)
+--|||++++..... .-...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.++.+.
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccc
Confidence 999999999888777 2233477788899999999999999998 99999999999999886 788999999986422
Q ss_pred CCcccccccccccCccc-ccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCcchHHHHHHhHHhhhhhchhhh
Q 001426 913 SSESSRASNSVAGSYGY-IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
- ........+..| .+|+......+..++|+||||.-+.|.++|..--.. +........+....
T Consensus 419 ~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~~~~~i~~~~~p~-------- 482 (524)
T KOG0601|consen 419 F----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----GVQSLTIRSGDTPN-------- 482 (524)
T ss_pred e----ecccccccccccccchhhccccccccccccccccccccccccCcccCcc----cccceeeecccccC--------
Confidence 1 111112223344 356666677888999999999999999988654322 11111111110000
Q ss_pred hhhhhhcccCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 1036 (1079)
... .......+.+.+..+++..||.+.+.....+
T Consensus 483 --------~~~---~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 --------LPG---LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --------CCc---hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 000 0123344556678899999999888765544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.5e-10 Score=134.24 Aligned_cols=207 Identities=24% Similarity=0.280 Sum_probs=148.3
Q ss_pred hCCCCCCeeeecCcEEEEEEEeC-CCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEcCCeEEEEE
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
+.+.+.+.+-+|+++.++.+.-. .+...+.|.......-.....+....+-.+.-..+||-+++....+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 45566678889999999987543 23333333221111111112223333434444456788887776666777889999
Q ss_pred EecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC--
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS-- 914 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~-- 914 (1079)
+|+.++++...++..+. .+.+........+..+.+|||.. .++|||++|.|.+...++..+++|||.......-
T Consensus 884 ~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred HHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999988764 44444555667788899999998 7899999999999999999999999844322110
Q ss_pred -------------------c--------ccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 001426 915 -------------------E--------SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRI 967 (1079)
Q Consensus 915 -------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p~~~~~ 967 (1079)
. .........+|+.|.|||...+......+|.|+.|++++|.++|..||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0011233568999999999999999999999999999999999999998755
Q ss_pred C
Q 001426 968 P 968 (1079)
Q Consensus 968 ~ 968 (1079)
+
T Consensus 1040 p 1040 (1205)
T KOG0606|consen 1040 P 1040 (1205)
T ss_pred h
Confidence 4
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-10 Score=131.44 Aligned_cols=128 Identities=34% Similarity=0.422 Sum_probs=78.2
Q ss_pred cccEEecCCCcCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEecccccccCCCCCcccccccccccccc
Q 001426 498 QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLS 577 (1079)
Q Consensus 498 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 577 (1079)
.|...+.++|++. .+..++.-++.|+.|||++|+++.. +.+..++.|++|||++|.|+.++--....+. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4566666677665 5555666666666777777766644 2556666666666666666644322233333 6666666
Q ss_pred CccccCCChhhhhcccchhhhhcccCCcccccccccccCCCcccEEeccCcccccc--ccccCcccccceeeccCCcCcC
Q 001426 578 SNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGS--LKVLGSLDNLVSLNVSYNHFSG 655 (1079)
Q Consensus 578 ~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~~~~~~l~~L~~L~ls~N~l~~ 655 (1079)
+|.++ .. ..+.+|++|+.||+++|-|++. ...++.|..|..|+|.+|++..
T Consensus 241 nN~l~-------------------------tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 241 NNALT-------------------------TL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ccHHH-------------------------hh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 66554 11 1245667777777777777763 3346677777777777777765
Q ss_pred C
Q 001426 656 I 656 (1079)
Q Consensus 656 ~ 656 (1079)
-
T Consensus 294 ~ 294 (1096)
T KOG1859|consen 294 A 294 (1096)
T ss_pred C
Confidence 3
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.1e-09 Score=86.62 Aligned_cols=60 Identities=37% Similarity=0.565 Sum_probs=32.8
Q ss_pred CCCcccccccccccccccccccCCCCceEecccccccCCCCCccccccccccccccCccc
Q 001426 522 GLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581 (1079)
Q Consensus 522 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 581 (1079)
+|++|++++|+|+.+.+..|.++++|++|++++|+|+.+.+.+|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 345555555555544444555555555555555555555555555555555555555543
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.7e-08 Score=96.58 Aligned_cols=129 Identities=20% Similarity=0.263 Sum_probs=83.7
Q ss_pred EEEEEEeCCCCeEEEEEeccccC------------CC-----------chhHHHHHHHHHHHhcCCCC--ceeeeeeEEE
Q 001426 773 IVYRVEIPSRQVIAVKKLWPVKN------------GE-----------LPERDQFSAEVQTLGSIRHK--NIVRLLGCCN 827 (1079)
Q Consensus 773 ~Vy~~~~~~~~~vavK~~~~~~~------------~~-----------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 827 (1079)
.||.|...+|..+|+|+.+.... .. .......++|++.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999999999999998753210 00 01124577899999999866 455666442
Q ss_pred cCCeEEEEEEecC--CCChhhhhhccCcCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEeCCCCCCeEECCCCcEEEee
Q 001426 828 NGRTRLLLFDYIS--NGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAY-LHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904 (1079)
Q Consensus 828 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~-LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 904 (1079)
..++||||++ |..+..+....- +.+....++.+++..+.. +|.. ||||||+.+.||+++++ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~---~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDL---SPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGG---GGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhccc---cchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEe
Confidence 3479999998 655554443221 123345577778776666 4677 99999999999999988 999999
Q ss_pred cccccccc
Q 001426 905 FGLAKLFE 912 (1079)
Q Consensus 905 FGla~~~~ 912 (1079)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.8e-09 Score=84.65 Aligned_cols=60 Identities=40% Similarity=0.529 Sum_probs=37.3
Q ss_pred cccEEecCCCcCcccCChhhhhhcCCCcccccccccccccccccccCCCCceEecccccc
Q 001426 498 QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNI 557 (1079)
Q Consensus 498 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 557 (1079)
+|++|++++|+|+...+++|.++++|++|++++|+|+.+.+.+|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666655555666666666666666666655556666666666666666654
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=6.8e-07 Score=96.46 Aligned_cols=262 Identities=16% Similarity=0.193 Sum_probs=154.9
Q ss_pred CCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcC-CCCceeeeeeE------E-EcCCeE
Q 001426 761 SDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGC------C-NNGRTR 832 (1079)
Q Consensus 761 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~-~~~~~~ 832 (1079)
.....+|+|+-+.+|-..--.+. +.|+++...... -.+.+..|... .||-+-.-+.| . ..+...
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~--VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQ--VAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecchhhch--hheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 44567999999999975322222 446664332211 11122333333 56543332222 1 122336
Q ss_pred EEEEEecCCCChhhhhh------ccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeecc
Q 001426 833 LLLFDYISNGSLAGLLH------EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFG 906 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG 906 (1079)
.+.|..+.+.--...+. +.-....|....++++.++.+.+.||+. |.+-+|+.++|+|+++++.|.+.|=.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 78888877642222221 1233478999999999999999999999 99999999999999999999998765
Q ss_pred ccccccCCcccccccccccCccccccccc-----CCCCCCccchHHHHHHHHHHHHhC-CCCCCCCCC---CcchHH-HH
Q 001426 907 LAKLFESSESSRASNSVAGSYGYIAPEYG-----YSLKITEKSDVYSYGVVLLEVLTG-KEPTDSRIP---DGAHII-TW 976 (1079)
Q Consensus 907 la~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvil~el~tg-~~p~~~~~~---~~~~~~-~~ 976 (1079)
.-... ........-+|...|.+||.. .+...+...|.|.+||++++++.| ++||.+... ...... .+
T Consensus 163 sfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 163 SFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred ceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 43222 112233345788999999963 345667889999999999999985 999976321 100011 11
Q ss_pred HHhHHhhhhhchhhhhhhhhhccc-CccHHH-HHHHHHHHHhccCC--CCCCCCCHHHHHHHHHhcccc
Q 001426 977 VNGELRERKREFTTILDRQLLMRS-GTQIQE-MLQVLGVALLCVNP--CPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~l~~l~~~Cl~~--dP~~RPt~~evl~~L~~~~~~ 1041 (1079)
..+.+-.-.. -.+.....+ ...... ...+.-+..+|+.. .|.-|||++..+..|..+.++
T Consensus 240 a~g~f~ya~~-----~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 240 AHGRFAYASD-----QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hcceeeechh-----ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 1111111000 000000000 001111 11333455667763 356899999999999887655
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-08 Score=76.15 Aligned_cols=41 Identities=34% Similarity=0.866 Sum_probs=30.0
Q ss_pred ChhhHHHHHHHhhCCCCCCCccccCCCCCC-CCCCccceeeec
Q 001426 25 NPEGLSLLSWLSTFNSSSSATFFSSWNPSH-RNPCNWDYIKCS 66 (1079)
Q Consensus 25 ~~~~~~ll~~~~~~~~~~~~~~l~sW~~~~-~~~c~W~gv~C~ 66 (1079)
+.|.+||++||.++..+ +...+++|+... .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~-~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNND-PSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-S-C-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccc-cCcccccCCCcCCCCCeeeccEEeC
Confidence 46889999999999754 478999999864 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.66 E-value=8.4e-07 Score=98.50 Aligned_cols=168 Identities=17% Similarity=0.267 Sum_probs=128.7
Q ss_pred CcEEEEEEEe-CCCCeEEEEEeccccCCCchhHHHHHHHHHHHhcCCCCceeeeeeEEEc----CCeEEEEEEecCC-CC
Q 001426 770 VSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN----GRTRLLLFDYISN-GS 843 (1079)
Q Consensus 770 ~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~ 843 (1079)
--.+.||+.. .+|..|+.|+++..+.... .....-+++++++.|.|+|++.+++.. +-.+++||+|+++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 3457888854 5899999999854333322 233456789999999999999999863 3457999999986 47
Q ss_pred hhhhhhc--------------cCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccc
Q 001426 844 LAGLLHE--------------KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 844 L~~~l~~--------------~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~ 909 (1079)
|.++-.. .+...++..+|.++.|+..||.++|+. |+.-+-+.+++|+++.+.+++|+..|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 7776532 234578899999999999999999999 99999999999999999999999888876
Q ss_pred cccCCcccccccccccCcccccccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 001426 910 LFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962 (1079)
Q Consensus 910 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el~tg~~p 962 (1079)
.+..+.. |.+ .-..+-|.=.+|.++..|.||+.-
T Consensus 442 vl~~d~~----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 442 VLQEDPT----------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eecCCCC----------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 5544320 111 123467999999999999999765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.3e-07 Score=98.57 Aligned_cols=143 Identities=15% Similarity=0.094 Sum_probs=100.6
Q ss_pred CeeeecCcEEEEEEEeCCCCeEEEEEeccccCCC-c-------hhHHHHHHHHHHHhcCCCCc--eeeeeeEEEc-----
Q 001426 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGE-L-------PERDQFSAEVQTLGSIRHKN--IVRLLGCCNN----- 828 (1079)
Q Consensus 764 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~-------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 828 (1079)
+.+-+.....|+++++ +|+.|.||......... . .....+.+|...+.++...+ ..+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555556777766 46678999763211000 0 01124789999998885443 3344555543
Q ss_pred CCeEEEEEEecCCC-Chhhhhhcc-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECC-------CCc
Q 001426 829 GRTRLLLFDYISNG-SLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-------QFE 899 (1079)
Q Consensus 829 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~ 899 (1079)
...-++|||++++. +|.+++... ....+...+..++.+++..+.-||.. ||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23468999999986 898888532 23355667778999999999999999 9999999999999975 468
Q ss_pred EEEeecccccc
Q 001426 900 AFLADFGLAKL 910 (1079)
Q Consensus 900 ~kl~DFGla~~ 910 (1079)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.4e-07 Score=95.58 Aligned_cols=137 Identities=21% Similarity=0.228 Sum_probs=98.5
Q ss_pred CCCCeeeecCcEEEEEEEeCCCCeEEEEEecc-------cc----------CCC--chhHHHHHHHHHHHhcCCCC--ce
Q 001426 761 SDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWP-------VK----------NGE--LPERDQFSAEVQTLGSIRHK--NI 819 (1079)
Q Consensus 761 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~-------~~----------~~~--~~~~~~~~~E~~~l~~l~h~--ni 819 (1079)
.+.+.||.|--+.||.|...+|..+|||.-+. .+ ..+ ...+..-++|.++|.++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34578999999999999999999999996321 11 011 11234567899999998655 66
Q ss_pred eeeeeEEEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCc
Q 001426 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFE 899 (1079)
Q Consensus 820 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 899 (1079)
.+.+++ ....+||||++|-.|...-- +.+....++..|++-+.-.-.. ||||+|+.+-||++++||.
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCC
Confidence 666654 45689999999966655431 2223334555555555555556 9999999999999999999
Q ss_pred EEEeecccccc
Q 001426 900 AFLADFGLAKL 910 (1079)
Q Consensus 900 ~kl~DFGla~~ 910 (1079)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2e-07 Score=108.36 Aligned_cols=157 Identities=18% Similarity=0.232 Sum_probs=102.9
Q ss_pred CHHHHhhCCCCCCeeeecCcEEEEEEEeCCCCeEEEEEeccccCCC--------------------------c-hhH---
Q 001426 752 SVDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGE--------------------------L-PER--- 801 (1079)
Q Consensus 752 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~-~~~--- 801 (1079)
.+++...+|+. +.|+.++-|.||+|++++|+.||||+.++..... . ...
T Consensus 120 ~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~ 198 (517)
T COG0661 120 PIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEF 198 (517)
T ss_pred CHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHH
Confidence 45555556654 6899999999999999999999999876543100 0 001
Q ss_pred -------HHHHHHHHHHhcCC-----CCceeeeeeEEEcCCeEEEEEEecCCCChhhhhhccCcCCCHHHHHHHHHHHHH
Q 001426 802 -------DQFSAEVQTLGSIR-----HKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAH 869 (1079)
Q Consensus 802 -------~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~ 869 (1079)
-++.+|...+.+++ .+++.-..=|..-.....++|||++|-.+.+...-+....+.+.+.....++.
T Consensus 199 ~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f- 277 (517)
T COG0661 199 EKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF- 277 (517)
T ss_pred HHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH-
Confidence 12445555555552 33433222233334567899999999999988532323345333322222211
Q ss_pred HHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCC
Q 001426 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 870 gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~ 914 (1079)
+..+-.. |++|.|.+|.||+++.+|++.+.|||+...+.+.
T Consensus 278 -~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 278 -LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred -HHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 2333334 8999999999999999999999999999877654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.6e-09 Score=121.36 Aligned_cols=126 Identities=30% Similarity=0.335 Sum_probs=83.3
Q ss_pred ccCeeeeccCcccCCCCCCCCCCCcccEEecCCCcCcccCChhhhhhcCCCccccccccccccccc-ccccCCCCceEec
Q 001426 474 RLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPE-NLGKLTSLNKLVL 552 (1079)
Q Consensus 474 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L 552 (1079)
+|...+.+.|.++ .+...+.-++.|+.|||++|+++.. +.+..++.|++|||++|++.. +|. ...++. |+.|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhhh-heeeee
Confidence 5677777777777 5566666677778888888887644 367777788888888888773 333 223333 888888
Q ss_pred ccccccCCCCCccccccccccccccCccccCCC-hhhhhcccchhhhhcccCCccc
Q 001426 553 SKNNITGLIPKSLGLCKDLQLLDLSSNRINGSI-PEEIGRLQGLDILLNLSWNALT 607 (1079)
Q Consensus 553 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~~L~l~~N~l~ 607 (1079)
++|.++.+ ..+.+|++|+.||+|+|-|.+.- -..+..|..| +.|+|.+|.+-
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L-~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSL-IVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHH-HHHhhcCCccc
Confidence 88888765 45677788888888888776421 1223444444 34466666655
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.5e-06 Score=85.55 Aligned_cols=141 Identities=15% Similarity=0.048 Sum_probs=102.7
Q ss_pred eeecCcEEEEEEEeCCCCeEEEEEeccccCCC---chhHHHHHHHHHHHhcCCCC--ceeeeeeEEEc----CCeEEEEE
Q 001426 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGE---LPERDQFSAEVQTLGSIRHK--NIVRLLGCCNN----GRTRLLLF 836 (1079)
Q Consensus 766 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----~~~~~lv~ 836 (1079)
-|+|+-+.|++....+. .+-+|.-......+ ......|.+|+..+.++... .+.++..+... ...-++|+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 37789999999887655 57888653111111 22457899999999998533 34444422211 12347999
Q ss_pred EecCC-CChhhhhhccC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCc--EEEeecccccc
Q 001426 837 DYISN-GSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFE--AFLADFGLAKL 910 (1079)
Q Consensus 837 e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DFGla~~ 910 (1079)
|.+++ -+|.+++.+.. ...+...+..++.+++..++-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98764 48888886542 2467777889999999999999999 9999999999999987666 99999987653
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.3e-09 Score=107.14 Aligned_cols=224 Identities=20% Similarity=0.163 Sum_probs=119.5
Q ss_pred cEEEcCCCcccccCCcccccc--CCCCEEeccCCcccCCCCcccCCc--CcccEEeccCCcccc-cCccccccccccceE
Q 001426 92 TSLVLSNANLTGEIPPAIGNL--SSLINLDLSFNALTGNIPEEIGKL--AELELLSLNSNSIHG-GIPREIGNCSKLRRL 166 (1079)
Q Consensus 92 ~~L~L~~~~l~~~~p~~l~~l--~~L~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L 166 (1079)
+.||+.+.++. |..++.+ ....++.+..--+...--.+.... +.||+||||...|+- .+-.-+..+++|+-|
T Consensus 139 ~~lDl~~r~i~---p~~l~~l~~rgV~v~Rlar~~~~~prlae~~~~frsRlq~lDLS~s~it~stl~~iLs~C~kLk~l 215 (419)
T KOG2120|consen 139 QTLDLTGRNIH---PDVLGRLLSRGVIVFRLARSFMDQPRLAEHFSPFRSRLQHLDLSNSVITVSTLHGILSQCSKLKNL 215 (419)
T ss_pred eeeccCCCccC---hhHHHHHHhCCeEEEEcchhhhcCchhhhhhhhhhhhhHHhhcchhheeHHHHHHHHHHHHhhhhc
Confidence 45666655543 5555555 334444444333321100111122 358888888877763 233345667888888
Q ss_pred ecccccccCCCChhhchhhhHHHHHhCCCCCcccCCCcc-cccccceeEeecccCCCccCCCcccccccccccccccccc
Q 001426 167 ELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE-ISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTAN 245 (1079)
Q Consensus 167 ~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~-l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~ 245 (1079)
.|.++++.+.+...+++-..|+.|+++++.++....... +.+|+.|..|+++-|.+....-..+
T Consensus 216 SlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~--------------- 280 (419)
T KOG2120|consen 216 SLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVTVA--------------- 280 (419)
T ss_pred cccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhhHH---------------
Confidence 888888887777788877778888877776554432222 3345555555555444432211100
Q ss_pred ccccCCcccccccccceeccccccc--cc-CCCcCccCCCCCCeEeccCcc-cCCCcCcccccCCCccEEEcccccccCc
Q 001426 246 ITGYIPEEIGNCSALENLFLYENQI--FG-KIPDELGSLKNLKRLLLWQNN-LSGSIPEALGNCSSLTVIDVSLNSLGGE 321 (1079)
Q Consensus 246 ~~~~~p~~l~~l~~L~~L~L~~n~l--~~-~~p~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 321 (1079)
-..++ ++|..|+|++..- .. .+..-..+.++|.+|||+.|. ++......|..++.|++|.++.+.. .
T Consensus 281 -----V~his--e~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY~--i 351 (419)
T KOG2120|consen 281 -----VAHIS--ETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCYD--I 351 (419)
T ss_pred -----Hhhhc--hhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehhhhcC--C
Confidence 00011 3455555555421 00 011112346677777776653 3433344566677777777776653 3
Q ss_pred cccc---cccccccceeecccccc
Q 001426 322 VPVS---LANLVALEELLLSGNNI 342 (1079)
Q Consensus 322 ~p~~---l~~l~~L~~L~Ls~N~l 342 (1079)
+|.. +...+.|.+|+..++--
T Consensus 352 ~p~~~~~l~s~psl~yLdv~g~vs 375 (419)
T KOG2120|consen 352 IPETLLELNSKPSLVYLDVFGCVS 375 (419)
T ss_pred ChHHeeeeccCcceEEEEeccccC
Confidence 4443 45667777777776643
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1e-07 Score=96.60 Aligned_cols=227 Identities=25% Similarity=0.290 Sum_probs=153.1
Q ss_pred ccccCCCCEEeccCCcccC----CCCcccCCcCcccEEeccCCc---ccccCcc-------ccccccccceEeccccccc
Q 001426 109 IGNLSSLINLDLSFNALTG----NIPEEIGKLAELELLSLNSNS---IHGGIPR-------EIGNCSKLRRLELYDNQLS 174 (1079)
Q Consensus 109 l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~L~~n~---l~~~~p~-------~~~~l~~L~~L~Ls~n~l~ 174 (1079)
+..+..++.+|||+|.|.. .+...|.+-.+|+..+++.-. ....+|. .+-+|++|+..+||+|.+.
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg 105 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG 105 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence 3456788888888888864 355566777888888887742 2233333 4457789999999999988
Q ss_pred CCCChhhchhhhHHHHHhCCCCCcccCCCcccccccceeEeecccCCCccCCCccccccccccccccccccccccCCccc
Q 001426 175 GNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI 254 (1079)
Q Consensus 175 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~L~~L~~L~l~~~~~~~~~p~~l 254 (1079)
...|..++.+ +++-+.|++|.+++|++...--.-++. .|.+|-. | ...
T Consensus 106 ~~~~e~L~d~---------------------is~~t~l~HL~l~NnGlGp~aG~rigk--al~~la~--n-------KKa 153 (388)
T COG5238 106 SEFPEELGDL---------------------ISSSTDLVHLKLNNNGLGPIAGGRIGK--ALFHLAY--N-------KKA 153 (388)
T ss_pred cccchHHHHH---------------------HhcCCCceeEEeecCCCCccchhHHHH--HHHHHHH--H-------hhh
Confidence 7777666543 445566888888888876332222221 2222211 1 123
Q ss_pred ccccccceecccccccccCCCcC-----ccCCCCCCeEeccCcccCCCcC-----cccccCCCccEEEcccccccCccc-
Q 001426 255 GNCSALENLFLYENQIFGKIPDE-----LGSLKNLKRLLLWQNNLSGSIP-----EALGNCSSLTVIDVSLNSLGGEVP- 323 (1079)
Q Consensus 255 ~~l~~L~~L~L~~n~l~~~~p~~-----l~~l~~L~~L~L~~n~l~~~~~-----~~l~~l~~L~~L~Ls~N~l~~~~p- 323 (1079)
.+-+.|+......|++. ..|.. +..-.+|+.+.+.+|.|.-... ..+..+.+|++|||.+|-++-...
T Consensus 154 a~kp~Le~vicgrNRle-ngs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~ 232 (388)
T COG5238 154 ADKPKLEVVICGRNRLE-NGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSR 232 (388)
T ss_pred ccCCCceEEEeccchhc-cCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHH
Confidence 45578999999999986 33332 3334689999999999873311 234567899999999999874433
Q ss_pred ---cccccccccceeecccccccccccccc------cccccCcEeeccCCcccc
Q 001426 324 ---VSLANLVALEELLLSGNNISGEIPSFF------GNFSRLKQLELDNNRFFG 368 (1079)
Q Consensus 324 ---~~l~~l~~L~~L~Ls~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~~ 368 (1079)
..++..+.|+.|.+..|-++......+ ...|+|..|-..+|.+.+
T Consensus 233 ~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~ 286 (388)
T COG5238 233 YLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRG 286 (388)
T ss_pred HHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcC
Confidence 345667779999999999986554332 235889999999998765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.7e-07 Score=106.35 Aligned_cols=100 Identities=27% Similarity=0.406 Sum_probs=77.3
Q ss_pred HHHHHHHHHHHHHhCCCCCeEEeCCCCCCeEECCCCcEEEeeccccccccCCcccc------c-ccccccCccccccccc
Q 001426 863 IILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR------A-SNSVAGSYGYIAPEYG 935 (1079)
Q Consensus 863 i~~~i~~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~------~-~~~~~gt~~y~aPE~~ 935 (1079)
=+.+++.|+.|+|.. .++||++|.|++|.++..+..||+.|+.+.......... . .........|.|||++
T Consensus 104 nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 344566999999988 499999999999999999999999999886544321111 1 1112245689999999
Q ss_pred CCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 001426 936 YSLKITEKSDVYSYGVVLLEVLT-GKEPTD 964 (1079)
Q Consensus 936 ~~~~~~~~sDvwSlGvil~el~t-g~~p~~ 964 (1079)
.....+.++|+||+|+++|.+.. |+.-+.
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhh
Confidence 98888999999999999999995 444443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1079 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-49 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-45 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-18 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-45 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 3e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-04 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 4e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1079 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 0.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-174 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-13 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-11 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-111 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-109 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-98 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-92 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-90 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-47 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-36 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-103 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-96 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-68 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-41 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-92 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 8e-92 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-91 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-81 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-68 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-32 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-87 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-74 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-42 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-21 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-77 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-75 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-73 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-69 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-12 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-05 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-75 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-67 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-30 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-71 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-67 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-58 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-55 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-50 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-58 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-54 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-53 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 9e-51 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-37 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 9e-12 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-57 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-56 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-50 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-36 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-18 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-55 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-53 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-49 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-49 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-46 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-34 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-18 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-55 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-54 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-53 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 8e-53 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-52 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-52 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-51 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-51 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-51 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 6e-50 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-49 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-49 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 9e-20 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-49 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-49 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-46 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-46 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-48 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-45 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-45 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-38 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-48 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-46 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 9e-45 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-40 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-40 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-10 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-45 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-34 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-32 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-25 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 8e-17 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-43 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-39 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-04 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-40 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-38 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-37 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-28 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-35 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-32 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-32 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-29 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-38 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-28 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-27 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-21 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 9e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-35 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-32 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-26 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-36 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-32 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-32 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-32 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-23 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-36 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-27 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-27 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-22 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-08 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-34 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-32 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-27 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-12 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-33 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 8e-33 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-32 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-27 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-27 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-26 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 9e-12 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-31 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-30 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-30 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-30 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-30 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-30 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 9e-30 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-25 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-25 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-09 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-09 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-29 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-29 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-29 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-29 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-29 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-29 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-29 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-29 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-29 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-29 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-29 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 5e-29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-25 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-20 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-20 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 9e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-26 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-25 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-15 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-28 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-28 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-28 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-28 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-28 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-28 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 4e-28 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-28 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-26 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-25 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-19 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 9e-19 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 8e-16 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-05 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-04 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 8e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-26 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-19 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-18 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-16 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-04 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 8e-28 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-28 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-27 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-27 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-20 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-10 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-27 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-20 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-05 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-27 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-27 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-27 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-27 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-27 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-27 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-27 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-27 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-27 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-27 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-27 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-27 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-27 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 6e-27 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-27 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 7e-27 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-26 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-26 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-26 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-26 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-26 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-26 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-26 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-26 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-23 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-21 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-18 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-11 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-26 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-26 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-26 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-26 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-25 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-16 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-12 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-25 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-25 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-25 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-25 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-25 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 6e-25 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 6e-25 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-25 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-21 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 9e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-12 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-25 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-24 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-24 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-24 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-21 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-21 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-11 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 5e-24 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 8e-24 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 9e-24 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-23 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-23 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-23 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-23 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-23 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-20 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-20 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-14 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-06 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-23 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-18 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-10 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-08 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-23 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-23 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-23 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-23 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-23 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-11 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-22 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-22 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-22 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-22 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-22 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-22 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-22 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-22 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-22 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-10 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-22 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-22 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-22 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 7e-22 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-18 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-10 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 5e-08 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-22 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-22 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 9e-22 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-21 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-21 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-21 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-21 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-21 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-21 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-21 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-20 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-20 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-20 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-20 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-19 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-19 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-12 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-19 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 9e-18 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-17 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-15 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 6e-07 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-19 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 5e-19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 9e-19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-08 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 8e-19 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 9e-19 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 9e-19 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 9e-19 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-18 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-18 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-18 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-18 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-18 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-18 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-18 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-18 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-18 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 7e-18 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-18 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-18 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-10 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-09 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 8e-18 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-17 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-17 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-17 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-17 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-17 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-17 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-09 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-08 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-07 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-17 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 8e-17 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 9e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-07 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-07 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-16 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-16 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-16 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-16 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-16 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 6e-16 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 6e-16 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 8e-16 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 9e-16 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-15 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-15 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-15 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-15 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 6e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 9e-11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-07 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 7e-15 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-14 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-14 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-14 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-14 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-14 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-14 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-14 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-14 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 6e-14 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 6e-14 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-13 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-13 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-13 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-13 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-13 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-13 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 3e-13 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 5e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-05 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-13 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-13 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 9e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 7e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 9e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-06 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 7e-13 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 8e-13 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-12 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 8e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-04 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-12 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-04 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-12 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-12 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-12 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-12 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-12 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-12 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-11 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-11 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-04 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-11 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-04 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 9e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 9e-05 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-11 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 9e-11 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 4e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-10 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-10 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-10 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-09 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 1e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-04 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 9e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-04 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 9e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 6e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-04 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-04 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 7e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-06 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 9e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 7e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 8e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 8e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 8e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 5e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-05 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 4e-05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 6e-04 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 6e-05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 9e-05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 3e-04 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 7e-05 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-04 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 5e-04 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 8e-04 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 9e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 583 bits (1504), Expect = 0.0
Identities = 195/606 (32%), Positives = 297/606 (49%), Gaps = 23/606 (3%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAI---GNLSSLINLDLSFNALTGNIPEEIGKLAELEL 141
L + L L LS +++G L +L +S N ++G++ + + LE
Sbjct: 147 GLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEF 204
Query: 142 LSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGE 201
L ++SN+ GIP +G+CS L+ L++ N+LSG+ I L+++ N G
Sbjct: 205 LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN-QFVGP 262
Query: 202 IPEEISNCKVLVFLGLADTGISGQIPRSV-GELTNLRTLSVYTANITGYIPEEIGNCSAL 260
IP K L +L LA+ +G+IP + G L L + + G +P G+CS L
Sbjct: 263 IPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320
Query: 261 ENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCS-SLTVIDVSLNSL 318
E+L L N G++P + L ++ LK L L N SG +PE+L N S SL +D+S N+
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 319 GGEVPVSLAN--LVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQ 376
G + +L L+EL L N +G+IP N S L L L N G IP ++G
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440
Query: 377 LKELLLFFAWQNQLHGNIP-ELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISN 435
L +L W N L G IP EL Y L+ L L N LTG +PS L N NL + L +N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 436 RFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGN 495
R +GEIP IG L L+L +N+FSG+IP+ +G L +L+L+ N F G IP +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 496 CTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMN--SIGGTIPENLGKLTSLNKLVLS 553
+ + N + G ++ + N G E L +L++ N ++
Sbjct: 561 QSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 554 KNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPES 613
G + + LD+S N ++G IP+EIG + L +LNL N ++G IP+
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL-FILNLGHNDISGSIPDE 675
Query: 614 FSNLSKLANLDLSNNMLTGSL-KVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFY 672
+L L LDLS+N L G + + + +L L +++S N+ SG +P F P + F
Sbjct: 676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL 735
Query: 673 GNQQLC 678
N LC
Sbjct: 736 NNPGLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 528 bits (1362), Expect = e-174
Identities = 192/663 (28%), Positives = 297/663 (44%), Gaps = 55/663 (8%)
Query: 16 SLFPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTEIAITSI 75
+L E L+S+ + W+ + +NPC +D + C
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLPDKNL---LPDWSSN-KNPCTFDGVTCRD-------- 49
Query: 76 HIPTSFPYQLLSFSHLTSLVLSNANLT---GEIPPAIGNLSSLINLDLSFNALTGNIPEE 132
+TS+ LS+ L + ++ +L+ L +L LS + + G++
Sbjct: 50 -------------DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG- 95
Query: 133 IGKLAELELLSLNSNSIHGGIP--REIGNCSKLRRLELYDNQLSGNIPAEIG-QLEALEI 189
A L L L+ NS+ G + +G+CS L+ L + N L G +L +LE+
Sbjct: 96 FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155
Query: 190 IRAGGNPGIHGEIPEEI---SNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANI 246
+ N I G C L L ++ ISG + V NL L V + N
Sbjct: 156 LDLSAN-SISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNF 212
Query: 247 TGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCS 306
+ IP +G+CSAL++L + N++ G + + LK L + N G IP
Sbjct: 213 STGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLK 269
Query: 307 SLTVIDVSLNSLGGEVPVSLA-NLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR 365
SL + ++ N GE+P L+ L L LSGN+ G +P FFG+ S L+ L L +N
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 366 FFGQIPP-TIGQLKELLLFFAWQNQLHGNIP-ELAYC-VKLQALDLSHNFLTGSVPSSLF 422
F G++P T+ +++ L + N+ G +P L L LDLS N +G + +L
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 389
Query: 423 N--LKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLEL 480
L +L L +N F+G+IPP + C+ L+ L L N SG IPS +G L +L L+L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 481 SENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPEN 540
N GEIP E+ LE + L N L G IPS L LN + LS N + G IP+
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 541 LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLN 600
+G+L +L L LS N+ +G IP LG C+ L LDL++N NG+IP + + G
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----- 564
Query: 601 LSWNALTGPIPESFSNLSKLANLDLSNNM--LTGSL-KVLGSLDNLVSLNVSYNHFSGIL 657
++ N + G N + N+ G + L L N++ + G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 658 PNT 660
T
Sbjct: 625 SPT 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-13
Identities = 30/97 (30%), Positives = 44/97 (45%), Gaps = 8/97 (8%)
Query: 574 LDLSSNRIN---GSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNML 630
+DLSS +N ++ + L GL+ L LS + + G + F + L +LDLS N L
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESL-FLSNSHINGSVSG-FKCSASLTSLDLSRNSL 112
Query: 631 TGSL---KVLGSLDNLVSLNVSYNHFSGILPNTKLFH 664
+G + LGS L LNVS N +
Sbjct: 113 SGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK 149
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-11
Identities = 19/78 (24%), Positives = 34/78 (43%), Gaps = 1/78 (1%)
Query: 590 GRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVS 649
++ +D L + N + S +L+ L +L LSN+ + GS+ +L SL++S
Sbjct: 50 DKVTSID-LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLS 108
Query: 650 YNHFSGILPNTKLFHGLP 667
N SG +
Sbjct: 109 RNSLSGPVTTLTSLGSCS 126
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-111
Identities = 92/584 (15%), Positives = 190/584 (32%), Gaps = 58/584 (9%)
Query: 109 IGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGG----IPREIGNCSKLR 164
+ + + L L +G +P+ IG+L ELE+L+L S+ P+ I
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 165 RLELYDNQLSGNIPAEIGQLEALEIIR-AGGNPGIHGEIPEEISNCKVLVFLGLADTGIS 223
+ + + + ++I+ + I + +G I+
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 224 GQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKN 283
+ ++V LT LR + + E E Y+ + +LK+
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKD 250
Query: 284 LKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNIS 343
L + ++ +P L + +I+V+ N ++ E+L
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACN-----------RGISGEQLKDDWQA-- 297
Query: 344 GEIPSFFGNFSRLKQLELDNNRFF-GQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVK 402
+ +++ + + N + ++ ++K+L + NQL G +P +K
Sbjct: 298 ---LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIK 354
Query: 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPP--EIGGCTGLIRLRLGSNN 460
L +L+L++N +T + + + L N+ IP + + + + N
Sbjct: 355 LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNE 413
Query: 461 FSG-------HIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQG-- 511
+ ++ + LS NQ + + L ++L N L
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473
Query: 512 -----TIPSSLEFLFGLNVLDLSMNSIGGTIPE-NLGKLTSLNKLVLSKNNITGLIPKSL 565
+ + + L +DL N + + L L + LS N+ + P
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQP 532
Query: 566 GLCKDLQLL------DLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSK 619
L+ D NR PE I L L + N + + E
Sbjct: 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ-LQIGSNDIRK-VNEKI--TPN 588
Query: 620 LANLDLSNNMLTG-SLKVLGSLDNLVSLNVSYNHFSGILPNTKL 662
++ LD+ +N L + + Y+ I L
Sbjct: 589 ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDAL 632
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 355 bits (914), Expect = e-109
Identities = 132/606 (21%), Positives = 215/606 (35%), Gaps = 43/606 (7%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE 138
T P L +++T L L++ L S L +LD+ FN ++ PE KL
Sbjct: 17 TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM 74
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
L++L+L N + + C+ L L L N + + + L + N G+
Sbjct: 75 LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN-GL 133
Query: 199 HGEIPEEISNCKVLVFLGLADTGISGQIPR--SVGELTNLRTLSVYTANITGYIPEEIGN 256
+ L L L++ I + ++L+ L + + I + P
Sbjct: 134 SSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHA 193
Query: 257 CSALENLFLYENQIFGKIPDELG---SLKNLKRLLLWQNNLSGSIPEALGNC--SSLTVI 311
L LFL Q+ + ++L + +++ L L + LS + ++LT++
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253
Query: 312 DVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIP 371
D+S N+L S A L LE L NNI ++ L L + I
Sbjct: 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS 313
Query: 372 PTIGQLKELLLFFAWQNQLHGNIPE-LAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQL 430
L + L+ L++ N + G + L NL L
Sbjct: 314 ---------------LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL 358
Query: 431 LLISNRFSGEIPPEIG----GCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFT 486
L ++ S + L L L N S L L L+L N+
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418
Query: 487 GEIPP-EIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG--TIPENLGK 543
E+ E + + L NK +S + L L L ++ + P
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
Query: 544 LTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRIN--------GSIPEEIGRLQGL 595
L +L L LS NNI + L + L++LDL N + G + L L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG-SLKVLGSLDNLVSLNVSYNHFS 654
IL NL N E F +L +L +DL N L V + +L SLN+ N +
Sbjct: 539 HIL-NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT 597
Query: 655 GILPNT 660
+
Sbjct: 598 SVEKKV 603
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = 1e-98
Identities = 121/610 (19%), Positives = 196/610 (32%), Gaps = 58/610 (9%)
Query: 76 HIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGK 135
I P L L L + L+ ++L L L N++ K
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 136 LAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIG--QLEALEIIRAG 193
L L L+ N + L+ L L +N++ E+ +L+ +
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 194 GNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGE---LTNLRTLSVYTANITGYI 250
N I P L L L + + + + T++R LS+ + ++
Sbjct: 180 SNQ-IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238
Query: 251 PEEIGNC--SALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSL 308
+ L L L N + D L L+ L NN+ +L ++
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298
Query: 309 TVID---------VSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQL 359
++ +SL SL S L LE L + N+I G + F LK L
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL 358
Query: 360 ELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPS 419
L N+ + L L L+L+ N ++
Sbjct: 359 SLSNSFTSLR-------------------TLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 420 SLFNLKNLTQLLLISNRFSGEIPP-EIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFL 478
+ L +L L L N E+ E G + + L N + + L+ L L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 479 ELSENQFTG--EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGT 536
L P L ++DL N + LE L L +LDL N++
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA-- 517
Query: 537 IPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLD 596
L K+ G L L +L+L SN + E L L
Sbjct: 518 --------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 597 ILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG--SLKVLGSLDNLVSLNVSYNHFS 654
I+ +L N L F+N L +L+L N++T + NL L++ +N F
Sbjct: 564 II-DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
Query: 655 GILPNTKLFH 664
+ F
Sbjct: 623 CTCESIAWFV 632
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = 9e-92
Identities = 113/586 (19%), Positives = 188/586 (32%), Gaps = 74/586 (12%)
Query: 114 SLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQL 173
S D S LT +P+++ + +L+L N + S+L L++ N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 174 SGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGEL 233
S P +L L+++ N +S ++
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNE-------------------------LSQLSDKTFAFC 96
Query: 234 TNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNN 293
TNL L + + +I L L L N + L+NL+ LLL N
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 294 LSGSIPEALG--NCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFG 351
+ E L SSL +++S N + P + L L L+ + +
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216
Query: 352 NF---SRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDL 408
+ ++ L L N++ T LK L LDL
Sbjct: 217 LELANTSIRNLSLSNSQLSTTSNTTFLGLK---------------------WTNLTMLDL 255
Query: 409 SHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSN--------- 459
S+N L S L L L N + G + L L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 460 NFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEF 519
+ L L L + +N G L+ + L + ++ F
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 520 LF----GLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKS-LGLCKDLQLL 574
+ L++L+L+ N I + L L L L N I + +++ +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 575 DLSSNRINGSIPEEIGRLQGLDILLNLSWNALTG--PIPESFSNLSKLANLDLSNNMLTG 632
LS N+ + L L L AL P F L L LDLSNN +
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQR-LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 633 -SLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQL 677
+ +L L+ L L++ +N+ + + + G P G L
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHA--NPGGPIYFLKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 6e-90
Identities = 122/588 (20%), Positives = 192/588 (32%), Gaps = 73/588 (12%)
Query: 76 HIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIG- 134
I + +L +L LS+ L+ L +L L LS N + EE+
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167
Query: 135 -KLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAG 193
+ L+ L L+SN I P +L L L + QL ++ ++
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE--------- 218
Query: 194 GNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGEL--TNLRTLSVYTANITGYIP 251
+ L L+++ +S + L TNL L + N+
Sbjct: 219 -------------LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 252 EEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVI 311
+ LE FL N I L L N++ L L ++ SI
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI------------- 312
Query: 312 DVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIP 371
SL SL S L LE L + N+I G + F LK L L N+ +
Sbjct: 313 --SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR-- 368
Query: 372 PTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLL 431
L L L+L+ N ++ + L +L L
Sbjct: 369 -----------------TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 411
Query: 432 LISNRFSGEIPP-EIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTG--E 488
L N E+ E G + + L N + + L+ L L L
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 489 IPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSI--------GGTIPEN 540
P L ++DL N + LE L L +LDL N++ G
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
Query: 541 LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLN 600
L L+ L+ L L N + + +L+++DL N +N L LN
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS-LN 590
Query: 601 LSWNALTGPIPESFS-NLSKLANLDLSNNMLTGSLKVLGSLDNLVSLN 647
L N +T + F L LD+ N + + + N ++
Sbjct: 591 LQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-47
Identities = 77/275 (28%), Positives = 112/275 (40%), Gaps = 14/275 (5%)
Query: 401 VKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNN 460
V + D SH LT VP L N+T L L N+ + L L +G N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 461 FSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFL 520
S P L L L L N+ + CT L + L N +Q +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 521 FGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKD--LQLLDLSS 578
L LDLS N + T +L +L +L+LS N I L + L + + L+ L+LSS
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 579 NRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFS---NLSKLANLDLSNNMLTG-SL 634
N+I P + L L L+ L + E + + NL LSN+ L+ S
Sbjct: 181 NQIKEFSPGCFHAIGRLFG-LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 635 KVLGSLD--NLVSLNVSYNHFSGILPNTKLFHGLP 667
L NL L++SYN+ + + ++ F LP
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDS--FAWLP 272
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-36
Identities = 52/339 (15%), Positives = 96/339 (28%), Gaps = 41/339 (12%)
Query: 72 ITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLIN-------------- 117
I+ +P + L L + + ++ G L +L
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 118 --------------LDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIP-REIGNCSK 162
L+L+ N ++ + L LE+L L N I + +E
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 163 LRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHG--EIPEEISNCKVLVFLGLADT 220
+ + L N+ + +L+ + + P + L L L++
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA-LKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 221 GISGQIPRSVGELTNLRTLSVYTANIT--------GYIPEEIGNCSALENLFLYENQIFG 272
I+ + L L L + N+ G + S L L L N
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 273 KIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLA-NLVA 331
+ L LK + L NNL+ N SL +++ N +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 332 LEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQI 370
L EL + N S + + + +
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-103
Identities = 114/282 (40%), Positives = 171/282 (60%), Gaps = 13/282 (4%)
Query: 761 SDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
S+ NI+G+G G VY+ + ++AVK+L + + E QF EV+ + H+N++
Sbjct: 33 SNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERTQGGEL-QFQTEVEMISMAVHRNLL 90
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHD 877
RL G C RLL++ Y++NGS+A L E+ + LDW R +I LG A GLAYLH
Sbjct: 91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
C P IIHRD+K+ NIL+ +FEA + DFGLAKL + + + + +V G+ G+IAPEY +
Sbjct: 151 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLST 209
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIP---DGAHIITWVNGELRERKREFTTILDR 994
K +EK+DV+ YGV+LLE++TG+ D D ++ WV G L+E+K ++D
Sbjct: 210 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK--LEALVDV 267
Query: 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLK 1036
L + + +E+ Q++ VALLC P ERP M +V ML+
Sbjct: 268 DL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = 1e-96
Identities = 122/614 (19%), Positives = 192/614 (31%), Gaps = 57/614 (9%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE 138
P L +L LS L + + L LDLS + L+
Sbjct: 20 YKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
L L L N I S L++L + L+ IG L+ L+ + N
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 199 HGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLR----TLSVYTANITGYIPEEI 254
++PE SN L L L+ I + L + +L + + P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 255 GNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLW------QNNLSGSIPEALGNCSS 307
L L L N + + L L+ L + NL AL +
Sbjct: 198 KEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 308 LTVIDVSLNSL---GGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364
LT+ + L L ++ L + L I F + LEL N
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNC 314
Query: 365 RFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLT--GSVPSSLF 422
+F + LK L + GN L+ LDLS N L+ G S F
Sbjct: 315 KFGQFPTLKLKSLKRLTFT----SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 423 NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRI-GLLHRLTFLELS 481
+L L L N + G L L +N + L L +L++S
Sbjct: 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 482 ENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL 541
+ LE++ + N Q P+
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-----------------------PDIF 466
Query: 542 GKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNL 601
+L +L L LS+ + L P + LQ+L++S N L L + L+
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV-LDY 525
Query: 602 SWNALTGPIPESFSNL-SKLANLDLSNNMLTGSLKV---LGSLDNLVSLNVSYNHFSGIL 657
S N + + + S LA L+L+ N + + L + + L V
Sbjct: 526 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECAT 585
Query: 658 PNTKLFHGLPASAF 671
P+ G+P +
Sbjct: 586 PSD--KQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-68
Identities = 95/563 (16%), Positives = 177/563 (31%), Gaps = 85/563 (15%)
Query: 76 HIPTSFPYQLLSFSHLTSLVLSNANLTG-EIPPAIGNLSSLINLDLSFNALTGNIPEEIG 134
++ + + + L L +++ + ++P NL++L +LDLS N + ++
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 135 KLAELEL----LSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEII 190
L ++ L L L+ N ++ I +L +L L +N S N+
Sbjct: 171 VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVM------------ 217
Query: 191 RAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYI 250
I L L + + + L L
Sbjct: 218 ------------KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC---------- 255
Query: 251 PEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTV 310
N + E Y + I D L N+ L +
Sbjct: 256 -----NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQH 308
Query: 311 IDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR--FFG 368
+++ G + L +L L+ + G + L+ L+L N F G
Sbjct: 309 LELVNCKFGQFPTLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 369 QIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLT 428
+ L+ LDLS N + + S+ L+ L
Sbjct: 364 CCSQSDFGTT-----------------------SLKYLDLSFNGVIT-MSSNFLGLEQLE 399
Query: 429 QLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTG 487
L + + LI L + + L L L+++ N F
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 488 EIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTS 546
P+I L +DL Q +L+ P++ L L VL++S N+ L S
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519
Query: 547 LNKLVLSKNNITGLIPKSLG-LCKDLQLLDLSSNRINGSIPEE--IGRLQGLDILLNLSW 603
L L S N+I + L L L+L+ N + + + ++ LL +
Sbjct: 520 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLL-VEV 578
Query: 604 NALTGPIPESFSNLSKLANLDLS 626
+ P + + +L+++
Sbjct: 579 ERMECATPSDKQGMP-VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-41
Identities = 79/430 (18%), Positives = 132/430 (30%), Gaps = 34/430 (7%)
Query: 1 MSRNEITIIL--LFVNISL----------FPAISALNPEGLSLLSWLS-TFNSSSSATFF 47
+S N + I F I L + +GL+ L +
Sbjct: 184 LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 48 SSWNPSH-RNPCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIP 106
++ S CN + + I F ++++S L + +
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN----CLTNVSSFSLVSVTIERVKD 299
Query: 107 PAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRL 166
+L+L L L L S GG + L L
Sbjct: 300 --FSYNFGWQHLELVNCKFGQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL 352
Query: 167 ELYDNQLS--GNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISG 224
+L N LS G +L+ + N G+ + + L L + +
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN-GVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 225 QIPRSV-GELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKI-PDELGSLK 282
SV L NL L + + S+LE L + N PD L+
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 283 NLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNI 342
NL L L Q L P A + SSL V+++S N+ L +L+ L S N+I
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 343 SGEIPSFFGN-FSRLKQLELDNNRFFGQIPPT--IGQLKELLLFFAWQNQLHGNIPELAY 399
+ S L L L N F + +K+ ++ P
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590
Query: 400 CVKLQALDLS 409
+ + +L+++
Sbjct: 591 GMPVLSLNIT 600
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 4e-92
Identities = 92/292 (31%), Positives = 149/292 (51%), Gaps = 16/292 (5%)
Query: 750 NFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPE-RDQFSAEV 808
NF N +G+G G+VY+ + + +AVKKL + + E + QF E+
Sbjct: 26 NFDER---PISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEI 81
Query: 809 QTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLH--EKKVFLDWDSRYKIILG 866
+ + +H+N+V LLG ++G L++ Y+ NGSL L + L W R KI G
Sbjct: 82 KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG 141
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
A+G+ +LH + IHRDIKS NIL+ F A ++DFGLA+ E + ++ + G+
Sbjct: 142 AANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198
Query: 927 YGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR 986
Y+APE +IT KSD+YS+GVVLLE++TG D ++ E K
Sbjct: 199 TAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEIEDEEKT 256
Query: 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
+D+++ + + + VA C++ +RP +K V +L+E+
Sbjct: 257 -IEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 8e-92
Identities = 88/282 (31%), Positives = 139/282 (49%), Gaps = 14/282 (4%)
Query: 761 SDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
++G GV G VY+ + +A+K+ P +F E++TL RH ++V
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP--ESSQGIE-EFETEIETLSFCRHPHLV 98
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHD 877
L+G C+ +L++ Y+ NG+L L+ + + W+ R +I +G A GL YLH
Sbjct: 99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR 158
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
IIHRD+KS NIL+ F + DFG++K + + S V G+ GYI PEY
Sbjct: 159 A---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG-AHIITWVNGELRERKREFTTILDRQL 996
++TEKSDVYS+GVVL EVL + +P ++ W + I+D L
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH--NNGQLEQIVDPNL 273
Query: 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
+ + + + A+ C+ E+RP+M DV L+
Sbjct: 274 --ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 8e-91
Identities = 103/660 (15%), Positives = 199/660 (30%), Gaps = 86/660 (13%)
Query: 18 FPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTEIAITSIHI 77
+ + +L + + + + + N + + NW++ K +
Sbjct: 261 LKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTI-HSLNWNFNKELDMWGDQPGV-- 317
Query: 78 PTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLA 137
L + +T L L+ G +P AIG L+ L L ++ T + +
Sbjct: 318 ------DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL 371
Query: 138 ELELLSLNSNSIHGGIPRE-IGNCSKLRRLELYDNQLSGN---IPAEIGQLEALEIIRAG 193
++ + I + + +L +L + ++ N P + +L+ + G
Sbjct: 372 TPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIG 431
Query: 194 GNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEE 253
I + I L + A++ + + + A
Sbjct: 432 NLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELS 486
Query: 254 IGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSG---------SIPEALGN 304
N L ++ LY ++PD L L L+ L + N + +
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546
Query: 305 CSSLTVIDVSLNSLGG-EVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDN 363
+ + + N+L SL +V L L N + + + FG +L L+LD
Sbjct: 547 GPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDY 604
Query: 364 NRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF- 422
N+ +IP +++ L SHN L +P+
Sbjct: 605 NQ-IEEIPEDFCAF----------------------TDQVEGLGFSHNKLK-YIPNIFNA 640
Query: 423 -NLKNLTQLLLISNRFSGEIPPEIGG------CTGLIRLRLGSNNFSGHIPSRIGLLHRL 475
++ + + N+ I + L N +
Sbjct: 641 KSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699
Query: 476 TFLELSENQFT-------GEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEF--LFGLNVL 526
+ + LS N T N L +DL NKL ++ L L+ +
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758
Query: 527 DLSMNSIGGTIPENLGKLTSLNKLVLSK------NNITGLIPKSLGLCKDLQLLDLSSNR 580
D+S N + P + L + N I P + C L L + SN
Sbjct: 759 DVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 581 INGSIPEEIGRLQGLDILLNLSWNALT-GPIPESFSNLSKLA-NLDLSNNMLTGSLKVLG 638
I + E++ L I L+++ N + + L LG
Sbjct: 818 IR-KVDEKL--TPQLYI-LDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 3e-81
Identities = 89/546 (16%), Positives = 170/546 (31%), Gaps = 59/546 (10%)
Query: 142 LSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGE 201
+ + ++ N ++ L L G +P IGQL L+++ G +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHS-ETVS 362
Query: 202 IPEEISNCKVLVFLGLADTGISGQIPRSVG------ELTNLRTLSVYTANITGYIPEEIG 255
I + L++L ++ I ++
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 256 NCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSL 315
+ N+I I + L L+ + + + ++
Sbjct: 423 ISLKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-----DY 476
Query: 316 NSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIG 375
+S +NL L ++ L ++P F + L+ L + NR
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKA 535
Query: 376 QLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPS-SLFNLKNLTQLLLIS 434
L + K+Q + +N L S SL + L L +
Sbjct: 536 DWTRL-------------ADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVH 582
Query: 435 NRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIG-LLHRLTFLELSENQFTGEIPP-- 491
N+ G L L+L N IP ++ L S N+ IP
Sbjct: 583 NKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIF 638
Query: 492 EIGNCTQLEMVDLHQNKLQG---TIPSSLEFLFGLN--VLDLSMNSIGGTIPENLGKLTS 546
+ + VD NK+ I S++ G+N + LS N I E +
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698
Query: 547 LNKLVLSKNNITGL-------IPKSLGLCKDLQLLDLSSNRINGSIPEEI--GRLQGLDI 597
++ ++LS N +T + + L +DL N++ S+ ++ L L
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSN 757
Query: 598 LLNLSWNALTGPIPESFSNLSKL------ANLDLSNNMLTGSL-KVLGSLDNLVSLNVSY 650
+ ++S+N + P N S+L D N + + + +L+ L +
Sbjct: 758 M-DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815
Query: 651 NHFSGI 656
N +
Sbjct: 816 NDIRKV 821
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 247 bits (631), Expect = 1e-68
Identities = 77/455 (16%), Positives = 149/455 (32%), Gaps = 43/455 (9%)
Query: 245 NITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGN 304
++ N + L L G++PD +G L LK L ++ + S
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 305 CSSLTVIDVSLNSLGGEVP-VSLANLVALEELLLSGNNISGE---IPSFFGNFSRLKQLE 360
+ + + + + + L L L + I+ P + LK +
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ 429
Query: 361 LDN-NRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPS 419
+ N I I +L +L + + + + + + + + +
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV----DWEDANSDYAKQYENEEL 485
Query: 420 SLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSG---------HIPSRIG 470
S NLK+LT + L + ++P + L L + N +
Sbjct: 486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545
Query: 471 LLHRLTFLELSENQFTGEIPPE--IGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDL 528
++ + N E P + +L ++D NK+ + L L L
Sbjct: 546 TGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKL 602
Query: 529 SMNSIGGTIPENLGK-LTSLNKLVLSKNNITGLIPKSLGL--CKDLQLLDLSSNRINGSI 585
N I IPE+ + L S N + IP + +D S N+I GS
Sbjct: 603 DYNQI-EEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKI-GSE 659
Query: 586 PEEIGRLQGLDIL-----LNLSWNALTGPIPESFSNLSKLANLDLSNNMLT--------G 632
I + LS+N + E F+ S ++ + LSNN++T
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 633 SLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLP 667
+ L ++++ +N + + + LP
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLTSL-SDDFRATTLP 753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-32
Identities = 46/273 (16%), Positives = 91/273 (33%), Gaps = 15/273 (5%)
Query: 404 QALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSG 463
+ALD + ++ + N + + + + ++ + L L G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKEL-DMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 464 HIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPS-SLEFLFG 522
+P IG L L L + T +M + +++++ L++
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
Query: 523 LNVLDLSMNSI-----GGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLS 577
LN+ DL ++I I ++ ++ N IT I K++ LQ++ +
Sbjct: 398 LNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFA 456
Query: 578 SNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSL-KV 636
++ N + S+SNL L +++L N L
Sbjct: 457 NSPFTYDNIAVDWED------ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510
Query: 637 LGSLDNLVSLNVSYNHFSGILPNTKLFHGLPAS 669
L L L SLN++ N + L
Sbjct: 511 LYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 6e-87
Identities = 107/570 (18%), Positives = 191/570 (33%), Gaps = 45/570 (7%)
Query: 76 HIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGK 135
IP + P + L S L L +L LDL+ + +
Sbjct: 26 EIPGTLP------NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQS 79
Query: 136 LAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGN 195
L+ L L +N + + L+ L +S + + LE + G N
Sbjct: 80 QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
Query: 196 PGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVY-TANITGYIPEEI 254
I + + L L + I + L LS+ N I
Sbjct: 140 -HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGA 198
Query: 255 GNCSALENLFLYENQIFGKIPDELG--SLKNLKRLLLWQNNLSGSIPEALGNCS--SLTV 310
+ + ++L Q I L ++++L + P S+
Sbjct: 199 FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVES 258
Query: 311 IDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQI 370
I++ + + L+EL L+ ++S E+PS S LK+L L N+F
Sbjct: 259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC 317
Query: 371 PPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQ 429
+ L L + N + + NL+NL +
Sbjct: 318 QISASNFP-----------------------SLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 430 LLLISNR--FSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTG 487
L L + S ++ + L L L N +L L+L+ +
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 488 EIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTI---PENLGK 543
+ N L++++L + L + + L L L+L N +L
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474
Query: 544 LTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSW 603
L L LVLS +++ + + K + +DLS NR+ S E + L+G+ LNL+
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI--YLNLAS 532
Query: 604 NALTGPIPESFSNLSKLANLDLSNNMLTGS 633
N ++ +P LS+ ++L N L +
Sbjct: 533 NHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 2e-74
Identities = 105/482 (21%), Positives = 158/482 (32%), Gaps = 22/482 (4%)
Query: 201 EIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSAL 260
EIP + N L + + + L NL L + I + + L
Sbjct: 26 EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 261 ENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGG 320
+ L L N + L K LK L Q +S L N +L + + N +
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 321 EVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELD-NNRFFGQIPPTIGQLKE 379
L+ L N I + + L L+ N I P
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 380 LLLFFAWQNQLHGNIPE---LAYCVKLQALDLSHNFLTGSVPSSLFNLK--NLTQLLLIS 434
Q I + + L P+ L ++ + L
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 435 NRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIG 494
+ F +GL L L + + S +PS + L L L LS N+F
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 495 NCTQLEMVDLHQNKLQGTIPS-SLEFLFGLNVLDLSMNSIG--GTIPENLGKLTSLNKLV 551
N L + + N + + + LE L L LDLS + I L L+ L L
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382
Query: 552 LSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL--LNLSWNALTGP 609
LS N L ++ C L+LLDL+ R+ + Q L +L LNLS + L
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP--FQNLHLLKVLNLSHSLLDIS 440
Query: 610 IPESFSNLSKLANLDLSNNMLTG----SLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHG 665
+ F L L +L+L N L +L L L +S+ S I + F
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA--FTS 498
Query: 666 LP 667
L
Sbjct: 499 LK 500
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-42
Identities = 68/372 (18%), Positives = 119/372 (31%), Gaps = 55/372 (14%)
Query: 74 SIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEI 133
+ ++ L + S+ L S L LDL+ L+ +P +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 134 GKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAG 193
L+ L+ L L++N N L L + N +
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG--------------- 342
Query: 194 GNPGIHGEIPEEISNCKVLVFLGLADTGI--SGQIPRSVGELTNLRTLSVYTANITGYIP 251
+ N + L L L+ I S + L++L++L++
Sbjct: 343 ---------TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393
Query: 252 EEIGNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTV 310
E C LE L L ++ K +L LK L L + L S + +L
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH 453
Query: 311 IDVSLNSLGG---EVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFF 367
+++ N + SL L LE L+LS ++S F + + ++L +NR
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513
Query: 368 GQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNL 427
+ LK + L+L+ N ++ +PS L L
Sbjct: 514 SSSIEALSHLKGIY------------------------LNLASNHISIILPSLLPILSQQ 549
Query: 428 TQLLLISNRFSG 439
+ L N
Sbjct: 550 RTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-21
Identities = 52/271 (19%), Positives = 82/271 (30%), Gaps = 28/271 (10%)
Query: 74 SIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEI 133
I QL + SHL SL LS A L LDL+F L +
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420
Query: 134 -GKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRA 192
L L++L+L+ + + + L+ L L N + L
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL-------- 472
Query: 193 GGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPE 252
L L L+ +S + L + + + +T E
Sbjct: 473 --------------QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518
Query: 253 EIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVID 312
+ + + L L N I +P L L + + L QN L + N L
Sbjct: 519 ALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC----SNIYFLEWYK 573
Query: 313 VSLNSLGGEVPVSLANLVALEELLLSGNNIS 343
++ L N L + LS +S
Sbjct: 574 ENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 1e-77
Identities = 87/338 (25%), Positives = 138/338 (40%), Gaps = 55/338 (16%)
Query: 297 SIPEALGNCSSL----TVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGN 352
I + LGN ++L D + G + + + L LSG N+ P
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP----- 67
Query: 353 FSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSH-N 411
IP ++ L L L + N
Sbjct: 68 -----------------IPSSLANLP-----------------------YLNFLYIGGIN 87
Query: 412 FLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGL 471
L G +P ++ L L L + SG IP + L+ L N SG +P I
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 472 LHRLTFLELSENQFTGEIPPEIGNCTQL-EMVDLHQNKLQGTIPSSLEFLFGLNVLDLSM 530
L L + N+ +G IP G+ ++L + + +N+L G IP + L L +DLS
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSR 206
Query: 531 NSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIG 590
N + G G + K+ L+KN++ + +GL K+L LDL +NRI G++P+ +
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 591 RLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNN 628
+L+ L LN+S+N L G IP+ NL + +NN
Sbjct: 266 QLKFL-HSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 1e-75
Identities = 69/313 (22%), Positives = 114/313 (36%), Gaps = 52/313 (16%)
Query: 223 SGQIPRSVGELTNLRTLSVYTANITG--YIPEEIGNCSALENLFLY-ENQIFGKIPDELG 279
G + + + + L + N+ IP + N L L++ N + G IP +
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 280 SLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSG 339
L L L + N+SG+IP+ L +L +D S
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD------------------------FSY 134
Query: 340 NNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAY 399
N +SG +P + L + D NR G IP + G +L
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL------------------- 175
Query: 400 CVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSN 459
++ +S N LTG +P + NL NL + L N G+ G ++ L N
Sbjct: 176 ---FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 460 NFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEF 519
+ + + +GL L L+L N+ G +P + L +++ N L G IP
Sbjct: 232 SLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290
Query: 520 LFGLNVLDLSMNS 532
+V + N
Sbjct: 291 Q-RFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 2e-73
Identities = 72/326 (22%), Positives = 133/326 (40%), Gaps = 41/326 (12%)
Query: 27 EGLSLLSWLSTFNSSSSATFFSSWNPS-HRNPCNWDYIKCSR-------TEIAITSIHI- 77
+ +LL + ++ SSW P+ W + C + ++ +++
Sbjct: 7 DKQALLQIKKDLGNPTT---LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 78 -PTSFPYQLLSFSHLTSLVLSNAN-LTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGK 135
P P L + +L L + N L G IPPAI L+ L L ++ ++G IP+ + +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 136 LAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGN 195
+ L L + N++ G +P I + L + N++SG IP G L
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL-------- 175
Query: 196 PGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIG 255
+ ++ ++G+IP + L NL + + + G G
Sbjct: 176 ----------------FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFG 218
Query: 256 NCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSL 315
+ + + L +N + + ++G KNL L L N + G++P+ L L ++VS
Sbjct: 219 SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 316 NSLGGEVPVSLANLVALEELLLSGNN 341
N+L GE+P NL + + N
Sbjct: 278 NNLCGEIPQGG-NLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-69
Identities = 73/272 (26%), Positives = 103/272 (37%), Gaps = 30/272 (11%)
Query: 435 NRFSGEIPPEIGGCTGLIRLRLGSNNFSG--HIPSRIGLLHRLTFLELS-ENQFTGEIPP 491
+ G + + L L N IPS + L L FL + N G IPP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 492 EIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLV 551
I TQL + + + G IP L + L LD S N++ GT+P ++ L +L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 552 LSKNNITGLIPKSLGLCKDL-QLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPI 610
N I+G IP S G L + +S NR+ G IP L L + +LS N L G
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV-DLSRNMLEGDA 213
Query: 611 PESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILP------------ 658
F + + L+ N L L +G NL L++ N G LP
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 659 ------------NTKLFHGLPASAFYGNQQLC 678
SA+ N+ LC
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 22/78 (28%), Positives = 38/78 (48%), Gaps = 3/78 (3%)
Query: 84 QLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLS 143
++ +L L L N + G +P + L L +L++SFN L G IP+ G L ++ +
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSA 297
Query: 144 LNSNSIHGGIPREIGNCS 161
+N G P + C+
Sbjct: 298 YANNKCLCGSP--LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 14/66 (21%), Positives = 26/66 (39%), Gaps = 4/66 (6%)
Query: 599 LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKV---LGSLDNLVSLNVS-YNHFS 654
+ G + ++ + ++ NLDLS L + L +L L L + N+
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 655 GILPNT 660
G +P
Sbjct: 91 GPIPPA 96
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 2e-75
Identities = 119/590 (20%), Positives = 190/590 (32%), Gaps = 69/590 (11%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE 138
+ P + S ++ LS L + N S L LDLS + + L
Sbjct: 24 SKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHH 81
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
L L L N I P + L L + +L+ IGQL L+ + N
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141
Query: 199 HGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCS 258
++P SN LV + L+ I + L +
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV------------------- 182
Query: 259 ALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPE-ALGNCSSLTVIDVSLNS 317
+L + N I I D+ L L L N S +I + L N + L V + L
Sbjct: 183 -NLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGE 240
Query: 318 LGGEVPVS------LANLVAL--EELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQ 369
E + + L + +E L+ N + F + + + L
Sbjct: 241 FKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-- 298
Query: 370 IPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQ 429
+ ++ K Q+L + L +L L
Sbjct: 299 -----------------------YLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKS 332
Query: 430 LLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFS--GHIPSRIGLLHRLTFLELSENQFTG 487
L L N+ S I + L L L N S G + L L+LS N
Sbjct: 333 LTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI- 389
Query: 488 EIPPEIGNCTQLEMVDLHQNKLQGTIP-SSLEFLFGLNVLDLSMNSIGGTIPENLGKLTS 546
+ +L+ +D + L+ S+ L L LD+S + LTS
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449
Query: 547 LNKLVLSKNNITGLIPKS-LGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNA 605
LN L ++ N+ + +L LDLS ++ L L LLN+S N
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL-QLLNMSHNN 508
Query: 606 LTGPIPESFSNLSKLANLDLSNNMLTG-SLKVLGSLDNLVSLNVSYNHFS 654
L ++ L L+ LD S N + + +L N++ N +
Sbjct: 509 LLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 8e-67
Identities = 111/573 (19%), Positives = 197/573 (34%), Gaps = 59/573 (10%)
Query: 103 GEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSK 162
G + P I + ++ L+ +P++I + + + L+ N + N S+
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 163 LRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGI 222
L+ L+L ++ L L + GNP I P S L L +T +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP-IQSFSPGSFSGLTSLENLVAVETKL 116
Query: 223 SGQIPRSVGELTNLRTLSVYTANITGY-IPEEIGNCSALENLFLYENQIFGKIPDELGSL 281
+ +G+L L+ L+V I +P N + L ++ L N I ++L L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 282 KNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNN 341
+ ++ L +D+SLN + + + L EL L GN
Sbjct: 177 RENPQVNL--------------------SLDMSLNPIDFIQDQAFQGI-KLHELTLRGNF 215
Query: 342 ISGEIPS-FFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYC 400
S I N + L L F + I + + + ++
Sbjct: 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM-----------EGLCDV--- 261
Query: 401 VKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNN 460
+ L++ L N++ + L ++ L +
Sbjct: 262 -TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQ 318
Query: 461 FSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFL 520
P+ L L L L+ N+ + I + L +DL +N L + S L
Sbjct: 319 LK-QFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 521 FG--LNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKS-LGLCKDLQLLDLS 577
L LDLS N + N L L L + + + S + L LD+S
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 578 SNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPES-FSNLSKLANLDLSNNMLTG-SLK 635
L L+ L ++ N+ + F+N + L LDLS L S
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTL-KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
Query: 636 VLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPA 668
V +L L LN+S+N+ + + ++ L +
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSH--YNQLYS 522
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-30
Identities = 51/273 (18%), Positives = 95/273 (34%), Gaps = 14/273 (5%)
Query: 439 GEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQ 498
G + P I + + S +P + ++LS N N ++
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPD--DIPSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 499 LEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNIT 558
L+ +DL + +++ + L L+ L L+ N I P + LTSL LV + +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 559 GLIPKSLGLCKDLQLLDLSSNRING-SIPEEIGRLQGLDILLNLSWNALTGPIPESFSNL 617
L +G L+ L+++ N I+ +P L L ++LS+N + L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVH-VDLSYNYIQTITVNDLQFL 176
Query: 618 SKLAN----LDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYG 673
+ LD+S N + L L + N S + T L
Sbjct: 177 RENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKT-CLQNLAGLHV-- 233
Query: 674 NQQLCVNRSQCHINNSLHGRNSTKNLIICALLS 706
+L + + N + + + L +
Sbjct: 234 -HRLILGEFKDERNLEIFEPSIMEGLCDVTIDE 265
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 3e-71
Identities = 72/317 (22%), Positives = 131/317 (41%), Gaps = 29/317 (9%)
Query: 749 LNFSVDDVVTR---LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFS 805
++ +++ + L + +G G V++ ++ + V AVK Q
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSW----QNE 66
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRT----RLLLFDYISNGSLAGLLHEKKVFLDWDSRY 861
EV +L ++H+NI++ +G G + L+ + GSL+ L + W+
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELC 124
Query: 862 KIILGVAHGLAYLHHDCV-------PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914
I +A GLAYLH D P I HRDIKS N+L+ A +ADFGLA FE+
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 915 ESSRASNSVAGSYGYIAPEY-----GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPD 969
+S+ ++ G+ Y+APE + + D+Y+ G+VL E+ + D + +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 970 GA---HIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP 1026
+ L + + R +L + M + C + E R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 1027 TMKDVTAMLKEIRHEND 1043
+ V + +++ +
Sbjct: 305 SAGCVGERITQMQRLTN 321
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 6e-67
Identities = 122/568 (21%), Positives = 195/568 (34%), Gaps = 109/568 (19%)
Query: 91 LTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIH 150
L S ++ +I L+ + L +T + L ++ L + I
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 151 GGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCK 210
+ + L ++ +NQL+ P
Sbjct: 60 --SIDGVEYLNNLTQINFSNNQLTDITP-------------------------------- 85
Query: 211 VLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQI 270
+ LT L + + I P + N + L L L+ NQI
Sbjct: 86 -------------------LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 124
Query: 271 FGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLV 330
D L +L NL RL L N +S AL +SL + LANL
Sbjct: 125 --TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLT 177
Query: 331 ALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQL 390
LE L +S N +S S + L+ L NN+
Sbjct: 178 TLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI------------------------ 211
Query: 391 HGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTG 450
+I L L L L+ N L +L +L NLT L L +N+ S P + G T
Sbjct: 212 -SDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 266
Query: 451 LIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQ 510
L L+LG+N S P + L LT LEL+ENQ I N L + L+ N +
Sbjct: 267 LTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNIS 322
Query: 511 GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKD 570
P + L L L N + + +L LT++N L N I+ L P L
Sbjct: 323 DISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTR 376
Query: 571 LQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNML 630
+ L L+ + + + + N++ + P + S+ D++ N+
Sbjct: 377 ITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIA---PATISDGGSYTEPDITWNLP 433
Query: 631 TGSLKVLGSLDNLVSLNVSYNHFSGILP 658
+ + +V + V++ FSG +
Sbjct: 434 SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-58
Identities = 104/427 (24%), Positives = 160/427 (37%), Gaps = 56/427 (13%)
Query: 233 LTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQN 292
L + N+T + + + L I K D + L NL ++ N
Sbjct: 23 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 78
Query: 293 NLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGN 352
L+ P L N + L I ++ N + P LANL L L L N I+ P N
Sbjct: 79 QLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKN 132
Query: 353 FSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNF 412
+ L +LEL +N +I L+ LQ L +
Sbjct: 133 LTNLNRLELSSNTI-------------------------SDISALSGLTSLQQLSFGNQV 167
Query: 413 LTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLL 472
L NL L +L + SN+ S + T L L +N S P +G+L
Sbjct: 168 TD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGIL 220
Query: 473 HRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNS 532
L L L+ NQ + + T L +DL N++ P L L L L L N
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 276
Query: 533 IGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRL 592
I P L LT+L L L++N + + P + K+L L L N I+ P + L
Sbjct: 277 ISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSL 330
Query: 593 QGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNH 652
L L N ++ S +NL+ + L +N ++ L L +L + L ++
Sbjct: 331 TKLQRL-FFYNNKVSDV--SSLANLTNINWLSAGHNQIS-DLTPLANLTRITQLGLNDQA 386
Query: 653 FSGILPN 659
++ N
Sbjct: 387 WTNAPVN 393
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-55
Identities = 100/401 (24%), Positives = 170/401 (42%), Gaps = 32/401 (7%)
Query: 262 NLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGE 321
+ I D +L + +L + N++ ++ + +T + + +
Sbjct: 6 ATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--K 59
Query: 322 VPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELL 381
+ L L ++ S N ++ P N ++L + ++NN+ P + L L
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLT 115
Query: 382 LFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEI 441
+ NQ+ +I L L L+LS N ++ S+L L +L QL N+ +
Sbjct: 116 GLTLFNNQIT-DIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLK 171
Query: 442 PPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEM 501
P + T L RL + SN S S + L L L + NQ + P +G T L+
Sbjct: 172 P--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 225
Query: 502 VDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLI 561
+ L+ N+L +L L L LDL+ N I + L LT L +L L N I+ +
Sbjct: 226 LSLNGNQL--KDIGTLASLTNLTDLDLANNQI--SNLAPLSGLTKLTELKLGANQISNIS 281
Query: 562 PKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLA 621
P L L L+L+ N++ P I L+ L L L +N ++ P S+L+KL
Sbjct: 282 P--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL-TLYFNNISDISP--VSSLTKLQ 334
Query: 622 NLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKL 662
L NN ++ + L +L N+ L+ +N S + P L
Sbjct: 335 RLFFYNNKVS-DVSSLANLTNINWLSAGHNQISDLTPLANL 374
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-50
Identities = 104/481 (21%), Positives = 180/481 (37%), Gaps = 80/481 (16%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSL 144
+ ++LT + SN LT P + NL+ L+++ ++ N + + L L L+L
Sbjct: 64 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTL 119
Query: 145 NSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPE 204
+N I P + N + L RLEL N +S
Sbjct: 120 FNNQITDIDP--LKNLTNLNRLELSSNTISD----------------------------- 148
Query: 205 EISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLF 264
++ LT+L+ LS +T P + N + LE L
Sbjct: 149 ----------------------ISALSGLTSLQQLSFGN-QVTDLKP--LANLTTLERLD 183
Query: 265 LYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPV 324
+ N++ L L NL+ L+ N +S P LG ++L + ++ N L +
Sbjct: 184 ISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIG 237
Query: 325 SLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFF 384
+LA+L L +L L+ N IS P ++L +L+L N+ I P + L L
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLE 293
Query: 385 AWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPE 444
+NQL +I ++ L L L N ++ P + +L L +L +N+ S
Sbjct: 294 LNENQLE-DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSS 348
Query: 445 IGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDL 504
+ T + L G N S P + L R+T L L++ +T N + V
Sbjct: 349 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKN 406
Query: 505 HQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKS 564
L P+++ D++ N E + + +G + +
Sbjct: 407 VTGAL--IAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVTQP 463
Query: 565 L 565
L
Sbjct: 464 L 464
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 5e-58
Identities = 111/546 (20%), Positives = 191/546 (34%), Gaps = 100/546 (18%)
Query: 86 LSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLN 145
+S + L + ++NLT E+P N+ S +++ N P G+ E+ + L
Sbjct: 8 VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 146 SNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE 205
+ LEL + LS ++P LE+L N E+PE
Sbjct: 67 DCL-----------DRQAHELELNNLGLS-SLPELPPHLESLVA---SCNS--LTELPEL 109
Query: 206 ISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFL 265
+ K L+ +S P L L V + +P E+ N S L+ + +
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDV 160
Query: 266 YENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVS 325
N + K+PD +L+ + N L +PE L N LT I NSL ++P
Sbjct: 161 DNNSL-KKLPDLPP---SLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSL-KKLPDL 213
Query: 326 LANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFA 385
+ LE ++ N + E+P N L + DNN +P L+
Sbjct: 214 PLS---LESIVAGNNILE-ELPE-LQNLPFLTTIYADNNL-LKTLPDLPPSLEA------ 261
Query: 386 WQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI 445
L++ N+LT +P +L L I + S P
Sbjct: 262 --------------------LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP--- 297
Query: 446 GGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLH 505
L L SN I S L L L +S N+ E+P LE +
Sbjct: 298 ----NLYYLNASSNE----IRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIAS 345
Query: 506 QNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSL 565
N L +P + L L + N + P+ + L +++ +
Sbjct: 346 FNHLA-EVPELPQ---NLKQLHVEYNPL-REFPDIPESVEDLRMN----SHLAEVPE--- 393
Query: 566 GLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDL 625
L ++L+ L + +N + P+ ++ L ++ + P + KL +
Sbjct: 394 -LPQNLKQLHVETNPLR-EFPDIPESVEDLR----MNSERVVDPYEFAHETTDKLEDDVF 447
Query: 626 SNNMLT 631
++
Sbjct: 448 EHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 7e-54
Identities = 99/523 (18%), Positives = 187/523 (35%), Gaps = 76/523 (14%)
Query: 129 IPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALE 188
I L+ +S+++ +P E N ++ N P G+ +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 189 IIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITG 248
+ R + L L + G+S +P +L +L ++T
Sbjct: 62 VSRLRDCL------------DRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT- 104
Query: 249 YIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSL 308
+PE + +L + P L+ L + N L +PE L N S L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFL 155
Query: 309 TVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFG 368
+IDV NSL ++P +L E + N + E+P N L + DNN
Sbjct: 156 KIIDVDNNSLK-KLPDLPPSL---EFIAAGNNQLE-ELPEL-QNLPFLTAIYADNNSL-K 208
Query: 369 QIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLT 428
++P L+ ++ N L +PEL L + +N L ++P +L+ L
Sbjct: 209 KLPDLPLSLESIVAGN---NILE-ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN 263
Query: 429 QLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGE 488
+ N + ++P T L + S P+ L +L S N+
Sbjct: 264 ---VRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-S 311
Query: 489 IPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLN 548
+ + LE +++ NKL +P+ L L S N + +PE L L+
Sbjct: 312 LCDLPPS---LEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLKQLH 363
Query: 549 KLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTG 608
+ N + P +DL++ ++ + +PE L+ L++ N L
Sbjct: 364 ---VEYNPLREF-PDIPESVEDLRM----NSHLA-EVPELPQNLK----QLHVETNPLRE 410
Query: 609 PIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYN 651
P+ + +L +++ + + + + +V +
Sbjct: 411 -FPDI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEH 449
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-53
Identities = 96/456 (21%), Positives = 170/456 (37%), Gaps = 69/456 (15%)
Query: 201 EIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSAL 260
E+P E N K A + P GE + +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ-----------A 73
Query: 261 ENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGG 320
L L + +P+ +L+ L+ N+L+ +PE + SL V + +L +L
Sbjct: 74 HELELNNLGL-SSLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD 128
Query: 321 EVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKEL 380
P LE L +S N + ++P N S LK +++DNN ++P L+ +
Sbjct: 129 LPP-------LLEYLGVSNNQLE-KLPEL-QNSSFLKIIDVDNNSL-KKLPDLPPSLEFI 178
Query: 381 LLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGE 440
NQL +PEL L A+ +N L +P +L+++ +N
Sbjct: 179 AAGN---NQLE-ELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE-- 228
Query: 441 IPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLE 500
PE+ L + +N +P L L + +N T ++P + T L+
Sbjct: 229 ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-DLPELPQSLTFLD 283
Query: 501 MVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGL 560
+ + + L P+ L L+ S N I ++ + L LN +S N + L
Sbjct: 284 VSENIFSGLSELPPN-------LYYLNASSNEIR-SLCDLPPSLEELN---VSNNKLIEL 332
Query: 561 IPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKL 620
P L+ L S N + +PE L+ L++ +N L P+ ++
Sbjct: 333 -PALPP---RLERLIASFNHLA-EVPELPQNLK----QLHVEYNPLRE-FPDIPESVE-- 380
Query: 621 ANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGI 656
+L +++++ V NL L+V N
Sbjct: 381 -DLRMNSHLAE----VPELPQNLKQLHVETNPLREF 411
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 9e-51
Identities = 87/421 (20%), Positives = 152/421 (36%), Gaps = 63/421 (14%)
Query: 249 YIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGN---- 304
+I + + L+ + + + ++P E ++K+ + + P G
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 305 ---------CSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSR 355
++++ L +P +L E L+ S N+++ E+P +
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKS 115
Query: 356 LKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTG 415
L + + L+ L + NQL +PEL L+ +D+ +N L
Sbjct: 116 LLVDNNNLK----ALSDLPPLLEYLGVSN---NQLE-KLPELQNSSFLKIIDVDNNSLK- 166
Query: 416 SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRL 475
+P +L + +N+ E PE+ L + +N+ +P L L
Sbjct: 167 KLPDLP---PSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPD---LPLSL 217
Query: 476 TFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
+ N PE+ N L + N L+ T+P L LNV D + +
Sbjct: 218 ESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL-- 272
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
PE LT L+ + ++ L P L L+ SSN I S+ + L+ L
Sbjct: 273 --PELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-SLCDLPPSLEEL 322
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
N+S N L +P L +L S N L +V NL L+V YN
Sbjct: 323 ----NVSNNKLIE-LPALPPRLERL---IASFNHLA---EVPELPQNLKQLHVEYNPLRE 371
Query: 656 I 656
Sbjct: 372 F 372
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-37
Identities = 65/333 (19%), Positives = 127/333 (38%), Gaps = 42/333 (12%)
Query: 327 ANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAW 386
+ L+E L +N++ E+P N + + + PP G+ +E+ +
Sbjct: 8 VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV---- 62
Query: 387 QNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIG 446
++L + + L+L++ L+ S+P +L++L N + E+P
Sbjct: 63 -SRLRDCLDR-----QAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQ 111
Query: 447 GCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQ 506
L+ S P L +L +S NQ ++P E+ N + L+++D+
Sbjct: 112 SLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDN 162
Query: 507 NKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLG 566
N L+ +P L + N + L L L + N++ L
Sbjct: 163 NSLK-KLPDLPP---SLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLKKLPD---- 212
Query: 567 LCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLS 626
L L+ + +N + E+ L L + N L +P+ +L L++
Sbjct: 213 LPLSLESIVAGNNIL--EELPELQNLPFLTTI-YADNNLLKT-LPDLPPSLE---ALNVR 265
Query: 627 NNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPN 659
+N LT ++ SL L ++ S + PN
Sbjct: 266 DNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 9e-12
Identities = 27/134 (20%), Positives = 49/134 (36%), Gaps = 18/134 (13%)
Query: 538 PENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDI 597
P N+ T L + + +N+T + P K + + + P G + + +
Sbjct: 5 PRNVS-NTFLQEPLRHSSNLTEM-PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 598 L------------LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVS 645
L L+ L+ +PE +L L S N LT ++ SL +L+
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLTELPELPQSLKSLLV 118
Query: 646 LNVSYNHFSGILPN 659
N + S + P
Sbjct: 119 DNNNLKALSDLPPL 132
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-57
Identities = 70/294 (23%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 760 LSDTNIVGKGVSGIVYRVEIPSR-QVIAVKKLWPVKNGE----LPERDQFSAEVQTLGSI 814
+ +GKG G+V++ + V+A+K L + + + +F EV + ++
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 815 RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL 874
H NIV+L G +N ++ +++ G L L +K + W + +++L +A G+ Y+
Sbjct: 81 NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 875 HHDCVPPIIHRDIKSNNILVGPQFEAF-----LADFGLAKLFESSESSRASNSVAGSYGY 929
+ PPI+HRD++S NI + E +ADFGL++ +S + + + G++ +
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQW 192
Query: 930 IAPE--YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR- 986
+APE TEK+D YS+ ++L +LTG+ P D I + E R
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI---REEGLRP 249
Query: 987 EFTTILDRQL--LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
+L ++ C + P++RP + L E+
Sbjct: 250 TIPEDCPPRLRNVIEL----------------CWSGDPKKRPHFSYIVKELSEL 287
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-56
Identities = 114/526 (21%), Positives = 172/526 (32%), Gaps = 28/526 (5%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE 138
P L +L LS L + + L LDLS + L+
Sbjct: 20 YKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
L L L N I S L++L + L+ IG L+ L+ + N
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 199 HGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVY---TANITGYIPEEIG 255
++PE SN L L L+ I + L + L++ + N +I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 256 NCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLW------QNNLSGSIPEALGNCSSL 308
L L L N + + L L+ L + NL AL +L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 309 TVIDVSLNSL---GGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR 365
T+ + L L ++ L + L I + F NF + LEL N +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFG-WQHLELVNCK 315
Query: 366 FFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLT--GSVPSSLFN 423
F + LK L N+ N L+ LDLS N L+ G S F
Sbjct: 316 FGQFPTLKLKSLKRLTFT---SNKGG-NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 424 LKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRI-GLLHRLTFLELSE 482
+L L L N + G L L +N + L L +L++S
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 483 NQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPS-SLEFLFGLNVLDLSMNSIGGTIPEN 540
I + LE++ + N Q L L LDLS + P
Sbjct: 431 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 541 LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIP 586
L+SL L ++ N + + LQ + L +N + S P
Sbjct: 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-50
Identities = 119/584 (20%), Positives = 190/584 (32%), Gaps = 91/584 (15%)
Query: 96 LSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPR 155
N +IP + S NLDLSFN L EL++L L+ I
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 156 EIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFL 215
+ S L L L N + + F
Sbjct: 71 AYQSLSHLSTLILTGNPIQ--------------------------SLALG-------AFS 97
Query: 216 GLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQI-FGKI 274
GL ++L+ L N+ IG+ L+ L + N I K+
Sbjct: 98 GL----------------SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 275 PDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSL----NSLGGEVPVSLANLV 330
P+ +L NL+ L L N + L + ++++SL N + + +
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200
Query: 331 ALEELLLSGNNISGEIPS-FFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQ 389
L +L L N S + + L+ L F + G L++
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE-----GNLEKF------DKS 249
Query: 390 LHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEIGGC 448
+ L ++ L++ LF L N++ L+S +
Sbjct: 250 ALEGLCNL----TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY-N 303
Query: 449 TGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNK 508
G L L + F + L L L + N+ + LE +DL +N
Sbjct: 304 FGWQHLELVNCKFGQFPTLK---LKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNG 358
Query: 509 LQ--GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKS-L 565
L G S L LDLS N + T+ N L L L +N+ + S
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 566 GLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPI-PESFSNLSKLANLD 624
++L LD+S + L L++L ++ N+ P+ F+ L L LD
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL-KMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 625 LSNNMLTG-SLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLP 667
LS L S SL +L LN++ N + F L
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI--FDRLT 518
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-36
Identities = 96/449 (21%), Positives = 160/449 (35%), Gaps = 50/449 (11%)
Query: 89 SHLTSLVLSNANLT-GEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELEL----LS 143
L L +++ + ++P NL++L +LDLS N + ++ L ++ L L
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 144 LNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAE-IGQLEALEIIR-----AGGNPG 197
L+ N ++ I +L +L L +N S N+ I L LE+ R
Sbjct: 184 LSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 198 IHGEIPEEISNCKVLVFLGLADTGISG---QIPRSVGELTNLRTLSVYTANITGYIPEEI 254
+ + L + I LTN+ + S+ + I + +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFS 301
Query: 255 GNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVS 314
N ++L L + P LK+LKRL N + E + SL +D+S
Sbjct: 302 YNFG-WQHLELVNCKFGQ-FPT--LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLS 355
Query: 315 LNSLG--GEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPP 372
N L G S +L+ L LS N + + S F +L+ L+ ++
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS-------- 406
Query: 373 TIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLL 432
LK++ F + + L LD+SH + L +L L +
Sbjct: 407 ---NLKQMSEFSVFLS-----------LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 433 ISNRFSGEIPPEI-GGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPP 491
N F P+I L L L P+ L L L ++ NQ +P
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPD 511
Query: 492 EI-GNCTQLEMVDLHQNKLQGTIPSSLEF 519
I T L+ + LH N + P
Sbjct: 512 GIFDRLTSLQKIWLHTNPWDCSCPRIDYL 540
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-18
Identities = 53/279 (18%), Positives = 90/279 (32%), Gaps = 17/279 (6%)
Query: 76 HIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIG--NLSSLINLDLSFNALTGNIPEEI 133
+ ++++S L + + + L ++ F
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTL----- 322
Query: 134 GKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLS--GNIPAEIGQLEALEIIR 191
KL L+ L+ SN + L L+L N LS G +L+ +
Sbjct: 323 -KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 192 AGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSV-GELTNLRTLSVYTANITGYI 250
N G+ + + L L + + SV L NL L + +
Sbjct: 380 LSFN-GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 251 PEEIGNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLT 309
S+LE L + N + L+NL L L Q L P A + SSL
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 310 VIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPS 348
V++++ N L L +L+++ L N P
Sbjct: 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 1e-55
Identities = 86/395 (21%), Positives = 144/395 (36%), Gaps = 50/395 (12%)
Query: 260 LENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLG 319
L I PD L R +L + +++ + S+T + V+ +
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 320 GEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKE 379
+ + L LE L L+GN I+ P N +L L + N+ + L
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 380 LLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSG 439
L + ++ + I LA K+ +L+L N S S L N+ L L + ++
Sbjct: 112 LRELYLNEDNISD-ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 440 EIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQL 499
I T L L L N P + L L + NQ T P + N T+L
Sbjct: 170 --VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223
Query: 500 EMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITG 559
+ + NK+ P L L+ L L + N I+
Sbjct: 224 NSLKIGNNKITDLSP--------------------------LANLSQLTWLEIGTNQISD 257
Query: 560 LIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSK 619
+ ++ L++L++ SN+I+ + L L+ L L+ N L E L+
Sbjct: 258 I--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL-FLNNNQLGNEDMEVIGGLTN 312
Query: 620 LANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFS 654
L L LS N +T ++ L SL + S + +
Sbjct: 313 LTTLFLSQNHIT-DIRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-53
Identities = 75/396 (18%), Positives = 156/396 (39%), Gaps = 51/396 (12%)
Query: 236 LRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLS 295
TL+ A I P + + L + + + L+++ +L++ ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 296 GSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSR 355
+ + ++L ++++ N + P L+NLV L L + N I+ S N +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 356 LKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTG 415
L++L L+ + + L ++ N ++ L+ L L ++ + +
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD 169
Query: 416 SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRL 475
+ + NL +L L L N+ P + T L N + P + + RL
Sbjct: 170 V--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223
Query: 476 TFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
L++ N+ T P + N +QL +++ N++ + ++++ L L +L++ N I
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQI-- 277
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
+ L L+ LN L L+ N + + +G +L L LS N I P
Sbjct: 278 SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--------- 328
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLT 631
++LSK+ + D +N ++
Sbjct: 329 ------------------LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-49
Identities = 88/354 (24%), Positives = 153/354 (43%), Gaps = 29/354 (8%)
Query: 306 SSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR 365
++L + +N + A+L +L +++ + + +L + +
Sbjct: 3 ATLATLPAPINQI-----FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEK 55
Query: 366 FFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLK 425
I L L NQ+ +I L+ VKL L + N +T S+L NL
Sbjct: 56 V--ASIQGIEYLTNLEYLNLNGNQIT-DISPLSNLVKLTNLYIGTNKITD--ISALQNLT 110
Query: 426 NLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQF 485
NL +L L + S + T + L LG+N+ + + + L +L ++E++
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKV 167
Query: 486 TGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLT 545
I N T L + L+ N+++ P L L L+ +N I T + +T
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI--TDITPVANMT 221
Query: 546 SLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNA 605
LN L + N IT L P L L L++ +N+I+ + L L +L N+ N
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML-NVGSNQ 276
Query: 606 LTGPIPESFSNLSKLANLDLSNNMLTGS-LKVLGSLDNLVSLNVSYNHFSGILP 658
++ +NLS+L +L L+NN L ++V+G L NL +L +S NH + I P
Sbjct: 277 ISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-49
Identities = 74/329 (22%), Positives = 131/329 (39%), Gaps = 24/329 (7%)
Query: 332 LEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLH 391
L I+ P + + + L T +L+ + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 392 GNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGL 451
+I + Y L+ L+L+ N +T S L NL LT L + +N+ + + T L
Sbjct: 58 -SIQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQNLTNL 112
Query: 452 IRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQG 511
L L +N S P + L ++ L L N ++ P + N T L + + ++K++
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD 169
Query: 512 TIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDL 571
P + L L L L+ N I L LTSL+ N IT + P + L
Sbjct: 170 VTP--IANLTDLYSLSLNYNQI--EDISPLASLTSLHYFTAYVNQITDITP--VANMTRL 223
Query: 572 QLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLT 631
L + +N+I P + L L L + N ++ + +L+KL L++ +N ++
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWL-EIGTNQISDI--NAVKDLTKLKMLNVGSNQIS 278
Query: 632 GSLKVLGSLDNLVSLNVSYNHFSGILPNT 660
+ VL +L L SL ++ N
Sbjct: 279 -DISVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-46
Identities = 83/426 (19%), Positives = 150/426 (35%), Gaps = 97/426 (22%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSL 144
+ VL A++T + L S+ L ++ + + I L LE L+L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNL 73
Query: 145 NSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPE 204
N N I P + N KL L + N+++
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKIT------------------------------ 101
Query: 205 EISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLF 264
++ LTNLR L + NI+ P + N + + +L
Sbjct: 102 ---------------------DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLN 138
Query: 265 LYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPV 324
L N L ++ L L + ++ + P + N + L + ++ N + P
Sbjct: 139 LGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP- 194
Query: 325 SLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFF 384
LA+L +L N I+ P N +RL L++ NN+
Sbjct: 195 -LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI------------------ 233
Query: 385 AWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPE 444
++ LA +L L++ N ++ +++ +L L L + SN+ S
Sbjct: 234 -------TDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISV 282
Query: 445 IGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDL 504
+ + L L L +N IG L LT L LS+N T P + + ++++ D
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
Query: 505 HQNKLQ 510
++
Sbjct: 341 ANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 53/271 (19%), Positives = 100/271 (36%), Gaps = 41/271 (15%)
Query: 392 GNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGL 451
I A + L +T + L+++T+L++ + + I T L
Sbjct: 13 NQIFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--IQGIEYLTNL 68
Query: 452 IRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQG 511
L L N + P + L +LT L + N+ T + N T L + L+++ +
Sbjct: 69 EYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNI-- 122
Query: 512 TIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDL 571
+ S L L + L+L N + L +T LN L ++++ + + P + DL
Sbjct: 123 SDISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDL 179
Query: 572 QLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLT 631
L L+ N+I P ++L+ L N +T
Sbjct: 180 YSLSLNYNQIEDISP---------------------------LASLTSLHYFTAYVNQIT 212
Query: 632 GSLKVLGSLDNLVSLNVSYNHFSGILPNTKL 662
+ + ++ L SL + N + + P L
Sbjct: 213 -DITPVANMTRLNSLKIGNNKITDLSPLANL 242
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 46/217 (21%), Positives = 82/217 (37%), Gaps = 15/217 (6%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE 138
S L + + L L ++ + + I NL+ L +L L++N + + L
Sbjct: 145 LSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED--ISPLASLTS 200
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
L + N I P + N ++L L++ +N+++ P + L L + G N I
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN-QI 255
Query: 199 HGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCS 258
+ + L L + IS + L+ L +L + + E IG +
Sbjct: 256 SD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311
Query: 259 ALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLS 295
L LFL +N I P L SL + +
Sbjct: 312 NLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 39/188 (20%), Positives = 73/188 (38%), Gaps = 13/188 (6%)
Query: 475 LTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIG 534
L +I P + + L + + + E L + L ++ +
Sbjct: 2 AATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 535 GTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQG 594
+ + LT+L L L+ N IT + P L L L + +N+I + + L
Sbjct: 57 -ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 595 LDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFS 654
L L L+ + ++ P +NL+K+ +L+L N L L ++ L L V+ +
Sbjct: 112 LREL-YLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVK 168
Query: 655 GILPNTKL 662
+ P L
Sbjct: 169 DVTPIANL 176
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-18
Identities = 37/141 (26%), Positives = 61/141 (43%), Gaps = 10/141 (7%)
Query: 522 GLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
G L I P L + VL K ++T ++ + + L ++ ++
Sbjct: 1 GAATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 582 NGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLD 641
+ + I L L+ LNL+ N +T P SNL KL NL + N +T + L +L
Sbjct: 57 --ASIQGIEYLTNLEY-LNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLT 110
Query: 642 NLVSLNVSYNHFSGILPNTKL 662
NL L ++ ++ S I P L
Sbjct: 111 NLRELYLNEDNISDISPLANL 131
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-55
Identities = 81/290 (27%), Positives = 127/290 (43%), Gaps = 38/290 (13%)
Query: 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPE-RDQFSAEVQTLGSIRHKN 818
L+ I+G G G VYR +V AVK + ++ + + E + ++H N
Sbjct: 9 LTLEEIIGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
I+ L G C L+ ++ G L +L K+ + D + +A G+ YLH +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEA 125
Query: 879 VPPIIHRDIKSNNILVGPQFEAF--------LADFGLAKLFESSESSRASNSVAGSYGYI 930
+ PIIHRD+KS+NIL+ + E + DFGLA+ + + S AG+Y ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWM 181
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWV-NGELR-ERKREF 988
APE + ++ SDV+SYGV+L E+LTG+ P DG + V +L
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--DGLAVAYGVAMNKLALPIPSTC 239
Query: 989 TTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
LM C NP P RP+ ++ L I
Sbjct: 240 PEPF--AKLMED----------------CWNPDPHSRPSFTNILDQLTTI 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 5e-54
Identities = 77/295 (26%), Positives = 131/295 (44%), Gaps = 39/295 (13%)
Query: 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
+ +VG+G G+V + + ++ V A+K++ ++ ER F E++ L + H NI
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWRAKDV-AIKQI---ESES--ERKAFIVELRQLSRVNHPNI 63
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLH--EKKVFLDWDSRYKIILGVAHGLAYLHHD 877
V+L G C N L+ +Y GSL +LH E + L + G+AYLH
Sbjct: 64 VKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 878 CVPPIIHRDIKSNNILVGPQFEAF-LADFGLAKLFESSESSRASNSVAGSYGYIAPEYGY 936
+IHRD+K N+L+ + DFG A + + GS ++APE
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFE 176
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR-EFTTILDRQ 995
+EK DV+S+G++L EV+T ++P D I A I W + R L +
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWA---VHNGTRPPLIKNLPKP 232
Query: 996 L--LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKP 1048
+ LM C + P +RP+M+++ ++ + ++P
Sbjct: 233 IESLMTR----------------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-53
Identities = 73/286 (25%), Positives = 113/286 (39%), Gaps = 44/286 (15%)
Query: 766 VGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNGELPER--DQFSAEVQTLGSIRHK 817
+G G G VY+ V AVK L + F EV L RH
Sbjct: 32 IGSGSFGTVYKGKWHGDV--------AVKML---NVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
NI+ +G + ++ + SL LH + + I A G+ YLH
Sbjct: 81 NILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA- 138
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---Y 934
IIHRD+KSNNI + + DFGLA S ++GS ++APE
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994
S + +SDVY++G+VL E++TG+ P + I G L + + +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 995 QL--LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
++ LM C+ +ERP+ + A ++E+
Sbjct: 257 RMKRLMAE----------------CLKKKRDERPSFPRILAEIEEL 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 8e-53
Identities = 89/295 (30%), Positives = 140/295 (47%), Gaps = 33/295 (11%)
Query: 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
L+ +G G G V+R E V AVK L ++F EV + +RH NI
Sbjct: 39 LNIKEKIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNI 96
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEK--KVFLDWDSRYKIILGVAHGLAYLHHD 877
V +G ++ +Y+S GSL LLH+ + LD R + VA G+ YLH+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN- 155
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
PPI+HR++KS N+LV ++ + DFGL++L S+ S S S AG+ ++APE
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRD 213
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR-EFTTILDRQL 996
EKSDVYS+GV+L E+ T ++P + + A ++ V + KR E L+ Q+
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNL--NPAQVVAAV---GFKCKRLEIPRNLNPQV 268
Query: 997 --LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPN 1049
++ C P +RP+ + +L+ + + PN
Sbjct: 269 AAIIEG----------------CWTNEPWKRPSFATIMDLLRPL--IKSAVPPPN 305
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-52
Identities = 71/327 (21%), Positives = 122/327 (37%), Gaps = 45/327 (13%)
Query: 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAE--VQTLGSIRHK 817
L ++G+G G VY+ + R V AVK R F E + + + H
Sbjct: 15 LKLLELIGRGRYGAVYKGSLDERPV-AVKVF------SFANRQNFINEKNIYRVPLMEHD 67
Query: 818 NIVRLLGCCN----NGRTRLLL-FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLA 872
NI R + +GR LL +Y NGSL L DW S ++ V GLA
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLA 125
Query: 873 YLHHD------CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS------ESSRAS 920
YLH + P I HRD+ S N+LV ++DFGL+ + E A+
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 921 NSVAGSYGYIAPEY-------GYSLKITEKSDVYSYGVVLLEVLT-------GKEPTDSR 966
S G+ Y+APE ++ D+Y+ G++ E+ G+ + +
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245
Query: 967 IPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLG-VALLCVNPCPEER 1025
+ + + + + + R + + ++ L C + E R
Sbjct: 246 MAFQTEV--GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 1026 PTMKDVTAMLKEIRHENDDLEKPNSLS 1052
T + + E+ + + + +
Sbjct: 304 LTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 70/304 (23%), Positives = 121/304 (39%), Gaps = 37/304 (12%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
++GKG G +V + +V+ +K+L + + F EV+ + + H N+++
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKEL---IRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+G + + +YI G+L G++ W R +A G+AYLH I
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS------------RASNSVAGSYGYI 930
IHRD+ S+N LV +ADFGLA+L ++ + +V G+ ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTT 990
APE EK DV+S+G+VL E++ +P V G L
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-------- 241
Query: 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI-RHENDDLEKPN 1049
+ + C + PE+RP+ + L+ + H L
Sbjct: 242 -----RYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
Query: 1050 SLSR 1053
L +
Sbjct: 293 QLEQ 296
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-51
Identities = 57/291 (19%), Positives = 109/291 (37%), Gaps = 40/291 (13%)
Query: 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
L+ + + SG +++ I VK L RD F+ E L H N+
Sbjct: 12 LNFLTKLNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSRD-FNEECPRLRIFSHPNV 69
Query: 820 VRLLGCCNNGRTRLL--LFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHH 876
+ +LG C + + ++ GSL +LHE +D K L +A G+A+LH
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--- 933
P I + S ++++ A ++ + F+S + ++APE
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQ 181
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR-EFTTIL 992
+D++S+ V+L E++T + P + E R +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPF-----ADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 993 DRQL--LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041
+ LM+ C+N P +RP + +L++++ +
Sbjct: 237 SPHVSKLMKI----------------CMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-51
Identities = 62/307 (20%), Positives = 120/307 (39%), Gaps = 37/307 (12%)
Query: 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
L ++GKG G VY +A++ + ++ E + F EV RH+N+
Sbjct: 35 LEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENV 91
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCV 879
V +G C + ++ +L ++ + K+ LD + +I + G+ YLH
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN---SVAGSYGYIAPE--- 933
I+H+D+KS N+ + + DFGL + ++ R + G ++APE
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 934 ------YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987
L ++ SDV++ G + E+ + P ++ II + ++ +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--PAEAIIWQMGTGMKPNLSQ 265
Query: 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEK 1047
+ ++ C EERPT + ML+++ N L
Sbjct: 266 IGMGKEISDILLF----------------CWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309
Query: 1048 PNSLSRA 1054
P ++
Sbjct: 310 PGHFWKS 316
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 6e-50
Identities = 80/319 (25%), Positives = 125/319 (39%), Gaps = 51/319 (15%)
Query: 752 SVDDVVTR-LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFS----A 806
S+ V R ++ VGKG G V+R V AVK RD+ S
Sbjct: 1 SMQRTVARDITLLECVGKGRYGEVWRGSWQGENV-AVKIF--------SSRDEKSWFRET 51
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTR----LLLFDYISNGSLAGLLHEKKVFLDWDSRYK 862
E+ +RH+NI+ + R L+ Y GSL L LD S +
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLR 109
Query: 863 IILGVAHGLAYLHHDCV-----PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917
I+L +A GLA+LH + P I HRD+KS NILV + +AD GLA + S +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 918 R--ASNSVAGSYGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR--- 966
+N G+ Y+APE ++ D++++G+VL EV
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 967 -------IPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVN 1019
+P+ +++R I +R + T + ++++ C
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQR--PNIPNRWFSDPTLTSLAKLMK------ECWY 281
Query: 1020 PCPEERPTMKDVTAMLKEI 1038
P R T + L +I
Sbjct: 282 QNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-49
Identities = 74/315 (23%), Positives = 110/315 (34%), Gaps = 50/315 (15%)
Query: 760 LSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFS--AEVQTLGSIRHK 817
+ +GKG G V+ + +V AVK + E + E+ +RH+
Sbjct: 39 IQMVKQIGKGRYGEVWMGKWRGEKV-AVKVFFT------TEEASWFRETEIYQTVLMRHE 91
Query: 818 NIVRLLGCCNNGRTR----LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAY 873
NI+ + G L+ DY NGSL L LD S K+ GL +
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCH 149
Query: 874 LH-----HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR--ASNSVAGS 926
LH P I HRD+KS NILV +AD GLA F S + N+ G+
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 927 YGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR----------IPDG 970
Y+ PE + +D+YS+G++L EV +P
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 971 AHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALL--CVNPCPEERPTM 1028
++ R + E L+ + L+ C P R T
Sbjct: 270 PSYEDMREIVCIKKLR---------PSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTA 319
Query: 1029 KDVTAMLKEIRHEND 1043
V L ++ D
Sbjct: 320 LRVKKTLAKMSESQD 334
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 3e-49
Identities = 127/683 (18%), Positives = 210/683 (30%), Gaps = 89/683 (13%)
Query: 76 HIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEI-G 134
+P L+LS + + L L L+L I +E
Sbjct: 18 QVPQVLN-------TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFR 70
Query: 135 KLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNI--PAEIGQLEALEIIRA 192
L L +L L S+ I+ P L L LY LS + L+AL +
Sbjct: 71 NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDL 130
Query: 193 GGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELT--NLRTLSVYTANITGYI 250
N + L + + I + L L S+ ++ +
Sbjct: 131 SKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRV 190
Query: 251 PEEIGNCS------ALENLFLYENQIFGKIPD------------ELGSLKNLKRLLLWQN 292
+ G C LE L + N I L ++ +
Sbjct: 191 SVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250
Query: 293 NLSGSIPEALGN--CSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFF 350
N+ SS+ +D+S + L L+ L L+ N I+ F
Sbjct: 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAF 310
Query: 351 GNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSH 410
L+ L L N G++ + K+ +DL
Sbjct: 311 YGLDNLQVLNLSYNLL-GELYSSN----------------------FYGLPKVAYIDLQK 347
Query: 411 NFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIG 470
N + + L+ L L L N + I + + L N +P
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPK--- 398
Query: 471 LLHRLTFLELSENQFTG-EIPPEIGNCTQLEMVDLHQNKLQGTIPSSL-EFLFGLNVLDL 528
+ + LSEN+ +I + L+++ L+QN+ L L L
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 529 SMNSIGGTI-----PENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRING 583
N + + L+ L L L+ N + L P L+ L L+SNR+
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT- 517
Query: 584 SIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNL 643
+ L +L++S N L P P+ F +LS LD+++N L
Sbjct: 518 VLSHND--LPANLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFICEC----ELSTF 568
Query: 644 VSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICA 703
++ N P +F G ++ C L K+L
Sbjct: 569 INWLNHTNVTIAGPPADIYCVYPD--SFSGVSLFSLSTEGCDEEEVL------KSLKFSL 620
Query: 704 LLSVTVTLFIVLFGIILFIRFRG 726
+ TVTL + L I+ +FRG
Sbjct: 621 FIVCTVTLTLFLMTILTVTKFRG 643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 9e-20
Identities = 73/453 (16%), Positives = 139/453 (30%), Gaps = 76/453 (16%)
Query: 1 MSRNEITIILLFVNISLFPAISALNPEGLSLLS--WLSTFNSSSSATFFSSWNPSHRNPC 58
++ N + + + E L + W + S S S
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAH 240
Query: 59 NWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINL 118
+ I P + L+ S + L LS+ + L L L
Sbjct: 241 HIMGAGFGFHNI-----KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295
Query: 119 DLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIP 178
+L++N + E L L++L+L+ N + K+ ++L N ++ I
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQ 354
Query: 179 AEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRT 238
+ + L L L D ++ ++ + ++
Sbjct: 355 DQT------------------------FKFLEKLQTLDLRDNALT-----TIHFIPSIPD 385
Query: 239 LSVYTANITGYIPEEIGNCSALENLFLYENQIFG-KIPDELGSLKNLKRLLLWQNNLSGS 297
+ + + + + L EN++ I L + +L+ L+L QN S
Sbjct: 386 IFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSC 441
Query: 298 IPEAL-GNCSSLTVIDVSLNSLGGEVPVSL-----ANLVALEELLLSGNNISGEIPSFFG 351
+ SL + + N L L L L+ L L+ N ++ P F
Sbjct: 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501
Query: 352 NFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHN 411
+ + L+ L L++NR + L+ LD+S N
Sbjct: 502 HLTALRGLSLNSNRLT-------------------------VLSHNDLPANLEILDISRN 536
Query: 412 FLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPE 444
L P +L+ L + N+F E
Sbjct: 537 QLLAPNPDV---FVSLSVLDITHNKFICECELS 566
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 8e-49
Identities = 58/359 (16%), Positives = 110/359 (30%), Gaps = 51/359 (14%)
Query: 251 PEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTV 310
+ S ENL+ + D L + + + N ++ +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQI 60
Query: 311 IDVSLNSLGGEVPVSLANL--VALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFG 368
+ +L L + L L + + P S L+ + +D
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-M 117
Query: 369 QIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLT 428
++P T+ Q L+ L L+ N L ++P+S+ +L L
Sbjct: 118 ELPDTMQQFA-----------------------GLETLTLARNPLR-ALPASIASLNRLR 153
Query: 429 QLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGE 488
+L + + E+P + L L L L
Sbjct: 154 ELSIRACPELTELPEPLASTD---------------ASGEHQGLVNLQSLRLEWTGIR-S 197
Query: 489 IPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLN 548
+P I N L+ + + + L + ++ L L LDL + P G L
Sbjct: 198 LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 549 KLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALT 607
+L+L + +P + L+ LDL +P I +L I + + +
Sbjct: 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI-ILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-48
Identities = 63/349 (18%), Positives = 115/349 (32%), Gaps = 51/349 (14%)
Query: 89 SHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNS 148
S +L + + N D + ++ + +
Sbjct: 12 SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRA 67
Query: 149 IHGGIPREIGNCS--KLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEI 206
+ + + + LEL L P + +L L+ + G+ E+P+ +
Sbjct: 68 LK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA-GLM-ELPDTM 123
Query: 207 SNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLY 266
L L LA + +P S+ L LR LS+ +PE + +
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD-------- 174
Query: 267 ENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSL 326
E L NL+ L L + S+P ++ N +L + + + L + ++
Sbjct: 175 -------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALGPAI 225
Query: 327 ANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAW 386
+L LEEL L G P FG + LK+L L + +P I +L
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT-------- 277
Query: 387 QNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISN 435
+L+ LDL +PS + L +L+ +
Sbjct: 278 ---------------QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 8e-48
Identities = 52/369 (14%), Positives = 102/369 (27%), Gaps = 51/369 (13%)
Query: 271 FGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLV 330
G + L + + L D + AN
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56
Query: 331 ALEELLLSGNNISGEIPSFFGNFSR--LKQLELDNNRFFGQIPPTIGQLKELLLFFAWQN 388
+ +G + + ++ LEL + Q P +L
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVP-LPQFPDQAFRLS---------- 104
Query: 389 QLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGC 448
LQ + + L +P ++ L L L N +P I
Sbjct: 105 -------------HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL 149
Query: 449 TGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNK 508
L L + + +P + + E L+ + L
Sbjct: 150 NRLRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTG 194
Query: 509 LQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLC 568
++ ++P+S+ L L L + + + + + L L +L L P G
Sbjct: 195 IR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 569 KDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNN 628
L+ L L ++P +I RL L+ L+L +P + L + + +
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEK-LDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
Query: 629 MLTGSLKVL 637
+ +
Sbjct: 312 LQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-47
Identities = 57/338 (16%), Positives = 105/338 (31%), Gaps = 28/338 (8%)
Query: 325 SLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFF 384
+ E L G+ + R + + + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIET 62
Query: 385 AWQNQLHGNIPELAYC--VKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIP 442
L L AL+L L P F L +L + + + E+P
Sbjct: 63 RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 443 PEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMV 502
+ GL L L N +P+ I L+RL L + E+P + +
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD----- 174
Query: 503 DLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIP 562
+ L L L L I ++P ++ L +L L + + ++ L
Sbjct: 175 ----------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-G 222
Query: 563 KSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLAN 622
++ L+ LDL + P G L L+ + L +P L++L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEK 281
Query: 623 LDLSNNMLTGSL-KVLGSLDNLVSLNVSYNHFSGILPN 659
LDL + L ++ L + V + + + +
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-46
Identities = 49/287 (17%), Positives = 105/287 (36%), Gaps = 24/287 (8%)
Query: 80 SFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSS--LINLDLSFNALTGNIPEEIGKLA 137
++ + ++ + L + + + + L+L L P++ +L+
Sbjct: 47 HSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS 104
Query: 138 ELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPG 197
L+ +++++ + +P + + L L L N L +PA I L L + P
Sbjct: 105 HLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPE 162
Query: 198 IHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNC 257
+ E+PE +++ L NL++L + I +P I N
Sbjct: 163 LT-ELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANL 205
Query: 258 SALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNS 317
L++L + + + + + L L+ L L + P G + L + + S
Sbjct: 206 QNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
Query: 318 LGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364
+P+ + L LE+L L G +PS + + +
Sbjct: 265 NLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-46
Identities = 62/342 (18%), Positives = 113/342 (33%), Gaps = 29/342 (8%)
Query: 203 PEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALEN 262
+ L S + L+ + N + N + +
Sbjct: 5 HHHHHHSSGRENLYFQG---STALRPYHDVLSQWQRHYNADRNRW-HSAWRQANSNNPQI 60
Query: 263 LFLYENQIFGKIPDELGSLK--NLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGG 320
+ D L L L L P+ S L + + L
Sbjct: 61 ETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 321 EVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKEL 380
E+P ++ LE L L+ N + +P+ + +RL++L + ++P +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 381 LLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGE 440
E V LQ+L L + S+P+S+ NL+NL L + ++ S
Sbjct: 177 --------------GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220
Query: 441 IPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSE-NQFTGEIPPEIGNCTQL 499
+ P I L L L + P G L L L + + +P +I TQL
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQL 279
Query: 500 EMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL 541
E +DL +PS + L ++ + + + ++
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ-AQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-43
Identities = 62/378 (16%), Positives = 110/378 (29%), Gaps = 75/378 (19%)
Query: 109 IGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLEL 168
+ S NL + + + + N N + +
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH----SAWRQANSNNPQIETR 63
Query: 169 YDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKV--LVFLGLADTGISGQI 226
L + + + V L L + Q
Sbjct: 64 TGRALK--------------------------ATADLLEDATQPGRVALELRSVPLP-QF 96
Query: 227 PRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKR 286
P L++L+ +++ A + +P+ + + LE L L N + +P + SL L+
Sbjct: 97 PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRE 154
Query: 287 LLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEI 346
L + +PE L + + LV L+ L L I +
Sbjct: 155 LSIRACPELTELPEPLASTDA---------------SGEHQGLVNLQSLRLEWTGIR-SL 198
Query: 347 PSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQAL 406
P+ N LK L++ N+ + P I L KL+ L
Sbjct: 199 PASIANLQNLKSLKIRNSPLS-ALGPAIHHLP-----------------------KLEEL 234
Query: 407 DLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIP 466
DL + P L +L+L +P +I T L +L L +P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 467 SRIGLLHRLTFLELSENQ 484
S I L + + +
Sbjct: 295 SLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-43
Identities = 54/369 (14%), Positives = 115/369 (31%), Gaps = 52/369 (14%)
Query: 151 GGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCK 210
G + S L + + Q + +N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW-----HSAWRQANSN 56
Query: 211 VLVFLGLADTGISGQIPRSVGELT--NLRTLSVYTANITGYIPEEIGNCSALENLFLYEN 268
+ + + T L + + + P++ S L+++ +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 269 QIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLAN 328
+ ++PD + L+ L L +N L ++P ++ + + L + + E+P LA+
Sbjct: 115 GL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 329 LVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQN 388
+ L+ L L+ +P +I L+
Sbjct: 173 T---------------DASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQ---------- 206
Query: 389 QLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGC 448
L++L + ++ L+ ++ ++ +L L +L L PP GG
Sbjct: 207 -------------NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 449 TGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNK 508
L RL L + +P I L +L L+L +P I ++ + +
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH- 311
Query: 509 LQGTIPSSL 517
LQ +
Sbjct: 312 LQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-43
Identities = 48/243 (19%), Positives = 95/243 (39%), Gaps = 15/243 (6%)
Query: 86 LSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLN 145
+ +L L + L + P LS L ++ + L +P+ + + A LE L+L
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLA 135
Query: 146 SNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEA---------LEIIRAGGNP 196
N + +P I + ++LR L + +P + +A L+ +R
Sbjct: 136 RNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT- 193
Query: 197 GIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGN 256
GI +P I+N + L L + ++ +S + ++ L L L + P G
Sbjct: 194 GIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251
Query: 257 CSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLN 316
+ L+ L L + +P ++ L L++L L +P + + +I V +
Sbjct: 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
Query: 317 SLG 319
Sbjct: 312 LQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 39/256 (15%), Positives = 74/256 (28%), Gaps = 19/256 (7%)
Query: 415 GSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHR 474
GS + L + + H R +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57
Query: 475 LTFLELSENQFTGEIPPEIGNCTQ--LEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNS 532
+ + + TQ ++L L P L L + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 533 IGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRL 592
+ +P+ + + L L L++N + L P S+ L+ L + + +PE +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 593 QGLDIL--------LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLV 644
L L W + +P S +NL L +L + N+ L+ + L L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLE 232
Query: 645 SLNVSYNHFSGILPNT 660
L++ P
Sbjct: 233 ELDLRGCTALRNYPPI 248
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-48
Identities = 101/582 (17%), Positives = 187/582 (32%), Gaps = 97/582 (16%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE 138
TS P L + + SL LS +T + ++L L L + + + L
Sbjct: 18 TSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
LE L L+ N + G S L+ L L N
Sbjct: 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ------------------------ 111
Query: 199 HGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEE-IGNC 257
+ + LTNL+TL + I
Sbjct: 112 ------TLGVTSLF------------------PNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 258 SALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNS 317
++L L + + L S++++ L L + + + SS+ +++ +
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 318 LGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQL 377
L L + S F +L + L+ + L
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT----L 263
Query: 378 KELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRF 437
L F ++ + + ++ V ++ L + +L + + L+ + ++ + +++
Sbjct: 264 NGLGDFNPSESDVVSELGKV-ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 438 SGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPE---IG 494
+P L L FL+LSEN E G
Sbjct: 323 F-LVPCSF---------------SQH--------LKSLEFLDLSENLMVEEYLKNSACKG 358
Query: 495 NCTQLEMVDLHQNKLQ--GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVL 552
L+ + L QN L+ L L L LD+S N+ +P++ + L L
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNL 417
Query: 553 SKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPE 612
S I + + + L++LD+S+N ++ S + RLQ L +S N L
Sbjct: 418 SSTGIRVV---KTCIPQTLEVLDVSNNNLD-SFSLFLPRLQELY----ISRNKLKTLPDA 469
Query: 613 SFSNLSKLANLDLSNNMLTG-SLKVLGSLDNLVSLNVSYNHF 653
S L + +S N L + L +L + + N +
Sbjct: 470 SL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-45
Identities = 96/565 (16%), Positives = 188/565 (33%), Gaps = 78/565 (13%)
Query: 111 NLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYD 170
+ + D + T +IP + A ++ L L+ N I ++ C+ L+ L L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 171 NQLSGNIPAEI-GQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRS 229
++++ I + L +LE + N + L +L L S
Sbjct: 60 SRIN-TIEGDAFYSLGSLEHLDLSDNH-LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 230 V-GELTNLRTLSVYTANITGYIPEE-IGNCSALENLFLYENQIFGKIPDELGSLKNLKRL 287
+ LTNL+TL + I ++L L + + L S++++ L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177
Query: 288 LLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIP 347
L + + + SS+ +++ +L L + S
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237
Query: 348 SFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALD 407
F +L + L+ + L L F ++ + + ++ V ++ L
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCT----LNGLGDFNPSESDVVSELGKV-ETVTIRRLH 292
Query: 408 LSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPS 467
+ +L + + L+ + ++ + +++ +P
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSF---------------SQH---- 332
Query: 468 RIGLLHRLTFLELSENQFTGEIPPE---IGNCTQLEMVDLHQNKLQ--GTIPSSLEFLFG 522
L L FL+LSEN E G L+ + L QN L+ L L
Sbjct: 333 ----LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 523 LNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRIN 582
L LD+S N+ +P++ + L LS I + + + L++LD+S+N ++
Sbjct: 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV---KTCIPQTLEVLDVSNNNLD 444
Query: 583 GSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDN 642
S L +L L +S N L +L
Sbjct: 445 -SFS----------------------------LFLPRLQELYISRNKLK-TLPDASLFPV 474
Query: 643 LVSLNVSYNHFSGILPNTKLFHGLP 667
L+ + +S N + F L
Sbjct: 475 LLVMKISRNQLKSVPDGI--FDRLT 497
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 9e-45
Identities = 100/524 (19%), Positives = 199/524 (37%), Gaps = 48/524 (9%)
Query: 89 SHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNS 148
+ + T IP + +++ +LDLSFN +T ++ A L++L L S+
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 149 IHGGIPREI-GNCSKLRRLELYDNQLSGNIPAE-IGQLEALEIIRAGGNPGIHGEIPEEI 206
I+ I + + L L+L DN LS ++ + G L +L+ + GNP +
Sbjct: 62 INT-IEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 207 SNCKVLVFLGLADTGISGQIPRSV-GELTNLRTLSVYTANITGYIPEEIGNCSALENLFL 265
N L L + + +I R LT+L L + ++ Y + + + + +L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 266 YENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVS 325
+ ++ + L +++ L L NL+ L + + S
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 326 LANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFA 385
L+ L +L + + F + + + + + + +G+++ + +
Sbjct: 240 FNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSES--DVVSELGKVETVTIRRL 291
Query: 386 W--QNQLHGNIPE-LAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEI 441
Q L ++ + K++ + + ++ + VP S +LK+L L L N E
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEY 350
Query: 442 PPE---IGGCTGLIRLRLGSNNFSGHIPSRIGL---LHRLTFLELSENQFTGEIPPEIGN 495
G L L L N+ + + L LT L++S N F +P
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
Query: 496 CTQLEMVDLHQNKLQ---GTIPSSLE--------------FLFGLNVLDLSMNSIGGTIP 538
++ ++L ++ IP +LE FL L L +S N + T+P
Sbjct: 409 PEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLP 467
Query: 539 ENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRIN 582
+ L + +S+N + + LQ + L +N +
Sbjct: 468 DA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 9e-38
Identities = 74/465 (15%), Positives = 157/465 (33%), Gaps = 71/465 (15%)
Query: 72 ITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIP 130
++ + + FP + ++L +L + N EI L+SL L++ +L
Sbjct: 110 YQTLGVTSLFP----NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165
Query: 131 EEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEII 190
+ + + ++ L+L+ + + S +R LEL D L+ + + E +
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPM 225
Query: 191 RAGGNPGIH---------GEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSV 241
+ G ++ I + F G+ P ++ L +
Sbjct: 226 KKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV-- 283
Query: 242 YTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEA 301
+ L + + +F + L+ +KR+ + + +
Sbjct: 284 --------------ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329
Query: 302 LGNCSSLTVIDVSLNSLGGEV---PVSLANLVALEELLLSGNNIS--GEIPSFFGNFSRL 356
+ SL +D+S N + E +L+ L+LS N++ + L
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL 389
Query: 357 KQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGS 416
L++ N F +P + + K++ L+LS +
Sbjct: 390 TSLDISRNT-FHPMPDSCQWPE-----------------------KMRFLNLSSTGIR-V 424
Query: 417 VPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLT 476
V + + + L L + +N + L L + N +P L L
Sbjct: 425 VKTCIP--QTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLK-TLPD-ASLFPVLL 476
Query: 477 FLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFL 520
+++S NQ +P I T L+ + LH N + +++L
Sbjct: 477 VMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS-CPRIDYL 519
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-48
Identities = 72/309 (23%), Positives = 120/309 (38%), Gaps = 46/309 (14%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAE--VQTLGSIRHKNIVR 821
+GKG G V+R + +V AVK E + E + +RH+NI+
Sbjct: 48 ESIGKGRFGEVWRGKWRGEEV-AVKIF------SSREERSWFREAEIYQTVMLRHENILG 100
Query: 822 LLGCC---NNGRTRLLL-FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
+ N T+L L DY +GSL L+ + + K+ L A GLA+LH +
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHME 158
Query: 878 CV-----PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR--ASNSVAGSYGYI 930
V P I HRD+KS NILV +AD GLA +S+ + A N G+ Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 931 APE------YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR----------IPDGAHII 974
APE + +++D+Y+ G+V E+ +P +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 975 TWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034
++ R I +R + + ++++ C R T +
Sbjct: 279 EMRKVVCEQKLR--PNIPNRWQSCEALRVMAKIMR------ECWYANGAARLTALRIKKT 330
Query: 1035 LKEIRHEND 1043
L ++ +
Sbjct: 331 LSQLSQQEG 339
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-46
Identities = 70/421 (16%), Positives = 133/421 (31%), Gaps = 28/421 (6%)
Query: 250 IPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLT 309
I E N + + + ++ + + S N+K L L N LS L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 310 VIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQ 369
++++S N L + L +L L L L+ N + E+ ++ L NN +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNN-ISR 113
Query: 370 IPPTIGQ-LKELLLFFAWQNQLHGNIPELAYC--VKLQALDLSHNFLTGSVPSSLF-NLK 425
+ + GQ K + L N++ + +L ++Q LDL N + + L +
Sbjct: 114 VSCSRGQGKKNIYL---ANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 426 NLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQF 485
L L L N ++ ++ L L L SN + + +T++ L N+
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 486 TGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLT 545
I + LE DL N F V ++ ++ +N + T
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 546 SLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDI---LLNLS 602
L L+ + + GS E + + ++
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 603 WNALTGPIPESFSNLSKLANLDLSNN----MLTGSLKVLGSLDNLVSLNVSYNHFSGILP 658
I + L+ ++ + LD + V
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404
Query: 659 N 659
Sbjct: 405 E 405
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-45
Identities = 61/393 (15%), Positives = 126/393 (32%), Gaps = 44/393 (11%)
Query: 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRL 356
+I E N + + V+ +SL + + ++EL LSGN +S + F++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 357 KQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGS 416
+ L L +N + +L L+ LDL++N++
Sbjct: 61 ELLNLSSNVLY-------------------------ETLDLESLSTLRTLDLNNNYVQ-- 93
Query: 417 VPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLT 476
L ++ L +N S + G G + L +N + G R+
Sbjct: 94 ---ELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 477 FLELSENQFTG-EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
+L+L N+ + LE ++L N + + + L LDLS N +
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-A 204
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
+ + + L N + I K+L ++L+ DL N + +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKN 261
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
+ ++ + ++ + D L++L +
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPA--PFADRLIALKRKEHALLS 319
Query: 656 ILPNTKLFHGLPASAFYGNQQLCVNRSQCHINN 688
+ L +Q ++ +
Sbjct: 320 GQGSE--TERLECERENQARQREIDALKEQYRT 350
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-40
Identities = 71/493 (14%), Positives = 144/493 (29%), Gaps = 22/493 (4%)
Query: 109 IGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLEL 168
N + ++ ++L + ++ L L+ N + ++ +KL L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 169 YDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPR 228
N L ++ L L + N +E+ + L A+ IS ++
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNY------VQELLVGPSIETLHAANNNIS-RVSC 116
Query: 229 SVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFG-KIPDELGSLKNLKRL 287
S + + + IT + G S ++ L L N+I + S L+ L
Sbjct: 117 SR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 288 LLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIP 347
L N + + + + L +D+S N L + + + + L N + I
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 348 SFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALD 407
L+ +L N F + + A Q C
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 408 LSHNFLTGSVPSSLFNLKNLT----QLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSG 463
L L LL + + E + +
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 464 HIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGL 523
I LE + ++ +L+ + + E L
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSPL 409
Query: 524 NVLDLSMNSIG-GTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRIN 582
+L + + + + ++ + ++ T L ++ L K DL+ N
Sbjct: 410 QLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASAN 469
Query: 583 GSIPEEIGRLQGL 595
++ E + R Q L
Sbjct: 470 ATLQELVVREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-40
Identities = 66/505 (13%), Positives = 129/505 (25%), Gaps = 94/505 (18%)
Query: 129 IPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALE 188
I E ++ + +S+ + + ++ L+L N LS A++ LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 189 IIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITG 248
++ N L
Sbjct: 62 LLNLSSN---------------------------------------VLYETL-------- 74
Query: 249 YIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSL 308
++ + S L L L N + EL +++ L NN+S +
Sbjct: 75 ----DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSC--SRGQGK 122
Query: 309 TVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISG-EIPSFFGNFSRLKQLELDNNRFF 367
I ++ N + + ++ L L N I + L+ L L N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 368 GQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNL 427
++ KL+ LDLS N L + + +
Sbjct: 183 -------------------------DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216
Query: 428 TQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTG 487
T + L +N+ I + L L N F R +++
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK 274
Query: 488 EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG----TIPENLGK 543
CT + + + L L + ++ S G +
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334
Query: 544 LTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSW 603
++ K +I + + L+ ++ + LD L
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD--GTLQQ 392
Query: 604 NALTGPIPESFSNLSKLANLDLSNN 628
+ + S L L
Sbjct: 393 AVGQIELQHATEEQSPLQLLRAIVK 417
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 53/350 (15%), Positives = 99/350 (28%), Gaps = 15/350 (4%)
Query: 87 SFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTG-NIPEEIGKLAELELLSLN 145
++ L+N +T G S + LDL N + N E LE L+L
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 146 SNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE 205
N I+ + ++ +KL+ L+L N+L+ + E + I N + I +
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK-LV-LIEKA 232
Query: 206 ISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFL 265
+ + L L G R N R +V + + C+
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
Query: 266 YENQIFGKIPDELGSLKNLKRLLLW----QNNLSGSIPEALGNCSSLTVIDVSLNSLGGE 321
L LKR Q + + + N + ID
Sbjct: 292 GAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTV 351
Query: 322 VPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR--FFGQIPPTIGQLKE 379
+ A L + ++ + + L L+
Sbjct: 352 IDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQL 411
Query: 380 LLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQ 429
L +++ + ++ D+ + T + LK L
Sbjct: 412 LRAIVKRYEEMYVE-QQSVQNNAIRDWDMYQHKET-QLAEENARLKKLNG 459
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 32/300 (10%), Positives = 74/300 (24%), Gaps = 27/300 (9%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE 138
+ S + +T + L N L I A+ +L + DL N +
Sbjct: 204 AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKN 261
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
+ ++ ++ + C+ +L AL+
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKE------- 314
Query: 199 HGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCS 258
L + + R + I +
Sbjct: 315 -------------HALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQ 360
Query: 259 ALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSL 318
A L + + ++ + + L L Q + A S L ++ +
Sbjct: 361 AKITLEQKKKALDEQVSNGRRAHAELDGTLQ-QAVGQIELQHATEEQSPLQLLRAIVKRY 419
Query: 319 GGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLK 378
+ + + + + +RLK+L + + T+ +L
Sbjct: 420 ---EEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELV 476
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-45
Identities = 78/381 (20%), Positives = 149/381 (39%), Gaps = 36/381 (9%)
Query: 308 LTVIDVSLNSLGGEVPVSLA--NLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR 365
DV ++ +V L + + + + + +F +++ L L++ +
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80
Query: 366 FFGQIPPTI----GQLKELLLFFAWQNQLHGNIPE--LAYCVKLQALDLSHNFLTGSVPS 419
+I +++L + F N + +P L L L N L+ S+P
Sbjct: 81 -IEEIDTYAFAYAHTIQKLYMGF---NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPR 134
Query: 420 SLF-NLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTF 477
+F N LT L + +N I + T L L+L SN + H+ + L+ L
Sbjct: 135 GIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFH 190
Query: 478 LELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTI 537
+S N + + +E +D N + + + L +L L N++ T
Sbjct: 191 ANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TD 240
Query: 538 PENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDI 597
L L ++ LS N + ++ + L+ L +S+NR+ ++ + L +
Sbjct: 241 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299
Query: 598 LLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGIL 657
L+LS N L + + +L NL L +N + +LK L + L +L +S+N +
Sbjct: 300 -LDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDCN- 354
Query: 658 PNTKLFHGLPASAFYGNQQLC 678
LF + A Q C
Sbjct: 355 SLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-34
Identities = 69/379 (18%), Positives = 131/379 (34%), Gaps = 52/379 (13%)
Query: 65 CSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFN 123
C ++ I F ++ ++ ++ + N+ + ++P + + + L+L+
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 79
Query: 124 ALTGNIPEEI-GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEI 181
+ I ++ L + N+I +P + N L L L N LS ++P I
Sbjct: 80 QIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGI 136
Query: 182 -GQLEALEIIRAGGNPGIHGEIPEEI-SNCKVLVFLGLADTGISGQIPRSVGELTNLRTL 239
L + N + I ++ L L L+ ++ + S+ + +L
Sbjct: 137 FHNTPKLTTLSMSNNN-LE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHA 191
Query: 240 SVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIP 299
+V ++ + A+E L N I + L L L NNL+
Sbjct: 192 NVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRG--PVNVELTILKLQHNNLT-DTA 242
Query: 300 EALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQL 359
L N L +D+S N L + + LE L +S N + + + LK L
Sbjct: 243 -WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 360 ELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPS 419
+L +N + Q +L+ L L HN + ++
Sbjct: 301 DLSHNH-LLHVERNQPQFD-----------------------RLENLYLDHNSIV-TLKL 335
Query: 420 SLFNLKNLTQLLLISNRFS 438
S L L L N +
Sbjct: 336 STH--HTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-32
Identities = 74/437 (16%), Positives = 132/437 (30%), Gaps = 100/437 (22%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEI-GKLA 137
L + + L++ + + + +P +
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFR 69
Query: 138 ELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNP 196
++ELL+LN I I +++L + N + +P + Q
Sbjct: 70 QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ------------- 114
Query: 197 GIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI-G 255
+ L L + +++ +P I
Sbjct: 115 -----------------------------------NVPLLTVLVLERNDLS-SLPRGIFH 138
Query: 256 NCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVS 314
N L L + N + +I D+ + +L+ L L N L+ + L SL +VS
Sbjct: 139 NTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 194
Query: 315 LNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTI 374
N L +LA +A+EEL S N+I+ + L L+L +N
Sbjct: 195 YNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL-------- 238
Query: 375 GQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLI 433
+ L L +DLS+N L + F ++ L +L +
Sbjct: 239 -----------------TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYIS 280
Query: 434 SNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEI 493
+NR + L L L N+ H+ RL L L N +
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-- 335
Query: 494 GNCTQLEMVDLHQNKLQ 510
L+ + L N
Sbjct: 336 STHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-25
Identities = 49/270 (18%), Positives = 94/270 (34%), Gaps = 27/270 (10%)
Query: 416 SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRI-GLLHR 474
+ S+L + + E + ++ +P+ + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 475 LTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSI 533
+ L L++ Q EI ++ + + N ++ P + + L VL L N +
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129
Query: 534 GGTIPENL-GKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRL 592
++P + L L +S NN+ + + LQ L LSSNR+ I L
Sbjct: 130 -SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL 188
Query: 593 QGLDI---------------LLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVL 637
++ L+ S N++ L+ L L +N LT L
Sbjct: 189 FHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLT-DTAWL 244
Query: 638 GSLDNLVSLNVSYNHFSGILPNTKLFHGLP 667
+ LV +++SYN I+ + F +
Sbjct: 245 LNYPGLVEVDLSYNELEKIMYHP--FVKMQ 272
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-17
Identities = 30/160 (18%), Positives = 60/160 (37%), Gaps = 8/160 (5%)
Query: 512 TIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDL 571
I S+L++ + + M + L + + + + L L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 572 QLLDLSSNRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNM 629
+LL+L+ +I I + L + +NA+ P F N+ L L L N
Sbjct: 72 ELLNLNDLQIE-EIDTYA--FAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128
Query: 630 LTG-SLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPA 668
L+ + + L +L++S N+ I +T F +
Sbjct: 129 LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT--FQATTS 166
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 62/359 (17%), Positives = 121/359 (33%), Gaps = 44/359 (12%)
Query: 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRL 356
+I E N + + V+ +SL + + ++EL LSGN +S + F++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 357 KQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGS 416
+ L L +N +L L+ LDL++N++
Sbjct: 61 ELLNLSSNVL-------------------------YETLDLESLSTLRTLDLNNNYVQ-- 93
Query: 417 VPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLT 476
L ++ L +N S + G G + L +N + G R+
Sbjct: 94 ---ELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 477 FLELSENQFTG-EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
+L+L N+ + LE ++L N + + + L LDLS N +
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-A 204
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
+ + + L N + I K+L ++L+ DL N + +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKN 261
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFS 654
+ ++ + + + L L D L++L ++H
Sbjct: 262 QRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAP-FADRLIAL--GHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 61/330 (18%), Positives = 104/330 (31%), Gaps = 39/330 (11%)
Query: 346 IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQA 405
I N +R K ++ ++ Q ++ Q ++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSL-KQALASLRQS----------------------AWNVKE 38
Query: 406 LDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHI 465
LDLS N L+ + L L L L SN ++ + L L L +N
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ--- 93
Query: 466 PSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNV 525
+ + + L + N + + G + + L NK+ +
Sbjct: 94 --ELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 526 LDLSMNSIGG-TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGS 584
LDL +N I E +L L L N I + + L+ LDLSSN++
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVF-AKLKTLDLSSNKLA-F 205
Query: 585 IPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLV 644
+ E G+ + +L N L I ++ L + DL N N
Sbjct: 206 MGPEFQSAAGVTWI-SLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 645 SLNVSYNHFSGILPNTKLFHGLPASAFYGN 674
V+ + + +P YG
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 63/324 (19%), Positives = 123/324 (37%), Gaps = 21/324 (6%)
Query: 89 SHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNS 148
+ +++++L + + ++ LDLS N L+ ++ +LELL+L+SN
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 149 IHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISN 208
++ ++ + S LR L+L +N + E+ ++E + A N I +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN-IS-RVSCSR-- 118
Query: 209 CKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITG-YIPEEIGNCSALENLFLYE 267
+ + LA+ I+ G + ++ L + I E + LE+L L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 268 NQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLA 327
N I+ + ++ LK L L N L+ + + + +T I + N L + +L
Sbjct: 179 NFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALR 234
Query: 328 NLVALEELLLSGNNIS-GEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAW 386
LE L GN G + FF R++ + + + L +
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY--- 291
Query: 387 QNQLHGNIPELAYCVKLQALDLSH 410
+ +L AL H
Sbjct: 292 -GAYCCEDLPAPFADRLIALGHHH 314
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 59/383 (15%), Positives = 109/383 (28%), Gaps = 69/383 (18%)
Query: 152 GIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKV 211
I N ++ + ++ D+ L A + Q
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQ---------------------------- 31
Query: 212 LVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIF 271
N++ L + ++ ++ + LE L L N +
Sbjct: 32 --------------------SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL- 70
Query: 272 GKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVA 331
+ D L SL L+ L L N + L S+ + + N++ VS +
Sbjct: 71 YETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR---VSCSRGQG 121
Query: 332 LEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFG-QIPPTIGQLKELLLFFAWQNQL 390
+ + L+ N I+ G SR++ L+L N L N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 391 HGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTG 450
+ ++ KL+ LDLS N L + + +T + L +N+ I +
Sbjct: 182 Y-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 451 LIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQ 510
L L N F R +++ CT
Sbjct: 239 LEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT-----LGHYG 292
Query: 511 GTIPSSLEFLFGLNVLDLSMNSI 533
L F ++ L +
Sbjct: 293 AYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 47/242 (19%), Positives = 83/242 (34%), Gaps = 14/242 (5%)
Query: 416 SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRL 475
++ N + + + + L L N S + + +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 476 TFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
L LS N ++ + + L +DL+ N + L + L + N+I
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRING-SIPEEIGRLQG 594
+ + + L+ N IT L G +Q LDL N I+ + E
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 595 LDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFS 654
L+ L NL +N + + +KL LDLS+N L S + +++ N
Sbjct: 171 LEHL-NLQYNFIYD-VKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227
Query: 655 GI 656
I
Sbjct: 228 LI 229
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 34/191 (17%), Positives = 63/191 (32%), Gaps = 8/191 (4%)
Query: 87 SFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTG-NIPEEIGKLAELELLSLN 145
++ L+N +T G S + LDL N + N E LE L+L
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 146 SNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE 205
N I+ + ++ +KL+ L+L N+L+ + E + I N + I +
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK-LV-LIEKA 232
Query: 206 ISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFL 265
+ + L L G R + + + + + + L
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 266 YENQIFGKIPD 276
Y +P
Sbjct: 291 YGAYCCEDLPA 301
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 13/71 (18%), Positives = 27/71 (38%), Gaps = 2/71 (2%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALT-GNIPEEIGKLA 137
+ S + +T + L N L I A+ +L + DL N G + + K
Sbjct: 204 AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 138 ELELLSLNSNS 148
++ ++ +
Sbjct: 263 RVQTVAKQTVK 273
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-40
Identities = 76/373 (20%), Positives = 139/373 (37%), Gaps = 48/373 (12%)
Query: 257 CSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLN 316
+ L + E+ + +PD L ++ L++ NNL+ S+P +L V L
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLEVSGNQLT 94
Query: 317 SLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQ 376
SL PV L+ L ++ L +L + N+ +P
Sbjct: 95 SL----PVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQL-TSLPVLPPG 142
Query: 377 LKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNR 436
L+EL + NQL ++P L +L L +N LT S+P L+ L+ + N+
Sbjct: 143 LQELSV---SDNQL-ASLPAL--PSELCKLWAYNNQLT-SLPMLPSGLQELS---VSDNQ 192
Query: 437 FSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNC 496
+ +P L +L +N + +P+ L L L +S N+ T +P
Sbjct: 193 LA-SLPTLPSE---LYKLWAYNNRLT-SLPA---LPSGLKELIVSGNRLT-SLPVLPSE- 242
Query: 497 TQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNN 556
L+ + + N+L ++P GL L + N + +PE+L L+S + L N
Sbjct: 243 --LKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 557 ITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPES-FS 615
++ + +++ S I L+L+ P E +
Sbjct: 296 LSERTLQ---ALREITSAPGYSGPII-RFDMAGASAPRETRALHLAAADWLVPAREGEPA 351
Query: 616 NLSKLANLDLSNN 628
+ +N
Sbjct: 352 PADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 8e-38
Identities = 72/343 (20%), Positives = 127/343 (37%), Gaps = 70/343 (20%)
Query: 291 QNNLSGSIPEALGNC--SSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPS 348
++ ++ + + C + V++V + L +P L + L++ NN++ +P+
Sbjct: 23 ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPA 78
Query: 349 FFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDL 408
L+ LE+ N+ +P L EL +F L L L +
Sbjct: 79 LPPE---LRTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHLPALPS------GLCKLWI 128
Query: 409 SHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSR 468
N LT S+P L+ L+ + N+ + +P
Sbjct: 129 FGNQLT-SLPVLPPGLQELS---VSDNQLA-SLPALPS---------------------- 161
Query: 469 IGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDL 528
L L NQ T +P +L + N+L ++P+ L+ L +
Sbjct: 162 -----ELCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKLWAYNN 211
Query: 529 SMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEE 588
+ S+ P L L +S N +T L P +L+ L +S NR+ S+P
Sbjct: 212 RLTSL----PALPSGLKELI---VSGNRLTSL-PVLPS---ELKELMVSGNRLT-SLPML 259
Query: 589 IGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLT 631
L L + N LT +PES +LS ++L N L+
Sbjct: 260 PSGLLSLS----VYRNQLTR-LPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 4e-37
Identities = 82/425 (19%), Positives = 137/425 (32%), Gaps = 77/425 (18%)
Query: 112 LSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDN 171
+ L++ + LT +P+ + + L + N++ +P LR LE+ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91
Query: 172 QLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVG 231
QL+ ++P L L I +P S L L + ++ +P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLT-----HLPALPSG---LCKLWIFGNQLT-SLPV--- 138
Query: 232 ELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQ 291
L+ LSV + +P L L+ Y NQ+ +P L+ L +
Sbjct: 139 LPPGLQELSVSDNQLAS-LPALPSE---LCKLWAYNNQL-TSLPMLPS---GLQELSVSD 190
Query: 292 NNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFG 351
N L+ S+P L + L SL P + L+EL++SGN ++ +P
Sbjct: 191 NQLA-SLPTLPSELYKLWAYNNRLTSL----PALPSG---LKELIVSGNRLT-SLPVLPS 241
Query: 352 NFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHN 411
LK+L + NR +P L L + N
Sbjct: 242 E---LKELMVSGNR-LTSLPMLPSGLLS--------------------------LSVYRN 271
Query: 412 FLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNN----FSGHIPS 467
LT +P SL +L + T + L N S E + G P
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPR 329
Query: 468 RIGLLHRLTFLELSENQFTG----EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGL 523
LH L + + G + L ++L T + F
Sbjct: 330 ETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKA 389
Query: 524 NVLDL 528
+
Sbjct: 390 QISSW 394
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 80/487 (16%), Positives = 139/487 (28%), Gaps = 121/487 (24%)
Query: 160 CSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLAD 219
+ L + ++ L+ +P+ +
Sbjct: 39 NNGNAVLNVGESGLT--------------------------TLPDCL------------- 59
Query: 220 TGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELG 279
++ TL + N+T +P L L + NQ+ +P
Sbjct: 60 -------------PAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQL-TSLPVLPP 101
Query: 280 SLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSG 339
L L +L S L + + N L +PV L+EL +S
Sbjct: 102 GLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQL-TSLPVLPPG---LQELSVSD 150
Query: 340 NNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAY 399
N ++ +P+ L +L NN+ +P L+E
Sbjct: 151 NQLA-SLPALPSE---LCKLWAYNNQ-LTSLPMLPSGLQE-------------------- 185
Query: 400 CVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSN 459
L +S N L S+P+ L L +NR + +P GL L + N
Sbjct: 186 ------LSVSDNQLA-SLPTLPSELYKLWAY---NNRLT-SLPALPS---GLKELIVSGN 231
Query: 460 NFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEF 519
+ +P L L +S N+ T +P L +++N+L +P SL
Sbjct: 232 RLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIH 282
Query: 520 LFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSN 579
L ++L N + + L ++TS + + L L
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA--- 339
Query: 580 RINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGS 639
+ +P G D LS+ N L
Sbjct: 340 --DWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQ 397
Query: 640 LDNLVSL 646
L +L
Sbjct: 398 LAEDEAL 404
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-28
Identities = 64/321 (19%), Positives = 104/321 (32%), Gaps = 39/321 (12%)
Query: 87 SFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNS 146
L +L +S LT +P L L ++P L +L +
Sbjct: 79 LPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCKLWIFGNQL 133
Query: 147 NSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEI 206
S +P L+ L + DNQL+ ++PA +L L N +P
Sbjct: 134 TS----LPVLPPG---LQELSVSDNQLA-SLPALPSELCKLWA---YNNQ--LTSLPMLP 180
Query: 207 SNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLY 266
S L L ++D ++ +P EL L + N +P L+ L +
Sbjct: 181 SG---LQELSVSDNQLA-SLPTLPSELYKLWAYN----NRLTSLPALPSG---LKELIVS 229
Query: 267 ENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSL 326
N++ +P LK L + N L+ S+P L + V N L +P SL
Sbjct: 230 GNRL-TSLPVLPSELKELM---VSGNRLT-SLPMLPSG---LLSLSVYRNQL-TRLPESL 280
Query: 327 ANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAW 386
+L + + L GN +S E F + + L A
Sbjct: 281 IHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
Query: 387 QNQLHGNIPELAYCVKLQALD 407
+ E A +
Sbjct: 340 DWLVPAREGEPAPADRWHMFG 360
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 60/320 (18%), Positives = 106/320 (33%), Gaps = 44/320 (13%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE 138
TS P L+ +L S L L + N LT ++P L E
Sbjct: 94 TSLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPGLQE 145
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
L + S +P L +L Y+NQL+ ++P L+ L + N +
Sbjct: 146 LSVSDNQLAS----LPALPSE---LCKLWAYNNQLT-SLPMLPSGLQELSV---SDNQ-L 193
Query: 199 HGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCS 258
+P S L T +P + L+ L V +T +P
Sbjct: 194 A-SLPTLPSELYKLWAYNNRLT----SLP---ALPSGLKELIVSGNRLT-SLPVLPSE-- 242
Query: 259 ALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVS---L 315
L+ L + N++ +P L L +++N L+ +PE+L + SS T +++ L
Sbjct: 243 -LKELMVSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
Query: 316 NSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPT-- 373
+ + + + ++ + P L R P
Sbjct: 297 SERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRW 356
Query: 374 --IGQLKELLLFFAWQNQLH 391
GQ F + ++L
Sbjct: 357 HMFGQEDNADAFSLFLDRLS 376
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-38
Identities = 87/375 (23%), Positives = 141/375 (37%), Gaps = 60/375 (16%)
Query: 285 KRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISG 344
+ +L + ++PE + + ++D+ N + A+ LEEL L+ N +S
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70
Query: 345 EIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQ 404
P F N L+ L L +NR IP + L
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRL-KLIPLGV----------------------FTGLSNLT 107
Query: 405 ALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSG 463
LD+S N + + +F +L NL L + N I FSG
Sbjct: 108 KLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISH---------------RAFSG 150
Query: 464 HIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFG 522
L+ L L L + T IP E + L ++ L + S + L+
Sbjct: 151 --------LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 523 LNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRIN 582
L VL++S T+ N +L L ++ N+T + ++ L+ L+LS N I+
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS 261
Query: 583 GSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG-SLKVLGS 639
+I L L L + L L P +F L+ L L++S N LT V S
Sbjct: 262 -TIEG--SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHS 318
Query: 640 LDNLVSLNVSYNHFS 654
+ NL +L + N +
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 61/271 (22%), Positives = 102/271 (37%), Gaps = 12/271 (4%)
Query: 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNF 461
+ LDL N + + +L +L L N S + P L L L SN
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRL 92
Query: 462 SGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEF 519
IP + L LT L++SEN+ + + + L+ +++ N L +
Sbjct: 93 K-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 520 LFGLNVLDLSMNSIGGTIPEN-LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSS 578
L L L L ++ +IP L L L L L NI + S L++L++S
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 579 NRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG-SLKVL 637
++ L L +++ LT + +L L L+LS N ++ +L
Sbjct: 210 WPYLDTMTPNCLYGLNLTSL-SITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSML 268
Query: 638 GSLDNLVSLNVSYNHFSGILPNTKLFHGLPA 668
L L + + + + P F GL
Sbjct: 269 HELLRLQEIQLVGGQLAVVEPYA--FRGLNY 297
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 76/388 (19%), Positives = 133/388 (34%), Gaps = 70/388 (18%)
Query: 58 CNWDY--IKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSL 115
C+ + C R +P P + L L + + L
Sbjct: 9 CSAQDRAVLCHRKRFV----AVPEGIP------TETRLLDLGKNRIKTLNQDEFASFPHL 58
Query: 116 INLDLSFNALTGNIPEEI-GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQL 173
L+L+ N ++ + L L L L SN + IP + S L +L++ +N++
Sbjct: 59 EELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI 116
Query: 174 SGNIPAEI-GQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGE 232
+ + L L+ + G N + F G
Sbjct: 117 V-ILLDYMFQDLYNLKSLEVGDND---------LVYISHRAFSG---------------- 150
Query: 233 LTNLRTLSVYTANITGYIPEEI-GNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQ 291
L +L L++ N+T IP E + L L L I L LK L +
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 292 NNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFG 351
++ +LT + ++ +L +++ +LV L L LS N IS S
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLH 269
Query: 352 NFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHN 411
RL++++L + + P L+ L++S N
Sbjct: 270 ELLRLQEIQLVGGQ-LAVVEPYA----------------------FRGLNYLRVLNVSGN 306
Query: 412 FLTGSVPSSLF-NLKNLTQLLLISNRFS 438
LT ++ S+F ++ NL L+L SN +
Sbjct: 307 QLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 73/403 (18%), Positives = 131/403 (32%), Gaps = 85/403 (21%)
Query: 88 FSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSN 147
+ +++ +P I + LDL N + +E LE L LN N
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 148 SIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEIS 207
+ P N LR L L N+L IP
Sbjct: 67 IVSAVEPGAFNNLFNLRTLGLRSNRLK--------------------------LIPLG-- 98
Query: 208 NCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI-GNCSALENLFLY 266
VF GL +NL L + I + + + + L++L +
Sbjct: 99 -----VFTGL----------------SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVG 136
Query: 267 ENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVS 325
+N + I L +L++L L + NL+ EAL + L V+ + ++ S
Sbjct: 137 DNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 326 LANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFA 385
L L+ L +S + L L + + +P
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN-LTAVPYLA----------- 243
Query: 386 WQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPE 444
+ + V L+ L+LS+N ++ ++ S+ L L ++ L+ + + + P
Sbjct: 244 -----------VRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPY 290
Query: 445 I-GGCTGLIRLRLGSNNFSGHIPSRI-GLLHRLTFLELSENQF 485
G L L + N + + + + L L L N
Sbjct: 291 AFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-21
Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 13/208 (6%)
Query: 464 HIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFG 522
+P G+ L+L +N+ + + + LE ++L++N + P + LF
Sbjct: 25 AVPE--GIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81
Query: 523 LNVLDLSMNSIGGTIPEN-LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
L L L N + IP L++L KL +S+N I L+ +L+ L++ N +
Sbjct: 82 LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 582 NGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG-SLKVLG 638
I GL+ L L L LT E+ S+L L L L + +
Sbjct: 141 V-YISH--RAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197
Query: 639 SLDNLVSLNVSYNHFSGILPNTKLFHGL 666
L L L +S+ + + +GL
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPN-CLYGL 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 68/276 (24%), Positives = 121/276 (43%), Gaps = 39/276 (14%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELP--ERDQFSAEVQTLGSIRHKNIVR 821
+G+G VY+ ++ + +A + +++ +L ER +F E + L ++H NIVR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCE---LQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 822 LLGCC---NNGRTRLLLF-DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
G+ ++L + +++G+L L KV + GL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM-KIKVLRSWCRQILKGLQFLH-T 147
Query: 878 CVPPIIHRDIKSNNILV-GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGY 936
PPIIHRD+K +NI + GP + D GLA L +S + +V G+ ++APE Y
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEM-Y 202
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA--HIITWVNGELRERKREFTTILDR 994
K E DVY++G+ +LE+ T + P +T +G + +
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKPASFDKVAIPEVK 260
Query: 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKD 1030
+++ C+ +ER ++KD
Sbjct: 261 EIIEG-----------------CIRQNKDERYSIKD 279
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-37
Identities = 85/402 (21%), Positives = 138/402 (34%), Gaps = 56/402 (13%)
Query: 291 QNNLSGSIPEALGNCSSLTVI----DVSLNSLGGEVPVSLA--NLVALEELLLSGNNISG 344
+ N+ PE S+L DV ++ +V L + + + +
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65
Query: 345 EIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQ 404
+ +F +++ L L++ + +I AY +Q
Sbjct: 66 LPAALLDSFRQVELLNLNDLQI-EEIDTYA----------------------FAYAHTIQ 102
Query: 405 ALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFS 462
L + N + +P +F N+ LT L+L N S +P I L L + +NN
Sbjct: 103 KLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 160
Query: 463 GHIPSRI-GLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLF 521
I L L+LS N+ T + L ++ N L S+L
Sbjct: 161 -RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPI 211
Query: 522 GLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
+ LD S NSI + + L L L NN+T L L +DLS N +
Sbjct: 212 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNEL 266
Query: 582 NGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGS 639
I + L L +S N L + + L LDLS+N L +
Sbjct: 267 E-KIMYHP--FVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQ 322
Query: 640 LDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLCVNR 681
D L +L + +N + +T H L N C +
Sbjct: 323 FDRLENLYLDHNSIVTLKLST--HHTLKNLTLSHNDWDCNSL 362
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 92/590 (15%), Positives = 184/590 (31%), Gaps = 70/590 (11%)
Query: 65 CSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFN 123
C ++ I F ++ ++ ++ + N+ + ++P + + + L+L+
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 85
Query: 124 ALTGNIPEEI-GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEI 181
+ I ++ L + N+I +P + N L L L N LS ++P I
Sbjct: 86 QIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGI 142
Query: 182 -GQLEALEIIRAGGNPGIHGEIPEEI-SNCKVLVFLGLADTGISGQIPRSVGELTNLRTL 239
L + N + I ++ L L L+ ++ + S+ + +L
Sbjct: 143 FHNTPKLTTLSMSNNN-LE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHA 197
Query: 240 SVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIP 299
+V ++ + A+E L N I + L L L NNL+
Sbjct: 198 NVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRG--PVNVELTILKLQHNNLT-DTA 248
Query: 300 EALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQL 359
L N L +D+S N L + + LE L +S N + + + LK L
Sbjct: 249 -WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306
Query: 360 ELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPS 419
+L +N + Q +L+ L L HN + ++
Sbjct: 307 DLSHNH-LLHVERNQPQFD-----------------------RLENLYLDHNSIV-TLKL 341
Query: 420 SLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLE 479
S L L L N + + R + + I + L H L E
Sbjct: 342 STH--HTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQ--LEHGLCCKE 395
Query: 480 ------------LSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLD 527
++ ++ G C+ + ++ Q+ L G L+
Sbjct: 396 SDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLE 455
Query: 528 LSMNSIGGTIPENLGKLTSLNKLV--LSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSI 585
+N + + + + +L+ L T L L + D +
Sbjct: 456 AEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLK 515
Query: 586 PEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLK 635
+ +L+ + N++ LD +
Sbjct: 516 ERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQ 565
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 91/553 (16%), Positives = 176/553 (31%), Gaps = 67/553 (12%)
Query: 129 IPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEI-GQLEAL 187
I + + ++ + E + + + ++ + +PA + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 188 EIIRAGGNPGIHGEIPEEI-SNCKVLVFLGLADTGISGQIPRSV-GELTNLRTLSVYTAN 245
E++ I EI + + L + I +P V + L L + +
Sbjct: 78 ELLNLNDL-QIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 246 ITGYIPEEI-GNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALG 303
++ +P I N L L + N + +I D+ + +L+ L L N L+ + L
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVD--LS 189
Query: 304 NCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDN 363
SL +VS N L +LA +A+EEL S N+I+ + L L+L +
Sbjct: 190 LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQH 241
Query: 364 NRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF- 422
N + L L +DLS+N L + F
Sbjct: 242 NNLT-------------------------DTAWLLNYPGLVEVDLSYNELE-KIMYHPFV 275
Query: 423 NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSE 482
++ L +L + +NR + L L L N+ H+ RL L L
Sbjct: 276 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 333
Query: 483 NQFTGEIPPEIGNCTQLEMVDLHQNKLQGT-IPSSLEFLFGLNVLDLSMNSIGGTIPENL 541
N + L+ + L N + + + V D + E+
Sbjct: 334 NSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHG 390
Query: 542 GKLTSLNKLVLSKN-------NITGLIPKSLGLC---KDLQLLDLSSNRINGSIPEEIGR 591
+K L + ++ + ++ G C + + S+ I +
Sbjct: 391 LCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQG 450
Query: 592 LQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYN 651
+ L+ +N + E L L + ++ D L + + N
Sbjct: 451 NEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRL--PKDGLARSSDNLN 508
Query: 652 HFSGILPNTKLFH 664
L + F
Sbjct: 509 KVFTHLKERQAFK 521
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-26
Identities = 87/539 (16%), Positives = 175/539 (32%), Gaps = 56/539 (10%)
Query: 89 SHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIPEEI-GKLAELELLSLNS 146
+ L + + +PP N+ L L L N L+ ++P I +L LS+++
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSN 156
Query: 147 NSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE 205
N++ I + + L+ L+L N+L+ ++ + + +L N
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNL------LST 206
Query: 206 ISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFL 265
++ + L + I+ + V L L + N+T + N L + L
Sbjct: 207 LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDL 261
Query: 266 YENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPV 324
N++ KI ++ L+RL + N L ++ +L V+D+S N L V
Sbjct: 262 SYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVER 318
Query: 325 SLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFF 384
+ LE L L N+I + LK L L +N + L F
Sbjct: 319 NQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW---------DCNSLRALF 366
Query: 385 AW--QNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIP 442
+ + +L+ + L + + L + L ++
Sbjct: 367 RNVARPAVDDADQHCKIDYQLE------HGLCCKESDKPYLDRLLQYIAL--TSVVEKVQ 418
Query: 443 PEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMV 502
G C+ + + L LE N+ E+ QL
Sbjct: 419 RAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV-------QQLTNE 471
Query: 503 DLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNIT-GLI 561
+ Q +L + + + L L + + + T L + K T
Sbjct: 472 QIQQEQLLQGLHAEI--DTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARR 529
Query: 562 PKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKL 620
++ K+ + L+ + + + + + L +L + + N
Sbjct: 530 TEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPDTR 588
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-36
Identities = 67/426 (15%), Positives = 133/426 (31%), Gaps = 64/426 (15%)
Query: 235 NLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNL 294
N + + + L +L + + I + L L +L+ NN+
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNI 76
Query: 295 SGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFS 354
+ ++ L ++LT + N L + + L L L N ++ ++
Sbjct: 77 T-TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLD--VSQNP 127
Query: 355 RLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLT 414
L L N +I + +L N+ ++ +L LD S N +T
Sbjct: 128 LLTYLNCARNTL-TEID--VSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKIT 183
Query: 415 GSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHR 474
+ K L +L +N + ++ + L L SN + I + L +
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234
Query: 475 LTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIG 534
LT+ + S N T E+ + ++L + Q L ++ ++
Sbjct: 235 LTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQAEGCR 286
Query: 535 GTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQG 594
++ T L L IT L L L L L++ + +
Sbjct: 287 KIKELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD-------- 334
Query: 595 LDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFS 654
S+ +KL +L N + +G + L + +
Sbjct: 335 -------------------VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTI 374
Query: 655 GILPNT 660
+ T
Sbjct: 375 TMPKET 380
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 89/473 (18%), Positives = 162/473 (34%), Gaps = 62/473 (13%)
Query: 91 LTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIH 150
S V + + + L++L +LD +++T ++ I KL L L SN+I
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNI- 76
Query: 151 GGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCK 210
+ + + L L N+L+ N+ + L L + N ++ +S
Sbjct: 77 TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT--KLD--VSQNP 127
Query: 211 VLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQI 270
+L +L A ++ +I V T L L + + + + L L N+I
Sbjct: 128 LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182
Query: 271 FGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLV 330
++ K L RL NN++ + L LT +D S N L + + L
Sbjct: 183 ---TELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLT 233
Query: 331 ALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQL 390
L S N ++ E+ S+L L +I + +L+ F A +
Sbjct: 234 QLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTD-LLEID--LTHNTQLIYFQAEGCRK 287
Query: 391 HGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTG 450
++ + +L LD +T L L L L + + E+ + T
Sbjct: 288 I-KELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTK 340
Query: 451 LIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQ 510
L L + + S +G + L +E Q +P E
Sbjct: 341 LKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTI-TMPKETLTNN------------- 384
Query: 511 GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPK 563
SL ++LD N + I G + ++ N++ P
Sbjct: 385 -----SLTIAVSPDLLDQFGNPM--NIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-32
Identities = 81/480 (16%), Positives = 153/480 (31%), Gaps = 75/480 (15%)
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
+ + + L L+ +++ ++ ++ I +L L + N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSN--- 74
Query: 199 HGEIPE-EISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNC 257
I ++S L +L ++ + V LT L L+ T +T ++
Sbjct: 75 --NITTLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQN 126
Query: 258 SALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNS 317
L L N + ++ L L N + + + LT +D S N
Sbjct: 127 PLLTYLNCARNTL---TEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 318 LGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQL 377
+ + ++ L L NNI+ ++ +L L+ +N +L
Sbjct: 182 ITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSN-----------KL 224
Query: 378 KELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRF 437
E+ ++ +L D S N LT + S L LT L I
Sbjct: 225 TEI---------------DVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDL 266
Query: 438 SGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCT 497
EI + T LI + + + +L L+ T E+ +
Sbjct: 267 L-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNP 318
Query: 498 QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNI 557
+L + L+ +L + + L L I +GK+ +LN ++
Sbjct: 319 KLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQT 373
Query: 558 TGLIP-----KSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPE 612
+ SL + LLD N +N P + G ++W L+ P
Sbjct: 374 ITMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQAT--NTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-32
Identities = 82/420 (19%), Positives = 150/420 (35%), Gaps = 44/420 (10%)
Query: 282 KNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNN 341
N + + + + ++LT +D +S+ ++ + L L +L+ + NN
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 342 ISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCV 401
I+ + + L L D+N+ + + L +L N+L + ++
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT-KLD-VSQNP 127
Query: 402 KLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNF 461
L L+ + N LT + S + LT+L N+ ++ T L L N
Sbjct: 128 LLTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKI 182
Query: 462 SGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEF-- 519
+ + + L L N T ++ + QL +D NKL + ++
Sbjct: 183 T-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL-----TEIDVTP 231
Query: 520 LFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSN 579
L L D S+N + L KLT+L+ + ++ + L + QL+ +
Sbjct: 232 LTQLTYFDCSVNPLTELDVSTLSKLTTLH---CIQTDLL-----EIDLTHNTQLIYFQAE 283
Query: 580 RINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGS 639
++ L LL+ +T S KL L L+N LT L +
Sbjct: 284 GCRKIKELDVTHNTQL-YLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD-VSH 337
Query: 640 LDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNSTKNL 699
L SL+ H K+ L + Q + + + NNSL S L
Sbjct: 338 NTKLKSLSCVNAHIQDFSSVGKIPA-LNNNFEAEGQTITMPKETLT-NNSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 61/358 (17%), Positives = 120/358 (33%), Gaps = 43/358 (12%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSL 144
+ + LT L LT ++ + L L+ + N LT I + +L L
Sbjct: 102 VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDC 155
Query: 145 NSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPE 204
+ N + + ++L L+ N+++ + + Q + L + N I +
Sbjct: 156 HLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTN-----NITK 205
Query: 205 -EISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENL 263
+++ L FL + ++ +I V LT L +T ++ S L L
Sbjct: 206 LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTL 259
Query: 264 FLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVP 323
+ + +I L L + + + + L ++D +
Sbjct: 260 HCIQTDL-LEID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGI---TE 311
Query: 324 VSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLF 383
+ L+ L L L+ ++ E+ + ++LK L N Q ++G++ L
Sbjct: 312 LDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHI--QDFSSVGKIPALNNN 366
Query: 384 FAWQNQLHGNIPE------LAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISN 435
F + Q E L V LD N + P T + N
Sbjct: 367 FEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQATNTITWEN 423
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-36
Identities = 87/406 (21%), Positives = 140/406 (34%), Gaps = 41/406 (10%)
Query: 234 TNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDEL-GSLKNLKRLLLWQN 292
++ + + +I L+ L + + I + L +L L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 293 NLSGSIPE-ALGNCSSLTVIDVSLNSLGGEV--PVSLANLVALEELLLSGNNISGEIP-S 348
+ A ++L V+ ++ +L G V L +LE L+L NNI P S
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 349 FFGNFSRLKQLELDNNRFFGQIPPTI---GQLKELLLFFAWQNQLHGNIPELAYCVKLQA 405
FF N R L+L N+ I Q K L L
Sbjct: 149 FFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITL--------------- 192
Query: 406 LDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHI 465
D++ +L + F ++T L L N F + I + +
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA---KRFFDAIAGTKIQSLILSNS 249
Query: 466 PSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNV 525
+ F + F G + ++ DL ++K+ + S L
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGL------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQ 303
Query: 526 LDLSMNSIGGTIPEN-LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGS 584
L L+ N I I +N LT L KL LS+N + + + L++LDLS N I +
Sbjct: 304 LTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RA 361
Query: 585 IPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNN 628
+ ++ GL L L L N L F L+ L + L N
Sbjct: 362 LGDQS--FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 81/458 (17%), Positives = 142/458 (31%), Gaps = 97/458 (21%)
Query: 89 SHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIPEEI-GKLAELELLSLNS 146
+H+ + LS ++ E+ + L L L + I L+ L +L L+
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 147 NSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE 205
N + + L L L L
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLD------------------------------- 116
Query: 206 ISNCKVLVFLGLADTGISGQIPRSV-GELTNLRTLSVYTANITGYIPEEI-GNCSALENL 263
+ + LT+L L + NI P N L
Sbjct: 117 -----------------GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL 159
Query: 264 FLYENQIFGKIPDELGSL--KNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGE 321
L N++ ++L + K+ L L L D++ LG E
Sbjct: 160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ----------------DMNEYWLGWE 203
Query: 322 VPVSLANLVALEELLLSGNNISGEIPSFF---GNFSRLKQLELDNNRFFGQIPPTIGQLK 378
+ ++ L LSGN + F ++++ L L N+
Sbjct: 204 KCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS-----------YNM 252
Query: 379 ELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRF 437
+ ++ DLS + + ++ S+F + +L QL L N
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311
Query: 438 SGEIPPEI-GGCTGLIRLRLGSNNFSGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-G 494
+ +I G T L++L L N I SR+ L +L L+LS N + +
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL 368
Query: 495 NCTQLEMVDLHQNKLQGTIPSS-LEFLFGLNVLDLSMN 531
L+ + L N+L+ ++P + L L + L N
Sbjct: 369 GLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 83/378 (21%), Positives = 136/378 (35%), Gaps = 52/378 (13%)
Query: 306 SSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPS-FFGNFSRLKQLELDNN 364
+ + +D+SLNS+ S + L L+ L + I + F S L L+LD N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 365 RFFGQIPPTI----GQLKELLLFFAWQNQLHG-NIPE--LAYCVKLQALDLSHNFLTGSV 417
+F Q+ L+ L L Q L G + L+ L L N +
Sbjct: 90 QF-LQLETGAFNGLANLEVLTLT---QCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145
Query: 418 PSSLF-NLKNLTQLLLISNRFSGEIPPEI---GGCTGLIRLRLGSNNFSGHIPSRIGLLH 473
P+S F N++ L L N+ I E LRL S
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSI-------------- 190
Query: 474 RLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSI 533
T +++E E T + +DL N + ++ + + S
Sbjct: 191 --TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248
Query: 534 GGTIPENLGKLTSLNKLV-LSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GR 591
N+G GL + + DLS ++I ++ + +
Sbjct: 249 ----SYNMGSSFGHTNFKDPDNFTFKGLEASGV------KTCDLSKSKIF-ALLKSVFSH 297
Query: 592 LQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSL--KVLGSLDNLVSLNVS 649
L+ L L+ N + +F L+ L L+LS N L S+ ++ +LD L L++S
Sbjct: 298 FTDLEQL-TLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLS 355
Query: 650 YNHFSGILPNTKLFHGLP 667
YNH + + F GLP
Sbjct: 356 YNHIRALGDQS--FLGLP 371
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 60/296 (20%), Positives = 102/296 (34%), Gaps = 33/296 (11%)
Query: 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNF 461
+ +DLS N + +S L++L L + I G + LI L+L N F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 462 SGHIPSRI-GLLHRLTFLELSENQFTG-EIPPEI-GNCTQLEMVDLHQNKLQGTIPSSL- 517
+ + L L L L++ G + T LEM+ L N ++ P+S
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 518 EFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVL----------SKNNITGLIPKSLGL 567
+ +VLDL+ N + E+L + +L ++ + +
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 568 CKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNL------------SWNALTGPIPESFS 615
+ LDLS N S+ + + +L P +F
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 616 NL--SKLANLDLSNNMLTG-SLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPA 668
L S + DLS + + V +L L ++ N + I N F GL
Sbjct: 271 GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA--FWGLTH 324
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 9e-16
Identities = 39/191 (20%), Positives = 65/191 (34%), Gaps = 12/191 (6%)
Query: 497 TQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL-GKLTSLNKLVLSKN 555
+ VDL N + +S L L L + + G I N L+SL L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 556 NITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPES 613
L + +L++L L+ ++G++ + L L L L N + P S
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG-NFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 614 -FSNLSKLANLDLSNNMLT----GSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPA 668
F N+ + LDL+ N + L + L +S +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGK-HFTLLRLSSITLQDMNEYW--LGWEKC 205
Query: 669 SAFYGNQQLCV 679
+ N +
Sbjct: 206 GNPFKNTSITT 216
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 33/171 (19%), Positives = 62/171 (36%), Gaps = 8/171 (4%)
Query: 10 LLFVNISLFPAISALNPEGLSLLSWLS----TFNSSSSATFFSSWNPSHRNPCNWDYIKC 65
L +N NP + ++ L F S + FF + +
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251
Query: 66 SRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAI-GNLSSLINLDLSFNA 124
+ T+ P +F ++ L S + + LS + + + ++ + + L L L+ N
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNE 310
Query: 125 LTGNIPEEI-GKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLS 174
+ I + L L L+L+ N + R N KL L+L N +
Sbjct: 311 IN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-34
Identities = 95/541 (17%), Positives = 185/541 (34%), Gaps = 77/541 (14%)
Query: 96 LSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPR 155
S L +P + L++S N ++ +I L++L +L ++ N I
Sbjct: 7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 156 EIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFL 215
+L L+L N+L I L+ + N F
Sbjct: 64 VFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNA-----------------FD 103
Query: 216 GLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIP 275
L G ++ L+ L + T ++ I + + + L + K
Sbjct: 104 ALPICKE-------FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE- 155
Query: 276 DELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEEL 335
+ L++ L + + + S TV ++ L+++ ++ +
Sbjct: 156 -DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI--------KCVLEDNKC 206
Query: 336 LLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP 395
+ ++ + + L +E N F I
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFI-------------------------RIL 241
Query: 396 ELAYCVKLQALDLSHNFLTGSVPSSLF-----NLKNLTQLLLISNRFSGEIPPEIGGCTG 450
+L + + +S+ L G + F +LK L+ ++S+ F +
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301
Query: 451 LIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQ 510
+ + + L+ S N T + G+ T+LE + L N+L+
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 511 GTIPSSLEF--LFGLNVLDLSMNSIGGTIPENL-GKLTSLNKLVLSKNNITGLIPKSLGL 567
+ + L LD+S NS+ + SL L +S N +T I + L
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP- 420
Query: 568 CKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSN 627
+++LDL SN+I SIP+++ +L+ L L N++ N L F L+ L + L
Sbjct: 421 -PRIKVLDLHSNKIK-SIPKQVVKLEALQEL-NVASNQLKSVPDGIFDRLTSLQKIWLHT 477
Query: 628 N 628
N
Sbjct: 478 N 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-32
Identities = 75/431 (17%), Positives = 151/431 (35%), Gaps = 33/431 (7%)
Query: 250 IPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLT 309
+P+++ L + +N I ++ SL L+ L++ N + L
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 310 VIDVSLNSLGGEVPVSLANLVALEELLLSGNNI-SGEIPSFFGNFSRLKQLELDNNRFFG 368
+D+S N L +S V L+ L LS N + I FGN S+LK L L
Sbjct: 73 YLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129
Query: 369 QIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLT 428
I L + + +G + L F T + ++ T
Sbjct: 130 SSVLPIAHLNISKVLLV-LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 429 QLLLISNRFSG-----------EIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLL---HR 474
L + I ++ L L L + + + RI L
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 475 LTFLELSENQFTGEIPPEIGNCT-----QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLS 529
+ + +S + G++ + + L + + + E +N+ + +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
Query: 530 MNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI 589
++ K++ L S N +T + ++ G +L+ L L N++ + +
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIA 367
Query: 590 GRLQGLDIL--LNLSWNALT-GPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLD-NLVS 645
+ L L++S N+++ S L +L++S+N+LT + + L +
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT--IFRCLPPRIKV 425
Query: 646 LNVSYNHFSGI 656
L++ N I
Sbjct: 426 LDLHSNKIKSI 436
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 81/464 (17%), Positives = 149/464 (32%), Gaps = 71/464 (15%)
Query: 87 SFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNS 146
S S L L++S+ + L LDLS N L I L+ L L+
Sbjct: 43 SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSF 99
Query: 147 NSIHG-GIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE 205
N+ I +E GN S+L+ L L L + I L +++ G E PE
Sbjct: 100 NAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG 159
Query: 206 ISNCKVL----------VFLGLADTGISGQIPRSVGELTNL------------------- 236
+ + F + D + + + +
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
Query: 237 ---RTLSVYTANITGYIPEEIGNC---SALENLFLYENQIFGKIPDELG-----SLKNLK 285
L++ T I + + + ++ G++ SLK L
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 286 RLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGE 345
+ + S++ + + +++ + + + L S N ++
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339
Query: 346 IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQA 405
+ G+ + L+ L L N+ ++ ++ LQ
Sbjct: 340 VFENCGHLTELETLILQMNQ-LKELSKIAEMTTQM--------------------KSLQQ 378
Query: 406 LDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGH 464
LD+S N ++ K+L L + SN + I + + L L SN
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-S 435
Query: 465 IPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQN 507
IP ++ L L L ++ NQ +P I T L+ + LH N
Sbjct: 436 IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-16
Identities = 64/392 (16%), Positives = 133/392 (33%), Gaps = 39/392 (9%)
Query: 72 ITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPE 131
++ I F + S L L LS +L I +L+ L + E
Sbjct: 102 FDALPICKEFG----NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG--EKE 155
Query: 132 EIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIR 191
+ L + SL+ I + S L + + + + +
Sbjct: 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215
Query: 192 AGGNPGIHGEIPEEIS-------------NCKVLVFLGLADTGISGQIPRSVGEL--TNL 236
NP + I + + +++ + GQ+ + T+L
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275
Query: 237 RTLSVYTANITGYIPEEIGNCSALENL---FLYENQIFGKIPDELGSLKNLKRLLLWQNN 293
+ LS++ + + N+ + + L N
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335
Query: 294 LSGSIPEALGNCSSLTVIDVSLNSLG--GEVPVSLANLVALEELLLSGNNI-SGEIPSFF 350
L+ ++ E G+ + L + + +N L ++ + +L++L +S N++ E
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395
Query: 351 GNFSRLKQLELDNNRF----FGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQAL 406
L L + +N F +PP ++K L L N++ ++ LQ L
Sbjct: 396 SWTKSLLSLNMSSNILTDTIFRCLPP---RIKVLDL---HSNKIKSIPKQVVKLEALQEL 449
Query: 407 DLSHNFLTGSVPSSLF-NLKNLTQLLLISNRF 437
+++ N L SVP +F L +L ++ L +N +
Sbjct: 450 NVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 6e-16
Identities = 59/309 (19%), Positives = 102/309 (33%), Gaps = 14/309 (4%)
Query: 458 SNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSL 517
N H+P L + T L +S+N + +I + ++L ++ + N++Q S
Sbjct: 9 KNGLI-HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF 65
Query: 518 EFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGL-IPKSLGLCKDLQLLDL 576
+F L LDLS N + I +L L LS N L I K G L+ L L
Sbjct: 66 KFNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 577 SSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKV 636
S+ + S I L +LL L PE + + +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESL--HIVFPTNKEFHF 180
Query: 637 LGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLHGRNST 696
+ + N+ ++ +L + K + L S Q + N +
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFL--SILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 697 KNLIICALLSVTVTLFIVLFGIILFIRFRGTTFRENDEEENELEWDFTPFQKLNFSVDDV 756
+ L L+ T + + + L + F + L F +
Sbjct: 239 RIL---QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 757 VTRLSDTNI 765
S+ NI
Sbjct: 296 YEIFSNMNI 304
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 51/321 (15%), Positives = 110/321 (34%), Gaps = 14/321 (4%)
Query: 6 ITIILLFVNISLFPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKC 65
++ ++F F I ++ + ++ L + + + N
Sbjct: 166 ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225
Query: 66 SRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTG-----EIPPAIGNLSSLINLDL 120
+ I T QL+ + + +SN L G + + +L +L +
Sbjct: 226 TLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283
Query: 121 SFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAE 180
+ + + + + + S L+ +N L+ +
Sbjct: 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFEN 343
Query: 181 IGQLEALEIIRAGGNP-GIHGEIPEEISNCKVLVFLGLADTGISGQIPRSV-GELTNLRT 238
G L LE + N +I E + K L L ++ +S + +L +
Sbjct: 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403
Query: 239 LSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSI 298
L++ + +T I + ++ L L+ N+I IP ++ L+ L+ L + N L S+
Sbjct: 404 LNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SV 459
Query: 299 PE-ALGNCSSLTVIDVSLNSL 318
P+ +SL I + N
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPW 480
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 67/295 (22%), Positives = 113/295 (38%), Gaps = 45/295 (15%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G V VE + A+K+ + E +R++ E H NI+RL+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKR---ILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 825 CC----NNGRTRLLLFDYISNGSLAGLL---HEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
C LL + G+L + +K FL D ++LG+ GL +H
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA-------GSYGYI 930
HRD+K NIL+G + + L D G + Y
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 931 APE----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERK- 985
APE + I E++DV+S G VL ++ G+ P D G + V +L +
Sbjct: 211 APELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269
Query: 986 REFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040
++ L QL + M+ V+ P +RP + + + L+ ++
Sbjct: 270 PRHSSAL-WQL-------LNSMMT--------VD--PHQRPHIPLLLSQLEALQP 306
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-33
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 46/287 (16%)
Query: 767 GKGVSGIVYR--VEIPSRQVIAVKKLWPVKNGE-LPERDQFSAEVQTLGSIRHKNIVRLL 823
G+G G V+ + + V AVK + + +F E + L H NIVRL+
Sbjct: 123 GRGNFGEVFSGRLRADNTLV-AVKSC---RETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
G C + ++ + + G L + L + +++ A G+ YL I
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE---YG 935
HRD+ + N LV + ++DFG+++ + +G + APE YG
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA-----SGGLRQVPVKWTAPEALNYG 290
Query: 936 YSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994
+ + +SDV+S+G++L E + G P P+ N + RE +++
Sbjct: 291 ---RYSSESDVWSFGILLWETFSLGASP----YPN------LSNQQTREF-------VEK 330
Query: 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041
+ + + L C P +RP+ + L+ IR
Sbjct: 331 GGRLPCPELCPDAVFRL--MEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 52/237 (21%), Positives = 95/237 (40%), Gaps = 25/237 (10%)
Query: 735 EENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPV 793
E+NE + +++ + V ++ VG+G G V+R + + AVK
Sbjct: 35 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK----- 89
Query: 794 KNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV 853
++ E+ + IV L G G + + + GSL L+ +
Sbjct: 90 ---KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC 146
Query: 854 FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ-FEAFLADFGLAKLFE 912
+ + Y + GL YLH I+H D+K++N+L+ A L DFG A +
Sbjct: 147 LPEDRALY-YLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202
Query: 913 SSESSRA---SNSVAGSYGYIAPE----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
++ + + G+ ++APE K D++S ++L +L G P
Sbjct: 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA----KVDIWSSCCMMLHMLNGCHP 255
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
++GKG GIVY ++ ++ IA+K+ + + E+ ++HKNIV+ L
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKE---IPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLL-HEKKVFLDWDSRYKIILG-VAHGLAYLHHDCVPP 881
G + + + + GSL+ LL + D + + GL YLH +
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 882 IIHRDIKSNNILVGPQF-EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------Y 934
I+HRDIK +N+L+ ++DFG +K + + + + G+ Y+APE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
GY +D++S G ++E+ TGK P
Sbjct: 201 GYGK----AADIWSLGCTIIEMATGKPP 224
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 55/306 (17%), Positives = 102/306 (33%), Gaps = 55/306 (17%)
Query: 351 GNFSRLKQLELDNN--RFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDL 408
N L Q N + + ++ L +N+ + E + L L
Sbjct: 8 NNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE-CLINQFSELQL 66
Query: 409 SHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSR 468
+ L+ S+P +L +T L + N +P
Sbjct: 67 NRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPAS--------------------- 101
Query: 469 IGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDL 528
L +L+ +N+ + +P + L D+ N+L +P L ++
Sbjct: 102 ------LEYLDACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPA---LLEYINA 147
Query: 529 SMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEE 588
N + +PE L L+ + N +T L P+ L+ LD+S+N + S+P
Sbjct: 148 DNNQLT-MLPELPTSLEVLS---VRNNQLTFL-PELPE---SLEALDVSTNLLE-SLPAV 198
Query: 589 IGRLQGL---DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVS 645
R +I N +T IPE+ +L + L +N L+ ++ S
Sbjct: 199 PVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP 257
Query: 646 LNVSYN 651
Sbjct: 258 DYHGPR 263
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 56/318 (17%), Positives = 103/318 (32%), Gaps = 34/318 (10%)
Query: 254 IGNCSALENLFLYEN--QIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVI 311
I N +L Y + + +N + E L + + +
Sbjct: 7 INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSEL 64
Query: 312 DVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIP 371
++ +L +P +L + L ++ N + +P + L+ L+ +NR +P
Sbjct: 65 QLNRLNL-SSLPDNLPPQ--ITVLEITQNALI-SLPELPAS---LEYLDACDNR-LSTLP 116
Query: 372 PTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLL 431
LK L + NQL +PEL L+ ++ +N LT +P +L L
Sbjct: 117 ELPASLKHLDVD---NNQLT-MLPEL--PALLEYINADNNQLT-MLPEL---PTSLEVLS 166
Query: 432 LISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLT----FLELSENQFTG 487
+ +N+ + +P L L + +N +P+ H F EN+ T
Sbjct: 167 VRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT- 220
Query: 488 EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSL 547
IP I + + L N L I SL D I ++ +
Sbjct: 221 HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ--TAQPDYHGPRIYFSMSDGQQNTLHR 278
Query: 548 NKLVLSKNNITGLIPKSL 565
+
Sbjct: 279 PLADAVTAWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-27
Identities = 62/406 (15%), Positives = 129/406 (31%), Gaps = 39/406 (9%)
Query: 77 IPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKL 136
+ + + + + ++ L L+ L+ ++P+ +
Sbjct: 25 TYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLPP- 80
Query: 137 AELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNP 196
++ +L + N++ +P + L L+ DN+LS +P L+ L++ N
Sbjct: 81 -QITVLEITQNALIS-LPELPAS---LEYLDACDNRLS-TLPELPASLKHLDV---DNNQ 131
Query: 197 GIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGN 256
+PE + L ++ + ++ +P T+L LSV +T ++PE +
Sbjct: 132 LT--MLPELPAL---LEYINADNNQLT-MLPEL---PTSLEVLSVRNNQLT-FLPELPES 181
Query: 257 CSALENLFLYENQIFGKIPDELGSLKNLKRLLLW----QNNLSGSIPEALGNCSSLTVID 312
LE L + N + +P + + ++ +N ++ IPE + + I
Sbjct: 182 ---LEALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236
Query: 313 VSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPP 372
+ N L + SL+ A G I + N + F
Sbjct: 237 LEDNPLSSRIRESLSQQTAQP--DYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294
Query: 373 TIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLL 432
+ Q+ N + L+ V + V + L L +L
Sbjct: 295 DVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFRE----QVAAWLEKLSASAELRQ 350
Query: 433 ISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFL 478
S + + L L H S + L
Sbjct: 351 QSFAVAADATESCEDRVALTWNNLRKTLLV-HQASEGLFDNDTGAL 395
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 71/491 (14%), Positives = 133/491 (27%), Gaps = 103/491 (20%)
Query: 109 IGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNC--SKLRRL 166
I N SL + +N ++G + + E +L + + C ++ L
Sbjct: 7 INNNFSLSQ-NSFYNTISGTYADYFSAWDKWEKQALPGEN-RNEAVSLLKECLINQFSEL 64
Query: 167 ELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQI 226
+L LS ++P +
Sbjct: 65 QLNRLNLS-SLPDNLPP------------------------------------------- 80
Query: 227 PRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKR 286
+ L + + +PE + LE L +N++ +P+ SLK+L
Sbjct: 81 --------QITVLEITQNALI-SLPELPAS---LEYLDACDNRL-STLPELPASLKHLD- 126
Query: 287 LLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEI 346
+ N L+ +PE L I+ N L +P + LE L + N ++ +
Sbjct: 127 --VDNNQLT-MLPELPAL---LEYINADNNQL-TMLPELPTS---LEVLSVRNNQLT-FL 175
Query: 347 PSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQAL 406
P + L+ L++ N +P +
Sbjct: 176 PELPES---LEALDVSTNL-LESLPAVPVRNHHSEE-------------------TEIFF 212
Query: 407 DLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIP 466
N +T +P ++ +L ++L N S E G +
Sbjct: 213 RCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSD 270
Query: 467 SRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVL 526
+ LHR + F ++ + H N L
Sbjct: 271 GQQNTLHRPLA-DAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNT 328
Query: 527 DLSMNSIGGTIPENLGKLTSL-NKLVLSKNNITGLIPKSLGLC-KDLQLLDLSSNRINGS 584
+ E L L + + T + L +L+ L G
Sbjct: 329 SGFREQV-AAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGL 387
Query: 585 IPEEIGRLQGL 595
+ G L L
Sbjct: 388 FDNDTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 9e-12
Identities = 42/260 (16%), Positives = 85/260 (32%), Gaps = 20/260 (7%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE 138
T P + L L + N LT +P +L +L D+S N L ++P +
Sbjct: 153 TMLPELP---TSLEVLSVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHH 204
Query: 139 LE----LLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGG 194
E N I IP I + + L DN LS I + Q A
Sbjct: 205 SEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH--- 260
Query: 195 NPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI 254
P I+ + + N V ++ + + + ++ + +
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL-DRL 319
Query: 255 GNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQN-NLSGSIPEALGNC-SSLTVID 312
+ + N + Q+ ++L + L++ + + S + + ++L
Sbjct: 320 SDTVSARNTSGFREQVA-AWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTL 378
Query: 313 VSLNSLGGEVPVSLANLVAL 332
+ + G L++L
Sbjct: 379 LVHQASEGLFDNDTGALLSL 398
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-31
Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 66/313 (21%)
Query: 764 NIVGKGVSGIVYR--VEIPSRQVI--AVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
I+G G SG V + +P ++ + A+K L +R F +E +G H NI
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA--GYTERQRRDFLSEASIMGQFDHPNI 112
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HHD 877
+RL G GR +++ +Y+ NGSL L ++ GV G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG- 171
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----AP 932
+HRD+ + N+LV ++DFGL+++ E + + + G I AP
Sbjct: 172 ----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA----AYTTTGGKIPIRWTAP 223
Query: 933 E---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREF 988
E + + SDV+S+GVV+ EVL G+ P + +I+ V R
Sbjct: 224 EAIAFR---TFSSASDVWSFGVVMWEVLAYGERPYWNM--TNRDVISSVEEGYR------ 272
Query: 989 TTILDR---------QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039
L QL ML C + +RP + ++L +
Sbjct: 273 ---LPAPMGCPHALHQL----------MLD-------CWHKDRAQRPRFSQIVSVLDALI 312
Query: 1040 HENDDLEKPNSLS 1052
+ L ++S
Sbjct: 313 RSPESLRATATVS 325
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIVR 821
+G+G G V+ + +K+ + + +++ + EV L +++H NIV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKE---INISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHE-KKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
+ ++ DY G L ++ K V D + + L ++H
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---R 144
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGY 936
I+HRDIKS NI + L DFG+A++ S+ + + G+ Y++PE Y
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPY 202
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEP 962
+ KSD+++ G VL E+ T K
Sbjct: 203 N----NKSDIWALGCVLYELCTLKHA 224
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-30
Identities = 77/329 (23%), Positives = 126/329 (38%), Gaps = 66/329 (20%)
Query: 764 NIVGKGVSGIVYR--VEIPSRQVI--AVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
+VG G G V +++PS++ I A+K L +R F E +G H NI
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--GYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HHD 877
+RL G + +++ +Y+ NGSL L + ++ G+A G+ YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----AP 932
+HRD+ + NIL+ ++DFGL ++ E + + G I +P
Sbjct: 168 ----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA----AYTTRGGKIPIRWTSP 219
Query: 933 E---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREF 988
E Y K T SDV+SYG+VL EV++ G+ P +I V+ R
Sbjct: 220 EAIAYR---KFTSASDVWSYGIVLWEVMSYGERPYWEM--SNQDVIKAVDEGYR------ 268
Query: 989 TTILDR---------QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039
L QL ML C RP + + ++L ++
Sbjct: 269 ---LPPPMDCPAALYQL----------MLD-------CWQKDRNNRPKFEQIVSILDKLI 308
Query: 1040 HENDDLEKPNSLSRAVTNPKAAVHCSSFS 1068
L+ S + +N +
Sbjct: 309 RNPGSLKIITSAAARPSNLLLDQSNVDIT 337
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 48/228 (21%)
Query: 767 GKGVSGIVYR------VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
G+G G V+ + ++AVK L K+ L R F E + L +++H++IV
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---------------KIIL 865
+ G C +G +++F+Y+ +G L L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 866 GVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSV 923
+A G+ YL H +HRD+ + N LVG + DFG+++ S++ R
Sbjct: 141 QIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR----- 190
Query: 924 AGSYGYI-----APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
G + + PE Y K T +SDV+S+GV+L E+ T GK+P
Sbjct: 191 VGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHK 817
++ +G G G+V + + +AVK + K G D+F E QT+ + H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI---KEG-SMSEDEFFQEAQTMMKLSHP 63
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--H 875
+V+ G C+ ++ +YISNG L L L+ ++ V G+A+L H
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI----- 930
IHRD+ + N LV ++DFG+ + + +
Sbjct: 124 Q-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG------TKFPVKWS 172
Query: 931 APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
APE Y K + KSDV+++G+++ EV + GK P
Sbjct: 173 APEVFHYF---KYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-30
Identities = 68/353 (19%), Positives = 123/353 (34%), Gaps = 83/353 (23%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN--IVR 821
+G G S V++V +Q+ A+K + ++ + D + E+ L ++ + I+R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVP 880
L + ++ + N L L +KK W+ + + + +H H
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQHG--- 128
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------- 933
I+H D+K N L+ L DFG+A + +S +S G+ Y+ PE
Sbjct: 129 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDS---------RIPDGAHIIT---WV 977
KI+ KSDV+S G +L + GK P I D H I
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 978 NGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV------ 1031
+L++ +L L + P++R ++ ++
Sbjct: 247 EKDLQD------------VLKC---------------CLKRD--PKQRISIPELLAHPYV 277
Query: 1032 --------------TAMLKEIRHENDDLEKPNSLSRAVTNPKAAVHCSSFSRS 1070
T +K + + L PNS+ +A S
Sbjct: 278 QIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 49/210 (23%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G G G+V+ ++ +A+K + + G + F E + + + H +V+L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI---REG-AMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HHDCVPP 881
G C L+ +++ +G L+ L ++ ++ + L V G+AYL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----- 124
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE--- 933
+IHRD+ + N LVG ++DFG+ + + + ++ +PE
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG------TKFPVKWASPEVFS 178
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+ + + KSDV+S+GV++ EV + GK P
Sbjct: 179 FS---RYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 60/294 (20%), Positives = 110/294 (37%), Gaps = 63/294 (21%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN--IVR 821
+G G S V++V +Q+ A+K + ++ + D + E+ L ++ + I+R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVP 880
L + ++ + N L L +KK W+ + + + +H H
Sbjct: 93 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQHG--- 147
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------- 933
I+H D+K N L+ L DFG+A + +S +S G+ Y+ PE
Sbjct: 148 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDS---------RIPDGAHIIT---WV 977
KI+ KSDV+S G +L + GK P I D H I
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 978 NGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+L++ +L L + P++R ++ ++
Sbjct: 266 EKDLQD------------VLKC---------------CLKRD--PKQRISIPEL 290
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 58/277 (20%), Positives = 104/277 (37%), Gaps = 24/277 (8%)
Query: 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNF 461
LDL +N ++ L++L L+L++N+ S +I + L +L + N+
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL 114
Query: 462 SGHIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGT-IPSSLEF 519
IP L L L + +N+ ++P + + +++ N L+ +
Sbjct: 115 V-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 520 LFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSN 579
LN L +S + IP++L +LN+L L N I + + L L L L N
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN 227
Query: 580 RINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLT------ 631
+I I L L L L+L N L+ +P +L L + L N +T
Sbjct: 228 QIR-MIENGS--LSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVND 283
Query: 632 -GSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLP 667
+ +++ N F +
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 75/360 (20%), Positives = 121/360 (33%), Gaps = 71/360 (19%)
Query: 304 NCS-SLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELD 362
C L V+ S L VP ++ L L N+IS F L L L
Sbjct: 30 GCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLV 86
Query: 363 NNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF 422
NN+ +I + KLQ L +S N L +P +L
Sbjct: 87 NNKI-SKIHEKA----------------------FSPLRKLQKLYISKNHLV-EIPPNLP 122
Query: 423 NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSE 482
+L +L + NR ++P FSG L + +E+
Sbjct: 123 --SSLVELRIHDNRIR-KVPK---------------GVFSG--------LRNMNCIEMGG 156
Query: 483 NQFT-GEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPEN- 540
N P + +L + + + KL IP L LN L L N I I
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELED 212
Query: 541 LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLN 600
L + + L +L L N I + SL L+ L L +N+++ +P + L+ L + +
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQV-VY 270
Query: 601 LSWNALTGPIPESFS------NLSKLANLDLSNNMLTGSL---KVLGSLDNLVSLNVSYN 651
L N +T F + + L NN + + + +++
Sbjct: 271 LHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 65/351 (18%), Positives = 113/351 (32%), Gaps = 57/351 (16%)
Query: 90 HLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSI 149
HL + S+ L +P I LDL N ++ ++ L L L L +N I
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 150 HGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNC 209
+ KL++L + N L IP +L +R N I
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDN---------RIRKV 138
Query: 210 KVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANIT-GYIPEEIGNCSALENLFLYEN 268
VF GL N+ + + + + L L + E
Sbjct: 139 PKGVFSGL----------------RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182
Query: 269 QIFGKIPDELGSLKNLKRLLLWQNNLSGSIPE-ALGNCSSLTVIDVSLNSLGGEVPVSLA 327
++ IP +L + L L L N + +I L S L + + N + SL+
Sbjct: 183 KL-TGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 328 NLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQ 387
L L EL L N +S +P+ + L+ + L N ++ F
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN-ITKVGVND---------FC-- 285
Query: 388 NQLHGNIPELAYCVKLQALDLSHNFLT-GSVPSSLF-NLKNLTQLLLISNR 436
+ + L +N + V + F + + + + +
Sbjct: 286 -----PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 33/124 (26%), Positives = 51/124 (41%), Gaps = 12/124 (9%)
Query: 546 SLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL--LNLSW 603
L + S + +PK + D LLDL +N I+ + + +GL L L L
Sbjct: 34 HLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDIS-ELRK--DDFKGLQHLYALVLVN 87
Query: 604 NALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLF 663
N ++ ++FS L KL L +S N L + +LV L + N + F
Sbjct: 88 NKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP-NLPSSLVELRIHDNRIRKVPKGV--F 143
Query: 664 HGLP 667
GL
Sbjct: 144 SGLR 147
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 36/175 (20%), Positives = 57/175 (32%), Gaps = 35/175 (20%)
Query: 495 NCT-QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPEN-LGKLTSLNKLVL 552
C L +V L+ +P + +LDL N I + ++ L L LVL
Sbjct: 30 GCHCHLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVL 85
Query: 553 SKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPE 612
N I+ + K+ + LQ L +S N + IP +
Sbjct: 86 VNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL----------------------- 121
Query: 613 SFSNLSKLANLDLSNNMLTG-SLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGL 666
S L L + +N + V L N+ + + N F GL
Sbjct: 122 ----PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 73/312 (23%), Positives = 128/312 (41%), Gaps = 53/312 (16%)
Query: 765 IVGKGVSGIVYR-----VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
++G G G VY+ +A+K L +R F E +G H NI
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA--GYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HHD 877
+RL G + + +++ +Y+ NG+L L EK ++ G+A G+ YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN- 167
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES-SESSRASNSVAGSYGYI-----A 931
+HRD+ + NILV ++DFGL+++ E E++ ++ G I A
Sbjct: 168 ----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG-----GKIPIRWTA 218
Query: 932 PE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWV-NGELRERKR 986
PE Y K T SDV+S+G+V+ EV+T G+ P ++ + +G
Sbjct: 219 PEAISYR---KFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFRLPTPM 273
Query: 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLE 1046
+ + + + LM + C RP D+ ++L ++ D L+
Sbjct: 274 DCPSAIYQ--LM----------------MQCWQQERARRPKFADIVSILDKLIRAPDSLK 315
Query: 1047 KPNSLSRAVTNP 1058
V+
Sbjct: 316 TLADFDPRVSIR 327
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 78/329 (23%), Positives = 127/329 (38%), Gaps = 90/329 (27%)
Query: 759 RLSDTNIVGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLG 812
+ +G+G G V+ + + ++AVK L K R F E + L
Sbjct: 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLT 98
Query: 813 SIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY----------- 861
++H++IVR G C GR L++F+Y+ +G L L +
Sbjct: 99 MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 862 ---KIILGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916
+ VA G+ YL H +HRD+ + N LVG + DFG+++ S++
Sbjct: 159 QLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 917 SRASNSVAGSYGYI-----APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRI 967
R G + PE Y K T +SDV+S+GVVL E+ T GK+P
Sbjct: 214 YR-----VGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTYGKQPWYQ-- 263
Query: 968 PDGAHIITWVNGE----LRERKREFTTILDR------QL--LMRSGTQIQEMLQVLGVAL 1015
N E + + + L+R ++ +MR
Sbjct: 264 --------LSNTEAIDCITQGRE-----LERPRACPPEVYAIMRG--------------- 295
Query: 1016 LCVNPCPEERPTMKDVTAMLKEIRHENDD 1044
C P++R ++KDV A L+ +
Sbjct: 296 -CWQREPQQRHSIKDVHARLQALAQAPPV 323
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G VYR + +A+KK+ + R E+ L + H N+++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 825 CCNNGRTRLLLFDYISNGSLAGLL---HEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
++ + G L+ ++ ++K + + +K + + L ++H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--- 156
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYS 937
++HRDIK N+ + L D GL + F S + A++S+ G+ Y++PE GY+
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYN 214
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEP 962
KSD++S G +L E+ + P
Sbjct: 215 ----FKSDIWSLGCLLYEMAALQSP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 75/311 (24%), Positives = 126/311 (40%), Gaps = 76/311 (24%)
Query: 767 GKGVSGIVYR------VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGSIRHKNI 819
G+ G VY+ Q +A+K L K+ E P R++F E ++H N+
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---------------KII 864
V LLG + ++F Y S+G L L + D S ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 865 LGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922
+A G+ YL HH ++H+D+ + N+LV + ++D GL + +++ +
Sbjct: 135 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK---- 185
Query: 923 VAGSYGYI-----APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHI 973
+ APE YG K + SD++SYGVVL EV + G +P
Sbjct: 186 -LLGNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVVLWEVFSYGLQP----YCG---- 233
Query: 974 ITWVNGELRERKREFTTILDRQLLMRSG---TQIQE-MLQVLGVALLCVNPCPEERPTMK 1029
+ N ++ E I +RQ+L + M++ C N P RP K
Sbjct: 234 --YSNQDVVEM------IRNRQVLPCPDDCPAWVYALMIE-------CWNEFPSRRPRFK 278
Query: 1030 DVTAMLKEIRH 1040
D+ + L+ +
Sbjct: 279 DIHSRLRAWGN 289
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 758 TRLSDTNIVGKGVSGIVYR---------VEIPSRQVIAVKKLWPVKNGELP-ERDQFSAE 807
T ++G G G VY+ V+IP +A+K+L + P + E
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP----VAIKEL---REATSPKANKEILDE 67
Query: 808 VQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGV 867
+ S+ + ++ RLLG C T L+ + G L + E K + + +
Sbjct: 68 AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 868 AHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAG 925
A G+ YL ++HRD+ + N+LV + DFGLAKL + E +
Sbjct: 127 AKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--- 178
Query: 926 SYGYI-----APEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
G + A E T +SDV+SYGV + E++T G +P
Sbjct: 179 --GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 72/336 (21%), Positives = 125/336 (37%), Gaps = 49/336 (14%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN--IVR 821
+G G S V++V +Q+ A+K + ++ + D + E+ L ++ + I+R
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVP 880
L + ++ + N L L +KK W+ + + + +H H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQHG--- 175
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------- 933
I+H D+K N L+ L DFG+A + +S +S G+ Y+ PE
Sbjct: 176 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDS---------RIPDGAHIIT---WV 977
KI+ KSDV+S G +L + GK P I D H I
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 978 NGELRERKREFTTILDRQLLMRSGTQ---IQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034
+L++ + + L R Q I E+L + + P + K T
Sbjct: 294 EKDLQD--------VLKCCLKRDPKQRISIPELLA---HPYVQIQTHPVNQM-AKGTTEE 341
Query: 1035 LKEIRHENDDLEKPNSLSRAVTNPKAAVHCSSFSRS 1070
+K + + L PNS+ +A S
Sbjct: 342 MKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 377
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIVR 821
+G G G ++ +++ K+ + G + E ++ EV L ++H NIVR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 822 LLGCCNNGRTRLL--LFDYISNGSLAGLL---HEKKVFLDWDSRYKIILGVAHGLAYLH- 875
+ L + +Y G LA ++ +++ +LD + +++ + L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 876 -HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY 934
D ++HRD+K N+ + + L DFGLA++ S + + G+ Y++PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQ 187
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ EKSD++S G +L E+ P
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 34/235 (14%)
Query: 749 LNFSVDDVVTRLSDTNI-----VGKGVSGIVYRVEI----PSRQVIAVKKLWPVKNG-EL 798
L +V VV S + +G+G G VY + + AVK L ++
Sbjct: 11 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDI 67
Query: 799 PERDQFSAEVQTLGSIRHKNIVRLLGCC-NNGRTRLLLFDYISNGSLAGLLHEKKVFLDW 857
E QF E + H N++ LLG C + + L++ Y+ +G L + +
Sbjct: 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 127
Query: 858 DSRYKIILGVAHGLAYLH-HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916
L VA G+ YL V HRD+ + N ++ +F +ADFGLA+ E
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 917 SRASNSVAGSYGYI-----APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
N + + A E K T KSDV+S+GV+L E++T G P
Sbjct: 184 YSVHNK---TGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-29
Identities = 67/319 (21%), Positives = 121/319 (37%), Gaps = 67/319 (21%)
Query: 735 EENELEWDFTPFQ--KLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWP 792
E+++ + + + K++F DV+ G G G + + + +AVK++
Sbjct: 8 EQDDGDEETSVVIVGKISFCPKDVL---------GHGAEGTIVYRGMFDNRDVAVKRI-L 57
Query: 793 VKNGELPERDQFSAEVQTL-GSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEK 851
+ +R EVQ L S H N++R + + + + + + +L + +K
Sbjct: 58 PECFSFADR-----EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK 111
Query: 852 KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFE-----AFLADFG 906
++ GLA+LH I+HRD+K +NIL+ A ++DFG
Sbjct: 112 DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 907 LAKLFESSESSRAS-NSVAGSYGYIAPEY---GYSLKITEKSDVYSYGVVLLEVLTGKEP 962
L K S + + V G+ G+IAPE T D++S G V V++
Sbjct: 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
Query: 963 TDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGV--------- 1013
P F L RQ + G + L
Sbjct: 229 -----P-------------------FGKSLQRQANILLGACSLDCLHPEKHEDVIARELI 264
Query: 1014 -ALLCVNPCPEERPTMKDV 1031
++ ++ P++RP+ K V
Sbjct: 265 EKMIAMD--PQKRPSAKHV 281
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 61/306 (19%)
Query: 764 NIVGKGVSGIVYR-----VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
+GKG G V ++ + +V+AVKKL ++ F E++ L S++H N
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDN 72
Query: 819 IVRLLGCCNNGRTR--LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH- 875
IV+ G C + R L+ +Y+ GSL L + K +D + + G+ YL
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI----- 930
IHRD+ + NILV + + DFGL K+ + G
Sbjct: 133 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF----FKVKEPGESPIFWY 184
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHII------TWVNGELRER 984
APE K + SDV+S+GVVL E+ T E + S + +I + L E
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE- 243
Query: 985 KREFTTILDRQLLMRSG----------TQIQE-MLQVLGVALLCVNPCPEERPTMKDVTA 1033
L+++ +I M + C N +RP+ +D+
Sbjct: 244 ------------LLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSFRDLAL 284
Query: 1034 MLKEIR 1039
+ +IR
Sbjct: 285 RVDQIR 290
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 767 GKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCC 826
G G G+V + + +A+K + K G D+F E + + ++ H+ +V+L G C
Sbjct: 33 GTGQFGVVKYGKWRGQYDVAIKMI---KEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 827 NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HHDCVPPIIH 884
R ++ +Y++NG L L E + ++ V + YL +H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-----FLH 143
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE---YGY 936
RD+ + N LV Q ++DFGL++ E + + PE Y
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG------SKFPVRWSPPEVLMYS- 196
Query: 937 SLKITEKSDVYSYGVVLLEVLT-GKEP 962
K + KSD++++GV++ E+ + GK P
Sbjct: 197 --KFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 76/331 (22%), Positives = 122/331 (36%), Gaps = 64/331 (19%)
Query: 767 GKGVSGIVYR-----VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVR 821
GKG G V + + ++AVK+L ++ ++ F E+Q L ++ IV+
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 822 LLGCCNNGRTR--LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDC 878
G + L+ +Y+ +G L L + LD + G+ YL C
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE 933
+HRD+ + NILV + +ADFGLAKL + V G APE
Sbjct: 149 ----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREPGQSPIFWYAPE 200
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLT-GKEP----TDSRIPDGAHIITWVNGELRERKREF 988
+ +SDV+S+GVVL E+ T + + G L E
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE----- 255
Query: 989 TTILDRQLLMRSG----------TQIQE-MLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037
L+ G ++ E M C P P++RP+ + L
Sbjct: 256 --------LLEEGQRLPAPPACPAEVHELMKL-------CWAPSPQDRPSFSALGPQLDM 300
Query: 1038 IRHENDDLEKPNSLSRAVTNPKAAVHCSSFS 1068
+ + E + +P+ H SFS
Sbjct: 301 LWSGSRGCETHAFTA----HPEGKHHSLSFS 327
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 62/330 (18%), Positives = 114/330 (34%), Gaps = 44/330 (13%)
Query: 326 LANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFA 385
L ++ +N++ + + L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV------------------- 53
Query: 386 WQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI 445
I + Y L L+L N +T + L NL +T+L L N + I
Sbjct: 54 ------TTIEGVQYLNNLIGLELKDNQIT--DLAPLKNLTKITELELSGNPLK-NVSA-I 103
Query: 446 GGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLH 505
G + L L S + + + L L L L NQ T I P + T L+ + +
Sbjct: 104 AGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIG 159
Query: 506 QNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSL 565
++ + + L L L L N I + L L +L ++ L N I+ + P L
Sbjct: 160 NAQV--SDLTPLANLSKLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQISDVSP--L 213
Query: 566 GLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDL 625
+L ++ L++ I L +++ S + P + S+ A+ +L
Sbjct: 214 ANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPNL 270
Query: 626 SNNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
+ N+ + V + + V+ + FSG
Sbjct: 271 TWNLTSFINNVSYTFNQSVTFKNTTVPFSG 300
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 60/276 (21%), Positives = 100/276 (36%), Gaps = 25/276 (9%)
Query: 393 NIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLI 452
I + + +T + +L +T L + I + LI
Sbjct: 11 VIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLI 66
Query: 453 RLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGT 512
L L N + + + L ++T LELS N + I ++ +DL ++ T
Sbjct: 67 GLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQI--T 120
Query: 513 IPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQ 572
+ L L L VL L +N I T L LT+L L + ++ L P L L
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLT 176
Query: 573 LLDLSSNRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNML 630
L N+I +I L L L ++L N ++ +N S L + L+N +
Sbjct: 177 TLKADDNKI-----SDISPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTI 229
Query: 631 TGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGL 666
T + + +NLV NV + +
Sbjct: 230 T--NQPVFYNNNLVVPNVVKGPSGAPIAPATISDNG 263
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 52/254 (20%), Positives = 98/254 (38%), Gaps = 19/254 (7%)
Query: 111 NLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYD 170
L++ I + + +T L + LS + I + + L LEL D
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKD 72
Query: 171 NQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSV 230
NQ++ ++ + L + + GNP + + I+ + + L L T I+ P +
Sbjct: 73 NQIT-DLA-PLKNLTKITELELSGNP-L--KNVSAIAGLQSIKTLDLTSTQITDVTP--L 125
Query: 231 GELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLW 290
L+NL+ L + IT P + + L+ L + Q+ L +L L L
Sbjct: 126 AGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV--SDLTPLANLSKLTTLKAD 181
Query: 291 QNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFF 350
N +S I L + +L + + N + P LAN L + L+ I+ + +
Sbjct: 182 DNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYN 237
Query: 351 GNFSRLKQLELDNN 364
N ++ +
Sbjct: 238 NNLVVPNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 21/268 (7%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSL 144
+ ++ + +N+T + +L + L +T I E + L L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLEL 70
Query: 145 NSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPE 204
N I P + N +K+ LEL N L N+ A I L++++ +
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTST---QITDVT 123
Query: 205 EISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLF 264
++ L L L I+ P + LTNL+ LS+ A ++ P + N S L L
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179
Query: 265 LYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPV 324
+N+I I L SL NL + L N +S L N S+L ++ ++ ++ +
Sbjct: 180 ADDNKI-SDISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVF 235
Query: 325 SLANLVALEELLLSGNNISGEIPSFFGN 352
NLV ++ G + + P+ +
Sbjct: 236 YNNNLVVP--NVVKGPSGAPIAPATISD 261
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 77/309 (24%), Positives = 122/309 (39%), Gaps = 63/309 (20%)
Query: 764 NIVGKGVSGIVYR-----VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
+GKG G V ++ + +V+AVKKL ++ F E++ L S++H N
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDN 103
Query: 819 IVRLLGCCNNGRTR--LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH- 875
IV+ G C + R L+ +Y+ GSL L + K +D + + G+ YL
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI----- 930
IHRD+ + NILV + + DFGL K+ + G
Sbjct: 164 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVKEPGESPIFWY 215
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDS----------RIPDGAHIITWVNGE 980
APE K + SDV+S+GVVL E+ T E + S G I+ +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 981 LRERKREFTTILDR--------QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVT 1032
L+ R L R ++M C N +RP+ +D+
Sbjct: 276 LKNNGR-----LPRPDGCPDEIYMIMTE----------------CWNNNVNQRPSFRDLA 314
Query: 1033 AMLKEIRHE 1041
+ +IR +
Sbjct: 315 LRVDQIRDQ 323
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 74/361 (20%), Positives = 125/361 (34%), Gaps = 72/361 (19%)
Query: 304 NCS-SLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELD 362
C L V+ S L +VP L L L N I+ F N L L L
Sbjct: 28 RCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILI 84
Query: 363 NNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF 422
NN+ +I P G L VKL+ L LS N L +P +
Sbjct: 85 NNKI-SKISP--GAFAPL--------------------VKLERLYLSKNQLK-ELPEKMP 120
Query: 423 NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSE 482
K L +L + N + ++ + F+G L+++ +EL
Sbjct: 121 --KTLQELRVHENEIT-KVRK---------------SVFNG--------LNQMIVVELGT 154
Query: 483 NQFT-GEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPEN 540
N I +L + + + TIP L L L L N I +
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAA 210
Query: 541 -LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILL 599
L L +L KL LS N+I+ + SL L+ L L++N++ +P + + + + +
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV-V 268
Query: 600 NLSWNALTG------PIPESFSNLSKLANLDLSNNMLTGSL---KVLGSLDNLVSLNVSY 650
L N ++ P + + + + L +N + + ++ +
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328
Query: 651 N 651
Sbjct: 329 Y 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 31/314 (9%)
Query: 283 NLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNI 342
+L+ + L +P+ L ++D+ N + NL L L+L N I
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 343 SGEIPSFFGNFSRLKQLELDNNRFFGQIPPTI-GQLKELLLFFAWQNQLHGNIPE--LAY 399
S P F +L++L L N+ ++P + L+EL + +N++ + +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELRV---HENEIT-KVRKSVFNG 143
Query: 400 CVKLQALDLSHNFLT-GSVPSSLF-NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLG 457
++ ++L N L + + F +K L+ + + + IP G L L L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLD 200
Query: 458 SNNFSGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPS 515
N + + + L+ L L LS N + + N L + L+ NKL +P
Sbjct: 201 GNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPG 257
Query: 516 SLEFLFGLNVLDLSMNSIGGTIPEN-------LGKLTSLNKLVLSKNNITGL-IPKSLGL 567
L + V+ L N+I I N K S + + L N + I S
Sbjct: 258 GLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
Query: 568 C-KDLQLLDLSSNR 580
C + L + +
Sbjct: 317 CVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 70/353 (19%), Positives = 117/353 (33%), Gaps = 60/353 (16%)
Query: 90 HLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSI 149
HL + S+ L ++P + LDL N +T + L L L L +N I
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 150 HGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNC 209
P KL RL L NQL +P + L+ +R N EI+
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHEN---------EITK- 135
Query: 210 KVLVFLGLADTGISGQIPRSV-GELTNLRTLSVYTANIT-GYIPEEI-GNCSALENLFLY 266
+ +SV L + + + T + I L + +
Sbjct: 136 ----------------VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 267 ENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPE-ALGNCSSLTVIDVSLNSLGGEVPVS 325
+ I IP G +L L L N ++ + +L ++L + +S NS+ S
Sbjct: 180 DTNI-TTIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGS 235
Query: 326 LANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFA 385
LAN L EL L+ N + ++P + ++ + L NN I F
Sbjct: 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI-SAIGSND---------FC 284
Query: 386 WQNQLHGNIPELAYCVKLQALDLSHNFLT-GSVPSSLF-NLKNLTQLLLISNR 436
+ L N + + S F + + L + +
Sbjct: 285 PPGYNTK-------KASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 68/324 (20%), Positives = 122/324 (37%), Gaps = 40/324 (12%)
Query: 58 CNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLI 116
C+ ++CS + +P P L L N +T EI NL +L
Sbjct: 31 CHLRVVQCSDLGLE----KVPKDLP------PDTALLDLQNNKIT-EIKDGDFKNLKNLH 79
Query: 117 NLDLSFNALTGNIPEEIGKLAELELLSLNSN---SIHGGIPREIGNCSKLRRLELYDNQL 173
L L N ++ P L +LE L L+ N + +P+ L+ L +++N++
Sbjct: 80 TLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPK------TLQELRVHENEI 133
Query: 174 SGNIPAEI-GQLEALEIIRAGGNPGIHGEIPEEI-SNCKVLVFLGLADTGISGQIPRSVG 231
+ + + L + ++ G NP I K L ++ +ADT I+ IP+ +
Sbjct: 134 T-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL- 190
Query: 232 ELTNLRTLSVYTANITGYIPEEI-GNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLL 289
+L L + IT + + L L L N I + + L + +L+ L L
Sbjct: 191 -PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSI-SAVDNGSLANTPHLRELHL 247
Query: 290 WQNNLSGSIPEALGNCSSLTVIDVSLNSLGG------EVPVSLANLVALEELLLSGNNIS 343
N L +P L + + V+ + N++ P + + L N +
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
Query: 344 -GEIPSF-FGNFSRLKQLELDNNR 365
EI F ++L N +
Sbjct: 307 YWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 40/177 (22%), Positives = 72/177 (40%), Gaps = 15/177 (8%)
Query: 495 NCT-QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPEN-LGKLTSLNKLVL 552
C L +V L+ +P L +LDL N I I + L +L+ L+L
Sbjct: 28 RCQCHLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLIL 83
Query: 553 SKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPE 612
N I+ + P + L+ L LS N++ +PE++ + L L + N +T
Sbjct: 84 INNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQ-ELRVHENEITKVRKS 139
Query: 613 SFSNLSKLANLDLSNNMLTGSL---KVLGSLDNLVSLNVSYNHFSGILPNTKLFHGL 666
F+ L+++ ++L N L S + L + ++ + + I L L
Sbjct: 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG--LPPSL 194
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 65/294 (22%), Positives = 116/294 (39%), Gaps = 46/294 (15%)
Query: 764 NIVGKGVSGIVYRVEIPSRQV-IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+ +G G G VY + +AVK L K E ++F E + I+H N+V+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDT-MEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHE-KKVFLDWDSRYKIILGVAHGLAYLH-HDCVP 880
LG C ++ ++++ G+L L E + + + ++ + YL +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-- 339
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKI 940
IHR++ + N LVG +ADFGL++L A + APE K
Sbjct: 340 --IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKF 396
Query: 941 TEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM- 998
+ KSDV+++GV+L E+ T G P ++ E L++ M
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPG----------IDLSQVYEL-------LEKDYRME 439
Query: 999 ------RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLE 1046
++ M C P +RP+ ++ + + E+ +
Sbjct: 440 RPEGCPEKVYEL--MRA-------CWQWNPSDRPSFAEIHQAFETMFQESSISD 484
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 44/303 (14%), Positives = 102/303 (33%), Gaps = 69/303 (22%)
Query: 767 GKGVSGIVYR--------VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
G+G +++ + +K L + F + + HK+
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASMMSKLSHKH 73
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HH 876
+V G C G +L+ +++ GSL L + K ++ + ++ +A + +L +
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAF--------LADFGLAKLFESSESSRASNSVAGSYG 928
+IH ++ + NIL+ + + L+D G++ +
Sbjct: 134 -----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------IL 177
Query: 929 YI-----APE-YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGEL 981
PE + +D +S+G L E+ + G +P + +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA----------LDSQRK 227
Query: 982 RERKREFTTILDRQLLMR-SGTQIQE-MLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039
+ DR L ++ + C++ P+ RP+ + + L +
Sbjct: 228 LQF------YEDRHQLPAPKAAELANLINN-------CMDYEPDHRPSFRAIIRDLNSLF 274
Query: 1040 HEN 1042
+
Sbjct: 275 TPD 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 766 VGKGVSGIVYRVE--IPSRQVIAVKKLWP--VKNGELPERDQFSAEVQTLGSIRHKNIVR 821
+G G VY E I + +V A+K ++ + E +R F EV + H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKV-AIKAIFIPPREKEETLKR--FEREVHNSSQLSHQNIVS 75
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
++ L+ +YI +L+ + L D+ + G+ + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDM---R 131
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
I+HRDIK NIL+ + DFG+AK S S +N V G+ Y +PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 942 EKSDVYSYGVVLLEVLTGKEP 962
E +D+YS G+VL E+L G+ P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP 211
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 25/218 (11%)
Query: 759 RLSDTNIVGKGVSGIVYR----VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGS 813
++GKG G+VY + +R A+K L E+ + + F E +
Sbjct: 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL---SRITEMQQVEAFLREGLLMRG 78
Query: 814 IRHKNIVRLLGCCNNGR-TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLA 872
+ H N++ L+G +L Y+ +G L + + L VA G+
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 873 YL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSY--G 928
YL +HRD+ + N ++ F +ADFGLA+ E
Sbjct: 139 YLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 929 YIAPE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+ A E + T KSDV+S+GV+L E+LT G P
Sbjct: 194 WTALESLQTY---RFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 766 VGKGVSGIVYRVE--IPSRQVIAVKKLWP--VKNGELPERDQFSAEVQTLGSIRHKNIVR 821
VG+G G VY E + R V A+K + + R E +T G ++ ++V
Sbjct: 42 VGRGGMGDVYEAEDTVRERIV-ALKLMSETLSSDPVFRTR--MQREARTAGRLQEPHVVP 98
Query: 822 LLGCCNNGRTRLLLF---DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
+ + G L+ I+ LA +L + L I+ + L H
Sbjct: 99 IH---DFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAA- 153
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL 938
HRD+K NILV A+L DFG+A + ++ + G+ Y+APE
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL-GNTVGTLYYMAPERFSES 210
Query: 939 KITEKSDVYSYGVVLLEVLTGKEP 962
T ++D+Y+ VL E LTG P
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP 234
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 31/301 (10%), Positives = 72/301 (23%), Gaps = 53/301 (17%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+ G +V+ V ++ + A+K E ++ + ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 824 GCCN--------------------------NGRTRLLLFDYIS-----NGSLAGLLHEKK 852
LLL S S ++ +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 853 VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912
+ + + + A L ++H +N+ + P L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 913 SSESSRASNSVAGSYGYIAPEY--GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG 970
+ + + Y E+ + T + + G+ + V P P
Sbjct: 243 --KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 971 AHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKD 1030
++ L S T + + ++ L L + R +
Sbjct: 301 KGSW---------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD--RRRRLLPLE 349
Query: 1031 V 1031
Sbjct: 350 A 350
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 22/292 (7%)
Query: 740 EWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGEL 798
+ + DD + +G G G+V++V PS V+A K +
Sbjct: 19 AFLTQKQKVGELKDDD----FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA- 73
Query: 799 PERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWD 858
R+Q E+Q L IV G + + +++ GSL +L + +
Sbjct: 74 -IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-Q 131
Query: 859 SRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918
K+ + V GL YL I+HRD+K +NILV + E L DFG++ S
Sbjct: 132 ILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186
Query: 919 ASNSVAGSYGYIAPE----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHII 974
+NS G+ Y++PE YS +SD++S G+ L+E+ G+ P ++
Sbjct: 187 -ANSFVGTRSYMSPERLQGTHYS----VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241
Query: 975 TWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP 1026
E + + L + G + + + + VN P + P
Sbjct: 242 FGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+GKG G V++ ++ +++V+A+K + ++ E E + E+ L + + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
++ +Y+ GS LL LD I+ + GL YLH + IH
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE---KKIH 142
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYSLKI 940
RDIK+ N+L+ E LADFG+A ++ R N+ G+ ++APE Y
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAY---- 196
Query: 941 TEKSDVYSYGVVLLEVLTGKEP 962
K+D++S G+ +E+ G+ P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 59/293 (20%), Positives = 108/293 (36%), Gaps = 55/293 (18%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G G+V+ + A+K++ + N EL R++ EV+ L + H IVR
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNREL-AREKVMREVKALAKLEHPGIVRYFN 70
Query: 825 C---------CNNGRTRLLLF---DYISNGSLAGLLHEKKV--FLDWDSRYKIILGVAHG 870
++ L+ +L ++ + + I L +A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE----------SSRAS 920
+ +LH ++HRD+K +NI + DFGL + E +
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 921 NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE 980
G+ Y++PE + + K D++S G++L E+L +
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------PFSTQMERVRTLTD 239
Query: 981 LRERK--REFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+R K FT + +M +Q+ML P P ERP ++
Sbjct: 240 VRNLKFPPLFTQKYPCEYVM-----VQDMLS----------PSPMERPEAINI 277
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 64/235 (27%), Positives = 95/235 (40%), Gaps = 16/235 (6%)
Query: 403 LQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNN 460
+ L+L N + + + F +L +L L L N +I G L L L N
Sbjct: 77 TRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134
Query: 461 FSGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDL-HQNKLQGTIPSSL 517
+ IPS L +L L L N IP L +DL KL+ +
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 518 EFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLS 577
E LF L L+L M +I NL L L +L +S N+ + P S L+ L +
Sbjct: 193 EGLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250
Query: 578 SNRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNML 630
+++++ I GL L LNL+ N L+ + F+ L L L L +N
Sbjct: 251 NSQVS-LIERNA--FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 61/252 (24%), Positives = 84/252 (33%), Gaps = 32/252 (12%)
Query: 332 LEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLH 391
L L NNI F + L+ L+L N QI
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGA----------------- 118
Query: 392 GNIPELAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEI-GGCT 449
L L+L N+LT +PS F L L +L L +N IP
Sbjct: 119 -----FNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVP 171
Query: 450 GLIRLRLGSNNFSGHIPSRI-GLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNK 508
L+RL LG +I L L +L L P + LE +++ N
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNH 229
Query: 509 LQGTIPSSLEFLFGLNVLDLSMNSIGGTIPEN-LGKLTSLNKLVLSKNNITGLIPKSLGL 567
P S L L L + + + I N L SL +L L+ NN++ L
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288
Query: 568 CKDLQLLDLSSN 579
+ L L L N
Sbjct: 289 LRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 60/273 (21%), Positives = 98/273 (35%), Gaps = 42/273 (15%)
Query: 402 KLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNF 461
+ + + L+ VP + N L L+ N I + F
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ-MIQA---------------DTF 95
Query: 462 SGHIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFL 520
LH L L+L N +I L ++L N L + E+L
Sbjct: 96 RH--------LHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYL 146
Query: 521 FGLNVLDLSMNSIGGTIPEN-LGKLTSLNKLVLSKNN-ITGLIPKSLGLCKDLQLLDLSS 578
L L L N I +IP ++ SL +L L + + + + +L+ L+L
Sbjct: 147 SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205
Query: 579 NRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG-SLK 635
I ++ L L L L +S N P SF LS L L + N+ ++
Sbjct: 206 CNIK-----DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260
Query: 636 VLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPA 668
L +LV LN+++N+ S + + F L
Sbjct: 261 AFDGLASLVELNLAHNNLSSLPHDL--FTPLRY 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 64/293 (21%), Positives = 94/293 (32%), Gaps = 64/293 (21%)
Query: 76 HIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIPEEI- 133
+P P S+ L L N+ I +L L L L N++ I
Sbjct: 68 EVPQGIP------SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAF 119
Query: 134 GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRA 192
LA L L L N + IP SKLR L L +N + +IP+
Sbjct: 120 NGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYA----------- 166
Query: 193 GGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPE 252
F + +L L + YI E
Sbjct: 167 ---------------------FNR----------------VPSLMRLDLGELKKLEYISE 189
Query: 253 EI-GNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVI 311
L+ L L I +P+ L L L+ L + N+ P + SSL +
Sbjct: 190 GAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247
Query: 312 DVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364
V + + + L +L EL L+ NN+S F L +L L +N
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-19
Identities = 62/280 (22%), Positives = 96/280 (34%), Gaps = 57/280 (20%)
Query: 88 FSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSN 147
+ + +V + L+ E+P I S+ L+L N + + L LE+L L N
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 148 SIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEIS 207
SI + L LEL+DN L+ IP
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT--------------------------VIPSG-- 141
Query: 208 NCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI-GNCSALENLFLY 266
F L + LR L + I IP +L L L
Sbjct: 142 -----AFEYL----------------SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLG 179
Query: 267 ENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVS 325
E + I + L NLK L L N+ +P L L +++S N P S
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGS 237
Query: 326 LANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR 365
L +L++L + + +S + F + L +L L +N
Sbjct: 238 FHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 8e-16
Identities = 42/196 (21%), Positives = 66/196 (33%), Gaps = 22/196 (11%)
Query: 498 QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNI 557
Q V + L +P + L+L N+I + L L L L +N+I
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 558 TGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFS 615
+ + L L+L N + IP + L L L L N + +F+
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGA--FEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 616 NLSKLANLDLS-NNMLTG-SLKVLGSLDNLVSLNVSYNHFSGI-----LPN-TKLF---- 663
+ L LDL L S L NL LN+ + + L +L
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGN 228
Query: 664 --HGLPASAFYGNQQL 677
+ +F+G L
Sbjct: 229 HFPEIRPGSFHGLSSL 244
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 6/88 (6%)
Query: 89 SHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIPEE-IGKLAELELLSLNS 146
L L +S + EI P + LSSL L + + ++ I LA L L+L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAH 275
Query: 147 NSIHGGIPREI-GNCSKLRRLELYDNQL 173
N++ +P ++ L L L+ N
Sbjct: 276 NNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 23/81 (28%), Positives = 38/81 (46%), Gaps = 9/81 (11%)
Query: 72 ITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIP 130
I P SF S L L + N+ ++ I A L+SL+ L+L+ N L+ ++P
Sbjct: 230 FPEIR-PGSFH----GLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLP 282
Query: 131 EEI-GKLAELELLSLNSNSIH 150
++ L L L L+ N +
Sbjct: 283 HDLFTPLRYLVELHLHHNPWN 303
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 62/234 (26%), Positives = 94/234 (40%), Gaps = 14/234 (5%)
Query: 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNF 461
+ L+L N + +S +L++L L L N I G L L L N
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL 124
Query: 462 SGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDL-HQNKLQGTIPSSLE 518
+ IP+ L +L L L N IP L +DL +L + E
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
Query: 519 FLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSS 578
L L L+L+M ++ IP L L L++L LS N+++ + P S LQ L +
Sbjct: 183 GLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
Query: 579 NRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNML 630
++I I L L +NL+ N LT + F+ L L + L +N
Sbjct: 241 SQIQ-VIERNA--FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-26
Identities = 60/252 (23%), Positives = 86/252 (34%), Gaps = 32/252 (12%)
Query: 332 LEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLH 391
L L N I + F + L+ L+L N I
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGA----------------- 107
Query: 392 GNIPELAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEI-GGCT 449
L L+L N LT ++P+ F L L +L L +N IP
Sbjct: 108 -----FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIP 160
Query: 450 GLIRLRLGSNNFSGHIPSRI-GLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNK 508
L RL LG +I L L +L L+ P + +L+ +DL N
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNH 218
Query: 509 LQGTIPSSLEFLFGLNVLDLSMNSIGGTIPEN-LGKLTSLNKLVLSKNNITGLIPKSLGL 567
L P S + L L L + + I I N L SL ++ L+ NN+T L
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277
Query: 568 CKDLQLLDLSSN 579
L+ + L N
Sbjct: 278 LHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 59/273 (21%), Positives = 99/273 (36%), Gaps = 42/273 (15%)
Query: 402 KLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNF 461
+ + L VP + N L L N+ I N+F
Sbjct: 44 QFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQ-IIKV---------------NSF 84
Query: 462 SGHIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFL 520
L L L+LS N I L ++L N+L + +L
Sbjct: 85 KH--------LRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYL 135
Query: 521 FGLNVLDLSMNSIGGTIPENL-GKLTSLNKLVLSKNN-ITGLIPKSLGLCKDLQLLDLSS 578
L L L N I +IP ++ SL +L L + ++ + + +L+ L+L+
Sbjct: 136 SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM 194
Query: 579 NRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG-SLK 635
+ IP L L L L+LS N L+ P SF L L L + + +
Sbjct: 195 CNLR-EIPN----LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249
Query: 636 VLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPA 668
+L +LV +N+++N+ + + + F L
Sbjct: 250 AFDNLQSLVEINLAHNNLTLLPHDL--FTPLHH 280
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-19
Identities = 62/294 (21%), Positives = 103/294 (35%), Gaps = 66/294 (22%)
Query: 76 HIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIPEEI- 133
+P ++ L L + I + +L L L LS N + I
Sbjct: 57 EVPDGIS------TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAF 108
Query: 134 GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEI-GQLEALEIIR 191
LA L L L N + IP SKL+ L L +N + +IP+ ++ +L +
Sbjct: 109 NGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLD 166
Query: 192 AGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIP 251
G + I E F G L+NLR L++ N+ IP
Sbjct: 167 LGELKRLS-YISEG-------AFEG----------------LSNLRYLNLAMCNLR-EIP 201
Query: 252 EEIGNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTV 310
+ L+ L L N + I L +L++L + Q+ + I
Sbjct: 202 -NLTPLIKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQ-VIERN--------- 249
Query: 311 IDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364
+ NL +L E+ L+ NN++ F L+++ L +N
Sbjct: 250 --------------AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 62/280 (22%), Positives = 96/280 (34%), Gaps = 57/280 (20%)
Query: 88 FSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSN 147
+ + ++ NL E+P I ++ L+L N + L LE+L L+ N
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 148 SIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEIS 207
I + L LEL+DN+L+ IP
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLT--------------------------TIPNG-- 130
Query: 208 NCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI-GNCSALENLFLY 266
F+ L + L+ L + I IP +L L L
Sbjct: 131 -----AFVYL----------------SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLG 168
Query: 267 ENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVS 325
E + I + L NL+ L L NL IP L L +D+S N L P S
Sbjct: 169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGS 226
Query: 326 LANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR 365
L+ L++L + + I + F N L ++ L +N
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 47/197 (23%), Positives = 72/197 (36%), Gaps = 24/197 (12%)
Query: 498 QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPEN-LGKLTSLNKLVLSKNN 556
Q V + L+ +P + +L+L N I I N L L L LS+N+
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99
Query: 557 ITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESF 614
I + + +L L+L NR+ +IP L L L L N + +F
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGA--FVYLSKLKELWLRNNPIESIPSYAF 156
Query: 615 SNLSKLANLDLS-NNMLTG-SLKVLGSLDNLVSLNVSYNHFSGI-----LPN-TKL---- 662
+ + L LDL L+ S L NL LN++ + I L +L
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSG 216
Query: 663 --FHGLPASAFYGNQQL 677
+ +F G L
Sbjct: 217 NHLSAIRPGSFQGLMHL 233
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 23/81 (28%), Positives = 39/81 (48%), Gaps = 9/81 (11%)
Query: 72 ITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIP 130
+++I P SF HL L + + + I A NL SL+ ++L+ N LT +P
Sbjct: 219 LSAIR-PGSFQ----GLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLP 271
Query: 131 EEI-GKLAELELLSLNSNSIH 150
++ L LE + L+ N +
Sbjct: 272 HDLFTPLHHLERIHLHHNPWN 292
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 68/321 (21%), Positives = 107/321 (33%), Gaps = 70/321 (21%)
Query: 759 RLSDTNIVGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNGELP-ERDQFSAEVQTL 811
++ +G G G VY PS +AVK L + F E +
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALII 87
Query: 812 GSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLL------HEKKVFLDWDSRYKIIL 865
H+NIVR +G R +L + ++ G L L + L +
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 866 GVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFL---ADFGLAKLFESSESSRAS 920
+A G YL +H IHRDI + N L+ + DFG+A+ + R
Sbjct: 148 DIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-- 200
Query: 921 NSVAGSYGYI-----APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGA 971
G + PE G T K+D +S+GV+L E+ + G P P
Sbjct: 201 ---KGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGYMP----YPS-- 248
Query: 972 HIITWVNGELRERKREFTTILDRQLLMRSG---TQIQE-MLQVLGVALLCVNPCPEERPT 1027
N E+ E + + + M Q C PE+RP
Sbjct: 249 ----KSNQEVLEF------VTSGGRMDPPKNCPGPVYRIMTQ-------CWQHQPEDRPN 291
Query: 1028 MKDVTAMLKEIRHENDDLEKP 1048
+ ++ + D +
Sbjct: 292 FAIILERIEYCTQDPDVINTA 312
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-28
Identities = 91/442 (20%), Positives = 154/442 (34%), Gaps = 55/442 (12%)
Query: 233 LTNLRTLSVYTANITGYIPEEI-GNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQ 291
L+ LR L + I + + LE L + N++ I + +L+ L L
Sbjct: 75 LSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSF 130
Query: 292 NNLSGSIPEA--LGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELL-LSGNNISGEIPS 348
N+ +P GN + LT + +S + +A+L LL L +I G
Sbjct: 131 NDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETE 189
Query: 349 FFGNFSRLK-QLELDNNRFF------GQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCV 401
+ L N F QL + L +L + EL
Sbjct: 190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP 249
Query: 402 KLQALDLSHNFLTGSVPSSLFNL---KNLTQLLLISNRFSGEIPPEIG------------ 446
L + L H T LF + + L + + + I E
Sbjct: 250 TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309
Query: 447 -----------------GCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEI 489
+ L ++ TFL ++N FT +
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 490 PPEIGNCTQLEMVDLHQNKLQ--GTIPSSLEFLFGLNVLDLSMNSIGGTIPENL-GKLTS 546
+L+ + L +N L+ + + + L LD+S+NS+ + S
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429
Query: 547 LNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNAL 606
+ L LS N +TG + + L +++LDL +NRI SIP+++ LQ L L N++ N L
Sbjct: 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQEL-NVASNQL 485
Query: 607 TGPIPESFSNLSKLANLDLSNN 628
F L+ L + L +N
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 92/499 (18%), Positives = 161/499 (32%), Gaps = 36/499 (7%)
Query: 92 TSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHG 151
+ + SN NLT +P + L LS N+++ +I L+EL +L L+ N I
Sbjct: 34 SMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS 90
Query: 152 GIPREI-GNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCK 210
+ + L L++ N+L NI + +L + N + +E N
Sbjct: 91 -LDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLT 146
Query: 211 VLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQI 270
L FLGL+ V L L + E L L +
Sbjct: 147 KLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPN 206
Query: 271 FGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLV 330
S+ L L L L+ NC L L + V+L ++
Sbjct: 207 SLFSVQVNMSVNALGHLQLSNIKLNDE------NCQRLMTFLSELTRGPTLLNVTLQHIE 260
Query: 331 ALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQL 390
+ + ++ FF ++ L + N +I E L +
Sbjct: 261 TTWKCSV-------KLFQFFWP-RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV 312
Query: 391 HGN----IPELAYC--VKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPE 444
E Y ++ LS + + + T L N F+ +
Sbjct: 313 KNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG 372
Query: 445 IGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFT----GEIPPEIGNCTQLE 500
L L L N + + ++ LE + +
Sbjct: 373 CSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431
Query: 501 MVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGL 560
+++L N L G++ L + VLDL N I +IP+++ L +L +L ++ N + +
Sbjct: 432 VLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSV 488
Query: 561 IPKSLGLCKDLQLLDLSSN 579
LQ + L N
Sbjct: 489 PDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-27
Identities = 77/429 (17%), Positives = 147/429 (34%), Gaps = 31/429 (7%)
Query: 250 IPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPE-ALGNCSSL 308
+P+++ + L L +N I ++ L L+ L L N + S+ L
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102
Query: 309 TVIDVSLNSLGGEVPVSLANLVALEELLLSGNNI-SGEIPSFFGNFSRLKQLELDNNRFF 367
+DVS N L +S + +L L LS N+ + FGN ++L L L +F
Sbjct: 103 EYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 368 GQIPPTIGQLKELLLFFA-WQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKN 426
+ L + + G E L L + + ++
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 427 LTQLLLISNRFSG-------EIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLL---HRLT 476
L L L + + + E+ L+ + L + ++ +
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 477 FLELSENQFTGEIPPEIGNCTQLEMV-----DLHQNKLQGTIPSSLEFLFGLNVLDLSMN 531
+L + T I E ++ + + + + +N+ LS++
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 532 SIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGR 591
+S L ++N T + + K LQ L L N + + +
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALM 398
Query: 592 LQGLDIL--LNLSWNALT-GPIPESFSNLSKLANLDLSNNMLTGSLKVLGSL-DNLVSLN 647
+ + L L++S N+L + + + L+LS+NMLTGS V L + L+
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS--VFRCLPPKVKVLD 456
Query: 648 VSYNHFSGI 656
+ N I
Sbjct: 457 LHNNRIMSI 465
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 75/436 (17%), Positives = 139/436 (31%), Gaps = 47/436 (10%)
Query: 90 HLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPE--EIGKLAELELLSLNSN 147
L L +S+ L I ++SL +LDLSFN +P E G L +L L L++
Sbjct: 101 DLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAA 156
Query: 148 SIHGGIPREIGNCS-KLRRLELYDNQLSGNIPAEIGQLEALEI-IRAGGNPGIHGEIPEE 205
+ + L+L + G + + + N ++
Sbjct: 157 KFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216
Query: 206 ISNCKVLVFLGLADTGISGQIPRSV----GELTNLRTLSVYTANITGYIPEEIGNC---S 258
++ L + + Q + L +++ T ++
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 259 ALENLFLYENQIFGKIPDELG-----SLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDV 313
+E L +Y I +I E +LK+L + S + + + +
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 314 SLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPT 373
S++ V + + L + N + + RL+ L L N
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG-LKNFFKV 395
Query: 374 IGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNL-KNLTQLLL 432
K + L+ LD+S N L +++ L L
Sbjct: 396 ALMTKNMS--------------------SLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
Query: 433 ISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPE 492
SN +G + + + L L +N IP + L L L ++ NQ +P
Sbjct: 436 SSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDG 491
Query: 493 I-GNCTQLEMVDLHQN 507
+ T L+ + LH N
Sbjct: 492 VFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 59/389 (15%), Positives = 110/389 (28%), Gaps = 22/389 (5%)
Query: 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRL 356
+P+ + +S NS+ ++ L L L LS N I F L
Sbjct: 45 HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102
Query: 357 KQLELDNNRFFGQIPP-TIGQLKELLLFFAWQNQLHGNIPELAY---CVKLQALDLSHNF 412
+ L++ +NR I + L+ L L F N +P KL L LS
Sbjct: 103 EYLDVSHNRL-QNISCCPMASLRHLDLSF---NDFD-VLPVCKEFGNLTKLTFLGLSAAK 157
Query: 413 LTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLL 472
+ +L LL + + E L L + S +
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 473 HRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNS 532
+ L L+LS + E + + L +
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT---------LQHIETTWKCSVK 268
Query: 533 IGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRL 592
+ + ++ L +++ S K L + + + S
Sbjct: 269 LFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328
Query: 593 QGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGS-LKVLGSLDNLVSLNVSYN 651
++I LS + + S L+ + N+ T S + +L L +L + N
Sbjct: 329 AEMNIK-MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 652 HFSGILPNTKLFHGLPASAFYGNQQLCVN 680
+ + + +N
Sbjct: 388 GLKNFFKVALMTKNMSSLETLDVSLNSLN 416
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 40/246 (16%), Positives = 82/246 (33%), Gaps = 51/246 (20%)
Query: 72 ITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPE 131
+ + S F+ + +LS ++ + SS L+ + N T ++ +
Sbjct: 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371
Query: 132 EIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIR 191
L L+ L L N + + + LE D L+ ++
Sbjct: 372 GCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN-SLN------------- 416
Query: 192 AGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIP 251
S R+ ++ L++ + +TG +
Sbjct: 417 -------------------------------SHAYDRTCAWAESILVLNLSSNMLTGSVF 445
Query: 252 EEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPE-ALGNCSSLTV 310
+ ++ L L+ N+I IP ++ L+ L+ L + N L S+P+ +SL
Sbjct: 446 RCLP--PKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY 501
Query: 311 IDVSLN 316
I + N
Sbjct: 502 IWLHDN 507
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 65/300 (21%), Positives = 111/300 (37%), Gaps = 64/300 (21%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
++G+G G V + + A+KK+ + + +EV L S+ H+ +VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE----KLSTILSEVMLLASLNHQYVVRYY 68
Query: 824 GC----------CNNGRTRLLLF---DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+ + LF +Y NG+L L+H + + D +++ +
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS---------- 920
L+Y+H IIHRD+K NI + + DFGLAK S
Sbjct: 129 LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 921 --NSVAGSYGYIAPE-------YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA 971
S G+ Y+A E Y EK D+YS G++ E++ R
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYN------EKIDMYSLGIIFFEMIYPFSTGMER----V 235
Query: 972 HIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+I+ +LR EF D + I+ ++ P +RP + +
Sbjct: 236 NILK----KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH----------DPNKRPGARTL 281
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 31/222 (13%)
Query: 758 TRLSDTNIVGKGVSGIVYRVEIPSR----QVIAVKKLWPVKNG-ELPERDQFSAEVQTLG 812
+ ++G+G G VY + AVK L ++ E QF E +
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMK 145
Query: 813 SIRHKNIVRLLGCCNNGRT-RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGL 871
H N++ LLG C L++ Y+ +G L + + L VA G+
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205
Query: 872 AYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
+L +HRD+ + N ++ +F +ADFGLA+ E +
Sbjct: 206 KFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNKTGAK 257
Query: 930 I-----APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+ A E K T KSDV+S+GV+L E++T G P
Sbjct: 258 LPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 61/271 (22%), Positives = 100/271 (36%), Gaps = 40/271 (14%)
Query: 406 LDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHI 465
+ + LT SVP+ + + T+L L SN+ L F
Sbjct: 12 IRCNSKGLT-SVPTGIP--SSATRLELESNKLQ----------------SLPHGVFDK-- 50
Query: 466 PSRIGLLHRLTFLELSENQFT-GEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFGL 523
L +LT L LS N + + T L+ +DL N + T+ S+ L L
Sbjct: 51 ------LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL 103
Query: 524 NVLDLSMNSIGGTIPEN--LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
LD +++ + E L +L L +S + L++L ++ N
Sbjct: 104 EHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162
Query: 582 NGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG-SLKVLG 638
+ +I L L L+LS L P +F++LS L L++S+N
Sbjct: 163 QENFLPDI--FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 639 SLDNLVSLNVSYNHFSGILPNTKLFHGLPAS 669
L++L L+ S NH P+S
Sbjct: 221 CLNSLQVLDYSLNHIMTSKKQE--LQHFPSS 249
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 58/284 (20%), Positives = 97/284 (34%), Gaps = 35/284 (12%)
Query: 305 CSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364
CS + + L VP + + L L N + F ++L +L L +N
Sbjct: 7 CSGTEI-RCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62
Query: 365 RFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNL 424
L+ LDLS N + ++ S+ L
Sbjct: 63 GL-SFKGCCSQSDFGT--------------------TSLKYLDLSFNGVI-TMSSNFLGL 100
Query: 425 KNLTQLLLISNRFSGEIPPE--IGGCTGLIRLRLGSNNFSGHIPSRI-GLLHRLTFLELS 481
+ L L + ++ LI L + + + I L L L+++
Sbjct: 101 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMA 158
Query: 482 ENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPEN 540
N F P+I L +DL Q +L+ P++ L L VL++S N+ ++
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTF 217
Query: 541 -LGKLTSLNKLVLSKNNITGLIPKSL-GLCKDLQLLDLSSNRIN 582
L SL L S N+I + L L L+L+ N
Sbjct: 218 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 57/260 (21%), Positives = 103/260 (39%), Gaps = 16/260 (6%)
Query: 92 TSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHG 151
T + ++ LT +P I SS L+L N L KL +L LSL+SN +
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 152 G--IPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE--IS 207
+ + L+ L+L N + + + LE LE + + ++ E
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN--LKQMSEFSVFL 123
Query: 208 NCKVLVFLGLADTGISGQIPRSV-GELTNLRTLSVYTANITGYIPEEI-GNCSALENLFL 265
+ + L++L ++ T + L++L L + + +I L L L
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 266 YENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPV 324
+ Q+ ++ SL +L+ L + NN +SL V+D SLN +
Sbjct: 183 SQCQL-EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241
Query: 325 SLANLV-ALEELLLSGNNIS 343
L + +L L L+ N+ +
Sbjct: 242 ELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 23/103 (22%), Positives = 39/103 (37%), Gaps = 12/103 (11%)
Query: 570 DLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNN 628
+ +S + S+P I L+ L N L F L++L L LS+N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSSATRLE----LESNKLQSLPHGVFDKLTQLTKLSLSSN 62
Query: 629 MLTG---SLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPA 668
L+ + +L L++S+N + + F GL
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN--FLGLEQ 102
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 758 TRLSDTNIVGKGVSGIVYR---------VEIPSRQVIAVKKLWPVKNGELP-ERDQFSAE 807
T L ++G GV G V++ ++IP + +K + ++ +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIP----VCIKVI---EDKSGRQSFQAVTDH 65
Query: 808 VQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGV 867
+ +GS+ H +IVRLLG C G + L+ Y+ GSL + + + L + +
Sbjct: 66 MLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 868 AHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAG 925
A G+ YL H ++HR++ + N+L+ + +ADFG+A L + +
Sbjct: 125 AKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 926 SYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
++A E + K T +SDV+SYGV + E++T G EP
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 66/311 (21%), Positives = 113/311 (36%), Gaps = 73/311 (23%)
Query: 764 NIVGKGVSGIVYRVEIP-----SRQVIAVKKLWPVKNGELP-ERDQFSAEVQTLGSIRHK 817
+G+G G V + + +AVK L K E++ L ++ H+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNHIADLKKEIEILRNLYHE 83
Query: 818 NIVRLLGCC--NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH 875
NIV+ G C + G L+ +++ +GSL L + K ++ + K + + G+ YL
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 876 -HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS-RASNSVAGSYGYI--- 930
+HRD+ + N+LV + + + DFGL K E+ + +
Sbjct: 144 SRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD-----RDSPVF 194
Query: 931 --APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITW-------- 976
APE K SDV+S+GV L E+LT + I
Sbjct: 195 WYAPECLMQS---KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 977 VNGELRERKREFTTILDR---------QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPT 1027
+ L+E KR L QL M + C P R +
Sbjct: 252 LVNTLKEGKR-----LPCPPNCPDEVYQL----------MRK-------CWEFQPSNRTS 289
Query: 1028 MKDVTAMLKEI 1038
+++ + +
Sbjct: 290 FQNLIEGFEAL 300
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 60/302 (19%), Positives = 119/302 (39%), Gaps = 55/302 (18%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
++G G G V++ + + +K+ VK ++ EV+ L + H NIV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKR---VKY----NNEKAEREVKALAKLDHVNIVHY 69
Query: 823 LGC-------------CNNGRTRLLLF---DYISNGSLAGLLHEKK-VFLDWDSRYKIIL 865
GC ++ LF ++ G+L + +++ LD ++
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 866 GVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAG 925
+ G+ Y+H +I+RD+K +NI + + + DFGL ++ G
Sbjct: 130 QITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKG 183
Query: 926 SYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERK 985
+ Y++PE S ++ D+Y+ G++L E+L + + + T R
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA----FETSKFFT------DLRD 233
Query: 986 REFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDL 1045
+ I D++ + +LQ LL PE+RP ++ L + +
Sbjct: 234 GIISDIFDKKE--------KTLLQ----KLLSKK--PEDRPNTSEILRTLTVWKKSPEKN 279
Query: 1046 EK 1047
E+
Sbjct: 280 ER 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 766 VGKGVSGIVYRVE--IPSRQVIAVKKLWP--VKNGELPERDQFSAEVQTLGSIRHKNIVR 821
+G G V+ R V AVK L ++ R F E Q ++ H IV
Sbjct: 20 LGFGGMSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLR--FRREAQNAAALNHPAIVA 76
Query: 822 LL--GCCNNGRTRL--LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
+ G L ++ +Y+ +L ++H + + ++I L + H +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN 135
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR-ASNSVAGSYGYIAPEYGY 936
IIHRD+K NI++ + DFG+A+ S +S + +V G+ Y++PE
Sbjct: 136 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEP 962
+ +SDVYS G VL EVLTG+ P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 65/314 (20%), Positives = 126/314 (40%), Gaps = 68/314 (21%)
Query: 759 RLSDTNIVGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLG 812
+++ + +G+G G+VY V+ +A+K + + + ER +F E +
Sbjct: 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMK 83
Query: 813 SIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---------KI 863
++VRLLG + G+ L++ + ++ G L L + + + ++
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 864 ILGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921
+A G+AYL + +HRD+ + N +V F + DFG+ + ++ R
Sbjct: 144 AGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--- 195
Query: 922 SVAGSYGYI-----APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAH 972
G G + +PE G T SDV+S+GVVL E+ T ++P
Sbjct: 196 --KGGKGLLPVRWMSPESLKDG---VFTTYSDVWSFGVVLWEIATLAEQP----YQG--- 243
Query: 973 IITWVNGELRERKREFTTILDRQLLMRSG---TQIQE-MLQVLGVALLCVNPCPEERPTM 1028
N ++ +++ LL + + E M C P+ RP+
Sbjct: 244 ---LSNEQVLRF------VMEGGLLDKPDNCPDMLFELMRM-------CWQYNPKMRPSF 287
Query: 1029 KDVTAMLKEIRHEN 1042
++ + +KE
Sbjct: 288 LEIISSIKEEMEPG 301
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 758 TRLSDTNIVGKGVSGIVYR---------VEIPSRQVIAVKKLWPVKNGELP-ERDQFSAE 807
T ++G G G VY+ V+IP +A+K+L + P + E
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP----VAIKEL---REATSPKANKEILDE 67
Query: 808 VQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGV 867
+ S+ + ++ RLLG C T L+ + G L + E K + + +
Sbjct: 68 AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 868 AHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAG 925
A G+ YL ++HRD+ + N+LV + DFGLAKL + E +
Sbjct: 127 AKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----- 176
Query: 926 SYGYI-----APEYGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
G + A E T +SDV+SYGV + E++T G +P
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 764 NIVGKGVSGIVYRVEIPSRQV-IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+ +G G G VY + +AVK L K E ++F E + I+H N+V+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KED-TMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHE-KKVFLDWDSRYKIILGVAHGLAYL-HHDCVP 880
LG C ++ ++++ G+L L E + + + ++ + YL +
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-- 132
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE-- 933
IHRD+ + N LVG +ADFGL++L + + APE
Sbjct: 133 --IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG------AKFPIKWTAPESL 184
Query: 934 -YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
Y K + KSDV+++GV+L E+ T G P
Sbjct: 185 AYN---KFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 767 GKGVSGIVYR--VEIPSRQV-IAVKKLWPVKNGELPE-RDQFSAEVQTLGSIRHKNIVRL 822
G G G V + + +Q+ +A+K L K G ++ E Q + + + IVRL
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HHDCVP 880
+G C +L+ + G L L K+ + + +++ V+ G+ YL +
Sbjct: 76 IGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---- 130
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE-- 933
+HRD+ + N+L+ + A ++DFGL+K + +S A S G APE
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY----YTARSAGKWPLKWYAPECI 185
Query: 934 -YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+ K + +SDV+SYGV + E L+ G++P
Sbjct: 186 NFR---KFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 77/289 (26%), Positives = 128/289 (44%), Gaps = 30/289 (10%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G+G G V+ +A+K L K G + F E Q + +RH+ +V+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ ++ +Y+S GSL L + +L + +A G+AY+
Sbjct: 246 AVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 301
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
+HRD+++ NILVG +ADFGLA+L E +E + + + APE + T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 360
Query: 943 KSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
KSDV+S+G++L E+ T G+ P VN E+ ++ ++R M
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPG----------MVNREVLDQ-------VERGYRMPCP 403
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNS 1050
+ E L L C PEERPT + + A L++ + +P
Sbjct: 404 PECPESLHDL--MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 53/279 (18%)
Query: 767 GKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
GKG + + + +++V A K + + +R++ S E+ S+ H+++V G
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885
+ ++ + SL L +K + ++RY + + G YLH + V IHR
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLHRNRV---IHR 165
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY----GYSLKIT 941
D+K N+ + E + DFGLA E + + G+ YIAPE G+S
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHS---- 219
Query: 942 EKSDVYSYGVVLLEVLTGKEPTDS--------RIPDGAHII-TWVNGELRERKREFTTIL 992
+ DV+S G ++ +L GK P ++ RI + I +N
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS--------- 270
Query: 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
L+ + +L + P RPT+ ++
Sbjct: 271 ---LIQK---------------MLQTD--PTARPTINEL 289
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 69/304 (22%), Positives = 107/304 (35%), Gaps = 65/304 (21%)
Query: 767 GKGVSGIVYR-----VEIPSRQVIAVKKLWPVKNGELP-ERDQFSAEVQTLGSIRHKNIV 820
G+G G V + +++AVK L K P R + E+ L ++ H++I+
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKAL---KADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 821 RLLGCCNNGRTR--LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HD 877
+ GCC + L+ +Y+ GSL L + + G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH 154
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----AP 932
IHRD+ + N+L+ + DFGLAK G AP
Sbjct: 155 Y----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRVREDGDSPVFWYAP 206
Query: 933 EYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIIT----WVNGE----LRE 983
E K SDV+S+GV L E+LT I L
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266
Query: 984 RKREFTTILDR------QL--LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
+R L R ++ LM++ C RPT +++ +L
Sbjct: 267 GER-----LPRPDKCPAEVYHLMKN----------------CWETEASFRPTFENLIPIL 305
Query: 1036 KEIR 1039
K +
Sbjct: 306 KTVH 309
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 35/213 (16%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G G G V+ +AVK L K G + D F AE + ++H+ +VRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSM-SPDAFLAEANLMKQLQHQRLVRLY 74
Query: 824 GCCNNGRTR---LLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYL-HHDC 878
T+ ++ +Y+ NGSL L + L + + +A G+A++ +
Sbjct: 75 AVV----TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE 933
IHRD+++ NILV +ADFGLA+L E +E + APE
Sbjct: 131 ----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG------AKFPIKWTAPE 180
Query: 934 ---YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
YG T KSDV+S+G++L E++T G+ P
Sbjct: 181 AINYG---TFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+GKG G V + +V AVK + KN + F AE + +RH N+V+LL
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKV-AVKCI---KNDATAQ--AFLAEASVMTQLRHSNLVQLL 80
Query: 824 GCCNNGRTRLLL-FDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYL-HHDCVP 880
G + L + +Y++ GSL L + + L D K L V + YL ++
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF-- 138
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAK-LFESSESSRASNSVAGSYGYI-----APE- 933
+HRD+ + N+LV A ++DFGL K + ++ + + APE
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----------LPVKWTAPEA 185
Query: 934 --YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
K + KSDV+S+G++L E+ + G+ P
Sbjct: 186 LREK---KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 69/329 (20%), Positives = 108/329 (32%), Gaps = 86/329 (26%)
Query: 759 RLSDTNIVGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNGELP-ERDQFSAEVQTL 811
++ +G G G VY PS +AVK L + F E +
Sbjct: 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALII 128
Query: 812 GSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSR------YKIIL 865
H+NIVR +G R +L + ++ G L L E + S +
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 866 GVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFL---ADFGLAKLFESSESSRAS 920
+A G YL +H IHRDI + N L+ + DFG+A+ + R
Sbjct: 189 DIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-- 241
Query: 921 NSVAGSYGYI-----APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGA 971
G + PE G T K+D +S+GV+L E+ + G P P
Sbjct: 242 ---KGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGYMP----YPS-- 289
Query: 972 HIITWVNGE----LRERKREFTTILDR------QL--LMRSGTQIQEMLQVLGVALLCVN 1019
N E + R +D + +M C
Sbjct: 290 ----KSNQEVLEFVTSGGR-----MDPPKNCPGPVYRIMTQ----------------CWQ 324
Query: 1020 PCPEERPTMKDVTAMLKEIRHENDDLEKP 1048
PE+RP + ++ + D +
Sbjct: 325 HQPEDRPNFAIILERIEYCTQDPDVINTA 353
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 765 IVGKGVSGIVYR--VEIPSRQVI--AVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
+G+G G V++ P + A+K R++F E T+ H +IV
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL-HHDCV 879
+L+G ++ + + G L L +K LD S ++ LAYL
Sbjct: 80 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF- 137
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE- 933
+HRDI + N+LV L DFGL++ E S +AS G + APE
Sbjct: 138 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK------GKLPIKWMAPES 188
Query: 934 --YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+ + T SDV+ +GV + E+L G +P
Sbjct: 189 INFR---RFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 53/279 (18%)
Query: 767 GKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
GKG + + + +++V A K + + +R++ S E+ S+ H+++V G
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHR 885
+ ++ + SL L +K + ++RY + + G YLH + V IHR
Sbjct: 84 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLHRNRV---IHR 139
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYSLKIT 941
D+K N+ + E + DFGLA E + + G+ YIAPE G+S
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHS---- 193
Query: 942 EKSDVYSYGVVLLEVLTGKEPTDS--------RIPDGAHII-TWVNGELRERKREFTTIL 992
+ DV+S G ++ +L GK P ++ RI + I +N
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS--------- 244
Query: 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
L+ + +L + P RPT+ ++
Sbjct: 245 ---LIQK---------------MLQTD--PTARPTINEL 263
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 67/301 (22%), Positives = 115/301 (38%), Gaps = 57/301 (18%)
Query: 765 IVGKGVSGIVYR-----VEIPSRQVIAVKKLWPVKNGELP-ERDQFSAEVQTLGSIRHKN 818
I+G+G G VY + V AVK K +++F +E + ++ H +
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINV-AVKTC---KKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HH 876
IV+L+G T ++ + G L L K L + L + +AYL +
Sbjct: 75 IVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----A 931
+HRDI NILV L DFGL++ E + +AS + +
Sbjct: 134 -----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV------TRLPIKWMS 182
Query: 932 PE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWV-NGELRERKR 986
PE + + T SDV+ + V + E+L+ GK+P + +I + G+ +
Sbjct: 183 PESINFR---RFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIGVLEKGDRLPKPD 237
Query: 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLE 1046
+L LM C + P +RP ++ L ++ D+
Sbjct: 238 LCPPVLYT--LM----------------TRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 279
Query: 1047 K 1047
Sbjct: 280 M 280
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 744 TPFQKLNFSVDDVV---TRLSDTNIVGKGVSGIVYRVEI----PSRQVIAVKKLWPVKNG 796
++L ++DVV L I+G+G G V + + +AVK + + N
Sbjct: 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNS 75
Query: 797 ELPERDQFSAEVQTLGSIRHKNIVRLLGCC-----NNGRTRLLLFDYISNGSLAGLL--- 848
E ++F +E + H N++RLLG C +++ ++ G L L
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 849 --HEKKVFLDWDSRYKIILGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904
+ + K ++ +A G+ YL + +HRD+ + N ++ +AD
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVAD 190
Query: 905 FGLAKLFESSESSRASNSVAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEV 956
FGL+K S + R G + A E SL T KSDV+++GV + E+
Sbjct: 191 FGLSKKIYSGDYYR-----QGRIAKMPVKWIAIE---SLADRVYTSKSDVWAFGVTMWEI 242
Query: 957 LT-GKEP 962
T G P
Sbjct: 243 ATRGMTP 249
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G + +V P ++ +A+K+ ++ + D+ E+Q + H NIV
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK---------IILGVAHGLAYLH 875
L+ +S GS+ ++ K + + + I+ V GL YLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGL-AKLFESSESSRAS--NSVAGSYGYIAP 932
+ IHRD+K+ NIL+G +ADFG+ A L + +R + G+ ++AP
Sbjct: 139 KNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 933 E-----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
E GY K+D++S+G+ +E+ TG P
Sbjct: 196 EVMEQVRGYD----FKADIWSFGITAIELATGAAP 226
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 767 GKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
GKG VYR I + +A+K + + + EV+ ++H +I+ L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 826 CNNGRTRL-LLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
+ + L+ + NG + L + K F + ++R+ + + G+ YLH + +
Sbjct: 80 FED-SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-FMHQIITGMLYLHSHGI---L 134
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------YGYS 937
HRD+ +N+L+ +ADFGLA + ++ G+ YI+PE +G
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTPNYISPEIATRSAHGL- 191
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEP 962
+SDV+S G + +L G+ P
Sbjct: 192 -----ESDVWSLGCMFYTLLIGRPP 211
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 765 IVGKGVSGIVYR--VEIPSRQVI--AVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
+G G G+V R + PS + + AVK L P + D F EV + S+ H+N++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HHDC 878
RL G ++ + GSL L + + + + + VA G+ YL
Sbjct: 85 RLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR-- 141
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE 933
IHRD+ + N+L+ + + DFGL + ++ V + + APE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPFAWCAPE 194
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+ + SD + +GV L E+ T G+EP
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 767 GKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
GKG G VY E S+ ++A+K L+ + + Q EV+ +RH NI+RL G
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 826 CNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
++ TR+ L+ +Y G++ L + F + + I +A+ L+Y H V IH
Sbjct: 78 FHD-ATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRV---IH 132
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------YGYSL 938
RDIK N+L+G E +ADFG + + SSR + G+ Y+ PE +
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVH---APSSRR-TDLCGTLDYLPPEMIEGRMHD--- 185
Query: 939 KITEKSDVYSYGVVLLEVLTGKEP 962
EK D++S GV+ E L GK P
Sbjct: 186 ---EKVDLWSLGVLCYEFLVGKPP 206
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 72/299 (24%), Positives = 120/299 (40%), Gaps = 64/299 (21%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+GKG G V + +V AVK + KN + F AE + +RH N+V+LL
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV-AVKCI---KNDATAQ--AFLAEASVMTQLRHSNLVQLL 252
Query: 824 GCCNNGRTRLLL-FDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYL-HHDCVP 880
G + L + +Y++ GSL L + + L D K L V + YL ++
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF-- 310
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAK-LFESSESSRASNSVAGSYGYI-----APEY 934
+HRD+ + N+LV A ++DFGL K + ++ + + APE
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----------LPVKWTAPEA 357
Query: 935 GYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993
K + KSDV+S+G++L E+ + G+ P P ++ R ++
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVP----YPR------IPLKDVVPR-------VE 400
Query: 994 RQLLM-------RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDL 1045
+ M + + M C + RPT + L+ IR L
Sbjct: 401 KGYKMDAPDGCPPAVYDV--MKN-------CWHLDAATRPTFLQLREQLEHIRTHELHL 450
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 69/305 (22%), Positives = 112/305 (36%), Gaps = 69/305 (22%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLG-SIRHKNIVRL 822
I+G G SG V + +AVK++ D E++ L S H N++R
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDDHPNVIRY 74
Query: 823 LGCCNNGRTRLL--------LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL 874
R + L D + + + E + ++ +A G+A+L
Sbjct: 75 YCSETTDRFLYIALELCNLNLQDLVESK---NVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 875 HHDCVPPIIHRDIKSNNILV-------------GPQFEAFLADFGLAKLFESSESSRAS- 920
H IIHRD+K NILV ++DFGL K +S +SS +
Sbjct: 132 HSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 921 -NSVAGSYGYIAPE-------YGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGA 971
N+ +G+ G+ APE ++T D++S G V +L+ GK P + +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 972 HIITWVNGELRERKREFTTILD-----RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP 1026
+II G + + L I +M+ P +RP
Sbjct: 249 NII---RGIFSLDEMKCLHDRSLIAEATDL-------ISQMIDHD----------PLKRP 288
Query: 1027 TMKDV 1031
T V
Sbjct: 289 TAMKV 293
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/246 (22%), Positives = 103/246 (41%), Gaps = 47/246 (19%)
Query: 748 KLNFSVDDVV---TRLSDTNIVGKGVSGIVYRVEI----PSRQVIAVKKLWPVKNGELPE 800
+L ++DV+ + + ++GKG G V ++ S +AVK L K +
Sbjct: 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADIIAS 66
Query: 801 RD--QFSAEVQTLGSIRHKNIVRLLGCC------NNGRTRLLLFDYISNGSLAGLL---- 848
D +F E + H ++ +L+G +++ ++ +G L L
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 849 -HEKKVFLDWDSRYKIILGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADF 905
E L + + ++ +A G+ YL + IHRD+ + N ++ +ADF
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADF 181
Query: 906 GLAKLFESSESSRASNSVAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEVL 957
GL++ S + R G + A E SL T SDV+++GV + E++
Sbjct: 182 GLSRKIYSGDYYR-----QGCASKLPVKWLALE---SLADNLYTVHSDVWAFGVTMWEIM 233
Query: 958 T-GKEP 962
T G+ P
Sbjct: 234 TRGQTP 239
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (285), Expect = 3e-26
Identities = 58/276 (21%), Positives = 106/276 (38%), Gaps = 22/276 (7%)
Query: 377 LKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNR 436
+ E + + I + +L +T +V L ++ Q++ ++
Sbjct: 1 MGETITV---STPIK-QIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 54
Query: 437 FSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNC 496
+ I + +L L N + I + L L +L L EN+ ++ + +
Sbjct: 55 IK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDL 108
Query: 497 TQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNN 556
+L+ + L N + + + L L L L L N I T L +LT L+ L L N
Sbjct: 109 KKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQ 164
Query: 557 ITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSN 616
I+ ++P L LQ L LS N I S + L+ LD+L L SN
Sbjct: 165 ISDIVP--LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVL-ELFSQECLNKPINHQSN 219
Query: 617 LSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNH 652
L + ++ L + +++ + NV ++
Sbjct: 220 LVVPNTVKNTDGSLV-TPEIISDDGDYEKPNVKWHL 254
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 52/281 (18%), Positives = 101/281 (35%), Gaps = 41/281 (14%)
Query: 284 LKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNIS 343
+ + + I + ++ S+ V L ++++++ + ++I
Sbjct: 1 MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 344 GEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKL 403
+ + +L L+ N +L +I L L
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGN-----------KLT--------------DIKPLTNLKNL 89
Query: 404 QALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSG 463
L L N + SSL +LK L L L N S +I + L L LG+N +
Sbjct: 90 GWLFLDENKIK--DLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT- 144
Query: 464 HIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGL 523
+ + L +L L L +NQ + +I P + T+L+ + L +N + + +L L L
Sbjct: 145 -DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNL 199
Query: 524 NVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKS 564
+VL+L + L N + + ++ S
Sbjct: 200 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-22
Identities = 46/193 (23%), Positives = 77/193 (39%), Gaps = 18/193 (9%)
Query: 472 LHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMN 531
L + T + ++ + + + ++ ++ +++L + L L+ N
Sbjct: 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 75
Query: 532 SIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGR 591
+ T + L L +L L L +N I L L K L+ L L N I +I
Sbjct: 76 KL--TDIKPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI-----SDING 126
Query: 592 LQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVS 649
L L L L L N +T S L+KL L L +N ++ + L L L +L +S
Sbjct: 127 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLS 183
Query: 650 YNHFSGILPNTKL 662
NH S + L
Sbjct: 184 KNHISDLRALAGL 196
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 2e-21
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 15/232 (6%)
Query: 204 EEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENL 263
+ L ++ + EL ++ + ++I + I + L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKL 70
Query: 264 FLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVP 323
FL N++ I L +LKNL L L +N + + +L + L + + N +
Sbjct: 71 FLNGNKL-TDIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI--SDI 124
Query: 324 VSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLF 383
L +L LE L L N I+ + ++L L L++N+ I P + L +L
Sbjct: 125 NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI-SDIVP-LAGLTKLQNL 180
Query: 384 FAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISN 435
+ +N + ++ LA L L+L + NL +
Sbjct: 181 YLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 3e-18
Identities = 45/232 (19%), Positives = 90/232 (38%), Gaps = 21/232 (9%)
Query: 135 KLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGG 194
AE +L S+ + + + ++ ++ + ++ I L + + G
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 74
Query: 195 NPGIHGEIP--EEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPE 252
N ++ + ++N K L +L L + I + S+ +L L++LS+ I+
Sbjct: 75 N-----KLTDIKPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS--DIN 125
Query: 253 EIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVID 312
+ + LE+L+L N+I L L L L L N +S I L + L +
Sbjct: 126 GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLY 181
Query: 313 VSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364
+S N + +LA L L+ L L + + N ++ +
Sbjct: 182 LSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 46/249 (18%), Positives = 92/249 (36%), Gaps = 17/249 (6%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSL 144
+ ++T L L+ LT +I P + NL +L L L N + ++ + L +L+ LSL
Sbjct: 61 IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSL 116
Query: 145 NSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPE 204
N I + + +L L L +N+++ +I + +L L+ + N I +I
Sbjct: 117 EHNGISDING--LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQ-IS-DI-V 169
Query: 205 EISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLF 264
++ L L L+ IS R++ L NL L +++ N +
Sbjct: 170 PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227
Query: 265 LYENQIFG----KIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGG 320
+ + + L + N +S + + + +
Sbjct: 228 NTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLK 287
Query: 321 EVPVSLANL 329
EV ++
Sbjct: 288 EVYTVSYDV 296
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 32/287 (11%)
Query: 767 GKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCC 826
G+G G V+ +A+K L K G + F E Q + +RH+ +V+L
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTL---KPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 827 NNGRTRLLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLH-HDCVPPIIH 884
+ ++ +Y+S GSL L + +L + +A G+AY+ + +H
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VH 386
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKS 944
RD+++ NILVG +ADFGLA+L E +E + + + APE + T KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445
Query: 945 DVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQ 1003
DV+S+G++L E+ T G+ P VN E+ ++ ++R M +
Sbjct: 446 DVWSFGILLTELTTKGRVPYPG----------MVNREVLDQ-------VERGYRMPCPPE 488
Query: 1004 IQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNS 1050
E L L C PEERPT + + A L++ + +P
Sbjct: 489 CPESLHDL--MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 767 GKGVSGIVYR--VEIPSRQV-IAVKKLWPVKNG--ELPERDQFSAEVQTLGSIRHKNIVR 821
G G G V + ++ +AVK L KN + +D+ AE + + + IVR
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKIL---KNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HHDCV 879
++G C + +L+ + G L L + + + + +++ V+ G+ YL +
Sbjct: 83 MIGICE-AESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN--- 137
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE- 933
+HRD+ + N+L+ Q A ++DFGL+K + E+ A ++G APE
Sbjct: 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPEC 191
Query: 934 --YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
Y K + KSDV+S+GV++ E + G++P
Sbjct: 192 INYY---KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 66/313 (21%), Positives = 107/313 (34%), Gaps = 52/313 (16%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
I+G+G + V+R + + A+K L D E + L + HKNIV+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 824 GCCNNGRTRLL-----------LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLA 872
TR L+ + S A L E + ++ V G+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-------IVLRDVVGGMN 126
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAF----LADFGLAKLFESSESSRASNSVAGSYG 928
+L + I+HR+IK NI+ + L DFG A+ E E S+ G+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEE 180
Query: 929 YIAPE--------YGYSLKITEKSDVYSYGVVLLEVLTGKEP-TDSRIPDG-----AHII 974
Y+ P+ + K D++S GV TG P P II
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 975 T-----WVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMK 1029
T ++G + D + +Q +L + +L + E+
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD--QEKCWGFD 298
Query: 1030 DVTAMLKEIRHEN 1042
A +I H
Sbjct: 299 QFFAETSDILHRG 311
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G G G V+ +AVK + K G + F AE + +++H +V+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM---KPGS-MSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLL-HEKKVFLDWDSRYKIILGVAHGLAYL-HHDCVPP 881
++ ++++ GSL L ++ +A G+A++ +
Sbjct: 250 AVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY--- 305
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APEYGY 936
IHRD+++ NILV +ADFGLA++ E +E + APE
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG------AKFPIKWTAPEAIN 358
Query: 937 SLKITEKSDVYSYGVVLLEVLT-GKEP 962
T KSDV+S+G++L+E++T G+ P
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 64/276 (23%), Positives = 99/276 (35%), Gaps = 48/276 (17%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLL 823
+G G G V++V ++ AVK+ G +R + AEV + + +H VRL
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
G L + SL L + + LA+LH ++
Sbjct: 124 QAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLV 179
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY---GYSLKI 940
H D+K NI +GP+ L DFGL ++ A G Y+APE Y
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQGSY---- 232
Query: 941 TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRS 1000
+DV+S G+ +LEV E GE ++ +R
Sbjct: 233 GTAADVFSLGLTILEVACNMEL-------------PHGGEGWQQ-------------LRQ 266
Query: 1001 GTQIQEMLQVLGVAL-----LCVNPCPEERPTMKDV 1031
G E L L + + P P+ R T + +
Sbjct: 267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 53/264 (20%), Positives = 105/264 (39%), Gaps = 17/264 (6%)
Query: 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNF 461
+++LDLS+N +T S L NL L+L SN + I + L L L N
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 462 SGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI--GNCTQLEMVDLHQNKLQGTIPS-SL 517
S ++ S L LTFL L N + + + T+L+++ + I
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 518 EFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLS 577
L L L++ + + P++L + +++ L+L L+ + + ++ L+L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230
Query: 578 SNRINGSIPEEI-----GRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNML 630
++ E+ L + ++ +L + + + +S L L+ S N L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 631 TG-SLKVLGSLDNLVSLNVSYNHF 653
+ L +L + + N +
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 61/336 (18%), Positives = 110/336 (32%), Gaps = 60/336 (17%)
Query: 305 CSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364
C + S SL +P L A++ L LS N I+ S L+ L L +N
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 365 RFFGQIPPTI----GQLKELLLFFAWQNQLHGNIPE--LAYCVKLQALDLSHNFLTGSVP 418
I G L+ L L N L N+ L L+L N
Sbjct: 87 GI-NTIEEDSFSSLGSLEHLDL---SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGE 141
Query: 419 SSLF-NLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFSGHIPSRIGLLHRLT 476
+SLF +L L L + + +I + G T L L + +++ + P + + ++
Sbjct: 142 TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201
Query: 477 FLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535
L L Q + + +E ++L L + +
Sbjct: 202 HLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT----------------FHFSELST 244
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
+L K + + ++ ++ ++ + L L+ S N++ S+P+ I
Sbjct: 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISG-LLELEFSRNQLK-SVPDGI------ 296
Query: 596 DILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLT 631
F L+ L + L N
Sbjct: 297 ------------------FDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 62/315 (19%), Positives = 111/315 (35%), Gaps = 50/315 (15%)
Query: 65 CSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFN 123
C + ++ SI P+ + SL LSN +T I + +L L L+ N
Sbjct: 36 CKGSSGSLNSI--PSGLT------EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSN 86
Query: 124 ALTGNIPEEI-GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEI 181
+ I E+ L LE L L+ N + + S L L L N +
Sbjct: 87 GIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSL 144
Query: 182 -GQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLS 240
L L+I+R G +I + F GL T L L
Sbjct: 145 FSHLTKLQILRVGNMDTFT-KIQRK-------DFAGL----------------TFLEELE 180
Query: 241 VYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDEL-GSLKNLKRLLLWQNNLSG--- 296
+ +++ Y P+ + + + +L L+ Q + + +++ L L +L
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQH-ILLLEIFVDVTSSVECLELRDTDLDTFHF 239
Query: 297 -SIPE----ALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFG 351
+ +L + + ++ SL +V L + L EL S N + F
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFD 298
Query: 352 NFSRLKQLELDNNRF 366
+ L+++ L N +
Sbjct: 299 RLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 45/193 (23%), Positives = 72/193 (37%), Gaps = 11/193 (5%)
Query: 480 LSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPE 539
S IP + ++ +DL N++ S L+ L L L+ N I TI E
Sbjct: 38 GSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEE 93
Query: 540 NL-GKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI--GRLQGLD 596
+ L SL L LS N ++ L L L+L N ++ E L L
Sbjct: 94 DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152
Query: 597 ILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG-SLKVLGSLDNLVSLNVSYNHFSG 655
IL + + T + F+ L+ L L++ + L K L S+ N+ L +
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212
Query: 656 ILPNTKLFHGLPA 668
+L +
Sbjct: 213 LLEI--FVDVTSS 223
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 45/178 (25%), Positives = 67/178 (37%), Gaps = 13/178 (7%)
Query: 496 CTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKN 555
C + + L +IPS L + LDLS N I +L + +L LVL+ N
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 556 NITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPES 613
I + S L+ LDLS N + ++ + L L LNL N S
Sbjct: 87 GINTIEEDSFSSLGSLEHLDLSYNYL-SNLSSSW--FKPLSSLTFLNLLGNPYKTLGETS 143
Query: 614 -FSNLSKLANLDLSNNMLTGSL--KVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPA 668
FS+L+KL L + N + K L L L + + P + +
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS--LKSIQN 199
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 73/330 (22%), Positives = 118/330 (35%), Gaps = 98/330 (29%)
Query: 767 GKGVSGIVYR------VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
G+G G V++ + ++AVK L + + F E + + NIV
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDNPNIV 113
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY------------------- 861
+LLG C G+ LLF+Y++ G L L +
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 862 ----KIILGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915
I VA G+AYL +HRD+ + N LVG +ADFGL++ S++
Sbjct: 174 AEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 916 SSRASNSVAGSYGYI-----APE---YGYSLKITEKSDVYSYGVVLLEVLT-GKEP---- 962
+ A I PE Y + T +SDV++YGVVL E+ + G +P
Sbjct: 229 YYK-----ADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPYYGM 280
Query: 963 TDSRIPDGAHIITWVNGELRERKREFTTILDR------QL--LMRSGTQIQEMLQVLGVA 1014
+ +R+ L +L LMR
Sbjct: 281 AHEEVIY----------YVRDGNI-----LACPENCPLELYNLMRL-------------- 311
Query: 1015 LLCVNPCPEERPTMKDVTAMLKEIRHENDD 1044
C + P +RP+ + +L+ + +
Sbjct: 312 --CWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 66/313 (21%), Positives = 107/313 (34%), Gaps = 52/313 (16%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
I+G+G + V+R + + A+K L D E + L + HKNIV+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 824 GCCNNGRTRLL-----------LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLA 872
TR L+ + S A L E + ++ V G+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-------IVLRDVVGGMN 126
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAF----LADFGLAKLFESSESSRASNSVAGSYG 928
+L + I+HR+IK NI+ + L DFG A+ E E S+ G+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEE 180
Query: 929 YIAPE--------YGYSLKITEKSDVYSYGVVLLEVLTGKEP-TDSRIPDG-----AHII 974
Y+ P+ + K D++S GV TG P P II
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 975 T-----WVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMK 1029
T ++G + D + +Q +L + +L + E+
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD--QEKCWGFD 298
Query: 1030 DVTAMLKEIRHEN 1042
A +I H
Sbjct: 299 QFFAETSDILHRM 311
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 56/218 (25%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
SV D + + +G+G SG VY +++ + Q +A++++ ++ +++ E+
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQP--KKELIINEILV 70
Query: 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+ ++ NIV L G ++ +Y++ GSL ++ E +D +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQA 128
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
L +LH + +IHRDIKS+NIL+G L DFG +S R +++ G+ ++
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWM 183
Query: 931 APE------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
APE YG K D++S G++ +E++ G+ P
Sbjct: 184 APEVVTRKAYGP------KVDIWSLGIMAIEMIEGEPP 215
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 767 GKGVSGIVYR--VEIPSRQV-IAVKKLWPVKNGELPE-RDQFSAEVQTLGSIRHKNIVRL 822
G G G V + + +Q+ +A+K L K G ++ E Q + + + IVRL
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL--HHDCVP 880
+G C +L+ + G L L K+ + + +++ V+ G+ YL +
Sbjct: 402 IGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---- 456
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APEYG 935
+HR++ + N+L+ + A ++DFGL+K + +S A S G APE
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECI 511
Query: 936 YSLKITEKSDVYSYGVVLLEVLT-GKEP 962
K + +SDV+SYGV + E L+ G++P
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-25
Identities = 46/215 (21%), Positives = 80/215 (37%), Gaps = 25/215 (11%)
Query: 766 VGKGVSGIVYR---VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+ G G +Y + R V +K L + E AE Q L + H +IV++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAM--AMAERQFLAEVVHPSIVQI 144
Query: 823 L--GCCNNGRTRLLLF---DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
+ + + +Y+ SL +K L +L + L+YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSI 201
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
+++ D+K NI++ + + L D G S + G+ G+ APE
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEI-VR 250
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAH 972
T +D+Y+ G L + + R DG
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 67/238 (28%), Positives = 101/238 (42%), Gaps = 36/238 (15%)
Query: 742 DFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPE 800
+P Q +F+ +D L D +G+G G V ++ PS Q++AVK++ E E
Sbjct: 10 KISPEQHWDFTAED----LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDE-KE 63
Query: 801 RDQFSAEVQT-LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDS 859
+ Q ++ + S IV+ G + + + + S K V+ D
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDD 120
Query: 860 RY------KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL-AKLFE 912
KI L L +L + IIHRDIK +NIL+ L DFG+ +L
Sbjct: 121 VIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-- 176
Query: 913 SSESSRASNSVAGSYGYIAPE--------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
S A AG Y+APE GY +SDV+S G+ L E+ TG+ P
Sbjct: 177 --VDSIAKTRDAGCRPYMAPERIDPSASRQGYD----VRSDVWSLGITLYELATGRFP 228
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 767 GKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
GKG G VY E ++ ++A+K L+ + + Q E++ +RH NI+R+
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82
Query: 826 CNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
++ R R+ L+ ++ G L L + F + S + +A L Y H V IH
Sbjct: 83 FHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHERKV---IH 137
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYSLKI 940
RDIK N+L+G + E +ADFG + + S R ++ G+ Y+ PE +
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVH---APSLRR-RTMCGTLDYLPPEMIEGKTH---- 189
Query: 941 TEKSDVYSYGVVLLEVLTGKEP 962
EK D++ GV+ E L G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
+G+G G VY+ + Q++A+K++ PV++ + + E+
Sbjct: 23 LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVES----DLQEIIKEISI 77
Query: 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+ ++V+ G ++ +Y GS++ ++ + L D I+ G
Sbjct: 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
L YLH IHRDIK+ NIL+ + A LADFG+A + + R N+V G+ ++
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NTVIGTPFWM 192
Query: 931 APE----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
APE GY +D++S G+ +E+ GK P
Sbjct: 193 APEVIQEIGY----NCVADIWSLGITAIEMAEGKPP 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-25
Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 765 IVGKGVSGIVYR--VEIPSRQVI--AVKKLWPVKNG-ELPERDQFSAEVQTLGSIRHKNI 819
+G+G G V++ P + A+K KN R++F E T+ H +I
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDC 878
V+L+G ++ + + G L L +K LD S ++ LAYL
Sbjct: 454 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI-----APE 933
V HRDI + N+LV L DFGL++ E S +AS G + APE
Sbjct: 513 V----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK------GKLPIKWMAPE 562
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLT-GKEP 962
+ T SDV+ +GV + E+L G +P
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 54/230 (23%), Positives = 83/230 (36%), Gaps = 32/230 (13%)
Query: 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNF 461
Q + L N ++ +S +NLT L L SN + I G L +L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 462 SGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPS-SLE 518
+ L RL L L E+ P + L+ + L N LQ +P +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 519 FLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSS 578
L L L L N I L SL++L+L +N + + P + L L L +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 579 NRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNN 628
N ++ ++P E + L L L L++N
Sbjct: 211 NNLS-ALPTEA------------------------LAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 52/244 (21%), Positives = 80/244 (32%), Gaps = 33/244 (13%)
Query: 292 NNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFG 351
L ++P + ++ I + N + S L L L N ++ + F
Sbjct: 21 QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 352 NFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHN 411
+ L+QL+L +N + P +L L L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPAT----------------------FHGLGRLHTLHLDRC 115
Query: 412 FLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFSGHIPSRI 469
L + LF L L L L N +P + L L L N S +P R
Sbjct: 116 GLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERA 172
Query: 470 -GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLD 527
LH L L L +N+ + P + +L + L N L +L L L L
Sbjct: 173 FRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231
Query: 528 LSMN 531
L+ N
Sbjct: 232 LNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 48/210 (22%), Positives = 78/210 (37%), Gaps = 13/210 (6%)
Query: 464 HIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFG 522
+P G+ + L N+ + +P C L ++ LH N L ++ L
Sbjct: 25 AVPV--GIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 523 LNVLDLSMNSIGGTIPEN-LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
L LDLS N+ ++ L L+ L L + + L P LQ L L N +
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 582 NGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG-SLKVLG 638
++P+ + L L L L N ++ +F L L L L N +
Sbjct: 142 Q-ALPD--DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 639 SLDNLVSLNVSYNHFSGILPNTKLFHGLPA 668
L L++L + N+ S + L A
Sbjct: 199 DLGRLMTLYLFANNLSALPTE--ALAPLRA 226
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 60/238 (25%), Positives = 91/238 (38%), Gaps = 42/238 (17%)
Query: 258 SALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNS 317
+A + +FL+ N+I + +NL L L N L+ I
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RID------------------ 72
Query: 318 LGGEVPVSLANLVALEELLLSGNNISGEIPS-FFGNFSRLKQLELDNNRFFGQIPPTI-- 374
+ L LE+L LS N + F RL L LD ++ P +
Sbjct: 73 -----AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126
Query: 375 --GQLKELLLFFAWQNQLHGNIPE--LAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQ 429
L+ L L N L +P+ L L L N ++ SVP F L +L +
Sbjct: 127 GLAALQYLYLQ---DNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDR 181
Query: 430 LLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFSGHIPSRI-GLLHRLTFLELSENQF 485
LLL NR + + P L+ L L +NN S +P+ L L +L L++N +
Sbjct: 182 LLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 58/251 (23%), Positives = 89/251 (35%), Gaps = 35/251 (13%)
Query: 118 LDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNI 177
L +P I A + + L+ N I C L L L+ N L+ I
Sbjct: 16 TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RI 71
Query: 178 PAEI-GQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNL 236
A L LE + N + + F G L L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLR-SVDPA-------TFHG----------------LGRL 107
Query: 237 RTLSVYTANITGYIPEEI-GNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNL 294
TL + + + + +AL+ L+L +N + +PD+ L NL L L N +
Sbjct: 108 HTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRI 165
Query: 295 SGSIPE-ALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNF 353
S S+PE A SL + + N + P + +L L L L NN+S
Sbjct: 166 S-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224
Query: 354 SRLKQLELDNN 364
L+ L L++N
Sbjct: 225 RALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 50/229 (21%), Positives = 81/229 (35%), Gaps = 41/229 (17%)
Query: 72 ITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIP 130
I+ + + +LT L L + L I A L+ L LDLS NA ++
Sbjct: 44 ISHVP-----AASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVD 97
Query: 131 EEI-GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEI-GQLEAL 187
L L L L+ + + + + L+ L L DN L +P + L L
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNL 155
Query: 188 EIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANIT 247
+ GN IS+ F G L +L L ++ +
Sbjct: 156 THLFLHGN---------RISSVPERAFRG----------------LHSLDRLLLHQNRVA 190
Query: 248 GYIPEEI-GNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNL 294
++ + L L+L+ N + +P E L L+ L+ L L N
Sbjct: 191 -HVHPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDNPW 237
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 65/231 (28%), Positives = 98/231 (42%), Gaps = 52/231 (22%)
Query: 764 NIVGKGVSGIVYRVEI---PSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGSI-RHKN 818
+++G+G G V + I R A+K++ K + F+ E++ L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---------------KI 863
I+ LLG C + L +Y +G+L L + +V +
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 864 ILGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASN 921
VA G+ YL IHRD+ + NILVG + A +ADFGL SR
Sbjct: 148 AADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGL---------SRGQE 193
Query: 922 S-VAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEVLT-GKEP 962
V + G + A E SL T SDV+SYGV+L E+++ G P
Sbjct: 194 VYVKKTMGRLPVRWMAIE---SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 74/324 (22%), Positives = 130/324 (40%), Gaps = 82/324 (25%)
Query: 759 RLSDTNIVGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTL 811
L +G G G V + + +AVK L K+ E++ +E++ +
Sbjct: 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIM 103
Query: 812 GSI-RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY--------- 861
+ +H+NIV LLG C +G L++ +Y G L L K L+ D +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 862 ----KIILGVAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915
VA G+A+L + IHRD+ + N+L+ A + DFGLA+ +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMND- 217
Query: 916 SSRASNSVAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEVLT-GKEPTDSR 966
SN + + APE S+ T +SDV+SYG++L E+ + G P
Sbjct: 218 ----SNYIVKGNARLPVKWMAPE---SIFDCVYTVQSDVWSYGILLWEIFSLGLNPY--- 267
Query: 967 IPDGAHIITWVNGELRERKREFTTILDR------QL--LMRSGTQIQEMLQVLGVALLCV 1018
P G + + +++ + + + + +M++ C
Sbjct: 268 -P-GILVNSKFYKLVKDGYQ-----MAQPAFAPKNIYSIMQA----------------CW 304
Query: 1019 NPCPEERPTMKDVTAMLKEIRHEN 1042
P RPT + + + L+E E+
Sbjct: 305 ALEPTHRPTFQQICSFLQEQAQED 328
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
D L +G+G +GIV E S + +AVK + ++ + R+ EV
Sbjct: 39 DQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQ--RRELLFNEVVI 95
Query: 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+ +H N+V + G +L +++ G+L ++ + + L+ + + V
Sbjct: 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQA 153
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
LAYLH +IHRDIKS++IL+ L+DFG R S+ G+ ++
Sbjct: 154 LAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWM 208
Query: 931 APE------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
APE Y + D++S G++++E++ G+ P
Sbjct: 209 APEVISRSLYAT------EVDIWSLGIMVIEMVDGEPP 240
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 42/212 (19%), Positives = 79/212 (37%), Gaps = 23/212 (10%)
Query: 766 VGKGVS--GIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+GKG V P+ + + V+++ ++ E+ H NIV
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLL-HEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
++ +++ GS L+ ++ + I+ GV L Y+HH
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY-- 149
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG-----YIAPE--- 933
+HR +K+++IL+ + +L+ S + Y +++PE
Sbjct: 150 -VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 934 ---YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
GY KSD+YS G+ E+ G P
Sbjct: 209 QNLQGY----DAKSDIYSVGITACELANGHVP 236
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 69/310 (22%), Positives = 109/310 (35%), Gaps = 66/310 (21%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLL 823
+ +G VY + + S + A+K+L E + EV + + H NIV+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRL-LSNEEE--KNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 824 GCC-------NNGRTRLL---------LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGV 867
+ G+ L L +++ G L V KI
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-------LKIFYQT 145
Query: 868 AHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA--- 924
+ ++H PPIIHRD+K N+L+ Q L DFG A S
Sbjct: 146 CRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 925 -------GSYGYIAPE----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHI 973
+ Y PE Y I EK D+++ G +L + + P +
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHPF-----EDGAK 258
Query: 974 ITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033
+ VNG+ + + L I+ MLQ VN PEER ++ +V
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSL-------IRAMLQ--------VN--PEERLSIAEVVH 301
Query: 1034 MLKEIRHEND 1043
L+EI +
Sbjct: 302 QLQEIAAARN 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 50/259 (19%), Positives = 87/259 (33%), Gaps = 25/259 (9%)
Query: 393 NIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLL---LISNRFSGEIPPEIGGCT 449
++ + L+ L + + + + ++ L L + +G PP + T
Sbjct: 60 QFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119
Query: 450 G--LIRLRLGSNNFSGHIPS----RIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVD 503
G L L L + +++ + L L L +++ ++ L +D
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 504 LHQNKLQGTI-------PSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNN 556
L N G P L L + + M + G L L LS N+
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 557 ITGLIPKSLGL-CKDLQLLDLSSNRINGSIPEEIGR-LQGLDILLNLSWNALTGPIPESF 614
+ L L+LS + +P+ + L LD LS+N L P S
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLD----LSYNRLDR-NP-SP 292
Query: 615 SNLSKLANLDLSNNMLTGS 633
L ++ NL L N S
Sbjct: 293 DELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 54/270 (20%), Positives = 85/270 (31%), Gaps = 21/270 (7%)
Query: 403 LQALDLSHNFLTGSVP-SSLFNLKNLTQLLLISNRFSGEIPP---EIGGCTGLIRLRLGS 458
L+ L + + + +L +L + + R I + G +GL L L +
Sbjct: 45 LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104
Query: 459 NNFSGHIPSRIGLLH--RLTFLELSENQFTGE--IPPEIGNC--TQLEMVDLHQNKLQGT 512
+G P + L L L + E+ L+++ + Q
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164
Query: 513 IPSSLEFLFGLNVLDLSMNSIGGTIPEN----LGKLTSLNKLVLSKNNITGL---IPKSL 565
+ L+ LDLS N G K +L L L +
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 566 GLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDL 625
LQ LDLS N + + LNLS+ L + LS L DL
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL---DL 281
Query: 626 SNNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
S N L L + +L++ N F
Sbjct: 282 SYNRLD-RNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 4e-21
Identities = 43/233 (18%), Positives = 77/233 (33%), Gaps = 20/233 (8%)
Query: 446 GGCTGLIRLRLGSNNFSGHIPSRIGL-LHRLTFLELSENQFTGEIPP---EIGNCTQLEM 501
GG L L + + + L L + + I + + L+
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99
Query: 502 VDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL------GKLTSLNKLVLSKN 555
+ L ++ GT P L G ++ L++ ++ + L L +++
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159
Query: 556 NITGLIPKSLGLCKDLQLLDLSSNRINGSI-------PEEIGRLQGLDILLNLSWNALTG 608
+ + + + L LDLS N G P + LQ L L N +G
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA-LRNAGMETPSG 218
Query: 609 PIPESFSNLSKLANLDLSNNMLTGSLKVLGS--LDNLVSLNVSYNHFSGILPN 659
+ +L LDLS+N L + L SLN+S+ +
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKG 271
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 6e-21
Identities = 58/258 (22%), Positives = 90/258 (34%), Gaps = 21/258 (8%)
Query: 423 NLKNLTQLLLISNRFSGEIP-PEIGGCTGLIRLRLGSNNFSGHIPS---RIGLLHRLTFL 478
++L LL + + +I L RL + + I R+ + L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 479 ELSENQFTGEIPPEIGNCT--QLEMVDLHQNKLQGTIPSSLEFLF----GLNVLDLSMNS 532
L + TG PP + T L +++L E GL VL ++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 533 IGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKD----LQLLDLSSNRINGSIPEE 588
E + +L+ L LS N G LC LQ+L L + + +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME-TPSGV 219
Query: 589 IGRLQGLD---ILLNLSWNALTG-PIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLV 644
L L+LS N+L S S+L +L+LS L K L + L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA--KLS 277
Query: 645 SLNVSYNHFSGILPNTKL 662
L++SYN +L
Sbjct: 278 VLDLSYNRLDRNPSPDEL 295
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 5e-16
Identities = 55/317 (17%), Positives = 94/317 (29%), Gaps = 56/317 (17%)
Query: 110 GNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPR---EIGNCSKLRRL 166
G S L +I K L+ L++ + I I + S L+ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 167 ELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQI 226
L + +++G P + + ++ +L ++ +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDL--------------------NILNLRNVSWATRDAWL 140
Query: 227 PRSVGEL-TNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDE----LGSL 281
L L+ LS+ A+ + E++ AL L L +N G+
Sbjct: 141 AELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKF 200
Query: 282 KNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNN 341
L+ L L + + G A V L+ L LS N+
Sbjct: 201 PTLQVLALRNAGM---------------------ETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 342 ISGEIP-SFFGNFSRLKQLELDNNRFFGQIPPTIGQ-LKELLLFFAWQNQLHGNIPELAY 399
+ S+L L L Q+P + L L L N+L P
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTG-LKQVPKGLPAKLSVLDL---SYNRLDR-NPSPDE 294
Query: 400 CVKLQALDLSHNFLTGS 416
++ L L N S
Sbjct: 295 LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 40/227 (17%), Positives = 75/227 (33%), Gaps = 18/227 (7%)
Query: 84 QLLSFSHLTSLVLSNANLTGEIPPAIGNLS--SLINLDLSFNALTGNIPE----EIGKLA 137
++L S L L L N +TG PP + + L L+L + +
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 138 ELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEI----GQLEALEIIRAG 193
L++LS+ ++ L L+L DN G + L+++
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 194 GNPG--IHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGE-LTNLRTLSVYTANITGYI 250
G + L L L+ + + + L +L++ + +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-V 268
Query: 251 PEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGS 297
P+ + + L L L N++ + P L + L L N S
Sbjct: 269 PKGLP--AKLSVLDLSYNRL-DRNPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G G VY+ + + A K + K+ E E + + E++ L + H IV+LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVI-ETKSEE--ELEDYIVEIEILATCDHPYIVKLLG 83
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
+ ++ ++ G++ ++ E L + + L +LH + IH
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI---IH 140
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---------YG 935
RD+K+ N+L+ + + LADFG++ + R +S G+ ++APE
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPEVVMCETMKDTP 198
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y K+D++S G+ L+E+ + P
Sbjct: 199 Y----DYKADIWSLGITLIEMAQIEPP 221
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 76/335 (22%), Positives = 123/335 (36%), Gaps = 100/335 (29%)
Query: 767 GKGVSGIVYR--------VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGSI-RH 816
G+G G V + +AVK L K+ + +E++ + I +H
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG---------- 866
KNI+ LLG C ++ +Y S G+L L ++ S +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 867 -----VAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919
+A G+ YL IHRD+ + N+LV +ADFGLA+ + + +
Sbjct: 161 SCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 214
Query: 920 SNSVAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEVLT-GKEP----TDSR 966
+ G + APE +L T +SDV+S+GV++ E+ T G P
Sbjct: 215 ----KTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 967 IPDGAHIITWVNGELRERKREFTTILDR------QL--LMRSGTQIQEMLQVLGVALLCV 1018
+ L+E R +D+ +L +MR C
Sbjct: 268 LFK----------LLKEGHR-----MDKPANCTNELYMMMRD----------------CW 296
Query: 1019 NPCPEERPTMKDVTAMLKEIRHEND-----DLEKP 1048
+ P +RPT K + L I DL +P
Sbjct: 297 HAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQP 331
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 73/321 (22%), Positives = 126/321 (39%), Gaps = 84/321 (26%)
Query: 767 GKGVSGIVYR------VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNI 819
G G G V ++ + +AVK L P + L ER+ +E++ L + H NI
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP--SAHLTEREALMSELKVLSYLGNHMNI 89
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG------------- 866
V LLG C G L++ +Y G L L K+ I+
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 867 ----VAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920
VA G+A+L + IHRD+ + NIL+ + DFGLA+ ++ +
Sbjct: 150 FSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 921 NSVAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGA 971
+ + APE S+ T +SDV+SYG+ L E+ + G P +P +
Sbjct: 205 GN-----ARLPVKWMAPE---SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-MPVDS 255
Query: 972 HIITWVNGELRERKREFTTILDR------QL--LMRSGTQIQEMLQVLGVALLCVNPCPE 1023
++E R + ++ +M++ C + P
Sbjct: 256 KFYK----MIKEGFR-----MLSPEHAPAEMYDIMKT----------------CWDADPL 290
Query: 1024 ERPTMKDVTAMLKEIRHENDD 1044
+RPT K + ++++ E+ +
Sbjct: 291 KRPTFKQIVQLIEKQISESTN 311
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 29/228 (12%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFS 805
Q+ ++D L + +G G G V+++ + VIAVK++ + E +
Sbjct: 18 QRYQAEIND----LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNK-EENKRIL 71
Query: 806 AEVQTL-GSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKII 864
++ + S IV+ G + + + + + + K+
Sbjct: 72 MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE-RILGKMT 130
Query: 865 LGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL-AKLFESSESSRASNSV 923
+ + L YL +IHRD+K +NIL+ + + L DFG+ +L +A +
Sbjct: 131 VAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRS 184
Query: 924 AGSYGYIAPE---------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
AG Y+APE Y ++DV+S G+ L+E+ TG+ P
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYD----IRADVWSLGISLVELATGQFP 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 749 LNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAE 807
+ DD L +G+G G+V ++ +PS Q++AVK++ N + E+ + +
Sbjct: 2 MEVKADD----LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMD 55
Query: 808 VQ-TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLL---HEKKVFLDWDSRYKI 863
+ ++ ++ V G + + + + SL +K + D KI
Sbjct: 56 LDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 864 ILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL-AKLFESSESSRASNS 922
+ + L +LH +IHRD+K +N+L+ + + DFG+ L A +
Sbjct: 115 AVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDI 168
Query: 923 VAGSYGYIAPE--------YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHII 974
AG Y+APE GYS+ KSD++S G+ ++E+ + P
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP----YDSWGTPF 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 74/328 (22%), Positives = 121/328 (36%), Gaps = 95/328 (28%)
Query: 767 GKGVSGIVYR--------VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGSI-RH 816
G+G G V + +AVK L K+ + +E++ + I +H
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG---------- 866
KNI+ LLG C ++ +Y S G+L L ++ S +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 867 -----VAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919
+A G+ YL IHRD+ + N+LV +ADFGLA+ + + +
Sbjct: 207 SCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 260
Query: 920 SNSVAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEVLT-GKEP----TDSR 966
+ G + APE +L T +SDV+S+GV++ E+ T G P
Sbjct: 261 ----KTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 967 IPDGAHIITWVNGELRERKREFTTILDR------QL--LMRSGTQIQEMLQVLGVALLCV 1018
+ L+E R +D+ +L +MR C
Sbjct: 314 LFK----------LLKEGHR-----MDKPANCTNELYMMMRD----------------CW 342
Query: 1019 NPCPEERPTMKDVTAMLKEIRHENDDLE 1046
+ P +RPT K + L I + E
Sbjct: 343 HAVPSQRPTFKQLVEDLDRILTLTTNEE 370
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 44/317 (13%), Positives = 84/317 (26%), Gaps = 68/317 (21%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH------- 816
++G+ + + V + + Q EV L +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 817 ---------KNIVRLLGCCNNGRTR-------------LLLFDYISNGSLAGLLHEKKVF 854
++V+ R R L + + +L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 855 ---LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911
L +R ++ L V LA LHH ++H ++ +I++ + FL F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 912 ESSESSRASNSVAGSYGYIAPEYGYSLK-----ITEKSDVYSYGVVLLEVLTGKEPTDSR 966
+S S A + +T D ++ G+ + + P
Sbjct: 262 GASAVSP-IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 967 IPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP 1026
G W+ + + R LL L E+R
Sbjct: 321 AALG--GSEWIFRSCKNIPQPV-----RALLEG---------------FLRYP--KEDRL 356
Query: 1027 TMKDV--TAMLKEIRHE 1041
T +++R E
Sbjct: 357 LPLQAMETPEYEQLRTE 373
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 68/322 (21%), Positives = 116/322 (36%), Gaps = 44/322 (13%)
Query: 334 ELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGN 393
E + I F+ + L T +L + A + + +
Sbjct: 6 ETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-S 60
Query: 394 IPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIR 453
+ + Y + L L+ N LT L NLKNL L L N+ ++
Sbjct: 61 VQGIQYLPNVTKLFLNGNKLT--DIKPLANLKNLGWLFLDENKVK-DLSS---------- 107
Query: 454 LRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTI 513
+ L +L L L N + +I + + QLE + L NK+ T
Sbjct: 108 ---------------LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TD 148
Query: 514 PSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQL 573
+ L L L+ L L N I + L LT L L LSKN+I+ L ++L K+L +
Sbjct: 149 ITVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDV 204
Query: 574 LDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGS 633
L+L S + + I L + + + PE S+ ++ ++ +
Sbjct: 205 LELFSQEC---LNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 261
Query: 634 LKVLGSLDNLVSLNVSYNHFSG 655
+V V++ + F G
Sbjct: 262 NEVSFIFYQPVTIGKAKARFHG 283
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 49/213 (23%), Positives = 79/213 (37%), Gaps = 16/213 (7%)
Query: 447 GCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQ 506
I+ L + + L+ + + + + + I + + L+
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 507 NKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLG 566
NKL L L L L L N + +L L L L L N I+ + L
Sbjct: 78 NKLTDI--KPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGISDING--LV 131
Query: 567 LCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLS 626
L+ L L +N+I + + RL LD L +L N ++ + L+KL NL LS
Sbjct: 132 HLPQLESLYLGNNKI--TDITVLSRLTKLDTL-SLEDNQISDI--VPLAGLTKLQNLYLS 186
Query: 627 NNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPN 659
N ++ L+ L L NL L + N
Sbjct: 187 KNHIS-DLRALAGLKNLDVLELFSQECLNKPIN 218
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 52/239 (21%), Positives = 93/239 (38%), Gaps = 15/239 (6%)
Query: 326 LANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFA 385
+ L +++ + + + Q+ +N+ + I L + F
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFL 75
Query: 386 WQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI 445
N+L +I LA L L L N + SSL +LK L L L N S +I +
Sbjct: 76 NGNKLT-DIKPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGIS-DING-L 130
Query: 446 GGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLH 505
L L LG+N + + + L +L L L +NQ + +I P + T+L+ + L
Sbjct: 131 VHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLS 186
Query: 506 QNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKS 564
+N + + +L L L+VL+L + L N + + ++ S
Sbjct: 187 KNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 15/232 (6%)
Query: 204 EEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENL 263
+ L ++ + EL ++ + ++I + I + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKL 73
Query: 264 FLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVP 323
FL N++ I L +LKNL L L +N + + +L + L + + N +
Sbjct: 74 FLNGNKL-TDIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI--SDI 127
Query: 324 VSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLF 383
L +L LE L L N I+ + ++L L L++N+ I P + L +L
Sbjct: 128 NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 183
Query: 384 FAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISN 435
+ +N + ++ LA L L+L + NL +
Sbjct: 184 YLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 40/191 (20%), Positives = 69/191 (36%), Gaps = 36/191 (18%)
Query: 472 LHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMN 531
L + T + ++ + + + + +++L + L L+ N
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGN 78
Query: 532 SIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGR 591
+ T + L L +L L L +N + L L K L+ L L N I+
Sbjct: 79 KL--TDIKPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS--------- 125
Query: 592 LQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYN 651
DI +L +L +L L NN +T + VL L L +L++ N
Sbjct: 126 ----DI--------------NGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDN 166
Query: 652 HFSGILPNTKL 662
S I+P L
Sbjct: 167 QISDIVPLAGL 177
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 58/286 (20%), Positives = 109/286 (38%), Gaps = 20/286 (6%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSL 144
+F+ L ++T + L+S+ + + + + ++ + I L + L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 145 NSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPE 204
N N + P + N L L L +N++ ++ + + L+ L+ + N GI
Sbjct: 76 NGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHN-GI--SDIN 128
Query: 205 EISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLF 264
+ + L L L + I+ + LT L TLS+ I+ +P + + L+NL+
Sbjct: 129 GLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184
Query: 265 LYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPV 324
L +N I L LKNL L L+ N + + SL +
Sbjct: 185 LSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 242
Query: 325 SLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQI 370
S + + E+ SF F + + RF G++
Sbjct: 243 SDDGDYEKPNVKWHLPEFTNEV-SF--IFYQPVTIGKAKARFHGRV 285
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 18/118 (15%), Positives = 35/118 (29%), Gaps = 30/118 (25%)
Query: 539 ENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL 598
+ K L K ++T + + + +++ I +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-------------SV- 61
Query: 599 LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGI 656
+ L + L L+ N LT +K L +L NL L + N +
Sbjct: 62 -------------QGIQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFLDENKVKDL 105
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 48/257 (18%), Positives = 92/257 (35%), Gaps = 21/257 (8%)
Query: 404 QALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFS 462
+ + +T +PS L +N +L + + I G L ++ + N+
Sbjct: 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67
Query: 463 GHIPSRI-GLLHRLTFLELSE-NQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPS-SLE 518
I + + L +L + + + N I PE N L+ + + ++ +P
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125
Query: 519 FLFGLNVLDLSMNSIGGTIPEN-LGKLTS-LNKLVLSKNNITGLIPKSLGLCKDLQLLDL 576
+LD+ N TI N L+ L L+KN I + + + +L
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 577 SSNRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSL 634
+N + +P ++ G L++S + NL KL N L
Sbjct: 186 DNNNLE-ELPNDV--FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKL 239
Query: 635 KVLGSLDNLVSLNVSYN 651
L L L+ +++Y
Sbjct: 240 PTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 5e-18
Identities = 59/293 (20%), Positives = 92/293 (31%), Gaps = 49/293 (16%)
Query: 299 PEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSF-FGNFSRLK 357
+ +CS+ + + E+P L EL + I F F L+
Sbjct: 3 HHRICHCSNRVF-LCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLE 57
Query: 358 QLELDNNRFFGQIPPTI----GQLKELLLFFAWQNQLHGNIPE--LAYCVKLQALDLSHN 411
++E+ N I + +L E+ + A N L I LQ L +S+
Sbjct: 58 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKA--NNLL-YINPEAFQNLPNLQYLLISNT 114
Query: 412 FLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRI-- 469
+ +P + Q + L + N I
Sbjct: 115 GIK-HLPDVHKI--HSLQKV---------------------LLDIQDNINIHTIERNSFV 150
Query: 470 GLLHRLTFLELSENQFTGEIPPEIGNCTQL-EMVDLHQNKLQGTIPSSLEFLFGLNVLDL 528
GL L L++N EI N TQL E+ N L+ G +LD+
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 529 SMNSIGGTIPENLGKLTSLNKL-VLSKNNITGLIPKSLGLCKDLQLLDLSSNR 580
S I ++P L +L KL S N+ L L L L+
Sbjct: 210 SRTRI-HSLPSYG--LENLKKLRARSTYNLKKLPT--LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 46/254 (18%), Positives = 78/254 (30%), Gaps = 16/254 (6%)
Query: 118 LDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNI 177
+ +T IP ++ L + L ++E+ N + I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 178 PAEI-GQLEALEIIRAGGNPGIHGEIPEEI-SNCKVLVFLGLADTGISGQIPRSV-GELT 234
A++ L L IR + I E N L +L +++TGI +P
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSL 128
Query: 235 NLRTLSVYTANITGYIPEEI--GNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQN 292
L + I G L+L +N I +I + + L L L N
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDN 187
Query: 293 NLSGSIPE-ALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFG 351
N +P S ++D+S + L NL L ++P+
Sbjct: 188 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLE- 243
Query: 352 NFSRLKQLELDNNR 365
L + L
Sbjct: 244 KLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 30/148 (20%), Positives = 52/148 (35%), Gaps = 8/148 (5%)
Query: 524 NVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRING 583
V + + IP +L + +L + + + DL+ +++S N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 584 SIPEEI-GRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSL--KVLGSL 640
I ++ L L + N L PE+F NL L L +SN + L
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 641 DNLVSLNVSYNHFSGILPNTKLFHGLPA 668
V L++ N + F GL
Sbjct: 128 LQKVLLDIQDNINIHTIER-NSFVGLSF 154
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 47/252 (18%), Positives = 80/252 (31%), Gaps = 42/252 (16%)
Query: 72 ITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLS-FNALTGNI 129
+ I +F F L + +S ++ I NL L + + N L I
Sbjct: 42 LRVIQ-KGAFS----GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YI 95
Query: 130 PEEI-GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEIGQLEAL 187
E L L+ L +++ I +P + + L++ DN I L
Sbjct: 96 NPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER--NSFVGL 152
Query: 188 EIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANIT 247
V L L GI +I S T L L++ N
Sbjct: 153 ---------------------SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNL 190
Query: 248 GYIPEEI-GNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNC 305
+P ++ S L + +I +P L +LK L+ + +P L
Sbjct: 191 EELPNDVFHGASGPVILDISRTRI-HSLPSYGLENLKKLRARSTYNLK---KLP-TLEKL 245
Query: 306 SSLTVIDVSLNS 317
+L ++ S
Sbjct: 246 VALMEASLTYPS 257
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 59/237 (24%), Positives = 91/237 (38%), Gaps = 57/237 (24%)
Query: 767 GKGVSGIVYR------VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGSIRHKNI 819
G+G G V + +AVK L K E +E L + H ++
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG------------- 866
++L G C+ LL+ +Y GSL G L E +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 867 ----------VAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914
++ G+ YL ++HRD+ + NILV + ++DFGL++
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 915 ESSRASNSVAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEVLT-GKEP 962
+S S G I A E SL T +SDV+S+GV+L E++T G P
Sbjct: 204 DSYV-----KRSQGRIPVKWMAIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 76/328 (23%), Positives = 120/328 (36%), Gaps = 95/328 (28%)
Query: 767 GKGVSGIVYR--------VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGSI-RH 816
G+G G V + +AVK L K+ + +E++ + I +H
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMIGKH 134
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSLAG-LLHEKKVFLDWDSRYKIILG--------- 866
KNI+ LLG C ++ +Y S G+L L + L++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 867 -----VAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919
VA G+ YL IHRD+ + N+LV +ADFGLA+ + +
Sbjct: 195 SCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK- 248
Query: 920 SNSVAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEVLT-GKEP----TDSR 966
+ G + APE +L T +SDV+S+GV+L E+ T G P
Sbjct: 249 ----KTTNGRLPVKWMAPE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 967 IPDGAHIITWVNGELRERKREFTTILDR------QL--LMRSGTQIQEMLQVLGVALLCV 1018
+ L+E R +D+ +L +MR C
Sbjct: 302 LFK----------LLKEGHR-----MDKPSNCTNELYMMMRD----------------CW 330
Query: 1019 NPCPEERPTMKDVTAMLKEIRHENDDLE 1046
+ P +RPT K + L I + E
Sbjct: 331 HAVPSQRPTFKQLVEDLDRIVALTSNQE 358
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 71/335 (21%), Positives = 122/335 (36%), Gaps = 91/335 (27%)
Query: 759 RLSDTNIVGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTL 811
L ++G G G V + +AVK L K + ER+ +E++ +
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMM 102
Query: 812 GSI-RHKNIVRLLGCCNNGRTRLLLFDYISNGSL--------------AGLLHEKKVFLD 856
+ H+NIV LLG C L+F+Y G L +K +
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 857 WDSRYKIILG--------VAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFG 906
+ + VA G+ +L +HRD+ + N+LV + DFG
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFG 217
Query: 907 LAKLFESSESSRASNSVAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEVLT 958
LA+ S + + + APE SL T KSDV+SYG++L E+ +
Sbjct: 218 LARDIMSDSNYVVRGN-----ARLPVKWMAPE---SLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 959 -GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR--------QLLMRSGTQIQEMLQ 1009
G P IP A+ ++ + +D+ ++M+S
Sbjct: 270 LGVNPYPG-IPVDANFYK----LIQNGFK-----MDQPFYATEEIYIIMQS--------- 310
Query: 1010 VLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDD 1044
C +RP+ ++T+ L + ++
Sbjct: 311 -------CWAFDSRKRPSFPNLTSFLGCQLADAEE 338
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 73/331 (22%), Positives = 118/331 (35%), Gaps = 85/331 (25%)
Query: 759 RLSDTNIVGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTL 811
RL +G+G G V + + + +AVK L K G E +E++ L
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKIL 84
Query: 812 GSI-RHKNIVRLLGCC-NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILG--- 866
I H N+V LLG C G +++ ++ G+L+ L K+ L
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 867 ------------VAHGLAYL--HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFE 912
VA G+ +L IHRD+ + NIL+ + + DFGLA+
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 913 SSESSRASNSVAGSYGYI-----APEYGYSL---KITEKSDVYSYGVVLLEVLT-GKEPT 963
+ APE ++ T +SDV+S+GV+L E+ + G P
Sbjct: 200 KDPDYV-----RKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 964 DSRIPDGAHIITWVNGELRERKREFTTILDR------QL--LMRSGTQIQEMLQVLGVAL 1015
P G I L+E R + ++ M
Sbjct: 252 ----P-GVKIDEEFCRRLKEGTR-----MRAPDYTTPEMYQTMLD--------------- 286
Query: 1016 LCVNPCPEERPTMKDVTAMLKEIRHENDDLE 1046
C + P +RPT ++ L + N +
Sbjct: 287 -CWHGEPSQRPTFSELVEHLGNLLQANAQQD 316
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 56/293 (19%), Positives = 104/293 (35%), Gaps = 40/293 (13%)
Query: 767 GKGVSGIVYRVEIPSRQVIAVKKL--------------WPVKNGELPERDQFSAEVQTLG 812
+G + E ++ A+KK K + D F E+Q +
Sbjct: 40 NQGKFNKIILCEKDNKFY-ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 813 SIRHKNIVRLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY-------KII 864
I+++ + G N + ++++Y+ N S+ V + + II
Sbjct: 99 DIKNEYCLTCEGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 865 LGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA 924
V + +Y+H++ I HRD+K +NIL+ L+DFG ++ +
Sbjct: 158 KSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSR 211
Query: 925 GSYGYIAPE--YGYSLKITEKSDVYSYGVVLLEVLTGKEP--TDSRIPDGAHIITWVNGE 980
G+Y ++ PE S K D++S G+ L + P + + + I
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI--RTKN 269
Query: 981 LR--ERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ + F L + S + L N P ER T +D
Sbjct: 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN--PAERITSEDA 320
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 31/185 (16%), Positives = 66/185 (35%), Gaps = 10/185 (5%)
Query: 472 LHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMN 531
L ++ L + L + T + +E+ + L ++
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNI 76
Query: 532 SIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGR 591
T + L++L +L + ++T +L L LLD+S + + SI +I
Sbjct: 77 HA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 592 LQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYN 651
L ++ + +LS+N I L +L +L++ + + + + L L
Sbjct: 135 LPKVNSI-DLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQ 191
Query: 652 HFSGI 656
G
Sbjct: 192 TIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 27/162 (16%), Positives = 60/162 (37%), Gaps = 5/162 (3%)
Query: 497 TQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNN 556
+ + T + + L + L+ ++ T + ++ L ++ +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIH 77
Query: 557 ITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSN 616
T P + +L+ L + + + L L +L ++S +A I +
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL-DISHSAHDDSILTKINT 134
Query: 617 LSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILP 658
L K+ ++DLS N + L +L L SLN+ ++
Sbjct: 135 LPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 39/230 (16%), Positives = 75/230 (32%), Gaps = 35/230 (15%)
Query: 331 ALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQL 390
A E+ L + + IP F L + T Q+ L +
Sbjct: 2 AAEQTGLKASQDNVNIPD--STFKAYLNGLLGQSST---ANITEAQMNSLTYITLANINV 56
Query: 391 HGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTG 450
++ + Y ++ L +++ T + + L NL +L ++ + + P + G
Sbjct: 57 T-DLTGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSG--- 110
Query: 451 LIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQ 510
L LT L++S + I +I ++ +DL N
Sbjct: 111 ---------------------LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
Query: 511 GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGL 560
I L+ L L L++ + + + LN+L I G
Sbjct: 150 TDI-MPLKTLPELKSLNIQFDGV--HDYRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 34/211 (16%), Positives = 64/211 (30%), Gaps = 32/211 (15%)
Query: 422 FNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELS 481
L S L + L + N + + I H + L ++
Sbjct: 17 IPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTIN 74
Query: 482 ENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL 541
T P I + LE + + + +L L L +LD+S ++ +I +
Sbjct: 75 NIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 542 GKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNL 601
L +N + LS N I L +L+ L++ + ++ D
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-------------DY---- 174
Query: 602 SWNALTGPIPESFSNLSKLANLDLSNNMLTG 632
+ KL L + + G
Sbjct: 175 ----------RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 27/183 (14%), Positives = 66/183 (36%), Gaps = 9/183 (4%)
Query: 261 ENLFLYENQIFGKIPDE---LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNS 317
Y N + G+ + +L + L N++ + + ++ + ++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77
Query: 318 LGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQL 377
P ++ L LE L + G +++ + + L L++ ++ I I L
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 378 KELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRF 437
++ N +I L +L++L++ + + + + L QL S
Sbjct: 136 PKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTI 193
Query: 438 SGE 440
G+
Sbjct: 194 GGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 38/253 (15%), Positives = 76/253 (30%), Gaps = 59/253 (23%)
Query: 259 ALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSL 318
A E L +Q IPD + K LL Q++ +
Sbjct: 2 AAEQTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTA----------------------- 36
Query: 319 GGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLK 378
++ A + +L + L+ N++ ++ + +K L ++N
Sbjct: 37 ----NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA------------ 78
Query: 379 ELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFS 438
N ++ L+ L + +T +L L +LT L + +
Sbjct: 79 -------------TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 439 GEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQ 498
I +I + + L N I + L L L + + I + +
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPK 182
Query: 499 LEMVDLHQNKLQG 511
L + + G
Sbjct: 183 LNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 29/229 (12%), Positives = 67/229 (29%), Gaps = 37/229 (16%)
Query: 117 NLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGN 176
L + NIP+ L +S + L + L + ++ +
Sbjct: 5 QTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-D 58
Query: 177 IPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNL 236
+ I + L + + + P + L+NL
Sbjct: 59 L--------------------------TGIEYAHNIKDLTINNIHATNYNP--ISGLSNL 90
Query: 237 RTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSG 296
L + ++T + ++L L + + I ++ +L + + L N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGE 345
I L L +++ + + + + L +L I G+
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 7e-16
Identities = 30/161 (18%), Positives = 59/161 (36%), Gaps = 8/161 (4%)
Query: 88 FSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSN 147
+ LT + L+N N+T ++ I ++ +L ++ T N I L+ LE L +
Sbjct: 43 MNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGK 98
Query: 148 SIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEIS 207
+ + + L L++ + +I +I L + I N I +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI--TDIMPLK 156
Query: 208 NCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITG 248
L L + G+ + + L L ++ I G
Sbjct: 157 TLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 23/112 (20%), Positives = 47/112 (41%), Gaps = 3/112 (2%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSL 144
+ S+L L + ++T + P + L+SL LD+S +A +I +I L ++ + L
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 145 NSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNP 196
+ N I + +L+ L + + + + I L + A
Sbjct: 144 SYNGAITDIM-PLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQT 192
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 45/312 (14%), Positives = 84/312 (26%), Gaps = 79/312 (25%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-------- 815
++G+ + + + V + + Q EV L +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 816 -----------------HKNIVRLLGCCNNGRTRLLLFDY----ISNGSLAGLLHEKKV- 853
K ++R+ + F Y + + +L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 854 --FLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911
L +R ++ L V LA LHH ++H ++ +I++ + FL F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 912 ESSESSRASNSVAGSYGYIAPEY-----------GYSLKITEKSDVYSYGVVLLEVLTGK 960
+ S S G+ PE +T D ++ G+V+ +
Sbjct: 257 GARVVSS------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 961 EP-TDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVN 1019
P T G+ I + + R LL L
Sbjct: 311 LPITKDAALGGSEWI-------FRSCKNIPQPV-RALLEG---------------FLRYP 347
Query: 1020 PCPEERPTMKDV 1031
E+R
Sbjct: 348 --KEDRLLPLQA 357
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 42/229 (18%), Positives = 80/229 (34%), Gaps = 49/229 (21%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSI-RHKNIVR 821
+G G G V++ + + A+K+ K D+ +A EV + +H ++VR
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKR---SKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 822 LLGCCNNGRTRLLLF-DYISNGSLAGLLHEKKV---FLDWDSRYKIILGVAHGLAYLHHD 877
+L+ +Y + GSLA + E + ++L V GL Y+H
Sbjct: 76 YFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 878 CVPPIIHRDIKSNNILVGPQFEAF-------------------LADFGLAKLFESSESSR 918
++H DIK +NI + + D G S
Sbjct: 135 ---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS----- 186
Query: 919 ASNSVAGSYGYIAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
G ++A E Y + K+D+++ + ++ +
Sbjct: 187 -PQVEEGDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL 230
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
++ D +VG G G VY+ + + Q+ A+K + + E ++ E+
Sbjct: 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTGDEEEEIKQEINM 73
Query: 811 LGSI-RHKNIVRLLGC-----CNNGRTRL-LLFDYISNGSLAGLLHEKKV-FLDWDSRYK 862
L H+NI G +L L+ ++ GS+ L+ K L +
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 863 IILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922
I + GL++LH V IHRDIK N+L+ E L DFG++ + + R N+
Sbjct: 134 ICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NT 188
Query: 923 VAGSYGYIAPE---------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
G+ ++APE Y KSD++S G+ +E+ G P
Sbjct: 189 FIGTPYWMAPEVIACDENPDATY----DFKSDLWSLGITAIEMAEGAPP 233
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 65/283 (22%), Positives = 112/283 (39%), Gaps = 51/283 (18%)
Query: 764 NIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+G G G V + + A+K + + + EV L + H NI++L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKII-RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ R L+ + G L + + F + D+ II V G+ YLH I
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-VIIKQVLSGVTYLHKHN---I 157
Query: 883 IHRDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAGSYGYIAPE-----Y 934
+HRD+K N+L+ + + + DFGL+ +FE+ + + G+ YIAPE Y
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPEVLRKKY 214
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRIPDGAHIITWVNGELRERKREFTT 990
EK DV+S GV+L +L G P TD I + G+ E+
Sbjct: 215 D------EKCDVWSIGVILFILLAGYPPFGGQTDQEILR--KVE---KGKYTFDSPEWKN 263
Query: 991 ILD--RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ + + L+ + +L + + R + +
Sbjct: 264 VSEGAKDLIKQ---------------MLQFD--SQRRISAQQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 50/283 (17%)
Query: 764 NIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
++GKG G V + + Q AVK + + + +++ EVQ L + H NI++L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ L+ + + G L + +K F + D+ +II V G+ Y+H + I
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-RIIRQVLSGITYMHKNK---I 147
Query: 883 IHRDIKSNNILV---GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-----Y 934
+HRD+K N+L+ + DFGL+ FE+S+ + G+ YIAPE Y
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHGTY 204
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRIPDGAHIITWVNGELRERKREFTT 990
EK DV+S GV+L +L+G P + I + G+ ++
Sbjct: 205 D------EKCDVWSTGVILYILLSGCPPFNGANEYDILK--KVE---KGKYTFELPQWKK 253
Query: 991 ILD--RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ + + L+ + +L P R + +D
Sbjct: 254 VSESAKDLIRK---------------MLTYV--PSMRISARDA 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 3e-22
Identities = 54/212 (25%), Positives = 85/212 (40%), Gaps = 20/212 (9%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL-- 823
G G G V R + + + +A+K+ + + ER + E+Q + + H N+V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER--WCLEIQIMKKLNHPNVVSAREV 80
Query: 824 ----GCCNNGRTRLLLFDYISNGSLAGLL--HEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
LL +Y G L L E L ++ ++ L YLH +
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 878 CVPPIIHRDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAGSYGYIAPEY 934
IIHRD+K NI++ P + + D G AK + E G+ Y+APE
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPEL 194
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966
K T D +S+G + E +TG P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 59/302 (19%), Positives = 108/302 (35%), Gaps = 68/302 (22%)
Query: 685 HINNSLHGRNSTKNLIICALLSVTVTLFIVLFGIILFIRFRGTTFRENDEEENELEWDFT 744
+N L G+ + L + ++++++ V F T + L ++
Sbjct: 86 FVNTELVGKGKRRPLNNNSEIALSLSRNKV-------FVFFDLTVDDQSVYPKALRDEYI 138
Query: 745 PFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVK-----KLWPVKNGEL 798
+ L G G G V E + + +A++ K E
Sbjct: 139 MSKTL-----------------GSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREA 181
Query: 799 PERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL--------LFDYISNGSLAGLLHE 850
E++ L + H I+++ + ++ LFD + L E
Sbjct: 182 DPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG---NKRLKE 238
Query: 851 KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF---LADFGL 907
+ + + YLH + IIHRD+K N+L+ Q E + DFG
Sbjct: 239 A------TCK-LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 288
Query: 908 AKLFESSESSRASNSVAGSYGYIAPE-------YGYSLKITEKSDVYSYGVVLLEVLTGK 960
+K+ + R ++ G+ Y+APE GY+ + D +S GV+L L+G
Sbjct: 289 SKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGY 341
Query: 961 EP 962
P
Sbjct: 342 PP 343
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 44/269 (16%), Positives = 86/269 (31%), Gaps = 19/269 (7%)
Query: 387 QNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIG 446
++ + +L +T S L + ++ + +
Sbjct: 6 PTPIN-QVFPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAG-MQ 60
Query: 447 GCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQ 506
T L L L N S + + L +L L ++ N+ + L + L
Sbjct: 61 FFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDN 115
Query: 507 NKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLG 566
N+L SL L L +L + N + LG L+ L L L N IT L
Sbjct: 116 NEL--RDTDSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITNTGG--LT 169
Query: 567 LCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLS 626
K + +DL+ + + L + + + ++ P SN + +
Sbjct: 170 RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVL 226
Query: 627 NNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
+ + +V +++ + F G
Sbjct: 227 WELPVYTDEVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 40/171 (23%), Positives = 69/171 (40%), Gaps = 15/171 (8%)
Query: 493 IGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVL 552
+L + + T S + L G+ + ++I + T+L +L L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHL 70
Query: 553 SKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL-LNLSWNALTGPIP 611
S N I+ L P L L+ L ++ NR+ + + + + L L N L
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRDT-- 121
Query: 612 ESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKL 662
+S +L L L + NN L S+ +LG L L L++ N + T+L
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEITNTGGLTRL 171
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 43/233 (18%), Positives = 76/233 (32%), Gaps = 38/233 (16%)
Query: 204 EEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENL 263
V L ++ + EL+ ++ + +NI + + L+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKEL 68
Query: 264 FLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVP 323
L NQI + L L L+ L + +N L ++ + + L+ + + N L
Sbjct: 69 HLSHNQI-SDLSP-LKDLTKLEELSVNRNRLK-NL-NGIPSAC-LSRLFLDNNEL--RDT 121
Query: 324 VSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLF 383
SL +L LE L + N + I G S+L+ L+L N +I
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGN----EI------------- 162
Query: 384 FAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNR 436
N L K+ +DL+ L + R
Sbjct: 163 --------TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGR 207
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 46/235 (19%), Positives = 78/235 (33%), Gaps = 40/235 (17%)
Query: 131 EEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEII 190
LA +L S+ + S ++ ++ + ++
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL------------- 56
Query: 191 RAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYI 250
+ L L L+ IS + + +LT L LSV +
Sbjct: 57 -------------AGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK--N 99
Query: 251 PEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTV 310
I + L LFL N++ + D L LKNL+ L + N L SI LG S L V
Sbjct: 100 LNGIPSAC-LSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEV 154
Query: 311 IDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR 365
+D+ N + L L + + L+G E + ++ + R
Sbjct: 155 LDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGR 207
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 47/287 (16%), Positives = 89/287 (31%), Gaps = 45/287 (15%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSL 144
++ L ++T + LS + N + + + ++ + L+ L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70
Query: 145 NSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPE 204
+ N I P + + +KL L + N+L L +
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLK--------NLNGIP---------------- 104
Query: 205 EISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLF 264
L L L + + S+ L NL LS+ + +G S LE L
Sbjct: 105 ----SACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLD 156
Query: 265 LYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEV-P 323
L+ N+I L LK + + L E + L + + + G + P
Sbjct: 157 LHGNEI--TNTGGLTRLKKVNWIDLTGQKCV---NEPVKYQPELYITNTVKDPDGRWISP 211
Query: 324 VSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQI 370
++N + + + FS + F G +
Sbjct: 212 YYISNGGSYVDGCVLWELPV-YTDEVSYKFSEYINVGETEAIFDGTV 257
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-22
Identities = 69/221 (31%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 751 FSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQ-FSAEV 808
F DD SD +G G G VY ++ + +V+A+KK+ + E+ Q EV
Sbjct: 47 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEV 105
Query: 809 QTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA 868
+ L +RH N ++ GC T L+ +Y GS + LL K L + G
Sbjct: 106 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGAL 164
Query: 869 HGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG 928
GLAYLH +IHRD+K+ NIL+ L DFG A S + NS G+
Sbjct: 165 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPA--NSFVGTPY 215
Query: 929 YIAPE-------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
++APE Y K DV+S G+ +E+ K P
Sbjct: 216 WMAPEVILAMDEGQY----DGKVDVWSLGITCIELAERKPP 252
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 68/334 (20%), Positives = 117/334 (35%), Gaps = 70/334 (20%)
Query: 732 NDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNI---------VGKGVSGIVYRV-EIPS 781
+ + + FQ + + V + + I +G G G V E
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRK-KEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 782 RQVIAVK----------KLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831
A+K + ++ E+ L S+ H NI++L + +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNN 891
L+ ++ G L + + F + D+ I+ + G+ YLH I+HRDIK N
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAA-NIMKQILSGICYLHKHN---IVHRDIKPEN 176
Query: 892 ILV---GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-----YGYSLKITEK 943
IL+ + DFGL+ F G+ YIAPE Y EK
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKKKYN------EK 227
Query: 944 SDVYSYGVVLLEVLTGKEP----TDSRIPDGAHIITWVNGELRERKREFTTILD--RQLL 997
DV+S GV++ +L G P D I + G+ ++ I D ++L+
Sbjct: 228 CDVWSCGVIMYILLCGYPPFGGQNDQDIIK--KVE---KGKYYFDFNDWKNISDEAKELI 282
Query: 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+L + +R T ++
Sbjct: 283 KL---------------MLTYD--YNKRCTAEEA 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-22
Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 51/283 (18%)
Query: 764 NIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
++GKG G V + + ++Q AVK + + + + EV+ L + H NI++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ + ++ + + G L + ++K F + D+ +II V G+ Y+H I
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-RIIKQVFSGITYMHKHN---I 142
Query: 883 IHRDIKSNNILV---GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-----Y 934
+HRD+K NIL+ + + DFGL+ F+ + G+ YIAPE Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGTY 199
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRIPDGAHIITWVNGELRERKREFTT 990
EK DV+S GV+L +L+G P + I + G+ ++ T
Sbjct: 200 D------EKCDVWSAGVILYILLSGTPPFYGKNEYDILK--RVE---TGKYAFDLPQWRT 248
Query: 991 ILD--RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
I D + L+ + +L + P R T
Sbjct: 249 ISDDAKDLIRK---------------MLTFH--PSLRITATQC 274
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-22
Identities = 70/426 (16%), Positives = 134/426 (31%), Gaps = 87/426 (20%)
Query: 278 LGSLKNLKRLLLWQNNLS----GSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVA-- 331
L L+ + + L L+ I AL +L +++ N LG + +
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 332 ---LEELLLSGNNISGE----IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFF 384
+++L L ++G + S L++L L +N +G LL
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL--------LGDAGLQLLCE 135
Query: 385 AWQNQLHGNIPELAYCVKLQALDLSHNFLT----GSVPSSLFNLKNLTQLLLISNRFSGE 440
+ +L+ L L + L+ + S L + +L + +N +
Sbjct: 136 GLLDP----------QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA 185
Query: 441 IPPEIGGC-----TGLIRLRLGSNNFS----GHIPSRIGLLHRLTFLELSENQFTGE--- 488
+ L L+L S + + + L L L N+
Sbjct: 186 GVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245
Query: 489 --IPPEIGNCTQLEMVDLHQNKLQ----GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLG 542
P + ++L + + + + G + L L L L+ N +G L
Sbjct: 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 305
Query: 543 KL-----TSLNKLVLSKNNITGL----IPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQ 593
+ L L + + T L + L L +S+NR+ +
Sbjct: 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA--------- 356
Query: 594 GLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGS-----LKVLGSLDNLVSLNV 648
G+ L L S L L L++ ++ S L + +L L++
Sbjct: 357 GVREL----CQGLG-------QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 405
Query: 649 SYNHFS 654
S N
Sbjct: 406 SNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-18
Identities = 76/452 (16%), Positives = 143/452 (31%), Gaps = 91/452 (20%)
Query: 233 LTNLRTLSVYTANIT----GYIPEEIGNCSALENLFLYENQI----FGKIPDELGSLK-N 283
L + + + +T I + AL L L N++ + L +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 284 LKRLLLWQNNLS----GSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLV-----ALEE 334
+++L L L+ G + L +L + +S N LG L + LE+
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 335 LLLSGNNISGE----IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQL 390
L L ++S + S K+L + NN + L + L +
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI---NEAGVRVLCQGLK----DSPC 199
Query: 391 HGNIPELAYCVKLQALDLSHNFLT----GSVPSSLFNLKNLTQLLLISNRFSGE-----I 441
+L+AL L +T + + + +L +L L SN+
Sbjct: 200 -----------QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELC 248
Query: 442 PPEIGGCTGLIRLRLGSNNFS----GHIPSRIGLLHRLTFLELSENQFTGEIPPEIG--- 494
P + + L L + + G + + L L L+ N+ E +
Sbjct: 249 PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETL 308
Query: 495 --NCTQLEMVDLHQNKLQGT----IPSSLEFLFGLNVLDLSMNSIGGTIPENLGKL---- 544
QLE + + S L L L +S N + L +
Sbjct: 309 LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP 368
Query: 545 -TSLNKLVLSKNNIT----GLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILL 599
+ L L L+ +++ + +L L+ LDLS+N + + G+ L+
Sbjct: 369 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA---------GILQLV 419
Query: 600 NLSWNALTGPIPESFSNLSKLANLDLSNNMLT 631
++ L L L + +
Sbjct: 420 ----ESVR-------QPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 83/521 (15%), Positives = 151/521 (28%), Gaps = 134/521 (25%)
Query: 113 SSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQ 172
+ +LD+ E+ ELL L + + L D
Sbjct: 3 LDIQSLDIQCE--------ELSDARWAELLPLLQQ---------------CQVVRLDDCG 39
Query: 173 LSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGE 232
+ + +I A + L L L + V +
Sbjct: 40 --------LTEARCKDISSA-------------LRVNPALAELNLRSNELGDVGVHCVLQ 78
Query: 233 L-----TNLRTLSVYTANIT----GYIPEEIGNCSALENLFLYENQIFGKIPDELGSL-- 281
++ LS+ +T G + + L+ L L +N + L
Sbjct: 79 GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL 138
Query: 282 ---KNLKRLLLWQNNLS----GSIPEALGNCSSLTVIDVSLNSLGGEVPVSLA-----NL 329
L++L L +LS + L + VS N + L +
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198
Query: 330 VALEELLLSGNNISGE----IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQ--LKELLLF 383
LE L L ++ + + + + L++L L +N+ +G + EL
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK--------LGDVGMAELC-- 248
Query: 384 FAWQNQLHGNIPELAYCVKLQALDLSHNFLT----GSVPSSLFNLKNLTQLLLISNRFSG 439
LH + +L+ L + +T G + L ++L +L L N
Sbjct: 249 ---PGLLHPSS-------RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 298
Query: 440 EIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGE----IPPEIGN 495
E G L L +L L + FT +
Sbjct: 299 E------GARLLCETLLEPGC-------------QLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 496 CTQLEMVDLHQNKLQGTIPSSL-----EFLFGLNVLDLSMNSIG----GTIPENLGKLTS 546
L + + N+L+ L + L VL L+ + ++ L S
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399
Query: 547 LNKLVLSKNNITG----LIPKSLGLCK-DLQLLDLSSNRIN 582
L +L LS N + + +S+ L+ L L +
Sbjct: 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-12
Identities = 55/296 (18%), Positives = 95/296 (32%), Gaps = 47/296 (15%)
Query: 403 LQALDLSHNFLT-GSVPSSLFNLKNLTQLLLISNRFSGE----IPPEIGGCTGLIRLRLG 457
+Q+LD+ L+ L L+ + L + I + L L L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 458 SNNFSGHIPSRI--GLLH---RLTFLELSENQFTGE----IPPEIGNCTQLEMVDLHQNK 508
SN + GL ++ L L TG + + L+ + L N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 509 LQGTIPSSLEFLFG--------LNVLDLSMNSIGGTIPENLGKL----TSLNKLVLSKNN 556
L + L+ L L L L S+ E L + +L +S N+
Sbjct: 125 LG---DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 557 ITG----LIPKSLGLCKD-LQLLDLSSNRINGSIPEEIGR-LQGLDIL--LNLSWNALTG 608
I ++ + L L+ L L S + ++ + L L L N L
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241
Query: 609 P-----IPESFSNLSKLANLDLSNNMLTGS-----LKVLGSLDNLVSLNVSYNHFS 654
P S+L L + +T +VL + ++L L+++ N
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-10
Identities = 50/323 (15%), Positives = 100/323 (30%), Gaps = 62/323 (19%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIG-----NLSSLINLDLSFNALTGNIPEEIGKLAE- 138
L + L L LS+ L + L L L + +L+ E + +
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 139 ---LELLSLNSNSIHGGIPREIG-----NCSKLRRLELYDNQLSGNIPAEIGQLEALEII 190
+ L++++N I+ R + + +L L+L + ++
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG--------VTSDNCRDLC 220
Query: 191 RAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGE-----LTNLRTLSVYTAN 245
+++ L L L + + + LRTL ++
Sbjct: 221 GI-------------VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267
Query: 246 IT----GYIPEEIGNCSALENLFLYENQIFGKIPDELGSL-----KNLKRLLLWQNNLSG 296
IT G + + +L+ L L N++ + L L+ L + + +
Sbjct: 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA 327
Query: 297 ----SIPEALGNCSSLTVIDVSLNSLGGEVPVSLA-----NLVALEELLLSGNNISGE-- 345
L L + +S N L L L L L+ ++S
Sbjct: 328 ACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSC 387
Query: 346 --IPSFFGNFSRLKQLELDNNRF 366
+ + L++L+L NN
Sbjct: 388 SSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-08
Identities = 52/283 (18%), Positives = 85/283 (30%), Gaps = 67/283 (23%)
Query: 90 HLTSLVLSNANLTGE----IPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE-----LE 140
L +L L + +T + + + + +SL L L N L E+ L
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 141 LLSLNSNSIH----GGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNP 196
L + I G + R + L+ L L N+ +G A + P
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE--------LGDEGARLLCETLLEP 311
Query: 197 GIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGN 256
C+ L L + + + +
Sbjct: 312 -----------GCQ-LESLWVKSCSFTAACCSHFSSV--------------------LAQ 339
Query: 257 CSALENLFLYENQIFGKIPDELG-----SLKNLKRLLLWQNNLS----GSIPEALGNCSS 307
L L + N++ EL L+ L L ++S S+ L S
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399
Query: 308 LTVIDVSLNSLGGEVPVSLANLVA-----LEELLLSGNNISGE 345
L +D+S N LG + L V LE+L+L S E
Sbjct: 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
++GKG G V + + ++Q AVK + + + + EV+ L + H NI++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
+ + ++ + + G L + ++K F + D+ +II V G+ Y+H I+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-RIIKQVFSGITYMHKHN---IV 143
Query: 884 HRDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAGSYGYIAPE-----YG 935
HRD+K NIL+ + + + DFGL+ F+ + G+ YIAPE Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGTYD 200
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
EK DV+S GV+L +L+G P + I
Sbjct: 201 ------EKCDVWSAGVILYILLSGTPPFYGKNEYDI 230
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 7e-22
Identities = 32/215 (14%), Positives = 66/215 (30%), Gaps = 21/215 (9%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT---LGSIRHKNIVRL 822
+G+G VY K+ + +K + +F Q L ++
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF 132
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVF----LDWDSRYKIILGVAHGLAYLHHDC 878
+L+ + S G+L ++ K + + + + + +H
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC- 191
Query: 879 VPPIIHRDIKSNNILVGPQFEAF-----------LADFGLAKLFESSESSRASNSVAGSY 927
IIH DIK +N ++G F L D G + + + +
Sbjct: 192 --EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249
Query: 928 GYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
G+ E + + D + + +L G
Sbjct: 250 GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
GKG +V R V + A K + K + + E + ++H NIVRL
Sbjct: 15 GKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPIIH 884
L+FD ++ G L + ++ + + D+ I + +AY H + I+H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-HCIQQILESIAYCHSNG----IVH 128
Query: 885 RDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAGSYGYIAPE------YG 935
R++K N+L+ + + LADFGLA SE A + AG+ GY++PE Y
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYS 185
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
+ D+++ GV+L +L G P R+
Sbjct: 186 ------KPVDIWACGVILYILLVGYPPFWDEDQHRL 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-21
Identities = 66/320 (20%), Positives = 105/320 (32%), Gaps = 79/320 (24%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIVRL 822
+G+G G+V +E +R + A+K + K ++ +D EV+ + + H NI RL
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 823 LGCCNNGRTRLLLFDYISNGSL---------------------------------AGLLH 849
+ + L+ + G L A
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 850 EKKVFLDWDSRY------KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFL- 902
D I+ + L YLH+ I HRDIK N L +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 903 -ADFGLAKLFESSESSRAS--NSVAGSYGYIAPE--YGYSLKITEKSDVYSYGVVLLEVL 957
DFGL+K F + + AG+ ++APE + K D +S GV+L +L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 958 TGKEP----TDSRIPDGAHIITWVNGELRERKREFTTILD--RQLLMRSGTQIQEMLQVL 1011
G P D+ ++ N +L + + R LL
Sbjct: 271 MGAVPFPGVNDADTIS--QVL---NKKLCFENPNYNVLSPLARDLLSN------------ 313
Query: 1012 GVALLCVNPCPEERPTMKDV 1031
LL N +ER
Sbjct: 314 ---LLNRN--VDERFDAMRA 328
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 52/224 (23%), Positives = 83/224 (37%), Gaps = 52/224 (23%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVK-----KLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
G G G V E + + +A+K K E E++ L + H I+
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 821 RLLGC------------CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA 868
++ G LFD + L E + +
Sbjct: 79 KIKNFFDAEDYYIVLELMEGGE----LFDKVVG---NKRLKEA------TCK-LYFYQML 124
Query: 869 HGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAG 925
+ YLH + IIHRD+K N+L+ Q E + DFG +K+ + R ++ G
Sbjct: 125 LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---TLCG 178
Query: 926 SYGYIAPE-------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ Y+APE GY+ + D +S GV+L L+G P
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPP 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 50/228 (21%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G G V+ V E S +K + K+ +Q AE++ L S+ H NI+++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTI--NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 825 C-------------CNNGRTRLLLFDYI-SNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
C G L + I S + L E V +++ + +
Sbjct: 88 VFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYV-------AELMKQMMNA 136
Query: 871 LAYLH-HDCVPPIIHRDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAGS 926
LAY H ++H+D+K NIL + DFGLA+LF+S E S + AG+
Sbjct: 137 LAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGT 189
Query: 927 YGYIAPE---YGYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
Y+APE + K D++S GVV+ +LTG P + +
Sbjct: 190 ALYMAPEVFKRDVT----FKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 53/233 (22%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVK-----KLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
++GKG +V R + + Q AVK K + + E ++H +
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKF---TSSPGLSTEDLKREASICHMLKHPH 87
Query: 819 IVRLLGCCNNGRTRLL---------LFDYI-SNGSLAGLLHEKKVFLDWDSRY-KIILGV 867
IV LL ++ + L I + E S Y + IL
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-----SHYMRQILEA 142
Query: 868 AHGLAYLH-HDCVPPIIHRDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSV 923
L Y H ++ IIHRD+K + +L+ + + L FG+A ES +
Sbjct: 143 ---LRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGR 193
Query: 924 AGSYGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEP---TDSRI 967
G+ ++APE YG + DV+ GV+L +L+G P T R+
Sbjct: 194 VGTPHFMAPEVVKREPYG------KPVDVWGCGVILFILLSGCLPFYGTKERL 240
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
GKG +V R V + A K + K + + E + ++H NIVRL
Sbjct: 38 GKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPIIH 884
L+FD ++ G L + ++ + + D+ I + +AY H + I+H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-HCIQQILESIAYCHSNG----IVH 151
Query: 885 RDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAGSYGYIAPE------YG 935
R++K N+L+ + + LADFGLA SE A + AG+ GY++PE Y
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYS 208
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
+ D+++ GV+L +L G P R+
Sbjct: 209 ------KPVDIWACGVILYILLVGYPPFWDEDQHRL 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 4e-21
Identities = 53/291 (18%), Positives = 102/291 (35%), Gaps = 45/291 (15%)
Query: 759 RLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGEL---PERDQFSAEVQTLGSIR 815
+L IV + + E ++ + + L D S +++ +
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 816 HKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV--FLDWDSRYKIILGVAHGLAY 873
KN V L + + +L ++ + + I + +A + +
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA--------- 924
LH ++HRD+K +NI + DFGL + E + +
Sbjct: 180 LHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236
Query: 925 -GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE 983
G+ Y++PE + + K D++S G++L E+L R+ IIT
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----RIIT------DV 286
Query: 984 RKREFTTILDRQLLMRSGTQ---IQEMLQVLGVALLCVNPCPEERPTMKDV 1031
R +F + + + + +Q+ML P P ERP D+
Sbjct: 287 RNLKFPLLFTQ----KYPQEHMMVQDMLS----------PSPTERPEATDI 323
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-21
Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+GKG +V R V++ + Q A + K + + E + ++H NIVRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMII-NTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPI 882
+ L+FD ++ G L + ++ + + D+ I + + + H +
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-HCIQQILEAVLHCHQMG----V 131
Query: 883 IHRDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAGSYGYIAPE------ 933
+HR++K N+L+ + + LADFGLA E + +A AG+ GY++PE
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDP 189
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
YG + D+++ GV+L +L G P R+
Sbjct: 190 YG------KPVDLWACGVILYILLVGYPPFWDEDQHRL 221
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVK-----KLWPVKNGELPE-RDQFSAEVQTLGSI-RH 816
I+G+GVS +V R + P+ + AVK E+ E R+ EV L + H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHH 876
NI++L L+FD + G L L EK + ++R KI+ + + LH
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KIMRALLEVICALHK 142
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--- 933
I+HRD+K NIL+ L DFG + + E R V G+ Y+APE
Sbjct: 143 LN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIE 196
Query: 934 ---YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
++ D++S GV++ +L G P
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G+G G V V+ +R A KK + + + D+F E++ + S+ H NI+RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPI 882
+ L+ + + G L + K+VF + D+ +I+ V +AY H + +
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-RIMKDVLSAVAYCHKLN----V 127
Query: 883 IHRDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAGSYGYIAPE-----Y 934
HRD+K N L L DFGLA F+ + + G+ Y++P+ Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGLY 184
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
G + D +S GV++ +L G P TDS +
Sbjct: 185 G------PECDEWSAGVMMYVLLCGYPPFSAPTDSEV 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
G G V+ + + ++ A+K +K E+ L I+H+NIV L
Sbjct: 18 GSGAFSEVFLVKQRLTGKLFALKC---IKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPIIH 884
+ L+ +S G L + E+ V+ + D+ +I V + YLH + I+H
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-LVIQQVLSAVKYLHENG----IVH 129
Query: 885 RDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYS 937
RD+K N+L E + DFGL+K+ ++ S + G+ GY+APE YS
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS----TACGTPGYVAPEVLAQKPYS 185
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEP 962
+ D +S GV+ +L G P
Sbjct: 186 KAV----DCWSIGVITYILLCGYPP 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 25/208 (12%), Positives = 51/208 (24%), Gaps = 38/208 (18%)
Query: 766 VGKGVSGIVYRV--EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
G ++ RQV A+ + P + + L I + R+L
Sbjct: 39 HGGVPPLQFWQALDTALDRQV-ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
+ L++ ++I GSL + + + +A H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---GVA 151
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEK 943
+ + V + LA + +
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA-------NPQ 182
Query: 944 SDVYSYGVVLLEVLTGKEPTDSRIPDGA 971
D+ G L +L + P
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSG 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 31/212 (14%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIV 820
I+G+G V E+ + + A+K L + + + ++ E + + H V
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH-H 876
+L + Y NG L + + F + +R+ +I+ L YLH
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA----LEYLHGK 149
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--- 933
IIHRD+K NIL+ + DFG AK+ +NS G+ Y++PE
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 934 ---YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
S SD+++ G ++ +++ G P
Sbjct: 206 EKSACKS------SDLWALGCIIYQLVAGLPP 231
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 765 IVGKGVSGIVYR-VEIPSRQVIAVK-----KLWPVKNGELPERDQFSAEVQTLGSIR-HK 817
++G+GVS +V R V + AVK R+ E L + H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
+I+ L+ + L+FD + G L L EK + ++R I+ + +++LH +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-SIMRSLLEAVSFLHAN 219
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---- 933
I+HRD+K NIL+ + L+DFG + E E R + G+ GY+APE
Sbjct: 220 N---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEILKC 273
Query: 934 ------YGYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
GY ++ D+++ GV+L +L G P +
Sbjct: 274 SMDETHPGYGKEV----DLWACGVILFTLLAGSPPFWHRRQILM 313
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 53/245 (21%), Positives = 80/245 (32%), Gaps = 44/245 (17%)
Query: 393 NIPELAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEIGGCTGL 451
N+P + LDLS N L + S F + L L L I
Sbjct: 25 NLP-----FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA------ 71
Query: 452 IRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQ 510
+ L L+ L L+ N + + L+ + + L
Sbjct: 72 ---------YQS--------LSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
Query: 511 GTIPSSL-EFLFGLNVLDLSMNSIGGTIPEN--LGKLTSLNKLVLSKNNITGLIPKSLGL 567
++ + L L L+++ N I + LT+L L LS N I + L +
Sbjct: 114 -SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 568 CKDLQL----LDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANL 623
+ L LDLS N +N I + L L L N L F L+ L +
Sbjct: 172 LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL-ALDTNQLKSVPDGIFDRLTSLQKI 229
Query: 624 DLSNN 628
L N
Sbjct: 230 WLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 39/210 (18%)
Query: 465 IPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSL-EFLFG 522
IP L L+LS N + + +L+++DL + ++Q TI + L
Sbjct: 22 IPD--NLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 523 LNVLDLSMNSIGGTIPENL-GKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
L+ L L+ N I ++ L+SL KLV + N+ L +G K L+ L+++ N I
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 582 NGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLT----GSLKVL 637
S PE FSNL+ L +LDLS+N + L+VL
Sbjct: 137 Q-SFKL-----------------------PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172
Query: 638 GSLDNL-VSLNVSYNHFSGILPNTKLFHGL 666
+ L +SL++S N + I P F +
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGA--FKEI 200
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 15/212 (7%)
Query: 234 TNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDEL-GSLKNLKRLLLWQN 292
+ + L + + + L+ L L +I I D SL +L L+L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGN 86
Query: 293 NLSGSIP-EALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNI-SGEIPSFF 350
+ S+ A SSL + +L + +L L+EL ++ N I S ++P +F
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 351 GNFSRLKQLELDNNRFFGQIPPTI----GQLKELLL-FFAWQNQLHGNIPELAY-CVKLQ 404
N + L+ L+L +N+ I T Q+ L L N ++ I A+ ++L+
Sbjct: 146 SNLTNLEHLDLSSNK-IQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLK 203
Query: 405 ALDLSHNFLTGSVPSSLF-NLKNLTQLLLISN 435
L L N L SVP +F L +L ++ L +N
Sbjct: 204 ELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 51/233 (21%), Positives = 75/233 (32%), Gaps = 33/233 (14%)
Query: 306 SSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR 365
S +D+S N L S + L+ L LS I + + S L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 366 FFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF-NL 424
+ + LQ L L S+ + +L
Sbjct: 88 -IQSLALGA----------------------FSGLSSLQKLVAVETNLA-SLENFPIGHL 123
Query: 425 KNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFSGHIPSRI-GLLHRLTF----L 478
K L +L + N PE T L L L SN I +LH++ L
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSL 182
Query: 479 ELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMN 531
+LS N I P +L+ + L N+L+ + L L + L N
Sbjct: 183 DLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 52/275 (18%), Positives = 82/275 (29%), Gaps = 73/275 (26%)
Query: 77 IPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIPEEI-G 134
IP + P +L LS L + + + L LDLS + I +
Sbjct: 22 IPDNLP------FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQ 73
Query: 135 KLAELELLSLNSN---SIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIR 191
L+ L L L N S+ G S L++L + L+ ++
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFS---GLSSLQKLVAVETNLA-SLENF----------- 118
Query: 192 AGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIP 251
G L L+ L+V I +
Sbjct: 119 ---------------------PI----------------GHLKTLKELNVAHNLIQSFKL 141
Query: 252 EEI-GNCSALENLFLYENQIFGKIP----DELGSLKNLK-RLLLWQNNLSGSIPEALGNC 305
E N + LE+L L N+I I L + L L L N ++ I
Sbjct: 142 PEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199
Query: 306 SSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGN 340
L + + N L L +L+++ L N
Sbjct: 200 IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 12/208 (5%)
Query: 423 NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSE 482
+ + ++ + +PP++ L L N + + RLT L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 483 NQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL- 541
+ T G L +DL N+LQ ++P + L L VLD+S N + ++P
Sbjct: 65 AELT--KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 542 GKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLN 600
L L +L L N + L P L L+ L L++N + +P + L+ LD L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL-L 178
Query: 601 LSWNALTGPIPESFSNLSKLANLDLSNN 628
L N+L IP+ F L L N
Sbjct: 179 LQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 52/184 (28%), Positives = 75/184 (40%), Gaps = 17/184 (9%)
Query: 283 NLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNI 342
+ L L +N L L + LT +++ L ++ V L L L LS N +
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHNQL 89
Query: 343 SGEIPSFFGNFSRLKQLELDNNRFFGQIPPTI----GQLKELLLFFAWQNQLHGNIPE-- 396
+P L L++ NR +P G+L+EL L N+L +P
Sbjct: 90 Q-SLPLLGQTLPALTVLDVSFNR-LTSLPLGALRGLGELQELYL---KGNELK-TLPPGL 143
Query: 397 LAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLR 455
L KL+ L L++N LT +P+ L L+NL LLL N IP G L
Sbjct: 144 LTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAF 201
Query: 456 LGSN 459
L N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 50/191 (26%), Positives = 76/191 (39%), Gaps = 17/191 (8%)
Query: 393 NIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLI 452
++P L LS N L ++L LTQL L + G L
Sbjct: 28 DLP-----KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLG 80
Query: 453 RLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQG 511
L L N +P L LT L++S N+ T +P +L+ + L N+L+
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK- 137
Query: 512 TIPSSLEF--LFGLNVLDLSMNSIGGTIPENL-GKLTSLNKLVLSKNNITGLIPKSLGLC 568
T+P L L L L+ N++ +P L L +L+ L+L +N++ IPK
Sbjct: 138 TLPPGL-LTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGS 194
Query: 569 KDLQLLDLSSN 579
L L N
Sbjct: 195 HLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 48/202 (23%), Positives = 71/202 (35%), Gaps = 27/202 (13%)
Query: 234 TNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNN 293
+ L + + + + + L L L ++ G+L L L L N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQ 88
Query: 294 LSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNF 353
L S+P +LTV+DVS N L +L L L+EL L GN + P
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 354 SRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFL 413
+L++L L NN ++P + N L L L L N L
Sbjct: 148 PKLEKLSLANNN-LTELPAGL--------L----NGLE----------NLDTLLLQENSL 184
Query: 414 TGSVPSSLFNLKNLTQLLLISN 435
++P F L L N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 46/231 (19%), Positives = 74/231 (32%), Gaps = 57/231 (24%)
Query: 88 FSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSN 147
T L LS L + + L L+L LT + + G L L L L+ N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHN 87
Query: 148 SIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEIS 207
+ +P L L++ N+L+ ++P
Sbjct: 88 QLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG--------------------------- 118
Query: 208 NCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI-GNCSALENLFLY 266
G L L+ L + + +P + LE L L
Sbjct: 119 -----ALRG----------------LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLA 156
Query: 267 ENQIFGKIPDEL-GSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLN 316
N + ++P L L+NL LLL +N+L +IP+ L + N
Sbjct: 157 NNNL-TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 34/125 (27%), Positives = 50/125 (40%), Gaps = 8/125 (6%)
Query: 544 LTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSW 603
+ S ++ K N+T +P L KD +L LS N + + L L NL
Sbjct: 9 VASHLEVNCDKRNLTA-LPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQL-NLDR 64
Query: 604 NALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLF 663
LT + L L LDLS+N L + +L L L+VS+N + +
Sbjct: 65 AELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA--L 120
Query: 664 HGLPA 668
GL
Sbjct: 121 RGLGE 125
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G+G + IVYR + +++ A+K L + ++ E+ L + H NI++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT-----EIGVLLRLSHPNIIKLK 114
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPI 882
L+ + ++ G L + EK + + D+ + + +AYLH + I
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-DAVKQILEAVAYLHENG----I 169
Query: 883 IHRDIKSNNIL-VGPQFEAFL--ADFGLAKLFESSESSRASNSVAGSYGYIAPE----YG 935
+HRD+K N+L P +A L ADFGL+K+ E + +V G+ GY APE
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---TVCGTPGYCAPEILRGCA 226
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y ++ D++S G++ +L G EP
Sbjct: 227 YGPEV----DMWSVGIITYILLCGFEP 249
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIV 820
+G+G G V++ + +++A+K+ V+ + E SA E+ L ++HKNIV
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKR---VRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
RL ++ + L+F++ L LD + + + GL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--YG--- 935
++HRD+K N+L+ E LA+FGLA+ F S V + Y P+ +G
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKL 178
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEP 962
YS I D++S G + E+ P
Sbjct: 179 YSTSI----DMWSAGCIFAELANAGRP 201
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 38/211 (18%), Positives = 79/211 (37%), Gaps = 19/211 (9%)
Query: 403 LQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNN 460
Q L L L ++PS F NL N++++ + + ++ + + + + +
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 461 FSGHIPSRI-GLLHRLTFLELSENQFTGEIPPE--IGNCTQLEMVDLHQNKLQGTIP--- 514
+I L L FL + P + + ++++ N +IP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 515 -SSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNN-ITGLIPKSL-GLCKDL 571
L L L N ++ T L+ + L+KN +T + + G+
Sbjct: 151 FQGLCNE--TLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 572 QLLDLSSNRINGSIPEEIGRLQGLDILLNLS 602
LLD+S + ++P + L+ L L+ +
Sbjct: 208 SLLDVSQTSVT-ALPSKG--LEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-19
Identities = 46/261 (17%), Positives = 87/261 (33%), Gaps = 38/261 (14%)
Query: 395 PELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIR 453
C + + ++ + +PS + L LI IP + R
Sbjct: 5 SPPCECHQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISR 59
Query: 454 LRLGSNNFSGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQG 511
+ + + + S L ++T +E+ + I P+ L+ + + L+
Sbjct: 60 IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK- 118
Query: 512 TIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSL--GLCK 569
P L ++ + L ++ N IP + GLC
Sbjct: 119 MFPD-LTKVYSTD---------------------IFFILEITDNPYMTSIPVNAFQGLCN 156
Query: 570 DLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNL-SKLANLDLSNN 628
+ L L +N S+ LD + LT ++F + S + LD+S
Sbjct: 157 ETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
Query: 629 MLTGSL--KVLGSLDNLVSLN 647
+T +L K L L L++ N
Sbjct: 216 SVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 47/262 (17%), Positives = 86/262 (32%), Gaps = 54/262 (20%)
Query: 305 CSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSF-FGNFSRLKQLELDN 363
C V+ + +P + + L L ++ IPS F N + ++ +
Sbjct: 10 CHQEEDFRVTCKDIQ-RIPSLPPST---QTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 364 NRFFGQIPPTI----GQLKELLLFFAWQNQLHGNIPE--LAYCVKLQALDLSHNFLTGSV 417
+ Q+ ++ + + + I L L+ L + + L
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIR---NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MF 120
Query: 418 PSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRI--GLLHRL 475
P + L + N + IP GL +
Sbjct: 121 PDLTK----------------------VYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158
Query: 476 TFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLF-----GLNVLDLSM 530
L+L N FT + N T+L+ V L++NK I F G ++LD+S
Sbjct: 159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKD---AFGGVYSGPSLLDVSQ 214
Query: 531 NSIGGTIP----ENLGKLTSLN 548
S+ +P E+L +L + N
Sbjct: 215 TSV-TALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 43/277 (15%), Positives = 83/277 (29%), Gaps = 77/277 (27%)
Query: 163 LRRLELYDNQLSGNIPAEI-GQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTG 221
+ L+L + L IP+ L + I + + ++ F L
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQ-QLESH-------SFYNL---- 79
Query: 222 ISGQIPRSVGELTNLRTLSVYTANITGYIPEEI-GNCSALENLFLYENQIFGKIPDE--L 278
+ + + + YI + L+ L ++ + PD +
Sbjct: 80 ------------SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKV 126
Query: 279 GSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLS 338
S L + N SIP N+ G L N L L
Sbjct: 127 YSTDIFFILEITDNPYMTSIPV---------------NAFQG-----LCNE--TLTLKLY 164
Query: 339 GNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELA 398
N + + + N ++L + L+ N++ I A+ G
Sbjct: 165 NNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKD-----------AFGGVYSG------ 206
Query: 399 YCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISN 435
LD+S +T ++PS ++L +L+ +
Sbjct: 207 ----PSLLDVSQTSVT-ALPSKGL--EHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 36/213 (16%), Positives = 72/213 (33%), Gaps = 15/213 (7%)
Query: 89 SHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNIPEEI-GKLAELELLSLNS 146
+L L +L IP A NL ++ + +S + + L+++ + + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 147 NSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAE--IGQLEALEIIRAGGNPGIHGEIP 203
I + L+ L +++ L P + + I+ NP + IP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMT-SIP 147
Query: 204 EEI--SNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI--GNCSA 259
C + L L + G + + T L + + I ++ G S
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 260 LENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQ 291
L + + + +P + L LK L W
Sbjct: 207 PSLLDVSQTSV-TALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 22/131 (16%), Positives = 45/131 (34%), Gaps = 10/131 (7%)
Query: 544 LTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI----GRLQGLDILL 599
S L L + ++ + + ++ + +S + + ++ ++I
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 600 NLSWNALTGPIPESFSNLSKLANLDLSNNMLT--GSLKVLGSLDNLVSLNVSYNHFSGIL 657
LT P++ L L L + N L L + S D L ++ N + +
Sbjct: 90 T---RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 658 PNTKLFHGLPA 668
P F GL
Sbjct: 147 PVN-AFQGLCN 156
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 8e-19
Identities = 53/256 (20%), Positives = 98/256 (38%), Gaps = 32/256 (12%)
Query: 727 TTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVI 785
T N + W Q + D V+ +G G G+V+R E +
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185
Query: 786 AVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL- 844
A K V +++ E+QT+ +RH +V L + +++++++S G L
Sbjct: 186 AAKF---VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 845 ------AGLLHEKKVFLDWDSRY-KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ 897
+ E + Y + + GL ++H + +H D+K NI+ +
Sbjct: 243 EKVADEHNKMSEDEA-----VEYMRQVCK---GLCHMHEN---NYVHLDLKPENIMFTTK 291
Query: 898 FEAFL--ADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLE 955
L DFGL + +S + G+ + APE + +D++S GV+
Sbjct: 292 RSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 956 VLTGKEP----TDSRI 967
+L+G P D
Sbjct: 349 LLSGLSPFGGENDDET 364
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLG 824
G+G V + + + Q AVK ++ R + EV+ L + H+N++ L+
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKI---IEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
L+F+ + GS+ +H+++ F + ++ ++ VA L +LH+ I H
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGIAH 134
Query: 885 RDIKSNNIL-VGPQFEAFL--ADFGLAKLFESSESSRASNS-----VAGSYGYIAPE--- 933
RD+K NIL P + + DF L + + ++ GS Y+APE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 934 --YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ ++ D++S GV+L +L+G P
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIVR 821
+G+G G+VY+ + + A+KK ++ + E + E+ L ++H NIV+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKK---IRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
L + + +L+F+++ L LL + L+ + +L + +G+AY H
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--YG---Y 936
++HRD+K N+L+ + E +ADFGLA+ F + ++ + + Y AP+ G Y
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLW-YRAPDVLMGSKKY 178
Query: 937 SLKITEKSDVYSYGVVLLEVLTGK 960
S I D++S G + E++ G
Sbjct: 179 STTI----DIWSVGCIFAEMVNGT 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 19/213 (8%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVK---KLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
G G IV + E + A K K + R++ EV L + H N++ L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
N +L+ + +S G L L +K+ + ++ I + G+ YLH I
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-SFIKQILDGVNYLHTKK---I 136
Query: 883 IHRDIKSNNILV----GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL 938
H D+K NI++ P L DFGLA E + ++ G+ ++APE
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVAPEIVNYE 193
Query: 939 KITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
+ ++D++S GV+ +L+G P T
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQET 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 33/220 (15%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVK---KLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
G G IV + E + A K K + R++ EV L + H NI+ L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 823 LGCCNNGRTRLLLFDYISNGSL------AGLLHEKKVFLDWDSRY-KIILGVAHGLAYLH 875
N +L+ + +S G L L E++ + + K IL G+ YLH
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----TSFIKQILD---GVNYLH 132
Query: 876 HDCVPPIIHRDIKSNNILV----GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIA 931
I H D+K NI++ P L DFGLA E + ++ G+ ++A
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVA 186
Query: 932 PEYGYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
PE + ++D++S GV+ +L+G P T
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 29/219 (13%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLG-SIRHKNIVRLLG 824
G G + R + + AVK + K+ P E++ L +H NI+ L
Sbjct: 31 GVGSYSVCKRCIHKATNMEFAVKII--DKSKRDPTE-----EIEILLRYGQHPNIITLKD 83
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPII 883
++G+ ++ + + G L + +K F + ++ ++ + + YLH ++
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-AVLFTITKTVEYLHAQG----VV 138
Query: 884 HRDIKSNNILVGPQFEAF----LADFGLAKLFESSESSRASNSVAGSYGYIAPE----YG 935
HRD+K +NIL + + DFG AK + + + ++APE G
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQG 196
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHII 974
Y D++S GV+L +LTG P + D I
Sbjct: 197 YDAAC----DIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIVR 821
VG+G G+VY+ + +++A+K+ ++ E +A E+ L + H NIV
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKR---IRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
L+ ++ R L+F+++ L +L E K L + + G+A+ H
Sbjct: 84 LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--- 139
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--YG---Y 936
I+HRD+K N+L+ LADFGLA+ F ++ V + Y AP+ G Y
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMGSKKY 197
Query: 937 SLKITEKSDVYSYGVVLLEVLTGK 960
S + D++S G + E++TGK
Sbjct: 198 STSV----DIWSIGCIFAEMITGK 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIV 820
+G+G G+V++ + Q++A+KK E + A E++ L ++H N+V
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKK---FLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
LL R L+F+Y + ++ L + + I + + H
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN-- 122
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--YG--- 935
IHRD+K NIL+ L DFG A+L + S + VA + Y +PE G
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRW-YRSPELLVGDTQ 179
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGK 960
Y + DV++ G V E+L+G
Sbjct: 180 YGPPV----DVWAIGCVFAELLSGV 200
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLG 824
G+G I + V S Q AVK + + ++ E+ L H NIV+L
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKII-SKRMEANTQK-----EITALKLCEGHPNIVKLHE 73
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
++ L+ + ++ G L + +KK F + ++ I+ + ++++H ++H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS-YIMRKLVSAVSHMHDVG---VVH 129
Query: 885 RDIKSNNIL-VGPQFEAFL--ADFGLAKLFESSESSRASNSVAGSYGYIAPE------YG 935
RD+K N+L + DFG A+L ++ + + Y APE Y
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTPCFTLHYAAPELLNQNGYD 187
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEP 962
E D++S GV+L +L+G+ P
Sbjct: 188 ------ESCDLWSLGVILYTMLSGQVP 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 51/258 (19%), Positives = 97/258 (37%), Gaps = 35/258 (13%)
Query: 726 GTTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQV 784
G + D+ ++ + P Q + V +G G G+V+R VE + +V
Sbjct: 20 GPKINDYDKFYEDIWKKYVP-QPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRV 78
Query: 785 IAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSL 844
K + ++ E+ + + H ++ L + +L+ +++S G L
Sbjct: 79 FVAKF---INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 845 -------AGLLHEKKVFLDWDSRY-KIILGVAHGLAYLH-HDCVPPIIHRDIKSNNILVG 895
+ E +V Y + GL ++H H I+H DIK NI+
Sbjct: 136 FDRIAAEDYKMSEAEV-----INYMRQACE---GLKHMHEHS----IVHLDIKPENIMCE 183
Query: 896 PQFEAFL--ADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVL 953
+ + + DFGLA E + + + APE + +D+++ GV+
Sbjct: 184 TKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
Query: 954 LEVLTGKEP----TDSRI 967
+L+G P D
Sbjct: 241 YVLLSGLSPFAGEDDLET 258
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIV 820
+VG+G G+V + + +++A+KK + + + A E++ L +RH+N+V
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKK---FLESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
LL C + L+F+++ + ++ L LD+ K + + +G+ + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--YG--- 935
IIHRDIK NILV L DFG A+ ++ + VA + Y APE G
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRW-YRAPELLVGDVK 201
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGK 960
Y + DV++ G ++ E+ G+
Sbjct: 202 YGKAV----DVWAIGCLVTEMFMGE 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIV 820
+G+G G V++ + Q +A+KK V E +A E++ L ++H+N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 821 RLLGCC-------NNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLA 872
L+ C N + + L+FD+ + LAGLL V +++ + +GL
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG---- 928
Y+H + I+HRD+K+ N+L+ LADFGLA+ F S A NS Y
Sbjct: 139 YIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF-----SLAKNSQPNRYTNRVV 190
Query: 929 ---YIAPE--YG---YSLKITEKSDVYSYGVVLLEVLTGK 960
Y PE G Y I D++ G ++ E+ T
Sbjct: 191 TLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 31/219 (14%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVK---KLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
G G IV + + + + A K K + R++ EV L IRH NI+ L
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY--KIILGVAHGLAYLHHDCVP 880
N +L+ + +S G L L EK+ + ++ K IL G+ YLH
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSKR-- 128
Query: 881 PIIHRDIKSNNILV----GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--- 933
I H D+K NI++ P L DFG+A E+ + ++ G+ ++APE
Sbjct: 129 -IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---NIFGTPEFVAPEIVN 184
Query: 934 -YGYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
L+ D++S GV+ +L+G P T
Sbjct: 185 YEPLGLEA----DMWSIGVITYILLSGASPFLGETKQET 219
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-18
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIV 820
+ +G+G VY+ + + Q++A+KK+ E + +A E++ L + H NI+
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
LL + L+FD++ L ++ + + L +L GL YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--YG--- 935
I+HRD+K NN+L+ LADFGLAK F S + ++ V + Y APE +G
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRW-YRAPELLFGARM 189
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGK 960
Y + + D+++ G +L E+L
Sbjct: 190 YGVGV----DMWAVGCILAELLLRV 210
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 51/226 (22%), Positives = 100/226 (44%), Gaps = 38/226 (16%)
Query: 760 LSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
+S T I+G G G V++ E + +A K +K + ++++ E+ + + H N
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKI---IKTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSL-------AGLLHEKKVFLDWDSRY-KIILGVAHG 870
+++L + +L+ +Y+ G L + L E + K I G
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT-----ILFMKQICE---G 199
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFL--ADFGLAKLFESSESSRASNSVAGSYG 928
+ ++H I+H D+K NIL + + DFGLA+ ++ E + G+
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK---VNFGTPE 253
Query: 929 YIAPE---YGYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
++APE Y + ++ +D++S GV+ +L+G P D+
Sbjct: 254 FLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 87.5 bits (216), Expect = 8e-18
Identities = 49/265 (18%), Positives = 86/265 (32%), Gaps = 11/265 (4%)
Query: 332 LEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLH 391
L L+ + K+ L +R ++L +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST 362
Query: 392 GNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGL 451
EL C +LQ L+ + + ++ + L L FS + L
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422
Query: 452 IRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQG 511
LR + F + L L+ T + + + +DL N+L+
Sbjct: 423 DDLR---SKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR- 476
Query: 512 TIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGL-IPKSLGLCKD 570
+P +L L L VL S N++ + + L L +L+L N + + L C
Sbjct: 477 ALPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534
Query: 571 LQLLDLSSNRINGSIPEEIGRLQGL 595
L LL+L N + RL +
Sbjct: 535 LVLLNLQGNSL-CQEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 83.7 bits (206), Expect = 1e-16
Identities = 59/273 (21%), Positives = 99/273 (36%), Gaps = 17/273 (6%)
Query: 386 WQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI 445
W+ N P + L A L+ + + + +L+ +R +
Sbjct: 287 WRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDS 345
Query: 446 GGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLH 505
L R L S S + S + L LE I I L+ +
Sbjct: 346 ATDEQLFRCEL-SVEKSTVLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYE 401
Query: 506 QNKLQGTIPSSLEFLFGLNVLDLSM--NSIGGTIPENLGKLTSLNKLVLSKNNITGLIPK 563
+ LQ S+L+ + + L + + + L L+ ++T L
Sbjct: 402 KETLQYF--STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--C 457
Query: 564 SLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANL 623
L + LDLS NR+ ++P + L+ L++L S NAL + +NL +L L
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVL-QASDNALE--NVDGVANLPRLQEL 513
Query: 624 DLSNNMLTG--SLKVLGSLDNLVSLNVSYNHFS 654
L NN L +++ L S LV LN+ N
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 2e-12
Identities = 35/165 (21%), Positives = 57/165 (34%), Gaps = 7/165 (4%)
Query: 24 LNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTEIAITSIHIPTSFPY 83
E L S L + +A + + + + T +
Sbjct: 400 YEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-TVLCH 458
Query: 84 QLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLS 143
L +T L LS+ L +PPA+ L L L S NAL N+ + L L+ L
Sbjct: 459 -LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELL 514
Query: 144 LNSNSIHG-GIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEAL 187
L +N + + + +C +L L L N L +L +
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 7e-11
Identities = 40/283 (14%), Positives = 81/283 (28%), Gaps = 29/283 (10%)
Query: 33 SWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLT 92
+ L + + + + + + +R W A + +P + + S
Sbjct: 273 TLLLMVDEAPLSVEWRTPDGRNRPSHVW----LCDLPAASLNDQLPQHTFRVIWTGSDSQ 328
Query: 93 SLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIH-- 150
+ + L +LS T + E+ EL+ L +
Sbjct: 329 KECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLT 387
Query: 151 -GGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIP------ 203
+ R + + Y + L P L+ L N + E
Sbjct: 388 IILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH 447
Query: 204 ---------EEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI 254
+ ++ L L+ + +P ++ L L L + + +
Sbjct: 448 LAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGV 504
Query: 255 GNCSALENLFLYENQIFGKIPD--ELGSLKNLKRLLLWQNNLS 295
N L+ L L N++ + L S L L L N+L
Sbjct: 505 ANLPRLQELLLCNNRL-QQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 2e-10
Identities = 43/237 (18%), Positives = 78/237 (32%), Gaps = 22/237 (9%)
Query: 251 PEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTV 310
+ L L + + EL S K L+ L +I + L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 311 IDVSLNSLGGEVPVSLANLVALEELLLSG-----NNISGEIPSFFGNFSRLKQLELDNNR 365
+L + L A++ + + + E ++ ++ L L +
Sbjct: 401 EKETLQYF--------STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 366 FFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLK 425
+ + QL + N+L P LA L+ L S N L +V + NL
Sbjct: 453 L--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLP 508
Query: 426 NLTQLLLISNRFSG-EIPPEIGGCTGLIRLRLGSNNFSGHIPSR---IGLLHRLTFL 478
L +LLL +NR + C L+ L L N+ + +L ++ +
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 40/208 (19%), Positives = 67/208 (32%), Gaps = 10/208 (4%)
Query: 458 SNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSL 517
++ H I + + QL +L K + S L
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSEL 368
Query: 518 EFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLS 577
E L L+ TI + L L + + L K++ + L DL
Sbjct: 369 ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL--KAVDPMRAAYLDDLR 426
Query: 578 SNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVL 637
S + + + +L+L+ LT + L + +LDLS+N L L
Sbjct: 427 SKFLLENSVLK--MEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPAL 482
Query: 638 GSLDNLVSLNVSYN---HFSGILPNTKL 662
+L L L S N + G+ +L
Sbjct: 483 AALRCLEVLQASDNALENVDGVANLPRL 510
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 72/336 (21%), Positives = 117/336 (34%), Gaps = 84/336 (25%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVK-----KLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
G G G V+ V+ + + VK K+ E P+ + + E+ L + H NI+
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 821 RLLGCCNNGRTRLL----------LFDYISNGSLAGLLHEKKVFLDWDSRYK---IILGV 867
++L N L LF +I L E + Y ++ V
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEP------LASYIFRQLVSAV 143
Query: 868 AHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSY 927
YL IIHRDIK NI++ F L DFG A E + G+
Sbjct: 144 G----YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTI 193
Query: 928 GYIAPEY----GYSLKITEKSDVYSYGVVLLEVLTGKEPTDS--RIPDGA-HIITWVNGE 980
Y APE Y + +++S GV L ++ + P + A H V+ E
Sbjct: 194 EYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKE 250
Query: 981 LRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV------TAM 1034
L L+ +LQ PE R T++ + T
Sbjct: 251 LMS------------LVSG-------LLQP----------VPERRTTLEKLVTDPWVTQP 281
Query: 1035 LKEIRHENDDLEKPNSLSRAVTNPKAAVHCSSFSRS 1070
+ + +++ + N V + A++ + S S
Sbjct: 282 VNLADYTWEEVFRVNKPESGVLS-AASLEMGNRSLS 316
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 764 NIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGE-LPERDQFSA--EVQTLGSIRHKNI 819
+ +G+G VY+ + ++A+K++ +++ E P +A EV L ++H NI
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAP----CTAIREVSLLKDLKHANI 62
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCV 879
V L + ++ L+F+Y+ L L + ++ + + + GLAY H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK- 120
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--YG-- 935
++HRD+K N+L+ + E LADFGLA+ S + N V + Y P+ G
Sbjct: 121 --VLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPDILLGST 176
Query: 936 -YSLKITEKSDVYSYGVVLLEVLTGK 960
YS +I D++ G + E+ TG+
Sbjct: 177 DYSTQI----DMWGVGCIFYEMATGR 198
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 43/218 (19%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVK---KLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
G G +V + E + A K K + R+ EV L I+H N++ L
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 823 LGCCNNGRTRLLLFDYISNGSL------AGLLHEKKVFLDWDSRY-KIILGVAHGLAYLH 875
N +L+ + ++ G L L E++ + + K IL G+ YLH
Sbjct: 80 HEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA-----TEFLKQILN---GVYYLH 131
Query: 876 -HDCVPPIIHRDIKSNNILV----GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
I H D+K NI++ P+ + DFGLA + + ++ G+ ++
Sbjct: 132 SLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFV 184
Query: 931 APE------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
APE G ++D++S GV+ +L+G P
Sbjct: 185 APEIVNYEPLG------LEADMWSIGVITYILLSGASP 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 33/219 (15%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH-KNIVRLLG 824
G+G +V + + + Q A K L + R + E+ L + ++ L
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFL-KKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 825 CCNNGRTRLLLFDYISNGSL--------AGLLHEKKVFLDWDSRY-KIILGVAHGLAYLH 875
N +L+ +Y + G + A ++ E V R K IL G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV-----IRLIKQILE---GVYYLH 148
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAF---LADFGLAKLFESSESSRASNSVAGSYGYIAP 932
+ I+H D+K NIL+ + + DFG+++ + R + G+ Y+AP
Sbjct: 149 QNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EIMGTPEYLAP 202
Query: 933 EYGYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
E IT +D+++ G++ +LT P +
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 46/238 (19%)
Query: 741 WDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELP 799
WD+ + + D +G+G V+ + I + + + VK L PVK
Sbjct: 23 WDYESH-VVEWGNQD---DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----- 73
Query: 800 ERDQFSAEVQTLGSIR-HKNIVRLLGCC--NNGRTRLLLFDYISNGSLAGLLHEKKVFLD 856
+ + E++ L ++R NI+ L RT L+F++++N L + D
Sbjct: 74 -KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTD 129
Query: 857 WDSRYKI--ILGVAHGLAYLH-HDCVPPIIHRDIKSNNILVGPQF-EAFLADFGLAKLFE 912
+D R+ + IL L Y H I+HRD+K +N+++ + + L D+GLA E
Sbjct: 130 YDIRFYMYEIL---KALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLA---E 179
Query: 913 SSESSRASN-SVAGSYGYIAPE-------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ N VA Y + PE Y YSL D++S G +L ++ KEP
Sbjct: 180 FYHPGQEYNVRVASRY-FKGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEP 230
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--EVQTLGSIRHKNIV 820
+G+G G VY+ ++ + + +A+K+ ++ E +A EV L ++H+NI+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKR---IRLEHEEEGVPGTAIREVSLLKELQHRNII 96
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
L ++ L+F+Y N L + + + + + +G+ + H
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK-SFLYQLINGVNFCHSRR-- 152
Query: 881 PIIHRDIKSNNILVGPQFEAF-----LADFGLAKLFESSESSRASNSVAGSYGYIAPE-- 933
+HRD+K N+L+ + + DFGLA+ F + ++ + + Y PE
Sbjct: 153 -CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEIITLW-YRPPEIL 209
Query: 934 YG---YSLKITEKSDVYSYGVVLLEVLTGK 960
G YS + D++S + E+L
Sbjct: 210 LGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 47/224 (20%)
Query: 766 VGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G GIV+R VE S++ K + VK + + E+ L RH+NI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTD---QVLVKKEISILNIARHRNILHLHE 68
Query: 825 CCNNGRTRLLLFDYISNGSL-------AGLLHEKKVFLDWDSRY-KIILGVAHGLAYLH- 875
+ +++F++IS + A L+E+++ Y + L +LH
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREI-----VSYVHQVCE---ALQFLHS 120
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFL--ADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
H+ I H DI+ NI+ + + + +FG A+ + ++ R + + Y APE
Sbjct: 121 HN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR---LLFTAPEYYAPE 173
Query: 934 ------YGYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRI 967
+D++S G ++ +L+G P T+ +I
Sbjct: 174 VHQHDVVST------ATDMWSLGTLVYVLLSGINPFLAETNQQI 211
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 57/194 (29%), Positives = 82/194 (42%), Gaps = 15/194 (7%)
Query: 441 IPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQL 499
IP I +L L SN S L +L L L++N+ +P I L
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 500 EMVDLHQNKLQGTIPSSL-EFLFGLNVLDLSMNSIGGTIPENL-GKLTSLNKLVLSKNNI 557
E + + NKLQ +P + + L L L L N + ++P + LT L L L N +
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 558 TGLIPKSL--GLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSWNALTGPIPESF 614
L PK + L L+ L L +N++ +PE +L L L L N L +F
Sbjct: 146 QSL-PKGVFDKLTS-LKELRLYNNQLK-RVPEGAFDKLTELKTL-KLDNNQLKRVPEGAF 201
Query: 615 SNLSKLANLDLSNN 628
+L KL L L N
Sbjct: 202 DSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 19/181 (10%)
Query: 475 LTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEF--LFGLNVLDLSMN 531
L+L N+ + +P + T+L ++ L+ NKLQ T+P+ + F L L L ++ N
Sbjct: 39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI-FKELKNLETLWVTDN 95
Query: 532 SIGGTIPENL-GKLTSLNKLVLSKNNITGL---IPKSLGLCKDLQLLDLSSNRINGSIPE 587
+ +P + +L +L +L L +N + L + SL L L L N + S+P+
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLT---KLTYLSLGYNELQ-SLPK 150
Query: 588 EI-GRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSL 646
+ +L L L L N L +F L++L L L NN L + G+ D+L L
Sbjct: 151 GVFDKLTSLKEL-RLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE--GAFDSLEKL 207
Query: 647 N 647
Sbjct: 208 K 208
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 57/194 (29%), Positives = 82/194 (42%), Gaps = 19/194 (9%)
Query: 393 NIPELAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEI-GGCTG 450
NIP + LDL N L+ S+PS F L L L L N+ +P I
Sbjct: 34 NIP-----ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 451 LIRLRLGSNNFSGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNK 508
L L + N +P + L L L L NQ +PP + + T+L + L N+
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 509 LQGTIPSSLEF--LFGLNVLDLSMNSIGGTIPENL-GKLTSLNKLVLSKNNITGLIPKSL 565
LQ ++P + F L L L L N + +PE KLT L L L N + + +
Sbjct: 145 LQ-SLPKGV-FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAF 201
Query: 566 GLCKDLQLLDLSSN 579
+ L++L L N
Sbjct: 202 DSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 52/234 (22%), Positives = 82/234 (35%), Gaps = 59/234 (25%)
Query: 88 FSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEI-GKLAELELLSLNS 146
+ L L + L+ A L+ L L L+ N L +P I +L LE L +
Sbjct: 36 PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94
Query: 147 NSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE 205
N + +P + L L L NQL ++P
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPR------------------------- 127
Query: 206 ISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEI-GNCSALENLF 264
VF LT L LS+ + +P+ + ++L+ L
Sbjct: 128 -------VFDS----------------LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELR 163
Query: 265 LYENQIFGKIPDEL-GSLKNLKRLLLWQNNLSGSIPE-ALGNCSSLTVIDVSLN 316
LY NQ+ ++P+ L LK L L N L +PE A + L ++ + N
Sbjct: 164 LYNNQL-KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 38/229 (16%)
Query: 117 NLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGN 176
++D S LT IP I A+ + L L SN + + +KLR L L DN+L
Sbjct: 20 SVDCSSKKLTA-IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-T 75
Query: 177 IPAEI-GQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSV-GELT 234
+PA I +L+ LE L + D + +P V +L
Sbjct: 76 LPAGIFKELKNLE-------------------------TLWVTDNKLQ-ALPIGVFDQLV 109
Query: 235 NLRTLSVYTANITGYIPEEI-GNCSALENLFLYENQIFGKIPDEL-GSLKNLKRLLLWQN 292
NL L + + +P + + + L L L N++ +P + L +LK L L+ N
Sbjct: 110 NLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNN 167
Query: 293 NLSGSIPE-ALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGN 340
L +PE A + L + + N L + +L L+ L L N
Sbjct: 168 QLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 40/136 (29%), Positives = 63/136 (46%), Gaps = 8/136 (5%)
Query: 233 LTNLRTLSVYTANITGYIPEEI-GNCSALENLFLYENQIFGKIPDEL-GSLKNLKRLLLW 290
LT LR L + + +P I LE L++ +N++ +P + L NL L L
Sbjct: 60 LTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLD 117
Query: 291 QNNLSGSIPE-ALGNCSSLTVIDVSLNSLGGEVPVSL-ANLVALEELLLSGNNISGEIPS 348
+N L S+P + + LT + + N L +P + L +L+EL L N +
Sbjct: 118 RNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEG 175
Query: 349 FFGNFSRLKQLELDNN 364
F + LK L+LDNN
Sbjct: 176 AFDKLTELKTLKLDNN 191
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 6e-17
Identities = 65/235 (27%), Positives = 98/235 (41%), Gaps = 62/235 (26%)
Query: 756 VVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI 814
+DT ++G G G+VY+ S +++A+KK+ L ++ + E+Q + +
Sbjct: 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKL 104
Query: 815 RHKNIVRLLGC-CNNGRTRL-----LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA 868
H NIVRL ++G + L+ DY+ ++ SR K L V
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-----VYR---VARHYSRAKQTLPVI 156
Query: 869 H----------GLAYLH-HDCVPPIIHRDIKSNNILVGPQFEAF-LADFGLAKLFESSES 916
+ LAY+H I HRDIK N+L+ P L DFG AK E
Sbjct: 157 YVKLYMYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 917 SRASNSVAGSYGYI------APE-----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
+ + YI APE Y+ I DV+S G VL E+L G+
Sbjct: 213 NVS---------YICSRYYRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 66/274 (24%), Positives = 114/274 (41%), Gaps = 39/274 (14%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
G+G G V V + + +AVK + + + PE E+ + H+N+V+ G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHENVVKFYGH 73
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK---IILGVAHGLAYLHHDCVPPI 882
G + L +Y S G L + + D++ ++ GV YLH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---I 126
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYSL 938
HRDIK N+L+ + ++DFGLA +F + R N + G+ Y+APE +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH- 185
Query: 939 KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER-KREFTTILDRQLL 997
E DV+S G+VL +L G+ P D + E + +++ +++
Sbjct: 186 --AEPVDVWSCGIVLTAMLAGELPWD----QPSDSCQ----EYSDWKEKKTYLNPWKKID 235
Query: 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ ++L N P R T+ D+
Sbjct: 236 SAPLALLHKILV--------EN--PSARITIPDI 259
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-17
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 33/212 (15%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVR 821
+GKG G V V+ ++++ A+K + + ER++ E+Q + + H +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYM---NKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH-HD 877
L + ++ D + G L L + F + + ++++ L YL
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA----LDYLQNQR 135
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---- 933
IIHRD+K +NIL+ + DF +A + ++AG+ Y+APE
Sbjct: 136 ----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSS 188
Query: 934 ---YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
GYS + D +S GV E+L G+ P
Sbjct: 189 RKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 50/174 (28%), Positives = 69/174 (39%), Gaps = 17/174 (9%)
Query: 465 IPSRIGLLHRLTFLELSENQFTGEIPPEI--GNCTQLEMVDLHQNKLQGTIPS-SLEFLF 521
+P L L+LS N + + E T L + L N L I S + +
Sbjct: 33 VPQ--SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 522 GLNVLDLSMNSIGGTIPEN-LGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNR 580
L LDLS N + T+ E L +L L+L N+I + + LQ L LS N+
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 581 INGSIPEEI----GRLQGLDILLNLSWNALTGPIPESFSNLSKL--ANLDLSNN 628
I+ P E+ +L L LL+LS N L L L L NN
Sbjct: 148 IS-RFPVELIKDGNKLPKLM-LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 40/170 (23%), Positives = 61/170 (35%), Gaps = 23/170 (13%)
Query: 332 LEELLLSGNNISGEIPS--FFGNFSRLKQLELDNNRFFGQIPP----TIGQLKELLLFFA 385
L LS NN+S + + + L L L +N I + L+ L L
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLS-- 96
Query: 386 WQNQLHGNIPE--LAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIP 442
N LH + E + L+ L L +N + V + F ++ L +L L N+ S P
Sbjct: 97 -SNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFP 152
Query: 443 PEI----GGCTGLIRLRLGSNNFSGHIPSRIGLLHRLT--FLELSENQFT 486
E+ L+ L L SN + + L L L N
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 36/139 (25%), Positives = 51/139 (36%), Gaps = 15/139 (10%)
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSL--GLCKDLQLLDLSSNRINGSIPEEIGRLQ 593
+P++L T+ L LS NN++ L + L L L LS N +N I
Sbjct: 32 NVPQSLPSYTA--LLDLSHNNLSRLRAEWTPTRLTN-LHSLLLSHNHLN-FISS--EAFV 85
Query: 594 GLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSL--KVLGSLDNLVSLNVS 649
+ L L+LS N L FS+L L L L NN + + + L L +S
Sbjct: 86 PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144
Query: 650 YNHFSGILPNTKLFHGLPA 668
N S
Sbjct: 145 QNQISRFPVEL--IKDGNK 161
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 47/245 (19%), Positives = 80/245 (32%), Gaps = 72/245 (29%)
Query: 58 CNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP--AIGNLSSL 115
C + + CS+ ++ ++P S P S+ L LS+ NL+ + L++L
Sbjct: 18 CASNILSCSKQQLP----NVPQSLP------SYTALLDLSHNNLS-RLRAEWTPTRLTNL 66
Query: 116 INLDLSFNALTGNIPEEI-GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQL 173
+L LS N L I E + L L L+SN +H + + + L L LY+N +
Sbjct: 67 HSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI 124
Query: 174 SGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGEL 233
+ F +
Sbjct: 125 V-VVDRN--------------------------------AFED----------------M 135
Query: 234 TNLRTLSVYTANITGYIPEEI----GNCSALENLFLYENQIFGKIPDELGSLKNLKRLLL 289
L+ L + I+ P E+ L L L N++ +L L + L
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 290 W-QNN 293
+ NN
Sbjct: 195 YLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 25/120 (20%), Positives = 49/120 (40%), Gaps = 12/120 (10%)
Query: 87 SFSHLTSLV---LSNANLTGEIPPAI-GNLSSLINLDLSFNALTGNIPEEI-GKLAELEL 141
+F + +L LS+ +L + + +L +L L L N + + +A+L+
Sbjct: 83 AFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQK 140
Query: 142 LSLNSN---SIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEAL--EIIRAGGNP 196
L L+ N + ++ KL L+L N+L ++ +L A + NP
Sbjct: 141 LYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 48/255 (18%), Positives = 79/255 (30%), Gaps = 82/255 (32%)
Query: 118 LDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREI--GNCSKLRRLELYDNQLSG 175
L S L N+P+ + + LL L+ N++ + E + L L L N L+
Sbjct: 23 LSCSKQQLP-NVPQSL--PSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLN- 77
Query: 176 NIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTN 235
I +E F+ + N
Sbjct: 78 FISSE--------------------------------AFVPV----------------PN 89
Query: 236 LRTLSVYTANITGYIPEEI-GNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNN 293
LR L + + ++ + E + + ALE L LY N I + + L++L L QN
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 294 LSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNF 353
+S E + + + L L L LS N + +
Sbjct: 148 ISRFPVELIKDGNKLP---------------------KLMLLDLSSNKLKKLPLTDLQKL 186
Query: 354 SRLKQ--LELDNNRF 366
+ L L NN
Sbjct: 187 PAWVKNGLYLHNNPL 201
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 61/282 (21%), Positives = 106/282 (37%), Gaps = 60/282 (21%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
GKG V I + + +A+K + + + EV+ + + H NIV+L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK---IILGVAHGLAYLHHDCVPPI 882
+T L+ +Y S G + L + ++R K I+ V Y H I
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCHQKR---I 135
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY----GYSL 938
+HRD+K+ N+L+ +ADFG + F A G+ Y APE Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPPYAAPELFQGKKYDG 192
Query: 939 KITEKSDVYSYGVVLLEVLTGKEPTDS--------RIPDGA-HIITWVNGELRERKREFT 989
+ DV+S GV+L +++G P D R+ G I +++ +
Sbjct: 193 P---EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN------ 243
Query: 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
++ L + P +R T++ +
Sbjct: 244 -------------LLKRFLVL----------NPIKRGTLEQI 262
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVR 821
+GKG G V V+ + + A+K L K + +D+ + E + L + RH +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKIL---KKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 822 LLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHD 877
L RL + +Y + G L L ++VF + +R+ +I+ L YLH +
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LDYLHSE 267
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---- 933
+++RD+K N+++ + DFGL K E + + G+ Y+APE
Sbjct: 268 K--NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 934 --YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
YG ++ D + GVV+ E++ G+ P
Sbjct: 324 NDYGRAV------DWWGLGVVMYEMMCGRLP 348
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 70/351 (19%), Positives = 129/351 (36%), Gaps = 78/351 (22%)
Query: 737 NELEWDF-TPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYR---VEIPSRQVIAVKKLWP 792
+++++DF V+D+ VG+G G VY+ + + A+K++
Sbjct: 1 DKMDYDFKVKLSSERERVEDLFEYEGCK--VGRGTYGHVYKAKRKDGKDDKDYALKQI-- 56
Query: 793 VKNGELPERDQFSA----EVQTLGSIRHKNIVRLLG-CCNNGRTRL-LLFDYISNGSLAG 846
E S E+ L ++H N++ L ++ ++ LLFDY + L
Sbjct: 57 -------EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWH 108
Query: 847 LLHEKKVFLDWDSRYKIILGVA--------HGLAYLHHDCVPPIIHRDIKSNNILVGPQF 898
++ + ++ G+ G+ YLH + ++HRD+K NILV +
Sbjct: 109 IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEG 165
Query: 899 EAF----LADFGLAKLFESSESSRAS-NSVAGSYGYIAPE--YG---YSLKITEKSDVYS 948
+AD G A+LF S A + V ++ Y APE G Y+ I D+++
Sbjct: 166 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWA 221
Query: 949 YGVVLLEVLTGK-----------------------------EPTDSRIPDGAHIITWVNG 979
G + E+LT + P D D +
Sbjct: 222 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL 281
Query: 980 ELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKD 1030
R+ +T + + + + L LL ++ P +R T +
Sbjct: 282 MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD--PIKRITSEQ 330
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 65/274 (23%), Positives = 113/274 (41%), Gaps = 39/274 (14%)
Query: 767 GKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
G+G G V + + +AVK + + + PE E+ + H+N+V+ G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHENVVKFYGH 73
Query: 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK---IILGVAHGLAYLHHDCVPPI 882
G + L +Y S G L + + D++ ++ GV YLH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---I 126
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYSL 938
HRDIK N+L+ + ++DFGLA +F + R N + G+ Y+APE +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH- 185
Query: 939 KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER-KREFTTILDRQLL 997
E DV+S G+VL +L G+ P D + E + +++ +++
Sbjct: 186 --AEPVDVWSCGIVLTAMLAGELPWD----QPSDSCQ----EYSDWKEKKTYLNPWKKID 235
Query: 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ ++L N P R T+ D+
Sbjct: 236 SAPLALLHKILV--------EN--PSARITIPDI 259
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 47/227 (20%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLG 824
G GV+G V + Q A+K L + + EV +IV +L
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLL--------YDSPKARQEVDHHWQASGGPHIVCILD 89
Query: 825 CC---NNGRTRLLL-FDYISNGSLAGLLHEKKVFLDWDSRY------KIILGVAHGLAYL 874
++G+ LL+ + + G L + E+ D + +I+ + + +L
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERG-----DQAFTEREAAEIMRDIGTAIQFL 144
Query: 875 HHDCVPPIIHRDIKSNNIL-VGPQFEAFL--ADFGLAKLFESSESSRASNSVAGSYGYIA 931
H I HRD+K N+L + +A L DFG AK + + + Y+A
Sbjct: 145 HSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYVA 197
Query: 932 PE----YGYSLKITEKSDVYSYGVVLLEVLTGKEP----TDSRIPDG 970
PE Y + D++S GV++ +L G P T I G
Sbjct: 198 PEVLGPEKY----DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG 240
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-16
Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 63/241 (26%)
Query: 750 NFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEV 808
+ + ++ ++G G G+V++ + S +V A+KK+ L ++ + E+
Sbjct: 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKV-------LQDKRFKNREL 83
Query: 809 QTLGSIRHKNIVRLLGC-----CNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRYK 862
Q + ++H N+V L L L+ +Y+ ++ ++ K
Sbjct: 84 QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-----VYR---ASRHYAKLK 135
Query: 863 IILGVAH----------GLAYLH-HDCVPPIIHRDIKSNNILVGPQFEAF-LADFGLAKL 910
+ + LAY+H I HRDIK N+L+ P L DFG AK+
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191
Query: 911 FESSESSRASNSVAGSYGYI------APE-----YGYSLKITEKSDVYSYGVVLLEVLTG 959
+ E + + YI APE Y+ I D++S G V+ E++ G
Sbjct: 192 LIAGEPNVS---------YICSRYYRAPELIFGATNYTTNI----DIWSTGCVMAELMQG 238
Query: 960 K 960
+
Sbjct: 239 Q 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-16
Identities = 54/233 (23%), Positives = 86/233 (36%), Gaps = 50/233 (21%)
Query: 755 DVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLW---PVKNGELPERDQFSAEVQT 810
+ R + G+G G V E + +A+KK+ +N EL +Q
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-------QIMQD 72
Query: 811 LGSIRHKNIVRLLGC-CNNGRTRL------LLFDYISNGSLAGLLHEKKVFLDWDSRYKI 863
L + H NIV+L G ++ +Y+ + LH R ++
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-----LHR---CCRNYYRRQV 124
Query: 864 ILGVAH----------GLAYLHHDCVPPIIHRDIKSNNILVGPQ-FEAFLADFGLAKLFE 912
+ LH V + HRDIK +N+LV L DFG AK
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 913 SSESSRASNSVAGSYGYIAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
SE + + Y Y APE Y+ + D++S G + E++ G+
Sbjct: 184 PSEPN--VAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQF--SA--EVQTLGSIRHKN 818
+G G VY+ + + +A+K++ +L + +A E+ + ++H+N
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKELKHEN 64
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVF-----LDWDSRYKIILGVAHGLAY 873
IVRL + L+F+++ N L + + V L+ + + GLA+
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
H + I+HRD+K N+L+ + + L DFGLA+ F + S+ V + Y AP+
Sbjct: 124 CHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWYRAPD 178
Query: 934 --YG---YSLKITEKSDVYSYGVVLLEVLTGK 960
G YS I D++S G +L E++TGK
Sbjct: 179 VLMGSRTYSTSI----DIWSCGCILAEMITGK 206
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA--EV---QTLGSIRHK 817
+G G G VY+ + S +A+K + G S EV + L + H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 818 NIVRLL----GCCNNGRTRLLL-FDYISNGSLAGLL-HEKKVFLDWDSRYKIILGVAHGL 871
N+VRL+ + ++ L F+++ L L L ++ ++ GL
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 872 AYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIA 931
+LH +C I+HRD+K NILV LADFGLA+++ S + V + Y A
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVVVTLW-YRA 187
Query: 932 PE--YG--YSLKITEKSDVYSYGVVLLEVLTGK 960
PE Y+ + D++S G + E+ K
Sbjct: 188 PEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-15
Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 43/252 (17%)
Query: 729 FRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAV 787
F ++ L+W + Q + D D ++G+G G V+ ++ + ++ A
Sbjct: 162 FLDSLYFLRFLQWKWLEAQPM--GEDW----FLDFRVLGRGGFGEVFACQMKATGKLYAC 215
Query: 788 KKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVRLLGCCNNGRTRL-LLFDYISNGS 843
KKL L +R + E + L + + IV L +T L L+ ++ G
Sbjct: 216 KKL---NKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGD 271
Query: 844 L----AGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP 896
+ + + F + + + +I+ G L +LH II+RD+K N+L+
Sbjct: 272 IRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENVLLDD 324
Query: 897 QFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------YGYSLKITEKSDVYSYG 950
++D GLA E + AG+ G++APE Y +S+ D ++ G
Sbjct: 325 DGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV------DYFALG 376
Query: 951 VVLLEVLTGKEP 962
V L E++ + P
Sbjct: 377 VTLYEMIAARGP 388
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-15
Identities = 60/252 (23%), Positives = 108/252 (42%), Gaps = 44/252 (17%)
Query: 729 FRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVE-IPSRQVIAV 787
F E+D+ +W + +++D S I+G+G G VY + ++ A+
Sbjct: 165 FIESDKFTRFCQWKNVELNI-HLTMND----FSVHRIIGRGGFGEVYGCRKADTGKMYAM 219
Query: 788 KKLWPVKNGELPERDQFS---AEVQTLGSIRHKN---IVRLLGCCNNGRTRL-LLFDYIS 840
K L + + + E L + + IV + + +L + D ++
Sbjct: 220 KCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMN 275
Query: 841 NGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ 897
G L L + VF + D R+ +IILG L ++H+ +++RD+K NIL+
Sbjct: 276 GGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMHNRF---VVYRDLKPANILLDEH 328
Query: 898 FEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-------YGYSLKITEKSDVYSYG 950
++D GLA F + ++ G++GY+APE Y S D +S G
Sbjct: 329 GHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSA------DWFSLG 378
Query: 951 VVLLEVLTGKEP 962
+L ++L G P
Sbjct: 379 CMLFKLLRGHSP 390
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 52/227 (22%), Positives = 82/227 (36%), Gaps = 55/227 (24%)
Query: 767 GKGVSGIVYRVE-IPSRQVIAVK-----KLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
G+G G V V + AVK KL + NGE E+Q L +RHKN++
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGE----ANVKKEIQLLRRLRHKNVI 69
Query: 821 RL---------------LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK--- 862
+L + C G + D + +
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFP----------VCQAHGYFCQ 117
Query: 863 IILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922
+I G+ YLH I+H+DIK N+L+ ++ G+A+ + +
Sbjct: 118 LIDGL----EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 923 VAGSYGYIAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
GS + PE +S K D++S GV L + TG P +
Sbjct: 171 SQGSPAFQPPEIANGLDTFS---GFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 62/250 (24%), Positives = 99/250 (39%), Gaps = 30/250 (12%)
Query: 727 TTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNI---VGKGVSGIVYRV-EIPSR 782
R+N +N L K+ D+ + D + +G+G G V V +R
Sbjct: 39 PALRKNKNIDNFLSRYKDTINKIR----DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR 94
Query: 783 QVIAVKKLWPVKNGELPERDQ---FSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI 839
+V A+K L E+ +R F E + +V+L + R ++ +Y+
Sbjct: 95 KVYAMKLL---SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151
Query: 840 SNGSLAGLLHEKKVFLDWDSRY--KIILGVAHGLAYLH-HDCVPPIIHRDIKSNNILVGP 896
G L L+ V W Y +++L L +H IHRD+K +N+L+
Sbjct: 152 PGGDLVNLMSNYDVPEKWARFYTAEVVLA----LDAIHSMG----FIHRDVKPDNMLLDK 203
Query: 897 QFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYSLKITEKSDVYSYGVV 952
LADFG R ++ G+ YI+PE G + D +S GV
Sbjct: 204 SGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 953 LLEVLTGKEP 962
L E+L G P
Sbjct: 263 LYEMLVGDTP 272
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 53/256 (20%), Positives = 98/256 (38%), Gaps = 37/256 (14%)
Query: 727 TTFRENDEEENELEW---DFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSR 782
+ ++ + L+W +++ DD ++G+G V V +
Sbjct: 31 SELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEIL----KVIGRGAFSEVAVVKMKQTG 86
Query: 783 QVIAVKKLWPVKNGELPERDQ---FSAEVQTLGSIRHKNIVRLLGCCNNGRTRL-LLFDY 838
QV A+K + ++ +R + F E L + + I +L L L+ +Y
Sbjct: 87 QVYAMKIM---NKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEY 142
Query: 839 ISNGSLAGLL-HEKKVFLDWDSRY---KIILGVAHGLAYLH-HDCVPPIIHRDIKSNNIL 893
G L LL + +R+ +I++ + +H +HRDIK +NIL
Sbjct: 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVHRLG----YVHRDIKPDNIL 194
Query: 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVY------ 947
+ LADFG + + R S G+ Y++PE ++ + Y
Sbjct: 195 LDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDW 253
Query: 948 -SYGVVLLEVLTGKEP 962
+ GV E+ G+ P
Sbjct: 254 WALGVFAYEMFYGQTP 269
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 64/250 (25%), Positives = 98/250 (39%), Gaps = 70/250 (28%)
Query: 807 EVQTLGSIRHKNIVRL---------------LGCCNNGRTRLLLFDYISNGSLAGLLHEK 851
E+ L + H N+V+L N G + + + L E
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----VMEVPTLKPL----SED 137
Query: 852 ---KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908
F D +I G+ YLH+ IIHRDIK +N+LVG +ADFG++
Sbjct: 138 QARFYFQD------LIKGIE----YLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 909 KLFESSESSRASNSVAGSYGYIAPE------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
F+ S+ + SN+ G+ ++APE +S K DV++ GV L + G+ P
Sbjct: 185 NEFKGSD-ALLSNT-VGTPAFMAPESLSETRKIFSGK---ALDVWAMGVTLYCFVFGQCP 239
Query: 963 -TDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPC 1021
D RI L + I + L I E L+ L +L N
Sbjct: 240 FMDERIM-----------CLHSK------IKSQALEFPDQPDIAEDLKDLITRMLDKN-- 280
Query: 1022 PEERPTMKDV 1031
PE R + ++
Sbjct: 281 PESRIVVPEI 290
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 53/347 (15%), Positives = 105/347 (30%), Gaps = 79/347 (22%)
Query: 91 LTSLVLSNANLTGE----IPPAIGNLSSLINLDLSFNALTGN----IPEEIGKLAELELL 142
+ L +T E + + S+ + LS N + + E I +LE+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 143 SLNSNSIHGGIPREIG-----------NCSKLRRLELYDNQLSGNIPAEIGQLEALEIIR 191
+ G + EI C KL + L DN +
Sbjct: 66 EFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF------- 117
Query: 192 AGGNPGIHGEIPEEISNCKVLVFLGLADTGIS-------------GQIPRSVGELTNLRT 238
+S L L L + G+ + + LR+
Sbjct: 118 --------------LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 163
Query: 239 LSVYTANITG----YIPEEIGNCSALENLFLYENQIFGK-----IPDELGSLKNLKRLLL 289
+ + + + L + + +N I + + + L + LK L L
Sbjct: 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDL 223
Query: 290 WQNNLSG----SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVA------LEELLLSG 339
N + ++ AL + +L + ++ L ++ + + L+ L L
Sbjct: 224 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 283
Query: 340 NNISGE-----IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELL 381
N I + L LEL+ NR F + + +++E+
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNR-FSEEDDVVDEIREVF 329
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 59/361 (16%), Positives = 111/361 (30%), Gaps = 76/361 (21%)
Query: 302 LGNCSSLTVIDVSLNSLGGE----VPVSLANLVALEELLLSGNNISGE----IPSFFGNF 353
+ S+ + L+++ E V L +++E++LSGN I E + +
Sbjct: 1 MAR-FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 354 SRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFL 413
L+ E + F G++ I + LLL L C KL + LS N
Sbjct: 60 KDLEIAEFSDI-FTGRVKDEIPEALRLLL------------QALLKCPKLHTVRLSDNAF 106
Query: 414 TG----SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRI 469
+ L L L L +N + ++ + +
Sbjct: 107 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ------AGA-----KIARALQELAVNKKA 155
Query: 470 GLLHRLTFLELSENQFTGE----IPPEIGNCTQLEMVDLHQNKL-----QGTIPSSLEFL 520
L + N+ + L V + QN + + + L +
Sbjct: 156 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215
Query: 521 FGLNVLDLSMNSIGGT----IPENLGKLTSLNKLVLSKNNITG----LIPKSLGLCKDLQ 572
L VLDL N+ + L +L +L L+ ++ + + +++
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275
Query: 573 L--LDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNML 630
L L L N I + L + + L L+L+ N
Sbjct: 276 LQTLRLQYNEIEL---------DAVRTLKT----VID-------EKMPDLLFLELNGNRF 315
Query: 631 T 631
+
Sbjct: 316 S 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 59/384 (15%), Positives = 109/384 (28%), Gaps = 84/384 (21%)
Query: 254 IGNCSALENLFLYENQI----FGKIPDELGSLKNLKRLLLWQNNLSG----SIPEALGNC 305
+ S +E L + I + L ++K ++L N + + E + +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 306 SSLTVIDVSLNSLGGEVPVSLANLVA----------LEELLLSGNNISGE----IPSFFG 351
L + + S G L L + LS N + F
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 352 NFSRLKQLELDNNRFFGQIPPTIG-----QLKELLLFFAWQNQLHGNIPELAYCVKLQAL 406
+ L+ L L NN +G ++ L A + L+++
Sbjct: 120 KHTPLEHLYLHNNG--------LGPQAGAKIARALQELAVNKKAKNAP-------PLRSI 164
Query: 407 DLSHNFLTG----SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFS 462
N L + + + L + ++ N E G L+ L
Sbjct: 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE------GIEHLLLEGLAYCQ-- 216
Query: 463 GHIPSRIGLLHRLTFLELSENQFTGE----IPPEIGNCTQLEMVDLHQNKLQGT----IP 514
L L+L +N FT + + + L + L+ L +
Sbjct: 217 -----------ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265
Query: 515 SSLEFLF--GLNVLDLSMNSIGGTIPENLG-----KLTSLNKLVLSKNNIT--GLIPKSL 565
+ L GL L L N I L K+ L L L+ N + + +
Sbjct: 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEI 325
Query: 566 G-LCKDLQLLDLSSNRINGSIPEE 588
+ +L + +E
Sbjct: 326 REVFSTRGRGELDELDDMEELTDE 349
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 61/328 (18%), Positives = 100/328 (30%), Gaps = 88/328 (26%)
Query: 85 LLSFSHLTSLVLSNA---NLTGEIPP-------AIGNLSSLINLDLSFNALTGNIPEEIG 134
+ S L S+ + EIP A+ L + LS NA E +
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115
Query: 135 KLAE----LELLSLNSNSI-------------HGGIPREIGNCSKLRRLELYDNQLSGNI 177
LE L L++N + + ++ N LR + N+L
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL---- 171
Query: 178 PAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLR 237
N + + + ++L + + GI R G
Sbjct: 172 ----------------ENGSMKE-WAKTFQSHRLLHTVKMVQNGI-----RPEG------ 203
Query: 238 TLSVYTANITGYIPEEIGNCSALENLFLYENQIFGK----IPDELGSLKNLKRLLLWQNN 293
I + E + C L+ L L +N + L S NL+ L L
Sbjct: 204 --------IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255
Query: 294 LSG----SIPEALGNCS--SLTVIDVSLNSLGGEVPVSLA-----NLVALEELLLSGNNI 342
LS ++ +A L + + N + + +L + L L L+GN
Sbjct: 256 LSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
Query: 343 S------GEIPSFFGNFSRLKQLELDNN 364
S EI F R + ELD+
Sbjct: 316 SEEDDVVDEIREVFSTRGRGELDELDDM 343
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 52/287 (18%), Positives = 90/287 (31%), Gaps = 74/287 (25%)
Query: 403 LQALDLSHNFLTG----SVPSSLFNLKNLTQLLLISNRFSGE----IPPEIGGCTGLIRL 454
++ L + +T SV + L ++ +++L N E + I L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 455 RLGSNNFSGHIPSRIGL-----------LHRLTFLELSENQFTGE----IPPEIGNCTQL 499
S+ F+G + I +L + LS+N F + + T L
Sbjct: 66 EF-SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 500 EMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPE-----NLGKLTSLNKLVLSK 554
E + LH N L + I + E L ++ +
Sbjct: 125 EHLYLHNNGLG----------------PQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 555 NNITG----LIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPI 610
N + K+ + L + + N I R +G++ LL
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGI---------RPEGIEHLLL---------- 209
Query: 611 PESFSNLSKLANLDLSNNMLT--GSL---KVLGSLDNLVSLNVSYNH 652
E + +L LDL +N T GS L S NL L ++
Sbjct: 210 -EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 32/208 (15%), Positives = 59/208 (28%), Gaps = 41/208 (19%)
Query: 475 LTFLELSENQFTGE----IPPEIGNCTQLEMVDLHQNKL--QGT--IPSSLEFLFGLNVL 526
+ L + T E + + ++ + L N + + + ++ L +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 527 DLSMNSIGGTIPEN----------LGKLTSLNKLVLSKNNITG----LIPKSLGLCKDLQ 572
+ S G E L K L+ + LS N + L L+
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 573 LLDLSSNRINGSIPEEIGR-LQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLT 631
L L +N + +I R LQ L + L ++ N L
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNA-------------PPLRSIICGRNRLE 172
Query: 632 --GSL---KVLGSLDNLVSLNVSYNHFS 654
K S L ++ + N
Sbjct: 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIR 200
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 7e-15
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVR 821
+GKG G V V + + A+K L + + +D+ + E + L + RH +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKIL---RKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 822 LLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH-H 876
L RL + +Y + G L L ++VF + +R+ +I+ L YLH
Sbjct: 70 LK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA----LEYLHSR 124
Query: 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--- 933
D +++RDIK N+++ + DFGL K E + G+ Y+APE
Sbjct: 125 D----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLE 178
Query: 934 ---YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
YG ++ D + GVV+ E++ G+ P
Sbjct: 179 DNDYGRAV------DWWGLGVVMYEMMCGRLP 204
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-15
Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 42/215 (19%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLG 824
G G++G V + +++ A+K L + + EV+ + +IVR++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIVD 122
Query: 825 CCNNGRTR----LLLFDYISNGSLAGLLHEKKVFLDWDSRY------KIILGVAHGLAYL 874
N L++ + + G L + ++ D + +I+ + + YL
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYL 177
Query: 875 HHDCVPPIIHRDIKSNNIL-VGPQFEAFL--ADFGLAKLFESSESSRASNSVAGSYGYIA 931
H I HRD+K N+L + A L DFG AK S S + + Y+A
Sbjct: 178 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVA 231
Query: 932 PE----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
PE Y + D++S GV++ +L G P
Sbjct: 232 PEVLGPEKYD----KSCDMWSLGVIMYILLCGYPP 262
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 1e-14
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVR 821
+G G G V+ + + + A+K L K + Q E L + H I+R
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVL---KKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH-HD 877
+ G + + ++ DYI G L LL + + F + +++ ++ L L YLH D
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEYLHSKD 126
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE---- 933
II+RD+K NIL+ + DFG AK + ++ G+ YIAPE
Sbjct: 127 ----IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVST 177
Query: 934 YGYSLKITEKS-DVYSYGVVLLEVLTGKEP 962
Y+ KS D +S+G+++ E+L G P
Sbjct: 178 KPYN-----KSIDWWSFGILIYEMLAGYTP 202
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 54/250 (21%), Positives = 100/250 (40%), Gaps = 46/250 (18%)
Query: 729 FRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNI---VGKGVSGIVYRV-EIPSRQV 784
F +E+ +W+ +L + +G G G V V S
Sbjct: 18 FLAKAKEDFLKKWETPSQNTA---------QLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 785 IAVKKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISN 841
A+K L ++ + Q E + L ++ +V+L + ++ +Y++
Sbjct: 69 YAMKIL---DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 842 GSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH-HDCVPPIIHRDIKSNNILVGPQ 897
G + L F + +R+ +I+L YLH D +I+RD+K N+L+ Q
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHSLD----LIYRDLKPENLLIDQQ 177
Query: 898 FEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYSLKITEKS-DVYSYGVV 952
+ DFG AK + ++ G+ +APE GY+ K+ D ++ GV+
Sbjct: 178 GYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYN-----KAVDWWALGVL 227
Query: 953 LLEVLTGKEP 962
+ E+ G P
Sbjct: 228 IYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 37/214 (17%)
Query: 766 VGKGVSGIVYRVE----IPSRQVIAVKKLWPVKNGELPERDQF--SAEVQTLGSIRHKNI 819
+G+G G V+ V+ +RQ+ A+K L K L RD+ E L + H I
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 820 VRLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH 875
V+L +L L+ D++ G L L ++ +F + D ++ ++ L L +LH
Sbjct: 89 VKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA----LDHLH 143
Query: 876 -HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE- 933
II+RD+K NIL+ + L DFGL+K ES + + + S G+ Y+APE
Sbjct: 144 SLG----IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEV 197
Query: 934 -----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ S D +S+GV++ E+LTG P
Sbjct: 198 VNRRGHTQSA------DWWSFGVLMFEMLTGTLP 225
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-14
Identities = 54/250 (21%), Positives = 103/250 (41%), Gaps = 42/250 (16%)
Query: 729 FRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAV 787
+ ++ L+W + Q + + + ++GKG G V ++ + ++ A
Sbjct: 161 YLDSIYFNRFLQWKWLERQPV--TKNT----FRQYRVLGKGGFGEVCACQVRATGKMYAC 214
Query: 788 KKLWPVKNGELPERDQFS---AEVQTLGSIRHKNIVRLLGCCNNGRTRL-LLFDYISNGS 843
KKL + + +R + E Q L + + +V L + L L+ ++ G
Sbjct: 215 KKL---EKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGD 270
Query: 844 LAGLLHE--KKVFLDWDSRY---KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF 898
L ++ + F + + + +I G L LH + I++RD+K NIL+
Sbjct: 271 LKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRER---IVYRDLKPENILLDDHG 323
Query: 899 EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE------YGYSLKITEKSDVYSYGVV 952
++D GLA E G+ GY+APE Y +S D ++ G +
Sbjct: 324 HIRISDLGLAV--HVPEGQTI-KGRVGTVGYMAPEVVKNERYTFSP------DWWALGCL 374
Query: 953 LLEVLTGKEP 962
L E++ G+ P
Sbjct: 375 LYEMIAGQSP 384
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 36/230 (15%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFS 805
++ S V+ R + +G G GIV + + +A+KKL P ++Q
Sbjct: 14 VEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR------PFQNQTH 67
Query: 806 A-----EVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD-YI---------SNGSLAGLLHE 850
A E+ + + HKNI+ LL ++ D YI L HE
Sbjct: 68 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 127
Query: 851 KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910
+ +L Y+++ G+ +LH + IHRD+K +NI+V + DFGLA+
Sbjct: 128 RMSYL----LYQML----CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 911 FESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGK 960
+S + V Y Y APE + E D++S G ++ E++ G
Sbjct: 177 AGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 764 NIVGKGVSGIVYRV--EIPSRQVIAVKKLWPVKNGE-LPERDQFSA--EV---QTLGSIR 815
+G+G G V++ + +A+K++ E +P S EV + L +
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFE 72
Query: 816 HKNIVRLL----GCCNNGRTRLLL-FDYISNGSLAGLL-HEKKVFLDWDSRYKIILGVAH 869
H N+VRL + T+L L F+++ L L + + ++ ++ +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GL +LH ++HRD+K NILV + LADFGLA+++ S ++ V + Y
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLW-Y 185
Query: 930 IAPE--YG--YSLKITEKSDVYSYGVVLLEVLTGK 960
APE Y+ + D++S G + E+ K
Sbjct: 186 RAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 79/292 (27%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVK---KLWPVKNGELPERDQFSAEVQTLGSIRHK--NIV 820
G G G VY + + +A+K K GELP + EV L + ++
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 821 RLLGCCNNGRTRLL----------LFDYISNGSLAGLLHEKKVFLDWDSRYK---IILGV 867
RLL + +L LFD+I+ G L E+ +R ++ V
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEE------LARSFFWQVLEAV 162
Query: 868 AHGLAYLHHDCVPPIIHRDIKSNNILV-GPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
+ H+ V +HRDIK NIL+ + E L DFG L + + + G+
Sbjct: 163 R----HCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGT 211
Query: 927 YGYIAPEY----GYSLKITEKSDVYSYGVVLLEVLTGKEP--TDSRIPDGA-HIITWVNG 979
Y PE+ Y + + V+S G++L +++ G P D I G V+
Sbjct: 212 RVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 268
Query: 980 ELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
E + L I+ L + P +RPT +++
Sbjct: 269 EC------------QHL-------IRWCLAL----------RPSDRPTFEEI 291
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 61/219 (27%), Positives = 88/219 (40%), Gaps = 47/219 (21%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL--- 822
G G G V + +AVK L K L + E+Q L RH +I++L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 823 ----------LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK---IILGVAH 869
+ + G LFDYI G + E ++R I+ V
Sbjct: 80 ISTPTDFFMVMEYVSGGE----LFDYICK---HGRVEEM------EARRLFQQILSAVD- 125
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
Y H ++HRD+K N+L+ A +ADFGL+ + E R S GS Y
Sbjct: 126 ---YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNY 176
Query: 930 IAPE----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
APE Y+ + D++S GV+L +L G P D
Sbjct: 177 AAPEVISGRLYA---GPEVDIWSCGVILYALLCGTLPFD 212
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 63/262 (24%), Positives = 102/262 (38%), Gaps = 33/262 (12%)
Query: 718 IILFIRFRGTTFRENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNI---VGKGVSGIV 774
I L+ + R LEW + V + D I +G+G G V
Sbjct: 35 ICLYDECNNSPLRREKNILEYLEW----AKPFTSKVKQMRLHREDFEILKVIGRGAFGEV 90
Query: 775 YRV-EIPSRQVIAVKKLWPVKNGELPERDQ---FSAEVQTLGSIRHKNIVRLLGCCNNGR 830
V + +V A+K L E+ +R + F E L + K I L +
Sbjct: 91 AVVKLKNADKVFAMKIL---NKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147
Query: 831 TRLLLFDYISNGSLAGLLH-EKKVFLDWDSRY---KIILGVAHGLAYLH-HDCVPPIIHR 885
L+ DY G L LL + + +R+ ++++ + +H +HR
Sbjct: 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA----IDSVHQLH----YVHR 199
Query: 886 DIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-----YGYSLKI 940
DIK +NIL+ LADFG + + S+ G+ YI+PE G +
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRY 258
Query: 941 TEKSDVYSYGVVLLEVLTGKEP 962
+ D +S GV + E+L G+ P
Sbjct: 259 GPECDWWSLGVCMYEMLYGETP 280
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-14
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 36/222 (16%)
Query: 755 DVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA-----EV 808
V+ R + +G G GIV + + +A+KKL P ++Q A E+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR------PFQNQTHAKRAYREL 112
Query: 809 QTLGSIRHKNIVRLL------GCCNNGRTRLLLFDY----ISNGSLAGLLHEKKVFLDWD 858
+ + HKNI+ LL + L+ + + L HE+ +L
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL--- 169
Query: 859 SRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918
Y+++ G + +LH + IHRD+K +NI+V + DFGLA+ +S
Sbjct: 170 -LYQMLCG----IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM- 220
Query: 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGK 960
+ V Y Y APE + E D++S G ++ E++ K
Sbjct: 221 -TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 6e-14
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 765 IVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSI-RHKNI 819
++GKG G V E + ++ AVK L K + + D E + L + +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 820 VRLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
+L C RL + +Y++ G L + + F + + + +A GL +L
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAAEIAIGLFFLQSK- 461
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE----- 933
II+RD+K +N+++ + +ADFG+ K E+ + + G+ YIAPE
Sbjct: 462 --GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 934 -YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
YG S+ D +++GV+L E+L G+ P
Sbjct: 518 PYGKSV------DWWAFGVLLYEMLAGQAP 541
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 38/214 (17%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
G+G G V ++Q +A+K + + + E+ L +RH +I++L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 826 CNNGRTRLL--------LFDYISNGSLAGLLHEKKVFLDWDSRYK---IILGVAHGLAYL 874
++ LFDYI + E + R II + Y
Sbjct: 78 ITTPTDIVMVIEYAGGELFDYIVE---KKRMTED------EGRRFFQQIICAI----EYC 124
Query: 875 HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE- 933
H I+HRD+K N+L+ +ADFGL+ + + S GS Y APE
Sbjct: 125 HRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEV 178
Query: 934 ---YGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
Y+ + DV+S G+VL +L G+ P D
Sbjct: 179 INGKLYA---GPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 766 VGKGVSGIVYRVEIP----SRQVIAVK---KLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
+GKG G V++V + ++ A+K K V+N + + AE L ++H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK--DTAHTKAERNILEEVKHPF 82
Query: 819 IVRLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYL 874
IV L+ +L L+ +Y+S G L L + +F++ + + +I + L +L
Sbjct: 83 IVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA----LGHL 137
Query: 875 H-HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE 933
H II+RD+K NI++ Q L DFGL K ES +++ G+ Y+APE
Sbjct: 138 HQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPE 191
Query: 934 ------YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ ++ D +S G ++ ++LTG P
Sbjct: 192 ILMRSGHNRAV------DWWSLGALMYDMLTGAPP 220
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 66/219 (30%), Positives = 90/219 (41%), Gaps = 47/219 (21%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL--- 822
G G G V + +AVK L K L + E+Q L RH +I++L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 823 ----------LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK---IILGVAH 869
+ + G LFDYI G L EK +SR I+ GV
Sbjct: 85 ISTPSDIFMVMEYVSGGE----LFDYICK---NGRLDEK------ESRRLFQQILSGVD- 130
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
Y H V +HRD+K N+L+ A +ADFGL+ + E R S GS Y
Sbjct: 131 ---YCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNY 181
Query: 930 IAPE----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
APE Y+ + D++S GV+L +L G P D
Sbjct: 182 AAPEVISGRLYA---GPEVDIWSSGVILYALLCGTLPFD 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 37/217 (17%)
Query: 766 VGKGVSGIVYRVEIP----SRQVIAVK---KLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
+G G G V+ V + ++ A+K K V+ + E + E Q L IR
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR--TERQVLEHIRQSP 119
Query: 819 -IVRLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAY 873
+V L T+L L+ DYI+ G L L +++ F + + + +I+L L +
Sbjct: 120 FLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA----LEH 174
Query: 874 LH-HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAP 932
LH II+RDIK NIL+ L DFGL+K F + E+ RA G+ Y+AP
Sbjct: 175 LHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YDFCGTIEYMAP 229
Query: 933 E------YGYSLKITEKS-DVYSYGVVLLEVLTGKEP 962
+ G+ K+ D +S GV++ E+LTG P
Sbjct: 230 DIVRGGDSGHD-----KAVDWWSLGVLMYELLTGASP 261
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 56/218 (25%), Positives = 84/218 (38%), Gaps = 47/218 (21%)
Query: 767 GKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
G G G+ + +++++AVK + + E+ S+RH NIVR
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYI----ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 826 CNNGRTRLL----------LFDYISNGSLAGLLHEKKVFLDWDSRYK---IILGVAHGLA 872
T L L++ I N AG E ++R+ ++ GV +
Sbjct: 85 ILT-PTHLAIIMEYASGGELYERICN---AGRFSED------EARFFFQQLLSGV----S 130
Query: 873 YLHHDCVPPIIHRDIKSNNILVGPQFEAFL--ADFGLAKLFESSESSRASNSVAGSYGYI 930
Y H + HRD+K N L+ L DFG +K S G+ YI
Sbjct: 131 YCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYI 184
Query: 931 APE----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
APE Y K +DV+S GV L +L G P +
Sbjct: 185 APEVLLRQEYDGK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 51/248 (20%), Positives = 82/248 (33%), Gaps = 66/248 (26%)
Query: 761 SDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
S +G G GIV +I S + A+KK+ + R E+ + + H NI
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN--R-----ELDIMKVLDHVNI 62
Query: 820 VRLLGC---CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSR---------------- 860
++L+ + + N
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 861 --YKII---------LGVAH----------GLAYLH-HDCVPPIIHRDIKSNNILVGPQF 898
+K++ + + + ++H I HRDIK N+LV +
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICHRDIKPQNLLVNSKD 178
Query: 899 EAF-LADFGLAKLFESSESSRASNSVAGSYGYIAPE-----YGYSLKITEKSDVYSYGVV 952
L DFG AK SE S + + Y APE Y+ I D++S G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPS--VAYICSRF-YRAPELMLGATEYTPSI----DLWSIGCV 231
Query: 953 LLEVLTGK 960
E++ GK
Sbjct: 232 FGELILGK 239
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 3e-13
Identities = 65/475 (13%), Positives = 141/475 (29%), Gaps = 62/475 (13%)
Query: 206 ISNCKVLVFLGLADTGISGQIPRSVGEL----TNLRTLSVYTANITGYIPEEI--GNCSA 259
+ L G + V E+ L+++ ++ + +
Sbjct: 80 LKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADD 139
Query: 260 LENLFLYENQIFG--KIPDELGSLKNLKRLLLWQNNLSGSIPEALG----NCSSLTVIDV 313
LE L L + F + + + +K LL+ +++ S + L + +SL V++
Sbjct: 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNF 199
Query: 314 SLNSLGGEVPVSLANLVA----LEELLLSGNNIS--GEIPSFFGNFSRLKQLELDNNRFF 367
+ P L + L + + I N L+ +
Sbjct: 200 YMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGM 259
Query: 368 GQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSH-NFLTGSVPSSLFNLKN 426
+ + ++L + + +++ LDL + T + + N
Sbjct: 260 PEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN 319
Query: 427 LTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFT 486
L L + + C L RLR+ + GL+ + + L++
Sbjct: 320 LEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ---- 375
Query: 487 GEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTS 546
C +LE + ++ ++ + S+ SIG L L
Sbjct: 376 --------GCQELEYMAVY----------------VSDITNESLESIG----TYLKNLCD 407
Query: 547 LNKLVLSKNNITGLIPKSLGL------CKDLQLLDLSSN--RINGSIPEEIGRLQGLDIL 598
++L + +P G+ CK L+ + IG+
Sbjct: 408 FRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRW 467
Query: 599 LNLSWNALTGP-IPESFSNLSKLANLDLSNNMLT--GSLKVLGSLDNLVSLNVSY 650
+ L + + + E L L++ + + L +L L V
Sbjct: 468 MLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQG 522
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 53/310 (17%), Positives = 96/310 (30%), Gaps = 38/310 (12%)
Query: 89 SHLTSLVLSNANLT--GEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNS 146
L S+ + + + A NL L+ + + +L L L S
Sbjct: 220 RSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL-S 278
Query: 147 NSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEI----GQLEALEIIRAGGNPGIHGEI 202
+P +++R+L+L L + LE LE G+ G+
Sbjct: 279 YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLE--- 335
Query: 203 PEEISNCKVLVFLGLADTGISGQIPRSVGELT------------NLRTLSVYTANITGYI 250
CK L L + + G ++ L ++VY ++IT
Sbjct: 336 -VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNES 394
Query: 251 PEEIG-NCSALENLFLYENQIFGKIPDE---------LGSLKNLKRLLLWQN--NLSGSI 298
E IG L + L +I D L K L+R + L+
Sbjct: 395 LESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454
Query: 299 PEALG-NCSSLTVIDVSLNSLGGEVPVSLA-NLVALEELLLSGNNISGE-IPSFFGNFSR 355
+G ++ + + E + + L++L + G S I +
Sbjct: 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPS 514
Query: 356 LKQLELDNNR 365
L+ L + R
Sbjct: 515 LRYLWVQGYR 524
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 31/236 (13%), Positives = 71/236 (30%), Gaps = 19/236 (8%)
Query: 433 ISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLL----HRLTFLELSENQFTGE 488
+S RF ++ G L N+ G++ + + +L + +
Sbjct: 68 LSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDL 127
Query: 489 IPPEI--GNCTQLEMVDLHQNKLQGT--IPSSLEFLFGLNVLDLSMNSIG-------GTI 537
+ LE + L + T + S + + L + +S +
Sbjct: 128 DLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHEL 187
Query: 538 PENLGKLTSLNKLVLSKNNITGLIPKSLGL-CKDLQLLDLSSNRI--NGSIPEEIGRLQG 594
++ L LN + I+ +++ C+ L + + I + L+
Sbjct: 188 AQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEE 247
Query: 595 LDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSY 650
+L+ + + KL L LS + + L++ Y
Sbjct: 248 FC-GGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLY 302
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 39/257 (15%), Positives = 86/257 (33%), Gaps = 32/257 (12%)
Query: 89 SHLTSLVLSNANL-TGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLA-ELELLSLNS 146
+ + L L A L T + I +L L+ N + E + + +L+ L +
Sbjct: 293 AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIER 351
Query: 147 NSIHGGIPREIG------------NCSKLRRLELYDNQLSGNIPAEIGQ----LEALEII 190
+ G+ E G C +L + +Y + ++ IG L ++
Sbjct: 352 GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411
Query: 191 RAGGNPGIHGEIPEE-----ISNCKVLVFLGLAD--TGISGQIPRSVGEL-TNLRTLSVY 242
I + + CK L G++ +G+ N+R + +
Sbjct: 412 LLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLG 471
Query: 243 TANITGYIPEEIG-NCSALENLFLYENQIFGK-IPDELGSLKNLKRLLL--WQNNLSGSI 298
+ E C L+ L + + I + L +L+ L + ++ +++G
Sbjct: 472 YVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQD 531
Query: 299 PEALG-NCSSLTVIDVS 314
+ ++ +I
Sbjct: 532 LMQMARPYWNIELIPSR 548
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 44/177 (24%), Positives = 70/177 (39%), Gaps = 22/177 (12%)
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
VA G+ +L IHRD+ + NIL+ + + DFGLA+
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 927 YGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERK 985
++APE + T +SDV+S+GV+L E+ + G P + + R R
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG-VKIDEEFCRRLKEGTRMRA 317
Query: 986 REFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042
++TT Q ML C + P +RPT ++ L + N
Sbjct: 318 PDYTTPEMYQT----------MLD-------CWHGEPSQRPTFSELVEHLGNLLQAN 357
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 12/103 (11%)
Query: 759 RLSDTNIVGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNG-ELPERDQFSAEVQTL 811
RL +G+G G V + + + +AVK L K G E +E++ L
Sbjct: 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKIL 79
Query: 812 GSI-RHKNIVRLLGCCN-NGRTRLLLFDYISNGSLAGLLHEKK 852
I H N+V LLG C G +++ ++ G+L+ L K+
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-13
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 36/213 (16%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSI-RHKNIV 820
+GKG G V + + AVK L K + + D E + L H +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVL---KKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 821 RLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH- 875
+L C RL + ++++ G L + + + F + +R+ +II L +LH
Sbjct: 88 QLFCCFQT-PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA----LMFLHD 142
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-- 933
II+RD+K +N+L+ + LADFG+ K E + + + G+ YIAPE
Sbjct: 143 KG----IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEIL 196
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
YG ++ D ++ GV+L E+L G P
Sbjct: 197 QEMLYGPAV------DWWAMGVLLYEMLCGHAP 223
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 50/145 (34%), Positives = 69/145 (47%), Gaps = 11/145 (7%)
Query: 488 EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL-GKLTS 546
EIP + + L QN ++ P + L +DLS N I + + L S
Sbjct: 25 EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 547 LNKLVLSKNNITGLIPKSL--GLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSW 603
LN LVL N IT L PKSL GL LQLL L++N+IN + + L L+ LL+L
Sbjct: 82 LNSLVLYGNKITEL-PKSLFEGLFS-LQLLLLNANKIN-CLRVDAFQDLHNLN-LLSLYD 137
Query: 604 NALTGPIPESFSNLSKLANLDLSNN 628
N L +FS L + + L+ N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 34/154 (22%), Positives = 60/154 (38%), Gaps = 28/154 (18%)
Query: 404 QALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFS 462
+ L N + +P F K L ++ L +N+ S E+ P+ F
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA---------------FQ 77
Query: 463 GHIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLF 521
G L L L L N+ T E+P + L+++ L+ NK+ + + L
Sbjct: 78 G--------LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLH 128
Query: 522 GLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKN 555
LN+L L N + L ++ + L++N
Sbjct: 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 40/137 (29%), Positives = 59/137 (43%), Gaps = 12/137 (8%)
Query: 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
IP NL ++ ++ L +N I + P + K L+ +DLS+N+I+ + QGL
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP--DAFQGL 79
Query: 596 DIL--LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLK--VLGSLDNLVSLNVSYN 651
L L L N +T F L L L L+ N + L+ L NL L++ N
Sbjct: 80 RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138
Query: 652 HFSGILPNTKLFHGLPA 668
I T F L A
Sbjct: 139 KLQTIAKGT--FSPLRA 153
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 32/140 (22%), Positives = 58/140 (41%), Gaps = 19/140 (13%)
Query: 306 SSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLE---LD 362
++T I + N++ P + + L + LS N IS E+ F L+ L L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP--DAFQGLRSLNSLVLY 88
Query: 363 NNRFFGQIPPTI----GQLKELLLFFAWQNQLHGNIPELAYC--VKLQALDLSHNFLTGS 416
N+ ++P ++ L+ LLL N+++ + A+ L L L N L +
Sbjct: 89 GNK-ITELPKSLFEGLFSLQLLLLN---ANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-T 142
Query: 417 VPSSLF-NLKNLTQLLLISN 435
+ F L+ + + L N
Sbjct: 143 IAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 39/165 (23%), Positives = 63/165 (38%), Gaps = 38/165 (23%)
Query: 58 CNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLI 116
C+ + + C + IPT+ P +T + L + IPP A L
Sbjct: 11 CSNNIVDCRGKGLT----EIPTNLP------ETITEIRLEQNTIK-VIPPGAFSPYKKLR 59
Query: 117 NLDLSFNALT-------------------GN----IPEEI-GKLAELELLSLNSNSIHGG 152
+DLS N ++ GN +P+ + L L+LL LN+N I+
Sbjct: 60 RIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-C 118
Query: 153 IPREI-GNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNP 196
+ + + L L LYDN+L L A++ + NP
Sbjct: 119 LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNP 163
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 29/130 (22%), Positives = 56/130 (43%), Gaps = 8/130 (6%)
Query: 215 LGLADTGISGQIPRSV-GELTNLRTLSVYTANITGYIPEEI-GNCSALENLFLYENQIFG 272
+ L I IP LR + + I+ + + +L +L LY N+I
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-T 93
Query: 273 KIPDEL-GSLKNLKRLLLWQNNLSGSIPE-ALGNCSSLTVIDVSLNSLGGEVPVSLANLV 330
++P L L +L+ LLL N ++ + A + +L ++ + N L + + L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 331 ALEELLLSGN 340
A++ + L+ N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 36/186 (19%), Positives = 61/186 (32%), Gaps = 59/186 (31%)
Query: 128 NIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEAL 187
N+P + + L N+I P KLRR++L +NQ+S
Sbjct: 29 NLP------ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS------------- 69
Query: 188 EIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANIT 247
E+ + F G L +L +L +Y IT
Sbjct: 70 -------------ELAPD-------AFQG----------------LRSLNSLVLYGNKIT 93
Query: 248 GYIPEEI-GNCSALENLFLYENQIFGKIPDEL-GSLKNLKRLLLWQNNLSGSIPEALGNC 305
+P+ + +L+ L L N+I + + L NL L L+ N L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 306 SSLTVI 311
++ +
Sbjct: 152 RAIQTM 157
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 7e-13
Identities = 102/621 (16%), Positives = 194/621 (31%), Gaps = 170/621 (27%)
Query: 95 VLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIP 154
+LS EI I + ++ F L EE+ + E+L +N + I
Sbjct: 45 ILSKE----EIDHIIMSKDAVSGTLRLFWTLLSK-QEEMVQKFVEEVLRINYKFLMSPIK 99
Query: 155 REIGNCSKLRRL------ELY-DNQL--SGNIP--AEIGQL-EALEIIRAGGNPGIHGEI 202
E S + R+ LY DNQ+ N+ +L +AL +R N I G
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG-- 157
Query: 203 PEEISNC-K-VLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGN-CSA 259
+ K + + ++ + L++ N + E +
Sbjct: 158 ---VLGSGKTWVALDVCLSYKVQCKMDFKI------FWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 260 LENLFLYENQIFGKIPDELGSLKN-LKRLLLWQ---NNL-------SGSIPEALG-NCSS 307
++ + + I + S++ L+RLL + N L + A +C
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI 268
Query: 308 L-TVIDVSL-NSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLEL---- 361
L T + + L ++L+ ++ E+ S + + +L
Sbjct: 269 LLTTRFKQVTDFLSAATTTH----ISLDHHSMTLT--PDEVKSLLLKYLDCRPQDLPREV 322
Query: 362 -DNNRFFGQIPPTIGQLKELLLFFA--WQNQLHGNIPELAYCVKLQALDLSHNFLTGSVP 418
N P + + E + W N H N +L ++ S N L P
Sbjct: 323 LTTN------PRRLSIIAESIRDGLATWDNWKHVNCDKLT-----TIIESSLNVLE---P 368
Query: 419 SSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFL 478
+ + + L + F P S HIP+ LL + +
Sbjct: 369 A---EYRKMFDRLSV---F-----PP-----------------SAHIPT--ILLSLI-WF 397
Query: 479 ELSENQFTGEIPPEIGN-CTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTI 537
++ + + N + +V+ + +IPS ++ L+L +
Sbjct: 398 DVIK-----SDVMVVVNKLHKYSLVEKQPKESTISIPS----IY----LELKVK------ 438
Query: 538 PENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGR-LQGLD 596
EN +L++ ++ N IPK D DL ++ IG L+ ++
Sbjct: 439 LEN---EYALHRSIVDHYN----IPK--TFDSD----DLIPPYLDQYFYSHIGHHLKNIE 485
Query: 597 ----------ILLNLSWNALTGPIPESFSNL-SKLANLDLSNNMLTGSLKVLGSLDNLVS 645
+ L+ + L K+ + + N L L L
Sbjct: 486 HPERMTLFRMVFLDFRF-------------LEQKIRHDSTAWNASGSILNTLQQLKF--- 529
Query: 646 LNVSYNHFSGILPNTKLFHGL 666
Y + I N + L
Sbjct: 530 ----YKPY--ICDNDPKYERL 544
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 9e-09
Identities = 70/491 (14%), Positives = 156/491 (31%), Gaps = 111/491 (22%)
Query: 610 IPESFSNLSKLANLD---LSNNMLTGSLKVLGSL----DNLV------SLNVSYN----- 651
+ + ++ +D +S + ++G+L++ +L + +V L ++Y
Sbjct: 38 VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP 97
Query: 652 -HFSGILP--NTKLFHGLPASAFYGNQQLC---VNRSQCH--INNSLHGRNSTKNLIICA 703
P T+++ + NQ V+R Q + + +L KN++I
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 704 LL----SVTVTLFIVLFGIILFIRFRG--TTFRENDEEENELEWDFTPFQKLNFSVDDVV 757
+L + + + + + F+ + + E LE QKL + +D
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE----MLQKLLYQIDPNW 213
Query: 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEV--------Q 809
T SD S I R+ ++ + K P +N L + +A+ +
Sbjct: 214 TSRSD------HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK 267
Query: 810 TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHE--KKVFLDWDSRYKIILGV 867
L + R K + L T + L + L + K + L + L
Sbjct: 268 ILLTTRFKQVTDFLS--AATTTHISL-----DHHSMTLTPDEVKSLLLKY-------LDC 313
Query: 868 AHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADF-GLAKLFESSESSRASNSVAGS 926
+P R++ + N + D ++ + + + S
Sbjct: 314 RP-------QDLP----REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362
Query: 927 YGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR 986
+ P E ++ V P + IP + W + +
Sbjct: 363 LNVLEPA--------EYRKMFDRLSVF--------PPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI-------- 1038
+ L+ + + + + + L E + +++ A+ + I
Sbjct: 407 VVNKLHKYSLVEKQPK--ESTISIPSIYL-------ELKVKLENEYALHRSIVDHYNIPK 457
Query: 1039 RHENDDLEKPN 1049
++DDL P
Sbjct: 458 TFDSDDLIPPY 468
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 4e-06
Identities = 52/364 (14%), Positives = 103/364 (28%), Gaps = 101/364 (27%)
Query: 8 IILLFVNISLFPAISALNPEGLSLLSWLSTFNSSSSATFFSSW---------------NP 52
I+L + +SA +SL T + + NP
Sbjct: 268 ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 53 ---------SHRNPCNWDYIK---CSRTEIAI-TSIHI--PTSFP--YQLLS-FSHLTSL 94
WD K C + I +S+++ P + + LS F
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP----- 382
Query: 95 VLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIP 154
+A+ IP + LS + + + + + + +L SL +
Sbjct: 383 --PSAH----IPTIL--LSLI------WFDVIKSDVMVV--VNKLHKYSL--------VE 418
Query: 155 REIGNCSKLRRLELYDNQLSGNIPAEIGQ------LEALEIIRAGGNPGIHGEIPEEISN 208
++ K + + L + E ++ I + + IP +
Sbjct: 419 KQ----PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDS---DDLIPPYLDQ 471
Query: 209 CKVLVFLG--LADTGISGQIP--RSVGELTNLRTL------SVYTANITGYIPEEIGNCS 258
+G L + ++ R V + R L N +G I +
Sbjct: 472 -YFYSHIGHHLKNIEHPERMTLFRMV--FLDFRFLEQKIRHDSTAWNASGSI------LN 522
Query: 259 ALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSL 318
L+ L Y+ I P + + L I E L ++ ++L +
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNAILDFLP-------KIEENLICSKYTDLLRIALMAE 575
Query: 319 GGEV 322
+
Sbjct: 576 DEAI 579
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 64/294 (21%), Positives = 102/294 (34%), Gaps = 81/294 (27%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVK---KLWPVKNGELPERDQFSAEVQTLGSIR----HKN 818
GKG G V+ + R +A+K + + L + EV L + H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 819 IVRLLGCCNNGRTRLL----------LFDYISNGSLAGLLHEKKVFLDWDSRYK---IIL 865
++RLL +L LFDYI+ G L E SR ++
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEG------PSRCFFGQVVA 150
Query: 866 GVAHGLAYLHHDCVPPIIHRDIKSNNILV-GPQFEAFLADFGLAKLFESSESSRASNSVA 924
+ + H V +HRDIK NIL+ + A L DFG L +
Sbjct: 151 AIQ----HCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF----D 199
Query: 925 GSYGYIAPEY----GYSLKITEKSDVYSYGVVLLEVLTGKEP--TDSRIPDGA-HIITWV 977
G+ Y PE+ Y + V+S G++L +++ G P D I + H V
Sbjct: 200 GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256
Query: 978 NGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ + L I+ L P RP+++++
Sbjct: 257 SPDC------------CAL-------IRRCLAP----------KPSSRPSLEEI 281
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 37/152 (24%), Positives = 63/152 (41%), Gaps = 25/152 (16%)
Query: 508 KLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGL 567
+ + + + E + L + I + L L + L LS NNI + SL
Sbjct: 16 ERKSVVATEAEKV----ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSG 68
Query: 568 CKDLQLLDLSSNRINGSIPEEIGRLQGLDIL------LNLSWNALTGPIPESFSNLSKLA 621
++L++L L N I +++ LD + L +S+N + L L
Sbjct: 69 MENLRILSLGRNLIK--------KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLR 118
Query: 622 NLDLSNNMLT--GSLKVLGSLDNLVSLNVSYN 651
L +SNN +T G + L +LD L L ++ N
Sbjct: 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 14/156 (8%)
Query: 492 EIGNCTQLEMVDLHQ--NKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNK 549
+ T+ E V+LH ++ + ++L L L LS N+I I +L + +L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRI 74
Query: 550 LVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL--LNLSWNALT 607
L L +N I I + L+ L +S N+I + ++ L L L +S N +T
Sbjct: 75 LSLGRNLIKK-IENLDAVADTLEELWISYNQI-----ASLSGIEKLVNLRVLYMSNNKIT 128
Query: 608 GPIP-ESFSNLSKLANLDLSNNMLTGSLKVLGSLDN 642
+ + L KL +L L+ N L K +
Sbjct: 129 NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 41/160 (25%), Positives = 64/160 (40%), Gaps = 22/160 (13%)
Query: 478 LELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTI 537
L ++ + + + L N ++ I SSL + L +L L N I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI--KK 84
Query: 538 PENLGKLT-SLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLD 596
ENL + +L +L +S N I L + +L++L +S+N+I EI +L LD
Sbjct: 85 IENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITN--WGEIDKLAALD 140
Query: 597 IL--LNLSWNALTGPIPES----------FSNLSKLANLD 624
L L L+ N L E+ L L LD
Sbjct: 141 KLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 31/117 (26%), Positives = 49/117 (41%), Gaps = 8/117 (6%)
Query: 250 IPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLT 309
+ + A ++L L N I KI L ++NL+ L L +N + I +L
Sbjct: 40 MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 310 VIDVSLNSLGGEVPVSLANLVALEELLLSGNNIS--GEIPSFFGNFSRLKQLELDNN 364
+ +S N + + LV L L +S N I+ GEI +L+ L L N
Sbjct: 97 ELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 33/123 (26%), Positives = 50/123 (40%), Gaps = 9/123 (7%)
Query: 325 SLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRF--FGQIPPTIGQLKELLL 382
+L+ L A + L LS NNI +I S L+ L L N + L+EL +
Sbjct: 43 TLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWI 100
Query: 383 FFAWQNQLHGNIPELAYCVKLQALDLSHNFLTG-SVPSSLFNLKNLTQLLLISNRFSGEI 441
NQ+ ++ + V L+ L +S+N +T L L L LLL N +
Sbjct: 101 S---YNQIA-SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156
Query: 442 PPE 444
Sbjct: 157 KEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 34/186 (18%), Positives = 61/186 (32%), Gaps = 41/186 (22%)
Query: 401 VKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNN 460
+ L + + ++L LK L L +N +I
Sbjct: 25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISS------------- 65
Query: 461 FSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFL 520
+ + L L L N +I LE + + N++ ++ S +E L
Sbjct: 66 --------LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKL 114
Query: 521 FGLNVLDLSMNSIGG-TIPENLGKLTSLNKLVLSKNNITGLIPKS----------LGLCK 569
L VL +S N I + L L L L+L+ N + ++ +
Sbjct: 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174
Query: 570 DLQLLD 575
+L+ LD
Sbjct: 175 NLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 27/129 (20%), Positives = 45/129 (34%), Gaps = 32/129 (24%)
Query: 531 NSIGGTIPENLGKLTSLNKLVL--SKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEE 588
++I T K+ L I + +L K + L LS+N I E+
Sbjct: 9 DAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EK 62
Query: 589 IGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSL-DNLVSLN 647
I S S + L L L N++ ++ L ++ D L L
Sbjct: 63 I----------------------SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99
Query: 648 VSYNHFSGI 656
+SYN + +
Sbjct: 100 ISYNQIASL 108
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 64/391 (16%), Positives = 117/391 (29%), Gaps = 91/391 (23%)
Query: 292 NNLSGS-----IPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVA-----LEELLLSGNN 341
L+ + E +T +D+SLN+L V L A + L LSGN+
Sbjct: 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS 62
Query: 342 ISGE-----IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQ--LKELLLFFAWQNQLHGNI 394
+ + + + + L L N + EL+ A
Sbjct: 63 LGFKNSDELVQILAAIPANVTSLNLSGNF--------LSYKSSDELVKTLAAIPF----- 109
Query: 395 PELAYCVKLQALDLSHNFLTGSVPSSLFNL-----KNLTQLLLISNRFSGEIPPEIGGCT 449
+ LDL N + S ++T L L N +
Sbjct: 110 -------TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK------SSD 156
Query: 450 GLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIG-----NCTQLEMVDL 504
LI++ L + + + L L N + E+ + +DL
Sbjct: 157 ELIQI-LAAIPAN------------VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDL 203
Query: 505 HQNKLQGTIPSSLEFLF-----GLNVLDLSMNSIGGT----IPENLGKLTSLNKLVLSKN 555
N L + L ++F + L+L +N + G + L L + L +
Sbjct: 204 SANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYD 263
Query: 556 NITGL-------IPKSLGLCKDLQLLDLSSNRINGS----IPEEIGRLQGLDILLNLSWN 604
+ + + + + + L+D + I+ S I I L G + +L
Sbjct: 264 IVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323
Query: 605 ALT-----GPIPESFSNLSKLANLDLSNNML 630
L E + +L + L
Sbjct: 324 CLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 49/299 (16%), Positives = 97/299 (32%), Gaps = 60/299 (20%)
Query: 397 LAYCVKLQALDLSHNFLTGSVPSSLF-----NLKNLTQLLLISNRFSGEIPPEIGGCTGL 451
+ + +LDLS N L L ++T L L N + L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK------NSDEL 71
Query: 452 IRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIG-----NCTQLEMVDLHQ 506
+++ L + + +T L LS N + + E+ + ++DL
Sbjct: 72 VQI-LAAIPAN------------VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118
Query: 507 NKLQGT----IPSSLEFLF-GLNVLDLSMNSIGGTIPENLGKL-----TSLNKLVLSKNN 556
N + L + L+L N +G + L ++ ++N L L NN
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178
Query: 557 ITGLIPKSLG-----LCKDLQLLDLSSNRINGS----IPEEIGRLQGLDILLNLSWNALT 607
+ L + + LDLS+N + + + + LNL N L
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238
Query: 608 GP----IPESFSNLSKLANLDLSNNMLTGS--------LKVLGSLDNLVSLNVSYNHFS 654
GP + +L L + L +++ ++ ++ ++ +
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 48/337 (14%), Positives = 111/337 (32%), Gaps = 59/337 (17%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIG-----NLSSLINLDLSFNALTGNIPEEIGKL--- 136
+TSL LS NL + +S+ +L+LS N+L +E+ ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 137 --AELELLSLNSNSIHGGIPREIG-----NCSKLRRLELYDNQLSGNIPAEIGQL----- 184
A + L+L+ N + E+ + L+L N S +E Q
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 185 EALEIIRAGGNPGIHGEIPEEIS------NCKVLVFLGLADTGISGQIPRSVGEL----- 233
++ + GN + + +E+ + L L ++ + + +
Sbjct: 138 ASITSLNLRGN-DLGIKSSDELIQILAAIPAN-VNSLNLRGNNLASKNCAELAKFLASIP 195
Query: 234 TNLRTLSVYTANITGYIPEEIG-----NCSALENLFLYENQIFGK----IPDELGSLKNL 284
++ +L + + E+ + + +L L N + G + SLK+L
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 285 KRLLLWQNNLSG-------SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVA-----L 332
+ + L + + ++ A N + ++D + + + ++NL+
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315
Query: 333 EELLLSGNNIS-----GEIPSFFGNFSRLKQLELDNN 364
+ L + L++
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCK 352
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 66/378 (17%), Positives = 110/378 (29%), Gaps = 86/378 (22%)
Query: 108 AIGNLSSLINLDLSFNALTGNIPEEIGKL-----AELELLSLNSNSIHGGIPREIG---- 158
+ +LDLS N L E+ + A + L+L+ NS+ E+
Sbjct: 17 FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 159 -NCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGL 217
+ + L L N LS E+ + L + + L L
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELV--KTLA------------------AIPFTITVLDL 116
Query: 218 ADTGISGQIPRSVGELTN-LRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPD 276
S +S E L S + +L L N + K D
Sbjct: 117 GWNDFS---SKSSSEFKQAFSNL----------------PAS-ITSLNLRGNDLGIKSSD 156
Query: 277 ELGSL-----KNLKRLLLWQNNLS----GSIPEAL-GNCSSLTVIDVSLNSLGGEVPVSL 326
EL + N+ L L NNL+ + + L +S+T +D+S N LG + L
Sbjct: 157 ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAEL 216
Query: 327 A-----NLVALEELLLSGNNISGE----IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQL 377
A + L L N + G + + L+ + LD + + + Q
Sbjct: 217 AYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDI-VKNM--SKEQC 273
Query: 378 KELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRF 437
K L K+ +D + + S + NL
Sbjct: 274 KALGAA-------------FPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSL 320
Query: 438 SGEIPPEIGGCTGLIRLR 455
+ I
Sbjct: 321 LNQCLIFAQKHQTNIEDL 338
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-12
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLG-SIRHKNIV 820
+GKG G V AVK L + + ++ + +E L +++H +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVL---QKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 821 RLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH- 875
L +L + DYI+ G L L ++ FL+ +R+ +I L YLH
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA----LGYLHS 157
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-- 933
+ I++RD+K NIL+ Q L DFGL K E+ E + +++ G+ Y+APE
Sbjct: 158 LN----IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSR 966
Y ++ D + G VL E+L G P SR
Sbjct: 212 HKQPYDRTV------DWWCLGAVLYEMLYGLPPFYSR 242
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 44/225 (19%), Positives = 88/225 (39%), Gaps = 31/225 (13%)
Query: 755 DVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPER---DQFSA----- 806
+ + + + G G V +A+K+++ + D F
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 807 EVQTLGSIRHKNIVRLL-----GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRY 861
E++ L H NI+ L L+ + + LA ++H++++ +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS-PQHI 136
Query: 862 KIIL-GVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920
+ + + GL LH V +HRD+ NIL+ + + DF LA+ + + +
Sbjct: 137 QYFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANK--T 191
Query: 921 NSVAGSYGYIAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
+ V + Y APE G++ + D++S G V+ E+ K
Sbjct: 192 HYVTHRW-YRAPELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSI-RHKNIV 820
+GKG G V E + ++ AVK L K + + D E + L + +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 821 RLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH- 875
+L C RL + +Y++ G L + + F + + + +I +G L +L
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQS 139
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-- 933
II+RD+K +N+++ + +ADFG+ K E+ + + G+ YIAPE
Sbjct: 140 KG----IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEII 193
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
YG S+ D +++GV+L E+L G+ P
Sbjct: 194 AYQPYGKSV------DWWAFGVLLYEMLAGQAP 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 36/213 (16%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLG-SIRHKNIV 820
+GKG G V+ E + Q A+K L K + D E + L + H +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 821 RLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH- 875
+ + L + +Y++ G L + F + + +IILG L +LH
Sbjct: 82 HMFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG----LQFLHS 136
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-- 933
I++RD+K +NIL+ +ADFG+ K E+ +N+ G+ YIAPE
Sbjct: 137 KG----IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEIL 190
Query: 934 ----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
Y +S+ D +S+GV+L E+L G+ P
Sbjct: 191 LGQKYNHSV------DWWSFGVLLYEMLIGQSP 217
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 51/214 (23%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSI-RHKNI 819
++G+G V V + ++ A+K + K + + + E H +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVV---KKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 820 VRLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH 875
V L C +RL + +Y++ G L + ++ + +R+ +I L L YLH
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH 127
Query: 876 -HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE- 933
II+RD+K +N+L+ + L D+G+ K E +++ G+ YIAPE
Sbjct: 128 ERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEI 181
Query: 934 -----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
YG+S+ D ++ GV++ E++ G+ P
Sbjct: 182 LRGEDYGFSV------DWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-12
Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS---AEVQTLGSI-RHKNI 819
++G+G V V + ++ A++ + K + + + E H +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVV---KKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 820 VRLLGCCNNGRTRL-LLFDYISNGSLAGLLHEKKVFLDWDSRY---KIILGVAHGLAYLH 875
V L C +RL + +Y++ G L + ++ + +R+ +I L L YLH
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH 170
Query: 876 -HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE- 933
II+RD+K +N+L+ + L D+G+ K E +++ G+ YIAPE
Sbjct: 171 ERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEI 224
Query: 934 -----YGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
YG+S+ D ++ GV++ E++ G+ P
Sbjct: 225 LRGEDYGFSV------DWWALGVLMFEMMAGRSP 252
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 49/228 (21%)
Query: 755 DVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA-----EV 808
++ VG G G V ++ S + +A+KKL P + + A E+
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR------PFQSEIFAKRAYREL 74
Query: 809 QTLGSIRHKNIVRLL------GCCNNGRTRLLLFDYI----SNGSLAGLLHE-KKVFLDW 857
L ++H+N++ LL N L+ ++ E + +
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-- 132
Query: 858 DSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917
Y+++ GL Y+H V +HRD+K N+ V E + DFGLA+ +
Sbjct: 133 ---YQML----KGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLAR----HADA 178
Query: 918 RASNSVAGSYGYIAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
+ V + Y APE Y+ + D++S G ++ E+LTGK
Sbjct: 179 EMTGYVVTRW-YRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 57/237 (24%), Positives = 106/237 (44%), Gaps = 46/237 (19%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFS 805
+ + V DV R ++ + +G+G G+V + ++ +A+KK+ P ++ +R
Sbjct: 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR---- 71
Query: 806 A--EVQTLGSIRHKNIVRLL-----GCCNNGRTRLLLFDY--------ISNGSLAGLLHE 850
E++ L RH+NI+ + + ++ D + L+ H
Sbjct: 72 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-H- 129
Query: 851 KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910
FL Y+I+ GL Y+H V +HRD+K +N+L+ + + DFGLA++
Sbjct: 130 ICYFL-----YQIL----RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 911 FESSESSRA--SNSVAGSYGYIAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
+ + VA + Y APE GY+ I D++S G +L E+L+ +
Sbjct: 178 ADPDHDHTGFLTEYVATRW-YRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 50/243 (20%), Positives = 101/243 (41%), Gaps = 54/243 (22%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFS 805
+++ +++ +++G+G G+V P+ +++A+KK+ P R
Sbjct: 3 KRIVYNISS---DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR---- 55
Query: 806 A--EVQTLGSIRHKNIVRLL-----GCCNNGRTRLLLFDY--------ISNGSLAGLLHE 850
E++ L +H+NI+ + N ++ + IS L+ H
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD-H- 113
Query: 851 KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910
+ F+ Y+ + + LH V IHRD+K +N+L+ + + DFGLA++
Sbjct: 114 IQYFI-----YQTL----RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 911 FESSESSRASNSVAGSY--GYI------APE-----YGYSLKITEKSDVYSYGVVLLEVL 957
+ S + + + S ++ APE YS + DV+S G +L E+
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELF 217
Query: 958 TGK 960
+
Sbjct: 218 LRR 220
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 49/190 (25%), Positives = 74/190 (38%), Gaps = 31/190 (16%)
Query: 441 IPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNC-TQL 499
+P I T +L L S + + L +LT+L L NQ + + + T+L
Sbjct: 29 VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTEL 85
Query: 500 EMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITG 559
+ L N+L ++P V D LT L+KL L N +
Sbjct: 86 GTLGLANNQLA-SLPL--------GVFD---------------HLTQLDKLYLGGNQLKS 121
Query: 560 LIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSWNALTGPIPESFSNLS 618
L L+ L L++N++ SIP +L L L+LS N L +F L
Sbjct: 122 LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQT-LSLSTNQLQSVPHGAFDRLG 179
Query: 619 KLANLDLSNN 628
KL + L N
Sbjct: 180 KLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 404 QALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFS 462
+ LDL L ++ L LT L L N+ + + T L L L +N +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 463 GHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSL-EF 519
+P + L +L L L NQ +P + T+L+ + L+ N+LQ +IP+ +
Sbjct: 97 S-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 520 LFGLNVLDLSMN---SIGGTIPENLGKLTSL 547
L L L LS N S+ + LGKL ++
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 41/174 (23%), Positives = 64/174 (36%), Gaps = 38/174 (21%)
Query: 489 IPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL-GKLTSL 547
+P I T+ +DL L ++ L L L+L N + T+ + LT L
Sbjct: 29 VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 548 NKLVLSKNNITGL---IPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWN 604
L L+ N + L + L L L L N++ S+P +
Sbjct: 86 GTLGLANNQLASLPLGVFDHL---TQLDKLYLGGNQLK-SLPSGV--------------- 126
Query: 605 ALTGPIPESFSNLSKLANLDLSNNMLTGSL--KVLGSLDNLVSLNVSYNHFSGI 656
F L+KL L L+ N L S+ L NL +L++S N +
Sbjct: 127 ---------FDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSV 170
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 44/180 (24%), Positives = 67/180 (37%), Gaps = 33/180 (18%)
Query: 261 ENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPE-ALGNCSSLTVIDVSLNSLG 319
E L L + L L L L N L ++ + + L + ++ N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 320 GEVPVSL-ANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLK 378
+P+ + +L L++L L GN + F ++LK+L L+ N QL+
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTN-----------QLQ 144
Query: 379 ELLLFFAWQNQLHGNIPELAY--CVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISN 435
+ P A+ LQ L LS N L SVP F L L + L N
Sbjct: 145 SI--------------PAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 44/188 (23%), Positives = 64/188 (34%), Gaps = 39/188 (20%)
Query: 128 NIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEI-GQLEA 186
IP A+ E L L S + +KL L L NQL + A + L
Sbjct: 32 GIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 187 LEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANI 246
L + N ++++ + VF LT L L + +
Sbjct: 85 LGTLGLANN---------QLASLPLGVFDH----------------LTQLDKLYLGGNQL 119
Query: 247 TGYIPEEI-GNCSALENLFLYENQIFGKIPDEL-GSLKNLKRLLLWQNNLSGSIPE-ALG 303
+P + + L+ L L NQ+ IP L NL+ L L N L S+P A
Sbjct: 120 KS-LPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFD 176
Query: 304 NCSSLTVI 311
L I
Sbjct: 177 RLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 23/86 (26%), Positives = 36/86 (41%), Gaps = 8/86 (9%)
Query: 92 TSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEI-GKLAELELLSLNSN--- 147
L L + L L+ L L+L +N L + + L EL L L +N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 148 SIHGGIPREIGNCSKLRRLELYDNQL 173
S+ G+ + ++L +L L NQL
Sbjct: 97 SLPLGVFDHL---TQLDKLYLGGNQL 119
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 24/112 (21%), Positives = 41/112 (36%), Gaps = 5/112 (4%)
Query: 491 PEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKL 550
+ N + +DL K+ I + L + +D S N I + L L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 69
Query: 551 VLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLS 602
+++ N I + DL L L++N + ++ L L L L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLC 119
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 30/134 (22%), Positives = 44/134 (32%), Gaps = 18/134 (13%)
Query: 525 VLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGS 584
++ L+ I +L L I +I +D S N I
Sbjct: 1 MVKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-- 55
Query: 585 IPEEIGRLQGLDIL-----LNLSWNALTGPIPESFSNLSKLANLDLSNNMLT--GSLKVL 637
+L G +L L ++ N + L L L L+NN L G L L
Sbjct: 56 ------KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL 109
Query: 638 GSLDNLVSLNVSYN 651
SL +L L + N
Sbjct: 110 ASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 29/171 (16%), Positives = 49/171 (28%), Gaps = 30/171 (17%)
Query: 263 LFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEV 322
+ L I + + + + L L + I ID S N +
Sbjct: 2 VKLTAELI-EQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RK 56
Query: 323 PVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLL 382
L L+ LL++ N I L +L L NN + +L +L
Sbjct: 57 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS--------LVELGDLD- 107
Query: 383 FFAWQNQLHGNIPELAYCVKLQALDLSHNFLT---GSVPSSLFNLKNLTQL 430
LA L L + N +T ++ + + L
Sbjct: 108 -------------PLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 24/116 (20%), Positives = 36/116 (31%), Gaps = 8/116 (6%)
Query: 84 QLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALT--GNIPEEIGKLAELEL 141
Q + L L + I L +D S N + P L L+
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKT 68
Query: 142 LSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSG-NIPAEIGQLEALEIIRAGGNP 196
L +N+N I L L L +N L + L++L + NP
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 124
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 28/173 (16%), Positives = 50/173 (28%), Gaps = 31/173 (17%)
Query: 406 LDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHI 465
+ L+ + + + N +L L + I + S+N +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDF-SDNEIRKL 57
Query: 466 PSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNV 525
LL RL L ++ N+ L + L N L L L
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDL----- 106
Query: 526 LDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLI---PKSLGLCKDLQLLD 575
+ L L SL L + +N +T + +++LD
Sbjct: 107 -------------DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 26/137 (18%), Positives = 49/137 (35%), Gaps = 29/137 (21%)
Query: 325 SLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFF 384
N V EL L G I I + + ++ +N ++++L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN-----------EIRKL---- 57
Query: 385 AWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFS--GEIP 442
P L +L+ L +++N + L +LT+L+L +N G++
Sbjct: 58 -------DGFPLL---RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLD 107
Query: 443 PEIGGCTGLIRLRLGSN 459
P + L L + N
Sbjct: 108 P-LASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 32/161 (19%), Positives = 48/161 (29%), Gaps = 38/161 (23%)
Query: 159 NCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLA 218
N + R L+L + I +E L + + +
Sbjct: 17 NAVRDRELDLRGYK--------IPVIENLG------------------ATLDQFDAIDFS 50
Query: 219 DTGIS--GQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQI--FGKI 274
D I P L L+TL V I L L L N + G +
Sbjct: 51 DNEIRKLDGFPL----LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL 106
Query: 275 PDELGSLKNLKRLLLWQN---NLSGSIPEALGNCSSLTVID 312
D L SLK+L L + +N N + + V+D
Sbjct: 107 -DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 10/145 (6%)
Query: 488 EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEF--LFGLNVLDLSMNSIGGTIPEN-LGKL 544
+IP I T + L+ N+ + ++ F L L ++ S N I I E
Sbjct: 25 KIPEHIPQYTA--ELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGA 80
Query: 545 TSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSW 603
+ +N+++L+ N + + K + L+ L L SNRI + + L + LL+L
Sbjct: 81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVR-LLSLYD 138
Query: 604 NALTGPIPESFSNLSKLANLDLSNN 628
N +T P +F L L+ L+L N
Sbjct: 139 NQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 36/137 (26%), Positives = 58/137 (42%), Gaps = 14/137 (10%)
Query: 513 IPSSLEFLFGLNVLDLSMNSIGGTIPEN--LGKLTSLNKLVLSKNNITGLIPKSLGLCKD 570
IP L L+ N + KL L K+ S N IT + +
Sbjct: 30 IPQYTA------ELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 571 LQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNM 629
+ + L+SNR+ ++ ++ L+ L L L N +T +SF LS + L L +N
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLK-TLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ 140
Query: 630 LTGSLKVLGSLDNLVSL 646
+T ++ G+ D L SL
Sbjct: 141 IT-TVAP-GAFDTLHSL 155
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 12/130 (9%)
Query: 71 AITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSLINLDLSFNALTGNI 129
T + F L + SN +T +I A S + + L+ N L N+
Sbjct: 43 EFTVLEATGIFK----KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NV 96
Query: 130 PEEI-GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLSGNIPAEI-GQLEA 186
++ L L+ L L SN I + + S +R L LYDNQ++ + L +
Sbjct: 97 QHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS 154
Query: 187 LEIIRAGGNP 196
L + NP
Sbjct: 155 LSTLNLLANP 164
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 30/155 (19%), Positives = 49/155 (31%), Gaps = 26/155 (16%)
Query: 283 NLKRLLLWQNNLSGSIPEAL-GNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNN 341
L L N + + L I+ S N + + + E+LL+ N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 342 ISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCV 401
+ F LK L L +NR + L
Sbjct: 93 LENVQHKMFKGLESLKTLMLRSNR-ITCVGN--DSFIGL--------------------S 129
Query: 402 KLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISN 435
++ L L N +T +V F L +L+ L L++N
Sbjct: 130 SVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 23/102 (22%), Positives = 45/102 (44%), Gaps = 9/102 (8%)
Query: 570 DLQLLDLSSNRINGSIPEEIGRLQGLDIL--LNLSWNALTGPIPESFSNLSKLANLDLSN 627
L L++N + G + L L +N S N +T +F S + + L++
Sbjct: 33 YTAELRLNNNEFT-VLEAT-GIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90
Query: 628 NMLTGSL--KVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLP 667
N L ++ K+ L++L +L + N + + ++ F GL
Sbjct: 91 NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDS--FIGLS 129
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 26/110 (23%), Positives = 47/110 (42%), Gaps = 8/110 (7%)
Query: 402 KLQALDLSHNFLTGSVPSSLFN-LKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSN 459
+L+ ++ S+N +T + F + ++LL SNR + ++ G L L L SN
Sbjct: 58 QLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSN 115
Query: 460 NFSGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQN 507
+ + + L + L L +NQ T + P L ++L N
Sbjct: 116 RIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 23/109 (21%), Positives = 36/109 (33%), Gaps = 4/109 (3%)
Query: 258 SALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPE-ALGNCSSLTVIDVSL 315
L + N+I I + + +LL N L ++ SL + +
Sbjct: 57 PQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRS 114
Query: 316 NSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364
N + S L ++ L L N I+ P F L L L N
Sbjct: 115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 38/215 (17%), Positives = 67/215 (31%), Gaps = 66/215 (30%)
Query: 58 CNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAI-GNLSSLI 116
C + CS ++ IP P + L L+N T I L L
Sbjct: 11 CEGTTVDCSNQKLN----KIPEHIP------QYTAELRLNNNEFTVLEATGIFKKLPQLR 60
Query: 117 NLDLSFNALTGNIPEEI-GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLS 174
++ S N +T +I E + + + L SN + + ++ L+ L L N+++
Sbjct: 61 KINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT 118
Query: 175 GNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELT 234
+ + F+GL +
Sbjct: 119 --------------------------CVGND-------SFIGL----------------S 129
Query: 235 NLRTLSVYTANITGYIPEEI-GNCSALENLFLYEN 268
++R LS+Y IT + +L L L N
Sbjct: 130 SVRLLSLYDNQITT-VAPGAFDTLHSLSTLNLLAN 163
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 52/240 (21%), Positives = 98/240 (40%), Gaps = 59/240 (24%)
Query: 755 DVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA-----EV 808
D+ +R D +G G +G+V+ V+ + +A+KK+ D S E+
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--------VLTDPQSVKHALREI 59
Query: 809 QTLGSIRHKNIVRLL-------GCCNNGRTRLLLFD--YISNGSLAGLLHE--------- 850
+ + + H NIV++ + L + YI + L
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119
Query: 851 --KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-EAFLADFGL 907
++F+ Y+++ GL Y+H V +HRD+K N+ + + + DFGL
Sbjct: 120 EHARLFM-----YQLL----RGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 908 AKLFESSESSRA--SNSVAGSYGYIAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
A++ + S + S + + Y +P Y+ I D+++ G + E+LTGK
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKW-YRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 46/227 (20%)
Query: 755 DVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA-----EV 808
+V D VG G G V V+ + +A+KKL+ P + + A E+
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR------PFQSELFAKRAYREL 75
Query: 809 QTLGSIRHKNIVRLL------GCCNNGRTRLLLFDY--------ISNGSLAGLLHEKKVF 854
+ L +RH+N++ LL ++ L+ + + + L +
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE--DRIQFL 133
Query: 855 LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914
+ Y+++ GL Y+H + IHRD+K N+ V E + DFGLA+
Sbjct: 134 V-----YQML----KGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR----Q 177
Query: 915 ESSRASNSVAGSYGYIAPEYGYSLKI-TEKSDVYSYGVVLLEVLTGK 960
S + V + Y APE + T+ D++S G ++ E++TGK
Sbjct: 178 ADSEMTGYVVTRW-YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 49/234 (20%)
Query: 404 QALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSG 463
+L +T + L ++ Q++ ++ I + L LG N
Sbjct: 22 IKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLH- 76
Query: 464 HIPSRIGLLHRLT---FLELSENQFTGEIPPEIGNC-TQLEMVDLHQNKLQGTIPSSLEF 519
I L LT +L L+ NQ +P + + T L+ + L +N+LQ ++P
Sbjct: 77 ----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPD---- 126
Query: 520 LFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPK---SLGLCKDLQLLDL 576
V D KLT+L L L+ N + L L +L LDL
Sbjct: 127 ----GVFD---------------KLTNLTYLNLAHNQLQSLPKGVFDKLT---NLTELDL 164
Query: 577 SSNRINGSIPEEI-GRLQGLDILLNLSWNALTGPIPE-SFSNLSKLANLDLSNN 628
S N++ S+PE + +L L L L N L +P+ F L+ L + L +N
Sbjct: 165 SYNQLQ-SLPEGVFDKLTQLKDL-RLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 441 IPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLE 500
P + + + L + + ++ L + + + + + I +
Sbjct: 13 FPDDAF-AETI-KANLKKKSVT-DAVTQNEL-NSIDQIIANNSDIKSV--QGIQYLPNVR 66
Query: 501 MVDLHQNKLQGTIPSSLE-F--LFGLNVLDLSMNSIGGTIPENL-GKLTSLNKLVLSKNN 556
+ L NKL + L L L L+ N + ++P + KLT+L +LVL +N
Sbjct: 67 YLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ 120
Query: 557 ITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSWNALTGPIPES-F 614
+ L +L L+L+ N++ S+P+ + +L L L +LS+N L +PE F
Sbjct: 121 LQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTEL-DLSYNQLQS-LPEGVF 177
Query: 615 SNLSKLANLDLSNNMLTGSLKVLGSLDNLVSL 646
L++L +L L N L G D L SL
Sbjct: 178 DKLTQLKDLRLYQNQLKSVPD--GVFDRLTSL 207
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 43/193 (22%), Positives = 78/193 (40%), Gaps = 20/193 (10%)
Query: 465 IPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLN 524
P L + T + + ++ + + + ++ ++ +++L +
Sbjct: 13 FPDDAFA--ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNVR 66
Query: 525 VLDLSMNSIGGTIPENLG---KLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
L L N + ++ +LT+L L+L+ N + L +L+ L L N++
Sbjct: 67 YLALGGNKL-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL 121
Query: 582 NGSIPEEI-GRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSL--KVLG 638
S+P+ + +L L L NL+ N L F L+ L LDLS N L SL V
Sbjct: 122 Q-SLPDGVFDKLTNLTYL-NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD 178
Query: 639 SLDNLVSLNVSYN 651
L L L + N
Sbjct: 179 KLTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 14/186 (7%)
Query: 333 EELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHG 392
+ L +++ + + + + Q+ +N+ + I L + N+LH
Sbjct: 22 IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH- 76
Query: 393 NIPELAYCVKLQALDLSHNFLTGSVPSSLFN-LKNLTQLLLISNRFSGEIPPEI-GGCTG 450
+I L L L L+ N L S+P+ +F+ L NL +L+L+ N+ +P + T
Sbjct: 77 DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTN 134
Query: 451 LIRLRLGSNNFSGHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNK 508
L L L N +P + L LT L+LS NQ +P + TQL+ + L+QN+
Sbjct: 135 LTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQ 192
Query: 509 LQGTIP 514
L+ ++P
Sbjct: 193 LK-SVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 44/184 (23%), Positives = 70/184 (38%), Gaps = 41/184 (22%)
Query: 260 LENLFLYENQIFGKIPDELG---SLKNLKRLLLWQNNLSGSIPE-ALGNCSSLTVIDVSL 315
+ L L N++ ++ L NL L+L N L S+P ++L + +
Sbjct: 65 VRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVE 118
Query: 316 NSLGGEVPVSLAN-LVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTI 374
N L +P + + L L L L+ N + F + L +L+L N
Sbjct: 119 NQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN---------- 167
Query: 375 GQLKELLLFFAWQNQLHGNIPELAY--CVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLL 431
QL+ L PE + +L+ L L N L SVP +F L +L +
Sbjct: 168 -QLQSL--------------PEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIW 211
Query: 432 LISN 435
L N
Sbjct: 212 LHDN 215
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 54/292 (18%), Positives = 96/292 (32%), Gaps = 76/292 (26%)
Query: 730 RENDEEENELEWDFTPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVK 788
+E + + T S + R +++G G G V + ++V+A+K
Sbjct: 25 QEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK 84
Query: 789 KLWPVKNGELPERDQFSA-----EVQTLGSIRHKNIVRLL-----GCCNNGRTRLLLFDY 838
K+ D E+ L + H ++V++L ++ +
Sbjct: 85 KI------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI 138
Query: 839 I---------SNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH-HDCVPPIIHRDIK 888
+ L L H K L Y ++ G+ Y+H I+HRD+K
Sbjct: 139 ADSDFKKLFRTPVYLTEL-H-IKTLL-----YNLL----VGVKYVHSAG----ILHRDLK 183
Query: 889 SNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG-------------------- 928
N LV + DFGLA+ + E+ + ++
Sbjct: 184 PANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243
Query: 929 -----YIAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG 970
Y APE Y+ I DV+S G + E+L + + D
Sbjct: 244 VVTRWYRAPELILLQENYTEAI----DVWSIGCIFAELLNMIKENVAYHADR 291
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 3e-10
Identities = 42/266 (15%), Positives = 70/266 (26%), Gaps = 60/266 (22%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSA 806
+ FS +L +G+GV G V++ V A+K + ++ +L
Sbjct: 9 GPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPV-AIKII-AIEGPDLVNGSHQKT 66
Query: 807 EVQTLGSI---------------RHKNIVRLLG--CCNNGRTRLLLFDYISNGSLAG--- 846
+ L I R + + L C LLL + S G
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 847 -----------------------LLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
L + + I+ + LA
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFE 184
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEK 943
HRD+ N+L+ L K S G Y+L E+
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLER 233
Query: 944 SD--VYSYGVVLLEVLTGKEPTDSRI 967
V+ + ++ TG I
Sbjct: 234 DGIVVFCDVSMDEDLFTGDGDYQFDI 259
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 755 DVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA-----EV 808
+V R + + VG G G V + + +AVKKL P + A E+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYREL 79
Query: 809 QTLGSIRHKNIVRLLGCCNNGRTRLLLFD-YISNGSLAGLLHE-----------KKVFLD 856
+ L ++H+N++ LL R+ D Y+ + L+ + +
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI- 138
Query: 857 WDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916
Y+I+ GL Y+H IIHRD+K +N+ V E + DFGLA+ +
Sbjct: 139 ----YQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTA 183
Query: 917 SRASNSVAGSYGYIAPE-----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
+ VA + Y APE Y+ + D++S G ++ E+LTG+
Sbjct: 184 DEMTGYVATRW-YRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGR 227
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 28/109 (25%), Positives = 41/109 (37%), Gaps = 5/109 (4%)
Query: 495 NCTQLEMVDLHQNKLQ-GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLS 553
+ + L K G I L L L + NL KL L KL LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELS 79
Query: 554 KNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLS 602
+N I G + +L L+LS N++ + L+ L+ L +L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLD 126
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 29/115 (25%), Positives = 45/115 (39%), Gaps = 8/115 (6%)
Query: 86 LSFSHLTSLVLSNANLT-GEIPPAIGNLSSLINLDLSFNALT--GNIPEEIGKLAELELL 142
+ + + LVL N G+I +L L L L N+P KL +L+ L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKL 76
Query: 143 SLNSNSIHGGIPREIGNCSKLRRLELYDNQLSG-NIPAEIGQLEALEIIRAGGNP 196
L+ N I GG+ L L L N+L + + +LE L+ +
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCE 131
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 37/179 (20%), Positives = 52/179 (29%), Gaps = 52/179 (29%)
Query: 256 NCSALENLFLYENQI-FGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVS 314
+A+ L L + GKI NL+ L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI------------------- 62
Query: 315 LNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTI 374
S+ L L L++L LS N I G + L L L N+ +
Sbjct: 63 --SVSN-----LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK--------L 107
Query: 375 GQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLT---GSVPSSLFNLKNLTQL 430
+ L L L++LDL + +T S L LT L
Sbjct: 108 KDISTLE--------------PLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 34/133 (25%), Positives = 55/133 (41%), Gaps = 8/133 (6%)
Query: 352 NFSRLKQLELDNNRF-FGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSH 410
+ +++L LDN + G+I + L L ++ L KL+ L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSE 80
Query: 411 NFLTGSVPSSLFNLKNLTQLLLISNRFS--GEIPPEIGGCTGLIRLRLGSN---NFSGHI 465
N + G + L NLT L L N+ + P + L L L + N + +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLNDYR 139
Query: 466 PSRIGLLHRLTFL 478
S LL +LT+L
Sbjct: 140 ESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 31/115 (26%), Positives = 48/115 (41%), Gaps = 8/115 (6%)
Query: 423 NLKNLTQLLLISNRFS-GEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELS 481
+ +L+L + + + G+I L L L N + S + L +L LELS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSL-INVGLISV-SNLPKLPKLKKLELS 79
Query: 482 ENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFG---LNVLDLSMNSI 533
EN+ G + L ++L NKL+ S+LE L L LDL +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEV 132
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 92/571 (16%), Positives = 179/571 (31%), Gaps = 77/571 (13%)
Query: 85 LLSFSHLTSLVLSNANLTGEIPPAIGNLSS----LINLDLSFNALTGNIPEEIGK-LAEL 139
L H L G + P I +SS L + L +T + E I K
Sbjct: 73 LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNF 132
Query: 140 ELLSLNSNSI--HGGIPREIGNCSKLRRLELYDNQLSG-------NIPAEIGQLEALEII 190
++L L+S G+ C L+ L+L ++ + + P L +L I
Sbjct: 133 KVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI- 191
Query: 191 RAGGNPGIHGEIPEEI-SNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGY 249
+ + E + + C L L L ++ + L L
Sbjct: 192 -SCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELG--------- 241
Query: 250 IPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLT 309
G +A +Y + L K L+ L + + + +P CS LT
Sbjct: 242 ----TGGYTAEVRPDVYSG-----LSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLT 292
Query: 310 VIDVSLNSLGGEVPVSLA-NLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFG 368
+++S ++ V L L+ L + + L++L + + F
Sbjct: 293 TLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFV 352
Query: 369 QIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTG-SVPSSLFNLKNL 427
P + L+ C KL+++ +T ++ + N N+
Sbjct: 353 MEPNVALTEQGLVSV-------------SMGCPKLESVLYFCRQMTNAALITIARNRPNM 399
Query: 428 TQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTG 487
T+ + L + + L L LS T
Sbjct: 400 TRF-------------RLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS-GLLTD 445
Query: 488 EIPPEIG-NCTQLEMVDLHQNKL-QGTIPSSLEFLFGLNVLDLSMNSIGG-TIPENLGKL 544
++ IG ++EM+ + + L L L++ G + N KL
Sbjct: 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKL 505
Query: 545 TSLNKLVLSKNNITGLIPKSLG-LCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSW 603
++ L +S +++ K LG L + + P+ ++ +
Sbjct: 506 ETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDER----GAPDSRPESCPVERVFIYR- 560
Query: 604 NALTGP---IPESFSNLSKLANLDLSNNMLT 631
+ GP +P N+ + + + S ++T
Sbjct: 561 -TVAGPRFDMPGFVWNMDQDSTMRFSRQIIT 590
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 54/337 (16%), Positives = 107/337 (31%), Gaps = 39/337 (11%)
Query: 347 PSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELA-YCVKLQA 405
+ F +++ +EL F L+ W ++ I ++ L+
Sbjct: 59 ATVIRRFPKVRSVELKGKPHFADFN---------LVPDGWGGYVYPWIEAMSSSYTWLEE 109
Query: 406 LDLSHNFLTGSVPSSLF-NLKNLTQLLLIS-NRFSGEIPPEIG-GCTGLIRLRLGSNNFS 462
+ L +T + + KN L+L S FS + I C L L L ++
Sbjct: 110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVD 169
Query: 463 G----HIPSRIGLLHRLTFLELS--ENQFTGE-IPPEIGNCTQLEMVDLHQNKLQGTIPS 515
+ L L +S ++ + + + C L+ + L++ + +
Sbjct: 170 DVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLAT 229
Query: 516 SLEFLFGLNVLDLSMNSIGGT------IPENLGKLTSLNKLVLSKNNITGLIPKSLGLCK 569
L+ L L + + L L L + + +P +C
Sbjct: 230 LLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCS 289
Query: 570 DLQLLDLSSNRINGSIPEEIGR----LQGLDILLNLSWNALTGPIPESFSNLSKL----- 620
L L+LS + ++ LQ L +L + L + + +L +L
Sbjct: 290 RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLE-VLASTCKDLRELRVFPS 348
Query: 621 -ANLDLSNNMLT--GSLKVLGSLDNLVSLNVSYNHFS 654
+ N LT G + V L S+ +
Sbjct: 349 EPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMT 385
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 39/213 (18%), Positives = 72/213 (33%), Gaps = 43/213 (20%)
Query: 750 NFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA-- 806
N V D +++G+G G VY + + + +A+KK+ D
Sbjct: 21 NVHVPD---NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR------MFEDLIDCKR 71
Query: 807 ---EVQTLGSIRHKNIVRLL-----GCCNNGRTRLLLFDYI---------SNGSLAGLLH 849
E+ L ++ I+RL ++ + + L H
Sbjct: 72 ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE-H 130
Query: 850 EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909
K L Y ++ G ++H + IHRD+K N L+ + DFGLA+
Sbjct: 131 -IKTIL-----YNLL----LGENFIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 910 LFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
S + + N + + ++T
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 18/134 (13%), Positives = 36/134 (26%), Gaps = 26/134 (19%)
Query: 305 CSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSF-FGNFSRLKQLELDN 363
+ + + + + L L EL + + L+ L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 364 NRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFN 423
+ + P + +L L+LS N L S+
Sbjct: 66 SG-LRFVAPDA----------------------FHFTPRLSRLNLSFNALE-SLSWKTVQ 101
Query: 424 LKNLTQLLLISNRF 437
+L +L+L N
Sbjct: 102 GLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 21/119 (17%), Positives = 42/119 (35%), Gaps = 13/119 (10%)
Query: 58 CNWD-YIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPP-AIGNLSSL 115
+ ++C+R ++ P +LT L + N + + L L
Sbjct: 7 PHGSSGLRCTRDG----ALDSLHHLPG----AENLTELYIENQQHLQHLELRDLRGLGEL 58
Query: 116 INLDLSFNALTGNIPEEI-GKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQL 173
NL + + L + + L L+L+ N++ + + L+ L L N L
Sbjct: 59 RNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 15/95 (15%), Positives = 29/95 (30%), Gaps = 3/95 (3%)
Query: 496 CTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPEN-LGKLTSLNKLVLSK 554
+ ++ L L L + + L L L L + K
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 555 NNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI 589
+ + + P + L L+LS N + S+ +
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKT 99
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 4e-06
Identities = 19/108 (17%), Positives = 40/108 (37%), Gaps = 4/108 (3%)
Query: 428 TQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSR-IGLLHRLTFLELSENQFT 486
+ L + + + + G L L + + H+ R + L L L + ++
Sbjct: 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 487 GEIPPEI-GNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSI 533
+ P+ +L ++L N L+ ++ L L LS N +
Sbjct: 70 -FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 7e-06
Identities = 23/112 (20%), Positives = 44/112 (39%), Gaps = 3/112 (2%)
Query: 448 CTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPE-IGNCTQLEMVDLHQ 506
G LR + + LT L + Q + + +L + + +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 507 NKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNIT 558
+ L+ P + F L+ L+LS N++ ++ + SL +LVLS N +
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 7e-06
Identities = 18/107 (16%), Positives = 40/107 (37%), Gaps = 5/107 (4%)
Query: 92 TSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEE-IGKLAELELLSLNSNSIH 150
+ L + + + +L L + ++ + L EL L++ + +
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 151 GGIPREI-GNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNP 196
+ + +L RL L N L ++ + Q +L+ + GNP
Sbjct: 70 -FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 21/92 (22%), Positives = 40/92 (43%), Gaps = 2/92 (2%)
Query: 250 IPEEIGNCSALENLFLYENQIFGKIPDE-LGSLKNLKRLLLWQNNLSGSIPEALGNCSSL 308
+ L L++ Q + L L L+ L + ++ L P+A L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 309 TVIDVSLNSLGGEVPVSLANLVALEELLLSGN 340
+ +++S N+L + ++L+EL+LSGN
Sbjct: 83 SRLNLSFNAL-ESLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 18/118 (15%), Positives = 33/118 (27%), Gaps = 25/118 (21%)
Query: 345 EIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQ 404
+ L +L ++N + + L+ L +L+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLEL--RDLRGL--------------------GELR 59
Query: 405 ALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNF 461
L + + L V F L++L L N + + L L L N
Sbjct: 60 NLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 20/94 (21%), Positives = 32/94 (34%), Gaps = 2/94 (2%)
Query: 226 IPRSVGELTNLRTLSVYTANITGYIPEE-IGNCSALENLFLYENQIFGKIPDELGSLKNL 284
+ NL L + ++ + L NL + ++ + PD L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 285 KRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSL 318
RL L N L S+ SL + +S N L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 68/254 (26%)
Query: 748 KLNFSVDDVVTRLSDTNIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSA 806
+++ V + +GKG GIV++ ++ + +V+AVKK++ ++ A
Sbjct: 2 RVDRHVLR---KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD------AFQNSTDA 52
Query: 807 -----EVQTLGSIR-HKNIVRLLGCC--NNGRTRLLLFDY--------ISNGSLAGLLHE 850
E+ L + H+NIV LL +N R L+FDY I L + H
Sbjct: 53 QRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-H- 110
Query: 851 KKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910
K+ + Y++I + YLH + +HRD+K +NIL+ + +ADFGL++
Sbjct: 111 KQYVV-----YQLI----KVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRS 158
Query: 911 FESSESSRASNSVAGSYG-------------------YIAPE-----YGYSLKITEKSDV 946
F + + ++ + Y APE Y+ I D+
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DM 214
Query: 947 YSYGVVLLEVLTGK 960
+S G +L E+L GK
Sbjct: 215 WSLGCILGEILCGK 228
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 28/109 (25%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 495 NCTQLEMVDLHQNKLQ-GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLS 553
+ ++ + L ++ G + + L L + T NL KL L KL LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELS 72
Query: 554 KNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLS 602
N ++G + C +L L+LS N+I I L+ L+ L +L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLD 119
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 34/179 (18%), Positives = 54/179 (30%), Gaps = 52/179 (29%)
Query: 256 NCSALENLFLYENQI-FGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVS 314
S ++ L L ++ GK+ + L+ L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT------------------- 55
Query: 315 LNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTI 374
S+ L L L++L LS N +SG + L L L N+ I
Sbjct: 56 --SIAN-----LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK--------I 100
Query: 375 GQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSV---PSSLFNLKNLTQL 430
L + L L++LDL + +T + L LT L
Sbjct: 101 KDLSTIE--------------PLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 7e-07
Identities = 28/114 (24%), Positives = 46/114 (40%), Gaps = 8/114 (7%)
Query: 87 SFSHLTSLVLSNANLT-GEIPPAIGNLSSLINLDLSFNALT--GNIPEEIGKLAELELLS 143
+ S + LVL N+ G++ L L LT N+P KL +L+ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 144 LNSNSIHGGIPREIGNCSKLRRLELYDNQLSG-NIPAEIGQLEALEIIRAGGNP 196
L+ N + GG+ C L L L N++ + + +LE L+ +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCE 124
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 37/133 (27%), Positives = 58/133 (43%), Gaps = 8/133 (6%)
Query: 352 NFSRLKQLELDNNRF-FGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSH 410
S +K+L LDN+R G++ + +EL L +I L KL+ L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSD 73
Query: 411 NFLTGSVPSSLFNLKNLTQLLLISNRFS--GEIPPEIGGCTGLIRLRLGSN---NFSGHI 465
N ++G + NLT L L N+ I P + L L L + N + +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNCEVTNLNDYR 132
Query: 466 PSRIGLLHRLTFL 478
+ LL +LT+L
Sbjct: 133 ENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 5/91 (5%)
Query: 568 CKDLQLLDLSSNRIN-GSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLS 626
D++ L L ++R N G + + L+ L + LT + L+KL L+LS
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFL-STINVGLT--SIANLPKLNKLKKLELS 72
Query: 627 NNMLTGSLKVLG-SLDNLVSLNVSYNHFSGI 656
+N ++G L+VL NL LN+S N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 27/115 (23%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 423 NLKNLTQLLLISNRFS-GEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELS 481
++ +L+L ++R + G++ L L + + I + + L++L LELS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 482 ENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFG---LNVLDLSMNSI 533
+N+ +G + C L ++L NK++ S++E L L LDL +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNCEV 125
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 41/144 (28%), Positives = 58/144 (40%), Gaps = 12/144 (8%)
Query: 489 IPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL-GKLTSL 547
+P I Q ++ LH N++ P + L L L L N +G +P + LT L
Sbjct: 34 VPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 548 NKLVLSKNNITGLIPK---SLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWN 604
L L N +T L L L+ L + N++ +P I RL L L L N
Sbjct: 91 TVLDLGTNQLTVLPSAVFDRLV---HLKELFMCCNKLT-ELPRGIERLTHLTHL-ALDQN 145
Query: 605 ALTGPIPESFSNLSKLANLDLSNN 628
L +F LS L + L N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 18/138 (13%)
Query: 513 IPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGL---IPKSLGLCK 569
IP++ + +L L N I P L +L +L L N + L + SL
Sbjct: 38 IPTNAQ------ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSL---T 88
Query: 570 DLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNN 628
L +LDL +N++ +P + RL L L + N LT +P L+ L +L L N
Sbjct: 89 QLTVLDLGTNQLT-VLPSAVFDRLVHLKEL-FMCCNKLTE-LPRGIERLTHLTHLALDQN 145
Query: 629 MLTGSLKVLGSLDNLVSL 646
L G+ D L SL
Sbjct: 146 QLKSIPH--GAFDRLSSL 161
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 5/109 (4%)
Query: 404 QALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFS 462
Q L L N +T P +L NL +L L SN+ +P + T L L LG+N +
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 463 GHIPSRI-GLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQ 510
+PS + L L L + N+ T E+P I T L + L QN+L+
Sbjct: 102 V-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 44/177 (24%), Positives = 61/177 (34%), Gaps = 52/177 (29%)
Query: 261 ENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGG 320
+ L+L++NQI P SL NLK L L N L ++P V D
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVG--------VFD-------- 85
Query: 321 EVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKEL 380
+L L L L N ++ + F LK+L + N +L E
Sbjct: 86 -------SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCN-----------KLTE- 126
Query: 381 LLFFAWQNQLHGNIPE-LAYCVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISN 435
+P + L L L N L S+P F L +LT L N
Sbjct: 127 -------------LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 32/108 (29%), Positives = 47/108 (43%), Gaps = 3/108 (2%)
Query: 545 TSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSW 603
T+ L L N IT L P +L+ L L SN++ ++P + L L + L+L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTV-LDLGT 97
Query: 604 NALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYN 651
N LT F L L L + N LT + + L +L L + N
Sbjct: 98 NQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN 145
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 33/112 (29%), Positives = 49/112 (43%), Gaps = 5/112 (4%)
Query: 87 SFSHLTSLVLSNANLTGEIPPAI-GNLSSLINLDLSFNALTGNIPEEI-GKLAELELLSL 144
S +L L L + L +P + +L+ L LDL N LT +P + +L L+ L +
Sbjct: 62 SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFM 119
Query: 145 NSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNP 196
N + +PR I + L L L NQL +L +L GNP
Sbjct: 120 CCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 43/212 (20%), Positives = 80/212 (37%), Gaps = 57/212 (26%)
Query: 767 GKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLG 824
G G++G V + +++ A+K +++ R EV+ + +IVR++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKM---LQDCPKARR-----EVELHWRASQCPHIVRIVD 78
Query: 825 CCNNGRTR----LLLFDYISNGSLAGLLHEKKVFLDWDSRY------KIILGVAHGLAYL 874
N L++ + + G L + ++ D + +I+ + + YL
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYL 133
Query: 875 H-HDCVPPIIHRDIKSNNIL-VGPQFEAFL--ADFGLAKLFESSESSRASNSVAGSYGYI 930
H + I HRD+K N+L + A L DFG AK Y
Sbjct: 134 HSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-----------TGEKYD-- 176
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ D++S GV++ +L G P
Sbjct: 177 -----------KSCDMWSLGVIMYILLCGYPP 197
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 6e-07
Identities = 24/180 (13%), Positives = 58/180 (32%), Gaps = 22/180 (12%)
Query: 487 GEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLG--KL 544
++ P + L + + L L++ + ++ E++ L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRP---NLKSLEIISGGLPDSVVEDILGSDL 218
Query: 545 TSLNKLVL---SKNNITGLIPKSL------GLCKDLQLLDLSSNRINGSIPEEIGRLQGL 595
+L KLVL ++ +L+ L + + E L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 596 DIL--LNLSWNALTG----PIPESFSNLSKLANLDLSNNMLT--GSLKVLGSLDNLVSLN 647
L +++S LT + + + L +++ N L+ ++ SL + ++
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 1e-05
Identities = 27/163 (16%), Positives = 53/163 (32%), Gaps = 21/163 (12%)
Query: 510 QGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLG--L 567
Q + L+ + LN L + + +L L + + + + +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIK---GTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 568 CKDLQLLDL---SSNRINGSIPEEIGRLQGLDIL-----LNLSWNALTGPIPESFSN--- 616
+L+ L L + L D L + + E F
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 617 LSKLANLDLSNNMLTGS-----LKVLGSLDNLVSLNVSYNHFS 654
L +L +D+S +LT L + + +L +N+ YN+ S
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 6e-05
Identities = 31/205 (15%), Positives = 67/205 (32%), Gaps = 31/205 (15%)
Query: 245 NITGYIPEEIGNCSALENLFLY-----ENQIFGKIPDELGS-LKNLKRLLLWQNNLSGSI 298
+I I E + E LF E +I +L L + L + + ++
Sbjct: 126 DIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185
Query: 299 PEALGNCSSLTVIDVSLNSLGGEVP--VSLANLVALEELLLS-------GNNISGEIPSF 349
+L +++ L V + ++L LE+L+L +
Sbjct: 186 SIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL 245
Query: 350 F--GNFSRLKQLELDNNRFFGQIP------PTIGQLKELLLFFAWQNQLHGN-----IPE 396
F F LK L + + + + QL+ + + L +
Sbjct: 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS---AGVLTDEGARLLLDH 302
Query: 397 LAYCVKLQALDLSHNFLTGSVPSSL 421
+ L+ +++ +N+L+ + L
Sbjct: 303 VDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 2e-04
Identities = 28/208 (13%), Positives = 61/208 (29%), Gaps = 25/208 (12%)
Query: 145 NSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNP-----GIH 199
+ + I GI + L D + I Q++ ++ A
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 200 GEIPEEISNCKVLVFLGLADTGISGQIPRSVG--ELTNLRTLSVYTANITGYIPE----- 252
+ L L + G+ + + +L NL L +Y + Y +
Sbjct: 183 NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY-VGVEDYGFDGDMNV 241
Query: 253 -----EIGNCSALENLFLYENQIFGKIPDELGS---LKNLKRLLLWQNNLSGS----IPE 300
L+ L + + + + + L L+ + + L+ + +
Sbjct: 242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLD 301
Query: 301 ALGNCSSLTVIDVSLNSLGGEVPVSLAN 328
+ L I++ N L E+ L
Sbjct: 302 HVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 6e-04
Identities = 13/70 (18%), Positives = 28/70 (40%), Gaps = 7/70 (10%)
Query: 87 SFSHLTSLVLSNANLTGEIPPAIGN---LSSLINLDLSFNALTGN----IPEEIGKLAEL 139
F +L L + +A + L L +D+S LT + + + K+ L
Sbjct: 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHL 309
Query: 140 ELLSLNSNSI 149
+ +++ N +
Sbjct: 310 KFINMKYNYL 319
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 46/230 (20%), Positives = 81/230 (35%), Gaps = 57/230 (24%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-------- 815
+G G V+ + + + +A+K V+ + + E++ L +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKI---VRGDK-VYTEAAEDEIKLLQRVNDADNTKED 81
Query: 816 ---HKNIVRLLGC----CNNGR-----TRLL---LFDYISNGSLAGLLHEKKVFLDWDSR 860
+I++LL NG +L L I G+ V
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI-PLIYV------- 133
Query: 861 YKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF------LADFGLAKLFESS 914
+I + GL Y+H C IIH DIK N+L+ +AD G A
Sbjct: 134 KQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CW 187
Query: 915 ESSRASNSVAGSYGYIAPE----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
+NS+ + Y +PE + D++S ++ E++TG
Sbjct: 188 YDEHYTNSIQ-TREYRSPEVLLGAPWGCGA----DIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 58/225 (25%), Positives = 87/225 (38%), Gaps = 61/225 (27%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHK------ 817
++GKG G V + Q +A+K V+N + Q + E++ L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK---MVRNEK-RFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 818 NIVRLLGC-------CNNGRTRLL---LFDYISNGSLAGL-LHEKKVFLDWDSRYKIILG 866
N++ +L C LL L++ I G L + F IL
Sbjct: 160 NVIHMLENFTFRNHICMT--FELLSMNLYELIKKNKFQGFSLPLVRKFA------HSIL- 210
Query: 867 VAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF--LADFGLAKLFESSE-----SSRA 919
L LH IIH D+K NIL+ Q + + DFG + +E SR
Sbjct: 211 --QCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-YEHQRVYTYIQSRF 264
Query: 920 SNSVAGSYGYIAPE----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
Y APE Y + I D++S G +L E+LTG
Sbjct: 265 ---------YRAPEVILGARYGMPI----DMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 53/241 (21%), Positives = 90/241 (37%), Gaps = 58/241 (24%)
Query: 749 LNFSVDDVVT-RLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSA 806
+ R +++GKG G V + ++ +A+K +KN + +Q
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKI---IKNKK-AFLNQAQI 99
Query: 807 EVQTLGSIRH------KNIVRLLGC-------C-------NNGRTRLLLFDYISNGSLAG 846
EV+ L + IV L C N L+D + N + G
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN------LYDLLRNTNFRG 153
Query: 847 L-LHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAF--LA 903
+ L+ + F + + L +L + IIH D+K NIL+ + +
Sbjct: 154 VSLNLTRKFA------QQMC---TALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIV 203
Query: 904 DFGLAKLFESSESSRASNSVAGSYGYIAPE----YGYSLKITEKSDVYSYGVVLLEVLTG 959
DFG S + + S Y +PE Y L I D++S G +L+E+ TG
Sbjct: 204 DFG-----SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAI----DMWSLGCILVEMHTG 254
Query: 960 K 960
+
Sbjct: 255 E 255
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 35/142 (24%), Positives = 56/142 (39%), Gaps = 30/142 (21%)
Query: 488 EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL-GKLTS 546
+P I + L N+ +P L L ++DLS N I T+ +T
Sbjct: 24 VLPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 547 LNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNAL 606
L L+LS N + + P++ K L+LL L N I+ +PE
Sbjct: 80 LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGA----------------- 121
Query: 607 TGPIPESFSNLSKLANLDLSNN 628
F++LS L++L + N
Sbjct: 122 -------FNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 10/105 (9%)
Query: 545 TSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSW 603
+ +L L N T L+PK L K L L+DLS+NRI+ ++ + + L L LS+
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLT-LILSY 87
Query: 604 NALTGPIPESFSNLSKLANLDLSNNMLTGSLKVL--GSLDNLVSL 646
N L P +F L L L L N + V+ G+ ++L +L
Sbjct: 88 NRLRCIPPRTFDGLKSLRLLSLHGN----DISVVPEGAFNDLSAL 128
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 31/102 (30%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 453 RLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQG 511
L L N F+ +P + LT ++LS N+ + + + N TQL + L N+L+
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 512 TIPSSLEF--LFGLNVLDLSMNSIGGTIPE----NLGKLTSL 547
IP F L L +L L N I +PE +L L+ L
Sbjct: 92 CIPPRT-FDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 570 DLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNM 629
D+ L L N+ +P+E+ + L L++LS N ++ +SFSN+++L L LS N
Sbjct: 32 DVTELYLDGNQFT-LVPKELSNYKHLT-LIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 630 LTGSL--KVLGSLDNLVSLNVSYNHFSGI 656
L + + L +L L++ N S +
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDISVV 117
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 35/142 (24%), Positives = 55/142 (38%), Gaps = 17/142 (11%)
Query: 58 CNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLIN 117
C ++CS + + IP +T L L T +P + N L
Sbjct: 10 CLDTVVRCSNKGLKVLPKGIPRD----------VTELYLDGNQFT-LVPKELSNYKHLTL 58
Query: 118 LDLSFNALTGNIPEEI-GKLAELELLSLNSNSIHGGIPREI-GNCSKLRRLELYDNQLSG 175
+DLS N ++ + + + +L L L+ N + IP LR L L+ N +S
Sbjct: 59 IDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDIS- 115
Query: 176 NIPAEI-GQLEALEIIRAGGNP 196
+P L AL + G NP
Sbjct: 116 VVPEGAFNDLSALSHLAIGANP 137
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 29/117 (24%), Positives = 44/117 (37%), Gaps = 29/117 (24%)
Query: 322 VPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELL 381
VP L+N L + LS N IS F N ++L L L N +L+ +
Sbjct: 46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN-----------RLRCI- 93
Query: 382 LFFAWQNQLHGNIPELAY--CVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISN 435
P + L+ L L N ++ VP F +L L+ L + +N
Sbjct: 94 -------------PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 525 VLDLSMNSIGGTIPENL-GKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRING 583
L L+ N +G + L G+L L KL L +N +TG+ P + +Q L L N+I
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 584 SIPEEI-GRLQGLDILLNLSWNALTGPIPE-SFSNLSKLANLDLSNN 628
I ++ L L L NL N ++ + SF +L+ L +L+L++N
Sbjct: 92 EISNKMFLGLHQLKTL-NLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 34/145 (23%), Positives = 52/145 (35%), Gaps = 28/145 (19%)
Query: 65 CSRTEI-----AITSI--HIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAI-GNLSSLI 116
C T + + I IP T L+L++ L + G L L+
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLH----------TTELLLNDNELGRISSDGLFGRLPHLV 57
Query: 117 NLDLSFNALTGNIPEEI-GKLAELELLSLNSN---SIHGGIPREIGNCSKLRRLELYDNQ 172
L+L N LT I + ++ L L N I + + L+ L LYDNQ
Sbjct: 58 KLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQ---LKTLNLYDNQ 113
Query: 173 LSGNIPAEI-GQLEALEIIRAGGNP 196
+S + L +L + NP
Sbjct: 114 IS-CVMPGSFEHLNSLTSLNLASNP 137
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 25/113 (22%), Positives = 42/113 (37%), Gaps = 28/113 (24%)
Query: 404 QALDLSHNFLTGSVPSSLFN-LKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFS 462
L L+ N L LF L +L +L L N+ + I P F
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNA---------------FE 75
Query: 463 GHIPSRIGLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIP 514
G + L+L EN+ EI ++ QL+ ++L+ N++ +
Sbjct: 76 G--------ASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 9/143 (6%)
Query: 489 IPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL-GKLTSL 547
+P I T +DL N L+ + L L L L N + ++P + KLTSL
Sbjct: 22 VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 548 NKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSWNAL 606
L LS N + L L+ L L++N++ S+P+ + +L L L L N L
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDL-RLYQNQL 136
Query: 607 TGPIPE-SFSNLSKLANLDLSNN 628
+P+ F L+ L + L +N
Sbjct: 137 KS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 42/150 (28%), Positives = 62/150 (41%), Gaps = 16/150 (10%)
Query: 502 VDLHQNKLQGT---IPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNIT 558
V+ + IP+ LDL NS+ +LTSL +L L N +
Sbjct: 12 VECYSQGRTSVPTGIPAQTT------YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ 65
Query: 559 GLIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSWNALTGPIPE-SFSN 616
L L L+LS+N++ S+P + +L L L L+ N L +P+ F
Sbjct: 66 SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKEL-ALNTNQLQS-LPDGVFDK 122
Query: 617 LSKLANLDLSNNMLTGSLKVLGSLDNLVSL 646
L++L +L L N L G D L SL
Sbjct: 123 LTQLKDLRLYQNQLKSVPD--GVFDRLTSL 150
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 40/137 (29%), Positives = 59/137 (43%), Gaps = 13/137 (9%)
Query: 306 SSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNR 365
+ T +D+ NSL L +L +L L GN + F + L L L N+
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 366 FFGQIPPTI----GQLKELLLFFAWQNQLHGNIPELAY--CVKLQALDLSHNFLTGSVPS 419
+P + QLKEL L NQL ++P+ + +L+ L L N L SVP
Sbjct: 88 -LQSLPNGVFDKLTQLKELAL---NTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPD 141
Query: 420 SLF-NLKNLTQLLLISN 435
+F L +L + L N
Sbjct: 142 GVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 33/117 (28%), Positives = 50/117 (42%), Gaps = 6/117 (5%)
Query: 441 IPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNC-TQL 499
+P I T L L +N+ L LT L L N+ +P + N T L
Sbjct: 22 VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 500 EMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL-GKLTSLNKLVLSKN 555
++L N+LQ + L L L L+ N + ++P+ + KLT L L L +N
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 7/114 (6%)
Query: 404 QALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIRLRLGSNNFS 462
LDL N L L +LTQL L N+ +P + T L L L +N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 463 GHIPSRI-GLLHRLTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQGTIP 514
+P+ + L +L L L+ NQ +P + TQL+ + L+QN+L+ ++P
Sbjct: 90 S-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 32/110 (29%), Positives = 43/110 (39%), Gaps = 6/110 (5%)
Query: 545 TSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSW 603
L L N++ L L L L N++ S+P + +L L L NLS
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYL-NLST 85
Query: 604 NALTGPIPESFSNLSKLANLDLSNNMLTGSL--KVLGSLDNLVSLNVSYN 651
N L F L++L L L+ N L SL V L L L + N
Sbjct: 86 NQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 42/242 (17%), Positives = 66/242 (27%), Gaps = 74/242 (30%)
Query: 862 KIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG-------------------------- 895
KII V GL YLH C IIH DIK NIL+
Sbjct: 150 KIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 896 ---------------PQFEAFLADFGLAKLFESSESSRASNSVAG---SYGYIAPEYGYS 937
E A+ K+ + + + Y + E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG 267
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG--------AHII--------TWV---- 977
+D++S + E+ TG + + A II +
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327
Query: 978 --------NGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMK 1029
G+L+ + L L+ + +E L + PE+R T
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387
Query: 1030 DV 1031
+
Sbjct: 388 EC 389
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 30/168 (17%), Positives = 60/168 (35%), Gaps = 31/168 (18%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVK--KLWPVKNGELP---------ERDQFSAEVQTLGS 813
+G G G++Y + A K+ +NG L + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 814 IRHKNIVRLLGC----CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA- 868
+ + I G R ++ + + L + + F + +L +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTF-----KKSTVLQLGI 158
Query: 869 ---HGLAYLHHDCVPPIIHRDIKSNNILVGPQFE--AFLADFGLAKLF 911
L Y+H + +H DIK+ N+L+G + +LAD+GL+ +
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 12/43 (27%), Positives = 23/43 (53%), Gaps = 5/43 (11%)
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEA--FLADFGLAKLF 911
L +LH + +H ++ + NI V P+ ++ LA +G A +
Sbjct: 172 LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 14/43 (32%), Positives = 24/43 (55%), Gaps = 5/43 (11%)
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFE--AFLADFGLAKLF 911
L Y+H +H DIK++N+L+ + +L D+GLA +
Sbjct: 165 LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 44/215 (20%), Positives = 82/215 (38%), Gaps = 33/215 (15%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH-KNIVRLL 823
+G G G + + + + + +A+K L P+K+ Q E + + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-LEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVY 71
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA----HGLAYLHHDCV 879
G+ ++ + + SL L K +L +A + Y+H
Sbjct: 72 YFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFS----LKTVLMIAIQLISRMEYVHSKN- 125
Query: 880 PPIIHRDIKSNNILVGPQFEA-----FLADFGLAKLFESSESS-----RASNSVAGSYGY 929
+I+RD+K N L+G + DF LAK + E+ R S+ G+ Y
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 930 --IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
I G + + D+ + G + + L G P
Sbjct: 184 MSINTHLGKEQ--SRRDDLEALGHMFMYFLRGSLP 216
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 39/272 (14%), Positives = 81/272 (29%), Gaps = 52/272 (19%)
Query: 403 LQALDLSHNFLTGSVPSSL-----FNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLG 457
L+ L+L+ +T + + L ++ L S + G L+ +
Sbjct: 74 LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPA------GLRTLLPV--- 124
Query: 458 SNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIG-----NCTQLEMVDLHQNKLQGT 512
R L L N E ++ + Q+ + L N L
Sbjct: 125 --------------FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAA 170
Query: 513 ----IPSSLEFLFGLNVLDLSMNSIGGT----IPENLGKLTSLNKLVLSKNNITG----L 560
+ L + L L +G + L + L +L ++ N
Sbjct: 171 GVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230
Query: 561 IPKSLGLCKDLQLLDLSSNRINGS----IPEEIGRLQGLD--ILLNLSWNALTGPIPESF 614
+ ++ L+LL L N ++ + + G +G ++ A++
Sbjct: 231 LARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVIL 290
Query: 615 SN-LSKLANLDLSNNMLTGSLKVLGSLDNLVS 645
S L + D + L + D+ +
Sbjct: 291 SEVQRNLNSWDRARVQRHLELLLRDLEDSRGA 322
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 48/347 (13%), Positives = 101/347 (29%), Gaps = 58/347 (16%)
Query: 229 SVGELTNLRTLSVYTANITGYIPEEIGNCSALENL-FLYENQIFGKIPDELGSLKNLKRL 287
+ L L + + + L++L F YE Q L +L++L
Sbjct: 21 PIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFS---AEVLSSLRQL 77
Query: 288 LLWQNNLSGSIPEALG-----NCSSLTVIDVSLNSLGGEVPVSLAN-LVALEELLLSGNN 341
L ++ + +L ++++ L +L + +L L N+
Sbjct: 78 NLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNS 137
Query: 342 ISGE-----IPSFFGNFSRLKQLELDNNRF-------FGQIPPTIGQLKELLLFFAWQNQ 389
+ E + ++ L L NN + + L L
Sbjct: 138 LGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL---LHTG 194
Query: 390 LHGNI------PELAYCVKLQALDLSHNFLTGS----VPSSLFNLKNLTQLLLISNRFS- 438
L G+ +L +LQ L++++N + + + +L L L N S
Sbjct: 195 L-GDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253
Query: 439 ------GEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIG-LLHRLTFLELSENQFTGEIPP 491
++ G ++ S + + + L + + Q
Sbjct: 254 EGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQ------- 306
Query: 492 EIGNCTQLEMVDLHQNKLQGT----IPSSLEFLFGLNVLDLSMNSIG 534
+L + DL ++ L + L + S G
Sbjct: 307 ---RHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 44/234 (18%), Positives = 81/234 (34%), Gaps = 42/234 (17%)
Query: 89 SHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSF-NALTGNIPEEIG----KLAELEL-- 141
S L +L L L+ I + S+L+ L+LS + + + + +L EL L
Sbjct: 118 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 177
Query: 142 -LSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHG 200
+ + + +L L N+ Q L +
Sbjct: 178 CFDFTEKHVQVAVAH---VSETITQLNLSG--YRKNL-----QKSDLSTL---------- 217
Query: 201 EIPEEISNCKVLVFLGLAD-TGISGQIPRSVGELTNLRTLSV-YTANITGYIPEEIGNCS 258
+ C LV L L+D + + +L L+ LS+ +I E+G
Sbjct: 218 -----VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 272
Query: 259 ALENLFLYENQIFGKIPDE--LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTV 310
L+ L Q+FG +PD + L L + ++ + +GN + +
Sbjct: 273 TLKTL-----QVFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEI 321
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 52/238 (21%), Positives = 84/238 (35%), Gaps = 15/238 (6%)
Query: 280 SLKNLKRLLLWQNNLS-GSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLS 338
S ++ + L + + ++ L CS L + + L + +LA L L LS
Sbjct: 91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 150
Query: 339 G-NNISGE-IPSFFGNFSRLKQLEL------DNNRFFGQIPPTIGQLKELLLFFAWQNQL 390
G + S + + + SRL +L L + + +L L +N
Sbjct: 151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQ 210
Query: 391 HGNIPELA-YCVKLQALDLSH-NFLTGSVPSSLFNLKNLTQLLLIS-NRFSGEIPPEIGG 447
++ L C L LDLS L F L L L L E E+G
Sbjct: 211 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 270
Query: 448 CTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLH 505
L L++ G + L L L+++ + FT P IGN E+ +
Sbjct: 271 IPTLKTLQVFGIVPDG---TLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIK 325
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 49/272 (18%), Positives = 94/272 (34%), Gaps = 27/272 (9%)
Query: 390 LHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCT 449
LH ++ + A +F+ + + L S + + C+
Sbjct: 59 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 118
Query: 450 GLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSE-NQFTGEIPPEIG-NCTQLEMVDLHQN 507
L L L S I + + L L LS + F+ + +C++L+ ++L
Sbjct: 119 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 178
Query: 508 KLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGL 567
D + + + +T LN L + N+ +L
Sbjct: 179 F------------------DFTEKHVQVAVAHVSETITQLN-LSGYRKNLQKSDLSTLVR 219
Query: 568 -CKDLQLLDLSS-NRINGSIPEEIGRLQGLDILLNLSW-NALTGPIPESFSNLSKLANLD 624
C +L LDLS + +E +L L L+LS + + L L
Sbjct: 220 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH-LSLSRCYDIIPETLLELGEIPTLKTLQ 278
Query: 625 LSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGI 656
+ + G+L++L + L L ++ +HF+ I
Sbjct: 279 VFGIVPDGTLQLL--KEALPHLQINCSHFTTI 308
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 43/215 (20%), Positives = 83/215 (38%), Gaps = 33/215 (15%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH-KNIVRLL 823
+G+G G+++ + + Q +A+K P ++ + Q E +T + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFE-PRRS----DAPQLRDEYRTYKLLAGCTGIPNVY 72
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA----HGLAYLHHDCV 879
G +L+ D + SL LL K + A + +H
Sbjct: 73 YFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFS----VKTVAMAAKQMLARVQSIHEKS- 126
Query: 880 PPIIHRDIKSNNILVGPQFEA-----FLADFGLAKLFESSESS-----RASNSVAGSYGY 929
+++RDIK +N L+G ++ DFG+ K + + R +++G+ Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 930 --IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
I G + + D+ + G V + L G P
Sbjct: 185 MSINTHLGREQ--SRRDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 48/213 (22%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH-KNIVRLL 823
+G G G +Y I + + +A+K VK + Q E + ++ I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLE-CVKT----KHPQLHIESKIYKMMQGGVGIPTIR 71
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA----HGLAYLHHDCV 879
C G +++ + + SL L + K +L +A + Y+H
Sbjct: 72 WCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFS----LKTVLLLADQMISRIEYIHSKN- 125
Query: 880 PPIIHRDIKSNNILVGP---QFEAFLADFGLAKLFESSESS-----RASNSVAGSYGY-- 929
IHRD+K +N L+G ++ DFGLAK + + + R + ++ G+ Y
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
I G + + D+ S G VL+ G P
Sbjct: 184 INTHLGIEQ--SRRDDLESLGYVLMYFNLGSLP 214
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 13/110 (11%)
Query: 333 EELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTI----GQLKELLLFFAWQN 388
L L N + F ++L +L L N+ +P + +L L L +N
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQ-IQSLPDGVFDKLTKLTILYL---HEN 86
Query: 389 QLHGNIPELAY--CVKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISN 435
+L ++P + +L+ L L N L SVP +F L +L ++ L +N
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 33/104 (31%), Positives = 44/104 (42%), Gaps = 7/104 (6%)
Query: 545 TSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEI-GRLQGLDILLNLSW 603
+S +L L N + L L L LS N+I S+P+ + +L L I L L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTI-LYLHE 85
Query: 604 NALTGPIPES-FSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSL 646
N L +P F L++L L L N L G D L SL
Sbjct: 86 NKLQS-LPNGVFDKLTQLKELALDTNQLKSVPD--GIFDRLTSL 126
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 48/237 (20%), Positives = 79/237 (33%), Gaps = 63/237 (26%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH-----KN 818
+G G G V + I +++ AVK V+N + E L I++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKV---VRNIK-KYTRSAKIEADILKKIQNDDINNNN 97
Query: 819 IVRLLGC-------CNNGRTRLL---LFDYISNGSLAGL-LHEKKVFLDWDSRYKIILGV 867
IV+ G C L L++ I+ + G + + K++ +I+
Sbjct: 98 IVKYHGKFMYYDHMCLI--FEPLGPSLYEIITRNNYNGFHIEDIKLYC-----IEILKA- 149
Query: 868 AHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA--- 924
L YL + H D+K NIL+ + + S
Sbjct: 150 ---LNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 925 ---GS--------YGYI------APE----YGYSLKITEKSDVYSYGVVLLEVLTGK 960
G I APE G+ + D++S+G VL E+ TG
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSS----DMWSFGCVLAELYTGS 256
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLL 823
+G G G +Y I + + +A+K VK + Q E + ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLE-NVKT----KHPQLLYESKIYRILQGGTGIPNVR 69
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA----HGLAYLHHDCV 879
G +L+ D + SL L + L K +L +A + + ++H
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLS----LKTVLMLADQMINRVEFVHSKS- 123
Query: 880 PPIIHRDIKSNNILVGPQFEA---FLADFGLAKLFESSESS-----RASNSVAGSYGY-- 929
+HRDIK +N L+G A ++ DFGLAK + + + R + ++ G+ Y
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 930 IAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP 962
+ G + + D+ S G VL+ L G P
Sbjct: 182 VNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLP 212
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 32/137 (23%), Positives = 54/137 (39%), Gaps = 17/137 (12%)
Query: 498 QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNI 557
+ +DL + + LN M + I EN+ +L SLN LS N +
Sbjct: 128 SQQALDL-KGLRSDPDLVAQNIDVVLNRRSC-MAATLRIIEENIPELLSLN---LSNNRL 182
Query: 558 TGL--IPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDIL-LNLSWNALTGPIPES- 613
L + + +L++L+LS N + E+ +++GL + L L N+L +
Sbjct: 183 YRLDDMSSIVQKAPNLKILNLSGNEL--KSERELDKIKGLKLEELWLDGNSLCDTFRDQS 240
Query: 614 ------FSNLSKLANLD 624
KL LD
Sbjct: 241 TYISAIRERFPKLLRLD 257
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1079 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-17 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-16 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-09 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 5e-62
Identities = 68/279 (24%), Positives = 110/279 (39%), Gaps = 24/279 (8%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G G G VY+ + +AVK L + F EV L RH NI+ +
Sbjct: 14 QRIGSGSFGTVYKGK--WHGDVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFM 70
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
G + ++ + SL LH + + I A G+ YLH II
Sbjct: 71 GYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSII 126
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY---GYSLKI 940
HRD+KSNNI + + DFGLA + S ++GS ++APE
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 941 TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRS 1000
+ +SDVY++G+VL E++TG+ P + I G L + + + +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR-- 244
Query: 1001 GTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039
+ C+ +ERP + A ++ +
Sbjct: 245 ------------LMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 73/281 (25%), Positives = 118/281 (41%), Gaps = 28/281 (9%)
Query: 759 RLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
L +G G G V+ +AVK L K G + D F AE + ++H+
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSM-SPDAFLAEANLMKQLQHQR 69
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLH-EKKVFLDWDSRYKIILGVAHGLAYLHHD 877
+VRL ++ +Y+ NGSL L + L + + +A G+A++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
IHRD+++ NILV +ADFGLA+L E +E A + APE
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY 184
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997
T KSDV+S+G++L E++T + + I G R
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-------- 236
Query: 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
+E+ Q++ LC PE+RPT + ++L++
Sbjct: 237 -------EELYQLM---RLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-56
Identities = 68/297 (22%), Positives = 113/297 (38%), Gaps = 26/297 (8%)
Query: 766 VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGC 825
+GKG G V+R + +V AVK + AE+ +RH+NI+ +
Sbjct: 11 IGKGRFGEVWRGKWRGEEV-AVKIF----SSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 826 C----NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCV-- 879
L+ DY +GSL L+ + + K+ L A GLA+LH + V
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 880 ---PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES--SRASNSVAGSYGYIAPEY 934
P I HRD+KS NILV +AD GLA +S+ A N G+ Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 935 ------GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE--LRERKR 986
+ +++D+Y+ G+V E+ V + + E ++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEND 1043
R + + + + + C R T + L ++ +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-54
Identities = 70/316 (22%), Positives = 118/316 (37%), Gaps = 36/316 (11%)
Query: 759 RLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHK 817
+ +G G G+V++V PS V+A K + + R+Q E+Q L
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHECNSP 64
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
IV G + + +++ GSL +L + + K+ + V GL YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK 123
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
I+HRD+K +NILV + E L DFG++ S + NS G+ Y++PE
Sbjct: 124 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQG 177
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEP--TDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995
+ +SD++S G+ L+E+ G+ P V G+ E T
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 996 LLMRSGTQIQEMLQVLGVALL----------------------CVNPCPEERPTMKDVTA 1033
++ + L ++ C+ P ER +K +
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 1034 M--LKEIRHENDDLEK 1047
+K E D
Sbjct: 298 HAFIKRSDAEEVDFAG 313
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 9e-54
Identities = 59/276 (21%), Positives = 111/276 (40%), Gaps = 26/276 (9%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G G G+V+ ++ +A+K + + F E + + + H +V+L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
G C L+F+++ +G L+ L ++ ++ + L V G+AYL +I
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEK 943
HRD+ + N LVG ++DFG+ + + + S + +PE + + K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 182
Query: 944 SDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQ 1003
SDV+S+GV++ EV + + + + G + R +T
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST------------- 229
Query: 1004 IQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039
V + C PE+RP + L EI
Sbjct: 230 -----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 60/275 (21%), Positives = 116/275 (42%), Gaps = 26/275 (9%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G G G+V + + +A+K + E D+F E + + ++ H+ +V+L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLY 65
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
G C R ++ +Y++NG L L E + ++ V + YL +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEK 943
HRD+ + N LV Q ++DFGL++ E + S + PE K + K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 944 SDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQ 1003
SD++++GV++ E+ + + R + N E E I L R
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYER---------FTNSETAEH------IAQGLRLYRPHLA 226
Query: 1004 IQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
+++ ++ C + +ERPT K + + + ++
Sbjct: 227 SEKVYTIM---YSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (471), Expect = 5e-53
Identities = 67/309 (21%), Positives = 118/309 (38%), Gaps = 36/309 (11%)
Query: 750 NFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPS----RQVIAVKKLWPVKNGELPERDQFS 805
F+ + ++ + ++G G G V + +A+K L + +R F
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--QRRDFL 75
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIIL 865
+E +G H N++ L G +++ +++ NGSL L + ++
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135
Query: 866 GVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAG 925
G+A G+ YL +HRD+ + NILV ++DFGL++ E S S G
Sbjct: 136 GIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 926 SYG---YIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR 982
+ APE K T SDV+SYG+V+ EV++ E + + +I + + R
Sbjct: 193 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYR 251
Query: 983 ERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042
+ + L C RP + L ++
Sbjct: 252 LPPPM-----------------DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM---- 290
Query: 1043 DDLEKPNSL 1051
+ PNSL
Sbjct: 291 --IRNPNSL 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-52
Identities = 74/308 (24%), Positives = 122/308 (39%), Gaps = 46/308 (14%)
Query: 759 RLSDTNIVGKGVSGIVYRVEI------PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLG 812
RLS +G G G V + +AVK L + L ER+ +E++ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALMSELKVLS 81
Query: 813 SI-RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKK-----------------VF 854
+ H NIV LLG C G L++ +Y G L L K+ +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 855 LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914
LD + VA G+A+L IHRD+ + NIL+ + DFGLA+ ++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHII 974
+ + ++APE ++ T +SDV+SYG+ L E+ + +P +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 975 TWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034
+ R E EM ++ C + P +RPT K + +
Sbjct: 259 KMIKEGFRMLSPEHAP--------------AEMYDIM---KTCWDADPLKRPTFKQIVQL 301
Query: 1035 LKEIRHEN 1042
+++ E+
Sbjct: 302 IEKQISES 309
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-52
Identities = 67/294 (22%), Positives = 125/294 (42%), Gaps = 29/294 (9%)
Query: 759 RLSDTNIVGKGVSGIVYRVEIPS-----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGS 813
++ ++G G G VY+ + + +A+K L + +R F E +G
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQ 65
Query: 814 IRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAY 873
H NI+RL G + + +++ +Y+ NG+L L EK ++ G+A G+ Y
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 874 LHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES-SESSRASNSVAGSYGYIAP 932
L + +HRD+ + NILV ++DFGL+++ E E++ ++ + AP
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 933 EYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992
E K T SDV+S+G+V+ EV+T E + + ++ +N R
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPM----- 236
Query: 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLE 1046
+ + + C RP D+ ++L ++ D L+
Sbjct: 237 ------------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-52
Identities = 66/297 (22%), Positives = 124/297 (41%), Gaps = 33/297 (11%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPSR---QVIAVKKLWPVKNGELPERDQ 803
+KL D+++ ++D + G G G V + R +A+K L + E + ++
Sbjct: 1 KKLFLKRDNLL--IADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLK--QGTEKADTEE 55
Query: 804 FSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKI 863
E Q + + + IVRL+G C +L+ + G L L K+ + + ++
Sbjct: 56 MMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 864 ILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR-ASNS 922
+ V+ G+ YL +HRD+ + N+L+ + A ++DFGL+K + +S A ++
Sbjct: 115 LHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 923 VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGEL 981
+ APE K + +SDV+SYGV + E L+ G++P G ++ ++
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGK 229
Query: 982 RERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
R L+ C E+RP V ++
Sbjct: 230 RMECPPECPPELYALMSD-----------------CWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-52
Identities = 70/281 (24%), Positives = 116/281 (41%), Gaps = 35/281 (12%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+GKG G V + +V AVK + KN F AE + +RH N+V+LL
Sbjct: 13 QTIGKGEFGDVMLGDYRGNKV-AVKCI---KNDA--TAQAFLAEASVMTQLRHSNLVQLL 66
Query: 824 GCCNNGRTRL-LLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
G + L ++ +Y++ GSL L + + L D K L V + YL
Sbjct: 67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NN 123
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
+HRD+ + N+LV A ++DFGL K S++ ++ + APE K +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFS 178
Query: 942 EKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
KSDV+S+G++L E+ + RIP + G + + +++
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV-YEVMKN-- 235
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR-HE 1041
C + RP+ + L+ I+ HE
Sbjct: 236 ---------------CWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (458), Expect = 3e-51
Identities = 71/322 (22%), Positives = 125/322 (38%), Gaps = 56/322 (17%)
Query: 746 FQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELP 799
L + ++ + +G+G G V++ P ++AVK L + +
Sbjct: 5 LLSLEYPRNN----IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-- 58
Query: 800 ERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVF----- 854
+ F E + + NIV+LLG C G+ LLF+Y++ G L L
Sbjct: 59 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 855 ------------------LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP 896
L + I VA G+AYL +HRD+ + N LVG
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGE 175
Query: 897 QFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEV 956
+ADFGL++ S++ +A + A ++ PE + + T +SDV++YGVVL E+
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235
Query: 957 LTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALL 1016
+ + I +G + L++ + L
Sbjct: 236 FSYGLQPYYGMAHEEVIYYVRDGNILACPENCP------------------LELYNLMRL 277
Query: 1017 CVNPCPEERPTMKDVTAMLKEI 1038
C + P +RP+ + +L+ +
Sbjct: 278 CWSKLPADRPSFCSIHRILQRM 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-51
Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 28/293 (9%)
Query: 759 RLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
L +G+G G V+ +A+K L P + F E Q + +RH+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEK 73
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLH-EKKVFLDWDSRYKIILGVAHGLAYLHHD 877
+V+L + ++ +Y+S GSL L E +L + +A G+AY+
Sbjct: 74 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
+HRD+++ NILVG +ADFGLA+L E +E + A + APE
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY 188
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997
+ T KSDV+S+G++L E+ T + + + G E L L+
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLM 247
Query: 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNS 1050
+ C PEERPT + + A L++ + +P
Sbjct: 248 CQ-----------------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-50
Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 51/301 (16%)
Query: 765 IVGKGVSGIVYRV------EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHK 817
++G G G V + +AVK L + ER+ +E++ + + H+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHE 101
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKV----------------------FL 855
NIV LLG C L+F+Y G L L K+ L
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 856 DWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915
++ VA G+ +L +HRD+ + N+LV + DFGLA+ S
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218
Query: 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIIT 975
+ + ++APE + T KSDV+SYG++L E+ + IP A+
Sbjct: 219 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278
Query: 976 WVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAML 1035
+ + + + T ++ C +RP+ ++T+ L
Sbjct: 279 LIQNGFKMDQPFYATEEIYIIMQS-----------------CWAFDSRKRPSFPNLTSFL 321
Query: 1036 K 1036
Sbjct: 322 G 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 31/274 (11%)
Query: 764 NIVGKGVSGIVYR-VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+G+G VY+ ++ + +A +L K + ER +F E + L ++H NIVR
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRF 73
Query: 823 LGCC----NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
+ +L+ + +++G+L L KV + + GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRT 132
Query: 879 VPPIIHRDIKSNNILV-GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYS 937
PPIIHRD+K +NI + GP + D GLA L +S + +V G+ ++APE Y
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM-YE 186
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997
K E DVY++G+ +LE+ T + P +G + ++++
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
C+ +ER ++KD+
Sbjct: 247 EG-----------------CIRQNKDERYSIKDL 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-50
Identities = 62/284 (21%), Positives = 114/284 (40%), Gaps = 28/284 (9%)
Query: 762 DTNIVGKGVSGIVYRVEIPSR---QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
+ +G G G V + + + +AVK L N +D+ AE + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-LKDELLAEANVMQQLDNPY 69
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
IVR++G C + +L+ + G L L + + + + +++ V+ G+ YL
Sbjct: 70 IVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS-RASNSVAGSYGYIAPEYGYS 937
+HRD+ + N+L+ Q A ++DFGL+K + E+ +A + APE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 938 LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLL 997
K + KSDV+S+GV++ E + + + GE
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP-------- 236
Query: 998 MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041
+EM ++ LC E RP V L+ ++
Sbjct: 237 -------REMYDLM---NLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-50
Identities = 65/270 (24%), Positives = 106/270 (39%), Gaps = 25/270 (9%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+G+G G V + + +AVK + + + PE E+ + H+N+V+
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 68
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
G G + L +Y S G L + + + + G+ YLH I
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKI-T 941
HRDIK N+L+ + ++DFGLA +F + R N + G+ Y+APE +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 942 EKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
E DV+S G+VL +L G+ P D W + + LL +
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK-- 242
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+L N P R T+ D+
Sbjct: 243 -------------ILVEN--PSARITIPDI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 7e-50
Identities = 66/286 (23%), Positives = 110/286 (38%), Gaps = 30/286 (10%)
Query: 764 NIVGKGVSGIVYRVEIP----SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
++G+G G VY + + AVK L + + E QF E + H N+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 90
Query: 820 VRLLGCC-NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
+ LLG C + + L++ Y+ +G L + + L VA G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE--SSRASNSVAGSYGYIAPEYGY 936
+HRD+ + N ++ +F +ADFGLA+ E S ++A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996
+ K T KSDV+S+GV+L E++T P + L+ R+ L
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRRLLQPEYCPDPL 263
Query: 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042
V L C +P E RP+ ++ + + I
Sbjct: 264 YE--------------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 2e-49
Identities = 70/285 (24%), Positives = 113/285 (39%), Gaps = 32/285 (11%)
Query: 751 FSVDDVVTRLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQ 809
F DD SD +G G G VY + + +V+A+KK+ + EV+
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 810 TLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAH 869
L +RH N ++ GC T L+ +Y + L KK L + G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQ 126
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGY 929
GLAYLH +IHRD+K+ NIL+ L DFG A + +NS G+ +
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYW 177
Query: 930 IAPEYGYSL---KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR 986
+APE ++ + K DV+S G+ +E+ K P + + + E +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQS 236
Query: 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ R + C+ P++RPT + +
Sbjct: 237 GHWSEYFRNFVDS-----------------CLQKIPQDRPTSEVL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 6e-49
Identities = 59/285 (20%), Positives = 117/285 (41%), Gaps = 33/285 (11%)
Query: 758 TRLSDTNIV---GKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGS 813
+R D ++ G G G ++ +++ K+L E E+ +EV L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRE 59
Query: 814 IRHKNIVRLLGCC--NNGRTRLLLFDYISNGSLAGLLH---EKKVFLDWDSRYKIILGVA 868
++H NIVR T ++ +Y G LA ++ +++ +LD + +++ +
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 869 HGLAYLH--HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGS 926
L H D ++HRD+K N+ + + L DFGLA++ S + + G+
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGT 177
Query: 927 YGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR 986
Y++PE + EKSD++S G +L E+ P + G+ R
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIREGKFRRIPY 236
Query: 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
++ L +++ R +N RP+++++
Sbjct: 237 RYSDEL-NEIITR-----------------MLNLKDYHRPSVEEI 263
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (439), Expect = 8e-49
Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 31/289 (10%)
Query: 764 NIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+ +G G G VY +AVK L + E ++F E + I+H N+V+L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
LG C ++ ++++ G+L L E + + + ++ + YL
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KN 135
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
IHRD+ + N LVG +ADFGL++L + ++ A + APE K +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 942 EKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
KSDV+++GV+L E+ T I D + + + + R + E
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERPE-------------- 239
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN---DDLEK 1047
+V + C P +RP+ ++ + + E+ D++EK
Sbjct: 240 ---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 72/270 (26%), Positives = 116/270 (42%), Gaps = 31/270 (11%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+GKG G VY S+ ++A+K L+ + + Q EV+ +RH NI+RL
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
G ++ L+ +Y G++ L + F D I +A+ L+Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCHS---KRV 127
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
IHRDIK N+L+G E +ADFG + SS ++ G+ Y+ PE E
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDE 183
Query: 943 KSDVYSYGVVLLEVLTGKEPTDSRIP-DGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
K D++S GV+ E L GK P ++ + I+ V + E R L+ R
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLISR-- 237
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ P +RP +++V
Sbjct: 238 ---------------LLKHNPSQRPMLREV 252
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-48
Identities = 70/329 (21%), Positives = 119/329 (36%), Gaps = 51/329 (15%)
Query: 744 TPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVEIPS---RQVIAVKKLWPVKNGELPE 800
T + L+++ + +++G+G G V + I R A+K++ + + +
Sbjct: 2 TIYPVLDWN------DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--D 53
Query: 801 RDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVF----- 854
F+ E++ L + H NI+ LLG C + L +Y +G+L L + +V
Sbjct: 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113
Query: 855 ----------LDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLAD 904
L VA G+ YL IHRD+ + NILVG + A +AD
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD 170
Query: 905 FGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTD 964
FGL++ E ++A E T SDV+SYGV+L E+++
Sbjct: 171 FGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227
Query: 965 SRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEE 1024
+ G E+ +V + C P E
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDD------------------EVYDLMRQCWREKPYE 269
Query: 1025 RPTMKDVTAMLKEIRHENDDLEKPNSLSR 1053
RP+ + L + E +
Sbjct: 270 RPSFAQILVSLNRMLEERKTYVNTTLYEK 298
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 7e-48
Identities = 62/279 (22%), Positives = 110/279 (39%), Gaps = 26/279 (9%)
Query: 766 VGKGVSGIVYRVEIPSR----QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVR 821
+G G G+V R E + +AVK L P + D F EV + S+ H+N++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
L G + ++ + GSL L + + + + + VA G+ YL
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KR 131
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLF-ESSESSRASNSVAGSYGYIAPEYGYSLKI 940
IHRD+ + N+L+ + + DFGL + ++ + + + APE +
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 941 TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRS 1000
+ SD + +GV L E+ T + + + R + E
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP---------- 241
Query: 1001 GTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIR 1039
Q++ V+ + C PE+RPT + L E +
Sbjct: 242 ----QDIYNVM---VQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 8e-48
Identities = 58/272 (21%), Positives = 103/272 (37%), Gaps = 31/272 (11%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G G VY+ + + + A K + E + + E+ L S H NIV+LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVI---DTKSEEELEDYMVEIDILASCDHPNIVKLLD 76
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
+L ++ + G++ ++ E + L + L YLH IIH
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 885 RDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY-----GYSLK 939
RD+K+ NIL + LADFG++ + R +S G+ ++APE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRP 191
Query: 940 ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMR 999
K+DV+S G+ L+E+ + P P + + + + + L +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251
Query: 1000 SGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
C+ + R T +
Sbjct: 252 -----------------CLEKNVDARWTTSQL 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 66/281 (23%), Positives = 108/281 (38%), Gaps = 29/281 (10%)
Query: 765 IVGKGVSGIVYRVEIPSRQ----VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV 820
+G+G G V++ S + +A+K + R++F E T+ H +IV
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQFDHPHIV 71
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
+L+G ++ + + G L L +K LD S ++ LAYL
Sbjct: 72 KLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---K 127
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKI 940
+HRDI + N+LV L DFGL++ E S + ++ ++APE +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRF 186
Query: 941 TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRS 1000
T SDV+ +GV + E+L + + I NGE L L+ +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL-YSLMTK- 244
Query: 1001 GTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041
C P RP ++ A L I E
Sbjct: 245 ----------------CWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-47
Identities = 67/281 (23%), Positives = 127/281 (45%), Gaps = 28/281 (9%)
Query: 752 SVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQT 810
SV D + + +G+G SG VY ++ + Q +A++++ + P+++ E+
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILV 70
Query: 811 LGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHG 870
+ ++ NIV L G ++ +Y++ GSL ++ E + D +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQA 128
Query: 871 LAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYI 930
L +LH + +IHRDIKS+NIL+G L DFG +S R +++ G+ ++
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWM 183
Query: 931 APEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTT 990
APE K D++S G++ +E++ G+ P + P A + NG + E +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ R L R C++ E+R + K++
Sbjct: 244 AIFRDFLNR-----------------CLDMDVEKRGSAKEL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (428), Expect = 1e-46
Identities = 61/339 (17%), Positives = 125/339 (36%), Gaps = 33/339 (9%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFS 805
Q + D V+ +G G G+V+RV E + A K + +++
Sbjct: 15 QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVR 71
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIIL 865
E+QT+ +RH +V L + +++++++S G L + ++ + D + +
Sbjct: 72 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 131
Query: 866 GVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF--EAFLADFGLAKLFESSESSRASNSV 923
V GL ++H + +H D+K NI+ + E L DFGL + +S
Sbjct: 132 QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVT 185
Query: 924 AGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA-HIITWVNGELR 982
G+ + APE + +D++S GV+ +L+G P D + + +
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 245
Query: 983 ERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM--LKEIRH 1040
+ + + + + + P R T+ L
Sbjct: 246 DSAFSGISEDGKDFIRK-----------------LLLADPNTRMTIHQALEHPWLTPGNA 288
Query: 1041 ENDDLEKPNSLSRAVTNPKAAVHCSSFSRSAEPLIRSPS 1079
D + P+S + + + ++ PL R +
Sbjct: 289 PGRDSQIPSSRYTKIRDSIKTKY-DAWPEPLPPLGRISN 326
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-46
Identities = 63/312 (20%), Positives = 121/312 (38%), Gaps = 32/312 (10%)
Query: 764 NIVGKGVSGIVYRVEIPS-----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKN 818
++G G G VY+ + +A+K+L + + + E + S+ + +
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPH 72
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
+ RLLG C T L+ + G L + E K + + +A G+ YL
Sbjct: 73 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-- 129
Query: 879 VPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL 938
++HRD+ + N+LV + DFGLAKL + E + ++A E
Sbjct: 130 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 939 KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998
T +SDV+SYGV + E++T IP E ++IL++ +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----------------SEISSILEKGERL 232
Query: 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLEKPNSLSRAVTNP 1058
+ ++ + C + RP +++ ++ D ++ +
Sbjct: 233 PQPPICTIDVYMI--MVKCWMIDADSRPKFRELIIEFSKMAR---DPQRYLVIQGDERMH 287
Query: 1059 KAAVHCSSFSRS 1070
+ S+F R+
Sbjct: 288 LPSPTDSNFYRA 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 1e-45
Identities = 60/294 (20%), Positives = 116/294 (39%), Gaps = 38/294 (12%)
Query: 764 NIVGKGVSGIVYR------VEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHK 817
+G+G G+VY V+ +A+K + + + ER +F E +
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCH 83
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVF---------LDWDSRYKIILGVA 868
++VRLLG + G+ L++ + ++ G L L + ++ +A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 869 HGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYG 928
G+AYL+ +HRD+ + N +V F + DFG+ + ++ R
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 929 YIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREF 988
+++PE T SDV+S+GVVL E+ T E + + + + G L ++
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 260
Query: 989 TTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042
+L + +C P+ RP+ ++ + +KE
Sbjct: 261 PDMLFE------------------LMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-44
Identities = 55/278 (19%), Positives = 103/278 (37%), Gaps = 25/278 (8%)
Query: 764 NIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
I+G+G V E+ + + A+K L + + + E + + H V+L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ Y NG L + + F + +R+ + L YLH I
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG---KGI 129
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
IHRD+K NIL+ + DFG AK+ +NS G+ Y++PE +
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 943 KSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGT 1002
SD+++ G ++ +++ G P + + E ++ F D L+ +
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQKIIKLEYDFPEKFFPKARD--LVEK--- 243
Query: 1003 QIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040
LL ++ +R +++ H
Sbjct: 244 ------------LLVLD--ATKRLGCEEMEGYGPLKAH 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 3e-42
Identities = 68/299 (22%), Positives = 112/299 (37%), Gaps = 47/299 (15%)
Query: 764 NIVGKGVSGIVYRVEIPSR--------QVIAVKKLWPVKNGELPERDQFSAEVQTLGSI- 814
+G+G G V E +AVK L + + +E++ + I
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIG 76
Query: 815 RHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVF---------------LDWDS 859
+HKNI+ LLG C ++ +Y S G+L L ++ L
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 860 RYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919
VA G+ YL IHRD+ + N+LV +ADFGLA+ + +
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 920 SNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNG 979
+ + ++APE + T +SDV+S+GV+L E+ T +P G
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253
Query: 980 ELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038
++ T E+ ++ C + P +RPT K + L I
Sbjct: 254 HRMDKPSNCT---------------NELYMMM---RDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (391), Expect = 8e-42
Identities = 46/270 (17%), Positives = 95/270 (35%), Gaps = 30/270 (11%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G G+V+R E + +V K + ++ E+ + + H ++ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFI---NTPYPLDKYTVKNEISIMNQLHHPKLINLHD 93
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
+ +L+ +++S G L + + + + GL ++H I+H
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 885 RDIKSNNILVGPQFEAF--LADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
DIK NI+ + + + DFGLA E + + APE +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGF 207
Query: 943 KSDVYSYGVVLLEVLTGKEP-TDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
+D+++ GV+ +L+G P + + + E E + + +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN-- 265
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ P +R T+ D
Sbjct: 266 ---------------LLQKEPRKRLTVHDA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-42
Identities = 70/302 (23%), Positives = 116/302 (38%), Gaps = 45/302 (14%)
Query: 764 NIVGKGVSGIVYRV------EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH- 816
+G+G G V + + + +AVK L + E +E++ L I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKILIHIGHH 76
Query: 817 KNIVRLLGCC-NNGRTRLLLFDYISNGSLAGLLHEK---------------KVFLDWDSR 860
N+V LLG C G +++ ++ G+L+ L K K FL +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 861 YKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920
VA G+ +L IHRD+ + NIL+ + + DFGLA+
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 921 NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE 980
++APE + T +SDV+S+GV+L E+ + + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 253
Query: 981 LRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040
R R ++TT EM Q + L C + P +RPT ++ L +
Sbjct: 254 TRMRAPDYTT--------------PEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 296
Query: 1041 EN 1042
N
Sbjct: 297 AN 298
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (378), Expect = 7e-41
Identities = 66/295 (22%), Positives = 117/295 (39%), Gaps = 33/295 (11%)
Query: 758 TRLSD----TNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLG 812
+ LSD I+G G V+ + + +AVK L + +F E Q
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 813 SIRHKNIVRLLGCC----NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVA 868
++ H IV + G ++ +Y+ +L ++H + + ++I
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADAC 121
Query: 869 HGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA-SNSVAGSY 927
L + H IIHRD+K NI++ + DFG+A+ S +S + +V G+
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 928 GYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP-TDSRIPDGAHIITWVNGELRERKR 986
Y++PE + +SDVYS G VL EVLTG+ P T A+ + +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238
Query: 987 EFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP-TMKDVTAMLKEIRH 1040
E + ++++ + PE R T ++ A L + +
Sbjct: 239 EGLSADLDAVVLK-----------------ALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 7e-41
Identities = 53/270 (19%), Positives = 98/270 (36%), Gaps = 25/270 (9%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+++G G V E +++++A+K + K + E+ L I+H NIV L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCI--AKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+G L+ +S G L + EK F ++I V + YLH +
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
+ + + ++DFGL+K+ + ++ G+ GY+APE ++
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSK 188
Query: 943 KSDVYSYGVVLLEVLTGKEP-TDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
D +S GV+ +L G P D I E + + + +
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH-- 246
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ PE+R T +
Sbjct: 247 ---------------LMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-40
Identities = 52/271 (19%), Positives = 104/271 (38%), Gaps = 33/271 (12%)
Query: 766 VGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G+G GIV+R E S++ K + + ++ E+ L RH+NI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV----KVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
+ +++F++IS + ++ L+ + V L +LH I H
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 885 RDIKSNNILVGPQFEAF--LADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
DI+ NI+ + + + +FG A+ + ++ R + + Y APE ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVST 182
Query: 943 KSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD--RQLLMRS 1000
+D++S G ++ +L+G P + I +N E + F I + R
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTFDEEAFKEISIEAMDFVDR- 240
Query: 1001 GTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ + R T +
Sbjct: 241 ----------------LLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (365), Expect = 4e-39
Identities = 69/284 (24%), Positives = 110/284 (38%), Gaps = 41/284 (14%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPE------RDQFSAEVQTLGSIR- 815
I+G+GVS +V R P+ + AVK + G R+ EV L +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 816 HKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLH 875
H NI++L L+FD + G L L EK L KI+ + + LH
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALH 127
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY- 934
I+HRD+K NIL+ L DFG + + E R V G+ Y+APE
Sbjct: 128 K---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEII 181
Query: 935 -----GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989
++ D++S GV++ +L G P R + ++G + E+
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGNYQFGSPEWD 240
Query: 990 TILD--RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
D + L+ R + P++R T ++
Sbjct: 241 DYSDTVKDLVSR-----------------FLVVQPQKRYTAEEA 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (358), Expect = 3e-38
Identities = 59/279 (21%), Positives = 113/279 (40%), Gaps = 19/279 (6%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G+G G+VY+ + + A+KK+ K E E+ L ++H NIV+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLY 66
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
+ + +L+F+++ L + L+ + +L + +G+AY H ++
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEK 943
HRD+K N+L+ + E +ADFGLA+ F + ++ + + S K +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 944 SDVYSYGVVLLEVLTGKEPTDS-----------RIPDGAHIITWVNGELRERKREFTTIL 992
D++S G + E++ G RI + W N + T+
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ + E L +L ++ P +R T K
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLD--PNQRITAKQA 278
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (362), Expect = 7e-38
Identities = 57/282 (20%), Positives = 105/282 (37%), Gaps = 32/282 (11%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEV---QTLGSIRHKNI 819
I+G+G G VY + ++ A+K L + E + + I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 820 VRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCV 879
V + + + D ++ G L L + VF + D R+ + GL ++H+
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEHMHN--- 125
Query: 880 PPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY-GYSL 938
+++RD+K NIL+ ++D GLA F + ++ G++GY+APE +
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV 181
Query: 939 KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998
+D +S G +L ++L G P H I + + + + R LL
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040
LL + R A +E++
Sbjct: 242 G---------------LLQRD--VNRRLGCLGRGA--QEVKE 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-38
Identities = 58/269 (21%), Positives = 102/269 (37%), Gaps = 28/269 (10%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLG-SIRHKNIVR 821
++GKG G V+ E + Q A+K L + + E + L + H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 822 LLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP 881
+ + +Y++ G L + F D + GL +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLHSKG--- 123
Query: 882 IIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKIT 941
I++RD+K +NIL+ +ADFG+ K ++ N+ G+ YIAPE K
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYN 181
Query: 942 EKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSG 1001
D +S+GV+L E+L G+ P + D + + + R + LL++
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPFYPRWLEKEA-KDLLVK-- 236
Query: 1002 TQIQEMLQVLGVALLCVNPCPEERPTMKD 1030
PE+R ++
Sbjct: 237 ---------------LFVREPEKRLGVRG 250
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 67/328 (20%), Positives = 132/328 (40%), Gaps = 49/328 (14%)
Query: 744 TPFQKLNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVK---NGELP 799
T F++ N VDD +G G +V + E + A K + + +
Sbjct: 1 TVFRQEN--VDDYYDTG---EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 800 ERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDS 859
R+ EV L I+H N++ L N +L+ + ++ G L L EK+ + ++
Sbjct: 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 115
Query: 860 RYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV----GPQFEAFLADFGLAKLFESSE 915
+ L +++ I H D+K NI++ P+ + DFGLA +
Sbjct: 116 TEFL----KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP-TDSRIPDGAHII 974
+ ++ G+ ++APE + ++D++S GV+ +L+G P + +
Sbjct: 172 EFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228
Query: 975 TWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034
+ VN E + T+ L + + R + P++R T++D
Sbjct: 229 SAVNYEFEDEYFSNTSALAKDFIRR-----------------LLVKDPKKRMTIQDS--- 268
Query: 1035 LKEIRHE---NDDLEKPNSLSRAVTNPK 1059
++H D ++ LS A ++P+
Sbjct: 269 ---LQHPWIKPKDTQQA--LSSAWSHPQ 291
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-37
Identities = 57/299 (19%), Positives = 113/299 (37%), Gaps = 24/299 (8%)
Query: 764 NIVGKGVSGIVYRVE--IPSRQVIAVKKLWPVKNGELPERDQFS--AEVQTLGSIRHKNI 819
+G+G G V++ + +A+K++ E A ++ L + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 820 VRLLGCCNNGRTR-----LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL 874
VRL C RT L+F+++ L + + ++ ++ + GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 875 HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY 934
H ++HRD+K NILV + LADFGLA+++ + SV + Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEV 186
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG--AHIITWVNGELRERKREFTTIL 992
D++S G + E+ K I+ + E +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 993 DRQLLMRSGTQIQEMLQVLGVALL-----CVNPCPEERPTMKDVTAM--LKEIRHENDD 1044
+ +S I++ + + C+ P +R + + +++ ++
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN 305
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (350), Expect = 9e-37
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+G G G V+ + + + A+K L L + + + E L + H I+R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
G + + ++ DYI G L LL + + F + +++ V L YLH I
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLHS---KDI 125
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
I+RD+K NIL+ + DFG AK ++ G+ YIAPE + +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKPYNK 180
Query: 943 KSDVYSYGVVLLEVLTGKEP 962
D +S+G+++ E+L G P
Sbjct: 181 SIDWWSFGILIYEMLAGYTP 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 1e-36
Identities = 44/286 (15%), Positives = 95/286 (33%), Gaps = 29/286 (10%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G G +Y I + + +A+K + Q E + ++ + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 825 CCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIH 884
C ++ + SL L + + + + + Y+H IH
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIH 126
Query: 885 RDIKSNNILV---GPQFEAFLADFGLAKLFESSESS-----RASNSVAGSYGYIAPEYGY 936
RD+K +N L+ ++ DFGLAK + + + R + ++ G+ Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996
++ + + D+ S G VL+ G P E + L
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------TPIEVL 240
Query: 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042
++ L C + +++P + + + + H
Sbjct: 241 CKGYPSEFATYLN------FCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-36
Identities = 82/316 (25%), Positives = 118/316 (37%), Gaps = 39/316 (12%)
Query: 761 SDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI 819
+DT ++G G G+VY+ + S +++A+KK+ L ++ + E+Q + + H NI
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNI 75
Query: 820 VRLLGCC------NNGRTRLLLFDYISNGSLAGLLH--EKKVFLDWDSRYKIILGVAHGL 871
VRL + L+ DY+ H K L + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 872 AYLHHDCVPPIIHRDIKSNNILVGPQFEAF-LADFGLAKLFESSESSRASNSVAGSYGYI 930
AY+H I HRDIK N+L+ P L DFG AK E + S S Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYR 189
Query: 931 AP-EYGYSLKITEKSDVYSYGVVLLEVLTGKEP--TDSRIPDGAHIITWVNGELRERKRE 987
AP + T DV+S G VL E+L G+ DS + II + RE+ RE
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 988 ---------FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM--LK 1036
F I + L LL P R T + A
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT--PTARLTPLEACAHSFFD 307
Query: 1037 EIRHENDDLEKPNSLS 1052
E+R N L
Sbjct: 308 ELRDPNVKLPNGRDTP 323
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-36
Identities = 61/295 (20%), Positives = 120/295 (40%), Gaps = 25/295 (8%)
Query: 755 DVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGS 813
DV R ++ + +G+G G+V + ++ +A+KK+ P ++ +R E++ L
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 62
Query: 814 IRHKNIVRLLGCCNNG----RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAH 869
RH+NI+ + + L ++ L LL + L D + +
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILR 120
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS-NSVAGSYG 928
GL Y+H ++HRD+K +N+L+ + + DFGLA++ + +
Sbjct: 121 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 929 YIAPEY-GYSLKITEKSDVYSYGVVLLEVLTGKEP--TDSRIPDGAHIITWVNGELRERK 985
Y APE S T+ D++S G +L E+L+ + + HI+ + +E
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 986 REFTTILDRQLLMRSGTQIQEMLQVL-------GVALL--CVNPCPEERPTMKDV 1031
+ R L+ + + L + LL + P +R ++
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 30/286 (10%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPE--RDQFSAEVQTLGSIRHKNIV 820
+ +G+G VY+ + Q++A+KK+ E + E++ L + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 821 RLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVP 880
LL + L+FD++ ++ + + L +L GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 881 PIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLK- 939
I+HRD+K NN+L+ LADFGLAK F S + + Y APE + +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARM 177
Query: 940 ITEKSDVYSYGVVLLEVLTGKEPTDSR--------------IPDGAHIITWVNGELRERK 985
D+++ G +L E+L P +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 986 REFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+ F I + +G + +++Q L N P R T
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQ----GLFLFN--PCARITATQA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 61/279 (21%), Positives = 111/279 (39%), Gaps = 17/279 (6%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+G+G G+VY+ + +V+A+KK+ E E+ L + H NIV+L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKL 66
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
L + L+F+++ + + + + GLA+ H +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE-YGYSLKIT 941
+HRD+K N+L+ + LADFGLA+ F R + Y APE +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 942 EKSDVYSYGVVLLEVLTGKEP--TDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM- 998
D++S G + E++T + DS I I + T++ D +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 999 ----RSGTQIQEMLQVLGVALL--CVNPCPEERPTMKDV 1031
+ +++ L G +LL ++ P +R + K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 5e-35
Identities = 56/275 (20%), Positives = 100/275 (36%), Gaps = 41/275 (14%)
Query: 765 IVGKGVSGIVYRV-EIPSRQVIAVKKLWP---VKNGELPERDQFSAEVQTLGSIR--HKN 818
++G G G VY + +A+K + GELP + EV L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 819 IVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC 878
++RLL + +L+ + ++ L + V + + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 879 VPPIIHRDIKSNNILVGPQ-FEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY-GY 936
++HRDIK NIL+ E L DFG L + + G+ Y PE+ Y
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRY 183
Query: 937 SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996
+ V+S G++L +++ G P + I+ Q+
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------------------EEIIRGQV 221
Query: 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
R ++ Q L L + P +RPT +++
Sbjct: 222 FFRQ--RVSSECQHLIRWCLALR--PSDRPTFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 56/279 (20%), Positives = 106/279 (37%), Gaps = 17/279 (6%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+G+G G V++ + + +++A+K++ + E E+ L ++HKNIVRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRL 66
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
++ + L+F++ D + + + GL + H +
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
+HRD+K N+L+ E LA+FGLA+ F S V + + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 943 KSDVYSYGVVLLEVLTGKEP--TDSRIPDGAHIITWVNGELRERKREFTTIL------DR 994
D++S G + E+ P + + D I + G E + T L
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 995 QLLMRSGTQIQEMLQVLGVALL--CVNPCPEERPTMKDV 1031
S + L G LL + P +R + ++
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (325), Expect = 1e-33
Identities = 42/293 (14%), Positives = 97/293 (33%), Gaps = 33/293 (11%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH-KNIVRLL 823
+G+G G+++ + + Q +A+K + Q E +T + I +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCTGIPNVY 67
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
G +L+ D + LL + + + +H ++
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123
Query: 884 HRDIKSNNILVGPQFE-----AFLADFGLAKLFESSESSR-----ASNSVAGSYGYIAPE 933
+RDIK +N L+G ++ DFG+ K + + + +++G+ Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 934 YGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILD 993
+ + + D+ + G V + L G P GE ++
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------TPL 237
Query: 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDLE 1046
R+L + + + N + P + + ++ + E
Sbjct: 238 RELCAGFPEEFYKYMH------YARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 6e-33
Identities = 58/292 (19%), Positives = 113/292 (38%), Gaps = 29/292 (9%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
+G+G G V++ + Q +A+KK+ E E++ L ++H+N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNL 74
Query: 823 LGCCNNGRTR--------LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYL 874
+ C + L+FD+ + GLL V +++ + +GL Y+
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 875 HHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS--NSVAGSYGYIAP 932
H I+HRD+K+ N+L+ LADFGLA+ F +++S+ + + + Y P
Sbjct: 134 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 933 EYGYSLK-ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGA-HIITWVNGELRE------- 983
E + D++ G ++ E+ T +I+ + G +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 984 --RKREFTTILDRQLLMRSGTQIQEMLQVLGVALL--CVNPCPEERPTMKDV 1031
E ++ Q + + L+ + P +R D
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-32
Identities = 60/277 (21%), Positives = 112/277 (40%), Gaps = 36/277 (12%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRL 822
++G G++G V ++ +++ A+K L + + EV+ + +IVR+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRI 70
Query: 823 LGCC----NNGRTRLLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHD 877
+ + L++ + + G L + ++ +I+ + + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 878 CVPPIIHRDIKSNNILV---GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEY 934
I HRD+K N+L P L DFG AK S S + + Y+APE
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEV 184
Query: 935 GYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994
K + D++S GV++ +L G P S G I + +R + EF
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMGQYEFPNPEW- 241
Query: 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDV 1031
+++ E +++L LL P +R T+ +
Sbjct: 242 -------SEVSEEVKMLIRNLLKTE--PTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 4e-32
Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 7/200 (3%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRL 822
++GKG G V V + + A+K L E E + L + RH + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 823 LGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPI 882
+ +Y + G L L ++VF + +R+ A ++ L + +
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG----AEIVSALEYLHSRDV 126
Query: 883 IHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITE 942
++RDIK N+++ + DFGL K S ++ + G+ Y+APE
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGR 184
Query: 943 KSDVYSYGVVLLEVLTGKEP 962
D + GVV+ E++ G+ P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLP 204
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (311), Expect = 2e-31
Identities = 45/199 (22%), Positives = 81/199 (40%), Gaps = 10/199 (5%)
Query: 765 IVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLL 823
+G G G V V+ S A+K L K +L + + E + L ++ +V+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 824 GCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPII 883
+ ++ +Y++ G + L F + YLH +I
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLHSLD---LI 163
Query: 884 HRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEK 943
+RD+K N+L+ Q + DFG AK + ++ G+ +APE S +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKA 218
Query: 944 SDVYSYGVVLLEVLTGKEP 962
D ++ GV++ E+ G P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 70/314 (22%), Positives = 120/314 (38%), Gaps = 25/314 (7%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFS 805
Q++ + +V D VG G G V + + +A+KKL+ EL +
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAY 65
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHE---KKVFLDWDSRYK 862
E++ L +RH+N++ LL T D+ G K L D
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125
Query: 863 IILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNS 922
++ + GL Y+H IIHRD+K N+ V E + DFGLA+ + S +
Sbjct: 126 LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGY 178
Query: 923 VAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP-TDSRIPDGAHIITWVNGEL 981
V + ++ T+ D++S G ++ E++TGK S D I V G
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238
Query: 982 RERKREFTTILDRQLLMRSGTQIQEM--------LQVLGVALL--CVNPCPEERPTMKDV 1031
+ + + M+ ++++ L V LL + E+R T +
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
Query: 1032 TAM--LKEIRHEND 1043
A + + D
Sbjct: 299 LAHPYFESLHDTED 312
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 120 bits (302), Expect = 3e-30
Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 40/292 (13%)
Query: 764 NIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVR 821
+G+G V+ I + + + VK L PVK + + E++ L ++R NI+
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIIT 94
Query: 822 LLGCC--NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCV 879
L RT L+F++++N L L + + L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG- 149
Query: 880 PPIIHRDIKSNNILVGPQF-EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSL 938
I+HRD+K +N+++ + + L D+GLA+ + + N S + PE
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDY 204
Query: 939 K-ITEKSDVYSYGVVLLEVLTGKEPTDS------------RIPDGAHIITWVNGELRERK 985
+ D++S G +L ++ KEP ++ + +++ E
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 986 REFTTILDRQLLMRSGTQIQEMLQVL----GVALL--CVNPCPEERPTMKDV 1031
F IL R R + Q L + L + + R T ++
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-30
Identities = 70/287 (24%), Positives = 115/287 (40%), Gaps = 35/287 (12%)
Query: 764 NIVGKGVSGIVYRVE----IPSRQVIAVKKLWPVKNGELPE-RDQFSAEVQTLGSIRHK- 817
++G G G V+ V + ++ A+K L + + + E Q L IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 818 NIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD 877
+V L L+ DYI+ G L L +++ F + + + + V + L H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----VQIYVGEIVLALEHL 145
Query: 878 CVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPE--YG 935
II+RDIK NIL+ L DFGL+K F + E+ RA + G+ Y+AP+ G
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRG 204
Query: 936 YSLKITEKSDVYSYGVVLLEVLTGKEP--TDSRIPDGAHIITWVNGELRERKREFTTILD 993
+ D +S GV++ E+LTG P D A I + +E + +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA- 263
Query: 994 RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040
+ L+ R + P++R A EI+
Sbjct: 264 KDLIQR-----------------LLMKDPKKRLGCGPRDA--DEIKE 291
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-28
Identities = 68/302 (22%), Positives = 124/302 (41%), Gaps = 27/302 (8%)
Query: 747 QKLNFSVDDVVTRLSDTNIVGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFS 805
Q+LN ++ +V R + + VG G G V + +AVKKL + +
Sbjct: 7 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 65
Query: 806 AEVQTLGSIRHKNIVRLLGCCNNGRT-----RLLLFDYISNGSLAGLLHEKKVFLDWDSR 860
E++ L ++H+N++ LL R+ + L ++ L ++ +K L D
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHV 123
Query: 861 YKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRAS 920
+I + GL Y+H IIHRD+K +N+ V E + DFGLA+ + +
Sbjct: 124 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-- 178
Query: 921 NSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEP-TDSRIPDGAHIITWVNG 979
VA + + + D++S G ++ E+LTG+ + D +I + G
Sbjct: 179 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 980 ELRERKREFTTILDRQLLMRSGTQIQEM--------LQVLGVALL--CVNPCPEERPTMK 1029
+ + + ++S TQ+ +M L V LL + ++R T
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 1030 DV 1031
Sbjct: 297 QA 298
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 115 bits (288), Expect = 4e-28
Identities = 81/386 (20%), Positives = 144/386 (37%), Gaps = 35/386 (9%)
Query: 111 NLSSLINLDLSFNALTGNIP-EEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELY 169
L+ + L +T + ++ ++ L+ L SI G + + L ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 170 DNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRS 229
+NQL+ P + L L I N ++N L T I +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 230 VG--------ELTNLRTLSVYTANITGYIPEEIGNCSALENL----FLYENQIFGKIPDE 277
++++ LS T+ ++ + L NL L +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 278 LGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLL 337
L L NL+ L+ N +S P G ++L + ++ N L +LA+L L +L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 338 SGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPEL 397
+ N IS P ++L +L+L N+ P + L L +NQ +I +
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ-LEDISPI 303
Query: 398 AYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLG 457
+ L L L N ++ P + +L L +L +N+ S + T + L G
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 458 SNNFSGHIPSRIGLLHRLTFLELSEN 483
N S P + L R+T L L++
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 112 bits (280), Expect = 5e-27
Identities = 89/405 (21%), Positives = 153/405 (37%), Gaps = 55/405 (13%)
Query: 268 NQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEA-LGNCSSLTVIDVSLNSLGGEVPVSL 326
NQIF D +L + +L + N++ ++ + L ++L + + S+ G +
Sbjct: 13 NQIF---TDT--ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----V 62
Query: 327 ANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAW 386
L L ++ S N ++ P N ++L + ++NN+ P L F
Sbjct: 63 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 120
Query: 387 QNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIG 446
Q + L +L+ + + + L LT L +S +
Sbjct: 121 QITDIDPLKNLTNLNRLELSSNTISDI--------SALSGLTSLQQLSFGNQVTDLKPLA 172
Query: 447 GCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQ 506
T L RL + SN S + L L L + NQ + P I T L+ + L+
Sbjct: 173 NLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNG 228
Query: 507 NKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIP---- 562
N+L+ +L L L LDL+ N I P L LT L +L L N I+ + P
Sbjct: 229 NQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGL 284
Query: 563 ----------------KSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNAL 606
+ K+L L L N I+ P + L L L + N +
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL-FFANNKV 341
Query: 607 TGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYN 651
+ S +NL+ + L +N ++ L L +L + L ++
Sbjct: 342 SDV--SSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (266), Expect = 3e-25
Identities = 77/411 (18%), Positives = 139/411 (33%), Gaps = 63/411 (15%)
Query: 233 LTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQN 292
L + N+T + + + + L I K D + L NL ++ N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 76
Query: 293 NLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGN 352
L+ P L N + L I ++ N + P++ + L + + +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 353 FSRLKQL---------------ELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPEL 397
+ + + L L N++
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL- 193
Query: 398 AYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLG 457
A L++L ++N ++ P L NL +L L N+ + T L L L
Sbjct: 194 AKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 458 SNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSL 517
+N S P + L +LT L+L NQ + P + T L ++L++N+L+ P
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPI-- 303
Query: 518 EFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLS 577
L L L L N+I P + LT L +L + N ++ SL ++ L
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 578 SNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNN 628
N+I+ P +NL+++ L L++
Sbjct: 360 HNQISDLTP---------------------------LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.1 bits (230), Expect = 1e-20
Identities = 82/373 (21%), Positives = 128/373 (34%), Gaps = 33/373 (8%)
Query: 88 FSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSN 147
+T+L + + L++L ++ S N LT P + L +L + +N+N
Sbjct: 43 LDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98
Query: 148 SIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEIS 207
I P L + N IS
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLT-------------NLNRLELSSNTIS 145
Query: 208 NCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANI-TGYIPEEIGNCSALENLFLY 266
+ L L G + L NL TL + + + LE+L
Sbjct: 146 DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIAT 205
Query: 267 ENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSL 326
NQI P + + NL L L N L L + ++LT +D++ N + P L
Sbjct: 206 NNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 259
Query: 327 ANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAW 386
+ L L EL L N IS I G + +N + L L L+F
Sbjct: 260 SGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF-- 316
Query: 387 QNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIG 446
N + I ++ KLQ L ++N ++ SSL NL N+ L N+ S P +
Sbjct: 317 -NNISD-ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LA 370
Query: 447 GCTGLIRLRLGSN 459
T + +L L
Sbjct: 371 NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.9 bits (123), Expect = 2e-07
Identities = 19/147 (12%), Positives = 50/147 (34%), Gaps = 11/147 (7%)
Query: 1 MSRNEITIILLFVNISLFPAISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNW 60
++ N+I+ + +S ++ L + + ++ + N
Sbjct: 248 LANNQISNLA---PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS 304
Query: 61 DYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDL 120
+ + + +I + S + L L +N ++ ++ NL+++ L
Sbjct: 305 NLKNLTYLTLYFNNISDISPVS----SLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 121 SFNALTGNIPEEIGKLAELELLSLNSN 147
N ++ P + L + L LN
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 3e-05
Identities = 14/66 (21%), Positives = 28/66 (42%), Gaps = 3/66 (4%)
Query: 597 ILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGI 656
+ L +T + ++ +L ++ L + S+ + L+NL +N S N + I
Sbjct: 25 MKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTDI 81
Query: 657 LPNTKL 662
P L
Sbjct: 82 TPLKNL 87
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 9e-26
Identities = 61/309 (19%), Positives = 111/309 (35%), Gaps = 32/309 (10%)
Query: 748 KLNFSVDDVVTRLSDTNIVGKGVSGIVYRV-EIPSRQVIAVKKLWPVKNGELPERDQFSA 806
++ S V+ R + +G G GIV + + +A+KKL + +
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYR 65
Query: 807 EVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYISNGSLA--GLLHEKKVFLDWDSRYKII 864
E+ + + HKNI+ LL +T D L L ++ LD + ++
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 125
Query: 865 LGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRASNSVA 924
+ G+ +LH IIHRD+K +NI+V + DFGLA+ +S
Sbjct: 126 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYV 179
Query: 925 GSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGK--------------------EPTD 964
+ Y APE + E D++S G ++ E++ K P
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 965 SRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALL--CVNPCP 1022
+ + + L L + ++ ++ LL + P
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 1023 EERPTMKDV 1031
+R ++ D
Sbjct: 300 AKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (252), Expect = 1e-23
Identities = 46/311 (14%), Positives = 98/311 (31%), Gaps = 51/311 (16%)
Query: 766 VGKGVSGIVYRVE-IPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLG 824
+G G V+ + + + +A+K + G+ + E++ L + + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 825 CC---------------NNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAH 869
NG +++F+ + LA + + + +I +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 870 GLAYLHHDCVPPIIHRDIKSNNILVGPQ-FEAFLADFGLAKLFESSESSRASNSVAGSYG 928
GL Y+H C IIH DIK N+L+ L +A L + + +
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 929 YIAPEYGYSLKITEKSDVYSYGVVLLEVLTGK--------------------------EP 962
Y +PE +D++S ++ E++TG E
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 963 TDSRIPDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALL--CVNP 1020
+ +G + T+ N R + ++ + + L +
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
Query: 1021 CPEERPTMKDV 1031
P +R +
Sbjct: 315 DPRKRADAGGL 325
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.7 bits (247), Expect = 2e-23
Identities = 70/290 (24%), Positives = 113/290 (38%), Gaps = 16/290 (5%)
Query: 90 HLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSI 149
HL + S+ L ++P + LDL N +T + L L L L +N I
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 150 HGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNC 209
P KL RL L NQL +P ++ + + + + ++
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
Query: 210 KVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQ 269
V+ LG SG + + L + + NIT IP+ G +L L L N+
Sbjct: 127 IVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNK 182
Query: 270 IFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANL 329
I L L NL +L L N++S +L N L + ++ N L +VP LA+
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADH 241
Query: 330 VALEELLLSGNNISG------EIPSFFGNFSRLKQLELDNNRF-FGQIPP 372
++ + L NNIS P + + + L +N + +I P
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.2 bits (243), Expect = 8e-23
Identities = 56/271 (20%), Positives = 94/271 (34%), Gaps = 13/271 (4%)
Query: 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFS 462
LDL +N +T NLKNL L+LI+N+ S P L RL L N
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 463 GHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFG 522
L L E + + + +E+ + K G + + +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGAFQGMKK 151
Query: 523 LNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRIN 582
L+ + ++ +I TIP+ L SL +L L N IT + SL +L L LS N I+
Sbjct: 152 LSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 583 GSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTG-------SLK 635
+ L L + +P ++ + + L NN ++
Sbjct: 209 AVDNGSLANTPHLRELHLNNNK--LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 636 VLGSLDNLVSLNVSYNHFSGILPNTKLFHGL 666
+ +++ N F +
Sbjct: 267 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.4 bits (241), Expect = 1e-22
Identities = 53/288 (18%), Positives = 100/288 (34%), Gaps = 14/288 (4%)
Query: 273 KIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVAL 332
K+P +L + L L N ++ N +L + + N + P + A LV L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 333 EELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHG 392
E L LS N + L+ E + + + + Q+ + L
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 393 NIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLI 452
KL + ++ +T ++P L +LT+L L N+ + + G L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 453 RLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQG- 511
+L L N+ S + L L L+ N+ ++P + + +++V LH N +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257
Query: 512 -----TIPSSLEFLFGLNVLDLSMNSI--GGTIPENLGKLTSLNKLVL 552
P + + L N + P + + L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 89.7 bits (221), Expect = 5e-20
Identities = 48/275 (17%), Positives = 87/275 (31%), Gaps = 14/275 (5%)
Query: 177 IPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNL 236
+P ++ ++ N I + N K L L L + IS P + L L
Sbjct: 25 VPKDLPP--DTALLDLQNNK-ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 237 RTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSG 296
L + + + L ++ + + L + + L SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140
Query: 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRL 356
A L+ I ++ ++ + +L EL L GN I+ + + L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 357 KQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTG- 415
+L L N ++ L N+L LA +Q + L +N ++
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257
Query: 416 -----SVPSSLFNLKNLTQLLLISNRFS-GEIPPE 444
P + + + L SN EI P
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.7 bits (195), Expect = 1e-16
Identities = 35/186 (18%), Positives = 79/186 (42%), Gaps = 7/186 (3%)
Query: 475 LTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIG 534
L ++ S+ ++P ++ ++DL NK+ + L L+ L L N I
Sbjct: 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 535 GTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQG 594
P L L +L LSKN + L K ++L++ + ++ S+ + ++
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 595 LDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFS 654
++ L + +G +F + KL+ + +++ +T + G +L L++ N +
Sbjct: 129 VE--LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKIT 184
Query: 655 GILPNT 660
+ +
Sbjct: 185 KVDAAS 190
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 98.7 bits (244), Expect = 6e-23
Identities = 74/326 (22%), Positives = 113/326 (34%), Gaps = 29/326 (8%)
Query: 27 EGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCN--WDYIKCSRTEIAITSIHIPTSFPYQ 84
+ +LL + ++ SSW P+ + CN W + C
Sbjct: 7 DKQALLQIKKDLGNPTT---LSSWLPTT-DCCNRTWLGVLCDTDT--------------- 47
Query: 85 LLSFSHLTSLVLSNANLTG--EIPPAIGNLSSLINLDLSFNA-LTGNIPEEIGKLAELEL 141
+ +L LS NL IP ++ NL L L + L G IP I KL +L
Sbjct: 48 --QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 142 LSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGE 201
L + ++ G IP + L L+ N LSG +P I L L I GN I G
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR-ISGA 164
Query: 202 IPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALE 261
IP+ + L + + + N+ +
Sbjct: 165 IPDSYGSFSKLFT-SMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 262 NLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGE 321
++G KNL L L N + G++P+ L L ++VS N+L GE
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 322 VPVSLANLVALEELLLSGNNISGEIP 347
+P NL + + N P
Sbjct: 284 IP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 92.5 bits (228), Expect = 8e-21
Identities = 84/317 (26%), Positives = 128/317 (40%), Gaps = 16/317 (5%)
Query: 274 IPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALE 333
P + +L +K+ L LS +P +C + T + V ++ V+
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVN-------- 53
Query: 334 ELLLSGNNISG--EIPSFFGNFSRLKQLELDNNRFF-GQIPPTIGQLKELLLFFAWQNQ- 389
L LSG N+ IPS N L L + G IPP I +L +L +
Sbjct: 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113
Query: 390 LHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCT 449
L+ L LD S+N L+G++P S+ +L NL + NR SG IP G +
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
Query: 450 GLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKL 509
L S N L F++LS N G+ G+ + + L +N L
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
Query: 510 QGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCK 569
+ N LDL N I GT+P+ L +L L+ L +S NN+ G IP G +
Sbjct: 234 AFDLGKVGLSKNL-NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQ 291
Query: 570 DLQLLDLSSNRINGSIP 586
+ ++N+ P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.4 bits (225), Expect = 2e-20
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 5/256 (1%)
Query: 401 VKLQALDLSHNFLTG--SVPSSLFNLKNLTQLLLISN-RFSGEIPPEIGGCTGLIRLRLG 457
++ LDLS L +PSSL NL L L + G IPP I T L L +
Sbjct: 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109
Query: 458 SNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSL 517
N SG IP + + L L+ S N +G +PP I + L + N++ G IP S
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 518 EFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLS 577
L + +L + LS+N + G G K+ Q + L+
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 578 SNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVL 637
N + + + L+L N + G +P+ + L L +L++S N L G +
Sbjct: 230 KNSLAFDLGKVGLSKN--LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 638 GSLDNLVSLNVSYNHF 653
G+L + N
Sbjct: 288 GNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 80.6 bits (197), Expect = 7e-17
Identities = 67/262 (25%), Positives = 106/262 (40%), Gaps = 50/262 (19%)
Query: 467 SRIGLLHRLTFLELSENQFTG--EIPPEIGNCTQLEMVDLHQN-KLQGTIPSSLEFLFGL 523
+R+ L+LS IP + N L + + L G IP ++ L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 524 NVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRING 583
+ L ++ ++ G IP+ L ++ +L L S N ++G +P S+ +L + NRI+G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 584 SIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANL-------------------- 623
+IP+ G L + +S N LTG IP +F+NL+
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 624 --------------------------DLSNNMLTGSL-KVLGSLDNLVSLNVSYNHFSGI 656
DL NN + G+L + L L L SLNVS+N+ G
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 657 LPNTKLFHGLPASAFYGNQQLC 678
+P SA+ N+ LC
Sbjct: 284 IPQGGNLQRFDVSAYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 79.0 bits (193), Expect = 3e-16
Identities = 64/258 (24%), Positives = 99/258 (38%), Gaps = 4/258 (1%)
Query: 212 LVFLGLADTGISG--QIPRSVGELTNLRTLSV-YTANITGYIPEEIGNCSALENLFLYEN 268
+ L L+ + IP S+ L L L + N+ G IP I + L L++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 269 QIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLAN 328
+ G IPD L +K L L N LSG++P ++ + +L I N + G +P S +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 329 LVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQN 388
L + N L ++L N G G K +N
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 389 QLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGC 448
L ++ ++ L LDL +N + G++P L LK L L + N GEI P+ G
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNL 290
Query: 449 TGLIRLRLGSNNFSGHIP 466
+N P
Sbjct: 291 QRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.5 bits (189), Expect = 9e-16
Identities = 65/262 (24%), Positives = 99/262 (37%), Gaps = 4/262 (1%)
Query: 158 GNCSKLRRLELYDNQLSGN--IPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFL 215
++ L+L L IP+ + L L + GG + G IP I+ L +L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 216 GLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIP 275
+ T +SG IP + ++ L TL ++G +P I + L + N+I G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 276 DELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEEL 335
D GS L + N +L +D+S N L +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM-LEGDASVLFGSDKNTQK 225
Query: 336 LLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIP 395
+ N G L L+L NNR +G +P + QLK L N L G IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 396 ELAYCVKLQALDLSHN-FLTGS 416
+ + ++N L GS
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.9 bits (164), Expect = 1e-12
Identities = 25/132 (18%), Positives = 50/132 (37%), Gaps = 3/132 (2%)
Query: 30 SLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFS 89
L + ++ + F + + T+ + + ++
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
Query: 90 HLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSI 149
+L L L N + G +P + L L +L++SFN L G IP + G L ++ + +N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
Query: 150 HGGIPREIGNCS 161
G P + C+
Sbjct: 304 LCGSP--LPACT 313
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (212), Expect = 6e-19
Identities = 56/257 (21%), Positives = 82/257 (31%), Gaps = 26/257 (10%)
Query: 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFS 462
Q + L N ++ +S +NLT L L SN + G L +L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 463 GHI-PSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLF 521
+ P+ L RL L L P L+ + L N LQ + L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 522 GLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
L L L N I L SL++L+L +N + + P + L L L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF---- 209
Query: 582 NGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLD 641
N L+ E+ + L L L L++N +
Sbjct: 210 ---------------------ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA 248
Query: 642 NLVSLNVSYNHFSGILP 658
L S + LP
Sbjct: 249 WLQKFRGSSSEVPCSLP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (208), Expect = 2e-18
Identities = 61/280 (21%), Positives = 99/280 (35%), Gaps = 7/280 (2%)
Query: 113 SSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQ 172
+ L +P I A + + L+ N I C L L L+ N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 173 LSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGE 232
L+ A L LE + N + P L L L G+ P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 233 LTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQN 292
L L+ L + + + + L +LFL+ N+I L +L RLLL QN
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 293 NLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGN 352
++ P A + L + + N+L +LA L AL+ L L+ N + +
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPL 246
Query: 353 FSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHG 392
++ L++ ++ +P +L L N L G
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (208), Expect = 2e-18
Identities = 56/287 (19%), Positives = 92/287 (32%), Gaps = 29/287 (10%)
Query: 153 IPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVL 212
+P I + +R+ L+ N++S A L I+ N + +
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 213 VFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFG 272
+ + P + L L TL + + P +AL+ L+L +N +
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 273 KIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVAL 332
D L NL L L N +S A SL + + N + P + +L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 333 EELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHG 392
L L NN+S L+ L L++N + +AW
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--------ARPLWAW------ 249
Query: 393 NIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSG 439
LQ S + + S+P L L +N G
Sbjct: 250 ----------LQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 3e-12
Identities = 44/270 (16%), Positives = 76/270 (28%), Gaps = 36/270 (13%)
Query: 76 HIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSL-------------------- 115
+P P + + L ++ + +L
Sbjct: 25 AVPVGIP------AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG 78
Query: 116 -----INLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYD 170
L P L L L L+ + P + L+ L L D
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138
Query: 171 NQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSV 230
N L L L + GN I L L L ++ P +
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNR-ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 231 GELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLW 290
+L L TL ++ N++ E + AL+ L L +N L++
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGS 256
Query: 291 QNNLSGSIPEALGNCSSLTVIDVSLNSLGG 320
+ + S+P+ L + ++ N L G
Sbjct: 257 SSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.9 bits (191), Expect = 7e-17
Identities = 30/204 (14%), Positives = 61/204 (29%), Gaps = 30/204 (14%)
Query: 764 NIVGKGVSGIVYRVEIPSRQVIAVKKLWP-------VKNGELPERDQFSAEVQTLGSIRH 816
++G+G V+ VK VK FS
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 817 KNIVRLLGCCNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYK-IILGVAHGLAYLH 875
+ + +L G + + N L L+ K+++ ++ + +A +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 876 HDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES----SRASNSVAGSYGYIA 931
H I+H D+ N+LV ++ DF + R ++ +
Sbjct: 121 HRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS--- 173
Query: 932 PEYGYSLKITEKSDVYSYGVVLLE 955
Y + D+ S +L+
Sbjct: 174 RTYRT------EKDINSAIDRILQ 191
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (187), Expect = 7e-16
Identities = 50/208 (24%), Positives = 67/208 (32%), Gaps = 6/208 (2%)
Query: 303 GNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELD 362
+S ++ +L +P L L LS N + + ++RL QL LD
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 363 NNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF 422
L L NQL L LD+S N LT +L
Sbjct: 64 RAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 423 NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSE 482
L L +L L N P + L +L L +NN + + L L L L E
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 483 NQFTGEIPPEIGNCTQLEMVDLHQNKLQ 510
N IP L LH N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.4 bits (150), Expect = 5e-11
Identities = 37/210 (17%), Positives = 78/210 (37%), Gaps = 8/210 (3%)
Query: 109 IGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLEL 168
+ ++S + ++ LT +P ++ K + +L L+ N ++ + ++L +L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 169 YDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPR 228
+L+ + + + +P L L ++ ++
Sbjct: 63 DRAELTKLQVDGTLPV----LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 229 SVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLL 288
++ L L+ L + + P + LE L L N + L L+NL LL
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 289 LWQNNLSGSIPEALGNCSSLTVIDVSLNSL 318
L +N+L +IP+ L + N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 3e-10
Identities = 33/212 (15%), Positives = 56/212 (26%), Gaps = 13/212 (6%)
Query: 87 SFSHLTSLV---LSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLS 143
S + S + NLT +PP + L LS N L + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 144 LNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIP 203
L+ + ++ L L D + + + + +P
Sbjct: 62 LDRAELT-----KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 204 EEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTAN-ITGYIPEEIGNCSALEN 262
+ +P + T N +T + L+
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 263 LFLYENQIFGKIPDELGSLKNLKRLLLWQNNL 294
L L EN ++ IP L L N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 7e-10
Identities = 42/210 (20%), Positives = 73/210 (34%), Gaps = 7/210 (3%)
Query: 444 EIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVD 503
E+ + + N + +P + T L LSEN + T+L ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 504 LHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPK 563
L + +L + + ++ ++P L +L L +S N +T L
Sbjct: 62 LDRAELTKLQV---DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 564 SLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANL 623
+L +LQ L L N ++P + L+L+ N LT + L L L
Sbjct: 119 ALRGLGELQELYLKGNE-LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 624 DLSNNMLTGSLKVLGSLDNLVSLNVSYNHF 653
L N L K L + N +
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 45/189 (23%), Positives = 64/189 (33%), Gaps = 7/189 (3%)
Query: 274 IPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALE 333
+P +L K+ L L +N L L + LT ++ L+ L L
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN--LDRAELTKLQVDGTLPVLG 80
Query: 334 ELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGN 393
L LS N + + L++ NR + L EL + N+L
Sbjct: 81 TLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 394 IPELAYCVKLQAL-DLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLI 452
P L L++N LT L L+NL LLL N IP G L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 453 RLRLGSNNF 461
L N +
Sbjct: 199 FAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 5e-05
Identities = 34/190 (17%), Positives = 58/190 (30%), Gaps = 7/190 (3%)
Query: 79 TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAE 138
T+ P L T L LS L + + L L+L LT + +
Sbjct: 23 TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPV-- 78
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
L +L+ + +G + ++P + +
Sbjct: 79 --LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136
Query: 199 HGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCS 258
P ++ L L LA+ ++ + L NL TL + N IP+
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE-NSLYTIPKGFFGSH 195
Query: 259 ALENLFLYEN 268
L FL+ N
Sbjct: 196 LLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 9e-04
Identities = 26/166 (15%), Positives = 48/166 (28%), Gaps = 14/166 (8%)
Query: 21 ISALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTEIAITSIHIP-- 78
+ + L + L+ N + + + D + + +P
Sbjct: 43 LYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL 102
Query: 79 ----------TSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDL-SFNALTG 127
TS P L + N +PP + + + + N LT
Sbjct: 103 TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162
Query: 128 NIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQL 173
+ L L+ L L NS++ IP+ L L+ N
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (157), Expect = 6e-12
Identities = 47/269 (17%), Positives = 90/269 (33%), Gaps = 16/269 (5%)
Query: 359 LELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVP 418
L+L + + + ++ + + E ++Q +DLS++ + S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCP-RSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 419 SSLF-NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRL--RLGSNNFSGHIPSRIGLLHRL 475
+ L L L R S I + + L+RL S + + + RL
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 476 TFL------ELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLS 529
L + +E + TQL + +N + + + + L LDLS
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 530 MN-SIGGTIPENLGKLTSLNKLVLSK-NNITGLIPKSLGLCKDLQLLDLSSNRINGSIPE 587
+ + + +L L L LS+ +I LG L+ L + +G++
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
Query: 588 EIGRLQGLDILLNLSWNALTGPIPESFSN 616
L L I + T + N
Sbjct: 244 LKEALPHLQINCSH----FTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 44/264 (16%), Positives = 76/264 (28%), Gaps = 16/264 (6%)
Query: 251 PEEIGNCSALENLFLYENQIF-GKIPDELGSLKNLKRLLLWQNNLSG-SIPEALGNCSSL 308
P+ G + + + F + E S ++ + L + + ++ L CS L
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 309 TVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPS----------FFGNFSRLKQ 358
+ + L + +LA L L LSG + E N S
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 359 LELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVP 418
+ + L + + + + L
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 419 SSLFNLKNLTQLLLIS-NRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTF 477
F L L L L E E+G L L++ G + L L
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL---LKEALPH 250
Query: 478 LELSENQFTGEIPPEIGNCTQLEM 501
L+++ + FT P IGN E+
Sbjct: 251 LQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 44/296 (14%), Positives = 88/296 (29%), Gaps = 65/296 (21%)
Query: 118 LDLSFNALTGNIPEEIGKLAELELLSLN-SNSIHGGIPREIGNCSKLRRLELYDNQLSGN 176
LDL+ L P+ G+L +++ S E + +++ ++L ++ + +
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 177 IPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNL 236
+ +S C L L L +S I ++ + +NL
Sbjct: 62 ------------------------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL 97
Query: 237 RTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSG 296
L++ + + S L + F + + Q NLSG
Sbjct: 98 VRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 157
Query: 297 ---------------------------------SIPEALGNCSSLTVIDVS-LNSLGGEV 322
+ + L + +S + E
Sbjct: 158 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET 217
Query: 323 PVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLK 378
+ L + L+ L + G G + L L+++ + F PTIG K
Sbjct: 218 LLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSHFTTIARPTIGNKK 270
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 34/262 (12%), Positives = 81/262 (30%), Gaps = 12/262 (4%)
Query: 68 TEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTG 127
+ +T ++ +LLS + + + + + + ++DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 128 N-IPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELY--DNQLSGNIPAEIGQL 184
+ + + + ++L+ LSL + I + S L RL L + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 185 EALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTG------ISGQIPRSVGELTNLRT 238
L+ + + + L +G S +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 239 LSVYTANITGYIPEEIGNCSALENLFLYE-NQIFGKIPDELGSLKNLKRLLLWQNNLSGS 297
+ + +E + L++L L I + ELG + LK L ++ G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 298 IPEALGNCSSLTVIDVSLNSLG 319
+ L + ++
Sbjct: 241 LQLLKEALPHLQINCSHFTTIA 262
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 36/248 (14%), Positives = 72/248 (29%), Gaps = 16/248 (6%)
Query: 235 NLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGK-IPDELGSLKNLKRLLLWQNN 293
+ + + + E ++++ L + I + L L+ L L
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 294 LSGSIPEALGNCSSLTVIDVSLNSLGGEVP--------VSLANLVALEELLLSGNNISGE 345
LS I L S+L +++S S E L L + ++
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 346 IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGN--IPELAYCVKL 403
+ ++L N + + + L+ + + N E L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 404 QALDLSH-NFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFS 462
Q L LS + L + L L + G + L++ ++F+
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFT 259
Query: 463 GHIPSRIG 470
IG
Sbjct: 260 TIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 2e-06
Identities = 19/91 (20%), Positives = 40/91 (43%), Gaps = 5/91 (5%)
Query: 572 QLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLT 631
Q LDL+ ++ + + + + + P+ E FS ++ ++DLSN+++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVI--AFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIE 59
Query: 632 GS--LKVLGSLDNLVSLNVSYNHFSGILPNT 660
S +L L +L++ S + NT
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 62.9 bits (151), Expect = 6e-11
Identities = 57/339 (16%), Positives = 110/339 (32%), Gaps = 26/339 (7%)
Query: 305 CSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364
++++ L +P +L E L+ S N+++ E+P + LK L +DNN
Sbjct: 37 DRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQS---LKSLLVDNN 88
Query: 365 RFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNL 424
+ L LL + N +PEL L+ +D+ +N L
Sbjct: 89 NLKA-----LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLP----DLP 139
Query: 425 KNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQ 484
+L + +N+ + I S +P + + + +
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199
Query: 485 FTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKL 544
+ L + + + L
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 545 TSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWN 604
+ L + N + I L L+ L++S+N++ +P RL+ L S+N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI----ASFN 314
Query: 605 ALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNL 643
L +PE NL +L + N L + S+++L
Sbjct: 315 HLAE-VPELPQNLKQL---HVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 3e-09
Identities = 46/341 (13%), Positives = 94/341 (27%), Gaps = 26/341 (7%)
Query: 257 CSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLN 316
L L + +P+ +L+ L+ N+L+ +PE + SL V + +L
Sbjct: 37 DRQAHELELNNLGL-SSLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91
Query: 317 SLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQ 376
+L P LL +S L++ +
Sbjct: 92 ALSDLPP------------LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLP 139
Query: 377 LKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNR 436
+ + + D + +P SL ++ +L
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199
Query: 437 FSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNC 496
+ L S + F
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 497 TQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNN 556
++L + N I S + L L++S N + +P +L L S N+
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLERLI---ASFNH 315
Query: 557 ITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDI 597
+ + L ++L+ L + N + P+ ++ L +
Sbjct: 316 LAEVPE----LPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 29/157 (18%), Positives = 50/157 (31%), Gaps = 9/157 (5%)
Query: 33 SWLSTFNSSSSATFFSSWNPSHRNPCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLT 92
+L+T + ++ P N + S+ S L
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 93 SLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGG 152
+ + EI SL L++S N L +P + LE L + N +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AE 318
Query: 153 IPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEI 189
+P N L++L + N L P +E L +
Sbjct: 319 VPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 4e-06
Identities = 22/100 (22%), Positives = 38/100 (38%), Gaps = 12/100 (12%)
Query: 264 FLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVP 323
Y N +I +L+ L + N L +P L + S N L EVP
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEVP 320
Query: 324 VSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDN 363
N L++L + N + E P + ++ L +++
Sbjct: 321 ELPQN---LKQLHVEYNPLR-EFPDIPES---VEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 6e-05
Identities = 18/58 (31%), Positives = 23/58 (39%), Gaps = 7/58 (12%)
Query: 599 LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGI 656
LN+S N L +P L +L S N L +V NL L+V YN
Sbjct: 289 LNVSNNKLIE-LPALPPRLERL---IASFNHLA---EVPELPQNLKQLHVEYNPLREF 339
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 5/66 (7%)
Query: 89 SHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNS 148
L L+N L+ +P +L SL S N+LT +PE L L + + N +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 149 IHGGIP 154
+ P
Sbjct: 93 LSDLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 0.001
Identities = 19/66 (28%), Positives = 32/66 (48%), Gaps = 9/66 (13%)
Query: 567 LCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLS 626
L + L+L++ ++ S+PE L+ L S N+LT +PE +L +L +
Sbjct: 36 LDRQAHELELNNLGLS-SLPELPPHLESLV----ASCNSLT-ELPELPQSLK---SLLVD 86
Query: 627 NNMLTG 632
NN L
Sbjct: 87 NNNLKA 92
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 56.3 bits (135), Expect = 5e-10
Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 7/121 (5%)
Query: 525 VLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGS 584
VL L+ + T+ +L +L + L LS N + L P +L + L++L S N +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 585 IPEEIGRLQGLDILLNLSWNALTG-PIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNL 643
L L N L + + +L L+L N L + L +
Sbjct: 59 DGVANLPRLQE---LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 644 V 644
+
Sbjct: 116 L 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 9e-08
Identities = 30/121 (24%), Positives = 44/121 (36%), Gaps = 7/121 (5%)
Query: 404 QALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSG 463
+ L L+H LT V L L +T L L NR +PP + L L+ N
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN 57
Query: 464 HIPSRIGLLHRLTFLELSENQFTG-EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFG 522
RL L L N+ + +C +L +++L N L E L
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 523 L 523
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 1e-07
Identities = 31/109 (28%), Positives = 44/109 (40%), Gaps = 8/109 (7%)
Query: 550 LVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGP 609
L L+ ++T L L + LDLS NR+ P L L L L +
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALE 56
Query: 610 IPESFSNLSKLANLDLSNNMLTG--SLKVLGSLDNLVSLNVSYNHFSGI 656
+ +NL +L L L NN L +++ L S LV LN+ N
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 2e-07
Identities = 26/107 (24%), Positives = 43/107 (40%), Gaps = 5/107 (4%)
Query: 335 LLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNI 394
L L+ +++ + + L+L +NR PP + L+ L + A N N+
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA-LENV 58
Query: 395 PELAYCVKLQALDLSHNFLTG-SVPSSLFNLKNLTQLLLISNRFSGE 440
+A +LQ L L +N L + L + L L L N E
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 1e-06
Identities = 27/125 (21%), Positives = 46/125 (36%), Gaps = 6/125 (4%)
Query: 310 VIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQ 369
V+ ++ L V L L+ + L LS N + P+ L+ L+ +N
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALENV 58
Query: 370 IPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTG--SVPSSLFN-LKN 426
+ LL + Q I L C +L L+L N L + L L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 427 LTQLL 431
++ +L
Sbjct: 119 VSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 2e-05
Identities = 24/117 (20%), Positives = 41/117 (35%), Gaps = 27/117 (23%)
Query: 94 LVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAEL-------------- 139
L L++ +LT + + L + +LDLS N L P + L L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 140 --------ELLSLNSNSIHGG-IPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEAL 187
+ L L +N + + + +C +L L L N L +L +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 5e-04
Identities = 18/66 (27%), Positives = 26/66 (39%), Gaps = 2/66 (3%)
Query: 599 LNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILP 658
L+L+ LT + L + +LDLS+N L L +L L L S N +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 659 NTKLFH 664
L
Sbjct: 61 VANLPR 66
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 56.0 bits (133), Expect = 9e-09
Identities = 44/326 (13%), Positives = 90/326 (27%), Gaps = 18/326 (5%)
Query: 282 KNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGE----VPVSLANLVALEELLL 337
K+LK + + S+ L S+ I +S N++G E + ++A+ LE
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 338 SGN---NISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNI 394
S + EIP + + +E L+ F ++ ++
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 395 PELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRL 454
+ QA L + + ++ + T
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 455 RLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIP 514
L + + G LE ++ N L+
Sbjct: 187 LLHTVKMVQNGIRPEG--IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 515 SSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSL-----GLCK 569
L + ++ + + L L L N I ++L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKL--ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302
Query: 570 DLQLLDLSSNRINGSIPEEIGRLQGL 595
DL L+L+ NR + + ++ +
Sbjct: 303 DLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 54.5 bits (129), Expect = 3e-08
Identities = 49/342 (14%), Positives = 91/342 (26%), Gaps = 48/342 (14%)
Query: 80 SFPYQLLSFSHLTSLVLSNANLTGE----IPPAIGNLSSLINLDLSFN---ALTGNIPEE 132
S LL + +VLS + E + I + L + S + IPE
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 133 IGKLAEL--ELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEII 190
+ L + + L++ + + L + + +A I
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 191 RAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYI 250
+ + + ++ S + + L N
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 251 PEEIGNCSALENLFL----------YENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPE 300
E L + + + L S NL+ L L LS
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 301 ALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIP-----SFFGNFSR 355
A+ + S + L+ L L N I +
Sbjct: 262 AVVDA------------------FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 356 LKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPEL 397
L LEL+ NR F + + +++E+ + G + EL
Sbjct: 304 LLFLELNGNR-FSEEDDVVDEIREVF-----STRGRGELDEL 339
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 43/333 (12%), Positives = 88/333 (26%), Gaps = 36/333 (10%)
Query: 274 IPDELGSLKNLKRLLLWQNNLSG----SIPEALGNCSSLTVIDVSLNS---LGGEVPVSL 326
+ L ++K ++L N + + E + + L + + S + E+P +L
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 327 ANLVALEELLLSGNNISGEIPSFFGNFSRL-KQLELDNNRFFGQIPPTIGQLKELLLFFA 385
L+ + + +F + G + A
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 386 WQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI 445
Q + L+++ N L +LL I PE
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 446 GGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLH 505
+ L + + + + + L + L+
Sbjct: 203 IEH-----------LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251
Query: 506 QNKLQGTIPSSLEFLFG------LNVLDLSMNSIGGTIPENL-----GKLTSLNKLVLSK 554
L +++ F L L L N I L K+ L L L+
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 555 NNITGLIPKSLGLCKDLQLLDLSSNRINGSIPE 587
N + + ++ ++ S R G + E
Sbjct: 312 NRFSEE-DDVVD-----EIREVFSTRGRGELDE 338
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 47/351 (13%), Positives = 100/351 (28%), Gaps = 38/351 (10%)
Query: 307 SLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGE----IPSFFGNFSRLKQLELD 362
SL + ++ V L +++E++LSGN I E + + L+ E
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 363 NNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLF 422
+ F G++ I + LLL + + A + +FL+ P
Sbjct: 68 DI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 423 NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSE 482
L N + + + L S + L + E ++
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR------LENGSMKEWAK 180
Query: 483 NQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLG 542
+ + + + ++ L + E + + + L
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 543 KLTSLNKLVLSKNNITGLIPKSLGLC------KDLQLLDLSSNRINGSIPEEIGRLQGLD 596
+L +L L+ ++ ++ LQ L L N I + +
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV---- 296
Query: 597 ILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLN 647
+ L L+L+ N + V+ + + S
Sbjct: 297 ----------------IDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.003
Identities = 11/68 (16%), Positives = 24/68 (35%), Gaps = 8/68 (11%)
Query: 114 SLINLDLSFNALTGN----IPEEIGKLAELELLSLNSNSIHG----GIPREIGNCSKLRR 165
S+ L +A+T + + + ++ + L+ N+I + I + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 166 LELYDNQL 173
E D
Sbjct: 64 AEFSDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 12/105 (11%), Positives = 26/105 (24%), Gaps = 5/105 (4%)
Query: 592 LQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSL-----KVLGSLDNLVSL 646
++G + L+ + + + LS N + + + S +L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 647 NVSYNHFSGILPNTKLFHGLPASAFYGNQQLCVNRSQCHINNSLH 691
S + L A +L R +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 41/342 (11%), Positives = 82/342 (23%), Gaps = 45/342 (13%)
Query: 139 LELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGI 198
L+L ++ + + + ++ + L N + +
Sbjct: 10 LKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWL----------------- 51
Query: 199 HGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCS 258
E + ++ F + + +IP ++ L +
Sbjct: 52 -SENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 110
Query: 259 ALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSL 318
FL ++ + L + + ++ + N L I N L
Sbjct: 111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 170
Query: 319 GGEVPVSLAN----LVALEELLLSGNNISGEIPSFFGNFSRLKQLEL---------DNNR 365
A L + + N I E EL +
Sbjct: 171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 230
Query: 366 FFGQIPPTIGQLKELLLFFAWQNQLHGNIPE-------LAYCVKLQALDLSHNFLTGSVP 418
+ + L L + LQ L L +N +
Sbjct: 231 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 290
Query: 419 SSLF-----NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLR 455
+L + +L L L NRFS E + + R
Sbjct: 291 RTLKTVIDEKMPDLLFLELNGNRFSEE-DDVVDEIREVFSTR 331
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 5e-08
Identities = 24/92 (26%), Positives = 35/92 (38%), Gaps = 15/92 (16%)
Query: 282 KNLKRLLLWQNNLSG----SIPEALGNCSSLTVIDVSLNSLGGEVPVSLA-----NLVAL 332
L+ L L ++S S+ L SL +D+S N LG + L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 333 EELLLSGNNISGEIPSFFGNFSRLKQLELDNN 364
E+L+L S E+ L+ LE D
Sbjct: 429 EQLVLYDIYWSEEMEDR------LQALEKDKP 454
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 9e-08
Identities = 14/75 (18%), Positives = 25/75 (33%), Gaps = 5/75 (6%)
Query: 523 LNVLDLSMNSIGGT-IPENLGKLTSLNKLVLSKNNITG----LIPKSLGLCKDLQLLDLS 577
+ LD+ + E L L + L +T I +L + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 578 SNRINGSIPEEIGRL 592
SN + + +
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 22/140 (15%), Positives = 41/140 (29%), Gaps = 23/140 (16%)
Query: 50 WNPSHRNPCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGE----I 105
+ S N ++ + + + S L L L++ +++ +
Sbjct: 330 SHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL 389
Query: 106 PPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRR 165
+ SL LDLS N L ++ + L +
Sbjct: 390 AATLLANHSLRELDLSNNCLGDAGILQLVESVRQ-------------------PGCLLEQ 430
Query: 166 LELYDNQLSGNIPAEIGQLE 185
L LYD S + + LE
Sbjct: 431 LVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 16/80 (20%), Positives = 28/80 (35%), Gaps = 9/80 (11%)
Query: 523 LNVLDLSMNSIGGT----IPENLGKLTSLNKLVLSKNNITGLIPKSLG-----LCKDLQL 573
L VL L+ + + + L SL +L LS N + L L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 574 LDLSSNRINGSIPEEIGRLQ 593
L L + + + + L+
Sbjct: 431 LVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 4e-07
Identities = 14/92 (15%), Positives = 35/92 (38%), Gaps = 10/92 (10%)
Query: 260 LENLFLYENQI-FGKIPDELGSLKNLKRLLLWQNNLSG----SIPEALGNCSSLTVIDVS 314
+++L + ++ + + L L+ + + L L+ I AL +L +++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 315 LNSLGGEVPVSLANLVA-----LEELLLSGNN 341
N LG + + +++L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 17/85 (20%), Positives = 31/85 (36%), Gaps = 9/85 (10%)
Query: 304 NCSSLTVIDVSLNSLGGEVPVSLA----NLVALEELLLSGNNISGEIPSFFG-----NFS 354
S L V+ ++ + SLA +L EL LS N +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 355 RLKQLELDNNRFFGQIPPTIGQLKE 379
L+QL L + + ++ + L++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 18/95 (18%), Positives = 34/95 (35%), Gaps = 12/95 (12%)
Query: 570 DLQLLDLSSNRINGS-IPEEIGRLQGLDILLNLSWNALTG----PIPESFSNLSKLANLD 624
D+Q LD+ ++ + E + LQ ++ L LT I + LA L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVV-RLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 625 LSNNMLTGS-LKVLGSL-----DNLVSLNVSYNHF 653
L +N L + + + L++
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 16/95 (16%), Positives = 30/95 (31%), Gaps = 10/95 (10%)
Query: 283 NLKRLLLWQNNLSGS-IPEALGNCSSLTVIDVSLNSLGGEVPVSLA----NLVALEELLL 337
+++ L + LS + E L V+ + L ++ AL EL L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 338 SGNNISGEIPSFFG-----NFSRLKQLELDNNRFF 367
N + ++++L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 15/83 (18%), Positives = 26/83 (31%), Gaps = 9/83 (10%)
Query: 256 NCSALENLFLYENQI----FGKIPDELGSLKNLKRLLLWQNNLSGSIPEALG-----NCS 306
S L L+L + + + L + +L+ L L N L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 307 SLTVIDVSLNSLGGEVPVSLANL 329
L + + E+ L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 16/80 (20%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 495 NCTQLEMVDLHQNKLQGT----IPSSLEFLFGLNVLDLSMNSIGGTIPENLGK-----LT 545
+ L ++ L + + + ++L L LDLS N +G L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 546 SLNKLVLSKNNITGLIPKSL 565
L +LVL + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 2e-05
Identities = 15/87 (17%), Positives = 27/87 (31%), Gaps = 9/87 (10%)
Query: 447 GCTGLIRLRLGSNNFSG----HIPSRIGLLHRLTFLELSENQFTGEIPPEIG-----NCT 497
+ L L L + S + + + H L L+LS N ++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 498 QLEMVDLHQNKLQGTIPSSLEFLFGLN 524
LE + L+ + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 17/92 (18%), Positives = 31/92 (33%), Gaps = 10/92 (10%)
Query: 475 LTFLELSENQFTGEIPPEI-GNCTQLEMVDLHQNKLQG----TIPSSLEFLFGLNVLDLS 529
+ L++ + + E+ Q ++V L L I S+L L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 530 MNSIGGTIPENLGKL-----TSLNKLVLSKNN 556
N +G + + + KL L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 14/113 (12%), Positives = 32/113 (28%), Gaps = 26/113 (23%)
Query: 401 VKLQALDLSHNFLTGSVPSSLF-NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSN 459
+ +Q+LD+ L+ + + L L+ + L +
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC----------------- 44
Query: 460 NFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIG-----NCTQLEMVDLHQN 507
I S + + L L L N+ + +++ + L
Sbjct: 45 ---KDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 5e-05
Identities = 12/64 (18%), Positives = 21/64 (32%), Gaps = 6/64 (9%)
Query: 599 LNLSWNALT-GPIPESFSNLSKLANLDLSNNMLTGS-----LKVLGSLDNLVSLNVSYNH 652
L++ L+ E L + + L + LT + L L LN+ N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 653 FSGI 656
+
Sbjct: 67 LGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 12/78 (15%), Positives = 23/78 (29%), Gaps = 4/78 (5%)
Query: 78 PTSFPYQLLSFSHLTSLVLSNANLTGE----IPPAIGNLSSLINLDLSFNALTGNIPEEI 133
+ L + L + LT I A+ +L L+L N L +
Sbjct: 16 DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCV 75
Query: 134 GKLAELELLSLNSNSIHG 151
+ + + S+
Sbjct: 76 LQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 7e-05
Identities = 16/83 (19%), Positives = 33/83 (39%), Gaps = 8/83 (9%)
Query: 545 TSLNKLVLSKNNITGL----IPKSLGLCKDLQLLDLSSNRINGSIPEEIGRL--QGLDIL 598
+ L L L+ +++ + +L L+ LDLS+N + + ++ Q +L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 599 --LNLSWNALTGPIPESFSNLSK 619
L L + + + L K
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 13/76 (17%), Positives = 27/76 (35%), Gaps = 5/76 (6%)
Query: 114 SLINLDLSFNALTGN-IPEEIGKLAELELLSLNSNSIHG----GIPREIGNCSKLRRLEL 168
+ +LD+ L+ E + L + +++ L+ + I + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 169 YDNQLSGNIPAEIGQL 184
N+L + Q
Sbjct: 63 RSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 1e-04
Identities = 11/109 (10%), Positives = 22/109 (20%), Gaps = 20/109 (18%)
Query: 332 LEELLLSGNNISGE-IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQL 390
++ L + +S + + + LD+ I
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------- 50
Query: 391 HGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSG 439
L L L+L N L + +
Sbjct: 51 ------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 15/82 (18%), Positives = 31/82 (37%), Gaps = 9/82 (10%)
Query: 400 CVKLQALDLSHNFLTG----SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGG-----CTG 450
L+ L L+ ++ S+ ++L +L +L L +N ++
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 451 LIRLRLGSNNFSGHIPSRIGLL 472
L +L L +S + R+ L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 16/92 (17%), Positives = 30/92 (32%), Gaps = 10/92 (10%)
Query: 91 LTSLVLSNANLTGE-IPPAIGNLSSLINLDLSFNALTG----NIPEEIGKLAELELLSLN 145
+ SL + L+ + L + L LT +I + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 146 SNSIHGGIPREIG-----NCSKLRRLELYDNQ 172
SN + + K+++L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 19/104 (18%), Positives = 30/104 (28%), Gaps = 24/104 (23%)
Query: 347 PSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQAL 406
S L+ L L + ++ L L+ L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAAT-------------------LLANHSLREL 402
Query: 407 DLSHNFLTGSVPSSLF-----NLKNLTQLLLISNRFSGEIPPEI 445
DLS+N L + L L QL+L +S E+ +
Sbjct: 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 19/106 (17%), Positives = 37/106 (34%), Gaps = 13/106 (12%)
Query: 219 DTGISGQIPRSVGELTNLRTLSVYTANITG----YIPEEIGNCSALENLFLYENQIFGKI 274
D G+ + LR L + +++ + + +L L L N +
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 275 PDELGS-----LKNLKRLLLWQNNLSGSIPEALG----NCSSLTVI 311
+L L++L+L+ S + + L + SL VI
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 18/108 (16%), Positives = 35/108 (32%), Gaps = 23/108 (21%)
Query: 332 LEELLLSGNNISGE----IPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQ 387
L L L+ ++S + + L++L+L NN + +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES---------- 420
Query: 388 NQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNL-KNLTQLLLIS 434
+ L+ L L + + + L L K+ L +IS
Sbjct: 421 --VRQP------GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 12/72 (16%), Positives = 21/72 (29%), Gaps = 4/72 (5%)
Query: 397 LAYCVKLQALDLSHNFLTG----SVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLI 452
L + Q + L LT + S+L L +L L SN +
Sbjct: 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82
Query: 453 RLRLGSNNFSGH 464
++ +
Sbjct: 83 SCKIQKLSLQNC 94
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 38/220 (17%), Positives = 67/220 (30%), Gaps = 15/220 (6%)
Query: 310 VIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQ 369
I ++ V+ A+L + L G ++ + L LEL +N+
Sbjct: 21 AIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDL 78
Query: 370 IPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQ 429
P K L + + A L + + L L NL
Sbjct: 79 APL-----KNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 430 LLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEI 489
L +I L N + + L +LT L+ +N+ +
Sbjct: 134 L----YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189
Query: 490 PPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLS 529
P + + L V L N++ P L L ++ L+
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 5e-07
Identities = 36/226 (15%), Positives = 68/226 (30%), Gaps = 17/226 (7%)
Query: 352 NFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHN 411
+ ++ + + T L + A+ + I + Y L L+L N
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDN 73
Query: 412 FLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGL 471
+T P +L + I T + ++ S + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 472 LHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMN 531
L+ +I + L Q + + L L L L N
Sbjct: 134 LY----------LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 532 SIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLS 577
I P L L +L ++ L N I+ + P L +L ++ L+
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 5e-07
Identities = 35/228 (15%), Positives = 64/228 (28%), Gaps = 19/228 (8%)
Query: 136 LAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGN 195
LA ++ +++ + + + + L + ++ I + L L + N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 196 PGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIG 255
+ ++ + ++ + L
Sbjct: 74 QITDLAPLKNLTKITE-----------LELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 256 NCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSL 315
A + +I + L N S L N S LT +
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 316 NSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDN 363
N + P LA+L L E+ L N IS P N S L + L N
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 40/247 (16%), Positives = 70/247 (28%), Gaps = 50/247 (20%)
Query: 395 PELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRL 454
P LA +K+ + +T +V + +L +T L + + LI L
Sbjct: 16 PALANAIKIA---AGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGL 68
Query: 455 RLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQ-------- 506
L N + P + L + + I T
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 507 ------NKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGL 560
I + N+ LS+ + + L L+ L L N I+ +
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 561 IPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKL 620
P L +L + L +N+I+ P +N S L
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP---------------------------LANTSNL 219
Query: 621 ANLDLSN 627
+ L+N
Sbjct: 220 FIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 5e-06
Identities = 35/221 (15%), Positives = 67/221 (30%), Gaps = 17/221 (7%)
Query: 212 LVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIF 271
+ + + ++ + ++ +L + TLS + +T E + + L L L +NQI
Sbjct: 21 AIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT 76
Query: 272 GKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVA 331
P + + L +I + + +L L
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL-- 134
Query: 332 LEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLH 391
+I + L + L +L A N++
Sbjct: 135 --------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186
Query: 392 GNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLL 432
I LA L + L +N ++ P L N NL + L
Sbjct: 187 D-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 32/212 (15%), Positives = 67/212 (31%), Gaps = 20/212 (9%)
Query: 451 LIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQ 510
I++ G +N + + L +T L T + L ++L N++
Sbjct: 21 AIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT 76
Query: 511 GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLT--------SLNKLVLSKNNITGLIP 562
P L + I T + + +N+ L
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136
Query: 563 KSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSW-----NALTGPIPESFSNL 617
+ L L++ + ++ L L L L+ N ++ P ++L
Sbjct: 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASL 194
Query: 618 SKLANLDLSNNMLTGSLKVLGSLDNLVSLNVS 649
L + L NN ++ + L + NL + ++
Sbjct: 195 PNLIEVHLKNNQISD-VSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 1e-04
Identities = 12/68 (17%), Positives = 30/68 (44%), Gaps = 3/68 (4%)
Query: 597 ILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGI 656
I + + +T + + ++L + L +T +++ + L+NL+ L + N + +
Sbjct: 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQITDL 78
Query: 657 LPNTKLFH 664
P L
Sbjct: 79 APLKNLTK 86
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 37/226 (16%), Positives = 62/226 (27%), Gaps = 23/226 (10%)
Query: 77 IPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKL 136
I FP + ++ + +N+T + A +L + L +T E + L
Sbjct: 9 INVIFP--DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYL 62
Query: 137 AELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNP 196
L L L N I P + L + I +
Sbjct: 63 NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 197 GI-------------HGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYT 243
+I + L+ + L+ L TL
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 244 ANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLL 289
I+ P + + L + L NQI P L + NL + L
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 16/96 (16%), Positives = 36/96 (37%), Gaps = 4/96 (4%)
Query: 50 WNPSHRNPCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAI 109
N + ++ + S L + S LT+L + ++ P +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 110 GNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLN 145
+L +LI + L N ++ P + + L +++L
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (121), Expect = 2e-07
Identities = 39/254 (15%), Positives = 68/254 (26%), Gaps = 19/254 (7%)
Query: 299 PEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQ 358
+ +CS+ + + E+P L EL + F F L++
Sbjct: 2 HHRICHCSNRVF-LCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 359 LELDNNRFFGQIPPTIGQLKELL---LFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTG 415
+E+ N I + L N L+ N LQ L +S+ +
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 416 SVPSSLFNLKNLTQLLLIS--NRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLH 473
+ L + N + E +G + L L N
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 474 RLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSI 533
N + ++D+ + ++ LE L L
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY---- 233
Query: 534 GGTIPENLGKLTSL 547
NL KL +L
Sbjct: 234 ------NLKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 1e-06
Identities = 29/232 (12%), Positives = 58/232 (25%), Gaps = 8/232 (3%)
Query: 90 HLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSI 149
+ + +T EIP + + I L L +LE + ++ N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 150 HGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEE---I 206
I ++ + + + + + +P+
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 207 SNCKVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLY 266
S KVL+ + + + VG L + I E
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 267 ENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSL 318
N + D L + + + L N L S +L
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR--STYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 39/240 (16%), Positives = 73/240 (30%), Gaps = 14/240 (5%)
Query: 406 LDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHI 465
+ +T +PS L +N +L + + G L ++ + N+ I
Sbjct: 13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 466 PSRIGLLHRLTFLELSE--NQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGL 523
+ + E N P N L+ + + ++
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 524 NVLDLSM--NSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
+LD+ N +G L L+KN I + + + +L +N +
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 582 NGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLD 641
+ G IL ++S + NL KL N LK L +L+
Sbjct: 190 EELPNDVFHGASGPVIL-DISRTRIHSLPSYGLENLKKLRARSTYN------LKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 3e-05
Identities = 30/238 (12%), Positives = 58/238 (24%), Gaps = 13/238 (5%)
Query: 58 CNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLIN 117
C+ C +++ IP+ P + L L A L
Sbjct: 8 CSNRVFLCQESKVT----EIPSDLP------RNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 118 LDLSFNALTGNI---PEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLS 174
+++S N + I + +N ++ + L
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 175 GNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELT 234
+I L+ + + E + V L L GI +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 235 NLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQN 292
N+ + S L + +I L +LK L+ +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 8e-05
Identities = 37/226 (16%), Positives = 60/226 (26%), Gaps = 18/226 (7%)
Query: 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEI--PPEIGGCTGLIRLRLGSNN 460
L L + +L ++ + N I +NN
Sbjct: 31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 90
Query: 461 FSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQ--NKLQGTIPSSLE 518
P L L +L +S + Q ++D+ N S +
Sbjct: 91 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 150
Query: 519 FLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSS 578
F +L L+ N I + NN+ L +LD+S
Sbjct: 151 LSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 210
Query: 579 NRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLD 624
RI+ + L+ L S NL KL L+
Sbjct: 211 TRIHSLPSYGLENLKKLRAR--------------STYNLKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 25/223 (11%), Positives = 52/223 (23%), Gaps = 8/223 (3%)
Query: 153 IPREIGNCSKLRRLELYDNQLSGNIPAEIGQL---EALEIIRAGGNPGIHGEIPEEISNC 209
IP ++ L +L E +EI + I ++ +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 210 KVLVFLGLADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQ 269
+ + +S + + L ++ N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 270 IFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANL 329
+ +G L L +N + A + N+L
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 330 VALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPP 372
L +S I N +L+ N + ++P
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 12/99 (12%), Positives = 24/99 (24%)
Query: 50 WNPSHRNPCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAI 109
N ++ + + + I + N NL
Sbjct: 138 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVF 197
Query: 110 GNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNS 148
S + LD+S + + L +L S +
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 31/247 (12%), Positives = 67/247 (27%), Gaps = 22/247 (8%)
Query: 334 ELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGN 393
L + ++ EIPS +L + +L QN +
Sbjct: 12 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 394 IPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIR 453
I + + ++ NL + + + + + TG+
Sbjct: 69 IEADVFSNLPKLHEIRI-----------EKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 454 LRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTI 513
L S + N T E +G + ++ L++N +Q
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNI--------NIHTIERNSFVGLSFESVILWLNKNGIQEIH 169
Query: 514 PSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQL 573
+ + N++ + + L +S+ I L L K L+
Sbjct: 170 NCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 229
Query: 574 LDLSSNR 580
+ +
Sbjct: 230 RSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 35/214 (16%), Positives = 61/214 (28%), Gaps = 6/214 (2%)
Query: 440 EIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQL 499
EIP ++ I LR L +E+S+N I ++ +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 500 EMVDLHQNKLQGTIPSSLEFLFGLNVLDL--SMNSIGGTIPENLGKLTSLNKLVLSKNNI 557
+ + F N+ L S I + L + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 558 TGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIP-ESFSN 616
I ++ + + + L N+ LNLS N +P + F
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 617 LSKLANLDLSNNMLTG-SLKVLGSLDNLVSLNVS 649
S LD+S + L +L L + +
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 38/260 (14%), Positives = 77/260 (29%), Gaps = 26/260 (10%)
Query: 257 CSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLN 316
C +FL + +IP +L +N L L A L I++S N
Sbjct: 6 CHCSNRVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 63
Query: 317 SLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQ 376
I ++ S ++ + +N +
Sbjct: 64 D--------------------VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLP 103
Query: 377 LKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNR 436
+ LL + ++ ++ K+ + + +S L + +L ++
Sbjct: 104 NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 163
Query: 437 FSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRI-GLLHRLTFLELSENQFTGEIPPEIGN 495
EI T L L L NN +P+ + L++S + + N
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223
Query: 496 CTQLEMVDLHQNKLQGTIPS 515
+L + K +P+
Sbjct: 224 LKKLRARSTYNLK---KLPT 240
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 33/202 (16%), Positives = 68/202 (33%), Gaps = 15/202 (7%)
Query: 233 LTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQN 292
++ ++T + + ++++ + + I + L N+ +L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 293 NLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGN 352
L+ ++L + +S + + L +N +I
Sbjct: 79 KLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 353 FSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALDLSHNF 412
+N + + +L + ++ +I LA KLQ L LS N
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLD----TLSLEDNQISDIVPLAGLTKLQNLYLSKNH 189
Query: 413 LTGSVPSSLFNLKNLTQLLLIS 434
++ +L LKNL L L S
Sbjct: 190 ISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 39/177 (22%), Positives = 68/177 (38%), Gaps = 14/177 (7%)
Query: 402 KLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNF 461
+ + +++ + + L N+T+L L N+ + L L+ F
Sbjct: 47 SIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD--------IKPLANLKNLGWLF 96
Query: 462 SGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLF 521
+ + S + I G ++ L+ + T + L L
Sbjct: 97 LDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLT 156
Query: 522 GLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSS 578
L+ L L N I +P L LT L L LSKN+I+ L ++L K+L +L+L S
Sbjct: 157 KLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 5e-06
Identities = 34/199 (17%), Positives = 61/199 (30%), Gaps = 16/199 (8%)
Query: 451 LIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQ 510
I+ L + + + L+ + + + + I + + L+ NKL
Sbjct: 26 TIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 81
Query: 511 GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKD 570
P + L L + LS + L
Sbjct: 82 DIKPLA-----NLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 571 LQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNML 630
L+ L L +N+I L + + + + L+KL NL LS N +
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTKLQNLYLSKNHI 190
Query: 631 TGSLKVLGSLDNLVSLNVS 649
+ L+ L L NL L +
Sbjct: 191 S-DLRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 39/201 (19%), Positives = 70/201 (34%), Gaps = 17/201 (8%)
Query: 402 KLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNF 461
+ +L +T +V + L ++ Q++ ++ I + +L L N
Sbjct: 25 ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKL 80
Query: 462 SGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLF 521
+ L L+ F E + + + + I +
Sbjct: 81 TDI--------KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 522 GLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
+ L + + T L +LT L+ L L N I+ ++P L LQ L LS N I
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190
Query: 582 NGSIPEEIGRLQGLDILLNLS 602
S + L+ LD+ L L
Sbjct: 191 --SDLRALAGLKNLDV-LELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 17/86 (19%), Positives = 40/86 (46%), Gaps = 8/86 (9%)
Query: 584 SIPEEIGRLQGLD-----ILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLG 638
++P I ++ D I NL ++T + ++ L+ + + +N+ + S++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQ 65
Query: 639 SLDNLVSLNVSYNHFSGILPNTKLFH 664
L N+ L ++ N + I P L +
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANLKN 91
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.1 bits (110), Expect = 3e-06
Identities = 42/195 (21%), Positives = 71/195 (36%), Gaps = 11/195 (5%)
Query: 304 NCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFF-GNFSRLKQLELD 362
+C TV D + L E+P + ELLL+ N + G L +LEL
Sbjct: 7 HCEGTTV-DCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELK 62
Query: 363 NNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPE-LAYCVKLQALDLSHNFLTGSVPSSL 421
N+ G P + +N++ + +L+ L+L N ++ +P S
Sbjct: 63 RNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSF 122
Query: 422 FNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELS 481
+L +LT L L SN F+ L + L PS+ + + +L
Sbjct: 123 EHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLP 178
Query: 482 ENQFTGEIPPEIGNC 496
++F C
Sbjct: 179 HSEFKCS-SENSEGC 192
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 44/189 (23%), Positives = 78/189 (41%), Gaps = 8/189 (4%)
Query: 491 PEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENL-GKLTSLNK 549
P + +C VD L+ IP + L L+ N +G + L G+L L K
Sbjct: 3 PAMCHCEGTT-VDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVK 58
Query: 550 LVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGP 609
L L +N +TG+ P + +Q L L N+I + L L L NL N ++
Sbjct: 59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTL-NLYDNQISCV 117
Query: 610 IPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPAS 669
+P SF +L+ L +L+L++N + + + L +++ P+ +
Sbjct: 118 MPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK--VRDVQIK 175
Query: 670 AFYGNQQLC 678
++ C
Sbjct: 176 DLPHSEFKC 184
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (108), Expect = 4e-06
Identities = 24/139 (17%), Positives = 44/139 (31%), Gaps = 6/139 (4%)
Query: 491 PEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKL 550
+ N + +DL K+ I + L + +D S N I + L L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 551 VLSKNNITGLIPKSLGLCKDLQLLDLSSNRING---SIPEEIGRLQGLDILLNLSWNALT 607
+++ N I + DL L L++N + P + +L
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 608 GPIPESFSNLSKLANLDLS 626
+ ++ LD
Sbjct: 129 HYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 1e-04
Identities = 20/145 (13%), Positives = 39/145 (26%), Gaps = 7/145 (4%)
Query: 389 QLHGNIPELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGC 448
+L + V+ + LDL + + + L + N
Sbjct: 6 ELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLL 62
Query: 449 TGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTG-EIPPEIGNCTQLEMVDLH-- 505
L L + +N L LT L L+ N + + L + +
Sbjct: 63 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
Query: 506 -QNKLQGTIPSSLEFLFGLNVLDLS 529
+ + + + VLD
Sbjct: 123 PVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 12/110 (10%), Positives = 32/110 (29%), Gaps = 4/110 (3%)
Query: 613 SFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSGILPNTKL----FHGLPA 668
++N + LDL + + +LD +++ S N + L +
Sbjct: 13 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNN 72
Query: 669 SAFYGNQQLCVNRSQCHINNSLHGRNSTKNLIICALLSVTVTLFIVLFGI 718
+ + L + + + L S+ ++ +
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 2e-04
Identities = 13/76 (17%), Positives = 21/76 (27%), Gaps = 3/76 (3%)
Query: 325 SLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFF 384
N V EL L G I I + + ++ +N L+ L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69
Query: 385 AWQNQLHGNIPELAYC 400
N++ L
Sbjct: 70 VNNNRICRIGEGLDQA 85
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 1e-05
Identities = 23/149 (15%), Positives = 44/149 (29%), Gaps = 4/149 (2%)
Query: 395 PELAYCVKLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEI-GGCTGLIR 453
P+ L + + L +NLT+L + + + + G L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 454 LRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTI 513
L + + P RL+ L LS N + + L+ + L N L +
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 514 -PSSLEFLFGLNVLDLSMNSIGGTIPENL 541
L+ + + + L
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 6e-04
Identities = 20/134 (14%), Positives = 42/134 (31%), Gaps = 3/134 (2%)
Query: 434 SNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRI-GLLHRLTFLELSENQFTGEIPPE 492
+ + + + G L L + + H+ R L L L + ++ P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 493 IGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTI-PENLGKLTSLNKLV 551
+L ++L N L+ ++ L L LS N + + L +
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGG 134
Query: 552 LSKNNITGLIPKSL 565
+ + + L
Sbjct: 135 VPEQKLQCHGQGPL 148
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 2e-05
Identities = 27/158 (17%), Positives = 57/158 (36%), Gaps = 14/158 (8%)
Query: 225 QIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNL 284
Q+ + + + ++ + ++ + L + + + ++ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67
Query: 285 KRLLLWQNNLSG--SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNI 342
L L N L + + +L ++++S N L E + + LEEL L GN++
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 343 SGEIPSFFGN----FSRLKQLE-LDNNRFFGQIPPTIG 375
S R +L LD + ++PP I
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLDGH----ELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 7e-05
Identities = 23/146 (15%), Positives = 51/146 (34%), Gaps = 5/146 (3%)
Query: 250 IPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLT 309
+ + L + + +L + L +++++ ++ N L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELL 68
Query: 310 VIDVSLNSLGG--EVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFF 367
+++S N L ++ + L+ L LSGN + E +L++L LD N
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 368 GQIPPTIGQLKELLLFFAWQNQLHGN 393
+ + F +L G+
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 8e-05
Identities = 26/155 (16%), Positives = 53/155 (34%), Gaps = 15/155 (9%)
Query: 503 DLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIP 562
+L +++ + + + + L + + +L L +++ +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLR 58
Query: 563 KSLGLCKDLQLLDLSSNRING--SIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKL 620
+L L+LS+NR+ + + + L IL NLS N L KL
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL-NLSGNELKSERELDKIKGLKL 117
Query: 621 ANLDLSNNMLTGS--------LKVLGSLDNLVSLN 647
L L N L+ + + L+ L+
Sbjct: 118 EELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 9e-04
Identities = 19/127 (14%), Positives = 45/127 (35%), Gaps = 5/127 (3%)
Query: 464 HIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGL 523
+ + + + L P++ +++ ++ + T+ E + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67
Query: 524 NVLDLSMNSIGGT--IPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
L+LS N + + + K +L L LS N + L+ L L N +
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 582 NGSIPEE 588
+ + ++
Sbjct: 128 SDTFRDQ 134
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 23/122 (18%), Positives = 43/122 (35%), Gaps = 9/122 (7%)
Query: 561 IPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLS-WNALTGPIPESFSNLSK 619
+ + D L + S P+ L +I + L+ +++ + N+ +
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR-SDPD----LVAQNIDVVLNRRSSMAATLRIIEENIPE 66
Query: 620 LANLDLSNNMLTGS---LKVLGSLDNLVSLNVSYNHFSGILPNTKLFHGLPASAFYGNQQ 676
L +L+LSNN L ++ NL LN+S N K+ +
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 677 LC 678
L
Sbjct: 127 LS 128
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 32/203 (15%), Positives = 61/203 (30%), Gaps = 52/203 (25%)
Query: 268 NQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEA-LGNCSSLTVIDVSLNSLGGEVPVSL 326
NQIF D +L + +L + N++ ++ + L ++L + + S+ G +
Sbjct: 9 NQIF---TDT--ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----V 58
Query: 327 ANLVALEELLLSGNNISG---------------------------------------EIP 347
L L ++ S N ++
Sbjct: 59 EYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 118
Query: 348 SFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALD 407
+ L L + L + + ++ LA L+ LD
Sbjct: 119 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLD 178
Query: 408 LSHNFLTGSVPSSLFNLKNLTQL 430
+S N ++ S L L NL L
Sbjct: 179 ISSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 42/196 (21%), Positives = 68/196 (34%), Gaps = 16/196 (8%)
Query: 451 LIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQ 510
++ LG N + + L ++T L+ I + L ++ N+L
Sbjct: 20 KMKTVLGKTNVTDTVSQTD--LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLT 75
Query: 511 GTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKD 570
P + + I + N L+ N L +
Sbjct: 76 DITP------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129
Query: 571 LQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNML 630
L L+LSSN I+ N S N +T P +NL+ L LD+S+N +
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQL---NFSSNQVTDLKP--LANLTTLERLDISSNKV 184
Query: 631 TGSLKVLGSLDNLVSL 646
+ + VL L NL SL
Sbjct: 185 S-DISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 8e-04
Identities = 11/59 (18%), Positives = 25/59 (42%), Gaps = 3/59 (5%)
Query: 597 ILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSYNHFSG 655
+ L +T + ++ +L ++ L + S+ + L+NL +N S N +
Sbjct: 21 MKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 28/197 (14%), Positives = 63/197 (31%), Gaps = 16/197 (8%)
Query: 402 KLQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNF 461
+ L +T +V + +L +T L I + L ++ +N
Sbjct: 19 EKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQL 74
Query: 462 SGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLF 521
+ P + + ++ + + + ++L L
Sbjct: 75 TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 134
Query: 522 GLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581
+ ++++ G +S N +T L P L L+ LD+SSN++
Sbjct: 135 LSSNTISDISALSGLTSLQQLNFSS--------NQVTDLKP--LANLTTLERLDISSNKV 184
Query: 582 NGSIPEEIGRLQGLDIL 598
+ + +L L+ L
Sbjct: 185 SD--ISVLAKLTNLESL 199
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 17/78 (21%), Positives = 29/78 (37%), Gaps = 9/78 (11%)
Query: 584 SIPEEIGRLQ--GLDILLNLSWNALTGPIP------ESFSNLSKLANLDLSNNMLTGSLK 635
+I + I + + L G IP + S L +L LS N + +
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS 64
Query: 636 VLGSLDNLVSLNVSYNHF 653
L ++NL L++ N
Sbjct: 65 SLSGMENLRILSLGRNLI 82
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1079 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.95 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.93 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.91 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.89 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.81 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.8 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.79 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.78 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.73 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.68 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.6 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.59 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.58 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.01 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.92 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.47 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.13 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.98 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.91 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.74 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.47 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.91 Aligned_cols=264 Identities=26% Similarity=0.358 Sum_probs=211.3
Q ss_pred HCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 17899883543476899999968987699999334568992238999999999852787750015527873991799999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||+||+|+.++ .||||++.... ......+.|.+|+.++++++|||||++++++.+ ...++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECC--EEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 518998898307885899999999--89999997346-998999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 35788734353015767999999999999999999998289999497089999768779995899402344224677654
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 917 (1079)
|+++|+|.+++......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 5899888999852357899999999999999998887509---9951614789979818997887500221333556776
Q ss_pred CCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHH
Q ss_conf 46566666766345334377---887851017889999999992999999999995227899876875421001011122
Q 001426 918 RASNSVAGSYGYIAPEYGYS---LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..+... +...+.... ..+.....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~--~~p~~~~~--- 234 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGY--LSPDLSKV--- 234 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTS--CCCCGGGS---
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCC--CCCCCHHC---
T ss_conf 312566557431799999505689999531516359999999978899899896999-999996588--89860003---
Q ss_pred HHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 321025731999999999997213999999999899999999501028
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~~ 1042 (1079)
.. .....+.+++.+||+.+|++||||+|+++.|+.+.+.-
T Consensus 235 ------~~--~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 235 ------RS--NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp ------CT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ------CC--CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf ------65--55499999999975889768929999999999999709
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=371.35 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=209.6
Q ss_pred HCCCCCCEEEECCCEEEEEEEECC-C---CEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 178998835434768999999689-8---769999933456899223899999999985278775001552787399179
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-R---QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
.+|+..++||+|+||+||+|..+. + ..||+|++.. .......+.|.+|+.++++++|||||+++|++.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS--GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS--SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 042785698027882999999957997889999999784--459899999999999998579988861899996288779
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99993578873435301576799999999999999999999828999949708999976877999589940234422467
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 913 (1079)
+||||+++|+|.+++......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 99972279853002104567999999999999999988988527---983576150448988999199888443157567
Q ss_pred CCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHHCHH
Q ss_conf 76544---6566666766345334377887851017889999999992-9999999999952278998768754210010
Q 001426 914 SESSR---ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 914 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
..... ......||+.|+|||+..+..++.++|||||||++|||+| |+.||.+... ..+...+.. .
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~---~------ 249 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQ---D------ 249 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHT---T------
T ss_pred CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--HHHHHHHHC---C------
T ss_conf 77765365025666883003878883699786121445357899998679999999999--999999973---7------
Q ss_pred HHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 1112232102573199999999999721399999999989999999950102
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~ 1041 (1079)
.. ..........+.+++.+||+.+|++||||+|+++.|+++.+.
T Consensus 250 ------~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 ------YR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------CC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf ------88--999742269999999997587976892999999999998418
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.26 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=210.3
Q ss_pred CCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf 78998835434768999999689876999993345689922389999999998527877500155278739917999993
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDY 838 (1079)
Q Consensus 759 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 838 (1079)
+|+..+.||+|+||+||+|...++..||||++... ....+.|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC----CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEE
T ss_conf 95888898208882999999889999999998788----67689999999999966899756535243159933799983
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 57887343530157679999999999999999999982899994970899997687799958994023442246776544
Q 001426 839 ISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSR 918 (1079)
Q Consensus 839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 918 (1079)
+++|+|.+++......+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+|+...... ..
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~ 157 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 157 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC-CE
T ss_conf 699918997520134788999999999999987765316---43104431532666688776865532100236887-33
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHHHHC
Q ss_conf 65666667663453343778878510178899999999929999999999952278998768754210010111223210
Q 001426 919 ASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 919 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
......||+.|+|||++.+..++.++||||||+++|||+++..|+...... ..+...+.. .... ..+.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~---~~~~-----~~p~--- 225 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDIST---GFRL-----YKPR--- 225 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHH---TCCC-----CCCT---
T ss_pred EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHH---CCCC-----CCCC---
T ss_conf 504300176667857860799984033210599999998789888778999-999999980---6888-----9954---
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 2573199999999999721399999999989999999950102
Q 001426 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 999 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~ 1041 (1079)
.....+.+++..||+.||++||||+|+++.|+++...
T Consensus 226 ------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 226 ------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ------3679999999997657976891999999999999857
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.17 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=206.8
Q ss_pred HHCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 617899883543476899999968-9876999993345689922389999999998527877500155278739917999
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 757 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
.++|++.+.||+|+||+||+|..+ +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 746089989721748099999999999799999984566--412799999999999857998884696540467436798
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99357887343530157679999999999999999999982899994970899997687799958994023442246776
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 915 (1079)
|||+++|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 82 mEy~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 86458980899975379-999999999999999999999975---98357546899788789987983231422404688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHH
Q ss_conf 5446566666766345334377887-851017889999999992999999999995227899876875421001011122
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKI-TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
.........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+...... .. +
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------~~---~ 228 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------LN---P 228 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT------ST---T
T ss_pred CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC------CC---C
T ss_conf 65311132557474287286189999971016173799999982997888898599999998638887------88---6
Q ss_pred HHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 321025731999999999997213999999999899999
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
.. .....+.+++.+||+.||++|||++|+++
T Consensus 229 ------~~--~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 ------WK--KIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ------GG--GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ------44--69999999999976799668909999961
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.85 Aligned_cols=260 Identities=24% Similarity=0.405 Sum_probs=210.1
Q ss_pred CCCCCCEEEECCCEEEEEEEECCC-----CEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 789988354347689999996898-----769999933456899223899999999985278775001552787399179
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIPSR-----QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 759 ~~~~~~~lg~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
.|+..++||+|+||.||+|..+.. ..||||++.. .........|.+|+.++++++|||||+++|++.+....+
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA--GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT--TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 968615981177909999999689987879999999884--459689999999999998568987832367783388038
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99993578873435301576799999999999999999999828999949708999976877999589940234422467
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 913 (1079)
+||||+.+|++.+++......+++..+..++.|++.|++|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf 99972135740222102345420899999999999854121212---342576564427888998499845510300357
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHH
Q ss_conf 765-4465666667663453343778878510178899999999929999999999952278998768754210010111
Q 001426 914 SES-SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
... ........||+.|+|||++.+..++.++||||||+++|||+++..|+........ +...+....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~----------- 230 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAINDGF----------- 230 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTC-----------
T ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH-HHHHHHCCC-----------
T ss_conf 87652674267777343488887049999735563448989999967988655689999-999986357-----------
Q ss_pred HHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 2232102573199999999999721399999999989999999950102
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~ 1041 (1079)
...... .....+.+++.+||+.+|++||||.|+++.|+++.+.
T Consensus 231 ----~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 ----RLPTPM--DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----CCCCCT--TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCH--HHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ----899850--4579999999997767976893999999999998669
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.80 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=207.1
Q ss_pred HCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 17899883543476899999968987699999334568992238999999999852787750015527873991799999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||.||+|..+++..||||++... ....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC----CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEE
T ss_conf 993886798107982899999999999999998647----6888999999999986799988578731045-97699999
Q ss_pred ECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 35788734353015-76799999999999999999999828999949708999976877999589940234422467765
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 916 (1079)
|+++|+|.+++... ...+++..+..++.|+++|+.|||+. +|+||||||+||++++++.+||+|||+|+.+....
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCC-
T ss_conf 57898288887514789887889999999999999999748---95467564225156202440423410147735886-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHHH
Q ss_conf 44656666676634533437788785101788999999999299999999999522789987687542100101112232
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
........|++.|+|||+..+..++.++||||||+++|||+||..|+...............+ ....
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~----~~~~--------- 230 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----YRMV--------- 230 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----CCCC---------
T ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC----CCCC---------
T ss_conf 442035677444458289837999824564525799999996898888888999999999706----8888---------
Q ss_pred HCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 102573199999999999721399999999989999999950102
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~ 1041 (1079)
... .....+.+++.+||+.+|++||||+++++.|+++...
T Consensus 231 ---~p~--~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 ---RPD--NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---CCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCC--CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ---965--5719999999997588976893999999986113213
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.49 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=207.2
Q ss_pred HCCCCCCEEEECCCEEEEEEEECC-C-----CEEEEEEECCCCCCCCHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCC
Q ss_conf 178998835434768999999689-8-----76999993345689922389999999998527-8775001552787399
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-R-----QVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGR 830 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 830 (1079)
++|+..+.||+|+||+||+|+... + ..||+|.+.... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 9939701983078819999998578855420499999966335--87899999999999997158996868778886299
Q ss_pred EEEEEEEECCCCCHHHHHHCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCC
Q ss_conf 1799999357887343530157----------------------679999999999999999999982899994970899
Q 001426 831 TRLLLFDYISNGSLAGLLHEKK----------------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIK 888 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 888 (1079)
..++||||+++|+|.++++... ..+++..+..++.|++.|++|||++ +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCC
T ss_conf 589999727999599999862577751022100001222001257789999999999999999999739---90505270
Q ss_pred CCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 9976877999589940234422467765446566666766345334377887851017889999999992-999999999
Q 001426 889 SNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRI 967 (1079)
Q Consensus 889 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~t-g~~p~~~~~ 967 (1079)
|+||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887279999633030003999999838999999989
Q ss_pred CCCCHHHHHHHHHHHHHHHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 9952278998768754210010111223210257319999999999972139999999998999999995
Q 001426 968 PDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKE 1037 (1079)
Q Consensus 968 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~ 1037 (1079)
.. ..+...+....+. ..+. .....+.+++.+||+.+|++||||+|+++.|..
T Consensus 272 ~~-~~~~~~~~~~~~~---------------~~p~--~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VD-ANFYKLIQNGFKM---------------DQPF--YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CS-HHHHHHHHTTCCC---------------CCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH-HHHHHHHHCCCCC---------------CCCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 89-9999998569989---------------9887--678999999999758896689399999999748
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.13 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=204.6
Q ss_pred HHHCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 861789988354347689999996-8987699999334568992238999999999852787750015527873991799
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 756 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 834 (1079)
..++|+..+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+.+++.++|||||++++++.+.+..|+
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 51053887898128582999999989998999999843017---279999999999986799988058577988999899
Q ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99935788734353015767999999999999999999998289999497089999768779995899402344224677
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 914 (1079)
||||+++|+|.+++.+. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 95 vmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEECCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 99703798089886415--999999999999999999999987---9722677688868878996864251564132136
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHH
Q ss_conf 65446566666766345334377887851017889999999992999999999995227899876875421001011122
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
. .......||+.|+|||+..+..++.++||||+||++|||++|+.||.+..... .+.... ......+.
T Consensus 170 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~----~~~~~~~~----- 237 (293)
T d1yhwa1 170 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIA----TNGTPELQ----- 237 (293)
T ss_dssp T--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHH----HHCSCCCS-----
T ss_pred C--CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH-HHHHHH----HCCCCCCC-----
T ss_conf 6--64444444777368266447998801203137299999804889989979999-999998----57999888-----
Q ss_pred HHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 321025731999999999997213999999999899999
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
... .....+.+++.+||+.||++|||++|+++
T Consensus 238 -----~~~--~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 -----NPE--KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -----SGG--GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----CCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----855--37999999999986699668909999964
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=367.32 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=210.2
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 17899883543476899999968-98769999933456899223899999999985278775001552787399179999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||+||+|... +++.||+|++... ....+.|.+|++++++++|||||+++++|.+.+..++||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC----CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEE
T ss_conf 9939865982088808999999999969999997776----103999999999998679998826775274578547876
Q ss_pred EECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 935788734353015-7679999999999999999999982899994970899997687799958994023442246776
Q 001426 837 DYISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 915 (1079)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf 314676067775303554157999999999999978889878---93057604576899899928983244546537887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHH
Q ss_conf 54465666667663453343778878510178899999999929999999999952278998768754210010111223
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
........|++.|+|||+..+..++.++||||||+++|||++|+.|+....+. ..+...+...
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~i~~~--------------- 232 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD--------------- 232 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTT---------------
T ss_pred -CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCC---------------
T ss_conf -22103556654666927872799981043021789999998679988774259-9999998558---------------
Q ss_pred HHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 21025731999999999997213999999999899999999501028
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~~ 1042 (1079)
....... .....+.+++..||+.||++||||+|+++.|+.+.++.
T Consensus 233 ~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 233 YRMERPE--GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred CCCCCCC--CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 8888874--33099999999975779768939999999999998757
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.38 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=206.7
Q ss_pred CCCCCCE-EEECCCEEEEEEEEC---CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 7899883-543476899999968---987699999334568992238999999999852787750015527873991799
Q 001426 759 RLSDTNI-VGKGVSGIVYRVEIP---SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 759 ~~~~~~~-lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 834 (1079)
+|...+. ||+|+||+||+|..+ ++..||||++.+. ......+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 718878487306080999999960897689999998820--397899999999999986799888068656036-80799
Q ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99935788734353015767999999999999999999998289999497089999768779995899402344224677
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 914 (1079)
||||+++|+|.+++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 9980789968997521256999999999999999987899868---8105767646604546885420331342115543
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHH
Q ss_conf 654-46566666766345334377887851017889999999992-9999999999952278998768754210010111
Q 001426 915 ESS-RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 915 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+...+.. ......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~---~~~~~~---- 233 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ---GKRMEC---- 233 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT---TCCCCC----
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH--HHHHHHHHC---CCCCCC----
T ss_conf 43211356211374335868872799995412322017899999389999999799--999999981---899999----
Q ss_pred HHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 2232102573199999999999721399999999989999999950102
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~ 1041 (1079)
+. .....+.+++.+||+.+|++||||.++.+.|+.....
T Consensus 234 --------p~--~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 --------PP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --------CT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --------97--6789999999997577976890999999999999998
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.10 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=203.9
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 17899883543476899999968-98769999933456899223899999999985278775001552787399179999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|++.+.||+|+||.||+|+.+ +++.||+|++.+...........+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 93578873435301576799999999999999999999828999949708999976877999589940234422467765
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 916 (1079)
||+++|+|.+++.+.+. +++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EECCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC-
T ss_conf 50479858988750489-99999999999999999999988---94652202344146689987115556335448885-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHHH
Q ss_conf 44656666676634533437788785101788999999999299999999999522789987687542100101112232
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... .......+..
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~----i~~~~~~~p~------ 225 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKR----ISRVEFTFPD------ 225 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHH----HHTTCCCCCT------
T ss_pred ---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHH----HHCCCCCCCC------
T ss_conf ---2355788763499997589989314404675999998329999888999--999999----9718999986------
Q ss_pred HCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 1025731999999999997213999999999899999
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
.....+.+++.+||+.||++|||++|+++
T Consensus 226 --------~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 226 --------FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --------68999999999976479768909999971
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.36 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=211.4
Q ss_pred HCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 17899883543476899999968987699999334568992238999999999852787750015527873991799999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||+||+|+.+++..||+|++.+.. ...+.|.+|+.++++++||||++++|+|.++...++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
T ss_conf 9979968982078839999998899899999987475----778999999999996689860158899850781699997
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 35788734353015767999999999999999999998289999497089999768779995899402344224677654
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 917 (1079)
|+++|++.+++......+++..+++++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.+.... .
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~ 155 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y 155 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-C
T ss_pred CCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC-C
T ss_conf 0489938886410246776899999999999999987546---84346654135887699847988614420235787-2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHHH
Q ss_conf 46566666766345334377887851017889999999992-99999999999522789987687542100101112232
Q 001426 918 RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......||+.|+|||+..+..++.++||||||+++|||+| |+.||..... ..+...+.. ... ..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~~~i~~---~~~-----~~---- 221 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQ---GLR-----LY---- 221 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHT---TCC-----CC----
T ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH--HHHHHHHHH---CCC-----CC----
T ss_conf 2524657887757807863799885210336432467397559999889999--999999980---797-----89----
Q ss_pred HCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 102573199999999999721399999999989999999950
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~ 1038 (1079)
.+. .....+.+++.+||++||++||||+++++.|.++
T Consensus 222 ---~p~--~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 ---RPH--LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---CCT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---CCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf ---965--4659999999997668976893999999874188
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=357.80 Aligned_cols=255 Identities=18% Similarity=0.233 Sum_probs=207.0
Q ss_pred HHHHCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 8861789988354347689999996-898769999933456899223899999999985278775001552787399179
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 755 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
.+.++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++|||||++++++.+++..|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 8540359989993177829999999899979999998872---6467999999999998679979891999999899999
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC--CCCCEEEEECCCCCCC
Q ss_conf 99993578873435301576799999999999999999999828999949708999976877--9995899402344224
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG--PQFEAFLADFGLAKLF 911 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~ 911 (1079)
+|||||++|+|.+++...+..+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+|+.+
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEEC
T ss_conf 99982899808888986389989999999999999999999977---926513144553113467884899525630343
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHH
Q ss_conf 67765446566666766345334377887851017889999999992999999999995227899876875421001011
Q 001426 912 ESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 912 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.... ......|++.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+.....+. ..+...
T Consensus 180 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~-----~~~~~~ 250 (352)
T d1koba_ 180 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCD-----WEFDED 250 (352)
T ss_dssp CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCC-----CCCCSS
T ss_pred CCCC---CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCC-----CCCCCC
T ss_conf 7887---201004764534899974799897633389899999999688998997999-9999998478-----898930
Q ss_pred HHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1223210257319999999999972139999999998999999
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~ 1034 (1079)
..+ .....+.+++.+||+.||++|||++|+++.
T Consensus 251 ~~~----------~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFS----------SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTT----------TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCC----------CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 024----------799999999999756996689189999609
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.53 Aligned_cols=272 Identities=25% Similarity=0.343 Sum_probs=208.2
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 17899883543476899999968-98769999933456899223899999999985278775001552787399179999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|+..+.||+|+||+||+|... +++.||+|++.... .......+.+|+.+++.++|||||++++++.+....++||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 68889789712778099999998999699999987540--9789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 9357887343530157679999999999999999999982-899994970899997687799958994023442246776
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHH-DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 915 (1079)
||+++|+|.+++.+.+. +++..+..++.|++.|+.|||+ + +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 84 Ey~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp ECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred ECCCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC-
T ss_conf 76799868998742499-999999999999999999999859---9971445779946878998999548776256788-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHH--HHHHHHHH--------
Q ss_conf 54465666667663453343778878510178899999999929999999999952278998--76875421--------
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWV--NGELRERK-------- 985 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~-------- 985 (1079)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.............. .+......
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf ---62111377141194687589989488899899999999988899899887899999988751775457742123332
Q ss_pred ------------HCHHHHHHHHHHCCCCC--CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf ------------00101112232102573--1999999999997213999999999899999--999501
Q 001426 986 ------------REFTTILDRQLLMRSGT--QIQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIR 1039 (1079)
Q Consensus 986 ------------~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~--~L~~~~ 1039 (1079)
....+..+......... .......+.+++.+|++.||++|||++|+++ .+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf 2111122235413477887665026876676444899999999998689946790899996098647698
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=359.73 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=207.1
Q ss_pred HHHHHCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf 888617899883543476899999968-9876999993345689922389999999998527877500155278739917
Q 001426 754 DDVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 754 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
+++.++|++.+.||+|+||.||+|... +++.||+|++.. ......+.+.+|+.++++++|||||++++++.+.+..
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECC---CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECC---CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 8786575898898407681999999889998999999845---2431699999999999867997999299999989999
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC--CCCEEEEECCCCCC
Q ss_conf 9999935788734353015767999999999999999999998289999497089999768779--99589940234422
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP--QFEAFLADFGLAKL 910 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~ 910 (1079)
++||||+++|+|.+++.+....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEE
T ss_conf 999985799889999976237899999999999999999999756---97600015467364168898699954521044
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHH
Q ss_conf 46776544656666676634533437788785101788999999999299999999999522789987687542100101
Q 001426 911 FESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTT 990 (1079)
Q Consensus 911 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1079)
+.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+....... .....
T Consensus 176 ~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~-----~~~~~ 246 (350)
T d1koaa2 176 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCD-----WNMDD 246 (350)
T ss_dssp CCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTC-----CCSCC
T ss_pred CCCCC---CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCC-----CCCCC
T ss_conf 25654---320006862421889975899872676554659999998598998997999-9999998478-----89894
Q ss_pred HHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 11223210257319999999999972139999999998999999
Q 001426 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~ 1034 (1079)
...+ .....+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~----------~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFS----------GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGG----------GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCC----------CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2235----------899999999999756896679089998629
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.76 Aligned_cols=253 Identities=19% Similarity=0.249 Sum_probs=207.3
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 17899883543476899999968-98769999933456899223899999999985278775001552787399179999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|++.+.||+|+||+||+|... +++.||+|++.+.........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 93578873435301576799999999999999999999828999949708999976877999589940234422467765
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 916 (1079)
||+++|+|.+++...+. +++..+..++.|++.|++|+|+. +|+||||||+||++++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ECCCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCC
T ss_conf 70489877776531599-99999999999999999762165---088476774123668885388603210242256776
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHHH
Q ss_conf 44656666676634533437788785101788999999999299999999999522789987687542100101112232
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
........||+.|+|||++.+..++.++||||+||++|||++|+.||....+. ..+..... . ...+..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~----~-~~~~p~------ 231 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQKIIK----L-EYDFPE------ 231 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHT----T-CCCCCT------
T ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHC----C-CCCCCC------
T ss_conf 43335556775525844002689896662304569999980388998995999-99999971----8-999985------
Q ss_pred HCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 10257319999999999972139999999998999999
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~ 1034 (1079)
.....+.+++.+||+.||++|||++|+...
T Consensus 232 --------~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 232 --------KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --------TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --------CCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf --------479999999999855797689197897377
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.67 Aligned_cols=250 Identities=23% Similarity=0.302 Sum_probs=202.8
Q ss_pred CCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 7899883543476899999968-987699999334568992238999999999852787750015527873991799999
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 759 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
.|++.+.||+|+||+||+|+.. ++..||+|++... .....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCC---CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 759847993077819999999999939999998728---99999999999999986799998849889800995899996
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 35788734353015767999999999999999999998289999497089999768779995899402344224677654
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 917 (1079)
|+++|+|.+++.+....+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC--
T ss_conf 2799818899986289999999999999999999999988---98871407003148789998997161230357786--
Q ss_pred CCCCCCCCCCCCCCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHH
Q ss_conf 4656666676634533437-----78878510178899999999929999999999952278998768754210010111
Q 001426 918 RASNSVAGSYGYIAPEYGY-----SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
.......||+.|+|||++. ...++.++||||+||++|||++|+.||....+. ..+.....+. .+...
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~~~~----~~~~~--- 236 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLKIAKSE----PPTLA--- 236 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHHSC----CCCCS---
T ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHCCC----CCCCC---
T ss_conf 410010256264799998320257888880665787899999982088999998999-9999997079----98777---
Q ss_pred HHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 22321025731999999999997213999999999899999
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
.+ . .....+.+++.+||+.||++|||++|+++
T Consensus 237 ~~-------~--~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QP-------S--RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SG-------G--GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC-------C--CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 65-------6--69999999999976699668919999962
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=357.14 Aligned_cols=250 Identities=26% Similarity=0.329 Sum_probs=200.7
Q ss_pred HHHCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 8617899883543476899999968-987699999334568992238999999999852787750015527873991799
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLL 834 (1079)
Q Consensus 756 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 834 (1079)
..+.|+..+.||+|+||+||+|... +++.||+|++...........+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 07856762797018880999999989993999999844443588999999999999997789998238999998998899
Q ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99935788734353015767999999999999999999998289999497089999768779995899402344224677
Q 001426 835 LFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESS 914 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 914 (1079)
|||||++|++..++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 v~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf 99806999457899737-9999999999999999999999868---976667884217987999789844365334677-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHH
Q ss_conf 65446566666766345334377---887851017889999999992999999999995227899876875421001011
Q 001426 915 ESSRASNSVAGSYGYIAPEYGYS---LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 915 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.....||+.|+|||++.+ ..++.++||||+||++|||++|..||...... ..+.... ....+..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~----~~~~~~~--- 234 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIA----QNESPAL--- 234 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHH----HSCCCCC---
T ss_pred -----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHH----HCCCCCC---
T ss_conf -----87313476636889983467888672145455899999998788999997999-9999998----2899988---
Q ss_pred HHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 122321025731999999999997213999999999899999
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
... .....+.+++.+||+.||++|||++|+++
T Consensus 235 --------~~~--~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 --------QSG--HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------SCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf --------878--88999999999977379657918999971
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.84 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=201.8
Q ss_pred CEEEECCCEEEEEEEEC---CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf 83543476899999968---987699999334568992238999999999852787750015527873991799999357
Q 001426 764 NIVGKGVSGIVYRVEIP---SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYIS 840 (1079)
Q Consensus 764 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 840 (1079)
+.||+|+||+||+|.++ .++.||+|++.... ......+.|.+|++++++++|||||+++|+|.+ +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCC
T ss_conf 7834587829999998169738599999988010-898999999999999986799898527777505-97799997478
Q ss_pred CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC-CC
Q ss_conf 88734353015767999999999999999999998289999497089999768779995899402344224677654-46
Q 001426 841 NGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS-RA 919 (1079)
Q Consensus 841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~ 919 (1079)
+|+|.+++.+.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+|+.+...... ..
T Consensus 91 ~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 91 LGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf 896899975225-789999999999999997668747---9556777611310235675123413453313432344322
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHHHHC
Q ss_conf 566666766345334377887851017889999999992-9999999999952278998768754210010111223210
Q 001426 920 SNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQLLM 998 (1079)
Q Consensus 920 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1079)
.....||++|+|||++.+..++.++||||||+++|||++ |+.||.+... ..+...+.. .....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~---~~~~~----------- 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEK---GERMG----------- 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT---TCCCC-----------
T ss_pred CCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH--HHHHHHHHC---CCCCC-----------
T ss_conf 44567784203916653799984344303403132896589999999899--999999982---89999-----------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 257319999999999972139999999998999999995010
Q 001426 999 RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 999 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~ 1040 (1079)
.+. .....+.+++.+||+.||++||||+++.+.|+....
T Consensus 231 -~p~--~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 -CPA--GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -CCT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHH
T ss_conf -986--567999999999758897689098999998528875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=358.01 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=209.9
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCE
Q ss_conf 17899883543476899999968------987699999334568992238999999999852787750015527873991
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
++|+..+.||+|+||+||+|+.+ +++.||||++.. .......+.|.+|+.++++++||||++++++|.+...
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~--~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT--TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECH--HCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf 89388679820788399999988876577882999999882--1085799999999999996689976552466605980
Q ss_pred EEEEEEECCCCCHHHHHHCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCC
Q ss_conf 79999935788734353015-----------------------7679999999999999999999982899994970899
Q 001426 832 RLLLFDYISNGSLAGLLHEK-----------------------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIK 888 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 888 (1079)
.++++||+++|+|.+++... ...+++..+..++.|++.|++|+|+. +++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEEC
T ss_conf 389998158992999998527554210000111001210346788989999999999999985541357---86854884
Q ss_pred CCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCC
Q ss_conf 9976877999589940234422467765446566666766345334377887851017889999999992999-999999
Q 001426 889 SNNILVGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKE-PTDSRI 967 (1079)
Q Consensus 889 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~-p~~~~~ 967 (1079)
|+||+++.++.+||+|||+|+...............|++.|+|||...+..++.++||||||+++|||++|.. ||...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~- 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred CCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCC-
T ss_conf 0116898999289833144211367764111577776767679899726889805630252362999980689999998-
Q ss_pred CCCCHHHHHHHHHHHHHHHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 9952278998768754210010111223210257319999999999972139999999998999999995010
Q 001426 968 PDGAHIITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 968 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~ 1040 (1079)
...........+. .... .. ..+..+.+++..||+.+|++||||.||+++|++++.
T Consensus 247 ~~~e~~~~v~~~~----~~~~------------p~--~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 247 AHEEVIYYVRDGN----ILAC------------PE--NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp CHHHHHHHHHTTC----CCCC------------CT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHCCC----CCCC------------CC--CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 9999999997399----7888------------73--252999999999748896579399999999998429
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.97 Aligned_cols=254 Identities=20% Similarity=0.314 Sum_probs=202.6
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC--CCEEEE
Q ss_conf 17899883543476899999968-987699999334568992238999999999852787750015527873--991799
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN--GRTRLL 834 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 834 (1079)
++|++.+.||+|+||+||+|+.+ +++.||+|.+..... .....+.+.+|++++++++|||||++++++.+ ....|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 337996798308891999999999997999999874657-9799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 99935788734353015---7679999999999999999999982899--994970899997687799958994023442
Q 001426 835 LFDYISNGSLAGLLHEK---KVFLDWDSRYKIILGVAHGLAYLHHDCV--PPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 835 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~--~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 909 (1079)
||||+++|+|.+++.+. ...+++..++.++.|++.|+.|||+.+. .+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHH
Q ss_conf 24677654465666667663453343778878510178899999999929999999999952278998768754210010
Q 001426 910 LFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 910 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
.+.... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ..+...+ .......+
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i---~~~~~~~~- 234 (269)
T d2java1 163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKI---REGKFRRI- 234 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH---HHTCCCCC-
T ss_pred ECCCCC--CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH--HHHHHHH---HCCCCCCC-
T ss_conf 224577--755667788232799998399999389887527899998018899899899--9999999---71899889-
Q ss_pred HHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 11122321025731999999999997213999999999899999
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
.. .....+.+++.+||+.||++|||++|+++
T Consensus 235 -----------~~--~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 -----------PY--RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----------CT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------CC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -----------74--35999999999976799557918999972
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.27 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=207.9
Q ss_pred CCCCCCEEEECCCEEEEEEEEC-CCC----EEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 7899883543476899999968-987----69999933456899223899999999985278775001552787399179
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQ----VIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 759 ~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
+|+..++||+|+||+||+|... +++ .||+|++... ......+.|.+|++++++++|||||+++|+|.++ ..+
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEE
T ss_conf 9978319820899299999995899889899999996513--4979999999999999867998881589999619-836
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99993578873435301576799999999999999999999828999949708999976877999589940234422467
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 913 (1079)
+++|++.+|+|.+++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+.+..
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 99984268740101113345799999999999999999999876---950476212031167998758602552223354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHH
Q ss_conf 765446566666766345334377887851017889999999992-9999999999952278998768754210010111
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
...........||+.|+|||++.+..++.++||||||+++|||+| |..||..... ..+...+....+ .
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~~~~---~------ 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGER---L------ 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHHTCC---C------
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHCCCC---C------
T ss_conf 44532236510586446708874699983565440799999999779999999998--999999975998---9------
Q ss_pred HHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 223210257319999999999972139999999998999999995010
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~ 1040 (1079)
.... .....+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 233 ------~~p~--~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 ------PQPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ------CCCT--TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------9985--568999999998478993469199999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.08 Aligned_cols=259 Identities=26% Similarity=0.397 Sum_probs=209.8
Q ss_pred HCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 17899883543476899999968987699999334568992238999999999852787750015527873991799999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|++.+.||+|+||.||+|..+++..||+|++... ....+.|.+|+.++++++|+|||+++|++.+ +..++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC----CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEE
T ss_conf 997984699307980999999999999999998804----4888999999999986666788689999823-97599999
Q ss_pred ECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 35788734353015-76799999999999999999999828999949708999976877999589940234422467765
Q 001426 838 YISNGSLAGLLHEK-KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 916 (1079)
|+++|++.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+|+.+....
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC-
T ss_conf 44799435420000355305999999999999999987541---14335312307999899929984425554256887-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHHH
Q ss_conf 44656666676634533437788785101788999999999299999999999522789987687542100101112232
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
........|++.|+|||+.....++.++||||||+++|||++|+.|+....... .....+.. .....
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i~~---~~~~~--------- 234 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER---GYRMP--------- 234 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHT---TCCCC---------
T ss_pred CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHH-HHHHHHHH---CCCCC---------
T ss_conf 335245455665458089837998917741323589999986899999888899-99999982---68999---------
Q ss_pred HCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 10257319999999999972139999999998999999995010289
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEND 1043 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~~~ 1043 (1079)
... .....+.+++.+||+.||++||+|++|+++|++......
T Consensus 235 ---~~~--~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 235 ---CPP--ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp ---CCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ---CCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf ---983--237999999999756697589199999998766623899
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=359.47 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=205.0
Q ss_pred HHHHHCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf 888617899883543476899999968-9876999993345689922389999999998527877500155278739917
Q 001426 754 DDVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTR 832 (1079)
Q Consensus 754 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 832 (1079)
+++.+.|+..+.||+|+||+||+|+.+ +++.||+|++.+.... .....+.+|+.++++++|||||++++++.+++..
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 87766669988994065839999999999989999998157731--2899999999999867998999198999989988
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC---CCCCEEEEECCCCC
Q ss_conf 999993578873435301576799999999999999999999828999949708999976877---99958994023442
Q 001426 833 LLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVG---PQFEAFLADFGLAK 909 (1079)
Q Consensus 833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~ 909 (1079)
|+||||+++|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||++. +++.+||+|||+|+
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEEEECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEE
T ss_conf 89885268984888653036-788789999999999998752413---05568704630011046888249983154358
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHH
Q ss_conf 24677654465666667663453343778878510178899999999929999999999952278998768754210010
Q 001426 910 LFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 910 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ........+. ..+.
T Consensus 159 ~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~-----~~~~ 229 (307)
T d1a06a_ 159 MEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAE-----YEFD 229 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHTTC-----CCCC
T ss_pred ECCCCC---EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHCCC-----CCCC
T ss_conf 725897---044003284225918873799980787345159999998597999998999-9999986168-----7778
Q ss_pred HHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 111223210257319999999999972139999999998999999
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~ 1034 (1079)
....+ .....+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~----------~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 SPYWD----------DISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTT----------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCC----------CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 76666----------789999999999760897579189998629
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.35 Aligned_cols=250 Identities=21% Similarity=0.228 Sum_probs=204.6
Q ss_pred HCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 1789988354347689999996-898769999933456899223899999999985278775001552787399179999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|++.+.||+|+||.||+|+. .+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 93578873435301576799999999999999999999828999949708999976877999589940234422467765
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 916 (1079)
||+++|+|.+++.+.+. +++..+..++.|++.|++|+|++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp ECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred ECCCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCC-
T ss_conf 03579860555532567-75999999999996521134315---96224647778476589988882056520035678-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHHH
Q ss_conf 44656666676634533437788785101788999999999299999999999522789987687542100101112232
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.......||+.|+|||+..+..++.++||||+||++|||++|+.||..... ..+.. .. ......+..
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~---~i-~~~~~~~p~------ 226 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFE---LI-LMEEIRFPR------ 226 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HH-HHCCCCCCT------
T ss_pred -CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH--HHHHH---HH-HCCCCCCCC------
T ss_conf -620551008899666650489888333102230678899878999999699--99999---98-528998986------
Q ss_pred HCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 1025731999999999997213999999999-----899999
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERPT-----MKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~eil~ 1033 (1079)
.....+.+++.+|++.||++||+ +.|+++
T Consensus 227 --------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 --------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf --------6899999999866638934422565234999972
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.63 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=208.7
Q ss_pred CCEEEECCCEEEEEEEECCC----CEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-CCEEEEEEE
Q ss_conf 88354347689999996898----7699999334568992238999999999852787750015527873-991799999
Q 001426 763 TNIVGKGVSGIVYRVEIPSR----QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN-GRTRLLLFD 837 (1079)
Q Consensus 763 ~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 837 (1079)
.++||+|+||+||+|....+ ..||||++.+ .......+.|.+|++++++++||||++++|++.+ +...++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf 6698136880999999977998799999999884--36978999999999999867899986786789806994389998
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 35788734353015767999999999999999999998289999497089999768779995899402344224677654
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 917 (1079)
|+++|+|.+++.......++..+..++.|++.|+.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 7406741442101345404899999999988765200336---7625776687576779998899106523225566555
Q ss_pred --CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHH
Q ss_conf --465666667663453343778878510178899999999929999999999952278998768754210010111223
Q 001426 918 --RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 918 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......||+.|+|||...+..++.++||||||+++|||++|+.||...............+.. .. .+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~----~~-----~p- 256 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----LL-----QP- 256 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC----CC-----CC-
T ss_pred CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC----CC-----CC-
T ss_conf 310025655564556768874379997457466199999999789999888999999999980898----89-----96-
Q ss_pred HHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 2102573199999999999721399999999989999999950102899
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDD 1044 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~~~~ 1044 (1079)
. .....+.+++.+||+.||++||+|.||++.|+.+......
T Consensus 257 ------~--~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 257 ------E--YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp ------T--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ------C--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf ------4--4759999999997688976893999999999999975201
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.43 Aligned_cols=255 Identities=21% Similarity=0.275 Sum_probs=205.4
Q ss_pred HHHCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCC---CHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCE
Q ss_conf 8617899883543476899999968-98769999933456899---2238999999999852787750015527873991
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGE---LPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 756 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
+.++|++.+.||+|+||+||+|..+ +++.||+|++.+..... ....+.+.+|+.++++++|||||++++++.+...
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC----CEEEEECCC
Q ss_conf 7999993578873435301576799999999999999999999828999949708999976877999----589940234
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF----EAFLADFGL 907 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgl 907 (1079)
.|+||||+++|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+|++|||+
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEECCCCCCCCCHHCCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf 999998677864310010356-421557899999999998766625---4221133301279825898666469643344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 42246776544656666676634533437788785101788999999999299999999999522789987687542100
Q 001426 908 AKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 908 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
|+...... ......|++.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+...... ...
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~-----~~~ 234 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAV-----NYE 234 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHTT-----CCC
T ss_pred HHHCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHHC-----CCC
T ss_conf 21057776---312247777430999981899997665221409999997088998899999-999999816-----888
Q ss_pred HHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 1011122321025731999999999997213999999999899999
Q 001426 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
+.....+ .....+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~----------~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FEDEYFS----------NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCHHHHT----------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHCC----------CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8701047----------88999999999986389668919999961
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.02 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=194.0
Q ss_pred CCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC----CCEEEEE
Q ss_conf 99883543476899999968-987699999334568992238999999999852787750015527873----9917999
Q 001426 761 SDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN----GRTRLLL 835 (1079)
Q Consensus 761 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 835 (1079)
+..+.||+|+||+||+|... ++..||+|++.... ......+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 85169700828499999999999599999985122-79899999999999998579998506999984033458889999
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEEECCCCCCEEEC-CCCCEEEEECCCCCCCC
Q ss_conf 9935788734353015767999999999999999999998289999--49708999976877-99958994023442246
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPP--IIHRDIKSNNILVG-PQFEAFLADFGLAKLFE 912 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~ 912 (1079)
|||+++|+|.+++.+.. .+++..+..++.|++.|++|||++ + |+||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf 95789894899975135-546999999999999999999978---99799687674351166799988980057654236
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHH
Q ss_conf 77654465666667663453343778878510178899999999929999999999952278998768754210010111
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
.. ......||+.|+|||+..+ .++.++||||+||++|||++|+.||...............+ ..+..+...
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~---~~~~~~~~~- 237 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG---VKPASFDKV- 237 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT---CCCGGGGGC-
T ss_pred CC----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC---CCCCCCCCC-
T ss_conf 87----6677553813008988478-99986711007999999987889998765599999999738---998656755-
Q ss_pred HHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 22321025731999999999997213999999999899999
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
....+.+++.+||++||++|||++|+++
T Consensus 238 -------------~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 238 -------------AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -------------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------------CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -------------7899999999976379758929999967
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.78 Aligned_cols=263 Identities=28% Similarity=0.440 Sum_probs=213.6
Q ss_pred HCCCCCCEEEECCCEEEEEEEE------CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCC
Q ss_conf 1789988354347689999996------89876999993345689922389999999998527-8775001552787399
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI------PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGR 830 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 830 (1079)
++|+..+.||+|+||.||+|+. ..++.||||++.+. ........+.+|+.+++.+ +|||||+++++|.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 996985498206882999999806644778869999998742--487799999999999876269998878998983199
Q ss_pred EEEEEEEECCCCCHHHHHHCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEE
Q ss_conf 1799999357887343530157-----------------67999999999999999999998289999497089999768
Q 001426 831 TRLLLFDYISNGSLAGLLHEKK-----------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNIL 893 (1079)
Q Consensus 831 ~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIl 893 (1079)
..++||||+++|+|.++++... ..+++..+..++.||+.|++|||++ +++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCC
T ss_conf 7899997379987999998535665444445332223345889999999999999999988757---9266624102100
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 77999589940234422467765446566666766345334377887851017889999999992999999999995227
Q 001426 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHI 973 (1079)
Q Consensus 894 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~ 973 (1079)
++.++.+|++|||.++...............||+.|+|||+..+..++.++||||||+++|||++++.|+.........+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 00257521023401023367886158620135968767788617999974001025899999985899887789989999
Q ss_pred HHHHHHHHHHHHHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 899876875421001011122321025731999999999997213999999999899999999501028
Q 001426 974 ITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~~ 1042 (1079)
...+....+. .... .....+.+++.+||++||++||||+|++++|++...+.
T Consensus 258 ~~~i~~~~~~---------------~~~~--~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 258 YKMIKEGFRM---------------LSPE--HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp HHHHHHTCCC---------------CCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHCCCCC---------------CCCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 9998668988---------------9854--36599999999975779657929999999998765349
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.16 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=206.3
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECC-
Q ss_conf 17899883543476899999968------9876999993345689922389999999998527-877500155278739-
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNG- 829 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 829 (1079)
++|+..+.||+|+||.||+|... +++.||+|++.. .......+.+..|...+.++ +|+||+.+++++.+.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE--GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECC--CCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCC
T ss_conf 99798449841678399999986777555783999999860--0171789999999999886149984997411540479
Q ss_pred CEEEEEEEECCCCCHHHHHHCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEE
Q ss_conf 91799999357887343530157---------------679999999999999999999982899994970899997687
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILV 894 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll 894 (1079)
...++||||+++|+|.++++... ..+++..+..++.|++.|+.|||++ +|+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEE
T ss_conf 757999984589929999985366666532220233214689999999999999999988737---97178677310657
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCCCCHH
Q ss_conf 7999589940234422467765446566666766345334377887851017889999999992999-999999995227
Q 001426 895 GPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKE-PTDSRIPDGAHI 973 (1079)
Q Consensus 895 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~-p~~~~~~~~~~~ 973 (1079)
+.++.+||+|||+|+...............||+.|+|||+..+..++.++||||||+++|||+++.. ||..... ...+
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~~~~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEF 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHHH
T ss_pred CCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCH-HHHH
T ss_conf 799828984575200113566522247516672102036864688996632213678999998688999989998-9999
Q ss_pred HHHHHHHHHHHHHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 899876875421001011122321025731999999999997213999999999899999999501028
Q 001426 974 ITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~~ 1042 (1079)
...+.... ...... .....+.+++.+||+.||++|||++|+++.|+++.+.+
T Consensus 247 ~~~~~~~~---~~~~~~--------------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 247 CRRLKEGT---RMRAPD--------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHHHHHTC---CCCCCT--------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHCCC---CCCCCC--------------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 99996389---888886--------------57899999999976779667919999999997998677
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=348.01 Aligned_cols=247 Identities=20% Similarity=0.235 Sum_probs=203.2
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 17899883543476899999968-98769999933456899223899999999985278775001552787399179999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|++.+.||+|+||.||+|+.+ +++.||+|++.+.........+.+.+|+.+++.++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 93578873435301576799999999999999999999828999949708999976877999589940234422467765
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 916 (1079)
||+.+|+|.+++.+.+. +++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred CCCCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC--
T ss_conf 23346622666751589-89999999999999989999859---9861767999936077897886101033322566--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHHH
Q ss_conf 44656666676634533437788785101788999999999299999999999522789987687542100101112232
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||....+ ..... .. .........
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~---~i-~~~~~~~p~------ 259 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYE---KI-VSGKVRFPS------ 259 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HH-HHCCCCCCT------
T ss_pred ---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH--HHHHH---HH-HCCCCCCCC------
T ss_conf ---6433676356788997179988533114500789999758899899599--99999---98-617988976------
Q ss_pred HCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 102573199999999999721399999999-----9899999
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTA 1033 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~eil~ 1033 (1079)
.....+.+++.+|++.||++|+ |++++++
T Consensus 260 --------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 --------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf --------6899999999998340998606553454999971
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=346.86 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=202.5
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 17899883543476899999968-98769999933456899223899999999985278775001552787399179999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+.........+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 93578873435301576799999999999999999999828999949708999976877999589940234422467765
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 916 (1079)
||++||++..++..... +++..+..++.|++.|++|+|++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EECCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECCC--
T ss_conf 50378632234322221-11007999999998765541247---6770556810503868998898317521671245--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHHH
Q ss_conf 44656666676634533437788785101788999999999299999999999522789987687542100101112232
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQL 996 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1079)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........+ ...+..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~-----~~~~p~------ 222 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNA-----ELRFPP------ 222 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHC-----CCCCCT------
T ss_pred ---CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHH-HHHHHHHCC-----CCCCCC------
T ss_conf ---64345763435999983899980430465333689997598999996999-999999708-----988997------
Q ss_pred HCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 102573199999999999721399999999-----98999999
Q 001426 997 LMRSGTQIQEMLQVLGVALLCVNPCPEERP-----TMKDVTAM 1034 (1079)
Q Consensus 997 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~eil~~ 1034 (1079)
.....+.+++.+|++.||.+|+ |++++++.
T Consensus 223 --------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 223 --------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf --------78999999999995449976664310219999819
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=347.61 Aligned_cols=251 Identities=19% Similarity=0.212 Sum_probs=196.8
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHH---HHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 17899883543476899999968-987699999334568992238999---99999985278775001552787399179
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQF---SAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
++|++.+.||+|+||.||+|+.. +++.||+|++.+...........+ ..|+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99993578873435301576799999999999999999999828999949708999976877999589940234422467
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 913 (1079)
+||||+++|+|.+++.+... +++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEECCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEECCC
T ss_conf 99991489838999873255-32789999999999999999977---962204442216785889679822010233378
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHH
Q ss_conf 765446566666766345334377-8878510178899999999929999999999952278998768754210010111
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
.. .....||+.|+|||++.. ..++.++||||+||++|||++|+.||........ .......... ...+.
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~~-~~~~~--- 229 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTM-AVELP--- 229 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSSC-CCCCC---
T ss_pred CC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHCCCC-CCCCC---
T ss_conf 86----43311345542168760389998441046778999999859998888998999--9999860468-88788---
Q ss_pred HHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 22321025731999999999997213999999999-----899999
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPT-----MKDVTA 1033 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~eil~ 1033 (1079)
. .....+.+++.+||+.||++||| ++|+++
T Consensus 230 ---------~--~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 ---------D--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---------S--SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---------C--CCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf ---------7--7899999999998566988808874357999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.04 Aligned_cols=253 Identities=19% Similarity=0.244 Sum_probs=204.7
Q ss_pred HHHHCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 88617899883543476899999968-98769999933456899223899999999985278775001552787399179
Q 001426 755 DVVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 755 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
++.++|++.+.||+|+||+||+|... +++.||+|.+... ......+.+|+++++.++|||||++++++.+++..|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf 8701058878983177839999999899969999997578----665999999999998579979890989998899889
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCC--CCEEEEECCCCCCC
Q ss_conf 9999357887343530157679999999999999999999982899994970899997687799--95899402344224
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ--FEAFLADFGLAKLF 911 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~~ 911 (1079)
+|||||++|+|.+++...+..+++..+..++.|++.|+.|||+. +|+||||||+||+++.+ ..+|++|||+++..
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCC
T ss_conf 99953899808899875389999999999999999999999876---997513554443443788518997644111003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHH
Q ss_conf 67765446566666766345334377887851017889999999992999999999995227899876875421001011
Q 001426 912 ESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 912 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
.... ......+++.|+|||...+..++.++||||+||++|||++|+.||...... ..+.....+. ..+...
T Consensus 155 ~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~i~~~~-----~~~~~~ 225 (321)
T d1tkia_ 155 KPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAE-----YTFDEE 225 (321)
T ss_dssp CTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTC-----CCCCHH
T ss_pred CCCC---CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCC-----CCCCHH
T ss_conf 4677---532122332223402104877784011302799999998289999998999-9999998389-----998802
Q ss_pred HHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 122321025731999999999997213999999999899999
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
..+ .....+.+++.+|+..||++|||++|+++
T Consensus 226 ~~~----------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFK----------EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHT----------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HCC----------CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 236----------78999999999986699668909999963
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.50 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=205.8
Q ss_pred HCCCCCCEEEECCCEEEEEEEECC-CC--EEEEEEECCCCCCCCHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCCEEE
Q ss_conf 178998835434768999999689-87--6999993345689922389999999998527-8775001552787399179
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS-RQ--VIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 833 (1079)
++|+..+.||+|+||+||+|..++ +. .||||++.... .....+.|.+|+++++++ +|||||+++|++.+++..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
T ss_conf 9968877982078828999999899969999999978233--85799999999999986228998836788884187369
Q ss_pred EEEEECCCCCHHHHHHCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC
Q ss_conf 999935788734353015---------------76799999999999999999999828999949708999976877999
Q 001426 834 LLFDYISNGSLAGLLHEK---------------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF 898 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~ 898 (1079)
+||||+++|+|.++++.. ...+++..+..++.|++.|+.|+|+. +|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCC
T ss_conf 99980289869999864035555512310123457899999999999999998766308---954555052048986887
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCCCCHHHHHH
Q ss_conf 589940234422467765446566666766345334377887851017889999999992999-9999999952278998
Q 001426 899 EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKE-PTDSRIPDGAHIITWV 977 (1079)
Q Consensus 899 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~-p~~~~~~~~~~~~~~~ 977 (1079)
.+||+|||+|+...... ......||..|+|||...+..++.++||||||+++|||++|.. ||.... ...+...+
T Consensus 165 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i 239 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKL 239 (309)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHG
T ss_pred CEEECCCCCCCCCCCCC---CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC--HHHHHHHH
T ss_conf 63874344322444223---45530137755553875269999622153138899999836899999999--99999999
Q ss_pred HHHHHHHHHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 76875421001011122321025731999999999997213999999999899999999501028999
Q 001426 978 NGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHENDDL 1045 (1079)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~~~~~ 1045 (1079)
.. ..... ... .....+.+++.+||+.||++||||.|+++.|+++.++....
T Consensus 240 ~~---~~~~~------------~~~--~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~ 290 (309)
T d1fvra_ 240 PQ---GYRLE------------KPL--NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290 (309)
T ss_dssp GG---TCCCC------------CCT--TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred HH---CCCCC------------CCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCCC
T ss_conf 82---68888------------876--67899999999976789668949999999999998618677
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.63 Aligned_cols=258 Identities=25% Similarity=0.349 Sum_probs=207.7
Q ss_pred HCCCCCCEEEECCCEEEEEEEECC----CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 178998835434768999999689----8769999933456899223899999999985278775001552787399179
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS----RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
++|+..+.||+|+||.||+|.... +..||+|.+.. .......+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT--TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEE
T ss_conf 996987799307882999999936996449999999365--6687999999999999986899998569889953-7479
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99993578873435301576799999999999999999999828999949708999976877999589940234422467
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 913 (1079)
+||||+++|++.+++......+++..+..++.|+++|+.|+|+. +++||||||+||+++.++.+||+|||+|+.+..
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 99984069807765422478999999999999998775230226---744141026553206789678765034213367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHH
Q ss_conf 765446566666766345334377887851017889999999992-9999999999952278998768754210010111
Q 001426 914 SESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTIL 992 (1079)
Q Consensus 914 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1079)
.. ........||+.|+|||+..+..++.++||||||+++|||++ |..||...... .+...+.. ......
T Consensus 161 ~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~---~~~~~~---- 230 (273)
T d1mp8a_ 161 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIEN---GERLPM---- 230 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT---TCCCCC----
T ss_pred CC-CEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH--HHHHHHHC---CCCCCC----
T ss_conf 76-233054005831032667516998874524442478999982699998889999--99999981---899989----
Q ss_pred HHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 2232102573199999999999721399999999989999999950102
Q 001426 993 DRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 993 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~ 1041 (1079)
.. .....+.+++..||+.||++|||+.|+++.|+.+.++
T Consensus 231 --------~~--~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 231 --------PP--NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --------87--7799999999997687976892999999999999778
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.63 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=207.7
Q ss_pred HCCCCCCEEEECCCEEEEEEEECC--C--CEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 178998835434768999999689--8--769999933456899223899999999985278775001552787399179
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS--R--QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 833 (1079)
++|+..+.||+|+||.||+|+... + ..||+|++.+.........+.|.+|+.++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99993578873435301576799999999999999999999828999949708999976877999589940234422467
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFES 913 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 913 (1079)
+||||+++|++.+++......+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.+|++|||+++.+..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred EEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHHCCC
T ss_conf 14654238612544421268999999999999999999875217---875205668881565565433256115553035
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHH
Q ss_conf 765-446566666766345334377887851017889999999992-999999999995227899876875421001011
Q 001426 914 SES-SRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTI 991 (1079)
Q Consensus 914 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1079)
... ........|+..|+|||...+..++.++||||||+++|||++ |+.||..... ......+. ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--~~~~~~i~---~~~~------ 232 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILHKID---KEGE------ 232 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHH---TSCC------
T ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHH---HCCC------
T ss_conf 887526547632573107999983799994215661489999999689999999699--99999998---4799------
Q ss_pred HHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 12232102573199999999999721399999999989999999950
Q 001426 992 LDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEI 1038 (1079)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~ 1038 (1079)
...... .....+.+++.+||++||++||||+|+.+.|++.
T Consensus 233 -----~~~~~~--~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 -----RLPRPE--DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf -----999854--4539999999997688966792999999999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.09 Aligned_cols=259 Identities=22% Similarity=0.366 Sum_probs=208.7
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCE
Q ss_conf 17899883543476899999968------987699999334568992238999999999852787750015527873991
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP------SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 831 (1079)
++|+..+.||+|+||+||+|... .++.||||++.+ .........|.+|+.++++++||||+++++++.....
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~--~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE--AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT--TSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 99188359820788189999987864477896899999870--1286899999999999997699988412547842881
Q ss_pred EEEEEEECCCCCHHHHHHCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEE
Q ss_conf 79999935788734353015---------767999999999999999999998289999497089999768779995899
Q 001426 832 RLLLFDYISNGSLAGLLHEK---------KVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFL 902 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 902 (1079)
.++||||+++|+|.+++... ...+++..+..++.|+++|+.|||+. +|+||||||+|||+++++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEEE
T ss_conf 0677760489988999875033211344468879999999999999999987647---9654328677540359964999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCHHHHHHHHHH
Q ss_conf 4023442246776544656666676634533437788785101788999999999299-999999999522789987687
Q 001426 903 ADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGK-EPTDSRIPDGAHIITWVNGEL 981 (1079)
Q Consensus 903 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~ 981 (1079)
+|||+|+.+.............|++.|+|||...+..++.++||||||+++|||++|. .||... .....+.....+.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~~~~~~~i~~~~- 252 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGG- 252 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHHHHHHHHTTC-
T ss_pred EECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHCC-
T ss_conf 42454202357763031340231632378888736998833344437899999996899999998-9999999998088-
Q ss_pred HHHHHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 54210010111223210257319999999999972139999999998999999995010
Q 001426 982 RERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~ 1040 (1079)
... ... .....+.+++.+||+.+|++||||.+++++|++..+
T Consensus 253 ---~~~------------~p~--~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 253 ---LLD------------KPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---CCC------------CCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---CCC------------CCC--CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf ---888------------863--353999999999757796589399999999787617
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=340.16 Aligned_cols=263 Identities=25% Similarity=0.334 Sum_probs=210.5
Q ss_pred HHCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC----E
Q ss_conf 61789988354347689999996-898769999933456899223899999999985278775001552787399----1
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR----T 831 (1079)
Q Consensus 757 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 831 (1079)
.++|++.+.||+|+||.||+|.. .+++.||+|++.+...........+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 79999935788734353015767999999999999999999998289999497089999768779995899402344224
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 911 (1079)
.|+||||+++|+|.+++...+. +++..+..++.|++.|++|||+. +|+||||||+||+++.++..+++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEEHHHHCCCCC-CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHHHHH
T ss_conf 9999977889871011203589-99999999999999999999857---9527634675566575432010034443221
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHH
Q ss_conf 6776-544656666676634533437788785101788999999999299999999999522789987687542100101
Q 001426 912 ESSE-SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTT 990 (1079)
Q Consensus 912 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1079)
.... .........||+.|+|||+..+..++.++||||+|+++|||++|+.||....+. ............ ...
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~~~~~~~~-~~~ 235 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPI-PPS 235 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCC-CGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHCCCC-CCC
T ss_conf 23544333346425762436999983999996632026528999997697998996999-----999999846999-971
Q ss_pred HHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHCC
Q ss_conf 112232102573199999999999721399999999-9899999999501
Q 001426 991 ILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP-TMKDVTAMLKEIR 1039 (1079)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~eil~~L~~~~ 1039 (1079)
...+ .....+.+++.+|++.||++|| |++++.+.|.++.
T Consensus 236 ~~~~----------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 ARHE----------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GTSS----------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHCC----------CCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 0034----------789999999999866797677739999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.66 Aligned_cols=277 Identities=25% Similarity=0.279 Sum_probs=200.9
Q ss_pred HCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC----EEE
Q ss_conf 1789988354347689999996898769999933456899223899999999985278775001552787399----179
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR----TRL 833 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 833 (1079)
++|...+.||+|+||.||+|+. +++.||+|++... .........|+..+..++||||++++++|.+.. ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCC----CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf 6899988982078819999999-9989999998720----0467999999999962799868326889983798604899
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99993578873435301576799999999999999999999828-----9999497089999768779995899402344
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHD-----CVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 908 (1079)
+||||+++|+|.+++++. .++|..++.++.|++.|+.|+|+. +.++|+||||||+|||++.++.+||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 999646698989998658--999899999999999999998876652046898661531731357868877688763866
Q ss_pred CCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 224677654--4656666676634533437788------78510178899999999929999999999952278998768
Q 001426 909 KLFESSESS--RASNSVAGSYGYIAPEYGYSLK------ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGE 980 (1079)
Q Consensus 909 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 980 (1079)
+........ .......||+.|+|||+..+.. ++.++||||||+++|||++|..|+.................
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred CCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC
T ss_conf 23467776200135525035476782210565454677767501220159999999628998876631124101225564
Q ss_pred --H-HHHHHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf --7-5421001011122321025731999999999997213999999999899999999501028
Q 001426 981 --L-RERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEN 1042 (1079)
Q Consensus 981 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~~ 1042 (1079)
. ...........++.... .....+....+.+++.+||+.||++||||.|+++.|+++..+.
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCG-GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 309999998750246888776-5577689999999999976069858959999999999888865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.42 Aligned_cols=259 Identities=26% Similarity=0.397 Sum_probs=209.4
Q ss_pred HCCCCCCEEEECCCEEEEEEEECC--------CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEC
Q ss_conf 178998835434768999999689--------876999993345689922389999999998527-87750015527873
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPS--------RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI-RHKNIVRLLGCCNN 828 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 828 (1079)
++|.+.+.||+|+||.||+|+... +..||+|++.+ .........+.+|...+.++ +|||||+++++|.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT--TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECC--CCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 9969700985167828999998578755566754999999881--12868899999999999981399969734652201
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEE
Q ss_conf 991799999357887343530157---------------67999999999999999999998289999497089999768
Q 001426 829 GRTRLLLFDYISNGSLAGLLHEKK---------------VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNIL 893 (1079)
Q Consensus 829 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIl 893 (1079)
++..++||||+++|+|.+++.... ..+++..+..++.|++.|++|+|+. +|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEE
T ss_conf 8868999973699909999986067764322233457434679999999999999999876637---9786302210224
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCH
Q ss_conf 77999589940234422467765446566666766345334377887851017889999999992-99999999999522
Q 001426 894 VGPQFEAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAH 972 (1079)
Q Consensus 894 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~t-g~~p~~~~~~~~~~ 972 (1079)
++.++.+||+|||.++...............+++.|+|||...+..++.++||||||+++|||++ |..||..... ..
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--~~ 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH--HH
T ss_conf 5478976762211101135555543146678884663266751798882555477588888740179898999999--99
Q ss_pred HHHHHHHHHHHHHHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 78998768754210010111223210257319999999999972139999999998999999995010
Q 001426 973 IITWVNGELRERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRH 1040 (1079)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~ 1040 (1079)
+...+.. ..... ... .....+.+++.+||+.||++||||+|+++.|+.+..
T Consensus 246 ~~~~i~~---~~~~~------------~p~--~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 LFKLLKE---GHRMD------------KPS--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHT---TCCCC------------CCS--SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHC---CCCCC------------CCC--CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9999972---88889------------874--352999999999766797679399999999988860
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.86 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=200.3
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHH-CCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 17899883543476899999968-98769999933456899223899999999985-27877500155278739917999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLG-SIRHKNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 835 (1079)
++|...+.||+|+||+||+|... +++.||+|++.+...........+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99357887343530157679999999999999999999982899994970899997687799958994023442246776
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 915 (1079)
|||+++|+|.+++...+. +++..+..++.||+.|++|||++ +|+||||||+|||+++++.+|++|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEECCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCC
T ss_conf 750379808998640478-99999999999999999999868---93403476540444489963015553023235665
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHHH
Q ss_conf 54465666667663453343778878510178899999999929999999999952278998768754210010111223
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFTTILDRQ 995 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1079)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..+ ..+... .......+..
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~----i~~~~~~~p~----- 224 (320)
T d1xjda_ 158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHS----IRMDNPFYPR----- 224 (320)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHCCCCCCT-----
T ss_pred --CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH----HHCCCCCCCC-----
T ss_conf --334545787776899998279988323201122789898738899999899--999999----9718998975-----
Q ss_pred HHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 2102573199999999999721399999999989-9999
Q 001426 996 LLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMK-DVTA 1033 (1079)
Q Consensus 996 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-eil~ 1033 (1079)
.....+.+++.+||+.||++||++. ++++
T Consensus 225 ---------~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 ---------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---------CCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf ---------679999999999654489878388999980
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.64 Aligned_cols=251 Identities=27% Similarity=0.366 Sum_probs=202.7
Q ss_pred HCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-CCEEEEEE
Q ss_conf 17899883543476899999968987699999334568992238999999999852787750015527873-99179999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN-GRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 836 (1079)
++|+..+.||+|+||.||+|+.+ ++.||+|++... ...+.+.+|++++++++||||++++|+|.+ ....++||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH-----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 99488579820798089999999-909999998857-----779999999999986789898549878872389289999
Q ss_pred EECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 9357887343530157-679999999999999999999982899994970899997687799958994023442246776
Q 001426 837 DYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSE 915 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 915 (1079)
||+++|+|.+++.+.. ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+|++|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCC-
T ss_conf 636999899998745788889999999999998523211337---6553666567601468997763245600344787-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHHCHHHHHHH
Q ss_conf 5446566666766345334377887851017889999999992-999999999995227899876875421001011122
Q 001426 916 SSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLT-GKEPTDSRIPDGAHIITWVNGELRERKREFTTILDR 994 (1079)
Q Consensus 916 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1079)
.....++..|+|||+..+..++.++||||||+++|||++ |+.||.... ...+...+.. ...+.+..
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i~~---~~~~~~~~---- 223 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEK---GYKMDAPD---- 223 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHTT---TCCCCCCT----
T ss_pred ----CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHC---CCCCCCCC----
T ss_conf ----7655666467781787279888588777579999999978999999999--9999999980---89999976----
Q ss_pred HHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 32102573199999999999721399999999989999999950102
Q 001426 995 QLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 995 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~ 1041 (1079)
.....+.+++.+||+.||++||||.+++++|++++..
T Consensus 224 ----------~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 224 ----------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ----------5799999999997566976893999999999999867
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.87 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=197.9
Q ss_pred HHHHHCCCCC-CEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHC-CCCCCEEEEEEEEEC--
Q ss_conf 8886178998-8354347689999996-8987699999334568992238999999999852-787750015527873--
Q 001426 754 DDVVTRLSDT-NIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGS-IRHKNIVRLLGCCNN-- 828 (1079)
Q Consensus 754 ~~~~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-- 828 (1079)
..+.++|.+. ++||+|+||+||+|.. .+++.||+|++.. ...+.+|+.++.+ .+|||||++++++.+
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CCCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC--------CHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
T ss_conf 97014879810796545486999999889998999999897--------4779999999998669999782989995034
Q ss_pred --CCEEEEEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC---CCCEEE
Q ss_conf --991799999357887343530157-67999999999999999999998289999497089999768779---995899
Q 001426 829 --GRTRLLLFDYISNGSLAGLLHEKK-VFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP---QFEAFL 902 (1079)
Q Consensus 829 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl 902 (1079)
+...|+|||||+||+|.+++.+.+ ..+++..+..++.|++.|++|||+. +|+||||||+||+++. .+.+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 6897899999778998499999862787757999999999999999999976---9864441002201135555663113
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 40234422467765446566666766345334377887851017889999999992999999999995227899876875
Q 001426 903 ADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR 982 (1079)
Q Consensus 903 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 982 (1079)
+|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+...... .........
T Consensus 156 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~ 230 (335)
T d2ozaa1 156 TDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIR 230 (335)
T ss_dssp CCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCC
T ss_pred CCCCEEEECCCCC---CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH--HHHHHHHHH
T ss_conf 5455123336888---64322677563792777489888888887645167788658899889887788--999999985
Q ss_pred HHHHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 4210010111223210257319999999999972139999999998999999
Q 001426 983 ERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~ 1034 (1079)
.....+ ...........+.+++.+|++.||++|||+.|+++.
T Consensus 231 ~~~~~~----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 231 MGQYEF----------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCSSSC----------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCC----------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 388888----------985434699999999999756996579099999709
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=336.96 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=202.7
Q ss_pred HHCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCH------HHHHHHHHHHHHHCCC-CCCEEEEEEEEEC
Q ss_conf 61789988354347689999996-89876999993345689922------3899999999985278-7750015527873
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELP------ERDQFSAEVQTLGSIR-HKNIVRLLGCCNN 828 (1079)
Q Consensus 757 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 828 (1079)
.++|+..+.||+|+||+||+|+. .+++.||+|++.+....... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99179999935788734353015767999999999999999999998289999497089999768779995899402344
Q 001426 829 GRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908 (1079)
Q Consensus 829 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 908 (1079)
++..|+||||+++|+|.+++...+ .+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCHHE
T ss_conf 760599997689866899998659-999999999999999999999875---9943234625489868998387124031
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 2246776544656666676634533437------7887851017889999999992999999999995227899876875
Q 001426 909 KLFESSESSRASNSVAGSYGYIAPEYGY------SLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR 982 (1079)
Q Consensus 909 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 982 (1079)
+.+.... ......||+.|+|||+.. ...++.++||||+|+++|||++|+.||....+. ........+..
T Consensus 158 ~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-~~~~~i~~~~~- 232 (277)
T d1phka_ 158 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGNY- 232 (277)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC-
T ss_pred EECCCCC---CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHH-HHHHHHHHCCC-
T ss_conf 6726887---213452467888988860534456788992331856560231032288898899999-99999981898-
Q ss_pred HHHHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 421001011122321025731999999999997213999999999899999
Q 001426 983 ERKREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
.... .........+.+++.+||+++|++|||++|+++
T Consensus 233 ----~~~~----------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 ----QFGS----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ----CCCT----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----CCCC----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ----8898----------543468999999999976589668919999973
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.30 Aligned_cols=264 Identities=23% Similarity=0.260 Sum_probs=196.7
Q ss_pred CCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCH--HHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf 883543476899999968-9876999993345689922--3899999999985278775001552787399179999935
Q 001426 763 TNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELP--ERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFDYI 839 (1079)
Q Consensus 763 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 839 (1079)
.++||+|+||+||+|..+ +++.||+|++......... ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 78873435301576799999999999999999999828999949708999976877999589940234422467765446
Q 001426 840 SNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESSRA 919 (1079)
Q Consensus 840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 919 (1079)
.++++..+... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.|+...... ..
T Consensus 83 ~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RA 156 (299)
T ss_dssp SEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CC
T ss_pred CCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC--CC
T ss_conf 45077655412-66778999999999999999886316---35503577625885377841146576100057875--54
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH---HHHHCHHHHHHHH
Q ss_conf 5666667663453343778-87851017889999999992999999999995227899876875---4210010111223
Q 001426 920 SNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR---ERKREFTTILDRQ 995 (1079)
Q Consensus 920 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 995 (1079)
.....||+.|+|||+.... .++.++||||+||++|||++|..||....+. ..+......... ..+..........
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHH-HHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf 330204733363999726778880564363042899998596999999999-9999999851899725452100021344
Q ss_pred H-HCCCCCCHH-----HHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 2-102573199-----9999999997213999999999899999
Q 001426 996 L-LMRSGTQIQ-----EMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 996 ~-~~~~~~~~~-----~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
. ......... ....+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 30347898867856568999999999976389456908999967
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.82 Aligned_cols=270 Identities=20% Similarity=0.246 Sum_probs=202.0
Q ss_pred HCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 1789988354347689999996-898769999933456899223899999999985278775001552787399179999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|++.+.||+|+||+||+|.. .+++.||+|++.... ........+.+|++++++++|||||++++++.+....|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 99776517723768099999999999799999980222-57589999999999998679983887445332243203788
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 93578873435301576799999999999999999999828999949708999976877999589940234422467765
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 916 (1079)
||+.++.+..........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.|+......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred EECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCCC-
T ss_conf 62377445554420256888899999999999999986528---89921357114011346762103578613436886-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH---HHHCHHHHH
Q ss_conf 44656666676634533437788-78510178899999999929999999999952278998768754---210010111
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLK-ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE---RKREFTTIL 992 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 992 (1079)
.......|++.|+|||...... ++.++||||+|+++|+|++|+.||...... ..+.......... .+.......
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHH-HHHHHHHHHCCCCCHHHCCCCCCCC
T ss_conf -41001036521541122136657774221033331342796687998988999-9999999832898333144422242
Q ss_pred HH--HHHCCCCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 22--3210257319-----999999999972139999999998999999
Q 001426 993 DR--QLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 993 ~~--~~~~~~~~~~-----~~~~~l~~l~~~cl~~~P~~RPt~~eil~~ 1034 (1079)
+. .......... .....+.+++.+|++.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1243454322220444166789999999999763995579189999678
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.34 Aligned_cols=274 Identities=20% Similarity=0.252 Sum_probs=199.3
Q ss_pred HHCCCCCCEEEECCCEEEEEEEEC-C-CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCC---CCCCEEEEEEEEEC---
Q ss_conf 617899883543476899999968-9-876999993345689922389999999998527---87750015527873---
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-S-RQVIAVKKLWPVKNGELPERDQFSAEVQTLGSI---RHKNIVRLLGCCNN--- 828 (1079)
Q Consensus 757 ~~~~~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 828 (1079)
.++|++.+.||+|+||+||+|+.. + ++.||+|++....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 5897988899215586999999988899899999980232451-679999999999998742589880236632214666
Q ss_pred --CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECC
Q ss_conf --991799999357887343530157679999999999999999999982899994970899997687799958994023
Q 001426 829 --GRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFG 906 (1079)
Q Consensus 829 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 906 (1079)
....++++||+.++.+..........+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEECCHH
T ss_conf 667469999974058714444430378999899999999999999999758---89835798627898589975421000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH---H
Q ss_conf 4422467765446566666766345334377887851017889999999992999999999995227899876875---4
Q 001426 907 LAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR---E 983 (1079)
Q Consensus 907 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~ 983 (1079)
.++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....+. ..+......... .
T Consensus 162 ~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred HHHHHCCC---CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHHCCCCHH
T ss_conf 10110023---4577765485114831001798881110003289999998787998998989-9999999840799611
Q ss_pred HHHCHHHHHHHHHHCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHC
Q ss_conf 21001011122321025731-----9999999999972139999999998999999--9950
Q 001426 984 RKREFTTILDRQLLMRSGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTAM--LKEI 1038 (1079)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~--L~~~ 1038 (1079)
.++................. ......+.+++.+|++.||++|||++|+++. ++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 05321111033302234564544044589999999999874896679189999669634075
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.27 Aligned_cols=279 Identities=20% Similarity=0.299 Sum_probs=203.4
Q ss_pred HHCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC----E
Q ss_conf 61789988354347689999996-898769999933456899223899999999985278775001552787399----1
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR----T 831 (1079)
Q Consensus 757 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 831 (1079)
..+|++.+.||+|+||+||+|.. .+++.||||++.+. ......+.+.+|+.+++.++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHH--CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 89859978994064809999999999949999998031--0958999999999999976898988588899505645541
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 79999935788734353015767999999999999999999998289999497089999768779995899402344224
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 911 (1079)
.+++++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|...
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEECCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 49999962598656644058--999999999999999999999978---9867778764378879997787545705650
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-H
Q ss_conf 67765-446566666766345334377-88785101788999999999299999999999522789987687542100-1
Q 001426 912 ESSES-SRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE-F 988 (1079)
Q Consensus 912 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 988 (1079)
..... ........|++.|+|||+... ..++.++||||+|+++|||++|+.||......+. .............. .
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQEDL 237 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHH
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHH--HHHHHHHCCCCCHHHH
T ss_conf 47776410101102652000387860478887410100467013377669799788888999--9987652069975664
Q ss_pred HH-----HHHHH--HHCCCCCCHHH-----HHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHCCCCCCC
Q ss_conf 01-----11223--21025731999-----9999999972139999999998999999--9950102899
Q 001426 989 TT-----ILDRQ--LLMRSGTQIQE-----MLQVLGVALLCVNPCPEERPTMKDVTAM--LKEIRHENDD 1044 (1079)
Q Consensus 989 ~~-----~~~~~--~~~~~~~~~~~-----~~~l~~l~~~cl~~~P~~RPt~~eil~~--L~~~~~~~~~ 1044 (1079)
.. ..... ........... ...+.+++.+|++.||++|||+.|+++. +++.....+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~ 307 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 307 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCCC
T ss_conf 2343322220244677557787778378999999999999764895679089998619865558897657
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=326.45 Aligned_cols=268 Identities=20% Similarity=0.252 Sum_probs=202.7
Q ss_pred HCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 17899883543476899999968987699999334568992238999999999852787750015527873991799999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLFD 837 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 837 (1079)
++|+..+.||+|+||+||+|+.++++.||+|++..... .....+.+.+|+.++++++||||+++++++.+....++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf 99634318722778189999968999999999812326-85899999999999986799868766012046773158997
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 35788734353015767999999999999999999998289999497089999768779995899402344224677654
Q 001426 838 YISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSESS 917 (1079)
Q Consensus 838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 917 (1079)
++.++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.|.......
T Consensus 81 ~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEHHHHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC--
T ss_conf 4004567899860-47751445689999999999986057---48826787750568689978732366430114676--
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH---HHHCHHHHHH
Q ss_conf 465666667663453343778-878510178899999999929999999999952278998768754---2100101112
Q 001426 918 RASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE---RKREFTTILD 993 (1079)
Q Consensus 918 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 993 (1079)
.......+++.|+|||...+. .++.++||||+|+++|||++|+.||.+.... ..+.......... .+........
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHH-HHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 54101024311013788717888884100211175899997797998988989-99999998638997110421233322
Q ss_pred --HHHHCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf --2321025731-----999999999997213999999999899999
Q 001426 994 --RQLLMRSGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 994 --~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
.......... ......+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 14333335676466651258999999999986689668909999856
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.18 Aligned_cols=243 Identities=21% Similarity=0.324 Sum_probs=194.4
Q ss_pred HHCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCH---HHHHHHHHHHHHHCCC--CCCEEEEEEEEECCC
Q ss_conf 617899883543476899999968-9876999993345689922---3899999999985278--775001552787399
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELP---ERDQFSAEVQTLGSIR--HKNIVRLLGCCNNGR 830 (1079)
Q Consensus 757 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 830 (1079)
..+|++.+.||+|+||+||+|... +++.||+|++.+....... ....+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEEECCC-CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCC-CCEEEEECCCC
Q ss_conf 17999993578-87343530157679999999999999999999982899994970899997687799-95899402344
Q 001426 831 TRLLLFDYISN-GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQ-FEAFLADFGLA 908 (1079)
Q Consensus 831 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla 908 (1079)
..++||||+.+ +++.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.+ +.+||+|||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEEECCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCCCCC
T ss_conf 68999983368622899986158-999999999999999999999877---97556676111477447884897754653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 22467765446566666766345334377887-85101788999999999299999999999522789987687542100
Q 001426 909 KLFESSESSRASNSVAGSYGYIAPEYGYSLKI-TEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 909 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||... . ....+ ...
T Consensus 159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~---~i~~~-----~~~ 222 (273)
T d1xwsa_ 159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E---EIIRG-----QVF 222 (273)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---HHHHC-----CCC
T ss_pred EECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC----H---HHHHC-----CCC
T ss_conf 532444----5566565877479999848997886533255403453675688998873----6---77615-----447
Q ss_pred HHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 1011122321025731999999999997213999999999899999
Q 001426 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
+. + . ....+.+++.+||+.||++|||++|+++
T Consensus 223 ~~----~--------~--~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 FR----Q--------R--VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CS----S--------C--CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC----C--------C--CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 78----7--------7--9999999999976089758939999853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.59 Aligned_cols=275 Identities=23% Similarity=0.279 Sum_probs=202.7
Q ss_pred HHHCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC----
Q ss_conf 8617899883543476899999968-98769999933456899223899999999985278775001552787399----
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGR---- 830 (1079)
Q Consensus 756 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 830 (1079)
+.++|++.+.||+|+||+||+|... +++.||+|++.+.. ......+.+.+|+++++.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCC
T ss_conf 4771899889801778199999999999899999985222-596999999999999986689875479998635765555
Q ss_pred --EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf --179999935788734353015767999999999999999999998289999497089999768779995899402344
Q 001426 831 --TRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908 (1079)
Q Consensus 831 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 908 (1079)
..++||||+ ++++..+.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||.|
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEECC-CCCHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 41599998405-52189998740--226999999999999999998737---8764566851111210012211343102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 224677654465666667663453343778-8785101788999999999299999999999522789987687542100
Q 001426 909 KLFESSESSRASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 909 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
+..... .....|++.|+|||+..+. .++.++||||+||++|||++|+.||..... ...+........ .....
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~-~~~~~ 241 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTG-TPPAE 241 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHC-CCCHH
T ss_pred ECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCH-HHHHHHHHHCCC-CCCHH
T ss_conf 206876-----31024553335889981787899650103003899999978699888976-899999985037-88488
Q ss_pred HHHHH--------HHHHHCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHCCCCCCC
Q ss_conf 10111--------22321025731-----9999999999972139999999998999999--9950102899
Q 001426 988 FTTIL--------DRQLLMRSGTQ-----IQEMLQVLGVALLCVNPCPEERPTMKDVTAM--LKEIRHENDD 1044 (1079)
Q Consensus 988 ~~~~~--------~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~--L~~~~~~~~~ 1044 (1079)
..... ........... ......+.+++.+|++.||++|||++|+++. ++++....++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~ 313 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 313 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred HHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCCC
T ss_conf 886530003443311578666556677556899999999999772995579299999639623758776646
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=317.05 Aligned_cols=263 Identities=17% Similarity=0.249 Sum_probs=200.5
Q ss_pred HCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEE-EEEEEEECCCEEEEE
Q ss_conf 1789988354347689999996-89876999993345689922389999999998527877500-155278739917999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIV-RLLGCCNNGRTRLLL 835 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv 835 (1079)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+..|+++++.++|++++ .+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC-----CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
T ss_conf 88999689850788099999998899899999972100-----5888999999999703899601799999519877899
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC---CCCEEEEECCCCCCCC
Q ss_conf 9935788734353015767999999999999999999998289999497089999768779---9958994023442246
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP---QFEAFLADFGLAKLFE 912 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~ 912 (1079)
|||+ ++++.+.+......+++..+..++.|++.|++|+|++ +|+||||||+||+++. +..+|++|||+|+.+.
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf 9873-8713332443068876899999999999999999979---94426678766064335777615650467513425
Q ss_pred CCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 77654-----4656666676634533437788785101788999999999299999999999522789987687542100
Q 001426 913 SSESS-----RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKRE 987 (1079)
Q Consensus 913 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1079)
..... .......||+.|+|||+..+..++.++||||||+++|||++|+.||.................... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-HSC
T ss_pred CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCC-CCC
T ss_conf 5445541000135776787353299999189989832188617789999849876655305779999998523567-898
Q ss_pred HHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 101112232102573199999999999721399999999989999999950102
Q 001426 988 FTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHE 1041 (1079)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~ 1041 (1079)
... ..+ .....+.+++..||+.+|++||+++++.+.|+++...
T Consensus 237 ~~~-~~~----------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 IEV-LCK----------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHH-HTT----------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH-HCC----------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 357-534----------7889999999998439955791999999999999997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.98 Aligned_cols=271 Identities=20% Similarity=0.260 Sum_probs=200.1
Q ss_pred HHCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-------
Q ss_conf 61789988354347689999996-8987699999334568992238999999999852787750015527873-------
Q 001426 757 VTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN------- 828 (1079)
Q Consensus 757 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 828 (1079)
..+|++.+.||+|+||+||+|.. .+++.||||++..... .......+.+|+.+++.++|+|++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf 2798899997227482999999989997999999842224-637899999999999983599966067654024654444
Q ss_pred -CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf -9917999993578873435301576799999999999999999999828999949708999976877999589940234
Q 001426 829 -GRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGL 907 (1079)
Q Consensus 829 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 907 (1079)
....++||||+.++.+.... .....+++..++.++.|++.|+.|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCCEEEEEEECCCCCCCCHHH-HCCCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEECCE
T ss_conf 576389998535787410122-2034433089999999999999885229---988567672220366899687631350
Q ss_pred CCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 4224677654--465666667663453343778-8785101788999999999299999999999522789987687542
Q 001426 908 AKLFESSESS--RASNSVAGSYGYIAPEYGYSL-KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRER 984 (1079)
Q Consensus 908 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 984 (1079)
++.+...... .......||+.|+|||+..+. .++.++||||+|+++|||++|+.||....+ .......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~~~-~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQL-CGSI 241 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHH-HCCC
T ss_pred EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCH-HHHHHHHHHH-CCCC
T ss_conf 0223554443211356602497874289970799989178700678646617448799899899-9999999984-1899
Q ss_pred HHCHHHHHH-----HHH--HCCCCCCH-------HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 100101112-----232--10257319-------999999999972139999999998999999
Q 001426 985 KREFTTILD-----RQL--LMRSGTQI-------QEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 985 ~~~~~~~~~-----~~~--~~~~~~~~-------~~~~~l~~l~~~cl~~~P~~RPt~~eil~~ 1034 (1079)
........+ ... ........ .....+.+++.+|++.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8255344320344433201334455503340444599899999999873896589099999749
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.43 Aligned_cols=270 Identities=27% Similarity=0.307 Sum_probs=194.4
Q ss_pred CCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC------CCE
Q ss_conf 7899883543476899999968-987699999334568992238999999999852787750015527873------991
Q 001426 759 RLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN------GRT 831 (1079)
Q Consensus 759 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 831 (1079)
+|+..++||+|+||+||+|+.. +++.||+|++..... ...+|++++++++|+||+++++++.. ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 76751698217683999999999997999999881606-------89999999986689898738789974476577318
Q ss_pred EEEEEEECCCCCHHHHHH--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC-CEEEEECCCC
Q ss_conf 799999357887343530--1576799999999999999999999828999949708999976877999-5899402344
Q 001426 832 RLLLFDYISNGSLAGLLH--EKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-EAFLADFGLA 908 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla 908 (1079)
.++||||++++.+..... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCH
T ss_conf 999984168860788886310368999999999999999999999866---87645788603787358971167336605
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH---H
Q ss_conf 22467765446566666766345334377-8878510178899999999929999999999952278998768754---2
Q 001426 909 KLFESSESSRASNSVAGSYGYIAPEYGYS-LKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE---R 984 (1079)
Q Consensus 909 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~ 984 (1079)
+.+.... ......|++.|+|||...+ ..++.++||||+||++|||++|+.||..... ...+....+..... .
T Consensus 171 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 171 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp EECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCHHH
T ss_pred HHCCCCC---CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCH-HHHHHHHHHHHCCCHHHH
T ss_conf 4404776---532002555556827764046888210002465277855028799898799-999999999748981776
Q ss_pred HH----CHHHHHHHHHHCC---CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCCCC
Q ss_conf 10----0101112232102---5731999999999997213999999999899999--999501028
Q 001426 985 KR----EFTTILDRQLLMR---SGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRHEN 1042 (1079)
Q Consensus 985 ~~----~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~--~L~~~~~~~ 1042 (1079)
+. ......-+..... ..........+.+++.+|++.||++|||++|+++ .++++...+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred HHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCC
T ss_conf 5430621011035544567444431568999999999997658955792999996698452466777
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=313.46 Aligned_cols=264 Identities=15% Similarity=0.216 Sum_probs=207.3
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCC-CCEEEEEEEEECCCEEEEE
Q ss_conf 17899883543476899999968-987699999334568992238999999999852787-7500155278739917999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRH-KNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv 835 (1079)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+|++.++.++| +|++.+++++.++...++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
T ss_conf 80699799841788299999998899799999975025-----8299999999999964899987799996018811799
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC-----CCCEEEEECCCCCC
Q ss_conf 9935788734353015767999999999999999999998289999497089999768779-----99589940234422
Q 001426 836 FDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGP-----QFEAFLADFGLAKL 910 (1079)
Q Consensus 836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~ 910 (1079)
|||+ +++|.+++...+..+++..+..++.|++.|++|+|+. +|+||||||+||+++. ++.+|++|||+|+.
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 9964-8887999975203110689999999999999999977---96626677131523475434479568723660577
Q ss_pred CCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHH-HHHHHHHHHHH
Q ss_conf 4677654-----46566666766345334377887851017889999999992999999999995227-89987687542
Q 001426 911 FESSESS-----RASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHI-ITWVNGELRER 984 (1079)
Q Consensus 911 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~ 984 (1079)
+...... .......||+.|+|||+..+..++.++||||+|+++|||++|+.||.......... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-- 233 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-- 233 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH--
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCC--
T ss_conf 146766541110246762775102679896488888699989831999999869876788530219999999970567--
Q ss_pred HHCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 10010111223210257319999999999972139999999998999999995010289
Q 001426 985 KREFTTILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAMLKEIRHEND 1043 (1079)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~L~~~~~~~~ 1043 (1079)
.....+. .+. ....+.+++..||..+|++||+++.+.+.|+++.++..
T Consensus 234 ~~~~~~l-~~~----------~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 234 STPLREL-CAG----------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HSCHHHH-TTT----------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCCHHHH-CCC----------CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCC
T ss_conf 9995896-579----------98999999999843993008599999999999999759
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=311.06 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=196.2
Q ss_pred HCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCC-CCCEEEEEEEEEC--CCEEE
Q ss_conf 1789988354347689999996-898769999933456899223899999999985278-7750015527873--99179
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNN--GRTRL 833 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~ 833 (1079)
++|++.+.||+|+||+||+|+. .+++.||+|++.+ ...+.+.+|+.+++.++ ||||+++++++.. ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~------~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECH------HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEE
T ss_conf 671897898317481999999889997999999888------99999999999998515799876799999816877126
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC-CEEEEECCCCCCCC
Q ss_conf 99993578873435301576799999999999999999999828999949708999976877999-58994023442246
Q 001426 834 LLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQF-EAFLADFGLAKLFE 912 (1079)
Q Consensus 834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~ 912 (1079)
+||||+.+++|..+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+|++|||+|+...
T Consensus 109 ~v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EEEEECCCCCHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf 8886317985899746----899999999999999999887643---344345644123774899836641565426646
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHH-----
Q ss_conf 776544656666676634533437788-78510178899999999929999999999952278998768754210-----
Q 001426 913 SSESSRASNSVAGSYGYIAPEYGYSLK-ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKR----- 986 (1079)
Q Consensus 913 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 986 (1079)
... ......+|+.|+|||...+.. ++.++||||+|+++|||++|+.||.......................
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf 887---44432248642476102688888845232335455587604889998876018999999998788415555542
Q ss_pred -------CHHHHHHHHHH------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf -------01011122321------025731999999999997213999999999899999
Q 001426 987 -------EFTTILDRQLL------MRSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 987 -------~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
.+......... ............+.+++.+|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 254447430000033343311211552112448999999999986699568908999964
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.56 Aligned_cols=269 Identities=18% Similarity=0.237 Sum_probs=203.8
Q ss_pred HCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 1789988354347689999996-898769999933456899223899999999985278775001552787399179999
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNNGRTRLLLF 836 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 836 (1079)
++|++.+.||+|+||+||+|+. .+++.||+|++.... ........+.+|+.+++.++||||+++++++.+....++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 99786269712868199999999999699999980321-78689999999999998567578882135444443115886
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 93578873435301576799999999999999999999828999949708999976877999589940234422467765
Q 001426 837 DYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLFESSES 916 (1079)
Q Consensus 837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 916 (1079)
+++.++++..++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.|+......
T Consensus 81 ~~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp ECCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred EECCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC-
T ss_conf 3023322211212356-540367899999999998774339---98600146761211337826652046011046887-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH---HHHCHHHHH
Q ss_conf 44656666676634533437788-78510178899999999929999999999952278998768754---210010111
Q 001426 917 SRASNSVAGSYGYIAPEYGYSLK-ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRE---RKREFTTIL 992 (1079)
Q Consensus 917 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 992 (1079)
.......+++.|+|||...... ++.++||||+||++|||++|+.||.........+.......... .+.......
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCC
T ss_conf -5100103443101466750698888044402654188998518999988999999999998611899735513443222
Q ss_pred HHHH---H-C--CC-CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 2232---1-0--25-731999999999997213999999999899999
Q 001426 993 DRQL---L-M--RS-GTQIQEMLQVLGVALLCVNPCPEERPTMKDVTA 1033 (1079)
Q Consensus 993 ~~~~---~-~--~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~ 1033 (1079)
+... . . .. .........+.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 113344454431043306568999999999986499668909999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.07 Aligned_cols=255 Identities=23% Similarity=0.286 Sum_probs=201.5
Q ss_pred HCCCCCCEEEECCCEEEEEEEEC----CCCEEEEEEECCCCCC-CCHHHHHHHHHHHHHHCCCC-CCEEEEEEEEECCCE
Q ss_conf 17899883543476899999968----9876999993345689-92238999999999852787-750015527873991
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEIP----SRQVIAVKKLWPVKNG-ELPERDQFSAEVQTLGSIRH-KNIVRLLGCCNNGRT 831 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 831 (1079)
++|+..+.||+|+||+||+|... +++.||+|.+.+.... .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 79999935788734353015767999999999999999999998289999497089999768779995899402344224
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKLF 911 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 911 (1079)
.++++||+.+|+|.+++...+. +++..+..++.|++.|+.|+|+. +|+||||||+||+++.++.+||+|||+|+.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEEECCCCCHHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCHHHH
T ss_conf 0012312341179999873045-43788888899999999885149---9896547732012469998887413202220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCHH
Q ss_conf 677654465666667663453343778--878510178899999999929999999999952278998768754210010
Q 001426 912 ESSESSRASNSVAGSYGYIAPEYGYSL--KITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREFT 989 (1079)
Q Consensus 912 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1079)
.... ........|++.|+|||...+. .++.++||||+||++|||++|+.||......... ............ .+.
T Consensus 180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~~~~~~~~~-~~~ 256 (322)
T d1vzoa_ 180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRILKSEP-PYP 256 (322)
T ss_dssp CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHHHHCCC-CCC
T ss_pred CCCC-CCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHCCCCCC-CCC
T ss_conf 3444-4322122233333106876057768871325177779999997689998888777799-999983356899-886
Q ss_pred HHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 11122321025731999999999997213999999999-----899999
Q 001426 990 TILDRQLLMRSGTQIQEMLQVLGVALLCVNPCPEERPT-----MKDVTA 1033 (1079)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~eil~ 1033 (1079)
. .....+.+++.+||++||++||| ++|+++
T Consensus 257 ------------~--~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 257 ------------Q--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------------T--TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------------C--CCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf ------------5--4799999999997445898819997450999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.09 Aligned_cols=267 Identities=22% Similarity=0.251 Sum_probs=200.6
Q ss_pred HHHCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC------
Q ss_conf 8617899883543476899999968-987699999334568992238999999999852787750015527873------
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEIP-SRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN------ 828 (1079)
Q Consensus 756 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 828 (1079)
+.++|++.++||+|+||+||+|... +++.||+|++.... ........+.+|+.++++++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCC
T ss_conf 3377599889621758599999999999899999988233-697999999999999986489876489989702564345
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99179999935788734353015767999999999999999999998289999497089999768779995899402344
Q 001426 829 GRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLA 908 (1079)
Q Consensus 829 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 908 (1079)
....|+||||+.++ +.+.+. ..+++..++.++.|++.|+.|||+. ||+||||||+||+++.++.+|++|||.+
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CCEEEEEEECCCHH-HHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 76269998414467-787650---3899999999999999999886522---1124567763211365443132010232
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH---HHH
Q ss_conf 22467765446566666766345334377887851017889999999992999999999995227899876875---421
Q 001426 909 KLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELR---ERK 985 (1079)
Q Consensus 909 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~ 985 (1079)
+..... .......+|+.|+|||+..+..++.++||||+||++|||++|+.||...... ............ +.+
T Consensus 167 ~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred HCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHH-HHHHHHHHHCCCCCHHHH
T ss_conf 114666---5533221465555813314777787743335662578986598998889778-899999972058987999
Q ss_pred HCH----H---------------HHHHHHHHC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 001----0---------------111223210-257319999999999972139999999998999999
Q 001426 986 REF----T---------------TILDRQLLM-RSGTQIQEMLQVLGVALLCVNPCPEERPTMKDVTAM 1034 (1079)
Q Consensus 986 ~~~----~---------------~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~eil~~ 1034 (1079)
... . ..+...... ...........+.+++.+|++.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 876566777764175435666421264333543210133379999999999876994579089999669
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=308.94 Aligned_cols=272 Identities=21% Similarity=0.246 Sum_probs=201.3
Q ss_pred HHHCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-----C
Q ss_conf 861789988354347689999996-8987699999334568992238999999999852787750015527873-----9
Q 001426 756 VVTRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNIVRLLGCCNN-----G 829 (1079)
Q Consensus 756 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 829 (1079)
+.++|++.+.||+|+||+||+|.. .+++.||+|++.+.. ......+.+.+|+.++++++|||+|++++++.. .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
T ss_conf 8987188889831788399999999999799999988200-286899999999999986689874259999963464566
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 91799999357887343530157679999999999999999999982899994970899997687799958994023442
Q 001426 830 RTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 909 (1079)
...+++++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred CCEEEEEEEECCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 8649999962588623200224--530999999999999999999738---87651667763345543220013210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHCH
Q ss_conf 246776544656666676634533437788-7851017889999999992999999999995227899876875421001
Q 001426 910 LFESSESSRASNSVAGSYGYIAPEYGYSLK-ITEKSDVYSYGVVLLEVLTGKEPTDSRIPDGAHIITWVNGELRERKREF 988 (1079)
Q Consensus 910 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1079)
.... ......|++.|+|||...+.. ++.++||||+|+++|+|++|+.||..... ......+...........
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCHHH
T ss_pred CCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHCCCCCHHH
T ss_conf 2575-----444434543555835533775678551243205899999768899788988--999999997307997577
Q ss_pred HH--------HHHHHHHCCCCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf 01--------11223210257319-----99999999997213999999999899999--9995010
Q 001426 989 TT--------ILDRQLLMRSGTQI-----QEMLQVLGVALLCVNPCPEERPTMKDVTA--MLKEIRH 1040 (1079)
Q Consensus 989 ~~--------~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~~P~~RPt~~eil~--~L~~~~~ 1040 (1079)
.. .............. .....+.+++.+|++.||++|||++|+++ .+.++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 3200102445444303557875556626789999999999977588345938999855995487999
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=305.45 Aligned_cols=294 Identities=30% Similarity=0.446 Sum_probs=207.9
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCC--CCCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 249105899987751778999855458899999999--632123117960587134588876234667752399838995
Q 001426 23 ALNPEGLSLLSWLSTFNSSSSATFFSSWNPSHRNPC--NWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNAN 100 (1079)
Q Consensus 23 ~~~~~~~~ll~~~~~~~~~~~~~~l~~W~~~~~~~C--~w~gv~C~~~~~~~~~~~lp~~~~~~~~~~~~l~~L~L~~~~ 100 (1079)
|.+.|++||++||+++.++ ..+++|.. +.||| .|+||+|+..+.. .+++.|+|++++
T Consensus 3 c~~~e~~aLl~~k~~~~~~---~~l~sW~~-~~d~C~~~w~gv~C~~~~~~-----------------~~v~~L~L~~~~ 61 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNP---TTLSSWLP-TTDCCNRTWLGVLCDTDTQT-----------------YRVNNLDLSGLN 61 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCC---GGGTTCCT-TSCTTTTCSTTEEECCSSSC-----------------CCEEEEEEECCC
T ss_pred CCHHHHHHHHHHHHHCCCC---CCCCCCCC-CCCCCCCCCCCEEEECCCCC-----------------EEEEEEECCCCC
T ss_conf 8989999999999977999---86778899-99998894889697489994-----------------798899898998
Q ss_pred CCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 555--5972312558888896369-8644899864487674447751488665467643226344554853554456778
Q 001426 101 LTG--EIPPAIGNLSSLINLDLSF-NALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNI 177 (1079)
Q Consensus 101 l~~--~~~~~l~~l~~L~~L~Ls~-n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 177 (1079)
++| .+|+++++|++|++|+|++ |.+.|.+|.+|+++++|++|+|++|++.+..+..+..+.+|++++++.|.+.+.+
T Consensus 62 l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~ 141 (313)
T d1ogqa_ 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141 (313)
T ss_dssp CSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCC
T ss_pred CCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC
T ss_conf 88888798478467533520202654333002431145420011020356434433222220111001111224555568
Q ss_pred CHHHCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 80000245689988099997556899221364325676302678866788430012343-31023333223557731236
Q 001426 178 PAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLGLADTGISGQIPRSVGELTNL-RTLSVYTANITGYIPEEIGN 256 (1079)
Q Consensus 178 p~~l~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L-~~L~l~~~~~~~~~p~~l~~ 256 (1079)
|..++ +++.++.++++.|.+.+.+|..+..+..+ +.+.+..|++.+..|..+..
T Consensus 142 p~~l~-------------------------~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~ 196 (313)
T d1ogqa_ 142 PPSIS-------------------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196 (313)
T ss_dssp CGGGG-------------------------GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG
T ss_pred CHHHC-------------------------CCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 51220-------------------------67400000023553356203121443112323102246435332433222
Q ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 56565420534435357996735887777686337656898675333678763898035445676641112212334010
Q 001426 257 CSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELL 336 (1079)
Q Consensus 257 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 336 (1079)
+..+ .+++..+...+..|..+..+++++.+++++|.+.+.++ .+..+++|+.|++++|++++.+|..+..+++|++|+
T Consensus 197 l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~ 274 (313)
T d1ogqa_ 197 LNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274 (313)
T ss_dssp CCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEE
T ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEE
T ss_conf 2222-33333343322222222222221112222222222222-222455444444765706660876884799999897
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 23643444345111365667674126873
Q 001426 337 LSGNNISGEIPSFFGNFSRLKQLELDNNR 365 (1079)
Q Consensus 337 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 365 (1079)
|++|++++.+|. +.++.+|+.+++++|+
T Consensus 275 Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 275 VSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred CCCCCCCCCCCC-CCCCCCCCHHHHCCCC
T ss_conf 958835166898-6667998978868895
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=276.56 Aligned_cols=269 Identities=19% Similarity=0.185 Sum_probs=190.9
Q ss_pred HCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCC-----------CCCEEEEEEE
Q ss_conf 1789988354347689999996-898769999933456899223899999999985278-----------7750015527
Q 001426 758 TRLSDTNIVGKGVSGIVYRVEI-PSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-----------HKNIVRLLGC 825 (1079)
Q Consensus 758 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~ 825 (1079)
.+|++.+.||+|+||+||+|+. .+++.||||++.+ .....+.+.+|+.+++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~----~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEC----CCCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEE
T ss_conf 857998997507781899999999997999999834----3133689999999999840145555542276764789987
Q ss_pred EEC--CCEEEEEEEECCCCCHHHHH--HCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEEECCCCCCEEECCCC--
Q ss_conf 873--99179999935788734353--0157679999999999999999999982-8999949708999976877999--
Q 001426 826 CNN--GRTRLLLFDYISNGSLAGLL--HEKKVFLDWDSRYKIILGVAHGLAYLHH-DCVPPIIHRDIKSNNILVGPQF-- 898 (1079)
Q Consensus 826 ~~~--~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~NIll~~~~-- 898 (1079)
+.. ....+.+++++..+...... ......+++..+..++.|++.|+.|||+ . +|+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred EEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCC
T ss_conf 631256520234320003542000001223467868999999999999988876405---86465677057056305765
Q ss_pred ----CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC----
Q ss_conf ----589940234422467765446566666766345334377887851017889999999992999999999995----
Q 001426 899 ----EAFLADFGLAKLFESSESSRASNSVAGSYGYIAPEYGYSLKITEKSDVYSYGVVLLEVLTGKEPTDSRIPDG---- 970 (1079)
Q Consensus 899 ----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~tg~~p~~~~~~~~---- 970 (1079)
.++++|||.+...... .....|++.|+|||+.....++.++||||+|++++||++|+.||.......
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCCCEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCH
T ss_conf 64430567531442123445-----4223665210571321466777643201237899999878899898755432102
Q ss_pred -CHHHHHHHH--HHHHHH----HCHHHHHH-----------------HHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf -227899876--875421----00101112-----------------232102573199999999999721399999999
Q 001426 971 -AHIITWVNG--ELRERK----REFTTILD-----------------RQLLMRSGTQIQEMLQVLGVALLCVNPCPEERP 1026 (1079)
Q Consensus 971 -~~~~~~~~~--~~~~~~----~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 1026 (1079)
..+...... ...... ......++ ................+.+++.+|+..||++||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 68999999983799878862453220001320122024323577644421000156743589999999998779945790
Q ss_pred CHHHHHHH--HHHC
Q ss_conf 98999999--9950
Q 001426 1027 TMKDVTAM--LKEI 1038 (1079)
Q Consensus 1027 t~~eil~~--L~~~ 1038 (1079)
|++|+++. +++.
T Consensus 321 ta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 321 DAGGLVNHPWLKDT 334 (362)
T ss_dssp CHHHHHTCGGGTTC
T ss_pred CHHHHHCCCCCCCC
T ss_conf 89999669340789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=5.8e-38 Score=227.00 Aligned_cols=73 Identities=21% Similarity=0.364 Sum_probs=33.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 3899555559723125588888963698644899864487674447751488665467643226344554853554456
Q 001426 96 LSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLS 174 (1079)
Q Consensus 96 L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 174 (1079)
+...++++.++ ...+.+|++|+++++.|+. + ..++.+++|++|++++|++++ +|. ++++++|++|++++|.+.
T Consensus 29 l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred HCCCCCCCCCC--HHHHCCCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCCC-CCC-CCCCCCCCCCCCCCCCCC
T ss_conf 67777788639--8895787899899989877-6-242458999989681881798-863-347711010301343332
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.5e-37 Score=224.64 Aligned_cols=79 Identities=28% Similarity=0.458 Sum_probs=43.5
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 52399838995555597231255888889636986448998644876744477514886654676432263445548535
Q 001426 90 HLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELY 169 (1079)
Q Consensus 90 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 169 (1079)
.++.|++++++++. + +.+..+++|++|+|++|++++ +| .++++++|++|++++|.+.+ ++ .++++++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~-i~-~l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCC
T ss_conf 87899899989877-6-242458999989681881798-86-33477110103013433322-22-11123343334433
Q ss_pred CCCCC
Q ss_conf 54456
Q 001426 170 DNQLS 174 (1079)
Q Consensus 170 ~n~l~ 174 (1079)
++.++
T Consensus 119 ~~~~~ 123 (384)
T d2omza2 119 NNQIT 123 (384)
T ss_dssp SSCCC
T ss_pred CCCCC
T ss_conf 22222
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.9e-36 Score=214.44 Aligned_cols=247 Identities=22% Similarity=0.311 Sum_probs=127.2
Q ss_pred CCCCCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 99632123117960587134588876234667752399838995555597231255888889636986448998644876
Q 001426 57 PCNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKL 136 (1079)
Q Consensus 57 ~C~w~gv~C~~~~~~~~~~~lp~~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l 136 (1079)
-|.|++|.|+..++...|.++| +.++.|+|++|+++...+.+|.++++|++|++++|.+....|..|.++
T Consensus 9 ~c~~~~~~C~~~~L~~lP~~l~----------~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l 78 (305)
T d1xkua_ 9 QCHLRVVQCSDLGLEKVPKDLP----------PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL 78 (305)
T ss_dssp EEETTEEECTTSCCCSCCCSCC----------TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTC
T ss_pred EECCCEEEECCCCCCCCCCCCC----------CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCC
T ss_conf 9559999855999885198889----------997989784991898696576046565231123443445235665279
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf 74447751488665467643226344554853554456778800002456899880999975568992213643256763
Q 001426 137 AELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLSGNIPAEIGQLEALEIIRAGGNPGIHGEIPEEISNCKVLVFLG 216 (1079)
Q Consensus 137 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~l~~l~~L~~L~ 216 (1079)
++|++|++++|+++ .+|..+. ..+..|++..|.+.+..+..+.... .+..+.
T Consensus 79 ~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~-------------------------~~~~l~ 130 (305)
T d1xkua_ 79 VKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLN-------------------------QMIVVE 130 (305)
T ss_dssp TTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCT-------------------------TCCEEE
T ss_pred CCCCEECCCCCCCC-CCCCCHH--HHHHHHHCCCCCHHHHHHHHHHCCC-------------------------CCCCCC
T ss_conf 85578315687567-6764001--1132321024610234444540133-------------------------110000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 02678866788430012343310233332235577312365656542053443535799673588777768633765689
Q 001426 217 LADTGISGQIPRSVGELTNLRTLSVYTANITGYIPEEIGNCSALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSG 296 (1079)
Q Consensus 217 l~~~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 296 (1079)
...+.. ......+..+..+++|+.+++.+|.+. .++..+ .++|+.|++++|....
T Consensus 131 ~~~n~~----------------------~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~ 185 (305)
T d1xkua_ 131 LGTNPL----------------------KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK 185 (305)
T ss_dssp CCSSCC----------------------CGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCE
T ss_pred CCCCCC----------------------CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCC--CCCCCEEECCCCCCCC
T ss_conf 123333----------------------346777642234565671203467745-167101--7766789897886778
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 86753336787638980354456766411122123340102364344434511136566767412687343
Q 001426 297 SIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFF 367 (1079)
Q Consensus 297 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 367 (1079)
..+..+..++.++.|++++|.+.+..+..+.++++|++|+|++|.++. +|..+..+++|+.|++++|+++
T Consensus 186 ~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCC
T ss_pred CCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCC
T ss_conf 882676413413301544553322234543344332243025540024-6311033467898989898657
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.2e-34 Score=204.74 Aligned_cols=84 Identities=31% Similarity=0.356 Sum_probs=31.2
Q ss_pred CCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 56678468995765688244530478802101542346656323467888637613650247787754534555312454
Q 001426 498 QLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLS 577 (1079)
Q Consensus 498 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 577 (1079)
+|+.|++++|.+....+..|..++.++.|++++|.+.++.+..|.++++|++|+|++|+|+.+ |..+..+++|+.|+++
T Consensus 172 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~l-p~~l~~l~~L~~L~Ls 250 (305)
T d1xkua_ 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLH 250 (305)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC-CTTTTTCSSCCEEECC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCC-CCCCCCCCCCCEEECC
T ss_conf 667898978867788826764134133015445533222345433443322430255400246-3110334678989898
Q ss_pred CCCCC
Q ss_conf 75255
Q 001426 578 SNRIN 582 (1079)
Q Consensus 578 ~N~l~ 582 (1079)
+|+|+
T Consensus 251 ~N~i~ 255 (305)
T d1xkua_ 251 NNNIS 255 (305)
T ss_dssp SSCCC
T ss_pred CCCCC
T ss_conf 98657
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-34 Score=205.15 Aligned_cols=110 Identities=26% Similarity=0.328 Sum_probs=41.7
Q ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 65654205344353579967358877776863376568986753336787638980354456766411122123340102
Q 001426 258 SALENLFLYENQIFGKIPDELGSLKNLKRLLLWQNNLSGSIPEALGNCSSLTVIDVSLNSLGGEVPVSLANLVALEELLL 337 (1079)
Q Consensus 258 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 337 (1079)
..|+.+++++|.++...+..|..+++|+.|++++|.+....+.+|.++++|+.+++++|++.+..|..|..+++|++|++
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 01211020014314458057404340502231417656625666546563413142114346628167665320002333
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 364344434511136566767412687343
Q 001426 338 SGNNISGEIPSFFGNFSRLKQLELDNNRFF 367 (1079)
Q Consensus 338 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 367 (1079)
++|.+.+..+..|.++++|+.|++++|++.
T Consensus 209 ~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 209 FANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp CSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 335221000002355465688981199887
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-33 Score=199.52 Aligned_cols=34 Identities=29% Similarity=0.357 Sum_probs=11.0
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 4010236434443451113656676741268734
Q 001426 333 EELLLSGNNISGEIPSFFGNFSRLKQLELDNNRF 366 (1079)
Q Consensus 333 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 366 (1079)
++|+|++|.++...+..|.++++|++|++++|++
T Consensus 35 ~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l 68 (284)
T d1ozna_ 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68 (284)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCC
T ss_conf 8897748817987977864142130000134454
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-30 Score=183.96 Aligned_cols=173 Identities=27% Similarity=0.234 Sum_probs=60.0
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 72896657778899654122521234211223300165787655999833999227976566853235346448655125
Q 001426 403 LQALDLSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSE 482 (1079)
Q Consensus 403 L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~ 482 (1079)
+.+++.+++.++ .+|..+. +++++|+|++|.|++..+..|..+++|++|+|++|+|+.+ + .++.+++|+.|++++
T Consensus 12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~ 86 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSH 86 (266)
T ss_dssp CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCS
T ss_pred CEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCC
T ss_conf 869980699988-6196757--6889898849928985977863456552213566544443-1-111122321111122
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 76568889988987756678468995765688244530478802101542346656323467888637613650247787
Q 001426 483 NQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIP 562 (1079)
Q Consensus 483 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 562 (1079)
|+++ ..+..+..+++|+.|++++|++....+..+..+.++..|++++|.+..+.+..+..+++++.+++++|+|+++.+
T Consensus 87 N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~ 165 (266)
T d1p9ag_ 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (266)
T ss_dssp SCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCC
T ss_conf 2221-111121222222222222231101100112222111122124342102212333221110000000156522372
Q ss_pred CCCCCCCCCCCCCCCCCCC
Q ss_conf 7545345553124547525
Q 001426 563 KSLGLCKDLQLLDLSSNRI 581 (1079)
Q Consensus 563 ~~~~~l~~L~~L~Ls~N~l 581 (1079)
..|..+++|+.|+|++|+|
T Consensus 166 ~~~~~l~~L~~L~Ls~N~L 184 (266)
T d1p9ag_ 166 GLLNGLENLDTLLLQENSL 184 (266)
T ss_dssp TTTTTCTTCCEEECCSSCC
T ss_pred CCCCCCCCCCEEECCCCCC
T ss_conf 0013421242343013978
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-29 Score=180.33 Aligned_cols=133 Identities=26% Similarity=0.211 Sum_probs=58.5
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCC
Q ss_conf 99833999227976566853235346448655125765688899889877566784689957656882445304788021
Q 001426 448 CTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLD 527 (1079)
Q Consensus 448 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 527 (1079)
+++|+.|++++|+++ ..+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.+..+.+..+..+..++.++
T Consensus 76 l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~ 154 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (266)
T ss_dssp CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCC
T ss_conf 223211111222221-1111212222222222222311011001122221111221243421022123332211100000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 0154234665632346788863761365024778775453455531245475255
Q 001426 528 LSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRIN 582 (1079)
Q Consensus 528 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 582 (1079)
+++|+++++.+..|..+++|++|+|++|+|+. +|..+..+++|+.|+|++|++.
T Consensus 155 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~-lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 155 LANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCHHHCCCCCCCEEEECCCCCC
T ss_conf 00156522372001342124234301397855-6866777888999983699987
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.95 E-value=5.1e-25 Score=154.11 Aligned_cols=73 Identities=29% Similarity=0.363 Sum_probs=34.5
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 52399838995555597231255888889636986448998644876744477514886654676432263445548535
Q 001426 90 HLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELY 169 (1079)
Q Consensus 90 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 169 (1079)
++++|+|++++++ .+|+. +++|++|+|++|.++ .+|.. +.+|+.|++++|.+. .++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCC-HHHHH---CCCCCCCCCC
T ss_conf 9989993799988-78898---789888989999796-33620---332033266551432-03210---2211111334
Q ss_pred CCCCC
Q ss_conf 54456
Q 001426 170 DNQLS 174 (1079)
Q Consensus 170 ~n~l~ 174 (1079)
+|.+.
T Consensus 107 ~n~l~ 111 (353)
T d1jl5a_ 107 NNQLE 111 (353)
T ss_dssp SSCCS
T ss_pred CCCCC
T ss_conf 55432
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.94 E-value=6.2e-24 Score=148.02 Aligned_cols=54 Identities=28% Similarity=0.364 Sum_probs=38.2
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 88888963698644899864487674447751488665467643226344554853554456
Q 001426 113 SSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLELYDNQLS 174 (1079)
Q Consensus 113 ~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 174 (1079)
.++++|||+++.++ .+|+. +++|++|+|++|+++ .+|..+ .+|+.|++++|.++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~ 91 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK 91 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS
T ss_pred CCCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC
T ss_conf 69989993799988-78898---789888989999796-336203---32033266551432
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=9.3e-27 Score=163.92 Aligned_cols=168 Identities=15% Similarity=0.160 Sum_probs=121.6
Q ss_pred CCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCC-----C----------CHHHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf 998835434768999999689876999993345689-----9----------2238999999999852787750015527
Q 001426 761 SDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNG-----E----------LPERDQFSAEVQTLGSIRHKNIVRLLGC 825 (1079)
Q Consensus 761 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 825 (1079)
.+.++||+|+||+||+|...+++.||+|+++..... . .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EECCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf 87399179999935788734353015767999999999999999999998289999497089999768779995899402
Q 001426 826 CNNGRTRLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCVPPIIHRDIKSNNILVGPQFEAFLADF 905 (1079)
Q Consensus 826 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 905 (1079)
.. .+++|||++++.+.+ ++......++.|++.++.|||+. +|+||||||+|||++++ .++++||
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred CC----CEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEEEEC
T ss_conf 28----889999504565420--------01578999999999999998268---88983689036114289-8999877
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCCCHHHHHHHHHH
Q ss_conf 3442246776544656666676634533-----437788785101788999999
Q 001426 906 GLAKLFESSESSRASNSVAGSYGYIAPE-----YGYSLKITEKSDVYSYGVVLL 954 (1079)
Q Consensus 906 gla~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DiwslGvil~ 954 (1079)
|.|......... .|.... ..+.+.+..++|+||..--+.
T Consensus 147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCH----------HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 884308998709----------99987799999997578998446899999874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-29 Score=180.43 Aligned_cols=136 Identities=20% Similarity=0.116 Sum_probs=63.4
Q ss_pred CCCCEEEEECCCCCCCCC----CCCCCCCCCCCEEEECCCCCCCCCCCC-----CCCCCCCCEEECCCCCCCCCCCHH--
Q ss_conf 998339992279765668----532353464486551257656888998-----898775667846899576568824--
Q 001426 448 CTGLIRLRLGSNNFSGHI----PSRIGLLHRLTFLELSENQFTGEIPPE-----IGNCTQLEMVDLHQNKLQGTIPSS-- 516 (1079)
Q Consensus 448 l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~ls~N~l~~~~p~~-----~~~l~~L~~L~l~~N~l~~~~~~~-- 516 (1079)
...++.+++++|.+.... ...+...+.++.+++++|.++...... ......|+.+++++|.+.......
T Consensus 254 ~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~ 333 (460)
T d1z7xw1 254 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 333 (460)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHCC
T ss_conf 11100001345433212334332211123433344444333224564211101233344433332333410233443213
Q ss_pred --HHHHCCCCCCCCCCCCCCCCCC----CCC-CCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf --4530478802101542346656----323-4678886376136502477----87754534555312454752557
Q 001426 517 --LEFLFGLNVLDLSMNSIGGTIP----ENL-GKLTSLNKLVLSKNNITGL----IPKSLGLCKDLQLLDLSSNRING 583 (1079)
Q Consensus 517 --~~~l~~L~~L~Ls~N~l~~~~~----~~~-~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~ 583 (1079)
+....+|++|+|++|+++.... ..+ ...+.|++|+|++|.|+.. ....+..+++|+.|++++|+++.
T Consensus 334 ~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 334 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred CCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCH
T ss_conf 322110111132012101357664001112204567778898979979759999999999629988989899996987
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.8e-29 Score=179.19 Aligned_cols=85 Identities=20% Similarity=0.188 Sum_probs=40.5
Q ss_pred CCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCC----CCCCC-C
Q ss_conf 5239983899555559-7231255888889636986448----99864487674447751488665467----64322-6
Q 001426 90 HLTSLVLSNANLTGEI-PPAIGNLSSLINLDLSFNALTG----NIPEEIGKLAELELLSLNSNSIHGGI----PREIG-N 159 (1079)
Q Consensus 90 ~l~~L~L~~~~l~~~~-~~~l~~l~~L~~L~Ls~n~i~~----~~p~~l~~l~~L~~L~L~~n~l~~~~----p~~~~-~ 159 (1079)
++++|+++.+++++.. ..-+..+++++.|+|++|.++. .++..+..+++|++|||++|.+++.. ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCC
Q ss_conf 344554853554456
Q 001426 160 CSKLRRLELYDNQLS 174 (1079)
Q Consensus 160 l~~L~~L~L~~n~l~ 174 (1079)
..+|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it 97 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLT 97 (460)
T ss_dssp TCCCCEEECTTSCCB
T ss_pred CCCCCEEECCCCCCC
T ss_conf 887788778887754
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=8e-24 Score=147.40 Aligned_cols=107 Identities=16% Similarity=0.252 Sum_probs=57.5
Q ss_pred CCCCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCC
Q ss_conf 963212311796058713458887623466775239983899555559723125588888963698644899-8644876
Q 001426 58 CNWDYIKCSRTEIAITSIHIPTSFPYQLLSFSHLTSLVLSNANLTGEIPPAIGNLSSLINLDLSFNALTGNI-PEEIGKL 136 (1079)
Q Consensus 58 C~w~gv~C~~~~~~~~~~~lp~~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~-p~~l~~l 136 (1079)
|.++.|.|...++...|..+| +.++.|++++|.++...+..|.++++|++|++++|.+...+ +..|.++
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~----------~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l 77 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLP----------RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 77 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSC----------SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESC
T ss_pred CCCCEEEEECCCCCCCCCCCC----------CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf 739999981899887688889----------9889998769918964966861464323211022112420100112222
Q ss_pred CCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 7444775148-8665467643226344554853554456
Q 001426 137 AELELLSLNS-NSIHGGIPREIGNCSKLRRLELYDNQLS 174 (1079)
Q Consensus 137 ~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 174 (1079)
++++++.+.. |.+....+..|.++++|++|++++|.+.
T Consensus 78 ~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 78 PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp TTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHC
T ss_conf 222221111123432222221222222222234211112
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=1.7e-23 Score=145.51 Aligned_cols=210 Identities=24% Similarity=0.337 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 52123421122330016578765599983399922797656685323534644865512576568889988987756678
Q 001426 423 NLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMV 502 (1079)
Q Consensus 423 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 502 (1079)
.+.++..++++.+++++.. .+.++.+|+.|++.+|+|+.. ..+..+++|+.|++++|.+++..+ +..+++++.+
T Consensus 17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCCC--HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCC
T ss_conf 9999999984888767757--987848868997779999766--457448888376357853202543--1123343201
Q ss_pred ECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 46899576568824453047880210154234665632346788863761365024778775453455531245475255
Q 001426 503 DLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRIN 582 (1079)
Q Consensus 503 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 582 (1079)
++++|.++.+ ..+..+++|+.++++++...+. ..+...+.+..+.++.+.+... ..+..+++|+.|++++|.+.
T Consensus 91 ~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 91 ELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp ECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CHHCCCCCHHHHHCHHHHHCHH--HHHCCCCCCCCCCCCCCCCC
T ss_conf 2111222222--2222222221221222443311--0000023012220000000000--00010211100233333333
Q ss_pred CCCHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 78815441010004334056874446611113478866478356751466444458546553000258
Q 001426 583 GSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSY 650 (1079)
Q Consensus 583 ~~~p~~~~~l~~L~~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~ls~ 650 (1079)
...+ +.++.+| ..+++++|.++++.+ |..+++|++|++++|+++..++ +..+++|+.|++++
T Consensus 165 ~~~~--l~~l~~L-~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 165 DLTP--LANLSKL-TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCGG--GTTCTTC-CEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEE
T ss_pred CCHH--HCCCCCC-EECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCCC-CCCCCCCCEEEEEC
T ss_conf 1001--0564633-564458884177853--4479999989795996899802-03699989897129
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.89 E-value=6.2e-23 Score=142.39 Aligned_cols=128 Identities=26% Similarity=0.306 Sum_probs=73.0
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCC
Q ss_conf 99922797656685323534644865512576568-88998898775667846899576568824453047880210154
Q 001426 453 RLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTG-EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMN 531 (1079)
Q Consensus 453 ~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 531 (1079)
.++.++++++ .+|..+. ++++.|+|++|+|+. ..+..|.++++|+.|++++|++..+.+..|..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf 9997089967-0298989--787889848987755302002578762721301363221212122211222210100355
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 2346656323467888637613650247787754534555312454752557
Q 001426 532 SIGGTIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRING 583 (1079)
Q Consensus 532 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 583 (1079)
+|+.+.+.+|.++++|++|+|++|+|+.+.+++|..+++|+.|+|++|++..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 3443497998079746552457745353597785687533420003644343
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.89 E-value=7.1e-23 Score=142.07 Aligned_cols=109 Identities=28% Similarity=0.348 Sum_probs=59.0
Q ss_pred CCEEEEECCCCCCC-CCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCC
Q ss_conf 83399922797656-68532353464486551257656888998898775667846899576568824453047880210
Q 001426 450 GLIRLRLGSNNFSG-HIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDL 528 (1079)
Q Consensus 450 ~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 528 (1079)
++++|+|++|+|+. ..+..|..+++|+.|++++|.+....+..|..+++|+.|++++|+|+.+.+.+|.++++|+.|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf 87889848987755302002578762721301363221212122211222210100355344349799807974655245
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 154234665632346788863761365024
Q 001426 529 SMNSIGGTIPENLGKLTSLNKLVLSKNNIT 558 (1079)
Q Consensus 529 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 558 (1079)
++|+|+++.+.+|..+++|++|+|++|.+.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 774535359778568753342000364434
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=2e-21 Score=133.92 Aligned_cols=179 Identities=27% Similarity=0.320 Sum_probs=0.0
Q ss_pred ECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 22797656685323534644865512576568889988987756678468995765688244530478802101542346
Q 001426 456 LGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGG 535 (1079)
Q Consensus 456 L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 535 (1079)
++.+.+++.++. ..+.+|+.|++++|.++...+ +..+++|+.|++++|+|+++.+ +..+++|+.|++++|++++
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~ 104 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD 104 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf 575765775188--795484589782798887444--7648998987698960258601--1358621201433333212
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 65632346788863761365024778775453455531245475255788154410100043340568744466111134
Q 001426 536 TIPENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFS 615 (1079)
Q Consensus 536 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~l~l~~N~l~~~~~~~~~ 615 (1079)
+. .+..+++|+.|++++|.+..+ ..+..++.++.+++++|.+ ..+..+..+++| ..+++++|.++++.+ +.
T Consensus 105 l~--~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l--~~~~~~~~l~~L-~~l~l~~n~l~~i~~--l~ 175 (210)
T d1h6ta2 105 LS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI--TDITVLSRLTKL-DTLSLEDNQISDIVP--LA 175 (210)
T ss_dssp GG--GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCC--CCCGGGGGCTTC-SEEECCSSCCCCCGG--GT
T ss_pred CC--CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCC-CCCCCCCCCCCCCCC--CC
T ss_conf 22--121222111223456532211--2201111122211222333--454310001332-100134643025645--36
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 78866478356751466444458546553000258
Q 001426 616 NLSKLANLDLSNNMLTGSLKVLGSLDNLVSLNVSY 650 (1079)
Q Consensus 616 ~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~ls~ 650 (1079)
++++|+.|++++|+++ ..+.+..+++|+.|++++
T Consensus 176 ~l~~L~~L~Ls~N~i~-~l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209 (210)
T ss_dssp TCTTCCEEECCSSCCC-BCGGGTTCTTCSEEEEEE
T ss_pred CCCCCCEEECCCCCCC-CCHHHCCCCCCCEEECCC
T ss_conf 7898999989799899-872116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=6.7e-21 Score=130.92 Aligned_cols=184 Identities=27% Similarity=0.361 Sum_probs=0.0
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 21233401023643444345111365667674126873433388321462469998740476655678521136672896
Q 001426 328 NLVALEELLLSGNNISGEIPSFFGNFSRLKQLELDNNRFFGQIPPTIGQLKELLLFFAWQNQLHGNIPELAYCVKLQALD 407 (1079)
Q Consensus 328 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~L~~L~ 407 (1079)
.+.++....++.+.++ .......+++++.|++++|.+. .+..+..+++|++|+
T Consensus 16 ~l~~~i~~~l~~~~~~--~~~~~~~l~~l~~L~l~~~~i~-------------------------~l~~l~~l~nL~~L~ 68 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVT--DTVSQTDLDQVTTLQADRLGIK-------------------------SIDGVEYLNNLTQIN 68 (199)
T ss_dssp HHHHHHHHHTTCSSTT--SEECHHHHTTCCEEECTTSCCC-------------------------CCTTGGGCTTCCEEE
T ss_pred HHHHHHHHHHCCCCCC--CCCCHHHHCCCCEEECCCCCCC-------------------------CCCCCCCCCCCCCCC
T ss_conf 9999999996778778--8559879468789989999997-------------------------752021378867575
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 65777889965412252123421122330016578765599983399922797656685323534644865512576568
Q 001426 408 LSHNFLTGSVPSSLFNLKNLTQLLLISNRFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTG 487 (1079)
Q Consensus 408 Ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 487 (1079)
+++|++++..+ +.++++|++|++++|.+....+ +..++.|+.|++++|.+....+ +..+++|+.|++++|++..
T Consensus 69 Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 142 (199)
T d2omxa2 69 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 142 (199)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC
T ss_pred CCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHHHCC
T ss_conf 45655667640--1677522311112222222211--1112232221112222223210--0012236776431111002
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 889988987756678468995765688244530478802101542346656323467888637
Q 001426 488 EIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKL 550 (1079)
Q Consensus 488 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 550 (1079)
. ..+..+++|+.|++++|++++..+ +.++++|+.|++++|+++++.+ +..+++|++|
T Consensus 143 ~--~~l~~~~~L~~L~l~~n~l~~l~~--l~~l~~L~~L~ls~N~i~~i~~--l~~L~~L~~L 199 (199)
T d2omxa2 143 I--SALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDISV--LAKLTNLESL 199 (199)
T ss_dssp C--GGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEE
T ss_pred C--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCC
T ss_conf 3--433321111112234555567701--1679989999787997998810--1278998949
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.81 E-value=6.3e-22 Score=136.70 Aligned_cols=15 Identities=40% Similarity=0.667 Sum_probs=7.0
Q ss_pred CCCCCCCCCCCCCCC
Q ss_conf 455531245475255
Q 001426 568 CKDLQLLDLSSNRIN 582 (1079)
Q Consensus 568 l~~L~~L~Ls~N~l~ 582 (1079)
+++|+.|++++|++.
T Consensus 301 ~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 301 MPDLLFLELNGNRFS 315 (344)
T ss_dssp CTTCCEEECTTSBSC
T ss_pred CCCCCEEECCCCCCC
T ss_conf 899998978798089
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=9.7e-22 Score=135.65 Aligned_cols=14 Identities=43% Similarity=0.655 Sum_probs=4.8
Q ss_pred CCCCCCEEECCCCC
Q ss_conf 63445548535544
Q 001426 159 NCSKLRRLELYDNQ 172 (1079)
Q Consensus 159 ~l~~L~~L~L~~n~ 172 (1079)
.+++|++|++++|.
T Consensus 69 ~c~~L~~L~L~~~~ 82 (284)
T d2astb2 69 QCSKLQNLSLEGLR 82 (284)
T ss_dssp TBCCCSEEECTTCB
T ss_pred HCCCCCCCCCCCCC
T ss_conf 48776514523467
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.79 E-value=3.1e-21 Score=132.79 Aligned_cols=11 Identities=36% Similarity=0.480 Sum_probs=3.6
Q ss_pred CCEEECCCCCC
Q ss_conf 64783567514
Q 001426 620 LANLDLSNNML 630 (1079)
Q Consensus 620 L~~L~Ls~N~l 630 (1079)
|+.|++++|.+
T Consensus 304 L~~L~l~~N~~ 314 (344)
T d2ca6a1 304 LLFLELNGNRF 314 (344)
T ss_dssp CCEEECTTSBS
T ss_pred CCEEECCCCCC
T ss_conf 99897879808
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=7.9e-21 Score=130.52 Aligned_cols=11 Identities=36% Similarity=0.410 Sum_probs=3.4
Q ss_pred CCCCEEECCCC
Q ss_conf 74447751488
Q 001426 137 AELELLSLNSN 147 (1079)
Q Consensus 137 ~~L~~L~L~~n 147 (1079)
++|++|+|+++
T Consensus 71 ~~L~~L~L~~~ 81 (284)
T d2astb2 71 SKLQNLSLEGL 81 (284)
T ss_dssp CCCSEEECTTC
T ss_pred CCCCCCCCCCC
T ss_conf 77651452346
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=6.5e-18 Score=114.10 Aligned_cols=128 Identities=17% Similarity=0.109 Sum_probs=74.7
Q ss_pred CCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCC
Q ss_conf 55999833999227976566853235346448655125765688899889877566784689957656882445304788
Q 001426 445 IGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLN 524 (1079)
Q Consensus 445 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 524 (1079)
+.+...+++|+|++|+|+.+ +..+..+++|+.|++++|+|+.. ..|..+++|+.|++++|++..+.+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf 16857484897889978865-76200414599898979978764--7744576130643102134577763223345344
Q ss_pred CCCCCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCC---CCCCCCCCCCCCC
Q ss_conf 02101542346656-323467888637613650247787---7545345553124
Q 001426 525 VLDLSMNSIGGTIP-ENLGKLTSLNKLVLSKNNITGLIP---KSLGLCKDLQLLD 575 (1079)
Q Consensus 525 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~ 575 (1079)
.|++++|+|..... ..+..+++|++|++++|.++.... ..+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred CCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEEC
T ss_conf 3420300016654211001365320664079963456106999998789958337
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=4.4e-17 Score=109.45 Aligned_cols=39 Identities=26% Similarity=0.237 Sum_probs=12.3
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 678886376136502477877545345553124547525
Q 001426 543 KLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRI 581 (1079)
Q Consensus 543 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 581 (1079)
.+++|++|++++|+++.+.+..+..+++|+.|++++|++
T Consensus 61 ~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i 99 (162)
T d1a9na_ 61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99 (162)
T ss_dssp CCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCC
T ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEECCCCC
T ss_conf 576130643102134577763223345344342030001
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=1.2e-15 Score=101.28 Aligned_cols=87 Identities=28% Similarity=0.435 Sum_probs=31.3
Q ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCC
Q ss_conf 8987756678468995765688244530478802101542346656323467888637613650247787-754534555
Q 001426 493 IGNCTQLEMVDLHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSKNNITGLIP-KSLGLCKDL 571 (1079)
Q Consensus 493 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L 571 (1079)
+..+++|++|++++|+|+. +|..|..+++|+.|++++|+|++. + .+..+++|++|++++|+|+.... ..+..+++|
T Consensus 16 l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L 92 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92 (124)
T ss_dssp GGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred CCCCCCCCEEECCCCCCCC-CHHHHHHHHCCCCCCCCCCCCCCC-C-CCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCC
T ss_conf 1058988989797871686-521565543135453243211235-7-412335557688889865888882565379999
Q ss_pred CCCCCCCCCCC
Q ss_conf 31245475255
Q 001426 572 QLLDLSSNRIN 582 (1079)
Q Consensus 572 ~~L~Ls~N~l~ 582 (1079)
+.|++++|+++
T Consensus 93 ~~L~l~~N~i~ 103 (124)
T d1dcea3 93 VLLNLQGNSLC 103 (124)
T ss_dssp CEEECTTSGGG
T ss_pred CEEECCCCCCC
T ss_conf 99989799688
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=3.3e-15 Score=98.87 Aligned_cols=84 Identities=24% Similarity=0.244 Sum_probs=33.1
Q ss_pred CCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 75239983899-55555972312558888896369864489986448767444775148866546764322634455485
Q 001426 89 SHLTSLVLSNA-NLTGEIPPAIGNLSSLINLDLSFNALTGNIPEEIGKLAELELLSLNSNSIHGGIPREIGNCSKLRRLE 167 (1079)
Q Consensus 89 ~~l~~L~L~~~-~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 167 (1079)
+.++.|++.++ .++...+.+|.++++|+.|+|++|+++...+..|.++++|++|+|++|+++ .+|.......+|+.|+
T Consensus 31 ~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~ 109 (156)
T d2ifga3 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELV 109 (156)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEE
T ss_pred CCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCCCC
T ss_conf 565743168986644369212256666672162021247742011124554333322678785-1574563353212433
Q ss_pred CCCCCC
Q ss_conf 355445
Q 001426 168 LYDNQL 173 (1079)
Q Consensus 168 L~~n~l 173 (1079)
|++|.+
T Consensus 110 L~~Np~ 115 (156)
T d2ifga3 110 LSGNPL 115 (156)
T ss_dssp CCSSCC
T ss_pred CCCCCC
T ss_conf 579863
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.59 E-value=7.8e-18 Score=113.68 Aligned_cols=144 Identities=22% Similarity=0.241 Sum_probs=0.0
Q ss_pred CCCCCCCCCC--CCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 2342112233--00165787655999833999227976566853235346448655125765688899889877566784
Q 001426 426 NLTQLLLISN--RFSGEIPPEIGGCTGLIRLRLGSNNFSGHIPSRIGLLHRLTFLELSENQFTGEIPPEIGNCTQLEMVD 503 (1079)
Q Consensus 426 ~L~~L~l~~N--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 503 (1079)
.++.+++.++ .+. ..+..+..+++|++|++++|+|+.+ ..+..+++|+.|++++|.|+ .++..+..+++|+.|+
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred CCCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCCCC--CCCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCC
T ss_conf 331002555568520-0246776260461519944689986--44247825357341353432-1000033221233333
Q ss_pred CCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCCC----------CCCCCCCC
Q ss_conf 68995765688244530478802101542346656-32346788863761365024778775----------45345553
Q 001426 504 LHQNKLQGTIPSSLEFLFGLNVLDLSMNSIGGTIP-ENLGKLTSLNKLVLSKNNITGLIPKS----------LGLCKDLQ 572 (1079)
Q Consensus 504 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~~~l~~L~ 572 (1079)
+++|+++.+ ..+..+++|+.|++++|+|+.... ..+..+++|++|++++|.+....+.. +..+++|+
T Consensus 100 l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~ 177 (198)
T d1m9la_ 100 ISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177 (198)
T ss_dssp CSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCC
T ss_pred CCCCCCCCC--CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 333222222--222222234111234102125542212367776302342798434676322220558999998788958
Q ss_pred CCC
Q ss_conf 124
Q 001426 573 LLD 575 (1079)
Q Consensus 573 ~L~ 575 (1079)
.||
T Consensus 178 ~LD 180 (198)
T d1m9la_ 178 KLD 180 (198)
T ss_dssp EES
T ss_pred EEC
T ss_conf 769
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.2e-14 Score=95.65 Aligned_cols=105 Identities=21% Similarity=0.148 Sum_probs=57.2
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 86551257656888998898775667846899-57656882445304788021015423466563234678886376136
Q 001426 476 TFLELSENQFTGEIPPEIGNCTQLEMVDLHQN-KLQGTIPSSLEFLFGLNVLDLSMNSIGGTIPENLGKLTSLNKLVLSK 554 (1079)
Q Consensus 476 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 554 (1079)
+.++.+++.+. ..|..+..+++|+.|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCC
T ss_conf 96985289976-58600257656574316898664436921225666667216202124774201112455433332267
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 5024778775453455531245475255
Q 001426 555 NNITGLIPKSLGLCKDLQLLDLSSNRIN 582 (1079)
Q Consensus 555 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 582 (1079)
|+|+.+.+..|..+ .|+.|+|++|++.
T Consensus 90 N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCCCCCHHHHCCC-CCCCCCCCCCCCC
T ss_conf 87851574563353-2124335798633
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.01 E-value=1.9e-09 Score=66.42 Aligned_cols=147 Identities=14% Similarity=0.079 Sum_probs=98.3
Q ss_pred HHHHHHCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCE
Q ss_conf 888861789988354347689999996898769999933456899223899999999985278-7750015527873991
Q 001426 753 VDDVVTRLSDTNIVGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR-HKNIVRLLGCCNNGRT 831 (1079)
Q Consensus 753 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 831 (1079)
+......|+..+..+.++.+.||++... +..+++|+........ ...+.+|...+..+. +-.+.++++++.+.+.
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCC---HHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 9975135279976789987718999908-9869999848876532---55699999999987606998728999750896
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC--------------------------------
Q ss_conf 799999357887343530157679999999999999999999982899--------------------------------
Q 001426 832 RLLLFDYISNGSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDCV-------------------------------- 879 (1079)
Q Consensus 832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-------------------------------- 879 (1079)
.++||++++|.++.+...... ....++.+++..+..+|+...
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEEECCCCCCCCCCCCCC------CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 499998604334354334402------69999998999999985568421435764465655577899877655554303
Q ss_pred ------------------------CCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf ------------------------994970899997687799958994023442
Q 001426 880 ------------------------PPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 880 ------------------------~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 909 (1079)
..++|+|+.+.||+++++..+-++||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 323200579999999984498678178986004764236499659996023144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=1.6e-10 Score=72.44 Aligned_cols=65 Identities=25% Similarity=0.098 Sum_probs=22.0
Q ss_pred HHHCCCCCCCCCCCCCCCCC--CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 53047880210154234665--632346788863761365024778775453455531245475255
Q 001426 518 EFLFGLNVLDLSMNSIGGTI--PENLGKLTSLNKLVLSKNNITGLIPKSLGLCKDLQLLDLSSNRIN 582 (1079)
Q Consensus 518 ~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 582 (1079)
..++.|+.|+|++|+|+.+. +..+..+++|+.|+|++|+|+.+.+-.+.....|+.+++++|++.
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCC
T ss_conf 7487878863777666677315889865885610004357213423442220331042664899767
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.87 E-value=4.6e-11 Score=75.52 Aligned_cols=15 Identities=33% Similarity=0.401 Sum_probs=5.5
Q ss_pred CCCCCEEECCCCCCC
Q ss_conf 788863761365024
Q 001426 544 LTSLNKLVLSKNNIT 558 (1079)
Q Consensus 544 l~~L~~L~L~~N~l~ 558 (1079)
+++|++|+|++|+|+
T Consensus 64 ~~~L~~L~Ls~N~i~ 78 (162)
T d1koha1 64 IPELLSLNLSNNRLY 78 (162)
T ss_dssp CTTCCCCCCCSSCCC
T ss_pred CCCCCEEECCCCCCC
T ss_conf 878788637776666
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.77 E-value=3.3e-08 Score=59.48 Aligned_cols=130 Identities=19% Similarity=0.134 Sum_probs=86.4
Q ss_pred EEEECCC-EEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCC--CCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf 3543476-89999996898769999933456899223899999999985278--77500155278739917999993578
Q 001426 765 IVGKGVS-GIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIR--HKNIVRLLGCCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 765 ~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~ 841 (1079)
.+..|.. +.||+....++..+++|...... ...+..|...++.+. .-.+.++++++.+.+..++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEEC
T ss_conf 7678654775899993898789999589667------7689999999999986599988613222456615999874413
Q ss_pred CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------------
Q ss_conf 8734353015767999999999999999999998289-------------------------------------------
Q 001426 842 GSLAGLLHEKKVFLDWDSRYKIILGVAHGLAYLHHDC------------------------------------------- 878 (1079)
Q Consensus 842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 878 (1079)
.++.+.. .... ..+.++...+..||+..
T Consensus 91 ~~~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 91 QDLLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp EETTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred CCCCCCC------CCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHH
T ss_conf 5543221------2689---999999999998736885448875541246889999998754110113401121379999
Q ss_pred ------------CCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf ------------9994970899997687799958994023442
Q 001426 879 ------------VPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 879 ------------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 909 (1079)
.+.++|+|+.+.||+++++..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 9999871876579567867888763577379658999853326
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.47 E-value=7.1e-07 Score=51.95 Aligned_cols=79 Identities=14% Similarity=0.156 Sum_probs=49.3
Q ss_pred CEEEECCCEEEEEEEECC-CCEEEEEEECCCCCC----CCHHHHHHHHHHHHHHCCC-C--CCEEEEEEEEECCCEEEEE
Q ss_conf 835434768999999689-876999993345689----9223899999999985278-7--7500155278739917999
Q 001426 764 NIVGKGVSGIVYRVEIPS-RQVIAVKKLWPVKNG----ELPERDQFSAEVQTLGSIR-H--KNIVRLLGCCNNGRTRLLL 835 (1079)
Q Consensus 764 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 835 (1079)
+.||.|....||++...+ ++.+++|.-.+.... -.........|++.++.+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf 9807985276899995799848999617713034677788877899999999998650579885528998--59887798
Q ss_pred EEECCCCCH
Q ss_conf 993578873
Q 001426 836 FDYISNGSL 844 (1079)
Q Consensus 836 ~e~~~~g~L 844 (1079)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EECCCCCCC
T ss_conf 713577653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.13 E-value=4.9e-07 Score=52.86 Aligned_cols=117 Identities=13% Similarity=0.076 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCC----CCCHHHHHHCCCCCCCCCCCCCC----CCCCCCCCCCCCCCEEECCCCCCCC----C
Q ss_conf 9877566784689-95765----68824453047880210154234----6656323467888637613650247----7
Q 001426 494 GNCTQLEMVDLHQ-NKLQG----TIPSSLEFLFGLNVLDLSMNSIG----GTIPENLGKLTSLNKLVLSKNNITG----L 560 (1079)
Q Consensus 494 ~~l~~L~~L~l~~-N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~----~ 560 (1079)
.+.++|+.|++++ +.+.. .+...+.....|+.|++++|.+. ..+...+...+.|++|+|++|.++. .
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 87754534555312454752557881544101000433405687444661111347886647835675
Q 001426 561 IPKSLGLCKDLQLLDLSSNRINGSIPEEIGRLQGLDILLNLSWNALTGPIPESFSNLSKLANLDLSNN 628 (1079)
Q Consensus 561 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 628 (1079)
...++...+.|+.|++++|++.....+....+... +..-+.|+.|+++.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~------------------L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMA------------------IEENESLLRVGISFA 141 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHH------------------HHHCSSCCEEECCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHH------------------HHHCCCCCEEECCCC
T ss_conf 99999848938987788776888657999999999------------------972998538648688
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.98 E-value=3.6e-05 Score=42.34 Aligned_cols=136 Identities=16% Similarity=0.200 Sum_probs=76.5
Q ss_pred CCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCE--EEEEE-----EEECCCEEEEEEEECCC
Q ss_conf 476899999968987699999334568992238999999999852787750--01552-----78739917999993578
Q 001426 769 GVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI--VRLLG-----CCNNGRTRLLLFDYISN 841 (1079)
Q Consensus 769 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~ 841 (1079)
+....||+++..+|..+++|+.++.. ...+.+..|...+..+....+ +..+. .....+..+.++++++|
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCC----CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCC
T ss_conf 61202699983899979999847877----88999999999999998559987875206898056653479999865277
Q ss_pred CCHHH-----H---------HHC--------CCCCCCHHH-------------------HHHHHHHHHHHHHHHHH----
Q ss_conf 87343-----5---------301--------576799999-------------------99999999999999982----
Q 001426 842 GSLAG-----L---------LHE--------KKVFLDWDS-------------------RYKIILGVAHGLAYLHH---- 876 (1079)
Q Consensus 842 g~L~~-----~---------l~~--------~~~~~~~~~-------------------~~~i~~~i~~~l~~LH~---- 876 (1079)
..+.. + ++. .....+... ...+...+...+..+..
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 68899999999998999999886303578655677897887665689998747699889899999999999999984545
Q ss_pred CCCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 8999949708999976877999589940234422
Q 001426 877 DCVPPIIHRDIKSNNILVGPQFEAFLADFGLAKL 910 (1079)
Q Consensus 877 ~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 910 (1079)
....+++|+|+.+.||+++++ ..++||+-+..
T Consensus 189 ~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 687120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.91 E-value=4.1e-05 Score=42.06 Aligned_cols=73 Identities=14% Similarity=0.286 Sum_probs=46.6
Q ss_pred CEEEECCCEEEEEEEECCC--------CEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCE-EEEEEEEECCCEEEE
Q ss_conf 8354347689999996898--------7699999334568992238999999999852787750-015527873991799
Q 001426 764 NIVGKGVSGIVYRVEIPSR--------QVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI-VRLLGCCNNGRTRLL 834 (1079)
Q Consensus 764 ~~lg~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 834 (1079)
+.++.|-.-.+|++...++ ..+.+++.- . . ...-...+|..+++.+.-.++ .++++++.+ +.
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~---~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N---P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S---C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C---C-CHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CE
T ss_conf 991785334348999688775445789817999659-9---6-1165899999999999757999808998189----56
Q ss_pred EEEECCCCCHH
Q ss_conf 99935788734
Q 001426 835 LFDYISNGSLA 845 (1079)
Q Consensus 835 v~e~~~~g~L~ 845 (1079)
|+||++|.++.
T Consensus 119 I~efi~g~~l~ 129 (395)
T d1nw1a_ 119 LEEYIPSRPLS 129 (395)
T ss_dssp EECCCCEEECC
T ss_pred EEEEECCCCCC
T ss_conf 99973455488
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.74 E-value=6.2e-05 Score=41.05 Aligned_cols=151 Identities=14% Similarity=0.075 Sum_probs=78.0
Q ss_pred HHHHHHCCCCCCE-----EEECCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCCCE--EEEEEE
Q ss_conf 8888617899883-----543476899999968987699999334568992238999999999852787750--015527
Q 001426 753 VDDVVTRLSDTNI-----VGKGVSGIVYRVEIPSRQVIAVKKLWPVKNGELPERDQFSAEVQTLGSIRHKNI--VRLLGC 825 (1079)
Q Consensus 753 ~~~~~~~~~~~~~-----lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~ 825 (1079)
++.+..+|...++ |..|.-.+.|+++..+++ +++|++.+.. ..+.+..|...+..+...++ ...+..
T Consensus 8 l~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 8 LRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCC-----CHHHHHHHHHHHHHHHHCCCCCCCCCEE
T ss_conf 999998679998568523788852673899978972-8999807899-----9889999999987543025554556410
Q ss_pred ------EECCCEEEEEEEECCCCCHHHHH--------------HCC--------CCCCCH------------------HH
Q ss_conf ------87399179999935788734353--------------015--------767999------------------99
Q 001426 826 ------CNNGRTRLLLFDYISNGSLAGLL--------------HEK--------KVFLDW------------------DS 859 (1079)
Q Consensus 826 ------~~~~~~~~lv~e~~~~g~L~~~l--------------~~~--------~~~~~~------------------~~ 859 (1079)
.........++.+..+......- +.. ...... ..
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHH
T ss_conf 48976213412550245311465533320467888889987645444320245310111012002456777765311412
Q ss_pred HHHHHHHHHHHHHHHHHC-CCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 999999999999999828-99994970899997687799958994023442
Q 001426 860 RYKIILGVAHGLAYLHHD-CVPPIIHRDIKSNNILVGPQFEAFLADFGLAK 909 (1079)
Q Consensus 860 ~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 909 (1079)
....+......+...... ...+++|+|+.+.||+++++...-+.||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 799999998764204855454503337863656402045412674222123
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.47 E-value=3.4e-06 Score=48.13 Aligned_cols=123 Identities=15% Similarity=0.134 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCEECCCC-CCCCCCCCCCCC----CCCCCCEEECCCCCCC----CCCCCCCCCCCCCCEEEC
Q ss_conf 3322355773123656565420534-435357996735----8877776863376568----986753336787638980
Q 001426 243 TANITGYIPEEIGNCSALENLFLYE-NQIFGKIPDELG----SLKNLKRLLLWQNNLS----GSIPEALGNCSSLTVIDV 313 (1079)
Q Consensus 243 ~~~~~~~~p~~l~~l~~L~~L~L~~-n~l~~~~~~~l~----~l~~L~~L~L~~n~l~----~~~~~~l~~l~~L~~L~L 313 (1079)
..++...+.....+.+.|++|++++ +.++......+. ..++|+.|++++|.++ ..+.+.+...++++.+++
T Consensus 2 ~~~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l 81 (166)
T d1io0a_ 2 STDVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNV 81 (166)
T ss_dssp CCCHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEEC
T ss_pred CCCHHHHHHHHHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHH
T ss_conf 76399999999955999868876899998989999999888419825743015896117789999987752122101210
Q ss_pred CCCCCCCCCC----CCCCCCCCCCE--EECCCCCCCC----CCCCCCCCCCCCCEEECCCCC
Q ss_conf 3544567664----11122123340--1023643444----345111365667674126873
Q 001426 314 SLNSLGGEVP----VSLANLVALEE--LLLSGNNISG----EIPSFFGNFSRLKQLELDNNR 365 (1079)
Q Consensus 314 s~n~l~~~~~----~~~~~l~~L~~--L~Ls~n~l~~----~~~~~~~~l~~L~~L~L~~N~ 365 (1079)
++|.++.... ..+...++|+. |++++|.+.. .+...+...++|+.|+++.+.
T Consensus 82 ~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 82 ESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp CSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 25432201478899999848652477321677867679999999999849984788581898
|